PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Demidenko, NV; Logacheva, MD; Penin, AA				Demidenko, Natalia V.; Logacheva, Maria D.; Penin, Aleksey A.			Selection and Validation of Reference Genes for Quantitative Real-Time PCR in Buckwheat (Fagopyrum esculentum) Based on Transcriptome Sequence Data	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; RT-PCR; ENVIRONMENTAL-STRESS; INTERNAL CONTROL; BRASSICA-NAPUS; ARABIDOPSIS; NORMALIZATION; EXPRESSION; RESPONSES; GENOME	Quantitative reverse transcription PCR (qRT-PCR) is one of the most precise and widely used methods of gene expression analysis. A necessary prerequisite of exact and reliable data is the accurate choice of reference genes. We studied the expression stability of potential reference genes in common buckwheat (Fagopyrum esculentum) in order to find the optimal reference for gene expression analysis in this economically important crop. Recently sequenced buckwheat floral transcriptome was used as source of sequence information. Expression stability of eight candidate reference genes was assessed in different plant structures (leaves and inflorescences at two stages of development and fruits). These genes are the orthologs of Arabidopsis genes identified as stable in a genome-wide survey gene of expression stability and a traditionally used housekeeping gene GAPDH. Three software applications - geNorm, NormFinder and BestKeeper - were used to estimate expression stability and provided congruent results. The orthologs of AT4G33380 (expressed protein of unknown function, Expressed1), AT2G28390 (SAND family protein, SAND) and AT5G46630 (clathrin adapter complex subunit family protein, CACS) are revealed as the most stable. We recommend using the combination of Expressed1, SAND and CACS for the normalization of gene expression data in studies on buckwheat using qRT-PCR. These genes are listed among five the most stably expressed in Arabidopsis that emphasizes utility of the studies on model plants as a framework for other species.	[Demidenko, Natalia V.; Penin, Aleksey A.] Moscow MV Lomonosov State Univ, Fac Biol, Dept Genet, Moscow, Russia; [Logacheva, Maria D.] Moscow MV Lomonosov State Univ, Dept Evolutionary Biochem, AN Belozersky Inst Phys Chem Biol, Moscow, Russia; [Logacheva, Maria D.; Penin, Aleksey A.] Moscow MV Lomonosov State Univ, Evolutionary Genom Lab, Fac Bioengn & Bioinformat, Moscow, Russia; [Logacheva, Maria D.; Penin, Aleksey A.] Russian Acad Sci, AA Kharkevich Inst Informat Transmiss Problems, Moscow, Russia	Lomonosov Moscow State University; Lomonosov Moscow State University; Lomonosov Moscow State University; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences	Demidenko, NV (corresponding author), Moscow MV Lomonosov State Univ, Fac Biol, Dept Genet, Moscow, Russia.	alekseypenin@gmail.com	Demidenko, Natalia/J-3202-2012; Logacheva, Maria/K-5217-2012; Penin, Aleksey/A-5477-2011	Penin, Aleksey/0000-0002-9057-3974	Russian Foundation for Basic Research [09-04-01363]; Ministry of Education and Science of Russian Federation [GK-16.512.11.2153]; President's program for support of scientific schools [3293.2010.4]; Innovative Project Grants for Young Scientists [UMNIK-13151-9]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Ministry of Education and Science of Russian Federation(Ministry of Education and Science, Russian Federation); President's program for support of scientific schools; Innovative Project Grants for Young Scientists	The study is supported by the Russian Foundation for Basic Research (project No 09-04-01363), the Ministry of Education and Science of Russian Federation (GK-16.512.11.2153 for AAP and P913 for MDL) and President's program for support of scientific schools (project No 3293.2010.4) and Innovative Project Grants for Young Scientists (UMNIK-13151-9) for NVD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; [Anonymous], OLIGOANALYZER; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen X, 2010, ANAL BIOCHEM, V405, P138, DOI 10.1016/j.ab.2010.05.032; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; de Almeida MR, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-73; Desgagne-Penix I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-252; Doyle J. J., 1987, PHYTOCHEM B, P11; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Huang JL, 2010, PLANT PHYSIOL, V153, P1526, DOI 10.1104/pp.110.157370; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jarosova J, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-146; Kim ST, 2004, AM J BOT, V91, P2102, DOI 10.3732/ajb.91.12.2102; Koo SC, 2010, PLANT J, V62, P807, DOI 10.1111/j.1365-313X.2010.04192.x; Lin YL, 2010, PLANT SCI, V178, P359, DOI 10.1016/j.plantsci.2010.02.005; Logacheva MD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-30; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Mao F, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-76; Nikolic DB, 2010, J AGR FOOD CHEM, V58, P3488, DOI 10.1021/jf904483a; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Portieles R, 2010, PLANT BIOTECHNOL J, V8, P678, DOI 10.1111/j.1467-7652.2010.00501.x; Qiu JL, 2008, EMBO J, V27, P2214, DOI 10.1038/emboj.2008.147; Ren XZ, 2010, PLANT J, V63, P417, DOI 10.1111/j.1365-313X.2010.04248.x; Riggins CW, 2010, PEST MANAG SCI, V66, P1042, DOI 10.1002/ps.2006; Sarosh BR, 2009, PLANT MOL BIOL, V70, P31, DOI 10.1007/s11103-009-9455-4; Timotijevic GS, 2010, J PLANT PHYSIOL, V167, P61, DOI 10.1016/j.jplph.2009.06.017; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Walley JW, 2010, PLANT PHYSIOL, V152, P866, DOI 10.1104/pp.109.149005; Wen R, 2008, PLANT CELL, V20, P213, DOI 10.1105/tpc.107.051862; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; PRIMERQUEST; REAL TIME PCR MINER; GENORM SOFTWARE	38	98	101	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19434	10.1371/journal.pone.0019434	http://dx.doi.org/10.1371/journal.pone.0019434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589908	Green Published, Green Submitted, gold			2022-12-27	WOS:000290531100009
J	Parbery-Clark, A; Strait, DL; Anderson, S; Hittner, E; Kraus, N				Parbery-Clark, Alexandra; Strait, Dana L.; Anderson, Samira; Hittner, Emily; Kraus, Nina			Musical Experience and the Aging Auditory System: Implications for Cognitive Abilities and Hearing Speech in Noise	PLOS ONE			English	Article							WORKING-MEMORY; OLDER-ADULTS; LANGUAGE IMPAIRMENTS; PITCH DISCRIMINATION; CORTICAL PLASTICITY; COMPETING SPEECH; BACKGROUND-NOISE; AGE-DIFFERENCES; VERBAL MEMORY; IN-NOISE	Much of our daily communication occurs in the presence of background noise, compromising our ability to hear. While understanding speech in noise is a challenge for everyone, it becomes increasingly difficult as we age. Although aging is generally accompanied by hearing loss, this perceptual decline cannot fully account for the difficulties experienced by older adults for hearing in noise. Decreased cognitive skills concurrent with reduced perceptual acuity are thought to contribute to the difficulty older adults experience understanding speech in noise. Given that musical experience positively impacts speech perception in noise in young adults (ages 18-30), we asked whether musical experience benefits an older cohort of musicians (ages 45-65), potentially offsetting the age-related decline in speech-in-noise perceptual abilities and associated cognitive function (i.e., working memory). Consistent with performance in young adults, older musicians demonstrated enhanced speech-in-noise perception relative to nonmusicians along with greater auditory, but not visual, working memory capacity. By demonstrating that speech-in-noise perception and related cognitive function are enhanced in older musicians, our results imply that musical training may reduce the impact of age-related auditory decline.	[Parbery-Clark, Alexandra; Strait, Dana L.; Anderson, Samira; Hittner, Emily; Kraus, Nina] Northwestern Univ, Auditory Neurosci Lab, Evanston, IL 60208 USA; [Strait, Dana L.; Kraus, Nina] Northwestern Univ, Inst Neurosci, Evanston, IL 60208 USA; [Kraus, Nina] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA; [Kraus, Nina] Northwestern Univ, Dept Physiol, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University; Northwestern University	Parbery-Clark, A (corresponding author), Northwestern Univ, Auditory Neurosci Lab, Evanston, IL 60208 USA.	nkraus@northwestern.edu	Parbery-Clark, Alexandra/G-2966-2012	Parbery-Clark, Alexandra/0000-0002-9485-4095; Strait, Dana/0000-0002-1279-6240	National Science Foundation [0842376]; Division Of Behavioral and Cognitive Sci [1057556] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	National Science Foundation: Small Grants for Exploratory Research No. 0842376. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar M, 2004, TRENDS COGN SCI, V8, P457, DOI 10.1016/j.tics.2004.08.011; Ahissar M, 2009, PHILOS T R SOC B, V364, P285, DOI 10.1098/rstb.2008.0253; Amitay S, 2006, J ACOUST SOC AM, V119, P1616, DOI 10.1121/1.2164988; Bao SW, 2004, NAT NEUROSCI, V7, P974, DOI 10.1038/nn1293; Bench J, 1979, Br J Audiol, V13, P108, DOI 10.3109/03005367909078884; Besson M, 2007, RESTOR NEUROL NEUROS, V25, P399; Bidebnan GM, 2010, BRAIN RES, V1355, P112, DOI 10.1016/j.brainres.2010.07.100; Bugos JA, 2007, AGING MENT HEALTH, V11, P464, DOI 10.1080/13607860601086504; Chan AS, 1998, NATURE, V396, P128, DOI 10.1038/24075; Cruickshanks KJ, 1998, AM J EPIDEMIOL, V148, P879; DANAHER EM, 1973, J SPEECH HEAR RES, V16, P439, DOI 10.1044/jshr.1603.439; Daneman M, 1996, PSYCHON B REV, V3, P422, DOI 10.3758/BF03214546; Davis H. R., 1998, COLORADO ASSESSMENT; DUBNO JR, 1984, J ACOUST SOC AM, V76, P87, DOI 10.1121/1.391011; Espinoza-Varas B, 2006, EXP AGING RES, V32, P209, DOI 10.1080/03610730600554008; Fitzgibbons PJ, 2010, SPRINGER HANDB AUDIT, V34, P111, DOI 10.1007/978-1-4419-0993-0_5; FITZGIBBONS PJ, 1994, J SPEECH HEAR RES, V37, P662, DOI 10.1044/jshr.3703.662; Forgeard Marie, 2008, PLoS One, V3, pe3566, DOI 10.1371/journal.pone.0003566; Francis AL, 2010, ATTEN PERCEPT PSYCHO, V72, P501, DOI 10.3758/APP.72.2.501; Franklin MS, 2008, PSYCHOL MUSIC, V36, P353, DOI 10.1177/0305735607086044; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Fujioka T, 2004, J COGNITIVE NEUROSCI, V16, P1010, DOI 10.1162/0898929041502706; Gehr SE, 1999, J ACOUST SOC AM, V106, P2793, DOI 10.1121/1.428104; GELFAND SA, 1986, J ACOUST SOC AM, V80, P1589, DOI 10.1121/1.394323; GORDONSALANT S, 1993, J SPEECH HEAR RES, V36, P1276, DOI 10.1044/jshr.3606.1276; Harris KC, 2010, HEARING RES, V264, P21, DOI 10.1016/j.heares.2009.09.017; Hartley DEH, 2003, INT J PEDIATR OTORHI, V67, pS137, DOI 10.1016/j.ijporl.2003.08.012; Hartley DEH, 2002, J ACOUST SOC AM, V112, P2962, DOI 10.1121/1.1512701; Heinrich A, 2008, Q J EXP PSYCHOL, V61, P735, DOI 10.1080/17470210701402372; Helfer KS, 2009, J AM ACAD AUDIOL, V20, P264, DOI 10.3766/jaaa.20.4.6; Ho YC, 2003, NEUROPSYCHOLOGY, V17, P439, DOI 10.1037/0894-4105.17.3.439; Huang Z, 2010, NEUROSCIENCE, V168, P179, DOI 10.1016/j.neuroscience.2010.03.027; Humes L E, 1996, J Am Acad Audiol, V7, P161; Jakobson LS, 2003, MUSIC PERCEPT, V20, P307, DOI 10.1525/mp.2003.20.3.307; JEON J. Y., 1997, PSYCHOL MUSIC, V25, P70, DOI [10.1177/0305735697251006, DOI 10.1177/0305735697251006]; Killion MC, 2004, J ACOUST SOC AM, V116, P2395, DOI 10.1121/1.1784440; Killion MC, 2000, HEAR J, V53, P46, DOI DOI 10.1097/00025572-200003000-00006; Koelsch S, 1999, NEUROREPORT, V10, P1309, DOI 10.1097/00001756-199904260-00029; Koelsch S, 2009, HUM BRAIN MAPP, V30, P859, DOI 10.1002/hbm.20550; Kral A, 2007, BRAIN RES REV, V56, P259, DOI 10.1016/j.brainresrev.2007.07.021; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Lee KM, 2009, J NEUROSCI, V29, P5832, DOI 10.1523/JNEUROSCI.6133-08.2009; Lee YS, 2007, LEARN INSTR, V17, P336, DOI 10.1016/j.learninstruc.2007.02.010; Magne C, 2006, J COGNITIVE NEUROSCI, V18, P199, DOI 10.1162/089892906775783660; Micheyl C, 2006, HEARING RES, V219, P36, DOI 10.1016/j.heares.2006.05.004; Moore DR, 2010, PEDIATRICS, V126, pE382, DOI 10.1542/peds.2009-2826; Munzer S., 2002, PSYCHOL BEITR, V44, P187; Musacchia G, 2007, P NATL ACAD SCI USA, V104, P15894, DOI 10.1073/pnas.0701498104; Nahum M, 2008, PLOS BIOL, V6, P978, DOI 10.1371/journal.pbio.0060126; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Newson RS, 2005, J GERONTOL B-PSYCHOL, V60, pP113, DOI 10.1093/geronb/60.3.P113; NILSSON M, 1994, J ACOUST SOC AM, V95, P1085, DOI 10.1121/1.408469; Oxenham AJ, 2003, J ACOUST SOC AM, V114, P1543, DOI 10.1121/1.1598197; Pallesen KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011120; Pantev C, 2003, ANN NY ACAD SCI, V999, P438, DOI 10.1196/annals.1284.054; Parbery-Clark A, 2009, EAR HEARING, V30, P653, DOI 10.1097/AUD.0b013e3181b412e9; Parbery-Clark A, 2009, J NEUROSCI, V29, P14100, DOI 10.1523/JNEUROSCI.3256-09.2009; Peretz Isabelle, 2003, COGNITIVE NEUROSCIEN; Pichora-Fuller M. K., 2006, HEARING CARE ADULTS, P71; Pichora-Fuller MK, 2003, INT J AUDIOL, V42, pS11; Pichora-Fuller MK, 2003, INT J AUDIOL, V42, pS26; RABBITT PMA, 1968, Q J EXP PSYCHOL, V20, P241, DOI 10.1080/14640746808400158; Rammsayer T. H., 2003, PSYCHOL MUSIC, V31, P123, DOI [DOI 10.1177/0305735603031002290, 10.1177/0305735603031002290]; Rammsayer T, 2006, MUSIC PERCEPT, V24, P37, DOI 10.1525/mp.2006.24.1.37; Salthouse T.A., 1985, HDB PSYCHOL AGING, V2nd, P400; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Schellenberg EG, 2008, TRENDS COGN SCI, V12, P45, DOI 10.1016/j.tics.2007.11.005; Schellenberg EG, 2008, EMPIR MUSICOL REV, V3, P205, DOI 10.18061/1811/35991; Schellenberg EG, 2009, MUSIC PERCEPT, V27, P139, DOI 10.1525/MP.2009.27.2.139; Schellenberg EG, 2006, EXPOSURE MUSIC TRUTH; Schneider Bruce A., 2001, Seminars in Hearing, V22, P227, DOI 10.1055/s-2001-15628; Schon D, 2004, PSYCHOPHYSIOLOGY, V41, P341, DOI 10.1111/1469-8986.00172.x; Shahin A, 2004, NEUROREPORT, V15, P1917, DOI 10.1097/00001756-200408260-00017; Shinn-Cunningham Barbara G, 2008, Trends Amplif, V12, P283, DOI 10.1177/1084713808325306; Sommers MS, 1996, PSYCHOL AGING, V11, P333, DOI 10.1037/0882-7974.11.2.333; Souza PE, 2007, J AM ACAD AUDIOL, V18, P54, DOI 10.3766/jaaa.18.1.5; Strait DL, 2010, HEARING RES, V261, P22, DOI 10.1016/j.heares.2009.12.021; Strait DL, 2009, EUR J NEUROSCI, V29, P661, DOI 10.1111/j.1460-9568.2009.06617.x; Strouse A, 1998, J ACOUST SOC AM, V104, P2385, DOI 10.1121/1.423748; TALLAL P, 1993, ANN NY ACAD SCI, V682, P27, DOI 10.1111/j.1749-6632.1993.tb22957.x; Tervaniemi M, 2005, EXP BRAIN RES, V161, P1, DOI 10.1007/s00221-004-2044-5; Trainor LJ, 2003, ANN NY ACAD SCI, V999, P506, DOI 10.1196/annals.1284.061; Tremblay KL, 2003, CLIN NEUROPHYSIOL, V114, P1332, DOI 10.1016/S1388-2457(03)00114-7; Tun PA, 2002, PSYCHOL AGING, V17, P453, DOI 10.1037//0882-7974.17.3.453; Tun PA, 1999, J GERONTOL B-PSYCHOL, V54, pP317, DOI 10.1093/geronb/54B.5.P317; WALTERS GS, 2005, MEMORY, V13, P403; Wechsler D., 2011, WASI 2 WECHSLER ABBR; WILSON RH, 1993, J REHABIL RES DEV, V30, P342; Wilson RH, 2007, J SPEECH LANG HEAR R, V50, P844, DOI 10.1044/1092-4388(2007/059); Wingfield A, 2007, J AM ACAD AUDIOL, V18, P548, DOI 10.3766/jaaa.18.7.3; Wong PCM, 2007, NAT NEUROSCI, V10, P420, DOI 10.1038/nn1872; Woodcock R. W., 2001, WOODCOCK JOHNSON 3 T; WRIGHT BA, 1998, PSYCHOPHYSICAL PHYSL, P604; Zacks R. T., 2000, HDB AGING COGNITION, V2nd, P293, DOI DOI 10.3758/S13423-011-0086-9	94	188	191	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e18082	10.1371/journal.pone.0018082	http://dx.doi.org/10.1371/journal.pone.0018082			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	762MQ	21589653	gold, Green Published			2022-12-27	WOS:000290483600001
J	Sun, M; Lo, EYY				Sun, Mei; Lo, Eugenia Y. Y.			Genomic Markers Reveal Introgressive Hybridization in the Indo-West Pacific Mangroves: A Case Study	PLOS ONE			English	Article							BAYESIAN-INFERENCE; EVOLUTION; HYBRIDS; BRUGUIERA; PROGRAM; MRBAYES; ORIGIN	Biodiversity of mangrove ecosystems is difficult to assess, at least partly due to lack of genetic verification of morphology-based documentation of species. Natural hybridization, on the one hand, plays an important role in evolution as a source of novel gene combinations and a mechanism of speciation. However, on the other hand, recurrent introgression allows gene flow between species and could reverse the process of genetic differentiation among populations required for speciation. To understand the dynamic evolutionary consequences of hybridization, this study examines genomic structure of hybrids and parental species at the population level. In the Indo-West Pacific, Bruguiera is one of the dominant mangrove genera and species ranges overlap extensively with one another. Morphological intermediates between sympatric Bruguiera gymnorrhiza and Bruguiera sexangula have been reported as a variety of B. sexangula or a new hybrid species, B. x rhynchopetala. However, the direction of hybridization and extent of introgression are unclear. A large number of species-specific inter-simple sequence repeat (ISSR) markers were found in B. gymnorrhiza and B. sexangula, and the additive ISSR profiling of B. x rhynchopetala ascertained its hybrid status and identified its parental origin. The varying degree of scatterness among hybrid individuals in Principal Coordinate Analysis and results from NewHybrids analysis indicate that B. x rhynchopetala comprises different generations of introgressants in addition to F(1)s. High genetic relatedness between B. x rhynchopetala and B. gymnorrhiza based on nuclear and chloroplast sequences suggests preferential hybrid backcrosses to B. gymnorrhiza. We conclude that B. x rhynchopetala has not evolved into an incipient hybrid species, and its persistence can be explained by recurrent hybridization and introgression. Genomic data provide insights into the hybridization dynamics of mangrove plants. Such information can assist in biodiversity assessment by helping detect novel taxa and/or define species boundaries.	[Sun, Mei] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Sun, Mei] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Lo, Eugenia Y. Y.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA	Harvard University; University of Hong Kong; Yale University	Sun, M (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	meisun@oeb.harvard.edu	Sun, Mei/D-3124-2009		HKRGC [HKU7261/00M]	HKRGC(Hong Kong Research Grants Council)	This research was funded by a HKRGC GRF grant (HKU7261/00M) to M. Sun. (URL:http://www.ugc.edu.hk/eng/rgc/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT RJ, 1992, TRENDS ECOL EVOL, V7, P401, DOI 10.1016/0169-5347(92)90020-C; Abeysinghe PD, 1999, HYDROBIOLOGIA, V413, P11, DOI 10.1023/A:1003899028558; Allen James A., 2000, Pacific Science, V54, P331; ANDERSON EC, USERS GUIDE PROGRAM; Anderson EC, 2008, PHILOS T R SOC B, V363, P2841, DOI 10.1098/rstb.2008.0043; [Anonymous], 2002, SE AL SEQUENCE ALIGN; Archibald JK, 2004, AM J BOT, V91, P1333, DOI 10.3732/ajb.91.9.1333; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Baack EJ, 2007, CURR OPIN GENET DEV, V17, P513, DOI 10.1016/j.gde.2007.09.001; Baumel A, 2003, PLANT SYST EVOL, V237, P87, DOI 10.1007/s00606-002-0251-8; Burgarella C, 2009, HEREDITY, V102, P442, DOI 10.1038/hdy.2009.8; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; CRAWFORD DJ, 1993, AM J BOT, V80, P89, DOI 10.2307/2445124; Doyle J. J., 1987, PHYTOCHEM B, P11; DUKE NC, 1984, AUST J BOT, V32, P87, DOI 10.1071/BT9840087; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; GE XJ, 2001, THESIS U HONG KONG; Grant V., 1981, PLANT SPECIATION; Gross BL, 2003, AM J BOT, V90, P1708, DOI 10.3732/ajb.90.12.1708; Hawkins JA, 1998, PLANT SYST EVOL, V213, P43, DOI 10.1007/BF00988907; Hegarty MJ, 2005, NEW PHYTOL, V165, P411, DOI 10.1111/j.1469-8137.2004.01253.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ioos R, 2007, MOL ECOL NOTES, V7, P133, DOI 10.1111/j.1471-8286.2006.01554.x; Kathiresan K., 1995, ENV ECOL, V13, P240; Kathiresan K, 2005, BIODIVERSITY MANGROV; Ko WC., 1978, ACTA PHYTOTAXONOMICA, V16, P109; Kovach W. L., 2005, MVSP MULTIVARIATE ST; LEGENDRE L, 1983, DEV ENV MODELING; Linder CR, 2004, AM J BOT, V91, P1700, DOI 10.3732/ajb.91.10.1700; Lo EYY, 2010, J EVOLUTION BIOL, V23, P2249, DOI 10.1111/j.1420-9101.2010.02087.x; Manly B.F.J., 1985, STAT NATURAL SELECTI; Minder AM, 2008, MOL ECOL, V17, P1552, DOI 10.1111/j.1365-294X.2008.03709.x; Muller K, 2006, MOL PHYLOGENET EVOL, V38, P667, DOI 10.1016/j.ympev.2005.07.011; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A., 2003, TRACER; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; RIESEBERG LH, 1993, CRIT REV PLANT SCI, V12, P213, DOI 10.1080/713608045; RIESEBERG LH, 1990, EVOLUTION, V44, P1498, DOI 10.1111/j.1558-5646.1990.tb03841.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stebbins G. L., 1959, Proceedings of the American Philosophical Society, V103, P231; Swofford D.L., 2002, PHYLOGENETIC ANAL US; TEMPLETON AR, 1992, GENETICS, V132, P619; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomlinson P.B., 2016, BOT MANGROVES, DOI [10.1017/CBO9781139946575, DOI 10.1017/CBO9781139946575]; Tyagi AP, 1998, SEX PLANT REPROD, V11, P60, DOI 10.1007/s004970050121; Wolfe AD, 1998, P NATL ACAD SCI USA, V95, P5112, DOI 10.1073/pnas.95.9.5112; Zhou RC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-149	49	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19671	10.1371/journal.pone.0019671	http://dx.doi.org/10.1371/journal.pone.0019671			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589927	Green Published, Green Submitted, gold			2022-12-27	WOS:000290483600020
J	Prescott, J; Kraft, P; Chasman, DI; Savage, SA; Mirabello, L; Berndt, SI; Weissfeld, JL; Han, JL; Hayes, RB; Chanock, SJ; Hunter, DJ; De Vivo, I				Prescott, Jennifer; Kraft, Peter; Chasman, Daniel I.; Savage, Sharon A.; Mirabello, Lisa; Berndt, Sonja I.; Weissfeld, Joel L.; Han, Jiali; Hayes, Richard B.; Chanock, Stephen J.; Hunter, David J.; De Vivo, Immaculata			Genome-Wide Association Study of Relative Telomere Length	PLOS ONE			English	Article							LOW-DOSE ASPIRIN; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; CIGARETTE-SMOKING; PATERNAL AGE; SEQUENCE VARIANTS; GENETIC-VARIATION; WOMENS HEALTH; RISK; CANCER	Telomere function is essential to maintaining the physical integrity of linear chromosomes and healthy human aging. The probability of forming proper telomere structures depends on the length of the telomeric DNA tract. We attempted to identify common genetic variants associated with log relative telomere length using genome-wide genotyping data on 3,554 individuals from the Nurses' Health Study and the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial that took part in the National Cancer Institute Cancer Genetic Markers of Susceptibility initiative for breast and prostate cancer. After genotyping 64 independent SNPs selected for replication in additional Nurses' Health Study and Women's Genome Health Study participants, we did not identify genome-wide significant loci; however, we replicated the inverse association of log relative telomere length with the minor allele variant [C] of rs16847897 at the TERC locus (per allele beta = -0.03, P = 0.003) identified by a previous genome-wide association study. We did not find evidence for an association with variants at the OBFC1 locus or other loci reported to be associated with telomere length. With this sample size we had > 80% power to detect beta estimates as small as +/- 0.10 for SNPs with minor allele frequencies of >= 0.15 at genome-wide significance. However, power is greatly reduced for beta estimates smaller than +/- 0.10, such as those for variants at the TERC locus. In general, common genetic variants associated with telomere length homeostasis have been difficult to detect. Potential biological and technical issues are discussed.	[Prescott, Jennifer; Han, Jiali; Hunter, David J.; De Vivo, Immaculata] Harvard Univ, Sch Med, Channing Lab, Brigham & Womens Hosp,Dept Med, Boston, MA 02115 USA; [Prescott, Jennifer; Kraft, Peter; Han, Jiali; Hunter, David J.; De Vivo, Immaculata] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Chasman, Daniel I.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Donald W Reynolds Ctr Cardiovasc Res, Boston, MA 02115 USA; [Savage, Sharon A.; Mirabello, Lisa; Berndt, Sonja I.; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, Dept Hlth & Human Serv, NIH, Bethesda, MD 20892 USA; [Weissfeld, Joel L.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Han, Jiali] Harvard Univ, Sch Med, Dept Dermatol, Brigham & Womens Hosp, Boston, MA 02115 USA; [Hayes, Richard B.] NYU Med Ctr, Div Epidemiol, New York, NY 10016 USA; [Hunter, David J.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Brigham & Women's Hospital; Harvard Medical School; New York University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Prescott, J (corresponding author), Harvard Univ, Sch Med, Channing Lab, Brigham & Womens Hosp,Dept Med, Boston, MA 02115 USA.	devivo@channing.harvard.edu	Savage, Sharon A/B-9747-2015; Savage, Sharon/AAB-5160-2019; Berndt, Sonja I/J-8423-2016; Mirabello, Lisa/H-5594-2018	Savage, Sharon A/0000-0001-6006-0740; Savage, Sharon/0000-0001-6006-0740; Hayes, Richard/0000-0002-0918-661X; De Vivo, Immaculata/0000-0002-7185-7402	National Institutes of Health (NIH) [CA49449, CA87969, CA065725, CA133914, U01-CA98233, T32 CA 09001]; National Cancer Institute [CA047988]; Amgen; National Heart, Lung, and Blood Institute [HL043851, HL69757]; Donald W. Reynolds Foundation; Leducq Foundation; NATIONAL CANCER INSTITUTE [T32CA009001, P01CA087969, U01CA049449, R01CA047988, R01CA065725, ZIACP010201, R01CA049449, R03CA133914, U01CA098233] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL069757, R01HL043851, U19HL069757] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Amgen(Amgen); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Donald W. Reynolds Foundation; Leducq Foundation(Leducq Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The NHS was supported by National Institutes of Health (NIH) grants CA49449, CA87969, CA065725, CA133914, and U01-CA98233. Dr. Prescott was supported by NIH training grant T32 CA 09001. The PLCO and work of Drs. Mirabello, Berndt, Hayes, Chanock, and Savage was supported by the Intramural Research Program of the National Institutes of Health and the National Cancer Institute. Primary financial support for the WGHS genome-wide scans was provided by Amgen, with additional financial support provided by the National Heart, Lung, and Blood Institute (HL043851 and HL69757), National Cancer Institute (CA047988), the Donald W. Reynolds Foundation, and the Leducq Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkad A, 2006, BJOG-INT J OBSTET GY, V113, P318, DOI 10.1111/j.1471-0528.2005.00839.x; ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Andrew T, 2006, AM J HUM GENET, V78, P480, DOI 10.1086/500052; Askree SH, 2004, P NATL ACAD SCI USA, V101, P8658, DOI 10.1073/pnas.0401263101; Atzmon G, 2010, P NATL ACAD SCI USA, V107, P1710, DOI 10.1073/pnas.0906191106; Baird DM, 2003, NAT GENET, V33, P203, DOI 10.1038/ng1084; Bakaysa SL, 2007, AGING CELL, V6, P769, DOI 10.1111/j.1474-9726.2007.00340.x; Bekaert S, 2007, AGING CELL, V6, P639, DOI 10.1111/j.1474-9726.2007.00321.x; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Britt-Compton B, 2006, HUM MOL GENET, V15, P725, DOI 10.1093/hmg/ddi486; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Burtner CR, 2010, NAT REV MOL CELL BIO, V11, P567, DOI 10.1038/nrm2944; Butler MG, 1998, CANCER GENET CYTOGEN, V105, P138, DOI 10.1016/S0165-4608(98)00029-6; Cassidy A, 2010, AM J CLIN NUTR, V91, P1273, DOI 10.3945/ajcn.2009.28947; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; Collerton J, 2007, EUR HEART J, V28, P172, DOI 10.1093/eurheartj/ehl437; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; COUNTER CM, 1995, BLOOD, V85, P2315, DOI 10.1182/blood.V85.9.2315.bloodjournal8592315; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2004, NAT REV MOL CELL BIO, V5, P323, DOI 10.1038/nrm1359; De Meyer T, 2007, HUM MOL GENET, V16, P3097, DOI 10.1093/hmg/ddm271; De Vivo I, 2009, CANCER EPIDEM BIOMAR, V18, P1152, DOI 10.1158/1055-9965.EPI-08-0998; di Fagagna FD, 2004, GENE DEV, V18, P1781, DOI 10.1101/gad.1214504; Epel ES, 2009, AGING-US, V1, P81; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Frenck RW, 1998, P NATL ACAD SCI USA, V95, P5607, DOI 10.1073/pnas.95.10.5607; Friedrich U, 2000, MECH AGEING DEV, V119, P89, DOI 10.1016/S0047-6374(00)00173-1; Garcia CK, 2007, NUCLEIC ACIDS RES, V35, P7406, DOI 10.1093/nar/gkm644; Gatbonton T, 2006, PLOS GENET, V2, P304, DOI 10.1371/journal.pgen.0020035; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Gohagan JK, 2000, CONTROL CLIN TRIALS, V21, p251S, DOI 10.1016/S0197-2456(00)00097-0; Goldman F, 2005, P NATL ACAD SCI USA, V102, P17119, DOI 10.1073/pnas.0505318102; Graakjaer J, 2006, HUM GENET, V119, P344, DOI 10.1007/s00439-006-0137-x; Graakjaer J, 2003, MECH AGEING DEV, V124, P629, DOI 10.1016/S0047-6374(03)00081-2; Greider CW, 1999, CELL, V97, P419, DOI 10.1016/S0092-8674(00)80750-3; Han JL, 2009, J INVEST DERMATOL, V129, P415, DOI 10.1038/jid.2008.238; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; Hosgood HD, 2009, LUNG CANCER, V66, P157, DOI 10.1016/j.lungcan.2009.02.005; Huda N, 2007, AGING CELL, V6, P709, DOI 10.1111/j.1474-9726.2007.00330.x; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Iwama H, 1998, HUM GENET, V102, P397, DOI 10.1007/s004390050711; Jang JS, 2008, CANCER SCI, V99, P1385, DOI 10.1111/j.1349-7006.2008.00831.x; Jeanclos E, 2000, HYPERTENSION, V36, P195, DOI 10.1161/01.HYP.36.2.195; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim SM, 2009, CANCER EPIDEM BIOMAR, V18, P816, DOI 10.1158/1055-9965.EPI-08-0935; Kimura M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040037; Kimura M, 2008, AM J EPIDEMIOL, V167, P799, DOI 10.1093/aje/kwm380; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Kyo S, 1997, CANCER RES, V57, P610; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Levy D, 2010, P NATL ACAD SCI USA, V107, P9293, DOI 10.1073/pnas.0911494107; Li MY, 2008, EUR J HUM GENET, V16, P635, DOI 10.1038/sj.ejhg.5202007; Lin KW, 2005, J CELL MOL MED, V9, P977, DOI 10.1111/j.1582-4934.2005.tb00395.x; Londono-Vallejo JA, 2001, NUCLEIC ACIDS RES, V29, P3164, DOI 10.1093/nar/29.15.3164; Mangino M, 2009, J MED GENET, V46, P451, DOI 10.1136/jmg.2008.064956; Mangino M, 2008, HUM MOL GENET, V17, P2518, DOI 10.1093/hmg/ddn152; Martens UM, 1998, NAT GENET, V18, P76, DOI 10.1038/ng0198-018; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; McGrath M, 2007, CANCER EPIDEM BIOMAR, V16, P815, DOI 10.1158/1055-9965.EPI-06-0961; Mefford HC, 2002, NAT REV GENET, V3, P91, DOI 10.1038/nrg727; MIRABELLO L, 2010, HUM MUTAT; Mirabello L, 2010, CANCER CAUSE CONTROL, V21, P77, DOI 10.1007/s10552-009-9436-6; Mirabello L, 2009, AGING CELL, V8, P405, DOI 10.1111/j.1474-9726.2009.00485.x; Nawrot TS, 2004, LANCET, V363, P507, DOI 10.1016/S0140-6736(04)15535-9; Nettleton JA, 2008, AM J CLIN NUTR, V88, P1405, DOI 10.3945/ajcn.2008.26429; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; Nordfjall K, 2005, P NATL ACAD SCI USA, V102, P16374, DOI 10.1073/pnas.0501724102; Nordfjall K, 2008, OBESITY, V16, P2682, DOI 10.1038/oby.2008.413; Nordfjall K, 2010, EUR J HUM GENET, V18, P385, DOI 10.1038/ejhg.2009.178; Nordfjall K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000375; Okuda K, 2002, PEDIATR RES, V52, P377, DOI 10.1203/01.PDR.0000022341.72856.72; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Ornish D, 2008, LANCET ONCOL, V9, P1048, DOI 10.1016/S1470-2045(08)70234-1; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; PRESCOTT J, 2010, CANCER; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Samani NJ, 2001, LANCET, V358, P472, DOI 10.1016/S0140-6736(01)05633-1; Savage SA, 2005, HUM MUTAT, V26, P343, DOI 10.1002/humu.20226; Savage SA, 2009, HEMATOL ONCOL CLIN N, V23, P215, DOI 10.1016/j.hoc.2009.01.003; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Stewart SA, 2006, ANNU REV CELL DEV BI, V22, P531, DOI 10.1146/annurev.cellbio.22.010305.104518; Takubo K, 2002, EXP GERONTOL, V37, P523, DOI 10.1016/S0531-5565(01)00218-2; Unryn BM, 2005, AGING CELL, V4, P97, DOI 10.1111/j.1474-9728.2005.00144.x; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Varadi V, 2009, EUR J CANCER, V45, P3008, DOI 10.1016/j.ejca.2009.08.012; Vasa-Nicotera M, 2005, AM J HUM GENET, V76, P147, DOI 10.1086/426734; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Vulliamy TJ, 2006, BLOOD, V107, P2680, DOI 10.1182/blood-2005-07-2622; Wan M, 2009, J BIOL CHEM, V284, P26725, DOI 10.1074/jbc.M109.021105; Willeit P, 2010, ARTERIOSCL THROM VAS, V30, P1649, DOI 10.1161/ATVBAHA.110.205492; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011; Yasumoto S, 1996, ONCOGENE, V13, P433; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Youngren K, 1998, HUM GENET, V102, P640, DOI 10.1007/s004390050755; Zee RYL, 2009, CLIN CHIM ACTA, V403, P139, DOI 10.1016/j.cca.2009.02.004	108	81	83	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19635	10.1371/journal.pone.0019635	http://dx.doi.org/10.1371/journal.pone.0019635			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21573004	Green Published, Green Accepted, gold			2022-12-27	WOS:000290440200017
J	Stoddart, ES; Senadheera, S; MacDougall, IJA; Griffith, R; Finch, AM				Stoddart, Emily S.; Senadheera, Sevvandi; MacDougall, Iain J. A.; Griffith, Renate; Finch, Angela M.			A Novel Structural Framework for alpha(1A/D)-Adrenoceptor Selective Antagonists Identified Using Subtype Selective Pharmacophores	PLOS ONE			English	Article							ARYLPIPERAZINE DERIVATIVES; BIOLOGICAL EVALUATION; LIGAND DESIGN; ALPHA(1)-ADRENOCEPTOR; RECEPTOR; MODEL; AFFINITY; VALIDATION; DEFICIENT; RESPONSES	In this study four and five-feature pharmacophores for selective antagonists at each of the three alpha(1)-adrenoceptor (AR) subtypes were used to identify novel alpha(1)-AR subtype selective compounds in the National Cancer Institute and Tripos LeadQuest databases. 12 compounds were selected, based on diversity of structure, predicted high affinity and selectivity at the alpha(1D)-subtype compared to alpha(1A)- and alpha(1B)-ARs. 9 out of 12 of the tested compounds displayed affinity at the alpha(1A) and alpha(1D)-AR subtypes and 6 displayed affinity at all three a1-AR subtypes, no alpha(1B)-AR selective compounds were identified. 8 of the 9 compounds with alpha(1)-AR affinity were antagonists and one compound displayed partial agonist characteristics. This virtual screening has successfully identified an alpha(1A/D)-AR selective antagonist, with low mu M affinity with a novel structural scaffold of a an isoquinoline fused three-ring system and good lead-like qualities ideal for further drug development.	[Stoddart, Emily S.; Senadheera, Sevvandi; Griffith, Renate; Finch, Angela M.] Univ New S Wales, Dept Pharmacol, Sch Med Sci, Kensington, NSW 2033, Australia; [MacDougall, Iain J. A.; Griffith, Renate] Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW, Australia	University of New South Wales Sydney; University of Newcastle	Stoddart, ES (corresponding author), Garvan Inst, Darlinghurst, NSW, Australia.	angela.finch@unsw.edu.au	Finch, Angela M/F-5962-2012; Griffith, Renate/A-3584-2015	Finch, Angela M/0000-0002-4598-6745; Griffith, Renate/0000-0001-7739-5686	UNSW	UNSW	This work was supported by a UNSW, Faculty Research Grant http://www.unsw.edu.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbaro R, 2002, BIOORGAN MED CHEM, V10, P361, DOI 10.1016/S0968-0896(01)00286-3; Barbaro R, 2001, J MED CHEM, V44, P2118, DOI 10.1021/jm010821u; Becker OM, 2006, J MED CHEM, V49, P3116, DOI 10.1021/jm0508641; Betti L, 2002, BIOORG MED CHEM LETT, V12, P437, DOI 10.1016/S0960-894X(01)00772-7; Bremner JB, 2001, CURR MED CHEM, V8, P607, DOI 10.2174/0929867013373110; Bremner JB, 2000, BIOORGAN MED CHEM, V8, P201, DOI 10.1016/S0968-0896(99)00263-1; Calzada BC, 2001, PHARMACOL RES, V44, P195, DOI 10.1006/phrs.2001.0857; Chengalvala M, 1999, J BIOCHEM BIOPH METH, V38, P163, DOI 10.1016/S0165-022X(98)00046-3; Chu CP, 2004, NEUROSCI LETT, V356, P33, DOI 10.1016/j.neulet.2003.11.014; Eilers M, 2005, BIOCHEMISTRY-US, V44, P8959, DOI 10.1021/bi047316u; Flohr S, 2002, J MED CHEM, V45, P1799, DOI 10.1021/jm0111043; Ford APDW, 1997, BRIT J PHARMACOL, V121, P1127, DOI 10.1038/sj.bjp.0701207; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Handzlik J, 2008, BIOORGAN MED CHEM, V16, P5982, DOI 10.1016/j.bmc.2008.04.058; Harasawa I, 2003, NEUROREPORT, V14, P1857, DOI 10.1097/00001756-200310060-00020; HIEBLE JP, 1995, PHARMACOL REV, V47, P267; Ivorra MD, 2005, PLANTA MED, V71, P897, DOI 10.1055/s-2005-871281; Jain KS, 2008, BIOORGAN MED CHEM, V16, P4759, DOI 10.1016/j.bmc.2008.02.091; Klabunde T, 2005, CHEMBIOCHEM, V6, P876, DOI 10.1002/cbic.200400369; Klabunde T, 2002, CHEMBIOCHEM, V3, P929, DOI 10.1002/1439-7633(20021004)3:10<928::AID-CBIC928>3.0.CO;2-5; Klebe G, 2006, DRUG DISCOV TODAY, V11, P580, DOI 10.1016/j.drudis.2006.05.012; Knauber J, 2000, EUR NEUROPSYCHOPHARM, V10, P423, DOI 10.1016/S0924-977X(00)00100-0; KO FN, 1994, BRIT J PHARMACOL, V112, P1174, DOI 10.1111/j.1476-5381.1994.tb13207.x; Li MY, 2005, BIOORG MED CHEM LETT, V15, P657, DOI 10.1016/j.bmcl.2004.11.032; Lopez-Rodriguez ML, 2001, J MED CHEM, V44, P186, DOI 10.1021/jm000929u; MacDougall IJA, 2006, J MOL GRAPH MODEL, V25, P146, DOI 10.1016/j.jmgm.2005.12.001; Malloy BJ, 1998, J UROLOGY, V160, P937, DOI 10.1016/S0022-5347(01)62836-2; Mishima K, 2004, BEHAV BRAIN RES, V152, P365, DOI 10.1016/j.bbr.2003.10.038; PEREZ DM, 1991, MOL PHARMACOL, V40, P876; Schwinn DA, 2008, INT J UROL, V15, P193, DOI 10.1111/j.1442-2042.2007.01956.x; Strappaghetti G, 2008, BIOORG MED CHEM LETT, V18, P5140, DOI 10.1016/j.bmcl.2008.07.084; Tanoue A, 2002, HYPERTENSION, V40, P101, DOI 10.1161/01.HYP.0000022062.70639.1C; Tanoue A, 2002, J CLIN INVEST, V109, P765, DOI 10.1172/JCI200214001; Tanoue A, 2002, LIFE SCI, V71, P2207, DOI 10.1016/S0024-3205(02)02012-X; Vaidehi N, 2010, DRUG DISCOV TODAY, V15, P951, DOI 10.1016/j.drudis.2010.08.018; Zuscik MJ, 2001, J BIOL CHEM, V276, P13738, DOI 10.1074/jbc.M008693200	36	3	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19695	10.1371/journal.pone.0019695	http://dx.doi.org/10.1371/journal.pone.0019695			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572949	Green Published, gold			2022-12-27	WOS:000290440200022
J	Nankabirwa, V; Tumwine, JK; Tylleskar, T; Nankunda, J; Sommerfelt, H				Nankabirwa, Victoria; Tumwine, James K.; Tylleskar, Thorkild; Nankunda, Jolly; Sommerfelt, Halvor		PROMISE EBF Res Consortium	Perinatal Mortality in Eastern Uganda: A Community Based Prospective Cohort Study	PLOS ONE			English	Article							PREGNANCY; MALARIA; KENYA; CHILD; AREA	Background: To achieve a child mortality reduction according to millennium development goal 4, it is necessary to considerably reduce neonatal mortality. We report stillbirth and early neonatal mortality risks as well as determinants of perinatal mortality in Eastern Uganda. Methods: A community-based prospective cohort study was conducted between 2006 and 2008. A total of 835 pregnant women were followed up for pregnancy outcome and survival of their children until 7 days after delivery. Mother's residence, age, parity, bed net use and whether delivery took place at home were included in multivariable regression analyses to identify risk factors for perinatal death. Results: The stillbirth risk was 19 per 1,000 pregnancies and the early neonatal death risk 22 per 1,000 live births. Overall, the perinatal mortality risk was 41 [95%CI: 27, 54] per 1,000 pregnancies. Of the deaths, 47% followed complicated deliveries and 24% preterm births. Perinatal mortality was 63/1,000 pregnancies among teenage mothers, 76/1,000 pregnancies among nulliparous women and 61/1,000 pregnancies among women delivering at home who, after controlling for potential confounders, had a 3.7 (95%CI: 1.8, 7.4) times higher perinatal mortality than women who gave birth in a health facility. This association was considerably stronger among nulliparous women [RR 8.0 (95%CI: 2.9, 21.6)] than among women with a previous live birth [RR 1.8 (95%CI: 0.7, 4.5)]. All perinatal deaths occurred among women who did not sleep under a mosquito net. Women living in urban slums had a higher risk of losing their babies than those in rural areas [RR: 2.7 (95%CI: 1.4, 5.3)]. Conclusion: Our findings strengthen arguments for ensuring that pregnant women have access to and use adequate delivery facilities and bed nets.	[Nankabirwa, Victoria; Nankunda, Jolly] Makerere Univ, Dept Paediat & Child Hlth, Sch Med, Coll Hlth Sci, Kampala, Uganda; [Nankabirwa, Victoria; Tumwine, James K.; Tylleskar, Thorkild; Nankunda, Jolly; Sommerfelt, Halvor] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Sommerfelt, Halvor] Norwegian Inst Publ Hlth, Div Infect Dis Control, Oslo, Norway	Makerere University; University of Bergen; Norwegian Institute of Public Health (NIPH)	Nankabirwa, V (corresponding author), Makerere Univ, Dept Paediat & Child Hlth, Sch Med, Coll Hlth Sci, Kampala, Uganda.	nankabirwav@gmail.com	Sommerfelt, Halvor/ABD-3552-2020; Van de Perre, Philippe/B-9692-2008; Tylleskär, Thorkild/S-5529-2017; Nankunda, Jolly/AAS-4036-2020; Fadnes, Lars T/E-9086-2016	Sommerfelt, Halvor/0000-0002-5670-9786; Van de Perre, Philippe/0000-0002-3912-0427; Tylleskär, Thorkild/0000-0003-4801-4324; Nankabirwa, Victoria/0000-0002-9952-8942; Olsen, Oystein Evjen/0000-0003-0963-4731; Fadnes, Lars T/0000-0001-8757-2092	EU [INCO-CT 2004-003660]; Research Council of Norway [172226]; NUFU; University of Bergen	EU(European Commission); Research Council of Norway(Research Council of Norway); NUFU; University of Bergen	The study was part of the EU-funded project PROMISE-EBF (contract no INCO-CT 2004-003660, web http://www.promiseresearch.net). It was also financially supported by the Research Council of Norway's GlobVac programme grant no 172226 Focus on Nutrition and Child Health: intervention studies in low-income countries, the NUFU grant "Essential Nutrition and Child Health in Uganda'' and the University of Bergen. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahman E, 2007, NEONATAL PERINATAL M; ANKER M, 1999, STANDARD VERBAL AUTO; Barros FC, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S3; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Gamble C, 2007, PLOS MED, V4, P506, DOI 10.1371/journal.pmed.0040107; GILLES HM, 1969, ANN TROP MED PARASIT, V63, P245, DOI 10.1080/00034983.1969.11686625; Goldenberg RL, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S1; JACKSON M, 2009, AM PUBL HLTH ASS 137; Kyobutungi Catherine, 2008, Popul Health Metr, V6, P1, DOI 10.1186/1478-7954-6-1; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S2; MAVALANKAR DV, 1991, B WORLD HEALTH ORGAN, V69, P435; Menezes EV, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S4; Soleman N, 2006, B WORLD HEALTH ORGAN, V84, P239, DOI 10.2471/BLT.05.027003; ter Kuile FO, 2003, AM J TROP MED HYG, V68, P50, DOI 10.4269/ajtmh.2003.68.50; UBOS, 2002, UG POP HOUS CENS; UBOS, 2007, UG DEM HLTH SURV 200; VOORHOEVE AM, 1979, TROP GEOGR MED, V31, P607; Zupan J, 2005, NEW ENGL J MED, V352, P2047, DOI 10.1056/NEJMp058032	19	45	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19674	10.1371/journal.pone.0019674	http://dx.doi.org/10.1371/journal.pone.0019674			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573019	Green Published, gold			2022-12-27	WOS:000290386800031
J	Chambers, JR; Bender, KS				Chambers, Jacob R.; Bender, Kelly S.			The RNA Chaperone Hfq Is Important for Growth and Stress Tolerance in Francisella novicida	PLOS ONE			English	Article							VIRULENCE GENE-EXPRESSION; ESCHERICHIA-COLI K-12; PATHOGENICITY ISLAND; YERSINIA-PSEUDOTUBERCULOSIS; INTRAMACROPHAGE GROWTH; LISTERIA-MONOCYTOGENES; BIOFILM FORMATION; HEAT-SHOCK; TULARENSIS; PROTEIN	The RNA-binding protein Hfq is recognized as an important regulatory factor in a variety of cellular processes, including stress resistance and pathogenesis. Hfq has been shown in several bacteria to interact with small regulatory RNAs and act as a post-transcriptional regulator of mRNA stability and translation. Here we examined the impact of Hfq on growth, stress tolerance, and gene expression in the intracellular pathogen Francisella novicida. We present evidence of Hfq involvement in the ability of F. novicida to tolerate several cellular stresses, including heat-shock and oxidative stresses, and alterations in hfq gene expression under these conditions. Furthermore, expression of numerous genes, including several associated with virulence, is altered in a hfq mutant strain suggesting they are regulated directly or indirectly by Hfq. Strikingly, we observed a delayed entry into stationary phase and increased biofilm formation in the hfq mutant. Together, these data demonstrate a critical role for Hfq in F. novicida growth and survival.	[Chambers, Jacob R.; Bender, Kelly S.] So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University	Chambers, JR (corresponding author), So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA.	bender@micro.siu.edu		Bender, Kelly/0000-0002-0025-2166	National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) [RAI082502A]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI082502] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) through an Academic Research Enhancement Award #RAI082502A to K. S. Bender. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd H, 2003, APPL ENVIRON MICROB, V69, P600, DOI 10.1128/AEM.69.1.600-606.2003; Attia AS, 2008, INFECT IMMUN, V76, P2520, DOI 10.1128/IAI.01652-07; Bai G, 2010, J BACTERIOL, V192, P4239, DOI 10.1128/JB.00504-10; Bell BL, 2010, INFECT IMMUN, V78, P2189, DOI 10.1128/IAI.00021-10; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; Broteke A, 2008, INFECT IMMUN, V76, P3473, DOI 10.1128/IAI.00430-08; Chao YJ, 2010, CURR OPIN MICROBIOL, V13, P24, DOI 10.1016/j.mib.2010.01.001; Charity JC, 2007, PLOS PATHOG, V3, P770, DOI 10.1371/journal.ppat.0030084; Chong A, 2008, INFECT IMMUN, V76, P5488, DOI 10.1128/IAI.00682-08; Christiansen JK, 2004, J BACTERIOL, V186, P3355, DOI 10.1128/JB.186.11.3355-3362.2004; Dean RE, 2009, MICROBIOL-SGM, V155, P4104, DOI 10.1099/mic.0.031021-0; Dietrich M, 2009, FEBS J, V276, P5507, DOI 10.1111/j.1742-4658.2009.07234.x; Ding YP, 2004, MOL MICROBIOL, V53, P345, DOI 10.1111/j.1365-2958.2004.04142.x; Djordjevic D, 2002, APPL ENVIRON MICROB, V68, P2950, DOI 10.1128/AEM.68.6.2950-2958.2002; Durham-Colleran MW, 2009, ENVIRON MICROBIOL, V59, P457; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Farewell A, 1998, MOL MICROBIOL, V29, P1039, DOI 10.1046/j.1365-2958.1998.00990.x; FRANZE MT, 1968, NATURE, V219, P588, DOI 10.1038/219588a0; Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104; Geng J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006213; Gottesman S., 2010, COLD SPRING HARB PER, DOI [10.1101/cshperspect.a003798, DOI 10.1101/CSHPERSPECT.A003798]; Guina T, 2007, J BACTERIOL, V189, P6580, DOI 10.1128/JB.00809-07; Guisbert E, 2007, J BACTERIOL, V189, P1963, DOI 10.1128/JB.01243-06; Hamilton HL, 2001, J BACTERIOL, V183, P4718, DOI 10.1128/JB.183.16.4718-4726.2001; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; Larson CL, 1955, PUBLIC HEALTH REP, V70, P253, DOI 10.2307/4589039; LoVullo ED, 2006, MICROBIOL-SGM, V152, P3425, DOI 10.1099/mic.0.29121-0; Margolis JJ, 2010, APPL ENVIRON MICROB, V76, P596, DOI 10.1128/AEM.02037-09; McCaffrey RL, 2006, J LEUKOCYTE BIOL, V80, P1224, DOI 10.1189/jlb.0406287; McLendon MK, 2006, ANNU REV MICROBIOL, V60, P167, DOI 10.1146/annurev.micro.60.080805.142126; Meibom KL, 2008, MOL MICROBIOL, V67, P1384, DOI 10.1111/j.1365-2958.2008.06139.x; Meibom KL, 2009, INFECT IMMUN, V77, P1866, DOI 10.1128/IAI.01496-08; Mellin JR, 2010, MICROBIOL-SGM, V156, P2316, DOI 10.1099/mic.0.039040-0; Moller T, 2002, MOL CELL, V9, P23, DOI 10.1016/S1097-2765(01)00436-1; Morner T., 1992, Revue Scientifique et Technique Office International des Epizooties, V11, P1123; Nano FE, 2004, J BACTERIOL, V186, P6430, DOI 10.1128/JB.186.19.6430-6436.2004; Nano FE, 2007, ANN NY ACAD SCI, V1105, P122, DOI 10.1196/annals.1409.000; Olsen AS, 2010, J MOL BIOL, V404, P173, DOI 10.1016/j.jmb.2010.09.038; Parker RR, 1951, B NATL I HLTH, V193, P7; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reeser RJ, 2007, APPL ENVIRON MICROB, V73, P1908, DOI 10.1128/AEM.00740-06; Schiano CA, 2010, INFECT IMMUN, V78, P2034, DOI 10.1128/IAI.01046-09; Schilling D, 2009, J BACTERIOL, V191, P5553, DOI 10.1128/JB.00490-09; Schmerk CL, 2009, MICROBIOL-SGM, V155, P1489, DOI 10.1099/mic.0.025379-0; Schulert GS, 2009, INFECT IMMUN, V77, P1324, DOI 10.1128/IAI.01318-08; Shevchuk NA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh014; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Sjostedt A, 2006, MICROBES INFECT, V8, P561, DOI 10.1016/j.micinf.2005.08.001; Sonnleitner E, 2006, MOL MICROBIOL, V59, P1542, DOI 10.1111/j.1365-2958.2006.05032.x; Su JL, 2007, INFECT IMMUN, V75, P3089, DOI 10.1128/IAI.01865-06; TSUI HCT, 1994, BIOCHIMIE, V76, P1168, DOI 10.1016/0300-9084(94)90046-9; Tsui HCT, 1996, J BACTERIOL, V178, P5719, DOI 10.1128/jb.178.19.5719-5731.1996; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Vecerek B, 2008, NUCLEIC ACIDS RES, V36, P133, DOI 10.1093/nar/gkm985; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104; Zhang AX, 2002, MOL CELL, V9, P11, DOI 10.1016/S1097-2765(01)00437-3	56	22	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19797	10.1371/journal.pone.0019797	http://dx.doi.org/10.1371/journal.pone.0019797			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573133	Green Published, gold, Green Submitted			2022-12-27	WOS:000290256400042
J	Chambers, JD; Bornstein, JC; Thomas, EA				Chambers, Jordan D.; Bornstein, Joel C.; Thomas, Evan A.			Multiple Neural Oscillators and Muscle Feedback Are Required for the Intestinal Fed State Motor Program	PLOS ONE			English	Article							INTRINSIC SENSORY NEURONS; PRIMARY AFFERENT NEURONS; POTASSIUM IK CHANNELS; GUINEA-PIG ILEUM; INTERMEDIATE-CONDUCTANCE; SYNAPTIC-TRANSMISSION; MYENTERIC NEURONS; RECURRENT NETWORKS; RECEPTOR BLOCKADE; MOTILITY REFLEXES	After a meal, the gastrointestinal tract exhibits a set of behaviours known as the fed state. A major feature of the fed state is a little understood motor pattern known as segmentation, which is essential for digestion and nutrient absorption. Segmentation manifests as rhythmic local constrictions that do not propagate along the intestine. In guinea-pig jejunum in vitro segmentation constrictions occur in short bursts together with other motor patterns in episodes of activity lasting 40-60 s and separated by quiescent episodes lasting 40-200 s. This activity is induced by luminal nutrients and abolished by blocking activity in the enteric nervous system (ENS). We investigated the enteric circuits that regulate segmentation focusing on a central feature of the ENS: a recurrent excitatory network of intrinsic sensory neurons (ISNs) which are characterized by prolonged after-hyperpolarizing potentials (AHPs) following their action potentials. We first examined the effects of depressing AHPs with blockers of the underlying channels (TRAM-34 and clotrimazole) on motor patterns induced in guinea-pig jejunum, in vitro, by luminal decanoic acid. Contractile episode durations increased markedly, but the frequency and number of constrictions within segmenting bursts and quiescent period durations were unaffected. We used these observations to develop a computational model of activity in ISNs, excitatory and inhibitory motor neurons and the muscle. The model predicted that: i) feedback to ISNs from contractions in the circular muscle is required to produce alternating activity and quiescence with the right durations; ii) transmission from ISNs to excitatory motor neurons is via fast excitatory synaptic potentials (EPSPs) and to inhibitory motor neurons via slow EPSPs. We conclude that two rhythm generators regulate segmentation: one drives contractions within segmentation bursts, the other the occurrence of bursts. The latter depends on AHPs in ISNs and feedback to these neurons from contraction of the circular muscle.	[Chambers, Jordan D.; Bornstein, Joel C.; Thomas, Evan A.] Univ Melbourne, Dept Physiol, Parkville, Vic 3052, Australia; [Thomas, Evan A.] Florey Neurosci Inst, Parkville, Vic, Australia; [Thomas, Evan A.] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3052, Australia	University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Chambers, JD (corresponding author), Univ Melbourne, Dept Physiol, Parkville, Vic 3052, Australia.	j.bornstein@unimelb.edu.au	Chambers, Jordan D/H-6168-2016; Thomas, Evan/L-6390-2017; Thomas, Evan/AAD-8431-2021; Bornstein, Joel/I-3322-2019	Chambers, Jordan D/0000-0002-6760-2079; Thomas, Evan/0000-0001-7742-2031; Bornstein, Joel/0000-0002-7518-7717	Australia National Health and Medical Research Council (NHMRC) [566642]; Melbourne Research Scholarship	Australia National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Melbourne Research Scholarship	This study was supported by Australia National Health and Medical Research Council (NHMRC, www.nhmrc.gov.au) Grant 566642. JD Chambers was supported by a Melbourne Research Scholarship (www.unimelb.edu.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex G, 2002, NEUROSCIENCE, V110, P361, DOI 10.1016/S0306-4522(01)00583-8; Alex G, 2001, NEUROSCIENCE, V104, P263, DOI 10.1016/S0306-4522(01)00064-1; Bertrand PP, 2006, J PHYSIOL-LONDON, V577, P689, DOI 10.1113/jphysiol.2006.117804; Bertrand PP, 2000, NEUROSCIENCE, V101, P459, DOI 10.1016/S0306-4522(00)00363-8; Bertrand PP, 2000, J COMPUT NEUROSCI, V8, P127, DOI 10.1023/A:1008969115017; Bertrand PP, 2004, NEUROSCIENCE, V128, P51, DOI 10.1016/j.neuroscience.2004.06.025; Bertrand PP, 2002, J NEUROSCI, V22, P4767, DOI 10.1523/JNEUROSCI.22-12-04767.2002; Bertrand PP, 1997, AM J PHYSIOL-GASTR L, V273, pG422; Bian XC, 2000, J PHYSIOL-LONDON, V528, P551, DOI 10.1111/j.1469-7793.2000.00551.x; Bornstein JC, 2002, INNERVATION GASTROIN, P1; Brookes SJH, 2001, ANAT RECORD, V262, P58; BULBRING E, 1958, J PHYSIOL-LONDON, V140, P381; Chambers JD, 2005, AM J PHYSIOL-GASTR L, V288, pG887, DOI 10.1152/ajpgi.00491.2004; Chambers JD, 2008, AM J PHYSL GASTROINT; Chambers JD, 2008, AM J PHYSIOL-GASTR L, V295, pG534, DOI 10.1152/ajpgi.90303.2008; Costa M, 2008, EUR REV MED PHARMACO, V12, P3; Ellis M., 2009, AUTON NEUROSCI-BASIC, V149, P42; Ellis M, 2009, AUTONOMIC NEUROSCIEN, V149, pS1115; Ferens D, 2007, NEUROGASTROENT MOTIL, V19, P383, DOI 10.1111/j.1365-2982.2007.00898.x; Foong JPP, 2010, AM J PHYSIOL-GASTR L, V298, pG384, DOI 10.1152/ajpgi.00438.2009; Foong JPP, 2009, NEUROREPORT, V20, P325, DOI 10.1097/WNR.0b013e3283232caa; Foong JP, 2010, AM J PHYSL IN PRESS; Fung C, 2010, FRONTIERS E IN PRESS; Furness J.B., 2006, ENTERIC NERVOUS SYST; Furness JB, 2004, AUTON NEUROSCI-BASIC, V112, P93, DOI 10.1016/j.autneu.2004.02.003; Furness JB, 2004, PROG NEUROBIOL, V72, P143, DOI 10.1016/j.pneurobio.2003.12.004; Furness JB, 2003, CELL TISSUE RES, V314, P179, DOI 10.1007/s00441-003-0808-z; GRAFE P, 1980, J PHYSIOL-LONDON, V305, P235, DOI 10.1113/jphysiol.1980.sp013360; Gwynne RM, 2007, CURR NEUROPHARMACOL, V5, P1, DOI 10.2174/157015907780077141; Gwynne RM, 2004, J PHYSIOL-LONDON, V556, P557, DOI 10.1113/jphysiol.2003.057182; Gwynne RM, 2007, AM J PHYSL GASTROINT; Hasler W, 2003, GASTROENTEROLOGY, P220; Hasler WL, 2008, TXB GASTROENTEROLOGY; Hennig GW, 1999, J PHYSIOL-LONDON, V517, P575, DOI 10.1111/j.1469-7793.1999.0575t.x; Heredia DJ, 2009, GASTROENTEROLOGY, V136, P1328, DOI 10.1053/j.gastro.2008.12.010; HUGE A, 1995, DIGEST DIS SCI, V40, P1024, DOI 10.1007/BF02064192; Huizinga JD, 2009, AM J PHYSIOL-GASTR L, V296, pG1, DOI 10.1152/ajpgi.90380.2008; Johnson PJ, 2004, NEUROSCIENCE, V126, P137, DOI 10.1016/j.neuroscience.2004.03.021; Johnson PJ, 1998, BRIT J PHARMACOL, V124, P1375, DOI 10.1038/sj.bjp.0701967; Johnson PJ, 1996, BRIT J PHARMACOL, V118, P973, DOI 10.1111/j.1476-5381.1996.tb15495.x; Joiner WJ, 2003, AM J PHYSIOL-GASTR L, V285, pG185, DOI 10.1152/ajpgi.00337.2002; Keating DJ, 2010, GASTROENTEROLOGY, V138, P659, DOI 10.1053/j.gastro.2009.09.020; Kunze WAA, 1998, J PHYSIOL-LONDON, V506, P827, DOI 10.1111/j.1469-7793.1998.827bv.x; Neylon CB, 2004, J NEUROCHEM, V90, P1414, DOI 10.1111/j.1471-4159.2004.02593.x; Nguyen TV, 2007, J NEUROPHYSIOL, V97, P2024, DOI 10.1152/jn.00935.2006; PAN H, 1995, EUR J PHARMACOL, V278, P67, DOI 10.1016/0014-2999(95)00101-P; PAN H, 1994, AM J PHYSIOL, V266, pG230, DOI 10.1152/ajpgi.1994.266.2.G230; Parsons SP, 2010, AM J PHYSIOL-GASTR L, V298, pG456, DOI 10.1152/ajpgi.00340.2009; SARR MG, 1980, AM J PHYSIOL, V239, pG167, DOI 10.1152/ajpgi.1980.239.3.G167; SCHEMANN M, 1986, GASTROENTEROLOGY, V90, P991, DOI 10.1016/0016-5085(86)90878-4; SCHMID HR, 1993, DIGEST DIS SCI, V38, P1062, DOI 10.1007/BF01295722; SIEGLE ML, 1988, AM J PHYSIOL, V254, pG552, DOI 10.1152/ajpgi.1988.254.4.G552; SONG ZM, 1994, NEUROSCI LETT, V180, P219, DOI 10.1016/0304-3940(94)90524-X; Spencer NJ, 2000, J PHYSIOL-LONDON, V522, P321, DOI 10.1111/j.1469-7793.2000.t01-1-00321.x; Tabak J, 2000, J NEUROSCI, V20, P3041; Thomas EA, 2000, NEUROSCI LETT, V287, P137, DOI 10.1016/S0304-3940(00)01182-4; Thomas EA, 2003, NEUROSCIENCE, V120, P333, DOI 10.1016/S0306-4522(03)00039-3; Thompson-Vest N, 2006, J ANAT, V208, P219, DOI 10.1111/j.1469-7580.2006.00515.x; Thornton PDJ, 2002, J PHYSIOL-LONDON, V539, P589, DOI 10.1113/jphysiol.2001.013399; TONINI M, 1990, NEUROSCIENCE, V38, P787, DOI 10.1016/0306-4522(90)90071-B; Wang B, 2010, NEUROGASTROENT MOTIL, V22, P98, DOI 10.1111/j.1365-2982.2009.01384.x; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; Zhu YH, 2007, AM J PHYSIOL-GASTR L, V292, pG1715, DOI 10.1152/ajpgi.00524.2006	63	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19597	10.1371/journal.pone.0019597	http://dx.doi.org/10.1371/journal.pone.0019597			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573176	Green Published, gold			2022-12-27	WOS:000290256400031
J	Zuo, YF; Wu, JX; Xu, ZM; Yang, SP; Yan, HJ; Tan, L; Meng, XQ; Ying, XF; Liu, RY; Kang, TB; Huang, WL				Zuo, Yufang; Wu, Jiangxue; Xu, Zumin; Yang, Shiping; Yan, Haijiao; Tan, Li; Meng, Xiangqi; Ying, Xiaofang; Liu, Ranyi; Kang, Tiebang; Huang, Wenlin			Minicircle-oriP-IFN gamma: A Novel Targeted Gene Therapeutic System for EBV Positive Human Nasopharyngeal Carcinoma	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; EPISOMAL TRANSGENE EXPRESSION; IN-VIVO; NUCLEAR ANTIGEN-1; DNA; VECTOR; INFECTION; PROTEINS; GROWTH; CANCER	Background: Nonviral vectors are attractively used for gene therapy owing to their distinctive advantages. Our previous study has demonstrated that transfer of human IFN gamma gene into nasopharyngeal carcinoma (NPC) by using a novel nonviral vector, minicircle (mc), under the control of cytomegalovirus (CMV) promoter was effective to inhibit tumor growth. However, therapies based on CMV promoter cannot express the targeted genes in cancer tissues. Previous studies indicated that the development of human NPC was closely associated with Epstein-Barr virus (EBV) and demonstrated the transcriptional enhancer function of oriP when bound by EBV protein. Therefore, the present study is to explore the targeted gene expression and the anti-tumor effect of a novel tumor-specific gene therapeutic system (mc-oriP-IFN gamma) in which the transgene expression was under the transcriptional regulation of oriP promoter. Methodology/Principal Findings: Dual-luciferase reporter assay and ELISA were used to assess the expression of luciferase and IFN gamma. WST assay was used to assess the cell proliferation. RT-PCR was used to detect the mRNA level of EBNA1. RNAi was used to knockdown the expression of EBNA1. NPC xenograft models in nude mice were used to investigate the targeted antitumor efficacy of mc-oriP-IFN gamma. Immunohistochemistry was used to detect the expression and the activity of the IFN gamma in tumor sections. Our results demonstrated that mc-oriP vectors mediated comparable gene expression and anti-proliferative effect in the EBV-positive NPC cell line C666-1 compared to mc-CMV vectors. Furthermore, mc-oriP vectors exhibited much lower killing effects on EBV-negative cell lines compared to mc-CMV vectors. The targeted expression of mc-oriP vectors was inhibited by EBNA1-siRNA in C666-1. This selective expression was corroborated in EBV-positive and -negative tumor models. Conclusions/Significance: This study demonstrates the feasibility of mc-oriP-IFN gamma as a safe and highly effective targeted gene therapeutic system for the treatment of EBV positive NPC.	[Zuo, Yufang; Wu, Jiangxue; Xu, Zumin; Yang, Shiping; Yan, Haijiao; Tan, Li; Meng, Xiangqi; Ying, Xiaofang; Liu, Ranyi; Kang, Tiebang; Huang, Wenlin] Sun Yat Sen Univ, State Key Lab Oncol S China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Wenlin] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China; [Xu, Zumin] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Chinese Academy of Sciences; Institute of Microbiology, CAS; Sun Yat Sen University	Zuo, YF (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol S China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	hwenl@mail.sysu.edu.cn	zuo, yufang/AAH-7155-2021; Liu, Ran-yi/F-8680-2011; Liu, Ran-yi/L-1008-2019; huang, wen/GXW-0661-2022	Meng, Xiangqi/0000-0002-6407-6122	National Basic Research Program of China (973 Program) [2010CB529904, 2010CB912201]; National Natural Science Foundation of China [30801360, 30973448]; Chinese Ministry of Education [109124]; Cancer Center of Sun Yat-Sen University; Sun Yat-Sen University [2009267]; Chinese Academy of Sciences [KSCX1-YW-10]; Creative Research Groups	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Cancer Center of Sun Yat-Sen University; Sun Yat-Sen University; Chinese Academy of Sciences(Chinese Academy of Sciences); Creative Research Groups	Funding was provided by the National Basic Research Program of China (973 Program, Nos. 2010CB529904 and 2010CB912201), the National Natural Science Foundation of China (Nos. 30801360 and 30973448), the Key Project of Chinese Ministry of Education (No. 109124), the Science Fund for Young Scholar of Cancer Center of Sun Yat-Sen University, the Science Fund for Young Teacher of Sun Yat-Sen University (2009267), a grant from Chinese Academy of Sciences KSCX1-YW-10, and by support from the Guangdong Recruitment Program of Creative Research Groups. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann M, 2006, P NATL ACAD SCI USA, V103, P14188, DOI 10.1073/pnas.0605985103; Bochkarev A, 1996, CELL, V84, P791, DOI 10.1016/S0092-8674(00)81056-9; Chang CW, 2008, J CONTROL RELEASE, V125, P155, DOI 10.1016/j.jconrel.2007.10.014; Chang DK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004171; Chen XJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009397; Chen ZY, 2008, MOL THER, V16, P548, DOI 10.1038/sj.mt.6300399; Chen ZY, 2004, GENE THER, V11, P856, DOI 10.1038/sj.gt.3302231; Chen ZY, 2005, HUM GENE THER, V16, P126, DOI 10.1089/hum.2005.16.126; Chen ZY, 2003, MOL THER, V8, P495, DOI 10.1016/S1525-0016(03)00168-0; Cheung ST, 1999, INT J CANCER, V83, P121, DOI 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F; Chia MC, 2004, MOL THER, V9, P804, DOI 10.1016/j.ymthe.2004.03.016; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; Dorer DE, 2009, ADV DRUG DELIVER REV, V61, P554, DOI 10.1016/j.addr.2009.03.013; Fauvet R, 2003, VIRCHOWS ARCH, V443, P38, DOI 10.1007/s00428-003-0813-3; Fecker LF, 2006, J INVEST DERMATOL, V126, P1366, DOI 10.1038/sj.jid.5700192; Friboulet L, 2008, NEOPLASIA, V10, P1183, DOI 10.1593/neo.08590; Glasgow JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008355; Hine CM, 2008, P NATL ACAD SCI USA, V105, P20810, DOI 10.1073/pnas.0807990106; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Hu SJ, 2010, CIRCULATION, V122, pS124, DOI 10.1161/CIRCULATIONAHA.109.928424; Huang M, 2009, CIRCULATION, V120, pS230, DOI 10.1161/CIRCULATIONAHA.108.841155; Jechlinger W, 2006, EXPERT REV VACCINES, V5, P803, DOI 10.1586/14760584.5.6.803; Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/NMETH.1426, 10.1038/nmeth.1426]; Judde JG, 1996, HUM GENE THER, V7, P647, DOI 10.1089/hum.1996.7.5-647; Leight ER, 2000, REV MED VIROL, V10, P83, DOI 10.1002/(SICI)1099-1654(200003/04)10:2&lt;83::AID-RMV262&gt;3.0.CO;2-T; Li JH, 2003, MOL THER, V8, P964, DOI 10.1016/j.ymthe.2003.08.018; Li JH, 2002, CANCER RES, V62, P171; Lindner SE, 2007, PLASMID, V58, P1, DOI 10.1016/j.plasmid.2007.01.003; Liu TF, 2007, CLIN CANCER RES, V13, P3960, DOI 10.1158/1078-0432.CCR-07-0089; Marshall E, 1999, SCIENCE, V286, P2244, DOI 10.1126/science.286.5448.2244; Niedobitek G, 1996, SEMIN CANCER BIOL, V7, P165, DOI 10.1006/scbi.1996.0023; Sher YP, 2009, ONCOGENE, V28, P3286, DOI 10.1038/onc.2009.187; Sivachandran N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000170; Teng ZP, 1996, VIRUS GENES, V13, P53, DOI 10.1007/BF00576978; Wang Y, 2007, CANCER RES, V67, P2535, DOI 10.1158/0008-5472.CAN-06-3530; Wu JX, 2006, CLIN CANCER RES, V12, P4702, DOI 10.1158/1078-0432.CCR-06-0520; Wu JX, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-55; Wu LL, 2003, TRENDS MOL MED, V9, P421, DOI 10.1016/j.molmed.2003.08.005; Yin QY, 2006, VIROLOGY, V346, P385, DOI 10.1016/j.virol.2005.11.021; Yip KW, 2004, MOL THER, V10, P533, DOI 10.1016/j.ymthe.2004.05.026; Zhang C, 2010, BIOMATERIALS, V31, P6075, DOI 10.1016/j.biomaterials.2010.04.042; Zhang XC, 2008, HUM GENE THER, V19, P820, DOI 10.1089/hum.2007.141; Zhu YL, 2006, INT J ONCOL, V28, P67	43	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19407	10.1371/journal.pone.0019407	http://dx.doi.org/10.1371/journal.pone.0019407			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573215	gold, Green Published, Green Submitted			2022-12-27	WOS:000290256400009
J	Momke, S; Kerkmann, A; Wohlke, A; Ostmeier, M; Hewicker-Trautwein, M; Ganter, M; Kijas, J; Distl, O				Moemke, Stefanie; Kerkmann, Andrea; Woehlke, Anne; Ostmeier, Miriam; Hewicker-Trautwein, Marion; Ganter, Martin; Kijas, James; Distl, Ottmar		Int Sheep Consortium	A Frameshift Mutation within LAMC2 Is Responsible for Herlitz Type Junctional Epidermolysis Bullosa (HJEB) in Black Headed Mutton Sheep	PLOS ONE			English	Article							MECHANOBULLOUS DISEASE; LAMININ-5; GENE; ASSOCIATION	Junctional epidermolysis bullosa (JEB) is a hereditary mechanobullous skin disease in humans and animals. A Herlitz type JEB was identified in German Black Headed Mutton (BHM) sheep and affected lambs were reproduced in a breeding trial. Affected lambs showed skin and mucous membranes blistering and all affected lambs died within the first weeks of life. The pedigree data were consistent with a monogenic autosomal recessive inheritance. Immunofluorescence showed a reduced expression of laminin 5 protein which consists of 3 subunits encoded by the genes LAMA3, LAMB3 and LAMC2. We screened these genes for polymorphisms. Linkage and genome-wide association analyses identified LAMC2 as the most likely candidate for HJEB. A two base pair deletion within exon 18 of the LAMC2 gene (FM872310:c.2746delCA) causes a frameshift mutation resulting in a premature stop codon (p.A928*) 13 triplets downstream of this mutation and in addition, introduces an alternative splicing of exon 18 LAMC2. This deletion showed a perfect co-segregation with HJEB in all 740 analysed BHM sheep. Identification of the LAMC2 deletion means an animal model for HJEB is now available to develop therapeutic approaches of relevance to the human form of this disease.	[Moemke, Stefanie; Kerkmann, Andrea; Woehlke, Anne] Univ Vet Med, Inst Genet & Anim Breeding, Hannover, Germany; [Kerkmann, Andrea; Ganter, Martin; Distl, Ottmar] Univ Vet Med, Forens Med & Ambulatory Serv, Clin Swine & Small Ruminants, Hannover, Germany; [Ostmeier, Miriam; Hewicker-Trautwein, Marion] Univ Vet Med, Inst Pathol, Hannover, Germany; [Kijas, James] Commonwealth Sci & Ind Res Org Livestock Ind, Brisbane, Qld, Australia	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Momke, S (corresponding author), Univ Vet Med, Inst Genet & Anim Breeding, Hannover, Germany.	ottmar.distl@tiho-hannover.de	Kijas, James W/A-4656-2011	Kijas, James W/0000-0002-1417-8278	FAZIT foundation Gemeinnutzige Verlagsgesellschaft mbH, Frankfurt/Main	FAZIT foundation Gemeinnutzige Verlagsgesellschaft mbH, Frankfurt/Main	A. Kerkmann was supported by the FAZIT foundation Gemeinnutzige Verlagsgesellschaft mbH, Frankfurt/Main. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Alhaidari Z, 2005, VET DERMATOL, V16, P69, DOI 10.1111/j.1365-3164.2005.00420.x; Alley M R, 1974, N Z Vet J, V22, P55, DOI 10.1080/00480169.1974.34133; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Bruckner-Tuderman L, 1992, Exp Dermatol, V1, P115, DOI 10.1111/j.1600-0625.1992.tb00001.x; BRUCKNERTUDERMAN L, 1991, J INVEST DERMATOL, V96, P452, DOI 10.1111/1523-1747.ep12470130; Capt A, 2005, J INVEST DERMATOL, V124, P530, DOI 10.1111/j.0022-202X.2004.23584.x; Castiglia D, 2001, J INVEST DERMATOL, V117, P731, DOI 10.1046/j.0022-202x.2001.01453.x; DUNSTAN RW, 1988, AM J DERMATOPATH, V10, P442; Graves KT, 2009, ANIM GENET, V40, P35, DOI 10.1111/j.1365-2052.2008.01795.x; Guaguere E, 2003, B ACAD VET FRANCE, V157, P47; Hiller M, 2008, TRENDS GENET, V24, P246, DOI 10.1016/j.tig.2008.03.003; Kerkmann A, 2010, BERL MUNCH TIERARZTL, V123, P413, DOI 10.2376/0005-9366-123-413; Masunaga T, 1996, J HISTOCHEM CYTOCHEM, V44, P1223, DOI 10.1177/44.11.8918896; Milenkovic D, 2003, GENET SEL EVOL, V35, P249, DOI [10.1051/gse:2003007, 10.1186/1297-9686-35-2-249]; Nagata M, 1997, BRIT J DERMATOL, V137, P445, DOI 10.1111/j.1365-2133.1997.tb03756.x; Nakano A, 2002, HUM GENET, V110, P41, DOI 10.1007/s00439-001-0630-1; PEREZ V, 2005, P 23 M EUR SOC VET P, P173; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sasaki T, 2001, J MOL BIOL, V314, P751, DOI 10.1006/jmbi.2001.5176; Schneider H, 2007, EUR J CELL BIOL, V86, P701, DOI 10.1016/j.ejcb.2006.07.004; Spirito F, 2002, J INVEST DERMATOL, V119, P684, DOI 10.1046/j.1523-1747.2002.01852.x; Zhang XHF, 2003, GENOME RES, V13, P2637, DOI 10.1101/gr.1679003	24	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e18943	10.1371/journal.pone.0018943	http://dx.doi.org/10.1371/journal.pone.0018943			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573221	Green Submitted, gold, Green Published			2022-12-27	WOS:000290224800007
J	Cesa, R; Premoselli, F; Renna, A; Ethell, IM; Pasquale, EB; Strata, P				Cesa, Roberta; Premoselli, Federica; Renna, Annamaria; Ethell, Iryna M.; Pasquale, Elena B.; Strata, Piergiorgio			Eph Receptors Are Involved in the Activity-Dependent Synaptic Wiring in the Mouse Cerebellar Cortex	PLOS ONE			English	Article							DENDRITIC SPINE MORPHOGENESIS; VESICULAR GLUTAMATE TRANSPORTERS; FOCAL ADHESION KINASE; ADULT-RAT; TYROSINE KINASE; PURKINJE-CELLS; SUBTOTAL LESION; INFERIOR OLIVE; EXPRESSION; EPHRINS	Eph receptor tyrosine kinases are involved in many cellular processes. In the developing brain, they act as migratory and cell adhesive cues while in the adult brain they regulate dendritic spine plasticity. Here we show a new role for Eph receptor signalling in the cerebellar cortex. Cerebellar Purkinje cells are innervated by two different excitatory inputs. The climbing fibres contact the proximal dendritic domain of Purkinje cells, where synapse and spine density is low; the parallel fibres contact the distal dendritic domain, where synapse and spine density is high. Interestingly, Purkinje cells have the intrinsic ability to generate a high number of spines over their entire dendritic arborisations, which can be innervated by the parallel fibres. However, the climbing fibre input continuously exerts an activity-dependent repression on parallel fibre synapses, thus confining them to the distal Purkinje cell dendritic domain. Such repression persists after Eph receptor activation, but is overridden by Eph receptor inhibition with EphA4/Fc in neonatal cultured cerebellar slices as well as mature acute cerebellar slices, following in vivo infusion of the EphA4/Fc inhibitor and in EphB receptor-deficient mice. When electrical activity is blocked in vivo by tetrodotoxin leading to a high spine density in Purkinje cell proximal dendrites, stimulation of Eph receptor activation recapitulates the spine repressive effects of climbing fibres. These results suggest that Eph receptor signalling mediates the repression of spine proliferation induced by climbing fibre activity in Purkinje cell proximal dendrites. Such repression is necessary to maintain the correct architecture of the cerebellar cortex.	[Cesa, Roberta; Premoselli, Federica; Renna, Annamaria] Univ Turin, Dept Neurosci, Turin, Italy; [Cesa, Roberta; Renna, Annamaria; Strata, Piergiorgio] Univ Turin, Natl Neurosci Inst Italy, Turin, Italy; [Ethell, Iryna M.] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA; [Pasquale, Elena B.] Sanford Burnham Med Res Inst, La Jolla, CA USA	University of Turin; University of Turin; University of California System; University of California Riverside; Sanford Burnham Prebys Medical Discovery Institute	Cesa, R (corresponding author), Univ Turin, Dept Neurosci, Turin, Italy.	piergiorgio.strata@unito.it		Ethell, Iryna/0000-0002-1324-6611	Italian Ministry of University and Research; European Community [214003-1]; Regione Piemonte, Italian Space Agency; Compagnia San Paolo Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067121] Funding Source: NIH RePORTER	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); European Community(European Commission); Regione Piemonte, Italian Space Agency(Agenzia Spaziale Italiana (ASI)Regione Piemonte); Compagnia San Paolo Foundation(Compagnia di San Paolo); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the Italian Ministry of University and Research, European Community contract number 214003-1, Regione Piemonte, Italian Space Agency, and Compagnia San Paolo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON MJ, 1977, J PHYSIOL-LONDON, V268, P757, DOI 10.1113/jphysiol.1977.sp011880; Aoto J, 2007, BRAIN RES, V1184, P72, DOI 10.1016/j.brainres.2006.11.033; AXELSSON J, 1959, J PHYSIOL-LONDON, V147, P178, DOI 10.1113/jphysiol.1959.sp006233; Beg AA, 2007, NEURON, V55, P768, DOI 10.1016/j.neuron.2007.07.036; Bourgin C, 2007, J CELL BIOL, V178, P1295, DOI 10.1083/jcb.200610139; Bouvier D, 2010, J NEUROCHEM, V113, P153, DOI 10.1111/j.1471-4159.2010.06582.x; Bravin M, 1999, P NATL ACAD SCI USA, V96, P1704, DOI 10.1073/pnas.96.4.1704; Calabrese B, 2006, PHYSIOLOGY, V21, P38, DOI 10.1152/physiol.00042.2005; Carulli D, 2004, PROG NEUROBIOL, V72, P373, DOI 10.1016/j.pneurobio.2004.03.007; Cesa R, 2005, PROG BRAIN RES, V148, P47, DOI 10.1016/S0079-6123(04)480005-4; Cesa R, 2005, EUR J NEUROSCI, V22, P579, DOI 10.1111/j.1460-9568.2005.04244.x; Cesa R, 2003, J NEUROSCI, V23, P2363; Cesa R, 2009, NEUROSCIENCE, V162, P624, DOI 10.1016/j.neuroscience.2009.02.061; Cesa R, 2007, J NEUROSCI, V27, P4603, DOI 10.1523/JNEUROSCI.5617-06.2007; Ciossek T, 1999, MOL BRAIN RES, V74, P231, DOI 10.1016/S0169-328X(99)00285-5; Cooper MA, 2009, J COMP NEUROL, V514, P310, DOI 10.1002/cne.22030; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Gerlai R, 1999, J NEUROSCI, V19, P9538; Greferath U, 2002, MECH DEVELOP, V119, pS231, DOI 10.1016/S0925-4773(03)00122-9; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Ichikawa R, 2002, J NEUROSCI, V22, P8487; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Iwasato T, 2007, CELL, V130, P742, DOI 10.1016/j.cell.2007.07.022; Karam SD, 2000, J NEUROSCI, V20, P6488, DOI 10.1523/JNEUROSCI.20-17-06488.2000; Kayser MS, 2008, NEURON, V59, P56, DOI 10.1016/j.neuron.2008.05.007; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Lai KO, 2009, CURR OPIN NEUROBIOL, V19, P275, DOI 10.1016/j.conb.2009.04.009; Liebl DJ, 2003, J NEUROSCI RES, V71, P7, DOI 10.1002/jnr.10457; Lippman J, 2005, J NEUROBIOL, V64, P47, DOI 10.1002/neu.20149; Mandolesi G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005243; Margolis SS, 2010, CELL, V143, P442, DOI 10.1016/j.cell.2010.09.038; Martone ME, 1997, BRAIN RES, V771, P238, DOI 10.1016/S0006-8993(97)00792-0; McClelland AC, 2009, P NATL ACAD SCI USA, V106, P20487, DOI 10.1073/pnas.0811862106; Migani P, 2007, BRAIN RES, V1182, P60, DOI 10.1016/j.brainres.2007.08.065; Migani P, 2009, BRAIN RES, V1247, P50, DOI 10.1016/j.brainres.2008.09.100; Miyazaki T, 2003, EUR J NEUROSCI, V17, P2563, DOI 10.1046/j.1460-9568.2003.02698.x; Moeller ML, 2006, J BIOL CHEM, V281, P1587, DOI 10.1074/jbc.M511756200; Morando L, 2001, P NATL ACAD SCI USA, V98, P9954, DOI 10.1073/pnas.171098398; Murai KK, 2004, NEUROSCIENTIST, V10, P304, DOI 10.1177/1073858403262221; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Nishida K, 2002, DEVELOPMENT, V129, P5647, DOI 10.1242/dev.00162; Olivieri G, 1999, J HISTOCHEM CYTOCHEM, V47, P855, DOI 10.1177/002215549904700702; Palay S. L., 1974, CEREBELLAR CORTEX CY; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2004, NAT NEUROSCI, V7, P417, DOI 10.1038/nn0504-417; PASQUALE EB, 1992, J NEUROSCI, V12, P3956; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Penzes P, 2008, TRENDS NEUROSCI, V31, P419, DOI 10.1016/j.tins.2008.06.001; ROSSI F, 1991, J COMP NEUROL, V308, P513, DOI 10.1002/cne.903080403; ROSSI F, 1993, NEUROSCIENCE, V53, P759, DOI 10.1016/0306-4522(93)90622-M; ROSSI F, 1991, J COMP NEUROL, V308, P536, DOI 10.1002/cne.903080404; Scelfo B, 2003, J NEUROPHYSIOL, V89, P2555, DOI 10.1152/jn.00884.2002; Shi L, 2007, P NATL ACAD SCI USA, V104, P16347, DOI 10.1073/pnas.0706626104; Shi Y, 2009, J NEUROSCI, V29, P8129, DOI 10.1523/JNEUROSCI.4681-08.2009; Sotelo C, 1978, Prog Brain Res, V48, P149; Sotelo C, 2009, NEUROSCIENCE, V162, P589, DOI 10.1016/j.neuroscience.2008.12.035; SOTELO C, 1975, BRAIN RES, V98, P574, DOI 10.1016/0006-8993(75)90374-1; Strata P, 1998, TRENDS NEUROSCI, V21, P407, DOI 10.1016/S0166-2236(98)01305-8; Tolias KF, 2007, P NATL ACAD SCI USA, V104, P7265, DOI 10.1073/pnas.0702044104; Wegmeyer H, 2007, NEURON, V55, P756, DOI 10.1016/j.neuron.2007.07.038; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Willson CA, 2006, J MOL HISTOL, V37, P369, DOI 10.1007/s10735-006-9067-0; Xiao DQ, 2006, BRAIN RES, V1067, P67, DOI 10.1016/j.brainres.2005.10.073; Yamaguchi Y, 2004, CURR OPIN NEUROBIOL, V14, P288, DOI 10.1016/j.conb.2004.04.003; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Yuzaki M, 2003, NEUROSCI RES, V46, P11, DOI 10.1016/S0168-0102(03)00036-1	68	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19160	10.1371/journal.pone.0019160	http://dx.doi.org/10.1371/journal.pone.0019160			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559471	Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700084
J	Lu, SS; Nie, JW; Luan, Q; Feng, QT; Xiao, Q; Chang, Z; Shan, CJ; Hess, D; Hemmings, BA; Yang, ZZ				Lu, Shuangshuang; Nie, Junwei; Luan, Qing; Feng, Qiuting; Xiao, Qi; Chang, Zai; Shan, Congjia; Hess, Daniel; Hemmings, Brian A.; Yang, Zhongzhou			Phosphorylation of the Twist1-Family Basic Helix-Loop-Helix Transcription Factors Is Involved in Pathological Cardiac Remodeling	PLOS ONE			English	Article							PROTEIN-KINASE B/AKT; DNA-BINDING; TRANSGENIC MICE; DEPENDENT PHOSPHORYLATION; SIGNALING PATHWAYS; HEART-FAILURE; HAND1; HYPERTROPHY; GROWTH; DHAND	Background: The Twist1-family basic helix-loop-helix (bHLH) transcription factors including Twist1, Hand1 and Hand2, play an essential role in heart development and are implicated in pathological heart remodeling. Previously, it was reported that these bHLH transcription factors can be regulated by phosphorylation within the basic-helix I domain, which is involved in developmental processes such as limb formation and trophoblast differentiation. However, how phosphorylation of Twist1 family functions in post-natal heart is elusive. Principal Findings: Here, we generated transgenic mice with over-expression of Hand1 and Twist1 mutants (to mimic or to abolish phosphorylation) in cardiomyocytes and found pathological cardiac remodeling leading to heart failure and sudden death. Gene expression profile analysis revealed up-regulation of growth-promoting genes and down-regulation of metabolic genes. It is well known that aberrant activation of Akt signaling causes pathological cardiac remodeling and results in heart failure. The basic-helix I domain of Twist1 family members contain Akt substrate consensus motif and may be downstream targets of Akt signaling. Using biochemical analysis, we demonstrated that Hand1 and Twist1 were phosphorylated by Akt in the basic-helix I domain. Phosphorylation of Hand1 regulated its transcriptional activation of luciferase reporter genes and DNA binding ability. Conclusions: This study provides novel insights into the regulation of Twist1 family in cardiac remodeling and suggests that the Twist1 family can be regulated by Akt signaling.	[Lu, Shuangshuang; Nie, Junwei; Luan, Qing; Feng, Qiuting; Xiao, Qi; Chang, Zai; Shan, Congjia; Yang, Zhongzhou] Nanjing Univ, Model Anim Res Ctr, Minist Educ, Key Lab Model Anim Dis Study, Nanjing 210008, Peoples R China; [Hess, Daniel; Hemmings, Brian A.] Friedrich Miescher Inst Biomed Res, Basel, Switzerland	Nanjing University; Friedrich Miescher Institute for Biomedical Research	Lu, SS (corresponding author), Nanjing Univ, Model Anim Res Ctr, Minist Educ, Key Lab Model Anim Dis Study, Nanjing 210008, Peoples R China.	zhongzhouyang@nju.edu.cn			National Key Basic Research Program of China [2006CB943503]; National Science Foundation of China [30500264, 30671040]	National Key Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Basic Research Program of China (2006CB943503) and the National Science Foundation of China (30500264 and 30671040) with grants to Zhongzhou Yang. The Friedrich Miescher Institute for Biomedical Research is part of the Novartis Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes RM, 2009, INT J DEV BIOL, V53, P909, DOI 10.1387/ijdb.082747rb; Borger DR, 1998, AM J PHYSIOL-HEART C, V274, pH965, DOI 10.1152/ajpheart.1998.274.3.H965; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Breckenridge RA, 2009, J MOL CELL CARDIOL, V47, P133, DOI 10.1016/j.yjmcc.2009.04.007; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; Cook SA, 2002, J BIOL CHEM, V277, P22528, DOI 10.1074/jbc.M201462200; DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Feng JH, 2004, J BIOL CHEM, V279, P35510, DOI 10.1074/jbc.M404936200; Firulli AB, 2003, GENE, V312, P27, DOI 10.1016/S0378-1119(03)00669-3; Firulli AB, 1998, NAT GENET, V18, P266, DOI 10.1038/ng0398-266; Firulli BA, 2005, NAT GENET, V37, P373, DOI 10.1038/ng1525; Firulli BA, 2003, MOL CELL, V12, P1225, DOI 10.1016/S1097-2765(03)00425-8; Firulli BA, 2007, J BIOL CHEM, V282, P27536, DOI 10.1074/jbc.M702613200; FOCUSES W, 2003, EMBO J, V22, P4666; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hill AA, 2004, MOL CELL BIOL, V24, P9835, DOI 10.1128/MCB.24.22.9835-9847.2004; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405; Ito K, 2009, P NATL ACAD SCI USA, V106, P8689, DOI 10.1073/pnas.0900064106; KIMBER S, 2002, BIOCHEM J, V361, P641; Kovacic S, 2003, J BIOL CHEM, V278, P39422, DOI 10.1074/jbc.M305371200; Liu N, 2009, DEVELOPMENT, V136, P933, DOI 10.1242/dev.034025; Martindill DMJ, 2007, NAT CELL BIOL, V9, P1131, DOI 10.1038/ncb1633; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; McFadden DG, 2002, DEVELOPMENT, V129, P3077; Murakami M, 2004, EUR J BIOCHEM, V271, P3330, DOI 10.1111/j.1432-1033.2004.04267.x; Muslin Anthony J, 2006, Novartis Found Symp, V274, P118; Natarajan A, 2001, J MOL CELL CARDIOL, V33, P1607, DOI 10.1006/jmcc.2001.1434; O'Neill BT, 2005, J CLIN INVEST, V115, P2059, DOI 10.1172/JCI25900; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Olson EN, 2003, GENE DEV, V17, P1937, DOI 10.1101/gad.1110103; Reamon-Buettner SM, 2009, HUM MOL GENET, V18, P3567, DOI 10.1093/hmg/ddp305; Riley P, 1998, NAT GENET, V18, P271, DOI 10.1038/ng0398-271; Shelton EL, 2008, DEV BIOL, V317, P282, DOI 10.1016/j.ydbio.2008.02.037; Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Simionato E, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-33; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Taniyama Yoshiaki, 2005, J Mol Cell Cardiol, V38, P375, DOI 10.1016/j.yjmcc.2004.12.002; Thattaliyath BD, 2002, BIOCHEM BIOPH RES CO, V297, P870, DOI 10.1016/S0006-291X(02)02297-0; Vincentz JW, 2008, DEV BIOL, V320, P131, DOI 10.1016/j.ydbio.2008.04.037; Walsh K, 2006, CIRCULATION, V113, P2032, DOI 10.1161/CIRCULATIONAHA.106.615138; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010; Yang ZZ, 2005, MOL CELL BIOL, V25, P10407, DOI 10.1128/MCB.25.23.10407-10418.2005; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200; Yang ZZ, 2004, BIOCHEM SOC T, V32, P350, DOI 10.1042/BST0320350	52	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19251	10.1371/journal.pone.0019251	http://dx.doi.org/10.1371/journal.pone.0019251			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559426	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700112
J	Medina, MW; Gao, F; Naidoo, D; Rudel, LL; Temel, RE; McDaniel, AL; Marshall, SM; Krauss, RM				Medina, Marisa Wong; Gao, Feng; Naidoo, Devesh; Rudel, Lawrence L.; Temel, Ryan E.; McDaniel, Allison L.; Marshall, Stephanie M.; Krauss, Ronald M.			Coordinately Regulated Alternative Splicing of Genes Involved in Cholesterol Biosynthesis and Uptake	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; COENZYME-A REDUCTASE; HEPATOMA-CELL LINE; MEVALONATE KINASE; MESSENGER-RNA; SYNTHASE; TRACT; SIMVASTATIN; SEQUENCE; EXON	Genes involved in cholesterol biosynthesis and uptake are transcriptionally regulated in response to cellular sterol content in a coordinated manner. A number of these genes, including 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) and LDL receptor (LDLR), undergo alternative splicing, resulting in reductions of enzyme or protein activity. Here we demonstrate that cellular sterol depletion suppresses, and sterol loading induces, alternative splicing of multiple genes involved in the maintenance of cholesterol homeostasis including HMGCR and LDLR, the key regulators of cellular cholesterol biosynthesis and uptake, respectively. These changes were observed in both in vitro studies of the HepG2 human hepatoma derived cell line, as well as in vivo studies of St. Kitts vervets, also known as African green monkeys, a commonly used primate model for investigating cholesterol metabolism. These effects are mediated in part by sterol regulation of polypyrimidine tract binding protein 1 (PTBP1), since knock-down of PTBP1 eliminates sterol induced changes in alternative splicing of several of these genes. Single nucleotide polymorphisms (SNPs) that influence HMGCR and LDLR alternative splicing (rs3846662 and rs688, respectively), have been associated with variation in plasma LDL-cholesterol levels. Sterol-induced changes in alternative splicing are blunted in carriers of the minor alleles for each of these SNPs, indicating an interaction between genetic and non-genetic regulation of this process. Our results implicate alternative splicing as a novel mechanism of enhancing the robust transcriptional response to conditions of cellular cholesterol depletion or accumulation. Thus coordinated regulation of alternative splicing may contribute to cellular cholesterol homeostasis as well as plasma LDL levels.	[Medina, Marisa Wong; Gao, Feng; Naidoo, Devesh; Krauss, Ronald M.] Childrens Hosp, Oakland Res Inst, Dept Atherosclerosis Res, Oakland, CA 94609 USA; [Rudel, Lawrence L.; Temel, Ryan E.; McDaniel, Allison L.; Marshall, Stephanie M.] Wake Forest Univ Hlth Sci, Dept Pathol Lipid Sci, Winston Salem, NC USA	Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; Wake Forest University; Wake Forest University School of Medicine	Medina, MW (corresponding author), Childrens Hosp, Oakland Res Inst, Dept Atherosclerosis Res, 747 52nd St, Oakland, CA 94609 USA.	mwmedina@chori.org; rkrauss@chori.org			National Institutes of Health [U01 HL69757, R01 HL 104133-01, R21 HL093507-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104133, R21HL093507, U01HL069757] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by a grant from the National Institutes of Health, U01 HL69757. Additional support was provided by National Institutes of Health grants R01 HL 104133-01 and R21 HL093507-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALASUBRAMANIAM S, 1977, P NATL ACAD SCI USA, V74, P1421, DOI 10.1073/pnas.74.4.1421; Becker L, CELL METAB, V11, P125; Bourliere F., 1988, PRIMATE RAD EVOLUTIO; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; BROWN MS, 1980, J LIPID RES, V21, P505; Brunel F, 1996, NUCLEIC ACIDS RES, V24, P1608, DOI 10.1093/nar/24.9.1608; Burkhardt R, 2008, ARTERIOSCL THROM VAS, V28, P2078, DOI 10.1161/ATVBAHA.108.172288; CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X; Chan RCC, 1997, MOL CELL BIOL, V17, P4667, DOI 10.1128/MCB.17.8.4667; CHANG TY, 1980, J BIOL CHEM, V255, P7787; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; George TN, 1998, AM J PHYSIOL-LUNG C, V274, pL560, DOI 10.1152/ajplung.1998.274.4.L560; GIL G, 1987, P NATL ACAD SCI USA, V84, P1863, DOI 10.1073/pnas.84.7.1863; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; GRAEF E, 1994, ONCOGENE, V9, P81; GRAEF E, 1995, VIROLOGY, V208, P696, DOI 10.1006/viro.1995.1201; Hartmann B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r11; Holla OL, 2009, MOL GENET METAB, V96, P245, DOI 10.1016/j.ymgme.2008.12.014; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Houten SM, 2001, EUR J HUM GENET, V9, P253, DOI 10.1038/sj.ejhg.5200595; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Knouff CW, 2008, PHARMACOGENET GENOM, V18, P1051, DOI 10.1097/FPC.0b013e32831270eb; Krauss RM, 2008, CIRCULATION, V117, P1537, DOI 10.1161/CIRCULATIONAHA.107.708388; Li H, 2009, J LIPID RES, V50, P820, DOI 10.1194/jlr.M800375-JLR200; LIN CH, 1995, RNA, V1, P234; Medina MW, 2008, CIRCULATION, V118, P355, DOI 10.1161/CIRCULATIONAHA.108.773267; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; ROSSER DSE, 1989, J BIOL CHEM, V264, P12653; Rozen S, 2000, Methods Mol Biol, V132, P365; RUDEL LL, 1990, J LIPID RES, V31, P1873; Rustighi A, 2002, BIOCHEMISTRY-US, V41, P1229, DOI 10.1021/bi011666o; Schmidt RJ, 2008, DNA CELL BIOL, V27, P183, DOI 10.1089/dna.2007.0667; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; SHEN MMS, 1981, J LIPID RES, V22, P236; Simon JA, 2006, AM J CARDIOL, V97, P843, DOI 10.1016/j.amjcard.2005.09.134; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; Thompson JF, 2005, PHARMACOGENOMICS J, V5, P352, DOI 10.1038/sj.tpj.6500328; Thompson JF, 2009, CIRC-CARDIOVASC GENE, V2, P173, DOI 10.1161/CIRCGENETICS.108.818062; Tveten K, 2006, CLIN CHIM ACTA, V373, P151, DOI 10.1016/j.cca.2006.05.031; Wagner EJ, 2001, MOL CELL BIOL, V21, P3281, DOI 10.1128/MCB.21.10.3281-3288.2001; WILKIN DJ, 1990, J BIOL CHEM, V265, P4607; Zhu H, 2007, HUM MOL GENET, V16, P1765, DOI 10.1093/hmg/ddm124	45	49	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19420	10.1371/journal.pone.0019420	http://dx.doi.org/10.1371/journal.pone.0019420			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559365	gold, Green Published, Green Submitted			2022-12-27	WOS:000290024700164
J	Pelle, R; Graham, SP; Njahira, MN; Osaso, J; Saya, RM; Odongo, DO; Toye, PG; Spooner, PR; Musoke, AJ; Mwangi, DM; Taracha, ELN; Morrison, WI; Weir, W; Silva, JC; Bishop, RP				Pelle, Roger; Graham, Simon P.; Njahira, Moses N.; Osaso, Julius; Saya, Rosemary M.; Odongo, David O.; Toye, Philip G.; Spooner, Paul R.; Musoke, Anthony J.; Mwangi, Duncan M.; Taracha, Evans L. N.; Morrison, W. Ivan; Weir, William; Silva, Joana C.; Bishop, Richard P.			Two Theileria parva CD8 T Cell Antigen Genes Are More Variable in Buffalo than Cattle Parasites, but Differ in Pattern of Sequence Diversity	PLOS ONE			English	Article							STRAIN SPECIFICITY; SYNCERUS-CAFFER; RESPONSES; SOFTWARE; IMMUNITY; PROTEIN; DNA; IMMUNIZATION; LYMPHOCYTES; POPULATION	Background: Theileria parva causes an acute fatal disease in cattle, but infections are asymptomatic in the African buffalo (Syncerus caffer). Cattle can be immunized against the parasite by infection and treatment, but immunity is partially strain specific. Available data indicate that CD8(+) T lymphocyte responses mediate protection and, recently, several parasite antigens recognised by CD8(+) T cells have been identified. This study set out to determine the nature and extent of polymorphism in two of these antigens, Tp1 and Tp2, which contain defined CD8(+) T-cell epitopes, and to analyse the sequences for evidence of selection. Methodology/Principal Findings: Partial sequencing of the Tp1 gene and the full-length Tp2 gene from 82 T. parva isolates revealed extensive polymorphism in both antigens, including the epitope-containing regions. Single nucleotide polymorphisms were detected at 51 positions (similar to 12%) in Tp1 and in 320 positions (similar to 61%) in Tp2. Together with two short indels in Tp1, these resulted in 30 and 42 protein variants of Tp1 and Tp2, respectively. Although evidence of positive selection was found for multiple amino acid residues, there was no preferential involvement of T cell epitope residues. Overall, the extent of diversity was much greater in T. parva isolates originating from buffalo than in isolates known to be transmissible among cattle. Conclusions/Significance: The results indicate that T. parva parasites maintained in cattle represent a subset of the overall T. parva population, which has become adapted for tick transmission between cattle. The absence of obvious enrichment for positively selected amino acid residues within defined epitopes indicates either that diversity is not predominantly driven by selection exerted by host T cells, or that such selection is not detectable by the methods employed due to unidentified epitopes elsewhere in the antigens. Further functional studies are required to address this latter point.	[Pelle, Roger; Graham, Simon P.; Njahira, Moses N.; Osaso, Julius; Saya, Rosemary M.; Odongo, David O.; Toye, Philip G.; Spooner, Paul R.; Musoke, Anthony J.; Mwangi, Duncan M.; Taracha, Evans L. N.; Bishop, Richard P.] ILRI, Nairobi, Kenya; [Morrison, W. Ivan] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin Inst, Edinburgh EH9 1QH, Midlothian, Scotland; [Weir, William] Univ Glasgow, Sch Vet, Inst Comparat Med, Glasgow, Lanark, Scotland; [Silva, Joana C.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Silva, Joana C.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	CGIAR; International Livestock Research Institute (ILRI); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Glasgow; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Pelle, R (corresponding author), ILRI, Nairobi, Kenya.	r.pelle@cgiar.org	Silva, Joana/GVT-6441-2022; Graham, Simon P/C-8337-2011; Silva, Joana/GYQ-9526-2022	Graham, Simon P/0000-0003-4852-405X; Odongo, David/0000-0001-5745-4327; Weir, William/0000-0001-8648-666X	Department for International Development, United Kingdom [R8042]; International Livestock Research Institute; BBSRC [BBS/E/D/05201236] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/05201236] Funding Source: researchfish	Department for International Development, United Kingdom; International Livestock Research Institute(CGIAR); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded with Grant No. R8042 from the Department for International Development, United Kingdom, and with International Livestock Research Institute core funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoolo L, 2008, VET IMMUNOL IMMUNOP, V121, P216, DOI 10.1016/j.vetimm.2007.09.012; BALDWIN CL, 1988, PARASITE IMMUNOL, V10, P393, DOI 10.1111/j.1365-3024.1988.tb00229.x; Brown C. G. D., 1979, Practical tissue culture applications. (Proc. Conf. Internat. Lab. Res. Anim. Dis., Nairobi, Kenya, August 24-29 1978)., P223; CONRAD PA, 1987, PARASITOLOGY, V94, P413, DOI 10.1017/S0031182000055761; Egan A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-524; Freeman AR, 2006, GENETICS, V173, P1503, DOI 10.1534/genetics.105.053280; GAUER M, 1995, PARASITOL RES, V81, P565, DOI 10.1007/BF00932023; Geysen D, 1999, TROP MED INT HEALTH, V4, pA21, DOI 10.1046/j.1365-3156.1999.00447.x; Goddeeris B.M., 1988, J TISSUE CULT METHOD, V11, P101, DOI [10.1007/BF01404140, DOI 10.1007/BF01404140]; GODDEERIS BM, 1990, IMMUNOLOGY, V69, P38; Graham Simon P, 2007, Immunome Res, V3, P2, DOI 10.1186/1745-7580-3-2; Graham SP, 2008, INFECT IMMUN, V76, P685, DOI 10.1128/IAI.01244-07; Graham SP, 2006, P NATL ACAD SCI USA, V103, P3286, DOI 10.1073/pnas.0511273103; GROOTENHUIS JG, 1987, PARASITOLOGY, V94, P425, DOI 10.1017/S0031182000055773; Katzer F, 2006, INFECT IMMUN, V74, P5456, DOI 10.1128/IAI.00472-06; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kumkhaek C, 2005, J IMMUNOL, V175, P3935, DOI 10.4049/jimmunol.175.6.3935; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MacHugh ND, 2009, EUR J IMMUNOL, V39, P2459, DOI 10.1002/eji.200939227; McKeever DJ, 2009, TRENDS PARASITOL, V25, P269, DOI 10.1016/j.pt.2009.03.005; MCKEEVER DJ, 1994, P NATL ACAD SCI USA, V91, P1959, DOI 10.1073/pnas.91.5.1959; MORRISON WI, 1989, VET IMMUNOL IMMUNOP, V20, P213, DOI 10.1016/0165-2427(89)90003-2; MORZARIA S, 1999, LIVE VACCINES THEILE, P56; Morzaria S. P., 1993, Genome analysis of protozoan parasites: Proceedings of a Workshop held at ILRAD, Nairobi, Kenya 11-13 November 1992., P67; MORZARIA SP, 1995, PARASITOLOGY, V111, P39, DOI 10.1017/S0031182000064581; Musoke A, 2005, VACCINE, V23, P3084, DOI 10.1016/j.vaccine.2004.09.039; Nene V, 1996, INFECT IMMUN, V64, P2056, DOI 10.1128/IAI.64.6.2056-2061.1996; Norval RAI., 1992, EPIDEMIOLOGY THEILER; Odongo DO, 2006, INT J PARASITOL, V36, P937, DOI 10.1016/j.ijpara.2006.01.008; Oura CAL, 2005, MOL BIOCHEM PARASIT, V140, P229, DOI 10.1016/j.molbiopara.2004.12.015; Oura CAL, 2003, INT J PARASITOL, V33, P1641, DOI 10.1016/S0020-7519(03)00280-7; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; RADLEY D E, 1975, Veterinary Parasitology, V1, P51, DOI 10.1016/0304-4017(75)90007-2; RADLEY DE, 1979, VET PARASITOL, V5, P117, DOI 10.1016/0304-4017(79)90003-7; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sambrook J, 1989, MOL CLONING LABORATO; TARACHA ELN, 1995, INFECT IMMUN, V63, P1258, DOI 10.1128/IAI.63.4.1258-1262.1995; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOYE PG, 1995, J IMMUNOL, V155, P1370; Uilenberg G, 1999, TROP MED INT HEALTH, V4, pA12, DOI 10.1046/j.1365-3156.1999.00446.x; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1998, MOL BIOL EVOL, V15, P1600, DOI 10.1093/oxfordjournals.molbev.a025888; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; YOUNG AS, 1973, BRIT VET J, V129, P382, DOI 10.1016/S0007-1935(17)36442-4	45	57	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19015	10.1371/journal.pone.0019015	http://dx.doi.org/10.1371/journal.pone.0019015			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559495	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000290024700052
J	Sandersius, SA; Chuai, M; Weijer, CJ; Newman, TJ				Sandersius, Sebastian A.; Chuai, Manli; Weijer, Cornelis J.; Newman, Timothy J.			Correlating Cell Behavior with Tissue Topology in Embryonic Epithelia	PLOS ONE			English	Article							PRIMITIVE STREAK FORMATION; DIVISION; CHICK; SHAPE	Measurements on embryonic epithelial tissues in a diverse range of organisms have shown that the statistics of cell neighbor numbers are universal in tissues where cell proliferation is the primary cell activity. Highly simplified non-spatial models of proliferation are claimed to accurately reproduce these statistics. Using a systematic critical analysis, we show that non-spatial models are not capable of robustly describing the universal statistics observed in proliferating epithelia, indicating strong spatial correlations between cells. Furthermore we show that spatial simulations using the Subcellular Element Model are able to robustly reproduce the universal histogram. In addition these simulations are able to unify ostensibly divergent experimental data in the literature. We also analyze cell neighbor statistics in early stages of chick embryo development in which cell behaviors other than proliferation are important. We find from experimental observation that cell neighbor statistics in the primitive streak region, where cell motility and ingression are also important, show a much broader distribution. A non-spatial Markov process model provides excellent agreement with this broader histogram indicating that cells in the primitive streak may have significantly weaker spatial correlations. These findings show that cell neighbor statistics provide a potentially useful signature of collective cell behavior.	[Sandersius, Sebastian A.; Newman, Timothy J.] Arizona State Univ, Dept Phys, Ctr Biol Phys, Tempe, AZ 85287 USA; [Chuai, Manli; Weijer, Cornelis J.; Newman, Timothy J.] Univ Dundee, Coll Life Sci, Wellcome Trust Bioctr, Div Cell & Dev Biol, Dundee, Scotland	Arizona State University; Arizona State University-Tempe; University of Dundee	Sandersius, SA (corresponding author), Arizona State Univ, Dept Phys, Ctr Biol Phys, Tempe, AZ 85287 USA.	t.newman@dundee.ac.uk	weijer, cornelis j/I-4538-2012	Weijer, Cornelis/0000-0003-2192-8150	Human Frontiers Science Program [RGP-0038]; National Institutes of Health Physical Sciences Oncology Centers [5U54CA143862]; Biotechnology and Biological Sciences Research Council [BB/G015082/1] Funding Source: researchfish; BBSRC [BB/G015082/1] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [U54CA143862] Funding Source: NIH RePORTER	Human Frontiers Science Program(Human Frontier Science Program); National Institutes of Health Physical Sciences Oncology Centers; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the Human Frontiers Science Program (RGP-0038, www.hfsp.org) and the National Institutes of Health Physical Sciences Oncology Centers (5U54CA143862, www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aegerter-Wilmsen T, 2010, DEVELOPMENT, V137, P499, DOI 10.1242/dev.041731; Blanchard GB, 2009, NAT METHODS, V6, P458, DOI [10.1038/nmeth.1327, 10.1038/NMETH.1327]; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.0.CO;2-5; Chickarmane V, 2010, ANNU REV PLANT BIOL, V61, P65, DOI 10.1146/annurev-arplant-042809-112213; Chuai M, 2008, CURR TOP DEV BIOL, V81, P135, DOI 10.1016/S0070-2153(07)81004-0; ERRERA L, 1988, BOT CENTRALBATT, V34; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hocevar A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011904; KADANOFF L, 2002, STAT PHYS; Lewis FT, 1926, ANAT REC, V33, P331, DOI 10.1002/ar.1090330502; Lewis FT, 1928, ANAT REC, V38, P341, DOI 10.1002/ar.1090380305; Naveed H, 2010, IEEE ENG MED BIO, P3808, DOI 10.1109/IEMBS.2010.5627601; NEWMAN T. J, 2007, SINGLE CELL BASED MO, P221; Newman TJ, 2005, MATH BIOSCI ENG, V2, P613, DOI 10.3934/mbe.2005.2.613; Patel AB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000412; SAHLIN P, LECT NOTES I COMPUTE, V4, P971; Sahlin P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011750; Sandersius SA, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015002; Schaller G, 2004, COMPUT PHYS COMMUN, V162, P9, DOI 10.1016/j.cpc.2004.06.066; Stern C.D., 2004, GASTRULATION CELLS E; Wottawah F, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.098103	26	22	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18081	10.1371/journal.pone.0018081	http://dx.doi.org/10.1371/journal.pone.0018081			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559520	Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700006
J	Teitz, T; Stanke, JJ; Federico, S; Bradley, CL; Brennan, R; Zhang, JK; Johnson, MD; Sedlacik, J; Inoue, M; Zhang, ZWM; Frase, S; Rehg, JE; Hillenbrand, CM; Finkelstein, D; Calabrese, C; Dyer, MA; Lahti, JM				Teitz, Tal; Stanke, Jennifer J.; Federico, Sara; Bradley, Cori L.; Brennan, Rachel; Zhang, Jiakun; Johnson, Melissa D.; Sedlacik, Jan; Inoue, Madoka; Zhang, Ziwei M.; Frase, Sharon; Rehg, Jerold E.; Hillenbrand, Claudia M.; Finkelstein, David; Calabrese, Christopher; Dyer, Michael A.; Lahti, Jill M.			Preclinical Models for Neuroblastoma: Establishing a Baseline for Treatment	PLOS ONE			English	Article							MYCN AMPLIFICATION; PROMINENT NUCLEOLI; TRANSGENIC MICE; STROMA-POOR; IN-VIVO; EXPRESSION; TUMORS; APOPTOSIS; TUMORIGENESIS; PROGRESS	Background: Preclinical models of pediatric cancers are essential for testing new chemotherapeutic combinations for clinical trials. The most widely used genetic model for preclinical testing of neuroblastoma is the TH-MYCN mouse. This neuroblastoma-prone mouse recapitulates many of the features of human neuroblastoma. Limitations of this model include the low frequency of bone marrow metastasis, the lack of information on whether the gene expression patterns in this system parallels human neuroblastomas, the relatively slow rate of tumor formation and variability in tumor penetrance on different genetic backgrounds. As an alternative, preclinical studies are frequently performed using human cell lines xenografted into immunocompromised mice, either as flank implant or orthtotopically. Drawbacks of this system include the use of cell lines that have been in culture for years, the inappropriate microenvironment of the flank or difficult, time consuming surgery for orthotopic transplants and the absence of an intact immune system. Principal Findings: Here we characterize and optimize both systems to increase their utility for preclinical studies. We show that TH-MYCN mice develop tumors in the paraspinal ganglia, but not in the adrenal, with cellular and gene expression patterns similar to human NB. In addition, we present a new ultrasound guided, minimally invasive orthotopic xenograft method. This injection technique is rapid, provides accurate targeting of the injected cells and leads to efficient engraftment. We also demonstrate that tumors can be detected, monitored and quantified prior to visualization using ultrasound, MRI and bioluminescence. Finally we develop and test a "standard of care'' chemotherapy regimen. This protocol, which is based on current treatments for neuroblastoma, provides a baseline for comparison of new therapeutic agents. Significance: The studies suggest that use of both the TH-NMYC model of neuroblastoma and the orthotopic xenograft model provide the optimal combination for testing new chemotherapies for this devastating childhood cancer.	[Teitz, Tal; Stanke, Jennifer J.; Inoue, Madoka; Lahti, Jill M.] St Jude Childrens Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA; [Stanke, Jennifer J.; Federico, Sara; Bradley, Cori L.; Brennan, Rachel; Zhang, Jiakun; Dyer, Michael A.] St Jude Childrens Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Federico, Sara] St Jude Childrens Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA; [Johnson, Melissa D.; Zhang, Ziwei M.; Calabrese, Christopher] St Jude Childrens Hosp, Anim Imaging Ctr, Memphis, TN 38105 USA; [Sedlacik, Jan; Hillenbrand, Claudia M.] St Jude Childrens Hosp, Dept Radiol Sci, Memphis, TN 38105 USA; [Rehg, Jerold E.] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; [Dyer, Michael A.] Univ Tennessee, Hlth Sci Ctr, Dept Ophthalmol, Memphis, TN USA; [Dyer, Michael A.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Lahti, Jill M.] Univ Tennessee, Hlth Sci Ctr, Dept Mol Sci, Memphis, TN USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Howard Hughes Medical Institute; University of Tennessee System; University of Tennessee Health Science Center	Teitz, T (corresponding author), St Jude Childrens Hosp, Dept Tumor Cell Biol, 332 N Lauderdale St, Memphis, TN 38105 USA.	Michael.Dyer@stjude.org; Jill.Lahti@stjude.org	Dyer, Michael/N-8134-2018; Hillenbrand, Claudia/A-5152-2009; Rehg, Jerold E/N-8111-2018; Hillenbrand, Claudia/AAH-2591-2021	Hillenbrand, Claudia/0000-0001-8694-2178; Hillenbrand, Claudia/0000-0001-8694-2178; Johnson, Melissa/0000-0002-3794-3518	Comprehensive Cancer Center [CA021765]; Cancer Center; National Institutes of Health [CA067938-09, EY014867, EY018599, CA114102]; American Cancer Society; Research to Prevent Blindness Foundation; American Syrian Lebanese Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [P30CA021765, R01CA067938, R01CA114102, R56CA067938] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018599, R01EY014867] Funding Source: NIH RePORTER	Comprehensive Cancer Center; Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); American Syrian Lebanese Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by Comprehensive Cancer Center Support Grant CA021765, a Cancer Center Development grant (JML), National Institutes of Health grants CA067938-09 (JML), EY014867, EY018599 (MAD) and CA114102 (JS) [http://www.nih.gov], grants from the American Cancer Society [http://www.cancer.org], and Research to Prevent Blindness Foundation to (MAD) [http://www.rpbusa.org/rpb/], and American Syrian Lebanese Associated Charities (ALSAC)[http://www.StJude.org]. MAD is a Howard Hughes Medical Institute Early Career Scientist [http://www.hhmi.org]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam G, 2009, AM J PATHOL, V175, P856, DOI 10.2353/ajpath.2009.090019; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Chen ZW, 2009, NEOPLASIA, V11, P753, DOI 10.1593/neo.09466; Cheng AJ, 2007, EUR J CANCER, V43, P1467, DOI 10.1016/j.ejca.2007.03.008; Chesler L, 2008, NEOPLASIA, V10, P1268, DOI 10.1593/neo.08778; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Dickson PV, 2007, J PEDIATR SURG, V42, P1172, DOI 10.1016/j.jpedsurg.2007.02.027; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Hackett CS, 2003, CANCER RES, V63, P5266; Hansford LM, 2004, P NATL ACAD SCI USA, V101, P12664, DOI 10.1073/pnas.0401083101; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Hero B, 2008, J CLIN ONCOL, V26, P1504, DOI 10.1200/JCO.2007.12.3349; Hoehner JC, 1996, LAB INVEST, V75, P659; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Janoueix-Lerosey I, 2010, ONCOGENE, V29, P1566, DOI 10.1038/onc.2009.518; Kobayashi C, 2005, CANCER-AM CANCER SOC, V103, P174, DOI 10.1002/cncr.20717; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Mathew P, 2001, NEOPLASIA, V3, P105, DOI 10.1038/sj.neo.7900146; Matthay KK, 1998, J CLIN ONCOL, V16, P2003, DOI 10.1200/JCO.1998.16.6.2003; Monclair T, 2009, J CLIN ONCOL, V27, P298, DOI 10.1200/JCO.2008.16.6876; Moore HC, 2008, J CLIN PATHOL, V61, P1098, DOI 10.1136/jcp.2007.054627; Murphy DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008154; Rofsky NM, 1999, RADIOLOGY, V212, P876, DOI 10.1148/radiology.212.3.r99se34876; Rounbehler RJ, 2009, CANCER RES, V69, P547, DOI 10.1158/0008-5472.CAN-08-2968; Schulte JH, 2008, INT J CANCER, V122, P699, DOI 10.1002/ijc.23153; Schulte JH, 2010, INT J CANCER, V127, P2374, DOI 10.1002/ijc.25436; Sedlacik J., 2009, P INT SOC MAG RESON, V17, P3595; Stracker TH, 2009, DNA REPAIR, V8, P1047, DOI 10.1016/j.dnarep.2009.04.012; Tang XX, 2006, CANCER RES, V66, P2826, DOI 10.1158/0008-5472.CAN-05-0854; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Tekautz TM, 2006, BBA-MOL CELL RES, V1763, P1000, DOI 10.1016/j.bbamcr.2006.06.014; Thiele C. J, 1998, NEUROBLASTOMA CELL L, V1, P21; Tornoczky T, 2004, CANCER-AM CANCER SOC, V100, P390, DOI 10.1002/cncr.20005; Tornoczky T, 2007, PATHOL ONCOL RES, V13, P269, DOI 10.1007/BF02940304; Wang XZ, 2007, MOL CELL BIOL, V27, P3098, DOI 10.1128/MCB.02357-06; Weidensteiner C, 2006, J MAGN RESON IMAGING, V24, P646, DOI 10.1002/jmri.20676; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985	41	63	64	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19133	10.1371/journal.pone.0019133	http://dx.doi.org/10.1371/journal.pone.0019133			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559450	gold, Green Submitted, Green Published			2022-12-27	WOS:000290024700073
J	Wu, D; Lin, F				Wu, Dan; Lin, Francis			Modeling Cell Gradient Sensing and Migration in Competing Chemoattractant Fields	PLOS ONE			English	Article							FORMYL PEPTIDE-RECEPTOR; NEURONAL MIGRATION; HUMAN NEUTROPHILS; UP-REGULATION; CHEMOTAXIS; INTERNALIZATION; DYNAMICS; DESENSITIZATION; FLUCTUATIONS; DISSOCIATION	Directed cell migration mediates physiological and pathological processes. In particular, immune cell trafficking in tissues is crucial for inducing immune responses and is coordinated by multiple environmental cues such as chemoattractant gradients. Although the chemotaxis mechanism has been extensively studied, how cells integrate multiple chemotactic signals for effective trafficking and positioning in tissues is not clearly defined. Results from previous neutrophil chemotaxis experiments and modeling studies suggested that ligand-induced homologous receptor desensitization may provide an important mechanism for cell migration in competing chemoattractant gradients. However, the previous mathematical model is oversimplified to cell gradient sensing in one-dimensional (1-D) environment. To better understand the receptor desensitization mechanism for chemotactic navigation, we further developed the model to test the role of homologous receptor desensitization in regulating both cell gradient sensing and migration in different configurations of chemoattractant fields in two-dimension (2-D). Our results show that cells expressing normal desensitizable receptors preferentially orient and migrate toward the distant gradient in the presence of a second local competing gradient, which are consistent with the experimentally observed preferential migration of cells toward the distant attractant source and confirm the requirement of receptor desensitization for such migratory behaviors. Furthermore, our results are in qualitative agreement with the experimentally observed cell migration patterns in different configurations of competing chemoattractant fields.	[Wu, Dan; Lin, Francis] Univ Manitoba, Dept Phys & Astron, Winnipeg, MB, Canada; [Lin, Francis] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; [Lin, Francis] Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada; [Lin, Francis] Univ Manitoba, Dept Biosyst Engn, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba	Wu, D (corresponding author), Univ Manitoba, Dept Phys & Astron, Winnipeg, MB, Canada.	flin@physics.umanitoba.ca		Lin, Francis/0000-0003-1736-193X	Natural Sciences and Engineering Research Council of Canada (NSERC); Manitoba Health Research Council (MHRC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Manitoba Health Research Council (MHRC)	Funding was provided by the Natural Sciences and Engineering Research Council of Canada (NSERC) (http://www.nserc-crsng.gc.ca/index_eng.asp) and the Manitoba Health Research Council (MHRC) (http://www.mhrc.mb.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai H, 1997, J BIOL CHEM, V272, P25037, DOI 10.1074/jbc.272.40.25037; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Britschgi MR, 2010, EUR J IMMUNOL, V40, P1266, DOI 10.1002/eji.200939921; Dekker LV, 2000, SCIENCE, V287, P982, DOI 10.1126/science.287.5455.982; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; DEVREOTES PN, 1988, ANNU REV CELL BIOL, V4, P649, DOI 10.1146/annurev.cb.04.110188.003245; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Foxman EF, 1999, J CELL BIOL, V147, P577, DOI 10.1083/jcb.147.3.577; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; Heit B, 2005, J CELL SCI, V118, P5205, DOI 10.1242/jcs.02632; Heit B, 2002, J CELL BIOL, V159, P91, DOI 10.1083/jcb.200202114; Heit B, 2008, NAT IMMUNOL, V9, P743, DOI 10.1038/ni.1623; Hoffman JF, 1996, J BIOL CHEM, V271, P18394, DOI 10.1074/jbc.271.31.18394; Iglesias Pablo A, 2002, Sci STKE, V2002, pre12, DOI 10.1126/stke.2002.148.re12; Kawai T, 2009, CURR OPIN HEMATOL, V16, P20, DOI 10.1097/MOH.0b013e32831ac557; Keller R, 2005, CURR OPIN CELL BIOL, V17, P533, DOI 10.1016/j.ceb.2005.08.006; Kunkel EJ, 2003, MICROCIRCULATION, V10, P313, DOI 10.1038/sj.mn.7800196; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; LAUFFENBURGER DA, 1982, CELL BIOPHYS, V4, P177, DOI 10.1007/BF02918312; Lin F, 2005, ANN BIOMED ENG, V33, P475, DOI 10.1007/s10439-005-2503-6; Lin F, 2008, J IMMUNOL, V181, P8335, DOI 10.4049/jimmunol.181.12.8335; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Matsubayashi Y, 2004, CURR BIOL, V14, P731, DOI 10.1016/j.cub.2004.03.060; McDougall S, 2006, PHILOS T R SOC A, V364, P1385, DOI [10.1098/rsta.2006.1773, 10.1098/rsta.2000.1773]; MOGHE PV, 1995, J IMMUNOL METHODS, V180, P193, DOI 10.1016/0022-1759(94)00314-M; Mueller SG, 1997, J BIOL CHEM, V272, P8207, DOI 10.1074/jbc.272.13.8207; NORGAUER J, 1991, J IMMUNOL, V146, P975; Normark S, 2001, NAT MED, V7, P1182, DOI 10.1038/nm1101-1182; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; SKLAR LA, 1984, J BIOL CHEM, V259, P5661; SKLAR LA, 1986, ADV IMMUNOL, V39, P95; SKLAR LA, 1987, J BIOL CHEM, V262, P135; TRANQUILLO RT, 1988, J CELL BIOL, V106, P303, DOI 10.1083/jcb.106.2.303; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; ZIGMOND SH, 1981, J CELL BIOL, V88, P644, DOI 10.1083/jcb.88.3.644	36	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18805	10.1371/journal.pone.0018805	http://dx.doi.org/10.1371/journal.pone.0018805			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559528	Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700027
J	Catalano, RD; Wilson, MR; Boddy, SC; McKinlay, ATM; Sales, KJ; Jabbour, HN				Catalano, Rob D.; Wilson, Martin R.; Boddy, Sheila C.; McKinlay, Andrew T. M.; Sales, Kurt J.; Jabbour, Henry N.			Hypoxia and Prostaglandin E Receptor 4 Signalling Pathways Synergise to Promote Endometrial Adenocarcinoma Cell Proliferation and Tumour Growth	PLOS ONE			English	Article							AUTOCRINE/PARACRINE REGULATION; PROSTANOID RECEPTORS; CANCER-CELLS; EXPRESSION; EP4; CYCLOOXYGENASE-2; COX-2; E-2; ANGIOGENESIS; INVOLVEMENT	The prostaglandin endoperoxide synthase (PTGS) pathway is a potent driver of tumour development in humans by enhancing the biosynthesis and signalling of prostaglandin (PG) E-2. PTGS2 expression and PGE(2) biosynthesis is elevated in endometrial adenocarcinoma, however the mechanism whereby PTGS and PGE2 regulate endometrial tumour growth is unknown. Here we investigated (a) the expression profile of the PGE synthase enzymes (PTGES, PTGES-2, PTGES-3) and PGE receptors (PTGER1-4) in endometrial adenocarcinomas compared with normal endometrium and (b) the role of PTGER4 in endometrial tumorigenesis in vivo. We found elevated expression of PTGES2 and PTGER4 and suppression of PTGER1 and PTGER3 in endometrial adenocarcinomas compared with normal endometrium. Using WT Ishikawa endometrial adenocarcinoma cells and Ishikawa cells stably transfected with the full length PTGER4 cDNA (PTGER4 cells) xenografted in the dorsal flanks of nude mice, we show that PTGER4 rapidly and significantly enhances tumour growth rate. Coincident with enhanced PTGER4-mediated tumour growth we found elevated expression of PTGS2 in PTGER4 xenografts compared with WT xenografts. Furthermore we found that the augmented growth rate of the PTGER4 xenografts was not due to enhanced angiogenesis, but regulated by an increased proliferation index and hypoxia. In vitro, we found that PGE2 and hypoxia independently induce expression of PTGER4 indicating two independent pathways regulating prostanoid receptor expression. Finally we have shown that PGE2 and hypoxia synergise to promote cellular proliferation of endometrial adenocarcinoma cells.	[Catalano, Rob D.; Wilson, Martin R.; Boddy, Sheila C.; McKinlay, Andrew T. M.; Sales, Kurt J.; Jabbour, Henry N.] Univ Edinburgh, Med Res Council, Human Reprod Sci Unit, Queens Med Res Inst, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Edinburgh	Catalano, RD (corresponding author), Univ Edinburgh, Med Res Council, Human Reprod Sci Unit, Queens Med Res Inst, Edinburgh, Midlothian, Scotland.	h.jabbour@hrsu.mrc.ac.uk	McKinlay, Andrew T. M./B-3613-2010	McKinlay, Andrew T. M./0000-0002-5639-3267; Sales, Kurt/0000-0002-9880-5143	Medical Research Council [U.1276.00.004.00002.01]; MRC [MC_U127684438] Funding Source: UKRI; Medical Research Council [MC_U127684438] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by Medical Research Council core funding (U.1276.00.004.00002.01) awarded to H.N.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abera AB, 2010, CELL SIGNAL, V22, P71, DOI 10.1016/j.cellsig.2009.09.012; Catalano RD, 2011, MOL HUM REPROD, V17, P182, DOI 10.1093/molehr/gaq094; Chell SD, 2006, CANCER RES, V66, P3106, DOI 10.1158/0008-5472.CAN-05-3702; Cherukuri DP, 2007, EXP CELL RES, V313, P2969, DOI 10.1016/j.yexcr.2007.06.004; Chiarugi V, 1998, INT J MOL MED, V2, P715; Daikoku T, 2008, CANCER RES, V68, P5619, DOI 10.1158/0008-5472.CAN-08-1274; Di Cristofano A, 2007, ANNU REV PATHOL-MECH, V2, P57, DOI 10.1146/annurev.pathol.2.010506.091905; Doll A, 2008, J STEROID BIOCHEM, V108, P221, DOI 10.1016/j.jsbmb.2007.09.020; DuBois RN, 1996, CANCER RES, V56, P733; Fujino H, 2003, TRENDS PHARMACOL SCI, V24, P335, DOI 10.1016/S0165-6147(03)00162-7; Fukuda R, 2003, CANCER RES, V63, P2330; Gately S, 2004, SEMIN ONCOL, V31, P2, DOI 10.1053/j.seminoncol.2004.03.040; George RJ, 2007, PROSTAG OTH LIPID M, V83, P112, DOI 10.1016/j.prostaglandins.2006.10.005; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hirani N, 2001, MOL MED, V7, P685, DOI 10.1007/BF03401959; Horree N, 2008, J CLIN PATHOL, V61, P36, DOI 10.1136/jcp.2006.043794; Horree N, 2007, HUM PATHOL, V38, P1232, DOI 10.1016/j.humpath.2007.01.008; IMTIYAZ HZ, 2010, CURR TOP MICROBIOL I, V810, P105; Iniguez MA, 2003, TRENDS MOL MED, V9, P73, DOI 10.1016/S1471-4914(02)00011-4; Jabbour HN, 2001, BRIT J CANCER, V85, P1023; Jabbour HN, 2004, TRENDS ENDOCRIN MET, V15, P398, DOI 10.1016/j.tem.2004.08.006; Jain RK, 2003, J CLIN INVEST, V112, P1134, DOI 10.1172/JCI200320087; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Ma XR, 2006, CANCER RES, V66, P2923, DOI 10.1158/0008-5472.CAN-05-4348; Marin-Hernandez A, 2009, MINI-REV MED CHEM, V9, P1084, DOI 10.2174/138955709788922610; Marnett LJ, 1999, J BIOL CHEM, V274, P22903, DOI 10.1074/jbc.274.33.22903; Murakami M, 2003, J BIOL CHEM, V278, P37937, DOI 10.1074/jbc.M305108200; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; NOYES RW, 1950, FERTIL STERIL, V1, P3, DOI 10.1016/s0015-0282(16)30062-0; Pijnenborg JMA, 2007, INT J GYNECOL CANCER, V17, P897, DOI 10.1111/j.1525-1438.2007.00893.x; Regan JW, 2003, LIFE SCI, V74, P143, DOI 10.1016/j.lfs.2003.09.031; Robertson Fredika M, 2008, J Exp Ther Oncol, V7, P299; Sales KJ, 2002, CANCER RES, V62, P424; Sales KJ, 2004, J CLIN ENDOCR METAB, V89, P6112, DOI 10.1210/jc.2004-0892; Sales KJ, 2008, MOL CELL ENDOCRINOL, V285, P51, DOI 10.1016/j.mce.2008.01.016; Sales KJ, 2010, AM J PATHOL, V176, P435, DOI 10.2353/ajpath.2010.090403; Sales KJ, 2009, BBA-MOL CELL RES, V1793, P1917, DOI 10.1016/j.bbamcr.2009.09.018; St-Germain ME, 2004, INT J ONCOL, V24, P1311; Tong BJ, 2000, NEOPLASIA, V2, P483, DOI 10.1038/sj.neo.7900119; Tsuji S, 1996, PROSTAG LEUKOTR ESS, V55, P179, DOI 10.1016/S0952-3278(96)90095-2; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; TSUJII M, 1995, CELL, V83, P493, DOI 10.1016/0092-8674(95)90127-2; Wang DZ, 2006, J EXP MED, V203, P941, DOI 10.1084/jem.20052124; Weinberg E, 2009, J CELL BIOCHEM, V108, P207, DOI 10.1002/jcb.22242; Zheng Y, 2009, CANCER RES, V69, P896, DOI 10.1158/0008-5472.CAN-08-2677	45	16	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19209	10.1371/journal.pone.0019209	http://dx.doi.org/10.1371/journal.pone.0019209			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589857	Green Published, gold, Green Submitted			2022-12-27	WOS:000290531100006
J	Giffard, M; Ferte, N; Ragot, F; El Hajji, M; Castro, B; Bonnete, F				Giffard, Marion; Ferte, Natalie; Ragot, Francois; El Hajji, Mohamed; Castro, Bertrand; Bonnete, Francoise			Urate Oxidase Purification by Salting-in Crystallization: Towards an Alternative to Chromatography	PLOS ONE			English	Article							X-RAY-SCATTERING; RELATIVE EFFECTIVENESS; PROTEIN SOLUTIONS; SOLUBILITY; LYSOZYME; AMYLASE; UREASE; GROWTH; PH	Background: Rasburicase (Fasturtec (R) or Elitek (R), Sanofi-Aventis), the recombinant form of urate oxidase from Aspergillus flavus, is a therapeutic enzyme used to prevent or decrease the high levels of uric acid in blood that can occur as a result of chemotherapy. It is produced by Sanofi-Aventis and currently purified via several standard steps of chromatography. This work explores the feasibility of replacing one or more chromatography steps in the downstream process by a crystallization step. It compares the efficacy of two crystallization techniques that have proven successful on pure urate oxidase, testing them on impure urate oxidase solutions. Methodology/Principal Findings: Here we investigate the possibility of purifying urate oxidase directly by crystallization from the fermentation broth. Based on attractive interaction potentials which are known to drive urate oxidase crystallization, two crystallization routes are compared: a) by increased polymer concentration, which induces a depletion attraction and b) by decreased salt concentration, which induces attractive interactions via a salting-in effect. We observe that adding polymer, a very efficient way to crystallize pure urate oxidase through the depletion effect, is not an efficient way to grow crystals from impure solution. On the other hand, we show that dialysis, which decreases salt concentration through its strong salting-in effect, makes purification of urate oxidase from the fermentation broth possible. Conclusions: The aim of this study is to compare purification efficacy of two crystallization methods. Our findings show that crystallization of urate oxidase from the fermentation broth provides purity comparable to what can be achieved with one chromatography step. This suggests that, in the case of urate oxidase, crystallization could be implemented not only for polishing or concentration during the last steps of purification, but also as an initial capture step, with minimal changes to the current process.	[Giffard, Marion; Ferte, Natalie; Bonnete, Francoise] Aix Marseille Univ, CNRS, UPR3118, Ctr Interdisciplinaire Nanosci Marseille, Marseille, France; [Ragot, Francois] Sanofi Aventis, Dept Biotechnol, Aramon, France; [El Hajji, Mohamed; Castro, Bertrand] Sanofi Aventis Res & Dev, Dept Analyt Sci, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Sanofi-Aventis; Sanofi France; Sanofi-Aventis; Sanofi France	Giffard, M (corresponding author), Aix Marseille Univ, CNRS, UPR3118, Ctr Interdisciplinaire Nanosci Marseille, Marseille, France.	bonnete@cinam.univ-mrs.fr	Bonneté, Francoise/AAL-6725-2020; bonnete, francoise/Q-2143-2015	bonnete, francoise/0000-0002-1690-1757	Sanofi-Aventis (France) [006978]	Sanofi-Aventis (France)(Sanofi-Aventis)	Sanofi-Aventis (France) supported this work with contract no 006978 (2006-2009) for a PhD thesis. Francois Ragot, Mohamed El Hajji and Bertrand Castro are employees of Sanofi-Aventis, which supplied the protein for the study, organized regular meetings and reports during the three PhD thesis years, validated study design, data collection and analysis. They accepted the decision to publish and participated in the writing of the manuscript.	ALDERTON G, 1946, J BIOL CHEM, V146, P1; ALEMAN C, 1998, Patent No. 5811096; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; ARAKAWA T, 1985, METHOD ENZYMOL, V114, P49; Bayol A, 2002, BIOTECHNOL APPL BIOC, V36, P21, DOI 10.1042/BA20010083; Bonnete F, 2001, J CRYST GROWTH, V232, P330, DOI 10.1016/S0022-0248(01)01054-5; Bonnete F, 1999, J CRYST GROWTH, V196, P403, DOI 10.1016/S0022-0248(98)00826-4; Budayova M, 1999, J CRYST GROWTH, V196, P210, DOI 10.1016/S0022-0248(98)00844-6; Cammalleri Lisa, 2007, Int J Med Sci, V4, P83; CARBONNAUX C, 1995, PROTEIN SCI, V4, P2123, DOI 10.1002/pro.5560041018; Faber C, 2007, J CHEM ENG DATA, V52, P707, DOI 10.1021/je0603123; Finet S, 2004, CURR OPIN COLLOID IN, V9, P112, DOI 10.1016/j.cocis.2004.05.014; Finet S, 2003, METHOD ENZYMOL, V368, P105, DOI 10.1016/S0076-6879(03)68007-9; Fraisse L, 2002, ANAL BIOCHEM, V309, P173, DOI 10.1016/S0003-2697(02)00293-2; Fromme P, 1998, BBA-BIOENERGETICS, V1365, P175, DOI 10.1016/S0005-2728(98)00059-0; Giffard M, 2008, CRYST GROWTH DES, V8, P4220, DOI 10.1021/cg800679v; Giffard M, 2009, CRYST GROWTH DES, V9, P4199, DOI 10.1021/cg900473n; Jacobsen C, 1998, BIOTECHNOL BIOENG, V57, P666, DOI 10.1002/(SICI)1097-0290(19980320)57:6<666::AID-BIT4>3.0.CO;2-J; JOHAL S, 1982, Patent No. [04334024, 4334024]; JUDGE RA, 1995, BIOTECHNOL BIOENG, V48, P316, DOI 10.1002/bit.260480404; Lawlis V. B., 1991, US Pat., Patent No. [5041377, 5,041,377]; Malfois M, 1996, J CHEM PHYS, V105, P3290, DOI 10.1063/1.471843; NIELSEN N, 1998, Patent No. 5837513; Retailleau P, 1997, BIOPHYS J, V73, P2156, DOI 10.1016/S0006-3495(97)78246-8; RIESKAUTT MM, 1989, J BIOL CHEM, V264, P745; Roberts B.M., 1997, U.S. Pat., Patent No. [US5597893 A, 5597893]; SCHMOLKA IR, 1977, J AM OIL CHEM SOC, V54, P110, DOI 10.1007/BF02894385; Sumner JB, 1926, J BIOL CHEM, V69, P435; Tardieu A, 1999, J CRYST GROWTH, V196, P193, DOI 10.1016/S0022-0248(98)00828-8; VISURI K, 1972, EUR J BIOCHEM, V28, P555, DOI 10.1111/j.1432-1033.1972.tb01944.x; VISURI K, 2006, Patent No. 7087719; Vivares D, 2006, CRYST GROWTH DES, V6, P287, DOI 10.1021/cg0500223; Vivares D, 2004, J PHYS CHEM B, V108, P6498, DOI 10.1021/jp037502u; Vivares D, 2002, EUR PHYS J E, V9, P15, DOI 10.1140/epje/i2002-10047-7; Vivares D, 2002, ACTA CRYSTALLOGR D, V58, P472, DOI 10.1107/S0907444902000124; Wagner O., 1973, US Patent, Patent No. 3773624; Walsh G., 2005, DIRECTORY THERAPEUTI; Weber M, 2008, CRYST GROWTH DES, V8, P711, DOI 10.1021/cg070070i; WU XW, 1992, J MOL EVOL, V34, P78, DOI 10.1007/BF00163854	39	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19013	10.1371/journal.pone.0019013	http://dx.doi.org/10.1371/journal.pone.0019013			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589929	gold, Green Published, Green Submitted			2022-12-27	WOS:000290483600005
J	Johnson, CJ; Bennett, JP; Biro, SM; Duque-Velasquez, JC; Rodriguez, CM; Bessen, RA; Rocke, TE				Johnson, Christopher J.; Bennett, James P.; Biro, Steven M.; Camilo Duque-Velasquez, Juan; Rodriguez, Cynthia M.; Bessen, Richard A.; Rocke, Tonie E.			Degradation of the Disease-Associated Prion Protein by a Serine Protease from Lichens	PLOS ONE			English	Article							TRANSMISSIBLE MINK ENCEPHALOPATHY; CHRONIC WASTING DISEASE; ANTIMICROBIAL ACTIVITY; SCRAPIE PRION; MULE DEER; IN-VITRO; AGENT; PRPSC; SOIL; INACTIVATION	The disease-associated prion protein (PrPTSE), the probable etiological agent of the transmissible spongiform encephalopathies (TSEs), is resistant to degradation and can persist in the environment. Lichens, mutualistic symbioses containing fungi, algae, bacteria and occasionally cyanobacteria, are ubiquitous in the environment and have evolved unique biological activities allowing their survival in challenging ecological niches. We investigated PrPTSE inactivation by lichens and found acetone extracts of three lichen species (Parmelia sulcata, Cladonia rangiferina and Lobaria pulmonaria) have the ability to degrade prion protein (PrP) from TSE-infected hamsters, mice and deer. Immunoblots measuring PrP levels and protein misfolding cyclic amplification indicated at least two logs of reductions in PrPTSE. Degradative activity was not found in closely related lichen species or in algae or a cyanobacterium that inhabit lichens. Degradation was blocked by Pefabloc SC, a serine protease inhibitor, but not inhibitors of other proteases or enzymes. Additionally, we found that PrP levels in PrPTSE-enriched preps or infected brain homogenates are also reduced following exposure to freshly-collected P. sulcata or an aqueous extract of the lichen. Our findings indicate that these lichen extracts efficiently degrade PrPTSE and suggest that some lichens could have potential to inactivate TSE infectivity on the landscape or be a source for agents to degrade prions. Further work to clone and characterize the protease, assess its effect on TSE infectivity and determine which organism or organisms present in lichens produce or influence the protease activity is warranted.	[Johnson, Christopher J.; Bennett, James P.; Biro, Steven M.; Rodriguez, Cynthia M.; Rocke, Tonie E.] US Geol Survey, Prion Res Lab, Natl Wildlife Hlth Ctr, Madison, WI USA; [Johnson, Christopher J.; Bessen, Richard A.] Montana State Univ, Dept Vet Mol Biol, Bozeman, MT 59717 USA; [Bennett, James P.] Univ Wisconsin, Inst Environm Studies, Madison, WI 53706 USA; [Biro, Steven M.; Rodriguez, Cynthia M.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Camilo Duque-Velasquez, Juan] Univ Antioquia, Fac Ciencias Agr, Grp Invest CENTAURO, Medellin, Antioquia, Colombia	United States Department of the Interior; United States Geological Survey; Montana State University System; Montana State University Bozeman; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Universidad de Antioquia	Johnson, CJ (corresponding author), US Geol Survey, Prion Res Lab, Natl Wildlife Hlth Ctr, Madison, WI USA.	cjjohnson@usgs.gov	Johnson, Christopher/B-1436-2009	Johnson, Christopher/0000-0003-4539-2581; Rocke, Tonie/0000-0003-3933-1563	United States Geological Survey	United States Geological Survey(United States Geological Survey)	This work was funded by the United States Geological Survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasi A, 2004, COMPOST SCI UTIL, V12, P185; AVALOS A, 1986, LICHEN PHYSL BIOCH, V1, P77; Bates ST, 2011, APPL ENVIRON MICROB, V77, P1309, DOI 10.1128/AEM.02257-10; Beckett RP, 2007, PHYSIOL PLANTARUM, V129, P588, DOI 10.1111/j.1399-3054.2006.00846.x; BESSEN RA, 1992, J GEN VIROL, V73, P329, DOI 10.1099/0022-1317-73-2-329; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; BROWN P, 1991, LANCET, V337, P269, DOI 10.1016/0140-6736(91)90873-N; Brown P, 2000, NEUROLOGY, V55, P1075, DOI 10.1212/WNL.55.8.1075; Candan M, 2007, Z NATURFORSCH C, V62, P619; Chen J, 2000, CATENA, V39, P121, DOI 10.1016/S0341-8162(99)00085-5; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Cook WE, 2007, J WILDLIFE DIS, V43, P498, DOI 10.7589/0090-3558-43.3.498; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; DAWSON HJ, 1984, SOIL SCI, V138, P40, DOI 10.1097/00010694-198407000-00007; Dickinson J, 2009, J HOSP INFECT, V72, P65, DOI 10.1016/j.jhin.2008.12.007; EASTON RM, 1994, GEOSCI CAN, V21, P59; FAHSELT D, 1994, SYMBIOSIS, V17, P127; Fujihara A, 2009, FEBS J, V276, P2841, DOI 10.1111/j.1742-4658.2009.07007.x; Georgsson G, 2006, J GEN VIROL, V87, P3737, DOI 10.1099/vir.0.82011-0; Gough KC, 2010, PRION, V4, P275, DOI 10.4161/pri.4.4.13678; Grube Martin, 2009, Fungal Biology Reviews, V23, P72, DOI 10.1016/j.fbr.2009.10.001; Heisey DM, 2010, J VIROL, V84, P210, DOI 10.1128/JVI.00560-09; Hinckley GT, 2008, ENVIRON SCI TECHNOL, V42, P5254, DOI 10.1021/es703186e; Hoinville LJ, 1996, REV SCI TECH OIE, V15, P827, DOI 10.20506/rst.15.3.959; Hui Z, 2004, BIOCHEM BIOPH RES CO, V321, P45, DOI 10.1016/j.bbrc.2004.06.100; Huneck S, 1996, IDENTIFICATION LICHE; Johnson C, 2006, J GEN VIROL, V87, P2109, DOI 10.1099/vir.0.81615-0; Johnson CJ, 2006, PLOS PATHOG, V2, P296, DOI 10.1371/journal.ppat.0020032; KIMBERLIN RH, 1977, J GEN VIROL, V34, P295, DOI 10.1099/0022-1317-34-2-295; Kranner I, 2008, BRYOLOGIST, V111, P576, DOI 10.1639/0007-2745-111.4.576; Langeveld JPM, 2003, J INFECT DIS, V188, P1782, DOI 10.1086/379664; Laufer Z, 2009, BRYOLOGIST, V112, P418, DOI 10.1639/0007-2745-112.2.418; Lawson VA, 2007, J GEN VIROL, V88, P2905, DOI 10.1099/vir.0.82961-0; Lorenzo M, 2005, CHEMOSPHERE, V60, P1124, DOI 10.1016/j.chemosphere.2004.12.051; Madamombe IT, 2003, PHARM BIOL, V41, P199, DOI 10.1076/phbi.41.3.199.15089; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; McLeod AH, 2004, BIOCHEM BIOPH RES CO, V317, P1165, DOI 10.1016/j.bbrc.2004.03.168; Meade-White KD, 2009, EMERG INFECT DIS, V15, P207, DOI 10.3201/eid1502.081173; Miller MW, 2003, NATURE, V425, P35, DOI 10.1038/425035a; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; NEARY K, 1991, J VIROL, V65, P1031, DOI 10.1128/JVI.65.2.1031-1034.1991; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Palsson P. A., 1979, Slow transmissible diseases of the nervous system. Volume 1., P357; Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201; Pilon JL, 2009, J VIROL METHODS, V161, P168, DOI 10.1016/j.jviromet.2009.04.040; Purvis OW, 1996, LICHENOLOGIST, V28, P571; Purvis W., 2000, LICHENS; Radeka M, 2007, J EUR CERAM SOC, V27, P1763, DOI 10.1016/j.jeurceramsoc.2006.05.001; Rankovic B, 2007, BRIT J BIOMED SCI, V64, P143, DOI 10.1080/09674845.2007.11732776; Rankovic B, 2007, Mikrobiologiia, V76, P817; Rapp D, 2006, ENVIRON SCI TECHNOL, V40, P6324, DOI 10.1021/es060943h; Russo F, 2009, J GEN VIROL, V90, P275, DOI 10.1099/vir.0.003251-0; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Saunders SE, 2010, ENVIRON SCI TECHNOL, V44, P4129, DOI 10.1021/es903520d; Scherbel C, 2007, ZOONOSES PUBLIC HLTH, V54, P185, DOI 10.1111/j.1863-2378.2007.01040.x; Schramm PT, 2006, REV MINERAL GEOCHEM, V64, P135, DOI 10.2138/rmg.2006.64.5; SHAPIRO IA, 1979, SOV J ECOL+, V10, P565; Tay T, 2004, Z NATURFORSCH C, V59, P384; Taylor DM, 2000, VET J, V159, P10, DOI 10.1053/tvjl.1999.0406; TAYLOR TN, 1995, NATURE, V378, P244, DOI 10.1038/378244a0; Thomas DN, 2005, TRENDS MICROBIOL, V13, P87, DOI 10.1016/j.tim.2004.11.002; Watts JC, 2006, PLOS PATHOG, V2, P152, DOI 10.1371/journal.ppat.0020026; Weissman L, 2005, APPL ENVIRON MICROB, V71, P6508, DOI 10.1128/AEM.71.11.6508-6514.2005; Weissmann C, 2005, ANNU REV MED, V56, P321, DOI 10.1146/annurev.med.56.062404.172936; Wickner RB, 2007, NAT REV MICROBIOL, V5, P611, DOI 10.1038/nrmicro1708; Yoshioka M, 2007, BIOSCI BIOTECH BIOCH, V71, P2565, DOI 10.1271/bbb.70257; Zavarzina A G, 2006, Mikrobiologiia, V75, P630	67	22	24	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19836	10.1371/journal.pone.0019836	http://dx.doi.org/10.1371/journal.pone.0019836			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589935	gold, Green Submitted, Green Published			2022-12-27	WOS:000290483600032
J	McMaken, S; Exline, MC; Mehta, P; Piper, M; Wang, YJ; Fischer, SN; Newland, CA; Schrader, CA; Balser, SR; Sarkar, A; Baran, CP; Marsh, CB; Cook, CH; Phillips, GS; Ali, NA				McMaken, Sara; Exline, Matthew C.; Mehta, Payal; Piper, Melissa; Wang, Yijie; Fischer, Sara N.; Newland, Christie A.; Schrader, Carrie A.; Balser, Shannon R.; Sarkar, Anasuya; Baran, Christopher P.; Marsh, Clay B.; Cook, Charles H.; Phillips, Gary S.; Ali, Naeem A.			Thrombospondin-1 Contributes to Mortality in Murine Sepsis through Effects on Innate Immunity	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; POSTOPERATIVE ADHESIONS; UNITED-STATES; FIBROBLASTS; EXPRESSION; EPIDEMIOLOGY; PHAGOCYTOSIS; PERITONITIS; HOMEOSTASIS; PNEUMONIA	Background: Thrombospondin-1 (TSP-1) is involved in many biological processes, including immune and tissue injury response, but its role in sepsis is unknown. Cell surface expression of TSP-1 on platelets is increased in sepsis and could activate the anti-inflammatory cytokine transforming growth factor beta (TGF beta 1) affecting outcome. Because of these observations we sought to determine the importance of TSP-1 in sepsis. Methodology/Principal Findings: We performed studies on TSP-1 null and wild type (WT) C57BL/6J mice to determine the importance of TSP-1 in sepsis. We utilized the cecal ligation puncture (CLP) and intraperitoneal E. coli injection (IP E. coli) models of peritoneal sepsis. Additionally, bone-marrow-derived macrophages (BMMs) were used to determine phagocytic activity. TSP-1-/- animals experienced lower mortality than WT mice after CLP. Tissue and peritoneal lavage TGF beta 1 levels were unchanged between animals of each genotype. In addition, there is no difference between the levels of major innate cytokines between the two groups of animals. PLF from WT mice contained a greater bacterial load than TSP-1-/- mice after CLP. The survival advantage for TSP-1-/- animals persisted when IP E. coli injections were performed. TSP-1-/- BMMs had increased phagocytic capacity compared to WT. Conclusions: TSP-1 deficiency was protective in two murine models of peritoneal sepsis, independent of TGF beta 1 activation. Our studies suggest TSP-1 expression is associated with decreased phagocytosis and possibly bacterial clearance, leading to increased peritoneal inflammation and mortality in WT mice. These data support the contention that TSP-1 should be more fully explored in the human condition.	[McMaken, Sara; Exline, Matthew C.; Mehta, Payal; Piper, Melissa; Wang, Yijie; Fischer, Sara N.; Newland, Christie A.; Schrader, Carrie A.; Balser, Shannon R.; Sarkar, Anasuya; Baran, Christopher P.; Marsh, Clay B.; Ali, Naeem A.] Ohio State Univ, Div Pulm Allergy Crit Care & Sleep Med, Dept Internal Med, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Cook, Charles H.] Ohio State Univ, Dept Surg, Columbus, OH 43210 USA; [Phillips, Gary S.] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	McMaken, S (corresponding author), Ohio State Univ, Div Pulm Allergy Crit Care & Sleep Med, Dept Internal Med, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	Naeem.Ali@osumc.edu	Exline, Matthew/E-3047-2011; Cook, Charles/D-5574-2009; Piper, Melissa/E-3872-2011; Cook, Charles/AAE-3222-2020	Cook, Charles/0000-0003-4446-3616; ALI, NORA'AINI/0000-0003-1391-2757	National Institutes of Health [K23 RR019544]; American Lung Association [RG-52369-N]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755, K23RR019544] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	National Institutes of Health K23 RR019544 to NAA; American Lung Association Award RG-52369-N to MCE. The funders had no role in the design of the study, data collection and analysis, decision to publish or preparation of the manuscript.	Adams J, 2004, INT J BIOCHEM CELL B, V36, P960, DOI 10.1016/j.biocel.2004.02.009; Ali NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001914; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Aytekin FO, 2007, AM J SURG, V193, P723, DOI 10.1016/j.amjsurg.2006.06.035; BAENZIGE.NL, 1971, P NATL ACAD SCI USA, V68, P240, DOI 10.1073/pnas.68.1.240; Baran CP, 2003, J BIOL CHEM, V278, P38628, DOI 10.1074/jbc.M305021200; Barker TH, 2004, J BIOL CHEM, V279, P23510, DOI 10.1074/jbc.M402169200; Chen H, 2000, MATRIX BIOL, V19, P597, DOI 10.1016/S0945-053X(00)00107-4; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Cook DJ, 1998, ANN INTERN MED, V129, P433, DOI 10.7326/0003-4819-129-6-199809150-00002; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; Dellinger RP, 2003, CRIT CARE MED, V31, P946, DOI 10.1097/01.CCM.0000057403.73299.A6; Diamond MP, 2005, FERTIL STERIL, V83, P405, DOI 10.1016/j.fertnstert.2004.06.073; DiPietro LA, 1996, AM J PATHOL, V148, P1851; Esemuede N, 2004, J SURG RES, V122, P135, DOI 10.1016/j.jss.2004.05.015; Gawaz M, 1997, INTENS CARE MED, V23, P379, DOI 10.1007/s001340050344; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; IGARASHI A, 1993, MOL BIOL CELL, V4, P637, DOI 10.1091/mbc.4.6.637; IRUELAARISPE ML, 1991, P NATL ACAD SCI USA, V88, P5026, DOI 10.1073/pnas.88.11.5026; Lawler J, 1998, J CLIN INVEST, V101, P982, DOI 10.1172/JCI1684; Maloney JP, 2002, FASEB J, V16, pA879; MANSFIELD PJ, 1994, J IMMUNOL, V153, P4219; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Martin-Manso G, 2008, CANCER RES, V68, P7090, DOI 10.1158/0008-5472.CAN-08-0643; Moodley Y, 2003, AM J PATHOL, V162, P771, DOI 10.1016/S0002-9440(10)63874-6; NARIZHNEVA NV, 2005, FASEB J; Piazuelo E, 2000, EUR SURG RES, V32, P191, DOI 10.1159/000008762; Pittet JF, 2001, J CLIN INVEST, V107, P1537, DOI 10.1172/JCI11963; REN Y, 1995, J IMMUNOL, V154, P2366; Riche FC, 2009, CRIT CARE, V13, DOI 10.1186/cc7931; Saed GM, 2004, J AM ASSOC GYN LAP, V11, P307, DOI 10.1016/S1074-3804(05)60041-2; Saltzman AK, 1996, AM J OBSTET GYNECOL, V174, P1502, DOI 10.1016/S0002-9378(96)70596-3; Sarkar A, 2006, AM J RESP CRIT CARE, V174, P1003, DOI 10.1164/rccm.200604-546OC; SCHULTZCHERRY S, 1994, J BIOL CHEM, V269, P26783; SIMMS HH, 1994, BLOOD, V83, P1398; Steinhauser ML, 1999, J IMMUNOL, V162, P5437; Streit M, 2000, EMBO J, V19, P3272, DOI 10.1093/emboj/19.13.3272; Tridandapani S, 2000, J BIOL CHEM, V275, P20480, DOI 10.1074/jbc.M909462199; van der Wal JBC, 2007, COLORECTAL DIS, V9, P9, DOI 10.1111/j.1463-1318.2007.01345.x; van Zoelen MAD, 2008, J IMMUNOL, V180, P3357, DOI 10.4049/jimmunol.180.5.3357; Wirtz S, 2006, J EXP MED, V203, P1875, DOI 10.1084/jem.20060471; Yang ZW, 2007, J CELL BIOL, V176, P787, DOI 10.1083/jcb.200611044	42	32	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19654	10.1371/journal.pone.0019654	http://dx.doi.org/10.1371/journal.pone.0019654			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573017	Green Published, Green Submitted, gold			2022-12-27	WOS:000290386800028
J	Bourgey, M; Lariviere, M; Richer, C; Sinnett, D				Bourgey, Mathieu; Lariviere, Mathieu; Richer, Chantal; Sinnett, Daniel			ALG: Automated Genotype Calling of Luminex Assays	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; ACUTE LYMPHOBLASTIC-LEUKEMIA; GENETIC ASSOCIATION; ERRORS; SUSCEPTIBILITY; POPULATION; POWER	Single nucleotide polymorphisms (SNPs) are the most commonly used polymorphic markers in genetics studies. Among the different platforms for SNP genotyping, Luminex is one of the less exploited mainly due to the lack of a robust (semi-automated and replicable) freely available genotype calling software. Here we describe a clustering algorithm that provides automated SNP calls for Luminex genotyping assays. We genotyped 3 SNPs in a cohort of 330 childhood leukemia patients, 200 parents of patient and 325 healthy individuals and used the Automated Luminex Genotyping (ALG) algorithm for SNP calling. ALG genotypes were called twice to test for reproducibility and were compared to sequencing data to test for accuracy. Globally, this analysis demonstrates the accuracy (99.6%) of the method, its reproducibility (99.8%) and the low level of no genotyping calls (3.4%). The high efficiency of the method proves that ALG is a suitable alternative to the current commercial software. ALG is semi-automated, and provides numerical measures of confidence for each SNP called, as well as an effective graphical plot. Moreover ALG can be used either through a graphical user interface, requiring no specific informatics knowledge, or through command line with access to the open source code. The ALG software has been implemented in R and is freely available for non-commercial use either at http://alg.sourceforge.net or by request to mathieu.bourgey@umontreal.ca	[Bourgey, Mathieu; Lariviere, Mathieu; Richer, Chantal; Sinnett, Daniel] Univ Montreal, St Justine Hosp, Res Ctr, Montreal, PQ, Canada; [Sinnett, Daniel] Univ Montreal, Fac Med, Dept Pediat, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal	Bourgey, M (corresponding author), Univ Montreal, St Justine Hosp, Res Ctr, Montreal, PQ, Canada.	daniel.sinnett@umontreal.ca	sinnett, daniel/S-4589-2017	sinnett, daniel/0000-0003-3625-6676; Bourgey, Mathieu/0000-0002-8432-834X	Canadian Institutes for Health Research; Cole Foundation; Francois-Karl Viau Chair in Pediatric Oncogenomics; Fonds de la Recherche en Sante du Quebec	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Cole Foundation; Francois-Karl Viau Chair in Pediatric Oncogenomics; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This study was supported by research funds provided by the Canadian Institutes for Health Research. MB is the recipient of a post-doctoral fellowship from the Cole Foundation. DS holds the Francois-Karl Viau Chair in Pediatric Oncogenomics and is a scholar of the Fonds de la Recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccichet A, 1997, LEUKEMIA RES, V21, P817, DOI 10.1016/S0145-2126(97)00075-1; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; de Leon J, 2008, CLIN LAB MED, V28, P599, DOI 10.1016/j.cll.2008.05.003; Gordon D, 2005, J CLIN INVEST, V115, P1408, DOI 10.1172/JCI24756; Gordon D, 2002, HUM HERED, V54, P22, DOI 10.1159/000066696; Gordon D, 2001, AM J HUM GENET, V69, P371, DOI 10.1086/321981; HEALY J, 2010, HEMATOLOGICA; Healy J, 2007, BLOOD, V109, P683, DOI 10.1182/blood-2006-02-003236; Huebner C, 2007, CANCER EPIDEM BIOMAR, V16, P1185, DOI 10.1158/1055-9965.EPI-06-0759; Ivanova M, 2008, HUM IMMUNOL, V69, P877, DOI 10.1016/j.humimm.2008.09.007; King CR, 2008, AM J CLIN PATHOL, V129, P876, DOI 10.1309/1E34UAPR06PJ6HML; Koo SH, 2007, BIOL PROCED ONLINE, V9, P27, DOI 10.1251/bpo131; Krajinovic M, 1999, BLOOD, V93, P1496, DOI 10.1182/blood.V93.5.1496.405a36_1496_1501; LaFramboise T, 2009, NUCLEIC ACIDS RES, V37, P4181, DOI 10.1093/nar/gkp552; Lin Y, 2008, BIOINFORMATICS, V24, P2665, DOI 10.1093/bioinformatics/btn509; Lovmar L, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-35; Moskvina V, 2006, HUM HERED, V61, P55, DOI 10.1159/000092553; MOTE VL, 1965, BIOMETRIKA, V52, P95, DOI 10.1093/biomet/52.1-2.95; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Rousseeuw J. P., 1987, J COMPUTATIONAL APPL, V20, P53; Strom CM, 2006, J MOL DIAGN, V8, P371, DOI 10.2353/jmoldx.2006.050115; SYLVESTER JE, 2010, MOL CANC THER; Tian F, 2008, CLIN CHEM LAB MED, V46, P486, DOI 10.1515/CCLM.2008.098; WASHINGTON C, 2000, J CLIN MICROBIOL; WEEKS DE, 1995, TRENDS GENET, V11, P513, DOI 10.1016/S0168-9525(00)89163-5; Yao Y, 2009, TISSUE ANTIGENS, V73, P561, DOI 10.1111/j.1399-0039.2009.01237.x	26	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19368	10.1371/journal.pone.0019368	http://dx.doi.org/10.1371/journal.pone.0019368			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573116	Green Published, gold, Green Submitted			2022-12-27	WOS:000290305600023
J	Lucifora, LO; Garcia, VB; Worm, B				Lucifora, Luis O.; Garcia, Veronica B.; Worm, Boris			Global Diversity Hotspots and Conservation Priorities for Sharks	PLOS ONE			English	Article							BIODIVERSITY HOTSPOTS; MARINE BIODIVERSITY; PREDATOR DIVERSITY; PATTERNS; COLLAPSE; RAYS	Sharks are one of the most threatened groups of marine animals, as high exploitation rates coupled with low resilience to fishing pressure have resulted in population declines worldwide. Designing conservation strategies for this group depends on basic knowledge of the geographic distribution and diversity of known species. So far, this information has been fragmented and incomplete. Here, we have synthesized the first global shark diversity pattern from a new database of published sources, including all 507 species described at present, and have identified hotspots of shark species richness, functional diversity and endemicity from these data. We have evaluated the congruence of these diversity measures and demonstrate their potential use in setting priority areas for shark conservation. Our results show that shark diversity across all species peaks on the continental shelves and at mid-latitudes (30-40 degrees N and S). Global hotspots of species richness, functional diversity and endemicity were found off Japan, Taiwan, the East and West coasts of Australia, Southeast Africa, Southeast Brazil and Southeast USA. Moreover, some areas with low to moderate species richness such as Southern Australia, Angola, North Chile and Western Continental Europe stood out as places of high functional diversity. Finally, species affected by shark finning showed different patterns of diversity, with peaks closer to the Equator and a more oceanic distribution overall. Our results show that the global pattern of shark diversity is uniquely different from land, and other well-studied marine taxa, and may provide guidance for spatial approaches to shark conservation. However, similar to terrestrial ecosystems, protected areas based on hotspots of diversity and endemism alone would provide insufficient means for safeguarding the diverse functional roles that sharks play in marine ecosystems.	[Lucifora, Luis O.] Consejo Nacl Invest Cient & Tecn, CIES, CeIBA, Puerto Iguazu, Misiones, Argentina; [Lucifora, Luis O.; Garcia, Veronica B.; Worm, Boris] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Dalhousie University	Lucifora, LO (corresponding author), Consejo Nacl Invest Cient & Tecn, CIES, CeIBA, Puerto Iguazu, Misiones, Argentina.	bworm@dal.ca	Lucifora, Luis/B-4602-2014	Worm, Boris/0000-0002-5742-8716; Lucifora, Luis/0000-0002-1443-303X	Lenfest Oceans Program; Sloan Foundation	Lenfest Oceans Program; Sloan Foundation(Alfred P. Sloan Foundation)	This study was supported financially by the Lenfest Oceans Program. Additional funding was provided by the Sloan Foundation (Census Of Marine Life FMAP Project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GR, 2008, AQUAT CONSERV, V18, P541, DOI 10.1002/aqc.880; [Anonymous], 2004, SHARK PRODUCT TRADE, DOI DOI 10.1098/rstb.2004.1568; Baum JK, 2004, ECOL LETT, V7, P135, DOI 10.1111/j.1461-0248.2003.00564.x; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Bonfil R., 1994, FAO FISHERIES TECHNI, V341, P119; Boyce DG, 2008, MAR ECOL PROG SER, V355, P267, DOI 10.3354/meps07237; Camhi MD, 2009, CONSERVATION STATUS; Camhi Merry D., 2008, Fish and Aquatic Resources Series, V13, P418; Carpenter KE, 2005, ENVIRON BIOL FISH, V72, P467, DOI 10.1007/s10641-004-3154-4; Clarke SC, 2006, ECOL LETT, V9, P1115, DOI 10.1111/j.1461-0248.2006.00968.x; Compagno L.J.V., 2001, SHARKS WORLD, V2; Compagno L.J.V., 2005, FIELD GUIDE SHARKS W; COMPAGNO LJV, 1990, ENVIRON BIOL FISH, V28, P33, DOI 10.1007/BF00751027; Compagno LJV., 1984, FAO FISH SYNOP, P20; COMPAGNO LJV, 1990, ELASMOBRANCHS LIVING, V90, P391; Ferretti F, 2008, CONSERV BIOL, V22, P952, DOI 10.1111/j.1523-1739.2008.00938.x; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Fowler Sarah L., 2005, P58; Godin AC, 2010, MAR POLICY, V34, P995, DOI 10.1016/j.marpol.2010.02.006; Graham KJ, 2001, MAR FRESHWATER RES, V52, P549, DOI 10.1071/MF99174; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Hughes TP, 2002, ECOL LETT, V5, P775, DOI 10.1046/j.1461-0248.2002.00383.x; Kareiva P, 2003, AM SCI, V91, P344, DOI 10.1511/2003.26.869; Last P. R., 2009, SHARKS RAYS AUSTR, V2; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Massa A., 2004, MAR ARGENTINO SUS RE, P193; Menni RC, 2010, BIODIVERS CONSERV, V19, P775, DOI 10.1007/s10531-009-9734-z; Mora C, 2003, NATURE, V421, P933, DOI 10.1038/nature01393; MUSICK JA, 1993, CONSERVATION BIOL EL, V115, P1; Pollard DA, 1996, AQUAT CONSERV, V6, P1, DOI 10.1002/(SICI)1099-0755(199603)6:1<1::AID-AQC177>3.0.CO;2-#; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Rutherford S, 1999, NATURE, V400, P749, DOI 10.1038/23449; Schnute JT, 2008, CAN TECH REP FISH AQ, V2549, P1; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399; Worm B, 2003, P NATL ACAD SCI USA, V100, P9884, DOI 10.1073/pnas.1333941100; Yano K, 2005, SHARKS RAYS MALAYSIA	38	96	105	3	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19356	10.1371/journal.pone.0019356	http://dx.doi.org/10.1371/journal.pone.0019356			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573162	Green Published, gold, Green Submitted			2022-12-27	WOS:000290256400006
J	Huang, ST; Yang, RC; Wu, HT; Wang, CN; Pang, JHS				Huang, Sheng-Teng; Yang, Rong-Chi; Wu, Hsiao-Ting; Wang, Chao-Nin; Pang, Jong-Hwei S.			Zinc-Chelation Contributes to the Anti-Angiogenic Effect of Ellagic Acid on Inhibiting MMP-2 Activity, Cell Migration and Tube Formation	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE-2; ACTIVATION; RECK; METASTASIS; PROTEIN; GROWTH; ROLES	Background: Ellagic acid (EA), a dietary polyphenolic compound, has been demonstrated to exert anti-angiogenic effect but the detailed mechanism is not yet fully understood. The aim of this study was to investigate whether the zinc chelating activity of EA contributed to its anti-angiogenic effect. Methods and Principal Findings: The matrix metalloproteinases-2 (MMP-2) activity, a zinc-required reaction, was directly inhibited by EA as examined by gelatin zymography, which was reversed dose-dependently by adding zinc chloride. In addition, EA was demonstrated to inhibit the secretion of MMP-2 from human umbilical vein endothelial cells (HUVECs) as analyzed by Western blot method, which was also reversed by the addition of zinc chloride. Reversion-inducing cysteine-rich protein with Kazal motifs (RECK), known to down-regulate the MMP-2 activity, was induced by EA at both the mRNA and protein levels which was correlated well with the inhibition of MMP-2 activity. Interestingly, zinc chloride could also abolish the increase of EA-induced RECK expression. The anti-angiogenic effect of EA was further confirmed to inhibit matrix-induced tube formation of endothelial cells. The migration of endothelial cells as analyzed by transwell filter assay was suppressed markedly by EA dose-dependently as well. Zinc chloride could reverse these two effects of EA also in a dose-dependent manner. Since magnesium chloride or calcium chloride could not reverse the inhibitory effect of EA, zinc was found to be involved in tube formation and migration of vascular endothelial cells. Conclusions/Significance: Together these results demonstrated that the zinc chelation of EA is involved in its anti-angiogenic effects by inhibiting MMP-2 activity, tube formation and cell migration of vascular endothelial cells. The role of zinc was confirmed to be important in the process of angiogenesis.	[Huang, Sheng-Teng; Wu, Hsiao-Ting] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Kaohsiung Med Ctr,Dept Chinese Med, Kaohsiung, Taiwan; [Wang, Chao-Nin] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Tao Yuan, Taiwan; [Pang, Jong-Hwei S.] Chang Gung Univ, Grad Inst Clin Med Sci, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Huang, ST (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Kaohsiung Med Ctr,Dept Chinese Med, Kaohsiung, Taiwan.	jonghwei@mail.cgu.edu.tw		PANG, JONG-HWEI/0000-0003-3432-0208	Chang Gung Memorial Hospital [CMRPG880811, CMRPG371623]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by the Chang Gung Memorial Hospital with CMRPG880811 and CMRPG371623. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KJ, 2001, J NUTR, V131, P2837, DOI 10.1093/jn/131.11.2837; BOCK PE, 1981, BIOCHEMISTRY-US, V20, P7258, DOI 10.1021/bi00528a032; Buniatian GH, 2003, CELL PROLIFERAT, V36, P307, DOI 10.1046/j.1365-2184.2003.00287.x; Chakraborty S, 2004, J ENVIRON PATHOL TOX, V23, P215, DOI 10.1615/JEnvPathToxOncol.v23.i3.50; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Clark JCM, 2007, CANCER METAST REV, V26, P675, DOI 10.1007/s10555-007-9093-8; Festa F, 2001, ANTICANCER RES, V21, P3903; Figueira RCS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-20; FORKMAN J, 1992, SEMIN CANCER BIOL, V3, P65; Gopalakrishna R, 2002, J NUTR, V132, p3819S, DOI 10.1093/jn/132.12.3819S; Hannum SM, 2004, CRIT REV FOOD SCI, V44, P1, DOI 10.1080/10408690490263756; Herrera MC, 2004, ANAL BIOANAL CHEM, V379, P1106, DOI 10.1007/s00216-004-2684-0; Huang SS, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/895857; INGBER DE, 1990, J CELL BIOL, V110, P1803, DOI 10.1083/jcb.110.5.1803; Innocenti A, 2010, BIOORGAN MED CHEM, V18, P2159, DOI 10.1016/j.bmc.2010.01.076; Ispanovic E, 2008, AM J PHYSIOL-CELL PH, V295, pC600, DOI 10.1152/ajpcell.00460.2007; Itoh T, 1998, CANCER RES, V58, P1048; Labrecque L, 2005, CARCINOGENESIS, V26, P821, DOI 10.1093/carcin/bgi024; Lassen U, 2010, BRIT J CANCER, V103, P12, DOI 10.1038/sj.bjc.6605726; Liu LT, 2003, CANCER RES, V63, P3069; Ma Q, 2009, P NATL ACAD SCI USA, V106, P8683, DOI 10.1073/pnas.0812688106; Marks PA, 2010, BBA-GENE REGUL MECH, V1799, P717, DOI 10.1016/j.bbagrm.2010.05.008; Marks PA, 2010, EXPERT OPIN INV DRUG, V19, P1049, DOI 10.1517/13543784.2010.510514; Mertens-Talcott SU, 2003, J NUTR, V133, P2669, DOI 10.1093/jn/133.8.2669; Narayanan BA, 2002, LIFE SCI, V70, P1821, DOI 10.1016/S0024-3205(02)01481-9; Narayanan BA, 2001, ANTICANCER RES, V21, P359; Noda M, 2003, CANCER METAST REV, V22, P167, DOI 10.1023/A:1023043315031; Raffetto JD, 2008, BIOCHEM PHARMACOL, V75, P346, DOI 10.1016/j.bcp.2007.07.004; Richardson S, 2003, OSTEOARTHR CARTILAGE, V11, P92, DOI 10.1053/joca.2002.0858; Rosenblum G, 2003, J BIOL CHEM, V278, P27009, DOI 10.1074/jbc.M301139200; Rumjahn SM, 2007, BRIT J CANCER, V97, P1372, DOI 10.1038/sj.bjc.6604019; Saleem A, 2002, J ETHNOPHARMACOL, V81, P327, DOI 10.1016/S0378-8741(02)00099-5; Seftor REB, 2001, CANCER RES, V61, P6322; Span PN, 2003, CANCER, V97, P2710, DOI 10.1002/cncr.11395; Talbot DC, 1996, EUR J CANCER, V32A, P2528; Yilmaz Y, 2004, J AGR FOOD CHEM, V52, P255, DOI 10.1021/jf030117h; Yoon SO, 2003, J BIOCHEM MOL BIOL, V36, P128	37	24	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e18986	10.1371/journal.pone.0018986	http://dx.doi.org/10.1371/journal.pone.0018986			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573219	gold, Green Published, Green Submitted			2022-12-27	WOS:000290224800012
J	Bhat, RK; Ellestad, KK; Wheatley, BM; Warren, R; Holt, RA; Power, C				Bhat, Rakesh K.; Ellestad, Kristofor K.; Wheatley, B. Matt; Warren, Rene; Holt, Robert A.; Power, Christopher			Age- and Disease-Dependent HERV-W Envelope Allelic Variation in Brain: Association with Neuroimmune Gene Expression	PLOS ONE			English	Article							HUMAN ENDOGENOUS RETROVIRUSES; MOLECULAR CHARACTERIZATION; MULTIPLE-SCLEROSIS; CODING CAPACITY; ENV; IDENTIFICATION; GLYCOPROTEIN; FAMILY; NEUROINFLAMMATION; SYNCYTIN-1	Background: The glycoprotein, Syncytin-1, is encoded by a human endogenous retrovirus (HERV)-W env gene and is capable of inducing neuroinflammation. The specific allele(s) responsible for Syncytin-1 expression in the brain is uncertain. Herein, HERV-W env diversity together with Syncytin-1 abundance and host immune gene profiles were examined in the nervous system using a multiplatform approach. Results: HERV-W env sequences were encoded by multiple chromosomal encoding loci in primary human neurons compared with less chromosomal diversity in astrocytes and microglia (p < 0.05). HERV-W env RNA sequences cloned from brains of patients with systemic or neurologic diseases were principally derived from chromosomal locus 7q21.2. Within the same specimens, HERV-W env transcript levels were correlated with the expression of multiple proinflammatory genes (p < 0.05). Deep sequencing of brain transcriptomes disclosed the env transcripts to be the most abundant HERV-W transcripts, showing greater expression in fetal compared with healthy adult brain specimens. Syncytin-1' s expression in healthy brain specimens was derived from multiple encoding loci and linked to distinct immune and developmental gene profiles. Conclusions: Syncytin-1 expression in the brain during disease was associated with neuroinflammation and was principally encoded by a full length provirus. The present studies also highlighted the diversity in HERV gene expression within the brain and reinforce the potential contributions of HERV expression to neuroinflammatory diseases.	[Bhat, Rakesh K.; Ellestad, Kristofor K.; Power, Christopher] Univ Alberta, Div Neurol, Edmonton, AB, Canada; [Wheatley, B. Matt] Univ Alberta, Div Neurosurg, Edmonton, AB, Canada; [Warren, Rene; Holt, Robert A.] British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada	University of Alberta; University of Alberta; British Columbia Cancer Agency	Bhat, RK (corresponding author), Univ Alberta, Div Neurol, Edmonton, AB, Canada.	chris.power@ualberta.ca	Power, Christopher/C-7181-2013; Holt, Robert A/C-3303-2009; Bhat, Rakesh/B-4320-2009; Bhat, Rakesh Kumar/AID-0687-2022; Warren, Rene/R-7681-2016	Holt, Robert A/0000-0002-7259-1247; Bhat, Rakesh Kumar/0000-0001-7649-0470; Warren, Rene/0000-0002-9890-2293; Power, Christopher/0000-0002-5131-9711	Multiple Sclerosis Society of Canada; Canada Research Chair (CRC)	Multiple Sclerosis Society of Canada; Canada Research Chair (CRC)(Canada Research Chairs)	These studies were supported by the Multiple Sclerosis Society of Canada. CP holds a Canada Research Chair (CRC) (Tier 1) in Neurological Infection and Immunity and an AHFMR Senior Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliel PM, 1998, CR ACAD SCI III-VIE, V321, P857, DOI 10.1016/S0764-4469(99)80026-2; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antony JM, 2004, NAT NEUROSCI, V7, P1088, DOI 10.1038/nn1319; Antony JM, 2007, AIDS RES HUM RETROV, V23, P1251, DOI 10.1089/aid.2006.0274; Antony JM, 2006, AIDS RES HUM RETROV, V22, P1253, DOI 10.1089/aid.2006.22.1253; Antony JM, 2007, J IMMUNOL, V179, P1210, DOI 10.4049/jimmunol.179.2.1210; Bannert N, 2006, ANNU REV GENOM HUM G, V7, P149, DOI 10.1146/annurev.genom.7.080505.115700; Blond JL, 1999, J VIROL, V73, P1175, DOI 10.1128/JVI.73.2.1175-1185.1999; Bonnaud B, 2004, MOL BIOL EVOL, V21, P1895, DOI 10.1093/molbev/msh206; Bonnaud B, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-57; Chandrasekar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007447; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Clausen J, 2003, Int MS J, V10, P22; Costas J, 2002, MOL BIOL EVOL, V19, P526, DOI 10.1093/oxfordjournals.molbev.a004108; de Parseval N, 2003, J VIROL, V77, P10414, DOI 10.1128/JVI.77.19.10414-10422.2003; Dewannieux M, 2006, GENOME RES, V16, P1548, DOI 10.1101/gr.5565706; Ellestad KK, 2009, J IMMUNOL, V183, P298, DOI 10.4049/jimmunol.0803576; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Khatkar MS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-171; Kim HS, 2008, MOL CELLS, V26, P53; Kim HS, 2001, AIDS RES HUM RETROV, V17, P643, DOI 10.1089/088922201300119752; LI WH, 1988, MOL BIOL EVOL, V5, P313; Maingat F, 2010, J IMMUNOL, V184, P1566, DOI 10.4049/jimmunol.0902575; Mangeney M, 2007, P NATL ACAD SCI USA, V104, P20534, DOI 10.1073/pnas.0707873105; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Mayer J, 2002, GENOMICS, V80, P331, DOI 10.1006/geno.2002.6839; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Noorali S, 2009, APPL IMMUNOHISTO M M, V17, P319, DOI 10.1097/PAI.0b013e31819640f9; Noorbakhsh F, 2005, J IMMUNOL, V174, P7320, DOI 10.4049/jimmunol.174.11.7320; Noorbakhsh F, 2010, FASEB J, V24, P1799, DOI 10.1096/fj.09-147819; OGAWA T, 2005, INCREASED PRODUCTIVI; Pavlicek A, 2002, GENOME RES, V12, P391, DOI 10.1101/gr.216902; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Ryan FP, 2004, J ROY SOC MED, V97, P560, DOI 10.1258/jrsm.97.12.560; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; VENABLES PJW, 1995, VIROLOGY, V211, P589, DOI 10.1006/viro.1995.1442; Voisset C, 2000, AIDS RES HUM RETROV, V16, P731, DOI 10.1089/088922200308738; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Zhu Y, 2009, FASEB J, V23, P2928, DOI 10.1096/fj.08-128819	41	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19176	10.1371/journal.pone.0019176	http://dx.doi.org/10.1371/journal.pone.0019176			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559469	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700092
J	Li, YQ; Du, XL; Lu, ZJ; Wu, DQ; Zhao, YL; Ren, B; Huang, JF; Huang, XQ; Xu, YH; Xu, YQ				Li, Yaqian; Du, Xilin; Lu, Zhi John; Wu, Daqiang; Zhao, Yilei; Ren, Bin; Huang, Jiaofang; Huang, Xianqing; Xu, Yuhong; Xu, Yuquan			Regulatory Feedback Loop of Two phz Gene Clusters through 5 '-Untranslated Regions in Pseudomonas sp M18	PLOS ONE			English	Article							PHENAZINE-1-CARBOXYLIC ACID; BIOLOGICAL-CONTROL; VIRULENCE FACTORS; AERUGINOSA PAO1; FLUORESCENT PSEUDOMONADS; ANTIBIOTIC PRODUCTION; PHENAZINE COMPOUNDS; FUNCTIONAL-ANALYSIS; BIOSYNTHESIS; PYOCYANIN	Background: Phenazines are important compounds produced by pseudomonads and other bacteria. Two phz gene clusters called phzA1-G1 and phzA2-G2, respectively, were found in the genome of Pseudomonas sp. M18, an effective biocontrol agent, which is highly homologous to the opportunistic human pathogen P. aeruginosa PAO1, however little is known about the correlation between the expressions of two phz gene clusters. Methodology/Principal Findings: Two chromosomal insertion inactivated mutants for the two gene clusters were constructed respectively and the correlation between the expressions of two phz gene clusters was investigated in strain M18. Phenazine-1-carboxylic acid (PCA) molecules produced from phzA2-G2 gene cluster are able to auto-regulate expression itself and activate the expression of phzA1-G1 gene cluster in a circulated amplification pattern. However, the post-transcriptional expression of phzA1-G1 transcript was blocked principally through 5'-untranslated region (UTR). In contrast, the phzA2-G2 gene cluster was transcribed to a lesser extent and translated efficiently and was negatively regulated by the GacA signal transduction pathway, mainly at a post-transcriptional level. Conclusions/Significance: A single molecule, PCA, produced in different quantities by the two phz gene clusters acted as the functional mediator and the two phz gene clusters developed a specific regulatory mechanism which acts through 5'-UTR to transfer a single, but complex bacterial signaling event in Pseudomonas sp. strain M18.	[Li, Yaqian; Du, Xilin; Wu, Daqiang; Zhao, Yilei; Ren, Bin; Huang, Jiaofang; Huang, Xianqing; Xu, Yuquan] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Lu, Zhi John] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA; [Li, Yaqian; Xu, Yuhong] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Yale University; Shanghai Jiao Tong University	Li, YQ (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	xuyq@sjtu.edu.cn	Xu, Yuhong/E-4247-2012	Huang, Xianqing/0000-0001-6649-518X; Wu, Daqiang/0000-0003-1581-1538	National Key Basic Research Program [2009CB118906]; National High Technology Research and Development Program of China [2006AA10A209, 2007AA02Z215]; Shanghai Leading Academic Discipline Project [B203]; Shanghai Science Technology Program [08391911900];  [201003273]	National Key Basic Research Program(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Shanghai Science Technology Program; 	This work was supported in part by grants from the National Key Basic Research Program (973 Program, No. 2009CB118906), the National High Technology Research and Development Program of China (863 Program, No. 2006AA10A209 and 2007AA02Z215), the postdoctoral funding (No. 201003273) and the Shanghai Leading Academic Discipline Project (No. B203) and Shanghai Science Technology Program (No. 08391911900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Berg G, 2005, ENVIRON MICROBIOL, V7, P1673, DOI 10.1111/j.1462-2920.2005.00891.x; Blumer C, 1999, P NATL ACAD SCI USA, V96, P14073, DOI 10.1073/pnas.96.24.14073; Brantl S, 2004, TRENDS MICROBIOL, V12, P473, DOI 10.1016/j.tim.2004.09.008; Burrowes E, 2006, MICROBIOL-SGM, V152, P405, DOI 10.1099/mic.0.28324-0; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chin-A-Woeng TFC, 2001, MOL PLANT MICROBE IN, V14, P1006, DOI 10.1094/MPMI.2001.14.8.1006; Chugani SA, 2001, P NATL ACAD SCI USA, V98, P2752, DOI 10.1073/pnas.051624298; Delaney SM, 2001, J BACTERIOL, V183, P318, DOI 10.1128/JB.183.1.318-327.2001; Dietrich LEP, 2008, SCIENCE, V321, P1203, DOI 10.1126/science.1160619; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; Dwivedi D, 2003, CURR SCI INDIA, V85, P1693; Fajardo A, 2008, CURR OPIN MICROBIOL, V11, P161, DOI 10.1016/j.mib.2008.02.006; Fitzpatrick DA, 2009, J MOL EVOL, V68, P171, DOI 10.1007/s00239-009-9198-5; Ge YH, 2004, FEMS MICROBIOL LETT, V237, P41, DOI [10.1016/j.femsle.2004.06.028, 10.1111/j.1574-6968.2004.tb09676.x]; Ge YH, 2007, FEMS MICROBIOL LETT, V268, P81, DOI 10.1111/j.1574-6968.2006.00562.x; Gibson J, 2009, APPL ENVIRON MICROB, V75, P504, DOI 10.1128/AEM.01037-08; Greenhagen BT, 2008, BIOCHEMISTRY-US, V47, P5281, DOI 10.1021/bi702480t; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Haas D, 2003, ANNU REV PHYTOPATHOL, V41, P117, DOI 10.1146/annurev.phyto.41.052002.095656; HASSETT DJ, 1992, INFECT IMMUN, V60, P328, DOI 10.1128/IAI.60.2.328-336.1992; Heeb S, 2001, MOL PLANT MICROBE IN, V14, P1351, DOI 10.1094/MPMI.2001.14.12.1351; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hu HB, 2005, J MICROBIOL BIOTECHN, V15, P86; Huang JF, 2009, APPL ENVIRON MICROB, V75, P6568, DOI 10.1128/AEM.01148-09; Huang XQ, 2008, J MICROBIOL BIOTECHN, V18, P828; Klockgether J, 2010, J BACTERIOL, V192, P1113, DOI 10.1128/JB.01515-09; Lapouge K, 2007, MOL MICROBIOL, V66, P341, DOI 10.1111/j.1365-2958.2007.05909.x; Latifi A, 1996, MOL MICROBIOL, V21, P1137, DOI 10.1046/j.1365-2958.1996.00063.x; Ledgham F, 2003, MOL MICROBIOL, V48, P199, DOI 10.1046/j.1365-2958.2003.03423.x; Li YQ, 2008, APPL MICROBIOL BIOT, V77, P1207, DOI 10.1007/s00253-007-1213-4; Linares JF, 2006, P NATL ACAD SCI USA, V103, P19484, DOI 10.1073/pnas.0608949103; Mandal M, 2004, NAT REV MOL CELL BIO, V5, P451, DOI 10.1038/nrm1403; Mavrodi DV, 2006, ANNU REV PHYTOPATHOL, V44, P417, DOI 10.1146/annurev.phyto.44.013106.145710; Mavrodi DV, 2010, APPL ENVIRON MICROB, V76, P866, DOI 10.1128/AEM.02009-09; Mavrodi DV, 1998, J BACTERIOL, V180, P2541, DOI 10.1128/JB.180.9.2541-2548.1998; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; Miller JH., 1972, EXPT MOL GENETICS; Mlot C, 2009, SCIENCE, V324, P1637, DOI 10.1126/science.324_1637; Parsons JF, 2007, BIOCHEMISTRY-US, V46, P1821, DOI 10.1021/bi6024403; Perneel M, 2008, ENVIRON MICROBIOL, V10, P778, DOI 10.1111/j.1462-2920.2007.01501.x; Pierson LS, 2010, APPL MICROBIOL BIOT, V86, P1659, DOI 10.1007/s00253-010-2509-3; Raaijmakers JM, 2002, ANTON LEEUW INT J G, V81, P537, DOI 10.1023/A:1020501420831; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rahme LG, 2000, P NATL ACAD SCI USA, V97, P8815, DOI 10.1073/pnas.97.16.8815; Reimmann C, 1997, MOL MICROBIOL, V24, P309, DOI 10.1046/j.1365-2958.1997.3291701.x; Sambrook J, 2001, MOL CLONING LAB MANU; Shi Mingqi, 2009, Weishengwu Xuebao, V49, P1306; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Yan A, 2007, MICROBIOL-SGM, V153, P16, DOI 10.1099/mic.0.29211-0; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	52	12	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19413	10.1371/journal.pone.0019413	http://dx.doi.org/10.1371/journal.pone.0019413			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559370	Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700162
J	Altmann, EG; Pierrehumbert, JB; Motter, AE				Altmann, Eduardo G.; Pierrehumbert, Janet B.; Motter, Adilson E.			Niche as a Determinant of Word Fate in Online Groups	PLOS ONE			English	Article							EVOLUTIONARY DYNAMICS; LANGUAGE; FREQUENCY; SEARCH; RATES	Patterns of word use both reflect and influence a myriad of human activities and interactions. Like other entities that are reproduced and evolve, words rise or decline depending upon a complex interplay between their intrinsic properties and the environments in which they function. Using Internet discussion communities as model systems, we define the concept of a word niche as the relationship between the word and the characteristic features of the environments in which it is used. We develop a method to quantify two important aspects of the size of the word niche: the range of individuals using the word and the range of topics it is used to discuss. Controlling for word frequency, we show that these aspects of the word niche are strong determinants of changes in word frequency. Previous studies have already indicated that word frequency itself is a correlate of word success at historical time scales. Our analysis of changes in word frequencies over time reveals that the relative sizes of word niches are far more important than word frequencies in the dynamics of the entire vocabulary at shorter time scales, as the language adapts to new concepts and social groupings. We also distinguish endogenous versus exogenous factors as additional contributors to the fates of words, and demonstrate the force of this distinction in the rise of novel words. Our results indicate that short-term nonstationarity in word statistics is strongly driven by individual proclivities, including inclinations to provide novel information and to project a distinctive social identity.	[Altmann, Eduardo G.; Pierrehumbert, Janet B.; Motter, Adilson E.] Northwestern Univ, NW Inst Complex Syst, Evanston, IL 60208 USA; [Altmann, Eduardo G.] Univ Fed Rio Grande do Sul, Dept Fis, Porto Alegre, RS, Brazil; [Altmann, Eduardo G.] Max Planck Inst Phys Komplexer Syst, Dresden, Germany; [Pierrehumbert, Janet B.] Northwestern Univ, Dept Linguist, Evanston, IL USA; [Motter, Adilson E.] Northwestern Univ, Dept Phys & Astron, Evanston, IL USA	Northwestern University; Universidade Federal do Rio Grande do Sul; Max Planck Society; Northwestern University; Northwestern University	Altmann, EG (corresponding author), Northwestern Univ, NW Inst Complex Syst, Evanston, IL 60208 USA.	motter@northwestern.edu	Altmann, Eduardo G./ABD-2012-2020; Altmann, Eduardo/A-3320-2009	Altmann, Eduardo G./0000-0002-1932-3710; Altmann, Eduardo/0000-0002-1932-3710; Pierrehumbert, Janet/0000-0002-5989-3574; Motter, Adilson E./0000-0003-1794-4828	Northwestern Institute on Complex Systems; Max Planck Society; JSMF [21002061]; NSF [DMS-0709212]; Sloan Research Fellowship	Northwestern Institute on Complex Systems; Max Planck Society(Max Planck SocietyFoundation CELLEX); JSMF; NSF(National Science Foundation (NSF)); Sloan Research Fellowship(Alfred P. Sloan Foundation)	E.G.A. was supported by the Northwestern Institute on Complex Systems and a Max Planck Society Otto Hahn Fellowship, J.B.P. by JSMF Grant No. 21002061, and A.E.M. by NSF Grant No. DMS-0709212 and a Sloan Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams DM, 2003, NATURE, V424, P900, DOI 10.1038/424900a; Altmann EG, 2009, PLOS ONE, V4, pA31, DOI 10.1371/journal.pone.0007678; Serrano MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005372; Baronchelli A, 2010, P NATL ACAD SCI USA, V107, P2403, DOI 10.1073/pnas.0908533107; Blythe RA, 2010, COGNITIVE SCI, V34, P620, DOI 10.1111/j.1551-6709.2009.01089.x; Cacoullos RT, 2009, LANGUAGE, V85, P321; Cattuto C, 2007, P NATL ACAD SCI USA, V104, P1461, DOI 10.1073/pnas.0610487104; Cattuto C, 2009, P NATL ACAD SCI USA, V106, P10511, DOI 10.1073/pnas.0901136106; Chesley P, 2010, LINGUISTICS, V48, P1343, DOI 10.1515/LING.2010.043; Church K. W., 1995, NAT LANG ENG, V1, P163, DOI [DOI 10.1017/S1351324900000139, 10.1017/S1351324900000139]; CLARK EV, 1990, J CHILD LANG, V17, P417, DOI 10.1017/S0305000900013842; COLWELL RK, 1971, ECOLOGY, V52, P567, DOI 10.2307/1934144; Crane R, 2008, P NATL ACAD SCI USA, V105, P15649, DOI 10.1073/pnas.0803685105; Crystal D, 2006, LANGUAGE AND THE INTERNET, 2ND EDITION, P1, DOI 10.2277/ 0521868599; Davis MH, 2009, PHILOS T R SOC B, V364, P3773, DOI 10.1098/rstb.2009.0111; Dijksterhuis A, 2001, ADV EXP SOC PSYCHOL, V33, P1, DOI 10.1016/S0065-2601(01)80003-4; Eble Connie., 1996, SLANG SOCIABILITY IN; Eckert Penelope, 2000, LINGUIST VAR; Fisher D., 2006, P 39 HAW INT C SYST, DOI DOI 10.1109/HICSS.2006.536; Fontanari JF, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.042901; Foote M, 2008, PALEOBIOLOGY, V34, P421, DOI 10.1666/08023.1; Fortunato S, 2006, P NATL ACAD SCI USA, V103, P12684, DOI 10.1073/pnas.0605525103; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Grice H.P., 1975, SYNTAX SEMANTICS; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Hotho A, 2006, LECT NOTES COMPUT SC, V4011, P411; Hruschka DJ, 2009, TRENDS COGN SCI, V13, P464, DOI 10.1016/j.tics.2009.08.008; Jablonski D, 2005, PALEOBIOLOGY, V31, P192, DOI 10.1666/0094-8373(2005)031[0192:MEAM]2.0.CO;2; Kirby S, 2008, P NATL ACAD SCI USA, V105, P10681, DOI 10.1073/pnas.0707835105; Kleinberg J, 2003, DATA MIN KNOWL DISC, V7, P373, DOI 10.1023/A:1024940629314; Komarova NL, 2001, B MATH BIOL, V63, P451, DOI 10.1006/bulm.2000.0222; KRUSKAL W, 1987, AM STAT, V41, P6, DOI 10.2307/2684310; Kuiper K, 2006, BEHAV BRAIN SCI, V29, P291, DOI 10.1017/S0140525X06359067; Labov, 2001, PRINCIPLES LINGUISTI; Lerman K., 2010, P 19 INT C WORLD WID, P621, DOI DOI 10.1145/1772690.1772754; Lieberman E, 2007, NATURE, V449, P713, DOI 10.1038/nature06137; Lu QM, 2009, J ECON INTERACT COOR, V4, P221, DOI 10.1007/s11403-009-0057-7; Lupyan G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008559; Malmgren RD, 2008, P NATL ACAD SCI USA, V105, P18153, DOI 10.1073/pnas.0800332105; Manning C.D., 1999, FDN STAT NATURAL LAN; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Munat Judit, 2007, LEXICAL CREATIVITY T; Nettle D, 1999, LINGUA, V108, P119, DOI 10.1016/S0024-3841(98)00047-3; Neuman Y, 2011, COMPLEXITY, V16, P58, DOI 10.1002/cplx.20347; Nickerson DW, 2008, AM POLIT SCI REV, V102, P49, DOI 10.1017/S0003055408080039; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Pagel M, 2007, NATURE, V449, P717, DOI 10.1038/nature06176; Pride J., 1980, LANGUAGE, V58, P231, DOI [10.2307/413545, DOI 10.2307/413545]; ROGERS EM, 2003, DI USION INNOVATIONS; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; Schifanella Rossano, 2010, P 3 ACM INT C WEB SE, P271, DOI DOI 10.1145/1718487.1718521; Seshadri M., 2008, PROC 14 ACM SIGKDD I, P596, DOI DOI 10.1145/1401890.1401963; Smitherman Geneva., 2000, BLACK TALK WORDS PHR, VRevised edn.; Sole RV, 2010, J R SOC INTERFACE, V7, P1647, DOI 10.1098/rsif.2010.0110; Sornette D, 2006, FRONTIERS COLL, P95; Steels L., 1997, EVOL COMMUN, V1, P1, DOI [DOI 10.1075/E0C.1.1.02STE, 10.1075/eoc.1.1.02ste, DOI 10.1075/EOC.1.1.02STE]; Szabo G, 2010, COMMUN ACM, V53, P80, DOI 10.1145/1787234.1787254; Trestian I, 2008, ACM SIGCOMM COMP COM, V38, P279, DOI 10.1145/1402946.1402991; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Watts DJ, 2007, J CONSUM RES, V34, P441, DOI 10.1086/518527; WEXLER P, 1980, FORMAL PRINCIPLES LA, P6010; Wichmann S, 2008, ADV COMPLEX SYST, V11, P357, DOI 10.1142/S0219525908001684	62	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19009	10.1371/journal.pone.0019009	http://dx.doi.org/10.1371/journal.pone.0019009			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	763CL	21589910	Green Submitted, Green Published, gold			2022-12-27	WOS:000290531100003
J	Eisenberg, ML; Hsieh, MH; Walters, RC; Krasnow, R; Lipshultz, LI				Eisenberg, Michael L.; Hsieh, Michael H.; Walters, Rustin Chanc; Krasnow, Ross; Lipshultz, Larry I.			The Relationship between Anogenital Distance, Fatherhood, and Fertility in Adult Men	PLOS ONE			English	Article							TESTICULAR DEVELOPMENTAL PROBLEMS; PROGRAMMING WINDOW; WHISTLE BLOWERS; NEWBORN-INFANTS; ANDROGEN ACTION; CANCER TRENDS; RAT; POPULATIONS; COUNTRIES; EXPOSURE	Background: Anogenital distance (AGD), a sexually dimorphic measure of genital development, is a marker for endocrine disruption in animal studies and may be shorter in infant males with genital anomalies. Given the correlation between anogenital distance and genital development, we sought to determine if anogenital distance varied in fertile compared to infertile adult men. Methods: A cross sectional study of consecutive men being evaluated for infertility and men with proven fertility was recruited from an andrology clinic. Anogenital distance (the distance from the posterior aspect of the scrotum to the anal verge) and penile length (PL) were measured using digital calipers. ANOVA and linear regression were used to determine correlations between AGD, fatherhood status, and semen analysis parameters (sperm density, motility, and total motile sperm count). Findings: A total of 117 infertile men (mean age: 35.3 +/- 17.4) and 56 fertile men (mean age: 44.8 +/- 9.7) were recruited. The infertile men possessed significantly shorter mean AGD and PL compared to the fertile controls (AGD: 31.8 vs 44.6 mm, PL: 107.1 vs 119.5 mm, p<0.01). The difference in AGD persisted even after accounting for ethnic and anthropomorphic differences. In addition to fatherhood, on both unadjusted and adjusted linear regression, AGD was significantly correlated with sperm density and total motile sperm count. After adjusting for demographic and reproductive variables, for each 1 cm increase in a man's AGD, the sperm density increases by 4.3 million sperm per mL (95% CI 0.53, 8.09, p = 0.03) and the total motile sperm count increases by 6.0 million sperm (95% CI 1.34, 10.58, p = 0.01). On adjusted analyses, no correlation was seen between penile length and semen parameters. Conclusion: A longer anogenital distance is associated with fatherhood and may predict normal male reproductive potential. Thus, AGD may provide a novel metric to assess reproductive potential in men.	[Eisenberg, Michael L.; Walters, Rustin Chanc; Krasnow, Ross; Lipshultz, Larry I.] Baylor Coll Med, Scott Dept Urol, Div Male Reprod Med & Surg, Houston, TX 77030 USA; [Hsieh, Michael H.] Stanford Univ, Sch Med, Dept Urol, Palo Alto, CA 94304 USA	Baylor College of Medicine; Stanford University	Eisenberg, ML (corresponding author), Baylor Coll Med, Scott Dept Urol, Div Male Reprod Med & Surg, Houston, TX 77030 USA.	eisenberg@stanford.edu		Krasnow, Ross/0000-0001-9773-9431; Eisenberg, Michael/0000-0001-5482-0141				CALLEGARI C, 1987, J PEDIATR-US, V111, P240, DOI 10.1016/S0022-3476(87)80075-6; CARLSEN E, 1992, BRIT MED J, V305, P609, DOI 10.1136/bmj.305.6854.609; Carpenter DO, 2008, ANN NY ACAD SCI, V1140, P155, DOI 10.1196/annals.1454.004; Christiansen S, 2008, INT J ANDROL, V31, P241, DOI 10.1111/j.1365-2605.2008.00866.x; Davis DL, 1998, JAMA-J AM MED ASSOC, V279, P1018, DOI 10.1001/jama.279.13.1018; Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231; GREENHAM L W, 1977, Laboratory Animals (London), V11, P181, DOI 10.1258/002367777780936620; Grigor KM, 2007, INT J ANDROL, V30, P204; Hsieh Michael H, 2008, Curr Urol Rep, V9, P137; Larsen WJ, 1997, HUMAN EMBRYOLOGY, P261; MacLeod DJ, 2010, INT J ANDROL, V33, P279, DOI 10.1111/j.1365-2605.2009.01005.x; Marois G., 1968, Biologie Medicale, V57, P44; Salazar-Martinez Eduardo, 2004, Environ Health, V3, P8, DOI 10.1186/1476-069X-3-8; Sathyanarayana S, 2010, INT J ANDROL, V33, P317, DOI 10.1111/j.1365-2605.2009.01044.x; Scott HM, 2008, ENDOCRINOLOGY, V149, P5280, DOI 10.1210/en.2008-0413; Scott HM, 2007, ENDOCRINOLOGY, V148, P2027, DOI 10.1210/en.2006-1622; Skakkebek NE, 2007, INT J ANDROL, V30, P198, DOI 10.1111/j.1365-2605.2007.00776.x; Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100; Thankamony A, 2009, ENVIRON HEALTH PERSP, V117, P1786, DOI 10.1289/ehp.0900881; Velde ET, 2010, HUM REPROD, V25, P1348, DOI 10.1093/humrep/deq085; Welsh M, 2010, INT J ANDROL, V33, pE144, DOI 10.1111/j.1365-2605.2009.00978.x	21	155	158	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e18973	10.1371/journal.pone.0018973	http://dx.doi.org/10.1371/journal.pone.0018973			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589916	Green Submitted, gold, Green Published			2022-12-27	WOS:000290483600004
J	Mesaki, K; Tanabe, K; Obayashi, M; Oe, N; Takei, K				Mesaki, Kumi; Tanabe, Kenji; Obayashi, Masanori; Oe, Natsuko; Takei, Kohji			Fission of Tubular Endosomes Triggers Endosomal Acidification and Movement	PLOS ONE			English	Article							VESICLE FORMATION; MUTANT DYNAMIN; V-ATPASE; ENDOCYTOSIS; PROTEINS; TRANSPORT; RECEPTOR; LYSOSOMES; CELLS; MICRODOMAINS	The early endosome acts as a sorting station for internalized molecules destined for recycling or degradation. While recycled molecules are sorted and delivered to tubular endosomes, residual compartments containing molecules to be degraded undergo "maturation" before final degradation in the lysosome. This maturation involves acidification, microtubule-dependent motility, and perinuclear localization. It is currently unknown how sorting and the processes of maturation cooperate with each other. Here, we show that fission of a tubular endosome triggers the maturation of the residual endosome, leading to degradation. Use of the dynamin inhibitor dynasore to block tubular endosome fission inhibited acidification, endosomal motility along microtubules, perinuclear localization, and degradation. However, tubular endosome fission was not affected by inhibiting endosomal acidification or by depolymerizing the microtubules. These results demonstrate that the fission of recycling tubules is the first important step in endosomal maturation and degradation in the lysosome. We believe this to be the first evidence of a cascade from sorting to degradation.	[Mesaki, Kumi; Tanabe, Kenji; Obayashi, Masanori; Oe, Natsuko; Takei, Kohji] Okayama Univ, Dept Neurosci, Grad Sch Med, Okayama 700, Japan	Okayama University	Mesaki, K (corresponding author), Okayama Univ, Dept Neurosci, Grad Sch Med, Okayama 700, Japan.	ktanabe@md.okayama-u.ac.jp	TANABE, Kenji/B-2319-2011	Takei, Kohji/0000-0002-6555-9425; Tanabe, Kenji/0000-0003-2645-9429	Ministry of Education, Science, Sports, and Culture of Japan [23113721]; Grants-in-Aid for Scientific Research [23770148] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan (23113721) http://kaken.nii.ac.jp/en/p/23113721. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babst M, 2005, TRAFFIC, V6, P2, DOI 10.1111/j.1600-0854.2004.00246.x; Baravalle G, 2005, CELL TISSUE RES, V320, P99, DOI 10.1007/s00441-004-1060-x; Bright NA, 2005, CURR BIOL, V15, P360, DOI 10.1016/j.cub.2005.01.049; Cao H, 2000, J CELL SCI, V113, P1993; CLAGUE MJ, 1994, J BIOL CHEM, V269, P21; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; DRISKELL OJ, 2006, NAT CELL BIOL; DUNN KW, 1989, J CELL BIOL, V109, P3303, DOI 10.1083/jcb.109.6.3303; GEUZE HJ, 1987, J CELL BIOL, V104, P1715, DOI 10.1083/jcb.104.6.1715; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; GRUENBERG J, 1989, J CELL BIOL, V108, P1301, DOI 10.1083/jcb.108.4.1301; HELENIUS A, 1983, TRENDS BIOCHEM SCI, V8, P245, DOI 10.1016/0968-0004(83)90350-X; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Murray JW, 2003, ADV DRUG DELIVER REV, V55, P1385, DOI 10.1016/j.addr.2003.07.008; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Puthenveedu MA, 2010, CELL, V143, P761, DOI 10.1016/j.cell.2010.10.003; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Recchi C, 2006, NAT CELL BIOL, V8, P107, DOI 10.1038/ncb0206-107; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; SCHMID SL, 1988, CELL, V52, P73, DOI 10.1016/0092-8674(88)90532-6; Schmid SL, 1998, NATURE, V392, P135, DOI 10.1038/32309; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; TRAER CJ, 2007, NAT CELL BIOL; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; van Dam EM, 2002, J BIOL CHEM, V277, P48876, DOI 10.1074/jbc.M206271200; van Dam EM, 2002, MOL BIOL CELL, V13, P169, DOI 10.1091/mbc.01-07-0380	41	49	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19764	10.1371/journal.pone.0019764	http://dx.doi.org/10.1371/journal.pone.0019764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572956	Green Submitted, Green Published, gold			2022-12-27	WOS:000290440200027
J	Wallace, E; Benayoun, M; van Drongelen, W; Cowan, JD				Wallace, Edward; Benayoun, Marc; van Drongelen, Wim; Cowan, Jack D.			Emergent Oscillations in Networks of Stochastic Spiking Neurons	PLOS ONE			English	Article							FAST RIPPLES; GAMMA; NOISE	Networks of neurons produce diverse patterns of oscillations, arising from the network's global properties, the propensity of individual neurons to oscillate, or a mixture of the two. Here we describe noisy limit cycles and quasi-cycles, two related mechanisms underlying emergent oscillations in neuronal networks whose individual components, stochastic spiking neurons, do not themselves oscillate. Both mechanisms are shown to produce gamma band oscillations at the population level while individual neurons fire at a rate much lower than the population frequency. Spike trains in a network undergoing noisy limit cycles display a preferred period which is not found in the case of quasi-cycles, due to the even faster decay of phase information in quasi-cycles. These oscillations persist in sparsely connected networks, and variation of the network's connectivity results in variation of the oscillation frequency. A network of such neurons behaves as a stochastic perturbation of the deterministic Wilson-Cowan equations, and the network undergoes noisy limit cycles or quasi-cycles depending on whether these have limit cycles or a weakly stable focus. These mechanisms provide a new perspective on the emergence of rhythmic firing in neural networks, showing the coexistence of population-level oscillations with very irregular individual spike trains in a simple and general framework.	[Wallace, Edward; Cowan, Jack D.] Univ Chicago, Dept Math, Chicago, IL 60637 USA; [Benayoun, Marc; van Drongelen, Wim] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [van Drongelen, Wim] Univ Chicago, Computat Inst, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Wallace, E (corresponding author), Univ Chicago, Dept Math, Chicago, IL 60637 USA.	ewallace@math.uchicago.edu		Wallace, Edward/0000-0001-8025-6361; van Drongelen, Wim/0000-0001-8950-5424	Dr. Ralph and Marian Falk Medical Research Trust; Frank Family Fund Fellowship; MSTP	Dr. Ralph and Marian Falk Medical Research Trust; Frank Family Fund Fellowship; MSTP	WvD and MB would like to thank the Dr. Ralph and Marian Falk Medical Research Trust, the Frank Family Fund Fellowship, and MSTP for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso D, 2007, J R SOC INTERFACE, V4, P575, DOI 10.1098/rsif.2006.0192; Anderson DF, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2799998; Benayoun M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000846; Boland RP, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051131; Borgers C, 2003, NEURAL COMPUT, V15, P509, DOI 10.1162/089976603321192059; Bragin A, 2002, J NEUROSCI, V22, P2012, DOI 10.1523/JNEUROSCI.22-05-02012.2002; Bratsun D, 2005, P NATL ACAD SCI USA, V102, P14593, DOI 10.1073/pnas.0503858102; Bressloff PC, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.051903; Bressloff PC, 2009, SIAM J APPL MATH, V70, P1488, DOI 10.1137/090756971; Brunel N, 2003, J NEUROPHYSIOL, V90, P415, DOI 10.1152/jn.01095.2002; Brunel N, 2008, CHAOS, V18, DOI 10.1063/1.2779858; Buice MA, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.051919; Cowan JD, 1990, P 1990 C ADV NEUR IN, V3, P62; Doiron B, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.030903; Ermentrout B, 1998, REP PROG PHYS, V61, P353, DOI 10.1088/0034-4885/61/4/002; Field R. J., 1985, OSCILLATIONS TRAVELI; Foffani G, 2007, NEURON, V55, P930, DOI 10.1016/j.neuron.2007.07.040; Freeman WJ, 2006, CLIN NEUROPHYSIOL, V117, P1228, DOI 10.1016/j.clinph.2006.03.012; Freeman WJ, 2000, J NEUROSCI METH, V95, P111, DOI 10.1016/S0165-0270(99)00160-0; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Gardiner C. W, 2009, STOCHASTIC METHODS, V13; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gireesh ED, 2008, P NATL ACAD SCI USA, V105, P7576, DOI 10.1073/pnas.0800537105; GOLOMB D, 1994, PHYSICA D, V72, P259, DOI 10.1016/0167-2789(94)90214-3; Hughes JR, 2008, EPILEPSY BEHAV, V13, P25, DOI 10.1016/j.yebeh.2008.01.011; Jefferys JGR, 1996, TRENDS NEUROSCI, V19, P202, DOI 10.1016/S0166-2236(96)10023-0; Mattia M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.052903; McKane AJ, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.041902; McKane AJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.218102; MEUNIER C, 1988, J STAT PHYS, V50, P345, DOI 10.1007/BF01022998; Miller KJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000609; NIKOLIC D, 2009, NEUR NETW IEEE INNS, P2272; Nisbet R M, 1982, MODELING FLUCTUATING; NISBET RM, 1976, NATURE, V263, P319, DOI 10.1038/263319a0; Olufsen MS, 2003, J COMPUT NEUROSCI, V14, P33, DOI 10.1023/A:1021124317706; Pikovsky AS, 1997, PHYS REV LETT, V78, P775, DOI 10.1103/PhysRevLett.78.775; Pineda-Krch M, 2007, OIKOS, V116, P53, DOI 10.1111/j.2006.0030-1299.14940.x; Roxin A, 2008, J NEUROSCI, V28, P10734, DOI 10.1523/JNEUROSCI.1016-08.2008; Staley KJ, 2007, NEURON, V55, P828, DOI 10.1016/j.neuron.2007.09.005; Traub RD, 2005, J NEUROPHYSIOL, V93, P2194, DOI 10.1152/jn.00983.2004; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; van Drongelen W, 2005, IEEE T NEUR SYS REH, V13, P236, DOI 10.1109/TNSRE.2005.847387; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1; WALLACE E, 2010, ARXIV10044280CONDMAT; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; WINFREE A, 2001, GEOMETRY BIOL TIME, P808	48	84	85	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e14804	10.1371/journal.pone.0014804	http://dx.doi.org/10.1371/journal.pone.0014804			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573105	gold, Green Published			2022-12-27	WOS:000290305600001
J	Eriksson, A; Anfora, G; Lucchi, A; Virant-Doberlet, M; Mazzoni, V				Eriksson, Anna; Anfora, Gianfranco; Lucchi, Andrea; Virant-Doberlet, Meta; Mazzoni, Valerio			Inter-Plant Vibrational Communication in a Leafhopper Insect	PLOS ONE			English	Article							VIRIDULA L HETEROPTERA; FUNCTIONAL-PROPERTIES; BEHAVIOR; HOMOPTERA; SIGNALS; ORGAN; MORPHOLOGY; SUBSTRATE; DETECTOR; SOUND	Vibrational communication is one of the least understood channels of communication. Most studies have focused on the role of substrate-borne signals in insect mating behavior, where a male and a female establish a stereotyped duet that enables partner recognition and localization. While the effective communication range of substrate-borne signals may be up to several meters, it is generally accepted that insect vibrational communication is limited to a continuous substrate. Until now, interplant communication in absence of physical contact between plants has never been demonstrated in a vibrational communicating insect. With a laser vibrometer we investigated transmission of natural and played back vibrational signals of a grapevine leafhopper, Scaphoideus titanus, when being transmitted between leaves of different cuttings without physical contact. Partners established a vibrational duet up to 6 cm gap width between leaves. Ablation of the antennae showed that antennal mechanoreceptors are not essential in detection of mating signals. Our results demonstrate for the first time that substrate discontinuity does not impose a limitation on communication range of vibrational signals. We also suggest that the behavioral response may depend on the signal intensity.	[Eriksson, Anna; Anfora, Gianfranco; Mazzoni, Valerio] Fdn Edmund Mach, Res & Innovat Ctr, San Michele All Adige, Italy; [Eriksson, Anna; Lucchi, Andrea] Univ Pisa, Dept Coltivaz & Difesa Specie Legnose, Pisa, Italy; [Virant-Doberlet, Meta] Natl Inst Biol, Dept Entomol, Ljubljana, Slovenia	Fondazione Edmund Mach; University of Pisa; National Institute of Biology - Slovenia	Eriksson, A (corresponding author), Fdn Edmund Mach, Res & Innovat Ctr, San Michele All Adige, Italy.	gianfranco.anfora@iasma.it	LUCCHI, ANDREA/N-4088-2015; Virant-Doberlet, Meta/G-9251-2019; Mazzoni, Valerio/ABE-4661-2021	LUCCHI, ANDREA/0000-0002-9379-6495; Virant-Doberlet, Meta/0000-0001-7510-2392; Mazzoni, Valerio/0000-0003-4036-5322; ANFORA, Gianfranco/0000-0003-2545-1409	Slovenian Research Agency, Fondi Ateneo of Pisa University [P1-0255, V4-0525]	Slovenian Research Agency, Fondi Ateneo of Pisa University(Slovenian Research Agency - Slovenia)	This research was supported by the Autonomous Province of Trento (Accordo di Programma 2010, http://www.uniricerca.provincia.tn.it/ accordi_programma/), Funding Research Programme P1-0255 and Research Project V4-0525 by Slovenian Research Agency, Fondi Ateneo of Pisa University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, PRINCIPLES ANIMAL CO; Barth FG, 2002, ZOOLOGY, V105, P271, DOI 10.1078/0944-2006-00082; Bennet-Clark HC, 1998, PHILOS T ROY SOC B, V353, P407, DOI 10.1098/rstb.1998.0219; Caldwell MS, 2010, CURR BIOL, V20, P1012, DOI 10.1016/j.cub.2010.03.069; Casas J, 1998, BIOL CONTROL, V11, P147, DOI 10.1006/bcon.1997.0593; CLARIDGE MF, 1985, ANNU REV ENTOMOL, V30, P297, DOI 10.1146/annurev.en.30.010185.001501; CLARIDGE MF, 1986, BIOL J LINN SOC, V27, P381, DOI 10.1111/j.1095-8312.1986.tb01743.x; Cocroft RB, 2006, ETHOLOGY, V112, P779, DOI 10.1111/j.1439-0310.2006.01226.x; Cocroft RB, 2005, BIOSCIENCE, V55, P323, DOI 10.1641/0006-3568(2005)055[0323:TBEOIV]2.0.CO;2; Cokl A, 2005, J EXP BIOL, V208, P1481, DOI 10.1242/jeb.01557; Cokl A, 1997, J EXP ZOOL, V278, P395, DOI 10.1002/(SICI)1097-010X(19970815)278:6&lt;395::AID-JEZ7&gt;3.0.CO;2-J; Cokl A, 2003, ANNU REV ENTOMOL, V48, P29, DOI 10.1146/annurev.ento.48.091801.112605; Cokl A, 1995, J EXP ZOOL, V273, P376, DOI 10.1002/jez.1402730503; COKL A, 1983, J COMP PHYSIOL, V150, P261; Cokl A, 2006, CONT T ENT, P71; Debaisieux P., 1938, CELLULE, V47, P77; Devetak D, 1978, BIOL VESTNIK LJUBLJA, V36, P131; DRASLAR K, 1973, J COMP PHYSIOL, V84, P175, DOI 10.1007/BF00697605; ENDLER JA, 1993, PHILOS T R SOC B, V340, P215, DOI 10.1098/rstb.1993.0060; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; GWYNNE DT, 1987, ANIM BEHAV, V35, P571, DOI 10.1016/S0003-3472(87)80283-X; Hill P.S., 2008, VIBRATIONAL COMMUNIC, DOI DOI 10.4159/9780674273825; Hill PSM, 2009, NATURWISSENSCHAFTEN, V96, P1355, DOI 10.1007/s00114-009-0588-8; HOWSE PE, 1970, J INSECT PHYSIOL, V16, P1665, DOI 10.1016/0022-1910(70)90266-0; HUNT RE, 1993, ANN ENTOMOL SOC AM, V86, P356, DOI 10.1093/aesa/86.3.356; HUNT RE, 1991, BEHAV ECOL SOCIOBIOL, V28, P315, DOI 10.1007/BF00164380; ICHIKAWA T, 1974, Applied Entomology and Zoology, V9, P196; Keil TA, 1997, MICROSC RES TECHNIQ, V39, P506, DOI 10.1002/(SICI)1097-0029(19971215)39:6<506::AID-JEMT5>3.0.CO;2-B; KIRCHNER WH, 1994, J COMP PHYSIOL A, V175, P261, DOI 10.1007/BF00192985; Markl H., 1983, P332; Mazzoni V, 2009, ENTOMOL EXP APPL, V133, P174, DOI 10.1111/j.1570-7458.2009.00911.x; Mazzoni V, 2009, B ENTOMOL RES, V99, P401, DOI 10.1017/S0007485308006408; McVean A, 1996, J ZOOL, V239, P101, DOI 10.1111/j.1469-7998.1996.tb05440.x; MICHEL K, 1983, REV CAN BIOL EXPTL, V42, P139; MICHELSEN A, 1982, BEHAV ECOL SOCIOBIOL, V11, P269, DOI 10.1007/BF00299304; Miklas N, 2001, J INSECT BEHAV, V14, P313, DOI 10.1023/A:1011115111592; Ossiannilsson F, 1949, OPUSCULA ENTOMOLOGIC, V10, P1; Percy DM, 2006, INVERTEBR SYST, V20, P431, DOI 10.1071/IS05057; Romani R, 2009, ARTHROPOD STRUCT DEV, V38, P473, DOI 10.1016/j.asd.2009.08.002; SCHVESTER D., 1963, ANN EPIPHYT [PARIS], V14, P175; SHAW SR, 1994, J EXP BIOL, V193, P13; SHAW SR, 1994, J NEUROBIOL, V25, P1167, DOI 10.1002/neu.480250911; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Stewart K.W., 1984, Annales de Limnologie, V20, P105; Virant-Doberlet M, 2004, NEOTROP ENTOMOL, V33, P121, DOI 10.1590/S1519-566X2004000200001; Virant-Doberlet M, 2006, CONT T ENT, P81; [No title captured]; [No title captured]	48	39	38	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19692	10.1371/journal.pone.0019692	http://dx.doi.org/10.1371/journal.pone.0019692			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573131	Green Published, Green Submitted, gold			2022-12-27	WOS:000290256400039
J	Mandili, G; Marini, C; Carta, F; Zanini, C; Prato, M; Khadjavi, A; Turrini, F; Giribaldi, G				Mandili, Giorgia; Marini, Cristina; Carta, Franco; Zanini, Cristina; Prato, Mauro; Khadjavi, Amina; Turrini, Franco; Giribaldi, Giuliana			Identification of Phosphoproteins as Possible Differentiation Markers in All-Trans-Retinoic Acid-Treated Neuroblastoma Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; HUMAN HEPATOCARCINOMA CELLS; GLUCOSE-REGULATED PROTEIN; NEURONAL DIFFERENTIATION; CANCER-CELLS; NEURITE OUTGROWTH; PROGNOSTIC MARKER; EWINGS-SARCOMA; SH-SY5Y CELLS; KINASE-C	Background: Neuroblastic tumors account for 9-10% of pediatric tumors and neuroblastoma (NB) is the first cause of death in pre-school age children. NB is classified in four stages, depending on the extent of spreading. A fifth type of NB, so-called stage 4S (S for special), includes patients with metastatic tumors but with an overall survival that approximates 75% at five years. In most of these cases, the tumor regresses spontaneously and regression is probably associated with delayed neuroblast cell differentiation. Methodology/Principal Findings: In order to identify new early markers to follow and predict this process for diagnostic and therapeutics intents, we mimicked the differentiation process treating NB cell line SJ-NK-P with all-trans-retinoic acid (ATRA) at different times; therefore the cell proteomic pattern by mass spectrometry and the phosphoproteomic pattern by a 2-DE approach coupled with anti-phosphoserine and anti-phosphotyrosine western blotting were studied. Conclusions/Significance: Proteomic analysis identified only two proteins whose expression was significantly different in treated cells versus control cells: nucleoside diphosphate kinase A (NDKA) and reticulocalbin-1 (RCN1), which were both downregulated after 9 days of ATRA treatment. However, phosphoproteomic analysis identified 8 proteins that were differentially serine-phosphorylated and 3 that were differentially tyrosine-phosphorylated after ATRA treatment. All proteins were significantly regulated (at least 0.5-fold down-regulated). Our results suggest that differentially phosphorylated proteins could be considered as more promising markers of differentiation for NB than differentially expressed proteins.	[Mandili, Giorgia; Marini, Cristina; Zanini, Cristina; Prato, Mauro; Khadjavi, Amina; Turrini, Franco; Giribaldi, Giuliana] Univ Turin, Dipartimento Genet Biol Biochim, Turin, Italy; [Carta, Franco] Nurex SRL, Sassari, Italy	University of Turin	Mandili, G (corresponding author), Univ Turin, Dipartimento Genet Biol Biochim, Turin, Italy.	giuliana.giribaldi@unito.it	Giribaldi, Giuliana/I-8115-2018	Giribaldi, Giuliana/0000-0003-1374-1919; carta, franco/0000-0001-7776-8243; Zanini, Cristina/0000-0002-6554-2113	Compagnia di San Paolo/FIRMS; 'Ricerca sanitaria finalizzata', Regione Piemonte (Italy)	Compagnia di San Paolo/FIRMS(Compagnia di San Paolo); 'Ricerca sanitaria finalizzata', Regione Piemonte (Italy)(Regione Piemonte)	This work was supported by the 'Oncology Special Project', Compagnia di San Paolo/FIRMS and by the 'Ricerca sanitaria finalizzata', Regione Piemonte (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thank Dott. Franco Carta and Nurex S.R.L. for the free of charge mass spectrometry analyses. As Franco Carta is employed by Nurex S.R.L., Nurex did have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEMAYOR E, 1989, ENVIRON HEALTH PERSP, V80, P3, DOI 10.2307/3430727; Akazawa YO, 2010, FREE RADICAL RES, V44, P410, DOI 10.3109/10715760903536349; Alique M, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-1; Amendola R, 2001, MED PEDIATR ONCOL, V36, P93, DOI 10.1002/1096-911X(20010101)36:1<93::AID-MPO1021>3.0.CO;2-3; Barbero G, 2006, ANAL BIOCHEM, V349, P62, DOI 10.1016/j.ab.2005.10.020; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Bunney TD, 2001, P NATL ACAD SCI USA, V98, P4249, DOI 10.1073/pnas.061437498; Canon E, 2004, MOL BIOL CELL, V15, P5583, DOI 10.1091/mbc.E04-05-0439; CARLINO A, 1994, BIOCHEM BIOPH RES CO, V201, P1548, DOI 10.1006/bbrc.1994.1880; Chlapek P, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-45; CICCARONE V, 1989, CANCER RES, V49, P219; Cimmino F, 2007, J PROTEOME RES, V6, P2550, DOI 10.1021/pr060701g; Clagett-Dame M, 2006, J NEUROBIOL, V66, P739, DOI 10.1002/neu.20241; DENHERTOG J, 1993, EMBO J, V12, P3789, DOI 10.1002/j.1460-2075.1993.tb06057.x; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; FREYRIA AM, 1995, BIOCHEM J, V305, P391, DOI 10.1042/bj3050391; Futami H, 2010, CANCER LETT, V297, P220, DOI 10.1016/j.canlet.2010.05.014; Gu L, 2003, CELL MOTIL CYTOSKEL, V54, P286, DOI 10.1002/cm.10099; Haque N, 2004, MOL BRAIN RES, V129, P163, DOI 10.1016/j.molbrainres.2004.07.001; Hsu WM, 2008, CLIN CANCER RES, V14, P6237, DOI 10.1158/1078-0432.CCR-07-4181; Hsu WM, 2005, INT J CANCER, V113, P920, DOI 10.1002/ijc.20693; HUNTER T, 1991, METHODS ENZYMOL, V200, P3; Inberg A, 2007, PROTEOMICS, V7, P910, DOI 10.1002/pmic.200600547; Isoardo G, 2005, J NEUROIMMUNOL, V161, P78, DOI 10.1016/j.jneuroim.2004.12.005; Kanai M, 2007, GENES CELLS, V12, P797, DOI 10.1111/j.1365-2443.2007.01091.x; Kim JE, 2005, J PROTEOME RES, V4, P1339, DOI 10.1021/pr050048h; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Latasa MJ, 2010, GLIA, V58, P1451, DOI 10.1002/glia.21020; Lee J, 2007, MOL CELL PROTEOMICS, V6, P669, DOI 10.1074/mcp.M600218-MCP200; Lee JH, 2004, J NEUROCHEM, V91, P634, DOI 10.1111/j.1471-4159.2004.02770.x; Lim YP, 2005, CLIN CANCER RES, V11, P3163, DOI 10.1158/1078-0432.CCR-04-2243; Lopez-Carballo G, 2002, J BIOL CHEM, V277, P25297, DOI 10.1074/jbc.M201869200; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Melino G, 1997, J NEURO-ONCOL, V31, P65, DOI 10.1023/A:1005733430435; Miloso M, 2004, J NEUROSCI RES, V75, P241, DOI 10.1002/jnr.10848; Misra UK, 2005, J BIOL CHEM, V280, P26278, DOI 10.1074/jbc.M414467200; Nakamura Y, 2000, GENES CELLS, V5, P823, DOI 10.1046/j.1365-2443.2000.00372.x; Navakauskiene R, 2004, PROTEOMICS, V4, P1029, DOI 10.1002/pmic.200300671; Niles RM, 2004, MUTAT RES-FUND MOL M, V555, P81, DOI 10.1016/j.mrfmmm.2004.05.020; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; OHTA Y, 1987, FEBS LETT, V222, P305, DOI 10.1016/0014-5793(87)80391-5; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pagliarini DJ, 2006, TRENDS BIOCHEM SCI, V31, P26, DOI 10.1016/j.tibs.2005.11.005; Pan J, 2005, J NEUROCHEM, V93, P571, DOI 10.1111/j.1471-4159.2005.03106.x; Reiss N, 1996, BIOCHEM MOL BIOL INT, V40, P1191; RETTIG WJ, 1987, CANCER RES, V47, P1383; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Salih E, 2005, MASS SPECTROM REV, V24, P828, DOI 10.1002/mas.20042; Sanli UA, 2003, ONCOL REP, V10, P2083; SCHWAB M, 2000, PATHOLOGY GENETICS T; SIDELL N, 1983, EXP CELL RES, V148, P21, DOI 10.1016/0014-4827(83)90184-2; Tanaka T, 2004, ONCOGENE, V23, P3980, DOI 10.1038/sj.onc.1207555; THIELE CJ, 1991, CANCER METAST REV, V10, P311, DOI 10.1007/BF00554793; Tonini GP, 2006, CURR PHARM DESIGN, V12, P2303, DOI 10.2174/138161206777585193; Ueda Koichiro, 2001, Kurume Medical Journal, V48, P159; Voigt A, 2003, MED PEDIATR ONCOL, V40, P205, DOI 10.1002/mpo.10250; Westermann F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r150; Xu YY, 2007, J CELL BIOCHEM, V100, P773, DOI 10.1002/jcb.21088; Xu YY, 2010, J CELL BIOCHEM, V109, P468, DOI 10.1002/jcb.22423; Yu YM, 2003, NEUROREPORT, V14, P941, DOI 10.1097/01.wnr.0000074341.81633.b8; Zanini C, 2008, VIRCHOWS ARCH, V452, P157, DOI 10.1007/s00428-007-0549-6; Zanini C, 2007, J NEUROCHEM, V103, P1344, DOI 10.1111/j.1471-4159.2007.04835.x	65	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e18254	10.1371/journal.pone.0018254	http://dx.doi.org/10.1371/journal.pone.0018254			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573212	Green Published, Green Submitted, gold			2022-12-27	WOS:000290256400002
J	Thomas, JD; Hatcher, CP; Satterfield, DA; Theodore, MJ; Bach, MC; Linscott, KB; Zhao, X; Wang, X; Mair, R; Schmink, S; Arnold, KE; Stephens, DS; Harrison, LH; Hollick, RA; Andrade, AL; Lamaro-Cardoso, J; de Lemos, APS; Gritzfeld, J; Gordon, S; Soysal, A; Bakir, M; Sharma, D; Jain, S; Satola, SW; Messonnier, NE; Mayer, LW				Thomas, Jennifer Dolan; Hatcher, Cynthia P.; Satterfield, Dara A.; Theodore, M. Jordan; Bach, Michelle C.; Linscott, Kristin B.; Zhao, Xin; Wang, Xin; Mair, Raydel; Schmink, Susanna; Arnold, Kathryn E.; Stephens, David S.; Harrison, Lee H.; Hollick, Rosemary A.; Andrade, Ana Lucia; Lamaro-Cardoso, Juliana; de Lemos, Ana Paula S.; Gritzfeld, Jenna; Gordon, Stephen; Soysal, Ahmet; Bakir, Mustafa; Sharma, Dolly; Jain, Shabnam; Satola, Sarah W.; Messonnier, Nancy E.; Mayer, Leonard W.			sodC-Based Real-Time PCR for Detection of Neisseria meningitidis	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; STREPTOCOCCUS-PNEUMONIAE; CEREBROSPINAL-FLUID; HAEMOPHILUS-INFLUENZAE; BACTERIAL-MENINGITIS; IDENTIFICATION; SEQUENCE; DIAGNOSIS; GENES; RESISTANCE	Real-time PCR (rt-PCR) is a widely used molecular method for detection of Neisseria meningitidis (Nm). Several rt-PCR assays for Nm target the capsule transport gene, ctrA. However, over 16% of meningococcal carriage isolates lack ctrA, rendering this target gene ineffective at identification of this sub-population of meningococcal isolates. The Cu-Zn superoxide dismutase gene, sodC, is found in Nm but not in other Neisseria species. To better identify Nm, regardless of capsule genotype or expression status, a sodC-based TaqMan rt-PCR assay was developed and validated. Standard curves revealed an average lower limit of detection of 73 genomes per reaction at cycle threshold (C-t) value of 35, with 100% average reaction efficiency and an average R-2 of 0.9925. 99.7% (624/626) of Nm isolates tested were sodC-positive, with a range of average C-t values from 13.0 to 29.5. The mean sodC C-t value of these Nm isolates was 17.6 +/- 2.2 (+/- SD). Of the 626 Nm tested, 178 were nongroupable (NG) ctrA-negative Nm isolates, and 98.9% (176/178) of these were detected by sodC rt-PCR. The assay was 100% specific, with all 244 non-Nm isolates testing negative. Of 157 clinical specimens tested, sodC detected 25/157 Nm or 4 additional specimens compared to ctrA and 24 more than culture. Among 582 carriage specimens, sodC detected Nm in 1 more than ctrA and in 4 more than culture. This sodC rt-PCR assay is a highly sensitive and specific method for detection of Nm, especially in carriage studies where many meningococcal isolates lack capsule genes.	[Thomas, Jennifer Dolan; Hatcher, Cynthia P.; Satterfield, Dara A.; Theodore, M. Jordan; Bach, Michelle C.; Linscott, Kristin B.; Zhao, Xin; Wang, Xin; Mair, Raydel; Schmink, Susanna; Messonnier, Nancy E.; Mayer, Leonard W.] Ctr Dis Control & Prevent, Meningitis & Vaccine Preventable Dis Branch, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Arnold, Kathryn E.] Georgia Dept Community Hlth, Div Publ Hlth, Atlanta, GA USA; [Stephens, David S.; Sharma, Dolly; Jain, Shabnam; Satola, Sarah W.] Emory Univ, Sch Med, Atlanta, GA USA; [Arnold, Kathryn E.; Stephens, David S.; Satola, Sarah W.] Georgia Emerging Infect Program, Atlanta, GA USA; [Stephens, David S.; Satola, Sarah W.] Vet Affairs Med Ctr, Atlanta, GA 30033 USA; [Sharma, Dolly; Jain, Shabnam] Childrens Healthcare Atlanta, Atlanta, GA USA; [Satterfield, Dara A.; Bach, Michelle C.] Agnes Scott Coll, Dept Biol, Decatur, GA 30030 USA; [Harrison, Lee H.; Hollick, Rosemary A.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Andrade, Ana Lucia; Lamaro-Cardoso, Juliana] Univ Fed Goias, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil; [de Lemos, Ana Paula S.] Adolfo Lutz Inst, Sao Paulo, Brazil; [Gritzfeld, Jenna; Gordon, Stephen] Univ Liverpool, Liverpool Sch Trop Med, Clin Grp, Liverpool L3 5QA, Merseyside, England; [Soysal, Ahmet; Bakir, Mustafa] Marmara Univ, Sch Med, Div Pediat Infect Dis, Istanbul, Turkey	Centers for Disease Control & Prevention - USA; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Children's Healthcare of Atlanta (CHOA); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universidade Federal de Goias; Instituto Adolfo Lutz; Liverpool School of Tropical Medicine; University of Liverpool; Marmara University	Thomas, JD (corresponding author), Ctr Dis Control & Prevent, Meningitis & Vaccine Preventable Dis Branch, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.	fsu8@cdc.gov	Iats, Inct/K-2300-2013; Satterfield, Dara/N-4484-2017; Lemos, Ana Paula/ABE-6240-2021; Stephens, David S/A-8788-2012; Andrade, Ana Lucia/L-5751-2013	Satterfield, Dara/0000-0003-3036-5580; Gordon, Stephen/0000-0001-6576-1116; Bach, Michelle/0000-0002-2342-5242	Brazilian National Council for Scientific and Technological Development (CNPq) [309196/2007-8]; National Institute of Science and Technology for Health Technology Assessment/IATS; National Institutes of Health [5D43TW006592]; FOGARTY INTERNATIONAL CENTER [D43TW006592] Funding Source: NIH RePORTER	Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institute of Science and Technology for Health Technology Assessment/IATS; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	ALA was supported by the Brazilian National Council for Scientific and Technological Development (CNPq grant # 309196/2007-8) (http://www.cnpq.br/english/cnpq/index.htm) and was supported by the National Institute of Science and Technology for Health Technology Assessment/IATS (http://www.iats.com.br/eng/instituto.php?id_cms_menu = 1). APS de Lemos was supported by the Fogarty International Center Global Infectious Diseases Research Training Program grant from the National Institutes of Health (5D43TW006592) (http://www.fic.nih.gov/). JG and SG thank the NIHR Biomedical Research Centre in Microbial Diseases (http://www.rlbuht.nhs.uk/NIHR_BRC/Introduction.asp) and the Northwest Regional Development Agency (http://www.nwda.co.uk/) for infrastructural support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; BINGEN E, 1990, EUR J CLIN MICROBIOL, V9, P278, DOI 10.1007/BF01968060; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Cavrini F, 2010, J CLIN MICROBIOL, V48, P3016, DOI 10.1128/JCM.00103-10; Chiba N, 2009, J INFECT CHEMOTHER, V15, P92, DOI 10.1007/s10156-009-0670-3; CLARK TA, 2008, 16 INT PATH NEISS C; Claus H, 2002, MICROBIOL-SGM, V148, P1813, DOI 10.1099/00221287-148-6-1813; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; Deutch S, 2008, SCAND J INFECT DIS, V40, P607, DOI 10.1080/00365540801914833; Dolan-Livengood JM, 2003, J INFECT DIS, V187, P1616, DOI 10.1086/374740; Fung WWM, 2006, J CLIN MICROBIOL, V44, P4222, DOI 10.1128/JCM.01376-06; Gurley ES, 2009, AM J TROP MED HYG, V81, P475, DOI 10.4269/ajtmh.2009.81.475; Hedberg ST, 2009, APMIS, V117, P856, DOI 10.1111/j.1600-0463.2009.02539.x; Janda WM, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P601; Jordens JZ, 2005, J MED MICROBIOL, V54, P463, DOI 10.1099/jmm.0.45847-0; Jordens JZ, 2002, J CLIN MICROBIOL, V40, P75, DOI 10.1128/JCM.40.1.75-79.2002; Uria MJ, 2008, J EXP MED, V205, P1423, DOI 10.1084/jem.20072577; Katz LS, 2009, NUCLEIC ACIDS RES, V37, pW606, DOI 10.1093/nar/gkp288; Kellerman SE, 2002, J INFECT DIS, V186, P40, DOI 10.1086/341067; Kroll JS, 1998, P NATL ACAD SCI USA, V95, P12381, DOI 10.1073/pnas.95.21.12381; LANGFORD PR, 1992, J GEN MICROBIOL, V138, P517, DOI 10.1099/00221287-138-3-517; LASCOLEA LJ, 1984, J CLIN MICROBIOL, V19, P187, DOI 10.1128/JCM.19.2.187-190.1984; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; McCrea KW, 2010, J CLIN MICROBIOL, V48, P714, DOI 10.1128/JCM.01416-09; Mhlanga B., 2009, Morbidity and Mortality Weekly Report, V58, P493; Mothershed EA, 2004, J CLIN MICROBIOL, V42, P320, DOI 10.1128/JCM.42.1.320-328.2004; NACLERIO RM, 1983, AM REV RESPIR DIS, V128, P597; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; O'Brien KL, 2001, J CLIN MICROBIOL, V39, P1021, DOI 10.1128/JCM.39.3.1021-1024.2001; POPOVIC T, 1999, LAB MANUAL DIAGNOSIS; Sadler F, 2003, EPIDEMIOL INFECT, V130, P59, DOI 10.1017/S0950268802007987; Sharma D, 2010, 7 INT S PNEUM PNEUM; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Staquet P, 2007, INTENS CARE MED, V33, P1168, DOI 10.1007/s00134-007-0667-2; Swartley JS, 1997, P NATL ACAD SCI USA, V94, P271, DOI 10.1073/pnas.94.1.271; Taha MK, 2005, J CLIN MICROBIOL, V43, P144, DOI 10.1128/JCM.43.1.144-149.2005; Taha MK, 2000, J CLIN MICROBIOL, V38, P855, DOI 10.1128/JCM.38.2.855-857.2000; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Tseng HJ, 2001, MOL MICROBIOL, V40, P1175, DOI 10.1046/j.1365-2958.2001.02460.x; Van Gastel E, 2007, EUR J CLIN MICROBIOL, V26, P651, DOI 10.1007/s10096-007-0350-0; VANDERENDE A, 1995, J CLIN MICROBIOL, V33, P3326, DOI 10.1128/JCM.33.12.3326-3327.1995; WANG X, 2011, INT J MED M IN PRESS; Wilks KE, 1998, INFECT IMMUN, V66, P213, DOI 10.1128/IAI.66.1.213-217.1998; Zhu Bing-Qing, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P360	45	65	67	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19361	10.1371/journal.pone.0019361	http://dx.doi.org/10.1371/journal.pone.0019361			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573213	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000290256400007
J	Hackett, NR; Shaykhiev, R; Walters, MS; Wang, R; Zwick, RK; Ferris, B; Witover, B; Salit, J; Crystal, RG				Hackett, Neil R.; Shaykhiev, Renat; Walters, Matthew S.; Wang, Rui; Zwick, Rachel K.; Ferris, Barbara; Witover, Bradley; Salit, Jacqueline; Crystal, Ronald G.			The Human Airway Epithelial Basal Cell Transcriptome	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; EMBRYONIC STEM-CELLS; CYSTIC-FIBROSIS; IN-VITRO; GENE-EXPRESSION; CIGARETTE SMOKERS; POOR-PROGNOSIS; BREAST-CANCER; UP-REGULATION; LUNG-CANCER	Background: The human airway epithelium consists of 4 major cell types: ciliated, secretory, columnar and basal cells. During natural turnover and in response to injury, the airway basal cells function as stem/progenitor cells for the other airway cell types. The objective of this study is to better understand human airway epithelial basal cell biology by defining the gene expression signature of this cell population. Methodology/Principal Findings: Bronchial brushing was used to obtain airway epithelium from healthy nonsmokers. Microarrays were used to assess the transcriptome of basal cells purified from the airway epithelium in comparison to the transcriptome of the differentiated airway epithelium. This analysis identified the "human airway basal cell signature" as 1,161 unique genes with > 5-fold higher expression level in basal cells compared to differentiated epithelium. The basal cell signature was suppressed when the basal cells differentiated into a ciliated airway epithelium in vitro. The basal cell signature displayed overlap with genes expressed in basal-like cells from other human tissues and with that of murine airway basal cells. Consistent with self-modulation as well as signaling to other airway cell types, the human airway basal cell signature was characterized by genes encoding extracellular matrix components, growth factors and growth factor receptors, including genes related to the EGF and VEGF pathways. Interestingly, while the basal cell signature overlaps that of basal-like cells of other organs, the human airway basal cell signature has features not previously associated with this cell type, including a unique pattern of genes encoding extracellular matrix components, G protein-coupled receptors, neuroactive ligands and receptors, and ion channels. Conclusion/Significance: The human airway epithelial basal cell signature identified in the present study provides novel insights into the molecular phenotype and biology of the stem/progenitor cells of the human airway epithelium.	[Hackett, Neil R.; Shaykhiev, Renat; Walters, Matthew S.; Wang, Rui; Zwick, Rachel K.; Ferris, Barbara; Witover, Bradley; Salit, Jacqueline; Crystal, Ronald G.] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA; [Crystal, Ronald G.] Weill Cornell Med Coll, Dept Med, Div Pulm & Crit Care Med, New York, NY USA	Cornell University; Cornell University	Hackett, NR (corresponding author), Weill Cornell Med Coll, Dept Med Genet, New York, NY USA.	geneticmedicine@med.cornell.edu	Shaykhiev, Renat/D-2855-2011	Zwick, Rachel/0000-0003-2012-5890; Walters, Matthew/0000-0003-0010-8444	Starr Foundation/Starr Cancer Consortium;  [P50 HL084936];  [UL1-RR024996]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024996] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL084936] Funding Source: NIH RePORTER	Starr Foundation/Starr Cancer Consortium; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported by P50 HL084936; UL1-RR024996; and the Starr Foundation/Starr Cancer Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiseshaiah P, 2008, J CELL PHYSIOL, V216, P405, DOI 10.1002/jcp.21410; AN G, 1993, J CELL PHYSIOL, V157, P562, DOI 10.1002/jcp.1041570316; Araya J, 2007, J CLIN INVEST, V117, P3551, DOI 10.1172/JCI32526; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhat-Nakshatri P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-411; Boers JE, 1998, AM J RESP CRIT CARE, V157, P2000, DOI 10.1164/ajrccm.157.6.9707011; Booth BW, 2010, EXP CELL RES, V316, P422, DOI 10.1016/j.yexcr.2009.11.006; Boxall C, 2006, EUR RESPIR J, V27, P208, DOI 10.1183/09031936.06.00130004; Broer S, 2008, PHYSIOL REV, V88, P249, DOI 10.1152/physrev.00018.2006; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Carolan BJ, 2006, CANCER RES, V66, P10729, DOI 10.1158/0008-5472.CAN-06-2224; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; CHEVILLARD M, 1993, EPITHELIAL CELL BIOL, V2, P17; Choe MM, 2006, NAT PROTOC, V1, P357, DOI 10.1038/nprot.2006.54; Coussens M, 2010, P NATL ACAD SCI USA, V107, P13842, DOI 10.1073/pnas.0913834107; Crystal Ronald G, 2008, Proc Am Thorac Soc, V5, P772, DOI 10.1513/pats.200805-041HR; Danel C, 1996, AM J RESP CRIT CARE, V153, P362, DOI 10.1164/ajrccm.153.1.8542144; Davies Donna E, 2009, Proc Am Thorac Soc, V6, P678, DOI 10.1513/pats.200907-067DP; DI CF, 2008, MOL CANCER RES, V6, P743; DVORAK A, 2010, AM J RESP CELL MOL B; Enomoto Y, 2009, J ALLERGY CLIN IMMUN, V124, P913, DOI 10.1016/j.jaci.2009.08.044; Erjefalt JS, 1997, THORAX, V52, P213, DOI 10.1136/thx.52.3.213; Evans MJ, 2001, EXP LUNG RES, V27, P401, DOI 10.1080/019021401300317125; Fukumoto J, 2010, AM J PHYSIOL-LUNG C, V298, pL131, DOI 10.1152/ajplung.90576.2008; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Hackett NR, 2003, AM J RESP CELL MOL, V29, P331, DOI 10.1165/rcmb.2002-0321OC; Hackett TL, 2008, STEM CELLS, V26, P2576, DOI 10.1634/stemcells.2008-0171; Hajj R, 2007, STEM CELLS, V25, P139, DOI 10.1634/stemcells.2006-0288; Harvey BG, 2007, J MOL MED, V85, P39, DOI 10.1007/s00109-006-0103-z; Heguy A, 2007, PHYSIOL GENOMICS, V29, P139, DOI 10.1152/physiolgenomics.00167.2006; Hicks W, 1997, EXP CELL RES, V237, P357, DOI 10.1006/excr.1997.3796; Hogenesch JB, 2000, J NEUROSCI, V20, part. no.; Hong KU, 2004, AM J PATHOL, V164, P577, DOI 10.1016/S0002-9440(10)63147-1; Hurt EM, 2008, BRIT J CANCER, V98, P756, DOI 10.1038/sj.bjc.6604242; Ito S., 1968, J CELL BIOL, V39, p168a; JETTEN AM, 1989, ENVIRON HEALTH PERSP, V80, P149, DOI 10.2307/3430740; Jiang QS, 1998, EUR J HUM GENET, V6, P12, DOI 10.1038/sj.ejhg.5200158; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Keysar SB, 2010, MOL CANCER THER, V9, P2450, DOI 10.1158/1535-7163.MCT-10-0530; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; Koo JS, 1999, AM J RESP CELL MOL, V20, P43, DOI 10.1165/ajrcmb.20.1.3310; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; LEIGH IM, 1995, BRIT J DERMATOL, V133, P501, DOI 10.1111/j.1365-2133.1995.tb02696.x; Leir SH, 2000, AM J PHYSIOL-LUNG C, V278, pL1129, DOI 10.1152/ajplung.2000.278.6.L1129; Li A, 1998, P NATL ACAD SCI USA, V95, P3902, DOI 10.1073/pnas.95.7.3902; Li O, 2007, FEBS LETT, V581, P3533, DOI 10.1016/j.febslet.2007.06.072; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Litjens SHM, 2006, TRENDS CELL BIOL, V16, P376, DOI 10.1016/j.tcb.2006.05.004; Matsuo K, 2000, NAT GENET, V24, P184, DOI 10.1038/72855; Matsuo M, 2006, CANCER SCI, V97, P155, DOI 10.1111/j.1349-7006.2006.00152.x; Matsuzaki Kyoichi, 2004, Int Wound J, V1, P135, DOI 10.1111/j.1742-4801.2004.00033.x; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Musch A, 2004, TRAFFIC, V5, P1, DOI 10.1046/j.1600-0854.2003.00149.x; Nakanishi K, 2006, VIRCHOWS ARCH, V448, P142, DOI 10.1007/s00428-005-0063-7; Ooi AT, 2010, CANCER RES, V70, P6639, DOI 10.1158/0008-5472.CAN-10-0455; Pfannkuche K, 2009, STEM CELL REV REP, V5, P224, DOI 10.1007/s12015-009-9078-9; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; PUCHELLE E, 1992, AM J RESP CELL MOL, V7, P485, DOI 10.1165/ajrcmb/7.5.485; Raman T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-493; Rawlins EL, 2008, COLD SH Q B, V73, P291, DOI 10.1101/sqb.2008.73.037; Rawlins EL, 2006, DEVELOPMENT, V133, P2455, DOI 10.1242/dev.02407; Rehfeld JF, 2004, BEST PRACT RES CL EN, V18, P569, DOI 10.1016/j.beem.2004.07.002; Reynolds SD, 2008, STEM CELLS, V26, P1337, DOI 10.1634/stemcells.2008-0053; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Ross AJ, 2007, AM J RESP CELL MOL, V37, P169, DOI 10.1165/rcmb.2006-0466OC; Ryu MH, 2010, BIOCHEM BIOPH RES CO, V393, P11, DOI 10.1016/j.bbrc.2010.01.060; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; Savagner P, 1997, J CELL BIOL, V137, P1403, DOI 10.1083/jcb.137.6.1403; SCHERMER A, 1989, DIFFERENTIATION, V42, P103, DOI 10.1111/j.1432-0436.1989.tb00611.x; Schneider MR, 2009, J CELL PHYSIOL, V218, P460, DOI 10.1002/jcp.21635; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; SHAYKHIEV R, 2010, CELL MOL LIFE SCI; Sheppard D, 2003, PHYSIOL REV, V83, P673, DOI 10.1152/physrev.00033.2002; Shum WWC, 2008, CELL, V135, P1108, DOI 10.1016/j.cell.2008.10.020; Sinner D, 2007, MOL CELL BIOL, V27, P7802, DOI 10.1128/MCB.02179-06; Smith KN, 2010, CELL STEM CELL, V7, P343, DOI 10.1016/j.stem.2010.06.023; Tetreault MP, 2010, GASTROENTEROLOGY, V139, P171, DOI 10.1053/j.gastro.2010.03.048; THOMPSON AB, 1995, EUR RESPIR J, V8, P127, DOI 10.1183/09031936.95.08010127; Tilley AE, 2009, AM J RESP CRIT CARE, V179, P457, DOI 10.1164/rccm.200705-795OC; Urbinati C, 2005, J CELL SCI, V118, P3949, DOI 10.1242/jcs.02518; Wadlow RC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006888; WHITCUTT MJ, 1988, IN VITRO CELL DEV B, V24, P420; Wistuba II, 2006, ANNU REV PATHOL-MECH, V1, P331, DOI 10.1146/annurev.pathol.1.110304.100103; Woodward WA, 2005, J CELL SCI, V118, P3585, DOI 10.1242/jcs.02532; Wu R, 1997, EUR RESPIR J, V10, P2398, DOI 10.1183/09031936.97.10102398; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018; Yang YZ, 2007, FASEB J, V21, P543, DOI 10.1096/fj.06-6694com; Zabner J, 2003, AM J PHYSIOL-LUNG C, V284, pL844, DOI 10.1152/ajplung.00355.2002; Zhong Sheng, 2004, Appl Bioinformatics, V3, P261, DOI 10.2165/00822942-200403040-00009; 2001, CELL TISSUE RES, V305, P285	95	138	140	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e18378	10.1371/journal.pone.0018378	http://dx.doi.org/10.1371/journal.pone.0018378			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21572528	gold, Green Submitted, Green Published			2022-12-27	WOS:000290224800001
J	Luchtefeld, M; Preuss, C; Ruhle, F; Bogalle, EP; Sietmann, A; Figura, S; Muller, W; Grote, K; Schieffer, B; Stoll, M				Luchtefeld, Maren; Preuss, Christoph; Ruehle, Frank; Bogalle, Eskindir P.; Sietmann, Anika; Figura, Stefanie; Mueller, Werner; Grote, Karsten; Schieffer, Bernhard; Stoll, Monika			Gp130-Dependent Release of Acute Phase Proteins Is Linked to the Activation of Innate Immune Signaling Pathways	PLOS ONE			English	Article							INSULIN-RESISTANCE; ATHEROSCLEROSIS; MICE; INFLAMMATION; DISEASE; LIPOCALIN-2; EXPRESSION; RESPONSES; MACROPHAGES; OBESITY	Background: Elevated levels of acute phase proteins (APP) are often found in patients with cardiovascular diseases. In a previous study, we demonstrated the importance of the IL-6-gp130 axis -as a key regulator of inflammatory acute phase signaling in hepatocytes-for the development of atherosclerosis. Background/Principal Findings: Gp130-dependent gene expression was analyzed in a previously established hepatocyte-specific gp130 knockout mouse model. We performed whole transcriptome analysis in isolated hepatocytes to measure tissue specific responses after proinflammatory stimulus with IL-6 across different time points. Our analyses revealed an unexpected small gene cluster that requires IL-6 stimulus for early activation. Several of the genes in this cluster are involved in different cell defense mechanisms. Thus, stressors that trigger both general stress and inflammatory responses lead to activation of a stereotypic innate cellular defense response. Furthermore, we identified a potential biomarker Lipocalin (LCN) 2 for the gp130 dependent early inflammatory response. Conclusions/Significance: Our findings suggest a complex network of tightly linked genes involved in the early activation of different parts of the innate immune response including acute phase proteins, complement and coagulation cascade.	[Luchtefeld, Maren; Bogalle, Eskindir P.; Grote, Karsten; Schieffer, Bernhard] Hannover Med Sch, Dept Cardiol & Angiol, D-3000 Hannover, Germany; [Preuss, Christoph; Ruehle, Frank; Sietmann, Anika; Figura, Stefanie; Stoll, Monika] Leibniz Inst Arteriosclerosis Res, Munster, Germany; [Mueller, Werner] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	Hannover Medical School; University of Manchester	Luchtefeld, M (corresponding author), Hannover Med Sch, Dept Cardiol & Angiol, D-3000 Hannover, Germany.	Schieffer.Bernhard@MH-Hannover.de	Witten, Anika/C-5297-2019; Muller, Werner/B-9044-2008	Muller, Werner/0000-0002-1297-9725; Grote, Karsten/0000-0001-7914-3159; Ruhle, Frank/0000-0001-7688-2394	Deutsche Forschungsgemeinschaft (Sonderforschungsbereich) [SFB 566/b9]	Deutsche Forschungsgemeinschaft (Sonderforschungsbereich)(German Research Foundation (DFG))	Drs. Schieffer and Grote are supported by funding from the Deutsche Forschungsgemeinschaft (Sonderforschungsbereich) SFB 566/b9. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKER S, 1994, AM J PHYSIOL, V266, pL278, DOI 10.1152/ajplung.1994.266.3.L278; Bjorkbacka H, 2004, NAT MED, V10, P416, DOI 10.1038/nm1008; Castillo L, 2010, J INTERF CYTOK RES, V30, P339, DOI 10.1089/jir.2009.0045; Danesh J, 1999, EUR HEART J, V20, P954, DOI 10.1053/euhj.1998.1309; Dittrich AM, 2010, CLIN EXP ALLERGY, V40, P1689, DOI 10.1111/j.1365-2222.2010.03508.x; FATTORI E, 1994, J EXP MED, V180, P1243, DOI 10.1084/jem.180.4.1243; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Guo H, 2010, DIABETES, V59, P1376, DOI 10.2337/db09-1735; Hemdahl AL, 2006, ARTERIOSCL THROM VAS, V26, P136, DOI 10.1161/01.ATV.0000193567.88685.f4; Hou TY, 2008, CURR CARDIOL REV, V4, P179, DOI 10.2174/157340308785160570; Kastl SP, 2008, ARTERIOSCL THROM VAS, V28, P498, DOI 10.1161/ATVBAHA.107.160580; Klein C, 2005, J CLIN INVEST, V115, P860, DOI 10.1172/JCI200523640; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; KORDULA T, 1992, FEBS LETT, V313, P143, DOI 10.1016/0014-5793(92)81431-K; Libby P, 2008, AM J MED, V121, P21, DOI 10.1016/j.amjmed.2008.06.014; Libby P, 2006, AM J CARDIOL, V98, p3Q, DOI 10.1016/j.amjcard.2006.09.020; Luchtefeld M, 2007, J EXP MED, V204, P1935, DOI 10.1084/jem.20070120; Lundberg AM, 2010, CLIN IMMUNOL, V134, P5, DOI 10.1016/j.clim.2009.07.016; Obayashi T, 2008, NUCLEIC ACIDS RES, V36, pD77, DOI 10.1093/nar/gkm840; Sander LE, 2008, J IMMUNOL, V181, P3586, DOI 10.4049/jimmunol.181.5.3586; Sander LE, 2010, J EXP MED, V207, P1453, DOI 10.1084/jem.20091474; Wang Y, 2007, CLIN CHEM, V53, P34, DOI 10.1373/clinchem.2006.075614; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007	23	13	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19427	10.1371/journal.pone.0019427	http://dx.doi.org/10.1371/journal.pone.0019427			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573245	Green Submitted, Green Published, gold			2022-12-27	WOS:000290224800029
J	Tayo, BO; Teil, M; Tong, LP; Qin, HZ; Khitrov, G; Zhang, WJ; Song, QB; Gottesman, O; Zhu, XF; Pereira, AC; Cooper, RS; Bottinger, EP				Tayo, Bamidele O.; Teil, Marie; Tong, Liping; Qin, Huaizhen; Khitrov, Gregory; Zhang, Weijia; Song, Quinbin; Gottesman, Omri; Zhu, Xiaofeng; Pereira, Alexandre C.; Cooper, Richard S.; Bottinger, Erwin P.			Genetic Background of Patients from a University Medical Center in Manhattan: Implications for Personalized Medicine	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; AFRICAN-DERIVED POPULATIONS; CORONARY-ARTERY-DISEASE; PRAVASTATIN PHARMACOKINETICS; GENOTYPING ALGORITHM; SUSCEPTIBILITY LOCI; WEST AFRICANS; HAPLOTYPE MAP; AMERICANS; GWAS	Background: The rapid progress currently being made in genomic science has created interest in potential clinical applications; however, formal translational research has been limited thus far. Studies of population genetics have demonstrated substantial variation in allele frequencies and haplotype structure at loci of medical relevance and the genetic background of patient cohorts may often be complex. Methods and Findings: To describe the heterogeneity in an unselected clinical sample we used the Affymetrix 6.0 gene array chip to genotype self-identified European Americans (N = 326), African Americans (N = 324) and Hispanics (N = 327) from the medical practice of Mount Sinai Medical Center in Manhattan, NY. Additional data from US minority groups and Brazil were used for external comparison. Substantial variation in ancestral origin was observed for both African Americans and Hispanics; data from the latter group overlapped with both Mexican Americans and Brazilians in the external data sets. A pooled analysis of the African Americans and Hispanics from NY demonstrated a broad continuum of ancestral origin making classification by race/ethnicity uninformative. Selected loci harboring variants associated with medical traits and drug response confirmed substantial within-and between-group heterogeneity. Conclusion: As a consequence of these complementary levels of heterogeneity group labels offered no guidance at the individual level. These findings demonstrate the complexity involved in clinical translation of the results from genome-wide association studies and suggest that in the genomic era conventional racial/ethnic labels are of little value.	[Tayo, Bamidele O.; Tong, Liping; Cooper, Richard S.] Loyola Univ Chicago, Stritch Sch Med, Dept Prevent Med & Epidemiol, Maywood, IL USA; [Teil, Marie; Khitrov, Gregory; Zhang, Weijia; Song, Quinbin; Gottesman, Omri; Bottinger, Erwin P.] Mt Sinai Sch Med, Charles R Bronfman Inst Personalized Med, New York, NY USA; [Qin, Huaizhen; Zhu, Xiaofeng] Case Western Univ, Dept Biostat & Epidemiol, Cleveland, OH USA; [Pereira, Alexandre C.] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil	Loyola University Chicago; Icahn School of Medicine at Mount Sinai; Case Western Reserve University; Universidade de Sao Paulo	Tayo, BO (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Dept Prevent Med & Epidemiol, Maywood, IL USA.	btayo@lumc.edu; erwin.bottinger@mssm.edu	Pereira, Alexandre/HHN-1038-2022; Zhu, Xiaofeng/O-6874-2019	Zhu, Xiaofeng/0000-0003-0037-411X	National Heart Lung and Blood Institute [RO1 HL53353]; Andrea and Charles Bronfman Philantropies; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053353] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Andrea and Charles Bronfman Philantropies; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Andrea and Charles Bronfman Philantropies (to EPB); NIH grant National Heart Lung and Blood Institute RO1 HL53353 (to RC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemo A, 2010, PUBLIC HEALTH GENOMI, V13, P72, DOI 10.1159/000218711; Adeyemo A, 2010, DIABETES, V59, P1549, DOI 10.2337/db09-1252; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Atzmon G, 2010, AM J HUM GENET, V86, P850, DOI 10.1016/j.ajhg.2010.04.015; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Behar DM, 2010, HUM MOL GENET, V19, P1816, DOI 10.1093/hmg/ddq040; Bryc K, 2010, P NATL ACAD SCI USA, V107, P8954, DOI 10.1073/pnas.0914618107; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Chierici M, 2010, PHARMACOGENOMICS J, V10, P355, DOI 10.1038/tpj.2010.47; Collins F, 2010, NATURE, V464, P674, DOI 10.1038/464674a; Cooper R, 1997, AM J PUBLIC HEALTH, V87, P160, DOI 10.2105/AJPH.87.2.160; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Falush D, 2003, GENETICS, V164, P1567; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Hamburg MA, 2010, NEW ENGL J MED, V363, P301, DOI 10.1056/NEJMp1006304; Hassanein MT, 2010, HUM MOL GENET, V19, P2907, DOI 10.1093/hmg/ddq178; Hawken SJ, 2010, HUM GENET, V128, P89, DOI 10.1007/s00439-010-0828-1; Hong H, 2010, PHARMACOGENOMICS J, V10, P364, DOI 10.1038/tpj.2010.24; Hong HX, 2010, J GENET, V89, P55, DOI 10.1007/s12041-010-0011-4; Kang SJ, 2010, HUM MOL GENET, V19, P2725, DOI 10.1093/hmg/ddq154; Kivisto KT, 2007, PHARM RES-DORDR, V24, P239, DOI 10.1007/s11095-006-9159-2; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Miclaus K, 2010, PHARMACOGENOMICS J, V10, P324, DOI 10.1038/tpj.2010.46; Miclaus K, 2010, PHARMACOGENOMICS J, V10, P336, DOI 10.1038/tpj.2010.36; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; *NEW YORK CIT DEP, 2004, NEW NEW YORK 2000 IM; Nishizato Y, 2003, CLIN PHARMACOL THER, V73, P554, DOI 10.1016/S0009-9236(03)00060-2; Ormond KE, 2010, LANCET, V375, P1749, DOI 10.1016/S0140-6736(10)60599-5; Perez-Andreu V, 2009, BLOOD, V113, P4977, DOI 10.1182/blood-2008-09-176222; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; QIN H, 2010, BIOINFORMATICS; Qin HZ, 2010, BIOINFORMATICS, V26, P2961, DOI 10.1093/bioinformatics/btq560; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rosenwaike I., 1972, POPULATION HIST NEW; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Shurin SB, 2008, NEW ENGL J MED, V358, P1061, DOI 10.1056/NEJMe0800801; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; The International HapMap Consortium, 2005, NATURE, V437, P1299, DOI DOI 10.1038/NATURE04226; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Tian C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003862; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Urban TJ, 2010, MT SINAI J MED, V77, P133, DOI 10.1002/msj.20168; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000037; Weiss KM, 2010, EVOL ANTHROPOL, V19, P92, DOI 10.1002/evan.20261; Zhang L, 2010, PHARMACOGENOMICS J, V10, P347, DOI 10.1038/tpj.2010.27	56	42	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19166	10.1371/journal.pone.0019166	http://dx.doi.org/10.1371/journal.pone.0019166			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573225	Green Published, gold, Green Submitted			2022-12-27	WOS:000290224800016
J	Weckworth, BV; Dawson, NG; Talbot, SL; Flamme, MJ; Cook, JA				Weckworth, Byron V.; Dawson, Natalie G.; Talbot, Sandra L.; Flamme, Melanie J.; Cook, Joseph A.			Going Coastal: Shared Evolutionary History between Coastal British Columbia and Southeast Alaska Wolves (Canis lupus)	PLOS ONE			English	Article							SQUIRRELS GLAUCOMYS-SABRINUS; MARTEN MARTES-AMERICANA; PACIFIC-NORTHWEST; ALEXANDER ARCHIPELAGO; GENETIC-STRUCTURE; MEXICAN WOLVES; WOLF; POPULATION; PHYLOGEOGRAPHY; DIFFERENTIATION	Background: Many coastal species occupying the temperate rainforests of the Pacific Northwest in North America comprise endemic populations genetically and ecologically distinct from interior continental conspecifics. Morphological variation previously identified among wolf populations resulted in recognition of multiple subspecies of wolves in the Pacific Northwest. Recently, separate genetic studies have identified diverged populations of wolves in coastal British Columbia and coastal Southeast Alaska, providing support for hypotheses of distinct coastal subspecies. These two regions are geographically and ecologically contiguous, however, there is no comprehensive analysis across all wolf populations in this coastal rainforest. Methodology/Principal Findings: By combining mitochondrial DNA datasets from throughout the Pacific Northwest, we examined the genetic relationship between coastal British Columbia and Southeast Alaska wolf populations and compared them with adjacent continental populations. Phylogenetic analysis indicates complete overlap in the genetic diversity of coastal British Columbia and Southeast Alaska wolves, but these populations are distinct from interior continental wolves. Analyses of molecular variation support the separation of all coastal wolves in a group divergent from continental populations, as predicted based on hypothesized subspecies designations. Two novel haplotypes also were uncovered in a newly assayed continental population of interior Alaska wolves. Conclusions/Significance: We found evidence that coastal wolves endemic to these temperate rainforests are diverged from neighbouring, interior continental wolves; a finding that necessitates new international strategies associated with the management of this species.	[Weckworth, Byron V.] Univ Calgary, Fac Environm Design, Calgary, AB T2N 1N4, Canada; [Dawson, Natalie G.; Cook, Joseph A.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Dawson, Natalie G.; Cook, Joseph A.] Univ New Mexico, Museum SW Biol, Albuquerque, NM 87131 USA; [Talbot, Sandra L.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK USA; [Flamme, Melanie J.] Yukon Charley Rivers Natl Preserve, Natl Pk Serv, Fairbanks, AK USA	University of Calgary; University of New Mexico; University of New Mexico; United States Department of the Interior; United States Geological Survey; United States Department of the Interior	Weckworth, BV (corresponding author), Univ Calgary, Fac Environm Design, Calgary, AB T2N 1N4, Canada.	byweck@gmail.com	Talbot, Sandra L/C-9433-2011	Cook, Joseph/0000-0003-3985-0670	U.S. Geological Survey Alaska Science Center; Yukon-Charley Rivers National Reserve; U.S. Fish & Wildlife Service; United States Department of Agriculture Forest Service Alaska Region and Forest Sciences Laboratory; National Science Foundation [NSF DEB 0196095, 0415668]	U.S. Geological Survey Alaska Science Center(United States Geological Survey); Yukon-Charley Rivers National Reserve; U.S. Fish & Wildlife Service(US Fish & Wildlife Service); United States Department of Agriculture Forest Service Alaska Region and Forest Sciences Laboratory(United States Department of Agriculture (USDA)United States Forest Service); National Science Foundation(National Science Foundation (NSF))	Funding was provided by the U.S. Geological Survey Alaska Science Center, Yukon-Charley Rivers National Reserve, U.S. Fish & Wildlife Service, United States Department of Agriculture Forest Service Alaska Region and Forest Sciences Laboratory, and National Science Foundation (NSF DEB 0196095 and 0415668). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal RK, 2007, J ZOOL SYST EVOL RES, V45, P163, DOI 10.1111/j.1439-0469.2006.00400.x; Andrew JM, 2002, WATERBIRDS, V25, P122; [Anonymous], 2013, INS PESTS POT GLOB, DOI DOI 10.1016/B978-0-12-386895-4.00005-3; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bidlack AL, 2002, CONSERV GENET, V3, P247, DOI 10.1023/A:1019966032259; Bidlack AL, 2001, ANIM CONSERV, V4, P283, DOI 10.1017/S1367943001008885; BOERTJE RD, 2003, 343 AL DEP FISH GAM; Burch J., 2002, NPSARNRTR200141; BURCH JW, 2009, NPSCAKNNRTR2009228; Carmichael LE, 2007, MOL ECOL, V16, P3466, DOI 10.1111/j.1365-294X.2007.03381.x; Cook JA, 2006, BIOL CONSERV, V133, P1, DOI 10.1016/j.biocon.2006.05.026; Darimont CT, 2007, BIOL J LINN SOC, V90, P125, DOI 10.1111/j.1095-8312.2007.00716.x; Darimont Chris T., 2008, BMC Ecology, V8, P14, DOI 10.1186/1472-6785-8-14; Darimont CT, 2004, J BIOGEOGR, V31, P1867, DOI 10.1111/j.1365-2699.2004.01141.x; Dawson N. G., 2008, THESIS U NEW MEXICO; Demboski JR, 1999, EVOLUTION, V53, P2008, DOI 10.1111/j.1558-5646.1999.tb04584.x; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fleming MA, 2002, MOL ECOL, V11, P795, DOI 10.1046/j.1365-294X.2002.01472.x; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Fredrickson RJ, 2007, P ROY SOC B-BIOL SCI, V274, P2365, DOI 10.1098/rspb.2007.0785; Geffen E, 2004, MOL ECOL, V13, P2481, DOI 10.1111/j.1365-294X.2004.02244.x; Goldman E.A., 1944, WOLVES N AM, P389; Gottelli D, 2004, MOL ECOL, V13, P2275, DOI 10.1111/j.1365-294X.2004.02226.x; Hall E., 1959, MAMMALS N AM, V2; Hall E.R., 1981, MAMMALS N AM, V2; Hansson B, 2005, ANIM CONSERV, V8, P83, DOI 10.1017/S1367943004001878; Hedrick PW, 2010, CONSERV GENET, V11, P615, DOI 10.1007/s10592-009-9999-5; Hilton-Taylor C., 2000, IUCN RED LIST THREAT; HOGAN KM, 1993, J MAMMAL, V74, P819, DOI 10.2307/1382420; Jaramillo-Correa JP, 2009, CAN J FOREST RES, V39, P286, DOI 10.1139/X08-181; KIESTER AR, 1994, REV WILDLIFE MANAGEM; Latch EK, 2008, ANIM CONSERV, V11, P234, DOI 10.1111/j.1469-1795.2008.00174.x; Leonard JA, 2005, MOL ECOL, V14, P9, DOI 10.1111/j.1365-294X.2004.02389.x; LUIKART G, 1997, THESIS U MONTANA MIS; MORITZ C, 1994, MOL ECOL, V3, P401, DOI 10.1111/j.1365-294X.1994.tb00080.x; Munoz-Fuentes V, 2009, J BIOGEOGR, V36, P1516, DOI 10.1111/j.1365-2699.2008.02067.x; Musiani M, 2007, MOL ECOL, V16, P4149, DOI 10.1111/j.1365-294X.2007.03458.x; National Park Service, 2006, NAT PARK SERV MAN PO; Nowak Ronald M., 1995, Canadian Circumpolar Institute Occasional Publication, V35, P375; Person D. K., 2001, THESIS U ALASKA FAIR; Person DK, 2008, J WILDLIFE MANAGE, V72, P1540, DOI 10.2193/2007-520; PERSON DK, 1996, PNWGTR384 USDA FOR S, P1; Rutledge LY, 2010, BIOL CONSERV, V143, P332, DOI 10.1016/j.biocon.2009.10.017; Sharma DK, 2004, P ROY SOC B-BIOL SCI, V271, pS1, DOI 10.1098/rsbl.2003.0071; Small MP, 2003, MOL ECOL, V12, P89, DOI 10.1046/j.1365-294X.2003.01720.x; Soltis DE, 1997, PLANT SYST EVOL, V206, P353, DOI 10.1007/BF00987957; Stone KD, 2002, MOL PHYLOGENET EVOL, V24, P169, DOI 10.1016/S1055-7903(02)00229-4; Stone KD, 2002, MOL ECOL, V11, P2049, DOI 10.1046/j.1365-294X.2002.01596.x; Stone KD, 2000, CAN J ZOOL, V78, P1218, DOI 10.1139/cjz-78-7-1218; SURING LH, 1993, STRATEGY MAINTAINING; Szepanski MM, 1999, OECOLOGIA, V120, P327, DOI 10.1007/s004420050866; Tanaka Y, 2007, ECOL RES, V22, P929, DOI 10.1007/s11284-007-0384-x; *US DEP INT ENV CA, 2001, CONS BORD SPEC PARTN; Weckworth BV, 2005, MOL ECOL, V14, P917, DOI 10.1111/j.1365-294X.2005.02461.x; Weckworth BV, 2010, J MAMMAL, V91, P363, DOI 10.1644/09-MAMM-A-036.1; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weir JT, 2004, P ROY SOC B-BIOL SCI, V271, P1881, DOI 10.1098/rspb.2004.2803; West E. W., 1991, STATUS REPORTS SELEC; Wooding S, 1997, MOL BIOL EVOL, V14, P1096, DOI 10.1093/oxfordjournals.molbev.a025719	61	16	17	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19582	10.1371/journal.pone.0019582	http://dx.doi.org/10.1371/journal.pone.0019582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573241	Green Published, Green Submitted, gold			2022-12-27	WOS:000290224800036
J	Della Libera, C; Perlato, A; Chelazzi, L				Della Libera, Chiara; Perlato, Andrea; Chelazzi, Leonardo			Dissociable Effects of Reward on Attentional Learning: From Passive Associations to Active Monitoring	PLOS ONE			English	Article							SCHEDULE-CONTROLLED BEHAVIOR; VISUAL-SEARCH TASKS; SELECTIVE ATTENTION; SPATIAL ATTENTION; HUMAN BRAIN; MEMORY; STIMULUS; CORTEX; CONTINGENCY; HUMANS	Visual selective attention (VSA) is the cognitive function that regulates ongoing processing of retinal input in order for selected representations to gain privileged access to perceptual awareness and guide behavior, facilitating analysis of currently relevant information while suppressing the less relevant input. Recent findings indicate that the deployment of VSA is shaped according to past outcomes. Targets whose selection has led to rewarding outcomes become relatively easier to select in the future, and distracters that have been ignored with higher gains are more easily discarded. Although outcomes (monetary rewards) were completely predetermined in our prior studies, participants were told that higher rewards would follow more efficient responses. In a new experiment we have eliminated the illusory link between performance and outcomes by informing subjects that rewards were randomly assigned. This trivial yet crucial manipulation led to strikingly different results. Items that were associated more frequently with higher gains became more difficult to ignore, regardless of the role (target or distracter) they played when differential rewards were delivered. Therefore, VSA is shaped by two distinct reward-related learning mechanisms: one requiring active monitoring of performance and outcome, and a second one detecting the sheer association between objects in the environment (whether attended or ignored) and the more-or-less rewarding events that accompany them.	[Della Libera, Chiara; Perlato, Andrea; Chelazzi, Leonardo] Univ Verona, Sect Physiol & Psychol, Dept Neurol Neuropsychol Morphol & Movement Sci, I-37100 Verona, Italy; [Della Libera, Chiara; Perlato, Andrea; Chelazzi, Leonardo] Natl Inst Neurosci, Verona, Italy	University of Verona	Della Libera, C (corresponding author), Univ Verona, Sect Physiol & Psychol, Dept Neurol Neuropsychol Morphol & Movement Sci, I-37100 Verona, Italy.	chiara.dellalibera@univr.it	Della Libera, Chiara/B-5102-2010; Chelazzi, Leonardo/B-6084-2011	Della Libera, Chiara/0000-0003-0286-0883; Chelazzi, Leonardo/0000-0001-8566-0611				Baddeley AD., 1990, HUMAN MEMORY THEORY; BARON A, 1969, J EXP ANAL BEHAV, V12, P701, DOI 10.1901/jeab.1969.12-701; Bjork JM, 2007, BEHAV BRAIN RES, V177, P165, DOI 10.1016/j.bbr.2006.10.034; Castro L, 2010, WIRES COGN SCI, V1, P89, DOI 10.1002/wcs.18; Chun MM, 2007, CURR OPIN NEUROBIOL, V17, P177, DOI 10.1016/j.conb.2007.03.005; Chun MM, 2011, ANNU REV PSYCHOL, V62, P73, DOI 10.1146/annurev.psych.093008.100427; Chun MM, 1998, COGNITIVE PSYCHOL, V36, P28, DOI 10.1006/cogp.1998.0681; Chun MM, 1999, PSYCHOL SCI, V10, P360, DOI 10.1111/1467-9280.00168; Ciaramitaro VM, 2001, VISION RES, V41, P57, DOI 10.1016/S0042-6989(00)00203-0; De Houwer J, 2005, COGNITION EMOTION, V19, P161, DOI 10.1080/02699930441000265; De Houwer J, 2001, PSYCHOL BULL, V127, P853, DOI 10.1037//0033-2909.127.6.853; Della Libera C, 2006, PSYCHOL SCI, V17, P222; Della Libera C, 2009, PSYCHOL SCI, V20, P778, DOI 10.1111/j.1467-9280.2009.02360.x; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; DICKINSON A, 1984, Q J EXP PSYCHOL-A, V36, P29, DOI 10.1080/14640748408401502; Dickinson A., 1994, ANIMAL LEARNING COGN, P45, DOI [10.1016/B978-0-08-057169-0.50009-7, DOI 10.1016/B978-0-08-057169-0.50009-7]; Dixon ML, 2009, PSYCHON B REV, V16, P418, DOI 10.3758/PBR.16.2.418; Duncan J, 2006, Q J EXP PSYCHOL, V59, P2, DOI 10.1080/17470210500260674; Egeth HE, 1997, ANNU REV PSYCHOL, V48, P269, DOI 10.1146/annurev.psych.48.1.269; Franko E, 2010, J COGNITIVE NEUROSCI, V22, P1425, DOI 10.1162/jocn.2009.21288; Geng JJ, 2002, PSYCHOL SCI, V13, P520, DOI 10.1111/1467-9280.00491; Hakyemez HS, 2008, NEUROIMAGE, V39, P2058, DOI 10.1016/j.neuroimage.2007.10.034; Hall G, 1994, ANIMAL LEARNING COGN, P15; HAYES SC, 1986, J EXP ANAL BEHAV, V46, P137, DOI 10.1901/jeab.1986.46-137; Hickey C, 2011, VIS COGN, V19, P117, DOI 10.1080/13506285.2010.503946; Hickey C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014087; Hickey C, 2010, J NEUROSCI, V30, P11096, DOI 10.1523/JNEUROSCI.1026-10.2010; Hoffmann J, 1999, J EXP PSYCHOL HUMAN, V25, P1127, DOI 10.1037/0096-1523.25.4.1127; Jagadeesh B, 2001, J NEUROPHYSIOL, V86, P290, DOI 10.1152/jn.2001.86.1.290; Jiang YH, 2001, Q J EXP PSYCHOL-A, V54, P1105, DOI 10.1080/02724980042000516; Kamin L. J., 1969, FUNDAMENTAL ISSUES A, P42; Kelley TA, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00216; Kelley TA, 2009, J VISION, V9, DOI 10.1167/9.7.16; Kiss M, 2009, PSYCHOL SCI, V20, P245, DOI 10.1111/j.1467-9280.2009.02281.x; Kristjansson A, 2010, ATTEN PERCEPT PSYCHO, V72, P1229, DOI 10.3758/APP.72.5.1229; Kristjansson A, 2010, ATTEN PERCEPT PSYCHO, V72, P5, DOI 10.3758/APP.72.1.5; Kruschke JK, 2000, PSYCHON B REV, V7, P636, DOI 10.3758/BF03213001; Kyllingsbaek S, 2001, PERCEPT PSYCHOPHYS, V63, P85, DOI 10.3758/BF03200505; Logan GD, 2002, PSYCHOL REV, V109, P376, DOI 10.1037//0033-295X.109.2.376; LOVIBOND PF, 1983, J EXP PSYCHOL ANIM B, V9, P225, DOI 10.1037/0097-7403.9.3.225; MILLER J, 1988, J EXP PSYCHOL HUMAN, V14, P453, DOI 10.1037/0096-1523.14.3.453; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Pashler HE., 1998, PSYCHOL ATTENTION, DOI [10.7551/mitpress/5677.001.0001, DOI 10.7551/MITPRESS/5677.001.0001]; Peck CJ, 2009, J NEUROSCI, V29, P11182, DOI 10.1523/JNEUROSCI.1929-09.2009; Pessiglione M, 2008, NEURON, V59, P561, DOI 10.1016/j.neuron.2008.07.005; Raymond JE, 2009, PSYCHOL SCI, V20, P981, DOI 10.1111/j.1467-9280.2009.02391.x; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; ROSENFARB IS, 1992, J EXP ANAL BEHAV, V58, P107, DOI 10.1901/jeab.1992.58-107; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Seitz AR, 2009, NEURON, V61, P700, DOI 10.1016/j.neuron.2009.01.016; Shanks DR, 2007, Q J EXP PSYCHOL, V60, P291, DOI 10.1080/17470210601000581; Shanks DR, 2010, ANNU REV PSYCHOL, V61, P273, DOI 10.1146/annurev.psych.093008.100519; SHANKS DR, 1993, BRIT J PSYCHOL, V84, P319, DOI 10.1111/j.2044-8295.1993.tb02486.x; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Tang YY, 2009, TRENDS COGN SCI, V13, P222, DOI 10.1016/j.tics.2009.01.009; Tricomi EM, 2004, NEURON, V41, P281, DOI 10.1016/S0896-6273(03)00848-1; Tseng CH, 2004, NATURE, V428, P657, DOI 10.1038/nature02443; Vidnyanszk Z, 2005, VISION RES, V45, P677, DOI 10.1016/j.visres.2004.10.009; Weil RS, 2010, J NEUROPHYSIOL, V104, P1746, DOI 10.1152/jn.00870.2009	60	61	61	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19460	10.1371/journal.pone.0019460	http://dx.doi.org/10.1371/journal.pone.0019460			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	756OZ	21559388	Green Submitted, gold, Green Published			2022-12-27	WOS:000290024700184
J	Huge, V; Lauchart, M; Magerl, W; Beyer, A; Moehnle, P; Kaufhold, W; Schelling, G; Azad, SC				Huge, Volker; Lauchart, Meike; Magerl, Walter; Beyer, Antje; Moehnle, Patrick; Kaufhold, Wibke; Schelling, Gustav; Azad, Shahnaz Christina			Complex Interaction of Sensory and Motor Signs and Symptoms in Chronic CRPS	PLOS ONE			English	Article							REGIONAL PAIN SYNDROME; POSTTRAUMATIC-STRESS-DISORDER; REFLEX SYMPATHETIC DYSTROPHY; SYNDROME TYPE-I; NEUROPATHIC PAIN; CORTICAL REORGANIZATION; NEUROGENIC INFLAMMATION; BRAIN; MECHANISMS; HYPERALGESIA	Spontaneous pain, hyperalgesia as well as sensory abnormalities, autonomic, trophic, and motor disturbances are key features of Complex Regional Pain Syndrome (CRPS). This study was conceived to comprehensively characterize the interaction of these symptoms in 118 patients with chronic upper limb CRPS (duration of disease: 43 +/- 23 months). Disease-related stress, depression, and the degree of accompanying motor disability were likewise assessed. Stress and depression were measured by Posttraumatic Stress Symptoms Score and Center for Epidemiological Studies Depression Test. Motor disability of the affected hand was determined by Sequential Occupational Dexterity Assessment and Michigan Hand Questionnaire. Sensory changes were assessed by Quantitative Sensory Testing according to the standards of the German Research Network on Neuropathic Pain. Almost two-thirds of all patients exhibited spontaneous pain at rest. Hand force as well as hand motor function were found to be substantially impaired. Results of Quantitative Sensory Testing revealed a distinct pattern of generalized bilateral sensory loss and hyperalgesia, most prominently to blunt pressure. Patients reported substantial motor complaints confirmed by the objective motor disability testings. Interestingly, patients displayed clinically relevant levels of stress and depression. We conclude that chronic CRPS is characterized by a combination of ongoing pain, pain-related disability, stress and depression, potentially triggered by peripheral nerve/tissue damage and ensuing sensory loss. In order to consolidate the different dimensions of disturbances in chronic CRPS, we developed a model based on interaction analysis suggesting a complex hierarchical interaction of peripheral (injury/sensory loss) and central factors (pain/disability/stress/depression) predicting motor dysfunction and hyperalgesia.	[Huge, Volker; Lauchart, Meike; Beyer, Antje; Moehnle, Patrick; Kaufhold, Wibke; Schelling, Gustav; Azad, Shahnaz Christina] Univ Munich, Dept Anaesthesiol, Munich, Germany; [Magerl, Walter] Heidelberg Univ, Ctr Biomed & Med Technol CBTM, Dept Neurobiol, Med Fac Mannheim, D-6800 Mannheim, Germany	University of Munich; Ruprecht Karls University Heidelberg	Huge, V (corresponding author), Univ Munich, Dept Anaesthesiol, Marchioninistr 15, Munich, Germany.	vhuge@med.uni-muenchen.de	Schelling, Gustav/U-2603-2018; Möhnle, Patrick/C-9243-2018	Schelling, Gustav/0000-0002-6538-0652; Möhnle, Patrick/0000-0003-4769-7100	German Federal Ministry of Education and Research (Bundesministerium fuer Bildung und Forschung; BMBF) [01EM 0118, 01EM 0506]; German Research Foundation [DFG FOR926/SP5, MA 1251/9-1]; nationwide German Research Network on Neuropathic Pain (DFNS)	German Federal Ministry of Education and Research (Bundesministerium fuer Bildung und Forschung; BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG)); nationwide German Research Network on Neuropathic Pain (DFNS)	This work was supported by the German Federal Ministry of Education and Research (Bundesministerium fuer Bildung und Forschung; BMBF) [grant number 01EM 0118 and 01EM 0506] and the German Research Foundation [grant number DFG FOR926/SP5 - grant MA 1251/9-1]. This research was supported by the nationwide German Research Network on Neuropathic Pain (DFNS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht PJ, 2006, PAIN, V120, P244, DOI 10.1016/j.pain.2005.10.035; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Baumgartner U, 2006, NEUROIMAGE, V30, P692, DOI 10.1016/j.neuroimage.2005.10.033; Berna C, 2010, BIOL PSYCHIAT, V67, P1083, DOI 10.1016/j.biopsych.2010.01.014; Bingel U, 2004, CEREB CORTEX, V14, P1340, DOI 10.1093/cercor/bhh094; Birklein F, 2000, ACTA NEUROL SCAND, V101, P262, DOI 10.1034/j.1600-0404.2000.101004262x./; Birklein F, 2001, PAIN, V93, P165, DOI 10.1016/S0304-3959(01)00309-8; Birklein F, 2008, NEUROSCI LETT, V437, P199, DOI 10.1016/j.neulet.2008.03.081; Bruehl S, 1999, PAIN, V81, P147, DOI 10.1016/S0304-3959(99)00011-1; Bruggeman AWA, 2009, NEUROLOGY, V73, P1711, DOI 10.1212/WNL.0b013e3181bd6b0d; CEYLER N, 2007, PAIN, V132, P195; Chen CC, 2009, NEUROIMAGE, V45, P453, DOI 10.1016/j.neuroimage.2008.12.041; CHUDLER EH, 1995, PAIN, V60, P3, DOI 10.1016/0304-3959(94)00172-B; Chung KC, 1998, J HAND SURG-AM, V23A, P575, DOI 10.1016/S0363-5023(98)80042-7; Cruccu G, 2004, EUR J NEUROL, V11, P153, DOI 10.1111/j.1468-1331.2004.00791.x; DAVIDOFF G, 1988, PAIN, V32, P27, DOI 10.1016/0304-3959(88)90020-6; de Mos M, 2008, PAIN, V139, P458, DOI 10.1016/j.pain.2008.07.002; de Mos M, 2009, CLIN J PAIN, V25, P590, DOI 10.1097/AJP.0b013e3181a11623; Defrin R, 2008, PAIN, V138, P450, DOI 10.1016/j.pain.2008.05.006; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; Eberle T, 2009, NEUROLOGY, V72, P505, DOI 10.1212/01.wnl.0000341930.35494.66; Flor H, 2006, NAT REV NEUROSCI, V7, P873, DOI 10.1038/nrn1991; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Geber C, 2008, PAIN, V139, P73, DOI 10.1016/j.pain.2008.03.006; Geber C, 2011, PAIN, V152, P548, DOI 10.1016/j.pain.2010.11.013; Geertzen JHB, 1998, ACTA ORTHOP SCAND, V69, P12, DOI 10.1080/17453674.1998.11744781; Geertzen JHB, 1998, ACTA ORTHOP SCAND, V69, P4, DOI 10.1080/17453674.1998.11744780; Geha PY, 2008, NEURON, V60, P570, DOI 10.1016/j.neuron.2008.08.022; Geisser ME, 1997, CLIN J PAIN, V13, P163, DOI 10.1097/00002508-199706000-00011; Gieteling EW, 2008, PAIN, V134, P302, DOI 10.1016/j.pain.2007.04.029; Grachev ID, 2000, PAIN, V89, P7, DOI 10.1016/S0304-3959(00)00340-7; Grande LA, 2004, PAIN, V110, P495, DOI 10.1016/j.pain.2004.03.032; Hansson P, 2007, PAIN, V129, P256, DOI 10.1016/j.pain.2007.03.030; Hautzinger M., 1993, ALLGEMEINE DEPRESSIO; HORGER MM, 1990, AM J OCCUP THER, V44, P342, DOI 10.5014/ajot.44.4.342; Huge V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002742; Kapfhammer HP, 2004, AM J PSYCHIAT, V161, P45, DOI 10.1176/appi.ajp.161.1.45; Kaufmann I, 2007, CLIN IMMUNOL, V125, P103, DOI 10.1016/j.clim.2007.07.004; KILO S, 1994, BRAIN, V117, P385, DOI 10.1093/brain/117.2.385; Klauenberg S, 2008, PAIN, V140, P332, DOI 10.1016/j.pain.2008.09.003; Koenigs M, 2008, NAT NEUROSCI, V11, P232, DOI 10.1038/nn2032; Kohr D, 2009, PAIN, V143, P246, DOI 10.1016/j.pain.2009.03.009; Lim SY, 2008, MOVEMENT DISORD, V23, P1689, DOI 10.1002/mds.22111; Maier C, 2010, PAIN; Maihofner C, 2007, BRAIN, V130, P2671, DOI 10.1093/brain/awm131; Maihofner C, 2004, NEUROLOGY, V63, P693, DOI 10.1212/01.WNL.0000134661.46658.B0; Maihofner C, 2003, NEUROLOGY, V61, P1707, DOI 10.1212/01.WNL.0000098939.02752.8E; May A, 2008, PAIN, V137, P7, DOI 10.1016/j.pain.2008.02.034; Metz AE, 2009, P NATL ACAD SCI USA, V106, P2423, DOI 10.1073/pnas.0809897106; Nederhand MJ, 2006, CLIN J PAIN, V22, P519, DOI 10.1097/01.ajp.0000202979.44163.da; Oaklander AL, 2009, ANN NEUROL, V65, P629, DOI 10.1002/ana.21692; Oerlemans HM, 1999, CLIN J PAIN, V15, P224, DOI 10.1097/00002508-199909000-00010; Pleger B, 2005, ANN NEUROL, V57, P425, DOI 10.1002/ana.20394; Pleger B, 2006, NEUROIMAGE, V32, P503, DOI 10.1016/j.neuroimage.2006.03.045; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Rolke R, 2006, EUR J PAIN, V10, P77, DOI 10.1016/j.ejpain.2005.02.003; Sandroni P, 2003, PAIN, V103, P199, DOI 10.1016/S0304-3959(03)00065-4; Schelling G, 2004, BIOL PSYCHIAT, V55, P627, DOI 10.1016/j.biopsych.2003.09.014; Schwenkreis P, 2003, NEUROLOGY, V61, P515, DOI 10.1212/WNL.61.4.515; Seifert F, 2009, BRAIN, V132, P788, DOI 10.1093/brain/awn346; STANTONHICKS M, 1995, PAIN, V63, P127, DOI 10.1016/0304-3959(95)00110-E; STERN EB, 1991, AM J OCCUP THER, V45, P801, DOI 10.5014/ajot.45.9.801; Stiasny-Kolster K, 2004, BRAIN, V127, P773, DOI 10.1093/brain/awh079; Stoll C, 1999, INTENS CARE MED, V25, P697, DOI 10.1007/s001340050932; TAIT RC, 1987, ARCH PHYS MED REHAB, V68, P438; Tan ECTH, 2009, INJURY, V40, P901, DOI 10.1016/j.injury.2009.01.134; Treede RD, 2002, PAIN, V98, P235, DOI 10.1016/S0304-3959(02)00203-8; TREEDE RD, 1992, PROG NEUROBIOL, V38, P397, DOI 10.1016/0301-0082(92)90027-C; van der Giesen FJ, 2009, ARTHRIT RHEUM-ARTHR, V61, P1025, DOI 10.1002/art.24866; van Lankveld W, 1996, J Hand Ther, V9, P27; Vaneker M, 2006, EUR J PAIN, V10, P639, DOI 10.1016/j.ejpain.2005.10.003; VELDMAN PHJM, 1993, LANCET, V342, P1012, DOI 10.1016/0140-6736(93)92877-V; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wasner G, 2001, BRAIN, V124, P587, DOI 10.1093/brain/124.3.587; Weber M, 2001, PAIN, V91, P251, DOI 10.1016/S0304-3959(00)00445-0; WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203, DOI 10.1093/oxfordjournals.aje.a112455	76	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18775	10.1371/journal.pone.0018775	http://dx.doi.org/10.1371/journal.pone.0018775			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559525	Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700025
J	Ojaveer, H; Eero, M				Ojaveer, Henn; Eero, Margit			Methodological Challenges in Assessing the Environmental Status of a Marine Ecosystem: Case Study of the Baltic Sea	PLOS ONE			English	Article							REGIME SHIFTS; INDICATORS; FISHERIES; MANAGEMENT; FRAMEWORK; UTILITY	Assessments of the environmental status of marine ecosystems are increasingly needed to inform management decisions and regulate human pressures to meet the objectives of environmental policies. This paper addresses some generic methodological challenges and related uncertainties involved in marine ecosystem assessment, using the central Baltic Sea as a case study. The objectives of good environmental status of the Baltic Sea are largely focusing on biodiversity, eutrophication and hazardous substances. In this paper, we conduct comparative evaluations of the status of these three segments, by applying different methodological approaches. Our analyses indicate that the assessment results are sensitive to a selection of indicators for ecological quality objectives that are affected by a broad spectrum of human activities and natural processes (biodiversity), less so for objectives that are influenced by a relatively narrow array of drivers (eutrophications, hazardous substances). The choice of indicator aggregation rule appeared to be of essential importance for assessment results for all three segments, whereas the hierarchical structure of indicators had only a minor influence. Trend-based assessment was shown to be a useful supplement to reference-based evaluation, being independent of the problems related to defining reference values and indicator aggregation methodologies. Results of this study will help in setting priorities for future efforts to improve environmental assessments in the Baltic Sea and elsewhere, and to ensure the transparency of the assessment procedure.	[Ojaveer, Henn] Univ Tartu, Estonian Marine Inst, Parnu, Estonia; [Eero, Margit] Tech Univ Denmark, Natl Inst Aquat Resources, Charlottenlund, Denmark	University of Tartu; Estonian Marine Institute; Technical University of Denmark	Ojaveer, H (corresponding author), Univ Tartu, Estonian Marine Inst, Parnu, Estonia.	henn.ojaveer@ut.ee	Eero, Margit/AAK-2845-2021; Ojaveer, Henn/K-2160-2016	Eero, Margit/0000-0002-1848-0597; Ojaveer, Henn/0000-0003-2742-6063	EU [044227, 212085, 266445]; Estonian Ministry of Education and Research [SF0180005s10]; Danish Network for Fisheries and Aquaculture Research (FISHNET)	EU(European Commission); Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Danish Network for Fisheries and Aquaculture Research (FISHNET)	The study was supported by EU FP6 and FP7 research projects IMAGE (044227), MEECE (212085) and VECTORS (266445), Estonian Ministry of Education and Research (SF0180005s10), and Danish Network for Fisheries and Aquaculture Research (FISHNET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JH, 2010, MAR POLLUT BULL, V60, P919, DOI 10.1016/j.marpolbul.2010.03.020; [Anonymous], 2008, STATE EVOLUTION BALT, DOI DOI 10.1002/9780470283134.CH2; Bergstrom L, 2010, 302 ICES; Bowen RE, 2003, OCEAN COAST MANAGE, V46, P299, DOI 10.1016/S0964-5691(03)00008-5; CAIRNS J, 1993, HYDROBIOLOGIA, V263, P1, DOI 10.1007/BF00006084; Cardinale M, 2011, MAR ECOL PROG SER, V425, P297, DOI 10.3354/meps09098; Cisin-Sain B, 2007, RGS IBG C PEOPL SEA; Commission of the European Communities (CEC), 2006, GREEN PAP FUT MAR PO; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Fisher WS, 2001, HUM ECOL RISK ASSESS, V7, P961, DOI 10.1080/20018091094781; Fulton EA, 2005, ICES J MAR SCI, V62, P540, DOI 10.1016/j.icesjms.2004.12.012; HELCOM, 2007, BALT SEA ACT PLAN HE, P101; HELCOM, 2009, BIOD BALT SEA INT TH, V116, P188; HELCOM, 2009, BALT SEA ENV P; HELCOM, 2010, BALT SEA ENV P, V122; Jennings S, 2005, ICES J MAR SCI, V62, P397, DOI 10.1016/j.icesjms.2004.07.030; Johnson D, 2008, ICES J MAR SCI, V65, P1387, DOI 10.1093/icesjms/fsn154; Kenny AJ, 2009, PROG OCEANOGR, V81, P132, DOI 10.1016/j.pocean.2009.04.007; Levin PS, 2009, PLOS BIOL, V7, P23, DOI 10.1371/journal.pbio.1000014; Link JS, 2005, ICES J MAR SCI, V62, P569, DOI 10.1016/j.icesjms.2004.12.015; Mee LD, 2008, MAR POLLUT BULL, V56, P187, DOI 10.1016/j.marpolbul.2007.09.038; MFSD, 2008, **NON-TRADITIONAL**, V164, P19; Miller B.J., 2002, The NetWeaver reference manual; Mollmann C, 2009, GLOBAL CHANGE BIOL, V15, P1377, DOI 10.1111/j.1365-2486.2008.01814.x; Munoz-Erickson TA, 2007, ECOL SOC, V12; Nobre AM, 2009, ENVIRON MANAGE, V44, P185, DOI 10.1007/s00267-009-9291-y; Ojaveer E, 2008, J MARINE SYST, V74, P672, DOI 10.1016/j.jmarsys.2008.07.001; OSPAR, 2009, ECOQO HDB; Osterblom H, 2010, MAR POLICY, V34, P1290, DOI 10.1016/j.marpol.2010.05.007; Osterblom H, 2007, ECOSYSTEMS, V10, P877, DOI 10.1007/s10021-007-9069-0; Paterson B, 2007, MAR FRESHWATER RES, V58, P1056, DOI 10.1071/MF07060; Piet GJ, 2010, ICES J MAR SCI, V67, P559, DOI 10.1093/icesjms/fsp293; Piet GJ, 2008, ICES J MAR SCI, V65, P1449, DOI 10.1093/icesjms/fsn124; Pinnegar JK, 2008, REV FISH BIOL FISHER, V18, P1, DOI 10.1007/s11160-007-9058-6; Queffelec B, 2009, MAR POLICY, V33, P871, DOI 10.1016/j.marpol.2009.04.016; Rees HL, 2008, ICES J MAR SCI, V65, P1381, DOI 10.1093/icesjms/fsn153; Rice JC, 2005, ICES J MAR SCI, V62, P516, DOI 10.1016/j.icesjms.2005.01.003; Rochet MJ, 2005, ICES J MAR SCI, V62, P1647, DOI 10.1016/j.icesjms.2005.06.009; Rogers SI, 2005, MAR POLLUT BULL, V50, P9, DOI 10.1016/j.marpolbul.2004.10.028; Shields D., 2002, ECOL INDIC, V2, P149, DOI [DOI 10.1016/S1470-160X(02)00042-0, 10.1016/S1470-160X(02)00042-0]; Shin YJ, 2010, ICES J MAR SCI, V67, P692, DOI 10.1093/icesjms/fsp294; U.S. Commission on Ocean Policy, 2004, OC BLUEPR 21 CENT; UNESCO, 2006, HDB MEAS PROG OUTC I, V46; *WSSD, 2002, WORLD SUMM SUST DEV	44	28	28	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19231	10.1371/journal.pone.0019231	http://dx.doi.org/10.1371/journal.pone.0019231			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559423	gold, Green Published, Green Submitted			2022-12-27	WOS:000290024700106
J	Saponetti, MS; Bobba, F; Salerno, G; Scarfato, A; Corcelli, A; Cucolo, A				Saponetti, Matilde Sublimi; Bobba, Fabrizio; Salerno, Grazia; Scarfato, Alessandro; Corcelli, Angela; Cucolo, Annamaria			Morphological and Structural Aspects of the Extremely Halophilic Archaeon Haloquadratum walsbyi	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; S-LAYERS; SQUARE; CULTIVATION; SURFACES; IMAGES; LIPIDS; MUCIN; CELLS	Ultrathin square cell Haloquadratum walsbyi from the Archaea domain are the most abundant microorganisms in the hypersaline water of coastal salterns and continental salt lakes. In this work, we explore the cell surface of these microorganisms using amplitude-modulation atomic-force microscopy in nearly physiological conditions. We demonstrate the presence of a regular corrugation with a periodicity of 16-20 nm attributed to the surface layer ( S-layer) protein lattice, striped domains asymmetrically distributed on the cell faces and peculiar bulges correlated with the presence of intracellular granules. Besides, subsequent images of cell evolution during the drying process indicate the presence of an external capsule that might correspond to the giant protein halomucin, predicted by the genome but never before observed by other microscopy studies.	[Saponetti, Matilde Sublimi; Bobba, Fabrizio; Salerno, Grazia; Scarfato, Alessandro; Cucolo, Annamaria] Univ Salerno, Dept Phys, Fisciano, Italy; [Saponetti, Matilde Sublimi; Bobba, Fabrizio; Salerno, Grazia; Scarfato, Alessandro; Cucolo, Annamaria] Univ Salerno, Res Ctr NanoMateS, Fisciano, Italy; [Saponetti, Matilde Sublimi; Bobba, Fabrizio; Salerno, Grazia; Scarfato, Alessandro; Cucolo, Annamaria] SPIN CNR, Fisciano, Italy; [Corcelli, Angela] Univ Bari, Dept Med Biochem Biol & Phys, Bari, Italy; [Corcelli, Angela] IPCF CNR, Bari, Italy	University of Salerno; University of Salerno; Consiglio Nazionale delle Ricerche (CNR); Istituto Superconduttori, Materiali e Dispositivi Innovativi (SPIN-CNR); Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR); Istituto per i Processi Chimico-Fisici (IPCF-CNR)	Saponetti, MS (corresponding author), Univ Salerno, Dept Phys, Fisciano, Italy.	m.sublimi@sa.infn.it	Scarfato, Alessandro/A-2582-2013	Corcelli, Angela/0000-0001-9658-8520; BOBBA, Fabrizio/0000-0002-3472-642X				Bansil R, 2006, CURR OPIN COLLOID IN, V11, P164, DOI 10.1016/j.cocis.2005.11.001; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Bolhuis H, 2004, ENVIRON MICROBIOL, V6, P1287, DOI 10.1111/j.1462-2920.2004.00692.x; Bolhuis H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-169; Bolshakova AV, 2001, ULTRAMICROSCOPY, V86, P121, DOI 10.1016/S0304-3991(00)00075-9; Burns DG, 2007, INT J SYST EVOL MICR, V57, P387, DOI 10.1099/ijs.0.64690-0; Burns DG, 2004, APPL ENVIRON MICROB, V70, P5258, DOI 10.1128/AEM.70.9.5258-5265.2004; Burns DG, 2004, FEMS MICROBIOL LETT, V238, P469, DOI 10.1016/j.femsle.2004.08.016; Corcelli A, 2006, METHOD MICROBIOL, V35, P585, DOI 10.1016/S0580-9517(08)70028-X; de Kruijff B, 2006, BIOL CHEM, V387, P235, DOI 10.1515/BC.2006.031; Deacon MP, 2000, BIOCHEM J, V348, P557, DOI 10.1042/0264-6021:3480557; Dufrene YF, 2001, MICRON, V32, P153, DOI 10.1016/S0968-4328(99)00106-7; Engelhardt H, 2007, J STRUCT BIOL, V160, P190, DOI 10.1016/j.jsb.2007.08.004; Fang SJ, 1997, J APPL PHYS, V82, P5891, DOI 10.1063/1.366489; Gad M, 1995, BIOPHYS J, V69, P2226, DOI 10.1016/S0006-3495(95)80147-5; Hayhurst EJ, 2008, P NATL ACAD SCI USA, V105, P14603, DOI 10.1073/pnas.0804138105; JAVOR B, 1982, J BACTERIOL, V151, P1532, DOI 10.1128/JB.151.3.1532-1542.1982; KANOKPHORN S, 2008, ELECT J BIOTECHNOLOG, V11; KASAS S, 1995, BIOPHYS J, V68, P1678, DOI 10.1016/S0006-3495(95)80344-9; Lobasso Simona, 2008, Archaea, V2, P177, DOI 10.1155/2008/870191; McMaster TJ, 1996, BIOPHYS J, V70, P2432, DOI 10.1016/S0006-3495(96)79813-2; Muller DJ, 1997, J STRUCT BIOL, V119, P172, DOI 10.1006/jsbi.1997.3875; Stark M, 2001, BIOPHYS J, V80, P3009, DOI 10.1016/S0006-3495(01)76266-2; STOECKENIUS W, 1981, J BACTERIOL, V148, P352, DOI 10.1128/JB.148.1.352-360.1981; Toca-Herrera JL, 2005, SMALL, V1, P339, DOI 10.1002/smll.200400035; Walsby AE, 2005, TRENDS MICROBIOL, V13, P193, DOI 10.1016/j.tim.2005.03.002; WALSBY AE, 1980, NATURE, V283, P69, DOI 10.1038/283069a0; WALSBY AE, 1972, BACTERIOL REV, V36, P1	28	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18653	10.1371/journal.pone.0018653	http://dx.doi.org/10.1371/journal.pone.0018653			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559517	gold, Green Published, Green Submitted			2022-12-27	WOS:000290024700018
J	Voronova, A; Fischer, A; Ryan, T; Al Madhoun, A; Skerjanc, IS				Voronova, Anastassia; Fischer, Anna; Ryan, Tammy; Al Madhoun, Ashraf; Skerjanc, Ilona Sylvia			Ascl1/Mash1 Is a Novel Target of Gli2 during Gli2-Induced Neurogenesis in P19 EC Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; ACHAETE-SCUTE HOMOLOG-1; CENTRAL-NERVOUS-SYSTEM; ENHANCER FACTOR 2C; SONIC HEDGEHOG; CARCINOMA-CELLS; GENE-EXPRESSION; NEURONAL DIFFERENTIATION; FLOOR PLATE; NEURAL DIFFERENTIATION	The Sonic Hedgehog (Shh) signaling pathway is important for neurogenesis in vivo. Gli transcription factors, effector proteins of the Shh signaling pathway, have neurogenic properties in vivo, which are still poorly understood. To study the molecular basis of neurogenic properties of Gli2, we used a well-established embryonic stem cell model, the P19 embryonal carcinoma (EC) cell line, which can be induced to differentiate into neurons in the presence of retinoic acid (RA). We found that, in the absence of RA, overexpression of Gli2 induced P19 EC cells to differentiate into neurons, but not astrocytes during the first ten days of differentiation. To our knowledge, this is the first indication that the expression of Gli factors can convert EC cells into neurons. Furthermore, Gli2 upregulated expression of the neurogenic basic helix-loop-helix (bHLH) factors, such as NeuroD, Neurog1 and Ascl1/Mash1 in P19 EC cells. Using chromatin immunoprecipitation assays, we showed that Gli2 bound to multiple regulatory regions in the Ascl1 gene, including promoter and enhancer regions during Gli2-induced neurogenesis. In addition, Gli2 activated the Ascl1/Mash1 promoter in vitro. Using the expression of a dominant-negative form of Gli2, fused to the Engrailed repression domain, we observed a reduction in gliogenesis and a significant downregulation of the bHLH factors Ascl1/Mash1, Neurog1 and NeuroD, leading to delayed neurogenesis in P19 EC cells, further supporting the hypothesis that Ascl1/Mash1 is a direct target of Gli2. In summary, Gli2 is sufficient to induce neurogenesis in P19 stem cells at least in part by directly upregulating Ascl1/Mash1. Our results provide mechanistic insight into the neurogenic properties of Gli2 in vitro, and offer novel plausible explanations for its in vivo neurogenic properties.	[Voronova, Anastassia; Fischer, Anna; Ryan, Tammy; Al Madhoun, Ashraf; Skerjanc, Ilona Sylvia] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Ottawa	Voronova, A (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	iskerjan@uottawa.ca	Voronova, Anastassia/GLR-8891-2022; Skerjanc, Ilona/AAN-3318-2020	Voronova, Anastassia/0000-0001-7504-1905; Al Madhoun, Ashraf/0000-0001-8593-3878; Ryan, Tammy/0000-0002-0428-8932	Canadian Institutes of Health Research [MOP-84458, MOP-53277]; Heart and Stroke Foundation of Canada; Heart and Stroke Foundation of Ontario; OGSST	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); OGSST	This work was supported by grants MOP-84458 and MOP-53277 (to ISS) from the Canadian Institutes of Health Research. AV was supported by a Heart and Stroke Foundation of Canada Doctoral Research Award. TP was supported by Heart and Stroke Foundation of Ontario and OGSST studentships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaba ARI, 1998, DEVELOPMENT, V125, P2203; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Black BL, 1996, J BIOL CHEM, V271, P26659, DOI 10.1074/jbc.271.43.26659; Borycki AG, 2000, DEVELOPMENT, V127, P2075; Brewster R, 1998, NATURE, V393, P579, DOI 10.1038/31242; Cai C, 2008, STEM CELLS, V26, P1097, DOI 10.1634/stemcells.2007-0684; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen H, 1997, P NATL ACAD SCI USA, V94, P5355, DOI 10.1073/pnas.94.10.5355; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Denham M, 2010, STEM CELLS, V28, P1805, DOI 10.1002/stem.510; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Ding Q, 1998, DEVELOPMENT, V125, P2533; Elmi M, 2007, MOL CELL NEUROSCI, V36, P248, DOI 10.1016/j.mcn.2007.07.001; Endo M, 2009, J BIOL CHEM, V284, P5107, DOI 10.1074/jbc.M807745200; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Farah MH, 2000, DEVELOPMENT, V127, P693; Fode C, 2000, GENE DEV, V14, P67; Furimsky M, 2006, DEV DYNAM, V235, P594, DOI 10.1002/dvdy.20658; Gianakopoulos PJ, 2005, J BIOL CHEM, V280, P21022, DOI 10.1074/jbc.M502977200; Gianakopoulos PJ, 2011, J BIOL CHEM; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; Hu MC, 2006, DEVELOPMENT, V133, P569, DOI 10.1242/dev.02220; Ikram MS, 2004, J INVEST DERMATOL, V122, P1503, DOI 10.1111/j.0022-202X.2004.22612.x; Imbeault S, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-13; Itoh F, 1997, TOHOKU J EXP MED, V182, P327, DOI 10.1620/tjem.182.327; Jin ZG, 2009, J BIOL CHEM, V284, P8160, DOI 10.1074/jbc.M805632200; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; Karlstrom RO, 2003, DEVELOPMENT, V130, P1549, DOI 10.1242/dev.00364; Kennedy KAM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-67; Kunnimalaiyaan M, 2006, J BIOL CHEM, V281, P39819, DOI 10.1074/jbc.M603578200; Lang KJD, 2004, J NEUROSCI RES, V76, P184, DOI 10.1002/jnr.20036; Lee DS, 2006, LIFE SCI, V80, P154, DOI 10.1016/j.lfs.2006.08.039; Lee J, 1997, DEVELOPMENT, V124, P2537; Li Z, 2008, J NEUROSCI, V28, P6557, DOI 10.1523/JNEUROSCI.0134-08.2008; Lipinski RJ, 2006, EXP CELL RES, V312, P1925, DOI 10.1016/j.yexcr.2006.02.019; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowe B, 2003, ANAL BIOCHEM, V315, P95, DOI 10.1016/S0003-2697(02)00695-4; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Marti E, 2002, TRENDS NEUROSCI, V25, P89, DOI 10.1016/S0166-2236(02)02062-3; MARTI E, 1995, NATURE, V375, P322, DOI 10.1038/375322a0; Matise MP, 1998, DEVELOPMENT, V125, P2759; MCBURNEY MW, 1982, DEV BIOL, V89, P503, DOI 10.1016/0012-1606(82)90338-4; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; McDermott A, 2005, DEVELOPMENT, V132, P345, DOI 10.1242/dev.01537; Miyagi S, 2009, CELL MOL LIFE SCI, V66, P3675, DOI 10.1007/s00018-009-0097-0; Mizugishi K, 2001, J BIOL CHEM, V276, P2180, DOI 10.1074/jbc.M004430200; Mo R, 1997, DEVELOPMENT, V124, P113; Nakada Y, 2004, DEVELOPMENT, V131, P1319, DOI 10.1242/dev.01008; Nguyen V, 2005, DEVELOPMENT, V132, P3267, DOI 10.1242/dev.01905; Ohlmeyer JT, 1998, NATURE, V396, P749, DOI 10.1038/25533; Okamoto S, 2000, P NATL ACAD SCI USA, V97, P7561, DOI 10.1073/pnas.130502697; Ovcharenko I, 2005, GENOME RES, V15, P184, DOI 10.1101/gr.3007205; Park HL, 2000, DEVELOPMENT, V127, P1593; Pattyn A, 2006, DEV BIOL, V295, P67, DOI 10.1016/j.ydbio.2006.03.008; Perron M, 2003, DEVELOPMENT, V130, P1565, DOI 10.1242/dev.00391; Petropoulos H, 2004, J BIOL CHEM, V279, P23874, DOI 10.1074/jbc.M312612200; Po A, 2010, EMBO J, V29, P2646, DOI 10.1038/emboj.2010.131; Rho JY, 2006, HUM REPROD, V21, P405, DOI 10.1093/humrep/dei328; Ridgeway AG, 2001, J BIOL CHEM, V276, P19033, DOI 10.1074/jbc.M011491200; Ridgeway AG, 2000, J BIOL CHEM, V275, P32398, DOI 10.1074/jbc.M004349200; Riobo NA, 2007, BIOCHEM J, V403, P369, DOI 10.1042/BJ20061723; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; Roessler E, 2003, P NATL ACAD SCI USA, V100, P13424, DOI 10.1073/pnas.2235734100; RUIZ IAA, 2002, NAT REV NEUROSCI, V3, P24, DOI DOI 10.1038/NRN704; Runnicki M.A., 1987, TERATOCARCINOMAS EMB, P19; Sasagawa S, 2002, GENESIS, V33, P86, DOI 10.1002/gene.10095; Savage J, 2010, DIFFERENTIATION, V79, P31, DOI 10.1016/j.diff.2009.08.008; Savage J, 2009, STEM CELLS, V27, P1231, DOI 10.1002/stem.57; Skerjanc IS, 2000, FEBS LETT, V472, P53, DOI 10.1016/S0014-5793(00)01438-1; Skerjanc IS, 1999, TRENDS CARDIOVAS MED, V9, P139, DOI 10.1016/S1050-1738(99)00017-1; SLACK RS, 1995, J CELL BIOL, V129, P779, DOI 10.1083/jcb.129.3.779; Smukler SR, 2006, J CELL BIOL, V172, P79, DOI 10.1083/jcb.200508085; Takanaga H, 2009, STEM CELLS, V27, P165, DOI 10.1634/stemcells.2008-0580; Teramoto S, 2005, ONCOL REP, V14, P1231; Theil T, 1999, DEVELOPMENT, V126, P3561; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tole S, 2000, DEV BIOL, V217, P254, DOI 10.1006/dbio.1999.9509; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; Ulrich H, 2006, CELL PROLIFERAT, V39, P281, DOI 10.1111/j.1365-2184.2006.00385.x; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Wakabayashi N, 2000, J BIOCHEM, V128, P1087, DOI 10.1093/oxfordjournals.jbchem.a022837; Wall DS, 2009, J CELL BIOL, V184, P101, DOI 10.1083/jcb.200805155; Wang L, 2007, J BIOL CHEM, V282, P32462, DOI 10.1074/jbc.M706880200; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Wijgerde M, 2002, GENE DEV, V16, P2849, DOI 10.1101/gad.1025702; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0	92	34	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19174	10.1371/journal.pone.0019174	http://dx.doi.org/10.1371/journal.pone.0019174			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559470	Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700090
J	Wang, W; Chen, DH; Chen, SC; Li, D; Li, M; Xia, SW; Zheng, HL				Wang, Wei; Chen, Donghui; Chen, Shicai; Li, Ding; Li, Meng; Xia, Siwen; Zheng, Hongliang			Laryngeal Reinnervation Using Ansa Cervicalis for Thyroid Surgery-Related Unilateral Vocal Fold Paralysis: A Long-Term Outcome Analysis of 237 Cases	PLOS ONE			English	Article							NERVE ANASTOMOSIS; PERCEPTUAL EVALUATION; MUSCLE; ELECTROMYOGRAPHY; RECONSTRUCTION; DENERVATION; EXPERIENCE; PHONATION; UPDATE	Objective: To evaluate the long-term efficacy of delayed laryngeal reinnervation using the main branch of the ansa cervicalis in treatment of unilateral vocal fold paralysis (UVFP) caused by thyroid surgery. Summary of Background Data: UVFP remains a serious complication of thyroid surgery. Up to now, a completely satisfactory surgical treatment of UVFP has been elusive. Methods: From Jan. 1996 to Jan. 2008, a total of 237 UVFP patients who underwent ansa cervicalis main branch-to-recurrent laryngeal nerve (RLN) anastomosis were enrolled as UVFP group; another 237 age-and gender-matched normal subjects served as control group. Videostroboscopy, vocal function assessment (acoustic analysis, perceptual evaluation and maximum phonation time), and electromyography were performed preoperatively and postoperatively. The mean follow-up period was 5.2+/-2.7 years, ranging from 2 to 12 years. Results: Analysis of videostroboscopic findings indicated that the glottic closure, vocal fold edge, vocal fold position, phase symmetry and regularity were significantly improved in the UVFP group (P<0.001, postoperative vs. preoperative). The postoperative parameters of vocal function were also significantly improved in the UVFP group (P<0.001) and showed no statistical differences compared to the control group (P>0.05, respectively). Postoperative laryngeal electromyography confirmed successful reinnervation of laryngeal muscle. Conclusions: Delayed laryngeal reinnervation with the main branch of ansa cervicalis is a feasible and effective approach for treatment of thyroid surgery-related UVFP; it can restore the physiological laryngeal phonatory function to the normal or a nearly normal voice quality.	[Wang, Wei; Chen, Donghui; Chen, Shicai; Li, Ding; Li, Meng; Xia, Siwen; Zheng, Hongliang] Second Mil Med Univ, Changhai Hosp, Dept Otorhinolaryngol Head & Neck Surg, Shanghai, Peoples R China	Naval Medical University	Wang, W (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Otorhinolaryngol Head & Neck Surg, Shanghai, Peoples R China.	zheng_hl2004@163.com		Li, Meng/0000-0001-8502-7621	National Natural Science Foundation of China [30772415, 81070774, 81070775]; Science and Technology Commission of Shanghai Municipality [09JC1400500, 10XD1405500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by Grant No. 30772415, 81070774, 81070775 for science research from National Natural Science Foundation of China, and Grant No. 09JC1400500 and No. 10XD1405500 from the Science and Technology Commission of Shanghai Municipality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen DH, 2010, LARYNGOSCOPE, V120, P353, DOI 10.1002/lary.20796; Chhetri DK, 1997, LARYNGOSCOPE, V107, P1366, DOI 10.1097/00005537-199710000-00014; Chou FF, 2003, J AM COLL SURGEONS, V197, P52, DOI 10.1016/S1072-7515(03)00235-7; CRUMLEY RL, 1991, LARYNGOSCOPE, V101, P384; CRUMLEY RL, 1986, LARYNGOSCOPE, V96, P611; DEDO HH, 1971, ANN OTO RHINOL LARYN, V80, P664, DOI 10.1177/000348947108000507; FAABORGANDERSEN K, 1964, ANN OTO RHINOL LARYN, V73, P248, DOI 10.1177/000348946407300127; Fessler R, ATLAS NEUROSURGICAL; Heman-Ackah YD, 2007, OTOLARYNG CLIN N AM, V40, P1003, DOI 10.1016/j.otc.2007.05.007; Hermann M, 2002, ANN SURG, V235, P261, DOI 10.1097/00000658-200202000-00015; JATZKO GR, 1994, SURGERY, V115, P139; KANO S, 1991, ARCH OTOLARYNGOL, V117, P1019; Lee WT, 2007, OTOLARYNG HEAD NECK, V136, P450, DOI 10.1016/j.otohns.2006.11.040; Lo CY, 2000, ARCH SURG-CHICAGO, V135, P204, DOI 10.1001/archsurg.135.2.204; Lorenz RR, 2008, ANN OTO RHINOL LARYN, V117, P40, DOI 10.1177/000348940811700109; Miyamaru S, 2008, LARYNGOSCOPE, V118, P1318, DOI 10.1097/MLG.0b013e31816f693f; Miyauchi A, 2009, SURGERY, V146, P1056, DOI 10.1016/j.surg.2009.09.018; Olson DEL, 1998, LARYNGOSCOPE, V108, P1767, DOI 10.1097/00005537-199812000-00002; Paniello RC, 2004, OTOLARYNG CLIN N AM, V37, P161, DOI 10.1016/S0030-6665(03)00164-6; Paniello RC, 2000, LARYNGOSCOPE, V110, P739, DOI 10.1097/00005537-200005000-00004; Rosen CA, 2005, LARYNGOSCOPE, V115, P423, DOI 10.1097/01.mlg.0000157830.38627.85; Shaw GY, 2009, ANN OTO RHINOL LARYN, V118, P6, DOI 10.1177/000348940911800102; Smith ME, 2008, INT J PEDIATR OTORHI, V72, P1311, DOI 10.1016/j.ijporl.2008.05.004; Yumoto E, 2006, LARYNGOSCOPE, V116, P1657, DOI 10.1097/01.mlg.0000233245.27582.fc; Zheng H, 1995, Zhonghua Er Bi Yan Hou Ke Za Zhi, V30, P108; Zheng H, 1994, J CLIN OTORHINOLARYN, V8, P81; Zheng HL, 1996, LARYNGOSCOPE, V106, P1522, DOI 10.1097/00005537-199612000-00015; Zheng HL, 1996, LARYNGOSCOPE, V106, P1516, DOI 10.1097/00005537-199612000-00014; Zheng HL, 1998, OTOLARYNG HEAD NECK, V119, P540, DOI 10.1016/S0194-5998(98)70122-6	29	50	61	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19128	10.1371/journal.pone.0019128	http://dx.doi.org/10.1371/journal.pone.0019128			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559458	gold, Green Published, Green Submitted			2022-12-27	WOS:000290024700071
J	Jiang, B; Yap, MKH; Leung, KH; Ng, PW; Fung, WY; Lam, WW; Gu, YS; Yip, SP				Jiang, Bo; Yap, Maurice K. H.; Leung, Kim Hung; Ng, Po Wah; Fung, Wai Yan; Lam, Wai Wa; Gu, Yang-shun; Yip, Shea Ping			PAX6 Haplotypes Are Associated with High Myopia in Han Chinese	PLOS ONE			English	Article							REFRACTIVE ERROR; HUMAN GENES; LINKAGE; EYE; POLYMORPHISMS; HERITABILITY; POPULATION; PREVALENCE; MUTATIONS; LOCUS	Background: The paired box 6 (PAX6) gene is considered as a master gene for eye development. Linkage of myopia to the PAX6 region on chromosome 11p13 was shown in several studies, but the results for association between myopia and PAX6 were inconsistent so far. Methodology/Principal Findings: We genotyped 16 single nucleotide polymorphisms (SNPs) in the PAX6 gene and its regulatory regions in an initial study for 300 high myopia cases and 300 controls (Group 1), and successfully replicated the positive results with another independent group of 299 high myopia cases and 299 controls (Group 2). Five SNPs were genotyped in the replication study. The spherical equivalent of subjects with high myopia was <= -8.0 dioptres. The PLINK package was used for genetic data analysis. No association was found between each of the SNPs and high myopia. However, exhaustive sliding-window haplotype analysis highlighted an important role for rs12421026 because haplotypes containing this SNP were found to be associated with high myopia. The most significant results were given by the 4-SNP haplotype window consisting of rs2071754, rs3026393, rs1506 and rs12421026 (P = 3.54 x 10(-10), 4.06 x 10(-11) and 1.56 x 10(-18) for Group 1, Group 2 and Combined Group, respectively) and the 3-SNP haplotype window composed of rs3026393, rs1506 and rs12421026 (P = 5.48 x 10(-10), 7.93 x 10(-12) and 6.28 x 10(-23) for the three respective groups). The results remained significant after correction for multiple comparisons by permutations. The associated haplotyes found in a previous study were also successfully replicated in this study. Conclusions/Significance: PAX6 haplotypes are associated with susceptibility to the development of high myopia in Chinese. The PAX6 locus plays a role in high myopia.	[Jiang, Bo; Gu, Yang-shun] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Ophthalmol, Hangzhou 310003, Zhejiang, Peoples R China; [Jiang, Bo; Leung, Kim Hung; Ng, Po Wah; Fung, Wai Yan; Lam, Wai Wa; Yip, Shea Ping] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Hong Kong, Hong Kong, Peoples R China; [Jiang, Bo; Yap, Maurice K. H.; Ng, Po Wah] Hong Kong Polytech Univ, Sch Optometry, Ctr Myopia Res, Hong Kong, Hong Kong, Peoples R China	Zhejiang University; Hong Kong Polytechnic University; Hong Kong Polytechnic University	Jiang, B (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Ophthalmol, Hangzhou 310003, Zhejiang, Peoples R China.	shea.ping.yip@inet.polyu.edu.hk	Yip, Shea Ping/A-1185-2016; Yap, Maurice KH/K-4927-2016	Yip, Shea Ping/0000-0002-2170-8185; Yap, Maurice KH/0000-0003-4687-4101; LEUNG, Kim Hung/0000-0001-8769-0144	Centre for Myopia Research, The Hong Kong Polytechnic University; Hong Kong Polytechnic University [1-ZV70, J-BB7P]	Centre for Myopia Research, The Hong Kong Polytechnic University(Hong Kong Polytechnic University); Hong Kong Polytechnic University(Hong Kong Polytechnic University)	This work is a contribution from the Centre for Myopia Research, The Hong Kong Polytechnic University, and was supported by grants from the Hong Kong Polytechnic University (1-ZV70 and J-BB7P). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000220; Ashery-Padan R, 2001, CURR OPIN CELL BIOL, V13, P706, DOI 10.1016/S0955-0674(00)00274-X; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Callaerts P, 1997, ANNU REV NEUROSCI, V20, P483, DOI 10.1146/annurev.neuro.20.1.483; Ciner E, 2009, AM J OPHTHALMOL, V147, P512, DOI 10.1016/j.ajo.2008.09.004; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Dirani M, 2008, INVEST OPHTH VIS SCI, V49, P3324, DOI 10.1167/iovs.07-1498; Edwards MH, 2004, ANN ACAD MED SINGAP, V33, P34; FANTES J, 1995, HUM MOL GENET, V4, P415, DOI 10.1093/hmg/4.3.415; Farbrother JE, 2004, INVEST OPHTH VIS SCI, V45, P2873, DOI 10.1167/iovs.03-1155; Griffin C, 2002, MECH DEVELOP, V112, P89, DOI 10.1016/S0925-4773(01)00646-3; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; Guggenheim JA, 2000, J MED GENET, V37, P227, DOI 10.1136/jmg.37.3.227; Guo YF, 2009, EUR J HUM GENET, V17, P785, DOI 10.1038/ejhg.2008.244; Hammond CJ, 2004, AM J HUM GENET, V75, P294, DOI 10.1086/423148; Han W, 2009, INVEST OPHTH VIS SCI, V50, P47, DOI 10.1167/iovs.07-0813; Han W, 2006, INVEST OPHTH VIS SCI, V47, P2291, DOI 10.1167/iovs.05-1344; Hewitt AW, 2007, OPHTHALMIC GENET, V28, P179, DOI 10.1080/13816810701356676; Hornbeak DM, 2009, CURR OPIN OPHTHALMOL, V20, P356, DOI 10.1097/ICU.0b013e32832f8040; Kammandel B, 1999, DEV BIOL, V205, P79, DOI 10.1006/dbio.1998.9128; Kempen AH, 2004, ARCH OPHTHALMOL-CHIC, V122, P495; Kleinjan DA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040029; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin LLK, 2001, J FORMOS MED ASSOC, V100, P684; Lopes MC, 2009, INVEST OPHTH VIS SCI, V50, P126, DOI 10.1167/iovs.08-2385; Mutti DO, 2007, MOL VIS, V13, P1012; Ng TK, 2009, MOL VIS, V15, P2239; Nielsen DM, 2008, GENET EPIDEMIOL, V32, P546, DOI 10.1002/gepi.20328; Plaza S, 1999, DEV GENES EVOL, V209, P165, DOI 10.1007/s004270050240; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saw SM, 2005, OPHTHAL PHYSL OPT, V25, P381, DOI 10.1111/j.1475-1313.2005.00298.x; Schedl A, 1996, CELL, V86, P71, DOI 10.1016/S0092-8674(00)80078-1; Seet B, 2001, BRIT J OPHTHALMOL, V85, P521, DOI 10.1136/bjo.85.5.521; Simpson CL, 2007, INVEST OPHTH VIS SCI, V48, P4421, DOI 10.1167/iovs.07-0231; Tang WC, 2008, CLIN EXP OPTOM, V91, P4, DOI 10.1111/j.1444-0938.2007.00181.x; Tang WC, 2007, MOL VIS, V13, P534; Tsai YY, 2008, EYE, V22, P576, DOI 10.1038/sj.eye.6702982; Tsonis PA, 2006, EXP EYE RES, V83, P233, DOI 10.1016/j.exer.2005.11.019; Tzoulaki I, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-27; Vitale S, 2008, ARCH OPHTHALMOL-CHIC, V126, P1111, DOI 10.1001/archopht.126.8.1111; Williams SC, 1998, MECH DEVELOP, V73, P225, DOI 10.1016/S0925-4773(98)00057-4; Wu MMM, 1999, OPTOMETRY VISION SCI, V76, P387, DOI 10.1097/00006324-199906000-00018; Xu ZP, 1997, J BIOL CHEM, V272, P3430, DOI 10.1074/jbc.272.6.3430; Zadnik K, 1997, OPTOMETRY VISION SCI, V74, P603, DOI 10.1097/00006324-199708000-00021; Zha Y, 2009, ARCH OPHTHALMOL-CHIC, V127, P541, DOI 10.1001/archophthalmol.2008.623; Zhou LM, 2004, CLIN CHEM, V50, P1328, DOI 10.1373/clinchem.2004.034322	47	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19587	10.1371/journal.pone.0019587	http://dx.doi.org/10.1371/journal.pone.0019587			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589860	Green Published, Green Submitted, gold			2022-12-27	WOS:000290531100020
J	Zinger, L; Lejon, DPH; Baptist, F; Bouasria, A; Aubert, S; Geremia, RA; Choler, P				Zinger, Lucie; Lejon, David P. H.; Baptist, Florence; Bouasria, Abderrahim; Aubert, Serge; Geremia, Roberto A.; Choler, Philippe			Contrasting Diversity Patterns of Crenarchaeal, Bacterial and Fungal Soil Communities in an Alpine Landscape	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; MICROBIAL COMMUNITY; PLANT DIVERSITY; GLOBAL PATTERNS; GRADIENT; ECOSYSTEM; DYNAMICS; MICROORGANISMS; BIOGEOGRAPHY; ARCHAEA	Background: The advent of molecular techniques in microbial ecology has aroused interest in gaining an understanding about the spatial distribution of regional pools of soil microbes and the main drivers responsible of these spatial patterns. Here, we assessed the distribution of crenarcheal, bacterial and fungal communities in an alpine landscape displaying high turnover in plant species over short distances. Our aim is to determine the relative contribution of plant species composition, environmental conditions, and geographic isolation on microbial community distribution. Methodology/Principal Findings: Eleven types of habitats that best represent the landscape heterogeneity were investigated. Crenarchaeal, bacterial and fungal communities were described by means of Single Strand Conformation Polymorphism. Relationships between microbial beta diversity patterns were examined by using Bray-Curtis dissimilarities and Principal Coordinate Analyses. Distance-based redundancy analyses and variation partitioning were used to estimate the relative contributions of different drivers on microbial beta diversity. Microbial communities tended to be habitat-specific and did not display significant spatial autocorrelation. Microbial beta diversity correlated with soil pH. Fungal beta-diversity was mainly related to soil organic matter. Though the effect of plant species composition was significant for all microbial groups, it was much stronger for Fungi. In contrast, geographic distances did not have any effect on microbial beta diversity. Conclusions/Significance: Microbial communities exhibit non-random spatial patterns of diversity in alpine landscapes. Crenarcheal, bacterial and fungal community turnover is high and associated with plant species composition through different set of soil variables, but is not caused by geographical isolation.	[Zinger, Lucie; Lejon, David P. H.; Baptist, Florence; Bouasria, Abderrahim; Aubert, Serge; Geremia, Roberto A.; Choler, Philippe] Univ Grenoble, CNRS UMR 5553, Lab Ecol Alpine, Grenoble, France; [Aubert, Serge; Choler, Philippe] Univ Grenoble, CNRS UMS 3370, Stn Alpine J Fourier, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Zinger, L (corresponding author), Max Planck Inst Marine Microbiol, Microbial Habitat Grp, Bremen, Germany.	lucie@zinger.fr	Geremia, Roberto A/A-7972-2010; Zinger, Lucie/D-2527-2010; Choler, Philippe/A-7270-2008	Zinger, Lucie/0000-0002-3400-5825; Choler, Philippe/0000-0002-9062-2721	'Microalpes' project [ANR-06-BLAN-0301]	'Microalpes' project	This work was supported by the ANR-06-BLAN-0301 'Microalpes' project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Bardgett RD, 2007, BIO HABIT, P1; Benichou P., 1987, METEOROLOGIE, V7, P23; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Bjork RG, 2008, SOIL BIOL BIOCHEM, V40, P266, DOI 10.1016/j.soilbio.2007.07.017; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Brodie E, 2002, MICROB ECOL, V44, P260, DOI 10.1007/s00248-002-2012-1; Chapman SK, 2006, NEW PHYTOL, V169, P27, DOI 10.1111/j.1469-8137.2005.01571.x; Choler P, 2005, ARCT ANTARCT ALP RES, V37, P444, DOI 10.1657/1523-0430(2005)037[0444:CSIAPT]2.0.CO;2; Choler P, 2002, J VEG SCI, V13, P851, DOI 10.1111/j.1654-1103.2002.tb02114.x; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; de Wit R, 2006, ENVIRON MICROBIOL, V8, P755, DOI 10.1111/j.1462-2920.2006.01017.x; Delbes C, 2000, ENVIRON MICROBIOL, V2, P506, DOI 10.1046/j.1462-2920.2000.00132.x; DeLong EF, 1998, CURR OPIN GENET DEV, V8, P649, DOI 10.1016/S0959-437X(98)80032-4; Djukic I, 2010, SOIL BIOL BIOCHEM, V42, P155, DOI 10.1016/j.soilbio.2009.10.006; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; Eviner VT, 2003, ANNU REV ECOL EVOL S, V34, P455, DOI 10.1146/annurev.ecolsys.34.011802.132342; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; King AJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1055; KORNER C, 1995, ECOL STUD-ANAL SYNTH, V113, P45; Kowalchuk GA, 2002, ANTON LEEUW INT J G, V81, P509, DOI 10.1023/A:1020565523615; Kudo G, 1996, ECOSCIENCE, V3, P483, DOI 10.1080/11956860.1996.11682367; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Legendre P., 2012, NUMERICAL ECOLOGY; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Millard P, 2010, NUTR CYCL AGROECOSYS, V88, P147, DOI 10.1007/s10705-009-9314-3; Mummey DL, 2003, FEMS MICROBIOL ECOL, V46, P113, DOI 10.1016/S0168-6496(03)00208-3; Nicol GW, 2008, ENVIRON MICROBIOL, V10, P2966, DOI 10.1111/j.1462-2920.2008.01701.x; Nielsen UN, 2010, J BIOGEOGR, V37, P1317, DOI 10.1111/j.1365-2699.2010.02281.x; Noll M, 2008, SOIL BIOL BIOCHEM, V40, P2611, DOI 10.1016/j.soilbio.2008.07.012; Oksanen J, 2022, COMMUNITY ECOLOGY PA; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Peu P, 2006, APPL ENVIRON MICROB, V72, P3578, DOI 10.1128/AEM.72.5.3578-3585.2006; Prosser JI, 2008, ENVIRON MICROBIOL, V10, P2931, DOI 10.1111/j.1462-2920.2008.01775.x; R Core Team, 2020, R LANG ENV STAT COMP; Ramette A, 2007, P NATL ACAD SCI USA, V104, P2761, DOI 10.1073/pnas.0610671104; Romani AM, 2006, ECOLOGY, V87, P2559, DOI 10.1890/0012-9658(2006)87[2559:IOBAFO]2.0.CO;2; Rousk J, 2008, FEMS MICROBIOL ECOL, V63, P350, DOI 10.1111/j.1574-6941.2008.00440.x; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Schulte E.E., 1996, SSSA SPEC PUBL, V46, P21, DOI DOI 10.2136/SSSASPECPUB46.C3; Schwarzenbach K, 2007, J MICROBIOL METH, V68, P358, DOI 10.1016/j.mimet.2006.09.015; Singh BK, 2010, NAT REV MICROBIOL, V8, P779, DOI 10.1038/nrmicro2439; Singh BK, 2009, APPL SOIL ECOL, V41, P239, DOI 10.1016/j.apsoil.2008.10.003; Sliwinski MK, 2004, APPL ENVIRON MICROB, V70, P1811, DOI 10.1128/AEM.70.3.1811-1820.2004; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Waldrop MP, 2006, ECOL LETT, V9, P1127, DOI 10.1111/j.1461-0248.2006.00965.x; Wallenstein MD, 2007, FEMS MICROBIOL ECOL, V59, P428, DOI 10.1111/j.1574-6941.2006.00260.x; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Yan F, 1996, SOIL BIOL BIOCHEM, V28, P617, DOI 10.1016/0038-0717(95)00180-8; Yergeau E, 2010, ENVIRON MICROBIOL, V12, P2096, DOI 10.1111/j.1462-2920.2009.02053.x; Zinger L, 2008, J MICROBIOL METH, V72, P42, DOI 10.1016/j.mimet.2007.10.005; Zinger L, 2009, ISME J, V3, P850, DOI 10.1038/ismej.2009.20	59	85	87	5	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19950	10.1371/journal.pone.0019950	http://dx.doi.org/10.1371/journal.pone.0019950			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589876	Green Published, gold			2022-12-27	WOS:000290531100034
J	Bakayan, A; Vaquero, CF; Picazo, F; Llopis, J				Bakayan, Adil; Vaquero, Cecilia F.; Picazo, Fernando; Llopis, Juan			Red Fluorescent Protein-Aequorin Fusions as Improved Bioluminescent Ca2+ Reporters in Single Cells and Mice	PLOS ONE			English	Article							IN-VIVO; ENERGY-TRANSFER; MONOMERIC RED; CALCIUM; LIGHT; COELENTERAZINE; LUMINESCENCE; PHOTOPROTEIN; APOAEQUORIN; SENSITIVITY	Bioluminescence recording of Ca2+ signals with the photoprotein aequorin does not require radiative energy input and can be measured with a low background and good temporal resolution. Shifting aequorin emission to longer wavelengths occurs naturally in the jellyfish Aequorea victoria by bioluminescence resonance energy transfer (BRET) to the green fluorescent protein (GFP). This process has been reproduced in the molecular fusions GFP-aequorin and monomeric red fluorescent protein (mRFP)-aequorin, but the latter showed limited transfer efficiency. Fusions with strong red emission would facilitate the simultaneous imaging of Ca2+ in various cell compartments. In addition, they would also serve to monitor Ca2+ in living organisms since red light is able to cross animal tissues with less scattering. In this study, aequorin was fused to orange and various red fluorescent proteins to identify the best acceptor in red emission bands. Tandem-dimer Tomato-aequorin (tdTA) showed the highest BRET efficiency (largest energy transfer critical distance R-0) and percentage of counts in the red band of all the fusions studied. In addition, red fluorophore maturation of tdTA within cells was faster than that of other fusions. Light output was sufficient to image ATP-induced Ca2+ oscillations in single HeLa cells expressing tdTA. Ca2+ rises caused by depolarization of mouse neuronal cells in primary culture were also recorded, and changes in fine neuronal projections were spatially resolved. Finally, it was also possible to visualize the Ca2+ activity of HeLa cells injected subcutaneously into mice, and Ca2+ signals after depositing recombinant tdTA in muscle or the peritoneal cavity. Here we report that tdTA is the brightest red bioluminescent Ca2+ sensor reported to date and is, therefore, a promising probe to study Ca2+ dynamics in whole organisms or tissues expressing the transgene.	[Bakayan, Adil] Univ Castilla La Mancha, Fac Med, Albacete, Spain; Univ Castilla La Mancha, CRIB, Albacete, Spain	Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha	Bakayan, A (corresponding author), Univ Castilla La Mancha, Fac Med, Albacete, Spain.	juan.llopis@uclm.es	Llopis, Juan/I-2622-2012; Romo, José A./J-3024-2012	Llopis, Juan/0000-0002-9460-0642; Romo, José A./0000-0003-2907-580X; Fernandez Vaquero, Cecilia/0000-0002-7415-9060	Spanish Ministry of Science and Innovation [BFU2008-03288, BFU2005-02078]; European Union [MRTN-CT-2005-019481]; Consejeria de Sanidad; Junta de Comunidades de Castilla-La Mancha [JI4002R2]; Centro Regional de Investigaciones Biomedicas (CRIB)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union(European Commission); Consejeria de Sanidad; Junta de Comunidades de Castilla-La Mancha(Junta de Comunidades de Castilla-La Mancha); Centro Regional de Investigaciones Biomedicas (CRIB)	This work was supported by grants from the Spanish Ministry of Science and Innovation MICINN/FEDER BFU2008-03288 and BFU2005-02078 (JL) and European Union project "From FLIM to FLIN'', MRTN-CT-2005-019481 (JL, AB fellowship holder). FP held a fellowship from Consejeria de Sanidad, Junta de Comunidades de Castilla-La Mancha (JI4002R2) and Centro Regional de Investigaciones Biomedicas (CRIB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN DG, 1977, SCIENCE, V195, P996, DOI 10.1126/science.841325; Alonso MT, 2009, ACTA PHYSIOL, V195, P37, DOI 10.1111/j.1748-1716.2008.01920.x; Badminton MN, 1995, BIOCHEM BIOPH RES CO, V217, P950, DOI 10.1006/bbrc.1995.2862; Baubet V, 2000, P NATL ACAD SCI USA, V97, P7260, DOI 10.1073/pnas.97.13.7260; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Caysa H, 2009, PHOTOCH PHOTOBIO SCI, V8, P52, DOI 10.1039/b814566k; Creton R, 1999, MICROSC RES TECHNIQ, V46, P390, DOI 10.1002/(SICI)1097-0029(19990915)46:6<390::AID-JEMT7>3.0.CO;2-S; Curie T, 2007, MOL IMAGING, V6, P30, DOI 10.2310/7290.2006.00033; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Gorokhovatsky AY, 2004, BIOCHEM BIOPH RES CO, V320, P703, DOI 10.1016/j.bbrc.2004.06.014; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; GRYNKIEWICZ G, 1985, NEW GENERATION CA2 I, P3440; Hink MA, 2003, J FLUORESC, V13, P185, DOI 10.1023/A:1022947411788; Inouye S, 2006, FEBS LETT, V580, P1977, DOI 10.1016/j.febslet.2006.02.065; Koushik SV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008031; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, V3rd, P443, DOI DOI 10.1007/978-0-387-46312-4_13; Lin MZ, 2009, CHEM BIOL, V16, P1169, DOI 10.1016/j.chembiol.2009.10.009; Manjarres IM, 2008, PFLUG ARCH EUR J PHY, V455, P961, DOI 10.1007/s00424-007-0349-5; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; MONTERO M, 1995, EMBO J, V14, P5467, DOI 10.1002/j.1460-2075.1995.tb00233.x; MORISE H, 1974, BIOCHEMISTRY-US, V13, P2656, DOI 10.1021/bi00709a028; NOMURA M, 1991, FEBS LETT, V295, P63, DOI 10.1016/0014-5793(91)81385-L; Ohmiya Y, 1996, CHEM BIOL, V3, P337, DOI 10.1016/S1074-5521(96)90116-7; Okuda A, 2003, CELL BIOCHEM FUNCT, V21, P61, DOI 10.1002/cbf.992; PRASHER D, 1985, BIOCHEM BIOPH RES CO, V126, P1259, DOI 10.1016/0006-291X(85)90321-3; Rogers KL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000974; RUEGG JC, 1987, NATURWISSENSCHAFTEN, V74, P579, DOI 10.1007/BF00368515; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; SHIMOMURA O, 1993, BIOCHEM J, V296, P549, DOI 10.1042/bj2960549; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; SHIMOMURA O, 1995, BIOCHEM J, V306, P537, DOI 10.1042/bj3060537; Stamatas GN, 2006, J INVEST DERMATOL, V126, P1753, DOI 10.1038/sj.jid.5700329; Strack RL, 2010, J AM CHEM SOC, V132, P8496, DOI 10.1021/ja1030084; Subach OM, 2010, CHEM BIOL, V17, P333, DOI 10.1016/j.chembiol.2010.03.005; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; Wachter RM, 2010, BIOCHEMISTRY-US, V49, P7417, DOI 10.1021/bi100901h; Waud JP, 2001, BIOCHEM J, V357, P687, DOI 10.1042/0264-6021:3570687; Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123; Zhao H, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2032388	43	36	45	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19520	10.1371/journal.pone.0019520	http://dx.doi.org/10.1371/journal.pone.0019520			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589654	gold, Green Submitted, Green Published			2022-12-27	WOS:000290483600014
J	Renaud, S; Pantalacci, S; Auffray, JC				Renaud, Sabrina; Pantalacci, Sophie; Auffray, Jean-Christophe			Differential Evolvability Along Lines of Least Resistance of Upper and Lower Molars in Island House Mice	PLOS ONE			English	Article							MAMMALIAN TEETH; MURINE RODENTS; MORPHOLOGICAL VARIATION; PHENOTYPIC VARIATION; PARALLEL EVOLUTION; VARIATION PATTERNS; CANARY-ISLANDS; CLIMATE-CHANGE; BODY-SIZE; SHAPE	Variation within a population is a key feature in evolution, because it can increase or impede response to selection, depending on whether or not the intrapopulational variance is correlated to the change under selection. Hence, main directions of genetic variance have been proposed to constitute "lines of least resistance to evolution'' along which evolution would be facilitated. Yet, the screening of selection occurs at the phenotypic level, and the phenotypic variance is not only the product of the underlying genetic variance, but also of developmental processes. It is thus a key issue for interpreting short and long term evolutionary patterns to identify whether main directions of phenotypic variance indeed constitute direction of facilitated evolution, and whether this is favored by developmental processes preferably generating certain phenotypes. We tackled these questions by a morphometric quantification of the directions of variance, compared to the direction of evolution of the first upper and lower molars of wild continental and insular house mice. The main phenotypic variance indeed appeared as channeling evolution between populations. The upper molar emerged as highly evolvable, because a strong allometric component contributed to its variance. This allometric relationship drove a repeated but independent evolution of a peculiar upper molar shape whenever size increased. This repeated evolution, together with knowledge about the molar development, suggest that the main direction of phenotypic variance correspond here to a "line of least developmental resistance'' along which evolution between population is channeled.	[Renaud, Sabrina] Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Pantalacci, Sophie] Univ Lyon, CNRS, Ecole Normale Super Lyon, Mol Zool Team,Inst Genom Fonct Lyon, Lyon, France; [Auffray, Jean-Christophe] Univ Montpellier 2, CNRS, Inst Sci Evolut, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Renaud, S (corresponding author), Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France.	Sabrina.Renaud@univ-lyon1.fr	Auffray, jean-christophe/HCI-4881-2022; AUFFRAY, Jean-Christophe/H-1907-2011; Renaud, Sabrina/AAV-3141-2020; Auffray, Jean-Christophe/AAW-1052-2020; Auffray, Jean-Christophe/AAH-6131-2019; Renaud, Sabrina/D-4247-2009	Renaud, Sabrina/0000-0002-8730-3113; Auffray, Jean-Christophe/0000-0002-5184-0507; Renaud, Sabrina/0000-0002-8730-3113	CNRS [GDR 2474]; ANR Quenottes	CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR Quenottes(French National Research Agency (ANR))	This work was supported by the GDR 2474 CNRS and the ANR Quenottes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann RR, 2000, AM J PHYS ANTHROPOL, V111, P489, DOI 10.1002/(SICI)1096-8644(200004)111:4<489::AID-AJPA5>3.0.CO;2-U; ALIBERT P, 1995, THESIS U MONTPELLIER; Arnold SJ, 2001, GENETICA, V112, P9, DOI 10.1023/A:1013373907708; Badyaev AV, 2000, P ROY SOC B-BIOL SCI, V267, P371, DOI 10.1098/rspb.2000.1011; Begin M, 2003, EVOLUTION, V57, P1107; Berry RJ, 1996, PHILOS T R SOC B, V351, P753, DOI 10.1098/rstb.1996.0070; Brakefield PM, 2006, TRENDS ECOL EVOL, V21, P362, DOI 10.1016/j.tree.2006.05.001; Butler PM., 1985, EVOLUTIONARY RELATIO, P381; Cardini A, 2007, ZOOMORPHOLOGY, V126, P121, DOI 10.1007/s00435-007-0036-2; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Etterson JR, 2001, SCIENCE, V294, P151, DOI 10.1126/science.1063656; Jacobs L.L., 1990, EUROPEAN NEOGENE MAM, P573; JACOBS LL, 1989, PAPERS FOSSIL RODENT, P157; Jernvall J, 1996, SCIENCE, V274, P1489, DOI 10.1126/science.274.5292.1489; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P2641, DOI 10.1073/pnas.050586297; Jernvall J, 2002, NATURE, V417, P538, DOI 10.1038/417538a; Kangas AT, 2004, NATURE, V432, P211, DOI 10.1038/nature02927; KANKOUASSI S, 2008, MAMMALIA, V72, P237; Kassai Y, 2005, SCIENCE, V309, P2067, DOI 10.1126/science.1116848; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; Keranen SVE, 1998, DEV GENES EVOL, V208, P477, DOI 10.1007/s004270050206; Klingenberg CP, 2008, ANNU REV ECOL EVOL S, V39, P115, DOI 10.1146/annurev.ecolsys.37.091305.110054; Klingenberg CP, 1996, NATO ADV SCI INST SE, V284, P23; Klingenberg CP, 2001, GENETICS, V157, P785; Kuhl F.P., 1982, COMPUTER GRAPHICS IM, V18, P259; Lazzari V, 2008, PALEOBIOLOGY, V34, P46, DOI 10.1666/06052.1; Lecompte E, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-199; Ledevin R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015470; Lomolino MV, 2005, J BIOGEOGR, V32, P1683, DOI 10.1111/j.1365-2699.2005.01314.x; LOMOLINO MV, 1985, AM NAT, V125, P310, DOI 10.1086/284343; Marroig G, 2001, EVOLUTION, V55, P2576; Michaux J, 2007, J BIOGEOGR, V34, P1412, DOI 10.1111/j.1365-2699.2007.01701.x; Olson E. C., 1958, MORPHOLOGICAL INTEGR; Pantalacci S, 2009, EVOL DEV, V11, P422, DOI 10.1111/j.1525-142X.2009.00348.x; Peterkova R, 2005, ARCH ORAL BIOL, V50, P219, DOI 10.1016/j.archoralbio.2004.10.020; Peterkova R, 1996, INT J DEV BIOL, V40, P1009; Polly PD, 2005, EVOL DEV, V7, P29, DOI 10.1111/j.1525-142X.2005.05004.x; Prochazka J, 2010, P NATL ACAD SCI USA, V107, P15497, DOI 10.1073/pnas.1002784107; Renaud S, 2005, P ROY SOC B-BIOL SCI, V272, P609, DOI 10.1098/rspb.2004.2992; Renaud S, 2004, ZOOL J LINN SOC-LOND, V142, P555, DOI 10.1111/j.1096-3642.2004.00140.x; Renaud S, 2002, PALAEOGEOGR PALAEOCL, V184, P163, DOI 10.1016/S0031-0182(02)00255-9; Renaud S, 2006, EVOLUTION, V60, P1701; Renaud S, 2009, EVOL DEV, V11, P590, DOI 10.1111/j.1525-142X.2009.00365.x; Rohlf FJ, 2000, SYST BIOL, V49, P740, DOI 10.1080/106351500750049806; Salazar-Ciudad I, 2002, P NATL ACAD SCI USA, V99, P8116, DOI 10.1073/pnas.132069499; Salazar-Ciudad I, 2010, NATURE, V464, P583, DOI 10.1038/nature08838; Schluter D, 2004, AM NAT, V163, P809, DOI 10.1086/383621; Schluter D, 1996, EVOLUTION, V50, P1766, DOI 10.1111/j.1558-5646.1996.tb03563.x; Shimizu T, 2004, J DENT RES, V83, P45, DOI 10.1177/154405910408300109; Skinner MM, 2010, J ANAT, V217, P245, DOI 10.1111/j.1469-7580.2010.01265.x; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; VIGNE JD, 1993, MAMMALIA, V57, P85, DOI 10.1515/mamm.1993.57.1.85; Zhang XS, 2005, EVOLUTION, V59, P1237	53	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e18951	10.1371/journal.pone.0018951	http://dx.doi.org/10.1371/journal.pone.0018951			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589657	gold, Green Published, Green Submitted			2022-12-27	WOS:000290483600003
J	Munk, RB; Sugiyama, K; Ghosh, P; Sasaki, CY; Rezanka, L; Banerjee, K; Takahashi, H; Sen, R; Longo, DL				Munk, Rachel B.; Sugiyama, Katsuki; Ghosh, Paritosh; Sasaki, Carl Y.; Rezanka, Louis; Banerjee, Kasturi; Takahashi, Hidenori; Sen, Ranjan; Longo, Dan L.			Antigen-Independent IFN-gamma Production by Human Naive CD4(+) T Cells Activated by IL-12 Plus IL-18	PLOS ONE			English	Article							NF-KAPPA-B; GENE-EXPRESSION; PROMOTER ACTIVATION; CYTOKINE RECEPTORS; PERIPHERAL-BLOOD; LYMPHOCYTES; INTERLEUKIN-12; TRANSCRIPTION; SYNERGIZES; INDUCTION	The role of T cells in innate immunity is not well defined. In this report, we show that a subset of human peripheral blood CD4(+) T cells responds to IL-12 plus IL-18, but not to IL-12 or IL-18 alone, by producing IFN-gamma in the absence of any antigenic stimulation or cell proliferation. Intracellular staining reveals a small percentage of resting CD4(+) T cells (0.5 to 1.5%) capable of producing IFN-gamma in response to IL-12 plus IL-18. Interestingly, both naive (CD45RA(+)) and memory (CD45RO(+)) CD4(+) populations were responsive to IL-12 plus IL-18 stimulation in producing IFN-gamma. The expression of IFN-gamma induced by IL-12 and IL-18 is sensitive to rapamycin and SB203580, indicating the possible involvement of mTOR and p38 MAP kinase, respectively, in this synergistic pathway. While p38MAP kinase is involved in transcription, mTOR is involved in message stabilization. We have also shown that NF kappa B family member, cRel, but not GADD45 beta and GADD45 gamma, plays an important role in IL-12 plus IL-18-induced IFN-gamma transcription. Thus, the present study suggests that naive CD4(+) T cells may participate in innate immunity or amplify adaptive immune responses through cytokine-induced antigen-independent cytokine production.	[Munk, Rachel B.; Sugiyama, Katsuki; Ghosh, Paritosh; Sasaki, Carl Y.; Rezanka, Louis; Takahashi, Hidenori; Longo, Dan L.] NIA, Lymphocyte Cell Biol Unit, Lab Mol Biol & Immunol, NIH, Baltimore, MD 21224 USA; [Banerjee, Kasturi; Sen, Ranjan] NIA, Gene Regulat Sect, Lab Mol Biol & Immunol, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Munk, RB (corresponding author), NIA, Lymphocyte Cell Biol Unit, Lab Mol Biol & Immunol, NIH, Baltimore, MD 21224 USA.	ghoshp@grc.nia.nih.gov	Longo, Dan L./F-6022-2011		National Institute on Aging, National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIGAG000621, ZIAAG000115, ZIAAG000386, ZIAAG000384] Funding Source: NIH RePORTER	National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by the Intramural Research Program of the National Institute on Aging, National Institutes of Health. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre-Schmutz I, 1999, EUR J IMMUNOL, V29, P245, DOI 10.1002/(SICI)1521-4141(199901)29:01<245::AID-IMMU245>3.3.CO;2-F; Barbulescu K, 1998, J IMMUNOL, V160, P3642; Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051; Bofill M, 2004, CLIN EXP IMMUNOL, V138, P460, DOI 10.1111/j.1365-2249.2004.02651.x; Cassatella MA, 2007, J IMMUNOL, V178, P7325, DOI 10.4049/jimmunol.178.11.7325; Chang JT, 2000, EUR J IMMUNOL, V30, P1113, DOI 10.1002/(SICI)1521-4141(200004)30:4<1113::AID-IMMU1113>3.0.CO;2-P; JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755; Kishore N, 2003, J BIOL CHEM, V278, P32861, DOI 10.1074/jbc.M211439200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McQuaid A, 2003, CLIN EXP IMMUNOL, V134, P321, DOI 10.1046/j.1365-2249.2003.02271.x; Nakahira M, 2002, J IMMUNOL, V168, P1146, DOI 10.4049/jimmunol.168.3.1146; Newton R, 1997, FEBS LETT, V418, P135, DOI 10.1016/S0014-5793(97)01362-8; Papadakis KA, 2005, J IMMUNOL, V174, P4985, DOI 10.4049/jimmunol.174.8.4985; Papadakis KA, 2004, J IMMUNOL, V172, P7002, DOI 10.4049/jimmunol.172.11.7002; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; Sattler A, 2009, BLOOD, V113, P1948, DOI 10.1182/blood-2008-02-139147; Smeltz RB, 2007, J IMMUNOL, V178, P4786, DOI 10.4049/jimmunol.178.8.4786; Sugimoto N, 2003, EUR J IMMUNOL, V33, P243, DOI 10.1002/immu.200390027; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Xu DM, 1998, J EXP MED, V188, P1485, DOI 10.1084/jem.188.8.1485; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264; Yang JF, 1999, EUR J IMMUNOL, V29, P548, DOI 10.1002/(SICI)1521-4141(199902)29:02<548::AID-IMMU548>3.0.CO;2-Z	23	28	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e18553	10.1371/journal.pone.0018553	http://dx.doi.org/10.1371/journal.pone.0018553			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572994	Green Published, gold, Green Submitted			2022-12-27	WOS:000290440200002
J	Pan, LL; Liu, XH; Gong, QH; Wu, D; Zhu, YZ				Pan, Li-Long; Liu, Xin-Hua; Gong, Qi-Hai; Wu, Dan; Zhu, Yi-Zhun			Hydrogen Sulfide Attenuated Tumor Necrosis Factor-alpha-Induced Inflammatory Signaling and Dysfunction in Vascular Endothelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; INDUCED OXIDATIVE STRESS; HEME OXYGENASE-1; ADHESION MOLECULES; NADPH OXIDASE; EXPRESSION; ACTIVATION; INHIBITION; DISEASE; H2S	Background: Hydrogen sulfide (H(2)S), the third physiologically relevant gaseous molecule, is recognized increasingly as an anti-inflammatory mediator in various inflammatory conditions. Herein, we explored the effects and mechanisms of sodium hydrosulfide (NaHS, a H(2)S donor) on tumor necrosis factor (TNF)-alpha-induced human umbilical vein endothelial cells (HUVEC) dysfunction. Methodology and Principal Findings: Application of NaHS concentration-dependently suppressed TNF-alpha-induced mRNA and proteins expressions of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1), mRNA expression of P-selectin and E-selectin as well as U937 monocytes adhesion to HUVEC. Western blot analysis revealed that the expression of the cytoprotective enzyme, heme oxygenase-1 (HO-1), was induced and coincident with the anti-inflammatory action of NaHS. Furthermore, TNF-alpha-induced NF-kappa B activation assessed by I kappa B alpha degradation and p65 phosphorylation and nuclear translocation and ROS production were diminished in cells subjected to treatment with NaHS. Significance: H(2)S can exert an anti-inflammatory effect in endothelial cells through a mechanism that involves the up-regulation of HO-1.	[Pan, Li-Long; Liu, Xin-Hua; Gong, Qi-Hai; Wu, Dan; Zhu, Yi-Zhun] Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai 200433, Peoples R China; [Zhu, Yi-Zhun] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Pan, LL (corresponding author), Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai 200433, Peoples R China.	zhuyz@fudan.edu.cn	Zhu, Yi Zhun/ABG-8449-2021; Qihai, Gong/AAM-9343-2021	Zhu, Yi Zhun/0000-0001-7700-8041; Qihai, Gong/0000-0002-8967-337X; Wu, Dan/0000-0001-6117-5099	National Basic Research Program of China (973 Program) [2010CB912600]; National Science Fund for Distinguished Young Scholars [30888002]; Synthetic Department of Research and Development Technique of New Drugs [2009ZX09301-011]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Synthetic Department of Research and Development Technique of New Drugs	This work was supported by the National Basic Research Program of China (973 Program, Grant No. 2010CB912600), National Science Fund for Distinguished Young Scholars (Grant No. 30888002), and Synthetic Department of Research and Development Technique of New Drugs (2009ZX09301-011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang SF, 2010, CRIT CARE MED, V38, P619, DOI 10.1097/CCM.0b013e3181c0df00; BARNES PJ, 1993, TRENDS PHARMACOL SCI, V14, P436, DOI 10.1016/0165-6147(93)90184-L; Borel JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006733; Chanani NK, 2002, CIRCULATION, V106, pI284, DOI 10.1161/01.cir.0000032904.33237.8e; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Frey RS, 2006, J BIOL CHEM, V281, P16128, DOI 10.1074/jbc.M508810200; Kida K, 2011, ANTIOXID REDOX SIGN, V15, P343, DOI 10.1089/ars.2010.3671; Kim EJ, 2010, ATHEROSCLEROSIS, V211, P77, DOI 10.1016/j.atherosclerosis.2010.01.040; Kumar S, 2007, BIOCHEM PHARMACOL, V73, P1602, DOI 10.1016/j.bcp.2007.01.015; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lefer DJ, 2007, P NATL ACAD SCI USA, V104, P17907, DOI 10.1073/pnas.0709010104; Li JM, 2005, MOL CELL BIOL, V25, P2320, DOI 10.1128/MCB.25.6.2320-2330.2005; Li L, 2008, TRENDS PHARMACOL SCI, V29, P84, DOI 10.1016/j.tips.2007.11.003; Li L, 2005, FASEB J, V19, P1196, DOI 10.1096/fj.04-3583fje; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lin CC, 2008, ARTERIOSCL THROM VAS, V28, P739, DOI 10.1161/ATVBAHA.107.160085; Lin SJ, 2005, ARTERIOSCL THROM VAS, V25, P334, DOI 10.1161/01.ATV.0000152114.00114.d8; Liu XH, 2010, CURR PHARM BIOTECHNO, V11, P895; Mukherjee TK, 2007, J IMMUNOL, V178, P1835, DOI 10.4049/jimmunol.178.3.1835; Naidu S, 2009, J IMMUNOL, V182, P7048, DOI 10.4049/jimmunol.0900006; Oh GS, 2006, FREE RADICAL BIO MED, V41, P106, DOI 10.1016/j.freeradbiomed.2006.03.021; Paine A, 2010, BIOCHEM PHARMACOL, V80, P1895, DOI 10.1016/j.bcp.2010.07.014; PAWLOWSKI NA, 1985, P NATL ACAD SCI USA, V82, P8208, DOI 10.1073/pnas.82.23.8208; REIFFENSTEIN RJ, 1992, ANNU REV PHARMACOL, V32, P109, DOI 10.1146/annurev.pa.32.040192.000545; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sasaki M, 2003, AM J PHYSIOL-CELL PH, V284, pC422, DOI 10.1152/ajpcell.00271.2002; Schubert SY, 2002, FASEB J, V16, P1931, DOI 10.1096/fj.02-0147fje; Seldon MP, 2007, J IMMUNOL, V179, P7840, DOI 10.4049/jimmunol.179.11.7840; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Szmitko PE, 2003, CIRCULATION, V108, P2041, DOI 10.1161/01.CIR.0000089093.75585.98; Taniguchi S, 2011, BRIT J PHARMACOL, V162, P1171, DOI 10.1111/j.1476-5381.2010.01119.x; Tyagi N, 2009, ANTIOXID REDOX SIGN, V11, P25, DOI 10.1089/ars.2008.2073; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Wang R, 2003, ANTIOXID REDOX SIGN, V5, P493, DOI 10.1089/152308603768295249; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Wang TM, 2011, J NUTR BIOCHEM, V22, P187, DOI 10.1016/j.jnutbio.2010.01.007; Wang YF, 2009, ARTERIOSCL THROM VAS, V29, P173, DOI 10.1161/ATVBAHA.108.179333; Yan SK, 2006, BIOCHEM BIOPH RES CO, V351, P485, DOI 10.1016/j.bbrc.2006.10.058; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yang WS, 2010, ATHEROSCLEROSIS, V211, P48, DOI 10.1016/j.atherosclerosis.2010.01.018; Zhang HL, 2007, J LEUKOCYTE BIOL, V82, P894, DOI 10.1189/jlb.0407237; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	45	106	113	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19766	10.1371/journal.pone.0019766	http://dx.doi.org/10.1371/journal.pone.0019766			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572963	gold, Green Published, Green Submitted			2022-12-27	WOS:000290440200028
J	Sasaki, S; Ishida, T; Toyota, M; Ota, A; Suzuki, H; Takaoka, A; Yasui, H; Yamamoto, H; Takagi, H; Maeda, M; Seito, T; Tsujisaki, M; Shinomura, Y; Imai, K				Sasaki, Shigeru; Ishida, Tadao; Toyota, Minoru; Ota, Akinobu; Suzuki, Hiromu; Takaoka, Akinori; Yasui, Hiroshi; Yamamoto, Hiroyuki; Takagi, Hideyasu; Maeda, Masahiro; Seito, Tsutomu; Tsujisaki, Masayuki; Shinomura, Yasuhisa; Imai, Kohzoh			Interferon-alpha/beta and Anti-Fibroblast Growth Factor Receptor 1 Monoclonal Antibody Suppress Hepatic Cancer Cells In Vitro and In Vivo	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; EXPRESSION; LINES; HEPATOCARCINOGENESIS; THERAPY; RESPOND; PLUS	Background: Hepatocellular carcinoma (HCC) is the most commonly occurring primary liver cancer and ranks as the fifth most frequently occurring cancer, overall, and the third leading cause of cancer deaths, worldwide. At present, effective therapeutic options available for HCC are limited; consequently, the prognosis for these patients is poor. Our aim in the present study was to identify a novel target for antibody therapy against HCC. Methodology/Principal Findings: We used Western blot and flow cytometric and immunocytochemical analyses to investigate the regulation of FGFR1 expression by interferon-alpha/beta in several human hepatic cancer cell lines. In addition, we tested the efficacy of combined treatment with anti-FGFR1 monoclonal antibody and interferon-alpha/beta in a murine xenograft model of human HCC. We found that interferon-alpha/beta induces expression of FGFR1 in human HCC cell lines, and that an anti-FGFR1 monoclonal antibody (mAb) targeting of the induced FGFR1 can effectively inhibit growth and survival of HCC cells in vitro and in vivo. Moreover, the combination of interferon-alpha, anti-FGFR1 mAb and peripheral blood mononuclear cells (PBMCs) exerted a significant antitumor effect in vitro. Conclusions: Our results suggest that the combined use of an anti-FGFR1 antibody and interferon-alpha/beta is a promising approach to the treatment of HCC.	[Sasaki, Shigeru; Ishida, Tadao; Suzuki, Hiromu; Yasui, Hiroshi; Yamamoto, Hiroyuki; Takagi, Hideyasu; Shinomura, Yasuhisa] Sapporo Med Univ, Dept Internal Med 1, Sapporo, Hokkaido, Japan; [Toyota, Minoru; Suzuki, Hiromu; Yasui, Hiroshi] Sapporo Med Univ, Dept Mol Biol, Sapporo, Hokkaido, Japan; [Ota, Akinobu; Maeda, Masahiro; Seito, Tsutomu] Immunobiol Labs Co Ltd, Fujioka, Japan; [Takaoka, Akinori] Hokkaido Univ, Div Signaling Canc & Immunol, Inst Med Genet, Sapporo, Hokkaido, Japan; [Tsujisaki, Masayuki] Tenshi Hosp, Dept Gastroenterol & Hematol, Sapporo, Hokkaido, Japan; [Imai, Kohzoh] Univ Tokyo, Inst Med Sci, Div Novel Therapy Canc, Adv Clin Res Ctr, Tokyo, Japan	Sapporo Medical University; Sapporo Medical University; Immuno-Biological Laboratories Co. Ltd.; Hokkaido University; University of Tokyo	Sasaki, S (corresponding author), Sapporo Med Univ, Dept Internal Med 1, Sapporo, Hokkaido, Japan.	ssasaki@sapmed.ac.jp; mtoyota@sapmed.ac.jp	Ota, Akinobu/AAI-9396-2020; Ota, Akinobu/CAC-5999-2022; Ota, Akinobu/H-4510-2019	Ota, Akinobu/0000-0002-6296-2921; Yasui, Hiroshi/0000-0003-0905-6855	Ministry of Education, Culture, Sports, Science, and Technology [17016060]; Japan Society for Promotion of Science [21590853, 17659218]; Grants-in-Aid for Scientific Research [21590853, 23591399] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Grants-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science, and Technology (17016060 to KI and TI); Grants-in-Aid for Scientific Research (C) from the Japan Society for Promotion of Science (21590853 to SS); Grant-in-Aid for Exploratory Research from the Japan Society for Promotion of Science (17659218 to SS and KI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo VD, 2009, CELL CYCLE, V8, P580, DOI 10.4161/cc.8.4.7657; Asada N, 2003, IN VITRO CELL DEV-AN, V39, P321; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dvorak P, 2005, FOLIA HISTOCHEM CYTO, V43, P203; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; El-Serag HB, 2004, GASTROENTEROLOGY, V127, pS27, DOI 10.1053/j.gastro.2004.09.013; GREINER JW, 1987, SCIENCE, V235, P895, DOI 10.1126/science.3580039; Harris M, 2004, LANCET ONCOL, V5, P292, DOI 10.1016/S1470-2045(04)01467-6; Hildebrandt MAT, 2010, ONCOGENE, V29, P5724, DOI 10.1038/onc.2010.305; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hu ZY, 1996, CARCINOGENESIS, V17, P931, DOI 10.1093/carcin/17.5.931; Huang XQ, 2006, CANCER RES, V66, P1481, DOI 10.1158/0008-5472.CAN-05-2412; Imai K, 2006, NAT REV CANCER, V6, P714, DOI 10.1038/nrc1913; Kan M, 1999, J BIOL CHEM, V274, P15947, DOI 10.1074/jbc.274.22.15947; KINEBUCHI M, 1991, J IMMUNOL, V146, P3721; Ku XM, 2007, SCAND J IMMUNOL, V65, P435, DOI 10.1111/j.1365-3083.2007.01930.x; McLaughlin P, 1998, J CLIN ONCOL, V16, P2825, DOI 10.1200/JCO.1998.16.8.2825; Mise M, 1996, HEPATOLOGY, V23, P455; MOTOO Y, 1991, LIVER, V11, P272; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Qu XJ, 2004, J UROLOGY, V172, P733, DOI 10.1097/01.ju.0000130751.83953.55; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; TAKAHASHI H, 1993, CANCER RES, V53, P1612; Tanaka S, 2009, CANCER SCI, V100, P1, DOI 10.1111/j.1349-7006.2008.01006.x; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Yang JL, 2004, GUT, V53, P123, DOI 10.1136/gut.53.1.123	28	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19618	10.1371/journal.pone.0019618	http://dx.doi.org/10.1371/journal.pone.0019618			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573021	Green Published, gold, Green Submitted			2022-12-27	WOS:000290386800025
J	Steindler, L; Schwalbach, MS; Smith, DP; Chan, F; Giovannoni, SJ				Steindler, Laura; Schwalbach, Michael S.; Smith, Daniel P.; Chan, Francis; Giovannoni, Stephen J.			Energy Starved Candidatus Pelagibacter Ubique Substitutes Light-Mediated ATP Production for Endogenous Carbon Respiration	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; ESCHERICHIA-COLI; PROTEORHODOPSIN; FUR; BACTERIUM; SAR11; PHOTOTROPHY; EXPRESSION; BINDING; OPERON	Previous studies have demonstrated that Candidatus Pelagibacter ubique, a member of the SAR11 clade, constitutively expresses proteorhodopsin (PR) proteins that can function as light-dependent proton pumps. However, exposure to light did not significantly improve the growth rate or final cell densities of SAR11 isolates in a wide range of conditions. Thus, the ecophysiological role of PR in SAR11 remained unresolved. We investigated a range of cellular properties and here show that light causes dramatic changes in physiology and gene expression in Cand. P. ubique cells that are starved for carbon, but provides little or no advantage during active growth on organic carbon substrates. During logarithmic growth there was no difference in oxygen consumption by cells in light versus dark. Energy starved cells respired endogenous carbon in the dark, becoming spheres that approached the minimum predicted size for cells, and produced abundant pili. In the light, energy starved cells maintained size, ATP content, and higher substrate transport rates, and differentially expressed nearly 10% of their genome. These findings show that PR is a vital adaptation that supports Cand. P. ubique metabolism during carbon starvation, a condition that is likely to occur in the extreme conditions of ocean environments.	[Steindler, Laura; Schwalbach, Michael S.; Smith, Daniel P.; Giovannoni, Stephen J.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Chan, Francis] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Steindler, L (corresponding author), Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA.	steve.giovannoni@oregonstate.edu	Smith, Daniel/L-6827-2019	Smith, Daniel/0000-0002-2479-2044	Marine Microbiology Initiative, Gordon and Betty Moore Foundation [607_01]	Marine Microbiology Initiative, Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This work was supported by Marine Microbiology Initiative award number 607_01 from the Gordon and Betty Moore Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baichoo N, 2002, J BACTERIOL, V184, P5826, DOI 10.1128/JB.184.21.5826-5832.2002; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; de la Torre JR, 2003, P NATL ACAD SCI USA, V100, P12830, DOI 10.1073/pnas.2133554100; DELORENZO V, 1987, J BACTERIOL, V169, P2624, DOI 10.1128/jb.169.6.2624-2630.1987; Dubnau D, 1999, ANNU REV MICROBIOL, V53, P217, DOI 10.1146/annurev.micro.53.1.217; Escolar L, 1998, J MOL BIOL, V283, P537, DOI 10.1006/jmbi.1998.2119; Frigaard NU, 2006, NATURE, V439, P847, DOI 10.1038/nature04435; Fuhrman JA, 2008, NAT REV MICROBIOL, V6, P488, DOI 10.1038/nrmicro1893; Giovannoni SJ, 2005, NATURE, V438, P82, DOI 10.1038/nature04032; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Gomez-Consarnau L, 2007, NATURE, V445, P210, DOI 10.1038/nature05381; Gomez-Consarnau L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000358; Gonzalez JM, 2008, P NATL ACAD SCI USA, V105, P8724, DOI 10.1073/pnas.0712027105; Johnson ET, 2010, APPL ENVIRON MICROB, V76, P4123, DOI 10.1128/AEM.02425-09; Knoll A, 1999, SIZE LIMITS VERY SMA; Lami R, 2009, ENVIRON MICROBIOL, V11, P3201, DOI 10.1111/j.1462-2920.2009.02028.x; Lee JW, 2007, BIOMETALS, V20, P485, DOI 10.1007/s10534-006-9070-7; Man DL, 2003, EMBO J, V22, P1725, DOI 10.1093/emboj/cdg183; Man-Aharonovich D, 2004, PHOTOCH PHOTOBIO SCI, V3, P459, DOI 10.1039/b316071h; Martinez A, 2007, P NATL ACAD SCI USA, V104, P5590, DOI 10.1073/pnas.0611470104; McCarren J, 2007, ENVIRON MICROBIOL, V9, P846, DOI 10.1111/j.1462-2920.2006.01203.x; Moore LR, 2007, LIMNOL OCEANOGR-METH, V5, P353, DOI 10.4319/lom.2007.5.353; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Riedel T, 2010, APPL ENVIRON MICROB, V76, P3187, DOI 10.1128/AEM.02971-09; Sabehi G, 2005, PLOS BIOL, V3, P1409, DOI 10.1371/journal.pbio.0030273; Sabehi G, 2003, ENVIRON MICROBIOL, V5, P842, DOI 10.1046/j.1462-2920.2003.00493.x; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schwalbach MS, 2010, ENVIRON MICROBIOL, V12, P490, DOI 10.1111/j.1462-2920.2009.02092.x; Sowell SM, 2008, APPL ENVIRON MICROB, V74, P4091, DOI 10.1128/AEM.00599-08; Sowell SM, 2009, ISME J, V3, P93, DOI 10.1038/ismej.2008.83; SOWELL SM, 2010, ISME J; Stingl U, 2007, APPL ENVIRON MICROB, V73, P2290, DOI 10.1128/AEM.02559-06; Thompson DK, 2002, APPL ENVIRON MICROB, V68, P881, DOI 10.1128/AEM.68.2.881-892.2002; Tripp HJ, 2008, NATURE, V452, P741, DOI 10.1038/nature06776; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vergin KL, 2007, ENVIRON MICROBIOL, V9, P2430, DOI 10.1111/j.1462-2920.2007.01361.x; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Walter JM, 2007, P NATL ACAD SCI USA, V104, P2408, DOI 10.1073/pnas.0611035104; Wan XF, 2004, J BACTERIOL, V186, P8385, DOI 10.1128/JB.186.24.8385-8400.2004	43	133	134	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19725	10.1371/journal.pone.0019725	http://dx.doi.org/10.1371/journal.pone.0019725			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573025	Green Published, gold			2022-12-27	WOS:000290386800033
J	Saino, N; Caprioli, M; Romano, M; Boncoraglio, G; Rubolini, D; Ambrosini, R; Bonisoli-Alquati, A; Romano, A				Saino, Nicola; Caprioli, Manuela; Romano, Maria; Boncoraglio, Giuseppe; Rubolini, Diego; Ambrosini, Roberto; Bonisoli-Alquati, Andrea; Romano, Andrea			Antioxidant Defenses Predict Long-Term Survival in a Passerine Bird	PLOS ONE			English	Article							HISTORY TRADE-OFFS; OXIDATIVE STRESS; SEXUAL SELECTION; FREE-RADICALS; LIFE-SPAN; RESISTANCE; DAMAGE; IMMUNOCOMPETENCE; CAROTENOIDS; SENESCENCE	Background: Normal and pathological processes entail the production of oxidative substances that can damage biological molecules and harm physiological functions. Organisms have evolved complex mechanisms of antioxidant defense, and any imbalance between oxidative challenge and antioxidant protection can depress fitness components and accelerate senescence. While the role of oxidative stress in pathogenesis and aging has been studied intensively in humans and model animal species under laboratory conditions, there is a dearth of knowledge on its role in shaping life-histories of animals under natural selection regimes. Yet, given the pervasive nature and likely fitness consequences of oxidative damage, it can be expected that the need to secure efficient antioxidant protection is powerful in molding the evolutionary ecology of animals. Here, we test whether overall antioxidant defense varies with age and predicts long-term survival, using a wild population of a migratory passerine bird, the barn swallow (Hirundo rustica), as a model. Methodology/Principal Findings: Plasma antioxidant capacity (AOC) of breeding individuals was measured using standard protocols and annual survival was monitored over five years (2006-2010) on a large sample of selection episodes. AOC did not covary with age in longitudinal analyses after discounting the effect of selection. AOC positively predicted annual survival independently of sex. Individuals were highly consistent in their relative levels of AOC, implying the existence of additive genetic variance and/or environmental (including early maternal) components consistently acting through their lives. Conclusions: Using longitudinal data we showed that high levels of antioxidant protection positively predict long-term survival in a wild animal population. Present results are therefore novel in disclosing a role for antioxidant protection in determining survival under natural conditions, strongly demanding for more longitudinal eco-physiological studies of life-histories in relation to oxidative stress in wild populations.	[Saino, Nicola; Caprioli, Manuela; Romano, Maria; Boncoraglio, Giuseppe; Rubolini, Diego; Bonisoli-Alquati, Andrea; Romano, Andrea] Univ Milan, Dipartimento Biol, Milan, Italy; [Boncoraglio, Giuseppe] Univ Cambridge, Dept Zool, Cambridge, England; [Ambrosini, Roberto] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy	University of Milan; University of Cambridge; University of Milano-Bicocca	Saino, N (corresponding author), Univ Milan, Dipartimento Biol, Milan, Italy.	nicola.saino@unimi.it	Alquati, Andrea Bonisoli/S-2082-2017; Romano, Andrea/B-3930-2012; Ambrosini, Roberto/F-3188-2012; Bonisoli Alquati, Andrea/A-6409-2008; Rubolini, Diego/F-2851-2011; Romano, Andrea/A-2780-2017	Alquati, Andrea Bonisoli/0000-0002-9255-7556; Ambrosini, Roberto/0000-0002-7148-1468; Rubolini, Diego/0000-0003-2703-5783; Romano, Andrea/0000-0002-0945-6018; Saino, Nicola/0000-0002-0230-3967	Universita degli Studi di Milano [PUR-2009]; University of Milano; Marie Curie Intra-European fellowship [PIEF-GA-2009-252120]	Universita degli Studi di Milano; University of Milano; Marie Curie Intra-European fellowship(European Commission)	Funding was provided by the Universita degli Studi di Milano (PUR-2009). GB was funded by a grant from the University of Milano and by a Marie Curie Intra-European fellowship (PIEF-GA-2009-252120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2006, CURR OPIN OBSTET GYN, V18, P325, DOI 10.1097/01.gco.0000193003.58158.4e; Allison P. D., 2010, SURVIVAL ANAL USING, VSecond; Alonso-Alvarez C, 2006, EVOLUTION, V60, P1913, DOI 10.1111/j.0014-3820.2006.tb00534.x; Andersson Malte, 1994; Badyaev AV, 2008, ANN NY ACAD SCI, V1133, P151, DOI 10.1196/annals.1438.009; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barja G, 2004, TRENDS NEUROSCI, V27, P595, DOI 10.1016/j.tins.2004.07.005; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Biard C, 2007, J EVOLUTION BIOL, V20, P326, DOI 10.1111/j.1420-9101.2006.01194.x; Bize P, 2008, ECOLOGY, V89, P2584, DOI 10.1890/07-1135.1; Blount JD, 2004, P ROY SOC B-BIOL SCI, V271, pS79, DOI 10.1098/rsbl.2003.0104; BOURDON RM, 1997, UNDERSTANDING ANIMAL; Brys K, 2007, EXP GERONTOL, V42, P845, DOI 10.1016/j.exger.2007.02.004; Charlesworth B., 1994, EVOLUTION AGE STRUCT, DOI [10.1017/CBO9780511525711, DOI 10.1017/CBO9780511525711]; Chen JH, 2007, NUCLEIC ACIDS RES, V35, P7417, DOI 10.1093/nar/gkm681; Costantini D, 2008, ECOL LETT, V11, P1238, DOI 10.1111/j.1461-0248.2008.01246.x; Costantini D, 2007, J COMP PHYSIOL B, V177, P723, DOI 10.1007/s00360-007-0169-0; Costantini D, 2006, COMP BIOCHEM PHYS A, V145, P137, DOI 10.1016/j.cbpa.2006.06.002; Costantini D, 2010, FUNCT ECOL, V24, P950, DOI 10.1111/j.1365-2435.2010.01746.x; Devevey G, 2010, J ORNITHOL, V151, P251, DOI 10.1007/s10336-009-0456-5; Dowling DK, 2009, P ROY SOC B-BIOL SCI, V276, P1737, DOI 10.1098/rspb.2008.1791; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fitze PS, 2003, OECOLOGIA, V137, P148, DOI 10.1007/s00442-003-1323-3; Halliwell B., 2007, FREE RADICALS BIOL M; HEYWOOD JS, 1989, EVOLUTION, V43, P1387, DOI [10.2307/2409455, 10.1111/j.1558-5646.1989.tb02590.x]; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Hulbert AJ, 2007, PHYSIOL REV, V87, P1175, DOI 10.1152/physrev.00047.2006; Isaksson C, 2006, BEHAV ECOL SOCIOBIOL, V60, P556, DOI 10.1007/s00265-006-0200-6; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; IWASA Y, 1991, EVOLUTION, V45, P1431, DOI [10.1111/j.1558-5646.1991.tb02646.x, 10.2307/2409890]; Jablonka E., 1995, EPIGENETIC INHERITAN; Koutsos EA, 2006, J NUTR, V136, P1027, DOI 10.1093/jn/136.4.1027; Koutsos EA, 2003, J NUTR, V133, P1132, DOI 10.1093/jn/133.4.1132; Koutsos EA, 2007, COMP BIOCHEM PHYS B, V147, P87, DOI 10.1016/j.cbpb.2006.12.011; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Marko G, 2011, J COMP PHYSIOL B, V181, P73, DOI 10.1007/s00360-010-0502-x; Moller AP, 2007, BEHAV ECOL SOCIOBIOL, V61, P1311, DOI 10.1007/s00265-007-0362-x; Moller AP, 2002, ECOLOGY, V83, P2220, DOI 10.2307/3072053; Moller AP, 2000, AVIAN POULT BIOL REV, V11, P137; Moller AP., 1994, SEXUAL SELECTION BAR; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Nilsson JA, 2002, P ROY SOC B-BIOL SCI, V269, P1735, DOI 10.1098/rspb.2002.2071; Nussey DH, 2008, FUNCT ECOL, V22, P393, DOI 10.1111/j.1365-2435.2008.01408.x; Nussey DH, 2009, FUNCT ECOL, V23, P809, DOI 10.1111/j.1365-2435.2009.01555.x; Rubolini D, 2006, J EVOLUTION BIOL, V19, P1571, DOI 10.1111/j.1420-9101.2006.01121.x; Rubolini D, 2004, BEHAV ECOL, V15, P592, DOI 10.1093/beheco/arh048; Safran RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009420; Saino N, 1999, J ANIM ECOL, V68, P999, DOI 10.1046/j.1365-2656.1999.00350.x; Saino N, 1997, P NATL ACAD SCI USA, V94, P549, DOI 10.1073/pnas.94.2.549; Saino N, 2004, P ROY SOC B-BIOL SCI, V271, P681, DOI 10.1098/rspb.2003.2656; Saino N, 2002, P ROY SOC B-BIOL SCI, V269, P1729, DOI 10.1098/rspb.2002.2088; Saino N, 2011, BEHAV ECOL, V22, P411, DOI 10.1093/beheco/arq220; Salomons HM, 2009, P ROY SOC B-BIOL SCI, V276, P3157, DOI 10.1098/rspb.2009.0517; Surai P.F., 2002, NATURAL ANTIOXIDANTS; Turner A., 2006, BARN SWALLOW; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; van de Pol M, 2006, AM NAT, V167, P766, DOI 10.1086/503331; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006	62	80	81	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19593	10.1371/journal.pone.0019593	http://dx.doi.org/10.1371/journal.pone.0019593			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573124	gold, Green Submitted, Green Published			2022-12-27	WOS:000290305600032
J	Duan, X; Ponomareva, L; Veeranki, S; Choubey, D				Duan, Xin; Ponomareva, Larissa; Veeranki, Sudhakar; Choubey, Divaker			IFI16 Induction by Glucose Restriction in Human Fibroblasts Contributes to Autophagy through Activation of the ATM/AMPK/p53 Pathway	PLOS ONE			English	Article							PROTEIN-KINASE; CELLULAR SENESCENCE; POTENTIAL MEDIATOR; TUMOR SUPPRESSION; OXIDATIVE STRESS; P53; AMP; CELLS; ATM; PHOSPHORYLATION	Background: Glucose restriction in cells increases the AMP/ATP ratio (energetic stress), which activates the AMPK/p53 pathway. Depending upon the energetic stress levels, cells undergo either autophagy or cell death. Given that the activated p53 induces the expression of IFI16 protein, we investigated the potential role of the IFI16 protein in glucose restriction-induced responses. Methodology/Principal Findings: We found that glucose restriction or treatment of human diploid fibroblasts (HDFs) with the activators of the AMPK/p53 pathway induced the expression of IFI16 protein. The induced levels of IFI16 protein were associated with the induction of autophagy and reduced cell survival. Moreover, the increase in the IFI16 protein levels was dependent upon the expression of the functional ATM protein kinase. Importantly, the knockdown of the IFI16 expression in HDFs inhibited the activation of the ATM/AMPK/p53 pathway in response to glucose restriction and also increased the survival of HDFs. Conclusions/Significance: Our observations demonstrate a role for the IFI16 protein in the energetic stress-induced regulation of autophagy and cell survival. Additionally, our findings also indicate that the loss of IFI16 expression, as found in certain cancers, may provide a survival advantage to cancer cells in microenvironments with low glucose levels.	[Duan, Xin; Ponomareva, Larissa; Veeranki, Sudhakar; Choubey, Divaker] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45221 USA; [Ponomareva, Larissa; Choubey, Divaker] Cincinnati VA Med Ctr, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Duan, X (corresponding author), Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45221 USA.	Divaker.choubey@uc.edu	Choubey, Divaker/A-4771-2008	Ponomareva, Larissa/0000-0003-2182-8774	Veterans Affairs (VA); National Institutes of Health [AG 025036]; NATIONAL INSTITUTE ON AGING [R01AG025036] Funding Source: NIH RePORTER	Veterans Affairs (VA)(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a Merit Award from the Veterans Affairs (VA) and a grant (AG 025036) from the National Institutes of Health to DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander A, 2010, CELL CYCLE, V9, P3685, DOI 10.4161/cc.9.18.13253; Alexander A, 2010, AUTOPHAGY, V6, P672, DOI 10.4161/auto.6.5.12509; Birnbaum MJ, 2005, MOL CELL, V19, P289, DOI 10.1016/j.molcel.2005.07.012; Calabrese Vittorio, 2006, Ital J Biochem, V55, P263; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Caro-Maldonado A, 2010, CELL DEATH DIFFER, V17, P1335, DOI 10.1038/cdd.2010.21; CHOUBEY D, 1993, J INTERFERON RES, V13, P43, DOI 10.1089/jir.1993.13.43; Choubey D, 2008, FRONT BIOSCI-LANDMRK, V13, P598, DOI 10.2741/2705; Deretic V, 2010, CURR OPIN CELL BIOL, V22, P252, DOI 10.1016/j.ceb.2009.12.009; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fogarty S, 2010, BBA-PROTEINS PROTEOM, V1804, P581, DOI 10.1016/j.bbapap.2009.09.012; Fujiuchi N, 2004, J BIOL CHEM, V279, P20339, DOI 10.1074/jbc.M400344200; Green DR, 2006, CELL, V126, P30, DOI 10.1016/j.cell.2006.06.032; Gugliesi F, 2005, J LEUKOCYTE BIOL, V77, P820, DOI 10.1189/jlb.0904507; HARRIS J, 2011, J BIOL CHEM     0112; Johnstone RW, 2000, ONCOGENE, V19, P6033, DOI 10.1038/sj.onc.1204005; Johnstone RW, 1999, MOL CELL BIOL, V19, P5833; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Liao JCC, 2011, STRUCTURE, V19, P418, DOI 10.1016/j.str.2010.12.015; Maclaine NJ, 2009, AGING-US, V1, P490, DOI 10.18632/aging.100047; Maiuri MC, 2010, CURR OPIN CELL BIOL, V22, P181, DOI 10.1016/j.ceb.2009.12.001; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Meijer AJ, 2007, AUTOPHAGY, V3, P238, DOI 10.4161/auto.3710; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Pandita TK, 2002, ONCOGENE, V21, P611, DOI 10.1038/sj.onc.1205060; PETROVSKI G, 2011, AUTOPHAGY, V7; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Sanz P, 2008, CURR PROTEIN PEPT SC, V9, P478, DOI 10.2174/138920308785915254; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Song LL, 2008, MOL CANCER RES, V6, P1732, DOI 10.1158/1541-7786.MCR-08-0208; Sun Y, 2007, MOL CELL BIOCHEM, V306, P239, DOI 10.1007/s11010-007-9575-6; Suzuki A, 2003, J BIOL CHEM, V278, P48, DOI 10.1074/jbc.M206025200; Tanaka T, 2006, CELL CYCLE, V5, P1940, DOI 10.4161/cc.5.17.3191; Um JH, 2007, J BIOL CHEM, V282, P20794, DOI 10.1074/jbc.C700070200; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang WG, 2003, J BIOL CHEM, V278, P27016, DOI 10.1074/jbc.M300318200; White E, 2010, CURR OPIN CELL BIOL, V22, P212, DOI 10.1016/j.ceb.2009.12.008; Xin H, 2004, ONCOGENE, V23, P6209, DOI 10.1038/sj.onc.1207836; Xin H, 2003, ONCOGENE, V22, P4831, DOI 10.1038/sj.onc.1206754; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229	48	41	44	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19532	10.1371/journal.pone.0019532	http://dx.doi.org/10.1371/journal.pone.0019532			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573174	gold, Green Published, Green Submitted			2022-12-27	WOS:000290256400019
J	Mul, JD; la Fleur, SE; Toonen, PW; Afrasiab-Middelman, A; Binnekade, R; Schetters, D; Verheij, MMM; Sears, RM; Homberg, JR; Schoffelmeer, ANM; Adan, RAH; DiLeone, RJ; De Vries, TJ; Cuppen, E				Mul, Joram D.; la Fleur, Susanne E.; Toonen, Pim W.; Afrasiab-Middelman, Anthonieke; Binnekade, Rob; Schetters, Dustin; Verheij, Michel M. M.; Sears, Robert M.; Homberg, Judith R.; Schoffelmeer, Anton N. M.; Adan, Roger A. H.; DiLeone, Ralph J.; De Vries, Taco J.; Cuppen, Edwin			Chronic Loss of Melanin-Concentrating Hormone Affects Motivational Aspects of Feeding in the Rat	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS SHELL; MESOLIMBIC DOPAMINE SYSTEM; PROTEIN-COUPLED RECEPTOR; CENTRAL-NERVOUS-SYSTEM; LATERAL HYPOTHALAMUS; FOOD SEEKING; BODY-WEIGHT; MONOAMINE TRANSPORTER; GLUTAMATE RECEPTORS; PALATABLE FOOD	Current epidemic obesity levels apply great medical and financial pressure to the strenuous economy of obesity-prone cultures, and neuropeptides involved in body weight regulation are regarded as attractive targets for a possible treatment of obesity in humans. The lateral hypothalamus and the nucleus accumbens shell (AcbSh) form a hypothalamic-limbic neuropeptide feeding circuit mediated by Melanin-Concentrating Hormone (MCH). MCH promotes feeding behavior via MCH receptor-1 (MCH1R) in the AcbSh, although this relationship has not been fully characterized. Given the AcbSh mediates reinforcing properties of food, we hypothesized that MCH modulates motivational aspects of feeding. Here we show that chronic loss of the rat MCH-precursor Pmch decreased food intake predominantly via a reduction in meal size during rat development and reduced high-fat food-reinforced operant responding in adult rats. Moreover, acute AcbSh administration of Neuropeptide-GE and Neuropeptide-EI (NEI), both additional neuropeptides derived from Pmch, or chronic intracerebroventricular infusion of NEI, did not affect feeding behavior in adult pmch(+/+) or pmch(-/-) rats. However, acute administration of MCH to the AcbSh of adult pmch(-/-) rats elevated feeding behavior towards wild type levels. Finally, adult pmch(-/-) rats showed increased ex vivo electrically evoked dopamine release and increased limbic dopamine transporter levels, indicating that chronic loss of Pmch in the rat affects the limbic dopamine system. Our findings support the MCH-MCH1R system as an amplifier of consummatory behavior, confirming this system as a possible target for the treatment of obesity. We propose that MCH-mediated signaling in the AcbSh positively mediates motivational aspects of feeding behavior. Thereby it provides a crucial signal by which hypothalamic neural circuits control energy balance and guide limbic brain areas to enhance motivational or incentive-related aspects of food consumption.	[Mul, Joram D.; Toonen, Pim W.; Cuppen, Edwin] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands; [la Fleur, Susanne E.; Adan, Roger A. H.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurosci & Pharmacol, Utrecht, Netherlands; [Afrasiab-Middelman, Anthonieke; Homberg, Judith R.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, NL-6525 ED Nijmegen, Netherlands; [Verheij, Michel M. M.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Mol Anim Physiol, NL-6525 ED Nijmegen, Netherlands; [Binnekade, Rob; Schetters, Dustin; Schoffelmeer, Anton N. M.; De Vries, Taco J.] Free Univ Med Ctr, Ctr Neurogen & Cognit Res, Dept Anat & Neurosci, Amsterdam, Netherlands; [Sears, Robert M.; DiLeone, Ralph J.] Yale Univ, Sch Med, Ribicoff Res Facil, Dept Psychiat, New Haven, CT USA; [DiLeone, Ralph J.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Cuppen, Edwin] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Radboud University Nijmegen; Vrije Universiteit Amsterdam; Yale University; Yale University; Utrecht University; Utrecht University Medical Center	Mul, JD (corresponding author), Univ Cincinnati, Dept Med, Metab Dis Unit, Cincinnati, OH 45221 USA.	e.cuppen@hubrecht.eu	Cuppen, Edwin/H-2389-2016; Cuppen, Edwin/F-5696-2011; De Vries, Taco J/B-2831-2014; Homberg, Judith R/D-2473-2010; Homberg, J.R./N-4172-2019; Mul, Joram/C-3125-2011	Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542; Mul, Joram/0000-0003-0453-2568; DiLeone, Ralph/0000-0002-4770-2590; De Vries, Taco/0000-0002-0340-4946; , robert/0000-0001-5688-1853	European Science Foundation; Netherlands Organisation for Scientific Research (NWO) [86410003]; National Institutes of Health [DK073677]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073677] Funding Source: NIH RePORTER	European Science Foundation(European Science Foundation (ESF)European Commission); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the European Science Foundation EURYI (to EC), by grant DK073677, from the National Institutes of Health (to RJD), and by The Netherlands Organisation for Scientific Research (NWO) grant #86410003 (to JRH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CR, 2003, ENDOCRINOLOGY, V144, P3943, DOI 10.1210/en.2003-0149; Alon T, 2006, J NEUROSCI, V26, P389, DOI 10.1523/JNEUROSCI.1203-05.2006; Bachner D, 1999, FEBS LETT, V457, P522, DOI 10.1016/S0014-5793(99)01092-3; Bittencourt J, 2008, PEPTIDES, V29, P1441, DOI 10.1016/j.peptides.2008.03.012; BITTENCOURT JC, 1992, J COMP NEUROL, V319, P218, DOI 10.1002/cne.903190204; Bittencourt JC, 1998, BRAIN RES, V805, P1, DOI 10.1016/S0006-8993(98)00598-8; Chambers J, 1999, NATURE, V400, P261, DOI 10.1038/22313; Chen YY, 2002, ENDOCRINOLOGY, V143, P2469, DOI 10.1210/en.143.7.2469; CHUNG S, 2009, P NATL ACAD SCI US; Della-Zuana O, 2002, INT J OBESITY, V26, P1289, DOI 10.1038/sj.ijo.0802079; Edwards R H, 1992, Curr Opin Neurobiol, V2, P586, DOI 10.1016/0959-4388(92)90023-E; Erickson JD, 1996, P NATL ACAD SCI USA, V93, P5166, DOI 10.1073/pnas.93.10.5166; Gao XB, 2001, J PHYSIOL-LONDON, V533, P237, DOI 10.1111/j.1469-7793.2001.0237b.x; Georgescu D, 2005, J NEUROSCI, V25, P2933, DOI 10.1523/JNEUROSCI.1714-04.2005; Ghitza UE, 2007, J NEUROSCI, V27, P11522, DOI 10.1523/JNEUROSCI.5405-06.2007; Ghitza UE, 2006, NEUROPSYCHOPHARMACOL, V31, P2188, DOI 10.1038/sj.npp.1300964; Gomori A, 2003, AM J PHYSIOL-ENDOC M, V284, pE583, DOI 10.1152/ajpendo.00350.2002; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Guesdon B, 2009, AM J PHYSIOL-REG I, V296, pR469, DOI 10.1152/ajpregu.90556.2008; Harris GC, 2005, NATURE, V437, P556, DOI 10.1038/nature04071; Hawes BE, 2000, ENDOCRINOLOGY, V141, P4524, DOI 10.1210/en.141.12.4524; Hervieu GJ, 2000, EUR J NEUROSCI, V12, P1194, DOI 10.1046/j.1460-9568.2000.00008.x; HODOS W, 1961, SCIENCE, V134, P943, DOI 10.1126/science.134.3483.943; HODOS W, 1963, J EXP ANAL BEHAV, V6, P387, DOI 10.1901/jeab.1963.6-387; Holtje M, 2000, J NEUROSCI, V20, P2131; Inoue K, 2003, J PHARMACOL EXP THER, V305, P385, DOI 10.1124/jpet.102.047712; Ito M, 2003, AM J PHYSIOL-ENDOC M, V284, pE940, DOI 10.1152/ajpendo.00529.2002; ITO M, 2009, BR J PHARM; Kelley AE, 2004, NEUROSCI BIOBEHAV R, V27, P765, DOI 10.1016/j.neubiorev.2003.11.015; Kowalski TJ, 2004, EUR J PHARMACOL, V497, P41, DOI 10.1016/j.ejphar.2004.06.027; Leinninger GM, 2009, CELL METAB, V10, P89, DOI 10.1016/j.cmet.2009.06.011; Lembo PMC, 1999, NAT CELL BIOL, V1, P267, DOI 10.1038/12978; Ludwig DS, 2001, J CLIN INVEST, V107, P379, DOI 10.1172/JCI10660; MALDONADOIRIZARRY CS, 1995, J NEUROSCI, V15, P6779; Marsh DJ, 2002, P NATL ACAD SCI USA, V99, P3240, DOI 10.1073/pnas.052706899; Mashiko S, 2005, ENDOCRINOLOGY, V146, P3080, DOI 10.1210/en.2004-1150; MORAN TH, 1992, AM J PHYSIOL, V262, pR46, DOI 10.1152/ajpregu.1992.262.1.R46; Morens C, 2005, BRAIN RES, V1062, P32, DOI 10.1016/j.brainres.2005.09.005; Mul JD, 2010, AM J PHYSIOL-ENDOC M, V298, pE477, DOI 10.1152/ajpendo.00154.2009; NAHON JL, 1989, ENDOCRINOLOGY, V125, P2056, DOI 10.1210/endo-125-4-2056; Nair SG, 2008, BRIT J PHARMACOL, V154, P406, DOI 10.1038/bjp.2008.3; Nair SG, 2006, PHYSIOL BEHAV, V88, P559, DOI 10.1016/j.physbeh.2006.05.014; NAIR SG, 2009, PSYCHOPHARMACOLOGY B; PANKSEPP J, 1973, J COMP PHYSIOL PSYCH, V82, P78, DOI 10.1037/h0033812; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; PETER D, 1995, J NEUROSCI, V15, P6179; Pissios P, 2003, ENDOCRINOLOGY, V144, P3514, DOI 10.1210/en.2002-0004; Pissios P, 2008, BIOL PSYCHIAT, V64, P184, DOI 10.1016/j.biopsych.2007.12.011; Qu DQ, 1996, NATURE, V380, P243, DOI 10.1038/380243a0; REDMOND DE, 1979, LIFE SCI, V25, P2149, DOI 10.1016/0024-3205(79)90087-0; Reynolds SM, 2001, J NEUROSCI, V21, P3261, DOI 10.1523/JNEUROSCI.21-09-03261.2001; Richardson NR, 1996, J NEUROSCI METH, V66, P1, DOI 10.1016/0165-0270(95)00153-0; Rossi M, 1997, ENDOCRINOLOGY, V138, P351, DOI 10.1210/en.138.1.351; Saito Y, 1999, NATURE, V400, P265, DOI 10.1038/22321; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; SCHOFFELMEER ANM, 1988, EUR J PHARMACOL, V154, P169, DOI 10.1016/0014-2999(88)90094-5; Sears RM, 2010, J NEUROSCI, V30, P8263, DOI 10.1523/JNEUROSCI.5858-09.2010; Shearman LP, 2003, EUR J PHARMACOL, V475, P37, DOI 10.1016/S0014-2999(03)02146-0; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; Silva JP, 2009, NATURE, V462, P646, DOI 10.1038/nature08589; Sita LV, 2007, NEUROSCIENCE, V148, P949, DOI 10.1016/j.neuroscience.2007.07.010; Smith DG, 2005, J NEUROSCI, V25, P914, DOI 10.1523/JNEUROSCI.4079-04.2005; Stratford TR, 1999, J NEUROSCI, V19, P11040, DOI 10.1523/JNEUROSCI.19-24-11040.1999; Stratford TR, 1997, J NEUROSCI, V17, P4434; Stratford TR, 1998, BEHAV BRAIN RES, V93, P43, DOI 10.1016/S0166-4328(97)00140-X; Tiesjema B, 2007, J NEUROSCI, V27, P14139, DOI 10.1523/JNEUROSCI.3280-07.2007; Tyhon A, 2008, PHARMACOL BIOCHEM BE, V88, P446, DOI 10.1016/j.pbb.2007.10.001; Tyhon A, 2006, BEHAV BRAIN RES, V173, P94, DOI 10.1016/j.bbr.2006.06.007; Verheij MMM, 2008, J NEUROCHEM, V105, P2122, DOI 10.1111/j.1471-4159.2008.05323.x; Verheij MMM, 2007, J NEUROCHEM, V100, P810, DOI 10.1111/j.1471-4159.2006.04259.x; ZAMIR N, 1986, BRAIN RES, V373, P240, DOI 10.1016/0006-8993(86)90337-9; Zheng H, 2005, NEUROSCIENCE, V135, P611, DOI 10.1016/j.neuroscience.2005.06.055	72	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19600	10.1371/journal.pone.0019600	http://dx.doi.org/10.1371/journal.pone.0019600			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573180	Green Published, Green Submitted, gold			2022-12-27	WOS:000290256400032
J	Priyandoko, D; Ishii, T; Kaul, SC; Wadhwa, R				Priyandoko, Didik; Ishii, Tetsuro; Kaul, Sunil C.; Wadhwa, Renu			Ashwagandha Leaf Derived Withanone Protects Normal Human Cells Against the Toxicity of Methoxyacetic Acid, a Major Industrial Metabolite	PLOS ONE			English	Article							GLYCOL MONOMETHYL ETHER; HUMAN BREAST-MILK; DEVELOPMENTAL TOXICITY; CANCER-CELLS; IN-VITRO; EXPOSURE; RAT; APOPTOSIS; EXTRACT; PATHWAY	The present day lifestyle heavily depends on industrial chemicals in the form of agriculture, cosmetics, textiles and medical products. Since the toxicity of the industrial chemicals has been a concern to human health, the need for alternative nontoxic natural products or adjuvants that serve as antidotes are in high demand. We have investigated the effects of Ayurvedic herb Ashwagandha (Withania somnifera) leaf extract on methoxyacetic acid (MAA) induced toxicity. MAA is a major metabolite of ester phthalates that are commonly used in industry as gelling, viscosity and stabilizer reagents. We report that the MAA cause premature senescence of normal human cells by mechanisms that involve ROS generation, DNA and mitochondrial damage. Withanone protects cells from MAA-induced toxicity by suppressing the ROS levels, DNA and mitochondrial damage, and induction of cell defense signaling pathways including Nrf2 and proteasomal degradation. These findings warrant further basic and clinical studies that may promote the use of withanone as a health adjuvant in a variety of consumer products where the toxicity has been a concern because of the use of ester phthalates.	[Priyandoko, Didik; Kaul, Sunil C.; Wadhwa, Renu] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan; [Priyandoko, Didik; Ishii, Tetsuro] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba	Priyandoko, D (corresponding author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan.	s-kaul@aist.go.jp; renu-wadhwa@aist.go.jp	Priyandoko, Didik/GNP-1593-2022; Kaul, Sunil C/L-8671-2018; Wadhwa, Renu/L-8898-2018	Priyandoko, Didik/0000-0001-8601-9818; Kaul, Sunil C/0000-0002-0046-3916; Wadhwa, Renu/0000-0001-8248-5192	Indonesian Government	Indonesian Government(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	DP is a recipient of the Indonesian Government Scholarship. Authors thank Nashi Widodo, Ran Gao and Navjot Shah for technical help and advice.	Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749; Bagchi G, 2008, INT J ANDROL, V31, P269, DOI 10.1111/j.1365-2605.2007.00846.x; Bagchi G, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-65; Bagchi G, 2009, TOXICOL APPL PHARM, V238, P101, DOI 10.1016/j.taap.2008.03.015; BEATTIE P J, 1986, Journal of Biochemical Toxicology, V1, P61, DOI 10.1002/jbt.2570010307; BROWN NA, 1984, TOXICOL LETT, V22, P93, DOI 10.1016/0378-4274(84)90051-1; Davis BJ, 1997, TOXICOL APPL PHARM, V142, P328, DOI 10.1006/taap.1996.8035; de Jong E, 2009, TOXICOL SCI, V110, P117, DOI 10.1093/toxsci/kfp083; Elkin ND, 2010, TOXICOL SCI, V117, P439, DOI 10.1093/toxsci/kfq210; Henley DV, 2009, ENVIRON HEALTH PERSP, V117, P1702, DOI 10.1289/ehp.0900800; Hogberg J, 2008, ENVIRON HEALTH PERSP, V116, P334, DOI 10.1289/ehp.10788; Jindo T, 2001, TOXICOL PATHOL, V29, P607, DOI 10.1080/019262301753385933; Latini G, 2009, ENVIRON INT, V35, P236, DOI 10.1016/j.envint.2008.06.002; Louisse J, 2010, TOXICOL APPL PHARM, V245, P236, DOI 10.1016/j.taap.2010.03.005; Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075; Miller R R, 1982, Fundam Appl Toxicol, V2, P158, DOI 10.1016/S0272-0590(82)80039-0; Rao AVSK, 2002, FEBS LETT, V527, P133, DOI 10.1016/S0014-5793(02)03196-4; Ruyani A, 2005, BIRTH DEFECTS RES A, V73, P517, DOI 10.1002/bdra.20146; Ruyani A, 2003, TOXICOL SCI, V75, P148, DOI 10.1093/toxsci/kfg159; Scofield EH, 2006, REPROD TOXICOL, V22, P718, DOI 10.1016/j.reprotox.2006.05.005; Syed V, 1998, ENDOCRINOLOGY, V139, P3503, DOI 10.1210/en.139.8.3503; Takagi A, 2002, IND HEALTH, V40, P371, DOI 10.2486/indhealth.40.371; Welsch F, 2005, TOXICOL LETT, V156, P13, DOI 10.1016/j.toxlet.2003.08.010; Widodo N, 2008, CANCER LETT, V262, P37, DOI 10.1016/j.canlet.2007.11.037; Widodo N, 2007, CLIN CANCER RES, V13, P2298, DOI 10.1158/1078-0432.CCR-06-0948; Widodo N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013536; Widodo N, 2009, J GERONTOL A-BIOL, V64, P1031, DOI 10.1093/gerona/glp088; Yates MS, 2007, DRUG NEWS PERSPECT, V20, P109, DOI 10.1358/dnp.2007.20.2.1083437	28	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19552	10.1371/journal.pone.0019552	http://dx.doi.org/10.1371/journal.pone.0019552			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573189	Green Published, gold, Green Submitted			2022-12-27	WOS:000290224800033
J	Lee, YA; Goto, Y				Lee, Young-A; Goto, Yukiori			Neurodevelopmental Disruption of Cortico-Striatal Function Caused by Degeneration of Habenula Neurons	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; VENTRAL TEGMENTAL AREA; LATERAL HABENULA; FASCICULUS RETROFLEXUS; DOPAMINERGIC-NEURONS; INHIBITORY INFLUENCE; PREFRONTAL CORTEX; BRAIN-DEVELOPMENT; DECISION-MAKING; RAT	Background: The habenula plays an important role on cognitive and affective functions by regulating monoamines transmission such as the dopamine and serotonin, such that its dysfunction is thought to underlie a number of psychiatric conditions. Given that the monoamine systems are highly vulnerable to neurodevelopmental insults, damages in the habenula during early neurodevelopment may cause devastating effects on the wide-spread brain areas targeted by monoamine innervations. Methodology/Principal Findings: Using a battery of behavioral, anatomical, and biochemical assays, we examined the impacts of neonatal damage in the habenula on neurodevelopmental sequelae of the prefrontal cortex (PFC) and nucleus accumbens (NAcc) and associated behavioral deficits in rodents. Neonatal lesion of the medial and lateral habenula by ibotenic acid produced an assortment of behavioral manifestations consisting of hyper-locomotion, impulsivity, and attention deficit, with hyper-locomotion and impulsivity being observed only in the juvenile period, whereas attention deficit was sustained up until adulthood. Moreover, these behavioral alterations were also improved by amphetamine. Our study further revealed that impulsivity and attention deficit were associated with disruption of PFC volume and dopamine (DA) receptor expression, respectively. In contrast, hyper-locomotion was associated with decreased DA transporter expression in the NAcc. We also found that neonatal administration of nicotine into the habenula of neonatal brains produced selective lesion of the medial habenula. Behavioral deficits with neonatal nicotine administration were similar to those caused by ibotenic acid lesion of both medial and lateral habenula during the juvenile period, whereas they were different in adulthood. Conclusions/Significance: Because of similarity between behavioral and brain alterations caused by neonatal insults in the habenula and the symptoms and suggested neuropathology in attention deficit/hyperactivity disorder (ADHD), these results suggest that neurodevelopmental deficits in the habenula and the consequent cortico-striatal dysfunctions may be involved in the pathogenesis and pathophysiology of ADHD.	[Lee, Young-A; Goto, Yukiori] McGill Univ, Dept Psychiat, Montreal, PQ, Canada	McGill University	Lee, YA (corresponding author), McGill Univ, Dept Psychiat, Montreal, PQ, Canada.	yukiori.goto@mcgill.ca			Canadian Institute of Health Research [MOP-82732]; McGill University Health Centre	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); McGill University Health Centre	This work was supported by Canadian Institute of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) MOP-82732 and McGill University Health Centre (http://muhc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida LG, 2010, J PSYCHIATR RES, V44, P1214, DOI 10.1016/j.jpsychires.2010.04.026; Amat J, 2001, BRAIN RES, V917, P118, DOI 10.1016/S0006-8993(01)02934-1; Amo R, 2010, J NEUROSCI, V30, P1566, DOI 10.1523/JNEUROSCI.3690-09.2010; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; Araki KY, 2007, BRAIN RES, V1156, P31, DOI 10.1016/j.brainres.2007.04.043; Batty MJ, 2010, J AM ACAD CHILD PSY, V49, P229, DOI 10.1016/j.jaac.2009.11.008; Biederman J, 2005, BIOL PSYCHIAT, V57, P1215, DOI 10.1016/j.biopsych.2004.10.020; Boire D, 2005, J CHEM NEUROANAT, V29, P193, DOI 10.1016/j.jchemneu.2005.01.003; Brinschwitz K, 2010, NEUROSCIENCE, V168, P463, DOI 10.1016/j.neuroscience.2010.03.050; Carlson J, 2001, BRAIN RES, V906, P127, DOI 10.1016/S0006-8993(01)02570-7; Chudasama Y, 2006, BIOL PSYCHOL, V73, P19, DOI 10.1016/j.biopsycho.2006.01.005; CREESE I, 1972, NATURE-NEW BIOL, V238, P247, DOI 10.1038/newbio238247a0; Daviss WB, 2008, J CHILD ADOL PSYCHOP, V18, P565, DOI 10.1089/cap.2008.032; DemotesMainard J, 1996, DEV BRAIN RES, V94, P166, DOI 10.1016/0165-3806(96)00041-7; Denk F, 2005, PSYCHOPHARMACOLOGY, V179, P587, DOI 10.1007/s00213-004-2059-4; Dias-Ferreira E, 2009, SCIENCE, V325, P621, DOI 10.1126/science.1171203; Ellison G, 2002, EUR NEUROPSYCHOPHARM, V12, P287, DOI 10.1016/S0924-977X(02)00020-2; Friedman A, 2011, NEUROPHARMACOLOGY, V60, P381, DOI 10.1016/j.neuropharm.2010.10.006; Friedman A, 2010, NEUROPHARMACOLOGY, V59, P452, DOI 10.1016/j.neuropharm.2010.06.008; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Glick SD, 2008, EUR J PHARMACOL, V599, P91, DOI 10.1016/j.ejphar.2008.09.038; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; Gurevich EV, 2000, J COMP NEUROL, V420, P35, DOI 10.1002/(SICI)1096-9861(20000424)420:1<35::AID-CNE3>3.0.CO;2-K; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Jhou TC, 2009, NEURON, V61, P786, DOI 10.1016/j.neuron.2009.02.001; JONES DNC, 1995, J NEUROSCI, V15, P7282; KALEN P, 1989, BRAIN RES, V492, P187, DOI 10.1016/0006-8993(89)90901-3; KAVOUSSI RJ, 1994, J CLIN PSYCHIAT, V55, P137; Kim U, 2005, J COMP NEUROL, V483, P236, DOI 10.1002/cne.20410; Kozak M, 2007, J CELL BIOCHEM, V102, P280, DOI 10.1002/jcb.21464; Langley K, 2005, Minerva Pediatr, V57, P359; Lecca S, 2011, NEUROPSYCHOPHARMACOL, V36, P589, DOI 10.1038/npp.2010.190; Lecourtier L, 2005, NEUROPSYCHOPHARMACOL, V30, P484, DOI 10.1038/sj.npp.1300595; Lecourtier L, 2004, EUR J NEUROSCI, V19, P2551, DOI 10.1111/j.0953-816X.2004.03356.x; Lecourtier L, 2008, EUR J NEUROSCI, V27, P1755, DOI 10.1111/j.1460-9568.2008.06130.x; Lee YA, 2010, BRIT J NUTR, V103, P479, DOI 10.1017/S0007114509992005; Lipska BK, 2000, NEUROPSYCHOPHARMACOL, V23, P223, DOI 10.1016/S0893-133X(00)00137-8; LISOPRAWSKI A, 1980, BRAIN RES, V183, P229, DOI 10.1016/0006-8993(80)90135-3; LUBOW RE, 1993, J CHILD PSYCHOL PSYC, V34, P959, DOI 10.1111/j.1469-7610.1993.tb01101.x; Lubow RE., 1989, LATENT INHIBITION CO; Lukaszewska Irena, 1993, Acta Neurobiologiae Experimentalis (Warsaw), V53, P243; Makris N, 2007, CEREB CORTEX, V17, P1364, DOI 10.1093/cercor/bhl047; Morissette MC, 2008, BEHAV BRAIN RES, V187, P17, DOI 10.1016/j.bbr.2007.08.021; Narr KL, 2009, J AM ACAD CHILD PSY, V48, P1014, DOI 10.1097/CHI.0b013e3181b395c0; NISHIKAWA T, 1985, BRAIN RES, V331, P81, DOI 10.1016/0006-8993(85)90717-6; NISHIKAWA T, 1986, BRAIN RES, V373, P324, DOI 10.1016/0006-8993(86)90347-1; Omelchenko N, 2009, EUR J NEUROSCI, V30, P1239, DOI 10.1111/j.1460-9568.2009.06924.x; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Petrof I, 2010, BEHAV BRAIN RES, V211, P248, DOI 10.1016/j.bbr.2010.03.045; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Ranft K, 2010, PSYCHOL MED, V40, P557, DOI 10.1017/S0033291709990821; Salas R, 2009, J NEUROSCI, V29, P3014, DOI 10.1523/JNEUROSCI.4934-08.2009; Sartorius A, 2010, BIOL PSYCHIAT, V67, pE9, DOI 10.1016/j.biopsych.2009.08.027; Savitz JB, 2011, BIOL PSYCHIAT, V69, P336, DOI 10.1016/j.biopsych.2010.09.027; Shaw P, 2006, ARCH GEN PSYCHIAT, V63, P540, DOI 10.1001/archpsyc.63.5.540; Shepard PD, 2006, SCHIZOPHRENIA BULL, V32, P417, DOI 10.1093/schbul/sbj083; Shumake J, 2003, Behav Cogn Neurosci Rev, V2, P198, DOI 10.1177/1534582303259057; Shumake J, 2010, J NEUROSCI, V30, P5876, DOI 10.1523/JNEUROSCI.3604-09.2010; Spencer TJ, 2007, J PEDIATR PSYCHOL, V32, P631, DOI 10.1093/jpepsy/jsm005; THORNTON EW, 1991, PHYSIOL BEHAV, V49, P819, DOI 10.1016/0031-9384(91)90324-H; Ueno K, 2002, BEHAV PHARMACOL, V13, P1, DOI 10.1097/00008877-200202000-00001; ValeMartinez A, 1997, NEUROBIOL LEARN MEM, V68, P68, DOI 10.1006/nlme.1997.3777; VANEDEN CG, 1985, J COMP NEUROL, V241, P268, DOI 10.1002/cne.902410303; Wang YH, 2009, NEUROSCI LETT, V461, P167, DOI 10.1016/j.neulet.2009.06.029; WinzerSerhan UH, 1997, J COMP NEUROL, V386, P540, DOI 10.1002/(SICI)1096-9861(19971006)386:4<540::AID-CNE2>3.0.CO;2-2; [No title captured]	66	40	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19450	10.1371/journal.pone.0019450	http://dx.doi.org/10.1371/journal.pone.0019450			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559387	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700178
J	Li, DS; Lott, WB; Lowry, K; Jones, A; Thu, HM; Aaskov, J				Li, Dongsheng; Lott, William B.; Lowry, Kym; Jones, Anita; Thu, Hlaing Myat; Aaskov, John			Defective Interfering Viral Particles in Acute Dengue Infections	PLOS ONE			English	Article							FLAVIVIRUS RNA; AEDES-AEGYPTI; PERSISTENT INFECTION; VIRUS-PARTICLES; KUNJIN VIRUS; FEVER VIRUS; LENGTH CDNA; REPLICATION; GENOMES; CELLS	While much of the genetic variation in RNA viruses arises because of the error-prone nature of their RNA-dependent RNA polymerases, much larger changes may occur as a result of recombination. An extreme example of genetic change is found in defective interfering (DI) viral particles, where large sections of the genome of a parental virus have been deleted and the residual sub-genome fragment is replicated by complementation by co-infecting functional viruses. While most reports of DI particles have referred to studies in vitro, there is some evidence for the presence of DI particles in chronic viral infections in vivo. In this study, short fragments of dengue virus (DENV) RNA containing only key regulatory elements at the 3' and 5' ends of the genome were recovered from the sera of patients infected with any of the four DENV serotypes. Identical RNA fragments were detected in the supernatant from cultures of Aedes mosquito cells that were infected by the addition of sera from dengue patients, suggesting that the sub-genomic RNA might be transmitted between human and mosquito hosts in defective interfering (DI) viral particles. In vitro transcribed sub-genomic RNA corresponding to that detected in vivo could be packaged in virus like particles in the presence of wild type virus and transmitted for at least three passages in cell culture. DENV preparations enriched for these putative DI particles reduced the yield of wild type dengue virus following co-infections of C6-36 cells. This is the first report of DI particles in an acute arboviral infection in nature. The internal genomic deletions described here are the most extensive defects observed in DENV and may be part of a much broader disease attenuating process that is mediated by defective viruses.	[Li, Dongsheng; Lott, William B.; Lowry, Kym; Jones, Anita; Aaskov, John] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Thu, Hlaing Myat] Virol Res Div, Dept Med Res, Yangon, Myanmar	Queensland University of Technology (QUT)	Li, DS (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.	j.aaskov@qut.edu.au	Lowry, Kym/AAK-2711-2021; Lott, William B/J-1062-2012	Lott, William B/0000-0001-7118-7560; Lowry, Kym/0000-0002-9666-149X	Australian National Health and Medical Research Council [497203]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grant 497203 from the Australian National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaskov J, 2006, SCIENCE, V311, P236, DOI 10.1126/science.1115030; Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005; BARRETT ADT, 1986, CURR TOP MICROBIOL, V128, P55; BRINTON MA, 1982, VIROLOGY, V116, P84, DOI 10.1016/0042-6822(82)90405-6; CATTANEO R, 1988, CELL, V55, P255, DOI 10.1016/0092-8674(88)90048-7; CLEAVES GR, 1981, VIROLOGY, V111, P73, DOI 10.1016/0042-6822(81)90654-1; Diamond MS, 2002, VIROLOGY, V304, P211, DOI 10.1006/viro.2002.1685; Ebner PD, 2008, VIROLOGY, V381, P98, DOI 10.1016/j.virol.2008.08.024; Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206; FOCKS DA, 1993, J MED ENTOMOL, V30, P1018, DOI 10.1093/jmedent/30.6.1018; Gualano RC, 1998, J GEN VIROL, V79, P437, DOI 10.1099/0022-1317-79-3-437; Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209; Henle W, 1943, SCIENCE, V98, P87, DOI 10.1126/science.98.2534.87; HUANG AS, 1970, NATURE, V226, P325, DOI 10.1038/226325a0; JOHNSTON RE, 1975, J VIROL, V16, P951, DOI 10.1128/JVI.16.4.951-958.1975; Jones CT, 2005, VIROLOGY, V331, P247, DOI 10.1016/j.virol.2004.10.034; Khromykh AA, 1998, J VIROL, V72, P5967, DOI 10.1128/JVI.72.7.5967-5977.1998; Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001; Khromykh AA, 2001, J VIROL, V75, P4633, DOI 10.1128/JVI.75.10.4633-4640.2001; KIRKEGAARD K, 1986, CELL, V47, P433, DOI 10.1016/0092-8674(86)90600-8; Lancaster MU, 1998, J VIROL, V72, P2474, DOI 10.1128/JVI.72.3.2474-2482.1998; Li Z, 2005, J VIROL METHODS, V130, P154, DOI 10.1016/j.jviromet.2005.06.022; Marriott AC, 2010, REV MED VIROL, V20, P51, DOI 10.1002/rmv.641; MIMS CA, 1956, BRIT J EXP PATHOL, V37, P129; Noppornpanth S, 2007, J VIROL, V81, P12496, DOI 10.1128/JVI.01059-07; NUESCH JPF, 1989, J GEN VIROL, V70, P3475, DOI 10.1099/0022-1317-70-12-3475; Pacini L, 2009, J VIROL, V83, P9079, DOI 10.1128/JVI.00308-09; Paranjape SM, 2010, CURR TOP MICROBIOL, V338, P15, DOI 10.1007/978-3-642-02215-9_2; Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007; Polacek C, 2009, J VIROL, V83, P1161, DOI 10.1128/JVI.01362-08; PONS M, 1969, VIROLOGY, V38, P68, DOI 10.1016/0042-6822(69)90128-7; POPESCU M, 1977, VIROLOGY, V77, P78, DOI 10.1016/0042-6822(77)90407-X; REPIK PM, 1983, AM J TROP MED HYG, V32, P577, DOI 10.4269/ajtmh.1983.32.577; ROUX L, 1991, ADV VIRUS RES, V40, P181; Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481; Thu HM, 2004, EMERG INFECT DIS, V10, P593, DOI 10.3201/eid1004.030216; Tuiskunen A, 2010, J GEN VIROL, V91, P1019, DOI 10.1099/vir.0.016667-0; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; VONMAGNUS P, 1954, ADV VIRUS RES, V2, P59, DOI 10.1016/S0065-3527(08)60529-1; Wang WK, 2002, J VIROL, V76, P4662, DOI 10.1128/JVI.76.9.4662-4665.2002; WHO, 1997, DENG HAEM FEV DIAGN; Wittke V, 2002, VIROLOGY, V301, P148, DOI 10.1006/viro.2002.1549; Yu L, 2008, VIROLOGY, V374, P170, DOI 10.1016/j.virol.2007.12.035; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	45	88	92	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19447	10.1371/journal.pone.0019447	http://dx.doi.org/10.1371/journal.pone.0019447			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559384	Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700176
J	Lubieniecka, JM; Streijger, F; Lee, JHT; Stoynov, N; Liu, J; Mottus, R; Pfeifer, T; Kwon, BK; Coorssen, JR; Foster, LJ; Grigliatti, TA; Tetzlaff, W				Lubieniecka, Joanna M.; Streijger, Femke; Lee, Jae H. T.; Stoynov, Nikolay; Liu, Jie; Mottus, Randy; Pfeifer, Tom; Kwon, Brian K.; Coorssen, Jens R.; Foster, Leonard J.; Grigliatti, Thomas A.; Tetzlaff, Wolfram			Biomarkers for Severity of Spinal Cord Injury in the Cerebrospinal Fluid of Rats	PLOS ONE			English	Article							PROTEINS; CONTUSION; FAMILY; EXCITOTOXICITY; REGENERATION; EXPRESSION; PROTEOMICS; ELEVATION; PROTECTS; CALCIUM	One of the major challenges in management of spinal cord injury (SCI) is that the assessment of injury severity is often imprecise. Identification of reliable, easily quantifiable biomarkers that delineate the severity of the initial injury and that have prognostic value for the degree of functional recovery would significantly aid the clinician in the choice of potential treatments. To find such biomarkers we performed quantitative liquid chromatography-mass spectrometry (LC-MS/MS) analyses of cerebrospinal fluid (CSF) collected from rats 24 h after either a moderate or severe SCI. We identified a panel of 42 putative biomarkers of SCI, 10 of which represent potential biomarkers of SCI severity. Three of the candidate biomarkers, Ywhaz, Itih4, and Gpx3 were also validated by Western blot in a biological replicate of the injury. The putative biomarkers identified in this study may potentially be a valuable tool in the assessment of the extent of spinal cord damage.	[Lubieniecka, Joanna M.; Mottus, Randy; Pfeifer, Tom; Grigliatti, Thomas A.; Tetzlaff, Wolfram] Univ British Columbia, Dept Zool, Inst Life Sci, Vancouver, BC, Canada; [Streijger, Femke; Lee, Jae H. T.; Liu, Jie; Kwon, Brian K.; Grigliatti, Thomas A.; Tetzlaff, Wolfram] Univ British Columbia, Blusson Spinal Cord Ctr, Int Collaborat Repair Discoveries ICORD, Vancouver, BC V5Z 1M9, Canada; [Stoynov, Nikolay; Foster, Leonard J.] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V5Z 1M9, Canada; [Stoynov, Nikolay; Foster, Leonard J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; [Pfeifer, Tom] Univ British Columbia, Ctr Drug Res & Dev CDRD, Vancouver, BC V5Z 1M9, Canada; [Coorssen, Jens R.] Univ Western Sydney, Sch Med, Dept Mol Physiol, Penrith, NSW 1797, Australia; [Kwon, Brian K.] Univ British Columbia, Dept Orthopaed, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; Western Sydney University; University of British Columbia	Lubieniecka, JM (corresponding author), Univ British Columbia, Dept Zool, Inst Life Sci, Vancouver, BC, Canada.	jlubieni@interchange.ubc.ca; grigliat@zoology.ubc.ca	Tetzlaff, Wolfram/AAY-4430-2020		Michael Smith Foundation for Health Research [MSFHR952]; Canada Foundation for Innovation; British Columbia Knowledge Development Fund; British Columbia Proteomics Network	Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); British Columbia Knowledge Development Fund; British Columbia Proteomics Network	This research was supported by the Michael Smith Foundation for Health Research (grant# MSFHR952). Mass spectrometry infrastructure was supported by the Canada Foundation for Innovation, the British Columbia Knowledge Development Fund, and the British Columbia Proteomics Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib-Conquy M, 2007, FEBS LETT, V581, P3723, DOI 10.1016/j.febslet.2007.03.074; Adibhatla Rao Muralikrishna, 2008, V49, P241, DOI 10.1007/978-1-4020-8831-5_9; Ambrus G, 2003, J IMMUNOL, V170, P1374, DOI 10.4049/jimmunol.170.3.1374; Back SA, 2005, NAT MED, V11, P966, DOI 10.1038/nm1279; Berg D, 2003, NAT REV NEUROSCI, V4, P752, DOI 10.1038/nrn1197; Boersema PJ, 2008, PROTEOMICS, V8, P4624, DOI 10.1002/pmic.200800297; Bost F, 1998, EUR J BIOCHEM, V252, P339, DOI 10.1046/j.1432-1327.1998.2520339.x; Boulos S, 2007, J NEUROSCI RES, V85, P3089, DOI 10.1002/jnr.21429; Burkhard PR, 2001, NEUROLOGY, V56, P1528, DOI 10.1212/WNL.56.11.1528; Cao F, 2008, J CLIN NEUROSCI, V15, P541, DOI 10.1016/j.jocn.2007.05.014; Chan QWT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r156; Chan QWT, 2006, MOL CELL PROTEOMICS, V5, P2252, DOI 10.1074/mcp.M600197-MCP200; Choo AMT, 2009, J NEUROSCI METH, V181, P6, DOI 10.1016/j.jneumeth.2009.04.007; Coorssen JR, 2002, ANAL BIOCHEM, V307, P54, DOI 10.1016/S0003-2697(02)00015-5; Cuadrado-Corrales N, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-25; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Feng ZW, 2002, MOL CELL BIOL, V22, P5357, DOI 10.1128/MCB.22.15.5357-5366.2002; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Gensel JC, 2006, J NEUROTRAUM, V23, P36, DOI 10.1089/neu.2006.23.36; Guez M, 2003, J NEUROTRAUM, V20, P853, DOI 10.1089/089771503322385782; HALL ED, 1993, ANN EMERG MED, V22, P1022, DOI 10.1016/S0196-0644(05)82745-3; Hall Edward D, 2004, NeuroRx, V1, P80, DOI 10.1602/neurorx.1.1.80; Hawryluk GWJ, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E14; Inoue KI, 2005, MOL PHARMACOL, V67, P673, DOI 10.1124/mol.104.005967; Jakeman LB, 2000, J NEUROTRAUM, V17, P299, DOI 10.1089/neu.2000.17.299; Khaladj N, 2008, EUR J VASC ENDOVASC, V36, P11, DOI 10.1016/j.ejvs.2008.01.011; Khwaja FW, 2007, J PROTEOME RES, V6, P559, DOI 10.1021/pr060240z; Kwon BK, 2010, J NEUROTRAUM, V27, P669, DOI 10.1089/neu.2009.1080; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Liu Y, 1999, J NEUROSCI, V19, P4370; Loy DN, 2005, NEUROSURGERY, V56, P391, DOI 10.1227/01.NEU.0000148906.83616.D2; Ma JJ, 2001, SCAND J PLAST RECONS, V35, P355; MATTSON MP, 1992, EXP GERONTOL, V27, P29, DOI 10.1016/0531-5565(92)90027-W; Mizutani A, 2003, BLOOD, V101, P3029, DOI 10.1182/blood-2002-08-2406; MORTENSEN P, 2009, J PROTEOME RES; Namikawa K, 1998, MOL BRAIN RES, V55, P315, DOI 10.1016/S0169-328X(98)00012-6; Naus S, 2004, J BIOL CHEM, V279, P16083, DOI 10.1074/jbc.M400560200; Ochi S, 2007, P NATL ACAD SCI USA, V104, P11394, DOI 10.1073/pnas.0701971104; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Pouw MH, 2009, SPINAL CORD, V47, P519, DOI 10.1038/sc.2008.176; Rabchevsky AG, 2001, J NEUROTRAUM, V18, P513, DOI 10.1089/089771501300227314; Ramer LM, 2005, SPINAL CORD, V43, P134, DOI 10.1038/sj.sc.3101715; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schwab JM, 2006, PROG NEUROBIOL, V78, P91, DOI 10.1016/j.pneurobio.2005.12.004; Sherman LS, 2008, TRENDS NEUROSCI, V31, P44, DOI 10.1016/j.tins.2007.11.001; Siman R, 2004, NEUROBIOL DIS, V16, P311, DOI 10.1016/j.nbd.2004.03.016; Struve J, 2005, GLIA, V52, P16, DOI 10.1002/glia.20215; Tsai MC, 2008, SURG NEUROL S1, V70, pS1; Tsai MC, 2008, SURG NEUROL, V70, P19, DOI 10.1016/j.surneu.2007.09.033; Van Linthout S, 2008, CIRCULATION, V117, P1563, DOI 10.1161/CIRCULATIONAHA.107.710830; Yamaguchi Y, 2000, CELL MOL LIFE SCI, V57, P276, DOI 10.1007/PL00000690; Zhang J, 2007, PROTEOM CLIN APPL, V1, P805, DOI 10.1002/prca.200700081	53	49	53	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19247	10.1371/journal.pone.0019247	http://dx.doi.org/10.1371/journal.pone.0019247			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559420	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700111
J	Marinaro, C; Butti, E; Bergamaschi, A; Papale, A; Furlan, R; Comi, G; Martino, G; Muzio, L				Marinaro, Cinzia; Butti, Erica; Bergamaschi, Andrea; Papale, Alessandro; Furlan, Roberto; Comi, Giancarlo; Martino, Gianvito; Muzio, Luca			In Vivo Fate Analysis Reveals the Multipotent and Self-Renewal Features of Embryonic AspM Expressing Cells	PLOS ONE			English	Article							NEURAL STEM-CELLS; ADULT MAMMALIAN FOREBRAIN; RADIAL GLIAL-CELLS; SUBVENTRICULAR ZONE; PROGENITOR CELLS; RECOMBINASE ACTIVITY; CELLULAR COMPOSITION; NEURONAL MIGRATION; GENE-TRANSFER; BRAIN	Radial Glia (RG) cells constitute the major population of neural progenitors of the mouse developing brain. These cells are located in the ventricular zone (VZ) of the cerebral cortex and during neurogenesis they support the generation of cortical neurons. Later on, during brain maturation, RG cells give raise to glial cells and supply the adult mouse brain of Neural Stem Cells (NSC). Here we used a novel transgenic mouse line expressing the CreER(T2) under the control of AspM promoter to monitor the progeny of an early cohort of RG cells during neurogenesis and in the post natal brain. Long term fate mapping experiments demonstrated that AspM-expressing RG cells are multi-potent, as they can generate neurons, astrocytes and oligodendrocytes of the adult mouse brain. Furthermore, AspM descendants give also rise to proliferating progenitors in germinal niches of both developing and post natal brains. In the latter -i.e. the Sub Ventricular Zone-AspM descendants acquired several feature of neural stem cells, including the capability to generate neurospheres in vitro. We also performed the selective killing of these early progenitors by using a Nestin-GFP(flox)-TK allele. The forebrain specific loss of early AspM expressing cells caused the elimination of most of the proliferating cells of brain, a severe derangement of the ventricular zone architecture, and the impairment of the cortical lamination. We further demonstrated that AspM is expressed by proliferating cells of the adult mouse SVZ that can generate neuroblasts fated to become olfactory bulb neurons.	[Marinaro, Cinzia; Butti, Erica; Bergamaschi, Andrea; Papale, Alessandro; Furlan, Roberto; Martino, Gianvito; Muzio, Luca] San Raffaele Inst, Inst Expt Neurol INSPE, Dept Neurosci, Milan, Italy; [Comi, Giancarlo] San Raffaele Inst, Inst Expt Neurol INSPE, Dept Neurol, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Marinaro, C (corresponding author), San Raffaele Inst, Inst Expt Neurol INSPE, Dept Neurosci, Milan, Italy.	muzio.luca@hsr.it	Butti, Erica/AAN-1950-2020; Furlan, Roberto/J-9177-2016; Furlan, Roberto/N-5224-2019; Papale, Alessandro/K-9556-2016; martino, gianvito/AAL-2682-2020; Muzio, Luca/AAB-2308-2022; Bergamaschi, Andrea/AAN-3705-2020	Furlan, Roberto/0000-0001-7376-9425; Furlan, Roberto/0000-0001-7376-9425; Papale, Alessandro/0000-0002-8794-0171; martino, gianvito/0000-0003-1295-9131; Muzio, Luca/0000-0002-1068-865X; MARINARO, CINZIA/0000-0002-6283-4831; Butti, Erica/0000-0003-0362-273X	Fondazione Italiana Sclerosi Multipla; National Multiple Sclerosis Society [rg4016a2/1]; BMW Italy	Fondazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM)); National Multiple Sclerosis Society(National Multiple Sclerosis Society); BMW Italy	This study was supported by the Fondazione Italiana Sclerosi Multipla. This investigation was supported in part by a grant from the National Multiple Sclerosis Society award no. rg4016a2/1. CM, AB, GM, and LM were supported by BMW Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; BAUDIER J, 1992, P NATL ACAD SCI USA, V89, P11627, DOI 10.1073/pnas.89.23.11627; Bhat RV, 1996, GLIA, V17, P169; Bond J, 2006, CURR OPIN CELL BIOL, V18, P95, DOI 10.1016/j.ceb.2005.11.004; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Bonini C, 1997, SCIENCE, V276, P1719, DOI 10.1126/science.276.5319.1719; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Carlen M, 2006, EXP CELL RES, V312, P2851, DOI 10.1016/j.yexcr.2006.05.012; Centonze D, 2009, J NEUROSCI, V29, P3442, DOI 10.1523/JNEUROSCI.5804-08.2009; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; De Marchis S, 2007, J NEUROSCI, V27, P657, DOI 10.1523/JNEUROSCI.2870-06.2007; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Giachino C, 2009, EUR J NEUROSCI, V30, P9, DOI 10.1111/j.1460-9568.2009.06798.x; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Gritti A, 1996, J NEUROSCI, V16, P1091; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kang WF, 2009, J NEUROSCI, V29, P14571, DOI 10.1523/JNEUROSCI.3844-09.2009; Kawaguchi A, 2001, MOL CELL NEUROSCI, V17, P259, DOI 10.1006/mcne.2000.0925; Kosaka T, 2005, CHEM SENSES, V30, pI107, DOI 10.1093/chemse/bjh137; Kosaka T, 2011, NEUROSCI RES, V69, P93, DOI 10.1016/j.neures.2010.10.002; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Leid M, 2004, GENE EXPR PATTERNS, V4, P733, DOI 10.1016/j.modgep.2004.03.009; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Louis SA, 2008, STEM CELLS, V26, P988, DOI 10.1634/stemcells.2007-0867; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Malatesta P, 2000, DEVELOPMENT, V127, P5253; McCarthy M, 2001, J NEUROSCI, V21, P6772, DOI 10.1523/JNEUROSCI.21-17-06772.2001; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Muzio L, 2003, CEREB CORTEX, V13, P641, DOI 10.1093/cercor/13.6.641; Muzio L., 2009, MOL CELL NEUROSCI; Muzio L, 2010, MOL CELL NEUROSCI, V43, P268, DOI 10.1016/j.mcn.2009.11.008; Nam HS, 2009, CELL STEM CELL, V5, P515, DOI 10.1016/j.stem.2009.08.017; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Ninkovic J, 2007, J NEUROSCI, V27, P10906, DOI 10.1523/JNEUROSCI.2572-07.2007; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Parrish-Aungst S, 2007, J COMP NEUROL, V501, P825, DOI 10.1002/cne.21205; Peretto P, 2005, J COMP NEUROL, V487, P407, DOI 10.1002/cne.20576; Pluchino S, 2008, BRAIN, V131, P2564, DOI 10.1093/brain/awn198; Pulvers JN, 2010, P NATL ACAD SCI US; Quinones-Hinojosa A, 2006, J COMP NEUROL, V494, P415, DOI 10.1002/cne.20798; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Silver DL, 2010, NAT NEUROSCI, V13, P551, DOI 10.1038/nn.2527; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Wakefield JG, 2001, J CELL BIOL, V153, P637, DOI 10.1083/jcb.153.4.637; Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435; Wildner O, 1999, ANN MED, V31, P421, DOI 10.3109/07853899908998799; Willaime-Morawek S, 2006, J CELL BIOL, V175, P159, DOI 10.1083/jcb.200604123; Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	77	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19419	10.1371/journal.pone.0019419	http://dx.doi.org/10.1371/journal.pone.0019419			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559369	gold, Green Published, Green Submitted			2022-12-27	WOS:000290024700163
J	Rocha, JJE; Korolchuk, VI; Robinson, IM; O'Kane, CJ				Rocha, Joao J. E.; Korolchuk, Viktor I.; Robinson, Iain M.; O'Kane, Cahir J.			A Phagocytic Route for Uptake of Double-Stranded RNA in RNAi	PLOS ONE			English	Article							TRANSMEMBRANE PROTEIN SID-1; ESCHERICHIA-COLI; DROSOPHILA; CELLS; INTERFERENCE; ORGANIZATION; DSRNA; IDENTIFICATION; TRAFFICKING; ENDOCYTOSIS	RNA interference (RNAi) has a range of physiological functions including as a defence mechanism against viruses. To protect uninfected cells in a multicellular organism, not only a cell-autonomous RNAi response is required but also a systemic one. However, the route of RNA spread in systemic RNAi remains unclear. Here we show that phagocytosis can be a route for double-stranded RNA uptake. Double-stranded RNA expressed in Escherichia coli induces robust RNAi in Drosophila S2 cells, with effectiveness comparable to that of naked dsRNA. We could separate this phagocytic uptake route from that for RNAi induced by naked dsRNA. Therefore, phagocytic uptake of dsRNA offers a potential route for systemic spread of RNAi.	[Rocha, Joao J. E.; Korolchuk, Viktor I.; O'Kane, Cahir J.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Robinson, Iain M.] Univ Exeter, Peninsula Coll Med & Dent, Plymouth, Devon, England	University of Cambridge; University of Exeter; University of Plymouth	Rocha, JJE (corresponding author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.	j.rocha@gen.cam.ac.uk; c.okane@gen.cam.ac.uk	O'Kane, Cahir/Q-6681-2019	O'Kane, Cahir/0000-0002-3488-2078; Korolchuk, Viktor/0000-0002-4071-592X	Medical Research Council [G0802208]; UK Biotechnology and Biological Sciences Research Council [8/C19002, BB/D019699/1]; BBSRC [BB/D019699/1] Funding Source: UKRI; MRC [G0802208] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D019699/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by grants G0802208 from the Medical Research Council to IMR and 8/C19002 and BB/D019699/1 from the UK Biotechnology and Biological Sciences Research Council to CJO'K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	D'Avino PP, 2004, J CELL BIOL, V166, P61, DOI 10.1083/jcb.200402157; Dunoyer P, 2010, SCIENCE, V328, P912, DOI 10.1126/science.1185880; Feinberg EH, 2003, SCIENCE, V301, P1545, DOI 10.1126/science.1087117; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Korolchuk VI, 2007, J CELL SCI, V120, P4367, DOI 10.1242/jcs.012336; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Molnar A, 2010, SCIENCE, V328, P872, DOI 10.1126/science.1187959; Pearson AM, 2003, MICROBES INFECT, V5, P815, DOI 10.1016/S1286-4579(03)00157-6; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Razzaq A, 2001, GENE DEV, V15, P2967, DOI 10.1101/gad.207801; Roignant JY, 2003, RNA, V9, P299, DOI 10.1261/rna.2154103; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Saleh MC, 2009, NATURE, V458, P346, DOI 10.1038/nature07712; SAMBROOK J, 2000, MOL CLONING LAB MANU; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Ulvila J, 2006, J BIOL CHEM, V281, P14370, DOI 10.1074/jbc.M513868200; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087	21	18	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19087	10.1371/journal.pone.0019087	http://dx.doi.org/10.1371/journal.pone.0019087			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559499	Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700064
J	Rossmanith, W				Rossmanith, Walter			Localization of Human RNase Z Isoforms: Dual Nuclear/Mitochondrial Targeting of the ELAC2 Gene Product by Alternative Translation Initiation	PLOS ONE			English	Article							TRNASE-Z; MITOCHONDRIAL; NUCLEAR; PROTEINS	RNase Z is an endonuclease responsible for the removal of 3' extensions from tRNA precursors, an essential step in tRNA biogenesis. Human cells contain a long form (RNase Z(L)) encoded by ELAC2, and a short form (RNase Z(S); ELAC1). We studied their subcellular localization by expression of proteins fused to green fluorescent protein. RNase Z(S) was found in the cytosol, whereas RNase Z(L) localized to the nucleus and mitochondria. We show that alternative translation initiation is responsible for the dual targeting of RNase Z(L). Due to the unfavorable context of the first AUG of ELAC2, translation apparently also starts from the second AUG, whereby the mitochondrial targeting sequence is lost and the protein is instead routed to the nucleus. Our data suggest that RNase Z(L) is the enzyme involved in both, nuclear and mitochondrial tRNA 3' end maturation.	Med Univ Vienna, Ctr Anat & Cell Biol, Vienna, Austria	Medical University of Vienna	Rossmanith, W (corresponding author), Med Univ Vienna, Ctr Anat & Cell Biol, Vienna, Austria.	walter.rossmanith@meduniwien.ac.at	Rossmanith, Walter/F-3662-2010	Rossmanith, Walter/0000-0003-2337-2248	Austrian Science Fund (FWF) [P17453]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The project was funded in part by the Austrian Science Fund (FWF): P17453. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canino G, 2009, PLANT PHYSIOL, V150, P1494, DOI 10.1104/pp.109.137950; Ceballos M, 2007, PROTEIN PEPTIDE LETT, V14, P137, DOI 10.2174/092986607779816050; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Deutscher Murray P., 1995, P51; Dubrovsky EB, 2004, NUCLEIC ACIDS RES, V32, P255, DOI 10.1093/nar/gkh182; Elbarbary RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005908; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Flicek P, 2010, NUCLEIC ACIDS RES, V38, pD557, DOI 10.1093/nar/gkp972; Gan XH, 2011, BIOCHEM J, V435, P103, DOI 10.1042/BJ20101619; Hartmann RK, 2009, PROG MOL BIOL TRANSL, V85, P319, DOI 10.1016/S0079-6603(08)00808-8; Hazbun TR, 2003, MOL CELL, V12, P1353, DOI 10.1016/S1097-2765(03)00476-3; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Korver W, 2003, INT J CANCER, V104, P283, DOI 10.1002/ijc.10945; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Lai LB, 2010, FEBS LETT, V584, P287, DOI 10.1016/j.febslet.2009.11.048; Lakshmipathy U, 1999, MOL CELL BIOL, V19, P3869; Mineri R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005713; Nair R, 2005, J MOL BIOL, V348, P85, DOI 10.1016/j.jmb.2005.02.025; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Redko Y, 2007, NAT REV MICROBIOL, V5, P278, DOI 10.1038/nrmicro1622; ROBERTS BL, 1987, CELL, V50, P465, DOI 10.1016/0092-8674(87)90500-9; Rossmanith W, 2001, MOL CELL BIOL, V21, P8236, DOI 10.1128/MCB.21.23.8236-8237.2001; ROSSMANITH W, 1995, J BIOL CHEM, V270, P12885, DOI 10.1074/jbc.270.21.12885; Rossmanith W, 1998, BIOCHEM BIOPH RES CO, V247, P234, DOI 10.1006/bbrc.1998.8766; Rossmanith W, 2009, CELL CYCLE, V8, P1650, DOI 10.4161/cc.8.11.8502; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Spath B, 2007, CELL MOL LIFE SCI, V64, P2404, DOI 10.1007/s00018-007-7160-5; Takahashi M, 2008, FEBS LETT, V582, P2532, DOI 10.1016/j.febslet.2008.06.020; Takaku H, 2003, NUCLEIC ACIDS RES, V31, P2272, DOI 10.1093/nar/gkg337; Vogel A, 2005, BIOL CHEM, V386, P1253, DOI 10.1515/BC.2005.142; Wang Y, 2002, P NATL ACAD SCI USA, V99, P12114, DOI 10.1073/pnas.192449499; Yan H, 2006, J BIOL CHEM, V281, P3926, DOI 10.1074/jbc.M509822200; Yanaihara N, 2001, GENOMICS, V72, P169, DOI 10.1006/geno.2000.6454	35	55	56	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19152	10.1371/journal.pone.0019152	http://dx.doi.org/10.1371/journal.pone.0019152			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559454	Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700079
J	Sariol, CA; Martinez, MI; Rivera, F; Rodriguez, IV; Pantoja, P; Abel, K; Arana, T; Giavedoni, L; Hodara, V; White, LJ; Anglero, YI; Montaner, LJ; Kraiselburd, EN				Sariol, Carlos A.; Martinez, Melween I.; Rivera, Francheska; Rodriguez, Idia Vanessa; Pantoja, Petraleigh; Abel, Kristina; Arana, Teresa; Giavedoni, Luis; Hodara, Vida; White, Laura J.; Anglero, Yesseinia I.; Montaner, Luis J.; Kraiselburd, Edmundo N.			Decreased Dengue Replication and an Increased Anti-viral Humoral Response with the use of Combined Toll-Like Receptor 3 and 7/8 Agonists in Macaques	PLOS ONE			English	Article							HUMAN DENDRITIC CELLS; SIMIAN IMMUNODEFICIENCY VIRUS; POLYRIBOINOSINIC-POLYRIBOCYTIDYLIC ACID; T-CELLS; VIRAL REPLICATION; PRIMARY INFECTION; RHESUS MACAQUES; GENE-EXPRESSION; YELLOW-FEVER; B-CELLS	Background: Pathogenic versus protective outcomes to Dengue virus (DENV) infection are associated with innate immune function. This study aimed to determine the role of increased TLR3- and TLR7/8-mediated innate signaling after Dengue infection of rhesus macaques in vivo to evaluate its impact on disease and anti-DENV immune responses. Methodology/Principal Findings: TLR3 and TLR7/8 agonists (emulsified in Montanide) were administered subcutaneously to rhesus macaques at 48 hours and 7 days after DENV infection. The Frequency and activation of myeloid dendritic cells, plasmacytoid dendritic cells, and B cells were measured by flow cytometry while the serum levels of 14 different cytokines and chemokines were quantified. Adaptive immune responses were measured by DENV-specific antibody subtype measurements. Results showed that the combined TLR agonists reduced viral replication and induced the development of a proinflammatory reaction, otherwise absent in Dengue infection alone, without any clear signs of exacerbated disease. Specifically, the TLR-induced response was characterized by activation changes in mDC subsets concurrent with higher serum levels of CXCL-10 and IL-1Ra. TLR stimulation also induced higher titers of anti-DENV antibodies and acted to increase the IgG2/IgG1 ratio of anti-DENV to favor the subtype associated with DENV control. We also observed an effect of DENV-mediated suppression of mDC activation consistent with prior in vitro studies. Conclusions/Significance: These data show that concurrent TLR3/7/8 activation of the innate immune response after DENV infection in vivo acts to increase antiviral mechanisms via increased inflammatory and humoral responses in rhesus macaques, resulting in decreased viremia and melioration of the infection. These findings underscore an in vivo protective rather than a pathogenic role for combined TLR3/7/8-mediated activation in Dengue infection of rhesus macaques. Our study provides definitive proof-of-concept into the mechanism by which DENV evades immune recognition and activation in vivo.	[Sariol, Carlos A.; Martinez, Melween I.; Rivera, Francheska; Rodriguez, Idia Vanessa; Pantoja, Petraleigh; Kraiselburd, Edmundo N.] Univ Puerto Rico, Caribbean Primate Res Ctr, Unit Comparat Med, San Juan, PR 00936 USA; [Sariol, Carlos A.; Arana, Teresa; Anglero, Yesseinia I.; Kraiselburd, Edmundo N.] Univ Puerto Rico, Dept Microbiol & Med Zool, San Juan, PR 00936 USA; [Sariol, Carlos A.] Univ Puerto Rico, Dept Internal Med, San Juan, PR 00936 USA; [Abel, Kristina] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Giavedoni, Luis; Hodara, Vida] Texas Biomed Res Inst, Dept Virol, San Antonio, TX USA; [Giavedoni, Luis; Hodara, Vida] Texas Biomed Res Inst, Dept Immunol, San Antonio, TX USA; [White, Laura J.] Univ N Carolina, Carolina Vaccine Inst, Chapel Hill, NC USA; [Montaner, Luis J.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	University of Puerto Rico; University of Puerto Rico Mayaguez; University of Puerto Rico; University of Puerto Rico; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Texas Biomedical Research Institute; Texas Biomedical Research Institute; University of North Carolina; University of North Carolina Chapel Hill; The Wistar Institute	Sariol, CA (corresponding author), Univ Puerto Rico, Caribbean Primate Res Ctr, Unit Comparat Med, Med Sci Campus, San Juan, PR 00936 USA.	carlos.sariol1@upr.edu	De Paris, Kristina/H-8174-2019; Sariol, Carlos A./W-6360-2019	De Paris, Kristina/0000-0001-5199-3004; Sariol, Carlos A./0000-0001-7535-4303	Northeast Biodefense Center [NBC-Lipkin AI57158]; NIH [U42 RR16021, U24 RR18108, UO1 1A1078060-01]; University of Puerto Rico Medical Sciences Campus [G12RR03051]; The Philadelphia Foundation; Commonwealth of Pennsylvania; Commonwealth Universal Research Enhancement Program; Pennsylvania Department of Health; Cancer Center [P30 CA10815]; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR016021, G12RR003051, U24RR018108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER	Northeast Biodefense Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Puerto Rico Medical Sciences Campus; The Philadelphia Foundation; Commonwealth of Pennsylvania; Commonwealth Universal Research Enhancement Program; Pennsylvania Department of Health; Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by a Northeast Biodefense Center Developmental grant (NBC-Lipkin AI57158) to C.A.S. (www.nbc.columbia.edu/) and partially by NIH grants U42 RR16021 and U24 RR18108 (http://cprc.rcm.upr.edu/) and the RCMI Program, University of Puerto Rico Medical Sciences Campus (G12RR03051)(http://rcmi.rcm.upr.edu/). L.J.W. was funded by NIH Grant (UO1 1A1078060-01), L.J.M. was funded by The Philadelphia Foundation (Robert I. Jacobs Fund), The Stengel-Miller family, AIDS funds from the Commonwealth of Pennsylvania and by the Commonwealth Universal Research Enhancement Program, Pennsylvania Department of Health, as well as by a Cancer Center Grant (P30 CA10815). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel K, 2006, J VIROL, V80, P6357, DOI 10.1128/JVI.02240-05; Abel K, 2002, J VIROL, V76, P8433, DOI 10.1128/JVI.76.16.8433-8445.2002; Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08; Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949; Becerra A, 2009, J MED VIROL, V81, P1403, DOI 10.1002/jmv.21538; BRUGGEMANN M, 1987, J EXP MED, V166, P1351, DOI 10.1084/jem.166.5.1351; Chang TH, 2006, MICROBES INFECT, V8, P157, DOI 10.1016/j.micinf.2005.06.014; DANGL JL, 1988, EMBO J, V7, P1989, DOI 10.1002/j.1460-2075.1988.tb03037.x; de Kruif MD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000215; Dejnirattisai W, 2008, J IMMUNOL, V181, P5865, DOI 10.4049/jimmunol.181.9.5865; Fink J, 2006, REV MED VIROL, V16, P263, DOI 10.1002/rmv.507; Green S, 2006, CURR OPIN INFECT DIS, V19, P429, DOI 10.1097/01.qco.0000244047.31135.fa; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Guzman MG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000811; HILL DA, 1971, P SOC EXP BIOL MED, V136, P853, DOI 10.3181/00379727-136-35379; Hiscott J, 2006, ONCOGENE, V25, P6844, DOI 10.1038/sj.onc.1209941; Ho LJ, 2004, IMMUNOL INVEST, V33, P423, DOI 10.1081/IMM-200038680; Ho LJ, 2001, J IMMUNOL, V166, P1499, DOI 10.4049/jimmunol.166.3.1499; Hsieh MF, 2006, J IMMUNOL, V177, P1855, DOI 10.4049/jimmunol.177.3.1855; Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005; Jones M, 2005, J VIROL, V79, P5414, DOI 10.1128/JVI.79.9.5414-5420.2005; Koraka P, 2001, J CLIN MICROBIOL, V39, P4332, DOI 10.1128/JCM.39.12.4332-4338.2001; KURANE I, 1994, ARCH VIROL, P59; Kurane I, 1990, Southeast Asian J Trop Med Public Health, V21, P658; Lambeth CR, 2005, J CLIN MICROBIOL, V43, P3267, DOI 10.1128/JCM.43.7.3267-3272.2005; Libraty DH, 2001, J VIROL, V75, P3501, DOI 10.1128/JVI.75.8.3501-3508.2001; Liu NS, 2003, NAT IMMUNOL, V4, P687, DOI 10.1038/ni941; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Mehlhop E, 2002, J IMMUNOL METHODS, V260, P219, DOI 10.1016/S0022-1759(01)00544-0; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; Navarro-Sanchez E, 2005, ARCH MED RES, V36, P425, DOI 10.1016/j.arcmed.2005.04.007; Nightingale ZD, 2008, J LEUKOCYTE BIOL, V84, P1028, DOI 10.1189/jlb.0208105; Palmer DR, 2005, J VIROL, V79, P2432, DOI 10.1128/JVI.79.4.2432-2439.2005; Pasare C, 1998, J IMMUNOL, V160, P778; Pichyangkul S, 2003, J IMMUNOL, V171, P5571, DOI 10.4049/jimmunol.171.10.5571; Pinto LMO, 1999, MEM I OSWALDO CRUZ, V94, P387, DOI 10.1590/S0074-02761999000300019; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Rodriguez-Madoz JR, 2010, J VIROL, V84, P9760, DOI 10.1128/JVI.01051-10; Rodriguez-Madoz JR, 2010, J VIROL, V84, P4845, DOI 10.1128/JVI.02514-09; Rothman AL, 2004, J CLIN INVEST, V113, P946, DOI [10.1172/JCI200421512, 10.1172/JCI21512]; Rothwell SW, 1996, AM J TROP MED HYG, V54, P503, DOI 10.4269/ajtmh.1996.54.503; Ruprecht CR, 2006, EUR J IMMUNOL, V36, P810, DOI 10.1002/eji.200535744; Sariol CA, 2007, CLIN VACCINE IMMUNOL; Sariol CA, 2007, CLIN VACCINE IMMUNOL, V14, P756, DOI 10.1128/CVI.00052-07; Stahl-Hennig C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000373; STEPHEN EL, 1979, J INFECT DIS, V139, P267, DOI 10.1093/infdis/139.3.267; STEPHEN EL, 1977, J INFECT DIS, V136, P122, DOI 10.1093/infdis/136.1.122; Suharti C, 2003, EUR CYTOKINE NETW, V14, P172; Sun PF, 2006, J IMMUNOL, V177, P6497, DOI 10.4049/jimmunol.177.9.6497; Sun PF, 2009, VIROLOGY, V383, P207, DOI 10.1016/j.virol.2008.10.022; Taweechaisupapong Suwimol, 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P664; Tsai YT, 2009, CELL MICROBIOL, V11, P604, DOI 10.1111/j.1462-5822.2008.01277.x; Uematsu S, 2006, J MOL MED-JMM, V84, P712, DOI 10.1007/s00109-006-0084-y; VANDEUREN M, 1995, J INFECT DIS, V172, P433, DOI 10.1093/infdis/172.2.433; Wang JP, 2006, J IMMUNOL, V177, P7114, DOI 10.4049/jimmunol.177.10.7114; Wang YC, 2005, J VIROL, V79, P14355, DOI 10.1128/JVI.79.22.14355-14370.2005; Wille-Reece U, 2005, P NATL ACAD SCI USA, V102, P15190, DOI 10.1073/pnas.0507484102; Wille-Reece U, 2005, J IMMUNOL, V174, P7676, DOI 10.4049/jimmunol.174.12.7676; Wille-Reece U, 2006, J EXP MED, V203, P1249, DOI 10.1084/jem.20052433; Xu W, 2008, J IMMUNOL, V181, P276, DOI 10.4049/jimmunol.181.1.276	60	52	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19323	10.1371/journal.pone.0019323	http://dx.doi.org/10.1371/journal.pone.0019323			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559444	Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700134
J	Sordelli, MS; Beltrame, JS; Burdet, J; Zotta, E; Pardo, R; Cella, M; Franchi, AM; Ribeiro, ML				Sordelli, Micaela S.; Beltrame, Jimena S.; Burdet, Juliana; Zotta, Elsa; Pardo, Romina; Cella, Maximiliano; Franchi, Ana M.; Ribeiro, Maria Laura			The Effect of Anandamide on Uterine Nitric Oxide Synthase Activity Depends on the Presence of the Blastocyst	PLOS ONE			English	Article							CANNABINOID RECEPTOR; 1ST POTENT; SR 144528; EXPRESSION; IMPLANTATION; ANTAGONIST; PREGNANCY; SR141716A; UTERUS; EMBRYO	Nitric oxide production, catalyzed by nitric oxide synthase (NOS), should be strictly regulated to allow embryo implantation. Thus, our first aim was to study NOS activity during peri-implantation in the rat uterus. Day 6 inter-implantation sites showed lower NOS activity (0.19 +/- 0.01 pmoles L-citrulline mg prot(-1) h(-1)) compared to days 4 (0.34 +/- 0.03) and 5 (0.35 +/- 0.02) of pregnancy and to day 6 implantation sites (0.33 +/- 0.01). This regulation was not observed in pseudopregnancy. Both dormant and active blastocysts maintained NOS activity at similar levels. Anandamide (AEA), an endocannabinoid, binds to cannabinoid receptors type 1 (CB1) and type 2 (CB2), and high concentrations are toxic for implantation and embryo development. Previously, we observed that AEA synthesis presents an inverted pattern compared to NOS activity described here. We adopted a pharmacological approach using AEA, URB-597 (a selective inhibitor of fatty acid amide hydrolase, the enzyme that degrades AEA) and receptor selective antagonists to investigate the effect of AEA on uterine NOS activity in vitro in rat models of implantation. While AEA (0.70 +/- 0.02 vs 0.40 +/- 0.04) and URB-597 (1.08 +/- 0.09 vs 0.83 +/- 0.06) inhibited NOS activity in the absence of a blastocyst (pseudopregnancy) through CB2 receptors, AEA did not modulate NOS on day 5 pregnant uterus. Once implantation begins, URB-597 decreased NOS activity on day 6 implantation sites via CB1 receptors (0.25 +/- 0.04 vs 0.40 +/- 0.05). While a CB1 antagonist augmented NOS activity on day 6 inter-implantation sites (0.17 +/- 0.02 vs 0.27 +/- 0.02), a CB2 antagonist decreased it (0.17 +/- 0.02 vs 0.12 +/- 0.01). Finally, we described the expression and localization of cannabinoid receptors during implantation. In conclusion, AEA levels close to and at implantation sites seems to modulate NOS activity and thus nitric oxide production, fundamental for implantation, via cannabinoid receptors. This modulation depends on the presence of the blastocyst. These data establish cannabinoid receptors as an interesting target for the treatment of implantation deficiencies.	[Sordelli, Micaela S.; Beltrame, Jimena S.; Ribeiro, Maria Laura] CEFYBO CONICET UBA, Lab Fisiol & Farmacol Reprod, Buenos Aires, DF, Argentina; [Burdet, Juliana; Zotta, Elsa] UBA, Dept Fisiol, Lab Fisiopatogenia, Buenos Aires, DF, Argentina; [Pardo, Romina] UBA, Fac Farm & Bioquim, Dept Cs Biol, Lab Fisiopatol Mol,Catedra Fisiopatol, Buenos Aires, DF, Argentina; [Cella, Maximiliano; Franchi, Ana M.] CEFYBO CONICET UBA, Lab Fisiopatol Prenez & Parto, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Sordelli, MS (corresponding author), CEFYBO CONICET UBA, Lab Fisiol & Farmacol Reprod, Buenos Aires, DF, Argentina.	marialribeiro@yahoo.com.ar		zotta, elsa/0000-0002-8763-5046; Ribeiro, Maria Laura/0000-0002-3679-0193	Proyecto de Investigacion Plurianuales (PIP) [2204]; Proyectos de Investigacion Cientifica y Tecnologica (PICT) [34784]	Proyecto de Investigacion Plurianuales (PIP); Proyectos de Investigacion Cientifica y Tecnologica (PICT)(ANPCyT)	This work was supported by Proyecto de Investigacion Plurianuales (PIP) 2008 N<SUP>o</SUP>2204 to Dr. Ana Franchi and Proyectos de Investigacion Cientifica y Tecnologica (PICT) 2005 N<SUP>o</SUP>34784 to Dr. Maria Laura Ribeiro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; Buckley NE, 1998, NEUROSCIENCE, V82, P1131; Cella M, 2008, PLACENTA, V29, P699, DOI 10.1016/j.placenta.2008.05.003; Coutts AA, 2000, BRIT J PHARMACOL, V129, P645, DOI 10.1038/sj.bjp.0703094; DAS SK, 1995, P NATL ACAD SCI USA, V92, P4332, DOI 10.1073/pnas.92.10.4332; Demuth DG, 2006, LIFE SCI, V78, P549, DOI 10.1016/j.lfs.2005.05.055; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; EIM, 2006, HUM REPROD, V21, P1680, DOI 10.1093/humrep/del075; Farina M, 2001, REPRODUCTION, V121, P403, DOI 10.1530/rep.0.1210403; Fonseca BM, 2009, PLACENTA, V30, P686, DOI 10.1016/j.placenta.2009.05.012; Fonseca BM, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-121; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Guo Y, 2005, J BIOL CHEM, V280, P23429, DOI 10.1074/jbc.C500168200; Hall W, 1998, LANCET, V352, P1611, DOI 10.1016/S0140-6736(98)05021-1; Howlett AC, 2004, NEUROPHARMACOLOGY, V47, P345, DOI 10.1016/j.neuropharm.2004.07.030; Lahav M, 1989, J Reprod Fertil Suppl, V37, P233; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockwood CJ, 2000, LANCET, V355, P1292, DOI 10.1016/S0140-6736(00)02108-5; Maccarrone M, 2008, BRIT J PHARMACOL, V153, P189, DOI 10.1038/sj.bjp.0707444; Matias I, 2002, EUR J BIOCHEM, V269, P3771, DOI 10.1046/j.1432-1033.2002.03078.x; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Maul H, 2003, CURR PHARM DESIGN, V9, P359, DOI 10.2174/1381612033391784; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Novaro V, 2001, REPROD FERT DEVELOP, V13, P411, DOI 10.1071/RD01036; Novaro V, 1997, REPROD FERT DEVELOP, V9, P557, DOI 10.1071/R97005; Ota H, 1999, REPROD FERT DEVELOP, V11, P183, DOI 10.1071/RD99044; Paria BC, 1996, MOL REPROD DEV, V45, P183, DOI 10.1002/(SICI)1098-2795(199610)45:2&lt;183::AID-MRD11&gt;3.0.CO;2-2; Paria BC, 2001, J BIOL CHEM, V276, P20523, DOI 10.1074/jbc.M100679200; Piomelli D, 2004, NAT MED, V10, P19, DOI 10.1038/nm0104-19; Portier M, 1999, J PHARMACOL EXP THER, V288, P582; Purcell TL, 1999, MOL HUM REPROD, V5, P467, DOI 10.1093/molehr/5.5.467; Ribeiro ML, 2009, REPROD BIOMED ONLINE, V18, P209, DOI 10.1016/S1472-6483(10)60258-1; Rinaldi-Carmona M, 1998, J PHARMACOL EXP THER, V284, P644; RINALDICARMONA M, 1995, LIFE SCI, V56, P1941, DOI 10.1016/0024-3205(95)00174-5; Saxena D, 2000, NITRIC OXIDE-BIOL CH, V4, P384, DOI 10.1006/niox.2000.0286; Schuel H, 2002, CHEM PHYS LIPIDS, V121, P211, DOI 10.1016/S0009-3084(02)00158-5; Stefano George B, 2003, Med Sci Monit, V9, pRA63; Vercelli CA, 2009, REPROD BIOMED ONLINE, V18, P824, DOI 10.1016/S1472-6483(10)60033-8; Vercelli CA, 2009, PLACENTA, V30, P579, DOI 10.1016/j.placenta.2009.04.003; Wang HB, 2003, P NATL ACAD SCI USA, V100, P14914, DOI 10.1073/pnas.2436379100; Willoughby KA, 1997, J PHARMACOL EXP THER, V282, P243	43	15	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18368	10.1371/journal.pone.0018368	http://dx.doi.org/10.1371/journal.pone.0018368			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559512	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700011
J	Sun, YC; Koumoutsi, A; Jarrett, C; Lawrence, K; Gherardini, FC; Darby, C; Hinnebusch, BJ				Sun, Yi-Cheng; Koumoutsi, Alexandra; Jarrett, Clayton; Lawrence, Kevin; Gherardini, Frank C.; Darby, Creg; Hinnebusch, B. Joseph			Differential Control of Yersinia pestis Biofilm Formation In Vitro and in the Flea Vector by Two c-di-GMP Diguanylate Cyclases	PLOS ONE			English	Article							EARLY-PHASE TRANSMISSION; STORAGE HMS(+) PHENOTYPE; ESCHERICHIA-COLI; PIGMENTATION PHENOTYPE; CAENORHABDITIS-ELEGANS; CYCLIC DIGUANYLATE; PROTEIN DOMAIN; PLAGUE; PSEUDOTUBERCULOSIS; MECHANISM	Yersinia pestis forms a biofilm in the foregut of its flea vector that promotes transmission by flea bite. As in many bacteria, biofilm formation in Y. pestis is controlled by intracellular levels of the bacterial second messenger c-di-GMP. Two Y. pestis diguanylate cyclase (DGC) enzymes, encoded by hmsT and y3730, and one phosphodiesterase (PDE), encoded by hmsP, have been shown to control biofilm production in vitro via their opposing c-di-GMP synthesis and degradation activities, respectively. In this study, we provide further evidence that hmsT, hmsP, and y3730 are the only three genes involved in c-di-GMP metabolism in Y. pestis and evaluated the two DGCs for their comparative roles in biofilm formation in vitro and in the flea vector. As with HmsT, the DGC activity of Y3730 depended on a catalytic GGDEF domain, but the relative contribution of the two enzymes to the biofilm phenotype was influenced strongly by the environmental niche. Deletion of y3730 had a very minor effect on in vitro biofilm formation, but resulted in greatly reduced biofilm formation in the flea. In contrast, the predominant effect of hmsT was on in vitro biofilm formation. DGC activity was also required for the Hms-independent autoaggregation phenotype of Y. pestis, but was not required for virulence in a mouse model of bubonic plague. Our results confirm that only one PDE (HmsP) and two DGCs (HmsT and Y3730) control c-di-GMP levels in Y. pestis, indicate that hmsT and y3730 are regulated post-transcriptionally to differentially control biofilm formation in vitro and in the flea vector, and identify a second c-di-GMP-regulated phenotype in Y. pestis.	[Sun, Yi-Cheng; Jarrett, Clayton; Lawrence, Kevin; Gherardini, Frank C.; Hinnebusch, B. Joseph] NIAID, Lab Zoonot Pathogens, Rocky Mt Labs, NIH, Hamilton, MT USA; [Koumoutsi, Alexandra; Darby, Creg] Univ Calif San Francisco, Dept Cell & Tissue Biol, Program Microbial Pathogenesis, San Francisco, CA 94143 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California San Francisco	Sun, YC (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100037, Peoples R China.	sunyc@ipbcams.ac.cn		Koumoutsi, Alexandra/0000-0001-8368-4193	Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); NIH [AI057512]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000905, R56AI057512, ZIAAI000796, R01AI057512] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); and NIH Grant AI057512 (to C.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Appleman JA, 2003, J BACTERIOL, V185, P4872, DOI 10.1128/JB.185.16.4872-4882.2003; Aravind L, 1999, FEMS MICROBIOL LETT, V176, P111, DOI 10.1016/S0378-1097(99)00197-4; Bobrov AG, 2008, ENVIRON MICROBIOL, V10, P1419, DOI 10.1111/j.1462-2920.2007.01554.x; Bobrov AG, 2011, MOL MICROBIOL, V79, P533, DOI 10.1111/j.1365-2958.2010.07470.x; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; CHIANG SL, 1995, MOL MICROBIOL, V17, P1133, DOI 10.1111/j.1365-2958.1995.mmi_17061133.x; Cotter PA, 2007, CURR OPIN MICROBIOL, V10, P17, DOI 10.1016/j.mib.2006.12.006; Darby C, 2002, NATURE, V417, P243, DOI 10.1038/417243a; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; Eisen RJ, 2007, J MED ENTOMOL, V44, P678, DOI 10.1603/0022-2585(2007)44[678:ETOYPB]2.0.CO;2; Eisen RJ, 2006, P NATL ACAD SCI USA, V103, P15380, DOI 10.1073/pnas.0606831103; Eisen RJ, 2009, VET RES, V40, DOI 10.1051/vetres:2008039; Erickson DL, 2008, J BACTERIOL, V190, P8163, DOI 10.1128/JB.01181-08; Erickson DL, 2006, J BACTERIOL, V188, P1113, DOI 10.1128/JB.188.3.1113-1119.2006; Felek S, 2010, INFECT IMMUN, V78, P1163, DOI 10.1128/IAI.00997-09; FETHERSTON JD, 1992, MOL MICROBIOL, V6, P2693, DOI 10.1111/j.1365-2958.1992.tb01446.x; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x; Hare JM, 1999, J BACTERIOL, V181, P4896, DOI 10.1128/JB.181.16.4896-4904.1999; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hinnebusch BJ, 2008, CURR TOP MICROBIOL, V322, P229; Hinnebusch BJ, 1996, SCIENCE, V273, P367, DOI 10.1126/science.273.5273.367; Jarrett CO, 2004, J INFECT DIS, V190, P783, DOI 10.1086/422695; Jonas K, 2009, FUTURE MICROBIOL, V4, P341, DOI [10.2217/fmb.09.7, 10.2217/FMB.09.7]; Jones HA, 1999, MICROBIOL-SGM, V145, P2117, DOI 10.1099/13500872-145-8-2117; Joshua GWP, 2003, MICROBIOL-SGM, V149, P3221, DOI 10.1099/mic.0.26475-0; Kirillina O, 2004, MOL MICROBIOL, V54, P75, DOI 10.1111/j.1365-2958.2004.04253.x; Kolodziejek AM, 2007, MICROBIOL-SGM, V153, P2941, DOI 10.1099/mic.0.2006/005694-0; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; LI QX, 1990, J BIOL CHEM, V265, P4111; Perry RD, 2004, J BACTERIOL, V186, P1638, DOI 10.1128/JB.186.6.1638-1647.2004; Perry RD, 1998, INFECT IMMUN, V66, P4611, DOI 10.1128/IAI.66.10.4611-4623.1998; PERRY RD, 1990, J BACTERIOL, V172, P5929, DOI 10.1128/jb.172.10.5929-5937.1990; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P11766, DOI 10.1073/pnas.0601182103; Simm R, 2005, J BACTERIOL, V187, P6816, DOI 10.1128/JB.187.19.6816-6823.2005; Sun YC, 2008, P NATL ACAD SCI USA, V105, P8097, DOI 10.1073/pnas.0803525105; Sun YC, 2009, FEMS MICROBIOL LETT, V290, P85, DOI 10.1111/j.1574-6968.2008.01409.x; SURGALLA MJ, 1969, APPL MICROBIOL, V18, P834, DOI 10.1128/AEM.18.5.834-837.1969; Suzuki K, 2006, GENE DEV, V20, P2605, DOI 10.1101/gad.1461606; Thomson NR, 2006, PLOS GENET, V2, P2039, DOI 10.1371/journal.pgen.0020206; Ulett GC, 2007, INFECT IMMUN, V75, P3233, DOI 10.1128/IAI.01952-06; Vetter SM, 2010, MICROBIOL-SGM, V156, P2216, DOI 10.1099/mic.0.037952-0	47	58	64	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19267	10.1371/journal.pone.0019267	http://dx.doi.org/10.1371/journal.pone.0019267			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559445	Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700118
J	Tam, JKV; Lau, KW; Lee, LTO; Chu, JYS; Ng, KM; Fournier, A; Vaudry, H; Chow, BKC				Tam, Janice K. V.; Lau, Kwan-Wa; Lee, Leo T. O.; Chu, Jessica Y. S.; Ng, Kwong-Man; Fournier, Alain; Vaudry, Hubert; Chow, Billy K. C.			Origin of Secretin Receptor Precedes the Advent of Tetrapoda: Evidence on the Separated Origins of Secretin and Orexin	PLOS ONE			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; VASOACTIVE-INTESTINAL-PEPTIDE; PROTEIN-COUPLED RECEPTORS; MOLECULAR-CLONING; NEUROPEPTIDE-Y; EXPRESSION; CDNA; MECHANISMS; HORMONE; BINDING	At present, secretin and its receptor have only been identified in mammals, and the origin of this ligand-receptor pair in early vertebrates is unclear. In addition, the elusive similarities of secretin and orexin in terms of both structures and functions suggest a common ancestral origin early in the vertebrate lineage. In this article, with the cloning and functional characterization of secretin receptors from lungfish and X. laevis as well as frog (X. laevis and Rana rugulosa) secretins, we provide evidence that the secretin ligand-receptor pair has already diverged and become highly specific by the emergence of tetrapods. The secretin receptor-like sequence cloned from lungfish indicates that the secretin receptor was descended from a VPAC-like receptor prior the advent of sarcopterygians. To clarify the controversial relationship of secretin and orexin, orexin type-2 receptor was cloned from X. laevis. We demonstrated that, in frog, secretin and orexin could activate their mutual receptors, indicating their coordinated complementary role in mediating physiological processes in non-mammalian vertebrates. However, among the peptides in the secretin/glucagon superfamily, secretin was found to be the only peptide that could activate the orexin receptor. We therefore hypothesize that secretin and orexin are of different ancestral origins early in the vertebrate lineage.	[Tam, Janice K. V.; Lau, Kwan-Wa; Lee, Leo T. O.; Chu, Jessica Y. S.; Chow, Billy K. C.] Univ Hong Kong, Sch Biol Sci, Res Ctr Heart Brain Hormone & Healthy Ageing, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China; [Ng, Kwong-Man] Univ Hong Kong, Stem Cell & Regenerat Med Program, Res Ctr Heart Brain Hormone & Healthy Ageing, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China; [Fournier, Alain] Univ Quebec, INRS Inst Armand Frappier, Laval, PQ, Canada; [Vaudry, Hubert] Univ Rouen, INSERM, U982, European Inst Peptide Res, Mont St Aignan, France	University of Hong Kong; University of Hong Kong; University of Quebec; Institut national de la recherche scientifique (INRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie	Tam, JKV (corresponding author), Univ Hong Kong, Sch Biol Sci, Res Ctr Heart Brain Hormone & Healthy Ageing, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China.	bkcc@hkusua.hku.hk	Lee, Leo T.O./AAB-1581-2021; Chow, Billy/D-3064-2009	Chow, Billy/0000-0003-3390-0307	Hong Kong Government RGC [7639/07M, 7696/09M]; Committee on Research and Conference [10208128]	Hong Kong Government RGC; Committee on Research and Conference	The present study was supported by the Hong Kong Government RGC grants 7639/07M to Billy K. C. Chow, 7696/09M to Leo T. O. Lee and the Committee on Research and Conference Grants 10208128 to Leo T. O. Lee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Alvarez CE, 2002, NEUROSCI LETT, V324, P169, DOI 10.1016/S0304-3940(02)00195-7; Bailes HJ, 2007, VISUAL NEUROSCI, V24, P377, DOI 10.1017/S0952523807070381; Bayliss WM, 1902, J PHYSIOL-LONDON, V28, P325; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Bulbul M, 2010, PEPTIDES, V31, P1099, DOI 10.1016/j.peptides.2010.03.007; CAMPBELL RM, 1992, GROWTH REGULAT, V2, P175; Cardoso JCR, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-108; Cardoso JCR, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-135; Castoe TA, 2009, P NATL ACAD SCI USA, V106, P8986, DOI 10.1073/pnas.0900233106; Chan KYY, 2001, ENDOCRINOLOGY, V142, P3926, DOI 10.1210/en.142.9.3926; Cheng CYY, 2009, J MOL ENDOCRINOL, V43, P81, DOI 10.1677/JME-08-0123; CHOW BKC, 1995, BIOCHEM BIOPH RES CO, V212, P204, DOI 10.1006/bbrc.1995.1957; Chu JSC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-130; Chu JYS, 2009, P NATL ACAD SCI USA, V106, P15961, DOI 10.1073/pnas.0903695106; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Feillet CA, 2010, J NEUROENDOCRINOL, V22, P620, DOI 10.1111/j.1365-2826.2010.01998.x; Flemstrom G, 2010, ACTA PHYSIOL, V198, P373, DOI 10.1111/j.1748-1716.2009.02067.x; Fradinger EA, 2005, MOL CELL ENDOCRINOL, V231, P49, DOI 10.1016/j.mce.2004.12.002; Galas L, 2001, J COMP NEUROL, V429, P242, DOI 10.1002/1096-9861(20000108)429:2<242::AID-CNE5>3.0.CO;2-Z; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Graham JB, 2004, PHYSIOL BIOCHEM ZOOL, V77, P720, DOI 10.1086/425184; Harmar AJ, 2001, GENOME BIOL, V2; Heinonen MV, 2008, ACTA PHYSIOL, V192, P471, DOI 10.1111/j.1748-1716.2008.01836.x; Holmqvist T, 2001, NEUROSCI LETT, V305, P177, DOI 10.1016/S0304-3940(01)01839-0; Hoo RLC, 2001, J MOL ENDOCRINOL, V27, P229, DOI 10.1677/jme.0.0270229; ISHIHARA T, 1991, EMBO J, V10, P1635, DOI 10.1002/j.1460-2075.1991.tb07686.x; JIANG SP, 1995, BIOCHEM BIOPH RES CO, V207, P883, DOI 10.1006/bbrc.1995.1268; Kane JK, 2000, BIOCHEM BIOPH RES CO, V272, P959, DOI 10.1006/bbrc.2000.2880; Laburthe M, 2002, RECEPTOR CHANNEL, V8, P137, DOI 10.1080/10606820290005191; Le Meuth-Metzinger V, 2005, PANCREAS, V31, P174, DOI 10.1097/01.mpa.0000174938.89815.e9; Massey SE, 2008, GENE, V418, P22, DOI 10.1016/j.gene.2008.03.017; Miller LJ, 2007, BIOCHEM SOC T, V35, P709, DOI 10.1042/BST0350709; Ng SSM, 2002, MOL NEUROBIOL, V26, P97, DOI 10.1385/MN:26:1:097; NILSSON A, 1980, EUR J BIOCHEM, V112, P383, DOI 10.1111/j.1432-1033.1980.tb07216.x; Ohkubo T, 2003, J MOL ENDOCRINOL, V31, P499, DOI 10.1677/jme.0.0310499; Ohkubo T, 2002, BBA-GENE STRUCT EXPR, V1577, P476, DOI 10.1016/S0167-4781(02)00483-9; Panula P, 2010, ACTA PHYSIOL, V198, P381, DOI 10.1111/j.1748-1716.2009.02038.x; PATEL DR, 1995, MOL PHARMACOL, V47, P467; Perret J, 2002, BIOCHEM J, V362, P389, DOI 10.1042/0264-6021:3620389; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; San Mauro D, 2010, MOL PHYLOGENET EVOL, V56, P554, DOI 10.1016/j.ympev.2010.04.019; SEGRE GV, 1993, TRENDS ENDOCRIN MET, V4, P309, DOI 10.1016/1043-2760(93)90071-L; Silva JP, 2009, NATURE, V462, P646, DOI 10.1038/nature08589; Siu FKY, 2006, REGUL PEPTIDES, V137, P95, DOI 10.1016/j.regpep.2006.02.011; Smart D, 2001, BRIT J PHARMACOL, V132, P1179, DOI 10.1038/sj.bjp.0703953; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Sutcliffe J G, 1999, Results Probl Cell Differ, V26, P239; Svoboda M, 1998, PEPTIDES, V19, P1055, DOI 10.1016/S0196-9781(98)00040-0; Szlachcic A, 2010, CURR PHARM DESIGN, V16, P1214, DOI 10.2174/138161210790945940; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tomasik PJ, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-92; Tse DLY, 2002, ENDOCRINOLOGY, V143, P1327, DOI 10.1210/en.143.4.1327; Tsujino N, 2009, PHARMACOL REV, V61, P162, DOI 10.1124/pr.109.001321; Ulrich CD, 1998, GASTROENTEROLOGY, V114, P382, DOI 10.1016/S0016-5085(98)70491-3; VanRampelbergh J, 1996, MOL PHARMACOL, V50, P1596; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Vaudry D, 2000, PHARMACOL REV, V52, P269; Zardoya R, 1996, P NATL ACAD SCI USA, V93, P13036, DOI 10.1073/pnas.93.23.13036	59	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19384	10.1371/journal.pone.0019384	http://dx.doi.org/10.1371/journal.pone.0019384			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559418	Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700153
J	Tseng, CH; Murray, KD; Jou, MF; Hsu, SM; Cheng, HJ; Huang, PH				Tseng, Chun-Hsien; Murray, Karl D.; Jou, Mu-Fan; Hsu, Su-Ming; Cheng, Hwai-Jong; Huang, Pei-Hsin			Sema3E/Plexin-D1 Mediated Epithelial-to-Mesenchymal Transition in Ovarian Endometrioid Cancer	PLOS ONE			English	Article							SEMAPHORIN 3E; SURFACE EPITHELIUM; GENE-EXPRESSION; E-CADHERIN; CELLS; SNAIL; GROWTH; IDENTIFICATION; METASTASIS; ACTIVATION	Cancer cells often employ developmental cues for advantageous growth and metastasis. Here, we report that an axon guidance molecule, Sema3E, is highly expressed in human high-grade ovarian endometrioid carcinoma, but not low-grade or other ovarian epithelial tumors, and facilitates tumor progression. Unlike its known angiogenic activity, Sema3E acted through Plexin-D1 receptors to augment cell migratory ability and concomitant epithelial-to-mesenchymal transition (EMT). Sema3E-induced EMT in ovarian endometrioid cancer cells was dependent on nuclear localization of Snail1 through activation of phosphatidylinositol-3-kinase and ERK/MAPK. RNAi-mediated knockdown of Sema3E, Plexin-D1 or Snail1 in Sema3E-expressing tumor cells resulted in compromised cell motility, concurrent reversion of EMT and diminished nuclear localization of Snail1. By contrast, forced retention of Snail1 within the nucleus of Sema3E-negative tumor cells induced EMT and enhanced cell motility. These results show that in addition to the angiogenic effects of Sema3E on tumor vascular endothelium, an EMT strategy could be exploited by Sema3E/Plexin-D1 signaling in tumor cells to promote cellular invasion/migration.	[Tseng, Chun-Hsien; Jou, Mu-Fan; Hsu, Su-Ming; Huang, Pei-Hsin] Natl Taiwan Univ, Grad Inst Pathol, Coll Med, Taipei 10764, Taiwan; [Murray, Karl D.; Cheng, Hwai-Jong] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Hsu, Su-Ming; Huang, Pei-Hsin] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan	National Taiwan University; University of California System; University of California Davis; National Taiwan University; National Taiwan University Hospital	Tseng, CH (corresponding author), Natl Taiwan Univ, Grad Inst Pathol, Coll Med, Taipei 10764, Taiwan.	hjcheng@ucdavis.edu; phhuang@ntu.edu.tw	Cheng, Hwai-Jong/AAY-5067-2021	Cheng, Hwai-Jong/0000-0003-0647-0567; HUANG, PEI-HSIN/0000-0002-2414-1487	National Taiwan University Hospital [NTUH98-P26-2, NTUH99-P21]	National Taiwan University Hospital(National Taiwan University)	This work was supported by a fund from National Taiwan University Hospital (NTUH98-P26-2 and NTUH99-P21) granted to P-H Huang. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 1997, EMBO J, V16, P6077, DOI 10.1093/emboj/16.20.6077; Ahmed N, 2007, J CELL PHYSIOL, V213, P581, DOI 10.1002/jcp.21240; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Basile JR, 2006, P NATL ACAD SCI USA, V103, P9017, DOI 10.1073/pnas.0508825103; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bellon A, 2010, NEURON, V66, P205, DOI 10.1016/j.neuron.2010.04.006; Berndt JD, 2006, DEVELOPMENT, V133, P3983, DOI 10.1242/dev.02583; Blanc V, 2010, PROSTATE        1014; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Capparuccia L, 2009, J CELL SCI, V122, P1723, DOI 10.1242/jcs.030197; Casazza A, 2010, J CLIN INVEST, V120, P2684, DOI 10.1172/JCI42118; Chauvet S, 2007, NEURON, V56, P807, DOI 10.1016/j.neuron.2007.10.019; Chedotal A, 2007, PROG EXP TUMOR RES, V39, P78, DOI 10.1159/000100048; Choi YI, 2008, IMMUNITY, V29, P888, DOI 10.1016/j.immuni.2008.10.008; Christensen C, 2005, CANCER RES, V65, P6167, DOI 10.1158/0008-5472.CAN-04-4309; Chung L, 2007, DEVELOPMENT, V134, P2935, DOI 10.1242/dev.005066; De Craene B, 2005, CELL SIGNAL, V17, P535, DOI 10.1016/j.cellsig.2004.10.011; Derijck AAHA, 2010, TRENDS CELL BIOL, V20, P568, DOI 10.1016/j.tcb.2010.06.007; Dominguez D, 2003, MOL CELL BIOL, V23, P5078, DOI 10.1128/MCB.23.14.5078-5089.2003; Giordano S, 2002, NAT CELL BIOL, V4, P720, DOI 10.1038/ncb843; Gitler AD, 2004, DEV CELL, V7, P107, DOI 10.1016/j.devcel.2004.06.002; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Martin-Satue M, 1999, J SURG ONCOL, V72, P18; Murray MJ, 1999, SEMIN REPROD ENDOCR, V17, P275, DOI 10.1055/s-2007-1016235; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Park SH, 2008, MOL ENDOCRINOL, V22, P2085, DOI 10.1210/me.2007-0512; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; Pecho-Vrieseling E, 2009, NATURE, V459, P842, DOI 10.1038/nature08000; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; Roodink I, 2008, AM J PATHOL, V173, P1873, DOI 10.2353/ajpath.2008.080136; Rosano L, 2005, CANCER RES, V65, P11649, DOI 10.1158/0008-5472.CAN-05-2123; Roth L, 2009, CELL MOL LIFE SCI, V66, P649, DOI 10.1007/s00018-008-8518-z; RUSSELL P, 1994, BLAUSTEINS PATHOLOGY, P705; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Shook D, 2003, MECH DEVELOP, V120, P1351, DOI 10.1016/j.mod.2003.06.005; Swiercz JM, 2004, J CELL BIOL, V165, P869, DOI 10.1083/jcb.200312094; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Theriault BL, 2007, CARCINOGENESIS, V28, P1153, DOI 10.1093/carcin/bgm015; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Torng PL, 2008, ONCOGENE, V27, P2137, DOI 10.1038/sj.onc.1210864; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Waimey KE, 2006, NEUROSCIENTIST, V12, P398, DOI 10.1177/1073858406292631; Xiang RH, 2002, CANCER RES, V62, P2637; Yamada T, 1997, P NATL ACAD SCI USA, V94, P14713, DOI 10.1073/pnas.94.26.14713; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zhou YP, 2008, TRENDS BIOCHEM SCI, V33, P161, DOI 10.1016/j.tibs.2008.01.006	51	47	48	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19396	10.1371/journal.pone.0019396	http://dx.doi.org/10.1371/journal.pone.0019396			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559368	Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700157
J	Vintermist, A; Bohm, S; Sadeghifar, F; Louvet, E; Mansen, A; Percipalle, P; Farrants, AKO				Vintermist, Anna; Bohm, Stefanie; Sadeghifar, Fatemeh; Louvet, Emilie; Mansen, Anethe; Percipalle, Pergiorgio; Farrants, Ann-Kristin Ostlund			The Chromatin Remodelling Complex B-WICH Changes the Chromatin Structure and Recruits Histone Acetyl-Transferases to Active rRNA Genes	PLOS ONE			English	Article							POLYMERASE-I TRANSCRIPTION; REPLICATION FOCI; EPIGENETIC STATE; CELL-CYCLE; MYOSIN-I; NORC; DNA; BINDING; INTERACTS; RDNA	The chromatin remodelling complex B-WICH, which comprises the William syndrome transcription factor (WSTF), SNF2h, and nuclear myosin 1 (NM1), is involved in regulating rDNA transcription, and SiRNA silencing of WSTF leads to a reduced level of 45S pre-rRNA. The mechanism behind the action of B-WICH is unclear. Here, we show that the B-WICH complex affects the chromatin structure and that silencing of the WSTF protein results in a compaction of the chromatin structure over a 200 basepair region at the rRNA promoter. WSTF knock down does not show an effect on the binding of the rRNA-specific enhancer and chromatin protein UBF, which contributes to the chromatin structure at active genes. Instead, WSTF knock down results in a reduced level of acetylated H3-Ac, in particular H3K9-Ac, at the promoter and along the gene. The association of the histone acetyl-transferases PCAF, p300 and GCN5 with the promoter is reduced in WSTF knock down cells, whereas the association of the histone acetyl-transferase MOF is retained. A low level of H3-Ac was also found in growing cells, but here histone acetyl-transferases were present at the rDNA promoter. We propose that the B-WICH complex remodels the chromatin structure at actively transcribed rRNA genes, and this allows for the association of specific histone acetyl-transferases.	[Vintermist, Anna; Bohm, Stefanie; Sadeghifar, Fatemeh; Mansen, Anethe; Farrants, Ann-Kristin Ostlund] Stockholm Univ, Dept Cell Biol, Wenner Gren Inst, S-10691 Stockholm, Sweden; [Louvet, Emilie; Percipalle, Pergiorgio] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden	Stockholm University; Karolinska Institutet	Vintermist, A (corresponding author), Stockholm Univ, Dept Cell Biol, Wenner Gren Inst, S-10691 Stockholm, Sweden.	anki.ostlund@cellbio.su.se			Cancer Foundation [090520]; Swedish Research Council; Magnus Bergvall Foundation; Fondation pour la Recherche Medicale (FRM); Wenner-Gren Foundation	Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Magnus Bergvall Foundation; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Wenner-Gren Foundation	Funding was provided by the Cancer Foundation (090520), Swedish Research Council, Magnus Bergvall Foundation, Fondation pour la Recherche Medicale (FRM) and Wenner-Gren Foundation. The funders had no role in study desogn, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMOUZNI G, 1994, DEV BIOL, V165, P654, DOI 10.1006/dbio.1994.1283; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Birch JL, 2008, BIOCHEM SOC T, V36, P619, DOI 10.1042/BST0360619; Birch JL, 2009, EMBO J, V28, P854, DOI 10.1038/emboj.2009.33; Bozhenok L, 2002, EMBO J, V21, P2231, DOI 10.1093/emboj/21.9.2231; Bradsher J, 2002, MOL CELL, V10, P819, DOI 10.1016/S1097-2765(02)00678-0; Brown SE, 2008, CELL CYCLE, V7, P382, DOI 10.4161/cc.7.3.5283; Brown SE, 2007, MOL CELL BIOL, V27, P4938, DOI 10.1128/MCB.01880-06; Cavellan E, 2006, J BIOL CHEM, V281, P16264, DOI 10.1074/jbc.M600233200; Chen DY, 2004, P NATL ACAD SCI USA, V101, P15106, DOI 10.1073/pnas.0404767101; CONCONI A, 1989, CELL, V57, P753, DOI 10.1016/0092-8674(89)90790-3; Fazzio TG, 2003, MOL CELL, V12, P1333, DOI 10.1016/S1097-2765(03)00436-2; Felle M, 2010, NUCLEIC ACIDS RES, V38, P5304, DOI 10.1093/nar/gkq263; Feng WJ, 2010, NAT STRUCT MOL BIOL, V17, P445, DOI 10.1038/nsmb.1778; Fomproix N, 2004, EXP CELL RES, V294, P140, DOI 10.1016/j.yexcr.2003.10.028; Fujiki R, 2005, EMBO J, V24, P3881, DOI 10.1038/sj.emboj.7600853; Gagnon-Kugler T, 2009, MOL CELL, V35, P414, DOI 10.1016/j.molcel.2009.07.008; Gorski SA, 2008, MOL CELL, V30, P486, DOI 10.1016/j.molcel.2008.04.021; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grummt I, 2007, HUM MOL GENET, V16, pR21, DOI 10.1093/hmg/ddm020; Hannan KM, 1998, AM J PHYSIOL-CELL PH, V275, pC130, DOI 10.1152/ajpcell.1998.275.1.C130; Hodawadekar SC, 2007, ONCOGENE, V26, P5528, DOI 10.1038/sj.onc.1210619; Jones HS, 2007, NAT STRUCT MOL BIOL, V14, P123, DOI 10.1038/nsmb1199; Jones MH, 2000, GENOMICS, V63, P40, DOI 10.1006/geno.1999.6071; Kitagawa H, 2003, CELL, V113, P905, DOI 10.1016/S0092-8674(03)00436-7; Lebedev A, 2008, J MOL BIOL, V382, P266, DOI 10.1016/j.jmb.2008.07.018; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Li XZ, 2009, MOL CELL, V36, P290, DOI 10.1016/j.molcel.2009.07.031; Mais C, 2005, GENE DEV, V19, P50, DOI 10.1101/gad.310705; Mayer C, 2005, GENE DEV, V19, P933, DOI 10.1101/gad.333205; Mayer C, 2008, EMBO REP, V9, P774, DOI 10.1038/embor.2008.109; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Merz K, 2008, GENE DEV, V22, P1190, DOI 10.1101/gad.466908; Moss T, 2004, CURR OPIN GENET DEV, V14, P210, DOI 10.1016/j.gde.2004.02.005; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; Nemeth A, 2004, NUCLEIC ACIDS RES, V32, P4091, DOI 10.1093/nar/gkh732; O'Sullivan AC, 2002, MOL CELL BIOL, V22, P657, DOI 10.1128/MCB.22.2.657-668.2002; Oya H, 2009, J BIOL CHEM, V284, P32472, DOI 10.1074/jbc.M109.009738; Percipalle P, 2006, EMBO REP, V7, P525, DOI 10.1038/sj.embor.7400657; Percipalle P, 2006, CURR OPIN CELL BIOL, V18, P267, DOI 10.1016/j.ceb.2006.03.001; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Philimonenko VV, 2004, NAT CELL BIOL, V6, P1165, DOI 10.1038/ncb1190; Pober BR, 2010, NEW ENGL J MED, V362, P239, DOI 10.1056/NEJMra0903074; Poot RA, 2004, NAT CELL BIOL, V6, P1236, DOI 10.1038/ncb1196; Rouquette J, 2005, EMBO J, V24, P2862, DOI 10.1038/sj.emboj.7600752; Russell J, 2005, TRENDS BIOCHEM SCI, V30, P87, DOI 10.1016/j.tibs.2004.12.008; Ryme J, 2009, J CELL BIOCHEM, V108, P565, DOI 10.1002/jcb.22288; Sanij E, 2009, EPIGENETICS-US, V4, P274, DOI 10.4161/epi.4.6.9449; Sanij E, 2008, J CELL BIOL, V183, P1259, DOI 10.1083/jcb.200805146; Santoro R, 2002, NAT GENET, V32, P393, DOI 10.1038/ng1010; Santoro R, 2005, MOL CELL BIOL, V25, P2539, DOI 10.1128/MCB.25.7.2539-2546.2005; Stefanovsky V, 2006, CELL CYCLE, V5, P735, DOI 10.4161/cc.5.7.2633; Takahashi Y, 2000, GENE DEV, V14, P804; van de Nobelen S, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-19; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xiao A, 2009, NATURE, V457, P57, DOI 10.1038/nature07668; Ye J, 2008, GENE DEV, V22, P322, DOI 10.1101/gad.455908; Young DW, 2007, NATURE, V445, P442, DOI 10.1038/nature05473; Yuan XJ, 2007, MOL CELL, V27, P585, DOI 10.1016/j.molcel.2007.06.021; Zhou YG, 2005, CURR BIOL, V15, P1434, DOI 10.1016/j.cub.2005.06.057; Zhou YG, 2002, EMBO J, V21, P4632, DOI 10.1093/emboj/cdf460; Zhou YG, 2009, NAT CELL BIOL, V11, P1010, DOI 10.1038/ncb1914	63	40	42	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19184	10.1371/journal.pone.0019184	http://dx.doi.org/10.1371/journal.pone.0019184			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559432	Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700094
J	Yang, QL; Zhang, D; Leng, M; Yang, L; Zhong, LW; Cooke, HJ; Shi, QH				Yang, Qingling; Zhang, Ding; Leng, Mei; Yang, Ling; Zhong, Liangwen; Cooke, Howard J.; Shi, Qinghua			Synapsis and Meiotic Recombination in Male Chinese Muntjac (Muntiacus reevesi)	PLOS ONE			English	Article							SYNAPTONEMAL COMPLEXES; INDIAN MUNTJAC; CROSSING-OVER; MOUSE; MLH1; EVOLUTION; CHROMOSOMES; PACHYTENE; FUSIONS; NUMBER	The muntjacs (Muntiacus, Cervidae) have been extensively studied in terms of chromosomal and karyotypic evolution. However, little is known about their meiotic chromosomes particularly the recombination patterns of homologous chromosomes. We used immunostained surface spreads to visualise synaptonemal complexes (SCs), recombination foci and kinetochores with antibodies against marker proteins. As in other mammals pachytene was the longest stage of meiotic prophase. 39.4% of XY bivalents lacked MLH1 foci compared to less than 0.5% of autosomes. The average number of MLH1 foci per pachytene cell in M. reevesi was 29.8. The distribution of MLH1 foci differed from other mammals. On SCs with one focus, the distribution was more even in M. reevesi than in other mammals; for SCs that have two or more MLH1 foci, usually there was a larger peak in the sub-centromere region than other regions on SC in M. reevesi. Additionally, there was a lower level of interference between foci in M. reevesi than in mouse or human. These observations may suggest that the regulation of homologous recombination in M. reevesi is slightly different from other mammals and will improve our understanding of the regulation of meiotic recombination, with respect to recombination frequency and position.	[Yang, Qingling; Zhang, Ding; Leng, Mei; Yang, Ling; Zhong, Liangwen; Shi, Qinghua] Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Zhang, Ding] Bengbu Med Collage, Dept Biol Sci, Bengbu, Peoples R China; [Cooke, Howard J.] Western Gen Hosp, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Cooke, Howard J.] Western Gen Hosp, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Bengbu Medical College; University of Edinburgh; University of Edinburgh	Yang, QL (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China.	qshi@ustc.edu.cn	Shi, Qinghua/N-2950-2013		National Basic Research Program China (973) [2006CB504003, 2007CB947401]; Chinese Academy of Sciences [KSCX1-YW-R-51]	National Basic Research Program China (973)(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Basic Research Program (2006CB504003, 2007CB947401) of China (973) and the Program of Knowledge Innovation (KSCX1-YW-R-51) of Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LK, 1999, GENETICS, V151, P1569; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Barlow AL, 1998, EUR J HUM GENET, V6, P350, DOI 10.1038/sj.ejhg.5200200; Basheva EA, 2008, CHROMOSOME RES, V16, P709, DOI 10.1007/s10577-008-1221-y; Borodin PM, 2008, GENETICS, V178, P621, DOI 10.1534/genetics.107.079665; Brown PW, 2005, AM J HUM GENET, V77, P556, DOI 10.1086/468188; Chi JX, 2005, CHROMOSOMA, V114, P167, DOI 10.1007/s00412-005-0004-x; Choo KHA, 1998, GENOME RES, V8, P81, DOI 10.1101/gr.8.2.81; Codina-Pascual M, 2005, HUM REPROD, V20, P2133, DOI 10.1093/humrep/dei023; Coop G, 2007, NAT REV GENET, V8, P23, DOI 10.1038/nrg1947; de Villena FPM, 2001, MAMM GENOME, V12, P318, DOI 10.1007/s003350020005; Falque M, 2007, GENETICS, V176, P1453, DOI 10.1534/genetics.106.070235; Froenicke L, 2002, AM J HUM GENET, V71, P1353, DOI 10.1086/344714; Fronicke L, 1997, CYTOGENET CELL GENET, V77, P223, DOI 10.1159/000134581; Gonsalves J, 2004, HUM MOL GENET, V13, P2875, DOI 10.1093/hmg/ddh302; Hassold T, 2000, HUM MOL GENET, V9, P2409, DOI 10.1093/hmg/9.16.2409; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hassold T, 2004, CYTOGENET GENOME RES, V107, P249, DOI 10.1159/000080602; Huang L, 2006, CHROMOSOME RES, V14, P637, DOI 10.1007/s10577-006-1073-2; Jensen-Seaman MI, 2004, GENOME RES, V14, P528, DOI 10.1101/gr.1970304; Li J, 2009, FERTIL STERIL, V4, p1293e17; LIMING S, 1980, CYTOGENET CELL GENET, V26, P22, DOI 10.1159/000131417; Lynn A, 2002, SCIENCE, V296, P2222, DOI 10.1126/science.1071220; Ma K, 1988, Yi Chuan Xue Bao, V15, P282; Murmann AE, 2008, GENETICA, V134, P345, DOI 10.1007/s10709-008-9242-1; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Pigozzi MI, 2001, CYTOGENET CELL GENET, V95, P129, DOI 10.1159/000059334; Rubtsov N. B., 2007, CELL TISSUE BIOL, V1, P503; Scherthan H, 1996, J CELL BIOL, V134, P1109, DOI 10.1083/jcb.134.5.1109; Shi Q, 2000, CYTOGENET CELL GENET, V90, P219, DOI 10.1159/000056773; Sun F, 2004, HUM REPROD, V19, P1770, DOI 10.1093/humrep/deh335; Sun F, 2004, AM J HUM GENET, V74, P521, DOI 10.1086/382138; Sun F, 2006, HUM REPROD, V21, P2335, DOI 10.1093/humrep/del190; Yang F, 1997, CHROMOSOMA, V106, P37, DOI 10.1007/s004120050222; YANG F, 1995, CHROMOSOMA, V103, P642, DOI 10.1007/BF00357691; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	36	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19255	10.1371/journal.pone.0019255	http://dx.doi.org/10.1371/journal.pone.0019255			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559438	Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700113
J	Yuan, TC; Wang, YP; Pao, L; Anderson, SM; Gu, HH				Yuan, Taichang; Wang, Yongping; Pao, Lily; Anderson, Steve M.; Gu, Haihua			Lactation Defect in a Widely Used MMTV-Cre Transgenic Line of Mice	PLOS ONE			English	Article							MOUSE MAMMARY EPITHELIUM; SIGNALING PATHWAY; GLAND INVOLUTION; CELL-DEVELOPMENT; TUMOR-FORMATION; RECEPTOR-ALPHA; EXPRESSION; GENE; PREGNANCY; STAT3	Background: MMTV-Cre mouse lines have played important roles in our understanding about the functions of numerous genes in mouse mammary epithelial cells during mammary gland development and tumorigenesis. However, numerous studies have not included MMTV-Cre mice as controls, and many investigators have not indicated which of the different MMTV-Cre founder lines were used in their studies. Here, we describe a lactation defect that severely limits the use of one of the most commonly used MMTV-Cre founder lines. Methodology/Principal Findings: To explore the role of protein tyrosine phosphatase Shp1 in mammary gland development, mice bearing the floxed Shp1 gene were crossed with MMTV-Cre mice and mammary gland development was examined by histological and biochemical techniques, while lactation competency was assessed by monitoring pup growth. Surprisingly, both the Shp1fl/+; MMTV-Cre and MMTV-Cre female mice displayed a severe lactation defect when compared to the Shp1 fl/+ control mice. Histological and biochemical analyses reveal that female mice expressing the MMTV-Cre transgene, either alone or in combination with floxed genes, exhibit defects in lobuloalveolar expansion, presence of large cytoplasmic lipid droplets in luminal alveolar epithelial cells postpartum, and precocious induction of involution. Using a PCR-based genotyping method, the three different founder lines can be distinguished, and we determined that the MMTV-Cre line A, the most widely used MMTV-Cre founder line, exhibits a profound lactation defect that limits its use in studies on mammary gland development. Conclusions/Significance: The identification of a lactation defect in the MMTV-Cre line A mice indicates that investigators must use MMTV-Cre alone mice as control in studies that utilize Cre recombinase to excise genes of interest from mammary epithelial cells. Our results also suggest that previous results obtained in studies using the MMTV-Cre line A line should be re-evaluated if the controls did not include mice expressing only Cre recombinase.	[Yuan, Taichang; Wang, Yongping; Anderson, Steve M.; Gu, Haihua] Univ Colorado, Sch Med, Dept Pathol, Aurora, CO USA; [Pao, Lily] Beth Israel & Deaconess Med Ctr, Div Hematol & Oncol, Canc Biol Program, Boston, MA USA; [Pao, Lily] Harvard Univ, Sch Med, Boston, MA USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Yuan, TC (corresponding author), Roche R&D China Ctr, Zhangjiang High Tech Pk, Shanghai, Peoples R China.	Haihua.gu@ucdenver.edu	Gu, Haihua/G-6364-2011		Pathology Department at University of Colorado Denver; Public Health Service [PO1 HD38129]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD038129] Funding Source: NIH RePORTER	Pathology Department at University of Colorado Denver; Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Pathology Department at University of Colorado Denver, and a grant from the Public Health Service PO1 HD38129 to SMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosti V, 2004, J EXP MED, V199, P867, DOI 10.1084/jem.20031983; Anderson SM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1653; Andrechek ER, 2000, P NATL ACAD SCI USA, V97, P3444, DOI 10.1073/pnas.050408497; ARONHEIM A, 1994, CELL, V78, P949, DOI 10.1016/0092-8674(94)90271-2; Boussadia O, 2002, MECH DEVELOP, V115, P53, DOI 10.1016/S0925-4773(02)00090-4; Buono KD, 2006, DEV BIOL, V293, P565, DOI 10.1016/j.ydbio.2006.02.043; Chan JHP, 2007, INT IMMUNOPHARMACOL, V7, P937, DOI 10.1016/j.intimp.2007.03.002; Chapman RS, 1999, GENE DEV, V13, P2604, DOI 10.1101/gad.13.19.2604; Chapman RS, 2000, ADV EXP MED BIOL, V480, P129; Crawford BE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010691; Cui Y, 2002, J BIOL CHEM, V277, P17830, DOI 10.1074/jbc.M200186200; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; Feng Y, 2007, P NATL ACAD SCI USA, V104, P14718, DOI 10.1073/pnas.0706933104; Freeburn RW, 1997, EXP HEMATOL, V25, P306; GREEN MC, 1975, J HERED, V66, P250, DOI 10.1093/oxfordjournals.jhered.a108625; Gu HH, 2003, J CELL BIOL, V161, P1151, DOI 10.1083/jcb.200212158; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Kucera GT, 1996, DEV BIOL, V173, P162, DOI 10.1006/dbio.1996.0014; Loladze AV, 2006, ENDOCRINOLOGY, V147, P5412, DOI 10.1210/en.2006-0427; Mak TW, 2001, NAT REV IMMUNOL, V1, P11, DOI 10.1038/35095551; Nemade RV, 2004, MECH DEVELOP, V121, P91, DOI 10.1016/j.mod.2003.09.007; OCHMAN H, 1988, GENETICS, V120, P621; Palmer CA, 2006, J MAMMARY GLAND BIOL, V11, P269, DOI 10.1007/s10911-006-9023-3; Pao LI, 2007, IMMUNITY, V27, P35, DOI 10.1016/j.immuni.2007.04.016; Robinson GW, 2007, DEV DYNAM, V236, P654, DOI 10.1002/dvdy.21058; Robinson GW, 2011, ANAL BIOCH; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Schwertfeger KL, 2003, J LIPID RES, V44, P1100, DOI 10.1194/jlr.M300045-JLR200; Seagroves TN, 2003, DEVELOPMENT, V130, P1713, DOI 10.1242/dev.00403; Selbert S, 1998, TRANSGENIC RES, V7, P387, DOI 10.1023/A:1008848304391; Tuveson DA, 2002, CURR OPIN GENET DEV, V12, P105, DOI 10.1016/S0959-437X(01)00272-6; Ursini-Siegel J, 2007, MOL CELL BIOL, V27, P6361, DOI 10.1128/MCB.00686-07; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Xue B, 1998, FASEB J, V12, pA505; Yip SS, 2000, INT J CANCER, V88, P363, DOI 10.1002/1097-0215(20001101)88:3<363::AID-IJC7>3.0.CO;2-4	36	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19233	10.1371/journal.pone.0019233	http://dx.doi.org/10.1371/journal.pone.0019233			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559430	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700107
J	Liu, LS; Li, Q; Sapolsky, R; Liao, M; Mehta, K; Bhargava, A; Pasricha, PJ				Liu, Liansheng; Li, Qian; Sapolsky, Robert; Liao, Min; Mehta, Kshama; Bhargava, Aditi; Pasricha, Pankaj J.			Transient Gastric Irritation in the Neonatal Rats Leads to Changes in Hypothalamic CRF Expression, Depression- and Anxiety-Like Behavior as Adults	PLOS ONE			English	Article							FORCED SWIM TEST; FUNCTIONAL DYSPEPSIA; NEUROENDOCRINE RESPONSES; PSYCHOSOCIAL FACTORS; MATERNAL SEPARATION; COLON IRRITATION; GUT AXIS; STRESS; RECEPTOR; GABA(A)	Aims: A disturbance of the brain-gut axis is a prominent feature in functional bowel disorders (such as irritable bowel syndrome and functional dyspepsia) and psychological abnormalities are often implicated in their pathogenesis. We hypothesized that psychological morbidity in these conditions may result from gastrointestinal problems, rather than causing them. Methods: Functional dyspepsia was induced by neonatal gastric irritation in male rats. 10-day old male Sprague-Dawley rats received 0.1% iodoacetamide (IA) or vehicle by oral gavage for 6 days. At 8-10 weeks of age, rats were tested with sucrose preference and forced-swimming tests to examine depression-like behavior. Elevated plus maze, open field and light-dark box tests were used to test anxiety-like behaviors. ACTH and corticosterone responses to a minor stressor, saline injection, and hypothalamic CRF expression were also measured. Results: Behavioral tests revealed changes of anxiety-and depression-like behaviors in IA-treated, but not control rats. As compared with controls, hypothalamic and amygdaloid CRF immunoreactivity, basal levels of plasma corticosterone and stress-induced ACTH were significantly higher in IA-treated rats. Gastric sensory ablation with resiniferatoxin had no effect on behaviors but treatment with CRF type 1 receptor antagonist, antalarmin, reversed the depression-like behavior in IA-treated rats Conclusions: The present results suggest that transient gastric irritation in the neonatal period can induce a long lasting increase in depression-and anxiety-like behaviors, increased expression of CRF in the hypothalamus, and an increased sensitivity of HPA axis to stress. The depression-like behavior may be mediated by the CRF1 receptor. These findings have significant implications for the pathogenesis of psychological co-morbidity in patients with functional bowel disorders.	[Liu, Liansheng; Mehta, Kshama; Pasricha, Pankaj J.] Stanford Univ, Med Ctr, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA; [Li, Qian] Univ Kansas, Dept Pharmacol & Toxicol, Kansas City, KS USA; [Sapolsky, Robert] Stanford Univ, Dept Biol, Sch Humanities & Sci, Stanford, CA 94305 USA; [Liao, Min; Bhargava, Aditi] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA	Stanford University; University of Kansas; Stanford University; University of California System; University of California San Francisco	Liu, LS (corresponding author), Stanford Univ, Med Ctr, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA.	Pasricha@stanford.edu			National Institute of Diabetes and Digestive and Kidney Diseases, NIDDK [080787]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080787] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study supported in part by the National Institute of Diabetes and Digestive and Kidney Diseases, NIDDK 080787 (AB). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Al-Chaer ED, 2000, GASTROENTEROLOGY, V119, P1276, DOI 10.1053/gast.2000.19576; Anand KJS, 2004, J PEDIATR-US, V144, P449, DOI 10.1016/j.jpeds.2003.12.035; Appendino G, 1997, LIFE SCI, V60, P681, DOI 10.1016/S0024-3205(96)00567-X; Aro P, 2009, GASTROENTEROLOGY, V137, P94, DOI 10.1053/j.gastro.2009.03.039; Barry S, 2006, WORLD J GASTROENTERO, V12, P2701, DOI 10.3748/wjg.v12.i17.2701; Bessa JM, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.001.2009; Caldji C, 2000, NEUROPSYCHOPHARMACOL, V22, P219, DOI 10.1016/S0893-133X(99)00110-4; Chang L, 2009, NEUROGASTROENT MOTIL, V21, P149, DOI 10.1111/j.1365-2982.2008.01171.x; Choung RS, 2006, WORLD J GASTROENTERO, V12, P673, DOI 10.3748/wjg.v12.i5.673; DETKE MJ, 1995, PSYCHOPHARMACOLOGY, V121, P66, DOI 10.1007/BF02245592; Dinan TG, 2006, GASTROENTEROLOGY, V130, P304, DOI 10.1053/j.gastro.2005.11.033; Ehlert U, 2005, J PSYCHOSOM RES, V59, P7, DOI 10.1016/j.jpsychores.2005.03.005; Fleming AS, 1999, NEUROSCI BIOBEHAV R, V23, P673, DOI 10.1016/S0149-7634(99)00011-1; Gluckman PD, 2007, J INTERN MED, V261, P461, DOI 10.1111/j.1365-2796.2007.01802.x; Goncalves L, 2008, EXP NEUROL, V213, P48, DOI 10.1016/j.expneurol.2008.04.043; Griebel G, 2002, J PHARMACOL EXP THER, V301, P333, DOI 10.1124/jpet.301.1.333; Hiroi R, 2006, BEHAV BRAIN RES, V166, P93, DOI 10.1016/j.bbr.2005.07.021; Hsu FC, 2003, P NATL ACAD SCI USA, V100, P12213, DOI 10.1073/pnas.2131679100; Hsu YC, 2009, AM J GASTROENTEROL, V104, P2534, DOI 10.1038/ajg.2009.328; Hu B, 2009, PAIN, V143, P206, DOI 10.1016/j.pain.2009.02.018; Jutkiewicz EM, 2005, PSYCHOPHARMACOLOGY, V180, P215, DOI 10.1007/s00213-005-2164-z; Kalinichev M, 2002, PHARMACOL BIOCHEM BE, V73, P131, DOI 10.1016/S0091-3057(02)00781-5; Katagiri F, 2006, PHARMACOLOGY, V77, P115, DOI 10.1159/000093485; Kehne John H., 2007, CNS & Neurological Disorders-Drug Targets, V6, P163, DOI 10.2174/187152707780619344; Kehne JH, 2010, PHARMACOL THERAPEUT, V128, P460, DOI 10.1016/j.pharmthera.2010.08.011; Kellow JE, 2006, GASTROENTEROLOGY, V130, P1412, DOI 10.1053/j.gastro.2005.08.061; LANGELUDDECKE P, 1990, J PSYCHOSOM RES, V34, P215, DOI 10.1016/0022-3999(90)90055-9; Lee KJ, 2004, BEST PRACT RES CL GA, V18, P707, DOI 10.1016/j.bpg.2004.04.007; LI Q, 1993, BRAIN RES, V630, P148, DOI 10.1016/0006-8993(93)90652-4; Li Q, 1999, J PHARMACOL EXP THER, V291, P999; Liu LS, 2008, GASTROENTEROLOGY, V134, P2070, DOI 10.1053/j.gastro.2008.02.093; MAGNI G, 1987, AM J PSYCHIAT, V144, P1222; Mayer EA, 2006, ALIMENT PHARM THER, V24, P919, DOI 10.1111/j.1365-2036.2006.03078.x; McCool BA, 2003, BRAIN RES, V963, P165, DOI 10.1016/S0006-8993(02)03966-5; Michl T, 2001, PAIN, V92, P19, DOI 10.1016/S0304-3959(00)00467-X; Mimidis K, 2008, DIGEST DIS, V26, P194, DOI 10.1159/000121346; Nosek K, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-23; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pliakas AM, 2001, J NEUROSCI, V21, P7397, DOI 10.1523/JNEUROSCI.21-18-07397.2001; Sena LM, 2003, BEHAV BRAIN RES, V142, P125, DOI 10.1016/S0166-4328(02)00399-6; Slawecki CJ, 2005, BEHAV NEUROSCI, V119, P1477, DOI 10.1037/0735-7044.119.6.1477; Strekalova T, 2004, NEUROPSYCHOPHARMACOL, V29, P2007, DOI 10.1038/sj.npp.1300532; Suzuki T, 2007, ANESTH ANALG, V104, P1570, DOI 10.1213/01.ane.0000261514.19946.66; Tache Y, 2001, AM J PHYSIOL-GASTR L, V280, pG173, DOI 10.1152/ajpgi.2001.280.2.G173; TOWELL A, 1987, PSYCHOPHARMACOLOGY, V92, P262; Van Oudenhove L, 2008, GUT, V57, P1666, DOI 10.1136/gut.2008.158162; Van Oudenhove L, 2009, GASTROENTEROLOGY, V137, P23, DOI 10.1053/j.gastro.2009.05.012; Videlock EJ, 2009, GASTROENTEROLOGY, V137, P1954, DOI 10.1053/j.gastro.2009.08.058; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wang J, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-28; Wang XY, 2009, J PROTEOME RES, V8, P2511, DOI 10.1021/pr801086k; Weaver ICG, 2007, EPIGENETICS, V2, P22, DOI 10.4161/epi.2.1.3881; Wigger A, 1999, PHYSIOL BEHAV, V66, P293, DOI 10.1016/S0031-9384(98)00300-X; Winston J, 2007, GASTROENTEROLOGY, V132, P615, DOI 10.1053/j.gastro.2006.11.014; Witteveen AB, 2010, PSYCHONEUROENDOCRINO, V35, P1113, DOI 10.1016/j.psyneuen.2009.12.013; Zeng Q, 2008, BRAIN RES, V1200, P27, DOI 10.1016/j.brainres.2008.01.038	56	31	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19498	10.1371/journal.pone.0019498	http://dx.doi.org/10.1371/journal.pone.0019498			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589865	Green Submitted, gold, Green Published			2022-12-27	WOS:000290531100014
J	Tousif, S; Singh, Y; Prasad, DVR; Sharma, P; Van Kaer, L; Das, G				Tousif, Sultan; Singh, Yogesh; Prasad, Durbaka Vijaya Raghava; Sharma, Pawan; Van Kaer, Luc; Das, Gobardhan			T Cells from Programmed Death-1 Deficient Mice Respond Poorly to Mycobacterium tuberculosis Infection	PLOS ONE			English	Article							DEFENSE-MECHANISM; INTERFERON-GAMMA; HOST IMMUNITY; PD-1 BLOCKADE; STEM-CELLS; AUTOPHAGY; LIGANDS; AUTOIMMUNITY; MACROPHAGES; MOLECULE	Background: Programmed Death-1 (PD-1; CD279) receptor molecule is widely believed to be a negative regulator predominantly expressed by exhausted/activated mouse T cells. Upon interaction with its ligands, PD-L1 and PD-L2, PD-1 inhibits activation of T cells and cytokine production, which has been documented in various viral and fungal infections as well as in vitro studies. Therefore, inhibition of T cell responses by PD-1 resulted in disease resistance in a variety of mouse infection models studied heretofore. Methodology/Principal Findings: Here, we report that PD-1 deficient (PD-1(-/-)) mice infected with Mycobacterium tuberculosis (M. tb) H37Rv by the aerosol route have increased susceptibility as compared with their wild type littermates. Surprisingly, M. tb antigen-specific T cell proliferation was dramatically reduced in PD-1 deficient animals compared with wild-type littermates, and this was due to increased numbers of regulatory T cells (Tregs) and recruitment of mesenchymal stem cells. Furthermore, PD-1(-/-) mice exhibited decreases in the autophagy-induced LC3-B marker protein in macrophages. Conclusions/Significance: Our findings suggest that PD-1 does not play an inhibitory role during M. tb infection and instead promotes mycobacterial clearance in mice.	[Tousif, Sultan; Singh, Yogesh; Sharma, Pawan; Das, Gobardhan] Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi, India; [Singh, Yogesh] Univ London Royal Vet Coll, Dept Vet Basic Sci, MicroRNA & Lymphocyte Dev Res Grp, London, England; [Prasad, Durbaka Vijaya Raghava] Yogi Vamana Univ, Dept Microbiol, Kadapa, Andhra Pradesh, India; [Van Kaer, Luc] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37212 USA	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; University of London; University of London Royal Veterinary College; Yogi Vemana University; Vanderbilt University	Tousif, S (corresponding author), Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi, India.	dasgo@icgeb.res.in	Sharma, Pawan/F-7806-2010; Singh, Yogesh/T-8230-2017; Van Kaer, Luc/H-1033-2015	Sharma, Pawan/0000-0002-2525-5451; Singh, Yogesh/0000-0001-6919-6273; Van Kaer, Luc/0000-0001-5275-2309; Tousif, Sultan/0000-0001-6174-6541	Wellcome Trust [WT01/GD/09/339]; Department of Biotechnology (DBT) Alliance; DBT, Government of India [DB/03/GD/08/306]; DBT; Wellcome-DBT	Wellcome Trust(Wellcome TrustEuropean Commission); Department of Biotechnology (DBT) Alliance(Department of Biotechnology (DBT) IndiaWellcome Trust DBT India Alliance); DBT, Government of India(Department of Biotechnology (DBT) India); DBT(Department of Biotechnology (DBT) India); Wellcome-DBT(Wellcome Trust DBT India Alliance)	This research work was supported by Grant WT01/GD/09/339 from the Wellcome Trust and Department of Biotechnology (DBT) Alliance (http://www.wellcomedbt.org) and DB/03/GD/08/306 from DBT(http://dbtindia.nic.in/index.asp), Government of India. ST is supported by a DBT grant and YS is supported by a Wellcome-DBT grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Barber DL, 2011, J IMMUNOL, V186, P1598, DOI 10.4049/jimmunol.1003304; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barnes PF, 2003, NEW ENGL J MED, V349, P1149, DOI 10.1056/NEJMra021964; BROWN KE, 2010, CURR OPIN IMMUNOL; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Chamie G, 2010, CLIN INFECT DIS, V50, pS245, DOI 10.1086/651498; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; Deretic V, 2006, CURR OPIN IMMUNOL, V18, P375, DOI 10.1016/j.coi.2006.05.019; Deretic V, 2009, CURR TOP MICROBIOL, V335, P169, DOI 10.1007/978-3-642-00302-8_8; Desvignes L, 2009, IMMUNITY, V31, P974, DOI 10.1016/j.immuni.2009.10.007; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Finnefrock AC, 2009, J IMMUNOL, V182, P980, DOI 10.4049/jimmunol.182.2.980; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Gotsman I, 2007, J CLIN INVEST, V117, P2974, DOI 10.1172/JCI31344; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Harris J, 2007, IMMUNITY, V27, P505, DOI 10.1016/j.immuni.2007.07.022; Jurado JO, 2008, J IMMUNOL, V181, P116, DOI 10.4049/jimmunol.181.1.116; Kaufmann SH, 2001, TRENDS CELL BIOL, V11, P526, DOI 10.1016/S0962-8924(01)02173-0; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Keir ME, 2007, CURR OPIN IMMUNOL, V19, P309, DOI 10.1016/j.coi.2007.04.012; Keir ME, 2005, J IMMUNOL, V175, P7372, DOI 10.4049/jimmunol.175.11.7372; Keir ME, 2005, IMMUNOL REV, V204, P128, DOI 10.1111/j.0105-2896.2005.00242.x; KOKKINOPOULOS D, 1992, J IMMUNOL METHODS, V154, P1, DOI 10.1016/0022-1759(92)90205-8; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Latchman YE, 2004, P NATL ACAD SCI USA, V101, P10691, DOI 10.1073/pnas.0307252101; Lazar-Molnar E, 2010, P NATL ACAD SCI USA, V107, P13402, DOI 10.1073/pnas.1007394107; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liang SC, 2006, EUR J IMMUNOL, V36, P58, DOI 10.1002/eji.200535458; Mehta R, 2004, J BIOL CHEM, V279, P22477, DOI 10.1074/jbc.M401652200; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Nunn P, 2005, NAT REV IMMUNOL, V5, P819, DOI 10.1038/nri1704; Raghuvanshi S, 2010, P NATL ACAD SCI USA, V107, P21653, DOI 10.1073/pnas.1007967107; Saunders PA, 2005, EUR J IMMUNOL, V35, P3561, DOI 10.1002/eji.200526347; Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105; Shafiani S, 2010, J EXP MED, V207, P1409, DOI 10.1084/jem.20091885; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Yoshida YO, 2010, J IMMUNOL, V184, P4414, DOI 10.4049/jimmunol.0903332; Zhang JY, 2008, J IMMUNOL, V181, P3741, DOI 10.4049/jimmunol.181.6.3741; Zhong XM, 2004, INT IMMUNOL, V16, P1181, DOI 10.1093/intimm/dxh121	47	64	69	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19864	10.1371/journal.pone.0019864	http://dx.doi.org/10.1371/journal.pone.0019864			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589883	Green Published, gold			2022-12-27	WOS:000290531100032
J	Salo, M; Helle, S; Toivonen, T				Salo, Matti; Helle, Samuli; Toivonen, Tuuli			Allocating Logging Rights in Peruvian Amazonia-Does It Matter to Be Local?	PLOS ONE			English	Article							FOREST; CONSERVATION; INFERENCE; ECUADOR	Background: The fate of tropical forests is a global concern, yet many far-reaching decisions affecting forest resources are made locally. We explore allocation of logging rights using a case study from Loreto, Peruvian Amazonia, where millions of hectares of tropical rainforest were offered for concession in a competitive tendering process that addressed issues related to locality. Methodology/Principal Findings: After briefly presenting the study area and the tendering process, we identify and define local and non-local actors taking part in the concession process. We then analyse their tenders, results of the tendering, and attributes of the concession areas. Our results show that there was more offer than demand for concession land in the tendering. The number of tenders the concession areas received was related to their size and geographic location in relation to the major cities, but not to their estimated timber volumes or median distances from transport routes. Small and Loreto-based actors offered lower yearly area-based fees compared to larger ones, but the offers did not significantly affect the results of the tenders. Local experience in the form of logging history or residence near the solicited concession areas, as well as being registered in the region of Loreto, improved the success of the tenders. Conclusions/Significance: The allocation process left a considerable number of forest areas under the management of small and local actors, and if Peru is to reach its goal of zero deforestation rate by safeguarding 75 per cent of its forests by 2020, the small and the local actors need to be integrated to the forest regime as important constituents of its legitimacy.	[Salo, Matti; Helle, Samuli] Univ Turku, Dept Biol, SF-20500 Turku, Finland; [Toivonen, Tuuli] Univ Helsinki, Dept Geosci & Geog, Helsinki, Finland	University of Turku; University of Helsinki	Salo, M (corresponding author), Univ Turku, Dept Biol, SF-20500 Turku, Finland.	mattsal@utu.fi	Salo, Matti/D-3292-2011	Salo, Matti/0000-0002-6328-5299; Toivonen, Tuuli/0000-0002-6625-4922	Alfred Kordelinin Saatio; Turun Yliopistosaatio; Academy of Finland [207270]; Oskar Oflunds Stiftelse; Kone Foundation; Finnish Society of Forest Science	Alfred Kordelinin Saatio; Turun Yliopistosaatio; Academy of Finland(Academy of Finland); Oskar Oflunds Stiftelse; Kone Foundation; Finnish Society of Forest Science	Alfred Kordelinin Saatio, Turun Yliopistosaatio, the Academy of Finland (grant no: 207270 to SH), Oskar Oflunds Stiftelse, Kone Foundation, and Finnish Society of Forest Science financially supported the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker TR, 2010, J APPL ECOL, V47, P1159, DOI 10.1111/j.1365-2664.2010.01885.x; BARRANTES R, 1996, BOSQUES MADERA ANAL; Bass MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008767; Bauch S, 2009, J FOREST, V107, P132; Blundell AG, 2007, ECOL APPL, V17, P323, DOI 10.1890/06-0127; CHIRIF A, 2002, QUEHACER, V135, P62; CHIRINOS C, 2003, INFORM FINAL ESTUDIO; Cumming G, 2009, STAT MED, V28, P205, DOI 10.1002/sim.3471; *DAR, 2011, INF ANN 2010 TRANSP; *DEF PUEBL, 2010, SER INF DEF INF, V151; DOUROJEANNI M, EXPLOTACION RECURSOS; Ebeling J, 2009, J ENVIRON MANAGE, V90, P1145, DOI 10.1016/j.jenvman.2008.05.003; Environmental Investigation Agency, 2010, PER FOR SECT READ NE; FERNANDEZ HT, 2004, SISTEMA INCENTIVOS M; Gray John, 2002, FOREST CONCESSION PO; Harrell FE, 2001, REGRESSION MODELING; HIDALGO J, 2003, ESTADO SITUCION FORE; Hiedanpaa J, 2011, FOREST POLICY ECON, V13, P159, DOI 10.1016/j.forpol.2010.11.007; Hughes N., 2010, SOC MOVEMENT STUD, V9, P85, DOI [DOI 10.1080/14742830903442550, 10.1080/14742830903442550]; *IIAP BIOD, 2004, ESTR REG DIV BIOL AM; *INRENA, 2004, MAP EV FOR BOSQ PROD; *INT TROP TIM ORG, 2010, TROPICAL TIMBER MARK, V15, P18; *IQ DIA, 2004, CONC FOR MUCH POS AN; Lipsitz S, 2009, CH CRC HANDB MOD STA, P43; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Moseley C, 2008, ENVIRON MANAGE, V42, P327, DOI 10.1007/s00267-008-9116-4; Mundry R, 2009, AM NAT, V173, P119, DOI 10.1086/593303; Oliveira PJC, 2007, SCIENCE, V317, P1233, DOI 10.1126/science.1146324; *PER, 2010, 0082010MINAM PER; *PER, 2001, DIAR OF EL PER, V19; *PER, 2003, 0502003INRENA PER; *PER, 2002, 0462002AG PER; *PER, 2010, LEY FOR FAU IN PRESS; Persha L, 2011, SCIENCE, V331, P1606, DOI 10.1126/science.1199343; Pitman NCA, 2008, BIOTROPICA, V40, P525, DOI 10.1111/j.1744-7429.2008.00424.x; *REG, 2002, COST INV BOSQ PLAN O; RUEDA JLA, 2009, ENERGETICA, V42, P53; Salo M, 2009, ENVIRON MANAGE, V44, P609, DOI 10.1007/s00267-009-9343-3; Smith J, 2006, FOREST POLICY ECON, V8, P458, DOI 10.1016/j.forpol.2005.08.001; *SUNAT, 2006, CONS RUC; Youatt A, 2009, NATURAL RESOURCES EN, V23, P19	41	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19704	10.1371/journal.pone.0019704	http://dx.doi.org/10.1371/journal.pone.0019704			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589922	gold, Green Published, Green Submitted			2022-12-27	WOS:000290483600024
J	Sousa-Ferreira, L; Alvaro, AR; Aveleira, C; Santana, M; Brandao, I; Kugler, S; de Almeida, LP; Cavadas, C				Sousa-Ferreira, Ligia; Alvaro, Ana Rita; Aveleira, Celia; Santana, Magda; Brandao, Ines; Kuegler, Sebastian; de Almeida, Luis Pereira; Cavadas, Claudia			Proliferative Hypothalamic Neurospheres Express NPY, AGRP, POMC, CART and Orexin-A and Differentiate to Functional Neurons	PLOS ONE			English	Article							LATERAL TUBERAL NUCLEUS; NEUROPEPTIDE-Y; HUNTINGTONS-DISEASE; SUBVENTRICULAR ZONE; ARCUATE NUCLEUS; ENERGY-BALANCE; ADULT MICE; BODY-WEIGHT; NEUROGENESIS; LEPTIN	Some pathological conditions with feeding pattern alterations, including obesity and Huntington disease (HD) are associated with hypothalamic dysfunction and neuronal cell death. Additionally, the hypothalamus is a neurogenic region with the constitutive capacity to generate new cells of neuronal lineage, in adult rodents. The aim of the present work was to evaluate the expression of feeding-related neuropeptides in hypothalamic progenitor cells and their capacity to differentiate to functional neurons which have been described to be affected by hypothalamic dysfunction. Our study shows that hypothalamic progenitor cells from rat embryos grow as floating neurospheres and express the feeding-related neuropeptides Neuropeptide Y (NPY), Agouti-related Protein (AGRP), Pro-OpioMelanocortin (POMC), Cocaine-and-Amphetamine Responsive Transcript (CART) and Orexin-A/Hypocretin-1. Moreover the relative mRNA expression of NPY and POMC increases during the expansion of hypothalamic neurospheres in proliferative conditions. Mature neurons were obtained from the differentiation of hypothalamic progenitor cells including NPY, AGRP, POMC, CART and Orexin-A positive neurons. Furthermore the relative mRNA expression of NPY, CART and Orexin-A increases after the differentiation of hypothalamic neurospheres. Similarly to the adult hypothalamic neurons the neurospheres-derived neurons express the glutamate transporter EAAT3. The orexigenic and anorexigenic phenotype of these neurons was identified by functional response to ghrelin and leptin hormones, respectively. This work demonstrates the presence of appetite-related neuropeptides in hypothalamic progenitor cells and neurons obtained from the differentiation of hypothalamic neurospheres, including the neuronal phenotypes that have been described by others as being affected by hypothalamic neurodegeneration. These in vitro models can be used to study hypothalamic progenitor cells aiming a therapeutic intervention to mitigate feeding dysfunction that are associated with hypothalamic neurodegeneration.	[Sousa-Ferreira, Ligia; Alvaro, Ana Rita; Aveleira, Celia; Santana, Magda; Brandao, Ines; de Almeida, Luis Pereira; Cavadas, Claudia] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Alvaro, Ana Rita] Univ Tras Os Montes & Alto Douro, Dept Biol & Environm, Vila Real, Portugal; [Kuegler, Sebastian] Univ Med Gottingen, Viral Vectors Lab, Dept Neurol, Gottingen, Germany; [Sousa-Ferreira, Ligia; Santana, Magda; de Almeida, Luis Pereira; Cavadas, Claudia] Univ Coimbra, Fac Pharm, Coimbra, Portugal	Universidade de Coimbra; University of Tras-os-Montes & Alto Douro; University of Gottingen; Universidade de Coimbra	Sousa-Ferreira, L (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal.	ccavadas@ci.uc.pt	Cavadas, Claudia/AAB-6904-2021; Cavadas, Claudia/K-8271-2014; Sousa-Ferreira, Lígia/M-4181-2013; de Almeida, Luis Pereira/O-8196-2019; Aveleira, Célia/AAI-2455-2021; Alvaro, Ana Rita/A-8168-2013; de Almeida, Luis Pereira/A-4605-2009; Brandão, Inês/Y-4252-2019; Santana, Magda/P-4244-2017; Aveleira, Célia A/L-1325-2014	Cavadas, Claudia/0000-0001-8020-9266; Cavadas, Claudia/0000-0001-8020-9266; Sousa-Ferreira, Lígia/0000-0002-7169-9491; de Almeida, Luis Pereira/0000-0001-5831-3307; Aveleira, Célia/0000-0002-2191-0682; Alvaro, Ana Rita/0000-0002-2387-374X; de Almeida, Luis Pereira/0000-0001-5831-3307; Brandão, Inês/0000-0003-3767-9515; Santana, Magda/0000-0003-4076-7516; Aveleira, Célia A/0000-0002-2191-0682	Portuguese Foundation for Science and Technology; FEDER; COMPETE [PTDC/SAU-FCF/099082/2008, SFRH/BD/30608/2006, PTDC/SAU-FCF/70384/2006, PTDC/SAU-NEU/73119/2006, SFRH/BPD/46086/2008, SFRH/BD/44664/2008]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); FEDER(European Commission); COMPETE	This work was supported by grants from the Portuguese Foundation for Science and Technology, FEDER and COMPETE (PTDC/SAU-FCF/099082/2008; SFRH/BD/30608/2006; PTDC/SAU-FCF/70384/2006; PTDC/SAU-NEU/73119/2006; SFRH/BPD/46086/2008; SFRH/BD/44664/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agasse F, 2008, STEM CELLS, V26, P1636, DOI 10.1634/stemcells.2008-0056; Agasse F, 2008, REJUV RES, V11, P187, DOI 10.1089/rej.2007.0600; Alvaro AR, 2009, J NEUROCHEM, V109, P1508, DOI 10.1111/j.1471-4159.2009.06079.x; Alvaro AR, 2008, J NEUROCHEM; Aziz A, 2008, BRAIN PATHOL, V18, P474, DOI 10.1111/j.1750-3639.2008.00135.x; Bergonzelli GE, 2001, DIABETES, V50, P2666, DOI 10.2337/diabetes.50.12.2666; Collin M, 2003, EUR J NEUROSCI, V18, P1265, DOI 10.1046/j.1460-9568.2003.02840.x; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Decressac M, 2009, NEUROBIOL DIS, V34, P441, DOI 10.1016/j.nbd.2009.02.017; Gabery S, 2010, ACTA NEUROPATHOL; Grayson BE, 2010, FRONT NEUROENDOCRIN, V31, P16, DOI 10.1016/j.yfrne.2009.10.001; Hansel DE, 2001, NATURE, V410, P940, DOI 10.1038/35073601; Kohno D, 2003, DIABETES, V52, P948, DOI 10.2337/diabetes.52.4.948; Kokoeva MV, 2007, J COMP NEUROL, V505, P209, DOI 10.1002/cne.21492; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Kotliarova S, 2005, J NEUROCHEM, V93, P641, DOI 10.1111/j.1471-4159.2005.03035.x; KREMER HPH, 1991, NEUROSCI LETT, V132, P101, DOI 10.1016/0304-3940(91)90443-W; KREMER HPH, 1990, J NEUROPATH EXP NEUR, V49, P371, DOI 10.1097/00005072-199007000-00002; Kugler S, 2003, VIROLOGY, V311, P89, DOI 10.1016/S0042-6822(03)00162-4; Li G, 2003, DIABETES, V52, P1951, DOI 10.2337/diabetes.52.8.1951; Li SH, 2003, J NEUROSCI, V23, P6956; Liu Y, 2010, NEUROSCIENCE, V166, P241, DOI 10.1016/j.neuroscience.2009.12.026; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Markakis EA, 2004, J NEUROSCI, V24, P2886, DOI 10.1523/JNEUROSCI.4161-03.2004; Moraes JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005045; Muroya S, 2004, EUR J NEUROSCI, V19, P1524, DOI 10.1111/j.1460-9568.2004.03255.x; Muroya S, 1999, NEUROSCI LETT, V264, P113, DOI 10.1016/S0304-3940(99)00185-8; MYERS RH, 1991, ARCH NEUROL-CHICAGO, V48, P800, DOI 10.1001/archneur.1991.00530200036015; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; Perez-Martin M, 2010, EUR J NEUROSCI, V31, P1533, DOI 10.1111/j.1460-9568.2010.07220.x; Petersen A, 2005, HUM MOL GENET, V14, P39, DOI 10.1093/hmg/ddi004; Pierce AA, 2010, J NEUROSCI, V30, P723, DOI 10.1523/JNEUROSCI.2479-09.2010; Salvi R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004392; SANBERG PR, 1981, MED J AUSTRALIA, V1, P407, DOI 10.5694/j.1326-5377.1981.tb135681.x; Susaki E, 2010, AGING-US, V2, P453, DOI 10.18632/aging.100172; Tiesjema B, 2007, OBESITY, V15, P2424, DOI 10.1038/oby.2007.288; van der Burg JMM, 2008, NEUROBIOL DIS, V29, P41, DOI 10.1016/j.nbd.2007.07.029; Xu AW, 2005, PLOS BIOL, V3, P2168, DOI 10.1371/journal.pbio.0030415; Xu Y, 2005, EXP NEUROL, V192, P251, DOI 10.1016/j.expneurol.2004.12.021	40	27	27	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19745	10.1371/journal.pone.0019745	http://dx.doi.org/10.1371/journal.pone.0019745			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589937	Green Published, gold			2022-12-27	WOS:000290483600029
J	Teacher, AGF; Shikano, T; Karjalainen, ME; Merila, J				Teacher, Amber G. F.; Shikano, Takahito; Karjalainen, Marika E.; Merila, Juha			Phylogeography and Genetic Structuring of European Nine-Spined Sticklebacks (Pungitius pungitius)-Mitochondrial DNA Evidence	PLOS ONE			English	Article							SALMON SALMO-SALAR; BALTIC SEA AREA; POSTGLACIAL COLONIZATION; FRESH-WATER; MITOCHONDRIAL-DNA; GLACIAL REFUGIA; NORTHERN EUROPE; GASTEROSTEUS-ACULEATUS; THYMALLUS-THYMALLUS; PUNGITIUS-PUNGITIUS	As a consequence of colonisation from different glacial refugia, many northern European taxa are split into distinct western and eastern lineages. However, as for the nine-spined stickleback (Pungitius pungitius), the exact location of the contact zone between lineages often remains poorly known. We assessed the genetic differentiation and diversity in the nine-spined stickleback within Europe using 1037 base pairs of cytochrome b sequence for 320 individuals from 57 locations, including pond, lake, river, and coastal habitats. Our main aims were (i) to locate the contact zone between the previously recognized western and eastern lineages, (ii) investigate latitudinal patterns in genetic diversity, (iii) compare genetic diversity among different habitat types, and (iv) date the known split between eastern and western lineages. The data revealed the split between eastern and western to be located across the Danish Straits and roughly following the Norway/Sweden border to the North. Reference sites from Canada form their own clades, and one of the Canadian sites was found to have a haplotype common to the Eastern European lineage, possibly representing an ancestral polymorphism. The split between the two European clades was dated to approximately 1.48 million years ago (Mya), and between Canada and Europe to approximately 1.62 Mya. After controlling for habitat effects, nucleotide (but not haplotype) diversity across populations decreased with increasing latitude. Coastal populations showed significantly higher haplotype diversity (but not nucleotide diversity) than pond populations, but there were no detectable differences in haplotype diversity among different freshwater habitat types (viz. river, lake and pond populations), or between coastal and lake/river populations. Sequences were found to cluster according to their geographic proximity, rather than by habitat type, and all habitat types were found within each major clade, implying that colonisation and adaptation between the coastal and freshwater environments in different regions must have occurred in parallel.	[Teacher, Amber G. F.; Shikano, Takahito; Karjalainen, Marika E.; Merila, Juha] Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland	University of Helsinki	Teacher, AGF (corresponding author), Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland.	amber.teacher@helsinki.fi	Teacher, Amber/G-9107-2012; Merila, Juha/A-4061-2008; Shikano, Takahito/D-7347-2015	Merila, Juha/0000-0001-9614-0072; Griffiths, Amber/0000-0002-7455-6795	Academy of Finland [138043, 129662, 134728]; European Community [FP/2007-2013, 217246]; Japan Society for the Promotion of Science	Academy of Finland(Academy of Finland); European Community(European Commission); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was funded by the Academy of Finland (grants 138043 to AGFT, and 129662 and 134728 to JM) and the European Community's Seventh Framework Programme (FP/2007-2013) under grant agreement no. 217246 made with the joint Baltic Sea research and development programme BONUS. TS was supported by the Japan Society for the Promotion of Science and Academy of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldenhoven JT, 2010, MOL ECOL, V19, P4061, DOI 10.1111/j.1365-294X.2010.04801.x; Asplund T, 2004, ANN ZOOL FENN, V41, P465; BANARESCU PM, 2001, FRESHWATER FISHES EU; BELL MA, 1994, EVOLUTIONARY BIOL TH, P14; Bell MA, 2009, COPEIA, P256, DOI 10.1643/CG-08-059; BERNATCHEZ L, 1995, MOL ECOL, V4, P285, DOI 10.1111/j.1365-294X.1995.tb00222.x; Cano JM, 2008, J INTEGRATIVE FIELD, V5, P1; DeWoody JA, 2000, J FISH BIOL, V56, P461, DOI 10.1111/j.1095-8649.2000.tb00748.x; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2010, GENEIOUS V5 1; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Elphinstone MS, 2003, MOL ECOL NOTES, V3, P317, DOI 10.1046/j.1471-8286.2003.00397.x; Garcia-Marin JL, 1999, HEREDITY, V82, P46, DOI 10.1038/sj.hdy.6884470; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; GYLLENSTEN U, 1985, J FISH BIOL, V26, P691, DOI 10.1111/j.1095-8649.1985.tb04309.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Johannesson K, 2006, MOL ECOL, V15, P2013, DOI 10.1111/j.1365-294X.2006.02919.x; Kontula T, 2001, MOL ECOL, V10, P1983, DOI 10.1046/j.1365-294X.2001.01328.x; Koskinen MT, 2000, MOL ECOL, V9, P1609, DOI 10.1046/j.1365-294x.2000.01065.x; Koskinen MT, 2002, HEREDITY, V88, P391, DOI 10.1038/sj.hdy.6800072; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Makhrov AA, 2006, RUSS J GENET+, V42, P1101, DOI 10.1134/S1022795406100036; Makinen HS, 2008, MOL PHYLOGENET EVOL, V46, P167, DOI 10.1016/j.ympev.2007.06.011; Makinen HS, 2006, MOL ECOL, V15, P1519, DOI 10.1111/j.1365-294X.2006.02871.x; McCartney MA, 2010, COPEIA, P103, DOI 10.1643/CG-07-169; McCusker MR, 2010, MOL ECOL, V19, P4852, DOI 10.1111/j.1365-294X.2010.04822.x; NEI M, 1981, GENETICS, V97, P145; Nesbo CL, 1999, MOL ECOL, V8, P1387, DOI 10.1046/j.1365-294x.1999.00699.x; NICHOLS RA, 1994, HEREDITY, V72, P312, DOI 10.1038/hdy.1994.41; Nilsson J, 2001, MOL ECOL, V10, P89, DOI 10.1046/j.1365-294X.2001.01168.x; Paepke Hans-Joachim, 2001, P277; R Core Team, 2018, R LANG ENV STAT COMP; Rambaut A, TRACER V1 5; RAWLINSON SE, 1982, J PALEONTOL, V56, P583; Saisa M, 2005, CAN J FISH AQUAT SCI, V62, P1887, DOI 10.1139/F05-094; Shikano T, 2010, MOL ECOL, V19, P1147, DOI 10.1111/j.1365-294X.2010.04553.x; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TAGGART JB, 1992, J FISH BIOL, V40, P963, DOI 10.1111/j.1095-8649.1992.tb02641.x; TIKKANEN M, 2002, FENNIA, V180, P1; Tonteri A, 2007, J FISH BIOL, V70, P381, DOI 10.1111/j.1095-8649.2007.01519.x; Tonteri A, 2005, ANN ZOOL FENN, V42, P1; Tonteri A, 2009, CAN J FISH AQUAT SCI, V66, P717, DOI 10.1139/F09-010; Verspoor E, 1999, BIOL J LINN SOC, V68, P129, DOI 10.1111/j.1095-8312.1999.tb01162.x; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; WARD RD, 1994, J FISH BIOL, V44, P213, DOI 10.1111/j.1095-8649.1994.tb01200.x; WEBB T, 1992, ANNU REV ECOL SYST, V23, P141, DOI 10.1146/annurev.es.23.110192.001041; Yule G. V., 1924, Philosophical Transactions of the Royal Society London B, V213, P21	52	35	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19476	10.1371/journal.pone.0019476	http://dx.doi.org/10.1371/journal.pone.0019476			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589917	Green Published, gold, Green Submitted			2022-12-27	WOS:000290483600011
J	Husson, J; Chemin, K; Bohineust, A; Hivroz, C; Henry, N				Husson, Julien; Chemin, Karine; Bohineust, Armelle; Hivroz, Claire; Henry, Nelly			Force Generation upon T Cell Receptor Engagement	PLOS ONE			English	Article							DEPENDENT ACTIVATION; TCR; RIGIDITY; MOTILITY; ADHESION; DETERMINES; MECHANICS; DYNAMICS; VELOCITY; SYNAPSE	T cells are major players of adaptive immune response in mammals. Recognition of an antigenic peptide in association with the major histocompatibility complex at the surface of an antigen presenting cell (APC) is a specific and sensitive process whose mechanism is not fully understood. The potential contribution of mechanical forces in the T cell activation process is increasingly debated, although these forces are scarcely defined and hold only limited experimental evidence. In this work, we have implemented a biomembrane force probe (BFP) setup and a model APC to explore the nature and the characteristics of the mechanical forces potentially generated upon engagement of the T cell receptor (TCR) and/or lymphocyte function-associated antigen-1 (LFA-1). We show that upon contact with a model APC coated with antibodies towards TCR-CD3, after a short latency, the T cell developed a timed sequence of pushing and pulling forces against its target. These processes were defined by their initial constant growth velocity and loading rate (force increase per unit of time). LFA-1 engagement together with TCR-CD3 reduced the growing speed during the pushing phase without triggering the same mechanical behavior when engaged alone. Intracellular Ca2+ concentration ([Ca2+](i)) was monitored simultaneously to verify the cell commitment in the activation process. [Ca2+](i) increased a few tens of seconds after the beginning of the pushing phase although no strong correlation appeared between the two events. The pushing phase was driven by actin polymerization. Tuning the BFP mechanical properties, we could show that the loading rate during the pulling phase increased with the target stiffness. This indicated that a mechanosensing mechanism is implemented in the early steps of the activation process. We provide here the first quantified description of force generation sequence upon local bidimensional engagement of TCR-CD3 and discuss its potential role in a T cell mechanically-regulated activation process.	[Husson, Julien; Chemin, Karine; Bohineust, Armelle; Hivroz, Claire; Henry, Nelly] Inst Curie, Ctr Rech, Paris, France; [Husson, Julien; Henry, Nelly] CNRS, UMR168, Paris, France; [Chemin, Karine; Bohineust, Armelle; Hivroz, Claire] INSERM, U932, Paris, France; [Husson, Julien; Henry, Nelly] Univ Paris 06, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite	Husson, J (corresponding author), Inst Curie, Ctr Rech, Paris, France.	claire.hivroz@curie.fr; nelly.henry@curie.fr	Husson, Julien/B-8466-2018; Hivroz, Claire/H-2711-2014	Husson, Julien/0000-0002-8230-1469; Hivroz, Claire/0000-0002-6794-2890; Chemin, Karine/0000-0002-2597-7809; Bohineust, Armelle/0000-0002-9734-0049	Agence Nationale pour la Recherche PCV [07-188055]; Association pour la Recherche contre le Cancer; Agence Nationale pour la Recherche; Fondation pour la Recherche Medicale (FRM); La Ligue contre le Cancer	Agence Nationale pour la Recherche PCV(French National Research Agency (ANR)); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); La Ligue contre le Cancer(Ligue nationale contre le cancer)	This work was supported by grants from Agence Nationale pour la Recherche PCV (07-188055) and Association pour la Recherche contre le Cancer. JH was supported by a fellowship from Agence Nationale pour la Recherche. KC is a recipient of a grant from Fondation pour la Recherche Medicale (FRM) and AB is a recipient of a grant from La Ligue contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; AHMED KA, 2010, J CELL MOL MED; Allioux-Guerin M, 2009, BIOPHYS J, V96, P238, DOI 10.1529/biophysj.108.134627; Atilgan E, 2006, BIOPHYS J, V90, P65, DOI 10.1529/biophysj.105.071480; Aucher A, 2008, BLOOD, V111, P5621, DOI 10.1182/blood-2008-01-134155; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Carpentier B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004784; Choudhuri K, 2007, SEMIN IMMUNOL, V19, P255, DOI 10.1016/j.smim.2007.04.005; CRAMER LP, 1994, CURR OPIN CELL BIOL, V6, P82, DOI 10.1016/0955-0674(94)90120-1; Dustin ML, 2006, P NATL ACAD SCI USA, V103, P4335, DOI 10.1073/pnas.0600899103; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; EVANS E, 1995, BIOPHYS J, V68, P2580, DOI 10.1016/S0006-3495(95)80441-8; EVANS E, 1993, J CELL BIOL, V122, P1295, DOI 10.1083/jcb.122.6.1295; FAURE S, 2004, NAT IMMUNOL, V1, P1; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Heinrich V, 2001, BIOPHYS J, V81, P1452, DOI 10.1016/S0006-3495(01)75800-6; Heinrich V, 2007, BIOPHYS J, V93, P363, DOI 10.1529/biophysj.107.104091; Heinrich V, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2909529; Herant M, 2006, J CELL SCI, V119, P1903, DOI 10.1242/jcs.02876; Hosseini BH, 2009, P NATL ACAD SCI USA, V106, P17852, DOI 10.1073/pnas.0905384106; Janmey PA, 2009, CELL MOTIL CYTOSKEL, V66, P597, DOI 10.1002/cm.20382; Kandula S, 2004, J IMMUNOL, V173, P4443, DOI 10.4049/jimmunol.173.7.4443; Kim ST, 2009, J BIOL CHEM, V284, P31028, DOI 10.1074/jbc.M109.052712; Li YC, 2010, J IMMUNOL, V184, P5959, DOI 10.4049/jimmunol.0900775; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Ma ZY, 2008, FASEB J, V22, P1002, DOI 10.1096/fj.07-9331hyp; Marcy Y, 2004, P NATL ACAD SCI USA, V101, P5992, DOI 10.1073/pnas.0307704101; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Miro F, 2006, J IMMUNOL, V177, P3625, DOI 10.4049/jimmunol.177.6.3625; Mitrossilis D, 2010, P NATL ACAD SCI USA, V107, P16518, DOI 10.1073/pnas.1007940107; Mitrossilis D, 2009, P NATL ACAD SCI USA, V106, P18243, DOI 10.1073/pnas.0903994106; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Parekh SH, 2005, NAT CELL BIOL, V7, P1219, DOI 10.1038/ncb1336; Picard C, 2009, EUR J IMMUNOL, V39, P1966, DOI 10.1002/eji.200939385; Qi SY, 2001, P NATL ACAD SCI USA, V98, P6548, DOI 10.1073/pnas.111536798; Saez A, 2007, P NATL ACAD SCI USA, V104, P8281, DOI 10.1073/pnas.0702259104; Scholer A, 2008, IMMUNITY, V28, P258, DOI 10.1016/j.immuni.2007.12.016; Schreiber CH, 2010, P NATL ACAD SCI USA, V107, P9141, DOI 10.1073/pnas.1002538107; Sedwick CE, 1999, J IMMUNOL, V162, P1367; Simson DA, 1998, BIOPHYS J, V74, P2080, DOI 10.1016/S0006-3495(98)77915-9; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; Stuurman N., 2007, MICROSC TODAY, V15, P42, DOI DOI 10.1017/S1551929500055541; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; Trautmann A, 2003, CURR OPIN IMMUNOL, V15, P249, DOI 10.1016/S0952-7915(03)00040-2; van der Merwe PA, 2001, IMMUNITY, V14, P665, DOI 10.1016/S1074-7613(01)00155-8	52	130	131	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19680	10.1371/journal.pone.0019680	http://dx.doi.org/10.1371/journal.pone.0019680			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572959	gold, Green Submitted, Green Published			2022-12-27	WOS:000290440200021
J	Khadra, A; Pietropaolo, M; Nepom, GT; Sherman, A				Khadra, Anmar; Pietropaolo, Massimo; Nepom, Gerald T.; Sherman, Arthur			Investigating the Role of T-Cell Avidity and Killing Efficacy in Relation to Type 1 Diabetes Prediction	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; COMPUTATIONAL APPROACH; AUTOIMMUNE RESPONSES; MINIMAL MODEL; INSULIN; AUTOANTIBODIES; PROGRESSION; RISK; CHILDREN; IDDM	During the progression of the clinical onset of Type 1 Diabetes (T1D), high-risk individuals exhibit multiple islet autoantibodies and high-avidity T cells which progressively destroy beta cells causing overt T1D. In particular, novel autoantibodies, such as those against IA-2 epitopes (aa1-577), had a predictive rate of 100% in a 10-year follow up (rapid progressors), unlike conventional autoantibodies that required 15 years of follow up for a 74% predictive rate (slow progressors). The discrepancy between these two groups is thought to be associated with T-cell avidity, including CD8(+) and/or CD4(+) T cells. For this purpose, we build a series of mathematical models incorporating first one clone then multiple clones of islet-specific and pathogenic CD8(+) and/or CD4(+) T cells, together with B lymphocytes, to investigate the interaction of T-cell avidity with autoantibodies in predicting disease onset. These models are instrumental in examining several experimental observations associated with T-cell avidity, including the phenomenon of avidity maturation (increased average T-cell avidity over time), based on intra-and cross-clonal competition between T cells in high-risk human subjects. The model shows that the level and persistence of autoantibodies depends not only on the avidity of T cells, but also on the killing efficacy of these cells. Quantification and modeling of autoreactive T-cell avidities can thus determine the level of risk associated with each type of autoantibodies and the timing of T1D disease onset in individuals that have been tested positive for these autoantibodies. Such studies may lead to early diagnosis of the disease in high-risk individuals and thus potentially serve as a means of staging patients for clinical trials of preventive or interventional therapies far before disease onset.	[Khadra, Anmar; Sherman, Arthur] NIDDK, Lab Biol Modeling, NIH, Bethesda, MD USA; [Pietropaolo, Massimo] Univ Michigan, Immunogenet Lab, Ann Arbor, MI 48109 USA; [Nepom, Gerald T.] Benaroya Res Inst Virginia Mason, Seattle, WA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Michigan System; University of Michigan; Benaroya Research Institute; Virginia Mason Medical Center	Khadra, A (corresponding author), NIDDK, Lab Biol Modeling, NIH, Bethesda, MD USA.	khadraa@niddk.nih.gov		Nepom, Gerald/0000-0002-8063-1464; Sherman, Arthur/0000-0002-8372-5941	National Institutes of Health [R01 DK53456, DK56200, NIDDK PA-04-081]; NIDDK; Brehm Coalition; University of Michigan Center for Computational Medicine and Biology (CCMB); Pilot Research Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053456, ZIADK013027, R01DK056200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Brehm Coalition; University of Michigan Center for Computational Medicine and Biology (CCMB)(University of Michigan System); Pilot Research Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health: grants R01 DK53456, DK56200, NIDDK PA-04-081 (M. Pietropaolo); Intramural Research Program of the NIDDK (A. Khadra and A. Sherman). Brehm Coalition (M. Pietropaolo). University of Michigan Center for Computational Medicine and Biology (CCMB). Pilot Research Program (M. Pietropaolo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergman RN, 2003, DIABETES, V52, P2168, DOI 10.2337/diabetes.52.8.2168; Bingley PJ, 1996, DIABETES, V45, P1720, DOI 10.2337/diabetes.45.12.1720; BINGLEY PJ, 1994, DIABETES, V43, P1304, DOI 10.2337/diabetes.43.11.1304; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Brusko TM, 2008, IMMUNOL REV, V223, P371, DOI 10.1111/j.1600-065X.2008.00637.x; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Cretti A, 2001, EUR J CLIN INVEST, V31, P405, DOI 10.1046/j.1365-2362.2001.00827.x; DEBOER RJ, 1994, J THEOR BIOL, V169, P375, DOI 10.1006/jtbi.1994.1160; Durinovic-Bello I, 2010, GENES IMMUN, V11, P188, DOI 10.1038/gene.2009.108; Estella E, 2006, DIABETES, V55, P2212, DOI 10.2337/db06-0129; FINEGOOD DT, 1995, DIABETES, V44, P249, DOI 10.2337/diabetes.44.3.249; Head M, 1996, J LAB CLIN MED, V128, P61, DOI 10.1016/S0022-2143(96)90114-6; Homann D, 1999, IMMUNITY, V11, P463, DOI 10.1016/S1074-7613(00)80121-1; Homann D, 2006, J CLIN INVEST, V116, P1212, DOI 10.1172/JCI28506; Khadra A, 2010, J IMMUNOL, V185, P5962, DOI 10.4049/jimmunol.1001306; Khadra A, 2010, INT IMMUNOL, V22, P571, DOI 10.1093/intimm/dxq041; Khadra A, 2009, J THEOR BIOL, V256, P126, DOI 10.1016/j.jtbi.2008.09.019; Kim PS, 2007, J THEOR BIOL, V246, P33, DOI 10.1016/j.jtbi.2006.12.012; Knip M, 2003, REV ENDOCR METAB DIS, V4, P213, DOI 10.1023/A:1025121510678; Kopito RR, 2000, NAT CELL BIOL, V2, pE207, DOI 10.1038/35041139; Kurrer MO, 1997, P NATL ACAD SCI USA, V94, P213, DOI 10.1073/pnas.94.1.213; Libman IM, 2003, DIABETES CARE, V26, P2876, DOI 10.2337/diacare.26.10.2876; Libman IM, 2003, DIABETES CARE, V26, P2871, DOI 10.2337/diacare.26.10.2871; Luppi P, 2000, DIABETOLOGIA, V43, P1484, DOI 10.1007/s001250051559; Maclaren N, 1999, J AUTOIMMUN, V12, P279, DOI 10.1006/jaut.1999.0281; Mahaffy JM, 2007, SIAM J APPL MATH, V67, P915, DOI 10.1137/060661144; Mallone R, 2005, BLOOD, V106, P2798, DOI 10.1182/blood-2004-12-4848; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Miao DM, 2007, FRONT BIOSCI-LANDMRK, V12, P1889, DOI 10.2741/2195; Morran MP, 2008, MT SINAI J MED, V75, P314, DOI 10.1002/msj.20052; Morran MP, 2010, ENDOCRINOLOGY, V151, P2528, DOI 10.1210/en.2009-1257; Nelson P, 2009, MATH BIOSCI ENG, V6, P753, DOI 10.3934/mbe.2009.6.753; Nepom GT, 2008, CLIN IMMUNOL, V129, P1, DOI 10.1016/j.clim.2008.06.013; Nepom GT, 2001, P NATL ACAD SCI USA, V98, P1763, DOI 10.1073/pnas.98.4.1763; Parham P, 2009, IMMUNE SYSTEM, V3rd; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Pietropaolo M, 2005, PEDIATR DIABETES, V6, P184, DOI 10.1111/j.1399-543X.2005.00127.x; Pietropaolo M, 1998, J AUTOIMMUN, V11, P1, DOI 10.1006/jaut.1997.0170; Pietropaolo M, 2001, CURR DIRECT AUTOIMMU, V4, P252; Pietropaolo M, 2002, DIABETOLOGIA, V45, P66, DOI 10.1007/s125-002-8246-5; Pietropaolo M, 2008, DIABETES, V57, P2872, DOI 10.2337/db07-1691; Pietropaolo M, 2007, DIABETES, V56, P1189, DOI 10.2337/db06-0880; Piganelli JD, 2007, PEDIATR DIABETES, V8, P249, DOI 10.1111/j.1399-5448.2007.00314.x; Redondo MJ, 2002, DIABETOLOGIA, V45, P605, DOI 10.1007/s00125-002-0781-1; Reijonen H, 2004, DIABETES, V53, P1987, DOI 10.2337/diabetes.53.8.1987; Rewers M, 1996, DIABETOLOGIA, V39, P807, DOI 10.1007/s001250050514; Rossini AA, 2004, DIABETES, V53, P267, DOI 10.2337/diabetes.53.2.267; Seyfert-Margolis V, 2006, DIABETES, V55, P2588, DOI 10.2337/db05-1378; Shahaf G, 2008, J THEOR BIOL, V255, P210, DOI 10.1016/j.jtbi.2008.08.005; Shannon M, 1999, J IMMUNOL, V162, P3950; Shochat E, 2007, B MATH BIOL, V69, P2299, DOI 10.1007/s11538-007-9221-1; Skowera A, 2008, J CLIN INVEST, V118, P3390, DOI 10.1172/JCI35449; Standifer NE, 2009, CLIN IMMUNOL, V132, P312, DOI 10.1016/j.clim.2009.04.013; Tsai SE, 2010, IMMUNITY, V32, P568, DOI 10.1016/j.immuni.2010.03.015; Vendrame F, 2010, DIABETES, V59, P947, DOI 10.2337/db09-0498; Verge CF, 1996, DIABETES, V45, P926, DOI 10.2337/diabetes.45.7.926; VERNINO L, 1992, J IMMUNOL, V148, P404; Winer S, 2003, NAT MED, V9, P198, DOI 10.1038/nm818; Yamamoto AM, 1998, J AUTOIMMUN, V11, P643, DOI 10.1006/jaut.1998.0244; YOON JW, 1995, DIABETES METAB REV, V11, P83, DOI 10.1002/dmr.5610110202	60	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e14796	10.1371/journal.pone.0014796	http://dx.doi.org/10.1371/journal.pone.0014796			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21573001	gold, Green Published, Green Submitted			2022-12-27	WOS:000290440200001
J	Alherbish, A; Charrois, TL; Ackman, ML; Tsuyuki, RT; Ezekowitz, JA				Alherbish, Aws; Charrois, Theresa L.; Ackman, Margaret L.; Tsuyuki, Ross T.; Ezekowitz, Justin A.			The Prevalence of Natural Health Product Use in Patients with Acute Cardiovascular Disease	PLOS ONE			English	Article							ALTERNATIVE MEDICINE; CONTROLLED-TRIAL; HERBAL PRODUCTS; HEART-FAILURE; UNITED-STATES; COMPLEMENTARY; ANTIOXIDANT; INDIVIDUALS; THERAPIES	Background: Natural health products (NHP) use may have implications with respect to adverse effects, drug interactions and adherence yet the prevalence of NHP use by patients with acute cardiovascular disease and the best method to ascertain this information is unknown. Objective: To identify the best method to ascertain information on NHP, and the prevalence of use in a population with acute cardiovascular disease. Methods: Structured interviews were conducted with a convenience sample of consecutive patients admitted with acute cardiovascular disease to the University of Alberta Hospital during January 2009. NHP use was explored using structured and open-ended questions based on Health Canada's definition of NHP. The medical record was reviewed, and documentation of NHP use by physicians, nurses, and pharmacists, compared against the gold-standard structured interview. Results: 88 patients were interviewed (mean age 62 years, standard deviation [SD 14]; 80% male; 41% admitted for acute coronary syndromes). Common co-morbidities included hypertension (59%), diabetes (26%) and renal impairment (19%). NHP use was common (78% of patients) and 75% of NHP users reported daily use. The category of NHP most commonly used was vitamins and minerals (73%) followed by herbal products (20%), traditional medicines including Chinese medicines (9%), homeopathic preparations (1%) and other products including amino acids, essential fatty acids and probiotics (35%). In a multivariable model, only older age was associated with increased NHP use (OR 1.5 per age decile [95%CI 1.03 to 2.2]). When compared to the interview, the highest rate of NHP documentation was the pharmacist history (41%). NHP were documented in 22% of patients by the physician and 19% by the nurse. Conclusions: NHP use is common in patients admitted with acute cardiovascular disease. However, health professionals do not commonly identify NHP as part of the medication profile despite its potential importance. Structured interview appears to be the best method to accurately identify patient use of NHP.	[Alherbish, Aws; Charrois, Theresa L.; Tsuyuki, Ross T.; Ezekowitz, Justin A.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Tsuyuki, Ross T.; Ezekowitz, Justin A.] Univ Alberta, Div Cardiol, Edmonton, AB, Canada; [Ackman, Margaret L.] Alberta Hlth Serv, Serv Pharm, Edmonton, AB, Canada	University of Alberta; University of Alberta; Alberta Health Services (AHS)	Alherbish, A (corresponding author), Univ Alberta, Dept Med, Edmonton, AB, Canada.	Justin.ezekowitz@ualberta.ca	Charrois, Theresa/AAA-4695-2021; Tsuyuki, Ross T/E-2462-2016; Ezekowitz, Justin A/C-4579-2013	Tsuyuki, Ross T/0000-0002-3724-598X; Ezekowitz, Justin A/0000-0002-2724-4086	Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	Salary support is provided to Dr. Ezekowitz by the Canadian Institutes of Health Research New Investigator program and the Alberta Heritage Foundation for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackman ML, 1999, ANN PHARMACOTHER, V33, P674, DOI 10.1345/aph.18283; Amira Oluwatoyin C, 2007, BMC Complement Altern Med, V7, P30, DOI 10.1186/1472-6882-7-30; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; *CAN NDMA, 2009, HLTH VIS 1999 2000 2; Cherniack E Paul, 2008, Complement Ther Clin Pract, V14, P116, DOI 10.1016/j.ctcp.2007.11.002; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; DE GG, 2001, LANCET, V357, P89; Decker C, 2007, AM J CARDIOL, V99, P930, DOI 10.1016/j.amjcard.2006.11.041; EISENBERG DM, 1993, NEW ENGL J MED, V328, P246, DOI 10.1056/NEJM199301283280406; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Greenfield S, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-47; *HLTH CAN, 2004, NAT HLTH PROD REG 20; Krasuski RA, 2006, CLIN CARDIOL, V29, P161, DOI 10.1002/clc.4960290407; McGinn T, 2004, CAN MED ASSOC J, V171, P1369, DOI 10.1503/cmaj.1031981; Najm W, 2003, ALTERN THER HEALTH M, V9, P50; Pharand C, 2003, ANN PHARMACOTHER, V37, P899, DOI 10.1345/aph.1C163; Stephens NG, 1996, LANCET, V347, P781, DOI 10.1016/S0140-6736(96)90866-1; Tachjian A, 2010, J AM COLL CARDIOL, V55, P515, DOI 10.1016/j.jacc.2009.07.074; Wood MJ, 2003, AM HEART J, V145, P806, DOI 10.1016/S0002-8703(03)00084-X; Yeh GY, 2006, AM J CARDIOL, V98, P673, DOI 10.1016/j.amjcard.2006.03.051; Yuan CS, 2004, ANN INTERN MED, V141, P23, DOI 10.7326/0003-4819-141-1-200407060-00011; Zick SM, 2005, J CARD FAIL, V11, P586, DOI 10.1016/j.cardfail.2005.06.427; 1996, BMJ, V313, P131	23	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19623	10.1371/journal.pone.0019623	http://dx.doi.org/10.1371/journal.pone.0019623			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573067	Green Published, gold			2022-12-27	WOS:000290386800027
J	Banerjee, R; Vats, P; Dahale, S; Kasibhatla, SM; Joshi, R				Banerjee, Ruma; Vats, Pankaj; Dahale, Sonal; Kasibhatla, Sunitha Manjari; Joshi, Rajendra			Comparative Genomics of Cell Envelope Components in Mycobacteria	PLOS ONE			English	Article							MYCOLIC ACIDS; PHTHIOCEROL DIMYCOCEROSATE; METABOLIC PATHWAYS; CRYSTAL-STRUCTURE; GENE DECAY; TUBERCULOSIS; LIPOARABINOMANNAN; IDENTIFICATION; SEQUENCE; WALL	Mycobacterial cell envelope components have been a major focus of research due to their unique features that confer intrinsic resistance to antibiotics and chemicals apart from serving as a low-permeability barrier. The complex lipids secreted by Mycobacteria are known to evoke/repress host-immune response and thus contribute to its pathogenicity. This study focuses on the comparative genomics of the biosynthetic machinery of cell wall components across 21-mycobacterial genomes available in GenBank release 179.0. An insight into survival in varied environments could be attributed to its variation in the biosynthetic machinery. Gene-specific motifs like 'DLLAQPTPAW' of ufaA1 gene, novel functional linkages such as involvement of Rv0227c in mycolate biosynthesis; Rv2613c in LAM biosynthesis and Rv1209 in arabinogalactan peptidoglycan biosynthesis were detected in this study. These predictions correlate well with the available mutant and coexpression data from TBDB. It also helped to arrive at a minimal functional gene set for these biosynthetic pathways that complements findings using TraSH.	[Banerjee, Ruma; Vats, Pankaj; Dahale, Sonal; Kasibhatla, Sunitha Manjari; Joshi, Rajendra] Ctr Dev Adv Comp, Bioinformat Grp, Pune, Maharashtra, India	Centre for Development of Advanced Computing (C-DAC)	Banerjee, R (corresponding author), Ctr Dev Adv Comp, Bioinformat Grp, Pune Univ Campus, Pune, Maharashtra, India.	rajendra@cdac.in	Vats, Pankaj/AAL-1443-2020	Banerjee, Ruma/0000-0001-7890-8666; Vats, Pankaj/0000-0001-8441-7732	Bioinformatics Division, Depatment of Information Technology, Government of India	Bioinformatics Division, Depatment of Information Technology, Government of India(Ministry of Electronics and Information Technology (MEITY), Government of India)	Bioinformatics Division, Depatment of Information Technology, Government of India. url: http://www.mit.gov.in/content/bio-informatics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000817; Alahari A, 2009, MOL MICROBIOL, V71, P1263, DOI 10.1111/j.1365-2958.2009.06604.x; Arakaki AK, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-107; Arnvig KB, 2009, MOL MICROBIOL, V73, P397, DOI 10.1111/j.1365-2958.2009.06777.x; Azad AK, 1997, J BIOL CHEM, V272, P16741, DOI 10.1074/jbc.272.27.16741; Azad AK, 1996, P NATL ACAD SCI USA, V93, P4787, DOI 10.1073/pnas.93.10.4787; Barkan D, 2010, J BACTERIOL, V192, P3661, DOI 10.1128/JB.00312-10; Barkan D, 2009, CHEM BIOL, V16, P499, DOI 10.1016/j.chembiol.2009.04.001; Behr MA, 2000, J BACTERIOL, V182, P3394, DOI 10.1128/JB.182.12.3394-3399.2000; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Beste DJV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005349; Bhowruth V, 2008, BIOCHEM SOC T, V36, P555, DOI 10.1042/BST0360555; Brosch R, 2007, P NATL ACAD SCI USA, V104, P5596, DOI 10.1073/pnas.0700869104; Buglino J, 2004, J BIOL CHEM, V279, P30634, DOI 10.1074/jbc.M404011200; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Caspi R, 2010, NUCLEIC ACIDS RES, V38, pD473, DOI 10.1093/nar/gkp875; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; DAFFE M, 1991, RES MICROBIOL, V142, P397, DOI 10.1016/0923-2508(91)90109-N; Date SV, 2003, NAT BIOTECHNOL, V21, P1055, DOI 10.1038/nbt861; DATE SV, 2008, METHOD MOL BIOL, P201; Daub CO, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-118; Delmas C, 1997, GLYCOBIOLOGY, V7, P811, DOI 10.1093/glycob/7.6.811; Dinadayala P, 2006, J BIOL CHEM, V281, P20027, DOI 10.1074/jbc.M603395200; Dos Vultos T, 2006, J BACTERIOL, V188, P3159, DOI 10.1128/JB.188.8.3159-3161.2006; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; Erb TJ, 2009, P NATL ACAD SCI USA, V106, P8871, DOI 10.1073/pnas.0903939106; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Flores AR, 2005, J BACTERIOL, V187, P1892, DOI 10.1128/JB.187.6.1892-1900.2005; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Gebhardt H, 2007, MICROBIOL-SGM, V153, P1424, DOI 10.1099/mic.0.2006/003541-0; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Glickman MS, 2003, J BIOL CHEM, V278, P7844, DOI 10.1074/jbc.M212458200; Glickman MS, 2001, J BIOL CHEM, V276, P2228, DOI 10.1074/jbc.C000652200; Goldstone RM, 2008, PROTEIN EXPRES PURIF, V57, P81, DOI 10.1016/j.pep.2007.08.015; Guenin-Mace L, 2009, TRANSBOUND EMERG DIS, V56, P255, DOI 10.1111/j.1865-1682.2009.01072.x; Guerardel Y, 2003, J BIOL CHEM, V278, P36637, DOI 10.1074/jbc.M305427200; Guerardel Y, 2002, J BIOL CHEM, V277, P30635, DOI 10.1074/jbc.M204398200; Hasan S, 2006, PLOS COMPUT BIOL, V2, P539, DOI 10.1371/journal.pcbi.0020061; Huang CYF, 2002, J BIOL CHEM, V277, P34367, DOI 10.1074/jbc.M202468200; Huet G, 2006, J BACTERIOL, V188, P3412, DOI 10.1128/JB.188.9.3412-3414.2006; Jackson M, 2000, J BIOL CHEM, V275, P30092, DOI 10.1074/jbc.M004658200; Jackson M, 2009, J BIOL CHEM, V284, P1949, DOI 10.1074/jbc.R800047200; Joe M, 2006, J AM CHEM SOC, V128, P5059, DOI 10.1021/ja057373q; Jothi R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-173; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Kaur D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005447; Kaur D, 2008, P NATL ACAD SCI USA, V105, P17973, DOI 10.1073/pnas.0807761105; Kinnings SL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000976; Li KB, 2003, BIOINFORMATICS, V19, P1585, DOI 10.1093/bioinformatics/btg192; Li LL, 2005, P NATL ACAD SCI USA, V102, P12344, DOI 10.1073/pnas.0505662102; Liu J, 1996, J BIOL CHEM, V271, P29545, DOI 10.1074/jbc.271.47.29545; Malen H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-18; Marri PR, 2006, FEMS MICROBIOL REV, V30, P906, DOI 10.1111/j.1574-6976.2006.00041.x; Meena LS, 2010, FEBS J, V277, P2416, DOI 10.1111/j.1742-4658.2010.07666.x; Minnikin DE, 2002, CHEM BIOL, V9, P545, DOI 10.1016/S1074-5521(02)00142-4; Monot M, 2009, NAT GENET, V41, P1282, DOI 10.1038/ng.477; Morris RP, 2005, P NATL ACAD SCI USA, V102, P12200, DOI 10.1073/pnas.0505446102; NIKAIDO H, 1993, MOL MICROBIOL, V8, P1025, DOI 10.1111/j.1365-2958.1993.tb01647.x; Onwueme KC, 2005, PROG LIPID RES, V44, P259, DOI 10.1016/j.plipres.2005.07.001; Parker SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004281; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Rachman H, 2006, INFECT IMMUN, V74, P1233, DOI 10.1128/IAI.74.2.1233-1242.2006; Raman K, 2005, PLOS COMPUT BIOL, V1, P349, DOI 10.1371/journal.pcbi.0010046; Raman K, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-109; Rao V, 2006, J CLIN INVEST, V116, P1660, DOI 10.1172/JCI27335; Reddy TBK, 2009, NUCLEIC ACIDS RES, V37, pD499, DOI 10.1093/nar/gkn652; Ripoll F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005660; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Scherman H, 2009, J BACTERIOL, V191, P6769, DOI 10.1128/JB.00431-09; Seki M, 2009, VACCINE, V27, P1710, DOI 10.1016/j.vaccine.2009.01.034; Simeone R, 2007, J BACTERIOL, V189, P4597, DOI 10.1128/JB.00169-07; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Stinear TP, 2007, GENOME RES, V17, P192, DOI 10.1101/gr.5942807; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Treumann A, 2002, J MOL BIOL, V316, P89, DOI 10.1006/jmbi.2001.5317; Trivedi OA, 2005, MOL CELL, V17, P631, DOI 10.1016/j.molcel.2005.02.009; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; Turnbull WB, 2004, ANGEW CHEM INT EDIT, V43, P3918, DOI 10.1002/anie.200454119; *UNIPROT CONS, 2010, NUCL ACIDS RES, V0038; Vignal C, 2003, J IMMUNOL, V171, P2014, DOI 10.4049/jimmunol.171.4.2014; Vissa V. D., 2001, Genome Biology, V2, P1023, DOI 10.1186/gb-2001-2-8-reviews1023; Vissa V, 2009, INDIAN J MICROBIOL, V49, P11, DOI 10.1007/s12088-009-0006-0; Woodruff PJ, 2004, J BIOL CHEM, V279, P28835, DOI 10.1074/jbc.M313103200; Yuan Y, 1998, MOL MICROBIOL, V29, P1449, DOI 10.1046/j.1365-2958.1998.01026.x; YUAN Y, 1995, P NATL ACAD SCI USA, V92, P6630, DOI 10.1073/pnas.92.14.6630; Yuan Y, 1996, P NATL ACAD SCI USA, V93, P12828, DOI 10.1073/pnas.93.23.12828; Zheng HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002375; Zuo YH, 2005, STRUCTURE, V13, P973, DOI 10.1016/j.str.2005.04.015	93	13	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19280	10.1371/journal.pone.0019280	http://dx.doi.org/10.1371/journal.pone.0019280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573108	gold, Green Published, Green Submitted			2022-12-27	WOS:000290305600019
J	Kou, I; Takahashi, A; Urano, T; Fukui, N; Ito, H; Ozaki, K; Tanaka, T; Hosoi, T; Shiraki, M; Inoue, S; Nakamura, Y; Kamatani, N; Kubo, M; Mori, S; Ikegawa, S				Kou, Ikuyo; Takahashi, Atsushi; Urano, Tomohiko; Fukui, Naoshi; Ito, Hideki; Ozaki, Kouichi; Tanaka, Toshihiro; Hosoi, Takayuki; Shiraki, Masataka; Inoue, Satoshi; Nakamura, Yusuke; Kamatani, Naoyuki; Kubo, Michiaki; Mori, Seijiro; Ikegawa, Shiro			Common Variants in a Novel Gene, FONG on Chromosome 2q33.1 Confer Risk of Osteoporosis in Japanese	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BONE-MINERAL DENSITY; SUSCEPTIBILITY LOCI; IDENTIFICATION; SNP; SITE	Osteoporosis is a common disease characterized by low bone mass, decreased bone quality and increased predisposition to fracture. Genetic factors have been implicated in its etiology; however, the specific genes related to susceptibility to osteoporosis are not entirely known. To detect susceptibility genes for osteoporosis, we conducted a genome-wide association study in Japanese using similar to 270,000 SNPs in 1,747 subjects (190 cases and 1,557 controls) followed by multiple levels of replication of the association using a total of similar to 5,000 subjects (2,092 cases and 3,114 controls). Through these staged association studies followed by resequencing and linkage disequilibrium mapping, we identified a single nucleotide polymorphism (SNP), rs7605378 associated with osteoporosis. (combined P = 1.51 x 10(-8), odds ratio = 1.25). This SNP is in a previously unknown gene on chromosome 2q33.1, FONG. FONG is predicted to encode a 147 amino-acid protein with a formiminotransferase domain in its N-terminal (FTCD_N domain) and is ubiquitously expressed in various tissues including bone. Our findings would give a new insight into osteoporosis etiology and pathogenesis.	[Kou, Ikuyo; Ikegawa, Shiro] RIKEN, Lab Bone & Joint Dis, Ctr Genom Med, Tokyo, Japan; [Takahashi, Atsushi; Kamatani, Naoyuki] RIKEN, Lab Stat Anal, Ctr Genom Med, Tokyo, Japan; [Urano, Tomohiko; Inoue, Satoshi] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Tokyo, Japan; [Urano, Tomohiko; Inoue, Satoshi] Univ Tokyo, Grad Sch Med, Dept Antiaging Med, Tokyo, Japan; [Urano, Tomohiko; Inoue, Satoshi] Saitama Med Univ, Div Gene Regulat & Signal Transduct, Res Ctr Genom Med, Hidaka, Japan; [Fukui, Naoshi] Sagamihara Natl Hosp, Natl Hosp Org, Dept Pathomechanisms, Clin Res Ctr Rheumatol & Allergy, Sagamihara, Kanagawa, Japan; [Ito, Hideki; Mori, Seijiro] Tokyo Metropolitan Geriatr Hosp, Dept Internal Med, Tokyo 173, Japan; [Ozaki, Kouichi; Tanaka, Toshihiro] RIKEN, Lab Cardiovasc Dis, Ctr Genom Med, Yokohama, Kanagawa, Japan; [Hosoi, Takayuki] Natl Ctr Geriatr & Gerontol, Dept Adv Med, Obu, Japan; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan; [Shiraki, Masataka] Res Inst & Practice Involut Dis, Azumino, Japan; [Nakamura, Yusuke] RIKEN, Ctr Genom Med, Lab Int Alliance, Yokohama, Kanagawa, Japan; [Kubo, Michiaki] RIKEN, Lab Genotyping, Ctr Genom Med, Yokohama, Kanagawa, Japan	RIKEN; RIKEN; University of Tokyo; University of Tokyo; Saitama Medical University; Tokyo Metropolitan Institute of Gerontology; RIKEN; National Center for Geriatrics & Gerontology; University of Tokyo; RIKEN; RIKEN	Kou, I (corresponding author), RIKEN, Lab Bone & Joint Dis, Ctr Genom Med, Tokyo, Japan.	sikegawa@ims.u-tokyo.ac.jp	Kubo, Michiaki/N-7947-2015; Ikegawa, Shiro/N-6895-2015; Urano, Tomohiko/AFS-9574-2022; Tanaka, Toshihiro/J-9310-2014	Ikegawa, Shiro/0000-0003-0316-2147; Tanaka, Toshihiro/0000-0001-6201-9784; Ozaki, Kouichi/0000-0003-0028-1570	Japanese Government Ministry of Education, Culture, Sport, Science and Technology	Japanese Government Ministry of Education, Culture, Sport, Science and Technology	This work was conducted as a part of the BioBank Japan Project that was supported by the Japanese Government Ministry of Education, Culture, Sport, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Akhtar N, 2010, ARTHRITIS RHEUM-US, V62, P1361, DOI 10.1002/art.27329; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Guo Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000806; Haga H, 2002, J HUM GENET, V47, P605, DOI 10.1007/s100380200092; Hata J, 2007, HUM MOL GENET, V16, P630, DOI 10.1093/hmg/ddm005; Hsu YH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000977; Kiel DP, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S14; Kubo M, 2007, NAT GENET, V39, P212, DOI 10.1038/ng1945; Kung AWC, 2010, AM J HUM GENET, V86, P229, DOI 10.1016/j.ajhg.2009.12.014; Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832; Liu YZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003160; Liu YJ, 2006, J BONE MINER RES, V21, P1511, DOI 10.1359/JBMR.051002; Liu YZ, 2003, J ENDOCRINOL, V177, P147, DOI 10.1677/joe.0.1770147; Mann V, 2001, J CLIN INVEST, V107, P899, DOI 10.1172/JCI10347; Miyaki S, 2010, GENE DEV, V24, P1173, DOI 10.1101/gad.1915510; Miyamoto Y, 2008, NAT GENET, V40, P994, DOI 10.1038/ng.176; Morimoto R, 2006, EMBO J, V25, P4175, DOI 10.1038/sj.emboj.7601317; MURLEY LL, 1995, BIOCHEMISTRY-US, V34, P10358, DOI 10.1021/bi00033a006; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Nakashima M, 2010, NAT GENET, V42, P768, DOI 10.1038/ng.645; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Orimo H, 2001, J BONE MINER METAB, V19, P331, DOI 10.1007/s007740170001; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Peacock M, 2002, ENDOCR REV, V23, P303, DOI 10.1210/er.23.3.303; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ralston SH, 2006, GENE DEV, V20, P2492, DOI 10.1101/gad.1449506; Reginster JY, 2006, BONE, V38, P4, DOI 10.1016/j.bone.2005.11.024; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Styrkarsdottir U, 2009, NAT GENET, V41, P15, DOI 10.1038/ng.284; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Xiong DH, 2009, AM J HUM GENET, V84, P388, DOI 10.1016/j.ajhg.2009.01.025	37	20	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19641	10.1371/journal.pone.0019641	http://dx.doi.org/10.1371/journal.pone.0019641			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573128	Green Published, gold, Green Submitted			2022-12-27	WOS:000290305600037
J	Ferrand, J; Noel, D; Lehours, P; Prochazkova-Carlotti, M; Chambonnier, L; Menard, A; Megraud, F; Varon, C				Ferrand, Jonathan; Noel, Daniele; Lehours, Philippe; Prochazkova-Carlotti, Martina; Chambonnier, Lucie; Menard, Armelle; Megraud, Francis; Varon, Christine			Human Bone Marrow-Derived Stem Cells Acquire Epithelial Characteristics through Fusion with Gastrointestinal Epithelial Cells	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; IN-VITRO DIFFERENTIATION; PROGENITOR CELLS; GROWTH; REGENERATION; HEPATOCYTES; CONTRIBUTE; THERAPY; REPAIR; LIVER	Bone marrow-derived mesenchymal stem cells (MSC) have the ability to differentiate into a variety of cell types and are a potential source for epithelial tissue repair. Several studies have demonstrated their ability to repopulate the gastrointestinal tract (GIT) in bone marrow transplanted patients or in animal models of gastrointestinal carcinogenesis where they were the source of epithelial cancers. However, mechanism of MSC epithelial differentiation still remains unclear and controversial with trans-differentiation or fusion events being evoked. This study aimed to investigate the ability of MSC to acquire epithelial characteristics in the particular context of the gastrointestinal epithelium and to evaluate the role of cell fusion in this process. In vitro coculture experiments were performed with three gastrointestinal epithelial cell lines and MSC originating from two patients. After an 8 day coculture, MSC expressed epithelial markers. Use of a semi-permeable insert did not reproduce this effect, suggesting importance of cell contacts. Tagged cells coculture or FISH on gender-mismatched cells revealed clearly that epithelial differentiation resulted from cellular fusion events, while expression of mesenchymal markers on fused cells decreased over time. In vivo cell xenograft in immunodeficient mice confirmed fusion of MSC with gastrointestinal epithelial cells and self-renewal abilities of these fused cells. In conclusion, our results indicate that fusion could be the predominant mechanism by which human MSC may acquire epithelial characteristics when in close contact with epithelial cells from gastrointestinal origin. These results could contribute to a better understanding of the cellular and molecular mechanisms allowing MSC engraftment into the GIT epithelium.	[Ferrand, Jonathan; Lehours, Philippe; Prochazkova-Carlotti, Martina; Chambonnier, Lucie; Menard, Armelle; Megraud, Francis; Varon, Christine] Univ Bordeaux, Bacteriol Lab, Bordeaux, France; [Ferrand, Jonathan; Lehours, Philippe; Chambonnier, Lucie; Menard, Armelle; Megraud, Francis; Varon, Christine] INSERM, U853, Bordeaux, France; [Noel, Daniele] Univ Montpellier I, Montpellier, France; [Noel, Daniele] INSERM, U844, Montpellier, France; [Prochazkova-Carlotti, Martina] Univ Bordeaux, EA2406, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UDICE-French Research Universities; Universite de Bordeaux	Ferrand, J (corresponding author), Univ Bordeaux, Bacteriol Lab, Bordeaux, France.	francis.megraud@chu-bordeaux.fr	Lehours, Philippe/I-2780-2014; Noel, Daniele/E-5719-2016	Prochazkova-Carlotti, Martina/0000-0002-7719-7679; menard, armelle/0000-0002-6130-736X; Ferrand, Jonathan/0000-0001-5797-2693; Varon, Christine/0000-0003-4026-2016; Noel, Daniele/0000-0002-3498-3776	Institut de Recherche des Maladies de l'Appareil Digestif; Institut Federatif de Recherche [66]; Association pour la Recherche contre le Cancer, Universite Victor Segalen Bordeaux [8412]; Institut National du Cancer [07/3D1616/IABC-23-12/NC-NG]; French Ministry of Education, Research, and Technologies; ARC	Institut de Recherche des Maladies de l'Appareil Digestif; Institut Federatif de Recherche; Association pour la Recherche contre le Cancer, Universite Victor Segalen Bordeaux(Fondation ARC pour la Recherche sur le Cancer); Institut National du Cancer(Institut National du Cancer (INCA) France); French Ministry of Education, Research, and Technologies; ARC(Australian Research Council)	This project was financially supported by the Institut de Recherche des Maladies de l'Appareil Digestif, the Institut Federatif de Recherche 66 (http://www.ifr66.u-bordeaux2.fr, Universite Victor Segalen Bordeaux 2, France), the Association pour la Recherche contre le Cancer (http://www.arc-cancer.net/, ARC, project number: 8412) and the Institut National du Cancer (http://www.e-cancer.fr, project number: 07/3D1616/IABC-23-12/NC-NG). J. Ferrand is the recipient of fellowships from the French Ministry of Education, Research, and Technologies and ARC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Charbord P, 2010, HUM GENE THER, V21, P1045, DOI 10.1089/hum.2010.115; Dittmar T, 2009, MED HYPOTHESES, V73, P542, DOI 10.1016/j.mehy.2009.05.044; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Francois S, 2006, STEM CELLS, V24, P1020, DOI 10.1634/stemcells.2005-0260; Goncalves MAFV, 2006, HUM MOL GENET, V15, P213, DOI 10.1093/hmg/ddi438; Gruson KI, 2009, BULL HOSP JT DIS, V67, P6; Harris RG, 2004, SCIENCE, V305, P90, DOI 10.1126/science.1098925; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; Hutchinson L, 2011, STEM CELLS DEV, V20, P11, DOI 10.1089/scd.2010.0139; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kemp K, 2011, NEUROPATH APPL NEURO, V37, P166, DOI 10.1111/j.1365-2990.2010.01122.x; Komarova S, 2006, MOL CANCER THER, V5, P755, DOI 10.1158/1535-7163.MCT-05-0334; Korbling M, 2002, NEW ENGL J MED, V346, P738, DOI 10.1056/NEJMoa3461002; Lange C, 2006, WORLD J GASTROENTERO, V12, P2394, DOI 10.3748/wjg.v12.i15.2394; Li H, 2007, CANCER RES, V67, P10889, DOI 10.1158/0008-5472.CAN-07-2665; Maestroni GJM, 1999, CELL MOL LIFE SCI, V55, P663, DOI 10.1007/s000180050322; Marlink KL, 2003, AM J PHYSIOL-GASTR L, V285, pG163, DOI 10.1152/ajpgi.00257.2002; Matsumoto T, 2005, GASTROENTEROLOGY, V128, P1851, DOI 10.1053/j.gastro.2005.03.085; Montzka K, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-16; Ogle BM, 2005, NAT REV MOL CELL BIO, V6, P567, DOI 10.1038/nrm1678; Ohlsson LB, 2003, EXP MOL PATHOL, V75, P248, DOI 10.1016/j.yexmp.2003.06.001; Okamoto R, 2004, J GASTROENTEROL, V39, P1, DOI 10.1007/s00535-003-1259-8; Okamoto R, 2002, NAT MED, V8, P1011, DOI 10.1038/nm755; Okumura T, 2009, LAB INVEST, V89, P1410, DOI 10.1038/labinvest.2009.88; Parris GE, 2005, MED HYPOTHESES, V65, P846, DOI 10.1016/j.mehy.2005.05.036; Paunescu V, 2007, J CELL MOL MED, V11, P502, DOI 10.1111/j.1582-4934.2007.00041.x; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Popov BV, 2007, TISSUE ENG, V13, P2441, DOI 10.1089/ten.2007.0001; Popp Felix C, 2006, Curr Stem Cell Res Ther, V1, P411; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rizvi AZ, 2006, P NATL ACAD SCI USA, V103, P6321, DOI 10.1073/pnas.0508593103; Sarosi G, 2008, DIS ESOPHAGUS, V21, P43, DOI 10.1111/j.1442-2050.2007.00744.x; Sato Y, 2005, BLOOD, V106, P756, DOI 10.1182/blood-2005-02-0572; Singaravelu K, 2009, RENAL FAILURE, V31, P492, DOI 10.1080/08860220902928981; Sivamani RK, 2011, FASEB J, V25, P122, DOI 10.1096/fj.09-148775; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Spees JL, 2003, P NATL ACAD SCI USA, V100, P2397, DOI 10.1073/pnas.0437997100; Spyridonidis A, 2004, AM J PATHOL, V164, P1147, DOI 10.1016/S0002-9440(10)63203-8; Sun B, 2005, STEM CELLS DEV, V14, P292, DOI 10.1089/scd.2005.14.292; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Tzaribachev N, 2008, ISR MED ASSOC J, V10, P232; Varon C, 2006, MOL CELL BIOL, V26, P3582, DOI 10.1128/MCB.26.9.3582-3594.2006; Vater C, 2011, ACTA BIOMATER, V7, P463, DOI 10.1016/j.actbio.2010.07.037; Wagner W, 2007, STEM CELL REV, V3, P239, DOI 10.1007/s12015-007-9001-1; Wang GS, 2005, P NATL ACAD SCI USA, V102, P186, DOI 10.1073/pnas.0406266102; Zhu W, 2006, EXP MOL PATHOL, V80, P267, DOI 10.1016/j.yexmp.2005.07.004	48	80	90	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19569	10.1371/journal.pone.0019569	http://dx.doi.org/10.1371/journal.pone.0019569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573181	Green Published, gold, Green Submitted			2022-12-27	WOS:000290256400026
J	Comhair, SAA; Gaston, BM; Ricci, KS; Hammel, J; Dweik, RA; Teague, WG; Meyers, D; Ampleford, EJ; Bleecker, ER; Busse, WW; Calhoun, WJ; Castro, M; Chung, KF; Curran-Everett, D; Israel, E; Jarjour, WN; Moore, W; Peters, SP; Wenzel, S; Hazen, SL; Erzurum, SC				Comhair, Suzy A. A.; Gaston, Benjamin M.; Ricci, Kristin S.; Hammel, Jeffrey; Dweik, Raed A.; Teague, W. Gerald; Meyers, Deborah; Ampleford, Elizabeth J.; Bleecker, Eugene R.; Busse, William W.; Calhoun, William J.; Castro, Mario; Chung, Kian Fan; Curran-Everett, Douglas; Israel, Elliot; Jarjour, W. Nizar; Moore, Wendy; Peters, Stephen P.; Wenzel, Sally; Hazen, Stanley L.; Erzurum, Serpil C.		Natl Heart Lung Blood Inst Severe	Detrimental Effects of Environmental Tobacco Smoke in Relation to Asthma Severity	PLOS ONE			English	Article							PASSIVE CIGARETTE-SMOKE; ADULT-ONSET ASTHMA; SUPEROXIDE-DISMUTASE; RESPIRATORY SYMPTOMS; LUNG-FUNCTION; OXIDATIVE STRESS; ANTIOXIDANT CAPACITY; PULMONARY-FUNCTION; HEALTH OUTCOMES; AIRWAY DISEASE	Background: Environmental tobacco smoke (ETS) has adverse effects on the health of asthmatics, however the harmful consequences of ETS in relation to asthma severity are unknown. Methods: In a multicenter study of severe asthma, we assessed the impact of ETS exposure on morbidity, health care utilization and lung functions; and activity of systemic superoxide dismutase (SOD), a potential oxidative target of ETS that is negatively associated with asthma severity. Findings: From 2002-2006, 654 asthmatics (non-severe 366, severe 288) were enrolled, among whom 109 non-severe and 67 severe asthmatics were routinely exposed to ETS as ascertained by history and validated by urine cotinine levels. ETS-exposure was associated with lower quality of life scores; greater rescue inhaler use; lower lung function; greater bronchodilator responsiveness; and greater risk for emergency room visits, hospitalization and intensive care unit admission. ETS-exposure was associated with lower levels of serum SOD activity, particularly in asthmatic women of African heritage. Interpretation: ETS-exposure of asthmatic individuals is associated with worse lung function, higher acuity of exacerbations, more health care utilization, and greater bronchial hyperreactivity. The association of diminished systemic SOD activity to ETS exposure provides for the first time a specific oxidant mechanism by which ETS may adversely affect patients with asthma.	[Gaston, Benjamin M.; Teague, W. Gerald] Univ Virginia, Dept Pediat, Charlottesville, VA USA; [Dweik, Raed A.; Erzurum, Serpil C.] Cleveland Clin, Resp Inst, Cleveland, OH 44106 USA; [Meyers, Deborah; Ampleford, Elizabeth J.; Bleecker, Eugene R.; Moore, Wendy; Peters, Stephen P.] Wake Forest Univ, Winston Salem, NC 27109 USA; [Busse, William W.; Jarjour, W. Nizar] Univ Wisconsin, Dept Internal Med, Madison, WI USA; [Calhoun, William J.] Univ Texas Med Branch Galveston, Dept Internal Med, Galveston, TX USA; [Comhair, Suzy A. A.; Ricci, Kristin S.; Hammel, Jeffrey; Dweik, Raed A.; Erzurum, Serpil C.] Cleveland Clin, Dept Pathobiol, Cleveland, OH 44106 USA; [Castro, Mario] Washington Univ, St Louis, MO USA; [Chung, Kian Fan] Imperial Coll Sch Med, Natl Heart & Lung Inst, London, England; [Curran-Everett, Douglas] Natl Jewish Ctr, Div Biostat, Denver, CO USA; [Israel, Elliot] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Wenzel, Sally] Univ Pittsburgh, Asthma Inst, Pittsburgh, PA USA; [Hazen, Stanley L.] Cleveland Clin, Dept Cell Biol, Cleveland, OH 44106 USA; [Hazen, Stanley L.] Cleveland Clin, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44106 USA	University of Virginia; Cleveland Clinic Foundation; Wake Forest University; University of Wisconsin System; University of Wisconsin Madison; University of Texas System; University of Texas Medical Branch Galveston; Cleveland Clinic Foundation; Washington University (WUSTL); Imperial College London; National Jewish Health; Harvard University; Brigham & Women's Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Comhair, SAA (corresponding author), Cleveland Clin, Dept Pathobiol, Cleveland, OH 44106 USA.	comhais@ccf.org; erzurus@ccf.org	Fain, Sean B./K-4260-2016; Chung, Kian Fan/I-8456-2019; Hazen, Stanley L/ABD-5845-2021; Chung, Kian Fan/B-1872-2012	Fain, Sean B./0000-0001-5461-0646; Chung, Kian Fan/0000-0001-7101-1426; Chung, Kian Fan/0000-0001-7101-1426; Calhoun, William/0000-0001-7075-712X; Curran-Everett, Douglas/0000-0001-5992-4839	NIH [HL081064, HL69170, HL69155, HL069174, HL069167, HL69116, HL69174, HL091762, 1UL1RR024989, 1UL1RR025011, RR03186, RR024992]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005, UL1TR000454, UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011, UL1RR024992, UL1RR024989, M01RR003186] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069167, R01HL069170, P01HL081064, R01HL091762, R01HL069174, R01HL069155, R01HL069116, P01HL103453] Funding Source: NIH RePORTER; Medical Research Council [G0801056B] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by HL081064, HL69170, HL69155, HL069174, HL069167, HL69116, HL69170, HL69174, HL69116, HL091762 and research resources provided by 1UL1RR024989, 1UL1RR025011 and RR03186, RR024992. All the funds are from the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberg AJ, 2000, AM J CLIN NUTR, V72, P1576; [Anonymous], 2000, AM J RESP CRIT CARE, V162, P2341; Arcaroli JJ, 2009, AM J RESP CRIT CARE, V179, P105, DOI 10.1164/rccm.200710-1566OC; Aycicek A, 2005, PEDIATR INT, V47, P635, DOI 10.1111/j.1442-200x.2005.02137.x; Barnoya J, 2005, CIRCULATION, V111, P2684, DOI 10.1161/CIRCULATIONAHA.104.492215; Bayir H, 2007, J NEUROCHEM, V101, P168, DOI 10.1111/j.1471-4159.2006.04353.x; Bernert JT, 1997, CLIN CHEM, V43, P2281; Comhair SAA, 1999, AM J RESP CRIT CARE, V159, P1824, DOI 10.1164/ajrccm.159.6.9810044; Comhair SAA, 2005, AM J RESP CRIT CARE, V172, P306, DOI 10.1164/rccm.200502-180OC; Comhair SAA, 2005, AM J PATHOL, V166, P663, DOI 10.1016/S0002-9440(10)62288-2; Comhair SAA, 2000, LANCET, V355, P624, DOI 10.1016/S0140-6736(99)04736-4; Comhair SAA, 2002, AM J PHYSIOL-LUNG C, V283, pL246, DOI 10.1152/ajplung.00491.2001; Cook DG, 1999, THORAX, V54, P357, DOI 10.1136/thx.54.4.357; DAHMS TE, 1981, CHEST, V80, P530, DOI 10.1378/chest.80.5.530; DeRaeve HR, 1997, AM J PHYSIOL-LUNG C, V272, pL148, DOI 10.1152/ajplung.1997.272.1.L148; Dietrich M, 2003, AM J CLIN NUTR, V77, P160, DOI 10.1093/ajcn/77.1.160; Dweik RA, 2001, P NATL ACAD SCI USA, V98, P2622, DOI 10.1073/pnas.051629498; Eisner MD, 1998, JAMA-J AM MED ASSOC, V280, P1909, DOI 10.1001/jama.280.22.1909; Eisner MD, 2005, THORAX, V60, P814, DOI 10.1136/thx.2004.037283; Eisner MD, 1998, AM J RESP CRIT CARE, V158, P170, DOI 10.1164/ajrccm.158.1.9801028; Eisner MD, 2001, PUBLIC HEALTH REP, V116, P148, DOI 10.1016/S0033-3549(04)50006-7; GASTON B, 1994, AM J RESP CRIT CARE, V149, P538, DOI 10.1164/ajrccm.149.2.7508323; Ghosh S, 2006, J IMMUNOL, V176, P5587, DOI 10.4049/jimmunol.176.9.5587; GREER JR, 1993, J OCCUP ENVIRON MED, V35, P909, DOI 10.1097/00043764-199309000-00014; Hu FB, 1997, J ASTHMA, V34, P67, DOI 10.3109/02770909709071205; Hung RJ, 2004, CARCINOGENESIS, V25, P973, DOI 10.1093/carcin/bgh080; Jaakkola MS, 2006, EUR RESPIR J, V28, P397, DOI 10.1183/09031936.06.00001306; Jaakkola MS, 2003, AM J PUBLIC HEALTH, V93, P2055, DOI 10.2105/AJPH.93.12.2055; Jaakkola MS, 2002, SCAND J WORK ENV HEA, V28, P52; Janson C, 2001, LANCET, V358, P2103, DOI 10.1016/S0140-6736(01)07214-2; JARJOUR NN, 1992, AM REV RESPIR DIS, V146, P905, DOI 10.1164/ajrccm/146.4.905; Jindal S K, 1999, Indian J Chest Dis Allied Sci, V41, P75; JINDAL SK, 1994, CHEST, V106, P746, DOI 10.1378/chest.106.3.746; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Kunzli N, 2000, SOZ PRAVENTIV MED, V45, P208, DOI 10.1007/BF01306015; Larsson ML, 2003, EUR RESPIR J, V21, P672, DOI 10.1183/09031936.03.00033702; LEUENBERGER P, 1994, AM J RESP CRIT CARE, V150, P1222, DOI 10.1164/ajrccm.150.5.7952544; MacPherson JC, 2001, J IMMUNOL, V166, P5763, DOI 10.4049/jimmunol.166.9.5763; MENON P, 1992, J ALLERGY CLIN IMMUN, V89, P560, DOI 10.1016/0091-6749(92)90323-T; MENON PK, 1991, J ALLERGY CLIN IMMUN, V88, P861, DOI 10.1016/0091-6749(91)90242-G; Menzies D, 2006, JAMA-J AM MED ASSOC, V296, P1742, DOI 10.1001/jama.296.14.1742; Moore WC, 2007, J ALLERGY CLIN IMMUN, V119, P405, DOI 10.1016/j.jaci.2006.11.639; Nowak D, 1996, EUR RESPIR J, V9, P652, DOI 10.1183/09031936.96.09040652; Nowak D, 1997, INT ARCH OCC ENV HEA, V69, P125; Oryszczyn MP, 2000, AM J RESP CRIT CARE, V161, P1241, DOI 10.1164/ajrccm.161.4.9905027; OSTRO BD, 1994, AM J RESP CRIT CARE, V149, P1400, DOI 10.1164/ajrccm.149.6.8004290; PRYOR WA, 1983, ENVIRON HEALTH PERSP, V47, P345, DOI 10.1289/ehp.8347345; Rahman I, 1999, AM J PHYSIOL-LUNG C, V277, pL1067, DOI 10.1152/ajplung.1999.277.6.L1067; Rahman I, 2000, THORAX, V55, P189, DOI 10.1136/thorax.55.3.189; Rahman I, 1996, AM J RESP CRIT CARE, V154, P1055, DOI 10.1164/ajrccm.154.4.8887607; Redondo-Horcajo M, 2010, CARDIOVASC RES, V87, P356, DOI 10.1093/cvr/cvq028; Roberts BR, 2007, J MOL BIOL, V373, P877, DOI 10.1016/j.jmb.2007.07.043; SANDSTROM J, 1994, J BIOL CHEM, V269, P19163; SHEPHARD RJ, 1979, ENVIRON RES, V20, P392, DOI 10.1016/0013-9351(79)90015-X; Simoni M, 2007, RESP MED, V101, P531, DOI 10.1016/j.rmed.2006.06.021; Sippel JM, 1999, CHEST, V115, P691, DOI 10.1378/chest.115.3.691; Smith LJ, 1997, FREE RADICAL BIO MED, V22, P1301, DOI 10.1016/S0891-5849(96)00550-3; STANKUS RP, 1988, J ALLERGY CLIN IMMUN, V82, P331, DOI 10.1016/0091-6749(88)90003-6; Thorn J, 2001, ALLERGY, V56, P287, DOI 10.1034/j.1398-9995.2001.00805.x; TREDANIEL J, 1994, EUR RESPIR J, V7, P173, DOI 10.1183/09031936.94.07010173; Venarske DL, 2006, J INFECT DIS, V193, P1536, DOI 10.1086/503809; WIEDEMANN HP, 1986, CHEST, V89, P180, DOI 10.1378/chest.89.2.180; Wu WJ, 2000, J CLIN INVEST, V105, P1455, DOI 10.1172/JCI9702; XU XP, 1995, AM J RESP CRIT CARE, V151, P41, DOI 10.1164/ajrccm.151.1.7812570	64	71	74	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e18574	10.1371/journal.pone.0018574	http://dx.doi.org/10.1371/journal.pone.0018574			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21572527	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000290224800003
J	Schaal, K; Tafflet, M; Nassif, H; Thibault, V; Pichard, C; Alcotte, M; Guillet, T; El Helou, N; Berthelot, G; Simon, S; Toussaint, JF				Schaal, Karine; Tafflet, Muriel; Nassif, Hala; Thibault, Valerie; Pichard, Capucine; Alcotte, Mathieu; Guillet, Thibaut; El Helou, Nour; Berthelot, Geoffroy; Simon, Serge; Toussaint, Jean-Francios			Psychological Balance in High Level Athletes: Gender-Based Differences and Sport-Specific Patterns	PLOS ONE			English	Article							GENERALIZED ANXIETY DISORDER; EATING-DISORDERS; SENSATION-SEEKING; SEX-DIFFERENCES; DEPRESSION; RISK; EXERCISE; PREVALENCE; METAANALYSIS; BEHAVIORS	Objectives: Few epidemiological studies have focused on the psychological health of high level athletes. This study aimed to identify the principal psychological problems encountered within French high level athletes, and the variations in their prevalence based on sex and the sport practiced. Methods: Multivariate analyses were conducted on nationwide data obtained from the athletes' yearly psychological evaluations. Results: A representative sample of 13% of the French athlete population was obtained. 17% of athletes have at least one ongoing or recent disorder, generalized anxiety disorder (GAD) being the most prevalent (6%), followed by non-specific eating disorders (4.2%). Overall, 20.2% of women had at least one psychopathology, against 15.1% in men. This female predominance applied to anxiety and eating disorders, depression, sleep problems and self-harming behaviors. The highest rates of GAD appeared in aesthetic sports (16.7% vs. 6.8% in other sports for men and 38.9% vs. 10.3% for women); the lowest prevalence was found in high risk sports athletes (3.0% vs. 3.5%). Eating disorders are most common among women in racing sports (14% vs. 9%), but for men were found mostly in combat sports (7% vs. 4.8%). Discussion: This study highlights important differences in psychopathology between male and female athletes, demonstrating that the many sex-based differences reported in the general population apply to elite athletes. While the prevalence of psychological problems is no higher than in the general population, the variations in psychopathology in different sports suggest that specific constraints could influence the development of some disorders.	[Schaal, Karine; Tafflet, Muriel; Nassif, Hala; Thibault, Valerie; Pichard, Capucine; Alcotte, Mathieu; Guillet, Thibaut; El Helou, Nour; Berthelot, Geoffroy; Toussaint, Jean-Francios] INSEP, Inst Rech Biomed & Epidemiol Sport IRMES, Paris, France; [Tafflet, Muriel] INSERM, Unit 970, Paris, France; [Nassif, Hala; El Helou, Nour; Toussaint, Jean-Francios] Univ Paris 05, Paris, France; [Pichard, Capucine; Simon, Serge] Ctr Hosp Univ, CAPS, Bordeaux, France; [Pichard, Capucine] INSEP, Dept Med, Paris, France; [Toussaint, Jean-Francios] Assistance Publ Hop Paris, Hotel Dieu, CIMS, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU Bordeaux; Sanofi-Aventis; Sanofi France; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Schaal, K (corresponding author), INSEP, Inst Rech Biomed & Epidemiol Sport IRMES, Paris, France.	karine.schaal@insep.fr	Helou, Nour El/AAH-6490-2021	Helou, Nour El/0000-0002-6012-0042; Schaal, Karine/0000-0001-9215-9665				Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P21; BANGASSER DA, 2010, MOL PSYCHIAT; Beck F, 2007, BAROMETRE SANTE, P608; Burtscher M, 1997, AM SOC TEST MATER, V1289, P23, DOI 10.1520/STP18285S; Byrne S, 2001, J SCI MED SPORT, V4, P145, DOI 10.1016/S1440-2440(01)80025-6; Byrne S, 2002, J SCI MED SPORT, V5, P80, DOI 10.1016/S1440-2440(02)80029-9; CARTON S, 1995, J AFFECT DISORDERS, V34, P219, DOI 10.1016/0165-0327(95)00020-N; Connaughton D, 2008, J SPORT SCI, V26, P83, DOI 10.1080/02640410701310958; Dale KS, 1999, MED SCI SPORT EXER, V31, P1382, DOI 10.1097/00005768-199910000-00004; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Ferrand C, 2005, PERCEPT MOTOR SKILL, V101, P877, DOI 10.2466/PMS.101.7.877-884; Flett GL, 1998, J PERS SOC PSYCHOL, V75, P1363, DOI 10.1037/0022-3514.75.5.1363; Fuller CW, 2007, CLIN J SPORT MED, V17, P182, DOI 10.1097/JSM.0b013e31805930b0; Hariri AR, 2005, ARCH GEN PSYCHIAT, V62, P146, DOI 10.1001/archpsyc.62.2.146; Hicks BM, 2007, J ABNORM PSYCHOL, V116, P433, DOI 10.1037/0021-843X.116.3.433; HOEHNSARIC R, 1985, ACTA PSYCHIAT SCAND, V72, P529, DOI 10.1111/j.1600-0447.1985.tb02650.x; Holt RIG, 2008, BRIT J PHARMACOL, V154, P542, DOI 10.1038/bjp.2008.99; Johnson U, 1997, SCAND J MED SCI SPOR, V7, P367; Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P789, DOI 10.1001/archpsyc.60.8.789; Kerr G. A., 1997, Journal of Sport Behavior, V20, P69; Klinkowski N, 2008, EUR CHILD ADOLES PSY, V17, P108, DOI 10.1007/s00787-007-0643-y; Koivula N, 2002, PERS INDIV DIFFER, V32, P865, DOI 10.1016/S0191-8869(01)00092-7; Kondro W, 2003, LANCET, V362, P1466, DOI 10.1016/S0140-6736(03)14733-2; Kovess-Masfety V, 2009, CAN J PSYCHIAT, V54, P701, DOI 10.1177/070674370905401007; Lakin J A, 1990, J Community Health Nurs, V7, P223, DOI 10.1207/s15327655jchn0704_5; Larkin M, 2004, J COMMUNITY APPL SOC, V14, P215, DOI 10.1002/casp.770; Lawlor DA, 2001, BMJ-BRIT MED J, V322, P763, DOI 10.1136/bmj.322.7289.763; LEDDY MH, 1994, RES Q EXERCISE SPORT, V65, P347, DOI 10.1080/02701367.1994.10607639; Leray E, 2010, EUR PSYCHIA IN PRESS; Looney Marilyn A, 2004, J Appl Meas, V5, P31; Lopez-Soler C, 2009, PSICOTHEMA, V21, P353; Lucia A, 2010, INTJ SPORT PHYSIOL, V5, P98, DOI 10.1123/ijspp.5.1.93; MacArthur D, 2005, HUM GENET, V116, P331, DOI 10.1007/s00439-005-1261-8; Masi G, 2004, J AM ACAD CHILD PSY, V43, P752, DOI 10.1097/01.chi.0000121065.29744.d3; McLean CP, 2009, CLIN PSYCHOL REV, V29, P496, DOI 10.1016/j.cpr.2009.05.003; Michel G, 1997, ENCEPHALE, V23, P403; Oppliger RA, 2003, INT J SPORT NUTR EXE, V13, P29, DOI 10.1123/ijsnem.13.1.29; OPPLIGER RA, 1993, PEDIATRICS, V91, P826; Parker G, 2001, ACTA PSYCHIAT SCAND, V103, P252, DOI 10.1034/j.1600-0447.2001.00375.x; PETRUZZELLO SJ, 1991, SPORTS MED, V11, P143, DOI 10.2165/00007256-199111030-00002; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Pomerantz EM, 1998, CHILD DEV, V69, P458, DOI 10.1111/j.1467-8624.1998.tb06202.x; Preti A, 2009, J PSYCHIATR RES, V43, P1125, DOI 10.1016/j.jpsychires.2009.04.003; Scully D, 1998, BRIT J SPORT MED, V32, P111, DOI 10.1136/bjsm.32.2.111; Smolak L, 2000, INT J EAT DISORDER, V27, P371, DOI 10.1002/(SICI)1098-108X(200005)27:4&lt;371::AID-EAT1&gt;3.0.CO;2-Y; Sundgot-Borgen J, 2004, CLIN J SPORT MED, V14, P25, DOI 10.1097/00042752-200401000-00005; VAMVAKOPOULOS NV, 1995, MEDIAT INFLAMM, V4, P163, DOI 10.1155/S0962935195000275; WILHELM K, 1994, PSYCHOL MED, V24, P97, DOI 10.1017/S0033291700026878; Wipfli BM, 2008, J SPORT EXERCISE PSY, V30, P392, DOI 10.1123/jsep.30.4.392; WITTCHEN HU, 1994, ARCH GEN PSYCHIAT, V51, P355	50	226	244	5	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19007	10.1371/journal.pone.0019007	http://dx.doi.org/10.1371/journal.pone.0019007			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	759EZ	21573222	Green Published, gold, Green Submitted			2022-12-27	WOS:000290224800014
J	Alvarado-Mora, MV; Fernandez, MFG; Gomes-Gouvea, MS; Neto, RSD; Carrilho, FJ; Pinho, JRR				Alvarado-Mora, Monica Viviana; Gutierrez Fernandez, Maria Fernanda; Gomes-Gouvea, Michele Soares; de Azevedo Neto, Raymundo Soares; Carrilho, Flair Jose; Rebello Pinho, Joao Renato			Hepatitis B (HBV), Hepatitis C (HCV) and Hepatitis Delta (HDV) Viruses in the Colombian Population-How Is the Epidemiological Situation?	PLOS ONE			English	Article							LATIN-AMERICA; SOUTH-AMERICA; MOLECULAR CHARACTERIZATION; SANTA-MARTA; GENOTYPE-I; INFECTION; DISEASE; VENEZUELA; SEQUENCE; INDIANS	Background: Viral hepatitis B, C and delta still remain a serious problem worldwide. In Colombia, data from 1980s described that HBV and HDV infection are important causes of hepatitis, but little is known about HCV infection. The aim of this study was to determine the currently frequency of HBV, HCV and HDV in four different Colombian regions. Methodology/Principal Findings: This study was conducted in 697 habitants from 4 Colombian departments: Amazonas, Choco, Magdalena and San Andres Islands. Epidemiological data were obtained from an interview applied to each individual aiming to evaluate risk factors related to HBV, HCV or HDV infections. All samples were tested for HBsAg, anti-HBc, anti-HBs and anti-HCV markers. Samples that were positive to HBsAg and/or anti-HBc were tested to anti-HDV. Concerning the geographical origin of the samples, the three HBV markers showed a statistically significant difference: HBsAg (p = 0.033) and anti-HBc (p < 0.001) were more frequent in Amazonas and Magdalena departments. Isolated anti-HBs (a marker of previous vaccination) frequencies were: Choco (53.26%), Amazonas (32.88%), Magdalena (17.0%) and San Andres (15.33%) p < 0.001. Prevalence of anti-HBc increased with age; HBsAg varied from 1.97 to 8.39% (p = 0.033). Amazonas department showed the highest frequency for anti-HCV marker (5.68%), while the lowest frequency was found in San Andres Island (0.66%). Anti-HDV was found in 9 (5.20%) out of 173 anti-HBc and/or HBsAg positive samples, 8 of them from the Amazonas region and 1 from them Magdalena department. Conclusions/Significance: In conclusion, HBV, HCV and HDV infections are detected throughout Colombia in frequency levels that would place some areas as hyperendemic for HBV, especially those found in Amazonas and Magdalena departments. Novel strategies to increase HBV immunization in the rural population and to strengthen HCV surveillance are reinforced by these results.	[Alvarado-Mora, Monica Viviana; Gomes-Gouvea, Michele Soares; Carrilho, Flair Jose; Rebello Pinho, Joao Renato] Univ Sao Paulo, Sao Paulo Inst Trop Med, Lab Gastroenterol & Hepatol, Sao Paulo, Brazil; [Gutierrez Fernandez, Maria Fernanda] Univ Sao Paulo, Sch Med, Dept Gastroenterol, Sao Paulo, Brazil; [Gutierrez Fernandez, Maria Fernanda] Pontificia Javeriana Univ, Dept Microbiol, Virol Lab, Bogota, Colombia; [de Azevedo Neto, Raymundo Soares] Univ Sao Paulo, Sch Med, Dept Pathol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Pontificia Universidad Javeriana; Universidade de Sao Paulo	Alvarado-Mora, MV (corresponding author), Univ Sao Paulo, Sao Paulo Inst Trop Med, Lab Gastroenterol & Hepatol, Sao Paulo, Brazil.	monica.viviana@usp.br	Alvarado-Mora, Monica/I-3180-2012; Pinho, Joao R. R./G-2850-2012; Carrilho, Flair J/I-3046-2012; Azevedo, Raymundo S/B-7593-2008; Gomes-Gouvea, Michele S/G-4216-2012	Pinho, Joao R. R./0000-0003-3999-0489; Azevedo, Raymundo S/0000-0003-0660-2371; Gomes-Gouvea, Michele S/0000-0001-5932-2360	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2007/53457-7, 2008/50461-6]; CNPq; Sao Paulo, SP, Brazil; Pontificia Universidad Javeriana, Bogota, Colombia	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo, SP, Brazil; Pontificia Universidad Javeriana, Bogota, Colombia	This work has been supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP 2007/53457-7 and 2008/50461-6 and CNPq, Sao Paulo, SP, Brazil and by Pontificia Universidad Javeriana, Bogota, Colombia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Mora MVA, 2011, INFECT GENET EVOL, V11, P103, DOI 10.1016/j.meegid.2010.10.003; Mora MVA, 2010, J MED VIROL, V82, P1889, DOI 10.1002/jmv.21908; Mora MVA, 2010, J GEN VIROL, V91, P501, DOI 10.1099/vir.0.015958-0; Beltran Mauricio, 2005, J Clin Virol, V34 Suppl 2, pS33, DOI 10.1016/S1386-6532(05)80032-0; Bensabath G, 1987, Bull Pan Am Health Organ, V21, P16; Bostan N, 2010, CRIT REV MICROBIOL, V36, P91, DOI 10.3109/10408410903357455; BUITRAGO B, 1986, HEPATOLOGY, V6, P1292, DOI 10.1002/hep.1840060611; Buitrago GB., 1991, BIOMEDICA, V11, P1; Carrilho FJ, 1998, THERAPIES FOR VIRAL HEPATITIS, P25; CASEY JL, 1993, P NATL ACAD SCI USA, V90, P9016, DOI 10.1073/pnas.90.19.9016; CHAO YC, 1990, VIROLOGY, V178, P384; De la Hoz F., 1992, BIOMEDICA, V12, P5; Echevarría José M., 2003, Cad. Saúde Pública, V19, P1583, DOI 10.1590/S0102-311X2003000600003; Espinal C. A., 1998, Biomedica, V18, P216; FAY OH, 1990, VACCINE, V8, pS100, DOI 10.1016/0264-410X(90)90228-E; Gaeta GB, 2000, HEPATOLOGY, V32, P824, DOI 10.1053/jhep.2000.17711; GAYOTTO LCD, 1991, PROG CLIN BIOL RES, V364, P123; Gish RG, 2006, J VIRAL HEPATITIS, V13, P787, DOI 10.1111/j.1365-2893.2006.00787.x; Gomes-Gouvea MS, 2009, J GEN VIROL, V90, P2638, DOI 10.1099/vir.0.013615-0; HADLER SC, 1984, ANN INTERN MED, V100, P339, DOI 10.7326/0003-4819-100-3-339; LAI MMC, 1995, ANNU REV BIOCHEM, V64, P259, DOI 10.1146/annurev.bi.64.070195.001355; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Le Gal F, 2006, EMERG INFECT DIS, V12, P1447, DOI 10.3201/eid1209.060112; LJUNGGREN KE, 1985, HEPATOLOGY, V5, P299, DOI 10.1002/hep.1840050225; MAKINO S, 1987, NATURE, V329, P343, DOI 10.1038/329343a0; Martinez M, 1991, BIOMEDICA, V11, P43; Ministerio de Salud, 1996, MAN NORM TECN ADM PR; Ministerio de Salud, 2002, B EP SEM SIT HEP B C; Pasquier C, 2005, J MED VIROL, V77, P390, DOI 10.1002/jmv.20468; PRIETO F, 2003, BIOMEDICA, V8, P2; Quintero A, 2001, J MED VIROL, V64, P356, DOI 10.1002/jmv.1058; Radjef N, 2004, J VIROL, V78, P2537, DOI 10.1128/JVI.78.5.2537-2544.2004; Ramsey GH, 1931, FEVER JAUNDICE PROVI; REEVES WC, 1975, AM J TROP MED HYG, V24, P873, DOI 10.4269/ajtmh.1975.24.873; Sakugawa H, 1999, J MED VIROL, V58, P366, DOI 10.1002/(SICI)1096-9071(199908)58:4&lt;366::AID-JMV8&gt;3.0.CO;2-X; Schmunis GA, 1998, EMERG INFECT DIS, V4, P5, DOI 10.3201/eid0401.980102; Schmunis GA, 2005, CLIN MICROBIOL REV, V18, P12, DOI 10.1128/CMR.18.1.12-29.2005; Shakil AO, 1997, VIROLOGY, V234, P160, DOI 10.1006/viro.1997.8644; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Slusarczyk J, 2000, VACCINE, V18, pS4, DOI 10.1016/S0264-410X(99)00451-X; Soza A, 2010, ANN HEPATOL, V9, pS30, DOI 10.1016/S1665-2681(19)31720-X; Tanaka J, 2000, VACCINE, V18, pS17, DOI 10.1016/S0264-410X(99)00455-7; Te Helen S, 2010, Clin Liver Dis, V14, P1, DOI 10.1016/j.cld.2009.11.009; Te HS, 2010, CLIN LIVER DIS, V14, pvii, DOI DOI 10.1016/J.CLD.2009.11.009]; Torres JR, 1996, GUT, V38, pS48, DOI 10.1136/gut.38.Suppl_2.S48; WANG KS, 1986, NATURE, V323, P508, DOI 10.1038/323508a0; Watanabe H, 2003, J GEN VIROL, V84, P3275, DOI 10.1099/vir.0.19499-0; World Health Organization, 2001, HEP DELT, P18; Wu JC, 1998, J GEN VIROL, V79, P1105, DOI 10.1099/0022-1317-79-5-1105; Yu H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009297	50	32	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18888	10.1371/journal.pone.0018888	http://dx.doi.org/10.1371/journal.pone.0018888			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559488	Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700033
J	Hedges, DJ; Guettouche, T; Yang, S; Bademci, G; Diaz, A; Andersen, A; Hulme, WF; Linker, S; Mehta, A; Edwards, YJK; Beecham, GW; Martin, ER; Pericak-Vance, MA; Zuchner, S; Vance, JM; Gilbert, JR				Hedges, Dale J.; Guettouche, Toumy; Yang, Shan; Bademci, Guney; Diaz, Ashley; Andersen, Ashley; Hulme, William F.; Linker, Sara; Mehta, Arpit; Edwards, Yvonne J. K.; Beecham, Gary W.; Martin, Eden R.; Pericak-Vance, Margaret A.; Zuchner, Stephan; Vance, Jeffery M.; Gilbert, John R.			Comparison of Three Targeted Enrichment Strategies on the SOLiD Sequencing Platform	PLOS ONE			English	Article							HYBRID SELECTION; DENSITY-FUNCTION; CAPTURE	Despite the ever-increasing throughput and steadily decreasing cost of next generation sequencing (NGS), whole genome sequencing of humans is still not a viable option for the majority of genetics laboratories. This is particularly true in the case of complex disease studies, where large sample sets are often required to achieve adequate statistical power. To fully leverage the potential of NGS technology on large sample sets, several methods have been developed to selectively enrich for regions of interest. Enrichment reduces both monetary and computational costs compared to whole genome sequencing, while allowing researchers to take advantage of NGS throughput. Several targeted enrichment approaches are currently available, including molecular inversion probe ligation sequencing (MIPS), oligonucleotide hybridization based approaches, and PCR-based strategies. To assess how these methods performed when used in conjunction with the ABI SOLID3+, we investigated three enrichment techniques: Nimblegen oligonucleotide hybridization array-based capture; Agilent SureSelect oligonucleotide hybridization solution-based capture; and Raindance Technologies' multiplexed PCR-based approach. Target regions were selected from exons and evolutionarily conserved areas throughout the human genome. Probe and primer pair design was carried out for all three methods using their respective informatics pipelines. In all, approximately 0.8 Mb of target space was identical for all 3 methods. SOLiD sequencing results were analyzed for several metrics, including consistency of coverage depth across samples, on-target versus off-target efficiency, allelic bias, and genotype concordance with array-based genotyping data. Agilent SureSelect exhibited superior on-target efficiency and correlation of read depths across samples. Nimblegen performance was similar at read depths at 20x and below. Both Raindance and Nimblegen SeqCap exhibited tighter distributions of read depth around the mean, but both suffered from lower on-target efficiency in our experiments. Raindance demonstrated the highest versatility in assay design.	[Hedges, Dale J.; Guettouche, Toumy; Bademci, Guney; Diaz, Ashley; Andersen, Ashley; Hulme, William F.; Linker, Sara; Mehta, Arpit; Edwards, Yvonne J. K.; Beecham, Gary W.; Martin, Eden R.; Pericak-Vance, Margaret A.; Zuchner, Stephan; Vance, Jeffery M.; Gilbert, John R.] Univ Miami, Miller Sch Med, Hussman Inst Human Genom, John T MacDonald Dept Human Genet, Miami, FL 33136 USA; [Yang, Shan] Life Technol Inc, Carlsbad, CA USA	University of Miami; Thermo Fisher Scientific	Hedges, DJ (corresponding author), Univ Miami, Miller Sch Med, Hussman Inst Human Genom, John T MacDonald Dept Human Genet, Miami, FL 33136 USA.	dhedges@med.miami.edu		Edwards, Yvonne/0000-0001-8505-3168; Bademci, Guney/0000-0002-4052-8833; Vance, Jeffery/0000-0003-3815-8199	methods development [1RC2HG005605];  [3P50NS071674-01S1]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072248, P50NS071674] Funding Source: NIH RePORTER	methods development; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Sample collection and processing associated with these experiments were funded in part by 3P50NS071674-01S1 (JV). Data analysis was supported by methods development funded through 1RC2HG005605 (EM). The funders had no role in study design, analysis, decision to publish, or preparation of the manuscript.	Bainbridge MN, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r62; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Hodges E, 2009, NAT PROTOC, V4, P960, DOI 10.1038/nprot.2009.68; Lind C, 2010, HUM IMMUNOL, V71, P1033, DOI 10.1016/j.humimm.2010.06.016; Melum E, 2010, HUM MUTAT, V31, P875, DOI 10.1002/humu.21276; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; ROSENBLATT M, 1956, ANN MATH STAT, V27, P832, DOI 10.1214/aoms/1177728190; Summerer D, 2009, GENOMICS, V94, P363, DOI 10.1016/j.ygeno.2009.08.012; Teer JK, 2010, GENOME RES, V20, P1420, DOI 10.1101/gr.106716.110; Tewhey R, 2009, NAT BIOTECHNOL, V27, P1025, DOI 10.1038/nbt.1583	12	53	56	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18595	10.1371/journal.pone.0018595	http://dx.doi.org/10.1371/journal.pone.0018595			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559511	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700015
J	Ibarrola-Villava, M; Fernandez, LP; Alonso, S; Boyano, MD; Pena-Chilet, M; Pita, G; Aviles, JA; Mayor, M; Gomez-Fernandez, C; Casado, B; Martin-Gonzalez, M; Izagirre, N; De la Rua, C; Asumendi, A; Perez-Yarza, G; Arroyo-Berdugo, Y; Boldo, E; Lozoya, R; Torrijos-Aguilar, A; Pitarch, A; Pitarch, G; Sanchez-Motilla, JM; Valcuende-Cavero, F; Tomas-Cabedo, G; Perez-Pastor, G; Diaz-Perez, JL; Gardeazabal, J; de Lizarduy, IM; Sanchez-Diez, A; Valdes, C; Pizarro, A; Casado, M; Carretero, G; Botella-Estrada, R; Nagore, E; Lazaro, P; Lluch, A; Benitez, J; Martinez-Cadenas, C; Ribas, G				Ibarrola-Villava, Maider; Fernandez, Lara P.; Alonso, Santos; Dolores Boyano, M.; Pena-Chilet, Maria; Pita, Guillermo; Aviles, Jose A.; Mayor, Matias; Gomez-Fernandez, Cristina; Casado, Beatriz; Martin-Gonzalez, Manuel; Izagirre, Neskuts; De la Rua, Concepcion; Asumendi, Aintzane; Perez-Yarza, Gorka; Arroyo-Berdugo, Yoana; Boldo, Enrique; Lozoya, Rafael; Torrijos-Aguilar, Arantxa; Pitarch, Ana; Pitarch, Gerard; Sanchez-Motilla, Jose M.; Valcuende-Cavero, Francisca; Tomas-Cabedo, Gloria; Perez-Pastor, Gemma; Diaz-Perez, Jose L.; Gardeazabal, Jesus; Martinez de Lizarduy, Inigo; Sanchez-Diez, Ana; Valdes, Carlos; Pizarro, Angel; Casado, Mariano; Carretero, Gregorio; Botella-Estrada, Rafael; Nagore, Eduardo; Lazaro, Pablo; Lluch, Ana; Benitez, Javier; Martinez-Cadenas, Conrado; Ribas, Gloria			A Customized Pigmentation SNP Array Identifies a Novel SNP Associated with Melanoma Predisposition in the SLC45A2 Gene	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; MALIGNANT-MELANOMA; OCULOCUTANEOUS ALBINISM; CUTANEOUS MELANOMA; TRANSCRIPTIONAL REGULATION; SKIN PIGMENTATION; COLOR VARIATION; RECEPTOR GENE; MATP GENE; VARIANTS	As the incidence of Malignant Melanoma (MM) reflects an interaction between skin colour and UV exposure, variations in genes implicated in pigmentation and tanning response to UV may be associated with susceptibility to MM. In this study, 363 SNPs in 65 gene regions belonging to the pigmentation pathway have been successfully genotyped using a SNP array. Five hundred and ninety MM cases and 507 controls were analyzed in a discovery phase I. Ten candidate SNPs based on a p-value threshold of 0.01 were identified. Two of them, rs35414 (SLC45A2) and rs2069398 (SILV/CKD2), were statistically significant after conservative Bonferroni correction. The best six SNPs were further tested in an independent Spanish series (624 MM cases and 789 controls). A novel SNP located on the SLC45A2 gene (rs35414) was found to be significantly associated with melanoma in both phase I and phase II (P < 0.0001). None of the other five SNPs were replicated in this second phase of the study. However, three SNPs in TYR, SILV/CDK2 and ADAMTS20 genes (rs17793678, rs2069398 and rs1510521 respectively) had an overall p-value < 0.05 when considering the whole DNA collection (1214 MM cases and 1296 controls). Both the SLC45A2 and the SILV/CDK2 variants behave as protective alleles, while the TYR and ADAMTS20 variants seem to function as risk alleles. Cumulative effects were detected when these four variants were considered together. Furthermore, individuals carrying two or more mutations in MC1R, a well-known low penetrance melanoma-predisposing gene, had a decreased MM risk if concurrently bearing the SLC45A2 protective variant. To our knowledge, this is the largest study on Spanish sporadic MM cases to date.	[Ibarrola-Villava, Maider; Pena-Chilet, Maria; Lluch, Ana; Ribas, Gloria] Fdn Hosp Clin Univ INCLIVA, Serv Oncol Med & Hematol, Valencia, Spain; [Ibarrola-Villava, Maider; Fernandez, Lara P.; Pita, Guillermo; Benitez, Javier; Ribas, Gloria] CNIO, Programa Genet Humana, Madrid, Spain; [Alonso, Santos; Izagirre, Neskuts; De la Rua, Concepcion] Univ Basque Country, Dept Genet Antropol Fis & Fisiol Anim, Leioa, Spain; [Dolores Boyano, M.; Asumendi, Aintzane; Perez-Yarza, Gorka; Arroyo-Berdugo, Yoana] Univ Basque Country, Dept Biol Celular & Histol, Leioa, Spain; [Aviles, Jose A.; Lazaro, Pablo] Hosp Gen Gregorio Maranon, Dept Dermatol, Madrid, Spain; [Mayor, Matias; Gomez-Fernandez, Cristina; Casado, Beatriz; Pizarro, Angel; Casado, Mariano] Hosp La Paz, Dept Dermatol, Madrid, Spain; [Martin-Gonzalez, Manuel] Hosp Ramon & Cajal, Dept Dermatol, E-28034 Madrid, Spain; [Boldo, Enrique; Lozoya, Rafael] Hosp Prov Castellon, Unidad Cirugia Oncol, Castellon de La Plana, Spain; [Torrijos-Aguilar, Arantxa] Hosp Prov Castellon, Serv Dermatol, Castellon de La Plana, Spain; [Pitarch, Ana; Pitarch, Gerard; Sanchez-Motilla, Jose M.] Hosp Gen Castellon, Serv Dermatol, Castellon de La Plana, Spain; [Valcuende-Cavero, Francisca; Tomas-Cabedo, Gloria; Perez-Pastor, Gemma] Hosp La Plana, Serv Dermatol, Vila Real, Castellon, Spain; [Diaz-Perez, Jose L.] Hosp Cruces, Serv Dermatol, Baracaldo, Spain; [Gardeazabal, Jesus; Martinez de Lizarduy, Inigo; Sanchez-Diez, Ana; Valdes, Carlos] Hosp Basurto, Serv Dermatol, Bilbao, Spain; [Carretero, Gregorio] Hosp Dr Negrin, Dept Dermatol, Las Palmas Gran Canaria, Spain; [Botella-Estrada, Rafael; Nagore, Eduardo] Inst Valenciano Oncol, Valencia, Spain; [Martinez-Cadenas, Conrado] Hosp Prov Castellon, Lab Biopatol Mol, Castellon de La Plana, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); University of Basque Country; University of Basque Country; General University Gregorio Maranon Hospital; Hospital Universitario La Paz; Hospital Universitario Ramon y Cajal; Hospital Universitario Cruces; Basurto Hospital; Instituto Valenciano De Oncologia	Ibarrola-Villava, M (corresponding author), Fdn Hosp Clin Univ INCLIVA, Serv Oncol Med & Hematol, Valencia, Spain.	martinezconrado@yahoo.es	Nagore, Eduardo/Z-2126-2019; Gardeazabal, Jesus/E-1751-2012; Álvarez, Lara Fernández/Z-4685-2019; Alonso, Santos/L-8316-2014; Peña-Chilet, Maria/A-8387-2015; Ribas-Despuig, Gloria/M-6190-2017; Perez-Yarza, Gorka/ABF-7159-2021; Boldo, Enrique/AAP-7388-2020; Lluch, Ana/R-5493-2019; Asumendi, Aintzane/ABF-7001-2021; BOYANO LOPEZ, MARIA DOLORES/ABF-6668-2021; Alvarez, Lara Paula Fernandez/ABF-3692-2020; Boyano, Maria Dolores/D-9114-2012; Ribas, Gloria/K-3379-2013	Nagore, Eduardo/0000-0003-3433-8707; Alonso, Santos/0000-0003-0221-4048; Peña-Chilet, Maria/0000-0002-6445-9617; Boldo, Enrique/0000-0001-6866-9796; Lluch, Ana/0000-0003-2766-407X; BOYANO LOPEZ, MARIA DOLORES/0000-0001-6051-1054; Bowcock, Anne/0000-0001-8691-9090; IZAGIRRE ARRIBALZAGA, NESKUTS/0000-0002-3345-9825; Ibarrola-Villava, Maider/0000-0003-0946-8075; Valcuende-Cavero, Francisca/0000-0002-4033-0771; Fernandez Alvarez, Lara Paula/0000-0001-8830-6300; DE LA RUA VACA, CONCEPCION/0000-0003-4599-0020; PEREZYARZA, GORKA/0000-0003-3236-491X; Ribas, Gloria/0000-0001-6883-4130; Asumendi, Aintzane/0000-0002-2156-2323	Ministerio de Educacion y Ciencia (MEC) [SAF2007-65542-C02-01, SAF2009_07072E, BES-2008-009234, CP08-0069]; Ministerio de Ciencia e Innovacion [CGL2008-04066/BOS]; Fundacion Mutua Madrilena and the Fundacion Hospital Provincial de Castellon, Spain;  [RD06-0020-1060]	Ministerio de Educacion y Ciencia (MEC)(Spanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Mutua Madrilena and the Fundacion Hospital Provincial de Castellon, Spain; 	This study was supported by grants from the Ministerio de Educacion y Ciencia (MEC) [SAF2007-65542-C02-01, SAF2009_07072E; BES-2008-009234 to M.I.V. and CP08-0069 "Miquel Servet SNS Contract'' to G.R.]; Ministerio de Ciencia e Innovacion [CGL2008-04066/BOS]; Network RD06-0020-1060; the Fundacion Mutua Madrilena and the Fundacion Hospital Provincial de Castellon, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-74; BAKKER ABH, 1994, J EXP MED, V179, P1005, DOI 10.1084/jem.179.3.1005; Bataille V, 2003, EUR J CANCER, V39, P1341, DOI 10.1016/S0959-8049(03)00313-7; Berson JF, 2001, MOL BIOL CELL, V12, P3451, DOI 10.1091/mbc.12.11.3451; Bishop JAN, 2005, DRUG TODAY, V41, P193, DOI 10.1358/dot.2005.41.3.892524; Bishop JN, 2006, BRIT J HOSP MED, V67, P299; Brown KM, 2008, NAT GENET, V40, P838, DOI 10.1038/ng.163; Costin GE, 2003, J CELL SCI, V116, P3203, DOI 10.1242/jcs.00598; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Du JY, 2002, J BIOL CHEM, V277, P402, DOI 10.1074/jbc.M110229200; Duffy DL, 2010, AM J HUM GENET, V87, P6, DOI 10.1016/j.ajhg.2010.05.017; Duffy DL, 2010, J INVEST DERMATOL, V130, P520, DOI 10.1038/jid.2009.258; Duffy DL, 2004, HUM MOL GENET, V13, P447, DOI 10.1093/hmg/ddh043; Fargnoli MC, 2006, MELANOMA RES, V16, P175, DOI 10.1097/01.cmr.0000198454.11580.b5; Fernandez L, 2008, HUM MUTAT, V29, P1161, DOI 10.1002/humu.20804; Fernandez LP, 2007, CARCINOGENESIS, V28, P1659, DOI 10.1093/carcin/bgm084; Fernandez LP, 2009, EXP DERMATOL, V18, P634, DOI 10.1111/j.1600-0625.2009.00846.x; Fukamachi S, 2001, NAT GENET, V28, P381, DOI 10.1038/ng584; Gerstenblith MR, 2007, HUM MUTAT, V28, P495, DOI 10.1002/humu.20476; Graf J, 2005, HUM MUTAT, V25, P278, DOI 10.1002/humu.20143; Graf J, 2007, HUM MUTAT, V28, P710, DOI 10.1002/humu.20504; Gudbjartsson DF, 2008, NAT GENET, V40, P886, DOI 10.1038/ng.161; Guedj M, 2008, HUM MUTAT, V29, P1154, DOI 10.1002/humu.20823; Gunnarsson U, 2007, GENETICS, V175, P867, DOI 10.1534/genetics.106.063107; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; Hearing VJ, 2005, J DERMATOL SCI, V37, P3, DOI 10.1016/j.jdermsci.2004.08.014; Ibarrola-Villava M, EXP DERMATOL, V19, P836; Kushimoto T, 2003, PIGM CELL RES, V16, P237, DOI 10.1034/j.1600-0749.2003.00034.x; Laayouni H, 2010, HUM GENET, V127, P455, DOI 10.1007/s00439-010-0798-3; LERNER AB, 1949, J BIOL CHEM, V178, P185; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Mariat D, 2003, GENET SEL EVOL, V35, P119, DOI 10.1051/gse:2002039; Matichard E, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011536; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Mohrenweiser HW, 2003, MUTAT RES-FUND MOL M, V526, P93, DOI 10.1016/S0027-5107(03)00049-6; Newton JM, 2001, AM J HUM GENET, V69, P981, DOI 10.1086/324340; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Ontology TG, 2000, NAT GENET, V25; Rao C, 2003, DEVELOPMENT, V130, P4665, DOI 10.1242/dev.00668; Ray K, 2007, PROG RETIN EYE RES, V26, P323, DOI 10.1016/j.preteyeres.2007.01.001; Rees JL, 2004, AM J HUM GENET, V75, P739, DOI 10.1086/425285; Saenz S, 2005, ACTAS DERMO-SIFILOGR, V96, P411, DOI 10.1016/S0001-7310(05)73105-7; Scherer D, 2009, INT J CANCER, V125, P1868, DOI 10.1002/ijc.24548; Silver DL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000003; Soejima M, 2006, MOL BIOL EVOL, V23, P179, DOI 10.1093/molbev/msj018; Sturm RA, 2004, TRENDS GENET, V20, P327, DOI 10.1016/j.tig.2004.06.010; Sulem P, 2008, NAT GENET, V40, P835, DOI 10.1038/ng.160; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Theos AC, 2005, PIGM CELL RES, V18, P322, DOI 10.1111/j.1600-0749.2005.00269.x; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328	51	18	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19271	10.1371/journal.pone.0019271	http://dx.doi.org/10.1371/journal.pone.0019271			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559390	Green Submitted, gold, Green Published			2022-12-27	WOS:000290024700121
J	Lau, C; Zhou, IY; Cheung, MM; Chan, KC; Wu, EX				Lau, Condon; Zhou, Iris Y.; Cheung, Matthew M.; Chan, Kevin C.; Wu, Ed X.			BOLD Temporal Dynamics of Rat Superior Colliculus and Lateral Geniculate Nucleus following Short Duration Visual Stimulation	PLOS ONE			English	Article							EVENT-RELATED FMRI; FUNCTIONAL MRI; MODEL; RESPONSES; REDUCTION; CONTRAST; GRADIENT; STIMULUS; CORTEX; ECHO	Background: The superior colliculus (SC) and lateral geniculate nucleus (LGN) are important subcortical structures for vision. Much of our understanding of vision was obtained using invasive and small field of view (FOV) techniques. In this study, we use non-invasive, large FOV blood oxygenation level-dependent (BOLD) fMRI to measure the SC and LGN's response temporal dynamics following short duration (1 s) visual stimulation. Methodology/Principal Findings: Experiments are performed at 7 tesla on Sprague Dawley rats stimulated in one eye with flashing light. Gradient-echo and spin-echo sequences are used to provide complementary information. An anatomical image is acquired from one rat after injection of monocrystalline iron oxide nanoparticles (MION), a blood vessel contrast agent. BOLD responses are concentrated in the contralateral SC and LGN. The SC BOLD signal measured with gradient-echo rises to 50% of maximum amplitude (PEAK) 0.2 +/- 0.2 s before the LGN signal (p < 0.05). The LGN signal returns to 50% of PEAK 1.4 +/- 1.2 s before the SC signal (p < 0.05). These results indicate the SC signal rises faster than the LGN signal but settles slower. Spin-echo results support these findings. The post-MION image shows the SC and LGN lie beneath large blood vessels. This subcortical vasculature is similar to that in the cortex, which also lies beneath large vessels. The LGN lies closer to the large vessels than much of the SC. Conclusions/Significance: The differences in response timing between SC and LGN are very similar to those between deep and shallow cortical layers following electrical stimulation, which are related to depth-dependent blood vessel dilation rates. This combined with the similarities in vasculature between subcortex and cortex suggest the SC and LGN timing differences are also related to depth-dependent dilation rates. This study shows for the first time that BOLD responses in the rat SC and LGN following short duration visual stimulation are temporally different.	[Lau, Condon; Zhou, Iris Y.; Cheung, Matthew M.; Chan, Kevin C.; Wu, Ed X.] Univ Hong Kong, Lab Biomed Imaging & Signal Proc, Hong Kong, Hong Kong, Peoples R China; [Lau, Condon; Zhou, Iris Y.; Cheung, Matthew M.; Chan, Kevin C.; Wu, Ed X.] Univ Hong Kong, Dept Elect & Elect Engn, Hong Kong, Hong Kong, Peoples R China; [Wu, Ed X.] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Wu, Ed X.] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Lau, C (corresponding author), Univ Hong Kong, Lab Biomed Imaging & Signal Proc, Hong Kong, Hong Kong, Peoples R China.	ewu@eee.hku.hk	Cheung, Matthew Man Hin/ABD-6962-2021; Zhou, Iris Yuwen/A-2089-2017; Chan, Kevin C/AAK-7665-2020; Zhou, Yuwen/D-8009-2013; Wu, Ed Xuekui/C-1579-2009	Cheung, Matthew Man Hin/0000-0002-3477-6865; Zhou, Iris Yuwen/0000-0002-4351-7398; Chan, Kevin C/0000-0003-4012-7084; Wu, Ed Xuekui/0000-0001-5581-1546	Hong Kong Research Grants Council [GRF HKU 7793/08M, GRF HKU 7808/09 M]	Hong Kong Research Grants Council(Hong Kong Research Grants Council)	This work was supported by the Hong Kong Research Grants Council (GRF HKU 7793/08M and GRF HKU 7808/09 M; http://www.ugc.edu.hk/eng/rgc/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Calkins DJ, 2008, INVEST OPHTH VIS SCI, V49, P5083, DOI 10.1167/iovs.08-2205; Chan KC, 2008, NEUROIMAGE, V40, P1166, DOI 10.1016/j.neuroimage.2008.01.002; Chan KC, 2011, NEUROIMAGE, V54, P389, DOI 10.1016/j.neuroimage.2010.07.015; Chan KC, 2010, NEUROIMAGE, V49, P2013, DOI 10.1016/j.neuroimage.2009.10.069; Chan KC, 2009, EXP EYE RES, V88, P61, DOI 10.1016/j.exer.2008.10.002; Clare S, 1999, MAGNET RESON MED, V42, P1117, DOI 10.1002/(SICI)1522-2594(199912)42:6<1117::AID-MRM16>3.0.CO;2-J; Cooper BG, 1998, HIPPOCAMPUS, V8, P340, DOI 10.1002/(SICI)1098-1063(1998)8:4<340::AID-HIPO4>3.0.CO;2-L; Dennie J, 1998, MAGN RESON MED, V40, P793, DOI 10.1002/mrm.1910400602; DuBois RM, 2000, NEUROIMAGE, V12, P63, DOI 10.1006/nimg.2000.0590; Dubowitz DJ, 1998, NEUROREPORT, V9, P2213, DOI 10.1097/00001756-199807130-00012; Goodall N, 2009, EXP EYE RES, V89, P511, DOI 10.1016/j.exer.2009.05.014; Himmelbach M, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-66; Huang W, 1996, P NATL ACAD SCI USA, V93, P6037, DOI 10.1073/pnas.93.12.6037; Jezzard P, 1997, MAGNET RESON MED, V38, P699, DOI 10.1002/mrm.1910380504; Liu TT, 2004, NEUROIMAGE, V21, P387, DOI 10.1016/j.neuroimage.2003.09.030; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Mandeville JB, 1999, J CEREBR BLOOD F MET, V19, P679, DOI 10.1097/00004647-199906000-00012; MARTIN PR, 1986, EXP BRAIN RES, V62, P77; Masamoto K, 2007, CEREB CORTEX, V17, P942, DOI 10.1093/cercor/bhl005; MOLOTCHNIKOFF S, 1986, EXP BRAIN RES, V62, P321; MOLOTCHNIKOFF S, 1983, BRAIN RES BULL, V10, P719, DOI 10.1016/0361-9230(83)90041-2; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Naismith RT, 2009, NEUROLOGY, V72, P589, DOI 10.1212/01.wnl.0000335766.22758.cd; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Paulson OB, 2010, J CEREBR BLOOD F MET, V30, P2, DOI 10.1038/jcbfm.2009.188; Pawela CP, 2008, NEUROIMAGE, V41, P525, DOI 10.1016/j.neuroimage.2008.02.022; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Polyak S., 1957, VERTEBRATE VISUAL SY; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; SAHIBZADA N, 1986, J NEUROSCI, V6, P723; Scremin OU, 2004, RAT NERVOUS SYSTEM; Sefton AJ, 2004, RAT NERVOUS SYSTEM; Silva AC, 2002, P NATL ACAD SCI USA, V99, P15182, DOI 10.1073/pnas.222561899; Tian PF, 2010, P NATL ACAD SCI USA, V107, P15246, DOI 10.1073/pnas.1006735107; Uludag K, 2009, NEUROIMAGE, V48, P150, DOI 10.1016/j.neuroimage.2009.05.051; Van Camp N, 2006, J NEUROPHYSIOL, V95, P3164, DOI 10.1152/jn.00400.2005; Van Camp N, 2005, J MAGN RESON IMAGING, V22, P483, DOI 10.1002/jmri.20417; Wall MB, 2009, NEUROIMAGE, V47, P1620, DOI 10.1016/j.neuroimage.2009.05.094; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024; Wu EX, 2004, NMR BIOMED, V17, P507, DOI 10.1002/nbm.921; Wu EX, 2004, NEUROSCI LETT, V365, P223, DOI 10.1016/j.neulet.2004.05.004; XUE JT, 1994, VISUAL NEUROSCI, V11, P1059, DOI 10.1017/S095252380000688X; Zhao FQ, 2004, MAGN RESON MED, V51, P518, DOI 10.1002/mrm.10720	45	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18914	10.1371/journal.pone.0018914	http://dx.doi.org/10.1371/journal.pone.0018914			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559482	Green Published, gold			2022-12-27	WOS:000290024700035
J	Otsuka, Y; Osaka, N; Yaoi, K; Osaka, M				Otsuka, Yuki; Osaka, Naoyuki; Yaoi, Ken; Osaka, Mariko			First-Person Perspective Effects on Theory of Mind without Self-Reference	PLOS ONE			English	Article							SOCIAL COGNITION; PREFRONTAL CORTEX; RHESUS-MONKEYS; ROLE REVERSAL; COMPREHENSION; SYSTEM; BRAIN; METAANALYSIS; CHIMPANZEES; KNOWLEDGE	This study examined dissociations between brain networks involved in theory of mind, which is needed for guessing others' mental states, and the self, which might constitute the basis for theory of mind's development. We used event-related fMRI to compare a condition that required participants to guess the mental state of a subject featured in first-person perspective sentences (1stPP condition) with a third-person perspective sentence condition (3rdPP condition). The caudate nucleus was marginally more activated in the 1stPP than in the 3rdPP condition, while the left dorsolateral prefrontal cortex (DLPFC) was significantly more activated in the 3rdPP condition as compared to the 1stPP condition. Furthermore, we examined the correlation between activation (signal intensity) of the caudate nucleus and left DLPFC with that of the right DLPFC, which is thought to be closely connected with sense of self. We found a significant correlation between caudate nucleus and right DLPFC activation in the 1stPP condition, and between left and right DLPFC activation in the 3rdPP condition. Although theory of mind and the self both appear to recruit the right DLPFC, this region seems to be accessed through the left DLPFC during theory of mind tasks, but through the caudate nucleus when tasks require self reference.	[Otsuka, Yuki; Osaka, Naoyuki; Yaoi, Ken] Kyoto Univ, Dept Psychol, Grad Sch Letters, Kyoto, Japan; [Osaka, Mariko] Osaka Univ, Dept Psychol, Suita, Osaka, Japan	Kyoto University; Osaka University	Otsuka, Y (corresponding author), Kyoto Univ, Dept Psychol, Grad Sch Letters, Kyoto, Japan.	yotsuka@bun.kyoto-u.ac.jp		Lauwereyns, Jan/0000-0003-0551-2550	Japan Society for the Promotion of Science [20830041, 19203032, 16203037]; MEXT, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by research grants from the Japan Society for the Promotion of Science (20830041, 19203032, 16203037 to YO, NO, and MO, respectively) and in part by the Global COE Program "Revitalizing Education for Dynamic Hearts and Minds," MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew ZK, 2007, BRAIN RES REV, V54, P286, DOI 10.1016/j.brainresrev.2007.04.003; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Blackwood NJ, 2003, NEUROIMAGE, V20, P1076, DOI 10.1016/S1053-8119(03)00331-8; Brett M., 2002, 8 INT C FUNCT MAPP H, DOI DOI 10.1016/S1053-8119(02)90010-8; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Ferstl EC, 2002, NEUROIMAGE, V17, P1599, DOI 10.1006/nimg.2002.1247; Ferstl EC, 2008, HUM BRAIN MAPP, V29, P581, DOI 10.1002/hbm.20422; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; GOEL V, 1995, NEUROREPORT, V6, P1741, DOI 10.1097/00001756-199509000-00009; Hadjikhani N, 2006, CEREB CORTEX, V16, P1276, DOI 10.1093/cercor/bh069; Johnson SC, 2005, J COGNITIVE NEUROSCI, V17, P1897, DOI 10.1162/089892905775008607; Keenan JP, 2000, TRENDS COGN SCI, V4, P338, DOI 10.1016/S1364-6613(00)01521-7; Keenan JP, 2005, CORTEX, V41, P695, DOI 10.1016/S0010-9452(08)70286-7; Legrand D, 2009, PSYCHOL REV, V116, P252, DOI 10.1037/a0014172; Markowitsch HJ, 1999, CORTEX, V35, P243, DOI 10.1016/S0010-9452(08)70797-4; Markowitsch HJ, 1997, PSYCHIAT RES-NEUROIM, V74, P119, DOI 10.1016/S0925-4927(97)03041-2; Otsuka Y, 2009, NEUROSCI LETT, V463, P150, DOI 10.1016/j.neulet.2009.07.064; POVINELLI DJ, 1992, ANIM BEHAV, V43, P633, DOI 10.1016/0003-3472(92)90085-N; POVINELLI DJ, 1991, J COMP PSYCHOL, V105, P318, DOI 10.1037/0735-7036.105.4.318; POVINELLI DJ, 1992, ANIM BEHAV, V44, P269, DOI 10.1016/0003-3472(92)90033-6; POVINELLI DJ, 1990, J COMP PSYCHOL, V104, P203, DOI 10.1037/0735-7036.104.3.203; Ritblatt SN, 2000, J GENET PSYCHOL, V161, P53, DOI 10.1080/00221320009596694; Rochat P, 1998, EXP BRAIN RES, V123, P102, DOI 10.1007/s002210050550; Saxe R, 2004, ANNU REV PSYCHOL, V55, P87, DOI 10.1146/annurev.psych.55.090902.142044; Talairach J., 1988, COPLANAR STEREOTAXIC; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Vogeley K, 2001, NEUROIMAGE, V14, P170, DOI 10.1006/nimg.2001.0789; Yaoi K, 2009, SOC NEUROSCI-UK, V4, P455, DOI 10.1080/17470910903027808	29	4	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19320	10.1371/journal.pone.0019320	http://dx.doi.org/10.1371/journal.pone.0019320			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	756OZ	21559448	Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700132
J	Ran, CZ; Zhao, W; Moir, RD; Moore, A				Ran, Chongzhao; Zhao, Wei; Moir, Robert D.; Moore, Anna			Non-Conjugated Small Molecule FRET for Differentiating Monomers from Higher Molecular Weight Amyloid Beta Species	PLOS ONE			English	Article							THIOFLAVIN-T BINDING; ALZHEIMERS-DISEASE; A-BETA; CEREBROSPINAL-FLUID; OLIGOMERS; PEPTIDE; FIBRILS; MEMORY; FIBRILLOGENESIS; MECHANISM	Background: Systematic differentiation of amyloid (A beta) species could be important for diagnosis of Alzheimer's disease (AD). In spite of significant progress, controversies remain regarding which species are the primary contributors to the AD pathology, and which species could be used as the best biomarkers for its diagnosis. These controversies are partially caused by the lack of reliable methods to differentiate the complicated subtypes of A beta species. Particularly, differentiation of A beta monomers from toxic higher molecular weight species (HrMW) would be beneficial for drug screening, diagnosis, and molecular mechanism studies. However, fast and cheap methods for these specific aims are still lacking. Principal Findings: We demonstrated the feasibility of a non-conjugated FRET (Forster resonance energy transfer) technique that utilized amyloid beta (A beta) species as intrinsic platforms for the FRET pair assembly. Mixing two structurally similar curcumin derivatives that served as the small molecule FRET pair with A beta 40 aggregates resulted in a FRET signal, while no signal was detected when using A beta 40 monomer solution. Lastly, this FRET technique enabled us to quantify the concentrations of A beta monomers and high molecular weight species in solution. Significance: We believe that this FRET technique could potentially be used as a tool for screening for inhibitors of A beta aggregation. We also suggest that this concept could be generalized to other misfolded proteins/peptides implicated in various pathologies including amyloid in diabetes, prion in bovine spongiform encephalopathy, tau protein in AD, and alpha-synuclein in Parkinson disease.	[Ran, Chongzhao; Zhao, Wei; Moore, Anna] Harvard Univ, MGH MIT HMS Athinoula A Martinos Ctr Biomed Imagi, Massachusetts Gen Hosp, Mol Imaging Lab,Dept Radiol,Sch Med, Charlestown, MA USA; [Moir, Robert D.] Massachusetts Gen Hosp, Dept Neurol, Alzheimers Dis Res Unit, Charlestown, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Ran, CZ (corresponding author), Harvard Univ, MGH MIT HMS Athinoula A Martinos Ctr Biomed Imagi, Massachusetts Gen Hosp, Mol Imaging Lab,Dept Radiol,Sch Med, Charlestown, MA USA.	amoore@helix.mgh.harvard.edu	Moir, Robert D./M-7612-2017	Moir, Robert D./0000-0001-5431-3553	NIA [K25AG036760]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K25AG036760] Funding Source: NIH RePORTER	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by K25AG036760 award from NIA to C.R. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Biancalana M, 2009, J MOL BIOL, V385, P1052, DOI 10.1016/j.jmb.2008.11.006; Buerger K, 2009, EXP GERONTOL, V44, P579, DOI 10.1016/j.exger.2009.06.003; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Groenning M., 2009, J CHEM BIOL; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HAMLEY IW, 2007, ANGEW CHEM INT ED EN, V46; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Lindgren M, 2010, FEBS J, V277, P1380, DOI 10.1111/j.1742-4658.2010.07571.x; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Maezawa I, 2008, J NEUROCHEM, V104, P457, DOI 10.1111/j.1471-4159.2007.04972.x; McLaurin J, 2000, J BIOL CHEM, V275, P18495, DOI 10.1074/jbc.M906994199; Moir RD, 2005, J BIOL CHEM, V280, P17458, DOI 10.1074/jbc.M414176200; Morley JE, 2010, J ALZHEIMERS DIS, V19, P441, DOI [10.3233/JAD-2009-1230, 10.3233/JAD-2010-1230]; Ran CZ, 2009, J AM CHEM SOC, V131, P15257, DOI 10.1021/ja9047043; Schoonenboom NSM, 2005, CLIN CHEM, V51, P189, DOI 10.1373/clinchem.2004.039735; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Smith NW, 2009, BIOORGAN MED CHEM, V17, P2366, DOI 10.1016/j.bmc.2009.02.016; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Venkateswarlu S, 2005, BIOORGAN MED CHEM, V13, P6374, DOI 10.1016/j.bmc.2005.06.050; Verwey NA, 2009, ANN CLIN BIOCHEM, V46, P235, DOI 10.1258/acb.2009.008232; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200	28	32	42	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19362	10.1371/journal.pone.0019362	http://dx.doi.org/10.1371/journal.pone.0019362			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559413	Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700148
J	Fonseca, F; de la Torre, R; Diaz, L; Pastor, A; Cuyas, E; Pizarro, N; Khymenets, O; Farre, M; Torrens, M				Fonseca, Francina; de la Torre, Rafael; Diaz, Laura; Pastor, Antonio; Cuyas, Elisabet; Pizarro, Nieves; Khymenets, Olha; Farre, Magi; Torrens, Marta			Contribution of Cytochrome P450 and ABCB1 Genetic Variability on Methadone Pharmacokinetics, Dose Requirements, and Response	PLOS ONE			English	Article							OPIOID RECEPTOR GENE; COMORBID PSYCHIATRIC-DISORDERS; STEADY-STATE CONCENTRATIONS; MULTIDRUG-RESISTANCE GENE; HUMAN LIVER-MICROSOMES; ONE-YEAR OUTCOMES; MAINTENANCE TREATMENT; PATIENT SATISFACTION; N-DEMETHYLATION; DOSAGE REQUIREMENTS	Although the efficacy of methadone maintenance treatment (MMT) in opioid dependence disorder has been well established, the influence of methadone pharmacokinetics in dose requirement and clinical outcome remains controversial. The aim of this study is to analyze methadone dosage in responder and nonresponder patients considering pharmacogenetic and pharmacokinetic factors that may contribute to dosage adequacy. Opioid dependence patients (meeting Diagnostic and Statistical Manual of Mental Disorders, [4(th) Edition] criteria) from a MMT community program were recruited. Patients were clinically assessed and blood samples were obtained to determine plasma concentrations of (R, S)-, (R) and (S)-methadone and to study allelic variants of genes encoding CYP3A5, CYP2D6, CYP2B6, CYP2C9, CYP2C19, and P-glycoprotein. Responders and nonresponders were defined by illicit opioid consumption detected in random urinalysis. The final sample consisted in 105 opioid dependent patients of Caucasian origin. Responder patients received higher doses of methadone and have been included into treatment for a longer period. No differences were found in terms of genotype frequencies between groups. Only CYP2D6 metabolizing phenotype differences were found in outcome status, methadone dose requirements, and plasma concentrations, being higher in the ultrarapid metabolizers. No other differences were found between phenotype and responder status, methadone dose requirements, neither in methadone plasma concentrations. Pharmacokinetic factors could explain some but not all differences in MMT outcome and methadone dose requirements.	[Fonseca, Francina; Diaz, Laura; Torrens, Marta] Inst Neuropsiquiatria & Addicc, Barcelona, Spain; [Fonseca, Francina; de la Torre, Rafael] Univ Pompeu Fabra CEXS UPF, Barcelona, Spain; [Fonseca, Francina; Diaz, Laura; Torrens, Marta] IMIM Hosp Mar Res Inst, Inst Municipal Invest Med, Disorders Use Subst Res Grp, Neuropsychopharmacol Res Program, Barcelona, Spain; [de la Torre, Rafael; Pastor, Antonio; Cuyas, Elisabet; Pizarro, Nieves; Khymenets, Olha; Farre, Magi] IMIM Hosp Mar Res Inst, Human Pharmacol & Clin Neurosci Res Grp, Neuropsychopharmacol Res Program, Inst Municipal Invest Med, Barcelona, Spain; [de la Torre, Rafael; Khymenets, Olha] Univ Santiago de Compostela, Hosp Clin, CIBER Fisiopatol Obesidad & Nutr CB06 03, Santiago De Compostela, Spain; [Pastor, Antonio; Cuyas, Elisabet; Pizarro, Nieves; Farre, Magi] Autonomous Univ Barcelona, Dept Pharmacol, Barcelona, Spain; [Torrens, Marta] Autonomous Univ Barcelona, Dept Psychiat, Barcelona, Spain	Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Institut Hospital del Mar d'Investigacions Mediques (IMIM); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Autonomous University of Barcelona; Autonomous University of Barcelona	Fonseca, F (corresponding author), Inst Neuropsiquiatria & Addicc, Parc Salut Mar, Barcelona, Spain.	rtorre@imim.es; mtorrens@hospitaldelmar.cat	Lozano, Nieves Pizarro/G-8390-2017; Khymenets, Olha/I-9752-2014; de la Torre, Rafael/D-3561-2018; Pastor, Antoni/AAD-4638-2020; Cuyas, Elisabet/G-8582-2018	Khymenets, Olha/0000-0002-8668-580X; de la Torre, Rafael/0000-0002-6765-1866; Pastor, Antoni/0000-0003-3692-0696; Cuyas, Elisabet/0000-0001-5353-440X; Fonseca, Francina/0000-0002-0779-6545; Pizarro Lozano, Nieves/0000-0003-2671-7184	TV3 Marato [01/810]; Fondo de Investigaciones Sanitarias de la Seguridad Social, FIS [PI040632, PI040619]; Instituto Carlos III [RTA 06/0001/1009]	TV3 Marato; Fondo de Investigaciones Sanitarias de la Seguridad Social, FIS(Instituto de Salud Carlos III); Instituto Carlos III(Instituto de Salud Carlos III)	Financial support was received from the TV3 Marato (01/810), Fondo de Investigaciones Sanitarias de la Seguridad Social, FIS (PI040632, PI040619), and the Instituto Carlos III (RTA 06/0001/1009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenaz I, 2010, FUND CLIN PHARMACOL, V24, P247, DOI 10.1111/j.1472-8206.2009.00753.x; Begre S, 2002, J CLIN PSYCHOPHARM, V22, P211, DOI 10.1097/00004714-200204000-00017; Bell J, 2006, DRUG ALCOHOL DEPEN, V81, P55, DOI 10.1016/j.drugalcdep.2005.05.010; Bruijnzeel AW, 2009, BRAIN RES REV, V62, P127, DOI 10.1016/j.brainresrev.2009.09.008; Bunten H, 2011, ADDICT BIOL, V16, P142, DOI 10.1111/j.1369-1600.2010.00274.x; Carlson MJ, 2001, PSYCHIATR SERV, V52, P1230, DOI 10.1176/appi.ps.52.9.1230; Coller JK, 2007, INT J CLIN PHARM TH, V45, P410; Coller JK, 2006, CLIN PHARMACOL THER, V80, P682, DOI 10.1016/j.clpt.2006.09.011; Crettol S, 2008, CLIN PHARMACOL THER, V83, P668, DOI 10.1038/sj.clpt.6100305; Crettol S, 2005, CLIN PHARMACOL THER, V78, P593, DOI 10.1016/j.clpt.2005.08.011; Crettol S, 2008, PROG NEURO-PSYCHOPH, V32, P1722, DOI 10.1016/j.pnpbp.2008.07.009; Crettol S, 2007, PHARMACOLOGY, V80, P304, DOI 10.1159/000107104; Crettol S, 2006, CLIN PHARMACOL THER, V80, P668, DOI 10.1016/j.clpt.2006.09.012; Cuyas E, 2010, PHARMACOGENOMICS, V11, P257, DOI 10.2217/PGS.09.165; Doehring A, 2009, PHARMACOGENET GENOM, V19, P407, DOI 10.1097/FPC.0b013e328320a3fd; Eap CB, 1997, J CLIN PSYCHOPHARM, V17, P113, DOI 10.1097/00004714-199704000-00010; Eap CB, 2001, J CLIN PSYCHOPHARM, V21, P229, DOI 10.1097/00004714-200104000-00016; Eap CB, 2000, DRUG ALCOHOL DEPEN, V61, P47, DOI 10.1016/S0376-8716(00)00121-6; Elkader AK, 2009, J CLIN PSYCHOPHARM, V29, P231, DOI 10.1097/JCP.0b013e3181a39113; Elkader AK, 2009, J CLIN PSYCHOPHARM, V29, P77, DOI 10.1097/JCP.0b013e318192eb00; Epstein DH, 2009, DRUG ALCOHOL DEPEN, V101, P92, DOI 10.1016/j.drugalcdep.2008.11.006; Evans WE, 2003, NEW ENGL J MED, V348, P538, DOI 10.1056/NEJMra020526; Farre M, 2002, DRUG ALCOHOL DEPEN, V65, P283, DOI 10.1016/S0376-8716(01)00171-5; FOJO AT, 1987, P NATL ACAD SCI USA, V84, P265, DOI 10.1073/pnas.84.1.265; Foster DJR, 1999, BRIT J CLIN PHARMACO, V47, P403, DOI 10.1046/j.1365-2125.1999.00921.x; Gatanaga H, 2007, CLIN INFECT DIS, V45, P1230, DOI 10.1086/522175; Gerber JG, 2004, CHIRALITY, V16, P36, DOI 10.1002/chir.10303; Gonzalez F., 2002, INSTRUMENTOS EVALUAC, P271; Haile CN, 2008, AM J DRUG ALCOHOL AB, V34, P355, DOI 10.1080/00952990802122564; Hasin D, 2006, AM J PSYCHIAT, V163, P689, DOI 10.1176/appi.ajp.163.4.689; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Hustert E, 2001, PHARMACOGENETICS, V11, P773, DOI 10.1097/00008571-200112000-00005; Iribarne C, 1996, CHEM RES TOXICOL, V9, P365, DOI 10.1021/tx950116m; Johnson RE, 2000, NEW ENGL J MED, V343, P1290, DOI 10.1056/NEJM200011023431802; Kelly T, 2003, ELECTROPHORESIS, V24, P2106, DOI 10.1002/elps.200305418; Kharasch ED, 2004, CLIN PHARMACOL THER, V76, P250, DOI 10.1016/j.clpt.2004.05.003; Klepstad P, 2004, ACTA ANAESTH SCAND, V48, P1232, DOI 10.1111/j.1399-6576.2004.00517.x; Kreek MJ, 2005, PHARMACOL REV, V57, P1, DOI 10.1124/pr.57.1.1; Kristensen K., 1995, LIFE SCI, V56, P45; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Lang T, 2001, PHARMACOGENETICS, V11, P399, DOI 10.1097/00008571-200107000-00004; Le Meur Y, 2006, CLIN PHARMACOL THER, V80, P51, DOI 10.1016/j.clpt.2006.03.012; Levran O, 2008, HUM MOL GENET, V17, P2219, DOI 10.1093/hmg/ddn122; Li YF, 2008, MOL DIAGN THER, V12, P109, DOI 10.1007/BF03256276; Mann A, 2008, NEUROPHARMACOLOGY, V55, P1147, DOI 10.1016/j.neuropharm.2008.07.017; Maxwell S, 1999, J PSYCHOACTIVE DRUGS, V31, P95, DOI 10.1080/02791072.1999.10471730; MCLELLAN AT, 1980, J NERV MENT DIS, V168, P26, DOI 10.1097/00005053-198001000-00006; Mitchell TB, 2004, BRIT J CLIN PHARMACO, V58, P609, DOI 10.1111/j.1365-2125.2004.02221.x; de los Cobos JP, 2007, DRUG ALCOHOL DEPEN, V89, P190, DOI 10.1016/j.drugalcdep.2006.12.018; Rendic S, 2002, DRUG METAB REV, V34, P83, DOI 10.1081/DMR-120001392; Reynolds KK, 2008, CLIN LAB MED, V28, P581, DOI 10.1016/j.cll.2008.10.003; Senbanjo R, 2009, DRUG ALCOHOL REV, V28, P608, DOI 10.1111/j.1465-3362.2009.00064.x; Shiran MR, 2009, BRIT J CLIN PHARMACO, V67, P29, DOI 10.1111/j.1365-2125.2008.03312.x; Shiran MR, 2003, BRIT J CLIN PHARMACO, V56, P220, DOI 10.1046/j.1365-2125.2003.01851.x; SIMPSON DD, 1981, ARCH GEN PSYCHIAT, V38, P875; SOLANS A, 1990, J PHARMACEUT BIOMED, V8, P905, DOI 10.1016/0731-7085(90)80140-K; Suh JW, 2006, CAN MED ASSOC J, V174, P1715, DOI 10.1503/cmaj.060664; Teesson M, 2006, DRUG ALCOHOL DEPEN, V83, P174, DOI 10.1016/j.drugalcdep.2005.11.009; Torrens M, 2004, AM J PSYCHIAT, V161, P1231, DOI 10.1176/appi.ajp.161.7.1231; Torrens M, 1998, DRUG ALCOHOL DEPEN, V52, P193, DOI 10.1016/S0376-8716(98)00096-9; Totah RA, 2008, ANESTHESIOLOGY, V108, P363, DOI 10.1097/ALN.0b013e3181642938; Totah RA, 2007, J PHARMACOL EXP THER, V321, P389, DOI 10.1124/jpet.106.117580; Tsuchiya K, 2004, BIOCHEM BIOPH RES CO, V319, P1322, DOI 10.1016/j.bbrc.2004.05.116; *US GEN ACC OFF, 1990, GAOHRD90104; Villafranca SW, 2006, DRUG ALCOHOL DEPEN, V83, P218, DOI 10.1016/j.drugalcdep.2005.11.020; Wang DX, 2006, AAPS J, V8, pE515, DOI 10.1208/aapsj080361; Wang DX, 2005, PHARMACOGENET GENOM, V15, P693, DOI 10.1097/01.fpc.0000178311.02878.83; Wang HB, 2008, CURR DRUG METAB, V9, P598, DOI 10.2174/138920008785821710; Wang JS, 2003, DRUG METAB DISPOS, V31, P742, DOI 10.1124/dmd.31.6.742; Wojnowski L, 2004, THER DRUG MONIT, V26, P192, DOI 10.1097/00007691-200404000-00019; WOLFF K, 1992, CLIN CHEM, V38, P438; Wolff K, 2000, ADDICTION, V95, P1771, DOI 10.1046/j.1360-0443.2000.951217717.x; WU D, 1993, BRIT J CLIN PHARMACO, V35, P30, DOI 10.1111/j.1365-2125.1993.tb05666.x; Wu WD, 2009, MOL DIAGN THER, V13, P331, DOI 10.2165/11317320-000000000-00000; Yuferov V, 2004, PHARMACOGENETICS, V14, P793, DOI 10.1097/00008571-200412000-00002; Zhou SF, 2009, CLIN PHARMACOKINET, V48, P761, DOI 10.2165/11318070-000000000-00000	76	73	77	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19527	10.1371/journal.pone.0019527	http://dx.doi.org/10.1371/journal.pone.0019527			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589866	Green Published, gold			2022-12-27	WOS:000290531100015
J	Kelly-Spratt, KS; Pitteri, SJ; Gurley, KE; Liggitt, D; Chin, A; Kennedy, J; Wong, CH; Zhang, Q; Buson, TB; Wang, H; Hanash, SM; Kemp, CJ				Kelly-Spratt, Karen S.; Pitteri, Sharon J.; Gurley, Kay E.; Liggitt, Denny; Chin, Alice; Kennedy, Jacob; Wong, Chee-Hong; Zhang, Qing; Buson, Tina Busald; Wang, Hong; Hanash, Samir M.; Kemp, Christopher J.			Plasma Proteome Profiles Associated with Inflammation, Angiogenesis, and Cancer	PLOS ONE			English	Article							BREAST-CANCER; BIOMARKER DISCOVERY; TGF-BETA; MASS-SPECTROMETRY; OVARIAN-CANCER; MOUSE MODEL; PROTEINS; GROWTH; PROGRESSION; METASTASIS	Tumor development is accompanied by a complex host systemic response, which includes inflammatory and angiogenic reactions. Both tumor-derived and systemic response proteins are detected in plasma from cancer patients. However, given their non-specific nature, systemic response proteins can confound the detection or diagnosis of neoplasia. Here, we have applied an in-depth quantitative proteomic approach to analyze plasma protein changes in mouse models of subacute irritant-driven inflammation, autoreactive inflammation, and matrix associated angiogenesis and compared results to previously described findings from mouse models of polyoma middle T-driven breast cancer and Pdx1-Cre Kras(G12D) Ink4a/Arf(lox/lox) -induced pancreatic cancer. Among the confounding models, approximately 1/3 of all quantified plasma proteins exhibited a significant change in abundance compared to control mice. Of the proteins that changed in abundance, the majority were unique to each model. Altered proteins included those involved in acute phase response, inflammation, extracellular matrix remodeling, angiogenesis, and TGF beta signaling. Comparison of changes in plasma proteins between the confounder models and the two cancer models revealed proteins that were restricted to the cancer-bearing mice, reflecting the known biology of these tumors. This approach provides a basis for distinguishing between protein changes in plasma that are cancer-related and those that are part of a non-specific host response.	[Kelly-Spratt, Karen S.; Gurley, Kay E.; Kemp, Christopher J.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Pitteri, Sharon J.; Chin, Alice; Kennedy, Jacob; Wong, Chee-Hong; Zhang, Qing; Buson, Tina Busald; Wang, Hong; Hanash, Samir M.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Liggitt, Denny] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Kelly-Spratt, KS (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, 1124 Columbia St, Seattle, WA 98104 USA.	cjkemp@fhcrc.org		Wong, Chee Hong/0000-0003-4546-4979; Pitteri, Sharon/0000-0002-3119-873X	The Paul G. Allen Family Foundation; NCI; Canary Foundation	The Paul G. Allen Family Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canary Foundation	This work was funded by The Paul G. Allen Family Foundation, the NCI Mouse Models of Human Cancer Consortium (MMHCC) program and the Canary Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Akhtar Nasim, 2002, Angiogenesis, V5, P75, DOI 10.1023/A:1021507031486; Akkiprik M, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2116; ALAM R, 1994, J IMMUNOL, V153, P3155; Bell R, 1998, BRIT J OBSTET GYNAEC, V105, P1136, DOI 10.1111/j.1471-0528.1998.tb09966.x; Blokzijl A, 2003, J CELL BIOL, V163, P723, DOI 10.1083/jcb.200305112; Carmeliet P, 2001, SCIENCE, V293, P1602, DOI 10.1126/science.1064981; Chan JM, 1998, SCIENCE, V279, P563, DOI 10.1126/science.279.5350.563; Chechlinska M, 2010, NAT REV CANCER, V10, P2, DOI 10.1038/nrc2782; Chen WJ, 1998, J IMMUNOL, V161, P6297; CID MC, 1993, J CLIN INVEST, V91, P977, DOI 10.1172/JCI116319; Costa Carla, 2007, Angiogenesis, V10, P149, DOI 10.1007/s10456-007-9074-0; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Etzioni R, 2003, NAT REV CANCER, V3, P243, DOI 10.1038/nrc1041; Etzioni R, 2002, J NATL CANCER I, V94, P981; Faca V, 2006, J PROTEOME RES, V5, P2009, DOI 10.1021/pr060102+; Faca VM, 2008, PLOS MED, V5, P953, DOI 10.1371/journal.pmed.0050123; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; Fernandez CA, 2005, CLIN CANCER RES, V11, P5390, DOI 10.1158/1078-0432.CCR-04-2391; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Girardi G, 2006, AM J REPROD IMMUNOL, V55, P396; Gutman S, 2006, NAT REV CANCER, V6, P565, DOI 10.1038/nrc1911; Jacobs JM, 2005, J PROTEOME RES, V4, P1073, DOI 10.1021/pr0500657; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kelly-Spratt KS, 2008, J PROTEOME RES, V7, P3613, DOI 10.1021/pr800210b; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; MacLean B, 2006, BIOINFORMATICS, V22, P2830, DOI 10.1093/bioinformatics/btl379; MAEDA K, 1995, J CLIN ONCOL, V13, P477, DOI 10.1200/JCO.1995.13.2.477; Maiuri MC, 2004, AM J PATHOL, V165, P115, DOI 10.1016/S0002-9440(10)63280-4; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Pitteri SJ, 2008, J PROTEOME RES, V7, P1481, DOI 10.1021/pr7007994; Prenzel KL, 2006, ONCOL REP, V15, P1397; Rauch A, 2006, J PROTEOME RES, V5, P112, DOI 10.1021/pr0503533; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; SHAW CA, 2009, CANCER EPIDEM BIOMAR, V18, P1365; Somiari SB, 2006, CANCER LETT, V233, P98, DOI 10.1016/j.canlet.2005.03.003; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; TRENTHAM DE, 1977, J EXP MED, V146, P857, DOI 10.1084/jem.146.3.857; Whiteaker JR, 2007, J PROTEOME RES, V6, P3962, DOI 10.1021/pr070202v; Wong K, 2002, CURR OPIN GENET DEV, V12, P583, DOI 10.1016/S0959-437X(02)00343-X; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Yang W, 2008, HEPATOLOGY, V48, P1396, DOI 10.1002/hep.22508; Ye B, 2003, CLIN CANCER RES, V9, P2904; Yee KO, 2009, BREAST CANCER RES TR, V114, P85, DOI 10.1007/s10549-008-9992-6; Yi CH, 2007, AM J PATHOL, V170, P1535, DOI 10.2353/ajpath.2007.060478	52	29	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19721	10.1371/journal.pone.0019721	http://dx.doi.org/10.1371/journal.pone.0019721			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589862	Green Submitted, Green Published, gold			2022-12-27	WOS:000290531100023
J	Beckage, N; Smith, L; Hills, T				Beckage, Nicole; Smith, Linda; Hills, Thomas			Small Worlds and Semantic Network Growth in Typical and Late Talkers	PLOS ONE			English	Article							LEXICAL DEVELOPMENT; LANGUAGE; EMERGENCE	Network analysis has demonstrated that systems ranging from social networks to electric power grids often involve a small world structure-with local clustering but global access. Critically, small world structure has also been shown to characterize adult human semantic networks. Moreover, the connectivity pattern of these mature networks is consistent with lexical growth processes in which children add new words to their vocabulary based on the structure of the language-learning environment. However, thus far, there is no direct evidence that a child's individual semantic network structure is associated with their early language learning. Here we show that, while typically developing children's early networks show small world structure as early as 15 months and with as few as 55 words, children with language delay ( late talkers) have this structure to a smaller degree. This implicates a maladaptive bias in word acquisition for late talkers, potentially indicating a preference for "oddball'' words. The findings provide the first evidence of a link between small-world connectivity and lexical development in individual children.	[Beckage, Nicole] Univ Calif Irvine, Dept Cognit Sci, Irvine, CA 92717 USA; [Smith, Linda] Indiana Univ, Bloomington, IN USA; [Hills, Thomas] Univ Basel, Dept Psychol, Basel, Switzerland	University of California System; University of California Irvine; Indiana University System; Indiana University Bloomington; University of Basel	Beckage, N (corresponding author), Univ Calif Irvine, Dept Cognit Sci, Irvine, CA 92717 USA.	nbeckage@uci.edu			NICCHD [HD028675]; Swiss National Science Foundation [100014 130397/1]; National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD028675] Funding Source: NIH RePORTER	NICCHD; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by NICCHD grant HD028675 to Linda Smith and a grant from the Swiss National Science Foundation (100014 130397/1) to Thomas Hills. The first author is supported by the National Science Foundation Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RC, 1985, THEORETICAL MODELS P, V3, P343; Banavar JR, 1999, NATURE, V399, P130, DOI 10.1038/20144; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BATES E, 1994, J CHILD LANG, V21, P85, DOI 10.1017/S0305000900008680; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Borge-Holthoefer J, 2010, ENTROPY-SWITZ, V12, P1264, DOI 10.3390/e12051264; Cancho RFI, 2001, P ROY SOC B-BIOL SCI, V268, P2261, DOI 10.1098/rspb.2001.1800; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; COLLINS AM, 1969, J VERB LEARN VERB BE, V8, P240, DOI 10.1016/S0022-5371(69)80069-1; Dale PS, 1996, BEHAV RES METH INS C, V28, P125, DOI 10.3758/BF03203646; DALE PS, 1989, J CHILD LANG, V16, P239, DOI 10.1017/S0305000900010394; DAVIS GF, 1941, DEEP S; Dupuy H. J., 1974, RATIONALE DEV STANDA; Erdos P., 1960, MATH I HUNG ACAD SCI, V5, P7; Fenson L, 2002, MACARTHUR COMMUNICAT; Hills TT, 2010, J MEM LANG, V63, P259, DOI 10.1016/j.jml.2010.06.002; Hills TT, 2009, COGNITION, V112, P381, DOI 10.1016/j.cognition.2009.06.002; Hills TT, 2009, PSYCHOL SCI, V20, P729, DOI 10.1111/j.1467-9280.2009.02365.x; Hofmann T, 1999, SIGIR'99: PROCEEDINGS OF 22ND INTERNATIONAL CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P50, DOI 10.1145/312624.312649; Li P, 2004, NEURAL NETWORKS, V17, P1345, DOI 10.1016/j.neunet.2004.07.004; MACWHINNEY B, 1995, CHILDES PROJECT TOOL; Moyle MJ, 2007, J SPEECH LANG HEAR R, V50, P508, DOI 10.1044/1092-4388(2007/035); Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Rescorla L, 2002, J SPEECH LANG HEAR R, V45, P360, DOI 10.1044/1092-4388(2002/028); SEGLEN PO, 1992, J AM SOC INFORM SCI, V43, P628, DOI 10.1002/(SICI)1097-4571(199210)43:9<628::AID-ASI5>3.0.CO;2-0; Sporns Olaf, 2002, Complexity, V8, P56, DOI 10.1002/cplx.10047; Steyvers M, 2005, COGNITIVE SCI, V29, P41, DOI 10.1207/s15516709cog2901_3; Thal DJ, 1997, DEV NEUROPSYCHOL, V13, P239, DOI 10.1080/87565649709540681; VIGIL DC, 2005, CHILD LANG TEACH THE, V21, P107, DOI DOI 10.1191/0265659005CT284OA; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WEISMER SE, 2006, ESSAYS HONOR RS CHAP, V83; Zubrick SR, 2007, J SPEECH LANG HEAR R, V50, P1562, DOI 10.1044/1092-4388(2007/106)	33	125	125	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19348	10.1371/journal.pone.0019348	http://dx.doi.org/10.1371/journal.pone.0019348			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	762MQ	21589924	Green Published, gold			2022-12-27	WOS:000290483600009
J	Huang, YH; Wu, CC; Chou, CK; Huang, CYF				Huang, Yei-Hsuan; Wu, Chun-Chi; Chou, Chen-Kung; Huang, Chi-Ying F.			A Translational Regulator, PUM2, Promotes Both Protein Stability and Kinase Activity of Aurora-A	PLOS ONE			English	Article							B1 MESSENGER-RNA; OOCYTE MATURATION; CYTOPLASMIC POLYADENYLATION; BINDING PROTEINS; CELL-CYCLE; PHOSPHORYLATION; COMPLEX; SPINDLE; IDENTIFICATION; DEGRADATION	Aurora-A, a centrosomal serine-threonine kinase, orchestrates several key aspects of cell division. However, the regulatory pathways for the protein stability and kinase activity of Aurora-A are still not completely understood. In this study, PUM2, an RNA-binding protein, is identified as a novel substrate and interacting protein of Aurora-A. Overexpression of the PUM2 mutant which fails to interact with Aurora-A, and depletion of PUM2 result in a decrease in the amount of Aurora-A. PUM2 physically binds to the D-box of Aurora-A, which is recognized by APC/C(Cdh1). Overexpression of PUM2 prevents ubiquitination and enhances the protein stability of Aurora-A, suggesting that PUM2 protects Aurora-A from APC/C(Cdh1)-mediated degradation. Moreover, association of PUM2 with Aurora-A not only makes Aurora-A more stable but also enhances the kinase activity of Aurora-A. Our study suggests that PUM2 plays two different but important roles during cell cycle progression. In interphase, PUM2 localizes in cytoplasm and plays as translational repressor through its RNA binding domain. However, in mitosis, PUM2 physically associates with Aurora-A to ensure enough active Aurora-A at centrosomes for mitotic entry. This is the first time to reveal the moonlight role of PUM2 in mitosis.	[Huang, Yei-Hsuan; Huang, Chi-Ying F.] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Wu, Chun-Chi] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Chou, Chen-Kung] Chang Gung Univ, Dept Life Sci, Tao Yuan, Taiwan	National Yang Ming Chiao Tung University; Chung Shan Medical University; Chang Gung University	Huang, YH (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan.	ckchou@mail.cgu.edu.tw; cyhuang5@ym.edu.tw	Huang, Chi-Ying/AFL-7729-2022; Huang, Chi-Ying/AAG-7672-2022	Huang, Chi-Ying/0000-0003-4898-4937; Huang, Chi-Ying/0000-0003-4898-4937	Ministry of Education, (National Yang Ming University), Center of Excellence for Cancer Research at Taipei Veterans General Hospital [DOH100-TD-C-111-007]; NSC [NSC99-3112-B-010-008, NSC98-3112-B-010-021-CC1]	Ministry of Education, (National Yang Ming University), Center of Excellence for Cancer Research at Taipei Veterans General Hospital; NSC(Ministry of Science and Technology, Taiwan)	This study was supported by the grants from the Ministry of Education, Aim for the Top University Plan (National Yang Ming University), Center of Excellence for Cancer Research at Taipei Veterans General Hospital (DOH100-TD-C-111-007) and NSC (NSC99-3112-B-010-008 and NSC98-3112-B-010-021-CC1) to Chi-Ying F. Huang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Cao QP, 2002, EMBO J, V21, P3852, DOI 10.1093/emboj/cdf353; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Castro A, 2002, EMBO REP, V3, P1209, DOI 10.1093/embo-reports/kvf241; Caudron M, 2005, SCIENCE, V309, P1373, DOI 10.1126/science.1115964; Cotteret S, 2005, DEV CELL, V9, P573, DOI 10.1016/j.devcel.2005.10.005; Dutertre S, 2004, J CELL SCI, V117, P2523, DOI 10.1242/jcs.01108; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Galgano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003164; Giet R, 2002, J CELL BIOL, V156, P437, DOI 10.1083/jcb.200108135; Giet R, 1999, J BIOL CHEM, V274, P15005, DOI 10.1074/jbc.274.21.15005; Groisman I, 2000, CELL, V103, P435, DOI 10.1016/S0092-8674(00)00135-5; Groisman I, 2002, CELL, V109, P473, DOI 10.1016/S0092-8674(02)00733-X; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Honda K, 2000, ONCOGENE, V19, P2812, DOI 10.1038/sj.onc.1203609; Hsu JM, 2004, J BIOL CHEM, V279, P32592, DOI 10.1074/jbc.M404950200; Jeganathan KB, 2006, CELL CYCLE, V5, P366, DOI 10.4161/cc.5.4.2483; Jeganathan KB, 2005, NATURE, V438, P1036, DOI 10.1038/nature04221; Kalab P, 2006, NATURE, V440, P697, DOI 10.1038/nature04589; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; Koffa MD, 2006, CURR BIOL, V16, P743, DOI 10.1016/j.cub.2006.03.056; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Lin YS, 2006, GENE EXPRESSION, V13, P15, DOI 10.3727/000000006783991962; Littlepage LE, 2002, GENE DEV, V16, P2274, DOI 10.1101/gad.1007302; Littlepage LE, 2002, P NATL ACAD SCI USA, V99, P15440, DOI 10.1073/pnas.202606599; Mendez R, 2000, MOL CELL, V6, P1253, DOI 10.1016/S1097-2765(00)00121-0; Nakahata S, 2003, MECH DEVELOP, V120, P865, DOI 10.1016/S0925-4773(03)00160-6; Pascreau G, 2005, J BIOL CHEM, V280, P13415, DOI 10.1074/jbc.M410584200; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Spassov DS, 2002, GENE, V299, P195, DOI 10.1016/S0378-1119(02)01060-0; Stebbins-Boaz B, 1999, MOL CELL, V4, P1017, DOI 10.1016/S1097-2765(00)80230-0; Taguchi S, 2002, FEBS LETT, V519, P59, DOI 10.1016/S0014-5793(02)02711-4; Trieselmann N, 2003, J CELL SCI, V116, P4791, DOI 10.1242/jcs.00798; Tsai MY, 2006, SCIENCE, V311, P1887, DOI 10.1126/science.1122771; Tsou AP, 2003, ONCOGENE, V22, P298, DOI 10.1038/sj.onc.1206129; Walter AO, 2000, ONCOGENE, V19, P4906, DOI 10.1038/sj.onc.1203847; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Wu JC, 2005, J BIOL CHEM, V280, P9013, DOI 10.1074/jbc.M411068200; Yu CTR, 2005, MOL CELL BIOL, V25, P5789, DOI 10.1128/MCB.25.14.5789-5800.2005; Zamore PD, 1997, RNA, V3, P1421; Zhao ZS, 2005, MOL CELL, V20, P237, DOI 10.1016/j.molcel.2005.08.035	41	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19718	10.1371/journal.pone.0019718	http://dx.doi.org/10.1371/journal.pone.0019718			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589936	gold, Green Submitted, Green Published			2022-12-27	WOS:000290483600027
J	Turner, SD; Berg, RL; Linneman, JG; Peissig, PL; Crawford, DC; Denny, JC; Roden, DM; McCarty, CA; Ritchie, MD; Wilke, RA				Turner, Stephen D.; Berg, Richard L.; Linneman, James G.; Peissig, Peggy L.; Crawford, Dana C.; Denny, Joshua C.; Roden, Dan M.; McCarty, Catherine A.; Ritchie, Marylyn D.; Wilke, Russell A.			Knowledge-Driven Multi-Locus Analysis Reveals Gene-Gene Interactions Influencing HDL Cholesterol Level in Two Independent EMR-Linked Biobanks	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DENSITY-LIPOPROTEIN CHOLESTEROL; MISSING HERITABILITY; LOCI; DISEASE; RISK; EPISTASIS; FAMILIES; TRAITS; TOOL	Genome-wide association studies (GWAS) are routinely being used to examine the genetic contribution to complex human traits, such as high-density lipoprotein cholesterol (HDL-C). Although HDL-C levels are highly heritable (h(2)similar to 0.7), the genetic determinants identified through GWAS contribute to a small fraction of the variance in this trait. Reasons for this discrepancy may include rare variants, structural variants, gene-environment (GxE) interactions, and gene-gene (GxG) interactions. Clinical practice-based biobanks now allow investigators to address these challenges by conducting GWAS in the context of comprehensive electronic medical records (EMRs). Here we apply an EMR-based phenotyping approach, within the context of routine care, to replicate several known associations between HDL-C and previously characterized genetic variants: CETP (rs3764261, p = 1.22e-25), LIPC (rs11855284, p = 3.92e-14), LPL (rs12678919, p = 1.99e-7), and the APOA1/C3/A4/A5 locus (rs964184, p = 1.06e-5), all adjusted for age, gender, body mass index (BMI), and smoking status. By using a novel approach which censors data based on relevant co-morbidities and lipid modifying medications to construct a more rigorous HDL-C phenotype, we identified an association between HDL-C and TRIB1, a gene which previously resisted identification in studies with larger sample sizes. Through the application of additional analytical strategies incorporating biological knowledge, we further identified 11 significant GxG interaction models in our discovery cohort, 8 of which show evidence of replication in a second biobank cohort. The strongest predictive model included a pairwise interaction between LPL (which modulates the incorporation of triglyceride into HDL) and ABCA1 (which modulates the incorporation of free cholesterol into HDL). These results demonstrate that gene-gene interactions modulate complex human traits, including HDL cholesterol.	[Turner, Stephen D.; Crawford, Dana C.; Ritchie, Marylyn D.] Vanderbilt Univ, Sch Med, Ctr Human Genet Res, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; [Berg, Richard L.; Linneman, James G.; Peissig, Peggy L.] Marshfield Clin Res Fdn, Biomed Informat Res Ctr, Marshfield, WI USA; [Denny, Joshua C.] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Roden, Dan M.; Wilke, Russell A.] Vanderbilt Univ, Sch Med, Dept Med, Div Clin Pharmacol, Nashville, TN 37212 USA; [Roden, Dan M.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [McCarty, Catherine A.] Marshfield Clin Res Fdn, Ctr Human Genet, Marshfield, WI USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Turner, SD (corresponding author), Vanderbilt Univ, Sch Med, Ctr Human Genet Res, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA.	russell.a.wilke@Vanderbilt.Edu	Crawford, Dana/C-1054-2012; Turner, Stephen/GXM-4654-2022; Denny, Josh/AAL-3359-2021; Ritchie, Marylyn/C-1114-2012; Crawford, Dana/O-5578-2019; Roden, Dan/ABD-5412-2021	Denny, Josh/0000-0002-3049-7332; Crawford, Dana/0000-0002-6437-6248; McCarty, Catherine/0000-0003-1089-0142	National Institutes of Health (NIH) [F31-NS066638, R01-LM010040, R01-DK080007, U01-HG004608, U01-HG04603, UL1-RR024975]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004608, U01HG004603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS066638] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010040] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work is supported by National Institutes of Health (NIH) grants F31-NS066638, R01-LM010040, R01-DK080007, U01-HG004608, U01-HG04603, and UL1-RR024975. No other external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar PS, 2010, NAT STRUCT MOL BIOL, V17, P901, DOI 10.1038/nsmb.1829; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashen MD, 2005, NEW ENGL J MED, V353, P1252, DOI 10.1056/NEJMcp044370; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Barzilai N, 2003, JAMA-J AM MED ASSOC, V290, P2030, DOI 10.1001/jama.290.15.2030; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bush WS, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P368; Carroll MD, 2005, JAMA-J AM MED ASSOC, V294, P1773, DOI 10.1001/jama.294.14.1773; Chasman DI, 2008, CIRC-CARDIOVASC GENE, V1, P21, DOI 10.1161/CIRCGENETICS.108.773168; Chen ES, 2008, J AM MED INFORM ASSN, V15, P87, DOI 10.1197/jamia.M2401; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; DENNY JC, 2010, CIRCULATION IN PRESS; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Edmondson AC, 2008, CIRC-CARDIOVASC GENE, V1, P3, DOI 10.1161/CIRCGENETICS.108.815530; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Ghosh SS, 2004, AM J HYPERTENS, V17, p91A; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Grewal T, 2003, J BIOL CHEM, V278, P16478, DOI 10.1074/jbc.C300085200; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; He XL, 2010, NAT GENET, V42, P272, DOI 10.1038/ng.524; Heid IM, 2008, CIRC-CARDIOVASC GENE, V1, P10, DOI 10.1161/CIRCGENETICS.108.776708; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Johnson LW, 2006, MAYO CLIN PROC, V81, P1615, DOI 10.4065/81.12.1615; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S17; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; Kooner JS, 2008, NAT GENET, V40, P149, DOI 10.1038/ng.2007.61; Kooperberg C, 2008, GENET EPIDEMIOL, V32, P255, DOI 10.1002/gepi.20300; Lunetta KL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-32; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCarty CA, 2007, PERS MED, V4, P183, DOI 10.2217/17410541.4.2.183; McCarty Catherine A, 2005, Per Med, V2, P49, DOI 10.1517/17410541.2.1.49; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Miller SG, 2007, CIRCULATION, V116, P126; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; NEUMAN RJ, 1992, GENET EPIDEMIOL, V9, P347, DOI 10.1002/gepi.1370090506; Peissig P, 2007, BASIC CLIN PHARMACOL, V100, P286, DOI 10.1111/j.1742-7843.2006.00035.x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Development Core Team, 2005, R LANG ENV STAT COMP; Ritchie MD, 2010, AM J HUM GENET, V86, P560, DOI 10.1016/j.ajhg.2010.03.003; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; RUBIN EM, 1991, NATURE, V353, P265, DOI 10.1038/353265a0; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Shao HF, 2008, P NATL ACAD SCI USA, V105, P19910, DOI 10.1073/pnas.0810388105; Sillanpaa MJ, 2004, ANN HUM GENET, V68, P646, DOI 10.1046/j.1529-8817.2004.00122.x; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thornton-Wells TA, 2004, TRENDS GENET, V20, P640, DOI 10.1016/j.tig.2004.09.007; TURNER SD, 2010, QUALITY CONTROL PROC, pCH1; Turner Stephen D, 2009, Expert Rev Clin Pharmacol, V2, P559, DOI 10.1586/ecp.09.32; Tyler AL, 2009, BIOESSAYS, V31, P220, DOI 10.1002/bies.200800022; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; WILKE RA, 2010, PREVENTIVE CARDIOLOG; Wilke RA, 2008, BASIC CLIN PHARMACOL, V103, P354, DOI 10.1111/j.1742-7843.2008.00291.x; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Xu H, 2010, J AM MED INFORM ASSN, V17, P19, DOI 10.1197/jamia.M3378; Zhang Y, 2009, PHARMACOGENOMICS, V10, P1929, DOI [10.2217/pgs.09.122, 10.2217/PGS.09.122]	76	47	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19586	10.1371/journal.pone.0019586	http://dx.doi.org/10.1371/journal.pone.0019586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589926	gold, Green Published			2022-12-27	WOS:000290483600017
J	Bossan, B; Koehncke, A; Hammerstein, P				Bossan, Benjamin; Koehncke, Arnulf; Hammerstein, Peter			A New Model and Method for Understanding Wolbachia-Induced Cytoplasmic Incompatibility	PLOS ONE			English	Article							MOSQUITO CULEX-PIPIENS; DROSOPHILA-SIMULANS; COMPATIBILITY TYPES; MULTIPLE INFECTIONS; EVOLUTION; CROSSES; MELANOGASTER; POPULATIONS; EXPRESSION; SPECIATION	Wolbachia are intracellular bacteria transmitted almost exclusively vertically through eggs. In response to this mode of transmission, Wolbachia strategically manipulate their insect hosts' reproduction. In the most common manipulation type, cytoplasmic incompatibility, infected males can only mate with infected females, but infected females can mate with all males. The mechanism of cytoplasmic incompatibility is unknown; theoretical and empirical findings need to converge to broaden our understanding of this phenomenon. For this purpose, two prominent models have been proposed: the mistiming-model and the lock-key-model. The former states that Wolbachia manipulate sperm of infected males to induce a fatal delay of the male pronucleus during the first embryonic division, but that the bacteria can compensate the delay by slowing down mitosis in fertilized eggs. The latter states that Wolbachia deposit damaging "locks'' on sperm DNA of infected males, but can also provide matching "keys'' in infected eggs to undo the damage. The lock-key-model, however, needs to assume a large number of locks and keys to explain all existing incompatibility patterns. The mistiming-model requires fewer assumptions but has been contradicted by empirical results. We therefore expand the mistiming-model by one quantitative dimension to create the new, so-called goalkeeper-model. Using a method based on formal logic, we show that both lock-key-and goalkeeper-model are consistent with existing data. Compared to the lock-key-model, however, the goalkeeper-model assumes only two factors and provides an idea of the evolutionary emergence of cytoplasmic incompatibility. Available cytological evidence suggests that the hypothesized second factor of the goalkeeper-model may indeed exist. Finally, we suggest empirical tests that would allow to distinguish between the models. Generalizing our results might prove interesting for the study of the mechanism and evolution of other host-parasite interactions.	[Bossan, Benjamin; Koehncke, Arnulf; Hammerstein, Peter] Humboldt Univ, Inst Theoret Biol, Berlin, Germany	Humboldt University of Berlin	Bossan, B (corresponding author), Humboldt Univ, Inst Theoret Biol, Berlin, Germany.	benjamin.bossan@hu-berlin.de		Kohncke, Arnulf/0000-0002-4104-0477				ATYAME C, MOL ECOL, V286; Bordenstein Seth R., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020043; Bordenstein SR, 2001, NATURE, V409, P707, DOI 10.1038/35055543; Bourtzis K, 1998, NATURE, V391, P852, DOI 10.1038/36017; Callaini G, 1997, J CELL SCI, V110, P271; Charlat S, 2005, GENETICS, V170, P495, DOI 10.1534/genetics.103.015198; Charlat S, 2004, EVOLUTION, V58, P1901, DOI 10.1111/j.0014-3820.2004.tb00478.x; Charlat S, 2001, GENETICS, V159, P1415; Clark ME, 2003, MECH DEVELOP, V120, P185, DOI 10.1016/S0925-4773(02)00424-0; Duron O, 2006, P ROY SOC B-BIOL SCI, V273, P495, DOI 10.1098/rspb.2005.3336; Duron O, 2006, HEREDITY, V96, P493, DOI 10.1038/sj.hdy.6800831; Duron O, 2006, MOL ECOL, V15, P3061, DOI 10.1111/j.1365-294X.2006.02996.x; Ferree PM, 2006, GENETICS, V173, P839, DOI 10.1534/genetics.105.053272; Flor M, 2007, J EVOLUTION BIOL, V20, P696, DOI 10.1111/j.1420-9101.2006.01252.x; Jaenike J, 2006, PLOS BIOL, V4, P1852, DOI 10.1371/journal.pbio.0040325; Kent BN, 2010, TRENDS MICROBIOL, V18, P173, DOI 10.1016/j.tim.2009.12.011; Landmann F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000343; Lassy CW, 1996, MECH DEVELOP, V57, P47, DOI 10.1016/0925-4773(96)00527-8; MERCOT H, 1995, GENETICS, V141, P1015; MONTCHAMPMOREAU C, 1991, GENETICS, V129, P399; Mouton L, 2005, HEREDITY, V94, P187, DOI 10.1038/sj.hdy.6800596; Mouton L, 2003, MOL ECOL, V12, P3459, DOI 10.1046/j.1365-294X.2003.02015.x; Mouton L, 2004, GENETICS, V168, P181, DOI 10.1534/genetics.104.026716; Nor I, 2010, LECT NOTES COMPUT SC, V6129, P202, DOI 10.1007/978-3-642-13509-5_19; ONEILL SL, 1990, NATURE, V348, P178, DOI 10.1038/348178a0; PerrotMinnot MJ, 1996, GENETICS, V143, P961; Poinsot D, 2003, BIOESSAYS, V25, P259, DOI 10.1002/bies.10234; Poinsot D, 1998, GENETICS, V150, P227; Rousset F, 1999, HEREDITY, V82, P620, DOI 10.1046/j.1365-2540.1999.00501.x; Sasaki T, 2005, HEREDITY, V95, P389, DOI 10.1038/sj.hdy.6800737; Shoemaker DD, 1999, EVOLUTION, V53, P1157, DOI [10.2307/2640819, 10.1111/j.1558-5646.1999.tb04529.x]; SINKINS SP, 1995, P ROY SOC B-BIOL SCI, V261, P325, DOI 10.1098/rspb.1995.0154; Telschow A, 2005, EVOLUTION, V59, P1607, DOI 10.1111/j.0014-3820.2005.tb01812.x; Telschow A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000701; Tram U, 2002, SCIENCE, V296, P1124, DOI 10.1126/science.1070536; Watanabe M., 2010, HDB FUEL CELLS FUNDA, P1; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Zabalou S, 2004, GENETICS, V167, P827, DOI 10.1534/genetics.103.015990; Zabalou S, 2008, GENETICS, V178, P2145, DOI 10.1534/genetics.107.086488	40	26	30	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19757	10.1371/journal.pone.0019757	http://dx.doi.org/10.1371/journal.pone.0019757			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572955	gold, Green Published, Green Submitted			2022-12-27	WOS:000290440200025
J	Chatelais, L; Jamin, A; Gras-Le Guen, C; Lalles, JP; Le Huerou-Luron, I; Boudry, G				Chatelais, Livie; Jamin, Agnes; Gras-Le Guen, Christele; Lalles, Jean-Paul; Le Huerou-Luron, Isabelle; Boudry, Gaelle			The Level of Protein in Milk Formula Modifies Ileal Sensitivity to LPS Later in Life in a Piglet Model	PLOS ONE			English	Article							INTESTINAL BARRIER FUNCTION; FACTOR-KAPPA-B; BACTERIAL TRANSLOCATION; PRETERM INFANTS; GLUTAMINE; RATS; INFLAMMATION; REQUIREMENTS; IMMUNITY; WEIGHT	Background: Milk formulas have higher protein contents than human milk. This high protein level could modify the development of intestinal microbiota, epithelial barrier and immune functions and have long-term consequences. Methodology/Principal findings: We investigated the effect of a high protein formula on ileal microbiota and physiology during the neonatal period and later in life. Piglets were fed from 2 to 28 days of age either a normoprotein (NP, equivalent to sow milk) or a high protein formula (HP, +40% protein). Then, they received the same solid diet until 160 days. During the formula feeding period ileal microbiota implantation was accelerated in HP piglets with greater concentrations of ileal bacteria at d7 in HP than NP piglets. Epithelial barrier function was altered with a higher permeability to small and large probes in Ussing chambers in HP compared to NP piglets without difference in bacterial translocation. Infiltration of T cells was increased in HP piglets at d28. IL-1b and NF-kappa B sub-units mRNA levels were reduced in HP piglets at d7 and d28 respectively; plasma haptoglobin also tended to be reduced at d7. Later in life, pro-inflammatory cytokines secretion in response to high doses of LPS in explants culture was reduced in HP compared to NP piglets. Levels of mRNA coding the NF-kappa B pathway sub-units were increased by the challenge with LPS in NP piglets, but not HP ones. Conclusions/Significance: A high protein level in formula affects the postnatal development of ileal microbiota, epithelial barrier and immune function in piglets and alters ileal response to inflammatory mediators later in life.	[Chatelais, Livie; Jamin, Agnes; Lalles, Jean-Paul; Le Huerou-Luron, Isabelle; Boudry, Gaelle] SENAH, INRA, UMR 1079, St Gilles, France; [Jamin, Agnes; Lalles, Jean-Paul; Le Huerou-Luron, Isabelle; Boudry, Gaelle] Agrocampus Ouest, Rennes, France; [Chatelais, Livie] CHU Rennes, Rennes, France; [Gras-Le Guen, Christele] CHU Nantes, Serv Reanimat Pediat, Hop Mere Enfan, F-44035 Nantes 01, France	INRAE; Institut Agro; Agrocampus Ouest; CHU Rennes; Nantes Universite; CHU de Nantes	Chatelais, L (corresponding author), SENAH, INRA, UMR 1079, St Gilles, France.	Gaelle.Boudry@rennes.inra.fr	Boudry, Gaelle/ABG-8836-2020	Boudry, Gaelle/0000-0002-5287-571X; Lalles, Jean-Paul/0000-0003-2732-5350; Luron, Isabelle/0000-0002-1769-5246; Jamin, Agnes/0000-0002-6210-4046; GRAS-LE GUEN, Christele/0000-0001-9060-2344	Agence Nationale de la Recherche [ANR-05-PNRA-09]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the Agence Nationale de la Recherche (Grant ANR-05-PNRA-09 ProtNeonat). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amesz EM, 2010, J PEDIATR GASTR NUTR, V50, P200, DOI 10.1097/MPG.0b013e3181a8150d; Andriamihaja M, 2010, AM J PHYSIOL-GASTR L, V299, pG1030, DOI 10.1152/ajpgi.00149.2010; Bailey M, 2006, VET RES, V37, P443, DOI 10.1051/vetres:2006013; Bailey M, 2005, VET IMMUNOL IMMUNOP, V108, P189, DOI 10.1016/j.vetimm.2005.07.010; Barreau F, 2004, GUT, V53, P501, DOI 10.1136/gut.2003.024174; Boudry G, 2011, PEDIATR RES, V69, P4, DOI 10.1203/PDR.0b013e3181fc9d13; Calder PC, 2006, BRIT J NUTR, V96, P774, DOI [10.1079/BJN20061917, 10.1079/BJN20061881]; Cario E, 2000, J IMMUNOL, V164, P966, DOI 10.4049/jimmunol.164.2.966; Coeffier M, 2003, CLIN NUTR, V22, P407, DOI 10.1016/S0261-5614(03)00040-2; D'Inca R, 2010, J NUTR, V140, P925, DOI 10.3945/jn.109.116822; De Plaen IG, 2007, PEDIATR RES, V61, P716, DOI 10.1203/pdr.0b013e3180534219; des Robert C, 2009, EARLY HUM DEV, V85, P41, DOI 10.1016/j.earlhumdev.2008.06.009; Dourmad JY, 1998, J ANIM SCI, V76, P542; Dupont C, 2003, AM J CLIN NUTR, V77, p1544S, DOI 10.1093/ajcn/77.6.1544S; Embleton ND, 2005, PEDIATR RES, V58, P855, DOI 10.1203/01.PDR.0000182586.46532.7C; Faure M, 2006, J NUTR, V136, P1558, DOI 10.1093/jn/136.6.1558; FERNANDEZ F, 1985, MICROBIOL ALIMENTS N, V3, P47; Gareau MG, 2007, GUT, V56, P1522, DOI 10.1136/gut.2006.117176; Gebbers JO, 2004, ANN NY ACAD SCI, V1029, P337, DOI 10.1196/annals.1309.015; Gronlund MM, 2000, ARCH DIS CHILD-FETAL, V83, pF186, DOI 10.1136/fn.83.3.F186; Halton TL, 2004, J AM COLL NUTR, V23, P373, DOI 10.1080/07315724.2004.10719381; Haynes TE, 2009, AMINO ACIDS, V37, P131, DOI 10.1007/s00726-009-0243-x; Jost R, 1999, INT J FOOD SCI TECH, V34, P533, DOI 10.1046/j.1365-2621.1999.00324.x; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Koletzko B, 2009, ADV EXP MED BIOL, V646, P15, DOI 10.1007/978-1-4020-9173-5_2; Koletzko B, 2009, AM J CLIN NUTR, V89, P1836, DOI 10.3945/ajcn.2008.27091; KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344; Laflamme N, 2001, FASEB J, V15, P155, DOI 10.1096/fj.00-0339com; Le Bacquer O, 2003, AM J PHYSIOL-GASTR L, V285, pG128, DOI 10.1152/ajpgi.00459.2002; Liboni KC, 2005, J NUTR, V135, P245, DOI 10.1093/jn/135.2.245; Mace K, 2006, NESTLE NUTR WORKS SE, V58, P189, DOI 10.1159/000095063; Menezes JD, 2003, INT IMMUNOL, V15, P447, DOI 10.1093/intimm/dxg043; Mitra AK, 2010, AM J PHYSIOL-CELL PH, V299, pC561, DOI 10.1152/ajpcell.00127.2010; Moro G, 2006, ARCH DIS CHILD, V91, P814, DOI 10.1136/adc.2006.098251; Mulder IE, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-79; Nanthakumar NN, 2000, P NATL ACAD SCI USA, V97, P6043, DOI 10.1073/pnas.97.11.6043; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; PREMJI SS, 2006, COCHRANE DB SYST REV, V1; Sarr O, 2011, AM J PHYSIOL-REG I, V300, pR387, DOI 10.1152/ajpregu.00459.2010; Shirkey TW, 2006, EXP BIOL MED, V231, P1333, DOI 10.1177/153537020623100807; Spehlmann ME, 2009, CURR OPIN GASTROEN, V25, P92, DOI 10.1097/MOG.0b013e328324f857; Spencer SJ, 2007, AM J PHYSIOL-REG I, V292, pR308, DOI 10.1152/ajpregu.00398.2006; Thureen P, 2005, PEDIATR RES, V57, p95R, DOI 10.1203/01.PDR.0000160434.69916.34; VEGALOPEZ MA, 1993, VET IMMUNOL IMMUNOP, V37, P49, DOI 10.1016/0165-2427(93)90015-V; Yajima M, 2001, J PEDIATR GASTR NUTR, V33, P592, DOI 10.1097/00005176-200111000-00015; Zareie M, 2006, GUT, V55, P1553, DOI 10.1136/gut.2005.080739	48	46	47	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19594	10.1371/journal.pone.0019594	http://dx.doi.org/10.1371/journal.pone.0019594			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573022	gold, Green Published, Green Submitted			2022-12-27	WOS:000290386800022
J	An, FM; Hsiao, SR; Chan, MT				An, Feng-Ming; Hsiao, Shuan-Rung; Chan, Ming-Tsair			Sequencing-Based Approaches Reveal Low Ambient Temperature-Responsive and Tissue-Specific MicroRNAs in Phalaenopsis Orchid	PLOS ONE			English	Article							SIRNA BIOGENESIS; FLOWERING-TIME; MESSENGER-RNA; ARABIDOPSIS; EXPRESSION; IDENTIFICATION; ACCUMULATION; TARGETS; MIRNAS; GENOME	Plant small RNAs (smRNAs) are short, non-coding RNA molecules that mediate RNA silencing and regulate a group of genes involved in plant development and responses to environmental stimuli. Low temperature is necessary to initiate stalk development in the orchid Phalaenopsis aphrodite subsp. formosana. To identify smRNAs in Phalaenopsis responding to low temperatures, a smRNA profiling analysis using high-throughput sequencing technology was performed. Subsequent bioinformatic analysis was applied to categorize the miRNAs identified. A total of 37,533,509 smRNA reads yielded 11,129 independent orchid miRNA sequences, representing 329 known miRNA families identified in other plant species. Because the genomic resources available for Phalaenopsis are limited, a transcriptomic database was established using deep sequencing data sets to identify miRNAs precursors and their target transcripts. Comparing small RNAs and the transcriptomic database, 14 putative miRNA precursors of 10 miRNA families were identified, as were hundreds of putative targets. Comparing sequencing data and smRNA northern hybridization results identified miR156, miR162, miR528 and miR535 as low temperature-induced miRNAs. In addition, tissue-specific expression of these miRNAs was investigated. It was concluded that miR156 and miR172 may be components of a regulatory pathway mediating transition from the vegetative to the reproductive phase in Phalaenopsis. The smRNA and transcriptomic databases could be the foundations for further research aimed at elucidating the control of the flowering time in orchids.	[An, Feng-Ming; Chan, Ming-Tsair] Natl Cheng Kung Univ, Coll Biosci & Biotechnol, Inst Biotechnol, Tainan 70101, Taiwan; [An, Feng-Ming; Hsiao, Shuan-Rung; Chan, Ming-Tsair] Acad Sinica, Biotechnol Ctr So Taiwan, Tainan, Taiwan; [Hsiao, Shuan-Rung; Chan, Ming-Tsair] Natl Cheng Kung Univ, Coll Biosci & Biotechnol, Inst Trop Plant Sci, Tainan 70101, Taiwan; [Chan, Ming-Tsair] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan	National Cheng Kung University; Academia Sinica - Taiwan; National Cheng Kung University; Academia Sinica - Taiwan	An, FM (corresponding author), Natl Cheng Kung Univ, Coll Biosci & Biotechnol, Inst Biotechnol, Tainan 70101, Taiwan.	mbmtchan@gate.sinica.edu.tw	Chan, Ming-Tsair/L-2465-2015	Chan, Ming-Tsair/0000-0002-1942-9160	Academia Sinica; National Science Council, Republic of China [98-2324-B-001-003-CC1]	Academia Sinica(Academia Sinica - Taiwan); National Science Council, Republic of China(Ministry of Science and Technology, Taiwan)	This research was supported by Academia Sinica and grant 98-2324-B-001-003-CC1 from the National Science Council, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arazi T, 2005, PLANT J, V43, P837, DOI 10.1111/j.1365-313X.2005.02499.x; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; BARLOW JJ, 1963, BIOCHEM BIOPH RES CO, V13, P61, DOI 10.1016/0006-291X(63)90163-3; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Blanchard MG, 2006, J EXP BOT, V57, P4043, DOI 10.1093/jxb/erl176; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Chen WH, 2008, PLANT CELL REP, V27, P1667, DOI 10.1007/s00299-008-0591-0; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Cheng YL, 2003, DEV CELL, V4, P53, DOI 10.1016/S1534-5807(02)00399-4; Chiou TJ, 2006, PLANT CELL, V18, P412, DOI 10.1105/tpc.105.038943; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; DAI X, 2010, BRIEF BIOINFORM; Deal RB, 2007, PLANT CELL, V19, P74, DOI 10.1105/tpc.106.048447; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Glazinska P, 2009, J PLANT PHYSIOL, V166, P1801, DOI 10.1016/j.jplph.2009.05.011; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Hsu CC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-3; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jamalkandi SA, 2009, FUNCT INTEGR GENOMIC, V9, P419, DOI 10.1007/s10142-009-0141-z; Jung JH, 2007, PLANT CELL, V19, P2736, DOI 10.1105/tpc.107.054528; Kawashima CG, 2009, PLANT J, V57, P313, DOI 10.1111/j.1365-313X.2008.03690.x; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee H, 2010, NUCLEIC ACIDS RES, V38, P3081, DOI 10.1093/nar/gkp1240; Liang G, 2010, PLANT J, V62, P1046, DOI 10.1111/j.1365-313X.2010.04216.x; Liu B, 2005, PLANT PHYSIOL, V139, P296, DOI 10.1104/pp.105.063420; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Mathieu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000148; Padmanabhan C, 2009, CURR OPIN PLANT BIOL, V12, P465, DOI 10.1016/j.pbi.2009.06.005; Risseeuw EP, 2003, PLANT J, V34, P753, DOI 10.1046/j.1365-313X.2003.01768.x; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sun W, 2010, ANNU REV BIOMED ENG, V12, P1, DOI 10.1146/annurev-bioeng-070909-105314; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Valoczi A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh171; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Xie FL, 2010, PLANTA, V232, P417, DOI 10.1007/s00425-010-1182-1; Yang HP, 2009, PLANT BIOTECHNOL J, V7, P621, DOI 10.1111/j.1467-7652.2009.00429.x; Zanca AS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-260; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhou XF, 2008, BBA-GENE REGUL MECH, V1779, P780, DOI 10.1016/j.bbagrm.2008.04.005	43	58	64	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e18937	10.1371/journal.pone.0018937	http://dx.doi.org/10.1371/journal.pone.0018937			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573107	Green Published, Green Submitted, gold			2022-12-27	WOS:000290305600009
J	Ashwood, P; Corbett, BA; Kantor, A; Schulman, H; Van de Water, J; Amaral, DG				Ashwood, Paul; Corbett, Blythe A.; Kantor, Aaron; Schulman, Howard; Van de Water, Judy; Amaral, David G.			In Search of Cellular Immunophenotypes in the Blood of Children with Autism	PLOS ONE			English	Article							DIAGNOSTIC OBSERVATION SCHEDULE; LYMPHOCYTE CYTOKINE PROFILES; DYE LABELING REAGENTS; IMMUNE ACTIVATION; PERIPHERAL-BLOOD; T-CELLS; SPECTRUM; PLASMA; SERUM; AUTOANTIBODIES	Background: Autism is a neurodevelopmental disorder characterized by impairments in social behavior, communication difficulties and the occurrence of repetitive or stereotyped behaviors. There has been substantial evidence for dysregulation of the immune system in autism. Methods: We evaluated differences in the number and phenotype of circulating blood cells in young children with autism (n = 70) compared with age-matched controls (n = 35). Children with a confirmed diagnosis of autism (4-6 years of age) were further subdivided into low (IQ < 68, n = 35) or high functioning (IQ >= 68, n = 35) groups. Age- and gender-matched typically developing children constituted the control group. Six hundred and forty four primary and secondary variables, including cell counts and the abundance of cell surface antigens, were assessed using microvolume laser scanning cytometry. Results: There were multiple differences in immune cell populations between the autism and control groups. The absolute number of B cells per volume of blood was over 20% higher for children with autism and the absolute number of NK cells was about 40% higher. Neither of these variables showed significant difference between the low and high functioning autism groups. While the absolute number of T cells was not different across groups, a number of cellular activation markers, including HLA-DR and CD26 on T cells, and CD38 on B cells, were significantly higher in the autism group compared to controls. Conclusions: These results support previous findings that immune dysfunction may occur in some children with autism. Further evaluation of the nature of the dysfunction and how it may play a role in the etiology of autism or in facets of autism neuropathology and/or behavior are needed.	[Ashwood, Paul] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Ashwood, Paul; Corbett, Blythe A.; Van de Water, Judy; Amaral, David G.] Univ Calif Davis, MIND Inst, Davis, CA 95616 USA; [Corbett, Blythe A.; Amaral, David G.] Univ Calif Davis, Dept Psychiat & Behav Sci, Davis, CA 95616 USA; [Kantor, Aaron; Schulman, Howard] PPD Biomarker Discovery Sci, Menlo Pk, CA USA; [Van de Water, Judy] Univ Calif Davis, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Ashwood, P (corresponding author), Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA.	dgamaral@ucdavis.edu						Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Ashwood P, 2006, J NEUROIMMUNOL, V173, P126, DOI 10.1016/j.jneuroim.2005.12.007; Ashwood P, 2004, J CLIN IMMUNOL, V24, P664, DOI 10.1007/s10875-004-6241-6; Ashwood P, 2003, J CLIN IMMUNOL, V23, P504, DOI 10.1023/B:JOCI.0000010427.05143.bb; ASHWOOD P, 2011, BRAIN BEHAV IN PRESS; Ashwood P, 2011, J NEUROIMMUNOL, V232, P196, DOI 10.1016/j.jneuroim.2010.10.025; Ashwood P, 2011, BRAIN BEHAV IMMUN, V25, P40, DOI 10.1016/j.bbi.2010.08.003; Ashwood P, 2008, J NEUROIMMUNOL, V204, P149, DOI 10.1016/j.jneuroim.2008.07.006; Ashwood P, 2006, J LEUKOCYTE BIOL, V80, P1, DOI 10.1189/jlb.1205707; Beavis AJ, 1996, CYTOMETRY, V24, P390; Berument SK, 1999, BRIT J PSYCHIAT, V175, P444, DOI 10.1192/bjp.175.5.444; Cabanlit M, 2007, ANN NY ACAD SCI, V1107, P92, DOI 10.1196/annals.1381.010; Careaga M, 2010, NEUROTHERAPEUTICS, V7, P283, DOI 10.1016/j.nurt.2010.05.003; Chakrabarti S, 2005, AM J PSYCHIAT, V162, P1133, DOI 10.1176/appi.ajp.162.6.1133; Corbett BA, 2007, MOL PSYCHIATR, V12, P292, DOI 10.1038/sj.mp.4001943; Croonenberghs J, 2002, PSYCHOL MED, V32, P1457, DOI 10.1017/S0033291702006037; Denney DR, 1996, J AUTISM DEV DISORD, V26, P87, DOI 10.1007/BF02276236; Dietz LJ, 1996, CYTOMETRY, V23, P177; Enstrom Amanda, 2008, Am J Biochem Biotechnol, V4, P114; Enstrom A, 2009, BRAIN BEHAV IMMUN, V23, P389, DOI 10.1016/j.bbi.2008.12.005; Enstrom AM, 2010, BRAIN BEHAV IMMUN, V24, P64, DOI 10.1016/j.bbi.2009.08.001; Enstrom AM, 2009, BRAIN BEHAV IMMUN, V23, P124, DOI 10.1016/j.bbi.2008.08.001; Gillberg C, 2000, BIOL AUTISTIC SYNDRO, V3rd; Grigorenko EL, 2008, PEDIATRICS, V122, pE438, DOI 10.1542/peds.2007-3604; Heuer L, 2008, AUTISM RES, V1, P275, DOI 10.1002/aur.42; Jyonouchi H, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-52; Kantor AB, 2004, BIOTECHNIQUES, V36, P520, DOI 10.2144/04363PF01; Krause I, 2002, J AUTISM DEV DISORD, V32, P337, DOI 10.1023/A:1016391121003; LECOUTEUR A, 1989, J AUTISM DEV DISORD, V19, P363, DOI 10.1007/BF02212936; Lord C, 2000, NEURON, V28, P355, DOI 10.1016/S0896-6273(00)00115-X; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; Lord C, 1997, J AUTISM DEV DISORD, V27, P501, DOI 10.1023/A:1025873925661; Molloy CA, 2006, J NEUROIMMUNOL, V172, P198, DOI 10.1016/j.jneuroim.2005.11.007; MUJUMDAR RB, 1993, BIOCONJUGATE CHEM, V4, P105, DOI 10.1021/bc00020a001; Norton SM, 2000, PROC SPIE, V3921, P20, DOI 10.1117/12.384214; Onore C, 2009, J NEUROIMMUNOL, V216, P126, DOI 10.1016/j.jneuroim.2009.09.005; PLIOPLYS AV, 1994, NEUROPSYCHOBIOLOGY, V29, P12, DOI 10.1159/000119056; Rice Catherine, 2009, Morbidity and Mortality Weekly Report, V58, P1; Roederer M, 1996, CYTOMETRY, V24, P191, DOI 10.1002/(SICI)1097-0320(19960701)24:3<191::AID-CYTO1>3.0.CO;2-L; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Sattler, 1986, STANFORD BINET INTEL; SOUTHWICK PL, 1990, CYTOMETRY, V11, P418, DOI 10.1002/cyto.990110313; Sparrow S. S., 2016, VINELAND ADAPTIVE BE, V3rd; STUBBS EG, 1976, J AUTISM CHILD SCHIZ, V6, P269, DOI 10.1007/BF01543467; Tsuchiya KJ, 2007, BIOL PSYCHIAT, V62, P1056, DOI 10.1016/j.biopsych.2006.12.018; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Vojdani A, 2008, J NEUROIMMUNOL, V205, P148, DOI 10.1016/j.jneuroim.2008.09.005; WALTON ID, 2000, P SPIE INT SOC OPT E, P192; WARREN RP, 1995, NEUROPSYCHOBIOLOGY, V31, P53, DOI 10.1159/000119172; WARREN RP, 1987, J AM ACAD CHILD PSY, V26, P333, DOI 10.1097/00004583-198705000-00008; WARREN RP, 1990, IMMUNOL INVEST, V19, P245, DOI 10.3109/08820139009041839; WARREN RP, 1986, J AUTISM DEV DISORD, V16, P189, DOI 10.1007/BF01531729; Wills S, 2009, BRAIN BEHAV IMMUN, V23, P64, DOI 10.1016/j.bbi.2008.07.007; YONK LJ, 1990, IMMUNOL LETT, V25, P341, DOI 10.1016/0165-2478(90)90205-5	56	72	78	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19299	10.1371/journal.pone.0019299	http://dx.doi.org/10.1371/journal.pone.0019299			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573236	gold, Green Submitted, Green Published			2022-12-27	WOS:000290224800020
J	Brockmeier, U; Platzek, C; Schneider, K; Patak, P; Bernardini, A; Fandrey, J; Metzen, E				Brockmeier, Ulf; Platzek, Corinna; Schneider, Kirsten; Patak, Pauline; Bernardini, Andre; Fandrey, Joachim; Metzen, Eric			The Function of Hypoxia-Inducible Factor (HIF) Is Independent of the Endoplasmic Reticulum Protein OS-9	PLOS ONE			English	Article							NF-KAPPA-B; HYDROXYLASE DOMAIN PROTEIN-2; TUMOR-SUPPRESSOR PROTEIN; PROLYL HYDROXYLASE; TRANSCRIPTIONAL REGULATION; MISFOLDED GLYCOPROTEINS; INTRACELLULAR CALCIUM; OXIDATIVE STRESS; GENE-EXPRESSION; OXYGEN SENSOR	The protein "amplified in osteosarcoma-9'' (OS-9) has been shown previously to interact with the prolyl hydroxylases PHD2 and PHD3. These enzymes initiate oxygen-dependent degradation of the a-subunit of hypoxia-inducible factor (HIF), a transcription factor that adapts cells to insufficient oxygen supply (hypoxia). A new model has been proposed where OS-9 triggers PHD dependent degradation of HIF-alpha. It was the aim of our study to define the molecular mode of action of OS-9 in the regulation of PHD and HIF activity. Although initial co-immunoprecipitation experiments confirmed physical interaction between OS-9 and PHD2, neither overexpression nor lentiviral inhibition of OS-9 expression affected HIF regulation. Subcellular localization experiments revealed a distinct reticular staining pattern for OS-9 while PHD2 was mainly localized in the cytoplasm. Further cell fractionation experiments and glycosylation tests indicated that OS-9 is a luminal ER protein. In vivo protein interaction analysis by fluorescence resonance energy transfer (FRET) showed no significant physical interaction of overexpressed PHD2-CFP and OS-9-YFP. We conclude that OS-9 plays no direct functional role in HIF degradation since physical interaction of OS-9 with oxygen sensing HIF prolyl hydroxylases cannot occur in vivo due to their different subcellular localization.	[Brockmeier, Ulf; Schneider, Kirsten; Bernardini, Andre; Fandrey, Joachim; Metzen, Eric] Univ Duisburg Essen, Inst Physiol, Essen, Germany; [Platzek, Corinna] Univ Lubeck, Inst Physiol, Lubeck, Germany; [Patak, Pauline] Univ Duisburg Essen, Dept Neurol, Essen, Germany	University of Duisburg Essen; University of Lubeck; University of Duisburg Essen	Brockmeier, U (corresponding author), Univ Duisburg Essen, Inst Physiol, Essen, Germany.	eric.metzen@uni-due.de	Fandrey, Joachim/AAA-3524-2021	Fandrey, Joachim/0000-0001-9585-0531	Medical Faculty of the University of Lubeck; Deutsche Forschungsgemeinschaft [FA225/22-1, ME1712/6-1]	Medical Faculty of the University of Lubeck; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a personal grant from the Medical Faculty of the University of Lubeck to Corinna Platzek; Deutsche Forschungsgemeinschaft (FA225/22-1, ME1712/6-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock F, 2009, J MOL BIOL, V385, P1032, DOI 10.1016/j.jmb.2008.11.045; Baek JH, 2005, MOL CELL, V17, P503, DOI 10.1016/j.molcel.2005.01.011; Barth S, 2009, J BIOL CHEM, V284, P23046, DOI 10.1074/jbc.M109.032631; Berchner-Pfannschmidt U, 2004, J BIOL CHEM, V279, P44976, DOI 10.1074/jbc.M313995200; Bernardini A, 2010, PROC SPIE, V7723, DOI 10.1117/12.854027; Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Chan DA, 2009, CANCER CELL, V15, P527, DOI 10.1016/j.ccr.2009.04.010; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Frede S, 2006, BIOCHEM J, V396, P517, DOI 10.1042/BJ20051839; Friedmann E, 2002, J BIOL CHEM, V277, P35274, DOI 10.1074/jbc.M201044200; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Kim HL, 2006, INT J ONCOL, V29, P255; Kimura Y, 1997, J BIOCHEM-TOKYO, V122, P1190; Kimura Y, 1998, J BIOCHEM-TOKYO, V123, P876; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Koditz J, 2007, BLOOD, V110, P3610, DOI 10.1182/blood-2007-06-094441; Lederkremer GZ, 2009, CURR OPIN STRUC BIOL, V19, P515, DOI 10.1016/j.sbi.2009.06.004; Litovchick L, 2002, J BIOL CHEM, V277, P34413, DOI 10.1074/jbc.M203986200; Liu H, 1997, J BIOL CHEM, V272, P21751, DOI 10.1074/jbc.272.35.21751; Liu Q, 2004, BLOOD, V104, P3993, DOI 10.1182/blood-2004-03-1017; Lu HS, 2005, J BIOL CHEM, V280, P41928, DOI 10.1074/jbc.M508718200; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; Metzen E, 2003, MOL BIOL CELL, V14, P3470, DOI 10.1091/mbc.e02-12-0791; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Michalak M, 2002, CELL CALCIUM, V32, P269, DOI 10.1016/S0143416002001884; Mikhaylova O, 2008, MOL CELL BIOL, V28, P2701, DOI 10.1128/MCB.01231-07; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Olivari S, 2007, FEBS LETT, V581, P3658, DOI 10.1016/j.febslet.2007.04.070; Ozer A, 2005, P NATL ACAD SCI USA, V102, P7481, DOI 10.1073/pnas.0502716102; Popov M, 2000, ANAL BIOCHEM, V279, P90, DOI 10.1006/abio.1999.4443; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Su YA, 1996, MOL CARCINOGEN, V15, P270, DOI 10.1002/(SICI)1098-2744(199604)15:4<270::AID-MC4>3.0.CO;2-K; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; Takeda K, 2007, CIRCULATION, V116, P774, DOI 10.1161/CIRCULATIONAHA.107.701516; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; Thoms BL, 2010, J BIOL CHEM, V285, P20472, DOI 10.1074/jbc.M110.115238; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Webb JD, 2009, CELL MOL LIFE SCI, V66, P3539, DOI 10.1007/s00018-009-0147-7; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Werno C, 2008, J CELL PHYSIOL, V215, P708, DOI 10.1002/jcp.21351; Wotzlaw C, 2007, FASEB J, V21, P700, DOI 10.1096/fj.06-6280com; Wotzlaw Christoph, 2010, PMC Biophys, V3, P5, DOI 10.1186/1757-5036-3-5; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087	56	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19151	10.1371/journal.pone.0019151	http://dx.doi.org/10.1371/journal.pone.0019151			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559462	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700078
J	Hoper, D; Hoffmann, B; Beer, M				Hoeper, Dirk; Hoffmann, Bernd; Beer, Martin			A Comprehensive Deep Sequencing Strategy for Full-Length Genomes of Influenza A	PLOS ONE			English	Article							VIRUS	Driven by the impact of influenza A viruses on human and animal health, much research is conducted on this pathogen. To support this research, we designed an all influenza A-embracing reverse transcription-PCR (RT-PCR) for the generation of DNA from influenza A virus negative strand RNA genome segments for full-length genome deep sequencing on a Genome Sequencer FLX instrument. For high reliability, the RT-PCRs are designed such that every genome segment is divided into two amplicons and for the most variable segments redundancy is included. Moreover, to minimize the risk of contamination of diagnostic real-time PCRs by sequencing amplicons, RT-PCR does not generate amplicons that are amenable to RT-qPCR detection. With the presented protocol we were able to generate virtually all amplicons (99.3% success rate) from isolates representing all so far known 16 hemagglutinin and 9 neuraminidase subtypes and from an additional 2009 pandemic influenza A H1N1 virus. Three isolates were sequenced to analyze the suitability of the DNA for sequencing. Moreover, we provide a short R script that disambiguates the sequences of the primers used. We show that using unambiguous primer sequences for read trimming prior to assembly with the genome sequencer assembler software results in higher quality of the final genome sequences. Using the disambiguated primer sequences, high quality full-length sequences for the three isolates used for sequencing trials could be established from the raw data in de novo assemblies.	[Hoeper, Dirk; Hoffmann, Bernd; Beer, Martin] Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany	Friedrich Loeffler Institute	Hoper, D (corresponding author), Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany.	martin.beer@fli.bund.de		Hoper, Dirk/0000-0001-8408-2274	Federal Ministry of Food, Agriculture and Consumer Protection (BMELV), Germany [FSI 1-1.1.2.]; European Union [223498]	Federal Ministry of Food, Agriculture and Consumer Protection (BMELV), Germany; European Union(European Commission)	This project was supported by the Federal Ministry of Food, Agriculture and Consumer Protection (BMELV), Germany (project no. FSI 1-1.1.2.) and by the European Union FP7 project "European Management Platform for Emerging and Re-emerging Infectious Disease Entities (EMPERIE)'' (no. 223498). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHARIF D, 2010, BIOL SEQUENCES RETRI; Earn DJD, 2002, TRENDS ECOL EVOL, V17, P334, DOI 10.1016/S0169-5347(02)02502-8; Greninger AL, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-82; Hoper D, 2009, J CLIN MICROBIOL, V47, P674, DOI 10.1128/JCM.01028-08; Hoffmann B, 2006, J VIROL METHODS, V136, P200, DOI 10.1016/j.jviromet.2006.05.020; Huang YH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-224; Leifer I, 2010, J GEN VIROL, V91, P2687, DOI 10.1099/vir.0.023200-0; Monger WA, 2010, ARCH VIROL, V155, P1515, DOI 10.1007/s00705-010-0694-0; *NOM COMM INT UN B, 1986, P NATL ACAD SCI USA, V83, P4; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Potgieter AC, 2009, J GEN VIROL, V90, P1423, DOI 10.1099/vir.0.009381-0; R Core Team, 2020, R LANG ENV STAT COMP; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; SIMONS JF, 2007, RNA VIRUS SEQUENCING; WILEY G, 2009, CURR PROTOC HUM GENE, V61; [No title captured]	16	39	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19075	10.1371/journal.pone.0019075	http://dx.doi.org/10.1371/journal.pone.0019075			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559493	Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700061
J	Hughes, ATL; Guilding, C; Piggins, HD				Hughes, Alun T. L.; Guilding, Clare; Piggins, Hugh D.			Neuropeptide Signaling Differentially Affects Phase Maintenance and Rhythm Generation in SCN and Extra-SCN Circadian Oscillators	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; NUCLEI CELLULAR RHYTHMICITY; RECEPTOR MESSENGER-RNA; SUPRACHIASMATIC NUCLEUS; VPAC(2) RECEPTOR; GENE-EXPRESSION; MICE LACKING; PHOTIC REGULATION; PERIOD HOMOLOGS; CLOCK	Circadian rhythms in physiology and behavior are coordinated by the brain's dominant circadian pacemaker located in the suprachiasmatic nuclei (SCN) of the hypothalamus. Vasoactive intestinal polypeptide (VIP) and its receptor, VPAC(2), play important roles in the functioning of the SCN pacemaker. Mice lacking VPAC(2) receptors (Vipr2(-/-)) express disrupted behavioral and metabolic rhythms and show altered SCN neuronal activity and clock gene expression. Within the brain, the SCN is not the only site containing endogenous circadian oscillators, nor is it the only site of VPAC(2) receptor expression; both VPAC(2) receptors and rhythmic clock gene/protein expression have been noted in the arcuate (Arc) and dorsomedial (DMH) nuclei of the mediobasal hypothalamus, and in the pituitary gland. The functional role of VPAC(2) receptors in rhythm generation and maintenance in these tissues is, however, unknown. We used wild type (WT) and Vipr2(-/-) mice expressing a luciferase reporter (PER2::LUC) to investigate whether circadian rhythms in the clock gene protein PER2 in these extra-SCN tissues were compromised by the absence of the VPAC(2) receptor. Vipr2(-/-) SCN cultures expressed significantly lower amplitude PER2:: LUC oscillations than WT SCN. Surprisingly, in Vipr2(-/-) Arc/ME/PT complex (Arc, median eminence and pars tuberalis), DMH and pituitary, the period, amplitude and rate of damping of rhythms were not significantly different to WT. Intriguingly, while we found WT SCN and Arc/ME/PT tissues to maintain a consistent circadian phase when cultured, the phase of corresponding Vipr2(-/-) cultures was reset by cull/culture procedure. These data demonstrate that while the main rhythm parameters of extra-SCN circadian oscillations are maintained in Vipr2(-/-) mice, the ability of these oscillators to resist phase shifts is compromised. These deficiencies may contribute towards the aberrant behavior and metabolism associated with Vipr2(-/-) animals. Further, our data indicate a link between circadian rhythm strength and the ability of tissues to resist circadian phase resetting.	[Hughes, Alun T. L.; Guilding, Clare; Piggins, Hugh D.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Hughes, ATL (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	alun.t.hughes@manchester.ac.uk	Hughes, Alun/HCI-2220-2022	Guilding, Clare/0000-0003-2823-1575; Piggins, Hugh/0000-0003-2555-9858; Hughes, Alun/0000-0001-7460-3216	Biology and Biotechnology Research Council (BBSRC); Wellcome Trust [WT086352]; Biotechnology and Biological Sciences Research Council [BB/G004307/1] Funding Source: researchfish	Biology and Biotechnology Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by project grants to HDP from the Biology and Biotechnology Research Council (BBSRC) and Wellcome Trust (WT086352). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Asnicar MA, 2002, ENDOCRINOLOGY, V143, P3994, DOI 10.1210/en.2002-220354; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bechtold DA, 2008, AM J PHYSIOL-REG I, V294, pR344, DOI 10.1152/ajpregu.00667.2007; Bernardis LL, 1998, P SOC EXP BIOL MED, V218, P284; Brown TM, 2007, J NEUROPHYSIOL, V97, P2553, DOI 10.1152/jn.01206.2006; Brown TM, 2005, J NEUROSCI, V25, P11155, DOI 10.1523/JNEUROSCI.3821-05.2005; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Bur IM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015316; Chauhan D, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S1; Ciarleglio CM, 2009, J NEUROSCI, V29, P1670, DOI 10.1523/JNEUROSCI.3801-08.2009; Colwell CS, 2003, AM J PHYSIOL-REG I, V285, pR939, DOI 10.1152/ajpregu.00200.2003; Cutler DJ, 2003, EUR J NEUROSCI, V17, P197, DOI 10.1046/j.1460-9568.2003.02425.x; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Doherty CJ, 2010, ANNU REV GENET, V44, P419, DOI 10.1146/annurev-genet-102209-163432; Dolatshad H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009855; Dragich JM, 2010, EUR J NEUROSCI, V31, P864, DOI 10.1111/j.1460-9568.2010.07119.x; Gerhold LM, 2001, BRAIN RES, V919, P48, DOI 10.1016/S0006-8993(01)02993-6; Guilding C, 2010, NEUROSCIENCE, V169, P1630, DOI 10.1016/j.neuroscience.2010.06.015; Guilding C, 2007, EUR J NEUROSCI, V25, P3195, DOI 10.1111/j.1460-9568.2007.05581.x; Guilding C, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-28; Hannibal J, 2011, AM J PHYSL IN PRESS; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Hastings M H, 2003, Novartis Found Symp, V253, P203; Hastings M.H., 1999, J NEUROSCI, V11, P1; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; Hezareh M, 1996, ANN NY ACAD SCI, V805, P315; HOUBEN H, 1993, MOL CELL ENDOCRINOL, V97, P159, DOI 10.1016/0303-7207(93)90223-7; Hu WP, 2011, SLEEP, V34, P49, DOI 10.1093/sleep/34.1.49; Hughes ATL, 2008, J BIOL RHYTHM, V23, P211, DOI 10.1177/0748730408316290; Hughes ATL, 2008, J NEUROCHEM, V106, P1646, DOI 10.1111/j.1471-4159.2008.05520.x; Hughes AT, 2004, J NEUROSCI, V24, P3522, DOI 10.1523/JNEUROSCI.5345-03.2004; IBATA Y, 1989, NEUROSCI LETT, V97, P1, DOI 10.1016/0304-3940(89)90129-8; Ishida A, 2005, CELL METAB, V2, P297, DOI 10.1016/j.cmet.2005.09.009; Kalamatianos T, 2004, J COMP NEUROL, V475, P19, DOI 10.1002/cne.20168; Kallo I, 2004, EUR J NEUROSCI, V19, P2201, DOI 10.1111/j.0953-816X.2004.03335.x; KALSBEEK A, 1993, J COMP NEUROL, V332, P293, DOI 10.1002/cne.903320304; Kamichi S, 2005, BRAIN RES, V1032, P162, DOI 10.1016/j.brainres.2004.10.068; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kriegsfeld LJ, 2003, EUR J NEUROSCI, V17, P212, DOI 10.1046/j.1460-9568.2003.02431.x; LAM KSL, 1991, NEUROENDOCRINOLOGY, V53, P45, DOI 10.1159/000125795; Loh DH, 2008, NEUROENDOCRINOLOGY, V88, P246, DOI 10.1159/000140676; Majumdar ID, 2011, CURR OPIN ENDOCRINOL, V18, P68, DOI 10.1097/MED.0b013e328340ff93; Marpegan L, 2009, J BIOL RHYTHM, V24, P135, DOI 10.1177/0748730409332042; Masumoto K, 2010, CURR BIOL, V20, P2199, DOI 10.1016/j.cub.2010.11.038; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; Messager S, 2000, EUR J NEUROSCI, V12, P2865, DOI 10.1046/j.1460-9568.2000.00174.x; MOREL G, 1982, NEUROENDOCRINOLOGY, V34, P85, DOI 10.1159/000123282; Oster H, 2003, GENE DEV, V17, P1366, DOI 10.1101/gad.256103; Pantazopoulos H, 2010, AM J PHYSIOL-REG I, V299, pR379, DOI 10.1152/ajpregu.00176.2010; Paxinos G., 2001, MOUSE BRAIN STEREOTA; PIGGINS HD, 1995, J NEUROSCI, V15, P5612; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; Power A, 2010, J BIOL RHYTHM, V25, P235, DOI 10.1177/0748730410374446; Reed HE, 2001, EUR J NEUROSCI, V13, P839, DOI 10.1046/j.0953-816x.2000.01437.x; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sahu A, 2004, ENDOCRINOLOGY, V145, P2613, DOI 10.1210/en.2004-0032; Sakamoto K, 1998, J BIOL CHEM, V273, P27039, DOI 10.1074/jbc.273.42.27039; Schroeder A, 2011, AM J PHYSIOL-HEART C, V300, pH241, DOI 10.1152/ajpheart.00190.2010; SCHWARTZ WJ, 1990, J NEUROSCI, V10, P3685; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Sheward WJ, 2007, J NEUROSCI, V27, P4351, DOI 10.1523/JNEUROSCI.4843-06.2007; Sheward WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009783; SHEWARD WJ, 1995, NEUROSCIENCE, V67, P409, DOI 10.1016/0306-4522(95)00048-N; Shieh KR, 2005, J BIOMED SCI, V12, P209, DOI 10.1007/s11373-004-8176-6; Ukai H, 2010, ANNU REV PHYSIOL, V72, P579, DOI 10.1146/annurev-physiol-073109-130051; VANDENPOL AN, 1980, J COMP NEUROL, V191, P661, DOI 10.1002/cne.901910410; Vosko AM, 2007, GEN COMP ENDOCR, V152, P165, DOI 10.1016/j.ygcen.2007.04.018; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yoshikawa T, 2005, J BIOL RHYTHM, V20, P500, DOI 10.1177/0748730405280775; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	77	22	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18926	10.1371/journal.pone.0018926	http://dx.doi.org/10.1371/journal.pone.0018926			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559484	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000290024700037
J	Jonsson, S; Lundberg, A; Kalvegren, H; Bergstrom, I; Szymanowski, A; Jonasson, L				Jonsson, Simon; Lundberg, Anna; Kalvegren, Hanna; Bergstrom, Ida; Szymanowski, Aleksander; Jonasson, Lena			Increased Levels of Leukocyte-Derived MMP-9 in Patients with Stable Angina Pectoris	PLOS ONE			English	Article							CIRCULATING MATRIX METALLOPROTEINASES; CORONARY-ARTERY-DISEASE; TISSUE INHIBITORS; PLASMA-CONCENTRATIONS; IN-VIVO; MATRIX-METALLOPROTEINASE-9; EXPRESSION; NEUTROPHILS; ACTIVATION; SERUM	Objective: There is a growing interest for matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in plasma as novel biomarkers in coronary artery disease (CAD). We aimed to identify the sources of MMP-8, MMP-9, TIMP-1 and TIMP-2 among peripheral blood cells and further explore whether gene expression or protein release was altered in patients with stable angina pectoris (SA). Methods: In total, plasma MMP-9 was measured in 44 SA patients and 47 healthy controls. From 10 patients and 10 controls, peripheral blood mononuclear cells (PBMC) and neutrophils were isolated and stimulated ex vivo. MMPs, TIMPs and myeloperoxidase were measured in plasma and supernatants by ELISA. The corresponding gene expression was measured by real-time PCR. Results: Neutrophils were the dominant source of MMP-8 and MMP-9. Upon moderate stimulation with IL-8, the neutrophil release of MMP-9 was higher in the SA patients compared with controls (p < 0.05). In PBMC, the TIMP-1 and MMP-9 mRNA expression was higher in SA patients compared with controls, p < 0.01 and 0.05, respectively. There were no differences in plasma levels between patients and controls except for TIMP-2, which was lower in patients, p < 0.01. Conclusion: Measurements of MMPs and TIMPs in plasma may be of limited use. Despite similar plasma levels in SA patients and controls, the leukocyte-derived MMP-9 and TIMP-1 are significantly altered in patients. The findings indicate that the leukocytes are more prone to release and produce MMP-9 in symptomatic and angiographically verified CAD-a phenomenon that may have clinical implications in the course of disease.	[Jonsson, Simon; Lundberg, Anna; Kalvegren, Hanna; Bergstrom, Ida; Szymanowski, Aleksander; Jonasson, Lena] Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci, Div Cardiovasc Med, Linkoping, Sweden	Linkoping University	Jonsson, S (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci, Div Cardiovasc Med, Linkoping, Sweden.	lena.jonasson@liu.se			Swedish Research Council [2008-2282]; Swedish Heart-Lung Foundation [20060566, 20090489]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation)	The work was funded by the Swedish Research Council (2008-2282, www.vr.se) and the Swedish Heart-Lung Foundation (20060566, 20090489, www.hjart-lungfonden.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardans JA, 2002, J LEUKOCYTE BIOL, V71, P1012; Aznaouridis K, 2007, ATHEROSCLEROSIS, V195, P212, DOI 10.1016/j.atherosclerosis.2006.12.015; Back M, 2010, PROG CARDIOVASC DIS, V52, P410, DOI 10.1016/j.pcad.2009.12.002; Bar-Or A, 2003, BRAIN, V126, P2738, DOI 10.1093/brain/awg285; Blankenberg S, 2003, CIRCULATION, V107, P1579, DOI 10.1161/01.CIR.0000058700.41738.12; Boekholdt SM, 2004, ARTERIOSCL THROM VAS, V24, P1503, DOI 10.1161/01.ATV.0000134294.54422.2e; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Brunner S, 2010, AM J CARDIOL, V105, P429, DOI 10.1016/j.amjcard.2009.10.013; CAMPEAU L, 1976, CIRCULATION, V54, P522, DOI 10.1161/circ.54.3.947585; Claesson R, 2002, J PERIODONTAL RES, V37, P353, DOI 10.1034/j.1600-0765.2002.00365.x; Fang L, 2010, CLIN SCI, V119, P175, DOI 10.1042/CS20100011; Fiotti N, 2008, INT J CARDIOL, V127, P350, DOI 10.1016/j.ijcard.2007.05.011; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Gerlach RF, 2007, CLIN BIOCHEM, V40, P119, DOI 10.1016/j.clinbiochem.2006.10.007; HASTY KA, 1986, J BIOL CHEM, V261, P5645; Houard X, 2009, FASEB J, V23, P1376, DOI 10.1096/fj.08-116202; Inokubo Y, 2001, AM HEART J, V141, P211, DOI 10.1067/mhj.2001.112238; Jefferis BJ, 2010, ATHEROSCLEROSIS, V208, P557, DOI 10.1016/j.atherosclerosis.2009.08.018; Johnatty RN, 1997, J IMMUNOL, V158, P2327; Jones GT, 2006, ARTERIOSCL THROM VAS, V26, pE121, DOI 10.1161/01.ATV.0000226544.93089.7f; Kai HK, 1998, J AM COLL CARDIOL, V32, P368, DOI 10.1016/S0735-1097(98)00250-2; Mannello F, 2008, ARTERIOSCL THROM VAS, V28, P611, DOI 10.1161/ATVBAHA.107.159608; Molloy KJ, 2004, CIRCULATION, V110, P337, DOI 10.1161/01.CIR.0000135588.65188.14; Momiyama Y, 2010, ATHEROSCLEROSIS, V209, P206, DOI 10.1016/j.atherosclerosis.2009.07.037; Morris T, 2009, J IMMUNOL, V183, P2089, DOI 10.4049/jimmunol.0900477; Nanni S, 2007, TRANSL RES, V149, P137, DOI 10.1016/j.trsl.2006.09.001; Negrotto S, 2006, J PHARMACOL EXP THER, V319, P972, DOI 10.1124/jpet.106.109389; Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898; Nijm J, 2005, AM J CARDIOL, V95, P452, DOI 10.1016/j.amjcard.2004.10.009; Noji Y, 2001, CLIN CHEM LAB MED, V39, P380, DOI 10.1515/CCLM.2001.060; Paulsson J, 2007, ATHEROSCLEROSIS, V192, P328, DOI 10.1016/j.atherosclerosis.2006.08.003; Pleiner J, 2004, CIRCULATION, V110, P3349, DOI 10.1161/01.CIR.0000147774.90396.ED; Pugin J, 1999, AM J RESP CELL MOL, V20, P458, DOI 10.1165/ajrcmb.20.3.3311; Rothenbacher D, 2006, ARTERIOSCL THROM VAS, V26, P194, DOI 10.1161/01.ATV.0000191633.52585.14; Sapienza P, 2005, SURGERY, V137, P355, DOI 10.1016/j.surg.2004.10.011; Sarndahl E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001056; Szymanowski A, 2011, PSYCHONEURO IN PRESS; Tayebjee MH, 2006, THROMB HAEMOSTASIS, V95, P202, DOI 10.1055/s-0037-1612586; Tayebjee MH, 2005, AM J CARDIOL, V96, P339, DOI 10.1016/j.amjcard.2005.03.072; Tuomainen AM, 2008, MICROB PATHOGENESIS, V44, P111, DOI 10.1016/j.micpath.2007.08.011; Tuomainen AM, 2007, ARTERIOSCL THROM VAS, V27, P2722, DOI 10.1161/ATVBAHA.107.154831; Zouridakis E, 2004, CIRCULATION, V110, P1747, DOI 10.1161/01.CIR.0000142664.18739.92	44	34	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19340	10.1371/journal.pone.0019340	http://dx.doi.org/10.1371/journal.pone.0019340			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559401	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700142
J	Sato, N; Yamakawa, N; Masuda, M; Sudo, K; Hatada, I; Muramatsu, M				Sato, Noriko; Yamakawa, Naomi; Masuda, Moe; Sudo, Katsuko; Hatada, Izuho; Muramatsu, Masaaki			Genome-Wide DNA Methylation Analysis Reveals Phytoestrogen Modification of Promoter Methylation Patterns during Embryonic Stem Cell Differentiation	PLOS ONE			English	Article							MOUSE; EXPRESSION; SECRETION; REGIONS; TARGETS; GENES; MICE	Background: Environmental challenges during development affect the fetal epigenome, but the period(s) vulnerable to epigenetic dysregulation is(are) not clear. By employing a soy phytoestrogen, genistein, that is known to alter the epigenetic states of the A(vy) allele during embryogenesis, we have explored the sensitive period for epigenetic regulation. The post-implantation period, when de novo DNA methylation actively proceeds, is amenable to in vitro analysis using a mouse embryonic stem (ES) cell differentiation system. Methods and Findings: Mouse ES cells were differentiated in the presence or absence of genistein, and DNA methylation patterns on day 10 were compared by microarray-based promoter methylation analysis coupled with a methylation-sensitive endonuclease (HpaII/McrBC)-dependent enrichment procedure. Moderate changes in methylation levels were observed in a subset of promoters following genistein treatment. Detailed investigation of the Ucp1 and Sytl1 promoters further revealed that genistein does not affect de novo methylation occurring between day 0 and day 4, but interferes with subsequent regulatory processes and leads to a decrease in methylation level for both promoters. Conclusion: Genistein perturbed the methylation pattern of differentiated ES cells after de novo methylation. Our observations suggest that, for a subset of genes, regulation after de novo DNA methylation in the early embryo may be sensitive to genistein.	[Sato, Noriko; Masuda, Moe; Muramatsu, Masaaki] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Epidemiol, Tokyo, Japan; [Yamakawa, Naomi] Tokyo Metropolitan Geriatr Hosp, Tokyo 173, Japan; [Yamakawa, Naomi] Inst Gerontol, Res Team Geriatr Dis, Tokyo, Japan; [Sudo, Katsuko] Tokyo Med Univ, Anim Res Ctr, Tokyo, Japan; [Hatada, Izuho] Gunma Univ, Inst Mol & Cellular Regulat, Biosignal Genome Resource Ctr, Lab Genome Sci, Gunma, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Metropolitan Institute of Gerontology; Tokyo Medical University; Gunma University	Sato, N (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Epidemiol, Tokyo, Japan.	nsato.epi@mri.tmd.ac.jp	Sato, Noriko/Y-7693-2019; liu, li/HGC-0900-2022	Sato, Noriko/0000-0002-0384-5362	 [22659070]; Grants-in-Aid for Scientific Research [22659070] Funding Source: KAKEN	; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Challenging Exploratory Research to NS (22659070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkowitz JKM, 2001, J BIOL CHEM, V276, P18855, DOI 10.1074/jbc.M011167200; Bernal AJ, 2010, BIRTH DEFECTS RES A, V88, P938, DOI 10.1002/bdra.20685; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Blewitt ME, 2006, PLOS GENET, V2, P399, DOI 10.1371/journal.pgen.0020049; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Cooney CA, 2002, J NUTR, V132, p2393S; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; Einstein F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008887; Facucho-Oliveira JM, 2007, J CELL SCI, V120, P4025, DOI 10.1242/jcs.016972; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; Kiskinis E, 2007, EMBO J, V26, P4831, DOI 10.1038/sj.emboj.7601908; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Leahy A, 1999, J EXP ZOOL, V284, P67, DOI 10.1002/(SICI)1097-010X(19990615)284:1&lt;67::AID-JEZ10&gt;3.0.CO;2-O; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Neumuller O, 2009, BLOOD, V114, P1396, DOI 10.1182/blood-2008-05-155234; Rakyan VK, 2008, GENOME RES, V18, P1518, DOI 10.1101/gr.077479.108; Rasbach KA, 2008, J PHARMACOL EXP THER, V325, P536, DOI 10.1124/jpet.107.134882; Saegusa C, 2008, ARCH BIOCHEM BIOPHYS, V475, P87, DOI 10.1016/j.abb.2008.04.031; Shore A, 2010, DIABETOLOGIA, V53, P1164, DOI 10.1007/s00125-010-1701-4; Suzuki Y, 2004, GENOME RES, V14, P1711, DOI 10.1101/gr.2435604; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003	24	22	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19278	10.1371/journal.pone.0019278	http://dx.doi.org/10.1371/journal.pone.0019278			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559447	Green Submitted, gold, Green Published			2022-12-27	WOS:000290024700123
J	Wang, J; Chen, Y; Yuan, QX; Tang, W; Zhang, XP; Osei, K				Wang, Jie; Chen, Ying; Yuan, Qingxin; Tang, Wei; Zhang, Xiaoping; Osei, Kwame			Control of Precursor Maturation and Disposal Is an Early Regulative Mechanism in the Normal Insulin Production of Pancreatic beta-Cells	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; NECROSIS FACTOR-ALPHA; ENDOPLASMIC-RETICULUM; DIABETES-MELLITUS; GLUCOSE-METABOLISM; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; QUALITY-CONTROL; ISLETS; PROINSULIN	The essential folding and maturation process of proinsulin in beta-cells is largely uncharacterized. To analyze this process, we improved approaches to immunoblotting, metabolic labeling, and data analysis used to determine the proportion of monomers and non-monomers and changes in composition of proinsulin in cells. We found the natural occurrence of a large proportion of proinsulin in various non-monomer states, i.e., aggregates, in normal mouse and human beta-cells and a striking increase in the proportion of proinsulin non-monomers in Ins2(+/Akita) mice in response to a mutation (C96Y) in the insulin 2 (Ins2) gene. Proinsulin emerges in monomer and abundant dual-fate non-monomer states during nascent protein synthesis and shows heavy and preferential ATP/redox-sensitive disposal among secretory proteins during early post-translational processes. These findings support the preservation of proinsulin's aggregation-prone nature and low relative folding rate that permits the plentiful production of non-monomer forms with incomplete folding. Thus, in normal mouse/human beta-cells, proinsulin's integrated maturation and degradation processes maintain a balance of natively and nonnatively folded states, i.e., proinsulin homeostasis (PIHO). Further analysis discovered the high susceptibility of PIHO to cellular energy and calcium changes, endoplasmic reticulum (ER) and reductive/oxidative stress, and insults by thiol reagent and cytokine. These results expose a direct correlation between various extra-/intracellular influences and (a) typical integrations of proinsulin maturation and disposal processes. Overall, our findings demonstrated that the control of precursor maturation and disposal acts as an early regulative mechanism in normal insulin production, and its disorder is crucially linked to beta-cell failure and diabetes pathogenesis.	[Wang, Jie; Yuan, Qingxin; Tang, Wei; Zhang, Xiaoping; Osei, Kwame] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Chen, Ying] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Chen, Ying] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA	University System of Ohio; Ohio State University; University of Chicago; University of Chicago	Wang, J (corresponding author), Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA.	jie.wang2@osumc.edu			Ohio State University	Ohio State University(Ohio State University)	This work was supported by the start-up fund and the Manuel Tzagournis Medical Research Award from The Ohio State University (to J.W.). There are no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; CAMPBELL IL, 1988, J IMMUNOL, V141, P2325; COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628; DIXIT PK, 1962, NATURE, V195, P388, DOI 10.1038/195388a0; Donath MY, 2008, ENDOCR REV, V29, P334, DOI 10.1210/er.2007-0033; Edghill EL, 2008, DIABETES, V57, P1034, DOI 10.2337/db07-1405; Eisenbarth GS, 2010, DIABETES, V59, P759, DOI 10.2337/db09-1855; Elouil H, 2007, DIABETOLOGIA, V50, P1442, DOI 10.1007/s00125-007-0674-4; Furuta M, 1998, J BIOL CHEM, V273, P3431, DOI 10.1074/jbc.273.6.3431; Guidarelli A, 1997, BIOCHEM J, V328, P801, DOI 10.1042/bj3280801; Guo ZY, 2008, ANTIOXID REDOX SIGN, V10, P127, DOI 10.1089/ars.2007.1860; Gupta S, 2010, P NATL ACAD SCI USA, V107, P13246, DOI 10.1073/pnas.1005704107; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Hegde RS, 2008, J CELL BIOL, V182, P225, DOI 10.1083/jcb.200804157; HELLMAN B, 1969, DIABETOLOGIA, V5, P22, DOI 10.1007/BF01212214; Himsworth HP, 1936, LANCET, V1, P127; HOWELL SL, 1972, NATURE-NEW BIOL, V235, P85, DOI 10.1038/newbio235085a0; Huang K, 2005, J BIOL CHEM, V280, P42345, DOI 10.1074/jbc.M507110200; HUANG XF, 1995, J BIOL CHEM, V270, P20417, DOI 10.1074/jbc.270.35.20417; Ihara Y, 1999, DIABETES, V48, P927, DOI 10.2337/diabetes.48.4.927; Izumi T, 2003, DIABETES, V52, P409, DOI 10.2337/diabetes.52.2.409; Jahr H, 1995, TRANSPLANT P, V27, P3220; KAHN CR, 1994, DIABETES, V43, P1066, DOI 10.2337/diab.43.8.1066; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kim HE, 2008, J ENDOCRINOL, V198, P549, DOI 10.1677/JOE-08-0131; Liu M, 2005, J BIOL CHEM, V280, P13209, DOI 10.1074/jbc.C400475200; Luheshi LM, 2008, CURR OPIN CHEM BIOL, V12, P25, DOI 10.1016/j.cbpa.2008.02.011; Mahler HC, 2009, J PHARM SCI-US, V98, P2909, DOI 10.1002/jps.21566; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Nozaki J, 2004, GENES CELLS, V9, P261, DOI 10.1111/j.1356-9597.2004.00721.x; ORCI L, 1985, CELL, V42, P671, DOI 10.1016/0092-8674(85)90124-2; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; PERMUTT MA, 1972, P NATL ACAD SCI USA, V69, P505, DOI 10.1073/pnas.69.2.505; Rapoport T A, 1980, Ann N Y Acad Sci, V343, P111, DOI 10.1111/j.1749-6632.1980.tb47246.x; Rebelato E, 2010, METABOLISM, V59, P409, DOI 10.1016/j.metabol.2009.08.010; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; ROE MW, 1994, J BIOL CHEM, V269, P18279; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; STEINER DF, 1967, SCIENCE, V157, P697, DOI 10.1126/science.157.3789.697; STEINER DF, 1968, P NATL ACAD SCI USA, V60, P622, DOI 10.1073/pnas.60.2.622; Steiner DF, 2001, CHEM BIOSYNTHESIS IS, P667; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; Tsiotra PC, 2001, INT J OBESITY, V25, P1018, DOI 10.1038/sj.ijo.0801657; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; UNGER RH, 1985, DIABETOLOGIA, V28, P119; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Westerlund J, 2001, DIABETES, V50, P1785, DOI 10.2337/diabetes.50.8.1785; WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881; WOLLHEIM CB, 1978, J CLIN INVEST, V62, P451, DOI 10.1172/JCI109146; Wollheim CB, 2002, DIABETES, V51, pS37, DOI 10.2337/diabetes.51.2007.S37; Yang SN, 2006, ENDOCR REV, V27, P621, DOI 10.1210/er.2005-0888; Yorimitsu T, 2007, TRENDS CELL BIOL, V17, P279, DOI 10.1016/j.tcb.2007.04.005	56	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19446	10.1371/journal.pone.0019446	http://dx.doi.org/10.1371/journal.pone.0019446			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559376	Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700175
J	Oliver, L; Hue, E; Rossignol, J; Bougras, G; Hulin, P; Naveilhan, P; Heymann, D; Lescaudron, L; Vallette, FM				Oliver, Lisa; Hue, Erika; Rossignol, Julien; Bougras, Gwenola; Hulin, Philippe; Naveilhan, Philippe; Heymann, Dominique; Lescaudron, Laurent; Vallette, Francois M.			Distinct Roles of Bcl-2 and Bcl-XI in the Apoptosis of Human Bone Marrow Mesenchymal Stem Cells during Differentiation	PLOS ONE			English	Article							NEGATIVE SELECTION; STROMAL CELLS; NUR77; SENESCENCE; EXPOSURE; FAMILY; DEATH; LIFE	Background: Adult mesenchymal stem cells (MSCs) can be maintained over extended periods of time before activation and differentiation. Little is known about the programs that sustain the survival of these cells. Principal Findings: Undifferentiated adult human MSCs (hMSCs) did not undergo apoptosis in response to different cell death inducers. Conversely, the same inducers can readily induce apoptosis when hMSCs are engaged in the early stages of differentiation. The survival of undifferentiated cells is linked to the expression of Bcl-Xl and Bcl-2 in completely opposite ways. Bcl-Xl is expressed at similar levels in undifferentiated and differentiated hMSCs while Bcl-2 is expressed only in differentiated cells. In undifferentiated hMSCs, the down-regulation of Bcl-Xl is associated with an increased sensitivity to apoptosis while the ectopic expression of Bcl-2 induced apoptosis. This apoptosis is linked to the presence of cytoplasmic Nur 77 in undifferentiated hMSCs. Significance: In hMSCs, the expression of Bcl-2 depends on cellular differentiation and can be either pro-or anti-apoptotic. Bcl-Xl, on the other hand, exhibits an anti-apoptotic activity under all conditions.	[Oliver, Lisa; Hue, Erika; Bougras, Gwenola; Vallette, Francois M.] INSERM, UMR 892, Equipe Labellisee Ligue Canc, Nantes, France; [Oliver, Lisa; Hue, Erika; Rossignol, Julien; Bougras, Gwenola; Naveilhan, Philippe; Heymann, Dominique; Lescaudron, Laurent; Vallette, Francois M.] Univ Nantes, Fac Med, Nantes, France; [Rossignol, Julien; Naveilhan, Philippe; Lescaudron, Laurent] INSERM, UMR 643, Nantes, France; [Hulin, Philippe] Univ Nantes, Cellular & Tissular Imaging Core Facil MicroPICel, Nantes, France; [Heymann, Dominique] INSERM, UMR 957, Nantes, France; [Lescaudron, Laurent] Univ Nantes, UFR Sci & Tech, Serv Physiol Anim & Humaine, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite	Oliver, L (corresponding author), INSERM, UMR 892, Equipe Labellisee Ligue Canc, Nantes, France.	francois.vallette@inserm.fr	Oliver, Lisa J/L-3070-2015; Heymann, Dominique/AAC-6014-2019; Vallette, Francois M/K-9047-2015; Rossignol, Julien/I-1013-2019; Vallette, Francois/N-2361-2018; Naveilhan, Philippe/K-2377-2015	Oliver, Lisa J/0000-0002-5588-7564; Heymann, Dominique/0000-0001-7777-0669; Vallette, Francois M/0000-0002-3296-8572; Rossignol, Julien/0000-0002-8662-0547; Naveilhan, Philippe/0000-0003-4093-4513; HUE, Erika/0000-0001-6930-3606	INSERM (Insitut National de la Sante et la Recherche Medicale); "Ligue Nationale contre le Cancer" (programme Equipe Labellisee)	INSERM (Insitut National de la Sante et la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); "Ligue Nationale contre le Cancer" (programme Equipe Labellisee)	This work was supported by grants from INSERM (Insitut National de la Sante et la Recherche Medicale) and a special grant from the "Ligue Nationale contre le Cancer" (programme Equipe Labellisee). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batista LFZ, 2009, MUTAT RES-REV MUTAT, V681, P197, DOI 10.1016/j.mrrev.2008.09.001; Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14; CAPLAN AI, 2007, J PATHOL, V217, P318; Cartron PF, 2003, MOL CELL BIOL, V23, P4701, DOI 10.1128/MCB.23.13.4701-4712.2003; Chao LC, 2008, MOL ENDOCRINOL, V22, P2596, DOI 10.1210/me.2008-0161; Haughn L, 2003, J BIOL CHEM, V278, P25158, DOI 10.1074/jbc.M212849200; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Ishii M, 2005, BIOCHEM BIOPH RES CO, V332, P297, DOI 10.1016/j.bbrc.2005.04.118; Kennea NL, 2005, CELL DEATH DIFFER, V12, P1439, DOI 10.1038/sj.cdd.4401641; Koester SK, 1997, CYTOMETRY, V29, P306; Levesque D, 2007, TRENDS NEUROSCI, V30, P22, DOI 10.1016/j.tins.2006.11.006; Li J, 2004, BRIT J HAEMATOL, V127, P326, DOI 10.1111/j.1365-2141.2004.05200.x; Li WZ, 2007, STEM CELLS, V25, P2118, DOI 10.1634/stemcells.2006-0771; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Luciano F, 2007, BLOOD, V109, P3849, DOI 10.1182/blood-2006-11-056879; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Mueller LP, 2006, STEM CELLS, V24, P2753, DOI 10.1634/stemcells.2006-0108; Oguro H, 2007, CURR OPIN IMMUNOL, V19, P503, DOI 10.1016/j.coi.2007.05.001; Orelio C, 2007, LEUKEMIA LYMPHOMA, V48, P16, DOI 10.1080/10428190601032529; PARK JR, 1995, BLOOD, V86, P868; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pontikoglou C, 2008, REGEN MED, V3, P731, DOI 10.2217/17460751.3.5.731; Ren HY, 2006, BIOCHEM BIOPH RES CO, V347, P12, DOI 10.1016/j.bbrc.2006.05.169; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Sohn SJ, 2007, CURR OPIN IMMUNOL, V19, P510, DOI 10.1016/j.coi.2007.06.001; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Streetz KL, 2008, HEPATOLOGY, V47, P706, DOI 10.1002/hep.22012; Thompson J, 2008, J EXP MED, V205, P1029, DOI 10.1084/jem.20080101; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Valtieri M, 2008, J CELL PHYSIOL, V217, P296, DOI 10.1002/jcp.21521; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhu WQ, 2006, STEM CELLS, V24, P416, DOI 10.1634/stemcells.2005-0121	35	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19820	10.1371/journal.pone.0019820	http://dx.doi.org/10.1371/journal.pone.0019820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589877	Green Published, Green Accepted, gold			2022-12-27	WOS:000290531100029
J	Bello-Morales, R; Perez-Hernandez, M; Rejas, MT; Matesanz, F; Alcina, A; Lopez-Guerrero, JA				Bello-Morales, Raquel; Perez-Hernandez, Marta; Teresa Rejas, Maria; Matesanz, Fuencisla; Alcina, Antonio; Antonio Lopez-Guerrero, Jose			Interaction of PLP with GFP-MAL2 in the Human Oligodendroglial Cell Line HOG	PLOS ONE			English	Article							PELIZAEUS-MERZBACHER DISEASE; TO-APICAL TRANSCYTOSIS; HEPATOMA HEPG2 CELLS; MYELIN MEMBRANE; SUBAPICAL COMPARTMENT; POLARITY DEVELOPMENT; PROTEOLIPID PROTEIN; MAL2; TRAFFICKING; BIOGENESIS	The velocity of the nerve impulse conduction of vertebrates relies on the myelin sheath, an electrically insulating layer that surrounds axons in both the central and peripheral nervous systems, enabling saltatory conduction of the action potential. Oligodendrocytes are the myelin-producing glial cells in the central nervous system. A deeper understanding of the molecular basis of myelination and, specifically, of the transport of myelin proteins, will contribute to the search of the aetiology of many dysmyelinating and demyelinating diseases, including multiple sclerosis. Recent investigations suggest that proteolipid protein (PLP), the major myelin protein, could reach myelin sheath by an indirect transport pathway, that is, a transcytotic route via the plasma membrane of the cell body. If PLP transport relies on a transcytotic process, it is reasonable to consider that this myelin protein could be associated with MAL2, a raft protein essential for transcytosis. In this study, carried out with the human oligodendrocytic cell line HOG, we show that PLP colocalized with green fluorescent protein (GFP)-MAL2 after internalization from the plasma membrane. In addition, both immunoprecipitation and immunofluorescence assays, indicated the existence of an interaction between GFP-MAL2 and PLP. Finally, ultrastructural studies demonstrated colocalization of GFP-MAL2 and PLP in vesicles and tubulovesicular structures. Taken together, these results prove for the first time the interaction of PLP and MAL2 in oligodendrocytic cells, supporting the transcytotic model of PLP transport previously suggested.	[Bello-Morales, Raquel; Perez-Hernandez, Marta; Teresa Rejas, Maria; Antonio Lopez-Guerrero, Jose] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cient, Madrid, Spain; [Matesanz, Fuencisla; Alcina, Antonio] Inst Parasitol & Biomed Lopez Neyra, Consejo Super Invest Cient, Granada, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN)	Bello-Morales, R (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cient, Madrid, Spain.	jal@cbm.uam.es	Bello-Morales, Raquel/AHD-5028-2022; LÓPEZ-GUERRERO, JOSÉ ANTONIO/L-5667-2017; Alcina, Antonio/T-1893-2017; Guerrero, Jose Antonio Lopez/Z-2413-2019; Matesanz, Fuencisla/F-3715-2016	LÓPEZ-GUERRERO, JOSÉ ANTONIO/0000-0003-2817-5956; Alcina, Antonio/0000-0001-7294-0948; Guerrero, Jose Antonio Lopez/0000-0002-7369-8388; Matesanz, Fuencisla/0000-0002-9429-1819; Bello-Morales, Raquel/0000-0002-4415-6483; Bello-Morales, Raquel/0000-0002-8526-6590; Perez-Hernandez, Marta/0000-0001-6119-103X	Severo Ochoa Foundation	Severo Ochoa Foundation	This work was supported by the Severo Ochoa Foundation project entitled "Differentiation and transcytosis in oligodendrocytes. Effect of HSV". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO MA, 1987, P NATL ACAD SCI USA, V84, P1997, DOI 10.1073/pnas.84.7.1997; APODACA G, 1994, J CELL BIOL, V125, P67, DOI 10.1083/jcb.125.1.67; Bakhti M, 2011, J BIOL CHEM, V286, P787, DOI 10.1074/jbc.M110.190009; Baron W, 2010, FEBS LETT, V584, P1760, DOI 10.1016/j.febslet.2009.10.085; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Bello-Morales R, 2005, J NEUROVIROL, V11, P190, DOI 10.1080/13550280590924179; Bello-Morales R, 2009, EXP CELL RES, V315, P3453, DOI 10.1016/j.yexcr.2009.08.003; BOISON D, 1995, J NEUROSCI, V15, P5502; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; de Marco MC, 2006, TRAFFIC, V7, P61, DOI 10.1111/j.1600-0854.2005.00361.x; de Marco MC, 2002, J CELL BIOL, V159, P37, DOI 10.1083/jcb.200206033; de Vries H, 1998, MOL BIOL CELL, V9, P599, DOI 10.1091/mbc.9.3.599; Dhaunchak AS, 2007, P NATL ACAD SCI USA, V104, P17813, DOI 10.1073/pnas.0704975104; Doeuvre L, 2009, J NEUROCHEM, V110, P457, DOI 10.1111/j.1471-4159.2009.06163.x; DUBOISDALCQ M, 1986, J CELL BIOL, V102, P384, DOI 10.1083/jcb.102.2.384; Gronborg M, 2010, J NEUROSCI, V30, P2, DOI 10.1523/JNEUROSCI.4074-09.2010; Hayashi T, 2004, P NATL ACAD SCI USA, V101, P14949, DOI 10.1073/pnas.0402890101; Hoekstra D, 2004, J CELL SCI, V117, P2183, DOI 10.1242/jcs.01217; Ihrke G, 1998, J CELL BIOL, V141, P115, DOI 10.1083/jcb.141.1.115; Jackman N, 2009, PHYSIOLOGY, V24, P290, DOI 10.1152/physiol.00016.2009; Klunder B, 2008, J NEUROSCI RES, V86, P1007, DOI 10.1002/jnr.21556; Koeppen AH, 2002, J NEUROPATH EXP NEUR, V61, P747, DOI 10.1093/jnen/61.9.747; Kramer-Albers EM, 2007, PROTEOM CLIN APPL, V1, P1446, DOI 10.1002/prca.200700522; Madrid R, 2010, DEV CELL, V18, P814, DOI [10.1016/j.devcel.2010.04.001, 10.1016/j.devce1.2010.04.001]; Maier O, 2003, J BIOL CHEM, V278, P164, DOI 10.1074/jbc.M208259200; Maier O, 2008, J MOL NEUROSCI, V35, P35, DOI 10.1007/s12031-007-9024-8; Marazuela M, 2004, J HISTOCHEM CYTOCHEM, V52, P243, DOI 10.1177/002215540405200212; Salzer JL, 2003, NEURON, V40, P297, DOI 10.1016/S0896-6273(03)00628-7; Schneider A, 2005, J CELL SCI, V118, P2415, DOI 10.1242/jcs.02365; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Simons M, 2000, J CELL BIOL, V151, P143, DOI 10.1083/jcb.151.1.143; Simons M, 2007, CURR OPIN NEUROBIOL, V17, P533, DOI 10.1016/j.conb.2007.08.003; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Trajkovic K, 2006, J CELL BIOL, V172, P937, DOI 10.1083/jcb.200509022; van IJzendoorn SCD, 1998, J CELL BIOL, V142, P683, DOI 10.1083/jcb.142.3.683; Wilson SHD, 2001, GENOMICS, V76, P81, DOI 10.1006/geno.2001.6610; Winterstein C, 2008, J CELL SCI, V121, P834, DOI 10.1242/jcs.022731; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722	39	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19388	10.1371/journal.pone.0019388	http://dx.doi.org/10.1371/journal.pone.0019388			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573057	gold, Green Published, Green Submitted			2022-12-27	WOS:000290386800011
J	Shen, CI; Wang, CH; Shen, SC; Lee, HC; Liao, JW; Su, HL				Shen, Ching-I; Wang, Ching-Ho; Shen, Shih-Cheng; Lee, Hsiu-Chin; Liao, Jiunn-Wang; Su, Hong-Lin			The Infection of Chicken Tracheal Epithelial Cells with a H6N1 Avian Influenza Virus	PLOS ONE			English	Article							RECEPTOR SPECIFICITY; MAACKIA-AMURENSIS; ACID SUBSTITUTIONS; TARGET-CELLS; H5N1 CHICKEN; BASAL-CELLS; BINDING; HEMAGGLUTININ; PATHOGENICITY; GLYCOPROTEINS	Sialic acids (SAs) linked to galactose (Gal) in alpha 2,3- and alpha 2,6-configurations are the receptors for avian and human influenza viruses, respectively. We demonstrate that chicken tracheal ciliated cells express alpha 2,3-linked SA, while goblet cells mainly express alpha 2,6-linked SA. In addition, the plant lectin MAL-II, but not MAA/MAL-I, is bound to the surface of goblet cells, suggesting that SA2,3-linked oligosaccharides with Gal beta 1-3GalNAc subterminal residues are specifically present on the goblet cells. Moreover, both alpha 2,3- and alpha 2,6-linked SAs are detected on single tracheal basal cells. At a low multiplicity of infection (MOI) avian influenza virus H6N1 is exclusively detected in the ciliated cells, suggesting that the ciliated cell is the major target cell of the H6N1 virus. At a MOI of 1, ciliated, goblet and basal cells are all permissive to the AIV infection. This result clearly elucidates the receptor distribution for the avian influenza virus among chicken tracheal epithelial cells and illustrates a primary cell model for evaluating the cell tropisms of respiratory viruses in poultry.	[Shen, Ching-I] Natl Chung Hsing Univ, Dept Vet Med, Taichung 40227, Taiwan; [Wang, Ching-Ho] Natl Taiwan Univ, Sch Vet Med, Taipei 10764, Taiwan; [Shen, Shih-Cheng; Lee, Hsiu-Chin; Su, Hong-Lin] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Liao, Jiunn-Wang] Natl Chung Hsing Univ, Grad Inst Vet Pathobiol, Taichung 40227, Taiwan; [Su, Hong-Lin] China Med Univ, Dept Phys Therapy, Taichung, Taiwan	National Chung Hsing University; National Taiwan University; National Chung Hsing University; National Chung Hsing University; China Medical University Taiwan	Shen, CI (corresponding author), Natl Chung Hsing Univ, Dept Vet Med, Taichung 40227, Taiwan.	jwliao@dragon.nchu.edu.tw; suhonglin@nchu.edu.tw		Liao, Jiunn-Wang/0000-0001-7374-1203	National Science Council [NSC 99-2321-B-005-012-MY3]; Taiwan Department of Health Clinical Trial and Research Center of Excellence in Taiwan [DOH100-TD-B-111-004]	National Science Council(Ministry of Science and Technology, Taiwan); Taiwan Department of Health Clinical Trial and Research Center of Excellence in Taiwan	The funding for this project was provided by the National Science Council (NSC 99-2321-B-005-012-MY3) and supported in part by Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH100-TD-B-111-004) in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brinkman-Van der Linden ECM, 2002, ANAL BIOCHEM, V303, P98, DOI 10.1006/abio.2001.5539; Buschiazzo A, 2008, CURR OPIN CHEM BIOL, V12, P565, DOI 10.1016/j.cbpa.2008.06.017; Cavanagh D, 2007, VET RES, V38, P281, DOI 10.1051/vetres:2006055; Chen YT, 2010, VET MICROBIOL, V142, P205, DOI 10.1016/j.vetmic.2009.09.064; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Functional glycomics research website, 2005, FUNCTIONAL GLYCOMICS; Gambaryan A, 2002, ARCH VIROL, V147, P1197, DOI 10.1007/s00705-002-0796-4; Gambaryan AS, 2004, VIROLOGY, V326, P310, DOI 10.1016/j.virol.2004.06.002; Gambaryan AS, 2003, AVIAN DIS, V47, P1154, DOI 10.1637/0005-2086-47.s3.1154; Glaser L, 2007, VIRUS RES, V126, P9, DOI 10.1016/j.virusres.2007.01.011; Hong KU, 2004, AM J PHYSIOL-LUNG C, V286, pL643, DOI 10.1152/ajplung.00155.2003; Hong KU, 2004, AM J PATHOL, V164, P577, DOI 10.1016/S0002-9440(10)63147-1; Hsu Chieh-Ning, 2006, Journal of Microbiology Immunology and Infection, V39, P292; Kesimer M, 2009, FASEB J, V23, P1858, DOI 10.1096/fj.08-119131; KNIBBS RN, 1991, J BIOL CHEM, V266, P83; KONAMI Y, 1994, FEBS LETT, V342, P334, DOI 10.1016/0014-5793(94)80527-X; LAMBLIN G, 1984, J BIOL CHEM, V259, P9051; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Mo IP, 1997, AVIAN DIS, V41, P125, DOI 10.2307/1592452; NAEVE CW, 1984, J VIROL, V51, P567, DOI 10.1128/JVI.51.2.567-569.1984; NELSON J, 1993, VIRUS RES, V29, P155, DOI 10.1016/0168-1702(93)90056-S; Nicholls JM, 2008, TRENDS MICROBIOL, V16, P149, DOI 10.1016/j.tim.2008.01.008; Nicholls JM, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-73; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; Pillai SPS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-5; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; Rowe RK, 2004, IN VITRO CELL DEV-AN, V40, P303; Schauer R, 2009, CARBOHYD RES, V344, P1494, DOI 10.1016/j.carres.2009.05.020; Shen CI, 2010, VET RES, V41, DOI 10.1051/vetres/2009054; SUZUKI Y, 1989, J VIROL, V63, P4298, DOI 10.1128/JVI.63.10.4298-4302.1989; Thompson CI, 2006, J VIROL, V80, P8060, DOI 10.1128/JVI.00384-06; Vines A, 1998, J VIROL, V72, P7626, DOI 10.1128/JVI.72.9.7626-7631.1998; Viswanathan K, 2010, GLYCOCONJUGATE J, V27, P561, DOI 10.1007/s10719-010-9303-4; Wan HQ, 2006, VIROLOGY, V346, P278, DOI 10.1016/j.virol.2005.10.035; Wang CW, 2003, AVIAN DIS, V47, P1416, DOI 10.1637/6093	37	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e18894	10.1371/journal.pone.0018894	http://dx.doi.org/10.1371/journal.pone.0018894			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573102	gold, Green Submitted, Green Published			2022-12-27	WOS:000290305600007
J	Zhang, JP; Lu, HY; Wu, NQ; Yang, XY; Diao, XM				Zhang, Jianping; Lu, Houyuan; Wu, Naiqin; Yang, Xiaoyan; Diao, Xianmin			Phytolith Analysis for Differentiating between Foxtail Millet (Setaria italica) and Green Foxtail (Setaria viridis)	PLOS ONE			English	Article							WHEAT TRITICUM-MONOCOCCUM; ORYZA-SATIVA POACEAE; WHITNEY-U-TEST; INFLORESCENCE BRACTS; GENETIC-VARIABILITY; COMMON MILLET; LOWER YANGTZE; P-BEAUV; DOMESTICATION; RICE	Foxtail millet (Setaria italica) is one of the oldest domesticated cereal crops in Eurasia, but identifying foxtail millets, especially in charred grains, and differentiating it from its wild ancestor, green foxtail (Setaria viridis), in the archaeobotanical remains, is still problematic. Phytolithic analysis provides a meaningful method for identifying this important crop. In this paper, the silicon structure patterns in the glumes, lemmas, and paleas from inflorescence bracts in 16 modern plants of foxtail millet and green foxtail from China and Europe are examined using light microscopy with phase-contrast and a microscopic interferometer. Our research shows that the silicon structure of Omega III from upper lemmas and paleas in foxtail millet and green foxtail can be correspondingly divided into two groups. The size of Omega III type phytolith of foxtail millet is bigger than that from green foxtail. Discriminant function analysis reveals that 78.4% of data on foxtail millet and 76.9% of data on green foxtail are correctly classified. This means certain morphotypes of phytoliths are relatively reliable tools for distinguishing foxtail millet from green foxtail. Our results also revealed that the husk phytolith morphologies of foxtail millets from China and Eastern Europe are markedly different from those from Western Europe. Our research gives a meaningful method of separating foxtail millet and green foxtail. The implications of these findings for understanding the history of foxtail millet domestication and cultivation in ancient civilizations are significant.	[Zhang, Jianping; Lu, Houyuan; Wu, Naiqin] Chinese Acad Sci, Key Lab Cenozo Geol & Environm, Inst Geol & Geophys, Beijing, Peoples R China; [Yang, Xiaoyan] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Diao, Xianmin] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Zhang, JP (corresponding author), Chinese Acad Sci, Key Lab Cenozo Geol & Environm, Inst Geol & Geophys, Beijing, Peoples R China.	jpzhang@mail.iggcas.ac.cn	Zhang, Jianping/A-8167-2014; Liu, Kam-Biu/B-4966-2012; Lu, houyuan/AAD-3100-2019; Lu, houyuan/L-8661-2019	Zhang, Jianping/0000-0003-0815-009X; Liu, Kam-Biu/0000-0002-0038-2198; Lu, houyuan/0000-0001-5721-6679; Yang, Xiaoyan/0000-0002-9088-1838	Chinese Academy of Sciences [XDA05130401]; National Basic Research Program of China [2010CB950201]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the "Strategic Priority Research Program'' of the Chinese Academy of Sciences, Grant No. XDA05130401, the National Basic Research Program of China (2010CB950201), the Chinese Academy of Sciences (100 Talents Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, ASIAN PERSPECT, V45, P129; Ball T, 1996, J ARCHAEOL SCI, V23, P619, DOI 10.1006/jasc.1996.0058; Ball TB, 1999, AM J BOT, V86, P1615, DOI 10.2307/2656798; Ball TB, 2009, BREEDING SCI, V59, P505, DOI 10.1270/jsbbs.59.505; Barton L, 2009, P NATL ACAD SCI USA, V106, P5523, DOI 10.1073/pnas.0809960106; Bellwood P, 2004, 1 FARMERS ORIGIN AGR; Benabdelmouna A, 2001, THEOR APPL GENET, V103, P668, DOI 10.1007/s001220100596; Bettinger RL, 2010, EVOL ANTHROPOL, V19, P9, DOI 10.1002/evan.20236; Crawford GW, 1992, ORIGINS AGR INT PERS, P7; d'Ennequin ML, 2000, THEOR APPL GENET, V100, P1061, DOI 10.1007/s001220051387; Fukunaga K, 2006, THEOR APPL GENET, V113, P261, DOI 10.1007/s00122-006-0291-5; Fukunaga K, 2003, EUPHYTICA, V129, P7, DOI 10.1023/A:1021589019323; Fukunaga K, 2002, GENET RESOUR CROP EV, V49, P95, DOI 10.1023/A:1013852007770; Fuller DQ, 2007, ANN BOT-LONDON, V100, P903, DOI 10.1093/aob/mcm048; Fuller DQ, 2007, ANTIQUITY, V81, P316, DOI 10.1017/S0003598X0009520X; Fuller DQ, 2010, ARCHAEOL ANTHROP SCI, V2, P115, DOI 10.1007/s12520-010-0035-y; [葛威 Ge Wei], 2010, [第四纪研究, Quaternary Sciences], V30, P377; Hancock JF, 2003, PLANT EVOLUTION ORIG; HARLAN JR, 1973, EVOLUTION, V27, P311, DOI [10.2307/2406971, 10.1111/j.1558-5646.1973.tb00676.x]; Harlan JR, 1992, CROPS MAN, V2nd; HARLAN JR, 1995, LIVING FIELDS AGR HE; Harvey EL, 2005, J ARCHAEOL SCI, V32, P739, DOI 10.1016/j.jas.2004.12.010; Hunt HV, 2008, VEG HIST ARCHAEOBOT, V17, pS5, DOI 10.1007/s00334-008-0187-1; Itzstein-Davey F, 2007, J ARCHAEOL SCI, V34, P2101, DOI 10.1016/j.jas.2007.02.018; Jones M. K., 2004, TRACES ANCESTRY STUD, P127; JUSUF M, 1985, THEOR APPL GENET, V71, P385, DOI 10.1007/BF00251177; Kachigan S.K., 1991, MULTIVARIATE STAT AN; Kasuya E, 2001, ANIM BEHAV, V61, P1247, DOI 10.1006/anbe.2001.1691; Kovach MJ, 2007, TRENDS GENET, V23, P578, DOI 10.1016/j.tig.2007.08.012; Lee GA, 2007, P NATL ACAD SCI USA, V104, P1087, DOI 10.1073/pnas.0609763104; Liu C., 2004, ARCHAEOLOGY, V8, P76; Lu HY, 2009, P NATL ACAD SCI USA, V106, P7367, DOI 10.1073/pnas.0900158106; Lu HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004448; Lu HY, 2005, NATURE, V437, P967, DOI 10.1038/437967a; Lu HY, 2003, DIVERS DISTRIB, V9, P73, DOI 10.1046/j.1472-4642.2003.00166.x; Lu HY, 2002, BOREAS, V31, P378, DOI 10.1080/030094802320942581; Lu Q.S., 1999, SORGHUM; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Morris LR, 2009, REV PALAEOBOT PALYNO, V157, P339, DOI 10.1016/j.revpalbo.2009.06.007; Nasu H, 2007, VEG HIST ARCHAEOBOT, V16, P481, DOI 10.1007/s00334-006-0068-4; PARRY DW, 1982, ANN BOT-LONDON, V49, P531, DOI 10.1093/oxfordjournals.aob.a086278; PEARSALL DM, 1995, ECON BOT, V49, P183, DOI 10.1007/BF02862923; Pearsall DM., 2015, PALEOETHNOBOTANY HDB; Perry Carole C., 2009, V47, P295, DOI 10.1007/978-3-540-88552-8_13; Piperno D.R., 2006, PHYTOLITH COMPREHENS; Piperno D.R., 1988, PHYTOLITH ANAL ARCHA; PIPERNO DR, 1984, AM ANTIQUITY, V49, P361, DOI 10.2307/280024; Rosen A. M., 1987, SHIQMIM STUDIES CO 1, V356, P547; Rosen A.M., 1992, PHYTOLITH SYSTEMATIC, P129; ROSEN AM, 1994, J ARCHAEOL SCI, V21, P125, DOI 10.1006/jasc.1994.1013; Rosner B, 1999, STAT MED, V18, P1387, DOI 10.1002/(SICI)1097-0258(19990615)18:11<1387::AID-SIM126>3.0.CO;2-V; Rovner I., 1971, QUAT RES, V1, P343, DOI [10.1016/0033-5894(71)90070-6, DOI 10.1016/0033-5894(71)90070-6]; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; SAKAMOTO S, 1987, JARQ-JPN AGR RES Q, V21, P84; SANGSTER AG, 1983, NEW PHYTOL, V93, P105, DOI 10.1111/j.1469-8137.1983.tb02696.x; Schontz D, 1999, PLANT BREEDING, V118, P190, DOI 10.1046/j.1439-0523.1999.118002190.x; Shelach G, 2000, J WORLD PREHIST, V14, P363, DOI 10.1023/A:1011124209079; Smith BD, 1999, EMERGENCE AGR; TUBB HJ, 1993, ANN BOT-LONDON, V72, P537, DOI 10.1006/anbo.1993.1142; Underhill AP, 1997, J WORLD PREHIST, V11, P103, DOI 10.1007/BF02221203; WANG RL, 1995, AM J BOT, V82, P308, DOI 10.2307/2445576; Wet J. M. J. de, 1979, Journal d'Agriculture Traditionnelle et de Botanique Appliquee, V26, P53; Willcox G, 2004, J ARCHAEOL SCI, V31, P145, DOI 10.1016/j.jas.2003.07.003; [阎共波 Yan Hongbo], 2003, [西北植物学报, Acta Botanica Boreali-Occidentalla Sinica], V23, P926; [杨晓燕 Yang Xiaoyan], 2010, [第四纪研究, Quaternary Sciences], V30, P364; Yang XY, 2009, CHINESE SCI BULL, V54, P1738, DOI 10.1007/s11434-009-0048-z; [杨晓燕 Yang Xiaoyan], 2005, [第四纪研究, Quaternary Sciences], V25, P224; Zhao ZJ, 1998, ECON BOT, V52, P134, DOI 10.1007/BF02861201; Zohary D, 2000, DOMESTICATION PLANTS, DOI DOI 10.1006/ANBO.2001.1505	69	63	77	5	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19726	10.1371/journal.pone.0019726	http://dx.doi.org/10.1371/journal.pone.0019726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573069	gold, Green Published			2022-12-27	WOS:000290305600043
J	Li, QH; Li, N; Hu, XX; Li, JX; Du, Z; Chen, L; Yin, GL; Duan, JJ; Zhang, HC; Zhao, YF; Wang, J; Li, N				Li, Qinghe; Li, Ning; Hu, Xiaoxiang; Li, Jinxiu; Du, Zhuo; Chen, Li; Yin, Guangliang; Duan, Jinjie; Zhang, Haichao; Zhao, Yaofeng; Wang, Jun; Li, Ning			Genome-Wide Mapping of DNA Methylation in Chicken	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; ARABIDOPSIS; TRANSCRIPTION; ELONGATION; M6P/IGF2R; CELLS; IGF2	Cytosine DNA methylation is an important epigenetic modification termed as the fifth base that functions in diverse processes. Till now, the genome-wide DNA methylation maps of many organisms has been reported, such as human, Arabidopsis, rice and silkworm, but the methylation pattern of bird remains rarely studied. Here we show the genome-wide DNA methylation map of bird, using the chicken as a model organism and an immunocapturing approach followed by high-throughput sequencing. In both of the red jungle fowl and the avian broiler, DNA methylation was described separately for the liver and muscle tissue. Generally, chicken displays analogous methylation pattern with that of animals and plants. DNA methylation is enriched in the gene body regions and the repetitive sequences, and depleted in the transcription start site (TSS) and the transcription termination site (TTS). Most of the CpG islands in the chicken genome are kept in unmethylated state. Promoter methylation is negatively correlated with the gene expression level, indicating its suppressive role in regulating gene transcription. This work contributes to our understanding of epigenetics in birds.	[Li, Qinghe; Hu, Xiaoxiang; Li, Jinxiu; Du, Zhuo; Chen, Li; Zhao, Yaofeng; Li, Ning] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Li, Ning; Yin, Guangliang; Duan, Jinjie; Zhang, Haichao; Wang, Jun] Beijing Genom Inst Shenzhen, Shenzhen, Peoples R China; [Li, Ning] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	China Agricultural University; Beijing Genomics Institute (BGI); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, QH (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	ninglbau@public3.bta.net.cn	Du, Zhuo/AAD-2263-2019; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Du, Zhuo/0000-0002-6322-4656; Wang, Jun/0000-0002-2113-5874; Wang, Jun/0000-0002-8540-8931; Duan, Jinjie/0000-0002-3402-302X	National Major Basic Research Program of China (973 program) [2007CB815704, 2009CB941600]; National High Technology and Development Program of China (863 Program) [2010AA10A102]; National Natural Science Foundation of China; China Agricultural University	National Major Basic Research Program of China (973 program)(National Basic Research Program of China); National High Technology and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agricultural University	This work was supported by the National Major Basic Research Program of China (973 program, No. 2007CB815704, No. 2009CB941600), the National High Technology and Development Program of China (863 Program, No. 2010AA10A102), the National Natural Science Foundation of China, and the Postgraduate Scientific Research Innovation Specific Program of China Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Burt D, 2003, SCIENCE, V300, P1669, DOI 10.1126/science.1086231; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; FUMIHITO A, 1994, P NATL ACAD SCI USA, V91, P12505, DOI 10.1073/pnas.91.26.12505; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Killian JK, 2000, MOL CELL, V5, P707, DOI 10.1016/S1097-2765(00)80249-X; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li N, 2010, METHODS, V52, P203, DOI 10.1016/j.ymeth.2010.04.009; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Nolan CM, 2001, DEV GENES EVOL, V211, P179, DOI 10.1007/s004270000132; O'Neill MJ, 2000, DEV GENES EVOL, V210, P18, DOI 10.1007/PL00008182; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Rountree MR, 1997, GENE DEV, V11, P2383, DOI 10.1101/gad.11.18.2383; Rubin CJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-208; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Ruike Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-137; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Xu Q, 2007, ANIM BIOTECHNOL, V18, P231, DOI 10.1080/10495390701574838; Yokomine T, 2005, GENOME RES, V15, P154, DOI 10.1101/gr.2609605; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	29	98	103	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19428	10.1371/journal.pone.0019428	http://dx.doi.org/10.1371/journal.pone.0019428			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573164	gold, Green Submitted, Green Published			2022-12-27	WOS:000290256400010
J	Mazloumian, A; Eom, YH; Helbing, D; Lozano, S; Fortunato, S				Mazloumian, Amin; Eom, Young-Ho; Helbing, Dirk; Lozano, Sergi; Fortunato, Santo			How Citation Boosts Promote Scientific Paradigm Shifts and Nobel Prizes	PLOS ONE			English	Article							SCIENCE; IMPACT; TEAMS	Nobel Prizes are commonly seen to be among the most prestigious achievements of our times. Based on mining several million citations, we quantitatively analyze the processes driving paradigm shifts in science. We find that groundbreaking discoveries of Nobel Prize Laureates and other famous scientists are not only acknowledged by many citations of their landmark papers. Surprisingly, they also boost the citation rates of their previous publications. Given that innovations must outcompete the rich-gets-richer effect for scientific citations, it turns out that they can make their way only through citation cascades. A quantitative analysis reveals how and why they happen. Science appears to behave like a self-organized critical system, in which citation cascades of all sizes occur, from continuous scientific progress all the way up to scientific revolutions, which change the way we see our world. Measuring the "boosting effect" of landmark papers, our analysis reveals how new ideas and new players can make their way and finally triumph in a world dominated by established paradigms. The underlying "boost factor" is also useful to discover scientific breakthroughs and talents much earlier than through classical citation analysis, which by now has become a widespread method to measure scientific excellence, influencing scientific careers and the distribution of research funds. Our findings reveal patterns of collective social behavior, which are also interesting from an attention economics perspective. Understanding the origin of scientific authority may therefore ultimately help to explain how social influence comes about and why the value of goods depends so strongly on the attention they attract.	[Mazloumian, Amin; Helbing, Dirk; Lozano, Sergi] ETH, Zurich, Switzerland; [Eom, Young-Ho; Fortunato, Santo] ISI, Complex Networks & Syst Lagrange Lab, Turin, Italy	Swiss Federal Institutes of Technology Domain; ETH Zurich	Mazloumian, A (corresponding author), ETH, Zurich, Switzerland.	fortunato@isi.it	Lozano, Sergi/B-5974-2015; Fortunato, Santo/M-7912-2019; Fortunato, Santo/C-3586-2009	Lozano, Sergi/0000-0003-1895-9327; Fortunato, Santo/0000-0002-9039-4730; Fortunato, Santo/0000-0002-9039-4730	European Commission [231200, 238597]	European Commission(European CommissionEuropean Commission Joint Research Centre)	A.M., S.L. and D.H. were partially supported by the Future and Emerging Technologies programme FP7-COSI-ICT of the European Commission through the project QLectives (grant no.: 231200). Y.-H. E. and S. F. gratefully acknowledge ICTeCollective, grant 238597 of the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aksnes DW, 2006, J AM SOC INF SCI TEC, V57, P169, DOI 10.1002/asi.20262; AMSTERDAMSKA O, 1989, SCIENTOMETRICS, V15, P449, DOI 10.1007/BF02017065; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Bettencourt LMA, 2006, PHYSICA A, V364, P513, DOI 10.1016/j.physa.2005.08.083; Bollen J, 2005, INFORM PROCESS MANAG, V41, P1419, DOI 10.1016/j.ipm.2005.03.024; Bonitz M, 1997, SCIENTOMETRICS, V40, P407, DOI 10.1007/BF02459289; Boyack KW, 2003, J AM SOC INF SCI TEC, V54, P447, DOI 10.1002/asi.10230; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Davenport T.H., 2001, ATTENTION EC UNDERST, DOI 10.1145/375348.376626; Egghe L., 1990, INTRO INFORMETRICS Q; GARFIELD E, 1955, SCIENCE, V122, P108, DOI 10.1126/science.122.3159.108; Garfield E, 1979, CITATION INDEXING IT; Guimera R, 2005, SCIENCE, V308, P697, DOI 10.1126/science.1106340; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Jones BF, 2008, SCIENCE, V322, P1259, DOI 10.1126/science.1158357; Kuhn T. S., 1996, STRUCTURE SCI REVOLU; Malmgren RD, 2010, NATURE, V465, P622, DOI 10.1038/nature09040; Malmgren RD, 2009, SCIENCE, V325, P1696, DOI 10.1126/science.1174562; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; MERTON RK, 1988, ISIS, V79, P606, DOI 10.1086/354848; Moed HF., 2005, CITATION ANAL RES EV; Oliveira JG, 2005, NATURE, V437, P1251, DOI 10.1038/4371251a; Petersen AM, 2011, P NATL ACAD SCI USA, V108, P18, DOI 10.1073/pnas.1016733108; Petersen AM, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.036114; Stanley H.E., 1971, INTRO PHASE TRANSITI; TRAJTENBERG M, 1990, RAND J ECON, V21, P172, DOI 10.2307/2555502; Van Raan AFJ, 2005, SCIENTOMETRICS, V62, P133, DOI 10.1007/s11192-005-0008-6; Wu F, 2007, P NATL ACAD SCI USA, V104, P17599, DOI 10.1073/pnas.0704916104; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099; [No title captured]	31	77	81	4	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e18975	10.1371/journal.pone.0018975	http://dx.doi.org/10.1371/journal.pone.0018975			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	759EZ	21573229	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000290224800010
J	Sarfo, FS; Lavender, CJ; Fyfe, JAM; Johnson, PDR; Stinear, TP; Phillips, RO				Sarfo, Fred S.; Lavender, Caroline J.; Fyfe, Janet A. M.; Johnson, Paul D. R.; Stinear, Timothy P.; Phillips, Richard O.			Mycobacterium ulcerans DNA Not Detected in Faecal Samples from Buruli Ulcer Patients: Results of a Pilot Study	PLOS ONE			English	Article							AUSTRALIA; MAMMALS	It has recently been shown that in a Buruli ulcer (BU) endemic region of southeastern Australia, significant numbers of possums (native tree-dwelling marsupials) have clinical BU disease. Furthermore, based on quantitative PCR (qPCR) analysis, animals with BU lesions (and some without) shed M. ulcerans DNA in their faeces, indicative of bacterial loads of up to 10 8 organisms/gram. These findings led us to propose that humans might also harbour M. ulcerans in their gastrointestinal tract and shed the bacterium in their faeces. We conducted a pilot study and collected faecal swabs from 26 patients with confirmed BU and 31 healthy household controls. Faecal samples were also collected from 10 healthy controls from non-endemic regions in Ghana. All 67 specimens were negative when tested by IS2404 PCR. The detection sensitivity of this method was >= 10(4) bacteria per gram (wet-weight) of human faecal material. We conclude that the human gastrointestinal tract is unlikely to be a significant reservoir of M. ulcerans.	[Sarfo, Fred S.; Phillips, Richard O.] Komfo Anokye Teaching Hosp, Kumasi, Ghana; [Lavender, Caroline J.; Fyfe, Janet A. M.] Victorian Infect Dis Reference Lab, Mycobacterium Reference Lab, Melbourne, Vic, Australia; [Johnson, Paul D. R.] Austin Hlth, Dept Infect Dis, Heidelberg, Vic, Australia; [Johnson, Paul D. R.; Stinear, Timothy P.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Johnson, Paul D. R.; Stinear, Timothy P.] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia	Kwame Nkrumah University Science & Technology; Victorian Infectious Diseases Reference Laboratory; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Monash University	Sarfo, FS (corresponding author), Komfo Anokye Teaching Hosp, Kumasi, Ghana.	tstinear@unimelb.edu.au	Phillips, Richard Odame/ABD-5394-2021	Phillips, Richard Odame/0000-0001-8992-0222; Stinear, Timothy/0000-0003-0150-123X; Lavender, Caroline/0000-0002-2213-4005	UBS Optimus Foundation	UBS Optimus Foundation	This research was supported by the UBS Optimus Foundation www.stopburuli.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Durnez L, 2010, APPL ENVIRON MICROB, V76, P4574, DOI 10.1128/AEM.00199-10; Fyfe JAM, 2007, APPL ENVIRON MICROB, V73, P4733, DOI 10.1128/AEM.02971-06; Fyfe JAM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000791; Johnson PDR, 2007, EMERG INFECT DIS, V13, P1653, DOI 10.3201/eid1311.061369; Johnson PDR, 2009, EMERG INFECT DIS, V15, P614, DOI 10.3201/eid1504.081162; PIDOT S, 2010, PLOS NEGL T IN PRESS; Roltgen K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000751	7	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19611	10.1371/journal.pone.0019611	http://dx.doi.org/10.1371/journal.pone.0019611			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573192	Green Published, Green Submitted, gold			2022-12-27	WOS:000290224800039
J	Hawse, JR; Cicek, M; Grygo, SB; Bruinsma, ES; Rajamannan, NM; van Wijnen, AJ; Lian, JB; Stein, GS; Oursler, MJ; Subramaniam, M; Spelsberg, TC				Hawse, John R.; Cicek, Muzaffer; Grygo, Sarah B.; Bruinsma, Elizabeth S.; Rajamannan, Nalini M.; van Wijnen, Andre J.; Lian, Jane B.; Stein, Gary S.; Oursler, Merry Jo; Subramaniam, Malayannan; Spelsberg, Thomas C.			TIEG1/KLF10 Modulates Runx2 Expression and Activity in Osteoblasts	PLOS ONE			English	Article							INDUCIBLE EARLY GENE-1; OSTEOCLAST-DIFFERENTIATION; TRANSCRIPTIONAL CONTROL; CBFA1 CONTRIBUTES; DISPLAY DEFECTS; BONE-FORMATION; MICE DISPLAY; KAPPA-B; GROWTH; PROTEIN	Deletion of TIEG1/KLF10 in mice results in a gender specific osteopenic skeletal phenotype with significant defects in both cortical and trabecular bone, which are observed only in female animals. Calvarial osteoblasts isolated from TIEG1 knockout (KO) mice display reduced expression levels of multiple bone related genes, including Runx2, and exhibit significant delays in their mineralization rates relative to wildtype controls. These data suggest that TIEG1 plays an important role in regulating Runx2 expression in bone and that decreased Runx2 expression in TIEG1 KO mice is in part responsible for the observed osteopenic phenotype. In this manuscript, data is presented demonstrating that over-expression of TIEG1 results in increased expression of Runx2 while repression of TIEG1 results in suppression of Runx2. Transient transfection and chromatin immunoprecipitation assays reveal that TIEG1 directly binds to and activates the Runx2 promoter. The zinc finger containing domain of TIEG1 is necessary for this regulation supporting that activation occurs through direct DNA binding. A role for the ubiquitin/proteasome pathway in fine tuning the regulation of Runx2 expression by TIEG1 is also implicated in this study. Additionally, the regulation of Runx2 expression by cytokines such as TGF beta 1 and BMP2 is shown to be inhibited in the absence of TIEG1. Co-immunoprecipitation and co-localization assays indicate that TIEG1 protein associates with Runx2 protein resulting in co-activation of Runx2 transcriptional activity. Lastly, Runx2 adenoviral infection of TIEG1 KO calvarial osteoblasts leads to increased expression of Runx2 and enhancement of their ability to differentiate and mineralize in culture. Taken together, these data implicate an important role for TIEG1 in regulating the expression and activity of Runx2 in osteoblasts and suggest that decreased expression of Runx2 in TIEG1 KO mice contributes to the observed osteopenic bone phenotype.	[Hawse, John R.; Cicek, Muzaffer; Grygo, Sarah B.; Bruinsma, Elizabeth S.; Subramaniam, Malayannan; Spelsberg, Thomas C.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Rajamannan, Nalini M.] Northwestern Univ, Dept Med, Div Cardiol, Feinberg Sch Med, Chicago, IL 60611 USA; [van Wijnen, Andre J.; Lian, Jane B.; Stein, Gary S.] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; [van Wijnen, Andre J.; Lian, Jane B.; Stein, Gary S.] Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01655 USA; [Oursler, Merry Jo] Mayo Clin, Endocrine Res Unit, Rochester, MN USA	Mayo Clinic; Northwestern University; Feinberg School of Medicine; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Mayo Clinic	Hawse, JR (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	hawse.john@mayo.edu	van Wijnen, Andre J./AAG-3578-2019	van Wijnen, Andre J./0000-0002-4458-0946	National Institutes of Health [DE14036, AR52004]; Mayo Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052004, R01AR049069, R01AR039588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014036, R37DE012528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE014036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health grants DE14036 (to T. C. S.) and AR52004 (to M.J.O.) as well as the Mayo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Bensamoun SF, 2006, BONE, V39, P1244, DOI 10.1016/j.bone.2006.05.021; Bensamoun SF, 2006, J APPL PHYSIOL, V101, P1419, DOI 10.1152/japplphysiol.00800.2005; Cao ZX, 2009, J BIOL CHEM, V284, P24914, DOI 10.1074/jbc.M109.000059; Chalaux E, 1999, FEBS LETT, V457, P478, DOI 10.1016/S0014-5793(99)01051-0; Choi JY, 2000, J BONE MINER RES, V15, pS157; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Drissi H, 2000, J CELL PHYSIOL, V184, P341, DOI 10.1002/1097-4652(200009)184:3<341::AID-JCP8>3.0.CO;2-Z; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Enomoto H, 2003, J BIOL CHEM, V278, P23971, DOI 10.1074/jbc.M302457200; Galindo M, 2005, J BIOL CHEM, V280, P20274, DOI 10.1074/jbc.M413665200; Gao YH, 1998, BIOCHEM BIOPH RES CO, V252, P697, DOI 10.1006/bbrc.1998.9643; Geoffroy V, 2002, MOL CELL BIOL, V22, P6222, DOI 10.1128/MCB.22.17.6222-6233.2002; Haddad Oualid, 2009, Journal of Musculoskeletal Research, V12, P127, DOI 10.1142/S0218957709002304; Harada H, 1999, J BIOL CHEM, V274, P6972, DOI 10.1074/jbc.274.11.6972; Hassan MQ, 2007, MOL CELL BIOL, V27, P3337, DOI 10.1128/MCB.01544-06; Hawse JR, 2008, BONE, V42, P1025, DOI 10.1016/j.bone.2008.02.004; Hawse JR, 2008, MOL ENDOCRINOL, V22, P1579, DOI 10.1210/me.2007-0253; Hefferan TE, 2000, J BIOL CHEM, V275, P20255, DOI 10.1074/jbc.C000135200; Hefferan TE, 2000, J CELL BIOCHEM, V78, P380, DOI 10.1002/1097-4644(20000901)78:3<380::AID-JCB4>3.0.CO;2-L; Hinoi E, 2006, J BIOL CHEM, V281, P18015, DOI 10.1074/jbc.M600603200; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; House CM, 2003, P NATL ACAD SCI USA, V100, P3101, DOI 10.1073/pnas.0534783100; Ito Y, 2003, CURR OPIN GENET DEV, V13, P43, DOI 10.1016/S0959-437X(03)00007-8; Jheon AH, 2001, J BIOL CHEM, V276, P18282, DOI 10.1074/jbc.M010885200; Johnsen SA, 2002, ONCOGENE, V21, P5783, DOI 10.1038/sj.onc.1205681; Johnsen SA, 2002, J BIOL CHEM, V277, P30754, DOI 10.1074/jbc.M204812200; Johnsen SA, 2004, SIGNAL TRANSDUCT, V4, P29; Jones DC, 2006, SCIENCE, V312, P1223, DOI 10.1126/science.1126313; Kanatani N, 2006, DEV BIOL, V296, P48, DOI 10.1016/j.ydbio.2006.03.039; Karsenty G, 1999, GENE DEV, V13, P3037, DOI 10.1101/gad.13.23.3037; Kern B, 2001, J BIOL CHEM, V276, P7101, DOI 10.1074/jbc.M006215200; Kim S, 2003, GENE DEV, V17, P1979, DOI 10.1101/gad.1119303; Kim Y, 2007, J CELL PHYSIOL, V211, P253, DOI 10.1002/jcp.20933; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lengner CJ, 2006, J CELL BIOL, V172, P909, DOI 10.1083/jcb.200508130; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; Liu W, 2001, J CELL BIOCHEM, V83, P271, DOI 10.1002/jcb.1234; Luan Y, 2007, J BIOL CHEM, V282, P16860, DOI 10.1074/jbc.M610943200; Miller J, 2002, NAT GENET, V32, P645, DOI 10.1038/ng1049; Monroe DG, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-104; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; O'Brien CA, 2002, BONE, V30, P453, DOI 10.1016/S8756-3282(01)00692-5; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pratap J, 2003, CANCER RES, V63, P5357; Rajamannan NM, 2007, J CELL BIOCHEM, V100, P315, DOI 10.1002/jcb.21049; Reinholz MM, 2004, BREAST CANCER RES TR, V86, P75, DOI 10.1023/B:BREA.0000032926.74216.7d; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Schmidt K, 2005, J CELL BIOL, V168, P899, DOI 10.1083/jcb.200408013; Subramaniam M, 1995, NUCLEIC ACIDS RES, V23, P4907, DOI 10.1093/nar/23.23.4907; Subramaniam M, 2005, MOL CELL BIOL, V25, P1191, DOI 10.1128/MCB.25.3.1191-1199.2005; SUBRAMANIAM M, 1995, J CELL BIOCHEM, V57, P52, DOI 10.1002/jcb.240570107; Subramaniam M, 2010, BIOCHEM BIOPH RES CO, V392, P72, DOI 10.1016/j.bbrc.2009.12.171; Subramaniam M, 2010, BIOFACTORS; Subramaniam M, 2007, J CELL BIOCHEM, V102, P539, DOI 10.1002/jcb.21492; Tachibana I, 1997, J CLIN INVEST, V99, P2365, DOI 10.1172/JCI119418; Thirunavukkarasu K, 2000, J BIOL CHEM, V275, P25163, DOI 10.1074/jbc.M000322200; Tribioli C, 1999, DEVELOPMENT, V126, P5699; Tsubone T, 2006, J ORTHOP RES, V24, P569, DOI 10.1002/jor.20101; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Venuprasad K, 2008, NAT IMMUNOL, V9, P245, DOI 10.1038/ni1564; Westendorf JJ, 2006, J CELL BIOCHEM, V98, P54, DOI 10.1002/jcb.20805; Yoshida CA, 2002, NAT GENET, V32, P633, DOI 10.1038/ng1015; Young DW, 2007, P NATL ACAD SCI USA, V104, P3189, DOI 10.1073/pnas.0611419104; Young DW, 2007, NATURE, V445, P442, DOI 10.1038/nature05473; Zaidi SK, 2007, P NATL ACAD SCI USA, V104, P19861, DOI 10.1073/pnas.0709650104; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zhang Y, 2009, J BIOL CHEM, V284, P3125, DOI 10.1074/jbc.M807466200; Zhang YW, 2000, P NATL ACAD SCI USA, V97, P10549, DOI 10.1073/pnas.180309597; Zhou G, 2006, P NATL ACAD SCI USA, V103, P19004, DOI 10.1073/pnas.0605170103	74	33	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19429	10.1371/journal.pone.0019429	http://dx.doi.org/10.1371/journal.pone.0019429			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559363	gold, Green Published, Green Submitted			2022-12-27	WOS:000290024700167
J	Prabha, S; Rao, DN; Nagaraja, V				Prabha, Swayam; Rao, Desirazu N.; Nagaraja, Valakunja			Distinct Properties of Hexameric but Functionally Conserved Mycobacterium tuberculosis Transcription-Repair Coupling Factor	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; STRUCTURAL BASIS; FACTOR MFD; DNA; PROTEIN; MOTIF; MODEL; UVRB	Transcription coupled nucleotide excision repair (TC-NER) is involved in correcting UV-induced damage and other roadblocks encountered in the transcribed strand. Mutation frequency decline (Mfd) is a transcription repair coupling factor, involved in repair of template strand during transcription. Mfd from M. tuberculosis (MtbMfd) is 1234 amino-acids long harboring characteristic modules for different activities. Mtbmfd complemented Escherichia coli mfd (Ecomfd) deficient strain, enhanced survival of UV irradiated cells and increased the road-block repression in vivo. The protein exhibited ATPase activity, which was stimulated similar to 1.5-fold in the presence of DNA. While the C-terminal domain (CTD) comprising amino acids 630 to 1234 showed similar to 2-fold elevated ATPase activity than MtbMfd, the N-terminal domain (NTD) containing the first 433 amino acid residues was able to bind ATP but deficient in hydrolysis. Overexpression of NTD of MtbMfd led to growth defect and hypersensitivity to UV light. Deletion of 184 amino acids from the C-terminal end of MtbMfd (Mfd Delta C) increased the ATPase activity by similar to 10-fold and correspondingly exhibited efficient translocation along DNA as compared to the MtbMfd and CTD. Surprisingly, MtbMfd was found to be distributed in monomer and hexamer forms both in vivo and in vitro and the monomer showed increased susceptibility to proteases compared to the hexamer. Mfd Delta C, on the other hand, was predominantly monomeric in solution implicating the extreme C-terminal region in oligomerization of the protein. Thus, although the MtbMfd resembles EcoMfd in many of its reaction characteristics, some of its hitherto unknown distinct properties hint at its species specific role in mycobacteria during transcription-coupled repair.	[Prabha, Swayam; Rao, Desirazu N.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Nagaraja, Valakunja] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Prabha, S (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	dnrao@biochem.iisc.ernet.in; vraj@mcbl.iisc.ernet.in			Department of Biotechnology, Government of India [DBTO/BBC/DNR/187]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This research was supported by a research grant from the Department of Biotechnology, Government of India (grant no. DBTO/BBC/DNR/187). The duration of this research grant was for three years (2006-2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambur OH, 2009, FEMS MICROBIOL REV, V33, P453, DOI 10.1111/j.1574-6976.2009.00173.x; Assenmacher N, 2006, J MOL BIOL, V355, P675, DOI 10.1016/j.jmb.2005.10.033; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chambers AL, 2003, NUCLEIC ACIDS RES, V31, P6409, DOI 10.1093/nar/gkg868; Chen BY, 2007, STRUCTURE, V15, P429, DOI 10.1016/j.str.2007.02.007; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Deaconescu AM, 2006, CELL, V124, P507, DOI 10.1016/j.cell.2005.11.045; Gorna AE, 2010, CLIN SCI, V119, P187, DOI 10.1042/CS20100041; Grossman L, 1998, CONT CANC RES, P11; Han J, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000083; HARSHEY RM, 1977, J BACTERIOL, V129, P616, DOI 10.1128/JB.129.2.616-622.1977; Hasegawa K, 2008, GENES CELLS, V13, P459, DOI 10.1111/j.1365-2443.2008.01185.x; Garcia MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011575; Joseph N, 2004, DNA REPAIR, V3, P1561, DOI 10.1016/j.dnarep.2004.06.014; LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015; Lloyd RS, 1992, DNA DAMAGE RECOGNITI, P25; Mahdi AA, 2003, EMBO J, V22, P724, DOI 10.1093/emboj/cdg043; Mellon I, 2005, MUTAT RES-FUND MOL M, V577, P155, DOI 10.1016/j.mrfmmm.2005.03.016; MELLON I, 1989, NATURE, V342, P95, DOI 10.1038/342095a0; Murphy MN, 2009, NUCLEIC ACIDS RES, V37, P6042, DOI 10.1093/nar/gkp680; Panne D, 2001, EMBO J, V20, P3210, DOI 10.1093/emboj/20.12.3210; Park JS, 2002, CELL, V109, P757, DOI 10.1016/S0092-8674(02)00769-9; Pruteanu M, 2009, MOL MICROBIOL, V71, P912, DOI 10.1111/j.1365-2958.2008.06574.x; Rodrigue S, 2006, FEMS MICROBIOL REV, V30, P926, DOI 10.1111/j.1574-6976.2006.00040.x; Sambrook J, 2001, MOL CLONING LAB MANU; Saxowsky TT, 2006, CHEM REV, V106, P474, DOI 10.1021/cr040466q; Scicchitano DA, 2004, DNA REPAIR, V3, P1537, DOI 10.1016/j.dnarep.2004.06.004; SEELEY TW, 1989, P NATL ACAD SCI USA, V86, P6577, DOI 10.1073/pnas.86.17.6577; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; SELBY CP, 1995, J BIOL CHEM, V270, P4890, DOI 10.1074/jbc.270.9.4890; SELBY CP, 1990, J BIOL CHEM, V265, P21330; SELBY CP, 1995, J BIOL CHEM, V270, P4882, DOI 10.1074/jbc.270.9.4882; Smith AJ, 2007, NUCLEIC ACIDS RES, V35, P1802, DOI 10.1093/nar/gkm019; Smith I, 2005, CONTROL MYCOBACTERIA, P219; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; VANHOUTEN B, 1990, MICROBIOL REV, V54, P18, DOI 10.1128/MMBR.54.1.18-51.1990; Washburn RS, 2003, J MOL BIOL, V329, P655, DOI 10.1016/S0022-2836(03)00465-0; Zalieckas JM, 1998, MOL MICROBIOL, V27, P1031, DOI 10.1046/j.1365-2958.1998.00751.x	38	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19131	10.1371/journal.pone.0019131	http://dx.doi.org/10.1371/journal.pone.0019131			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559463	Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700072
J	Rieckher, M; Birk, UJ; Meyer, H; Ripoll, J; Tavernarakis, N				Rieckher, Matthias; Birk, Udo Jochen; Meyer, Heiko; Ripoll, Jorge; Tavernarakis, Nektarios			Microscopic Optical Projection Tomography In Vivo	PLOS ONE			English	Article								We describe a versatile optical projection tomography system for rapid three-dimensional imaging of microscopic specimens in vivo. Our tomographic setup eliminates the in xy and z strongly asymmetric resolution, resulting from optical sectioning in conventional confocal microscopy. It allows for robust, high resolution fluorescence as well as absorption imaging of live transparent invertebrate animals such as C. elegans. This system offers considerable advantages over currently available methods when imaging dynamic developmental processes and animal ageing; it permits monitoring of spatio-temporal gene expression and anatomical alterations with single-cell resolution, it utilizes both fluorescence and absorption as a source of contrast, and is easily adaptable for a range of small model organisms.	[Rieckher, Matthias; Tavernarakis, Nektarios] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Greece; [Birk, Udo Jochen; Meyer, Heiko; Ripoll, Jorge] Fdn Res & Technol Hellas, Inst Elect Struct & Laser, Iraklion, Greece	Foundation for Research & Technology - Hellas (FORTH); Foundation for Research & Technology - Hellas (FORTH)	Rieckher, M (corresponding author), Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Greece.	jripoll@iesl.forth.gr; tavernarakis@imbb.forth.gr	Ripoll, Jorge/AAW-2245-2020; Birk, Udo/E-6445-2010; Tavernarakis, Nektarios/B-9684-2013; Ripoll, Jorge/J-8134-2012	Ripoll, Jorge/0000-0001-8856-7738; Birk, Udo/0000-0001-6313-7475; Tavernarakis, Nektarios/0000-0002-5253-1466; Ripoll, Jorge/0000-0001-8856-7738; Rieckher, Matthias/0000-0002-1945-9474	NIH National Center for Research Resources (NCRR); E.U. [LSHG-CT-2003-503259]; European Molecular Biology Organization (EMBO); European Research Council (ERC); Marie Curie Fellowships Programme [MEIF-CT-2006-041827]; European Commission Coordination Action ENINET [LSHM-CT-2005-19063]	NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); E.U.(European Commission); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); European Research Council (ERC)(European Research Council (ERC)European Commission); Marie Curie Fellowships Programme; European Commission Coordination Action ENINET(European CommissionEuropean Commission Joint Research Centre)	We thank D. Bazopoulou, M. Katidou and E. Megalou for technical assistance, and A. Fire for plasmid vectors. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR).; This work was funded by the E.U. projects "Molecular Imaging" (http://cordis.europa.eu/fp6/; LSHG-CT-2003-503259), by grants from the European Molecular Biology Organization (EMBO; http://www.embo.org/), the European Research Council (ERC; http://erc.europa.eu/), the Marie Curie Fellowships Programme (http://www.mariecurie.org/; MEIF-CT-2006-041827) and the European Commission Coordination Action ENINET (http://www.eni-net.org/; contract number LSHM-CT-2005-19063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artal-Sanz M, 2009, NATURE, V461, P793, DOI 10.1038/nature08466; Ben-Yakar A, 2009, CURR OPIN NEUROBIOL, V19, P561, DOI 10.1016/j.conb.2009.10.010; Birk UJ, 2010, BIOMED OPT EXPRESS, V1, P87, DOI 10.1364/BOE.1.000087; Boot MJ, 2008, NAT METHODS, V5, P609, DOI 10.1038/nmeth.1219; BRENNER S, 1974, GENETICS, V77, P71; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Colas JF, 2009, ORGANOGENESIS, V5, P211, DOI 10.4161/org.5.4.10426; Guo SX, 2008, NAT METHODS, V5, P531, DOI 10.1038/NMETH.1203; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Kak A. C., 2001, PRINCIPLES COMPUTERI; Kak A.V., 1988, PRINCIPLES COMPUTERI, DOI DOI 10.1137/1.9780898719277.CH7; Katsevich A, 2010, INVERSE PROBL, V26, DOI 10.1088/0266-5611/26/6/065007; McGinty J, 2008, J BIOPHOTONICS, V1, P390, DOI 10.1002/jbio.200810044; Miao Q, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3275470; Ntziachristos V, 2002, NAT MED, V8, P757, DOI 10.1038/nm729; Ripoll J, 2004, MODERN PHYS LETT B, V18; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Syntichaki P, 2003, NAT REV NEUROSCI, V4, P672, DOI 10.1038/nrn1174; Vinegoni C, 2008, NAT METHODS, V5, P45, DOI 10.1038/NMETH1149	20	40	41	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18963	10.1371/journal.pone.0018963	http://dx.doi.org/10.1371/journal.pone.0018963			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559481	gold, Green Published, Green Submitted			2022-12-27	WOS:000290024700044
J	Zheng, L; Foley, K; Huang, LQ; Leubner, A; Mo, GL; Olino, K; Edil, BH; Mizuma, M; Sharma, R; Le, DT; Anders, RA; Illei, PB; Van Eyk, JE; Maitra, A; Laheru, D; Jaffee, EM				Zheng, Lei; Foley, Kelly; Huang, Lanqing; Leubner, Ashley; Mo, Guanglan; Olino, Kelly; Edil, Barish H.; Mizuma, Masamichi; Sharma, Rajni; Le, Dung T.; Anders, Robert A.; Illei, Peter B.; Van Eyk, Jennifer E.; Maitra, Anirban; Laheru, Daniel; Jaffee, Elizabeth M.			Tyrosine 23 Phosphorylation-Dependent Cell-Surface Localization of Annexin A2 Is Required for Invasion and Metastases of Pancreatic Cancer	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; IMMUNE ACTIVATION; TUMOR VACCINE; EXPRESSION; GROWTH; THERAPY; PROTEIN; ADENOCARCINOMA; IMMUNOTHERAPY; PROGRESSION	The aggressiveness of pancreatic ductal adenocarcinoma (PDA) is characterized by its high metastatic potential and lack of effective therapies, which is the result of a lack of understanding of the mechanisms involved in promoting PDA metastases. We identified Annexin A2 (ANXA2), a member of the Annexin family of calcium-dependent phospholipid binding proteins, as a new molecule that promotes PDA invasion and metastases. We found ANXA2 to be a PDA-associated antigen recognized by post-treatment sera of patients who demonstrated prolonged survival following treatment with a PDA-specific vaccine. Cell surface ANXA2 increases with PDA development and progression. Knockdown of ANXA2 expression by RNA interference or blocking with anti-ANXA2 antibodies inhibits in vitro invasion of PDA cells. In addition, post-vaccination patient sera inhibits in vitro invasion of PDA cells, suggesting that therapeutic anti-ANXA2 antibodies are induced by the vaccine. Furthermore, cell-surface localization of ANXA2 is tyrosine 23 phosphorylation-dependent; and tyrosine 23 phosphorylation is required for PDA invasion. We demonstrated that tyrosine 23 phosphorylation resulting in surface expression of ANXA2 is required for TGF beta-induced, Rho-mediated epithelial-mesenchymal transition (EMT), linking the cellular function of ANXA2 which was previously shown to be associated with small GTPase-regulated cytoskeletal rearrangements, to the EMT process in PDA. Finally, using mouse PDA models, we showed that shRNA knock-down of ANXA2, a mutation at tyrosine 23, or anti-ANXA2 antibodies, inhibit PDA metastases and prolong mouse survival. Thus, ANXA2 is part of a novel molecular pathway underlying PDA metastases and a new target for development of PDA therapeutics.	[Zheng, Lei; Foley, Kelly; Huang, Lanqing; Leubner, Ashley; Mo, Guanglan; Olino, Kelly; Edil, Barish H.; Le, Dung T.; Anders, Robert A.; Illei, Peter B.; Maitra, Anirban; Laheru, Daniel; Jaffee, Elizabeth M.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA; [Zheng, Lei; Foley, Kelly; Huang, Lanqing; Leubner, Ashley; Mo, Guanglan; Edil, Barish H.; Le, Dung T.; Laheru, Daniel; Jaffee, Elizabeth M.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Zheng, Lei; Foley, Kelly; Huang, Lanqing; Leubner, Ashley; Mo, Guanglan; Edil, Barish H.; Le, Dung T.; Laheru, Daniel; Jaffee, Elizabeth M.] Johns Hopkins Univ, Sch Med, Skip Viragh Ctr Pancreat Canc, Baltimore, MD USA; [Mizuma, Masamichi; Sharma, Rajni; Anders, Robert A.; Illei, Peter B.; Maitra, Anirban; Jaffee, Elizabeth M.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Zheng, Lei; Edil, Barish H.; Le, Dung T.; Anders, Robert A.; Illei, Peter B.; Maitra, Anirban; Laheru, Daniel; Jaffee, Elizabeth M.] Johns Hopkins Univ, Sch Med, Sol Goldman Pancreat Canc Ctr, Baltimore, MD USA; [Zheng, Lei; Olino, Kelly; Edil, Barish H.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Foley, Kelly] Johns Hopkins Univ, Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD USA; [Van Eyk, Jennifer E.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Van Eyk, Jennifer E.] Johns Hopkins Univ, Sch Med, Johns Hopkins Bayview Prote Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Zheng, L (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA.	lzheng6@jhmi.edu; ejaffee@jhmi.edu	Olino, Kelly/X-2341-2019	Sharma, Rajni/0000-0003-0393-0943; Jaffee, Elizabeth/0000-0003-3841-6549; Olino, Kelly/0000-0001-6209-5218	NCI [P50 CA062924-14, R01 CA88058]; Lustgarten Foundation; Broad Foundation; Viragh Foundation; NIH [1K23 CA93566-01A1, 5T32 CA0090701-28]; ASCO; Sol Goldman Pancreatic Cancer Center; Leica Microsystems; NATIONAL CANCER INSTITUTE [T32CA009071, P30CA006973, R01CA088058, P50CA062924, K23CA148964, R01CA113669, K23CA093566, R01CA122081] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lustgarten Foundation; Broad Foundation; Viragh Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ASCO; Sol Goldman Pancreatic Cancer Center; Leica Microsystems; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the NCI SPORE in Gastrointestinal Cancers P50 CA062924-14 (E.M.J.), Lustgarten Foundation (E.M.J.), Broad Foundation (E.M.J.), NCI R01 CA88058 (E.M.J.), Viragh Foundation, NIH 1K23 CA93566-01A1 (D. L.), ASCO Young Investigator Award (L.Z.), NIH 5T32 CA0090701-28 Training Grant (L.Z.), the Sol Goldman Pancreatic Cancer Center (L.Z.). Dr. Jaffee is the first recipient of the Dana and Albert "Cubby" Broccoli Endowed Professorship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; I have read the journal's policy and have the following conflicts: Under a licensing agreement between BioSante and the Johns Hopkins University, the University is entitled to milestone payments and royalty on sales of the vaccine product described in this manuscript. We do not have any other relevant conflicts of interest to be disclosed. P. Illei has given a lecture sponsored by Leica Microsystems. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials.	ABRAMS HD, 1982, CELL, V29, P427, DOI 10.1016/0092-8674(82)90159-3; BIANCHI R, 1992, BIOCHIM BIOPHYS ACTA, V1160, P67, DOI 10.1016/0167-4838(92)90039-G; Chen YM, 1997, MOL CELL BIOL, V17, P6049, DOI 10.1128/MCB.17.10.6049; de Graauw M, 2008, MOL CELL BIOL, V28, P1029, DOI 10.1128/MCB.01247-07; Deora AB, 2004, J BIOL CHEM, V279, P43411, DOI 10.1074/jbc.M408078200; Esposito I, 2006, J PATHOL, V208, P673, DOI 10.1002/path.1935; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Goggins M, 1999, ANN ONCOL, V10, P4, DOI 10.1023/A:1008307913019; Gordon KJ, 2008, CARCINOGENESIS, V29, P252, DOI 10.1093/carcin/bgm249; HART IR, 1980, CANCER RES, V40, P2281; Hassan R, 2008, EUR J CANCER, V44, P46, DOI 10.1016/j.ejca.2007.08.028; Hastie C, 2008, J BIOL CHEM, V283, P12595, DOI 10.1074/jbc.M800189200; IMAMURA H, 1994, CANCER RES, V54, P3620; Jaffee EM, 1998, CANCER J SCI AM, V4, P194; Jaffee EM, 2001, J CLIN ONCOL, V19, P145, DOI 10.1200/JCO.2001.19.1.145; Jain A, 2003, ANN SURG ONCOL, V10, P810, DOI 10.1245/ASO.2003.10.006; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kim J, 2002, FRONT BIOSCI-LANDMRK, V7, pD341, DOI 10.2741/kim; Krishnan S, 2004, DEV BIOL, V265, P140, DOI 10.1016/j.ydbio.2003.08.026; Kwon MJ, 2005, FRONT BIOSCI-LANDMRK, V10, P300, DOI 10.2741/1529; Laheru D, 2008, CLIN CANCER RES, V14, P1455, DOI 10.1158/1078-0432.CCR-07-0371; LUTZ E, 2010, ANN SURG; Mackenzie RP, 2009, EXPERT REV ANTICANC, V9, P1473, DOI [10.1586/era.09.109, 10.1586/ERA.09.109]; Merrifield CJ, 2001, CURR BIOL, V11, P1136, DOI 10.1016/S0960-9822(01)00321-9; Morel E, 2009, J BIOL CHEM, V284, P1604, DOI 10.1074/jbc.M806499200; Nedjadi T, 2009, BRIT J CANCER, V101, P1145, DOI 10.1038/sj.bjc.6605289; Pierantoni C, 2008, CRIT REV ONCOL HEMAT, V67, P27, DOI 10.1016/j.critrevonc.2008.01.009; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Rescher U, 2008, J CELL SCI, V121, P2177, DOI 10.1242/jcs.028415; Salle V, 2008, J CLIN IMMUNOL, V28, P291, DOI 10.1007/s10875-008-9188-1; Sharma MC, 2007, CURR PHARM DESIGN, V13, P3568, DOI 10.2174/138161207782794167; Strimpakos A, 2008, CANCER METAST REV, V27, P495, DOI 10.1007/s10555-008-9134-y; Takano S, 2008, ANN SURG ONCOL, V15, P3157, DOI 10.1245/s10434-008-0061-5; Thomas AM, 2004, J EXP MED, V200, P297, DOI 10.1084/jem.20031435; Wang B, 2003, ONCOGENE, V22, P1771, DOI 10.1038/sj.onc.1206386; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yoshimura K, 2006, CANCER RES, V66, P1096, DOI 10.1158/0008-5472.CAN-05-2307; Zhao SJ, 2008, CANCER RES, V68, P4221, DOI 10.1158/0008-5472.CAN-07-5123; Zhao WQ, 2003, J BIOL CHEM, V278, P4205, DOI 10.1074/jbc.M210545200; Zhou XZ, 2003, HUM GENE THER, V14, P1089, DOI 10.1089/104303403322124800	40	128	139	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19390	10.1371/journal.pone.0019390	http://dx.doi.org/10.1371/journal.pone.0019390			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21572519	Green Submitted, gold, Green Published			2022-12-27	WOS:000290024700155
J	Volk, N; Shomron, N				Volk, Naama; Shomron, Noam			Versatility of MicroRNA Biogenesis	PLOS ONE			English	Article							RNA; PROTEINS; BINDING; COMPLEX	MicroRNAs (miRNAs) are short single-stranded RNA molecules that regulate gene expression. MiRNAs originate from large primary (pri) and precursor (pre) transcripts that undergo various processing steps along their biogenesis pathway till they reach their mature and functional form. It is not clear, however, whether all miRNAs are processed similarly. Here we show that the ratio between pre-miRNA and mature miRNA forms varies between different miRNAs. Moreover, over-expression of several factors involved in miRNA biogenesis, including Exportin-5, Drosha, NF90a, NF45 and KSRP, displayed bidirectional effects on pre/mature miRNA ratios, suggesting their intricate biogenesis sensitivity. In an attempt to identify additional factors that might explain the versatility in miRNA biogenesis we have analyzed the contribution of two hnRNP family members, hnRNPH1 and hnRNPR. Knock-down or over-expression of these genes suggested that hnRNPR inhibits, whereas hnRNPH1 facilitates, miRNA processing. Overall, our results emphasize that miRNA biogenesis is versatile.	[Volk, Naama; Shomron, Noam] Tel Aviv Univ, Sackler Fac Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Volk, N (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel.	nshomron@post.tau.ac.il			Chief Scientist Office, Ministry of Health, Israel; Kurz-Lion Foundation; Tel Aviv University, Faculty of Medicine, Schreiber Foundation; Israel Cancer Association; Wolfson Family Charitable Fund	Chief Scientist Office, Ministry of Health, Israel; Kurz-Lion Foundation; Tel Aviv University, Faculty of Medicine, Schreiber Foundation; Israel Cancer Association; Wolfson Family Charitable Fund	This work was supported by the Chief Scientist Office, Ministry of Health, Israel; The Kurz-Lion Foundation; The Tel Aviv University, Faculty of Medicine, Schreiber Foundation; Israel Cancer Association; and The Wolfson Family Charitable Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berezikov E, 2007, MOL CELL, V28, P328, DOI 10.1016/j.molcel.2007.09.028; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chou MY, 1999, MOL CELL BIOL, V19, P69; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Fisette JF, 2010, RNA, V16, P228, DOI 10.1261/rna.1890310; Folini M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-12; Fukuda A, 2009, J BIOL CHEM, V284, P23472, DOI 10.1074/jbc.M109.013656; Kabat JL, 2009, J BIOL CHEM, V284, P28490, DOI 10.1074/jbc.M109.023101; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Li Y, 2009, CANCER SCI, V100, P1234, DOI 10.1111/j.1349-7006.2009.01164.x; Pullmann R, 2007, MOL CELL BIOL, V27, P6265, DOI 10.1128/MCB.00500-07; Rossoll W, 2002, HUM MOL GENET, V11, P93, DOI 10.1093/hmg/11.1.93; Sakamoto S, 2009, MOL CELL BIOL, V29, P3754, DOI 10.1128/MCB.01836-08; Shiohama A, 2007, EXP CELL RES, V313, P4196, DOI 10.1016/j.yexcr.2007.07.020; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803	18	36	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19391	10.1371/journal.pone.0019391	http://dx.doi.org/10.1371/journal.pone.0019391			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572999	Green Published, Green Submitted, gold			2022-12-27	WOS:000290440200006
J	Maulucci, G; Papi, M; Arcovito, G; De Spirito, M				Maulucci, Giuseppe; Papi, Massimiliano; Arcovito, Giuseppe; De Spirito, Marco			The Thermal Structural Transition of alpha-Crystallin Inhibits the Heat Induced Self-Aggregation	PLOS ONE			English	Article							DIFFUSION-LIMITED AGGREGATION; CHAPERONE-LIKE ACTIVITY; CLUSTER-CLUSTER AGGREGATION; QUATERNARY STRUCTURE; EYE LENS; PROTEINS; SCATTERING; MODEL; STABILITY; CATARACTS	alpha-crystallin, the major constituent of human lens, is a member of the heat-shock proteins family and it is known to have a quaternary structural transition at T-c = 45 degrees C. The presence of calcium ions and/or temperature changes induce supramolecular self-aggregation, a process of relevance in the cataractogenesis. Here we investigate the potential effect of the bovine alpha-crystallin's structural transition on the self-aggregation process. Along all the temperatures investigated, aggregation proceeds by forming intermediate molecular assemblies that successively aggregate in clusters. The final morphology of the aggregates, above and below T-c, is similar, but the aggregation kinetics are completely different. The size of the intermediate molecular assemblies, and their repulsive energy barrier show a marked increase while crossing T-c. Our results highlight the key role of heat modified form of alpha-crystallin in protecting from aggregation and preserving the transparency of the lens under hyperthermic conditions.	[Maulucci, Giuseppe; Papi, Massimiliano; Arcovito, Giuseppe; De Spirito, Marco] Univ Cattolica Sacro Cuore, Ist Fis, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Maulucci, G (corresponding author), Univ Cattolica Sacro Cuore, Ist Fis, Rome, Italy.	m.despirito@rm.unicatt.it	De Spirito, Marco/C-5386-2008; Papi, Massimiliano/AAC-3657-2022; Papi, Massimiliano/B-3168-2012; De Spirito, Marco/U-3817-2019; Maulucci, Giuseppe/C-7400-2009	De Spirito, Marco/0000-0003-4260-5107; Papi, Massimiliano/0000-0002-0029-1309; De Spirito, Marco/0000-0003-4260-5107; Maulucci, Giuseppe/0000-0002-2154-319X				BALL RC, 1987, PHYS REV LETT, V58, P274, DOI 10.1103/PhysRevLett.58.274; Bassi FA, 1995, BIOPHYS J, V69, P2720, DOI 10.1016/S0006-3495(95)80143-8; BERNE B. J., 1976, DYNAMIC LIGHT SCATTE; BIOSCA JA, 1983, FEBS LETT, V153, P217, DOI 10.1016/0014-5793(83)80151-3; Clark JI, 2000, CURR OPIN STRUC BIOL, V10, P52, DOI 10.1016/S0959-440X(99)00048-2; CLEARY SF, 1980, P IEEE, V68, P49, DOI 10.1109/PROC.1980.11580; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; DELAYE M, 1982, BIOPHYS J, V37, P647; Doss-Pepe EW, 1998, EXP EYE RES, V67, P657, DOI 10.1006/exer.1998.0561; Garland DL, 1996, EXP EYE RES, V62, P285, DOI 10.1006/exer.1996.0034; GUPTASARMA P, 1992, BIOCHEMISTRY-US, V31, P4296, DOI 10.1021/bi00132a021; GUY AW, 1975, IEEE T MICROW THEORY, VMT23, P492, DOI 10.1109/TMTT.1975.1128606; Harding JJ, 2002, AGEING RES REV, V1, P465, DOI 10.1016/S1568-1637(02)00012-0; HIRATA A, 1994, IEEE T ELECTROMAGNET, V269, P592; Horwitz J, 2004, EXP EYE RES, V79, P817, DOI 10.1016/j.exer.2004.05.007; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; JEDZINIAK JA, 1972, INVEST OPHTH VISUAL, V11, P905; KOPPEL DE, 1972, J CHEM PHYS, V57, P4814, DOI 10.1063/1.1678153; KRAMAR P, 1987, BIOELECTROMAGNETICS, V8, P397, DOI 10.1002/bem.2250080408; KRAMPS HA, 1975, EUR J BIOCHEM, V50, P503, DOI 10.1111/j.1432-1033.1975.tb09889.x; Krivandin AV, 1999, BIOFIZIKA+, V44, P1088; Lin JC, 2003, IEEE ANTENN PROPAG M, V45, P171, DOI 10.1109/MAP.2003.1189664; LIN MY, 1990, PHYS REV A, V41, P2005, DOI 10.1103/PhysRevA.41.2005; LUTHRA M, 1993, J BIOL CHEM, V268, P18119; Maulucci G, 2005, BIOPHYS J, V88, P3545, DOI 10.1529/biophysj.104.048876; MEAKIN P, 1984, J PHYS A-MATH GEN, V17, pL975, DOI 10.1088/0305-4470/17/18/008; MIESBAUER LR, 1994, J BIOL CHEM, V269, P12494; Parasassi T, 2008, FASEB J, V22, P2350, DOI 10.1096/fj.07-097774; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P229, DOI 10.1016/0010-4655(82)90174-6; Putilina T, 2003, J BIOL CHEM, V278, P13747, DOI 10.1074/jbc.M208157200; Raman B, 1997, J BIOL CHEM, V272, P23559, DOI 10.1074/jbc.272.38.23559; RAMAN B, 1995, FEBS LETT, V365, P133, DOI 10.1016/0014-5793(95)00440-K; RAMAN B, 1994, J BIOL CHEM, V269, P27264; SANTINI SA, 1992, BIOCHEM J, V287, P107, DOI 10.1042/bj2870107; Schmelzer JWP, 2005, NUCLEATION THEORY AND APPLICATIONS, P1, DOI 10.1002/3527604790; SHIH WY, 1987, PHYS REV A, V36, P5015, DOI 10.1103/PhysRevA.36.5015; SIEZEN RJ, 1979, EXP EYE RES, V28, P551, DOI 10.1016/0014-4835(79)90043-5; TARDIEU A, 1986, J MOL BIOL, V192, P711, DOI 10.1016/0022-2836(86)90023-9; Verwey E.J., 1948, THEORY STABILITY LYO; Wainwright PR, 2007, PHYS MED BIOL, V52, P3335, DOI 10.1088/0031-9155/52/12/002; WALSH MT, 1991, J BIOL CHEM, V266, P20079; WEITZ DA, 1985, PHYS REV LETT, V54, P1416, DOI 10.1103/PhysRevLett.54.1416; WITTEN TA, 1981, PHYS REV LETT, V47, P1400, DOI 10.1103/PhysRevLett.47.1400; WITTEN TA, 1983, PHYS REV B, V27, P5686, DOI 10.1103/PhysRevB.27.5686; XIA JZ, 1994, BIOPHYS J, V66, P861, DOI 10.1016/S0006-3495(94)80862-8	45	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e18906	10.1371/journal.pone.0018906	http://dx.doi.org/10.1371/journal.pone.0018906			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573059	gold, Green Submitted, Green Published			2022-12-27	WOS:000290386800004
J	Nozawa, T; Furukawa, N; Aikawa, C; Watanabe, T; Haobam, B; Kurokawa, K; Maruyama, F; Nakagawa, I				Nozawa, Takashi; Furukawa, Nayuta; Aikawa, Chihiro; Watanabe, Takayasu; Haobam, Bijaya; Kurokawa, Ken; Maruyama, Fumito; Nakagawa, Ichiro			CRISPR Inhibition of Prophage Acquisition in Streptococcus pyogenes	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; GROUP-A STREPTOCOCCUS; PROVIDES ACQUIRED-RESISTANCE; GENOME SEQUENCE; IMMUNE-SYSTEM; M3 STRAIN; INTERFERENCE; EVOLUTION; ELEMENTS; BACTERIA	Streptococcus pyogenes, one of the major human pathogens, is a unique species since it has acquired diverse strain-specific virulence properties mainly through the acquisition of streptococcal prophages. In addition, S. pyogenes possesses clustered regularly interspaced short palindromic repeats (CRISPR)/Cas systems that can restrict horizontal gene transfer (HGT) including phage insertion. Therefore, it was of interest to examine the relationship between CRISPR and acquisition of prophages in S. pyogenes. Although two distinct CRISPR loci were found in S. pyogenes, some strains lacked CRISPR and these strains possess significantly more prophages than CRISPR harboring strains. We also found that the number of spacers of S. pyogenes CRISPR was less than for other streptococci. The demonstrated spacer contents, however, suggested that the CRISPR appear to limit phage insertions. In addition, we found a significant inverse correlation between the number of spacers and prophages in S. pyogenes. It was therefore suggested that S. pyogenes CRISPR have permitted phage insertion by lacking its own spacers. Interestingly, in two closely related S. pyogenes strains (SSI-1 and MGAS315), CRISPR activity appeared to be impaired following the insertion of phage genomes into the repeat sequences. Detailed analysis of this prophage insertion site suggested that MGAS315 is the ancestral strain of SSI-1. As a result of analysis of 35 additional streptococcal genomes, it was suggested that the influences of the CRISPR on the phage insertion vary among species even within the same genus. Our results suggested that limitations in CRISPR content could explain the characteristic acquisition of prophages and might contribute to strain-specific pathogenesis in S. pyogenes.	[Nozawa, Takashi; Furukawa, Nayuta; Watanabe, Takayasu; Haobam, Bijaya; Maruyama, Fumito; Nakagawa, Ichiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Bacterial Pathogenesis, Tokyo, Japan; [Aikawa, Chihiro] Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Kurokawa, Ken] Technol Sch, Tokyo Inst, Div Informat Biotechnol, Dept Bioinformat Engn, Yokohama, Kanagawa, Japan; [Kurokawa, Ken] Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa, Japan	Tokyo Medical & Dental University (TMDU); University of Tokyo	Nozawa, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Bacterial Pathogenesis, Tokyo, Japan.	fumito-m.bac@tmd.ac.jp	Maruyama, Fumito/AAK-5928-2020; Maruyama, Fumito/F-6875-2016	Maruyama, Fumito/0000-0003-2347-616X; Nozawa, Takashi/0000-0002-1822-5553; Watanabe, Takayasu/0000-0001-5487-8191	Japanese Ministry of Education;  [21390487];  [22592032]; Grants-in-Aid for Scientific Research [22380176] Funding Source: KAKEN	Japanese Ministry of Education(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aids for Scientific Research (#21390487 and #22592032), and by the Japanese Ministry of Education, Global Center of Excellence (GCOE) Program, "International Research Center for Molecular Science in Tooth and Bone Diseases.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanensen DM, 2005, NUCLEIC ACIDS RES, V33, pW728, DOI 10.1093/nar/gki415; Aklujkar M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-230; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aranaz A, 2004, J CLIN MICROBIOL, V42, P5388, DOI 10.1128/JCM.42.11.5388-5391.2004; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beres SB, 2002, P NATL ACAD SCI USA, V99, P10078, DOI 10.1073/pnas.152298499; Beres SB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000800; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Canchaya C, 2004, MOL MICROBIOL, V53, P9, DOI 10.1111/j.1365-2958.2004.04113.x; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Davies MR, 2007, J BACTERIOL, V189, P2646, DOI 10.1128/JB.01590-06; de la Cruz F, 2000, TRENDS MICROBIOL, V8, P128, DOI 10.1016/S0966-842X(00)01703-0; Deaconescu AM, 2007, CURR OPIN STRUC BIOL, V17, P96, DOI 10.1016/j.sbi.2007.01.005; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Dobrindt U, 2010, MED MICROBIOL IMMUN, V199, P145, DOI 10.1007/s00430-010-0161-2; Fischetti VA, 2007, TRENDS MICROBIOL, V15, P297, DOI 10.1016/j.tim.2007.05.003; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; He JK, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.128102; Hiller NL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001108; Hoe N, 1999, EMERG INFECT DIS, V5, P254, DOI 10.3201/eid0502.990210; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ianeva O D, 2009, Mikrobiol Z, V71, P54; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jansen Rund, 2002, OMICS A Journal of Integrative Biology, V6, P23, DOI 10.1089/15362310252780816; KELLI L, 2010, MULIDRUG RESISTANT E, V1; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Lillestol Reidun K., 2006, Archaea, V2, P59, DOI 10.1155/2006/542818; Lima-Mendez G, 2008, BIOINFORMATICS, V24, P863, DOI 10.1093/bioinformatics/btn043; Liu GR, 2002, J BACTERIOL, V184, P2626, DOI 10.1128/JB.184.10.2626-2633.2002; Liu MJ, 2009, APPL ENVIRON MICROB, V75, P4120, DOI 10.1128/AEM.02898-08; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Maruyama F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-358; McShan WM, 2008, J BACTERIOL, V190, P7773, DOI 10.1128/JB.00672-08; MEGRATH DVS, 2007, BACTERIOPHAGE GENETI; Nakagawa I, 2003, GENOME RES, V13, P1042, DOI 10.1101/gr.1096703; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Pal C, 2005, NAT GENET, V37, P1372, DOI 10.1038/ng1686; Papenfort K, 2010, CELL HOST MICROBE, V8, P116, DOI 10.1016/j.chom.2010.06.008; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Rambaut A, 2010, FIGTREE V131; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; SHEARER AC, 1993, PROTEIN SCI, V2, P1686, DOI 10.1002/pro.5560021014; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; STEWART CB, 1993, NATURE, V361, P603, DOI 10.1038/361603a0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang TH, 2005, MOL MICROBIOL, V55, P469, DOI 10.1111/j.1365-2958.2004.04428.x; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Touchon M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011126; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; van der Ploeg JR, 2009, MICROBIOL-SGM, V155, P1966, DOI 10.1099/mic.0.027508-0; van Embden JDA, 2000, J BACTERIOL, V182, P2393, DOI 10.1128/JB.182.9.2393-2401.2000; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; WESTRA ER, 2010, MOL MICROBIOL; Wiedenheft B, 2009, STRUCTURE, V17, P904, DOI 10.1016/j.str.2009.03.019; Xu P, 2007, J BACTERIOL, V189, P3166, DOI 10.1128/JB.01808-06; Zegans ME, 2009, J BACTERIOL, V191, P210, DOI 10.1128/JB.00797-08	70	70	82	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19543	10.1371/journal.pone.0019543	http://dx.doi.org/10.1371/journal.pone.0019543			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573110	Green Submitted, gold, Green Published			2022-12-27	WOS:000290305600029
J	Christians, JK; Cheema, MS; Vergara, IA; Watt, CA; Pinto, LJ; Chen, NS; Moore, MM				Christians, Julian K.; Cheema, Manjinder S.; Vergara, Ismael A.; Watt, Cortney A.; Pinto, Linda J.; Chen, Nansheng; Moore, Margo M.			Quantitative Trait Locus (QTL) Mapping Reveals a Role for Unstudied Genes in Aspergillus Virulence	PLOS ONE			English	Article							CANDIDA-ALBICANS; INVASIVE ASPERGILLOSIS; GALLERIA-MELLONELLA; FUNGAL-INFECTIONS; LINKAGE MAP; FUMIGATUS; NIDULANS; STRAINS; PATHOGENICITY; SIDEROPHORES	Infections caused by the fungus Aspergillus are a major cause of morbidity and mortality in immunocompromised populations. To identify genes required for virulence that could be used as targets for novel treatments, we mapped quantitative trait loci (QTL) affecting virulence in the progeny of a cross between two strains of A. nidulans (FGSC strains A4 and A91). We genotyped 61 progeny at 739 single nucleotide polymorphisms (SNP) spread throughout the genome, and constructed a linkage map that was largely consistent with the genomic sequence, with the exception of one potential inversion of similar to 527 kb on Chromosome V. The estimated genome size was 3705 cM and the average intermarker spacing was 5.0 cM. The average ratio of physical distance to genetic distance was 8.1 kb/cM, which is similar to previous estimates, and variation in recombination rate was significantly positively correlated with GC content, a pattern seen in other taxa. To map QTL affecting virulence, we measured the ability of each progeny strain to kill model hosts, larvae of the wax moth Galleria mellonella. We detected three QTL affecting in vivo virulence that were distinct from QTL affecting in vitro growth, and mapped the virulence QTL to regions containing 7-24 genes, excluding genes with no sequence variation between the parental strains and genes with only synonymous SNPs. None of the genes in our QTL target regions have been previously associated with virulence in Aspergillus, and almost half of these genes are currently annotated as "hypothetical". This study is the first to map QTL affecting the virulence of a fungal pathogen in an animal host, and our results illustrate the power of this approach to identify a short list of unknown genes for further investigation.	[Christians, Julian K.; Cheema, Manjinder S.; Watt, Cortney A.; Pinto, Linda J.; Moore, Margo M.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Vergara, Ismael A.; Chen, Nansheng] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University	Christians, JK (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.	julian_christians@sfu.ca	Chen, Nansheng/E-6450-2012; Christians, J.K./AAL-2547-2020	Christians, J.K./0000-0003-1797-0591; Vergara, Ismael/0000-0002-2960-2967	BC Transplant Research Foundation; Natural Sciences and Engineering Research Council (NSERC); Simon Fraser University	BC Transplant Research Foundation; Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Simon Fraser University	This study was funded by a BC Transplant Research Foundation Venture Grant to JKC and MMM, Natural Sciences and Engineering Research Council (NSERC) operating grants to JKC, MMM and NC and a Simon Fraser University President's Research Grant to JKC. NC is a Michael Smith Foundation for Health Research (MSFHR) Scholar and a Canadian Institutes of Health Research (CIHR) New Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpogheneta O, 2003, MYCOSES, V46, P77, DOI 10.1046/j.1439-0507.2003.00852.x; Aleksenko A, 2001, FUNGAL GENET BIOL, V32, P45, DOI 10.1006/fgbi.2001.1251; Araujo R, 2007, INT J ANTIMICROB AG, V29, P108, DOI 10.1016/j.ijantimicag.2006.09.019; Birdsell JA, 2002, MOL BIOL EVOL, V19, P1181, DOI 10.1093/oxfordjournals.molbev.a004176; Blanco JL, 2002, J CLIN MICROBIOL, V40, P1811, DOI 10.1128/JCM.40.5.1811-1813.2002; Brakhage AA, 2005, CURR DRUG TARGETS, V6, P875, DOI 10.2174/138945005774912717; Brennan M, 2002, FEMS IMMUNOL MED MIC, V34, P153, DOI 10.1111/j.1574-695X.2002.tb00617.x; Bruggeman J, 2003, FUNGAL GENET BIOL, V39, P136, DOI 10.1016/S1087-1845(03)00016-1; BUTCHER AC, 1968, HEREDITY, V23, P443, DOI 10.1038/hdy.1968.55; CADRE, CENTR ASP DAT REP AS; Chamilos G, 2010, MED MYCOL, V48, P506, DOI 10.3109/13693780903225813; Champion OL, 2009, MICROBIOL-SGM, V155, P1516, DOI 10.1099/mic.0.026823-0; Cheema MS, 2010, MED MYCOL       0906, V6; CHURCHILL GA, 1994, GENETICS, V138, P963; Clutterbuck A. John, 2008, V26, P57; Clutterbuck AJ, 1997, FUNGAL GENET BIOL, V21, P267, DOI 10.1006/fgbi.1997.0984; Clutterbuck AJ, ASPERGILLUS NIDULANS; Coleman JJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000486; CROFT JH, 1977, GENETICS PHYSL ASPER, P339; Dutsky SR, 1962, P ENTOMOL SOC WASH, V64, P56; EGELMITANI M, 1982, HEREDITAS, V97, P179, DOI 10.1111/j.1601-5223.1982.tb00870.x; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Gravelat FN, 2010, CELL MICROBIOL, V12, P473, DOI 10.1111/j.1462-5822.2009.01408.x; GRINDLE M, 1963, HEREDITY, V18, P191, DOI 10.1038/hdy.1963.21; Haas H, 2008, ANNU REV PHYTOPATHOL, V46, P149, DOI 10.1146/annurev.phyto.45.062806.094338; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hissen AHT, 2005, INFECT IMMUN, V73, P5493, DOI 10.1128/IAI.73.9.5493-5503.2005; Hohl TM, 2007, EUKARYOT CELL, V6, P1953, DOI 10.1128/EC.00274-07; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Jackson JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004224; Jin J, 2004, J CLIN MICROBIOL, V42, P4293, DOI 10.1128/JCM.42.9.4293-4296.2004; Keller N, 2006, MOLECULAR PRINCIPLES OF FUNGAL PATHOGENESIS, P235; Keurentjes JJB, 2007, GENETICS, V175, P891, DOI 10.1534/genetics.106.066423; Kontoyiannis DP, 2002, MYCOSES, V45, P406, DOI 10.1046/j.1439-0507.2002.00797.x; KOTHARY MH, 1984, INFECT IMMUN, V43, P320, DOI 10.1128/IAI.43.1.320-325.1984; Latge JP, 2001, TRENDS MICROBIOL, V9, P382, DOI 10.1016/S0966-842X(01)02104-7; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Leger RJS, 2000, APPL ENVIRON MICROB, V66, P320, DOI 10.1128/AEM.66.1.320-324.2000; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lin XR, 2006, PLOS GENET, V2, P1801, DOI 10.1371/journal.pgen.0020187; Lorieux M, 2010, PLANT AN GEN 14 C SA; Lynch Michael, 1998; Marra RE, 2004, GENETICS, V167, P619, DOI 10.1534/genetics.103.023408; Marsolier-Kergoat MC, 2009, GENETICS, V183, P31, DOI 10.1534/genetics.109.105049; MAYORGA ME, 1990, GENETICS, V126, P73; McCluskey K, 2010, J BIOSCIENCES, V35, P119, DOI 10.1007/s12038-010-0014-6; Mora-Montes HM, 2007, EUKARYOT CELL, V6, P2184, DOI 10.1128/EC.00350-07; Mouyna I, 2005, MOL MICROBIOL, V56, P1675, DOI 10.1111/j.1365-2958.2005.04654.x; Munoz P, 2006, CURR OPIN INFECT DIS, V19, P365, DOI 10.1097/01.qco.0000235164.70678.97; Mylonakis E, 2007, PLOS PATHOG, V3, P859, DOI 10.1371/journal.ppat.0030101; Neilands J.B., 1981, DEV IRON CHELATORS C, P13; O'Gorman CM, 2009, NATURE, V457, P471, DOI 10.1038/nature07528; Pastor A, 2006, MYCOSES, V49, P73, DOI 10.1111/j.1439-0507.2006.01188.x; Perfect JR, 2001, CLIN INFECT DIS, V33, P1824, DOI 10.1086/323900; PERFECT JR, 2006, MOL PRINC FUNG PATH, P3; Reeves EP, 2004, MYCOPATHOLOGIA, V158, P73, DOI 10.1023/B:MYCO.0000038434.55764.16; Schrettl M, 2007, PLOS PATHOG, V3, P1195, DOI 10.1371/journal.ppat.0030128; Schrettl M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001124; Segal BH, 1998, MEDICINE, V77, P345, DOI 10.1097/00005792-199809000-00004; Singh N, 2008, MYCOSES, V51, P99, DOI 10.1111/j.1439-0507.2007.01479.x; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Steinbach WJ, 2006, EUKARYOT CELL, V5, P1091, DOI 10.1128/EC.00139-06; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Sun S, 2007, GENETICS, V177, P1475, DOI 10.1534/genetics.107.078923; Theiss S, 2002, MOL MICROBIOL, V43, P571, DOI 10.1046/j.1365-2958.2002.02769.x; TILBURN J, 1990, GENETICS, V126, P81; Tripathi N, 2009, P ROY SOC B-BIOL SCI, V276, P2195, DOI 10.1098/rspb.2008.1930; Wang S., WINDOWS QTL CARTOGRA; Wasylnka JA, 2001, MICROBIOL-UK, V147, P869, DOI 10.1099/00221287-147-4-869; Wasylnka JA, 2000, INFECT IMMUN, V68, P3377, DOI 10.1128/IAI.68.6.3377-3384.2000; Wortman JR, 2009, FUNGAL GENET BIOL, V46, pS2, DOI 10.1016/j.fgb.2008.12.003; Zhang L, 2008, FEMS MICROBIOL LETT, V289, P155, DOI 10.1111/j.1574-6968.2008.01376.x	72	15	62	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19325	10.1371/journal.pone.0019325	http://dx.doi.org/10.1371/journal.pone.0019325			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559404	Green Submitted, gold, Green Published			2022-12-27	WOS:000290024700136
J	De Stefano, N; Stromillo, ML; Rossi, F; Battaglini, M; Giorgio, A; Portaccio, E; Hakiki, B; Malentacchi, G; Gasperini, C; Santangelo, M; Bartolozzi, ML; Sormani, MP; Federico, A; Amato, MP				De Stefano, Nicola; Stromillo, Maria Laura; Rossi, Francesca; Battaglini, Marco; Giorgio, Antonio; Portaccio, Emilio; Hakiki, Bahia; Malentacchi, Gianmichele; Gasperini, Claudio; Santangelo, Mario; Bartolozzi, Maria Letizia; Sormani, Maria Pia; Federico, Antonio; Amato, Maria Pia			Improving the Characterization of Radiologically Isolated Syndrome Suggestive of Multiple Sclerosis	PLOS ONE			English	Article							MAGNETIZATION-TRANSFER RATIO; VOXEL-BASED ANALYSIS; TRANSFER MR; ALZHEIMERS-DISEASE; IMAGING TECHNIQUES; BRAIN-DAMAGE; GRAY-MATTER; SPIN-ECHO; LESIONS; REMYELINATION	Objective: To improve the characterization of asymptomatic subjects with brain magnetic resonance imaging (MRI) abnormalities highly suggestive of multiple sclerosis (MS), a condition named as "radiologically isolated syndrome" (RIS). Methods: Quantitative MRI metrics such as brain volumes and magnetization transfer (MT) were assessed in 19 subjects previously classified as RIS, 20 demographically-matched relapsing-remitting MS (RRMS) patients and 20 healthy controls (HC). Specific measures were: white matter (WM) lesion volumes (LV), total and regional brain volumes, and MT ratio (MTr) in lesions, normal-appearing WM (NAWM) and cortex. Results: LV was similar in RIS and RRMS, without differences in distribution and frequency at lesion mapping. Brain volumes were similarly lower in RRMS and RIS than in HC (p<0.001). Lesional-MTr was lower in RRMS than in RIS (p = 0.048); NAWM-MTr and cortical-MTr were similar in RIS and HC and lower (p<0.01) in RRMS. These values were particularly lower in RRMS than in RIS in the sensorimotor and memory networks. A multivariate logistic regression analysis showed that 13/19 RIS had >= 70% probability of being classified as RRMS on the basis of their brain volume and lesional-MTr values. Conclusions: Macroscopic brain damage was similar in RIS and RRMS. However, the subtle tissue damage detected by MTr was milder in RIS than in RRMS in clinically relevant brain regions, suggesting an explanation for the lack of clinical manifestations of subjects with RIS. This new approach could be useful for narrowing down the RIS individuals with a high risk of progression to MS.	[De Stefano, Nicola; Stromillo, Maria Laura; Rossi, Francesca; Battaglini, Marco; Giorgio, Antonio; Federico, Antonio] Univ Siena, Dept Neurol & Behav Sci, I-53100 Siena, Italy; [Portaccio, Emilio; Hakiki, Bahia; Amato, Maria Pia] Univ Florence, Dept Neurol, Florence, Italy; [Malentacchi, Gianmichele] Arezzo Hosp, Neurol Unit, Arezzo, Italy; [Gasperini, Claudio] San Camillo Forlanini Hosp, Neurol Unit, Rome, Italy; [Santangelo, Mario] Carpi Hosp, Neurol Unit, Carpi, Italy; [Bartolozzi, Maria Letizia] Empoli Hosp, Neurol Unit, Empoli, Italy; [Sormani, Maria Pia] Univ Genoa, Biostat Unit, Dept Hlth Sci, Genoa, Italy	University of Siena; University of Florence; Azienda Ospedaliera San Camillo-Forlanini; University of Genoa	De Stefano, N (corresponding author), Univ Siena, Dept Neurol & Behav Sci, Via Laterina 8, I-53100 Siena, Italy.	destefano@unisi.it	Sormani, Maria Pia/ABH-8756-2020; Amato, Maria Pia/AAC-5940-2022; Hakiki, Bahia/AAB-8461-2022; amato, Maria Pia/AAL-5998-2020; De Stefano, Nicola/AHE-3052-2022; gasperini, claudio/K-5093-2016	Hakiki, Bahia/0000-0001-8540-7405; amato, Maria Pia/0000-0003-3325-3760; De Stefano, Nicola/0000-0003-4930-7639; Portaccio, Emilio/0000-0002-9662-1762; federico, antonio/0000-0002-5246-1621; SORMANI, MARIA PIA/0000-0001-6892-104X; gasperini, claudio/0000-0002-3959-4067	Italian MS Society; Merck Serono; Biogen-Idec; Bayer Schering; Sanofi Aventis; Bayer; Dompe; Novartis; Biogen Dompe	Italian MS Society; Merck Serono(Merck & Company); Biogen-Idec(Biogen); Bayer Schering(Bayer AG); Sanofi Aventis(Sanofi-Aventis); Bayer(Bayer AG); Dompe; Novartis(Novartis); Biogen Dompe(Biogen)	We have read the journal's policy and have the following conflicts: N. De Stefano has received honoraria from Schering, Biogen-Dompe, Teva and Merck-Serono for consulting services, speaking and travel support and research grant support from the Italian MS Society. E. Portaccio has received honoraria for participating in Advisory Board from Biogen-Idec and research support from Merck Serono, Biogen-Idec, Bayer Schering and Sanofi Aventis. C. Gasperini has received fees as invited speaker from Bayer, Dompe, Merck Serono and Novartis. M. P. Sormani has received honoraria from Actelion, Biogen Idec, Teva and Merck-Serono for consulting services, speaking and travel support. M. P. Amato has received personal compensation from Merck Serono, Biogen Dompe, Sanofi Aventis, Bayer Schering for serving on scientific advisory board and for speaking and financial support for research activites from Merck Serono, Sanofi Aventis, Biogen Dompe, Bayer Schering. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials as detailed online in the guide for authors. The other authors have no conflicts of interest.	Arnold DL, 2007, NEUROLOGY, V68, pS83, DOI 10.1212/01.wnl.0000275237.28259.9d; Audoin B, 2007, MULT SCLER J, V13, P483, DOI 10.1177/1352458506070450; Audoin B, 2004, J MAGN RESON IMAGING, V20, P765, DOI 10.1002/jmri.20178; Barkhof F, 2003, ARCH NEUROL-CHICAGO, V60, P1073, DOI 10.1001/archneur.60.8.1073; Battaglini M, 2009, INFLUENCE WHITE MATT; Battaglini M, 2008, NEUROIMAGE, V40, P583, DOI 10.1016/j.neuroimage.2007.10.067; Chen JT, 2007, NEUROIMAGE, V36, P1152, DOI 10.1016/j.neuroimage.2007.03.073; Chen JT, 2008, ANN NEUROL, V63, P254, DOI 10.1002/ana.21302; Comi G, 2009, CLIN THER, V31, P1142, DOI 10.1016/j.clinthera.2009.06.007; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; De Stefano N, 2006, ANN NEUROL, V59, P634, DOI 10.1002/ana.20767; De Stefano N, 2003, NEUROLOGY, V60, P1157, DOI 10.1212/01.WNL.0000055926.69643.03; De Stefano N, 2002, ARCH NEUROL-CHICAGO, V59, P1565, DOI 10.1001/archneur.59.10.1565; De Stefano N, 2006, BRAIN, V129, P2008, DOI 10.1093/brain/awl152; Di Perri C, 2008, ARCH NEUROL-CHICAGO, V65, P236, DOI 10.1001/archneurol.2007.51; DOUSSET V, 1992, RADIOLOGY, V182, P483, DOI 10.1148/radiology.182.2.1732968; ENGELL T, 1989, ACTA NEUROL SCAND, V79, P428, DOI 10.1111/j.1600-0404.1989.tb03811.x; Fazekas F, 2005, BRAIN, V128, P2926, DOI 10.1093/brain/awh567; Filippi M, 2010, J MAGN RESON IMAGING, V31, P770, DOI 10.1002/jmri.22102; Fox NC, 1999, LANCET, V353, P2125, DOI 10.1016/S0140-6736(99)00496-1; GILBERT JJ, 1983, ARCH NEUROL-CHICAGO, V40, P533, DOI 10.1001/archneur.1983.04050080033003; Ginestroni A, 2010, AM J NEURORADIOL, V31, P1807, DOI 10.3174/ajnr.A2225; Ginestroni A, 2009, J NEUROL, V256, P925, DOI 10.1007/s00415-009-5044-3; Goodin DS, 2009, MULT SCLER, V15, P1175, DOI 10.1177/1352458509107007; GROSSMAN RI, 1994, RADIOGRAPHICS, V14, P279, DOI 10.1148/radiographics.14.2.8190954; Horsfield MA, 2005, J NEUROIMAGING, V15, p58S, DOI 10.1177/1051228405282242; Lebrun C, 2010, MULT SCLER; Lebrun C, 2009, ARCH NEUROL-CHICAGO, V66, P841, DOI 10.1001/archneurol.2009.119; Lyoo IK, 1996, J NEUROPSYCH CLIN N, V8, P54; Mews I, 1998, MULT SCLER, V4, P55, DOI 10.1191/135245898678919582; Mitsumoto H, 2007, NEUROLOGY, V68, P1402, DOI 10.1212/01.wnl.0000260065.57832.87; Morris Z, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3016; Okuda DT, 2009, NEUROLOGY, V72, P800, DOI 10.1212/01.wnl.0000335764.14513.1a; Okuda DT, 2009, NAT REV NEUROL, V5, P591, DOI 10.1038/nrneurol.2009.157; Okuda DT, 2011, NEUROLOGY; PIKE GB, 1993, JMRI-J MAGN RESON IM, V3, P531; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Poser CM, 2004, ACTA NEUROL SCAND, V109, P239, DOI 10.1111/j.1600-0404.2004.00277.x; Rao S, 1990, MANUAL BRIEF REPEATA; Schmierer K, 2004, ANN NEUROL, V56, P407, DOI 10.1002/ana.20202; Sellner J, 2010, J NEUROL; Siva A, 2009, MULT SCLER J, V15, P918, DOI 10.1177/1352458509106214; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; van Buchem MA, 2000, NEUROIMAG CLIN N AM, V10, P771; van Waesberghe JHTM, 1998, AM J NEURORADIOL, V19, P675; van Waesberghe JHTM, 1999, ANN NEUROL, V46, P747; Zivadinov R, 2007, NEUROLOGY, V68, pS72, DOI 10.1212/01.wnl.0000275236.51129.d2	48	58	59	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19452	10.1371/journal.pone.0019452	http://dx.doi.org/10.1371/journal.pone.0019452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559385	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700179
J	Frank, RAW; McRae, AF; Pocklington, AJ; van de Lagemaat, LN; Navarro, P; Croning, MDR; Komiyama, NH; Bradley, SJ; Challiss, RAJ; Armstrong, JD; Finn, RD; Malloy, MP; MacLean, AW; Harris, SE; Starr, JM; Bhaskar, SS; Howard, EK; Hunt, SE; Coffey, AJ; Ranganath, V; Deloukas, P; Rogers, J; Muir, WJ; Deary, IJ; Blackwood, DH; Visscher, PM; Grant, SGN				Frank, Rene A. W.; McRae, Allan F.; Pocklington, Andrew J.; van de lagemaat, Louie N.; Navarro, Pau; Croning, Mike D. R.; Komiyama, Noboru H.; Bradley, Sophie J.; Challiss, R. A. John; Armstrong, J. Douglas; Finn, Robert D.; Malloy, Mary P.; MacLean, Alan W.; Harris, Sarah E.; Starr, John M.; Bhaskar, Sanjeev S.; Howard, Eleanor K.; Hunt, Sarah E.; Coffey, Alison J.; Ranganath, Venkatesh; Deloukas, Pano; Rogers, Jane; Muir, Walter J.; Deary, Ian J.; Blackwood, Douglas H.; Visscher, Peter M.; Grant, Seth G. N.			Clustered Coding Variants in the Glutamate Receptor Complexes of Individuals with Schizophrenia and Bipolar Disorder	PLOS ONE			English	Article							MENTAL-RETARDATION PROTEIN; NMDA RECEPTOR; GROUP-I; PREFRONTAL CORTEX; FAMILIES; DOMAIN; RISK; PHENCYCLIDINE; ACTIVATION; INHIBITION	Current models of schizophrenia and bipolar disorder implicate multiple genes, however their biological relationships remain elusive. To test the genetic role of glutamate receptors and their interacting scaffold proteins, the exons of ten glutamatergic 'hub' genes in 1304 individuals were re-sequenced in case and control samples. No significant difference in the overall number of non-synonymous single nucleotide polymorphisms (nsSNPs) was observed between cases and controls. However, cluster analysis of nsSNPs identified two exons encoding the cysteine-rich domain and first transmembrane helix of GRM1 as a risk locus with five mutations highly enriched within these domains. A new splice variant lacking the transmembrane GPCR domain of GRM1 was discovered in the human brain and the GRM1 mutation cluster could perturb the regulation of this variant. The predicted effect on individuals harbouring multiple mutations distributed in their ten hub genes was also examined. Diseased individuals possessed an increased load of deleteriousness from multiple concurrent rare and common coding variants. Together, these data suggest a disease model in which the interplay of compound genetic coding variants, distributed among glutamate receptors and their interacting proteins, contribute to the pathogenesis of schizophrenia and bipolar disorders.	[Frank, Rene A. W.; van de lagemaat, Louie N.; Croning, Mike D. R.; Komiyama, Noboru H.; Finn, Robert D.; Bhaskar, Sanjeev S.; Howard, Eleanor K.; Hunt, Sarah E.; Coffey, Alison J.; Ranganath, Venkatesh; Deloukas, Pano; Rogers, Jane; Grant, Seth G. N.] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [McRae, Allan F.; Visscher, Peter M.] Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Pocklington, Andrew J.; Armstrong, J. Douglas] Univ Edinburgh, Sch Informat, Edinburgh, Midlothian, Scotland; [Navarro, Pau] Western Gen Hosp, MRC Human Genet, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Malloy, Mary P.; MacLean, Alan W.; Muir, Walter J.; Blackwood, Douglas H.] Univ Edinburgh, Royal Edinburgh Hosp, Div Psychiat, Edinburgh, Midlothian, Scotland; [Harris, Sarah E.; Starr, John M.; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Bradley, Sophie J.; Challiss, R. A. John] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England	Wellcome Trust Sanger Institute; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh; University of Leicester	Frank, RAW (corresponding author), Wellcome Trust Sanger Inst, Genome Campus, Hinxton, Cambs, England.	sg3@sanger.ac.uk	Deloukas, Panos/B-2922-2013; Visscher, Peter/ABB-6151-2020; McRae, Allan F/J-2644-2014; Deary, Ian J/C-6297-2009; Navarro, Pau/AAJ-8091-2021; blackwood, douglas/AIB-8874-2022	Deloukas, Panos/0000-0001-9251-070X; Visscher, Peter/0000-0002-2143-8760; McRae, Allan F/0000-0001-5286-5485; Deary, Ian J/0000-0002-1733-263X; Navarro, Pau/0000-0001-5576-8584; Armstrong, Douglas/0000-0002-5397-3864; Hunt, Sarah/0000-0002-8350-1235; Challiss, John/0000-0001-5506-2848; Frank, Rene/0000-0001-9724-9547; Finn, Robert/0000-0001-8626-2148; Grant, Seth/0000-0001-8732-8735; Pocklington, Andrew/0000-0002-2137-0452	Genes to Cognition Program; Wellcome Trust Functional Genomics Initiative; MRC [G0700704, G0801418, MC_U127592696, MC_PC_U127592696] Funding Source: UKRI; Medical Research Council [G0700704, G0801418B, MC_U127592696, G0700704B, MC_PC_U127592696] Funding Source: researchfish; Chief Scientist Office [ETM/55, CZB/4/505] Funding Source: researchfish	Genes to Cognition Program; Wellcome Trust Functional Genomics Initiative(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	Research funded by Genes to Cognition Program and Wellcome Trust Functional Genomics Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; ANIS NA, 1983, BRIT J PHARMACOL, V79, P565, DOI 10.1111/j.1476-5381.1983.tb11031.x; Ashurst JL, 2005, NUCLEIC ACIDS RES, V33, pD459, DOI 10.1093/nar/gki135; Bayes A, 2010, NAT NEUROSCI, P1; Bertolino A, 2009, GENETICS SCHIZOPHREN, P1; Brody SA, 2003, EUR J NEUROSCI, V18, P3361, DOI 10.1111/j.1460-9568.2003.03073.x; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; CHOTHIA C, 1992, NATURE, V357, P543, DOI 10.1038/357543a0; Coba MP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000102; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Consortium IS, 2009, NATURE, P1; Creighton TE, 1997, TRENDS BIOCHEM SCI, V22, P6, DOI 10.1016/S0968-0004(96)20030-1; Cuthbert PC, 2007, J NEUROSCI, V27, P2673, DOI 10.1523/JNEUROSCI.4457-06.2007; Dickman DK, 2009, SCIENCE, V326, P1127, DOI 10.1126/science.1179685; Egan MF, 2004, P NATL ACAD SCI USA, V101, P12604, DOI 10.1073/pnas.0405077101; Endele S, 2010, NAT GENET, P1; Fagni Laurent, 2002, Sci STKE, V2002, pre8, DOI 10.1126/stke.2002.137.re8; Grant SGN, 2010, NEURON, V67, P8; Gunduz-Bruce H, 2009, BRAIN RES REV, V60, P279, DOI 10.1016/j.brainresrev.2008.07.006; Gupta DS, 2005, SYNAPSE, V57, P123, DOI 10.1002/syn.20164; Guruprasad K, 2000, J BIOSCIENCES, V25, P143, DOI 10.1007/BF03404909; Hermans E, 2001, BIOCHEM J, V359, P465, DOI 10.1042/0264-6021:3590465; Hu JH, 2010, NEURON, V68, P1128, DOI 10.1016/j.neuron.2010.11.008; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Jingami H, 2003, CURR OPIN NEUROBIOL, V13, P271, DOI 10.1016/S0959-4388(03)00067-9; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; MacDonald AW, 2009, SCHIZOPHRENIA BULL, V35, P493, DOI 10.1093/schbul/sbp017; Maeda J, 2003, NEUROSCI LETT, V336, P171, DOI 10.1016/S0304-3940(02)01261-2; Meier S, 2007, CURR BIOL, V17, P173, DOI 10.1016/j.cub.2006.10.063; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Pocklington AJ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100041; Rea AM, 2008, BIOCHEMISTRY; Sartorius LJ, 2006, J NEUROCHEM, V96, P1139, DOI 10.1111/j.1471-4159.2005.03609.x; Shen MY, 2005, CHEM PHYS LETT, V405, P224, DOI 10.1016/j.cplett.2005.02.029; Shi J, 2009, NATURE, V1-5; SIBANDA BL, 1985, NATURE, V316, P170, DOI 10.1038/316170a0; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Snyder EM, 2008, NAT REV DRUG DISCOV, V7, P471, DOI 10.1038/nrd2571; Snyder SH, 2006, NEURON, V49, P484, DOI 10.1016/j.neuron.2006.02.002; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Tarpey P, 2004, AM J HUM GENET, V75, P318, DOI 10.1086/422703; Tateyama M, 2004, NAT STRUCT MOL BIOL, V11, P637, DOI 10.1038/nsmb770; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Yao WD, 2008, BIOCHEM PHARMACOL, V75, P2055, DOI 10.1016/j.bcp.2008.01.018; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893; Zeggini E, 2005, NAT GENET, V37, P1320, DOI 10.1038/ng1670; Zeitz C, 2007, HUM MUTAT, V28, P771, DOI 10.1002/humu.20499; Zhang JP, 2007, J BIOL CHEM, V282, P15778, DOI 10.1074/jbc.M611485200	58	42	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19011	10.1371/journal.pone.0019011	http://dx.doi.org/10.1371/journal.pone.0019011			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559497	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700051
J	Hsieh, YH; Gaydos, CA; Hogan, MT; Uy, OM; Jackman, J; Jett-Goheen, M; Albertie, A; Dangerfield, DT; Neustadt, CR; Wiener, ZS; Rompalo, AM				Hsieh, Yu-Hsiang; Gaydos, Charlotte A.; Hogan, M. Terry; Uy, O. Manuel; Jackman, Joany; Jett-Goheen, Mary; Albertie, Ariel; Dangerfield, Derek T., II; Neustadt, Celia R.; Wiener, Zachary S.; Rompalo, Anne M.			What Qualities Are Most Important to Making a Point of Care Test Desirable for Clinicians and Others Offering Sexually Transmitted Infection Testing?	PLOS ONE			English	Article								Background: To investigate the possible effects of different levels of attributes of a point-of-care test (POCT) on sexually transmitted infection (STI) professionals' decisions regarding an ideal POCT for STI(s). Methods: An online survey was designed based on a large-scale in-depth focus discussion study among STI experts and professionals. The last section of the survey "build your own POCT'' was designed by employing the discrete choice experiment approach. Practicing clinicians from two venues, STI-related international conference attendees and U. S. STD clinic clinicians were invited to participate in the survey. Conditional logistical regression modeling was used for data analysis. Results: Overall, 256 subjects took the online survey with 218 (85%) completing it. Most of the participants were STD clinic clinicians who already used some POCTs in their practice. "The time frame required'' was identified as a major barrier that currently made it difficult to use STI POCTs. Chlamydia trachomatis was the organism chosen as the top priority for a new POCT, followed by a test that would diagnose early seroconversion for HIV, and a syphilis POCT. Without regard to organism type selected, sensitivity of 90-99% was always the most important attribute to be considered, followed by a cost of $20. However, when the test platform was prioritized for early HIV seroconversion or syphilis, sensitivity was still ranked as most important, but specificity was rated second most important. Conclusions: STI professionals preferred C. trachomatis as the top priority for a new POCT with sensitivity over 90%, low cost, and a very short completion time.	[Hsieh, Yu-Hsiang] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD 21218 USA; [Gaydos, Charlotte A.; Hogan, M. Terry; Jett-Goheen, Mary; Albertie, Ariel; Dangerfield, Derek T., II; Neustadt, Celia R.; Wiener, Zachary S.; Rompalo, Anne M.] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA; [Uy, O. Manuel; Jackman, Joany] Johns Hopkins Univ, Appl Phys Lab, Milton Eisenhower Res Ctr, Laurel, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	Hsieh, YH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD 21218 USA.	yhsieh1@jhmi.edu	Gaydos, Charlotte A./E-9937-2010	Dangerfield II, Derek T./0000-0002-2473-3183	NIH [U54-EB007958]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB007958] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by NIH grant U54-EB007958. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryan Stirling, 2004, Eur J Health Econ, V5, P199, DOI 10.1007/s10198-004-0241-6; Centers for Disease Control and Prevention, 2009, SEX TRANSM DIS SURV; Centers for Disease Control and Prevention, 2009, SEX TRANSM DIS US 20; Chan YM, 2009, PRENATAL DIAG, V29, P1270, DOI 10.1002/pd.2394; Hsieh YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014144; Huppert J, 2010, POINT CARE, V9, P36, DOI 10.1097/POC.0b013e3181d2d8cc; Peeling RW, 2006, SEX TRANSM INFECT, V82, pV1, DOI 10.1136/sti.2006.024265; Porteous T, 2006, BRIT J GEN PRACT, V56, P911; Ryan M, 2004, BMJ-BRIT MED J, V328, P360, DOI 10.1136/bmj.328.7436.360; van Dommelen L, 2010, SEX TRANSM INFECT, V86, P355, DOI 10.1136/sti.2010.042598; Watson V, 2009, VALUE HEALTH, V12, P621, DOI 10.1111/j.1524-4733.2008.00451.x; WHO/OMS, 2001, WHO SEX TRANSM DIS D	12	41	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19263	10.1371/journal.pone.0019263	http://dx.doi.org/10.1371/journal.pone.0019263			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559435	gold, Green Submitted, Green Published			2022-12-27	WOS:000290024700116
J	Santini, D; Schiavon, G; Vincenzi, B; Gaeta, L; Pantano, F; Russo, A; Ortega, C; Porta, C; Galluzzo, S; Armento, G; La Verde, N; Caroti, C; Treilleux, I; Ruggiero, A; Perrone, G; Addeo, R; Clezardin, P; Muda, AO; Tonini, G				Santini, Daniele; Schiavon, Gaia; Vincenzi, Bruno; Gaeta, Laura; Pantano, Francesco; Russo, Antonio; Ortega, Cinzia; Porta, Camillo; Galluzzo, Sara; Armento, Grazia; La Verde, Nicla; Caroti, Cinzia; Treilleux, Isabelle; Ruggiero, Alessandro; Perrone, Giuseppe; Addeo, Raffaele; Clezardin, Philippe; Muda, Andrea Onetti; Tonini, Giuseppe			Receptor Activator of NF-kappa B (RANK) Expression in Primary Tumors Associates with Bone Metastasis Occurrence in Breast Cancer Patients	PLOS ONE			English	Article							GENE-EXPRESSION; LIGAND RANKL; IN-VITRO; OSTEOCLAST DIFFERENTIATION; OSTEOPROTEGERIN LIGAND; POSSIBLE INVOLVEMENT; MYELOMA CELLS; MIGRATION; RANKL/RANK/OPG; MECHANISMS	Background: Receptor activator of NFkB (RANK), its ligand (RANKL) and the decoy receptor of RANKL (osteoprotegerin, OPG) play a pivotal role in bone remodeling by regulating osteoclasts formation and activity. RANKL stimulates migration of RANK-expressing tumor cells in vitro, conversely inhibited by OPG. Materials and Methods: We examined mRNA expression levels of RANKL/RANK/OPG in a publicly available microarray dataset of 295 primary breast cancer patients. We next analyzed RANK expression by immunohistochemistry in an independent series of 93 primary breast cancer specimens and investigated a possible association with clinicopathological parameters, bone recurrence and survival. Results: Microarray analysis showed that lower RANK and high OPG mRNA levels correlate with longer overall survival (P = 0.0078 and 0.0335, respectively) and disease-free survival (P = 0.059 and 0.0402, respectively). Immunohistochemical analysis of RANK showed a positive correlation with the development of bone metastases (P = 0.023) and a shorter skeletal disease-free survival (SDFS, P = 0.037). Specifically, univariate analysis of survival showed that "RANK-negative'' and "RANK-positive'' patients had a SDFS of 105.7 months (95% CI: 73.9-124.4) and 58.9 months (95% CI: 34.7-68.5), respectively. RANK protein expression was also associated with accelerated bone metastasis formation in a multivariate analysis (P = 0.029). Conclusions: This is the first demonstration of the role of RANK expression in primary tumors as a predictive marker of bone metastasis occurrence and SDFS in a large population of breast cancer patients.	[Santini, Daniele; Schiavon, Gaia; Vincenzi, Bruno; Pantano, Francesco; Galluzzo, Sara; Armento, Grazia; Tonini, Giuseppe] Univ Campus Biomed Rome, Dept Med Oncol, Rome, Italy; [Schiavon, Gaia] Erasmus Univ, Med Ctr, Dept Med Oncol, Daniel den Hoed Canc Ctr, Rotterdam, Netherlands; [Gaeta, Laura; Perrone, Giuseppe; Muda, Andrea Onetti] Univ Campus Biomed Rome, Dept Pathol, Rome, Italy; [Russo, Antonio] Univ Palermo, Dept Surg & Oncol Sci, Sect Med Oncol, Palermo, Italy; [Ortega, Cinzia] Inst Canc Res & Treatment IRCC, Div Med Oncol & Haematol, Candiolo, Italy; [Porta, Camillo] IRCCS San Matteo Univ Hosp Fdn, Dept Med Oncol, Pavia, Italy; [La Verde, Nicla] Osped Fatebenefratelli & Oftalm, Azienda Osped, Dept Oncol, Milan, Italy; [Caroti, Cinzia] Ente Osped Osped Galliera, SC Med Oncol, Genoa, Italy; [Treilleux, Isabelle; Clezardin, Philippe] Univ Lyon 1, INSERM, Res Unit U664, F-69365 Lyon, France; [Addeo, Raffaele] San Giovanni di Dio Hosp, Dept Med Oncol, Naples, Italy; [Ruggiero, Alessandro] Erasmus MC, Dept Radiol, Rotterdam, Netherlands	University Campus Bio-Medico - Rome Italy; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; University Campus Bio-Medico - Rome Italy; University of Palermo; IRCCS Fondazione del Piemonte per l'Oncologia; IRCCS Fondazione San Matteo; Ospedale di Vimercate; Ente Ospedaliero Ospedali Galliera; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Erasmus University Rotterdam; Erasmus MC	Santini, D (corresponding author), Univ Campus Biomed Rome, Dept Med Oncol, Rome, Italy.	d.santini@unicampus.it	Porta, Camillo/AAB-9482-2020; Clezardin, Philippe/M-8071-2014; Muda, Andrea Onetti/AAA-5105-2020; Perrone, Giuseppe/E-7062-2011; Pantano, Francesco/D-8459-2012; perrone, giuseppe/ABF-5105-2020; Perrone, Giuseppe/GLR-7098-2022; Onetti Muda, Andrea/G-5384-2012; la verde, nicla/AAW-9398-2020	Clezardin, Philippe/0000-0003-0149-4463; Perrone, Giuseppe/0000-0002-9538-5729; Pantano, Francesco/0000-0002-2894-9686; Onetti Muda, Andrea/0000-0002-0274-6178; la verde, nicla/0000-0002-2884-1632; Santini, Daniele/0000-0002-9118-3337; addeo, raffaele/0000-0001-9197-8060; Tonini, Giuseppe/0000-0003-4442-8677; Vincenzi, Bruno/0000-0001-8222-9025; Porta, Camillo/0000-0003-2412-1563				Armstrong AP, 2008, PROSTATE, V68, P92, DOI 10.1002/pros.20678; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Beleut M, 2010, P NATL ACAD SCI USA, V107, P2989, DOI 10.1073/pnas.0915148107; Bhatia P, 2005, CLIN CANCER RES, V11, P162; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Brown Julie M, 2004, Cancer Treat Res, V118, P149; Chen G, 2006, CANCER-AM CANCER SOC, V107, P289, DOI 10.1002/cncr.21978; COX DR, 1972, J R STAT SOC B, V34, P187; Cross SS, 2006, J CLIN PATHOL, V59, P716, DOI 10.1136/jcp.2005.030031; Danovi SA, 2010, NAT REV CANCER, V10, P45; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Farrugia AN, 2003, CANCER RES, V63, P5438; Granchi D, 2004, INT J CANCER, V111, P829, DOI 10.1002/ijc.20308; Huang L, 2003, J CLIN PATHOL-MOL PA, V56, P116, DOI 10.1136/mp.56.2.116; Huang L, 2000, AM J PATHOL, V156, P761, DOI 10.1016/S0002-9440(10)64942-5; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 2000, AM J PATHOL, V157, P435, DOI 10.1016/S0002-9440(10)64556-7; Lai FPL, 2004, BRIT J HAEMATOL, V126, P192, DOI 10.1111/j.1365-2141.2004.05018.x; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Lipton A, 2007, J CLIN ONCOL, V25, P4431, DOI 10.1200/JCO.2007.11.8604; Matsuzaki K, 1998, BIOCHEM BIOPH RES CO, V246, P199, DOI 10.1006/bbrc.1998.8586; McClung MR, 2006, NEW ENGL J MED, V354, P821, DOI 10.1056/NEJMoa044459; Mikami S, 2009, J PATHOL, V218, P530, DOI 10.1002/path.2567; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Santini D, 2011, J CELL PHYSIOL, V226, P780, DOI 10.1002/jcp.22402; Sasaki A, 2007, ANN SURG ONCOL, V14, P1191, DOI 10.1245/s10434-006-9277-4; Smid M, 2006, J CLIN ONCOL, V24, P2261, DOI 10.1200/JCO.2005.03.8802; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tada T, 2005, INT J CANCER, V116, P253, DOI 10.1002/ijc.21008; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Van Poznak C, 2006, J CLIN PATHOL, V59, P56, DOI 10.1136/jcp.2005.026534; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wittrant Y, 2006, INT J ONCOL, V28, P261	38	136	144	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19234	10.1371/journal.pone.0019234	http://dx.doi.org/10.1371/journal.pone.0019234			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559440	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000290024700108
J	Saulnier, DM; Santos, F; Roos, S; Mistretta, TA; Spinler, JK; Molenaar, D; Teusink, B; Versalovic, J				Saulnier, Delphine M.; Santos, Filipe; Roos, Stefan; Mistretta, Toni-Ann; Spinler, Jennifer K.; Molenaar, Douwe; Teusink, Bas; Versalovic, James			Exploring Metabolic Pathway Reconstruction and Genome-Wide Expression Profiling in Lactobacillus reuteri to Define Functional Probiotic Features	PLOS ONE			English	Article							ADHESION-PROMOTING PROTEIN; NF-KAPPA-B; EXOPOLYSACCHARIDE BIOSYNTHESIS; SURFACE-PROTEINS; GENE-CLUSTER; RHAMNOSUS GG; ACID; MUCUS; GUT; ATCC-55730	The genomes of four Lactobacillus reuteri strains isolated from human breast milk and the gastrointestinal tract have been recently sequenced as part of the Human Microbiome Project. Preliminary genome comparisons suggested that these strains belong to two different clades, previously shown to differ with respect to antimicrobial production, biofilm formation, and immunomodulation. To explain possible mechanisms of survival in the host and probiosis, we completed a detailed genomic comparison of two breast milk-derived isolates representative of each group: an established probiotic strain (L. reuteri ATCC 55730) and a strain with promising probiotic features (L. reuteri ATCC PTA 6475). Transcriptomes of L. reuteri strains in different growth phases were monitored using strain-specific microarrays, and compared using a pan-metabolic model representing all known metabolic reactions present in these strains. Both strains contained candidate genes involved in the survival and persistence in the gut such as mucus-binding proteins and enzymes scavenging reactive oxygen species. A large operon predicted to encode the synthesis of an exopolysaccharide was identified in strain 55730. Both strains were predicted to produce health-promoting factors, including antimicrobial agents and vitamins (folate, vitamin B12). Additionally, a complete pathway for thiamine biosynthesis was predicted in strain 55730 for the first time in this species. Candidate genes responsible for immunomodulatory properties of each strain were identified by transcriptomic comparisons. The production of bioactive metabolites by human-derived probiotics may be predicted using metabolic modeling and transcriptomics. Such strategies may facilitate selection and optimization of probiotics for health promotion, disease prevention and amelioration.	[Saulnier, Delphine M.; Mistretta, Toni-Ann; Spinler, Jennifer K.; Versalovic, James] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Versalovic, James] Baylor Coll Med, Dept Translat Biol, Houston, TX 77030 USA; [Versalovic, James] Baylor Coll Med, Program Mol Med, Houston, TX 77030 USA; [Santos, Filipe; Molenaar, Douwe; Teusink, Bas] Vrije Univ, Ctr Integrat Bioinformat, Amsterdam, Netherlands; [Santos, Filipe; Molenaar, Douwe; Teusink, Bas] Netherlands Consortium Syst Biol, Kluyver Ctr Genom Ind Fermentat, Delft, Netherlands; [Saulnier, Delphine M.; Spinler, Jennifer K.; Versalovic, James] Texas Childrens Hosp, Dept Pathol, Houston, TX 77030 USA; [Roos, Stefan] Swedish Univ Agr Sci, Dept Microbiol, S-75007 Uppsala, Sweden	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Vrije Universiteit Amsterdam; Baylor College of Medicine; Swedish University of Agricultural Sciences	Saulnier, DM (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.	Delphine.Saulnier@nizo.nl	Molenaar, Douwe/D-2017-2010; SAULNIER, Delphine DM/C-1307-2013; Santos, Filipe/M-7709-2013	Molenaar, Douwe/0000-0001-7108-4545; Teusink, Bas/0000-0003-3929-0423; Spinler, Jennifer/0000-0002-7830-7665; Santos, Filipe/0000-0001-7316-1479; Branco dos Santos, Filipe/0000-0002-4268-8080; Roos, Stefan/0000-0002-1606-1794	National Institutes of Health; National Institute of Diabetes, Digestive and Kidney Diseases [R01 DK065075, P30 DK56338]; National Center for Complementary and Alternative Medicine [R01 AT004326, R21 AT003482]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT003482, R01AT004326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338, R01DK065075] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes, Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work has been supported by National Institutes of Health, National Institute of Diabetes, Digestive and Kidney Diseases (R01 DK065075 and P30 DK56338), and National Center for Complementary and Alternative Medicine (R01 AT004326 and R21 AT003482). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JV receives financial research support (no salary) and holds a patent with Biogaia since 2004, Anti-Inflammatory Activity from Lactic Acid Bacteria (WO/2004/069178). JV and DMS have a patent pending with Biogaia but not related to the work and research presented in this manuscript. JV serves as a scientific advisor for Danone. However, this does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in PLoS ONE's guide for authors. All bacterial genome sequences presented in this manuscript are publicly available on National Center for Biotechnology Information (NCBI). All microarray data have also been deposited into a public database (GEO). All bacterial strains are deposited in public strain collections (ATCC, BEI), and available to everyone.	Abrahamsson TR, 2009, J PEDIATR GASTR NUTR, V49, P349, DOI 10.1097/MPG.0b013e31818f091b; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arskold E, 2008, J BACTERIOL, V190, P206, DOI 10.1128/JB.01227-07; Axelsson L.T., 1989, MICROB ECOL HEALTH D, V2, P131, DOI [DOI 10.3109/08910608909140210, 10.3109/08910608909140210]; Bartholome AL, 2004, JPEN-PARENTER ENTER, V28, P210, DOI 10.1177/0148607104028004210; Bath K, 2005, FEMS MICROBIOL LETT, V253, P75, DOI 10.1016/j.femsle.2005.09.042; Begley TP, 1999, ARCH MICROBIOL, V171, P293, DOI 10.1007/s002030050713; Belenguer A, 2006, APPL ENVIRON MICROB, V72, P3593, DOI 10.1128/AEM.72.5.3593-3599.2006; Bohle LA, 2010, APPL ENVIRON MICROB, V76, P7306, DOI 10.1128/AEM.01423-10; Chabot S, 2001, LAIT, V81, P683, DOI 10.1051/lait:2001157; Coccorullo P, 2010, J PEDIATR-US, V157, P598, DOI 10.1016/j.jpeds.2010.04.066; Colijn C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000489; Corfield AP, 2000, GUT, V47, P589, DOI 10.1136/gut.47.4.589; Coyne MJ, 2008, P NATL ACAD SCI USA, V105, P13099, DOI 10.1073/pnas.0804220105; CROW VL, 1982, J BACTERIOL, V150, P1024, DOI 10.1128/JB.150.3.1024-1032.1982; Eaton KA, 2010, INFECT IMMU IN PRESS; FAO/WHO, 2006, REPORT JOINT FAOWHO; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Hoppe B, 1998, J PEDIATR GASTR NUTR, V27, P383, DOI 10.1097/00005176-199810000-00002; Imura K, 1998, NUTRITION, V14, P143, DOI 10.1016/S0899-9007(97)00230-X; Indrio F, 2008, J PEDIATR-US, V152, P801, DOI 10.1016/j.jpeds.2007.11.005; Iwasaki W, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000402; Iyer C, 2008, CELL MICROBIOL, V10, P1442, DOI 10.1111/j.1462-5822.2008.01137.x; Jones SE, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-35; KANEUCHI C, 1988, APPL ENVIRON MICROB, V54, P3053, DOI 10.1128/AEM.54.12.3053-3056.1988; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Lamothe GT, 2002, ARCH MICROBIOL, V178, P218, DOI 10.1007/s00203-002-0447-x; Lebeer S, 2009, APPL ENVIRON MICROB, V75, P3554, DOI 10.1128/AEM.02919-08; Lin YP, 2008, INFLAMM BOWEL DIS, V14, P1068, DOI 10.1002/ibd.20448; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Markowitz VM, NUCL ACIDS RES, VD382-390; Mazmanian SK, 2000, P NATL ACAD SCI USA, V97, P5510, DOI 10.1073/pnas.080520697; Metges CC, 2000, J NUTR, V130, p1857S, DOI 10.1093/jn/130.7.1857S; Miniello VL, 2010, J PEDIATR GASTR NUTR, V50, P573, DOI 10.1097/MPG.0b013e3181bb343f; Miyoshi Y, 2006, BIOSCI BIOTECH BIOCH, V70, P1622, DOI 10.1271/bbb.50688; Molenaar D, 2005, J BACTERIOL, V187, P6119, DOI 10.1128/JB.187.17.6119-6127.2005; Morita H, 2008, DNA RES, V15, P151, DOI 10.1093/dnares/dsn009; Mulder NJ, 2005, NUCLEIC ACIDS RES, V33, pD201, DOI 10.1093/nar/gki106; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Notebaart RA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-296; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; OBRADORS N, 1988, J BACTERIOL, V170, P2159, DOI 10.1128/jb.170.5.2159-2162.1988; Oh PL, 2010, ISME J, V4, P377, DOI 10.1038/ismej.2009.123; Oh YK, 2007, J BIOL CHEM, V282, P28791, DOI 10.1074/jbc.M703759200; Oliveira AP, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-39; Pal C, 2005, NAT GENET, V37, P1372, DOI 10.1038/ng1686; Peant B, 2005, MICROBIOL-SGM, V151, P1839, DOI 10.1099/mic.0.27852-0; Preidis GA, 2011, PROBIOTICS IN PRESS; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Reuter G, 2001, Curr Issues Intest Microbiol, V2, P43; Rojas M, 2002, APPL ENVIRON MICROB, V68, P2330, DOI 10.1128/AEM.68.5.2330-2336.2002; Roos S, 1996, FEMS MICROBIOL LETT, V144, P33, DOI 10.1016/0378-1097(96)00334-5; Rosander A, 2008, APPL ENVIRON MICROB, V74, P6032, DOI 10.1128/AEM.00991-08; Santos F, 2008, VITAMIN B12 SYNTHESI; Santos F, 2008, MICROBIOL-SGM, V154, P81, DOI 10.1099/mic.0.2007/011569-0; Saulnier DMA, 2008, FEMS MICROBIOL ECOL, V66, P516, DOI 10.1111/j.1574-6941.2008.00561.x; SAVAGE DC, 1986, ANNU REV NUTR, V6, P155, DOI 10.1146/annurev.nu.06.070186.001103; Savino F, 2007, PEDIATRICS, V119, pE124, DOI 10.1542/peds.2006-1222; SCHEPPACH W, 1994, GUT, V35, pS35, DOI 10.1136/gut.35.1_Suppl.S35; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Selengut JD, 2007, NUCLEIC ACIDS RES, V35, pD260, DOI 10.1093/nar/gkl1043; Sinkiewicz Gabriela, 2008, Microbial Ecology in Health and Disease, V20, P122, DOI 10.1080/08910600802341007; Spinler JK, 2008, ANAEROBE, V14, P166, DOI 10.1016/j.anaerobe.2008.02.001; Stalhammar-Carlemalm M, 1999, MOL MICROBIOL, V33, P208, DOI 10.1046/j.1365-2958.1999.01470.x; Szajewska H, 2010, DANONE HLTH AFFAIRS, V1, P2; TALARICO TL, 1988, ANTIMICROB AGENTS CH, V32, P1854, DOI 10.1128/AAC.32.12.1854; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; Teusink B, 2006, J BIOL CHEM, V281, P40041, DOI 10.1074/jbc.M606263200; Thomas CM, 2010, GUT MICROBES, V1, P148, DOI 10.4161/gmic.1.3.11712; van Baarlen P, 2009, P NATL ACAD SCI USA, V106, P2371, DOI 10.1073/pnas.0809919106; van Pijkeren JP, 2006, APPL ENVIRON MICROB, V72, P4143, DOI 10.1128/AEM.03023-05; Ventura M, 2009, NAT REV MICROBIOL, V7, P61, DOI 10.1038/nrmicro2047; Wall T, 2007, APPL ENVIRON MICROB, V73, P3924, DOI 10.1128/AEM.01502-06; Walter J, 2010, P NATL ACAD IN PRESS; Whitehead K, 2008, APPL ENVIRON MICROB, V74, P1812, DOI 10.1128/AEM.02259-07; WHO, 2007, WHO TECH REP SER, V935, P1; Yasuda E, 2008, APPL ENVIRON MICROB, V74, P4746, DOI 10.1128/AEM.00412-08; YOUNG VR, 1994, J NUTR, V124, pS1517, DOI 10.1093/jn/124.suppl_8.1517S	80	115	119	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18783	10.1371/journal.pone.0018783	http://dx.doi.org/10.1371/journal.pone.0018783			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559529	Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700026
J	Tseng, ZJ; Mcnitt-Gray, JL; Flashner, H; Wang, XM; Enciso, R				Tseng, Zhijie Jack; Mcnitt-Gray, Jill L.; Flashner, Henryk; Wang, Xiaoming; Enciso, Reyes			Model Sensitivity and Use of the Comparative Finite Element Method in Mammalian Jaw Mechanics: Mandible Performance in the Gray Wolf	PLOS ONE			English	Article							CRANIAL FUNCTIONAL-MORPHOLOGY; ESTIMATED BITING FORCES; COMPUTER-SIMULATION; CROCUTA-CROCUTA; BONE-CRACKING; MUSCLE FORCE; TAIL CLUB; BIOMECHANICS; EVOLUTION; CARNIVORA	Finite Element Analysis (FEA) is a powerful tool gaining use in studies of biological form and function. This method is particularly conducive to studies of extinct and fossilized organisms, as models can be assigned properties that approximate living tissues. In disciplines where model validation is difficult or impossible, the choice of model parameters and their effects on the results become increasingly important, especially in comparing outputs to infer function. To evaluate the extent to which performance measures are affected by initial model input, we tested the sensitivity of bite force, strain energy, and stress to changes in seven parameters that are required in testing craniodental function with FEA. Simulations were performed on FE models of a Gray Wolf (Canis lupus) mandible. Results showed that unilateral bite force outputs are least affected by the relative ratios of the balancing and working muscles, but only ratios above 0.5 provided balancing-working side joint reaction force relationships that are consistent with experimental data. The constraints modeled at the bite point had the greatest effect on bite force output, but the most appropriate constraint may depend on the study question. Strain energy is least affected by variation in bite point constraint, but larger variations in strain energy values are observed in models with different number of tetrahedral elements, masticatory muscle ratios and muscle subgroups present, and number of material properties. These findings indicate that performance measures are differentially affected by variation in initial model parameters. In the absence of validated input values, FE models can nevertheless provide robust comparisons if these parameters are standardized within a given study to minimize variation that arise during the model-building process. Sensitivity tests incorporated into the study design not only aid in the interpretation of simulation results, but can also provide additional insights on form and function.	[Tseng, Zhijie Jack; Mcnitt-Gray, Jill L.; Flashner, Henryk; Wang, Xiaoming; Enciso, Reyes] Univ So Calif, Dept Biol Sci, Integrat & Evolutionary Biol Program, Los Angeles, CA 90089 USA; [Tseng, Zhijie Jack; Wang, Xiaoming] Nat Hist Museum Los Angeles Cty, Dept Vertebrate Paleontol, Los Angeles, CA USA; [Mcnitt-Gray, Jill L.] Univ So Calif, Dept Kinesiol, Los Angeles, CA USA; [Mcnitt-Gray, Jill L.] Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA; [Flashner, Henryk] Univ So Calif, Dept Aerosp & Mech Engn, Los Angeles, CA USA; [Enciso, Reyes] Univ So Calif, Ostrow Sch Dent, Los Angeles, CA USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Tseng, ZJ (corresponding author), Univ So Calif, Dept Biol Sci, Integrat & Evolutionary Biol Program, Los Angeles, CA 90089 USA.	jtseng@nhm.org	Wang, Xiaoming/I-9033-2019	Wang, Xiaoming/0000-0003-1610-3840	University of Southern California Zumberge; NSF [DEB-0909807]; American Society of Mammalogists	University of Southern California Zumberge; NSF(National Science Foundation (NSF)); American Society of Mammalogists	The work was supported by a University of Southern California Zumberge Grant (to JM, HF, XW, and RE), NSF Graduate Research Fellowship and Doctoral Dissertation Improvement Grant (DEB-0909807) and American Society of Mammalogists Grant-in-Aid of Research to ZJT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbour VM, 2009, ANAT REC, V292, P1412, DOI 10.1002/ar.20987; Bell PR, 2009, ANAT REC, V292, P1338, DOI 10.1002/ar.20978; BIKNEVICIUS AR, 1992, J ZOOL, V228, P479, DOI 10.1111/j.1469-7998.1992.tb04450.x; Bright JA, 2011, ANAT REC, V294, P610, DOI 10.1002/ar.21358; Davis JL, 2010, J EXP BIOL, V213, P1844, DOI 10.1242/jeb.041129; DESSEM D, 1989, J ANAT, V164, P101; Dumont ER, 2009, J THEOR BIOL, V256, P96, DOI 10.1016/j.jtbi.2008.08.017; Dumont ER, 2011, J ANAT, V218, P151, DOI 10.1111/j.1469-7580.2010.01247.x; Dumont ER, 2005, ANAT REC PART A, V283A, P319, DOI 10.1002/ar.a.20165; Ellis JL, 2008, J ANAT, V212, P769, DOI 10.1111/j.1469-7580.2008.00911.x; Farke AA, 2008, J EXP BIOL, V211, P3085, DOI 10.1242/jeb.019042; Fastnacht Michael, 2002, Senckenbergiana Lethaea, V82, P195; Grosse IR, 2007, ANAT REC, V290, P1069, DOI 10.1002/ar.20568; Habelitz S, 2001, ARCH ORAL BIOL, V46, P173, DOI 10.1016/S0003-9969(00)00089-3; HAINES D J, 1968, Journal of Biomechanics, V1, P117, DOI 10.1016/0021-9290(68)90014-6; Herring SW, 2000, AM J PHYS ANTHROPOL, V112, P575, DOI 10.1002/1096-8644(200008)112:4&lt;575::AID-AJPA10&gt;3.0.CO;2-0; Hulsey CD, 2008, EVOLUTION, V62, P1587, DOI 10.1111/j.1558-5646.2008.00384.x; Hylander WL, 2000, AM J PHYS ANTHROPOL, V112, P469, DOI 10.1002/1096-8644(200008)112:4<469::AID-AJPA5>3.0.CO;2-V; HYLANDER WL, 1979, AM J PHYS ANTHROPOL, V51, P433, DOI 10.1002/ajpa.1330510317; Kupczik K, 2008, J ANTHROPOL SCI, V86, P193; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; Mchenry CR, 2006, ANAT REC PART A, V288A, P827, DOI 10.1002/ar.a.20360; Moazen M, 2008, J ANAT, V213, P499, DOI 10.1111/j.1469-7580.2008.00980.x; Moreno K, 2008, J ANAT, V212, P736, DOI 10.1111/j.1469-7580.2008.00899.x; Nalla RK, 2003, NAT MATER, V2, P164, DOI 10.1038/nmat832; Panagiotopoulou O, 2011, J ANAT, V218, P75, DOI 10.1111/j.1469-7580.2010.01257.x; Qin QH, 2004, BIOMATERIALS, V25, P5081, DOI 10.1016/j.biomaterials.2003.12.042; Rayfield EJ, 2005, ZOOL J LINN SOC-LOND, V144, P309, DOI 10.1111/j.1096-3642.2005.00176.x; Rayfield EJ, 2004, P ROY SOC B-BIOL SCI, V271, P1451, DOI 10.1098/rspb.2004.2755; Rayfield EJ, 2001, NATURE, V409, P1033, DOI 10.1038/35059070; Rayfield EJ, 2007, ANNU REV EARTH PL SC, V35, P541, DOI 10.1146/annurev.earth.35.031306.140104; RENSBERGER JM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P151; RHO JY, 1995, MED ENG PHYS, V17, P347, DOI 10.1016/1350-4533(95)97314-F; Ross CF, 2005, ANAT REC PART A, V283A, P288, DOI 10.1002/ar.a.20170; Ross CF, 2005, ANAT REC PART A, V283A, P253, DOI 10.1002/ar.a.20177; SCAPINO RP, 1965, J MORPHOL, V116, P23, DOI 10.1002/jmor.1051160103; Schneider U, 1996, PHYS MED BIOL, V41, P111, DOI 10.1088/0031-9155/41/1/009; Schumacher GH., 1961, FUNKTIONELLE MORPHOL; Sellers WI, 2004, ANN ANAT, V186, P89, DOI 10.1016/S0940-9602(04)80132-8; Slater GJ, 2009, J EVOLUTION BIOL, V22, P2278, DOI 10.1111/j.1420-9101.2009.01845.x; Slater GJ, 2009, J ZOOL, V278, P181, DOI 10.1111/j.1469-7998.2009.00567.x; Slater GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013870; Soons J, 2010, PHILOS T R SOC B, V365, P1093, DOI 10.1098/rstb.2009.0280; Stefen C, 1997, TOOTH ENAMEL MICROSTRUCTURE, P123; Strait DS, 2009, P NATL ACAD SCI USA, V106, P2124, DOI 10.1073/pnas.0808730106; Strait DS, 2005, ANAT REC PART A, V283A, P275, DOI 10.1002/ar.a.20172; Tanner JB, 2008, BIOL J LINN SOC, V95, P246, DOI 10.1111/j.1095-8312.2008.01052.x; THOMASON JJ, 1991, CAN J ZOOL, V69, P2326, DOI 10.1139/z91-327; Tseng ZJ, 2011, BIOL J LINN SOC, V102, P540, DOI 10.1111/j.1095-8312.2010.01602.x; Tseng ZJ, 2011, PALEOBIOLOGY, V37, P140, DOI 10.1666/09045.1; Tseng ZJ, 2010, J MORPHOL, V271, P1386, DOI 10.1002/jmor.10881; Tseng ZJ, 2010, ZOOL J LINN SOC-LOND, V158, P683, DOI 10.1111/j.1096-3642.2009.00555.x; Tseng ZJ, 2009, BIOL J LINN SOC, V96, P51, DOI 10.1111/j.1095-8312.2008.01095.x; TURNBULL WD, 1970, FIELDIANA GEOLOGY, V18, P149; Wroe S, 2008, J ZOOL, V274, P332, DOI 10.1111/j.1469-7998.2007.00389.x; Wroe S, 2007, P ROY SOC B-BIOL SCI, V274, P2819, DOI 10.1098/rspb.2007.0906; Xing LD, 2009, ACTA GEOL SIN-ENGL, V83, P1031	57	33	33	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19171	10.1371/journal.pone.0019171	http://dx.doi.org/10.1371/journal.pone.0019171			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559475	Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700089
J	Guthoff, M; Stingl, KT; Tschritter, O; Rogic, M; Heni, M; Stingl, K; Hallschmid, M; Haring, HU; Fritsche, A; Preissl, H; Hennige, AM				Guthoff, Martina; Stingl, Krunoslav T.; Tschritter, Otto; Rogic, Maja; Heni, Martin; Stingl, Katarina; Hallschmid, Manfred; Haering, Hans-Ulrich; Fritsche, Andreas; Preissl, Hubert; Hennige, Anita M.			The Insulin-Mediated Modulation of Visually Evoked Magnetic Fields Is Reduced in Obese Subjects	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MULTIMODAL FOOD PERCEPTION; INTRANASAL INSULIN; NEUROCOGNITIVE BASES; IMPROVES MEMORY; BRAIN ACTIVITY; BODY-WEIGHT; HUMANS; LEPTIN; LOCALIZATION	Background: Insulin is an anorexigenic hormone that contributes to the termination of food intake in the postprandial state. An alteration in insulin action in the brain, named "cerebral insulin resistance'', is responsible for overeating and the development of obesity. Methodology/Principal Findings: To analyze the direct effect of insulin on food-related neuronal activity we tested 10 lean and 10 obese subjects. We conducted a magnetencephalography study during a visual working memory task in both the basal state and after applying insulin or placebo spray intranasally to bypass the blood brain barrier. Food and non-food pictures were presented and subjects had to determine whether or not two consecutive pictures belonged to the same category. Intranasal insulin displayed no effect on blood glucose, insulin or C-peptide concentrations in the periphery; however, it led to an increase in the components of evoked fields related to identification and categorization of pictures (at around 170 ms post stimuli in the visual ventral stream) in lean subjects when food pictures were presented. In contrast, insulin did not modulate food-related brain activity in obese subjects. Conclusions/Significance: We demonstrated that intranasal insulin increases the cerebral processing of food pictures in lean whereas this was absent in obese subjects. This study further substantiates the presence of a "cerebral insulin resistance'' in obese subjects and might be relevant in the pathogenesis of obesity.	[Guthoff, Martina; Tschritter, Otto; Heni, Martin; Haering, Hans-Ulrich; Fritsche, Andreas; Hennige, Anita M.] Univ Tubingen, Univ Hosp, Dept Endocrinol & Diabet Angiol Nephrol & Clin Ch, Tubingen, Germany; [Stingl, Krunoslav T.; Rogic, Maja; Preissl, Hubert] Univ Tubingen, MEG Ctr, Tubingen, Germany; [Stingl, Katarina] Univ Tubingen, Ctr Ophthalmol, Tubingen, Germany; [Hallschmid, Manfred] Med Univ Lubeck, Dept Neuroendocrinol, D-23538 Lubeck, Germany; [Preissl, Hubert] Univ Arkansas, Coll Med, Dept Obstet & Gynecol, Little Rock, AR 72205 USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Lubeck; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock	Guthoff, M (corresponding author), Univ Tubingen, Univ Hosp, Dept Endocrinol & Diabet Angiol Nephrol & Clin Ch, Tubingen, Germany.	andreas.fritsche@med.uni-tuebingen.de	Vidaković, Maja Rogić/AAL-3081-2020; Preißl, Hubert/E-9070-2012; Rogić Vidaković, Maja/D-5871-2017; Guthoff, Martina/D-3960-2018	Preißl, Hubert/0000-0002-8859-4661; Rogić Vidaković, Maja/0000-0001-8516-9718; Guthoff, Martina/0000-0002-4294-980X; Heni, Martin/0000-0002-8462-3832	Deutsche Forschungsgemeinschaft [KFO 114 Fr1561/3-3]; German Federal Ministry of Education and Research (BMBF)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was supported by the Deutsche Forschungsgemeinschaft (KFO 114 Fr1561/3-3), and in part by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedict C, 2004, PSYCHONEUROENDOCRINO, V29, P1326, DOI 10.1016/j.psyneuen.2004.04.003; Benedict C, 2007, NEUROENDOCRINOLOGY, V86, P136, DOI 10.1159/000106378; Benedict C, 2007, NEUROPSYCHOPHARMACOL, V32, P239, DOI 10.1038/sj.npp.1301193; Benedict L, 2006, NEUROENDOCRINOLOGY, V83, P20, DOI 10.1159/000093338; Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Chechlacz M, 2009, DIABETOLOGIA, V52, P524, DOI 10.1007/s00125-008-1253-z; Clegg DJ, 2006, DIABETES, V55, P978, DOI 10.2337/diabetes.55.04.06.db05-1339; Cornier MA, 2010, PHYSIOL BEHAV, V99, P538, DOI 10.1016/j.physbeh.2010.01.008; Cornier MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006310; Figlewicz DP, 2009, AM J PHYSIOL-REG I, V296, pR9, DOI 10.1152/ajpregu.90725.2008; Finlayson G, 2007, NEUROSCI BIOBEHAV R, V31, P987, DOI 10.1016/j.neubiorev.2007.03.004; Finlayson G, 2007, PHYSIOL BEHAV, V90, P36, DOI 10.1016/j.physbeh.2006.08.020; Frank TC, 2010, BRAIN RES, V1363, P81, DOI 10.1016/j.brainres.2010.09.071; Fuehrer D, 2008, OBESITY, V16, P945, DOI 10.1038/oby.2008.33; Guthoff M, 2010, J CLIN ENDOCR METAB, V95, P748, DOI 10.1210/jc.2009-1677; Hallschmid M, 2004, DIABETES, V53, P3024, DOI 10.2337/diabetes.53.11.3024; Hennige AM, 2009, DIABETOLOGIA, V52, P2416, DOI 10.1007/s00125-009-1522-5; Henson RN, 2009, NEUROIMAGE, V46, P168, DOI 10.1016/j.neuroimage.2009.01.062; Illum L, 2000, EUR J PHARM SCI, V11, P1, DOI 10.1016/S0928-0987(00)00087-7; Leibowitz SF, 2004, PEPTIDES, V25, P473, DOI 10.1016/j.peptides.2004.02.006; MARKS JL, 1991, ADV EXP MED BIOL, V293, P459; Mattout J, 2006, NEUROIMAGE, V30, P753, DOI 10.1016/j.neuroimage.2005.10.037; Mattout J., 2007, COMPUT INTELL NEUROS; Phillips C, 2005, NEUROIMAGE, V24, P997, DOI 10.1016/j.neuroimage.2004.10.030; Popovic V, 2005, NUTR NEUROSCI, V8, P1, DOI 10.1080/10284150400027107; Porte D, 2005, DIABETES, V54, P1264, DOI 10.2337/diabetes.54.5.1264; Porte D, 1998, DIABETOLOGIA, V41, P863, DOI 10.1007/s001250051002; Porubska K, 2006, NEUROIMAGE, V32, P1273, DOI 10.1016/j.neuroimage.2006.04.216; SCHWARTZ MW, 1990, PEPTIDES, V11, P467, DOI 10.1016/0196-9781(90)90044-6; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Seaquist ER, 2007, J CEREBR BLOOD F MET, V27, P154, DOI 10.1038/sj.jcbfm.9600316; STINGL K, 2010, NEUROIMAGE; Stockburger J, 2008, BEHAV NEUROSCI, V122, P936, DOI 10.1037/a0012517; Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533; Toepel U, 2009, NEUROIMAGE, V44, P967, DOI 10.1016/j.neuroimage.2008.10.005; Tschritter O, 2006, P NATL ACAD SCI USA, V103, P12103, DOI 10.1073/pnas.0604404103; UNGER JW, 1991, PROG NEUROBIOL, V36, P343, DOI 10.1016/0301-0082(91)90015-S; Verhagen JV, 2007, BRAIN RES REV, V53, P271, DOI 10.1016/j.brainresrev.2006.09.002; Verhagen JV, 2006, NEUROSCI BIOBEHAV R, V30, P613, DOI 10.1016/j.neubiorev.2005.11.003; Volkow ND, 2008, NEUROIMAGE, V42, P1537, DOI 10.1016/j.neuroimage.2008.06.002; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; Zhao WQ, 2001, MOL CELL ENDOCRINOL, V177, P125, DOI 10.1016/S0303-7207(01)00455-5	43	42	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19482	10.1371/journal.pone.0019482	http://dx.doi.org/10.1371/journal.pone.0019482			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589921	Green Submitted, Green Published, gold			2022-12-27	WOS:000290483600012
J	Vockel, M; Pollok, S; Breitenbach, U; Ridderbusch, I; Kreienkamp, HJ; Brandner, JM				Vockel, Matthias; Pollok, Simone; Breitenbach, Ute; Ridderbusch, Ina; Kreienkamp, Hans-Juergen; Brandner, Johanna M.			Somatostatin Inhibits Cell Migration and Reduces Cell Counts of Human Keratinocytes and Delays Epidermal Wound Healing in an Ex Vivo Wound Model	PLOS ONE			English	Article							LYSOPHOSPHATIDIC ACID; HUMAN NEUROBLASTOMA; GROWTH-FACTORS; RECEPTOR; ACTIVATION; RAC; EXPRESSION; MOTILITY; PROLIFERATION; CARCINOMA	The peptide hormone somatostatin (SST) and its five G protein-coupled receptors (SSTR1-5) were described to be present in the skin, but their cutaneous function(s) and skin-specific signalling mechanisms are widely unknown. By using receptor specific agonists we show here that the SSTRs expressed in keratinocytes are functionally coupled to the inhibition of adenylate cyclase. In addition, treatment with SSTR4 and SSTR5/1 specific agonists significantly influences the MAP kinase signalling pathway. As epidermal hormone receptors in general are known to regulate re-epithelialization following skin injury, we investigated the effect of SST on cell counts and migration of human keratinocytes. Our results demonstrate a significant inhibition of cell migration and reduction of cell counts by SST. We do not observe an effect on apoptosis and necrosis. Analysis of signalling pathways showed that somatostatin inhibits cell migration independent of its effect on cAMP. Migrating keratinocytes treated with SST show altered cytoskeleton dynamics with delayed lamellipodia formation. Furthermore, the activity of the small GTPase Rac1 is diminished, providing evidence for the control of the actin cytoskeleton by somatostatin receptors in keratinocytes. While activation of all receptors leads to redundant effects on cell migration, only treatment with a SSTR5/1 specific agonist resulted in decreased cell counts. In accordance with reduced cell counts and impaired migration we observe delayed re-epithelialization in an ex vivo wound healing model. Consequently, our experiments suggest SST as a negative regulator of epidermal wound healing.	[Vockel, Matthias; Pollok, Simone; Brandner, Johanna M.] Univ Hosp Hamburg Eppendorf, Dept Dermatol & Venerol, Hamburg, Germany; [Vockel, Matthias; Breitenbach, Ute] Beiersdorf AG, Hamburg, Germany; [Vockel, Matthias; Kreienkamp, Hans-Juergen] Univ Hosp Hamburg Eppendorf, Inst Human Genet, Hamburg, Germany; [Ridderbusch, Ina] Univ Hosp Hamburg Eppendorf, Dept Pediat Surg, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Beiersdorf AG; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Vockel, M (corresponding author), Max Planck Inst Mol Biomed, Munster, Germany.	brandner@uke.de		Kreienkamp, Hans-Jurgen/0000-0002-8871-9970	Beiersdorf AG	Beiersdorf AG	MV was financially supported via a grant to Johanna Brandner and HJK by Beiersdorf AG, but was employed at University Hospital Hamburg-Eppendorf during this study. The grant comprised the salary of MV and consumables. The grant ended in 2009. UB is an employee of Beiersdorf AG. UB, who is employed by the funder, played a role in data analysis. The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript.	Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Bartolome RA, 2008, CANCER RES, V68, P8221, DOI 10.1158/0008-5472.CAN-08-0561; Benali N, 2000, P NATL ACAD SCI USA, V97, P9180, DOI 10.1073/pnas.130196697; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bousquet C, 2004, DIGEST LIVER DIS, V36, pS2, DOI 10.1016/j.dld.2003.11.007; Brandner JM, 2002, EUR J CELL BIOL, V81, P253, DOI 10.1078/0171-9335-00244; Brandner JM., 2006, EWMA J, V6, P11; Cattaneo MG, 2006, MOL CELL ENDOCRINOL, V256, P34, DOI 10.1016/j.mce.2006.05.006; Cattaneo MG, 1996, FEBS LETT, V397, P164, DOI 10.1016/S0014-5793(96)01159-3; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen J, 2002, J INVEST DERMATOL, V119, P1261, DOI 10.1046/j.1523-1747.2002.19611.x; Chernyavsky AI, 2004, J CELL BIOL, V166, P261, DOI 10.1083/jcb.200401034; Christenn M, 2007, FEBS LETT, V581, P5173, DOI 10.1016/j.febslet.2007.10.003; Cordelier P, 1997, P NATL ACAD SCI USA, V94, P9343, DOI 10.1073/pnas.94.17.9343; Csaba Z, 2001, NEUROPEPTIDES, V35, P1, DOI 10.1054/npep.2001.0848; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fantini F, 1995, Exp Dermatol, V4, P365, DOI 10.1111/j.1600-0625.1995.tb00061.x; Gaudillere A, 1997, BRIT J DERMATOL, V137, P376, DOI 10.1111/j.1365-2133.1997.tb03741.x; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; HAEGERSTRAND A, 1989, P NATL ACAD SCI USA, V86, P5993, DOI 10.1073/pnas.86.15.5993; Hagstromer L, 2006, EXP DERMATOL, V15, P950, DOI 10.1111/j.1600-0625.2006.00487.x; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; JOHANSSON O, 1987, NEUROSCI LETT, V73, P225, DOI 10.1016/0304-3940(87)90249-7; Kasper M, 2011, P NATL ACAD SCI USA, V108, P4099, DOI 10.1073/pnas.1014489108; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; Khurana S, 2008, EXP CELL RES, V314, P530, DOI 10.1016/j.yexcr.2007.10.028; Kreienkamp HJ, 1997, FEBS LETT, V419, P92, DOI 10.1016/S0014-5793(97)01437-3; Liew CW, 2009, FEBS LETT, V583, P49, DOI 10.1016/j.febslet.2008.11.048; Liu SX, 2009, AM J PATHOL, V174, P1847, DOI 10.2353/ajpath.2009.080779; Lutz S, 2005, J BIOL CHEM, V280, P11134, DOI 10.1074/jbc.M411322200; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; McCawley LJ, 2000, MOL PHARMACOL, V58, P145, DOI 10.1124/mol.58.1.145; MERINEY SD, 1994, NATURE, V369, P336, DOI 10.1038/369336a0; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; PATEL YC, 1994, BIOCHEM BIOPH RES CO, V198, P605, DOI 10.1006/bbrc.1994.1088; Patel YC, 1999, FRONT NEUROENDOCRIN, V20, P157, DOI 10.1006/frne.1999.0183; PATEL YC, 1994, ENDOCRINOLOGY, V135, P2814, DOI 10.1210/en.135.6.2814; Pola S, 2003, J BIOL CHEM, V278, P40601, DOI 10.1074/jbc.M306510200; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollok S, 2010, J CELL MOL MED; Pullar CE, 2006, FASEB J, V20, P76, DOI 10.1096/fj.05-4188com; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Rohrer SP, 1998, SCIENCE, V282, P737, DOI 10.1126/science.282.5389.737; Sauer B, 2004, J INVEST DERMATOL, V123, P840, DOI 10.1111/j.0022-202X.2004.23458.x; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; SENAPATI A, 1986, NEUROSCI LETT, V71, P101, DOI 10.1016/0304-3940(86)90264-8; Taboubi S, 2007, FASEB J, V21, P4047, DOI 10.1096/fj.06-7476com; Tscharntke M, 2007, J CELL SCI, V120, P1480, DOI 10.1242/jcs.03426; van Leeuwen FN, 2003, J BIOL CHEM, V278, P400, DOI 10.1074/jbc.M210151200; Vockel M, 2010, EXP DERMATOL, V19, P888, DOI 10.1111/j.1600-0625.2010.01101.x; Waddell BE, 1997, AM SURGEON, V63, P446; Weckbecker G, 2003, NAT REV DRUG DISCOV, V2, P999, DOI 10.1038/nrd1255; Wente W, 2005, FEBS LETT, V579, P6305, DOI 10.1016/j.febslet.2005.10.009; Wong SY, 2011, P NATL ACAD SCI USA, V108, P4093, DOI 10.1073/pnas.1013098108; Yamada T, 2005, J BIOL CHEM, V280, P19358, DOI 10.1074/jbc.M414561200; zu Heringdorf DM, 2007, BBA-BIOMEMBRANES, V1768, P923, DOI 10.1016/j.bbamem.2006.09.026	57	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19740	10.1371/journal.pone.0019740	http://dx.doi.org/10.1371/journal.pone.0019740			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589940	Green Published, gold, Green Submitted			2022-12-27	WOS:000290483600028
J	de Abreu, RT; Carvalho, MD; Carneiro, CM; Giunchetti, RC; Teixeira-Carvalho, A; Martins, OA; Coura-Vital, W; Correa-Oliveira, R; Reis, AB				de Abreu, Raquel Tropia; Carvalho, Maria das Gracas; Carneiro, Claudia Martins; Giunchetti, Rodolfo Cordeiro; Teixeira-Carvalho, Andrea; Martins-Filho, Olindo Assis; Coura-Vital, Wendel; Correa-Oliveira, Rodrigo; Reis, Alexandre Barbosa			Influence of Clinical Status and Parasite Load on Erythropoiesis and Leucopoiesis in Dogs Naturally Infected with Leishmania (Leishmania) chagasi	PLOS ONE			English	Article							CANINE VISCERAL LEISHMANIASIS; BONE-MARROW; CIRCULATING LEUKOCYTES; LYMPH-NODE; DENSITY; EOSINOPHILS; PARAMETERS; PATHOLOGY; FEATURES; DONOVANI	Background: The bone marrow is considered to be an important storage of parasites in Leishmania-infected dogs, although little is known about cellular genesis in this organ during canine visceral leishmaniasis (CVL). Methodology/Principal Findings: The aim of the present study was to evaluate changes in erythropoiesis and leucopoiesis in bone marrow aspirates from dogs naturally infected with Leishmania chagasi and presenting different clinical statuses and bone marrow parasite densities. The evolution of CVL from asymptomatic to symptomatic status was accompanied by increasing parasite density in the bone marrow. The impact of bone marrow parasite density on cellularity was similar in dogs at different clinical stages, with animals in the high parasite density group. Erythroid and eosinophilic hypoplasia, proliferation of neutrophilic precursor cells and significant increases in lymphocytes and plasma cell numbers were the major alterations observed. Differential bone marrow cell counts revealed increases in the myeloid: erythroid ratio associated to increased numbers of granulopoietic cells in the different clinical groups compared with non-infected dogs. Conclusions: Analysis of the data obtained indicated that the assessment of bone marrow constitutes an additional and useful tool by which to elaborate a prognosis for CVL.	[de Abreu, Raquel Tropia; Carneiro, Claudia Martins; Coura-Vital, Wendel; Reis, Alexandre Barbosa] Univ Fed Ouro Preto, Lab Imunopatol, Nucleo Pesquisas Ciencias Biol, Dept Anal Clin, Ouro Preto, MG, Brazil; [Carvalho, Maria das Gracas] Univ Fed Minas Gerais, Lab Hematol Clin, Fac Farm, Belo Horizonte, MG, Brazil; [Giunchetti, Rodolfo Cordeiro] Univ Fed Ouro Preto, Lab Imunopatol, Nucleo Pesquisas Ciencias Biol, Dept Ciencias Biol, Ouro Preto, MG, Brazil; [Teixeira-Carvalho, Andrea; Martins-Filho, Olindo Assis] Fundacao Oswaldo Cruz, Lab Biomarcadores Diagnost & Monitoracao, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Giunchetti, Rodolfo Cordeiro; Correa-Oliveira, Rodrigo; Reis, Alexandre Barbosa] Fundacao Oswaldo Cruz, Lab Imunol Celular & Mol, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil	Universidade Federal de Ouro Preto; Universidade Federal de Minas Gerais; Universidade Federal de Ouro Preto; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	de Abreu, RT (corresponding author), Univ Fed Ouro Preto, Lab Imunopatol, Nucleo Pesquisas Ciencias Biol, Dept Anal Clin, Ouro Preto, MG, Brazil.	alexreis@nupeb.ufop.br	Coura-Vital, Wendel/AAP-9624-2021; Reis, Alexandre Barbosa/I-9945-2014; carneiro, Claudia Martins/AAP-4455-2020; Carvalho, Maria das Graças/AAY-1619-2021; carneiro, claudia m/B-6205-2013; Martins-Filho, Olindo Assis/ABE-6278-2021; Giunchetti, Rodolfo/O-9878-2014	Reis, Alexandre Barbosa/0000-0001-8123-4164; carneiro, Claudia Martins/0000-0002-6002-857X; Martins-Filho, Olindo Assis/0000-0002-5494-4889; /0000-0002-1434-7676; Cordeiro Giunchetti, Rodolfo/0000-0003-4181-7546; Correa-Oliveira, Rodrigo/0000-0001-6419-9459	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG/CNPq/PRONEX)	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG/CNPq/PRONEX)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	The study was supported by the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG/CNPq/PRONEX 2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRANCHES P, 1991, PARASITE IMMUNOL, V13, P537, DOI 10.1111/j.1365-3024.1991.tb00550.x; Amusategui I, 2003, EUR J EPIDEMIOL, V18, P147, DOI 10.1023/A:1023090929302; ANOSA VO, 1983, ZBL VET MED B, V30, P600; Barrouin-Melo SM, 2004, MEM I OSWALDO CRUZ, V99, P195, DOI 10.1590/S0074-02762004000200014; Bourdoiseau G, 1997, VET IMMUNOL IMMUNOP, V56, P345, DOI 10.1016/S0165-2427(96)05768-6; CARDOSO L, 1998, REV PORT C, V93, P122; CERVIA JS, 1993, INFECT IMMUN, V61, P1330, DOI 10.1128/IAI.61.4.1330-1333.1993; Coterell SEJ, 2000, INFECT IMMUN, V68, P1840, DOI 10.1128/IAI.68.4.1840-1848.2000; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Giunchetti RC, 2006, J COMP PATHOL, V135, P100, DOI 10.1016/j.jcpa.2006.06.005; Giunchetti RC, 2008, VET IMMUNOL IMMUNOP, V121, P23, DOI 10.1016/j.vetimm.2007.07.009; Giunchetti RC, 2008, RES VET SCI, V84, P269, DOI 10.1016/j.rvsc.2007.04.020; Guerra LL, 2009, PARASITOL RES, V104, P611, DOI 10.1007/s00436-008-1237-4; HOFF B, 1985, CAN J COMP MED, V49, P34; Jain NC, 1986, SCHALMS VET HEMATOLO, P8; KEENAN CM, 1984, VET PATHOL, V21, P74, DOI 10.1177/030098588402100113; MANCIANTI F, 1988, T ROY SOC TROP MED H, V82, P566, DOI 10.1016/0035-9203(88)90510-X; Manzillo VF, 2006, VET REC, V158, P690, DOI 10.1136/vr.158.20.690; MARTINEZMORENO A, 1993, VET PARASITOL, V51, P49, DOI 10.1016/0304-4017(93)90195-S; MIRKOVICH AM, 1986, CLIN EXP IMMUNOL, V64, P1; Mischke R, 2002, J VET MED A, V49, P499, DOI 10.1046/j.1439-0442.2002.00491.x; MOLINA R, 1994, T ROY SOC TROP MED H, V88, P491, DOI 10.1016/0035-9203(94)90446-4; MURRAY HW, 1995, J CLIN INVEST, V95, P1183, DOI 10.1172/JCI117767; Oliveira SHP, 1997, MEM I OSWALDO CRUZ, V92, P233, DOI 10.1590/S0074-02761997000800034; PEARSON RD, 1987, ANN TROP MED PARASIT, V81, P735, DOI 10.1080/00034983.1987.11812179; PENNY RHC, 1974, J SMALL ANIM PRACT, V15, P553, DOI 10.1111/j.1748-5827.1974.tb06535.x; Reis AB, 2006, CLIN EXP IMMUNOL, V146, P303, DOI 10.1111/j.1365-2249.2006.03206.x; Reis AB, 2006, VET IMMUNOL IMMUNOP, V112, P102, DOI 10.1016/j.vetimm.2006.02.001; Reis AB, 2006, RES VET SCI, V81, P68, DOI 10.1016/j.rvsc.2005.09.011; Reis AB, 2009, VET IMMUNOL IMMUNOP, V128, P87, DOI 10.1016/j.vetimm.2008.10.307; Sanchez MA, 2004, AM J TROP MED HYG, V70, P618, DOI 10.4269/ajtmh.2004.70.618; Travlos GS, 2006, TOXICOL PATHOL, V34, P548, DOI 10.1080/01926230600939856; TRYPHONAS L, 1977, CAN J COMP MED, V41, P1; Vieira J B, 1998, Rev Soc Bras Med Trop, V31 Suppl 2, P85; YAMAGUCHI RA, 1983, J AM ANIM HOSP ASSOC, V19, P723	35	23	23	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e18873	10.1371/journal.pone.0018873	http://dx.doi.org/10.1371/journal.pone.0018873			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572995	Green Published, gold			2022-12-27	WOS:000290440200004
J	Dittmar, K; Morse, S; Gruwell, M; Mayberry, J; DiBlasi, E				Dittmar, Katharina; Morse, Solon; Gruwell, Matthew; Mayberry, Jason; DiBlasi, Emily			Spatial and Temporal Complexities of Reproductive Behavior and Sex Ratios: A Case from Parasitic Insects	PLOS ONE			English	Article							BAT FLIES DIPTERA; PHYLOGENETIC ANALYSIS; LICE INSECTA; ECOLOGY; STREBLIDAE; SELECTION; COMPETITION; CHIROPTERA; MORTALITY; EVOLUTION	Background: Sex ratios are important empirical data in predicting sex allocation strategy and selection in populations. Therefore, they should be sampled at crucial developmental steps before and after parental investment. In parasites with free-living (off-host) developmental stages the timing and method of sampling is not trivial, because ecological niches are frequently poorly known. Consequently, information is scarce for sex ratios of these parasites between conception and sexual maturity. Often, only data from adult parasites are available, which usually were collected from the parasite's hosts. Generally, these ratios are assumed to represent operational sex ratios. Methodology/Principal Findings: We here report three years of empirical data on population sex differentials from a bat ectoparasite (Trichobius frequens) with off-host developmental stages. At emergence these parasites exhibit a significant and seasonally stable female biased sex ratio. This bias is lost in the adult population on the roosting host, which shows sex ratios at equality. This is best explained by a behaviorally driven, sex-dependent mortality differential. Because consistently only subsets of females are available to mate, the operational sex ratio in the population is likely male biased. Host capture experiments throughout the day show a statistically significant, but temporary male excess in bat flies on foraging bats. This phenomenon is partly driven by the diurnal rhythms of female larviposition, and partly due to parasites remaining in the bat roost during foraging. Because most previous research in bat flies is based only on foraging bats, female contributions to physical sex ratios have been underestimated. Conclusion/Significance: Our results highlight the importance of detailed natural history observations, and emphasize that ignoring the spatial and temporal heterogeneity of reproduction in any organism will lead to significant empirical sampling errors of sex ratios, and may obscure operational sex ratios.	[Dittmar, Katharina; Morse, Solon; Gruwell, Matthew; Mayberry, Jason; DiBlasi, Emily] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA; [Dittmar, Katharina; Morse, Solon; Gruwell, Matthew; Mayberry, Jason; DiBlasi, Emily] SUNY Buffalo, Grad Program Ecol Evolut & Behav, Buffalo, NY 14260 USA; [Gruwell, Matthew] Penn State Univ, Behrend Coll, Erie, PA 16563 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Dittmar, K (corresponding author), SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	katharinad@gmail.com			SUNY Buffalo; National Science Foundation [NSF DEB 0744628]; Direct For Biological Sciences [0743491] Funding Source: National Science Foundation	SUNY Buffalo; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Research related to this publication was funded by SUNY Buffalo, and the National Science Foundation through a grant awarded to KD, NSF DEB 0744628, nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL JF, 1962, EXP PARASITOL, V12, P176, DOI 10.1016/0014-4894(62)90055-3; CHARNOV E L, 1982; Ching L., 1968, MALAY NAT J, V21, P171; CLAYTON DH, 1992, J ANIM ECOL, V61, P781, DOI 10.2307/5631; Clayton DH, 1999, AM NAT, V154, P261, DOI 10.1086/303237; Codd JR, 2003, AUST J ZOOL, V51, P307, DOI 10.1071/ZO01079; COTGREAVE P, 1994, BEHAVIOUR, V131, P171, DOI 10.1163/156853994X00424; Dick CW, 2008, EVOL ECOL, V22, P757, DOI 10.1007/s10682-007-9201-9; Dick CW, 2006, MICROMAMMALS AND MACROPARASITES: FROM EVOLUTIONARY ECOLOGY TO MANAGEMENT, P179, DOI 10.1007/978-4-431-36025-4_11; DICK CW, 2005, THESIS TEXAS TU; Dittmar K, 2006, MOL PHYLOGENET EVOL, V38, P155, DOI 10.1016/j.ympev.2005.06.008; Dittmar Katharina, 2010, Speleobiology Notes, V2, P12; Dittmar K, 2009, J PARASITOL, V95, P308, DOI 10.1645/GE-1664.1; Dusing C, 1883, JENA Z NATURWISS, V16, P428; Fisher RA, 1930, GENETICAL THEORY NAT; FRITZ GN, 1983, J MED ENTOMOL, V20, P1, DOI 10.1093/jmedent/20.1.1; GHERNA RL, 1991, INT J SYST BACTERIOL, V41, P563, DOI 10.1099/00207713-41-4-563; Graciolli G, 2006, ZOOTAXA, P35, DOI 10.11646/zootaxa.1220.1.3; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; HURST LD, 1991, P ROY SOC B-BIOL SCI, V244, P91, DOI 10.1098/rspb.1991.0056; Kapranas A, 2011, J ANIM ECOL, V80, P192, DOI 10.1111/j.1365-2656.2010.01767.x; Kim K. C., 1985, Coevolution of parasitic arthropods and mammals, P3; Koga R, 2009, APPL ENTOMOL ZOOL, V44, P281, DOI 10.1303/aez.2009.281; Kvarnemo C, 1996, TRENDS ECOL EVOL, V11, P404, DOI 10.1016/0169-5347(96)10056-2; LEIGH EG, 1970, AM NAT, V104, P205, DOI 10.1086/282650; MAA TC, 1987, MANUAL NEARCTIC DIPT, V2, P1271; MADSEN T, 1993, AM NAT, V141, P167, DOI 10.1086/285467; MARSHALL AG, 1981, ECOL ENTOMOL, V6, P155, DOI 10.1111/j.1365-2311.1981.tb00602.x; MARSHALL AG, 1981, ECOLOGY ECTOPARASITI; Murray KL, 2008, J MAMMAL, V89, P1391, DOI 10.1644/08-MAMM-S-068.1; MURRAY M. D., 1961, AUSTRALIAN JOUR ZOOL, V9, P1, DOI 10.1071/ZO9610001; Oliveira RF, 1999, J FISH BIOL, V54, P499, DOI 10.1006/jfbi.1998.0886; OVERAL W L, 1980, University of Kansas Science Bulletin, V52, P1; OVERAL WL, 1980, THESIS U KANSAS; Petersen FT, 2007, MOL PHYLOGENET EVOL, V45, P111, DOI 10.1016/j.ympev.2007.04.023; PETERSON BV, 1974, CAN ENTOMOL, V106, P1049, DOI 10.4039/Ent1061049-10; REYNOLDS JD, 1986, BEHAV ECOL SOCIOBIOL, V18, P303, DOI 10.1007/BF00300008; Rozsa L, 1996, J ANIM ECOL, V65, P242, DOI 10.2307/5727; Rozsa L, 1997, J PARASITOL, V83, P543, DOI 10.2307/3284430; Trowbridge RE, 2006, J INVERTEBR PATHOL, V91, P64, DOI 10.1016/j.jip.2005.08.009; Walter DE, 2003, BIOL CONTROL, V26, P253, DOI 10.1016/S1049-9644(02)00171-8; WENZEL RL, 1976, BRIGH YOUNG U SCI, V20, P1; West SA, 2005, EVOLUTION, V59, P1211; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; West SA, 2009, MONOGR POPUL BIOL, V44, P162; Winchell JM, 1996, CAN J ZOOL, V74, P431, DOI 10.1139/z96-050	46	33	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19438	10.1371/journal.pone.0019438	http://dx.doi.org/10.1371/journal.pone.0019438			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572996	Green Published, Green Submitted, gold			2022-12-27	WOS:000290440200008
J	Bwanga, F; Haile, M; Joloba, ML; Ochom, E; Hoffner, S				Bwanga, Freddie; Haile, Melle; Joloba, Moses L.; Ochom, Emmanuel; Hoffner, Sven			Direct Nitrate Reductase Assay versus Microscopic Observation Drug Susceptibility Test for Rapid Detection of MDR-TB in Uganda	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS RESISTANCE; SPUTUM SAMPLES; RIFAMPIN; CULTURE	The most common method for detection of drug resistant (DR) TB in resource-limited settings (RLSs) is indirect susceptibility testing on Lowenstein-Jensen medium (LJ) which is very time consuming with results available only after 23 months. Effective therapy of DR TB is therefore markedly delayed and patients can transmit resistant strains. Rapid and accurate tests suitable for RLSs in the diagnosis of DR TB are thus highly needed. In this study we compared two direct techniques - Nitrate Reductase Assay (NRA) and Microscopic Observation Drug Susceptibility (MODS) for rapid detection of MDR-TB in a high burden RLS. The sensitivity, specificity, and proportion of interpretable results were studied. Smear positive sputum was collected from 245 consecutive re-treatment TB patients attending a TB clinic in Kampala, Uganda. Samples were processed at the national reference laboratory and tested for susceptibility to rifampicin and isoniazid with direct NRA, direct MODS and the indirect LJ proportion method as reference. A total of 229 specimens were confirmed as M. tuberculosis, of these interpretable results were obtained in 217 (95%) with either the NRA or MODS. Sensitivity, specificity and kappa agreement for MDR-TB diagnosis was 97%, 98% and 0.93 with the NRA; and 87%, 95% and 0.78 with the MODS, respectively. The median time to results was 10, 7 and 64 days with NRA, MODS and the reference technique, respectively. The cost of laboratory supplies per sample was low, around 5 USD, for the rapid tests. The direct NRA and MODS offered rapid detection of resistance almost eight weeks earlier than with the reference method. In the study settings, the direct NRA was highly sensitive and specific. We consider it to have a strong potential for timely detection of MDR-TB in RLS.	[Bwanga, Freddie; Joloba, Moses L.; Ochom, Emmanuel] Makerere Univ, Dept Med Microbiol, Sch Biomed Sci, Coll Hlth Sci, Kampala, Uganda; [Bwanga, Freddie; Haile, Melle; Hoffner, Sven] Swedish Inst Communicable Dis Control, Dept Bacteriol, Solna, Sweden; [Bwanga, Freddie; Hoffner, Sven] Karolinska Inst, Dept Microbiol Tumour & Cell Biol, Stockholm, Sweden	Makerere University; Swedish Institute for Infectious Disease Control; Karolinska Institutet	Bwanga, F (corresponding author), Makerere Univ, Dept Med Microbiol, Sch Biomed Sci, Coll Hlth Sci, Kampala, Uganda.	sven.hoffner@smi.se		Joloba, Moses/0000-0002-0334-9983; EMMANUEL, OCHOM/0000-0003-0999-3275	Swedish International Development Agency (Sida/SAREC)	Swedish International Development Agency (Sida/SAREC)	The study was supported by a grant from the Swedish International Development Agency (Sida/SAREC) (www.sida.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolabi D, 2008, J CLIN MICROBIOL, V46, P3243, DOI 10.1128/JCM.00083-08; Affolabi D, 2007, J CLIN MICROBIOL, V45, P2123, DOI 10.1128/JCM.00691-07; Albert H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-41; Angeby KAK, 2002, J CLIN MICROBIOL, V40, P553, DOI 10.1128/JCM.40.2.553-555.2002; Ani AE, 2009, J INFECT DEV COUNTR, V3, P16, DOI 10.3855/jidc.100; Brady Mark F, 2008, J Vis Exp, DOI 10.3791/845; Bwanga F, 2010, INT J TUBERC LUNG D, V14, P890; Bwanga F, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-67; CANETTI G, 1963, B WORLD HEALTH ORGAN, V29, P565; Carley S, 2005, EMERG MED J, V22, P180, DOI 10.1136/emj.2003.011148; *INN NV, 2009, INNO LIPARIFTBASSAY; KUBICA GP, 1963, AM REV RESPIR DIS, V87, P775; Laszlo A, 2003, WHOCDSCSRRMD20033; Maher D, 2006, INT J TUBERC LUNG D, V10, P240; Mello FCQ, 2007, J CLIN MICROBIOL, V45, P3387, DOI 10.1128/JCM.00580-07; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; RASTOGI N, 1989, RES MICROBIOL, V140, P419, DOI 10.1016/0923-2508(89)90017-X; Shikama MD, 2009, J ANTIMICROB CHEMOTH, V64, P794, DOI 10.1093/jac/dkp284; Solis LA, 2005, INT J TUBERC LUNG D, V9, P760; Visalakshi P, 2010, DIAGN MICR INFEC DIS, V66, P148, DOI 10.1016/j.diagmicrobio.2009.09.008; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; *WHO, 2005, WHOCDSCSRLYO200522; WHO, 2009, WHOHTMTB2009411; *WHO, 2010, NONC CULT DRUG DRUG; World Health Organization, 2008, MOL LIN PROB ASS RAP; World Health Organization, 2008, WHOHTMTB2008402; World Health Organization (WHO), 1998, LAB SERVICES TUBERCU; Wright A., 2006, Morbidity and Mortality Weekly Report, V55, P301; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7; Zimic M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009577; 2009, HAINLIFESCIENCE GENO	31	16	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19565	10.1371/journal.pone.0019565	http://dx.doi.org/10.1371/journal.pone.0019565			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573015	Green Published, Green Submitted, gold			2022-12-27	WOS:000290386800018
J	Lo, ATS; Salam, NK; Hibbs, DE; Rutledge, PJ; Todd, MH				Lo, Anthony T. S.; Salam, Noeris K.; Hibbs, David E.; Rutledge, Peter J.; Todd, Matthew H.			Polyamide-Scorpion Cyclam Lexitropsins Selectively Bind AT-Rich DNA Independently of the Nature of the Coordinated Metal	PLOS ONE			English	Article							MINOR-GROOVE-BINDING; PYRROLE-IMIDAZOLE POLYAMIDES; COPPER-CHELATING PEPTIDE; CROSS-LINKED POLYAMIDES; DOUBLE-STRANDED DNA; DISTAMYCIN ANALOGS; HAIRPIN POLYAMIDE; MOLECULAR RECOGNITION; CENTER-DOT; TRANSCRIPTION FACTORS	Cyclam was attached to 1-, 2- and 3-pyrrole lexitropsins for the first time through a synthetically facile copper-catalyzed "click" reaction. The corresponding copper and zinc complexes were synthesized and characterized. The ligand and its complexes bound AT-rich DNA selectively over GC-rich DNA, and the thermodynamic profile of the binding was evaluated by isothermal titration calorimetry. The metal, encapsulated in a scorpion azamacrocyclic complex, did not affect the binding, which was dominated by the organic tail.	[Salam, Noeris K.] Schrodinger Inc, New York, NY USA; [Lo, Anthony T. S.; Rutledge, Peter J.; Todd, Matthew H.] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia; [Hibbs, David E.] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Lo, ATS (corresponding author), Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia.	matthew.todd@sydney.edu.au	Rutledge, Peter J/D-6253-2012; Todd, Matthew/S-2678-2018	Lo, Anthony/0000-0002-5921-9854; Rutledge, Peter/0000-0002-0767-5196; Todd, Matthew/0000-0001-7096-4751	University of Sydney	University of Sydney(University of Sydney)	This work was supported by the University of Sydney, via a Major Equipment Grant for the purchase of the isothermal titration calorimeter. Schrodinger, Inc. provided software and hardware used for the generation of Figure 5. The funders had no other role in study design, data collection, decision to publish, or preparation of the manuscript.	Aoki S, 2004, CHEM REV, V104, P769, DOI 10.1021/cr020617u; BAILLY C, 1992, BIOCONJUGATE CHEM, V3, P100, DOI 10.1021/bc00014a002; Bailly C, 1998, BIOCONJUGATE CHEM, V9, P513, DOI 10.1021/bc980008m; Baraldi PG, 2000, BIOORG MED CHEM LETT, V10, P1397, DOI 10.1016/S0960-894X(00)00250-X; Baraldi PG, 2004, MED RES REV, V24, P475, DOI 10.1002/med.20000; Baraldi PG, 2007, BIOORGAN MED CHEM, V15, P17, DOI 10.1016/j.bmc.2006.07.004; BERMAN HM, 1994, CURR OPIN STRUC BIOL, V4, P345, DOI 10.1016/S0959-440X(94)90102-3; Bhattacharya S, 2000, TETRAHEDRON LETT, V41, P5571, DOI 10.1016/S0040-4039(00)00802-9; Boerner LJK, 2005, CURR OPIN CHEM BIOL, V9, P135, DOI 10.1016/j.cbpa.2005.02.010; Boger DL, 2000, J AM CHEM SOC, V122, P6382, DOI 10.1021/ja994192d; BRESLAUER KJ, 1987, P NATL ACAD SCI USA, V84, P8922, DOI 10.1073/pnas.84.24.8922; Brown T, 2007, BIOORGAN MED CHEM, V15, P474, DOI 10.1016/j.bmc.2006.09.037; BRUICE TC, 1992, P NATL ACAD SCI USA, V89, P1700, DOI 10.1073/pnas.89.5.1700; Buchmueller KL, 2006, BIOCHEMISTRY-US, V45, P13551, DOI 10.1021/bi061245c; Buchmueller KL, 2005, CHEMBIOCHEM, V6, P2305, DOI 10.1002/cbic.200500179; Buchmueller KL, 2005, J AM CHEM SOC, V127, P742, DOI 10.1021/ja044359p; BUCKIN VA, 1989, NATURE, V340, P321, DOI 10.1038/340321a0; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chaires JB, 2008, ANNU REV BIOPHYS, V37, P135, DOI 10.1146/annurev.biophys.36.040306.132812; Chaires JB, 2006, ARCH BIOCHEM BIOPHYS, V453, P26, DOI 10.1016/j.abb.2006.03.027; CHALIKIAN TV, 1994, BIOCHEMISTRY-US, V33, P8629, DOI 10.1021/bi00195a003; CHEN X, 1994, NAT STRUCT BIOL, V1, P169, DOI 10.1038/nsb0394-169; DERVAN PB, 1986, SCIENCE, V232, P464, DOI 10.1126/science.2421408; Dervan PB, 2003, CURR OPIN STRUC BIOL, V13, P284, DOI 10.1016/S0959-440X(03)00081-2; Dervan PB, 1999, CURR OPIN CHEM BIOL, V3, P688, DOI 10.1016/S1367-5931(99)00027-7; Dervan PB, 2001, BIOORGAN MED CHEM, V9, P2215, DOI 10.1016/S0968-0896(01)00262-0; Dolenc J, 2006, BIOPHYS J, V91, P1460, DOI 10.1529/biophysj.105.074617; Dudouet B, 2003, CHEM BIOL, V10, P859, DOI 10.1016/j.chembiol.2003.09.001; FAGAN P, 1992, J AM CHEM SOC, V114, P1080, DOI 10.1021/ja00029a042; Fishleigh RV, 2000, J MED CHEM, V43, P3257, DOI 10.1021/jm990620e; Gallicchio E, 1998, J AM CHEM SOC, V120, P4526, DOI 10.1021/ja974061h; Gallmeier HC, 2003, EUR J ORG CHEM, V2003, P3473, DOI 10.1002/ejoc.200300096; GILLI P, 1994, J PHYS CHEM-US, V98, P1515, DOI 10.1021/j100056a024; GRIFFIN JH, 1987, J AM CHEM SOC, V109, P6840, DOI 10.1021/ja00256a043; Hashimoto S, 2000, CHEM PHARM BULL, V48, P603; Hawkins CA, 2000, J AM CHEM SOC, V122, P5235, DOI 10.1021/ja0001198; Hegg EL, 1998, COORDIN CHEM REV, V173, P133, DOI 10.1016/S0010-8545(98)00157-X; HUANG L, 1993, BIOORG MED CHEM LETT, V3, P1751, DOI 10.1016/S0960-894X(00)80056-6; HUANG LR, 1995, BIOCONJUGATE CHEM, V6, P21, DOI 10.1021/bc00031a003; Hurley AL, 2001, ORG LETT, V3, P2761, DOI 10.1021/ol0163676; Iida H, 1999, CURR OPIN BIOTECH, V10, P29, DOI 10.1016/S0958-1669(99)80006-8; Izatt R.M., 1989, CHEM MACROCYCLIC LIG, Vviii, DOI 10.1126/science.246.4932.942.a; Jaramillo D, 2004, J ORG CHEM, V69, P8151, DOI 10.1021/jo048686r; Jaramillo D, 2006, INORG CHEM, V45, P6004, DOI 10.1021/ic060383n; Khalaf AI, 2004, J MED CHEM, V47, P2133, DOI 10.1021/jm031089x; Koh JT, 2007, ACS CHEM BIOL, V2, P599, DOI 10.1021/cb700183s; KOIKE T, 1991, J AM CHEM SOC, V113, P8935, DOI 10.1021/ja00023a048; KOPKA ML, 1985, P NATL ACAD SCI USA, V82, P1376, DOI 10.1073/pnas.82.5.1376; Lacy ER, 2002, J AM CHEM SOC, V124, P2153, DOI 10.1021/ja016154b; Lah J, 2004, J MOL BIOL, V342, P73, DOI 10.1016/j.jmb.2004.07.005; Lah J, 2000, BIOCHEMISTRY-US, V39, P9317, DOI 10.1021/bi000748u; Lansiaux A, 2002, J MED CHEM, V45, P1994, DOI 10.1021/jm010539n; Lee LW, 2010, J BIOL CHEM, V285, P11033, DOI 10.1074/jbc.R109.075044; LEE M, 1988, J AM CHEM SOC, V110, P3641, DOI 10.1021/ja00219a045; Li C, 2008, BIOORG MED CHEM LETT, V18, P5766, DOI 10.1016/j.bmcl.2008.09.074; Liang XY, 2004, CHEM SOC REV, V33, P246, DOI 10.1039/b313659k; Liu B, 2009, J MED CHEM, V52, P4604, DOI 10.1021/jm9002999; Liu D, 2006, BIOORG MED CHEM LETT, V16, P5032, DOI 10.1016/j.bmcl.2006.07.049; Lown J. William, 1994, Journal of Molecular Recognition, V7, P79, DOI 10.1002/jmr.300070205; MACCARTHY P, 1978, ANAL CHEM, V50, P2165, DOI 10.1021/ac50036a059; Mapp AK, 2000, P NATL ACAD SCI USA, V97, P3930, DOI 10.1073/pnas.97.8.3930; MARKY LA, 1987, P NATL ACAD SCI USA, V84, P4359, DOI 10.1073/pnas.84.13.4359; Marques MA, 2002, HELV CHIM ACTA, V85, P4485, DOI 10.1002/hlca.200290024; Melander C, 2004, J BIOTECHNOL, V112, P195, DOI 10.1016/j.jbiotec.2004.03.018; MICHELONI M, 1978, J CHEM SOC PERK T 2, P828, DOI 10.1039/p29780000828; MISRA VK, 1994, J MOL BIOL, V238, P245, DOI 10.1006/jmbi.1994.1285; Murty MSRC, 2004, BIOL PHARM BULL, V27, P468, DOI 10.1248/bpb.27.468; Neamati N, 1998, MOL PHARMACOL, V54, P280, DOI 10.1124/mol.54.2.280; Neidle S, 2001, NAT PROD REP, V18, P291, DOI 10.1039/a705982e; Nguyen B, 2009, ACCOUNTS CHEM RES, V42, P11, DOI 10.1021/ar800016q; NIKOLAEV VA, 1993, MOL BIOL+, V27, P117; O'Hare CC, 2002, P NATL ACAD SCI USA, V99, P72, DOI 10.1073/pnas.012588799; OTSUKA M, 1990, J AM CHEM SOC, V112, P838, DOI 10.1021/ja00158a052; OWA T, 1992, TETRAHEDRON, V48, P1193, DOI 10.1016/S0040-4020(01)90783-5; Parkinson JA, 2009, HELV CHIM ACTA, V92, P795, DOI 10.1002/hlca.200800390; PASSADORE M, 1995, BIOCHEM J, V308, P513, DOI 10.1042/bj3080513; PATEL DJ, 1982, P NATL ACAD SCI-BIOL, V79, P6424, DOI 10.1073/pnas.79.21.6424; PELTON JG, 1989, P NATL ACAD SCI USA, V86, P5723, DOI 10.1073/pnas.86.15.5723; Pilch DS, 1999, BIOCHEMISTRY-US, V38, P2143, DOI 10.1021/bi982628g; Pitie M, 2000, BIOCONJUGATE CHEM, V11, P892, DOI 10.1021/bc000050t; PJURA PE, 1987, J MOL BIOL, V197, P257, DOI 10.1016/0022-2836(87)90123-9; Ramana AV, 2008, BIOORG MED CHEM LETT, V18, P3007, DOI 10.1016/j.bmcl.2008.03.045; Reddy BSP, 1999, PHARMACOL THERAPEUT, V84, P1, DOI 10.1016/S0163-7258(99)00021-2; RENTZEPERIS D, 1995, BIOCHEMISTRY-US, V34, P2937, DOI 10.1021/bi00009a025; RODRIGUEZ M, 1992, INORG CHEM, V31, P1129, DOI 10.1021/ic00033a004; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Routier S, 1997, BIOORG MED CHEM LETT, V7, P1729, DOI 10.1016/S0960-894X(97)00299-0; Satz AL, 2002, ACCOUNTS CHEM RES, V35, P86, DOI 10.1021/ar0101032; Satz AL, 2001, J AM CHEM SOC, V123, P2469, DOI 10.1021/ja003095d; SCHULTZ PG, 1982, J AM CHEM SOC, V104, P6861; Seio K, 2005, J ORG CHEM, V70, P10311, DOI 10.1021/jo051247n; Sharma SK, 2000, J ORG CHEM, V65, P1102, DOI 10.1021/jo991571g; Simon P, 2008, NUCLEIC ACIDS RES, V36, P3531, DOI 10.1093/nar/gkn231; Spitzer GM, 2008, CHEMPHYSCHEM, V9, P2766, DOI 10.1002/cphc.200800647; Suckling CJ, 2008, J PHYS ORG CHEM, V21, P575, DOI 10.1002/poc.1323; Supekova L, 2002, CHEM BIOL, V9, P821, DOI 10.1016/S1074-5521(02)00174-6; Surovaya AN, 1999, MOL BIOL+, V33, P539; Taleb RI, 2007, CHEM-EUR J, V13, P3177, DOI 10.1002/chem.200601486; Tamanini E, 2010, INORG CHEM, V49, P3789, DOI 10.1021/ic901939x; Tamanini E, 2009, CHEM-EUR J, V15, P3720, DOI 10.1002/chem.200802425; Tamanini E, 2009, INORG CHEM, V48, P319, DOI 10.1021/ic8017634; Tanious FA, 2004, J AM CHEM SOC, V126, P143, DOI 10.1021/ja030403+; Thomas M, 2002, EUR J ORG CHEM, V2002, P3604; Tietze LF, 2003, ANGEW CHEM INT EDIT, V42, P3996, DOI 10.1002/anie.200200553; Trauger JW, 1996, NATURE, V382, P559, DOI 10.1038/382559a0; Treesuwan W, 2009, PHYS CHEM CHEM PHYS, V11, P10682, DOI 10.1039/b910574c; Tse WC, 2004, CHEM BIOL, V11, P1607, DOI 10.1016/j.chembiol.2003.08.012; Urbach AR, 2001, P NATL ACAD SCI USA, V98, P4343, DOI 10.1073/pnas.081070798; Vazquez ME, 2003, CHEM SOC REV, V32, P338, DOI 10.1039/b206274g; Vazquez O, 2007, ANGEW CHEM INT EDIT, V46, P6886, DOI 10.1002/anie.200702345; Vazquez O, 2008, CHEMBIOCHEM, V9, P2822, DOI 10.1002/cbic.200800345; WADE WS, 1992, J AM CHEM SOC, V114, P8783, DOI 10.1021/ja00049a006; Walker WL, 1997, BIOPOLYMERS, V44, P323, DOI 10.1002/(SICI)1097-0282(1997)44:4<323::AID-BIP2>3.0.CO;2-0; Weber PC, 2003, CURR OPIN STRUC BIOL, V13, P115, DOI 10.1016/S0959-440X(03)00003-4; Wemmer DE, 2000, ANNU REV BIOPH BIOM, V29, P439, DOI 10.1146/annurev.biophys.29.1.439; Wender PA, 2003, BIOORG MED CHEM LETT, V13, P1763, DOI 10.1016/S0960-894X(03)00212-9; Westrate L, 2009, BIOCHEMISTRY-US, V48, P5679, DOI 10.1021/bi900242t; White S, 1998, NATURE, V391, P468, DOI 10.1038/35106; White S, 1996, BIOCHEMISTRY-US, V35, P12532, DOI 10.1021/bi960744i; Xiao XS, 2007, ANGEW CHEM INT EDIT, V46, P2865, DOI 10.1002/anie.200604485; Yang YW, 1996, BIOCONJUGATE CHEM, V7, P670, DOI 10.1021/bc960065k; YOUNGQUIST RS, 1985, P NATL ACAD SCI USA, V82, P2565, DOI 10.1073/pnas.82.9.2565; Zhu YY, 2009, J PHYS CHEM B, V113, P839, DOI 10.1021/jp8091545; ZIMMER C, 1979, NUCLEIC ACIDS RES, V6, P2831, DOI 10.1093/nar/6.8.2831; ZIMMER C, 1986, PROG BIOPHYS MOL BIO, V47, P31, DOI 10.1016/0079-6107(86)90005-2	125	12	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e17446	10.1371/journal.pone.0017446	http://dx.doi.org/10.1371/journal.pone.0017446			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573061	Green Published, Green Submitted, gold			2022-12-27	WOS:000290386800001
J	Fassan, M; D'Arca, D; Letko, J; Vecchione, A; Gardiman, MP; McCue, P; Wildemore, B; Rugge, M; Shupp-Byrne, D; Gomella, LG; Morrione, A; Iozzo, RV; Baffa, R				Fassan, Matteo; D'Arca, Domenico; Letko, Juraj; Vecchione, Andrea; Gardiman, Marina P.; McCue, Peter; Wildemore, Bernadette; Rugge, Massimo; Shupp-Byrne, Dolores; Gomella, Leonard G.; Morrione, Andrea; Iozzo, Renato V.; Baffa, Raffaele			Mitostatin Is Down-Regulated in Human Prostate Cancer and Suppresses the Invasive Phenotype of Prostate Cancer Cells	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; GROWTH-FACTOR RECEPTOR; TUMOR-SUPPRESSOR; DECORIN GENE; CHROMOSOMAL IMBALANCES; ENDOTHELIAL-CELLS; BLADDER-CANCER; MIGRATION; CARCINOMA; EXPRESSION	MITOSTATIN, a novel putative tumor suppressor gene induced by decorin overexpression, is expressed in most normal human tissues but is markedly down-regulated in advanced stages of mammary and bladder carcinomas. Mitostatin negatively affects cell growth, induces cell death and regulates the expression and activation levels of Hsp27. In this study, we demonstrated that ectopic expression of Mitostatin in PC3, DU145, and LNCaP prostate cancer cells not only induced a significant reduction in cell growth, but also inhibited migration and invasion. Moreover, Mitostatin inhibited colony formation in soft-agar of PC3 and LNCaP cells as well as tumorigenicity of LNCaP cells in nude mice. Conversely, targeting endogenous Mitostatin by siRNA and anti-sense strategies in PC3 and DU145 prostate cancer cells enhanced the malignant phenotype in both cell lines. In agreement of these anti-oncogenic roles, we discovered that Mitostatin was absent in similar to 35% (n = 124) of prostate tumor samples and its overall reduction was associated with advanced cancer stages. Collectively, our findings indicate that MITOSTATIN may acts as a tumor suppressor gene in prostate cancer and provide a novel cellular and molecular mechanism to be further exploited and deciphered in our understanding of prostate cancer progression.	[Fassan, Matteo; D'Arca, Domenico; Letko, Juraj; Vecchione, Andrea; Shupp-Byrne, Dolores; Gomella, Leonard G.; Morrione, Andrea; Baffa, Raffaele] Thomas Jefferson Univ, Dept Urol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [McCue, Peter; Wildemore, Bernadette; Iozzo, Renato V.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Fassan, Matteo; Gardiman, Marina P.; Rugge, Massimo] Univ Padua, Dept Diagnost Med & Special Therapies, Padua, Italy; [Vecchione, Andrea] Univ Roma La Sapienza, Fac Med 2, Div Pathol, Osped St Andrea, Rome, Italy	Jefferson University; Jefferson University; University of Padua; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea	Fassan, M (corresponding author), Thomas Jefferson Univ, Dept Urol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA.	R_Baffa@mail.jci.tju.edu	Iozzo, Renato/AAS-1980-2020; Rugge, Massimo/K-7525-2016; D'Arca, Domenico/B-9212-2016; Fassan, Matteo/F-5152-2012; Letko, Juraj/AAN-5710-2020	D'Arca, Domenico/0000-0002-7240-6005; Fassan, Matteo/0000-0001-6515-5482; Letko, Juraj/0000-0001-6285-5846; Vecchione, Andrea/0000-0002-5497-6856; Iozzo, Renato/0000-0002-5908-5112	Sidney Kimmel Foundation for Cancer Research; Benjamin Perkins Bladder Cancer Fund; Martin Greitzer Fund; National Institutes of Health [RO1 CA39481, RO1 CA47282, RO1 CA120975, RO1 DK068419]; NATIONAL CANCER INSTITUTE [R01CA120975, R01CA047282, R01CA039481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068419] Funding Source: NIH RePORTER	Sidney Kimmel Foundation for Cancer Research; Benjamin Perkins Bladder Cancer Fund; Martin Greitzer Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was in part supported by the Sidney Kimmel Foundation for Cancer Research, the Benjamin Perkins Bladder Cancer Fund and the Martin Greitzer Fund (to R. B.), the National Institutes of Health grants RO1 CA39481, RO1 CA47282 and RO1 CA120975 (to R. V. I.), RO1 DK068419 (to A. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubele MM, 2000, DIAGN MOL PATHOL, V9, P14, DOI 10.1097/00019606-200003000-00003; Cerqua C, 2010, EMBO REP, V11, P854, DOI 10.1038/embor.2010.151; Csordas G, 2000, J BIOL CHEM, V275, P32879, DOI 10.1074/jbc.M005609200; DANIELSON KG, 1993, GENOMICS, V15, P146, DOI 10.1006/geno.1993.1022; Edlund M, 2001, CELL GROWTH DIFFER, V12, P99; Ferdous Z, 2010, J BIOMED MATER RES A, V93A, P419, DOI 10.1002/jbm.a.32545; FIELD JK, 1995, BRIT J CANCER, V72, P1180, DOI 10.1038/bjc.1995.483; Goldoni S, 2007, ONCOGENE, V26, P368, DOI 10.1038/sj.onc.1209803; Goldoni S, 2008, INT J CANCER, V123, P2473, DOI 10.1002/ijc.23930; Goldoni S, 2008, AM J PATHOL, V173, P844, DOI 10.2353/ajpath.2008.080275; Grant DS, 2002, ONCOGENE, V21, P4765, DOI 10.1038/sj.onc.1205595; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jiang F, 1998, AM J PATHOL, V153, P1467, DOI 10.1016/S0002-9440(10)65734-3; Kim YR, 2010, GUT LIVER, V4, P149, DOI 10.5009/gnl.2010.4.1.149; Kimura M, 1998, CANCER RES, V58, P2456; Kinsella MG, 2000, J BIOL CHEM, V275, P13924, DOI 10.1074/jbc.275.18.13924; Koo SH, 1999, CANCER GENET CYTOGEN, V110, P87, DOI 10.1016/S0165-4608(98)00193-9; Lovat F, 2009, CARCINOGENESIS, V30, P861, DOI 10.1093/carcin/bgp050; Merle B, 1999, J CELL BIOCHEM, V75, P538; Monami G, 2006, CANCER RES, V66, P7103, DOI 10.1158/0008-5472.CAN-06-0633; Monami G, 2009, AM J PATHOL, V174, P1037, DOI 10.2353/ajpath.2009.080735; Moscatello DK, 1998, J CLIN INVEST, V101, P406, DOI 10.1172/JCI846; Parcellier A, 2003, MOL CELL BIOL, V23, P5790, DOI 10.1128/MCB.23.16.5790-5802.2003; RABINOVITZ I, 1994, PROSTATE, V25, P97, DOI 10.1002/pros.2990250207; Reed CC, 2002, ONCOGENE, V21, P3688, DOI 10.1038/sj.onc.1205470; Rijken AM, 1999, GENE CHROMOSOME CANC, V26, P185, DOI 10.1002/(SICI)1098-2264(199911)26:3<185::AID-GCC1>3.0.CO;2-9; Romano G, 2001, GENE THER, V8, P600, DOI 10.1038/sj.gt.3301441; Santra M, 1997, J CLIN INVEST, V100, P149, DOI 10.1172/JCI119507; SANTRA M, 1995, P NATL ACAD SCI USA, V92, P7016, DOI 10.1073/pnas.92.15.7016; Sattler HP, 1999, PROSTATE, V39, P79; Schmutte C, 1997, CANCER RES, V57, P3010; Schonherr E, 2001, J BIOL CHEM, V276, P40687, DOI 10.1074/jbc.M105426200; Seidler DG, 2006, J BIOL CHEM, V281, P26408, DOI 10.1074/jbc.M602853200; Shi HY, 2001, CANCER RES, V61, P6945; Shiseki M, 1996, GENE CHROMOSOME CANC, V17, P71, DOI 10.1002/(SICI)1098-2264(199610)17:2<71::AID-GCC1>3.0.CO;2-Y; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Tamura M, 1999, CANCER RES, V59, P442; Tirkkonen M, 1997, CANCER RES, V57, P1222; Tralhao JG, 2003, FASEB J, V17, P464, DOI 10.1096/fj.02-0534fje; Vecchione A, 2007, J EXP CLIN CANC RES, V26, P25; Vecchione A, 2002, AM J PATHOL, V160, P1345, DOI 10.1016/S0002-9440(10)62561-8; Vecchione A, 2009, ONCOGENE, V28, P257, DOI 10.1038/onc.2008.381; Xaus J, 2001, BLOOD, V98, P2124, DOI 10.1182/blood.V98.7.2124; Xu GX, 2002, BIOL REPROD, V67, P681, DOI 10.1095/biolreprod67.2.681	44	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19771	10.1371/journal.pone.0019771	http://dx.doi.org/10.1371/journal.pone.0019771			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573075	Green Published, gold, Green Submitted			2022-12-27	WOS:000290305600047
J	Holme, P; Huss, M; Lee, SH				Holme, Petter; Huss, Mikael; Lee, Sang Hoon			Atmospheric Reaction Systems as Null-Models to Identify Structural Traces of Evolution in Metabolism	PLOS ONE			English	Article							LARGE-SCALE ORGANIZATION	The metabolism is the motor behind the biological complexity of an organism. One problem of characterizing its large-scale structure is that it is hard to know what to compare it to. All chemical reaction systems are shaped by the same physics that gives molecules their stability and affinity to react. These fundamental factors cannot be captured by standard null-models based on randomization. The unique property of organismal metabolism is that it is controlled, to some extent, by an enzymatic machinery that is subject to evolution. In this paper, we explore the possibility that reaction systems of planetary atmospheres can serve as a null-model against which we can define metabolic structure and trace the influence of evolution. We find that the two types of data can be distinguished by their respective degree distributions. This is especially clear when looking at the degree distribution of the reaction network (of reaction connected to each other if they involve the same molecular species). For the Earth's atmospheric network and the human metabolic network, we look into more detail for an underlying explanation of this deviation. However, we cannot pinpoint a single cause of the difference, rather there are several concurrent factors. By examining quantities relating to the modular-functional organization of the metabolism, we confirm that metabolic networks have a more complex modular organization than the atmospheric networks, but not much more. We interpret the more variegated modular arrangement of metabolism as a trace of evolved functionality. On the other hand, it is quite remarkable how similar the structures of these two types of networks are, which emphasizes that the constraints from the chemical properties of the molecules has a larger influence in shaping the reaction system than does natural selection.	[Holme, Petter; Lee, Sang Hoon] Umea Univ, Dept Phys, IceLab, Umea, Sweden; [Holme, Petter] Sungkyunkwan Univ, Dept Energy Sci, Suwon, South Korea; [Huss, Mikael] Sci Life Lab Stockholm, Solna, Sweden; [Huss, Mikael] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden	Umea University; Sungkyunkwan University (SKKU); Stockholm University	Holme, P (corresponding author), Umea Univ, Dept Phys, IceLab, Umea, Sweden.	petter.holme@physics.umu.se	Holme, Petter/A-7646-2008	Holme, Petter/0000-0003-2156-1096; Huss, Mikael/0000-0003-0839-2451	Swedish Research Council; Ministry of Education, Science and Technology [R31-2008-000-10029-0]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	PH was supported by the Swedish Research Council and the World Class University program through National Research Foundation Korea funded by Ministry of Education, Science and Technology R31-2008-000-10029-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, NETWORKS INTRO NETWO, DOI DOI 10.1093/ACPROF:OSO/9780199206650.001.0001; Bethe HA, 1939, PHYS REV, V55, P0434, DOI 10.1103/PhysRev.55.434; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Good BH, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046106; Holme P, 2003, BIOINFORMATICS, V19, P532, DOI 10.1093/bioinformatics/btg033; Holme P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016605; Holme P, 2010, CHINESE SCI BULL, V55, P3161, DOI 10.1007/s11434-010-4086-3; Holme P, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.034801; Huss M, 2007, IET SYST BIOL, V1, P280, DOI 10.1049/iet-syb:20060077; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Klamt S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000385; KREBS H. A., 1937, Enzymologia, V4, P148; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Miyake S, 2004, 2004 IEEE COMPUTATIONAL SYSTEMS BIOINFORMATICS CONFERENCE, PROCEEDINGS, P634; Serrano MA, 2010, ARXIV10083166; Sole RV, 2004, EUROPHYS LETT, V68, P170, DOI 10.1209/epl/i2004-10241-3; Veeramani B, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-95; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Woodall J, 2007, ASTRON ASTROPHYS, V466, P1197, DOI 10.1051/0004-6361:20064981; Yung Y.L., 1999, PHOTOCHEMISTRY PLANE	24	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19759	10.1371/journal.pone.0019759	http://dx.doi.org/10.1371/journal.pone.0019759			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573072	Green Published, gold, Green Submitted			2022-12-27	WOS:000290305600046
J	Rieder, F; Lopez, R; Franke, A; Wolf, A; Schleder, S; Dirmeier, A; Schirbel, A; Rosenstiel, P; Dotan, N; Schreiber, S; Rogler, G; Klebl, F				Rieder, Florian; Lopez, Rocio; Franke, Andre; Wolf, Alexandra; Schleder, Stephan; Dirmeier, Andrea; Schirbel, Anja; Rosenstiel, Philip; Dotan, Nir; Schreiber, Stefan; Rogler, Gerhard; Klebl, Frank			Characterization of Changes in Serum Anti-Glycan Antibodies in Crohn's Disease - a Longitudinal Analysis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; SACCHAROMYCES-CEREVISIAE ANTIBODIES; EVIDENCE-BASED CONSENSUS; TERM-FOLLOW-UP; SEROLOGICAL MARKERS; NOD2/CARD15 GENOTYPE; MICROBIAL ANTIGENS; DIAGNOSIS; BEHAVIOR	Introduction: Anti-glycan antibodies are a promising tool for differential diagnosis and disease stratification of patients with Crohn's disease (CD). We longitudinally assessed level and status changes of anti-glycan antibodies over time in individual CD patients as well as determinants of this phenomenon. Methods: 859 serum samples derived from a cohort of 253 inflammatory bowel disease (IBD) patients (207 CD, 46 ulcerative colitis (UC)) were tested for the presence of anti-laminarin (Anti-L), anti-chitin (Anti-C), anti-chitobioside (ACCA), anti-laminaribioside (ALCA), anti-mannobioside (AMCA) and anti-Saccharomyces cerevisiae (gASCA) antibodies by ELISA. All patients had at least two and up to eleven serum samples taken during the disease course. Results: Median follow-up time for CD was 17.4 months (Interquartile range (IQR) 8.0, 31.6 months) and for UC 10.9 months (IQR 4.9, 21.0 months). In a subgroup of CD subjects marked changes in the overall immune response (quartile sum score) and levels of individual markers were observed over time. The marker status (positive versus negative) remained widely stable. Neither clinical phenotype nor NOD2 genotype was associated with the observed fluctuations. In a longitudinal analysis neither changes in disease activity nor CD behavior led to alterations in the levels of the glycan markers. The ability of the panel to discriminate CD from UC or its association with CD phenotypes remained stable during follow-up. In the serum of UC patients neither significant level nor status changes were observed. Conclusions: While the levels of anti-glycan antibodies fluctuate in a subgroup of CD patients the antibody status is widely stable over time.	[Rieder, Florian; Wolf, Alexandra; Schleder, Stephan; Dirmeier, Andrea; Klebl, Frank] Univ Regensburg, Dept Internal Med 1, Regensburg, Germany; [Rieder, Florian; Schirbel, Anja] Cleveland Clin Fdn, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA; [Rieder, Florian] Cleveland Clin Fdn, Dept Gastroenterol, Cleveland, OH 44195 USA; [Lopez, Rocio] Cleveland Clin Fdn, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA; [Franke, Andre; Rosenstiel, Philip; Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Franke, Andre; Rosenstiel, Philip; Schreiber, Stefan] Univ Kiel, Dept Gen Internal Med, Kiel, Germany; [Dotan, Nir] Glycominds Ltd, Lod, Israel; [Rogler, Gerhard] Univ Zurich Hosp, Dept Internal Med, Clin Gastroenterol & Hepatol, Zurich, Switzerland	University of Regensburg; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Kiel; University of Kiel; University of Zurich; University Zurich Hospital	Rieder, F (corresponding author), Univ Regensburg, Dept Internal Med 1, Regensburg, Germany.	florian.rieder@t-online.de	Rosenstiel, Philip/A-5137-2009; Rogler, Gerhard/O-5308-2015; Franke, Andre/B-2151-2010	Rosenstiel, Philip/0000-0002-9692-8828; Rogler, Gerhard/0000-0002-1733-9188; Franke, Andre/0000-0003-1530-5811; Lopez, Ana Rocio/0000-0002-4319-420X; Schleder, Stephan/0000-0002-7785-3015	German Ministry of Education and Research (BMBF) via the Kompetenznetz "Chronisch entzundliche Darmerkrankungen''; DFG Excellence Cluster Inflammation at Interfaces; Deutsche Forschungsgemeinschaft (DFG)	German Ministry of Education and Research (BMBF) via the Kompetenznetz "Chronisch entzundliche Darmerkrankungen''(Federal Ministry of Education & Research (BMBF)); DFG Excellence Cluster Inflammation at Interfaces(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by the German Ministry of Education and Research (BMBF) via the Kompetenznetz "Chronisch entzundliche Darmerkrankungen'', the DFG Excellence Cluster Inflammation at Interfaces and by the Deutsche Forschungsgemeinschaft (DFG) to F.R. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Nir Dotan is employed by Glycominds Ltd. and was involved in study design and preparation of the manuscript.	Andres PG, 1999, GASTROENTEROL CLIN N, V28, P255, DOI 10.1016/S0889-8553(05)70056-X; Arnott IDR, 2004, AM J GASTROENTEROL, V99, P2376, DOI 10.1111/j.1572-0241.2004.40417.x; Bartunkova J, 2002, CLIN IMMUNOL, V102, P162, DOI 10.1006/clim.2001.5145; Desir B, 2004, CLIN GASTROENTEROL H, V2, P139, DOI 10.1016/S1542-3565(03)00321-5; Devlin SM, 2008, INFLAMM BOWEL DIS, V14, P125, DOI 10.1002/ibd.20292; Dotan I, 2006, GASTROENTEROLOGY, V131, P366, DOI 10.1053/j.gastro.2006.04.030; Dotan N, 2006, LUPUS, V15, P442, DOI 10.1191/0961203306lu2331oa; Dubinsky MC, 2008, CLIN GASTROENTEROL H, V6, P1105, DOI 10.1016/j.cgh.2008.04.032; Eser A, 2009, GASTROENTEROLOGY, V136, pA188; FARMER RG, 1985, GASTROENTEROLOGY, V88, P1818, DOI 10.1016/0016-5085(85)90006-X; Ferrante M, 2007, GUT, V56, P1394, DOI 10.1136/gut.2006.108043; Israeli E, 2005, GUT, V54, P1232, DOI 10.1136/gut.2004.060228; Landers CJ, 2002, GASTROENTEROLOGY, V123, P689, DOI 10.1053/gast.2002.35379; Louis E, 2001, GUT, V49, P777, DOI 10.1136/gut.49.6.777; Mow WS, 2004, GASTROENTEROLOGY, V126, P414, DOI 10.1053/j.gastro.2003.11.015; Oshitani N, 2000, J GASTROEN HEPATOL, V15, P1400, DOI 10.1046/j.1440-1746.2000.02357.x; Papp M, 2008, AM J GASTROENTEROL, V103, P665, DOI 10.1111/j.1572-0241.2007.01652.x; Rieder F, 2010, INFLAMM BOWEL DIS, V16, P1367, DOI 10.1002/ibd.21179; Rieder F, 2010, INFLAMM BOWEL DIS, V16, P263, DOI 10.1002/ibd.21046; Ruemmele FM, 1998, GASTROENTEROLOGY, V115, P822, DOI 10.1016/S0016-5085(98)70252-5; Seow CH, 2009, AM J GASTROENTEROL, V104, P1426, DOI 10.1038/ajg.2009.79; Simondi D, 2008, INFLAMM BOWEL DIS, V14, P645, DOI 10.1002/ibd.20368; Spivak J, 2006, INFLAMM BOWEL DIS, V12, P1122, DOI 10.1097/01.mib.0000235833.47423.d7; Stange EF, 2008, J CROHNS COLITIS, V2, P1, DOI 10.1016/j.crohns.2007.11.001; Stange EF, 2006, GUT, V55, DOI 10.1136/gut.2005.081950a; Targan SR, 2005, GASTROENTEROLOGY, V128, P2020, DOI 10.1053/j.gastro.2005.03.046; Targan SR, 1999, INFLAMM BOWEL DIS, V5, P61, DOI 10.1097/00054725-199902000-00008; Teml A, 2003, AM J GASTROENTEROL, V98, P2226, DOI 10.1016/S0002-9270(03)00658-0; TEUBER M, 2005, JALA-J ASSOC LAB AUT, V10, P43	29	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e18172	10.1371/journal.pone.0018172	http://dx.doi.org/10.1371/journal.pone.0018172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573154	Green Published, Green Submitted, gold			2022-12-27	WOS:000290305600003
J	Soberon, J; Ceballos, G				Soberon, Jorge; Ceballos, Gerardo			Species Richness and Range Size of the Terrestrial Mammals of the World: Biological Signal within Mathematical Constraints	PLOS ONE			English	Article							NESTEDNESS TEMPERATURE; BIODIVERSITY HOTSPOTS; DIVERSITY; NULL; CONSERVATION; PATTERNS; MODELS	We explore global spatial diversity patterns for terrestrial mammals using as a tool range-diversity plots. These plots display simultaneously information about the number of species in localities and their spatial covariance in composition. These are highly informative, as we show by linking range-diversity plots with maps and by highlighting the correspondences between well defined regions of the plots with geographical regions or with taxonomic groups. Range-diversity plots are mathematically constrained by the lines of maximum and minimum mean covariance in species composition. We show how regions in the range-diversity plot corresponding to the line of maximum covariance correspond to large continental masses, and regions near the lower limit of the range-diversity plot correspond to archipelagos and mountain ranges. We show how curves of constant covariance correspond to nested faunas. Finally, we show that the observed distribution of the covariance range has significantly longer tails than random, with clear geographic correspondences. At the scale of our data we found that range-diversity plots reveal biodiversity patterns that cannot be replicated by null models, and correspond to conspicuous terrain features and taxonomic groupings.	[Soberon, Jorge] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [Soberon, Jorge] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Ceballos, Gerardo] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico	University of Kansas; University of Kansas; Universidad Nacional Autonoma de Mexico	Soberon, J (corresponding author), Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA.	jsoberon@ku.edu	Soberon, Jorge/ABF-1306-2021; Soberon, Jorge/N-7444-2015	Soberon, Jorge/0000-0003-2160-4148; Soberon, Jorge/0000-0003-2160-4148; Ceballos, Gerardo/0000-0001-8374-2656	National University of Mexico (UNAM)	National University of Mexico (UNAM)(Universidad Nacional Autonoma de Mexico)	The National Commission on Biodiversity supported J. Soberon by allowing him to allocate time for the organization of data and analyses of preliminary versions of this research. The National University of Mexico (UNAM) supported G. Ceballos with funds for traveling and paying technical personnel to assemble the database. These funders had no role in designing the study, the data collection or the analysis; nor on the decision to publish or the preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida M, 2007, OIKOS, V116, P716, DOI 10.1111/j.2007.0030-1299.15803.x; Arita HT, 2008, AM NAT, V172, P519, DOI 10.1086/590954; Arita HT, 2005, J BIOGEOGR, V32, P961, DOI 10.1111/j.1365-2699.2005.01276.x; Austin MP, 1999, OIKOS, V86, P170, DOI 10.2307/3546582; Bell G, 2005, ECOLOGY, V86, P1757, DOI 10.1890/04-1028; Borregaard MK, 2010, ECOGRAPHY, V33, P402, DOI 10.1111/j.1600-0587.2010.06323.x; Ceballos G, 2005, SCIENCE, V309, P603, DOI 10.1126/science.1114015; Ceballos G, 2006, P NATL ACAD SCI USA, V103, P19374, DOI 10.1073/pnas.0609334103; Christen A., 2009, MISCELANEA MATEMATIC, V49, P51; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; EISENBERG JF, 1981, MAMMALIAN RAD ANLYSI; Fischer J, 2002, OIKOS, V99, P193, DOI 10.1034/j.1600-0706.2002.990121.x; Gaston KJ, 2007, P ROY SOC B-BIOL SCI, V274, P1567, DOI 10.1098/rspb.2007.0236; Gaston KJ, 2003, STRUCTURE DYNAMICS G; Godsoe W, 2010, SYST BIOL, V59, P298, DOI 10.1093/sysbio/syq005; Gotelli N., 2001, ECOSIM NULL MODELS S, V78, DOI 10.5281/zenodo.16504; Gotelli NJ, 2006, ECOGRAPHY, V29, P793, DOI 10.1111/j.2006.0906-7590.04714.x; Gotelli NJ, 2009, ECOL LETT, V12, P873, DOI 10.1111/j.1461-0248.2009.01353.x; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Graves GR, 2005, P NATL ACAD SCI USA, V102, P7871, DOI 10.1073/pnas.0500424102; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; Jetz W, 2009, P ROY SOC B-BIOL SCI, V276, P269, DOI 10.1098/rspb.2008.1005; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Kareiva P, 2003, AM SCI, V91, P344, DOI 10.1511/2003.26.869; Koleff P., 2008, CAPITAL NATURAL ME X; Legendre P., 2012, NUMERICAL ECOLOGY; Lennon JJ, 2000, ECOGRAPHY, V23, P101, DOI 10.1034/j.1600-0587.2000.230111.x; Lomolino M., 1998, BIOGEOGRAPHY; McKnight MW, 2007, PLOS BIOL, V5, P2424, DOI 10.1371/journal.pbio.0050272; Mittermeier RA, 1998, CONSERV BIOL, V12, P516, DOI 10.1046/j.1523-1739.1998.012003516.x; Orme CDL, 2006, PLOS BIOL, V4, P1276, DOI 10.1371/journal.pbio.0040208; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Rahbek C, 2007, P ROY SOC B-BIOL SCI, V274, P165, DOI 10.1098/rspb.2006.3700; Rodriguez-Girones MA, 2006, J BIOGEOGR, V33, P924, DOI 10.1111/j.1365-2699.2006.01444.x; Rosenzwieg M.L., 1975, P121; SMITH C H, 1983, Evolutionary Theory, V6, P225; Udvardy MDF, 1969, DYNAMIC ZOOGEOGRAPHY; Villalobos F, 2010, GLOBAL ECOL BIOGEOGR, V19, P200, DOI 10.1111/j.1466-8238.2009.00503.x; WHITTAKER RH, 1960, ECOL MONOGR, V30, P280, DOI 10.2307/1943563	39	26	27	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19359	10.1371/journal.pone.0019359	http://dx.doi.org/10.1371/journal.pone.0019359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573112	gold, Green Published, Green Submitted			2022-12-27	WOS:000290305600021
J	Kong, GY; Zhang, JP; Zhang, S; Shan, CL; Ye, LH; Zhang, XD				Kong, Guangyao; Zhang, Junping; Zhang, Shuai; Shan, Changliang; Ye, Lihong; Zhang, Xiaodong			Upregulated MicroRNA-29a by Hepatitis B Virus X Protein Enhances Hepatoma Cell Migration by Targeting PTEN in Cell Culture Model	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; HEPATOCELLULAR-CARCINOMA; HBX PROTEIN; EXPRESSION; GENE; OVEREXPRESSION; MIR-29; GROWTH; CANCER; LOCUS	Hepatitis B virus X protein (HBx) plays important roles in the development of hepatocellular carcinoma (HCC). MicroRNAs (miRNAs) contribute to cancer development by acting as oncogenes or tumor suppressors. Previously, we reported that HBx was able to promote the migration of hepatoma HepG2 cells. However, the regulation of miRNAs in the development of HBV-related HCC is poorly understood. In the present study, we reported that miR-29a was a novel regulator of migration of hepatoma cells mediated by HBx. Our data showed that the expression of miR-29a was dramatically increased in p21-HBx transgenic mice, HBx-transfected hepatoma HepG2-X (or H7402-X) cells and HepG2.2.15 cells that constitutively replicate HBV. However, our data showed that miR-29a was upregulated in 4 of the 11 clinical HCC samples. We found that the overexpression of miR-29a promoted the migration of HepG2 cells, while a specific miR-29a inhibitor could partially abolish the enhanced migration of HepG2-X cells. Moreover, we identified PTEN was one of the target genes of miR-29a in HepG2 cells. The deletion of the miR-29a-binding site was able to abolish the role of miR-29a in suppression of luciferase activity of the PTEN 3'UTR reporter. Meanwhile, the overexpression of PTEN was able to reverse the promoted migration of HepG2 cells mediated by miR-29a. Moreover, our data showed that the modulation of Akt phosphorylation, a downstream factor of PTEN, was involved in the cell migration enhanced by miR-29a, suggesting that miR-29a is responsible for the cell migration through its target gene PTEN. Thus, we conclude that miR-29a is involved in the regulation of migration of hepatoma cells mediated by HBx through PTEN in cell culture model.	[Kong, Guangyao; Zhang, Junping; Zhang, Shuai; Shan, Changliang; Zhang, Xiaodong] Nankai Univ, Key Lab Mol Microbiol & Technol, Minist Educ, Dept Canc Res,Inst Mol Biol,Coll Life Sci, Tianjin 300071, Peoples R China; [Ye, Lihong] Nankai Univ, Dept Biochem, Coll Life Sci, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Kong, GY (corresponding author), Nankai Univ, Key Lab Mol Microbiol & Technol, Minist Educ, Dept Canc Res,Inst Mol Biol,Coll Life Sci, Tianjin 300071, Peoples R China.	yelihong@nankai.edu.cn; zhangxd@nankai.edu.cn	Kong, Guangyao/L-2162-2013; Shan, changliang/L-9029-2016	Zhang, Shuai/0000-0003-0272-0856	National Basic Research Program of China (973 Program) [2007CB914804, 2007CB914802, 2009CB521702]; National Natural Science Foundation of China [30670959, 81000870]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Basic Research Program of China (973 Program; nos. 2007CB914804, 2007CB914802, and 2009CB521702) and the National Natural Science Foundation of China (nos. 30670959 and 81000870). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Chung TW, 2003, CANCER RES, V63, P3453; Chung TW, 2004, FASEB J, V18, P1123, DOI 10.1096/fj.03-1429fje; Dasari VR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010350; Dey N, 2008, CANCER RES, V68, P1862, DOI 10.1158/0008-5472.CAN-07-1182; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Garzon R, 2009, BLOOD, V114, P5331, DOI 10.1182/blood-2009-03-211938; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Gebeshuber CA, 2009, EMBO REP, V10, P400, DOI 10.1038/embor.2009.9; Goswami S, 2010, J BIOL CHEM, V285, P20532, DOI 10.1074/jbc.M110.109298; Han YC, 2010, J EXP MED, V207, P475, DOI 10.1084/jem.20090831; Katome T, 2003, J BIOL CHEM, V278, P28312, DOI 10.1074/jbc.M302094200; Lara-Pezzi E, 2001, J HEPATOL, V34, P409, DOI 10.1016/S0168-8278(00)00090-8; Li DM, 1997, CANCER RES, V57, P2124; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035; Li Y, 2001, WORLD J GASTROENTERO, V7, P630; Liu Y, 2010, HYPERTENSION, V55, P974, DOI 10.1161/HYPERTENSIONAHA.109.144428; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; McGlynn KA, 2005, BEST PRACT RES CL GA, V19, P3, DOI 10.1016/j.bpg.2004.10.004; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Qin XR, 2007, TRANSL RES, V150, P281, DOI 10.1016/j.trsl.2007.06.005; Santanam U, 2010, P NATL ACAD SCI USA, V107, P12210, DOI 10.1073/pnas.1007186107; Steele Robert, 2010, Genes Cancer, V1, P381; Ura S, 2009, HEPATOLOGY, V49, P1098, DOI 10.1002/hep.22749; Wan XW, 2003, J CANCER RES CLIN, V129, P100, DOI 10.1007/s00432-002-0410-x; Wang Q, 2010, NEOPLASIA, V12, P103, DOI 10.1593/neo.91298; Wang YL, 2004, HEPATOLOGY, V39, P318, DOI 10.1002/hep.20076; Xia LM, 2009, VIROLOGY, V385, P335, DOI 10.1016/j.virol.2008.11.042; You JC, 2009, ENDOCRINOLOGY, V150, P1607, DOI 10.1210/en.2008-0616; Zhang F, 2010, J MED VIROL, V82, P920, DOI 10.1002/jmv.21753; Zhang WY, 2009, ACTA PHARMACOL SIN, V30, P1153, DOI 10.1038/aps.2009.99; Zhang XD, 2006, J LAB CLIN MED, V147, P58, DOI 10.1016/j.lab.2005.10.003; Zhang XD, 2005, J MED VIROL, V77, P374, DOI 10.1002/jmv.20466; Zhang XY, 2009, HEPATOLOGY, V50, P490, DOI 10.1002/hep.23008	42	148	162	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19518	10.1371/journal.pone.0019518	http://dx.doi.org/10.1371/journal.pone.0019518			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573166	gold, Green Submitted, Green Published			2022-12-27	WOS:000290256400017
J	Phillips, M; Boman, E; Osterman, H; Willhite, D; Laska, M				Phillips, Matthew; Boman, Erik; Osterman, Hanna; Willhite, David; Laska, Matthias			Olfactory and Visuospatial Learning and Memory Performance in Two Strains of Alzheimer's Disease Model Mice-A Longitudinal Study	PLOS ONE			English	Article							APPSWE/PS1DE9 MOUSE MODEL; AGE-RELATED-CHANGES; CD-1 MICE; TRANSGENIC MICE; DISCRIMINATION ABILITY; ALIPHATIC-ALDEHYDES; ODOR DISCRIMINATION; SPIDER MONKEYS; SENSITIVITY; DEFICITS	Using a longitudinal study design, two strains of Alzheimer's disease ( AD) model mice, one expressing beta-amyloid plaques and one expressing Tau protein-associated neurofibrillary tangles were assessed for olfactory and visuospatial learning and memory and their performance compared to that of age-matched controls. No significant difference between AD and control mice was found in the initial set of olfactory tasks performed at 6 months of age whereas both strains of AD mice performed significantly poorer than the controls in visuospatial learning at this age. Subsequent tests performed on the same individual animals at 7, 8, 9, 11, 13, 15, and 18 months of age also failed to find systematic differences in olfactory performance between AD and control mice. In contrast, the AD mice performed consistently poorer than the controls in visuospatial re-learning tests performed at these ages. With most olfactory tasks, both AD and control mice displayed a marked decrease in performance between testing at 15 and 18 months of age. These results show that the two strains of AD model mice do not display an olfactory impairment in a time course consistent with human AD, but are impaired in visuospatial capabilities. The marked age-related changes observed with the olfactory tasks in both AD and control mice suggest that the observed lack of an AD-related olfactory impairment is not due to an insensitivity of the tests employed. Rather, they suggest that the olfactory system of the two AD mouse model strains may be surprisingly robust against AD-typical neuropathologies.	[Phillips, Matthew; Willhite, David] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06511 USA; [Phillips, Matthew] Yale Univ, Dept Phys, New Haven, CT USA; [Boman, Erik; Osterman, Hanna; Laska, Matthias] Linkoping Univ, Dept Phys Chem & Biol, Sect Zool, Linkoping, Sweden	Yale University; Yale University; Linkoping University	Phillips, M (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06511 USA.	malas@ifm.liu.se		Boman, Erik Maitz/0000-0003-1935-2682; Laska, Matthias/0000-0001-5583-2697	National Institute on Deafness and other Communication Disorders (NIDCD) [R01 DC000086, R03 DC008874]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000086, R03DC008874] Funding Source: NIH RePORTER	National Institute on Deafness and other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institute on Deafness and other Communication Disorders (NIDCD) R01 DC000086 (Gordon M. Shepherd) and R03 DC008874 (David Willhite). URL of the funder's website: www.nidcd.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Bodyak N, 1999, CHEM SENSES, V24, P637, DOI 10.1093/chemse/24.6.637; Boon WC, 2010, BEHAV BRAIN RES, V209, P27, DOI 10.1016/j.bbr.2010.01.013; Costanzo RM, 2010, CHEM SENSES, V35, P417, DOI 10.1093/chemse/bjq029; deIpolyi AR, 2008, NEUROBIOL AGING, V29, P253, DOI 10.1016/j.neurobiolaging.2006.10.021; DOTY RL, 1984, SCIENCE, V226, P1441, DOI 10.1126/science.6505700; Duyckaerts C, 2008, ACTA NEUROPATHOL, V115, P5, DOI 10.1007/s00401-007-0312-8; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fleischmann A, 2008, NEURON, V60, P1068, DOI 10.1016/j.neuron.2008.10.046; Forster S, 2010, J ALZHEIMERS DIS, V22, P581, DOI 10.3233/JAD-2010-091549; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Hedner M, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00024; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Joshi D, 2006, CHEM SENSES, V31, P655, DOI 10.1093/chemse/bjl006; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Laska M, 2007, NEUROSCIENCE, V144, P295, DOI 10.1016/j.neuroscience.2006.08.063; Laska M, 2006, BEHAV BRAIN RES, V167, P349, DOI 10.1016/j.bbr.2005.09.022; Laska M, 2008, J COMP PHYSIOL A, V194, P971, DOI 10.1007/s00359-008-0370-y; Laska M, 2007, J COMP PHYSIOL A, V193, P955, DOI 10.1007/s00359-007-0248-4; Laska M, 2009, J EXP ZOOL PART A, V311A, P278, DOI 10.1002/jez.527; Macknin JB, 2004, BRAIN RES, V1000, P174, DOI 10.1016/j.brainres.2004.01.047; Mesholam RI, 1998, ARCH NEUROL-CHICAGO, V55, P84, DOI 10.1001/archneur.55.1.84; Mirich JM, 2002, J COMP NEUROL, V454, P361, DOI 10.1002/cne.10426; Murphy C, 2002, JAMA-J AM MED ASSOC, V288, P2307, DOI 10.1001/jama.288.18.2307; Murphy C, 2001, ALZHEIMER'S DISEASE, P237, DOI 10.1002/0470846453.ch22; O'Leary TP, 2009, BEHAV BRAIN RES, V201, P120, DOI 10.1016/j.bbr.2009.01.039; Patel RC, 2009, NEUROBIOL AGING, V30, P829, DOI 10.1016/j.neurobiolaging.2007.08.007; Rosli Y, 1999, J ELECTRON MICROSC, V48, P77, DOI 10.1093/oxfordjournals.jmicro.a023653; Shimshek DR, 2005, PLOS BIOL, V3, P2017, DOI 10.1371/journal.pbio.0030354; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Vloeberghs E, 2008, BEHAV NEUROSCI, V122, P491, DOI 10.1037/0735-7044.122.3.491; Volianskis A, 2010, NEUROBIOL AGING, V31, P1173, DOI 10.1016/j.neurobiolaging.2008.08.005; Weast RC., 1987, HDB CHEM PHYS, V68; Wersinger SR, 2007, GENES BRAIN BEHAV, V6, P540, DOI 10.1111/j.1601-183X.2006.00281.x; Wesson DW, 2010, J NEUROSCI, V30, P505, DOI 10.1523/JNEUROSCI.4622-09.2010; Wilcock DM, 2010, CNS NEUROL DISORD-DR, V9, P386; Zhuo JM, 2008, CURR ALZHEIMER RES, V5, P385, DOI 10.2174/156720508785132280	39	29	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19567	10.1371/journal.pone.0019567	http://dx.doi.org/10.1371/journal.pone.0019567			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573167	gold, Green Published, Green Submitted			2022-12-27	WOS:000290256400025
J	Prochnow, N; Gebing, T; Ladage, K; Krause-Finkeldey, D; El Ouardi, A; Bitz, A; Streckert, J; Hansen, V; Dermietzel, R				Prochnow, Nora; Gebing, Tina; Ladage, Kerstin; Krause-Finkeldey, Dorothee; El Ouardi, Abdessamad; Bitz, Andreas; Streckert, Joachim; Hansen, Volkert; Dermietzel, Rolf			Electromagnetic Field Effect or Simply Stress? Effects of UMTS Exposure on Hippocampal Longterm Plasticity in the Context of Procedure Related Hormone Release	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; MOBILE PHONE; GLUCOCORTICOID-RECEPTOR; EMOTIONAL MEMORIES; COGNITIVE FUNCTION; KETAMINE-XYLAZINE; BRAIN TEMPERATURE; POTENTIATION; RAT; PSD-95	Harmful effects of electromagnetic fields (EMF) on cognitive and behavioural features of humans and rodents have been controversially discussed and raised persistent concern about adverse effects of EMF on general brain functions. In the present study we applied radio-frequency (RF) signals of the Universal Mobile Telecommunications System (UMTS) to full brain exposed male Wistar rats in order to elaborate putative influences on stress hormone release (corticosteron; CORT and adrenocorticotropic hormone; ACTH) and on hippocampal derived synaptic long-term plasticity (LTP) and depression (LTD) as electrophysiological hallmarks for memory storage and memory consolidation. Exposure was computer controlled providing blind conditions. Nominal brain-averaged specific absorption rates (SAR) as a measure of applied mass-related dissipated RF power were 0, 2, and 10 W/kg over a period of 120 min. Comparison of cage exposed animals revealed, regardless of EMF exposure, significantly increased CORT and ACTH levels which corresponded with generally decreased field potential slopes and amplitudes in hippocampal LTP and LTD. Animals following SAR exposure of 2 W/kg (averaged over the whole brain of 2.3 g tissue mass) did not differ from the sham-exposed group in LTP and LTD experiments. In contrast, a significant reduction in LTP and LTD was observed at the high power rate of SAR (10 W/kg). The results demonstrate that a rate of 2 W/kg displays no adverse impact on LTP and LTD, while 10 W/kg leads to significant effects on the electrophysiological parameters, which can be clearly distinguished from the stress derived background. Our findings suggest that UMTS exposure with SAR in the range of 2 W/kg is not harmful to critical markers for memory storage and memory consolidation, however, an influence of UMTS at high energy absorption rates (10 W/kg) cannot be excluded.	[Prochnow, Nora; Gebing, Tina; Ladage, Kerstin; Krause-Finkeldey, Dorothee; Dermietzel, Rolf] Ruhr Univ Bochum, Dept Neuroanat & Mol Brain Res, Bochum, Germany; [El Ouardi, Abdessamad; Bitz, Andreas; Streckert, Joachim; Hansen, Volkert] Univ Wuppertal, Chair Elect Theory, Wuppertal, Germany	Ruhr University Bochum; University of Wuppertal	Prochnow, N (corresponding author), Ruhr Univ Bochum, Dept Neuroanat & Mol Brain Res, Bochum, Germany.	rolf.dermietzel@rub.de						Abraham WC, 1997, HIPPOCAMPUS, V7, P137, DOI 10.1002/(SICI)1098-1063(1997)7:2<137::AID-HIPO3>3.0.CO;2-K; Anastassiou CA, 2011, NAT NEUROSCI, V14, P217, DOI 10.1038/nn.2727; Beique JC, 2003, J PHYSIOL-LONDON, V546, P859, DOI 10.1113/jphysiol.2002.031369; Beique JC, 2006, P NATL ACAD SCI USA, V103, P19535, DOI 10.1073/pnas.0608492103; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Bohus B, 1980, Acta Psychiatr Belg, V80, P714; Burkhardt M, 1997, HEALTH PHYS, V73, P770, DOI 10.1097/00004032-199711000-00004; Carlisle HJ, 2008, J PHYSIOL-LONDON, V586, P5885, DOI 10.1113/jphysiol.2008.163469; Chaouloff F, 2007, J NEUROSCI, V27, P7130, DOI 10.1523/JNEUROSCI.1150-07.2007; Chou CK, 1999, PHYS REV E, V60, P5998, DOI 10.1103/PhysRevE.60.5998; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Curcio G, 2004, NEUROREPORT, V15, P161, DOI 10.1097/00001756-200401190-00031; Diamond David M., 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/60803; Diamond DM, 1999, HIPPOCAMPUS, V9, P542, DOI 10.1002/(SICI)1098-1063(1999)9:5<542::AID-HIPO8>3.3.CO;2-E; Diamond DM, 2005, HIPPOCAMPUS, V15, P1006, DOI 10.1002/hipo.20107; Diamond DM, 2004, HIPPOCAMPUS, V14, P281, DOI 10.1002/hipo.10186; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; El-Hussein AE, 2000, SCIENCE, V290, P1364; Elias GM, 2007, TRENDS CELL BIOL, V17, P343, DOI 10.1016/j.tcb.2007.07.005; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Eltiti S, 2009, BIOELECTROMAGNETICS, V30, P556, DOI 10.1002/bem.20504; Erickson KM, 2003, ANESTH ANALG, V96, P1460, DOI 10.1213/01.ANE.0000061221.23197.CE; FOY MR, 1987, BEHAV NEURAL BIOL, V48, P138, DOI 10.1016/S0163-1047(87)90664-9; Garcia R, 1997, NEUROSCI LETT, V233, P41, DOI 10.1016/S0304-3940(97)00621-6; GORDON CJ, 1990, PHYSIOL BEHAV, V47, P963, DOI 10.1016/0031-9384(90)90025-Y; Hansen VW, 1999, IEEE T ELECTROMAGN C, V41, P487, DOI 10.1109/15.809852; HANSEN VW, 2004, WAVES GTEM CELLS COM, P435; Howland JG, 2008, PROG BRAIN RES, V169, P145, DOI 10.1016/S0079-6123(07)00008-8; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; JOELS M, 1992, NEUROENDOCRINOLOGY, V55, P344, DOI 10.1159/000126135; Joels M, 2008, EUR J PHARMACOL, V583, P312, DOI 10.1016/j.ejphar.2007.11.064; Joels Marian, 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/93202; Kim JJ, 2006, STRESS, V9, P1, DOI 10.1080/10253890600678004; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Kim JJ, 1996, P NATL ACAD SCI USA, V93, P4750, DOI 10.1073/pnas.93.10.4750; Kleinlogel H, 2008, BIOELECTROMAGNETICS, V29, P479, DOI 10.1002/bem.20419; KLEMM W, 1975, J ENDOCRINOL, V65, pP12; Kohda K, 2007, NEUROSCIENCE, V148, P22, DOI 10.1016/j.neuroscience.2007.05.041; Koivisto M, 2000, NEUROREPORT, V11, P1641, DOI 10.1097/00001756-200006050-00009; LaManna J C, 1988, Adv Exp Med Biol, V222, P383; Lei H, 2001, BRAIN RES, V913, P174, DOI 10.1016/S0006-8993(01)02786-X; Levine S, 1977, Acta Physiol Pol, V28, P93; Manahan-Vaughan D, 1999, P NATL ACAD SCI USA, V96, P8739, DOI 10.1073/pnas.96.15.8739; Mbonjo HNM, 2004, BIOELECTROMAGNETICS, V25, P415, DOI 10.1002/bem.20007; Mcewen B S, 1970, Prog Brain Res, V32, P200, DOI 10.1016/S0079-6123(08)61536-8; MCEWEN BS, 1969, BRAIN RES, V16, P227, DOI 10.1016/0006-8993(69)90096-1; MCEWEN BS, 1994, ANN NY ACAD SCI, V746, P134; MCEWEN BS, 1968, NATURE, V220, P911, DOI 10.1038/220911a0; MCGAUGH JL, 1983, ANNU REV PSYCHOL, V34, P297, DOI 10.1146/annurev.ps.34.020183.001501; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Mockett B, 2002, EUR J NEUROSCI, V15, P1819, DOI 10.1046/j.1460-9568.2002.02008.x; Nagashima K, 2000, AUTON NEUROSCI-BASIC, V85, P18, DOI 10.1016/S1566-0702(00)00216-2; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Preece AW, 1999, INT J RADIAT BIOL, V75, P447, DOI 10.1080/095530099140375; Regel SJ, 2006, ENVIRON HEALTH PERSP, V114, P1270, DOI 10.1289/ehp.8934; Riddervold IS, 2008, BIOELECTROMAGNETICS, V29, P257, DOI 10.1002/bem.20388; RYAN BK, 2009, HIPPOCAMPUS; Sacchetti B, 2002, EUR J NEUROSCI, V15, P143, DOI 10.1046/j.0953-816x.2001.01844.x; SARA SJ, 1994, J PHYSIOLOGY-PARIS, V88, P337, DOI 10.1016/0928-4257(94)90026-4; SARA SJ, 1995, COGNITIVE BRAIN RES, V2, P181, DOI 10.1016/0926-6410(95)90007-1; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Seitz H, 2005, SCI TOTAL ENVIRON, V349, P45, DOI 10.1016/j.scitotenv.2005.05.009; Shors TJ, 1997, SYNAPSE, V26, P209, DOI 10.1002/(SICI)1098-2396(199707)26:3<209::AID-SYN2>3.0.CO;2-B; Stein V, 2003, J NEUROSCI, V23, P5503; Tattersall JEH, 2001, BRAIN RES, V904, P43, DOI 10.1016/S0006-8993(01)02434-9; Tsoory MM, 2007, PROG BRAIN RES, V167, P35, DOI 10.1016/S0079-6123(07)67003-4; Unterlechner M, 2008, BIOELECTROMAGNETICS, V29, P145, DOI 10.1002/bem.20374; VANKOV A, 1995, EUR J NEUROSCI, V7, P1180, DOI 10.1111/j.1460-9568.1995.tb01108.x; VARRO P, 2009, BIOELECTROMAGNETICS; Wang BM, 2000, BIOELECTROMAGNETICS, V21, P52, DOI 10.1002/(SICI)1521-186X(200001)21:1<52::AID-BEM8>3.0.CO;2-6; WIXSON SK, 1987, LAB ANIM SCI, V37, P743; *WORKSH FGF, 2003, 281 COST FORSCH FUNK; Xu L, 1997, NATURE, V387, P497, DOI 10.1038/387497a0; Xu L, 1998, P NATL ACAD SCI USA, V95, P3204, DOI 10.1073/pnas.95.6.3204; Yang CH, 2005, J NEUROSCI, V25, P4288, DOI 10.1523/JNEUROSCI.0406-05.2005; Yang CH, 2004, J NEUROSCI, V24, P11029, DOI 10.1523/JNEUROSCI.3968-04.2004; Yao Li-Jun, 2004, Sheng Li Ke Xue Jin Zhan, V35, P73; Zhu MM, 2009, J COMP PHYSIOL B, V179, P701, DOI 10.1007/s00360-009-0352-6; Zhu MM, 2004, J THERM BIOL, V29, P599, DOI 10.1016/j.jtherbio.2004.08.029; Zwamborn APM, 2003, EFFECTS GLOBAL COMMU	80	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19437	10.1371/journal.pone.0019437	http://dx.doi.org/10.1371/journal.pone.0019437			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573218	gold, Green Published, Green Submitted			2022-12-27	WOS:000290256400011
J	Rantamaki, AH; Seppanen-Laakso, T; Oresic, M; Jauhiainen, M; Holopainen, JM				Rantamaki, Antti H.; Seppanen-Laakso, Tuulikki; Oresic, Matej; Jauhiainen, Matti; Holopainen, Juha M.			Human Tear Fluid Lipidome: From Composition to Function	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; INDUCED OXIDATION; NONPOLAR LIPIDS; HUMAN MEIBUM; QUANTIFICATION; CHROMATOGRAPHY; TISSUES	We have explored human aqueous tear fluid lipidome with an emphasis to identify the major lipids. We also address the physiological significance of the lipidome. The tears were analysed using thin layer chromatographic, enzymatic and mass spectrometric techniques. To emphasize the physiological aspect of the lipidome, we modelled the spreading of the non-polar tear fluid lipids at air-water interface in macroscopic scale with olive oil and egg yolk phosphatidylcholine. Based on enzymatic analysis the respective concentrations of choline-containing lipids, triglycerides, and cholesteryl esters were 48 +/- 14, 10 +/- 0, and 21 +/- 18 mu M. Ultra performance liquid chromatography quadrupole time of flight mass spectrometry analysis showed that phosphatidylcholine and phosphatidylethanolamine were the two most common polar lipids comprising 88 +/- 6% of all identified lipids. Triglycerides were the only non-polar lipids detected in mass spectrometric analysis i.e. no cholesteryl or wax esters were identified. The spreading experiments show that the presence of polar lipids is an absolute necessity for a proper spreading of non-polar tear fluid lipids. We provide evidence that polar lipids are the most common lipid species. Furthermore, we provide a physiological rationale for the observed lipid composition. The results open insights into the functional role of lipids in the tear fluid and also aids in providing new means to understand and treat diseases of the ocular surface.	[Rantamaki, Antti H.; Holopainen, Juha M.] Univ Helsinki, Dept Ophthalmol, Helsinki Eye Lab, Helsinki, Finland; [Seppanen-Laakso, Tuulikki; Oresic, Matej] VTT Tech Res Ctr Finland, Espoo, Finland; [Jauhiainen, Matti] Natl Inst Hlth & Welf, Helsinki, Finland; [Jauhiainen, Matti] FIMM Inst Mol Med Finland, Helsinki, Finland	University of Helsinki; VTT Technical Research Center Finland; Finland National Institute for Health & Welfare	Rantamaki, AH (corresponding author), Univ Helsinki, Dept Ophthalmol, Helsinki Eye Lab, Helsinki, Finland.	juha.holopainen@hus.fi	Oresic, Matej/K-7673-2016; Oresic, Matej/AAV-3978-2020; Rantamäki, Antti H/L-6565-2018	Oresic, Matej/0000-0002-2856-9165; Rantamäki, Antti H/0000-0001-8490-6069	Finnish Eye Foundation; Academy of Finland; Finnish Foundation for Cardiovascular Research; Sigrid Juselius Foundation	Finnish Eye Foundation; Academy of Finland(Academy of Finland); Finnish Foundation for Cardiovascular Research; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	The Finnish Eye Foundation (JMH), the Academy of Finland (JMH), the Finnish Foundation for Cardiovascular Research (MJ), and Sigrid Juselius Foundation (MJ, JMH) supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butovich IA, 2008, INVEST OPHTH VIS SCI, V49, P3779, DOI 10.1167/iovs.08-1889; Butovich IA, 2008, CURR EYE RES, V33, P405, DOI 10.1080/02713680802018419; Butovich IA, 2009, J LIPID RES, V50, P501, DOI 10.1194/jlr.M800426-JLR200; Chen JZ, 2010, INVEST OPHTH VIS SCI, V51, P6220, DOI 10.1167/iovs.10-5687; de Souza GA, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r72; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ham BM, 2005, ANAL CHEM, V77, P4439, DOI 10.1021/ac058000a; Ham BM, 2004, J MASS SPECTROM, V39, P1321, DOI 10.1002/jms.725; Jiang XT, 2007, RAPID COMMUN MASS SP, V21, P141, DOI 10.1002/rcm.2820; Khanal S, 2010, NANOMED-NANOTECHNOL, V6, P707, DOI 10.1016/j.nano.2010.06.002; Kulovesi P, 2010, BIOPHYS J, V99, P2559, DOI 10.1016/j.bpj.2010.08.001; Laaksonen R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000097; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; McCulley J P, 1997, Trans Am Ophthalmol Soc, V95, P79; Medina-Gomez G, 2005, DIABETES, V54, P1706, DOI 10.2337/diabetes.54.6.1706; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; Morandat S, 2003, BBA-BIOMEMBRANES, V1616, P137, DOI 10.1016/j.bbamem.2003.08.001; Murphy RC, 2001, CHEM RES TOXICOL, V14, P463, DOI 10.1021/tx000250t; Nygren H, 2011, METHODS MOL BIOL, V708, P247, DOI 10.1007/978-1-61737-985-7_15; Pietilainen KH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000218; Pike LJ, 2002, BIOCHEMISTRY-US, V41, P2075, DOI 10.1021/bi0156557; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; RANTAMAKI AH, 2011, PROG RETIN IN PRESS; Saari KM, 2001, INVEST OPHTH VIS SCI, V42, P318; SAVILLE JT, 2010, EXP EYE RES IN PRESS; Tiffany JM., 1997, BIOCH EYE, P45; WHIKEHART DR, 2004, BIOCH EYE, P11; WOLLENSAK G, 1990, GRAEF ARCH CLIN EXP, V228, P78, DOI 10.1007/BF02764296; Yetukuri L, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-12	29	99	99	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19553	10.1371/journal.pone.0019553	http://dx.doi.org/10.1371/journal.pone.0019553			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573170	Green Submitted, gold, Green Published			2022-12-27	WOS:000290256400022
J	Donate, A; Coppola, D; Cruz, Y; Heller, R				Donate, Amy; Coppola, Domenico; Cruz, Yolmari; Heller, Richard			Evaluation of a Novel Non-Penetrating Electrode for Use in DNA Vaccination	PLOS ONE			English	Article							IN-VIVO ELECTROPORATION; INFLUENZA-VIRUS INFECTION; CELLULAR IMMUNE-RESPONSES; GENE-TRANSFER; RHESUS MACAQUES; PLASMID DNA; CUTANEOUS TRANSFECTION; SKELETAL-MUSCLES; DELIVERY; VACCINES	Current progress in the development of vaccines has decreased the incidence of fatal and non-fatal infections and increased longevity. However, new technologies need to be developed to combat an emerging generation of infectious diseases. DNA vaccination has been demonstrated to have great potential for use with a wide variety of diseases. Alone, this technology does not generate a significant immune response for vaccination, but combined with delivery by electroporation (EP), can enhance plasmid expression and immunity. Most EP systems, while effective, can be invasive and painful making them less desirable for use in vaccination. Our lab recently developed a non-invasive electrode known as the multi-electrode array (MEA), which lies flat on the surface of the skin without penetrating the tissue. In this study we evaluated the MEA for its use in DNA vaccination using Hepatitis B virus as the infectious model. We utilized the guinea pig model because their skin is similar in thickness and morphology to humans. The plasmid encoding Hepatitis B surface antigen (HBsAg) was delivered intradermally with the MEA to guinea pig skin. The results show increased protein expression resulting from plasmid delivery using the MEA as compared to injection alone. Within 48 hours of treatment, there was an influx of cellular infiltrate in experimental groups. Humoral responses were also increased significantly in both duration and intensity as compared to injection only groups. While this electrode requires further study, our results suggest that the MEA has potential for use in electrically mediated intradermal DNA vaccination.	[Donate, Amy; Coppola, Domenico] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Donate, Amy; Heller, Richard] Old Dominion Univ, Ctr Bioelect, Norfolk, VA USA; [Heller, Richard] Old Dominion Univ, Coll Hlth Sci, Norfolk, VA USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Old Dominion University; Old Dominion University	Donate, A (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA.	rheller@odu.edu	Heller, Richard/I-6605-2012; Heller, Richard/ABF-1445-2020	Heller, Richard/0000-0003-1899-3859; Donate, Amy/0000-0002-0481-5675	National Institutes of Health [R01 EB005441]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This research was supported in part by a research grant from the National Institutes of Health R01 EB005441. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abdulhaqq SA, 2008, IMMUNOL RES, V42, P219, DOI 10.1007/s12026-008-8076-3; Babiuk S, 2002, VACCINE, V20, P3399, DOI 10.1016/S0264-410X(02)00269-4; Babiuk S, 2007, BIOELECTROCHEMISTRY, V70, P269, DOI 10.1016/j.bioelechem.2006.10.003; Bachy M, 2001, VACCINE, V19, P1688, DOI 10.1016/S0264-410X(00)00406-0; Best SR, 2009, VACCINE, V27, P5450, DOI 10.1016/j.vaccine.2009.07.005; Broderick KE, 2011, GENE THER, V18, P258, DOI 10.1038/gt.2010.137; Chen JJ, 2005, VACCINE, V23, P4322, DOI 10.1016/j.vaccine.2005.03.035; Chen Z, 2000, VACCINE, V18, P3214, DOI 10.1016/S0264-410X(00)00149-3; Daud AI, 2008, J CLIN ONCOL, V26, P5896, DOI 10.1200/JCO.2007.15.6794; Dobano C, 2007, VACCINE, V25, P6635, DOI 10.1016/j.vaccine.2007.06.036; Drabick JJ, 2001, MOL THER, V3, P249, DOI 10.1006/mthe.2000.0257; Dujardin N, 2001, PHARM RES-DORDR, V18, P61, DOI 10.1023/A:1011026726938; Encke J, 1999, INTERVIROLOGY, V42, P117, DOI 10.1159/000024971; Fattori Elena, 2002, Somatic Cell and Molecular Genetics, V27, P75, DOI 10.1023/A:1022927822244; Giese M, 1998, VIRUS GENES, V17, P219, DOI 10.1023/A:1008013720032; Gilbert RA, 1997, BBA-GEN SUBJECTS, V1334, P9, DOI 10.1016/S0304-4165(96)00119-5; Glasspool-Malone J, 2000, MOL THER, V2, P140, DOI 10.1006/mthe.2000.0107; Gurunathan S, 2000, ANNU REV IMMUNOL, V18, P927, DOI 10.1146/annurev.immunol.18.1.927; Heller LC, 2006, HUM GENE THER, V17, P890, DOI 10.1089/hum.2006.17.890; Heller R, 1996, FEBS LETT, V389, P225, DOI 10.1016/0014-5793(96)00590-X; Heller R, 2001, DNA CELL BIOL, V20, P21, DOI 10.1089/10445490150504666; Heller R, 2010, HUM GENE THER, V21, P357, DOI 10.1089/hum.2009.065; Hirao LA, 2008, VACCINE, V26, P440, DOI 10.1016/j.vaccine.2007.10.041; Hu H, 2009, VACCINE, V27, P1758, DOI 10.1016/j.vaccine.2009.01.021; Kadowaki S, 2000, VACCINE, V18, P2779, DOI 10.1016/S0264-410X(00)00087-6; Kim CY, 2008, EXP MOL MED, V40, P669, DOI 10.3858/emm.2008.40.6.669; Laddy DJ, 2009, J VIROL, V83, P4624, DOI 10.1128/JVI.02335-08; Littel-van den Hurk SV, 2008, VACCINE, V26, P5503, DOI 10.1016/j.vaccine.2008.07.093; Lu BJ, 2009, CLIN VACCINE IMMUNOL, V16, P73, DOI 10.1128/CVI.00261-08; Luxembourg A, 2008, VACCINE, V26, P5216, DOI 10.1016/j.vaccine.2008.03.064; Luxembourg A, 2006, VACCINE, V24, P4490, DOI 10.1016/j.vaccine.2005.08.014; Makidon PE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002954; Martinon F, 2009, HUM GENE THER, V20, P1291, DOI 10.1089/hum.2009.044; Maruyama H, 2001, GENE THER, V8, P1808, DOI 10.1038/sj.gt.3301604; McMahon JM, 2004, BIODRUGS, V18, P155, DOI 10.2165/00063030-200418030-00002; Medi Babu M., 2008, V423, P225, DOI 10.1007/978-1-59745-194-9_16; Medi BM, 2005, INT J PHARMACEUT, V294, P53, DOI 10.1016/j.ijpharm.2004.12.014; Muller I, 2009, TRENDS IMMUNOL, V30, P522, DOI 10.1016/j.it.2009.07.007; Muthumani K, 2009, CURR HIV RES, V7, P144, DOI 10.2174/157016209787581481; Muttil P, 2010, AAPS J, V12, P699, DOI 10.1208/s12248-010-9229-6; Nishi T, 1996, CANCER RES, V56, P1050; Otten G, 2004, VACCINE, V22, P2489, DOI 10.1016/j.vaccine.2003.11.073; Otten GR, 2006, VACCINE, V24, P4503, DOI 10.1016/j.vaccine.2005.08.017; Peachman KK, 2003, METHODS, V31, P232, DOI 10.1016/S1046-2023(03)00137-3; Ramanathan MP, 2009, VACCINE, V27, P4370, DOI 10.1016/j.vaccine.2009.01.137; Rosati M, 2009, P NATL ACAD SCI USA, V106, P15831, DOI 10.1073/pnas.0902628106; Scheerlinck JPY, 2004, VACCINE, V22, P1820, DOI 10.1016/j.vaccine.2003.09.053; Seo SH, 2009, VACCINE, V27, P5906, DOI 10.1016/j.vaccine.2009.07.033; Sueki H, 2000, EUR J DERMATOL, V10, P357; Tollefsen S, 2002, VACCINE, V20, P3370, DOI 10.1016/S0264-410X(02)00289-X; Trollet C, 2009, INFECT IMMUN, V77, P2221, DOI 10.1128/IAI.01269-08; Tuting T, 1998, J INVEST DERMATOL, V111, P183, DOI 10.1046/j.1523-1747.1998.00261.x; Vandermeulen G, 2007, J CONTROL RELEASE, V124, P81, DOI 10.1016/j.jconrel.2007.08.010; Wallace M, 2009, MOL THER, V17, P922, DOI 10.1038/mt.2009.27; Widera G, 2000, J IMMUNOL, V164, P4635, DOI 10.4049/jimmunol.164.9.4635; Wu CJ, 2004, VACCINE, V22, P1457, DOI 10.1016/j.vaccine.2003.10.011; Zhang L, 2004, BIOELECTROCHEMISTRY, V63, P369, DOI 10.1016/j.bioelechem.2003.11.011; Zhang L, 2002, BBA-GEN SUBJECTS, V1572, P1, DOI 10.1016/S0304-4165(02)00270-2; Zhao YG, 2006, VACCINE, V24, P897, DOI 10.1016/j.vaccine.2005.08.093; Zheng LY, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-17; Zucchelli S, 2000, J VIROL, V74, P11598, DOI 10.1128/JVI.74.24.11598-11607.2000; 2004, DRUGS R D, V5, P293	62	41	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19181	10.1371/journal.pone.0019181	http://dx.doi.org/10.1371/journal.pone.0019181			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559474	gold, Green Published, Green Submitted			2022-12-27	WOS:000290024700093
J	Konshina, AG; Boldyrev, IA; Utkin, YN; Omel'kov, AV; Efremov, RG				Konshina, Anastasia G.; Boldyrev, Ivan A.; Utkin, Yuri N.; Omel'kov, Anton V.; Efremov, Roman G.			Snake Cytotoxins Bind to Membranes via Interactions with Phosphatidylserine Head Groups of Lipids	PLOS ONE			English	Article							P-TYPE CARDIOTOXIN; DEPENDENT CONFORMATIONAL-CHANGE; PROTEIN-KINASE-C; NAJA-NAJA-ATRA; COBRA CARDIOTOXIN; VENOM CARDIOTOXIN; PHOSPHOLIPID ASYMMETRY; ANTIMICROBIAL PEPTIDES; GENETIC ALGORITHM; CRYSTAL-STRUCTURE	The major representatives of Elapidae snake venom, cytotoxins (CTs), share similar three-fingered fold and exert diverse range of biological activities against various cell types. CT-induced cell death starts from the membrane recognition process, whose molecular details remain unclear. It is known, however, that the presence of anionic lipids in cell membranes is one of the important factors determining CT-membrane binding. In this work, we therefore investigated specific interactions between one of the most abundant of such lipids, phosphatidylserine (PS), and CT 4 of Naja kaouthia using a combined, experimental and modeling, approach. It was shown that incorporation of PS into zwitterionic liposomes greatly increased the membrane-damaging activity of CT 4 measured by the release of the liposome-entrapped calcein fluorescent dye. The CT-induced leakage rate depends on the PS concentration with a maximum at approximately 20% PS. Interestingly, the effects observed for PS were much more pronounced than those measured for another anionic lipid, sulfatide. To delineate the potential PS binding sites on CT 4 and estimate their relative affinities, a series of computer simulations was performed for the systems containing the head group of PS and different spatial models of CT 4 in aqueous solution and in an implicit membrane. This was done using an original hybrid computational protocol implementing docking, Monte Carlo and molecular dynamics simulations. As a result, at least three putative PS-binding sites with different affinities to PS molecule were delineated. Being located in different parts of the CT molecule, these anion-binding sites can potentially facilitate and modulate the multi-step process of the toxin insertion into lipid bilayers. This feature together with the diverse binding affinities of the sites to a wide variety of anionic targets on the membrane surface appears to be functionally meaningful and may adjust CT action against different types of cells.	[Konshina, Anastasia G.; Boldyrev, Ivan A.; Utkin, Yuri N.; Omel'kov, Anton V.; Efremov, Roman G.] Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Moscow, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Konshina, AG (corresponding author), Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Moscow, Russia.	efremov@nmr.ru	Utkin, Yuri/L-2952-2019; Roman, Efremov/A-7460-2014; Konshina, Anastasia/T-8430-2017; Utkin, Yuri N./F-1958-2014; Boldyrev, Ivan/L-7879-2017	Utkin, Yuri/0000-0002-4609-970X; Roman, Efremov/0000-0002-5474-4721; Konshina, Anastasia/0000-0003-1270-9933; Utkin, Yuri N./0000-0002-4609-970X; 	Russian Foundation for Basic Research; RAS	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); RAS(Russian Academy of SciencesRegione Sardegna)	This work was supported by the Russian Foundation for Basic Research and by the RAS Programmes (MCB and "Basic Fundamental Research for Nanotechnologies and Nanomaterials"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN TM, 1984, LIPOSOME TECHNOLOGY, V3, P177; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Bevers EM, 2010, FEBS LETT, V584, P2724, DOI 10.1016/j.febslet.2010.03.020; Boas FE, 1998, P NATL ACAD SCI USA, V95, P3077, DOI 10.1073/pnas.95.6.3077; Buckland AG, 2000, BBA-MOL CELL BIOL L, V1483, P199, DOI 10.1016/S1388-1981(99)00188-2; BUTIKOFER P, 1990, J BIOL CHEM, V265, P16035; Chen KC, 2007, TOXICON, V50, P816, DOI 10.1016/j.toxicon.2007.06.011; CHIEN KY, 1994, J BIOL CHEM, V269, P14473; CHIOU SH, 1993, BIOCHEMISTRY-US, V32, P2062, DOI 10.1021/bi00059a025; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DAUPLAIS M, 1995, EUR J BIOCHEM, V230, P213, DOI 10.1111/j.1432-1033.1995.0213i.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dementieva DV, 1999, EUR J BIOCHEM, V263, P152, DOI 10.1046/j.1432-1327.1999.00478.x; Dubovskii PV, 2001, J MOL BIOL, V305, P137, DOI 10.1006/jmbi.2000.4283; DUFOURCQ J, 1982, TOXICON, V20, P165, DOI 10.1016/0041-0101(82)90187-8; DUFTON MJ, 1988, PHARMACOL THERAPEUT, V36, P1, DOI 10.1016/0163-7258(88)90111-8; Efremov R, 2001, THEOR CHEM ACC, V106, P48, DOI 10.1007/s002140000220; Efremov RG, 1999, BIOPHYS J, V76, P2448, DOI 10.1016/S0006-3495(99)77400-X; Efremov RG, 2002, BIOPHYS J, V83, P144, DOI 10.1016/S0006-3495(02)75156-4; EFREMOV RG, 1992, J PROTEIN CHEM, V11, P665, DOI 10.1007/BF01024968; Fadeel B, 2009, CRIT REV BIOCHEM MOL, V44, P264, DOI 10.1080/10409230903193307; Fadok VA, 1998, CELL DEATH DIFFER, V5, P551, DOI 10.1038/sj.cdd.4400404; Feofanov AV, 2005, BIOCHEM J, V390, P11, DOI 10.1042/BJ20041892; Feofanov AV, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1148, DOI 10.1023/B:BIRY.0000046890.46901.7e; Forouhar F, 2003, J BIOL CHEM, V278, P21980, DOI 10.1074/jbc.M208650200; GATINEAU E, 1987, BIOCHEMISTRY-US, V26, P8046, DOI 10.1021/bi00399a004; GATINEAU E, 1990, BIOCHEMISTRY-US, V29, P6480, DOI 10.1021/bi00479a021; GILQUIN B, 1993, BIOPOLYMERS, V33, P1659, DOI 10.1002/bip.360331104; Harris F, 2009, CURR PROTEIN PEPT SC, V10, P585, DOI 10.2174/138920309789630589; HODGES SJ, 1987, EUR J BIOCHEM, V165, P373, DOI 10.1111/j.1432-1033.1987.tb11450.x; Ishizuka I, 1997, PROG LIPID RES, V36, P245, DOI 10.1016/S0163-7827(97)00011-8; Jayaraman G, 1999, J BIOL CHEM, V274, P17869, DOI 10.1074/jbc.274.25.17869; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; JORGENSEN WL, 1989, J AM CHEM SOC, V111, P3770, DOI 10.1021/ja00192a057; Konshina A. G., 2003, Bioorganicheskaya Khimiya, V29, P577; Kukhtina VV, 2000, BIOORG KHIM+, V26, P803; Kumar TKS, 1997, J BIOMOL STRUCT DYN, V15, P431, DOI 10.1080/07391102.1997.10508957; Lee SC, 2005, J BIOL CHEM, V280, P9567, DOI 10.1074/jbc.M412398200; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Polyansky AA, 2010, J PHYS CHEM LETT, V1, P3108, DOI 10.1021/jz101163e; Polyansky AA, 2009, J PHYS CHEM B, V113, P1120, DOI 10.1021/jp803641x; Pyrkov TV, 2009, BIOINFORMATICS, V25, P1201, DOI 10.1093/bioinformatics/btp111; RAYNOR RL, 1991, J BIOL CHEM, V266, P2753; Scheuplein F, 2009, J IMMUNOL, V182, P2898, DOI 10.4049/jimmunol.0801711; Schlegel RA, 2001, CELL DEATH DIFFER, V8, P551, DOI 10.1038/sj.cdd.4400817; SESSIONS A, 1983, BIOCHIM BIOPHYS ACTA, V728, P103, DOI 10.1016/0005-2736(83)90442-X; Sevcsik E, 2008, BIOPHYS J, V94, P4688, DOI 10.1529/biophysj.107.123620; Shao C, 2008, J BIOL CHEM, V283, P7230, DOI 10.1074/jbc.M705195200; SHARONOV GV, 2008, INNOVATIVE MICROSCOP, P49; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; StevensTruss R, 1996, TOXICOL APPL PHARM, V139, P234, DOI 10.1006/taap.1996.0162; Sue SC, 2002, J BIOL CHEM, V277, P2666, DOI 10.1074/jbc.M104887200; Sue SC, 2001, BIOCHEMISTRY-US, V40, P10436, DOI 10.1021/bi010847n; Sue SC, 2001, BIOCHEMISTRY-US, V40, P12782, DOI 10.1021/bi010848f; Sun YJ, 1997, BIOCHEMISTRY-US, V36, P2403, DOI 10.1021/bi962594h; TAKECHI M, 1986, FEBS LETT, V205, P143, DOI 10.1016/0014-5793(86)80882-1; Tjong SC, 2007, BIOCHEMISTRY-US, V46, P12111, DOI 10.1021/bi700871x; Tjong SC, 2007, BIOCHEMISTRY-US, V46, P9941, DOI 10.1021/bi700995v; TZENG WF, 1988, BIOCHEM J, V256, P89, DOI 10.1042/bj2560089; van den Eijnde SM, 2001, J CELL SCI, V114, P3631; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; VERKLEIJ AJ, 1973, BIOCHIM BIOPHYS ACTA, V323, P178, DOI 10.1016/0005-2736(73)90143-0; Wang CH, 2006, J BIOL CHEM, V281, P656, DOI 10.1074/jbc.M507880200; Wang CH, 2005, FEBS LETT, V579, P3169, DOI 10.1016/j.febslet.2005.05.006; Wang PC, 2009, BIOCHEM BIOPH RES CO, V387, P617, DOI 10.1016/j.bbrc.2009.07.097; Wu PL, 2006, J BIOL CHEM, V281, P7937, DOI 10.1074/jbc.M513035200; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1; Zwaal RFA, 2005, CELL MOL LIFE SCI, V62, P971, DOI 10.1007/s00018-005-4527-3	69	39	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19064	10.1371/journal.pone.0019064	http://dx.doi.org/10.1371/journal.pone.0019064			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559494	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700058
J	Morlighem, JE; Aoki, S; Kishima, M; Hanami, M; Ogawa, C; Jalloh, A; Takahashi, Y; Kawai, Y; Saga, S; Hayashi, E; Ban, T; Izumi, S; Wada, A; Mano, M; Fukunaga, M; Kijima, Y; Shiomi, S; Inoue, K; Hata, T; Koretsune, Y; Kudo, K; Himeno, Y; Hirai, A; Takahashi, K; Sakai-Tagawa, Y; Iwatsuki-Horimoto, K; Kawaoka, Y; Hayashizaki, Y; Ishikawa, T				Morlighem, Jean-Etienne; Aoki, Shintaro; Kishima, Mami; Hanami, Mitsue; Ogawa, Chihiro; Jalloh, Amadu; Takahashi, Yukari; Kawai, Yuki; Saga, Satomi; Hayashi, Eiji; Ban, Toshiaki; Izumi, Shinyu; Wada, Akira; Mano, Masayuki; Fukunaga, Megumu; Kijima, Yoshiyuki; Shiomi, Shoji; Inoue, Kaoru; Hata, Takeshi; Koretsune, Yukihiro; Kudo, Koichiro; Himeno, Yuji; Hirai, Aizan; Takahashi, Kazuo; Sakai-Tagawa, Yuko; Iwatsuki-Horimoto, Kiyoko; Kawaoka, Yoshihiro; Hayashizaki, Yoshihide; Ishikawa, Toshihisa			Mutation Analysis of 2009 Pandemic Influenza A(H1N1) Viruses Collected in Japan during the Peak Phase of the Pandemic	PLOS ONE			English	Article							ORIGIN; HEMAGGLUTININ; EMERGENCE; CLEAVAGE; MODEL	Background: Pandemic influenza A(H1N1) virus infection quickly circulated worldwide in 2009. In Japan, the first case was reported in May 2009, one month after its outbreak in Mexico. Thereafter, A(H1N1) infection spread widely throughout the country. It is of great importance to profile and understand the situation regarding viral mutations and their circulation in Japan to accumulate a knowledge base and to prepare clinical response platforms before a second pandemic (pdm) wave emerges. Methodology: A total of 253 swab samples were collected from patients with influenza-like illness in the Osaka, Tokyo, and Chiba areas both in May 2009 and between October 2009 and January 2010. We analyzed partial sequences of the hemagglutinin (HA) and neuraminidase (NA) genes of the 2009 pdm influenza virus in the collected clinical samples. By phylogenetic analysis, we identified major variants of the 2009 pdm influenza virus and critical mutations associated with severe cases, including drug-resistance mutations. Results and Conclusions: Our sequence analysis has revealed that both HA-S220T and NA-N248D are major non-synonymous mutations that clearly discriminate the 2009 pdm influenza viruses identified in the very early phase (May 2009) from those found in the peak phase (October 2009 to January 2010) in Japan. By phylogenetic analysis, we found 14 micro-clades within the viruses collected during the peak phase. Among them, 12 were new micro-clades, while two were previously reported. Oseltamivir resistance-related mutations, i.e., NA-H275Y and NA-N295S, were also detected in sporadic cases in Osaka and Tokyo.	[Morlighem, Jean-Etienne; Aoki, Shintaro; Kishima, Mami; Hanami, Mitsue; Ogawa, Chihiro; Jalloh, Amadu; Takahashi, Yukari; Kawai, Yuki; Saga, Satomi; Hayashizaki, Yoshihide; Ishikawa, Toshihisa] RIKEN Yokohama Inst, Omics Sci Ctr, Yokohama, Kanagawa, Japan; [Hayashi, Eiji; Hirai, Aizan] Chiba Prefectural Togane Hosp, Togane, Japan; [Ban, Toshiaki; Himeno, Yuji] Isumi Med Ctr, Isumi, Japan; [Izumi, Shinyu; Kudo, Koichiro] Natl Ctr Global Hlth & Med, Tokyo, Japan; [Wada, Akira; Mano, Masayuki; Koretsune, Yukihiro] Osaka Natl Hosp, Natl Hosp Org, Osaka, Japan; [Fukunaga, Megumu] Toyonaka City Hosp, Toyonaka, Osaka, Japan; [Kijima, Yoshiyuki; Hata, Takeshi] Higashi Osaka City Gen Hosp, Higashi Osaka, Japan; [Shiomi, Shoji; Inoue, Kaoru] Osaka City Gen Hosp, Osaka, Japan; [Takahashi, Kazuo] Osaka Prefectural Inst Publ Hlth, Osaka 537, Japan; [Sakai-Tagawa, Yuko; Iwatsuki-Horimoto, Kiyoko; Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Tokyo, Japan	RIKEN; National Center for Global Health & Medicine - Japan; Osaka National Hospital; Osaka City General Hospital; Osaka Prefectural Institute of Public Health; University of Tokyo	Morlighem, JE (corresponding author), RIKEN Yokohama Inst, Omics Sci Ctr, Yokohama, Kanagawa, Japan.	toshi-i@gsc.riken.jp	Morlighem, Jean-Etienne/D-1814-2010; Hayashizaki, Yoshihide/N-6590-2015	Morlighem, Jean-Etienne/0000-0003-2754-8677	Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [23590145] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Special Coordination Funds for Promoting Science and Technology as well as a Research Grant for RIKEN Omics Science Center (to Y. Hayashizaki) from the Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P453; [Anonymous], 2009, NOV INFL; Baranovich T, 2010, J CLIN VIROL, V47, P23, DOI 10.1016/j.jcv.2009.11.003; CASTRUCCI MR, 1993, J VIROL, V67, P759, DOI 10.1128/JVI.67.2.759-764.1993; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Das K, 2010, NAT STRUCT MOL BIOL, V17, P530, DOI 10.1038/nsmb.1779; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; DESHPANDE KL, 1987, P NATL ACAD SCI USA, V84, P36, DOI 10.1073/pnas.84.1.36; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Englund J., 2009, Morbidity and Mortality Weekly Report, V58, P893; Fereidouni SR, 2009, EUROSURVEILLANCE, V14; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gubareva LV, 2000, LANCET, V355, P827, DOI 10.1016/S0140-6736(99)11433-8; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; GUNTHER I, 1993, VIRUS RES, V27, P147, DOI 10.1016/0168-1702(93)90078-2; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jhung M., 2010, Morbidity and Mortality Weekly Report, V59, P423; Kilander A, 2010, EUROSURVEILLANCE, V15, P6; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Kiso M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001079; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; Leung TWC, 2009, J CLIN VIROL, V46, P298, DOI 10.1016/j.jcv.2009.08.004; LUOH SM, 1992, J VIROL, V66, P1066, DOI 10.1128/JVI.66.2.1066-1073.1992; Mai LQ, 2010, NEW ENGL J MED, V362, P86, DOI 10.1056/NEJMc0910448; Matsuzaki Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-53; Munier S, 2010, J VIROL, V84, P940, DOI 10.1128/JVI.01581-09; Nelson Martha, 2009, PLoS Curr, V1, pRRN1126; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Pan CE, 2010, PLOS ONE, V5, pA31, DOI 10.1371/journal.pone.0009549; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, TRACER V1 4; Reid AH, 2003, EMERG INFECT DIS, V9, P1249; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Schnitzler SU, 2009, VIRUS GENES, V39, P279, DOI 10.1007/s11262-009-0404-8; SHEERAR MG, 1989, J GEN VIROL, V70, P3297, DOI 10.1099/0022-1317-70-12-3297; Shiino T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011057; SKEHEL JJ, 1984, P NATL ACAD SCI-BIOL, V81, P1779, DOI 10.1073/pnas.81.6.1779; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taubenberger JK, 1997, SCIENCE, V275, P1793, DOI 10.1126/science.275.5307.1793; WHO, 2010, H1N1 POSTP PER; *WHO, 2008, INFL A H1N1 VIR RES; WHO (World Health Organization), 2010, PAND H1N1 2009 UPD 9; World Health Organization (WHO), 2010, INFL UPD 115; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008905; Zambon M, 2001, ANTIVIR RES, V49, P147, DOI 10.1016/S0166-3542(01)00124-3; Zhou B, 2009, J VIROL, V83, P10309, DOI 10.1128/JVI.01109-09; Zhou HB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006277	53	37	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18956	10.1371/journal.pone.0018956	http://dx.doi.org/10.1371/journal.pone.0018956			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21572517	Green Submitted, gold, Green Published			2022-12-27	WOS:000290024700042
J	Raveh, B; London, N; Zimmerman, L; Schueler-Furman, O				Raveh, Barak; London, Nir; Zimmerman, Lior; Schueler-Furman, Ora			Rosetta FlexPepDockab-initio: Simultaneous Folding, Docking and Refinement of Peptides onto Their Receptors	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; STRUCTURAL BASIS; PHAGE DISPLAY; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURES; BINDING; RECOGNITION; IDENTIFICATION; DOMAIN; INTERFACES	Flexible peptides that fold upon binding to another protein molecule mediate a large number of regulatory interactions in the living cell and may provide highly specific recognition modules. We present Rosetta FlexPepDockab-initio, a protocol for simultaneous docking and de-novo folding of peptides, starting from an approximate specification of the peptide binding site. Using the Rosetta fragments library and a coarse-grained structural representation of the peptide and the receptor, FlexPepDockab-initio samples efficiently and simultaneously sampled the space of possible peptide backbone conformations and rigid-body orientations over the receptor surface of a given binding site. The subsequent all-atom refinement of the coarse-grained models includes full side-chain modeling of both the receptor and the peptide, resulting in high-resolution models in which key side-chain interactions are recapitulated. The protocol was applied to a benchmark in which peptides were modeled over receptors in either their bound backbone conformations or in their free, unbound form. Near-native peptide conformations were identified in 18/26 of the bound cases and 7/14 of the unbound cases. The protocol performswell on peptides from various classes of secondary structures, including coiled peptides with unusual turns and kinks. The results presented here significantly extend the scope of state-of-the-art methods for high-resolution peptide modeling, which can now be applied to a wide variety of peptide-protein interactions where no prior information about the peptide backbone conformation is available, enabling detailed structure-based studies and manipulation of those interactions.	[Raveh, Barak; London, Nir; Zimmerman, Lior; Schueler-Furman, Ora] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Microbiol & Mol Genet, IL-91010 Jerusalem, Israel; [Raveh, Barak] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel	Hebrew University of Jerusalem; Tel Aviv University	Raveh, B (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Microbiol & Mol Genet, IL-91010 Jerusalem, Israel.	oraf@ekmd.huji.ac.il	Schueler-Furman, Ora/AAC-5932-2020	Schueler-Furman, Ora/0000-0002-1624-0362; Zimmerman, Lior/0000-0003-2775-0330; London, Nir/0000-0003-2687-0699	Israel Academy of Science and Humanities ISF [306/6]; USA-Israel Bi-national Science Foundation [2009418]; European Commission [255827]	Israel Academy of Science and Humanities ISF; USA-Israel Bi-national Science Foundation(US-Israel Binational Science Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work has been supported by the Israel Science Foundation, funded by the Israel Academy of Science and Humanities ISF Grant 306/6, the USA-Israel Bi-national Science Foundation Grant 2009418 (to OSF), and in part by the 7th Framework Programme for Research of the European Commission, under FET-Open grant number 255827, CGL, Computational Geometry Learning (to BR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-451; Antes I, 2010, PROTEINS, V78, P1084, DOI 10.1002/prot.22629; Audie J, 2010, CURR PHARM DESIGN, V16, P567, DOI 10.2174/138161210790361425; BELITSKY M, 2011, MOL CELL IN PRESS; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brenke R, 2009, BIOINFORMATICS, V25, P621, DOI 10.1093/bioinformatics/btp036; Buch I, 2010, BIOCHEMISTRY-US, V49, P10890, DOI 10.1021/bi100822q; Burnier M, 2001, CIRCULATION, V103, P904, DOI 10.1161/01.CIR.103.6.904; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; CRAWLEY SW, 2010, J BIOL CHEM IN PRESS; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; Dutta S, 2010, J MOL BIOL, V398, P747, DOI 10.1016/j.jmb.2010.03.058; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gai SA, 2007, CURR OPIN STRUC BIOL, V17, P467, DOI 10.1016/j.sbi.2007.08.012; Gehmlich K, 2007, J MOL BIOL, V369, P665, DOI 10.1016/j.jmb.2007.03.050; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Guhaniyogi J, 2006, J MOL BIOL, V359, P624, DOI 10.1016/j.jmb.2006.03.050; Hashemzadeh Mehrnoosh, 2008, Exp Clin Cardiol, V13, P192; Hetenyi C, 2002, PROTEIN SCI, V11, P1729, DOI 10.1110/ps.0202302; Im YJ, 2003, J BIOL CHEM, V278, P8501, DOI 10.1074/jbc.M212263200; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KATZ C, 2011, CHEMSOC REV IN PRESS; Kondo T, 2010, SCIENCE, V329, P336, DOI 10.1126/science.1188158; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Ladner RC, 2004, DRUG DISCOV TODAY, V9, P525, DOI 10.1016/S1359-6446(04)03104-6; Li Y, 2005, MOL CELL, V17, P491, DOI 10.1016/j.molcel.2005.02.002; LI ZQ, 1987, P NATL ACAD SCI USA, V84, P6611, DOI 10.1073/pnas.84.19.6611; London N, 2010, PROTEINS, V78, P3140, DOI 10.1002/prot.22785; London N, 2010, STRUCTURE, V18, P188, DOI 10.1016/j.str.2009.11.012; Mandell JG, 1998, P NATL ACAD SCI USA, V95, P14705, DOI 10.1073/pnas.95.25.14705; Molek P, 2011, MOLECULES, V16, P857, DOI 10.3390/molecules16010857; Moncalian G, 2006, J BIOL CHEM, V281, P38845, DOI 10.1074/jbc.M606411200; Morrison KL, 2001, CURR OPIN CHEM BIOL, V5, P302, DOI 10.1016/S1367-5931(00)00206-4; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Niv MY, 2005, J AM CHEM SOC, V127, P14072, DOI 10.1021/ja054195s; Parthasarathi L, 2008, J CHEM INF MODEL, V48, P1943, DOI 10.1021/ci800174c; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Petsalaki E, 2008, CURR OPIN BIOTECH, V19, P344, DOI 10.1016/j.copbio.2008.06.004; Petsalaki E, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000335; Prasad PA, 2008, J COMPUT AID MOL DES, V22, P815, DOI 10.1007/s10822-008-9216-5; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Rubinstein M, 2009, BIOPOLYMERS, V91, P505, DOI 10.1002/bip.21164; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Stein A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002524; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; VANHEE P, 2011, TRENDS BIOT IN PRESS; Vanhee P, 2010, NUCLEIC ACIDS RES, V38, pD545, DOI 10.1093/nar/gkp893; Vanhee P, 2009, STRUCTURE, V17, P1128, DOI 10.1016/j.str.2009.06.013; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Wang C, 2005, PROTEIN SCI, V14, P1328, DOI 10.1110/ps.041222905; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Zachariae U, 2006, J BIOL CHEM, V281, P7413, DOI 10.1074/jbc.M510939200	55	187	190	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18934	10.1371/journal.pone.0018934	http://dx.doi.org/10.1371/journal.pone.0018934			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21572516	Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700038
J	Shapiro, AG; Knight, EJ; Lu, ZL				Shapiro, Arthur G.; Knight, Emily J.; Lu, Zhong-Lin			A First- and Second-Order Motion Energy Analysis of Peripheral Motion Illusions Leads to Further Evidence of "Feature Blur" in Peripheral Vision	PLOS ONE			English	Article							VISUAL-MOTION; PERCEPTION; CONTRAST; SENSITIVITY; INTEGRATION; DISCRIMINATION; MECHANISMS; FREQUENCY; FOVEAL; PHASE	Background: Anatomical and physiological differences between the central and peripheral visual systems are well documented. Recent findings have suggested that vision in the periphery is not just a scaled version of foveal vision, but rather is relatively poor at representing spatial and temporal phase and other visual features. Shapiro, Lu, Huang, Knight, and Ennis (2010) have recently examined a motion stimulus (the "curveball illusion") in which the shift from foveal to peripheral viewing results in a dramatic spatial/temporal discontinuity. Here, we apply a similar analysis to a range of other spatial/temporal configurations that create perceptual conflict between foveal and peripheral vision. Methodology/Principal Findings: To elucidate how the differences between foveal and peripheral vision affect super-threshold vision, we created a series of complex visual displays that contain opposing sources of motion information. The displays (referred to as the peripheral escalator illusion, peripheral acceleration and deceleration illusions, rotating reversals illusion, and disappearing squares illusion) create dramatically different perceptions when viewed foveally versus peripherally. We compute the first-order and second-order directional motion energy available in the displays using a three-dimensional Fourier analysis in the (x, y, t) space. The peripheral escalator, acceleration and deceleration illusions and rotating reversals illusion all show a similar trend: in the fovea, the first-order motion energy and second-order motion energy can be perceptually separated from each other; in the periphery, the perception seems to correspond to a combination of the multiple sources of motion information. The disappearing squares illusion shows that the ability to assemble the features of Kanisza squares becomes slower in the periphery. Conclusions/Significance: The results lead us to hypothesize "feature blur" in the periphery (i.e., the peripheral visual system combines features that the foveal visual system can separate). Feature blur is of general importance because humans are frequently bringing the information in the periphery to the fovea and vice versa.	[Shapiro, Arthur G.] American Univ, Dept Psychol, Washington, DC 20016 USA; [Knight, Emily J.] Guggenheim 2 Mayo Grad Mayo Med Sch, Rochester, MN USA; [Lu, Zhong-Lin] Univ So Calif, Dept Psychol, Grad Program Neurosci, Los Angeles, CA 90089 USA; [Lu, Zhong-Lin] Univ So Calif, Dept Biomed Engn, Grad Program Neurosci, Los Angeles, CA 90089 USA	American University; University of Southern California; University of Southern California	Shapiro, AG (corresponding author), American Univ, Dept Psychol, Washington, DC 20016 USA.	Arthur.Shapiro@american.edu		Lu, Zhong-Lin/0000-0002-7295-727X; Knight, Emily/0000-0002-6971-1148	National Eye Institute [EY017491, R15EY021008]; National Institute of Mental Health [MH081018]; NATIONAL EYE INSTITUTE [R15EY021008, R01EY017491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081018] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The work is supported by the National Eye Institute (EY017491 and R15EY021008 [Z-LL], and R15EY021008 [AGS]) and the National Institute of Mental Health (MH081018 [Z-LL]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; BENNETT PJ, 1987, NATURE, V326, P873, DOI 10.1038/326873a0; BRADY T, 2005, SOC NEUR ANN M; Bressler DW, 2006, VISION RES, V46, P1120, DOI 10.1016/j.visres.2005.10.012; CHUBB C, 1989, P NATL ACAD SCI USA, V86, P2985, DOI 10.1073/pnas.86.8.2985; Chung STL, 2001, VISION RES, V41, P1833, DOI 10.1016/S0042-6989(01)00071-2; COHEN MA, 1984, PERCEPT PSYCHOPHYS, V36, P428, DOI 10.3758/BF03207497; CORMACK R, 1992, VISION RES, V32, P73, DOI 10.1016/0042-6989(92)90114-X; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Falchier A, 2002, J NEUROSCI, V22, P5749; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; HILZ R, 1981, EXP BRAIN RES, V43, P111; Hsieh PJ, 2006, VISION RES, V46, P2251, DOI 10.1016/j.visres.2005.11.030; Juttner M, 1996, VISION RES, V36, P1007, DOI 10.1016/0042-6989(95)00250-2; KNIGHT EJ, 2007, ILLUSION CONTEST ENT; Levi DM, 2008, VISION RES, V48, P635, DOI 10.1016/j.visres.2007.12.009; Levi DM, 2002, J VISION, V2, P140, DOI 10.1167/2.2.2; LEVI DM, 1983, VISION RES, V23, P1005, DOI 10.1016/0042-6989(83)90011-1; LEVI DM, 1984, VISION RES, V24, P789, DOI 10.1016/0042-6989(84)90150-0; Lu ZL, 2001, J OPT SOC AM A, V18, P2331, DOI 10.1364/JOSAA.18.002331; Lu ZL, 1996, J OPT SOC AM A, V13, P2305, DOI 10.1364/JOSAA.13.002305; LU ZL, 1995, VISION RES, V35, P2697, DOI 10.1016/0042-6989(95)00025-U; MARKOV NT, 2008, SOC NEUR ANN M; MARTIN PR, 2004, VISUAL NEUROSCIENCES; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; MATEEFF S, 1983, BIOL CYBERN, V49, P111, DOI 10.1007/BF00320391; May KA, 2007, J VISION, V7, DOI 10.1167/7.12.13; MEILSTRUP PB, 2008, SOC NEUR ANN M; MORRONE MC, 1989, VISION RES, V29, P433, DOI 10.1016/0042-6989(89)90007-2; Nandy AS, 2007, J VISION, V7, DOI 10.1167/7.2.5; Pelli DG, 2008, NAT NEUROSCI, V11, P1129, DOI 10.1038/nn.2187; Pelli DG, 2004, J VISION, V4, P1136, DOI 10.1167/4.12.12; ROVAMO J, 1984, PERCEPTION, V13, P665, DOI 10.1068/p130665; Shapiro AG, 2005, J VISION, V5, P764, DOI 10.1167/5.10.2; Shapiro AG, 2004, J VISION, V4, P459, DOI 10.1167/4.6.5; SHAPIRO AG, 2008, SOC NEUR ANN M; Shapiro A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013296; Shapiro AG, 2008, J VISION, V8, DOI 10.1167/8.1.8; SHAPLEY R, 1985, PERCEPT PSYCHOPHYS, V37, P84, DOI 10.3758/BF03207143; Smith AT, 1998, VISION RES, V38, P403, DOI 10.1016/S0042-6989(97)00134-X; SOLOMON JA, 1994, VISION RES, V34, P2239, DOI 10.1016/0042-6989(94)90105-8; STRASBURGER H, 1994, EUR J NEUROSCI, V6, P1583, DOI 10.1111/j.1460-9568.1994.tb00548.x; STRASBURGER H, 1991, PERCEPT PSYCHOPHYS, V49, P495, DOI 10.3758/BF03212183; TOOTELL RBH, 1988, J NEUROSCI, V8, P1531; TOOTELL RBH, 1982, SCIENCE, V218, P902, DOI 10.1126/science.7134981; Tse PU, 2006, VISION RES, V46, P3881, DOI 10.1016/j.visres.2006.06.010; WASSLE H, 1989, NATURE, V341, P643, DOI 10.1038/341643a0; Whitney D, 2002, VIS COGN, V9, P139, DOI 10.1080/13506280143000368; Whitney D, 2000, NAT NEUROSCI, V3, P954, DOI 10.1038/78878; Xing J, 2000, VISION RES, V40, P3065, DOI 10.1016/S0042-6989(00)00152-8; Zanker JM, 1997, J OPT SOC AM A, V14, P1385, DOI 10.1364/JOSAA.14.001385; ZHANG J, 1993, VISION RES, V33, P2721, DOI 10.1016/0042-6989(93)90231-K	53	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18719	10.1371/journal.pone.0018719	http://dx.doi.org/10.1371/journal.pone.0018719			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559513	Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700021
J	Singh, A; Prasad, R				Singh, Ashutosh; Prasad, Rajendra			Comparative Lipidomics of Azole Sensitive and Resistant Clinical Isolates of Candida albicans Reveals Unexpected Diversity in Molecular Lipid Imprints	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; FLUCONAZOLE RESISTANCE; MULTIDRUG-RESISTANCE; PHOSPHATIDYLSERINE DECARBOXYLASE; DRUG SUSCEPTIBILITIES; MEMBRANE-PROTEIN; GENETIC-BASIS; DIACYLGLYCEROL; EPIDEMIOLOGY; ACTIVATION	Although transcriptome and proteome approaches have been applied to determine the regulatory circuitry behind multidrug resistance (MDR) in Candida, its lipidome remains poorly characterized. Lipids do acclimatize to the development of MDR in Candida, but exactly how the acclimatization is achieved is poorly understood. In the present study, we have used a high-throughput mass spectrometry-based shotgun approach and analyzed the lipidome of genetically matched clinical azole-sensitive (AS) and -resistant (AR) isolates of C. albicans. By comparing the lipid profiling of matched isolates, we have identified major classes of lipids and determined more than 200 individual molecular lipid species among these major classes. The lipidome analysis has been statistically validated by principal component analysis. Although each AR isolate was similar with regard to displaying a high MIC to drugs, they had a distinct lipid imprint. There were some significant commonalities in the lipid profiles of these pairs, including molecular lipid species ranging from monounsaturated to polyunsaturated fatty acid-containing phosphoglycerides. Consistent fluctuation in phosphatidyl serine, mannosylinositol-phosphorylceramides, and sterol esters levels indicated their compensatory role in maintaining lipid homeostasis among most AR isolates. Notably, overexpression of either CaCdr1p or CaMdr1p efflux pump proteins led to a different lipidomic response among AR isolates. This study clearly establishes the versatility of lipid metabolism in handling azole stress among various matched AR isolates. This comprehensive lipidomic approach will serve as a resource for assessing strategies aimed at disrupting the functions of Candida lipids, particularly the functional interactions between lipids and MDR determinants.	[Singh, Ashutosh; Prasad, Rajendra] Jawaharlal Nehru Univ, Sch Life Sci, Membrane Biol Lab, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Singh, A (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Membrane Biol Lab, New Delhi 110067, India.	rp47@mail.jnu.ac.in	SINGH, ASHUTOSH/AAR-1283-2021	SINGH, ASHUTOSH/0000-0002-0995-6696	Department of Biotechnology [BT/PR9100/Med/29/03/2007, BT/PR9563/BRB/10/567/2007, BT/PR11158/BRB/10/640/2008, BT/PR13641/MED/29/175/2010]; National Science Foundation [EPS 0236913, MCB 0455318, DBI 0521587]; Kansas Technology Enterprise Corporation; K-IDeA Networks of Biomedical Research Excellence (INBRE) of National Institutes of Health [P20RR16475]; Johnson Cancer Center; Kansas State University; University Grants Commission; Council of Scientific and Industrial Research, Government of India; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER	Department of Biotechnology; National Science Foundation(National Science Foundation (NSF)); Kansas Technology Enterprise Corporation; K-IDeA Networks of Biomedical Research Excellence (INBRE) of National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johnson Cancer Center; Kansas State University; University Grants Commission(University Grants Commission, India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The work presented in this paper has been supported in part by grants to R.P. from Department of Biotechnology (BT/PR9100/Med/29/03/2007, BT/PR9563/BRB/10/567/2007, BT/PR11158/BRB/10/640/2008, BT/PR13641/MED/29/175/2010). The lipid analyses described in this work were partly performed at the Kansas Lipidomics Research Center Analytical Laboratory, where equipment acquisition and method development were funded by National Science Foundation (EPS 0236913, MCB 0455318, DBI 0521587), Kansas Technology Enterprise Corporation, K-IDeA Networks of Biomedical Research Excellence (INBRE) of National Institutes of Health (P20RR16475), the Johnson Cancer Center, and Kansas State University. A.S. is thankful to the University Grants Commission, and Council of Scientific and Industrial Research, Government of India, for junior research fellowships award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Batova M, 2008, CURR GENET, V53, P313, DOI 10.1007/s00294-008-0187-9; Bleijerveld OB, 2006, ANAL BIOCHEM, V352, P1, DOI 10.1016/j.ab.2006.02.016; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bogdanov M, 1999, J BIOL CHEM, V274, P12339, DOI 10.1074/jbc.274.18.12339; Bogdanov M, 1996, J BIOL CHEM, V271, P11615, DOI 10.1074/jbc.271.20.11615; Chen YL, 2010, MOL MICROBIOL, V75, P1112, DOI 10.1111/j.1365-2958.2009.07018.x; Clark TA, 2002, CURR OPIN INFECT DIS, V15, P569, DOI 10.1097/00001432-200212000-00003; Cowen LE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000471; Devaiah SP, 2006, PHYTOCHEMISTRY, V67, P1907, DOI 10.1016/j.phytochem.2006.06.005; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Ferreira CR, 2010, J LIPID RES, V51, P1218, DOI 10.1194/jlr.D001768; Franz R, 1999, MYCOSES, V42, P453, DOI 10.1046/j.1439-0507.1999.00498.x; Franz R, 1998, ANTIMICROB AGENTS CH, V42, P3065, DOI 10.1128/AAC.42.12.3065; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Gulshan K, 2008, MOL CELL BIOL, V28, P5851, DOI 10.1128/MCB.00405-08; HAN XL, 1994, P NATL ACAD SCI USA, V91, P10635, DOI 10.1073/pnas.91.22.10635; HITCHCOCK CA, 1986, J GEN MICROBIOL, V132, P2421; Hunte C, 2005, BIOCHEM SOC T, V33, P938, DOI 10.1042/BST0330938; Karababa M, 2004, ANTIMICROB AGENTS CH, V48, P3064, DOI 10.1128/AAC.48.8.3064-3079.2004; KISHIMOTO A, 1980, J BIOL CHEM, V255, P2273; Kohli A, 2002, ANTIMICROB AGENTS CH, V46, P1046, DOI 10.1128/AAC.46.4.1046-1052.2002; LaFayette SL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001069; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Loffler J, 2000, FEMS MICROBIOL LETT, V185, P59, DOI 10.1016/S0378-1097(00)00071-9; Madani S, 2001, FASEB J, V15, P2595, DOI 10.1096/fj.01-0753int; Marie C, 2009, CURR FUNGAL INFECT R, V3, P163, DOI 10.1007/s12281-009-0021-y; Morschhauser J, 2002, BBA-MOL BASIS DIS, V1587, P240, DOI 10.1016/S0925-4439(02)00087-X; Mukhopadhyay K, 2004, ANTIMICROB AGENTS CH, V48, P1778, DOI 10.1128/AAC.48.5.1778-1787.2004; Mukhopadhyay K, 2002, ANTIMICROB AGENTS CH, V46, P3695, DOI 10.1128/AAC.46.12.3695-3705.2002; NEWTON AC, 1994, BIOCHEMISTRY-US, V33, P6651, DOI 10.1021/bi00187a035; NEWTON AC, 1993, ANNU REV BIOPH BIOM, V22, P1, DOI 10.1146/annurev.bb.22.060193.000245; Pasrija R, 2005, BIOCHEM SOC T, V33, P1219, DOI 10.1042/BST20051219; Pasrija R, 2008, ANTIMICROB AGENTS CH, V52, P694, DOI 10.1128/AAC.00861-07; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Prasad R, 2005, INT REV CYTOL, V242, P215; Richardson MD, 2005, J ANTIMICROB CHEMOTH, V56, P5, DOI 10.1093/jac/dki218; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Roberts LD, 2008, J CHROMATOGR B, V871, P174, DOI 10.1016/j.jchromb.2008.04.002; Sanglard D, 2005, MOL PRINCIPLES FUNGA, P197; Sanglard D, 2009, FEMS YEAST RES, V9, P1029, DOI 10.1111/j.1567-1364.2009.00578.x; Shahi P, 2009, BBA-PROTEINS PROTEOM, V1794, P852, DOI 10.1016/j.bbapap.2008.12.012; Shevchenko A, 2010, NAT REV MOL CELL BIO, V11, P593, DOI 10.1038/nrm2934; Singh A, 2010, OMICS, V14, P665, DOI 10.1089/omi.2010.0041; TAKAI Y, 1979, BIOCHEM BIOPH RES CO, V91, P1218, DOI 10.1016/0006-291X(79)91197-5; Tate CG, 2001, FEBS LETT, V504, P94, DOI 10.1016/S0014-5793(01)02711-9; Tortorano AM, 2006, INT J ANTIMICROB AG, V27, P359, DOI 10.1016/j.ijantimicag.2006.01.002; Wagner S, 2006, TRENDS BIOTECHNOL, V24, P364, DOI 10.1016/j.tibtech.2006.06.008; Watson AD, 2006, J LIPID RES, V47, P2101, DOI 10.1194/jlr.R600022-JLR200; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Wisching S, 2000, MOL MICROBIOL, V36, P856	52	21	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19266	10.1371/journal.pone.0019266	http://dx.doi.org/10.1371/journal.pone.0019266			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559392	Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700117
J	Steel, C; Nutman, TB				Steel, Cathy; Nutman, Thomas B.			Altered T Cell Memory and Effector Cell Development in Chronic Lymphatic Filarial Infection That Is Independent of Persistent Parasite Antigen	PLOS ONE			English	Article							CHRONIC VIRAL-INFECTION; CHRONIC CHAGAS-DISEASE; C HIV-1 INFECTION; LEISHMANIA-MAJOR; BANCROFTIAN FILARIASIS; HUMAN IMMUNOSENESCENCE; RECEPTOR EXPRESSION; ENDEMIC FILARIASIS; CYTOKINE CONTROL; PACIFIC ISLAND	Chronic lymphatic filarial (LF) infection is associated with suppression of parasite-specific T cell responses that persist even following elimination of infection. While several mechanisms have been implicated in mediating this T cell specific downregulation, a role for alterations in the homeostasis of T effector and memory cell populations has not been explored. Using multiparameter flow cytometry, we investigated the role of persistent filarial infection on the maintenance of T cell memory in patients from the filarial-endemic Cook Islands. Compared to filarial-uninfected endemic normals (EN), microfilaria (mf) positive infected patients (Inf) had a reduced CD4 central memory (T(CM)) compartment. In addition, Inf patients tended to have more effector memory cells (T(EM)) and fewer effector cells (T(EFF)) than did ENs giving significantly smaller T(EFF) : T(EM) ratios. These contracted T(CM) and T(EFF) populations were still evident in patients previously mf+ who had cleared their infection (CLInf). Moreover, the density of IL-7R alpha, necessary for T memory cell maintenance (but decreased in T effector cells), was significantly higher on memory cells of Inf and CLInf patients, although there was no evidence for decreased IL-7 or increased soluble IL7-R alpha, both possible mechanisms for signaling defects in memory cells. However, effector cells that were present in Inf and CLInf patients had lower percentages of HLA-DR suggesting impaired function. These changes in T cell populations appear to reflect chronicity of infection, as filarial-infected children, despite the presence of active infection, did not show alterations in the frequencies of these T cell phenotypes. These data indicate that filarial-infected patients have contracted T(CM) compartments and a defect in effector cell development, defects that persist even following clearance of infection. The fact that these global changes in memory and effector cell compartments do not yet occur in infected children makes early treatment of LF even more crucial.	[Steel, Cathy; Nutman, Thomas B.] NIH, Parasit Dis Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Steel, C (corresponding author), NIH, Parasit Dis Lab, Bethesda, MD 20892 USA.	csteel@niaid.nih.gov			NIH/NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000197] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the NIH/NIAID. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albareda MC, 2006, INT IMMUNOL, V18, P465, DOI 10.1093/intimm/dxh387; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Arens R, 2001, IMMUNITY, V15, P801, DOI 10.1016/S1074-7613(01)00236-9; Babu S, 2006, J IMMUNOL, V176, P3248, DOI 10.4049/jimmunol.176.5.3248; Babu S, 2006, J IMMUNOL, V176, P3885, DOI 10.4049/jimmunol.176.7.3885; Babu S, 2009, J INFECT DIS, V200, P288, DOI 10.1086/599797; Bhadra R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010842; Bouneauld C, 2005, J EXP MED, V201, P579, DOI 10.1084/jem.20040876; Boutboul F, 2005, AIDS, V19, P1981, DOI 10.1097/01.aids.0000191919.24185.46; Bruns H, 2009, J CLIN INVEST, V119, P1167, DOI 10.1172/JCI38482; Burgers WA, 2009, J IMMUNOL, V182, P4751, DOI 10.4049/jimmunol.0803801; Bustamante JM, 2008, NAT MED, V14, P542, DOI 10.1038/nm1744; Albareda MC, 2009, J IMMUNOL, V183, P4103, DOI 10.4049/jimmunol.0900852; Chandele A, 2008, J IMMUNOL, V180, P5309, DOI 10.4049/jimmunol.180.8.5309; Colpitts SL, 2010, J IMMUNOL, V185, P2416, DOI 10.4049/jimmunol.1000483; Cooper PJ, 1998, J INFECT DIS, V178, P1133, DOI 10.1086/515661; Cooper PJ, 2003, AM J RESP CRIT CARE, V168, P313, DOI 10.1164/rccm.200211-1320OC; Cooper PJ, 2001, INFECT IMMUN, V69, P1574, DOI 10.1128/IAI.69.3.1574-1580.2001; Crawley AM, 2010, J IMMUNOL, V184, P4679, DOI 10.4049/jimmunol.0903758; Faucher S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006690; Fuller MJ, 2005, J IMMUNOL, V174, P5926, DOI 10.4049/jimmunol.174.10.5926; Gollob KJ, 2008, INT IMMUNOPHARMACOL, V8, P1338, DOI 10.1016/j.intimp.2008.03.016; Hammerbeck CD, 2008, J IMMUNOL, V180, P2107, DOI 10.4049/jimmunol.180.4.2107; Harnett W, 2009, ADV EXP MED BIOL, V666, P88; Jenson JS, 2002, EUR J IMMUNOL, V32, P858, DOI 10.1002/1521-4141(200203)32:3<858::AID-IMMU858>3.0.CO;2-E; KING CL, 1993, J CLIN INVEST, V92, P1667, DOI 10.1172/JCI116752; Lang A, 2008, J IMMUNOL, V180, P4848, DOI 10.4049/jimmunol.180.7.4848; Lang KS, 2005, EUR J IMMUNOL, V35, P738, DOI 10.1002/eji.200425828; Lanzavecchia A, 2005, CURR OPIN IMMUNOL, V17, P326, DOI 10.1016/j.coi.2005.04.010; Lefrancois L, 2006, IMMUNOL REV, V211, P93, DOI 10.1111/j.0105-2896.2006.00393.x; Leng QB, 2006, INT IMMUNOL, V18, P637, DOI 10.1093/intimm/dxh375; Li JC, 2003, J EXP MED, V198, P1807, DOI 10.1084/jem.20030725; Liu D, 2009, J IMMUNOL, V183, P1921, DOI 10.4049/jimmunol.0901099; Maenetje P, 2010, J IMMUNOL, V184, P4926, DOI 10.4049/jimmunol.0903771; Mahanty S, 1996, J INFECT DIS, V173, P769, DOI 10.1093/infdis/173.3.769; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; Malhotra I, 2006, J INFECT DIS, V193, P1005, DOI 10.1086/500472; Mercier F, 2008, CLIN EXP IMMUNOL, V152, P72, DOI 10.1111/j.1365-2249.2008.03610.x; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Messaoudi I, 2006, J IMMUNOL, V177, P2784, DOI 10.4049/jimmunol.177.5.2784; Metenou S, 2010, J IMMUNOL, V184, P5375, DOI 10.4049/jimmunol.0904067; Metenou S, 2009, J IMMUNOL, V183, P916, DOI 10.4049/jimmunol.0900257; Nielsen NO, 2007, AM J TROP MED HYG, V77, P507, DOI 10.4269/ajtmh.2007.77.507; NUTMAN TB, 1987, J CLIN INVEST, V79, P1516, DOI 10.1172/JCI112982; Okoye A, 2007, J EXP MED, V204, P2171, DOI 10.1084/jem.20070567; OTTESEN EA, 1982, AM J TROP MED HYG, V31, P953, DOI 10.4269/ajtmh.1982.31.953; Ouyang Qin, 2003, Experimental Gerontology, V38, P911, DOI 10.1016/S0531-5565(03)00134-7; Pawelec G, 2006, ANN NY ACAD SCI, V1067, P56, DOI 10.1196/annals.1354.009; Pawelec G, 2009, REV MED VIROL, V19, P47, DOI 10.1002/rmv.598; Roederer M, 2001, CYTOMETRY, V45, P194, DOI 10.1002/1097-0320(20011101)45:3<194::AID-CYTO1163>3.0.CO;2-C; Sabin EA, 1996, J INFECT DIS, V173, P269, DOI 10.1093/infdis/173.1.269; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, EUR J IMMUNOL, V29, P2037, DOI 10.1002/(SICI)1521-4141(199906)29:06<2037::AID-IMMU2037>3.0.CO;2-V; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schierack P, 2003, INFECT IMMUN, V71, P2422, DOI 10.1128/IAI.71.5.2422-2429.2003; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Semnani RT, 2003, J IMMUNOL, V171, P1950, DOI 10.4049/jimmunol.171.4.1950; Shen T, 2010, ARCH VIROL, V155, P627, DOI 10.1007/s00705-010-0626-z; Shin H, 2007, CURR OPIN IMMUNOL, V19, P408, DOI 10.1016/j.coi.2007.06.004; Specht S, 2004, INFECT IMMUN, V72, P6287, DOI 10.1128/IAI.72.11.6287-6293.2004; Steel C, 2003, J IMMUNOL, V170, P1930, DOI 10.4049/jimmunol.170.4.1930; STEEL C, 1994, LANCET, V343, P890, DOI 10.1016/S0140-6736(94)90009-4; Steel C, 1996, J INFECT DIS, V174, P598, DOI 10.1093/infdis/174.3.598; Steel C, 2001, J INFECT DIS, V184, P73, DOI 10.1086/321004; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; van den Biggelaar AHJ, 2000, LANCET, V356, P1723, DOI 10.1016/S0140-6736(00)03206-2; Waller ECP, 2008, MED MICROBIOL IMMUN, V197, P83, DOI 10.1007/s00430-008-0082-5; WELLER PF, 1982, AM J TROP MED HYG, V31, P942, DOI 10.4269/ajtmh.1982.31.942; Wherry EJ, 2006, VIROLOGY, V353, P366, DOI 10.1016/j.virol.2006.06.017; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Xue HH, 2002, P NATL ACAD SCI USA, V99, P13759, DOI 10.1073/pnas.212214999; Zaph C, 2004, NAT MED, V10, P1104, DOI 10.1038/nm1108; Zaph C, 2006, J IMMUNOL, V177, P511, DOI 10.4049/jimmunol.177.1.511; Zhang XH, 2002, J EXP MED, V195, P283, DOI 10.1084/jem.20011267	75	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19197	10.1371/journal.pone.0019197	http://dx.doi.org/10.1371/journal.pone.0019197			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559422	Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700098
J	Wang, XH; Duan, XM; Yang, GL; Zhang, XY; Deng, LY; Zheng, H; Deng, CY; Wen, JL; Wang, N; Peng, C; Zhao, X; Wei, YQ; Chen, LJ				Wang, Xianhuo; Duan, Xingmei; Yang, Guangli; Zhang, Xiaoyan; Deng, Linyu; Zheng, Hao; Deng, Chongyang; Wen, Jiaolin; Wang, Ning; Peng, Cheng; Zhao, Xia; Wei, Yuquan; Chen, Lijuan			Honokiol Crosses BBB and BCSFB, and Inhibits Brain Tumor Growth in Rat 9L Intracerebral Gliosarcoma Model and Human U251 Xenograft Glioma Model	PLOS ONE			English	Article							P-GLYCOPROTEIN; IN-VIVO; MAGNOLIA BARK; BARRIER; THERAPY; AGENT; CELLS; MICE; ANGIOGENESIS; IDENTIFICATION	Background: Gliosarcoma is one of the most common malignant brain tumors, and anti-angiogenesis is a promising approach for the treatment of gliosarcoma. However, chemotherapy is obstructed by the physical obstacle formed by the blood-brain barrier (BBB) and blood-cerebrospinal fluid barrier (BCSFB). Honokiol has been known to possess potent activities in the central nervous system diseases, and anti-angiogenic and anti-tumor properties. Here, we hypothesized that honokiol could cross the BBB and BCSFB for the treatment of gliosarcoma. Methodologies: We first evaluated the abilities of honokiol to cross the BBB and BCSFB by measuring the penetration of honokiol into brain and blood-cerebrospinal fluid, and compared the honokiol amount taken up by brain with that by other tissues. Then we investigated the effect of honokiol on the growth inhibition of rat 9L gliosarcoma cells and human U251 glioma cells in vitro. Finally we established rat 9L intracerebral gliosarcoma model in Fisher 344 rats and human U251 xenograft glioma model in nude mice to investigate the anti-tumor activity. Principal Findings: We showed for the first time that honokiol could effectively cross BBB and BCSFB. The ratios of brain/plasma concentration were respectively 1.29, 2.54, 2.56 and 2.72 at 5, 30, 60 and 120 min. And about 10% of honokiol in plasma crossed BCSFB into cerebrospinal fluid (CSF). In vitro, honokiol produced dose-dependent inhibition of the growth of rat 9L gliosarcoma cells and human U251 glioma cells with IC(50) of 15.61 mu g/mL and 16.38 mu g/mL, respectively. In vivo, treatment with 20 mg/kg body weight of honokiol (honokiol was given twice per week for 3 weeks by intravenous injection) resulted in significant reduction of tumor volume (112.70 +/- 10.16 mm(3)) compared with vehicle group (238.63 +/- 19.69 mm(3), P = 0.000), with 52.77% inhibiting rate in rat 9L intracerebral gliosarcoma model, and (1450.83 +/- 348.36 mm(3)) compared with vehicle group (2914.17 +/- 780.52 mm(3), P = 0.002), with 50.21% inhibiting rate in human U251 xenograft glioma model. Honokiol also significantly improved the survival over vehicle group in the two models (P < 0.05). Conclusions/Significance: This study provided the first evidence that honokiol could effectively cross BBB and BCSFB and inhibit brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model. It suggested a significant strategy for offering a potential new therapy for the treatment of gliosarcoma.	[Wang, Xianhuo; Duan, Xingmei; Yang, Guangli; Zhang, Xiaoyan; Deng, Linyu; Zheng, Hao; Deng, Chongyang; Wen, Jiaolin; Wang, Ning; Zhao, Xia; Wei, Yuquan; Chen, Lijuan] Sichuan Univ, W China Med Sch, W China Hosp, State Key Lab Biotherapy, Chengdu 610064, Peoples R China; [Wang, Xianhuo; Duan, Xingmei; Yang, Guangli; Zhang, Xiaoyan; Deng, Linyu; Zheng, Hao; Deng, Chongyang; Wen, Jiaolin; Wang, Ning; Zhao, Xia; Wei, Yuquan; Chen, Lijuan] Sichuan Univ, W China Med Sch, W China Hosp, Ctr Canc, Chengdu 610064, Peoples R China; [Peng, Cheng; Chen, Lijuan] Chengdu Univ Tradit Chinese Med, State Key Lab Breeding Base Systemat Res Dev & Ut, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Chengdu University of Traditional Chinese Medicine	Wang, XH (corresponding author), Sichuan Univ, W China Med Sch, W China Hosp, State Key Lab Biotherapy, Chengdu 610064, Peoples R China.	lijuan17@hotmail.com	Wen, Jiaolin/GZL-0162-2022	Peng, Cheng/0000-0003-3303-906X; Wang, Xianhuo/0000-0002-7663-2923	National Key Programs of China [2009ZX09501-015]; National Natural Science Foundation of China [81071251]; State Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine, Chengdu University of Traditional Chinese Medicine	National Key Programs of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine, Chengdu University of Traditional Chinese Medicine	The work was supported by National Key Programs of China during the 11th Five-Year Plan Period (2009ZX09501-015), the National Natural Science Foundation of China (81071251) and the Open-Study Funds of State Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine, Chengdu University of Traditional Chinese Medicine. The URLs of three funder's websites are respectively http://www.most.gov.cn/, http://www.nsfc.gov.cn/Portal0/default124.htm and http://vtual.cdutcm.edu.cn/zyzyxt/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott N Joan, 2004, Drug Discov Today Technol, V1, P407, DOI 10.1016/j.ddtec.2004.11.014; Badruddoja MA, 2003, NEURO-ONCOLOGY, V5, P235, DOI 10.1215/S1152851703000073; Bai XH, 2003, J BIOL CHEM, V278, P35501, DOI 10.1074/jbc.M302967200; Barth RF, 1998, J NEURO-ONCOL, V36, P91, DOI 10.1023/A:1005805203044; Beaumont TL, 2007, J NEURO-ONCOL, V83, P39, DOI 10.1007/s11060-006-9295-x; BREM SS, 1990, AM J PATHOL, V137, P1121; BURGER PC, 1994, TUMORS CENTRAL NERVO, P265; Camphausen K, 2005, P NATL ACAD SCI USA, V102, P8287, DOI 10.1073/pnas.0502887102; Chen LJ, 2007, J CHROMATOGR A, V1142, P115, DOI 10.1016/j.chroma.2006.09.098; Crane C, 2009, J IMMUNOTHER, V32, P585, DOI 10.1097/CJI.0b013e3181a8efe6; Feng MR, 2002, CURR DRUG METAB, V3, P647, DOI 10.2174/1389200023337063; Gallo JM, 2003, CANCER RES, V63, P5114; Grossman SA, 2003, SEMIN ONCOL, V30, P19, DOI 10.1053/j.seminoncol.2003.11.035; Guo M, 2006, J PHARMACOL EXP THER, V317, P97, DOI 10.1124/jpet.105.097782; Hagihara N, 2000, CANCER RES, V60, P230; Haraguchi H, 1997, J PHARM PHARMACOL, V49, P209, DOI 10.1111/j.2042-7158.1997.tb06781.x; Hibasami H, 1998, INT J MOL MED, V2, P671; HIRANO T, 1994, LIFE SCI, V55, P1061, DOI 10.1016/0024-3205(94)00641-5; Hu J, 2008, EXP MOL MED, V40, P617, DOI 10.3858/emm.2008.40.6.617; Kim JH, 2003, RADIAT RES, V160, P662, DOI 10.1667/RR3069; Kim JH, 1999, INT J RADIAT ONCOL, V45, P1035, DOI 10.1016/S0360-3016(99)00273-4; Kuribara H, 1999, J PHARM PHARMACOL, V51, P97; Kuribara H, 1998, J PHARM PHARMACOL, V50, P819, DOI 10.1111/j.2042-7158.1998.tb07146.x; Kuribara H, 2000, PHARMACOL BIOCHEM BE, V67, P597, DOI 10.1016/S0091-3057(00)00401-9; LAMPSON LA, 1992, CANCER RES, V52, P1018; Liou KT, 2003, BRAIN RES, V992, P159, DOI 10.1016/j.brainres.2003.08.026; Maruyama Y, 1998, J NAT PROD, V61, P135, DOI 10.1021/np9702446; MEIS JM, 1991, CANCER, V67, P2342, DOI 10.1002/1097-0142(19910501)67:9<2342::AID-CNCR2820670922>3.0.CO;2-B; Murphy S, 2007, J NEURO-ONCOL, V85, P181, DOI 10.1007/s11060-007-9406-3; Quarles CC, 2007, MAGN RESON MED, V57, P680, DOI 10.1002/mrm.21193; Sade B, 2006, J NEUROSURG, V105, P904, DOI 10.3171/jns.2006.105.6.904; SAKATA A, 1994, BIOCHEM PHARMACOL, V48, P1989, DOI 10.1016/0006-2952(94)90601-7; Sasaki M, 1998, ANN ONCOL, V9, P1155, DOI 10.1023/A:1008488709359; Schinkel AH, 1996, J CLIN INVEST, V97, P2517, DOI 10.1172/JCI118699; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; SCHMIDEK HH, 1971, J NEUROSURG, V34, P335, DOI 10.3171/jns.1971.34.3.0335; Sung JH, 2009, TOXICOL SCI, V108, P452, DOI 10.1093/toxsci/kfn246; TEICHER BA, 1995, INT J CANCER, V61, P732, DOI 10.1002/ijc.2910610523; van Rooy I, 2010, PHARM RES-DORDR, V27, P673, DOI 10.1007/s11095-010-0053-6; Wang T, 2004, WORLD J GASTROENTERO, V10, P2205; WATANABE K, 1983, PLANTA MED, V49, P103, DOI 10.1055/s-2007-969825; WEN P, 1990, J NEUROIMMUNOL, V27, P239, DOI 10.1016/0165-5728(90)90074-W; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wu XN, 2003, TALANTA, V59, P115, DOI 10.1016/S0039-9140(02)00470-8; Yang SE, 2002, BIOCHEM PHARMACOL, V63, P1641, DOI 10.1016/S0006-2952(02)00894-8	45	103	112	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18490	10.1371/journal.pone.0018490	http://dx.doi.org/10.1371/journal.pone.0018490			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559510	Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700013
J	Caracciolo, L; Barbon, A; Palumbo, S; Mora, C; Toscano, CD; Bosetti, F; Barlati, S				Caracciolo, Luca; Barbon, Alessandro; Palumbo, Sara; Mora, Cristina; Toscano, Christopher D.; Bosetti, Francesca; Barlati, Sergio			Altered mRNA Editing and Expression of Ionotropic Glutamate Receptors after Kainic Acid Exposure in Cyclooxygenase-2 Deficient Mice	PLOS ONE			English	Article							D-ASPARTATE RECEPTOR; GLUR6 KAINATE RECEPTORS; CENTRAL-NERVOUS-SYSTEM; RAT-BRAIN; CEREBRAL-ISCHEMIA; NEURONAL DEATH; MEDIATED EXCITOTOXICITY; HUNTINGTONS-DISEASE; ALZHEIMERS-DISEASE; KINETIC-PROPERTIES	Kainic acid (KA) binds to the AMPA/KA receptors and induces seizures that result in inflammation, oxidative damage and neuronal death. We previously showed that cyclooxygenase-2 deficient (COX-2(-/-)) mice are more vulnerable to KA-induced excitotoxicity. Here, we investigated whether the increased susceptibility of COX-2(-/-) mice to KA is associated with altered mRNA expression and editing of glutamate receptors. The expression of AMPA GluR2, GluR3 and KA GluR6 was increased in vehicle-injected COX-2(-/-) mice compared to wild type (WT) mice in hippocampus and cortex, whereas gene expression of NMDA receptors was decreased. KA treatment decreased the expression of AMPA, KA and NMDA receptors in the hippocampus, with a significant effect in COX-2(-/-) mice. Furthermore, we analyzed RNA editing levels and found that the level of GluR3 R/G editing site was selectively increased in the hippocampus and decreased in the cortex in COX-2(-/-) compared with WT mice. After KA, GluR4 R/G editing site, flip form, was increased in the hippocampus of COX-2(-/-) mice. Treatment of WT mice with the COX-2 inhibitor celecoxib for two weeks decreased the expression of AMPA/KA and NMDAR subunits after KA, as observed in COX-2(-/-) mice. After KA exposure, COX-2(-/-) mice showed increased mRNA expression of markers of inflammation and oxidative stress, such as cytokines (TNF-alpha, IL-1 beta and IL-6), inducible nitric oxide synthase (iNOS), microglia (CD11b) and astrocyte (GFAP). Thus, COX-2 gene deletion can exacerbate the inflammatory response to KA. We suggest that COX-2 plays a role in attenuating glutamate excitotoxicity by modulating RNA editing of AMPA/KA and mRNA expression of all ionotropic glutamate receptor subunits and, in turn, neuronal excitability. These changes may contribute to the increased vulnerability of COX-2(-/-) mice to KA. The overstimulation of glutamate receptors as a consequence of COX-2 gene deletion suggests a functional coupling between COX-2 and the glutamatergic system.	[Caracciolo, Luca; Palumbo, Sara; Toscano, Christopher D.; Bosetti, Francesca] NIA, Mol Neurosci Unit, Brain Physiol & Metab Sect, NIH, Bethesda, MD 20892 USA; [Caracciolo, Luca; Barbon, Alessandro; Mora, Cristina; Barlati, Sergio] Univ Brescia, Div Biol & Genet, Dept Biomed Sci & Biotechnol, Brescia, Italy; [Caracciolo, Luca; Barbon, Alessandro; Mora, Cristina; Barlati, Sergio] Univ Brescia, Natl Inst Neurosci, Brescia, Italy	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Brescia; University of Brescia	Caracciolo, L (corresponding author), NIA, Mol Neurosci Unit, Brain Physiol & Metab Sect, NIH, Bethesda, MD 20892 USA.	frances@mail.nih.gov	Barbon, Alessandro/E-7037-2010; Palumbo, Sara/B-1603-2013; Mora, Cristina/K-1222-2018	Barbon, Alessandro/0000-0002-1127-7764; Palumbo, Sara/0000-0002-3809-6058; Mora, Cristina/0000-0003-3896-7893	National Institute on Aging, National Institutes of Health	National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was entirely supported by the Intramural Research Program of the National Institute on Aging, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aid S, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-17; Barbon A, 2003, MOL BRAIN RES, V117, P168, DOI 10.1016/S0169-328X(03)00317-6; Barbon A, 2007, EXP NEUROL, V208, P54, DOI 10.1016/j.expneurol.2007.07.009; Barbon A, 2010, J NEUROCHEM, V114, P397, DOI 10.1111/j.1471-4159.2010.06767.x; BEAL MF, 1994, NEUROBIOL AGING, V15, P275; Bernard A, 1999, EUR J NEUROSCI, V11, P604, DOI 10.1046/j.1460-9568.1999.00479.x; BERNARD A, 1994, J NEUROCHEM, V62, P2057, DOI 10.1046/j.1471-4159.1994.62052057.x; Bleakman D, 1998, NEUROPHARMACOLOGY, V37, P1187, DOI 10.1016/S0028-3908(98)00139-7; Borbely S, 2009, NEUROSCIENCE, V159, P358, DOI 10.1016/j.neuroscience.2008.12.027; BREDER CD, 1995, J COMP NEUROL, V355, P296, DOI 10.1002/cne.903550208; Candelario-Jalil E, 2001, J APPL TOXICOL, V21, P403, DOI 10.1002/jat.768; CHENG Y, 1994, NEUROCHEM RES, V19, P1557, DOI 10.1007/BF00969006; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1989, NEUROBIOL AGING, V10, P605, DOI 10.1016/0197-4580(89)90145-0; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; Dingledine R, 1999, PHARMACOL REV, V51, P7; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; EGEBJERG J, 1993, P NATL ACAD SCI USA, V90, P755, DOI 10.1073/pnas.90.2.755; Fujikawa DG, 2005, EPILEPSY BEHAV, V7, pS3, DOI 10.1016/j.yebeh.2005.08.003; Gascon S, 2008, MOL PSYCHIATR, V13, P99, DOI 10.1038/sj.mp.4002017; Gascon S, 2005, J BIOL CHEM, V280, P35018, DOI 10.1074/jbc.M504108200; Gluck MR, 2000, EPILEPSY RES, V39, P63, DOI 10.1016/S0920-1211(99)00111-4; GREENAMYRE JT, 1989, NEUROBIOL AGING, V10, P593, DOI 10.1016/0197-4580(89)90143-7; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Grigorenko EV, 1998, NEUROREPORT, V9, P2219, DOI 10.1097/00001756-199807130-00013; Grooms SY, 2000, P NATL ACAD SCI USA, V97, P3631, DOI 10.1073/pnas.050586497; Harada A, 2002, J CELL BIOL, V158, P541, DOI 10.1083/jcb.200110134; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hou ST, 2002, INT REV CYTOL, V221, P93; ISHII T, 1993, J BIOL CHEM, V268, P2836; Katori M, 2000, INFLAMM RES, V49, P367, DOI 10.1007/s000110050605; Kaufmann WE, 1996, P NATL ACAD SCI USA, V93, P2317, DOI 10.1073/pnas.93.6.2317; Kaufmann WE, 1997, PROSTAG OTH LIPID M, V54, P601, DOI 10.1016/S0090-6980(97)00128-7; Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a; KOHLER M, 1993, NEURON, V10, P491, DOI 10.1016/0896-6273(93)90336-P; KORCZAK B, 1995, RECEPTOR CHANNEL, V3, P41; Kortenbruck G, 2001, NEUROBIOL DIS, V8, P459, DOI 10.1006/nbdi.2001.0394; Krampfl K, 2002, EUR J NEUROSCI, V15, P51, DOI 10.1046/j.0953-816x.2001.01841.x; Kwak S, 2005, J MOL MED, V83, P110, DOI 10.1007/s00109-004-0599-z; LANGENBACH R, 1995, CELL, V83, P483, DOI 10.1016/0092-8674(95)90126-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Milatovic D, 2002, BRAIN RES, V957, P330, DOI 10.1016/S0006-8993(02)03669-7; Minghetti Luisa, 2007, Subcell Biochem, V42, P127; Molinuevo Jose L, 2005, Am J Alzheimers Dis Other Demen, V20, P77, DOI 10.1177/153331750502000206; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; Ohno K, 1997, NEUROCHEM INT, V31, P715, DOI 10.1016/S0197-0186(97)00011-9; Ozawa S, 1998, PROG NEUROBIOL, V54, P581, DOI 10.1016/S0301-0082(97)00085-3; Pereno GI, 2010, BRAIN RES, V1328, P130, DOI 10.1016/j.brainres.2010.01.087; Rapoport SI, 2002, ARCH GEN PSYCHIAT, V59, P592, DOI 10.1001/archpsyc.59.7.592; Rothstein JD, 1996, CLIN NEUROSCI, V3, P348; Rumbaugh G, 1999, J NEUROSCI, V19, P10603, DOI 10.1523/JNEUROSCI.19-24-10603.1999; Seeburg PH, 2002, NEURON, V35, P17, DOI 10.1016/S0896-6273(02)00760-2; SUN AY, 1992, PROG BRAIN RES, V94, P271; Sun AY, 1998, J BIOMED SCI, V5, P401; Swanson GT, 1996, J PHYSIOL-LONDON, V492, P129, DOI 10.1113/jphysiol.1996.sp021295; Toscano CD, 2008, BRAIN RES BULL, V75, P598, DOI 10.1016/j.brainresbull.2007.10.004; Toscano CD, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r14; Vollmar W, 2004, NEUROBIOL DIS, V15, P371, DOI 10.1016/j.nbd.2003.11.006; Wang Q, 2005, MOL NEUROBIOL, V31, P3, DOI 10.1385/MN:31:1-3:003; WEISS JH, 1991, CAN J NEUROL SCI, V18, P394, DOI 10.1017/S0317167100032522; Zeron MM, 2002, NEURON, V33, P849, DOI 10.1016/S0896-6273(02)00615-3	66	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19398	10.1371/journal.pone.0019398	http://dx.doi.org/10.1371/journal.pone.0019398			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589914	Green Submitted, gold, Green Published			2022-12-27	WOS:000290531100007
J	McAlpin, S; Duckett, P; Stow, A				McAlpin, Steve; Duckett, Paul; Stow, Adam			Lizards Cooperatively Tunnel to Construct a Long-Term Home for Family Members	PLOS ONE			English	Article							MICROSATELLITE LOCI; EGERNIA; EVOLUTION; SYSTEMATICS; SOCIALITY; INFERENCE	Constructing a home to protect offspring while they mature is common in many vertebrate groups, but has not previously been reported in lizards. Here we provide the first example of a lizard that constructs a long-term home for family members, and a rare case of lizards behaving cooperatively. The great desert skink, Liopholis kintorei from Central Australia, constructs an elaborate multi-tunnelled burrow that can be continuously occupied for up to 7 years. Multiple generations participate in construction and maintenance of burrows. Parental assignments based on DNA analysis show that immature individuals within the same burrow were mostly full siblings, even when several age cohorts were present. Parents were always captured at burrows containing their offspring, and females were only detected breeding with the same male both within- and across seasons. Consequently, the individual investments made to construct or maintain a burrow system benefit their own offspring, or siblings, over several breeding seasons.	[McAlpin, Steve; Duckett, Paul; Stow, Adam] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia	Macquarie University	McAlpin, S (corresponding author), Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia.	adam.stow@mq.edu.au		Stow, Adam/0000-0002-6796-4854	Parks Australia; Macquarie University	Parks Australia; Macquarie University	Funding and considerable in kind support was provided by Parks Australia for all monitoring and the direct observations of lizard behaviour carried out at Uluru - Kata Tjuta National Park, Northern Territory, Australia. Parks Australia designed the monitoring program for Liopholis kintorei; data for the monitoring program was collected by the first author under contract to Parks Australia. Macquarie University funded most of the collection and analysis of genetic material used in this study. This paper results from the partnership between Parks Australia and Macquarie University. The funders had no role in study design, analysis, decision to publish, or preparation of the manuscript.	Chapman A, 2009, NUMBERS LIVING SPECI; Chapple DG, 2004, BIOL J LINN SOC, V83, P157, DOI 10.1111/j.1095-8312.2004.00378.x; Chapple DG, 2003, HERPETOL MONOGR, V17, P145, DOI 10.1655/0733-1347(2003)017[0145:ELABIT]2.0.CO;2; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; DAVIS AR, 2010, P R SOC LONDON B; EMLEN ST, 1995, P NATL ACAD SCI USA, V92, P8092, DOI 10.1073/pnas.92.18.8092; Gardner MG, 1999, J HERED, V90, P301, DOI 10.1093/jhered/90.2.301; Gardner MG, 2008, ZOOL J LINN SOC-LOND, V154, P781, DOI 10.1111/j.1096-3642.2008.00422.x; Griffin AS, 2002, TRENDS ECOL EVOL, V17, P15, DOI 10.1016/S0169-5347(01)02355-2; JARVIS JUM, 1994, TRENDS ECOL EVOL, V9, P47, DOI 10.1016/0169-5347(94)90267-4; Konovalov DA, 2004, MOL ECOL NOTES, V4, P779, DOI 10.1111/j.1471-8286.2004.00796.x; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; McAlpin S., 2001, RECOVERY PLAN GREAT; Nowak MA, 2010, NATURE, V466, P1057, DOI 10.1038/nature09205; O'Connor D, 2003, MOL ECOL, V12, P743, DOI 10.1046/j.1365-294X.2003.01777.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pianka E.R., 2003, LIZARDS WINDOWS EVOL; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Stow AJ, 2002, MOL ECOL NOTES, V2, P256, DOI 10.1046/j.1471-8286.2002.00209.x; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Wang J, 2009, GENETICS, V181, P1579, DOI 10.1534/genetics.108.100214; While GM, 2009, BEHAV ECOL, V20, P245, DOI 10.1093/beheco/arp015	22	31	33	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19041	10.1371/journal.pone.0019041	http://dx.doi.org/10.1371/journal.pone.0019041			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589923	Green Published, Green Submitted, gold			2022-12-27	WOS:000290483600006
J	Procaccini, A; Lunt, B; Szurmant, H; Hwa, T; Weigt, M				Procaccini, Andrea; Lunt, Bryan; Szurmant, Hendrik; Hwa, Terence; Weigt, Martin			Dissecting the Specificity of Protein-Protein Interaction in Bacterial Two-Component Signaling: Orphans and Crosstalks	PLOS ONE			English	Article							DIRECT RESIDUE CONTACTS; CELL-CYCLE; BACILLUS-SUBTILIS; SYSTEMS; RECOGNITION; REGULATOR	Predictive understanding of the myriads of signal transduction pathways in a cell is an outstanding challenge of systems biology. Such pathways are primarily mediated by specific but transient protein-protein interactions, which are difficult to study experimentally. In this study, we dissect the specificity of protein-protein interactions governing two-component signaling (TCS) systems ubiquitously used in bacteria. Exploiting the large number of sequenced bacterial genomes and an operon structure which packages many pairs of interacting TCS proteins together, we developed a computational approach to extract a molecular interaction code capturing the preferences of a small but critical number of directly interacting residue pairs. This code is found to reflect physical interaction mechanisms, with the strongest signal coming from charged amino acids. It is used to predict the specificity of TCS interaction: Our results compare favorably to most available experimental results, including the prediction of 7 (out of 8 known) interaction partners of orphan signaling proteins in Caulobacter crescentus. Surveying among the available bacterial genomes, our results suggest 15 similar to 25% of the TCS proteins could participate in out-of-operon "crosstalks''. Additionally, we predict clusters of crosstalking candidates, expanding from the anecdotally known examples in model organisms. The tools and results presented here can be used to guide experimental studies towards a system-level understanding of two-component signaling.	[Procaccini, Andrea; Weigt, Martin] Human Genet Fdn, Turin, Italy; [Procaccini, Andrea; Weigt, Martin] Politecn Torino, Ctr Computat Studies, Turin, Italy; [Procaccini, Andrea; Weigt, Martin] Politecn Torino, Dipartimento Fis, Turin, Italy; [Lunt, Bryan; Hwa, Terence] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA; [Lunt, Bryan; Hwa, Terence] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Szurmant, Hendrik] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Polytechnic University of Turin; Polytechnic University of Turin; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute	Procaccini, A (corresponding author), Human Genet Fdn, Turin, Italy.	szurmant@scripps.edu; hwa@ucsd.edu; martin.weigt@hugef-torino.org	Hwa, Terence/J-4012-2013; Weigt, Martin/L-8851-2016; Hwa, Terry/GOJ-9904-2022	Hwa, Terence/0000-0003-1837-6842; Weigt, Martin/0000-0002-0492-3684; Lunt, Bryan/0000-0001-8328-8633	Center for Theoretical Biological Physics (CTBP) sponsored by the NSF [PHY-0822283]; NIH [R01GM077298, R01GM019416]; EC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM019416, R01GM077298] Funding Source: NIH RePORTER	Center for Theoretical Biological Physics (CTBP) sponsored by the NSF; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EC(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	T.H. acknowledges funding by the Center for Theoretical Biological Physics (CTBP) sponsored by the NSF (Grant PHY-0822283) and by NIH grant R01GM077298. H.S. was supported by NIH grant R01GM019416 awarded to James Hoch. B.L. and A.P. acknowledge funding from the EC via the STREP GENNETEC ("Genetic networks: emergence and complexity''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x; Biondi EG, 2006, NATURE, V444, P899, DOI 10.1038/nature05321; Burger L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100203; Burger L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000633; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Doan T, 2003, MICROBIOL-SGM, V149, P2331, DOI 10.1099/mic.0.26256-0; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Hoch JA, 2001, J BACTERIOL, V183, P4941, DOI 10.1128/JB.183.17.4941-4949.2001; Howell A, 2006, MOL MICROBIOL, V59, P1199, DOI 10.1111/j.1365-2958.2005.05017.x; Jiang M, 2000, MOL MICROBIOL, V38, P535, DOI 10.1046/j.1365-2958.2000.02148.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Lunt B, 2010, METHOD ENZYMOL, V471, P17, DOI 10.1016/S0076-6879(10)71002-8; Mezard M, 2009, J PHYSIOL-PARIS, V103, P107, DOI 10.1016/j.jphysparis.2009.05.013; Mora T, 2010, P NATL ACAD SCI USA, V107, P5405, DOI 10.1073/pnas.1001705107; Ohta N, 2003, J BACTERIOL, V185, P4424, DOI 10.1128/JB.185.15.4424-4431.2003; Reisinger SJ, 2007, J BACTERIOL, V189, P8308, DOI 10.1128/JB.00868-07; Rietkotter E, 2008, MOL MICROBIOL, V68, P768, DOI 10.1111/j.1365-2958.2008.06194.x; Shi XQ, 2008, J BACTERIOL, V190, P613, DOI 10.1128/JB.01502-07; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; SOKAL RR, 1958, U KANSAS SCI B, V38, P1409; Szurmant H, 2007, CURR OPIN STRUC BIOL, V17, P706, DOI 10.1016/j.sbi.2007.08.019; Szurmant H, 2010, CURR OPIN MICROBIOL, V13, P190, DOI 10.1016/j.mib.2010.01.007; Szurmant L, 2004, MICROBIOL MOL BIOL R, V68, P301, DOI 10.1128/MMBR.68.2.301-319.2004; Ulrich LE, 2010, NUCLEIC ACIDS RES, V38, pD401, DOI 10.1093/nar/gkp940; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; White RA, 2007, METHOD ENZYMOL, V422, P75, DOI 10.1016/S0076-6879(06)22004-4; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Wu JG, 1999, P NATL ACAD SCI USA, V96, P13068, DOI 10.1073/pnas.96.23.13068; Yamamoto H, 2000, MOL MICROBIOL, V37, P898, DOI 10.1046/j.1365-2958.2000.02055.x; Yamamoto K, 2005, MOL MICROBIOL, V56, P215, DOI 10.1111/j.1365-2958.2005.04532.x; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200; Zapf J, 2000, STRUCTURE, V8, P851, DOI 10.1016/S0969-2126(00)00174-X	36	65	66	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19729	10.1371/journal.pone.0019729	http://dx.doi.org/10.1371/journal.pone.0019729			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573011	Green Published, gold, Green Submitted			2022-12-27	WOS:000290386800034
J	Deiner, K; Lemmon, AR; Mack, AL; Fleischer, RC; Dumbacher, JP				Deiner, Kristy; Lemmon, Alan R.; Mack, Andrew L.; Fleischer, Robert C.; Dumbacher, John P.			A Passerine Bird's Evolution Corroborates the Geologic History of the Island of New Guinea	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; RAIN-FOREST; IRIAN-JAYA; SUBSTITUTIONS; BIOGEOGRAPHY; VEGETATION; PHYLOGENY; AUSTRALIA; COMMUNITY	New Guinea is a biologically diverse island, with a unique geologic history and topography that has likely played a role in the evolution of species. Few island-wide studies, however, have examined the phylogeographic history of lowland species. The objective of this study was to examine patterns of phylogeographic variation of a common and widespread New Guinean bird species (Colluricincla megarhyncha). Specifically, we test the mechanisms hypothesized to cause geographic and genetic variation (e.g., vicariance, isolation by distance and founder-effect with dispersal). To accomplish this, we surveyed three regions of the mitochondrial genome and a nuclear intron and assessed differences among 23 of the 30 described subspecies from throughout their range. We found support for eight highly divergent lineages within C. megarhyncha. Genetic lineages were found within continuous lowland habitat or on smaller islands, but all individuals within clades were not necessarily structured by predicted biogeographic barriers. There was some evidence of isolation by distance and potential founder-effects. Mitochondrial DNA sequence divergence among lineages was at a level often observed among different species or even genera of birds (5-11%), suggesting lineages within regions have been isolated for long periods of time. When topographical barriers were associated with divergence patterns, the estimated divergence date for the clade coincided with the estimated time of barrier formation. We also found that dispersal distance and range size are positively correlated across lineages. Evidence from this research suggests that different phylogeographic mechanisms concurrently structure lineages of C. megarhyncha and are not mutually exclusive. These lineages are a result of evolutionary forces acting at different temporal and spatial scales concordant with New Guinea's geological history.	[Deiner, Kristy; Dumbacher, John P.] Calif Acad Sci, Dept Vertebrate Zool & Anthropol, San Francisco, CA 94118 USA; [Deiner, Kristy; Dumbacher, John P.] Calif Acad Sci, Ctr Comparat Genom, San Francisco, CA 94118 USA; [Deiner, Kristy] Univ Calif Davis, Genom Variat Lab, Davis, CA 95616 USA; [Lemmon, Alan R.] Florida State Univ, Dept Comp Sci, Tallahassee, FL 32306 USA; [Mack, Andrew L.] Carnegie Museum Nat Hist, Pittsburgh, PA USA; [Fleischer, Robert C.; Dumbacher, John P.] Smithsonian Inst, Ctr Conservat & Evolutionary Genet, Washington, DC 20560 USA	California Academy of Sciences; California Academy of Sciences; University of California System; University of California Davis; State University System of Florida; Florida State University; Smithsonian Institution	Deiner, K (corresponding author), Calif Acad Sci, Dept Vertebrate Zool & Anthropol, San Francisco, CA 94118 USA.	kldeiner@ucdavis.edu	Dumbacher, John/B-5280-2009	Dumbacher, John/0000-0001-8942-1554; Mack, Andrew L./0000-0001-8823-9101; Deiner, Kristy/0000-0001-9755-3223	Smithsonian Scholarly Studies Program; National Zoo; Abbott and Sisley Funds; Christensen Fund; NSF [DEB 0108247]	Smithsonian Scholarly Studies Program(Smithsonian Institution); National Zoo(Smithsonian InstitutionSmithsonian National Zoological Park & Conservation Biology Institute); Abbott and Sisley Funds; Christensen Fund; NSF(National Science Foundation (NSF))	Funding was provided by the Smithsonian Scholarly Studies Program, Friends of the National Zoo, the Abbott and Sisley Funds, the Christensen Fund, and NSF Grant DEB 0108247 (PIs Dumbacher, Fleischer and Mack). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LD, 1997, NATURE, V385, P501, DOI 10.1038/385501a0; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Baldwin Bruce G., 1995, P259; Bandelt HJ, 2009, J HUM GENET, V54, P174, DOI 10.1038/jhg.2009.9; Beehler B.M., 1986, BIRDS NEW GUINEA; BELL HL, 1982, EMU, V82, P65, DOI 10.1071/MU9820065; BELL HL, 1982, EMU, V82, P24, DOI 10.1071/MU9820024; CRACRAFT J, 1986, PALEOBIOLOGY, V12, P383, DOI 10.1017/S0094837300003122; Cracraft J., 1983, Current Ornithology, V1, P159; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Davies JM, 1997, MAR FRESHWATER RES, V48, P513, DOI 10.1071/MF96128; de Guia APO, 2007, ECOL RES, V22, P604, DOI 10.1007/s11284-006-0059-z; DOW DB, 1984, TECTONOPHYSICS, V106, P109, DOI 10.1016/0040-1951(84)90224-5; Dow DB, 1977, GEOLOGY GEOPHYSICS B, V201, P41; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dumbacher JP, 2008, MOL PHYLOGENET EVOL, V49, P774, DOI 10.1016/j.ympev.2008.09.018; Dumbacher JP, 2003, MOL PHYLOGENET EVOL, V29, P540, DOI 10.1016/S1055-7903(03)00135-0; Edwards Scott V., 1997, P251, DOI 10.1016/B978-012498315-1/50015-7; Excoffier L, 2007, ARLEQUIN VER 3 11 IN; Fleischer RC, 1998, MOL ECOL, V7, P533, DOI 10.1046/j.1365-294x.1998.00364.x; FORD J, 1979, EMU, V79, P195, DOI 10.1071/MU9790195; Fu YX, 1997, GENETICS, V147, P915; Garrick RC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-118; Greenberg R, 1998, AUK, V115, P706, DOI 10.2307/4089418; Greenway JC, 1967, CHECK LIST BIRDS WOR; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Heads M, 2002, J BIOGEOGR, V29, P261, DOI 10.1046/j.1365-2699.2002.00667.x; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Higgins P. J., 2002, HDB AUSTR NZ ANTARCT, V6; Hillis David M., 1996, P515; HOPE G, 1994, PALAEOGEOGR PALAEOCL, V109, P385, DOI 10.1016/0031-0182(94)90187-2; Hope Geoff, 1996, P165; Jennings J.N., 1971, ABORIGINAL MAN ENV A, P1; JIN L, 1990, MOL BIOL EVOL, V7, P82; Kerr KCR, 2007, MOL ECOL NOTES, V7, P535, DOI 10.1111/j.1471-8286.2006.01670.x; KERSHAW AP, 1994, PALAEOGEOGR PALAEOCL, V109, P399, DOI 10.1016/0031-0182(94)90188-0; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Lemmon AR, 2008, SYST BIOL, V57, P544, DOI 10.1080/10635150802304761; Lovette IJ, 2004, AUK, V121, P1, DOI 10.1642/0004-8038(2004)121[0001:MDAMSF]2.0.CO;2; Mack AL, 1996, EMU, V96, P89, DOI 10.1071/MU9960089; Mack Andrew, 2007, P654; Mayr E., 1942, P1; Mayr E., 2001, BIRDS NO MELANESIA S; Mayr E., 1941, LIST NEW GUINEA BIRD; Mayr E., 1963, ANIMAL SPECIES EVOLU; McGuigan K, 2000, MAR FRESHWATER RES, V51, P713, DOI 10.1071/MF99159; Moritz C, 2001, P ROY SOC B-BIOL SCI, V268, P1875, DOI 10.1098/rspb.2001.1713; Murphy SA, 2007, J BIOGEOGR, V34, P1534, DOI 10.1111/j.1365-2699.2007.01706.x; NEI M, 1989, MOL BIOL EVOL, V6, P290; Nielsen R, 2005, STAT METHODS MOL EVO, P183; Peterson AT, 2006, J AVIAN BIOL, V37, P541, DOI 10.1111/j.0908-8857.2006.04029.x; Pigram C. J., 1987, BMR Journal of Australian Geology & Geophysics, V10, P193; Pigram C.J., 1991, J SE ASIAN EARTH SCI, V6, P307, DOI DOI 10.1016/0743-9547(91)90076-A; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ray N, 2005, MOL ECOL NOTES, V5, P177, DOI 10.1111/j.1471-8286.2004.00843.x; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Shaw Kerry L., 1995, P39; Slater Peter, 1986, SLATER FIELD GUIDE A; Sorenson MD, 1999, P ROY SOC B-BIOL SCI, V266, P2187, DOI 10.1098/rspb.1999.0907; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stevens C, 1998, GEOLOGY, V26, P847, DOI 10.1130/0091-7613(1998)026<0847:MCDARF>2.3.CO;2; TAJIMA F, 1989, GENETICS, V123, P597; Tarr Cheryl L., 1995, P147; Tavares ES, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-81; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Wagner WL, 1995, HAWAIIAN BIOGEOGRAPH; Wallace A, 1869, MALAY ARCHIPELAGO MA; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; Zink R.M., 1986, Current Ornithology, V4, P1; Zink RM, 1996, EVOLUTION, V50, P308, DOI 10.1111/j.1558-5646.1996.tb04494.x; Zink RM, 2004, P ROY SOC B-BIOL SCI, V271, P561, DOI 10.1098/rspb.2003.2617; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x; Zwickl D. J, 2006, GENETIC ALGORITHM AP; Zwiers PB, 2008, MOL PHYLOGENET EVOL, V46, P923, DOI 10.1016/j.ympev.2007.11.019	76	27	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19479	10.1371/journal.pone.0019479	http://dx.doi.org/10.1371/journal.pone.0019479			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573115	Green Published, Green Submitted, gold			2022-12-27	WOS:000290305600027
J	Isogai, E; Ohira, M; Ozaki, T; Oba, S; Nakamura, Y; Nakagawara, A				Isogai, Eriko; Ohira, Miki; Ozaki, Toshinori; Oba, Shigeyuki; Nakamura, Yohko; Nakagawara, Akira			Oncogenic LMO3 Collaborates with HEN2 to Enhance Neuroblastoma Cell Growth through Transactivation of Mash1	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; BREAST-CANCER; LIM DOMAIN; IN-VITRO; GENE; DIFFERENTIATION; PROTEINS; ACTS; MICE	Expression of Mash1 is dysregulated in human neuroblastoma. We have also reported that LMO3 (LIM-only protein 3) has an oncogenic potential in collaboration with neuronal transcription factor HEN2 in neuroblastoma. However, the precise molecular mechanisms of its transcriptional regulation remain elusive. Here we found that LMO3 forms a complex with HEN2 and acts as an upstream mediator for transcription of Mash1 in neuroblastoma. The high levels of LMO3 or Mash1 mRNA expression were significantly associated with poor prognosis in 100 primary neuroblastomas. The up-regulation of Mash1 remarkably accelerated the proliferation of SH-SY5Y neuroblastoma cells, while siRNA-mediated knockdown of LMO3 induced inhibition of growth of SH-SY5Y cells in association with a significant down-regulation of Mash1. Additionally, overexpression of both LMO3 and HEN2 induced expression of Mash1, suggesting that they might function as a transcriptional activator for Mash1. Luciferase reporter assay demonstrated that the co-expression of LMO3 and HEN2 attenuates HES1 (a negative regulator for Mash1)-dependent reduction of luciferase activity driven by the Mash1 promoter. Chromatin immunoprecipitation assay revealed that LMO3 and HEN2 reduce the amount of HES1 recruited onto putative HES1-binding sites and E-box within the Mash1 promoter. Furthermore, both LMO3 and HEN2 are physically associated with HES1 by immunoprecipitation assay. Thus, our present results suggest that a transcriptional complex of LMO3 and HEN2 may contribute to the genesis and malignant phenotype of neuroblastoma by inhibiting HES1 which suppresses the transactivation of Mash1.	[Isogai, Eriko; Nakamura, Yohko; Nakagawara, Akira] Chiba Canc Ctr Res Inst, Div Biochem & Innovat Canc Therapeut, Chuoh ku, Chiba, Japan; [Isogai, Eriko; Ohira, Miki] Chiba Canc Ctr Res Inst, Lab Canc Gen, Chuoh ku, Chiba, Japan; [Ozaki, Toshinori] Chiba Canc Ctr Res Inst, Lab Antitumor Res, Chuoh ku, Chiba, Japan; [Oba, Shigeyuki] Kyoto Univ, Grad Sch Informat, Dept Syst Sci, Integrated Syst Biol Lab, Kyoto, Japan	Chiba Cancer Center; Chiba Cancer Center; Chiba Cancer Center; Kyoto University	Isogai, E (corresponding author), Chiba Canc Ctr Res Inst, Div Biochem & Innovat Canc Therapeut, Chuoh ku, Chiba, Japan.	akiranak@chiba-cc.jp			Ministry of Health, Labour and Welfare for the Third Term Comprehensive Control Research for Cancer; Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [21591376, 21390317] Funding Source: KAKEN	Ministry of Health, Labour and Welfare for the Third Term Comprehensive Control Research for Cancer; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid from the Ministry of Health, Labour and Welfare for the Third Term Comprehensive Control Research for Cancer; a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology, Japan; and a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama M, 2005, CANCER RES, V65, P4587, DOI 10.1158/0008-5472.CAN-04-4630; Asmar J, 2008, DEV BIOL, V316, P487, DOI 10.1016/j.ydbio.2008.01.040; Axelson H, 2004, CANCER LETT, V204, P171, DOI 10.1016/S0304-3835(03)00453-1; Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; BAGLEY CG, 1992, P NATL ACAD SCI USA, V89, P38; Bao JX, 2000, DEVELOPMENT, V127, P425; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; BROWN L, 1994, MOL CELL BIOL, V14, P1245, DOI 10.1128/MCB.14.2.1245; Gestblom C, 1999, LAB INVEST, V79, P67; Good DJ, 1997, NAT GENET, V15, P397, DOI 10.1038/ng0497-397; Ichimiya S, 2001, MED PEDIATR ONCOL, V36, P132, DOI 10.1002/1096-911X(20010101)36:1<132::AID-MPO1031>3.0.CO;2-A; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Lanigan TM, 1998, J NEUROBIOL, V34, P126, DOI 10.1002/(SICI)1097-4695(19980205)34:2<126::AID-NEU3>3.0.CO;2-4; Mizuguchi H, 1999, HUM GENE THER, V10, P2013, DOI 10.1089/10430349950017374; Mizuguchi H, 1998, HUM GENE THER, V9, P2577, DOI 10.1089/hum.1998.9.17-2577; Morikawa Y, 2009, DEVELOPMENT, V136, P3575, DOI 10.1242/dev.038133; Nakagawara A, 2004, CANCER LETT, V204, P213, DOI 10.1016/S0304-3835(03)00457-9; NAKAGAWARA A, 2004, PROGR BRAIN RES, P14633; Rabbitts TH, 1998, GENE DEV, V12, P2651, DOI 10.1101/gad.12.17.2651; Ramain P, 2000, MOL CELL, V6, P781, DOI 10.1016/S1097-2765(05)00079-1; Sum EYM, 2005, P NATL ACAD SCI USA, V102, P7659, DOI 10.1073/pnas.0502990102; Tse E, 2004, MOL CELL BIOL, V24, P2063, DOI 10.1128/MCB.24.5.2063-2073.2004; Visvader JE, 2001, P NATL ACAD SCI USA, V98, P14452, DOI 10.1073/pnas.251547698; Watt F, 2007, CANCER GENE THER, V14, P287, DOI 10.1038/sj.cgt.7701012; Wildner H, 2008, DEVELOPMENT, V135, P473, DOI 10.1242/dev.011783	25	36	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19297	10.1371/journal.pone.0019297	http://dx.doi.org/10.1371/journal.pone.0019297			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573214	Green Submitted, Green Published, gold			2022-12-27	WOS:000290256400005
J	Bakanda, C; Birungi, J; Mwesigwa, R; Nachega, JB; Chan, K; Palmer, A; Ford, N; Mills, EJ				Bakanda, Celestin; Birungi, Josephine; Mwesigwa, Robert; Nachega, Jean B.; Chan, Keith; Palmer, Alexis; Ford, Nathan; Mills, Edward J.			Survival of HIV-Infected Adolescents on Antiretroviral Therapy in Uganda: Findings from a Nationally Representative Cohort in Uganda	PLOS ONE			English	Article							IMMUNOLOGICAL OUTCOMES; SOUTHERN AFRICA; ADHERENCE; CHILDREN	Background: Adolescents have been identified as a high-risk group for poor adherence to and defaulting from combination antiretroviral therapy (cART) care. However, data on outcomes for adolescents on cART in resource-limited settings remain scarce. Methods: We developed an observational study of patients who started cART at The AIDS Service Organization (TASO) in Uganda between 2004 and 2009. Age was stratified into three groups: children (<= 10 years), adolescents (11-19 years), and adults (>= 20 years). Kaplan-Meier survival curves were generated to describe time to mortality and loss to follow-up, and Cox regression used to model associations between age and mortality and loss to follow-up. To address loss to follow up, we applied a weighted analysis that assumes 50% of lost patients had died. Findings: A total of 23,367 patients were included in this analysis, including 810 (3.5%) children, 575 (2.5%) adolescents, and 21 982 (94.0%) adults. A lower percentage of children (5.4%) died during their cART treatment compared to adolescents (8.5%) and adults (10%). After adjusting for confounding, other features predicted mortality than age alone. Mortality was higher among males (p < 0.001), patients with a low initial CD4 cell count (p < 0.001), patients with advanced WHO clinical disease stage (p < 0.001), and shorter duration of time receiving cART (p < 0.001). The crude mortality rate was lower for children (22.8 per 1000 person-years; 95% CI: 16.1, 29.5), than adolescents (36.5 per 1000 person-years; 95% CI: 26.3, 46.8) and adults (37.5 per 1000 person-years; 95% CI: 35.9, 39.1). Interpretation: This study is the largest assessment of adolescents receiving cART in Africa. Adolescents did not have cART mortality outcomes different from adults or children.	[Bakanda, Celestin; Birungi, Josephine; Mwesigwa, Robert] AIDS Support Org TASO, Kampala, Uganda; [Nachega, Jean B.] Univ Stellenbosch, Fac Hlth Sci, Dept Med, Cape Town, South Africa; [Nachega, Jean B.] Univ Stellenbosch, Fac Hlth Sci, Ctr Infect Dis, Cape Town, South Africa; [Chan, Keith; Palmer, Alexis; Mills, Edward J.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Ford, Nathan] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa; [Mills, Edward J.] Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada	Stellenbosch University; Stellenbosch University; B.C. Centre for Excellence in HIV/AIDS; University of Cape Town; University of Ottawa	Bakanda, C (corresponding author), AIDS Support Org TASO, Kampala, Uganda.	emills@cfenet.ubc.ca		Nachega, Jean/0000-0002-2862-4443	European and Developing Countries Clinical Trials Partnership Fellowship	European and Developing Countries Clinical Trials Partnership Fellowship	EM has received a Canada Research Chair. JBN has received a European and Developing Countries Clinical Trials Partnership Fellowship.	Allison P. D., 1995, SURVIVAL ANAL USING; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; CHARLES M, 2008, B WORLD HEALTH ORGAN, V86, P909; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Ferrand RA, 2009, AIDS, V23, P2039, DOI 10.1097/QAD.0b013e32833016ce; Flynn PM, 2007, AIDS RES HUM RETROV, V23, P1208, DOI 10.1089/aid.2006.0290; Kiboneka A, 2008, AIDS, V22, P2493, DOI 10.1097/QAD.0b013e328318f148; Kiboneka A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b201; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Murphy DA, 2003, ARCH PEDIAT ADOL MED, V157, P249, DOI 10.1001/archpedi.157.3.249; Murphy DA, 2001, AIDS CARE, V13, P27, DOI 10.1080/09540120020018161; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; RONGKAVILIT C, 2007, J ADOLESCENT HEALTH, V40, P1; Sauvageot D, 2010, PEDIATRICS, V125, pE1039, DOI 10.1542/peds.2009-1062; Uganda Ministry of Health, 2003, NAT ANT TREATM CAR G; *UNAIDS, 2008, AIDS EP UPD; WHO UNAIDS UNICEF, 2007, UN ACC SCAL PRIOR HI; Wilson CM, 2010, JAIDS-J ACQ IMM DEF, V54, pS5, DOI 10.1097/QAI.0b013e3181e243a1	19	53	54	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19261	10.1371/journal.pone.0019261	http://dx.doi.org/10.1371/journal.pone.0019261			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559441	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700115
J	Kuhlein, HN; Tegeder, I; Moser, C; Lim, HY; Haussler, A; Spieth, K; Jennes, I; Marschalek, R; Beckhaus, T; Karas, M; Fauth, M; Ehnert, C; Geisslinger, G; Niederberger, E				Kuehlein, Hilmar Nils; Tegeder, Irmgard; Moeser, Christine; Lim, Hee-Young; Haeussler, Annett; Spieth, Katharina; Jennes, Ingo; Marschalek, Rolf; Beckhaus, Tobias; Karas, Michael; Fauth, Markus; Ehnert, Corina; Geisslinger, Gerd; Niederberger, Ellen			Nerve Injury Evoked Loss of Latexin Expression in Spinal Cord Neurons Contributes to the Development of Neuropathic Pain	PLOS ONE			English	Article							CARBOXYPEPTIDASE-A; RAT; INHIBITOR; CELL; PROTEINS; NEUROTENSIN; SENSITIVITY; ENDOTHELIN; MECHANISM; SUBSTRATE	Nerve injury leads to sensitization mechanisms in the peripheral and central nervous system which involve transcriptional and post-transcriptional modifications in sensory nerves. To assess protein regulations in the spinal cord after injury of the sciatic nerve in the Spared Nerve Injury model (SNI) we performed a proteomic analysis using 2D-difference gel electrophoresis (DIGE) technology. Among approximately 2300 protein spots separated on each gel we detected 55 significantly regulated proteins after SNI whereof 41 were successfully identified by MALDI-TOF MS. Out of the proteins which were regulated in the DIGE analyses after SNI we focused on the carboxypeptidase A inhibitor latexin because protease dysfunctions contribute to the development of neuropathic pain. Latexin protein expression was reduced after SNI which could be confirmed by Western Blot analysis, quantitative RT-PCR and in-situ hybridisation. The decrease of latexin was associated with an increase of the activity of carboxypeptidase A indicating that the balance between latexin and carboxypeptidase A was impaired in the spinal cord after peripheral nerve injury due to a loss of latexin expression in spinal cord neurons. This may contribute to the development of cold allodynia because normalization of neuronal latexin expression in the spinal cord by AAV-mediated latexin transduction or administration of a small molecule carboxypeptidase A inhibitor significantly reduced acetone-evoked nociceptive behavior after SNI. Our results show the usefulness of proteomics as a screening tool to identify novel mechanisms of nerve injury evoked hypernociception and suggest that carboxypeptidase A inhibition might be useful to reduce cold allodynia.	[Kuehlein, Hilmar Nils; Tegeder, Irmgard; Moeser, Christine; Lim, Hee-Young; Haeussler, Annett; Spieth, Katharina; Ehnert, Corina; Geisslinger, Gerd; Niederberger, Ellen] Univ Frankfurt Klinikum, Inst Klin Pharmakol, Pharmazentrum Frankfurt ZAFES, D-6000 Frankfurt, Germany; [Jennes, Ingo; Marschalek, Rolf] Goethe Univ Frankfurt, Inst Pharmazeut Biol ZAFES, Frankfurt, Germany; [Beckhaus, Tobias; Karas, Michael] Goethe Univ Frankfurt, Inst Pharmazeut Chem ZAFES, Frankfurt, Germany; [Fauth, Markus] Goethe Univ Frankfurt, Inst Mol Biowissensch, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Kuhlein, HN (corresponding author), Univ Frankfurt Klinikum, Inst Klin Pharmakol, Pharmazentrum Frankfurt ZAFES, D-6000 Frankfurt, Germany.	e.niederberger@em.uni-frankfurt.de	Tegeder, Irmgard/AAM-2266-2020; Marschalek, Rolf/D-3404-2011; Tegeder, Irmgard/AAM-2246-2020	Tegeder, Irmgard/0000-0001-7524-8025; Marschalek, Rolf/0000-0003-4870-3445; Tegeder, Irmgard/0000-0001-7524-8025	Deutsche Forschungsgemeinschaft [SFB-815 A12, TE322_5.1, NI705-3-1]; German Network of Neuropathic Pain [BMBF 01EM0103]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Network of Neuropathic Pain	This study was supported by the Deutsche Forschungsgemeinschaft (SFB-815 A12 and TE322_5.1 to IT), (NI705-3-1 to EN) and the German Network of Neuropathic Pain (BMBF 01EM0103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimatsu Y, 1999, NEUROSCIENCE, V88, P93, DOI 10.1016/S0306-4522(98)00185-7; Bai WZ, 2004, NEUROSCIENCE, V123, P257, DOI 10.1016/j.neuroscience.2003.08.056; Bradbury A F, 1976, Ciba Found Symp, V41, P61; BROWN KS, 1987, ANAL BIOCHEM, V161, P219, DOI 10.1016/0003-2697(87)90674-9; BYERS LD, 1972, J BIOL CHEM, V247, P606; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Clark AK, 2007, P NATL ACAD SCI USA, V104, P10655, DOI 10.1073/pnas.0610811104; Corvey C, 2005, J BIOL CHEM, V280, P25323, DOI 10.1074/jbc.M503719200; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Dray A, 2008, BRIT J ANAESTH, V101, P48, DOI 10.1093/bja/aen107; GOLDSTEIN SM, 1991, PEPTIDES, V12, P995, DOI 10.1016/0196-9781(91)90049-U; Griffin RS, 2007, J NEUROSCI, V27, P8699, DOI 10.1523/JNEUROSCI.2018-07.2007; HATANAKA Y, 1994, EUR J NEUROSCI, V6, P973, DOI 10.1111/j.1460-9568.1994.tb00592.x; Jin M, 2006, BRAIN RES, V1075, P117, DOI 10.1016/j.brainres.2005.12.099; Kawasaki Y, 2008, NAT MED, V14, P331, DOI 10.1038/nm1723; Khodorova A, 2009, J PAIN, V10, P4, DOI 10.1016/j.jpain.2008.09.009; Kieffer BL, 2002, PROG NEUROBIOL, V66, P285, DOI 10.1016/S0301-0082(02)00008-4; Krondahl E, 2000, J PHARM PHARMACOL, V52, P785, DOI 10.1211/0022357001774642; Kugler S, 2003, GENE THER, V10, P337, DOI 10.1038/sj.gt.3301905; Kugler S, 2001, MOL CELL NEUROSCI, V17, P78, DOI 10.1006/mcne.2000.0929; Lundequist A, 2004, J BIOL CHEM, V279, P32339, DOI 10.1074/jbc.M405576200; Lyons PJ, 2010, J BIOL CHEM, V285, P38234, DOI 10.1074/jbc.M110.158626; Matsugi S, 2007, CLIN CHIM ACTA, V378, P147, DOI 10.1016/j.cca.2006.11.010; Miller LA, 1998, INT ARCH ALLERGY IMM, V116, P147, DOI 10.1159/000023938; Niederberger E, 2008, ANESTHESIOLOGY, V108, P314, DOI 10.1097/01.anes.0000299838.13368.6e; Normant E, 1995, P NATL ACAD SCI USA, V92, P12225, DOI 10.1073/pnas.92.26.12225; O'Connor AB, 2009, AM J MED, V122, pS22, DOI 10.1016/j.amjmed.2009.04.007; Pallares I, 2005, P NATL ACAD SCI USA, V102, P3978, DOI 10.1073/pnas.0500678102; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Schneider LA, 2007, J EXP MED, V204, P2629, DOI 10.1084/jem.20071262; Sindrup SH, 1999, PAIN, V83, P389, DOI 10.1016/S0304-3959(99)00154-2; Stewart JD, 2000, CLIN CHIM ACTA, V292, P107, DOI 10.1016/S0009-8981(99)00209-0; Takiguchi-Hayashi K, 2001, DEV BRAIN RES, V132, P87, DOI 10.1016/S0165-3806(01)00262-0; Takiguchi-Hayashi K, 1998, BRAIN RES, V801, P9, DOI 10.1016/S0006-8993(98)00496-X; TAKIGUCHIHAYASHI K, 1995, NEUROREPORT, V6, P281, DOI 10.1097/00001756-199501000-00014; Tegeder I, 2006, NAT MED, V12, P1269, DOI 10.1038/nm1490; Wang JY, 2008, NEUROCHEM RES, V33, P2134, DOI 10.1007/s11064-008-9733-6; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0	38	5	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19270	10.1371/journal.pone.0019270	http://dx.doi.org/10.1371/journal.pone.0019270			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21572518	gold, Green Published, Green Submitted			2022-12-27	WOS:000290024700120
J	Romi, B; Soldaini, E; Pancotto, L; Castellino, F; Del Giudice, G; Schiavetti, F				Romi, Benedetta; Soldaini, Elisabetta; Pancotto, Laura; Castellino, Flora; Del Giudice, Giuseppe; Schiavetti, Francesca			Helicobacter pylori Induces Activation of Human Peripheral gamma delta plus T Lymphocytes	PLOS ONE			English	Article							PEPTIC-ULCER DISEASE; TYROSINE PHOSPHORYLATION; VIRULENCE FACTORS; CELL RESPONSES; GASTRIC-CANCER; CAGA; INFECTION; ANTIGEN; STRAINS; ADENOCARCINOMA	Helicobacter pylori is a Gram-negative bacterium that causes gastric and duodenal diseases in humans. Despite a robust antibody and cellular immune response, H. pylori infection persists chronically. To understand if and how H. pylori could modulate T cell activation, in the present study we investigated in vitro the interaction between H. pylori and human T lymphocytes freshly isolated from peripheral blood of H. pylori-negative donors. A direct interaction of live, but not killed bacteria with purified CD3+ T lymphocytes was observed by microscopy and confirmed by flow cytometry. Live H. pylori activated CD3+ T lymphocytes and predominantly gamma delta+ T cells bearing the TCR chain V delta 2. Upon interaction with H. pylori, these cells up-regulated the activation molecule CD69 and produced cytokines (such as TNF alpha, IFN gamma) and chemokines (such as MIP-1 beta, RANTES) in a non-antigen-specific manner. This activation required viable H. pylori and was not exhibited by other Gram-negative bacteria. The cytotoxin-associated antigen-A (CagA), was at least partially responsible of this activation. Our results suggest that H. pylori can directly interact with T cells and modulate the response of gamma delta+ T cells, thereby favouring an inflammatory environment which can contribute to the chronic persistence of the bacteria and eventually to the gastric pathology.	[Romi, Benedetta; Soldaini, Elisabetta; Pancotto, Laura; Castellino, Flora; Del Giudice, Giuseppe; Schiavetti, Francesca] Novartis Vaccines & Diagnost Res Ctr, Siena, Italy	Novartis	Romi, B (corresponding author), Novartis Vaccines & Diagnost Res Ctr, Siena, Italy.	francesca.schiavetti@novartis.com						Aihara M, 1997, INFECT IMMUN, V65, P3218, DOI 10.1128/IAI.65.8.3218-3224.1997; Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Bagchi D, 1996, FREE RADICAL RES, V24, P439, DOI 10.3109/10715769609088043; Bagnoli F, 2005, P NATL ACAD SCI USA, V102, P16339, DOI 10.1073/pnas.0502598102; Baltrus DA, 2009, J BACTERIOL, V191, P447, DOI 10.1128/JB.01416-08; Beetz S, 2007, IMMUNOL RES, V37, P97, DOI 10.1007/BF02685893; BLASER MJ, 1995, CANCER RES, V55, P2111; Bonneville M, 2006, CURR OPIN IMMUNOL, V18, P539, DOI 10.1016/j.coi.2006.07.002; Bukowski JF, 1999, ARTHRITIS RHEUM, V42, pS259; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri797; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Chien YH, 1996, ANNU REV IMMUNOL, V14, P511, DOI 10.1146/annurev.immunol.14.1.511; Ching CK, 1996, AM J GASTROENTEROL, V91, P949; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; DElios MM, 1997, J IMMUNOL, V158, P962; Dundon WG, 2001, INT J MED MICROBIOL, V290, P647, DOI 10.1016/S1438-4221(01)80002-3; Feurle J, 2002, J BIOL CHEM, V277, P148, DOI 10.1074/jbc.M106443200; Futagami S, 2006, J GASTROEN HEPATOL, V21, P32, DOI 10.1111/j.1440-1746.2005.04148.x; Lundgren A, 2003, INFECT IMMUN, V71, P1755, DOI 10.1128/IAI.71.4.1755-1762.2003; Montecucco C, 2001, NAT REV MOL CELL BIO, V2, P457, DOI 10.1038/35073084; Morita CT, 2000, SPRINGER SEMIN IMMUN, V22, P191, DOI 10.1007/s002810000042; Newton DJ, 2006, INFECT IMMUN, V74, P1097, DOI 10.1128/IAI.74.2.1097-1105.2006; Papini E, 1998, J CLIN INVEST, V102, P813, DOI 10.1172/JCI2764; Peek RM, 1995, LAB INVEST, V73, P760; Petersen AM, 2001, FEMS IMMUNOL MED MIC, V30, P103, DOI 10.1016/S0928-8244(00)00246-7; Pietschmann K, 2009, SCAND J IMMUNOL, V70, P245, DOI 10.1111/j.1365-3083.2009.02290.x; Pinto-Santini D, 2005, CANCER EPIDEM BIOMAR, V14, P1853, DOI 10.1158/1055-9965.EPI-04-0784; Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857; Ren SM, 2006, J BIOL CHEM, V281, P32344, DOI 10.1074/jbc.M606172200; Rohde M, 2003, MOL MICROBIOL, V49, P219, DOI 10.1046/j.1365-2958.2003.03549.x; Rosenplanter C, 2007, EUR J IMMUNOL, V37, P1905, DOI 10.1002/eji.200636676; Shrestha N, 2005, ANN NY ACAD SCI, V1062, P79, DOI 10.1196/annals.1358.011; Stein M, 2000, P NATL ACAD SCI USA, V97, P1263, DOI 10.1073/pnas.97.3.1263; Stein M, 2002, MOL MICROBIOL, V43, P971, DOI 10.1046/j.1365-2958.2002.02781.x; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; WANG Y, 1993, J GEN MICROBIOL, V139, P2485, DOI 10.1099/00221287-139-10-2485; Wesch D, 2006, J IMMUNOL, V176, P1348, DOI 10.4049/jimmunol.176.3.1348; Yurchenko E, 2006, J EXP MED, V203, P2451, DOI 10.1084/jem.20060956	38	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19324	10.1371/journal.pone.0019324	http://dx.doi.org/10.1371/journal.pone.0019324			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559446	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700135
J	Tian, G; Qiu, YF; Qi, ZZ; Wu, XH; Zhang, QW; Bi, YJ; Yang, YH; Li, YC; Yang, XY; Xin, YQ; Li, CX; Cui, BZ; Wang, ZY; Wang, H; Yang, RF; Wang, XY				Tian, Guang; Qiu, Yefeng; Qi, Zhizhen; Wu, Xiaohong; Zhang, Qingwen; Bi, Yujing; Yang, Yonghai; Li, Yuchuan; Yang, Xiaoyan; Xin, Youquan; Li, Cunxiang; Cui, Baizhong; Wang, Zuyun; Wang, Hu; Yang, Ruifu; Wang, Xiaoyi			Histopathological Observation of Immunized Rhesus Macaques with Plague Vaccines after Subcutaneous Infection of Yersinia pestis	PLOS ONE			English	Article							PNEUMONIC PLAGUE; MOUSE MODEL; PATHOLOGY; PROGRESSION; PROTECTION	In our previous study, complete protection was observed in Chinese-origin rhesus macaques immunized with SV1 (20 mu g F1 and 10 mu g rV270) and SV2 (200 mu g F1 and 100 mu g rV270) subunit vaccines and with EV76 live attenuated vaccine against subcutaneous challenge with 6 x 10(6) CFU of Y. pestis. In the present study, we investigated whether the vaccines can effectively protect immunized animals from any pathologic changes using histological and immunohistochemical techniques. In addition, the glomerular basement membranes (GBMs) of the immunized animals and control animals were checked by electron microscopy. The results show no signs of histopathological lesions in the lungs, livers, kidneys, lymph nodes, spleens and hearts of the immunized animals at Day 14 after the challenge, whereas pathological alterations were seen in the corresponding tissues of the control animals. Giemsa staining, ultrastructural examination, and immunohistochemical staining revealed bacteria in some of the organs of the control animals, whereas no bacterium was observed among the immunized animals. Ultrastructural observation revealed that no glomerular immune deposits on the GBM. These observations suggest that the vaccines can effectively protect animals from any pathologic changes and eliminate Y. pestis from the immunized animals. The control animals died from multi-organ lesions specifically caused by the Y. pestis infection. We also found that subcutaneous infection of animals with Y. pestis results in bubonic plague, followed by pneumonic and septicemic plagues. The histopathologic features of plague in rhesus macaques closely resemble those of rodent and human plagues. Thus, Chinese-origin rhesus macaques serve as useful models in studying Y. pestis pathogenesis, host response and the efficacy of new medical countermeasures against plague.	[Tian, Guang; Wu, Xiaohong; Bi, Yujing; Li, Yuchuan; Yang, Ruifu; Wang, Xiaoyi] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Qiu, Yefeng] Acad Mil Med Sci, Lab Anim Ctr, Beijing, Peoples R China; [Qi, Zhizhen; Zhang, Qingwen; Yang, Yonghai; Yang, Xiaoyan; Xin, Youquan; Li, Cunxiang; Cui, Baizhong; Wang, Zuyun; Wang, Hu] Qinghai Inst Endem Dis Prevent & Control Qinghai, Xining, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Academy of Military Medical Sciences - China	Tian, G (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	ruifuyang@gmail.com; wgenome@yahoo.com.cn	Yang, Ruifu/A-2273-2011; li, JACK/HHC-6755-2022	Yang, Ruifu/0000-0003-3219-7269; 	National Key Program for Infectious Diseases of China [2009ZX10004-4001]; National Natural Science Foundation of China [30930001]	National Key Program for Infectious Diseases of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Program for Infectious Diseases of China (2009ZX10004-4001) and the National Natural Science Foundation of China (contract no. 30930001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agar SL, 2008, MICROBIOL-SGM, V154, P1939, DOI 10.1099/mic.0.2008/017335-0; AGODOA LYC, 1987, KIDNEY INT, V32, P13, DOI 10.1038/ki.1987.165; Al-Haddawi MH, 2001, RES VET SCI, V70, P191, DOI 10.1053/rvsc.2001.0459; [Anonymous], 2000, Wkly Epidemiol Rec, V75, P338; Bashaw J, 2007, CLIN VACCINE IMMUNOL, V14, P605, DOI 10.1128/CVI.00398-06; Chen S, 2009, VET IMMUNOL IMMUNOP, V130, P226, DOI 10.1016/j.vetimm.2009.02.011; Chen Z, 2009, PHOTODERMATOL PHOTO, V25, P310, DOI 10.1111/j.1600-0781.2009.00465.x; Cornelius CA, 2008, INFECT IMMUN, V76, P5588, DOI 10.1128/IAI.00699-08; COUSER WG, 1985, KIDNEY INT, V28, P569, DOI 10.1038/ki.1985.167; Davis KJ, 1996, ARCH PATHOL LAB MED, V120, P156; Do Y, 2008, EUR J IMMUNOL, V38, P20, DOI 10.1002/eji.200737799; FMedSci SDWF, 2006, US NONH PRIM RES, P1; Guinet F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001688; Jennings GT, 2009, ANNU REV PHARMACOL, V49, P303, DOI 10.1146/annurev-pharmtox-061008-103129; Kurul S, 2004, PEDIATR NEPHROL, V19, P621, DOI 10.1007/s00467-004-1423-2; Lathem WW, 2005, P NATL ACAD SCI USA, V102, P17786, DOI 10.1073/pnas.0506840102; Parent MA, 2005, INFECT IMMUN, V73, P7304, DOI 10.1128/IAI.73.11.7304-7310.2005; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Qi ZZ, 2010, VACCINE, V28, P1655, DOI 10.1016/j.vaccine.2009.02.078; Qiu Y, 2010, SCAND J IMMUNOL, V72, P425, DOI 10.1111/j.1365-3083.2010.02456.x; Riedel Stefan, 2005, Proc (Bayl Univ Med Cent), V18, P116; Rohr LR, 2001, AM J CLIN PATHOL, V115, P703; Sebbane F, 2005, AM J PATHOL, V166, P1427, DOI 10.1016/S0002-9440(10)62360-7; Smiley ST, 2008, IMMUNOL REV, V225, P256, DOI 10.1111/j.1600-065X.2008.00674.x; Van Andel R, 2008, COMPARATIVE MED, V58, P68; Watson RP, 2001, VET PATHOL, V38, P165, DOI 10.1354/vp.38-2-165; Williamson ED, 2007, MICROB PATHOGENESIS, V42, P11, DOI 10.1016/j.micpath.2006.09.003; Williamson ED, 1999, CLIN EXP IMMUNOL, V116, P107; Williamson ED, 1997, VACCINE, V15, P1079, DOI 10.1016/S0264-410X(96)00303-9	29	13	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19260	10.1371/journal.pone.0019260	http://dx.doi.org/10.1371/journal.pone.0019260			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559437	Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700114
J	Nikolopoulos, G; Bagos, P; Lytras, T; Bonovas, S				Nikolopoulos, Georgios; Bagos, Pantelis; Lytras, Theodoros; Bonovas, Stefanos			An Ecological Study of the Determinants of Differences in 2009 Pandemic Influenza Mortality Rates between Countries in Europe	PLOS ONE			English	Article							INCOME INEQUALITY; AIR-POLLUTION; HEALTH-CARE; DEATH; UNEMPLOYMENT; INFECTION; OUTCOMES; CRISES	Background: Pandemic A (H1N1) 2009 mortality rates varied widely from one country to another. Our aim was to identify potential socioeconomic determinants of pandemic mortality and explain between-country variation. Methodology: Based on data from a total of 30 European countries, we applied random-effects Poisson regression models to study the relationship between pandemic mortality rates (May 2009 to May 2010) and a set of representative environmental, health care-associated, economic and demographic country-level parameters. The study was completed by June 2010. Principal Findings: Most regression approaches indicated a consistent, statistically significant inverse association between pandemic influenza-related mortality and per capita government expenditure on health. The findings were similar in univariable [coefficient: -0.00028, 95% Confidence Interval (CI): -0.00046, -0.00010, p = 0.002] and multivariable analyses (including all covariates, coefficient: -0.00107, 95% CI: -0.00196, -0.00018, p = 0.018). The estimate was barely insignificant when the multivariable model included only significant covariates from the univariate step (coefficient: -0.00046, 95% CI: -0.00095, 0.00003, p = 0.063). Conclusions: Our findings imply a significant inverse association between public spending on health and pandemic influenza mortality. In an attempt to interpret the estimated coefficient (-0.00028) for the per capita government expenditure on health, we observed that a rise of 100 international dollars was associated with a reduction in the pandemic influenza mortality rate by approximately 2.8%. However, further work needs to be done to unravel the mechanisms by which reduced government spending on health may have affected the 2009 pandemic influenza mortality.	[Nikolopoulos, Georgios; Lytras, Theodoros; Bonovas, Stefanos] Hellen Ctr Dis Control & Prevent, Athens, Greece; [Nikolopoulos, Georgios; Bagos, Pantelis] Univ Cent Greece, Dept Comp Sci & Biomed Informat, Lamia, Greece	University of Central Greece	Nikolopoulos, G (corresponding author), Hellen Ctr Dis Control & Prevent, Athens, Greece.	sbonovas@med.uoa.gr	Bonovas, Stefanos/GZG-4609-2022; Nikolopoulos, Georgios/H-5698-2011; Bonovas, Stefanos/H-5653-2011; Bagos, Pantelis G/H-5658-2011; Bagos, Pantelis/U-7140-2019	Nikolopoulos, Georgios/0000-0002-3307-0246; Bagos, Pantelis G/0000-0003-4935-2325; Bagos, Pantelis/0000-0003-4935-2325; Lytras, Theodore/0000-0002-4146-4122; Bonovas, Stefanos/0000-0001-6102-6579				Afkhami A, 2003, B HIST MED, V77, P367, DOI 10.1353/bhm.2003.0049; Akinkugbe O, 2009, SOC WORK PUBLIC HLTH, V24, P131, DOI 10.1080/19371910802569716; Babones SJ, 2008, SOC SCI MED, V66, P1614, DOI 10.1016/j.socscimed.2007.12.012; Bezruchka S, 2009, CAN MED ASSOC J, V181, P281, DOI 10.1503/cmaj.090553; Bokhari FAS, 2007, HEALTH ECON, V16, P257, DOI 10.1002/hec.1157; Castrodale L., 2009, Morbidity and Mortality Weekly Report, V58, P1341; Chan M., 2009, WORLD NOW START 2009; Chan MF, 2010, J CLIN NURS, V19, P884, DOI 10.1111/j.1365-2702.2009.02863.x; Chauhan AJ, 2003, BRIT MED BULL, V68, P95, DOI 10.1093/bmb/ldg022; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; De Vogli R, 2005, J EPIDEMIOL COMMUN H, V59, P158, DOI 10.1136/jech.2004.020651; Dorling D, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b829; Farahani M, 2010, HEALTH ECON, V19, P1361, DOI 10.1002/hec.1557; Ferguson N, 2006, LANCET, V368, P2187, DOI 10.1016/S0140-6736(06)69870-X; Gani A, 2009, HEALTH POLICY PLANN, V24, P72, DOI 10.1093/heapol/czn044; Granados JAT, 2005, INT J EPIDEMIOL, V34, P1194, DOI 10.1093/ije/dyi141; Granados JAT, 2008, J HEALTH ECON, V27, P544, DOI 10.1016/j.jhealeco.2007.09.006; Gupta S, 2003, HEALTH ECON, V12, P685, DOI 10.1002/hec.759; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; La Ruche G, 2009, EURO SURVEILL, V14; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Lynch J, 2001, LANCET, V358, P194, DOI 10.1016/S0140-6736(01)05407-1; Mathers CD, 1998, MED J AUSTRALIA, V168, P178, DOI 10.5694/j.1326-5377.1998.tb126776.x; Mckee M, 2009, LANCET, V373, P349, DOI 10.1016/S0140-6736(09)60098-2; MORGENSTERN H, 1982, AM J PUBLIC HEALTH, V72, P1336, DOI 10.2105/AJPH.72.12.1336; Murray CJL, 2006, LANCET, V368, P2211, DOI 10.1016/S0140-6736(06)69895-4; Nixon John, 2006, Eur J Health Econ, V7, P7, DOI 10.1007/s10198-005-0336-8; Pebody RG, 2010, EUROSURVEILLANCE, V15; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Salvi S, 2007, PAEDIATR RESPIR REV, V8, P275, DOI 10.1016/j.prrv.2007.08.008; Stieb DM, 2002, J AIR WASTE MANAGE, V52, P470, DOI 10.1080/10473289.2002.10470794; Stuckler D, 2008, PLOS MED, V5, P1079, DOI 10.1371/journal.pmed.0050143; Stuckler D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c3311; Stuckler David, 2009, Ulster Med J, V78, P142; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; Sydenstricker E, 1931, PUBLIC HEALTH REP, V46, P154, DOI 10.2307/4579923; World Health Organization, 2010, PAND H1N1 2009	37	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19432	10.1371/journal.pone.0019432	http://dx.doi.org/10.1371/journal.pone.0019432			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	762MQ	21589928	Green Submitted, Green Published, gold			2022-12-27	WOS:000290483600010
J	Stancak, A; Alghamdi, J; Nurmikko, TJ				Stancak, Andrej; Alghamdi, Jamaan; Nurmikko, Turo J.			Cortical Activation Changes during Repeated Laser Stimulation: A Magnetoencephalographic Study	PLOS ONE			English	Article							SOMATOSENSORY-EVOKED POTENTIALS; 2ND PAIN; TEMPORAL SUMMATION; HZ OSCILLATIONS; 1ST PAIN; LAMINA-I; WIND-UP; RESPONSES; SKIN; NEURONS	Repeated warm laser stimuli produce a progressive increase of the sensation of warmth and heat and eventually that of a burning pain. The pain resulting from repetitive warm stimuli is mediated by summated C fibre responses. To shed more light on the cortical changes associated with pain during repeated subnoxious warm stimution, we analysed magnetoencephalographic (MEG) evoked fields in eleven subjects during application of repetitive warm laser stimuli to the dorsum of the right hand. One set of stimuli encompassed 10 laser pulses occurring at 2.5 s intervals. Parameters of laser stimulation were optimised to elicit a pleasant warm sensation upon a single stimulus with a rise of skin temperature after repeated stimulation not exceeding the threshold of C mechano-heat fibres. Subjects reported a progressive increase of the intensity of heat and burning pain during repeated laser stimulation in spite of only mild (4.8 degrees C) increase of skin temperature from the first stimulus to the tenth stimulus. The mean reaction time, evaluated in six subjects, was 1.33 s, confirming involvement of C fibres. The neuromagnetic fields were modelled by five equivalent source dipoles located in the occipital cortex, cerebellum, posterior cingulate cortex, and left and right operculo-insular cortex. The only component showing statistically significant changes during repetitive laser stimulation was the late component of the contralateral operculo-insular source peaking at 1.05 s after stimulus onset. The amplitude increases of the late component of the contralateral operculo-insular source dipole correlated with the subjects' numerical ratings of warmth and pain. Results point to a pivotal role of the contralateral operculo-insular region in processing of C-fibre mediated pain during repeated subnoxious laser stimulation.	[Stancak, Andrej] Univ Liverpool, Dept Expt Psychol, Inst Psychol Hlth & Soc, Liverpool L69 3BX, Merseyside, England; [Stancak, Andrej] Charles Univ Prague, Fac Med 3, Prague, Czech Republic; [Alghamdi, Jamaan] Univ Liverpool, Dept Cellular & Mol Biol, Inst Translat Med, Liverpool L69 3BX, Merseyside, England; [Nurmikko, Turo J.] Univ Liverpool, Unit Neurosci, Pain Res Inst, Inst Aging & Chron Dis, Liverpool L69 3BX, Merseyside, England	University of Liverpool; Charles University Prague; University of Liverpool; University of Liverpool	Stancak, A (corresponding author), Univ Liverpool, Dept Expt Psychol, Inst Psychol Hlth & Soc, Liverpool L69 3BX, Merseyside, England.	a.stancak@liverpool.ac.uk	Alghamdi, Jamaan Salem/GLR-3477-2022; Alghamdi, Jamaan/D-2564-2012; Nurmikko, Turo/J-2917-2017	Alghamdi, Jamaan Salem/0000-0002-5563-898X; Nurmikko, Turo/0000-0003-1252-6256	Pain Relief Foundation; Czech Ministry of Education and Sports [CNS1M0517, RG0021620816]	Pain Relief Foundation; Czech Ministry of Education and Sports(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by the Pain Relief Foundation (www.painrelieffoundation.org.uk), and by the Czech Ministry of Education and Sports (CNS1M0517 and RG0021620816; http://msmt.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostino R, 2000, NEUROSCI LETT, V285, P115, DOI 10.1016/S0304-3940(00)01038-7; BECK PW, 1974, BRAIN RES, V67, P373, DOI 10.1016/0006-8993(74)90488-0; BESSOU P, 1969, J NEUROPHYSIOL, V32, P1025, DOI 10.1152/jn.1969.32.6.1025; Bingel U, 2002, PAIN, V99, P313, DOI 10.1016/S0304-3959(02)00157-4; BROMM B, 1991, REV NEUROL-FRANCE, V147, P625; Brown CA, 2008, PAIN, V135, P240, DOI 10.1016/j.pain.2007.05.022; Chen ACN, 2000, BRAIN TOPOGR, V13, P59, DOI 10.1023/A:1007886303206; Craig AD, 2006, J COMP NEUROL, V499, P953, DOI 10.1002/cne.21155; Craig AD, 2002, J NEUROPHYSIOL, V87, P1902, DOI 10.1152/jn.00578.2001; Craig AD, 2004, J NEUROPHYSIOL, V92, P2604, DOI 10.1152/jn.00385.2004; Defrin R, 2001, PAIN, V89, P253, DOI 10.1016/S0304-3959(00)00369-9; Dum RP, 2009, J NEUROSCI, V29, P14223, DOI 10.1523/JNEUROSCI.3398-09.2009; Farrell MJ, 2005, HUM BRAIN MAPP, V25, P129, DOI 10.1002/hbm.20125; Frot M, 2007, CEREB CORTEX, V17, P610, DOI 10.1093/cercor/bhk007; Garcia-Larrea L, 2010, BRAIN, V133, P2528, DOI 10.1093/brain/awq220; Granovsky Y, 2005, PAIN, V115, P238, DOI 10.1016/j.pain.2005.02.017; Green BG, 1998, SOMATOSENS MOT RES, V15, P269, DOI 10.1080/08990229870682; Hari R, 1999, PHILOS T R SOC B, V354, P1145, DOI 10.1098/rstb.1999.0470; Herrero JF, 2000, PROG NEUROBIOL, V61, P169, DOI 10.1016/S0301-0082(99)00051-9; Hoechstetter K, 2001, NEUROIMAGE, V14, P759, DOI 10.1006/nimg.2001.0855; Iannetti GD, 2008, J NEUROPHYSIOL, V100, P815, DOI 10.1152/jn.00097.2008; Iannetti GD, 2005, NEUROSCIENCE, V131, P199, DOI 10.1016/j.neuroscience.2004.10.035; Iannetti GD, 2003, J NEUROPHYSIOL, V89, P562, DOI 10.1152/jn.00393.2002; IGGO A, 1969, J PHYSIOL-LONDON, V200, P403, DOI 10.1113/jphysiol.1969.sp008701; KRUBITZER LA, 1992, J COMP NEUROL, V319, P123, DOI 10.1002/cne.903190111; LAMOTTE RH, 1978, J NEUROPHYSIOL, V41, P509, DOI 10.1152/jn.1978.41.2.509; Leandri M, 2006, NEUROPHYSIOL CLIN, V36, P207, DOI 10.1016/j.neucli.2006.08.004; Li J, 1999, PAIN, V79, P75, DOI 10.1016/S0304-3959(98)00154-7; Mazzola L, 2006, CEREB CORTEX, V16, P960, DOI 10.1093/cercor/bhj038; MENDELL LM, 1966, EXP NEUROL, V16, P316, DOI 10.1016/0014-4886(66)90068-9; Meyer RA, 2006, WALL MELZACKS TXB PA, V5, P3; Mouraux A, 2009, J NEUROPHYSIOL, V101, P3258, DOI 10.1152/jn.91181.2008; Nakata H, 2004, PAIN, V107, P91, DOI 10.1016/j.pain.2003.10.001; Obermann M, 2009, NEUROIMAGE, V46, P193, DOI 10.1016/j.neuroimage.2009.01.038; Ostrowsky K, 2002, CEREB CORTEX, V12, P376, DOI 10.1093/cercor/12.4.376; Peyron R, 2002, NEUROIMAGE, V17, P1336, DOI 10.1006/nimg.2002.1315; Ploner M, 2002, P NATL ACAD SCI USA, V99, P12444, DOI 10.1073/pnas.182272899; Ploner M, 2006, J NEUROSCI, V26, P10879, DOI 10.1523/JNEUROSCI.2386-06.2006; PRICE DD, 1977, PAIN, V3, P57, DOI 10.1016/0304-3959(77)90035-5; Price DD, 2002, PAIN, V99, P49, DOI 10.1016/S0304-3959(02)00053-2; PRICE DD, 1977, J INVEST DERMATOL, V69, P167, DOI 10.1111/1523-1747.ep12497942; Raphael KG, 2009, J OROFAC PAIN, V23, P54; Schlereth T, 2003, NEUROIMAGE, V20, P441, DOI 10.1016/S1053-8119(03)00345-8; SCHOUENBORG J, 1983, J NEUROPHYSIOL, V50, P1108, DOI 10.1152/jn.1983.50.5.1108; Sieweke N, 1999, PAIN, V80, P171, DOI 10.1016/S0304-3959(98)00200-0; Stancak A, 2007, NEUROSCIENCE, V147, P842, DOI 10.1016/j.neuroscience.2007.04.055; Stancak A, 2002, BRAIN RES, V936, P47, DOI 10.1016/S0006-8993(02)02502-7; Stancak A, 2006, NEUROIMAGE, V33, P660, DOI 10.1016/j.neuroimage.2006.06.049; Stancak A, 2010, BRAIN RES, V1317, P69, DOI 10.1016/j.brainres.2009.12.064; Staud R, 2001, PAIN, V91, P165, DOI 10.1016/S0304-3959(00)00432-2; Staud R, 2008, EUR J PAIN, V12, P1078, DOI 10.1016/j.ejpain.2008.02.002; Staud R, 2007, J PAIN, V8, P893, DOI 10.1016/j.jpain.2007.06.006; Staud R, 2007, PAIN, V129, P130, DOI 10.1016/j.pain.2006.10.010; TARKKA IM, 1993, J CLIN NEUROPHYSIOL, V10, P513, DOI 10.1097/00004691-199310000-00009; TILLMAN DB, 1995, J PHYSIOL-LONDON, V485, P767, DOI 10.1113/jphysiol.1995.sp020767; Valeriani M, 2000, CLIN NEUROPHYSIOL, V111, P1103, DOI 10.1016/S1388-2457(00)00273-X; Veldhuijzen DS, 2010, EUR J PAIN, V14, DOI 10.1016/j.ejpain.2009.10.002; Vierck CJ, 1997, J NEUROPHYSIOL, V78, P992, DOI 10.1152/jn.1997.78.2.992; Vrana J, 2005, NEUROSCI LETT, V386, P170, DOI 10.1016/j.neulet.2005.06.005; WILLIAMSON P, 1987, METHODS ANAL BRAIN E, P405; Yeomans DC, 1996, PAIN, V66, P253, DOI 10.1016/0304-3959(96)03082-5	61	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19744	10.1371/journal.pone.0019744	http://dx.doi.org/10.1371/journal.pone.0019744			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572954	gold, Green Submitted, Green Published			2022-12-27	WOS:000290440200023
J	dos Santos, PR; Rancez, M; Pretet, JL; Michel-Salzat, A; Messent, V; Bogdanova, A; Couedel-Courteille, A; Souil, E; Cheynier, R; Butor, C				dos Santos, Patricia Ribeiro; Rancez, Magali; Pretet, Jean-Luc; Michel-Salzat, Alice; Messent, Valerie; Bogdanova, Anna; Couedel-Courteille, Anne; Souil, Evelyne; Cheynier, Remi; Butor, Cecile			Rapid Dissemination of SIV Follows Multisite Entry after Rectal Inoculation	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; INJECTING DRUG-USERS; INTESTINAL EPITHELIAL-CELLS; HIV-1 RNA LEVELS; HOMOSEXUAL-MEN; DENDRITIC CELLS; TRANSEPITHELIAL TRANSPORT; HETEROSEXUAL TRANSMISSION; INTRAVAGINAL INOCULATION; ANTIRETROVIRAL THERAPY	Receptive ano-rectal intercourse is a major cause of HIV infection in men having sex with men and in heterosexuals. Current knowledge of the mechanisms of entry and dissemination during HIV rectal transmission is scarce and does not allow the development of preventive strategies. We investigated the early steps of rectal infection in rhesus macaques inoculated with the pathogenic isolate SIVmac251 and necropsied four hours to nine days later. All macaques were positive for SIV. Control macaques inoculated with heat-inactivated virus were consistently negative for SIV. SIV DNA was detected in the rectum as early as four hours post infection by nested PCR for gag in many laser-microdissected samples of lymphoid aggregates and lamina propria but never in follicle-associated epithelium. Scarce SIV antigen positive cells were observed by immunohistofluorescence in the rectum, among intraepithelial and lamina propria cells as well as in clusters in lymphoid aggregates, four hours post infection and onwards. These cells were T cells and non-T cells that were not epithelial cells, CD68(+) macrophages, DC-SIGN(+) cells or fascin(+) dendritic cells. DC-SIGN(+) cells carried infectious virus. Detection of Env singly spliced mRNA in the mucosa by nested RT-PCR indicated ongoing viral replication. Strikingly, four hours post infection colic lymph nodes were also infected in all macaques as either SIV DNA or infectious virus was recovered. Rapid SIV entry and dissemination is consistent with trans-epithelial transport. Virions appear to cross the follicle-associated epithelium, and also the digestive epithelium. Viral replication could however be more efficient in lymphoid aggregates. The initial sequence of events differs from both vaginal and oral infections, which implies that prevention strategies for rectal transmission will have to be specific. Microbicides will need to protect both digestive and follicle-associated epithelia. Vaccines will need to induce immunity in lymph nodes as well as in the rectum.	[dos Santos, Patricia Ribeiro; Rancez, Magali; Pretet, Jean-Luc; Michel-Salzat, Alice; Messent, Valerie; Bogdanova, Anna; Couedel-Courteille, Anne; Butor, Cecile] Univ Paris Diderot, Lab Transmiss & Disseminat Virales, Paris, France; [Cheynier, Remi] Univ Paris 05, Inst Cochin, INSERM, Dept Immunol Hematol,CNRS,URA8104,UMR S1016,U1016, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	dos Santos, PR (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, P-1200 Lisbon, Portugal.	butor@univ-paris-diderot.fr	Cheynier, Remi/E-9921-2010; Couedel-Courteille, Anne/O-7485-2017; Prétet, Jean-Luc/B-2911-2012	Cheynier, Remi/0000-0003-1146-660X; Couedel-Courteille, Anne/0000-0002-0060-2509; Prétet, Jean-Luc/0000-0002-8430-214X; RANCEZ, Magali/0000-0001-5184-1334; Messent, Valerie/0000-0001-7038-1302	Agence Nationale de Recherche sur le Sida et les Hepatites (ANRS); Institut National de Recherche Medicale; association "Ensemble contre le Sida"; Universite Paris Diderot; NIH [1 R21 AI42628-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI042628] Funding Source: NIH RePORTER	Agence Nationale de Recherche sur le Sida et les Hepatites (ANRS)(ANRSFrench National Research Agency (ANR)); Institut National de Recherche Medicale; association "Ensemble contre le Sida"; Universite Paris Diderot; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by several grants from the Agence Nationale de Recherche sur le Sida et les Hepatites (ANRS, http://www.anrs.fr), by the Institut National de Recherche Medicale (http://www.inserm.fr) and by grants from the association "Ensemble contre le Sida" (http://www.sidaction.org), the Universite Paris Diderot (http://www.univ-paris-diderot.fr) and the NIH (http://www.nih.gov, grant 1 R21 AI42628-01). PRS was a predoctoral fellow of the Fundacao para a Ciencia e a Tecnologia (http://alfa.fct.mctes.pt), then was Attache Temporaire d'Enseignement et de Recherche for the Universite Paris Diderot, MR is a predoctoral fellow of the Ministere de l'Enseignement Superieur et de la Recherche (http://www.enseignementsup-recherche.gouv.fr), JLP was a predoctoral fellow of the Fondation Merieux (http://www.fondation-merieux.org), then of the ANRS, VGM and AB were postdoctoral fellows of the association "Ensemble contre le Sida". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1987, J VIROL, V61, P209, DOI 10.1128/JVI.61.1.209-213.1987; Alioum A, 1998, EPIDEMIOLOGY, V9, P605, DOI 10.1097/00001648-199811000-00007; AMERONGEN HM, 1991, J ACQ IMMUN DEF SYND, V4, P760; [Anonymous], 1992, BMJ, V304, P809; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; BIGGAR RJ, 1990, AIDS, V4, P1059, DOI 10.1097/00002030-199011000-00002; BIRD G, 1994, AIDS, V8, P911; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Bomsel M, 1997, NAT MED, V3, P42, DOI 10.1038/nm0197-42; BORZY MS, 1988, J ACQ IMMUN DEF SYND, V1, P419; BRETTLE RP, 1995, QJM-INT J MED, V88, P479; Butler DM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000447; Centers for Disease Control and Prevention, 2011, HIV SURV REP 2009, V21; Chenine AL, 1998, AIDS RES HUM RETROV, V14, P1235, DOI 10.1089/aid.1998.14.1235; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Chrystie IL, 1998, J REPROD IMMUNOL, V41, P301, DOI 10.1016/S0165-0378(98)00066-7; CLAYTON F, 1992, GASTROENTEROLOGY, V103, P919, DOI 10.1016/0016-5085(92)90026-U; COATES RA, 1988, AM J EPIDEMIOL, V128, P729, DOI 10.1093/oxfordjournals.aje.a115026; Coombs RW, 1998, J INFECT DIS, V177, P320, DOI 10.1086/514213; Coplan PM, 1996, AM J EPIDEMIOL, V144, P817, DOI 10.1093/oxfordjournals.aje.a009016; Couedel-Courteille A, 2003, VIROLOGY, V316, P290, DOI 10.1016/j.virol.2003.08.021; Couedel-Courteille A, 1999, VIROLOGY, V260, P277, DOI 10.1006/viro.1999.9809; Coyne CB, 2007, CELL HOST MICROBE, V2, P181, DOI 10.1016/j.chom.2007.07.003; Cranage M, 2008, PLOS MED, V5, P1238, DOI 10.1371/journal.pmed.0050157; de Witte L, 2008, TRENDS MOL MED, V14, P12, DOI 10.1016/j.molmed.2007.11.001; DEBOURNE MNG, 1975, ANATOMY PHYSL, V1, P170; DORMONT D, 1993, 8 C CENT GARD FOND M, P157; ESKILD A, 1994, SCAND J SOC MED, V22, P309, DOI 10.1177/140349489402200411; Eskild A, 1997, SCAND J INFECT DIS, V29, P103, DOI 10.3109/00365549709035868; Exner TM, 2008, AIDS EDUC PREV, V20, P148, DOI 10.1521/aeap.2008.20.2.148; FANTINI J, 1993, P NATL ACAD SCI USA, V90, P2700, DOI 10.1073/pnas.90.7.2700; Fotopoulos G, 2002, P NATL ACAD SCI USA, V99, P9410, DOI 10.1073/pnas.142586899; GALAI N, 1995, J ACQ IMMUN DEF SYND, V8, P66; Gupta P, 1997, J VIROL, V71, P6271, DOI 10.1128/JVI.71.8.6271-6275.1997; Gurney KB, 2005, J VIROL, V79, P5762, DOI 10.1128/JVI.79.9.5762-5773.2005; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hirsch VM, 1998, NAT MED, V4, P1401, DOI 10.1038/3992; Hu JJ, 2000, J VIROL, V74, P6087, DOI 10.1128/JVI.74.13.6087-6095.2000; Hu Shiu-Lok, 2005, Current Drug Targets - Infectious Disorders, V5, P193, DOI 10.2174/1568005054201508; Jameson B, 2002, J VIROL, V76, P1866, DOI 10.1128/JVI.76.4.1866-1875.2002; Kittikraisak W, 2009, JAIDS-J ACQ IMM DEF, V51, P601, DOI 10.1097/QAI.0b013e3181a44700; Kuller L, 1998, AIDS RES HUM RETROV, V14, P1345, DOI 10.1089/aid.1998.14.1345; LEGRAND R, 1992, VACCINE, V10, P873, DOI 10.1016/0264-410X(92)90052-L; Leichliter JS, 2008, SEX TRANSM DIS, V35, P910, DOI 10.1097/OLQ.0b013e31818af12f; Leynaert B, 1998, AM J EPIDEMIOL, V148, P88, DOI 10.1093/oxfordjournals.aje.a009564; Lyles CM, 1999, EUR J EPIDEMIOL, V15, P99, DOI 10.1023/A:1007556327269; Margolis L, 2006, NAT REV MICROBIOL, V4, P312, DOI 10.1038/nrmicro1387; Marthas ML, 2001, AIDS RES HUM RETROV, V17, P1455, DOI 10.1089/088922201753197123; MATHIJS JM, 1988, LANCET, V1, P1111; Maynard E, 2009, PERSPECT SEX REPRO H, V41, P142, DOI 10.1363/4114209; Meng G, 2002, NAT MED, V8, P150, DOI 10.1038/nm0202-150; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Milush JA, 2004, AIDS, V18, P2371; Miyake A, 2006, J GEN VIROL, V87, P1311, DOI 10.1099/vir.0.81307-0; MOYER MP, 1991, J LEUKOCYTE BIOL, V49, P499, DOI 10.1002/jlb.49.5.499; NELSON JA, 1988, LANCET, V1, P259; Niess JH, 2010, J IMMUNOL, V184, P2026, DOI 10.4049/jimmunol.0901936; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; OPERSKALSKI EA, 1995, J INFECT DIS, V172, P648, DOI 10.1093/infdis/172.3.648; Parikh UM, 2009, J VIROL, V83, P10358, DOI 10.1128/JVI.01073-09; Pehrson P, 1997, AIDS, V11, P1007, DOI 10.1097/00002030-199708000-00009; PELLETIER E, 1995, VIROLOGY, V208, P644, DOI 10.1006/viro.1995.1195; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Pezzotti P, 1999, J ACQ IMMUN DEF SYND, V20, P275, DOI 10.1097/00042560-199903010-00010; Prins M, 1997, AIDS, V11, P621, DOI 10.1097/00002030-199705000-00010; Prins M, 2000, AIDS, V14, P1829, DOI 10.1097/00002030-200008180-00019; Prost S, 2008, J CLIN INVEST, V118, P1765, DOI 10.1172/JCI33037; Public Health Agency of Canada, 2010, HIV AIDS CAN SURV RE; REED L. J., 1938, AMER JOUR HYG, V27, P493; Renoux C, 2005, J VIROL, V79, P11231, DOI 10.1128/JVI.79.17.11231-11238.2005; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rezza G, 1998, J ACQ IMMUN DEF SYND, V17, pS13, DOI 10.1097/00042560-199801001-00005; Sansonetti PJ, 1999, SEMIN IMMUNOL, V11, P193, DOI 10.1006/smim.1999.0175; SEIDLIN M, 1993, AIDS, V7, P1247, DOI 10.1097/00002030-199309000-00015; Shacklett Barbara L, 2010, Curr Infect Dis Rep, V12, P19, DOI 10.1007/s11908-009-0072-9; Shen RZ, 2010, J LEUKOCYTE BIOL, V87, P663, DOI 10.1189/jlb.0909605; Shepard RN, 2000, J CLIN MICROBIOL, V38, P1414, DOI 10.1128/JCM.38.4.1414-1418.2000; Sodora DL, 1998, AIDS RES HUM RETROV, V14, pS119; Spijkerman IJB, 1996, EPIDEMIOLOGY, V7, P571, DOI 10.1097/00001648-199611000-00002; Spira AI, 1996, J EXP MED, V183, P215, DOI 10.1084/jem.183.1.215; Touloumi G, 2004, AIDS, V18, P1697, DOI 10.1097/01.aids.0000131395.14339.f5; UNAIDS, 2010, UNAIDS REP GLOB AIDS; van Wijk F, 2009, SEMIN IMMUNOL, V21, P130, DOI 10.1016/j.smim.2009.03.003; Varghese B, 2002, SEX TRANSM DIS, V29, P38, DOI 10.1097/00007435-200201000-00007; Veazey RS, 2008, CURR OPIN HIV AIDS, V3, P567, DOI 10.1097/COH.0b013e32830891bb; VELLA S, 1995, AIDS, V9, P51, DOI 10.1097/00002030-199501000-00007; Vernazza PL, 1997, AIDS, V11, P987, DOI 10.1097/00002030-199708000-00006; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; WOLFS TFW, 1989, VOX SANG, V57, P127, DOI 10.1111/j.1423-0410.1989.tb01149.x; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353; Zuckerman RA, 2004, J INFECT DIS, V190, P156, DOI 10.1086/421246	93	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19493	10.1371/journal.pone.0019493	http://dx.doi.org/10.1371/journal.pone.0019493			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573012	Green Submitted, gold, Green Published			2022-12-27	WOS:000290386800016
J	Kumar, V; Butcher, SJ; Oorni, K; Engelhardt, P; Heikkonen, J; Kaski, K; Ala-Korpela, M; Kovanen, PT				Kumar, Vibhor; Butcher, Sarah J.; Oorni, Katariina; Engelhardt, Peter; Heikkonen, Jukka; Kaski, Kimmo; Ala-Korpela, Mika; Kovanen, Petri T.			Three-Dimensional cryoEM Reconstruction of Native LDL Particles to 16 angstrom Resolution at Physiological Body Temperature	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; CRYOELECTRON MICROSCOPY; APOLIPOPROTEIN-B; STATISTICAL-ANALYSIS; SERUM-LIPOPROTEINS; TRANSFER PROTEIN; MODEL; LIPOVITELLIN; IMAGES; B-100	Background: Low-density lipoprotein (LDL) particles, the major carriers of cholesterol in the human circulation, have a key role in cholesterol physiology and in the development of atherosclerosis. The most prominent structural components in LDL are the core-forming cholesteryl esters (CE) and the particle-encircling single copy of a huge, non-exchangeable protein, the apolipoprotein B-100 (apoB-100). The shape of native LDL particles and the conformation of native apoB-100 on the particles remain incompletely characterized at the physiological human body temperature (37 degrees C). Methodology/Principal Findings: To study native LDL particles, we applied cryo-electron microscopy to calculate 3D reconstructions of LDL particles in their hydrated state. Images of the particles vitrified at 6 degrees C and 37 degrees C resulted in reconstructions at,16 A resolution at both temperatures. 3D variance map analysis revealed rigid and flexible domains of lipids and apoB-100 at both temperatures. The reconstructions showed less variability at 6 degrees C than at 37 degrees C, which reflected increased order of the core CE molecules, rather than decreased mobility of the apoB-100. Compact molecular packing of the core and order in a lipid-binding domain of apoB-100 were observed at 6 degrees C, but not at 37 degrees C. At 37 degrees C we were able to highlight features in the LDL particles that are not clearly separable in 3D maps at 6 degrees C. Segmentation of apoB-100 density, fitting of lipovitellin X-ray structure, and antibody mapping, jointly revealed the approximate locations of the individual domains of apoB-100 on the surface of native LDL particles. Conclusions/Significance: Our study provides molecular background for further understanding of the link between structure and function of native LDL particles at physiological body temperature.	[Kumar, Vibhor; Engelhardt, Peter; Heikkonen, Jukka; Kaski, Kimmo] Aalto Univ Aalto, Sch Sci & Technol, Dept Biomed Engn & Computat Sci, Ctr Excellence Computat Complex Syst Res, Helsinki, Finland; [Kumar, Vibhor] ASTAR, Genome Inst Singapore, Singapore, Singapore; [Butcher, Sarah J.] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Oorni, Katariina; Kovanen, Petri T.] Wihuri Res Inst, SF-00140 Helsinki, Finland; [Engelhardt, Peter] Univ Helsinki, Dept Pathol, Haartman Inst, Helsinki, Finland; [Engelhardt, Peter] Aalto Univ, Sch Sci & Technol, Dept Appl Phys, Nanomicroscopy Ctr, Espoo, Finland; [Heikkonen, Jukka] Univ Turku, Dept Informat Technol, Turku, Finland; [Ala-Korpela, Mika] Univ Oulu, Inst Clin Med, Computat Med Res Grp, Fac Med,Bioctr Oulu, Oulu, Finland; [Ala-Korpela, Mika] Univ Oulu, Dept Internal Med, SF-90220 Oulu, Finland; [Ala-Korpela, Mika] Univ Oulu, Bioctr Oulu, Clin Res Ctr, SF-90220 Oulu, Finland	Aalto University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Helsinki; Wihuri Research Institute; University of Helsinki; Aalto University; University of Turku; University of Oulu; University of Oulu; University of Oulu	Kumar, V (corresponding author), Aalto Univ Aalto, Sch Sci & Technol, Dept Biomed Engn & Computat Sci, Ctr Excellence Computat Complex Syst Res, Helsinki, Finland.	petri.kovanen@wri.fi	Oorni, Katariina/G-2484-2011; Kaski, Kimmo/AAO-4320-2021; Butcher, Sarah J/H-5579-2012; Kaski, Kimmo K K/G-8067-2012; Heikkonen, Jukka/R-4912-2017	Oorni, Katariina/0000-0002-9525-0250; Kaski, Kimmo/0000-0002-3805-9687; Kumar, Vibhor/0000-0002-9523-9422; Butcher, Sarah/0000-0001-7060-5871; Ala-Korpela, Mika/0000-0001-5905-1206	Academy of Finland [1129684]; Finnish Cardiovascular Research Foundation; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Finnish Cardiovascular Research Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work has been supported by the Academy of Finland Centre of Excellence Programme in Computational Complex Systems Research (KK), the Academy of Finland Centre of Excellence Programme in Virus Research (2006-2011; 1129684 to SJB), the Academy of Finland's Responding to Public Health Challenges Research Programme (MAK), the Finnish Cardiovascular Research Foundation (MAK), and the Sigrid Juselius Foundation (SJB). Wihuri Research Institute is maintained by the Jenny and Antti Wihuri Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAN M, 1984, NATURE, V308, P32, DOI 10.1038/308032a0; Anderson TA, 1998, STRUCT FOLD DES, V6, P895, DOI 10.1016/S0969-2126(98)00091-4; BAUMSTARK MW, 1990, BIOCHIM BIOPHYS ACTA, V1037, P48, DOI 10.1016/0167-4838(90)90100-T; BROWN MS, 1981, SCIENCE, V212, P628, DOI 10.1126/science.6261329; CHATTERTON JE, 1995, J LIPID RES, V36, P2027; Coronado-Gray A, 2005, LIPIDS, V40, P495, DOI 10.1007/s11745-005-1409-x; Coronado-Gray A, 2003, FEBS LETT, V533, P21, DOI 10.1016/S0014-5793(02)03731-6; Elad N, 2008, J STRUCT BIOL, V162, P108, DOI 10.1016/j.jsb.2007.11.007; Elmlund D, 2010, STRUCTURE, V18, P777, DOI 10.1016/j.str.2010.06.001; Frank J, 2006, 3 DIMENSIONAL ELECT; Garzon JI, 2007, BIOINFORMATICS, V23, P427, DOI 10.1093/bioinformatics/btl625; GINSBURG GS, 1984, PROG LIPID RES, V23, P135, DOI 10.1016/0163-7827(84)90002-X; Hegele RA, 2009, NAT REV GENET, V10, P109, DOI 10.1038/nrg2481; Hevonoja T, 2000, BBA-MOL CELL BIOL L, V1488, P189, DOI 10.1016/S1388-1981(00)00123-2; Huiskonen JT, 2004, NAT STRUCT MOL BIOL, V11, P850, DOI 10.1038/nsmb807; Jiang ZG, 2005, BIOCHEMISTRY-US, V44, P1163, DOI 10.1021/bi048286y; Johs A, 2006, J BIOL CHEM, V281, P19732, DOI 10.1074/jbc.M601688200; Koivuniemi A, 2008, BBA-PROTEINS PROTEOM, V1784, P1668, DOI 10.1016/j.bbapap.2008.06.007; Krisko A, 2007, PROTEINS, V66, P342, DOI 10.1002/prot.21229; Kumar V, 2004, J STRUCT BIOL, V145, P41, DOI 10.1016/j.jsb.2003.09.036; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Oorni K, 2000, J LIPID RES, V41, P1703; Orlova EV, 1999, P NATL ACAD SCI USA, V96, P8420, DOI 10.1073/pnas.96.15.8420; Penczek PA, 2006, J STRUCT BIOL, V154, P184, DOI 10.1016/j.jsb.2005.12.013; Penczek PA, 2006, J STRUCT BIOL, V154, P168, DOI 10.1016/j.jsb.2006.01.003; Pentikainen MO, 2000, J INTERN MED, V247, P359, DOI 10.1046/j.1365-2796.2000.00655.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POULOS GW, 2001, 3 DIMENSIONAL STRUCT; Prassl R, 2009, EUR BIOPHYS J BIOPHY, V38, P145, DOI 10.1007/s00249-008-0368-y; Qiu XY, 2007, NAT STRUCT MOL BIOL, V14, P106, DOI 10.1038/nsmb1197; Ren G, 2010, P NATL ACAD SCI USA, V107, P1059, DOI 10.1073/pnas.0908004107; Richardson PE, 2005, BIOPHYS J, V88, P2789, DOI 10.1529/biophysj.104.046235; Ritter S, 1997, PROTEINS, V28, P293; Roseman AM, 2000, ACTA CRYSTALLOGR D, V56, P1332, DOI 10.1107/S0907444900010908; Scheres SHW, 2007, NAT METHODS, V4, P27, DOI 10.1038/NMETH992; SCHUMAKER VN, 1994, ADV PROTEIN CHEM, V45, P205; Segrest JP, 1999, J LIPID RES, V40, P1401; Segrest JP, 2001, J LIPID RES, V42, P1346; SEGREST JP, 1994, ARTERIOSCLER THROMB, V14, P1674, DOI 10.1161/01.ATV.14.10.1674; Sherman MB, 2003, BIOCHEMISTRY-US, V42, P14988, DOI 10.1021/bi0354738; STEIM JM, 1968, SCIENCE, V162, P909, DOI 10.1126/science.162.3856.909; Thompson JR, 2002, BIOCHEMISTRY-US, V41, P9398, DOI 10.1021/bi025674w; van Antwerpen R, 1999, J LIPID RES, V40, P1827; VANANTWERPEN R, 1994, J LIPID RES, V35, P2223; vanAntwerpen R, 1997, J LIPID RES, V38, P659; VANHEEL M, 1981, ULTRAMICROSCOPY, V6, P187, DOI 10.1016/0304-3991(81)90059-0; Wang LCH, 2006, J ETHNOPHARMACOL, V103, P103, DOI 10.1016/j.jep.2005.07.010; White HE, 2004, J MOL BIOL, V336, P453, DOI 10.1016/j.jmb.2003.12.015; Williams KJ, 1998, CURR OPIN LIPIDOL, V9, P471, DOI 10.1097/00041433-199810000-00012	51	42	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e18841	10.1371/journal.pone.0018841	http://dx.doi.org/10.1371/journal.pone.0018841			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573056	Green Published, gold, Green Submitted			2022-12-27	WOS:000290386800003
J	Llopis-Hernandez, V; Rico, P; Ballester-Beltran, J; Moratal, D; Salmeron-Sanchez, M				Llopis-Hernandez, Virginia; Rico, Patricia; Ballester-Beltran, Jose; Moratal, David; Salmeron-Sanchez, Manuel			Role of Surface Chemistry in Protein Remodeling at the Cell-Material Interface	PLOS ONE			English	Article							FOCAL ADHESION KINASE; MATRIX METALLOPROTEINASES; FIBRONECTIN; ADSORPTION; DIFFERENTIATION; EXPRESSION; BINDING; FIBRINOGEN; INTEGRINS; ACTIVATOR	Background: The cell-material interaction is a complex bi-directional and dynamic process that mimics to a certain extent the natural interactions of cells with the extracellular matrix. Cells tend to adhere and rearrange adsorbed extracellular matrix (ECM) proteins on the material surface in a fibril-like pattern. Afterwards, the ECM undergoes proteolytic degradation, which is a mechanism for the removal of the excess ECM usually approximated with remodeling. ECM remodeling is a dynamic process that consists of two opposite events: assembly and degradation. Methodology/Principal Findings: This work investigates matrix protein dynamics on mixed self-assembled monolayers (SAMs) of -OH and -CH3 terminated alkanethiols. SAMs assembled on gold are highly ordered organic surfaces able to provide different chemical functionalities and well-controlled surface properties. Fibronectin (FN) was adsorbed on the different surfaces and quantified in terms of the adsorbed surface density, distribution and conformation. Initial cell adhesion and signaling on FN-coated SAMs were characterized via the formation of focal adhesions, integrin expression and phosphorylation of FAKs. Afterwards, the reorganization and secretion of FN was assessed. Finally, matrix degradation was followed via the expression of matrix metalloproteinases MMP2 and MMP9 and correlated with Runx2 levels. We show that matrix degradation at the cell material interface depends on surface chemistry in MMP-dependent way. Conclusions/Significance: This work provides a broad overview of matrix remodeling at the cell-material interface, establishing correlations between surface chemistry, FN adsorption, cell adhesion and signaling, matrix reorganization and degradation. The reported findings improve our understanding of the role of surface chemistry as a key parameter in the design of new biomaterials. It demonstrates the ability of surface chemistry to direct proteolytic routes at the cell-material interface, which gains a distinct bioengineering interest as a new tool to trigger matrix degradation in different biomedical applications.	[Llopis-Hernandez, Virginia; Rico, Patricia; Ballester-Beltran, Jose; Moratal, David; Salmeron-Sanchez, Manuel] Univ Politecn Valencia, Ctr Biomat & Tissue Engn, E-46071 Valencia, Spain; [Rico, Patricia; Salmeron-Sanchez, Manuel] CIBER Bioingn Biomat & Nanomed CIBER BBN, Valencia, Spain; [Salmeron-Sanchez, Manuel] Ctr Invest Principe Felipe, Regenerat Med Unit, Valencia, Spain	Universitat Politecnica de Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Prince Felipe Research Center	Llopis-Hernandez, V (corresponding author), Univ Politecn Valencia, Ctr Biomat & Tissue Engn, E-46071 Valencia, Spain.	masalsan@fis.upv.es	Rico, Patricia/N-2540-2014; Salmeron-Sanchez, Manuel/E-4680-2010; Moratal, David/D-1853-2010	Rico, Patricia/0000-0002-4918-9313; Salmeron-Sanchez, Manuel/0000-0002-8112-2100; Moratal, David/0000-0002-2825-3646; BALLESTER-BELTRAN, JOSE/0000-0002-3287-2925; Llopis-Hernandez, Virginia/0000-0002-7616-7347	Spanish Ministry of Science and Innovation [MAT2009-14440-C02-01]; Instituto de Salud Carlos III; Conselleria de Sanidad (Generalitat Valenciana)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Conselleria de Sanidad (Generalitat Valenciana)(Center for Forestry Research & Experimentation (CIEF))	The support of the Spanish Ministry of Science and Innovation through project MAT2009-14440-C02-01 is acknowledged. CIBER-BBN is an initiative funded by the VI National R&D&i Plan 2008-2011, Iniciativa Ingenio 2010, Consolider Program, CIBER Actions and financed by the Instituto de Salud Carlos III with assistance from the European Regional Development Fund. This work was supported by funds for research in the field of Regenerative Medicine through the collaboration agreement from the Conselleria de Sanidad (Generalitat Valenciana), and the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTANKOV G, 1994, J MATER SCI-MATER M, V5, P732, DOI 10.1007/BF00120366; Altankov G, 1997, J BIOMAT SCI-POLYM E, V8, P721, DOI 10.1163/156856297X00524; Altankov G, 1996, J MATER SCI-MATER M, V7, P425, DOI 10.1007/BF00122012; ALTANKOV G, 2006, J MATER SCI-MATER M, V7, P425; AOTA S, 1994, J BIOL CHEM, V269, P24756; Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013; AVNUR Z, 1981, CELL, V25, P121, DOI 10.1016/0092-8674(81)90236-1; Barrias CC, 2009, BIOMATERIALS, V30, P307, DOI 10.1016/j.biomaterials.2008.09.048; Bott K, 2010, BIOMATERIALS, V31, P8454, DOI 10.1016/j.biomaterials.2010.07.046; BUCK MR, 1992, BIOCHEM J, V282, P273, DOI 10.1042/bj2820273; Cary LA, 1996, J CELL SCI, V109, P1787; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Chung AS, 2009, J BIOMED MATER RES A, V91A, P742, DOI 10.1002/jbm.a.32259; Curino AC, 2005, J CELL BIOL, V169, P977, DOI 10.1083/jcb.200411153; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Dumbauld DW, 2010, J CELL PHYSIOL, V223, P746, DOI 10.1002/jcp.22084; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Gallagher PJ, 1997, J MUSCLE RES CELL M, V18, P1, DOI 10.1023/A:1018616814417; Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029; Gonzalez-Garcia C, 2010, COLLOID SURFACE B, V77, P181, DOI 10.1016/j.colsurfb.2010.01.021; Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210; GRINNELL F, 1986, J CELL BIOL, V103, P2697, DOI 10.1083/jcb.103.6.2697; Gugutkov D, 2009, LANGMUIR, V25, P10893, DOI 10.1021/la9012203; Hayami T, 2008, MATRIX BIOL, V27, P682, DOI 10.1016/j.matbio.2008.07.005; Hess J, 2001, J BIOL CHEM, V276, P20029, DOI 10.1074/jbc.M010601200; Heymans S, 2006, CIRCULATION, V114, P565, DOI 10.1161/CIRCULATIONAHA.105.591032; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; ILLC D, 1995, NATURE, V377, P539; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kenny HA, 2008, J CLIN INVEST, V118, P1367, DOI 10.1172/JCI33775; Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537; Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062; Koblinski JE, 2000, CLIN CHIM ACTA, V291, P113, DOI 10.1016/S0009-8981(99)00224-7; Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100; Martins MCL, 2003, J BIOMED MATER RES A, V67A, P158, DOI 10.1002/jbm.a.10096; McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H; Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a; Michael KE, 2009, MOL BIOL CELL, V20, P2508, DOI 10.1091/mbc.E08-01-0076; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Monchaux Emmanuelle, 2010, Front Biosci (Schol Ed), V2, P239; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Palacio MLB, 2011, J R SOC INTERFACE, V8, P630, DOI 10.1098/rsif.2010.0557; Phelps EA, 2010, P NATL ACAD SCI USA, V107, P3323, DOI 10.1073/pnas.0905447107; Pompe T, 2005, EUR BIOPHYS J BIOPHY, V34, P1049, DOI 10.1007/s00249-005-0490-z; Pratap J, 2005, MOL CELL BIOL, V25, P8581, DOI 10.1128/MCB.25.19.8581-8591.2005; Raynor JE, 2009, BIOINTERPHASES, V4, pFA3, DOI 10.1116/1.3089252; Reisenauer A, 2007, BIOL CHEM, V388, P639, DOI 10.1515/BC.2007.072; Reiske HR, 1999, J BIOL CHEM, V274, P12361, DOI 10.1074/jbc.274.18.12361; Rico P, 2009, TISSUE ENG PT A, V15, P3271, DOI [10.1089/ten.tea.2009.0141, 10.1089/ten.TEA.2009.0141]; Rodrigues SN, 2006, BIOMATERIALS, V27, P5357, DOI 10.1016/j.biomaterials.2006.06.010; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Rouahi M, 2006, BIOMATERIALS, V27, P2829, DOI 10.1016/j.biomaterials.2006.01.001; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schneider RK, 2010, BIOMATERIALS, V31, P467, DOI 10.1016/j.biomaterials.2009.09.059; SCHOEN RC, 1982, HYBRIDOMA, V1, P99, DOI 10.1089/hyb.1.1982.1.99; Shin H, 2007, BIOMATERIALS, V28, P126, DOI 10.1016/j.biomaterials.2006.08.007; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Sipe JD, 2002, ANN NY ACAD SCI, V961, P1, DOI 10.1111/j.1749-6632.2002.tb03040.x; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Tzoneva R, 2002, J MATER SCI-MATER M, V13, P1235, DOI 10.1023/A:1021131113711; Uchida M, 2000, J CELL PHYSIOL, V185, P207, DOI 10.1002/1097-4652(200011)185:2<207::AID-JCP5>3.0.CO;2-J; UGAROVA TP, 1995, BIOCHEMISTRY-US, V34, P4457, DOI 10.1021/bi00013a039; Wan R, 2008, TOXICOL APPL PHARM, V233, P276, DOI 10.1016/j.taap.2008.08.022; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1; Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010; Yang CM, 2004, J BIOL CHEM, V279, P22158, DOI 10.1074/jbc.M401343200; Zambuzzi WF, 2009, J MOL HISTOL, V40, P301, DOI 10.1007/s10735-009-9241-2; Zhao JH, 1998, J CELL BIOL, V143, P1997, DOI 10.1083/jcb.143.7.1997	72	65	66	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19610	10.1371/journal.pone.0019610	http://dx.doi.org/10.1371/journal.pone.0019610			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573010	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000290386800023
J	Sun, M; Yang, Y; Yang, PZ; Lei, B; Du, LP; Kijlstra, A				Sun, Min; Yang, Yan; Yang, Peizeng; Lei, Bo; Du, Liping; Kijlstra, Aize			Regulatory Effects of IFN-beta on the Development of Experimental Autoimmune Uveoretinitis in B10RIII Mice	PLOS ONE			English	Article							T-HELPER TYPE-1; INTERFERON-BETA; MULTIPLE-SCLEROSIS; DENDRITIC CELLS; I INTERFERON; TH17; INFLAMMATION; DISTINCT; DISEASE; ALPHA	Background: Experimental autoimmune uveoretinitis (EAU) serves as a model for human intraocular inflammation. IFN-beta has been used in the treatment of certain autoimmune diseases. Earlier studies showed that it ameliorated EAU; however, the mechanisms involved in this inhibition are still largely unknown. Methodology/Principal Findings: B10RIII mice were immunized with interphotoreceptor retinoid-binding protein (IRBP) peptide 161-180 in Complete Freund's adjuvant. Splenocytes from different time points after immunization were used to evaluate the expression of IFN-beta. An increased expression of IFN-beta was observed during EAU and its highest expression was observed on day 16, 3 days after the peak of intraocular inflammation. Splenocytes and draining lymph node cells from mice immunized with IRBP161-180 on day 13 and control mice were activated with anti-CD3/anti-CD28 antibodies or IRBP161-180 to evaluate the production of IFN-gamma and IL-17. The results showed that IFN-gamma and IL-17 were significantly higher in immunized mice as compared to the control mice when exposed to anti-CD3/anti-CD28 antibodies. However, the production of IFN-gamma and IL-17 was detected only in immunized mice, but not in the control mice when stimulated with IRBP161-180. Multiple subcutaneous injections of IFN-beta significantly inhibited EAU activity in association with a down-regulated expression of IFN-gamma, IL-17 and an enhanced IL-10 production. In an in vitro system using cells from mice, IFN-beta suppressed IFN-gamma production by CD4(+)CD62L(-) T cells, IL-17 production by CD4(+)CD62L(+/-) T cells and proliferation of CD4(+)CD62L(+/-) T cells. IFN-beta inhibited the secretion of IL-6, but promoted the secretion of IL-10 by monocytes. IFN-beta-treated monocytes inhibited IL-17 secretion by CD4(+)CD62L(+/-) T cells, but did not influence IFN-gamma expression and T cell proliferation. Conclusions/Significance: IFN-beta may exert its inhibitory effect on EAU by inhibiting Th1, Th17 cells and modulating relevant cytokines. IFN-beta may provide a potential treatment for diseases mediated by Th1 and Th17 cells.	[Sun, Min; Yang, Yan; Yang, Peizeng; Lei, Bo; Du, Liping] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China; [Sun, Min; Yang, Yan; Yang, Peizeng; Lei, Bo; Du, Liping] Chongqing Eye Inst, Chongqing, Peoples R China; [Yang, Yan] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Kijlstra, Aize] Univ Hosp Maastricht, Eye Res Inst Maastricht, Dept Ophthalmol, Maastricht, Netherlands	Chongqing Medical University; Sun Yat Sen University; Maastricht University; Maastricht University Medical Centre (MUMC)	Yang, PZ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China.	peizengycmu@126.com	Yang, Peizeng/C-6336-2013; Du, Liping/M-9495-2019	Lei, Bo/0000-0002-5497-0905	National Natural Science Foundation [30973242]; Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality; Natural Science Foundation of Chongqing [2009BA5037]; Chongqing Key Laboratory of Ophthalmology [2008CA5003]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality; Natural Science Foundation of Chongqing(Natural Science Foundation of Chongqing); Chongqing Key Laboratory of Ophthalmology	This work was supported by National Natural Science Foundation Project (30973242), http://159.226.244.15/portal/Proj_List.asp; Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality, http://cqkjdj.cstc.gov.cn/View.aspx?id = 1000; Key Project of Natural Science Foundation of Chongqing (CSTC, 2009BA5037), http://www.ctin.ac.cn/Class.aspx?clsId = 226; Chongqing Key Laboratory of Ophthalmology (CSTC, 2008CA5003) http://www.ctin.ac.cn/View.aspx?id = 14380; and PAR-EU Scholars Program, http://www.cqhrss.gov.cn/u/cqhrss/news_37398.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Berenson LS, 2004, IMMUNOL REV, V202, P157, DOI 10.1111/j.0105-2896.2004.00208.x; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Caspi Rachel R, 2002, Int Rev Immunol, V21, P197, DOI 10.1080/08830180212063; Caspi Rachel R, 2003, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1506s53; CASPI RR, 1988, J IMMUNOL, V140, P1490; Chang EY, 2007, J IMMUNOL, V178, P6705, DOI 10.4049/jimmunol.178.11.6705; Chen MY, 2009, EUR J IMMUNOL, V39, P2525, DOI 10.1002/eji.200838879; Crow MK, 2010, RHEUM DIS CLIN N AM, V36, P173, DOI 10.1016/j.rdc.2009.12.008; Dardalhon V, 2008, J AUTOIMMUN, V31, P252, DOI 10.1016/j.jaut.2008.04.017; Deuter CME, 2009, BRIT J OPHTHALMOL, V93, P906, DOI 10.1136/bjo.2008.153874; Durelli L, 2009, ANN NEUROL, V65, P499, DOI 10.1002/ana.21652; Ersoy E, 2005, EUR J NEUROL, V12, P208, DOI 10.1111/j.1468-1331.2004.00986.x; Furuzawa-Carballeda J, 2007, AUTOIMMUN REV, V6, P169, DOI 10.1016/j.autrev.2006.10.002; Guo BC, 2008, J CLIN INVEST, V118, P1680, DOI 10.1172/JCI33342; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hedegaard CJ, 2008, CLIN IMMUNOL, V129, P80, DOI 10.1016/j.clim.2008.06.007; Hegelich BM, 2006, NATURE, V439, P441, DOI 10.1038/nature04400; Kozovska ME, 1999, NEUROLOGY, V53, P1692, DOI 10.1212/WNL.53.8.1692; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Martin-Saavedra FM, 2008, MOL IMMUNOL, V45, P4008, DOI 10.1016/j.molimm.2008.06.006; McRae BL, 1998, J IMMUNOL, V160, P4298; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; NUSSENBLATT RB, 1991, INVEST OPHTH VIS SCI, V32, P3131; Okada AA, 1998, OCUL IMMUNOL INFLAMM, V6, P215, DOI 10.1076/ocii.6.4.215.4024; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Plskova J, 2007, AM J OPHTHALMOL, V144, P55, DOI 10.1016/j.ajo.2007.03.050; Pogue SL, 2004, J INTERF CYTOK RES, V24, P131, DOI 10.1089/107999004322813372; Ramgolam VS, 2009, J IMMUNOL, V183, P5418, DOI 10.4049/jimmunol.0803227; Rizzo LV, 1998, INT IMMUNOL, V10, P807, DOI 10.1093/intimm/10.6.807; Scheu S, 2008, P NATL ACAD SCI USA, V105, P20416, DOI 10.1073/pnas.0808537105; Somani AK, 2008, ARCH DERMATOL, V144, P1341, DOI 10.1001/archderm.144.10.1341; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Steinman L, 2009, EUR J IMMUNOL, V39, P2358, DOI 10.1002/eji.200939814; Stubiger N, 2003, ADV EXP MED BIOL, V528, P537; Sun M, 2010, INVEST OPHTH VIS SCI, V51, P383, DOI 10.1167/iovs.09-3514; Suzuki J, 2002, GRAEF ARCH CLIN EXP, V240, P314, DOI 10.1007/s00417-001-0425-z; Teige I, 2003, J IMMUNOL, V170, P4776, DOI 10.4049/jimmunol.170.9.4776; Warde Nick, 2010, Nat Rev Rheumatol, V6, P437, DOI 10.1038/nrrheum.2010.115; Yong VW, 1998, NEUROLOGY, V51, P682; Yoshimura T, 2008, INT IMMUNOL, V20, P209, DOI 10.1093/intimm/dxm135; Zang Y, 2003, J NEUROIMMUNOL, V137, P144, DOI 10.1016/S0165-5728(03)00049-3; Zhang X, 2010, CLIN NEUROL NEUROSUR, V112, P641, DOI 10.1016/j.clineuro.2010.04.020; Zhang X, 2009, J IMMUNOL, V182, P3928, DOI 10.4049/jimmunol.0802226	45	9	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19870	10.1371/journal.pone.0019870	http://dx.doi.org/10.1371/journal.pone.0019870			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573074	Green Published, Green Submitted, gold			2022-12-27	WOS:000290305600048
J	Wells, WA; Ge, CF; Patel, N; Oh, T; Gardiner, E; Kimerling, ME				Wells, William A.; Ge, Colin Fan; Patel, Nitin; Oh, Teresa; Gardiner, Elizabeth; Kimerling, Michael E.			Size and Usage Patterns of Private TB Drug Markets in the High Burden Countries	PLOS ONE			English	Article							TUBERCULOSIS-CONTROL; INDIA; PRACTITIONERS; MIX; COLLABORATION; PHILIPPINES; PROVIDERS; RESISTANT; DOTS; CARE	Background: Tuberculosis (TB) control is considered primarily a public health concern, and private sector TB treatment has attracted less attention. Thus, the size and characteristics of private sector TB drug sales remain largely unknown. Methodology/Principal Findings: We used IMS Health data to analyze private TB drug consumption in 10 high burden countries (HBCs), after first mapping how well IMS data coverage overlapped with private markets. We defined private markets as any channels not used or influenced by national TB programs. Private markets in four countries - Pakistan, the Philippines, Indonesia and India - had the largest relative sales volumes; annually, they sold enough first line TB drugs to provide 65-117% of the respective countries' estimated annual incident cases with a standard 6-8 month regimen. First line drug volumes in five countries were predominantly fixed dose combinations (FDCs), but predominantly loose drugs in the other five. Across 10 countries, these drugs were available in 37 (loose drug) plus 74 (FDCs) distinct strengths. There were 54 distinct, significant first line manufacturers (range 2-11 per country), and most companies sold TB drugs in only a single study country. FDC markets were, however, more concentrated, with 4 companies capturing 69% of FDC volume across the ten countries. Among second line drugs, fluoroquinolones were widely available, with significant volumes used for TB in India, Pakistan and Indonesia. However, certain WHO-recommended drugs were not available and in general there were insufficient drug volumes to cover the majority of the expected burden of multidrug-resistant TB (MDR-TB). Conclusions/Significance: Private TB drug markets in several HBCs are substantial, stable, and complicated. This calls for appropriate policy and market responses, including expansion of Public-Private Mix (PPM) programs, greater reach, flexibility and appeal of public programs, regulatory and quality enforcement, and expansion of public MDR-TB treatment programs.	[Wells, William A.; Gardiner, Elizabeth] Global Alliance TB Drug Dev, New York, NY USA; [Ge, Colin Fan; Patel, Nitin; Oh, Teresa] IMS Hlth, New York, NY USA; [Kimerling, Michael E.] Bill & Melinda Gates Fdn, Seattle, WA USA	Bill & Melinda Gates Foundation	Wells, WA (corresponding author), Global Alliance TB Drug Dev, New York, NY USA.	william.wells@tballiance.org		oh, teresa/0000-0002-4194-381X	Netherlands Ministry of Foreign Affairs' Department of Development Cooperation (DGIS) [14848]; United Kingdom Department for International Development (DfID) [733637048]; Bill & Melinda Gates Foundation [40827]; IMS Health, Inc.; Bill & Melinda Gates Foundation	Netherlands Ministry of Foreign Affairs' Department of Development Cooperation (DGIS); United Kingdom Department for International Development (DfID); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); IMS Health, Inc.; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Financial support for this study came from The Netherlands Ministry of Foreign Affairs' Department of Development Cooperation (DGIS; http://www.minbuza.nl/en; Grant #14848), The United Kingdom Department for International Development (DfID; http://www.dfid.gov.uk/; Grant code 733637048) and the Bill & Melinda Gates Foundation (http://www.gatesfoundation.org; Grant #40827). Three of the authors are employed by IMS Health, Inc., a for-profit company, which is also considered a funder. Certain individuals are employed by two of the sponsors (CGF, TO and NP by IMS Health, Inc., and MEK by the Bill & Melinda Gates Foundation). Although they did not initiate the study concept, they were involved in subsequent steps of developing the methodology, and conducting and writing up the study. Apart from this involvement of these individuals, the sponsoring organizations for the study had no role in study design, data collection, data analysis, data interpretation, or writing of this report. The corresponding author had access to all data in the study and had final responsibility for the decision to submit for publication.	Agrawal D, 2009, INT J TUBERC LUNG D, V13, P79; Ahmed Jameel, 2009, J Pak Med Assoc, V59, P82; [Anonymous], 2008, GUID PROGR MAN DRUG; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0; Dewan PK, 2006, BMJ-BRIT MED J, V332, P574, DOI 10.1136/bmj.38738.473252.7C; Hopewell PC, 2006, LANCET INFECT DIS, V6, P710, DOI 10.1016/S1473-3099(06)70628-4; Ipuge YAI, 1997, E AFR MED J, V74, P816; Jaggarajamma K, 2009, Indian J Tuberc, V56, P185; Krishnan N, 2009, INT J TUBERC LUNG D, V13, P112; Lonnroth K, 2006, B WORLD HEALTH ORGAN, V84, P876; Lonnroth K, 2004, B WORLD HEALTH ORGAN, V82, P580; Mantala MJ, 2003, TUBERCULOSIS, V83, P173, DOI 10.1016/S1472-9792(02)00067-7; Nathanson E, 2010, NEW ENGL J MED, V363, P1050, DOI 10.1056/NEJMra0908076; Pinto LM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-357; Portero JL, 2003, TROP MED INT HEALTH, V8, P329, DOI 10.1046/j.1365-3156.2003.01032.x; Quy HT, 2003, INT J TUBERC LUNG D, V7, P1139; Schwalbe NR, 2008, INT J TUBERC LUNG D, V12, P1173; *TB ALL, 2007, PATHW PAT CHART DYN; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; Uplekar M, 1998, INT J TUBERC LUNG D, V2, P324; Uplekar M, 2003, TUBERCULOSIS, V83, P156, DOI 10.1016/S1472-9792(02)00073-2; UPLEKAR MW, 1991, TUBERCLE, V72, P284, DOI 10.1016/0041-3879(91)90055-W; Wang L, 2009, INT J TUBERC LUNG D, V13, P1486; Wells WA, 2010, INT J TUBERC LUNG D, V14, P1538; WELLS WA, 2011, INT J TUBERC IN PRES; WHO, 2009, TREATM TUB GUID; World Health Organization, 2010, GLOB TUB CONTR WHO R; World Health Organization, 2006, ENG ALL HLTH CAR PRO; World Health Organization, 2009, GLOB TUB CONTR EP ST; World Health Organization, 1999, FIX DOS COMB TABL TR	31	78	78	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e18964	10.1371/journal.pone.0018964	http://dx.doi.org/10.1371/journal.pone.0018964			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573227	Green Published, gold			2022-12-27	WOS:000290224800009
J	Yazama, F; Tai, A				Yazama, Futoshi; Tai, Akihiro			Unexpected Role of alpha-Fetoprotein in Spermatogenesis	PLOS ONE			English	Article							BLOOD-TESTIS BARRIER; EXPERIMENTAL CRYPTORCHIDISM; PARTIAL-HEPATECTOMY; TESTICULAR CELLS; GERM-CELLS; HEAT-SHOCK; IN-VITRO; MOUSE; RAT; PROTEINS	Background: Heat shock severely affects sperm production (spermatogenesis) and results in a rapid loss of haploid germ cells, or in other words, sperm formation (spermiogenesis) is inhibited. However, the mechanisms behind the effects of heat shock on spermatogenesis are obscure. Methodology/Principal Findings: To identify the inhibitory factor of spermiogenesis, experimental cryptorchid (EC) mice were used in this study. Here we show that alpha-fetoprotein (AFP) is specifically expressed in the testes of EC mice by proteome analysis. AFP was also specifically localized spermatocytes by immunohistochemical analysis and was secreted into the circulation system of EC mice by immunoblot analysis. Since spermatogenesis of an advanced mammal cannot be reproduced with in vitro, we performed the microinjection of AFP into the seminiferous tubules of normal mice to determine whether AFP inhibits spermiogenesis in vivo. AFP was directly responsible for the block in spermiogenesis of normal mice. To investigate whether AFP inhibits cell differentiation in other models, using EC mice we performed a partial hepatectomy (PH) that triggers a rapid regenerative response in the remnant liver tissue. We also found that liver regeneration is inhibited in EC mice with PH. The result suggests that AFP released into the blood of EC mice regulates liver regeneration by inhibiting the cell division of hepatocytes. Conclusions/Significance: AFP is a well-known cancer-specific marker, but AFP has no known function in healthy human beings. Our findings indicate that AFP expressed under EC conditions plays a role as a regulatory factor in spermatogenesis and in hepatic generation.	[Yazama, Futoshi; Tai, Akihiro] Prefectural Univ Hiroshima, Dept Life Sci, Shobara City, Hiroshima, Japan		Yazama, F (corresponding author), Prefectural Univ Hiroshima, Dept Life Sci, Shobara City, Hiroshima, Japan.	fyzma@pu-hiroshima.ac.jp			Japan Science and Technology Agency	Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by grants from the Japan Science and Technology Agency to FY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELEV GI, 1963, TRANSPLANTATION, V1, P174, DOI 10.1097/00007890-196301020-00004; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; BERGSTRAND CG, 1957, SCAND J CLIN LAB INV, V9, P277, DOI 10.3109/00365515709079971; Biggiogera M, 1996, EXP CELL RES, V229, P77, DOI 10.1006/excr.1996.0345; Casado M, 2001, FASEB J, V15, P2016, DOI 10.1096/fj.01-0158fje; Cataldo L, 1997, EXP CELL RES, V231, P206, DOI 10.1006/excr.1996.3447; Dix DJ, 1997, CELL STRESS CHAPERON, V2, P73, DOI 10.1379/1466-1268(1997)002<0073:HEAFDG>2.3.CO;2; Feng LX, 2002, SCIENCE, V297, P392, DOI 10.1126/science.1073162; FUJISAWA M, 1988, J REPROD FERTIL, V84, P123, DOI 10.1530/jrf.0.0840123; HAGENAS L, 1977, ANDROLOGIA, V9, P250; HENRIKSEN K, 1995, INT J ANDROL, V18, P256, DOI 10.1111/ijan.1995.18.5.256; HIRANO H, 1989, J PROTEIN CHEM, V8, P115, DOI 10.1007/BF01025083; Hirano H., 1989, METHODS PROTEIN SEQU, P42; HOFMANN MC, 1992, EXP CELL RES, V201, P417, DOI 10.1016/0014-4827(92)90291-F; Inderbitzin D, 2006, MICROSURG, V26, P465, DOI 10.1002/micr.20271; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; Nikfarjam M, 2004, J INVEST SURG, V17, P291, DOI 10.1080/08941930490502871; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Sailer BL, 1997, J ANDROL, V18, P294; SETCHELL BP, 1975, HDB PHYSIOLOGY, V5, P143; Setchell BP, 1982, REPRODUCTION MAMMALS, P63; SHIOJIRI N, 1991, CANCER RES, V51, P2611; Staub C, 2000, EXP CELL RES, V260, P85, DOI 10.1006/excr.2000.4998; Tatarinov Y S, 1966, Fed Proc Transl Suppl, V25, P344; Yazama F, 2000, ANAT RECORD, V260, P402, DOI 10.1002/1097-0185(20001201)260:4<402::AID-AR100>3.0.CO;2-0; Yazama F, 2008, J REPROD DEVELOP, V54, P299, DOI 10.1262/jrd.19169; Yazama F, 2006, ANAT SCI INT, V81, P115, DOI 10.1111/j.1447-073X.2006.00139.x	28	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19387	10.1371/journal.pone.0019387	http://dx.doi.org/10.1371/journal.pone.0019387			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573244	gold, Green Published, Green Submitted			2022-12-27	WOS:000290224800027
J	He, L; Li, H; Chen, L; Miao, JY; Jiang, YL; Zhang, Y; Xiao, ZX; Hanley, G; Li, Y; Zhang, XM; LeSage, G; Peng, Y; Yin, DL				He, Lei; Li, Hui; Chen, Lin; Miao, Junying; Jiang, Yulin; Zhang, Yi; Xiao, Zuoxiang; Hanley, Gregory; Li, Yi; Zhang, Xiumei; LeSage, Gene; Peng, Ying; Yin, Deling			Toll-Like Receptor 9 Is Required for Opioid-Induced Microglia Apoptosis	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MORPHINE PROMOTES APOPTOSIS; BETA-ARRESTIN 2; INNATE IMMUNITY; MAP KINASES; CELL-DEATH; P38 MAPK; B-CELLS; RESPONSES; PATHWAY	Opioids have been widely applied in clinics as one of the most potent pain relievers for centuries, but their abuse has deleterious physiological effects beyond addiction. However, the underlying mechanism by which microglia in response to opioids remains largely unknown. Here we show that morphine induces the expression of Toll-like receptor 9 (TLR9), a key mediator of innate immunity and inflammation. Interestingly, TLR9 deficiency significantly inhibited morphine-induced apoptosis in microglia. Similar results were obtained when endogenous TLR9 expression was suppressed by the TLR9 inhibitor CpGODN. Inhibition of p38 MAPK by its specific inhibitor SB203580 attenuated morphine-induced microglia apoptosis in wild type microglia. Morphine caused a dramatic decrease in Bcl-2 level but increase in Bax level in wild type microglia, but not in TLR9 deficient microglia. In addition, morphine treatment failed to induce an increased levels of phosphorylated p38 MAPK and MAP kinase kinase 3/6 (MKK3/6), the upstream MAPK kinase of p38 MAPK, in either TLR9 deficient or mu-opioid receptor (mu OR) deficient primary microglia, suggesting an involvement of MAPK and mu OR in morphine-mediated TLR9 signaling. Moreover, morphine-induced TLR9 expression and microglia apoptosis appears to require mu OR. Collectively, these results reveal that opioids prime microglia to undergo apoptosis through TLR9 and mu OR as well. Taken together, our data suggest that inhibition of TLR9 and/or blockage of mu OR is capable of preventing opioid-induced brain damage.	[He, Lei; Li, Yi; Peng, Ying] Sun Yat Sen Univ, Dept Neurol, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [He, Lei; Li, Hui; Chen, Lin; Zhang, Yi; LeSage, Gene; Yin, Deling] E Tennessee State Univ, Coll Med, Dept Internal Med, Johnson City, TN 37614 USA; [Chen, Lin; Zhang, Xiumei] Shandong Univ, Sch Med, Dept Pharmacol, Jinan 250100, Peoples R China; [Miao, Junying] Shandong Univ, Sch Life Sci, Inst Dev Biol, Jinan 250100, Peoples R China; [Jiang, Yulin] E Tennessee State Univ, Dept Chem, Johnson City, TN 37614 USA; [Xiao, Zuoxiang] NCI, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD 21701 USA; [Hanley, Gregory] E Tennessee State Univ, Coll Med, Div Lab Anim Resources, Johnson City, TN 37614 USA	Sun Yat Sen University; East Tennessee State University; Shandong University; Shandong University; East Tennessee State University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); East Tennessee State University	He, L (corresponding author), Sun Yat Sen Univ, Dept Neurol, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China.	lesage@etsu.edu; docpengy@yahoo.com.cn; yin@etsu.edu			National Institutes of Health [DA020120-03A1]; East Tennessee State University Research Development Committee; NATIONAL INSTITUTE ON DRUG ABUSE [R15DA020120] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); East Tennessee State University Research Development Committee; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grant DA020120-03A1 and East Tennessee State University Research Development Committee grant to D. Yin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamboat ZM, 2010, HEPATOLOGY, V51, P621, DOI 10.1002/hep.23365; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Boronat MA, 2001, BRIT J PHARMACOL, V134, P1263, DOI 10.1038/sj.bjp.0704364; Chang CW, 2009, J BIOL CHEM, V284, P33195, DOI 10.1074/jbc.M109.020586; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009205; Cui Y, 2006, BRAIN RES, V1069, P235, DOI 10.1016/j.brainres.2005.11.066; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Esen N, 2006, J IMMUNOL, V176, P6802, DOI 10.4049/jimmunol.176.11.6802; Gomez-Lazaro M, 2007, MOL PHARMACOL, V71, P736, DOI 10.1124/mol.106.030718; Horvath RJ, 2009, J NEUROSCI, V29, P998, DOI 10.1523/JNEUROSCI.4595-08.2009; Hu SX, 2002, NEUROPHARMACOLOGY, V42, P829, DOI 10.1016/S0028-3908(02)00030-8; Ichijo H, 1999, ONCOGENE, V18, P6087, DOI 10.1038/sj.onc.1203129; Kim D, 2007, J BIOL CHEM, V282, P14975, DOI 10.1074/jbc.M607277200; Lehnardt S, 2006, J IMMUNOL, V177, P583, DOI 10.4049/jimmunol.177.1.583; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Li H, 2010, IMMUNOLOGY, V130, P556, DOI 10.1111/j.1365-2567.2010.03256.x; Li Y, 2010, BIOCHEM BIOPH RES CO, V391, P426, DOI 10.1016/j.bbrc.2009.11.074; Li Y, 2009, BIOCHEM BIOPH RES CO, V378, P857, DOI 10.1016/j.bbrc.2008.12.001; Liang XQ, 2010, BLOOD, V115, P5041, DOI 10.1182/blood-2009-03-213363; Ma WY, 2001, EUR J NEUROSCI, V14, P1091, DOI 10.1046/j.0953-816x.2001.01731.x; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Moorman J, 2009, BBA-MOL CELL RES, V1793, P1366, DOI 10.1016/j.bbamcr.2009.05.007; Nelyudova A, 2007, CELL CYCLE, V6, P2171, DOI 10.4161/cc.6.17.4610; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; Papadimitraki ED, 2006, ARTHRITIS RHEUM-US, V54, P3601, DOI 10.1002/art.22197; Porras A, 2004, MOL BIOL CELL, V15, P922, DOI 10.1091/mbc.E03-08-0592; Reed-Geaghan EG, 2009, J NEUROSCI, V29, P11982, DOI 10.1523/JNEUROSCI.3158-09.2009; Rifkin IR, 2005, IMMUNOL REV, V204, P27, DOI 10.1111/j.0105-2896.2005.00239.x; Roy S, 1996, NEUROCHEM RES, V21, P1375, DOI 10.1007/BF02532379; Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029; Singhal PC, 2002, J IMMUNOL, V168, P4025, DOI 10.4049/jimmunol.168.8.4025; Singhal PG, 1999, J LEUKOCYTE BIOL, V66, P650, DOI 10.1002/jlb.66.4.650; Svensson AL, 2008, P NATL ACAD SCI USA, V105, P7304, DOI 10.1073/pnas.0802531105; Tegeder I, 2004, PHARMACOL REV, V56, P351, DOI 10.1124/pr.56.3.2; Toh ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013416; Wang JH, 2008, J IMMUNOL, V180, P3594, DOI 10.4049/jimmunol.180.5.3594; Watkins LR, 2009, TRENDS PHARMACOL SCI, V30, P581, DOI 10.1016/j.tips.2009.08.002; Xie NC, 2010, NEUROPHARMACOLOGY, V59, P444, DOI 10.1016/j.neuropharm.2010.06.006; Xie NC, 2010, NEUROSCI LETT, V482, P51, DOI 10.1016/j.neulet.2010.07.004; Yin DL, 2006, J NEUROIMMUNOL, V174, P101, DOI 10.1016/j.jneuroim.2006.02.001; Yin DL, 1999, NATURE, V397, P218, DOI 10.1038/16612; Yin DL, 1997, NEUROSCI RES, V29, P121, DOI 10.1016/S0168-0102(97)00080-1; Yin DL, 2000, J EXP MED, V191, P1423, DOI 10.1084/jem.191.8.1423; Zhang Y, 2011, NEUROSCI LETT, V489, P43, DOI 10.1016/j.neulet.2010.11.063; Zheng LQ, 2008, BLOOD, V111, P2704, DOI 10.1182/blood-2007-07-104141; Zhou S, 2008, J NEUROIMMUNOL, V194, P70, DOI 10.1016/j.jneuroim.2007.11.018; Zhu JG, 2009, J CLIN INVEST, V119, P2388, DOI 10.1172/JCI37607	48	24	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18190	10.1371/journal.pone.0018190	http://dx.doi.org/10.1371/journal.pone.0018190			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559519	Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700008
J	Mayor, A; Hafiz, A; Bassat, Q; Rovira-Vallbona, E; Sanz, S; Machevo, S; Aguilar, R; Cistero, P; Sigauque, B; Menendez, C; Alonso, PL; Chitnis, CE				Mayor, Alfredo; Hafiz, Abdul; Bassat, Quique; Rovira-Vallbona, Eduard; Sanz, Sergi; Machevo, Sonia; Aguilar, Ruth; Cistero, Pau; Sigauque, Betuel; Menendez, Clara; Alonso, Pedro L.; Chitnis, Chetan E.			Association of Severe Malaria Outcomes with Platelet-Mediated Clumping and Adhesion to a Novel Host Receptor	PLOS ONE			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; HUMAN CEREBRAL MALARIA; RED-BLOOD-CELLS; PLASMODIUM-FALCIPARUM; CLINICAL-FEATURES; CYTOADHERENCE CHARACTERISTICS; UNCOMPLICATED MALARIA; MALAWIAN CHILDREN; AFRICAN CHILDREN; RANDOMIZED-TRIAL	Introduction: Severe malaria has been attributed partly to the sequestration of Plasmodium falciparum-infected erythrocytes (IEs) in the microvasculature of vital host organs. Identification of P. falciparum cytoadherence phenotypes that are associated with severe malaria may lead to the development of novel strategies against life-threatening malaria. Methods and Findings: Forty-six P. falciparum isolates from Mozambican children under 5 years of age with severe malaria (cases) were examined and compared to 46 isolates from sex and age matched Mozambican children with uncomplicated malaria (controls). Cytoadherence properties such as platelet-mediated clumping, rosetting and adhesion to purified receptors (CD36, ICAM1 and gC1qR), were compared between these matched pairs by non-parametric tests. The most common clinical presentation associated with severe malaria was prostration. Compared to matched controls, prevalence of platelet-mediated clumping was higher in cases (P = .019), in children presenting with prostration (P = .049) and in children with severe anaemia (P = .025). Prevalence of rosetting and gC1qR adhesion were also higher in isolates from cases with severe anemia and multiple seizures, respectively (P = .045 in both cases), than in controls. Conclusions: These data indicate a role for platelet-mediated clumping, rosetting and adhesion to gC1qR in the pathogenesis of severe malaria. Inhibition of these cytoadherence phenotypes may reduce the occurrence or improve the prognosis of severe malaria outcomes.	[Mayor, Alfredo; Bassat, Quique; Rovira-Vallbona, Eduard; Sanz, Sergi; Aguilar, Ruth; Cistero, Pau; Menendez, Clara; Alonso, Pedro L.] Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, Hosp Clin, IDIBAPS, Barcelona, Spain; [Mayor, Alfredo; Bassat, Quique; Machevo, Sonia; Aguilar, Ruth; Sigauque, Betuel; Menendez, Clara; Alonso, Pedro L.] CISM, Maputo, Mozambique; [Mayor, Alfredo; Bassat, Quique; Rovira-Vallbona, Eduard; Menendez, Clara; Alonso, Pedro L.] Consorcio Invest Biomed Epidemiol & Salud Publ CI, Madrid, Spain; [Chitnis, Chetan E.] ICGEB, New Delhi, India	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Centro de Investigacao em Saude de Manhica; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Mayor, A (corresponding author), Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, Hosp Clin, IDIBAPS, Barcelona, Spain.	cchitnis@icgeb.res.in	Alonso, Pedro L/AAZ-3645-2020; Cisteró, Pau/H-2468-2017; Rovira-Vallbona, Eduard/D-3053-2015; Sanz, Sergi/AAY-7211-2020; Bassat, Quique/P-2341-2016; Menéndez, Clara/Q-3446-2016; Mayor, Alfredo/H-7488-2017; Aguilar, Ruth/D-2147-2018	Alonso, Pedro L/0000-0003-3292-3443; Cisteró, Pau/0000-0001-7225-4331; Bassat, Quique/0000-0003-0875-7596; Menéndez, Clara/0000-0002-2641-6907; Mayor, Alfredo/0000-0003-3890-2897; Aguilar, Ruth/0000-0003-3277-3107; Rovira-Vallbona, Eduard/0000-0002-4765-1076; Chitnis, Chetan/0000-0002-8773-9865; Sanz Bravo, Sergi/0000-0001-5010-4527; Hafiz, Abdul/0000-0001-6402-5408	Instituto de Salud Carlos III [PS0901113, CP-04/00220, CM05/00134, FI06/00019]; European Commission; Spanish Agency for International Cooperation; Council of Scientific and Industrial Research [09/512 (70)/2004]; Department of Biotechnology, Government of India	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Agency for International Cooperation(Spanish Government); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This study received partial support from Instituto de Salud Carlos III (PS0901113) and Biomalpar grant of the European Commission (CEC). The Manhica Health Research Centre receives core support from the Spanish Agency for International Cooperation. AH was supported by a Fellowship from the Council of Scientific and Industrial Research (09/512 (70)/2004), AM, QB and ERV by the Instituto de Salud Carlos III (CP-04/00220, CM05/00134 and FI06/00019, respectively). CEC is a recipient of a TATA Innovation Fellowship from Department of Biotechnology, Government of India. Work in the laboratory of CEC is partially supported by EVIMalaR, PregVax, PreMalStruct and MalSig grants from the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; ALONSO PL, 1994, LANCET, V344, P1175, DOI 10.1016/S0140-6736(94)90505-3; Alonso PL, 2002, POPULATION HLTH DEV, P189; ALYAMAN F, 1995, T ROY SOC TROP MED H, V89, P55, DOI 10.1016/0035-9203(95)90658-4; Arman M, 2007, AM J TROP MED HYG, V77, P943, DOI 10.4269/ajtmh.2007.77.943; Arman M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-243; BARNWELL JW, 1989, J CLIN INVEST, V84, P765, DOI 10.1172/JCI114234; Bassat Q, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-37; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; Biswas AK, 2007, PLOS PATHOG, V3, P1271, DOI 10.1371/journal.ppat.0030130; Boggild AK, 2009, CLIN INFECT DIS, V49, P841, DOI 10.1086/605431; CARLSON J, 1990, LANCET, V336, P1457, DOI 10.1016/0140-6736(90)93174-N; Choe H, 2005, MOL MICROBIOL, V55, P1413, DOI 10.1111/j.1365-2958.2004.04478.x; Chotivanich K, 2004, J INFECT DIS, V189, P1052, DOI 10.1086/381900; Clark IA, 2000, PARASITOL TODAY, V16, P451, DOI 10.1016/S0169-4758(00)01757-9; Crawley J, 1996, QJM-INT J MED, V89, P591; Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204; Dondorp AM, 2007, J INFECT DIS, V196, P460, DOI 10.1086/519287; Faiz MA, 2005, LANCET, V366, P717; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; GHEBREHIWET B, 1994, J EXP MED, V179, P1809, DOI 10.1084/jem.179.6.1809; GOODYER ID, 1994, ANN TROP MED PARASIT, V88, P209, DOI 10.1080/00034983.1994.11812859; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; HO M, 1991, INFECT IMMUN, V59, P873, DOI 10.1128/IAI.59.3.873-878.1991; Howie SRC, 2011, B WORLD HEALTH ORGAN, V89, P46, DOI 10.2471/BLT.10.080010; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; McMorran BJ, 2009, SCIENCE, V323, P797, DOI 10.1126/science.1166296; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; MOLYNEUX ME, 1989, Q J MED, V71, P441; Montgomery J, 2007, MOL MICROBIOL, V65, P959, DOI 10.1111/j.1365-2958.2007.05837.x; Murphy SC, 2001, AM J TROP MED HYG, V64, P57, DOI 10.4269/ajtmh.2001.64.57; Newbold C, 1997, AM J TROP MED HYG, V57, P389, DOI 10.4269/ajtmh.1997.57.389; OCKENHOUSE CF, 1991, J INFECT DIS, V164, P163, DOI 10.1093/infdis/164.1.163; Pain A, 2001, P NATL ACAD SCI USA, V98, P1805, DOI 10.1073/pnas.98.4.1805; Patel SN, 2004, J INFECT DIS, V189, P204, DOI 10.1086/380764; REEDER JC, 1994, AM J TROP MED HYG, V51, P45, DOI 10.4269/ajtmh.1994.51.45; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Rogerson SJ, 1999, AM J TROP MED HYG, V61, P467, DOI 10.4269/ajtmh.1999.61.467; ROWE A, 1995, INFECT IMMUN, V63, P2323, DOI 10.1128/IAI.63.6.2323-2326.1995; Rowe JA, 2007, P NATL ACAD SCI USA, V104, P17471, DOI 10.1073/pnas.0705390104; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; Saute F, 2003, T ROY SOC TROP MED H, V97, P661, DOI 10.1016/S0035-9203(03)80098-6; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Traore B, 2000, AM J TROP MED HYG, V62, P38, DOI 10.4269/ajtmh.2000.62.38; TREUTIGER CJ, 1992, AM J TROP MED HYG, V46, P503, DOI 10.4269/ajtmh.1992.46.503; UDOMSANGPETCH R, 1989, J EXP MED, V169, P1835, DOI 10.1084/jem.169.5.1835; Vogt AM, 2006, PLOS PATHOG, V2, P853, DOI 10.1371/journal.ppat.0020100; WALLER D, 1995, CLIN INFECT DIS, V21, P577, DOI 10.1093/clinids/21.3.577; Wassmer SC, 2008, J INFECT DIS, V197, P72, DOI 10.1086/523761; Xiong ZQ, 2003, J NEUROSCI, V23, P955	54	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19422	10.1371/journal.pone.0019422	http://dx.doi.org/10.1371/journal.pone.0019422			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559373	Green Submitted, gold, Green Published			2022-12-27	WOS:000290024700165
J	Maziade, M; Rouleau, N; Cellard, C; Battaglia, M; Paccalet, T; Moreau, I; Gagnon, V; Gingras, N; Marino, C; Gilbert, E; Roy, MA; Merette, C				Maziade, Michel; Rouleau, Nancie; Cellard, Caroline; Battaglia, Marco; Paccalet, Thomas; Moreau, Isabel; Gagnon, Valerie; Gingras, Nathalie; Marino, Cecilia; Gilbert, Elsa; Roy, Marc-Andre; Merette, Chantal			Young Offspring at Genetic Risk of Adult Psychoses: The Form of the Trajectory of IQ or Memory May Orient to the Right Dysfunction at the Right Time	PLOS ONE			English	Article							QUEBEC MULTIGENERATIONAL FAMILIES; LONGITUDINAL BIRTH COHORT; EDINBURGH HIGH-RISK; BIPOLAR DISORDER; SCHIZOPHRENIC-PATIENTS; 1ST-DEGREE RELATIVES; COGNITIVE DEFICITS; MENTAL-DISORDERS; MAJOR PSYCHOSES; CHILDHOOD	Objective: Neurocognitive dysfunctions analogous to those of adult patients have been detected in children at risk of schizophrenia and bipolar disorder. This led to the following developmental question: Do IQ and memory impairments exhibit different developmental courses from childhood to young adulthood in terms of stability or fluctuations? Methods: In a high risk sample, we used a step by step sampling approach to narrow-down the early disease mechanisms. Upstream, we started with a 20-year follow-up of 48 densely affected multigenerational kindreds, including 1500 clinically characterized adult members. We then identified 400 adult members affected by a DSM-IV schizophrenia or bipolar disorder. Downstream, we finally focused on 65 offspring (of an affected parent) aged 7 to 22, who were administered a neuropsychological battery. We then constructed cross-sectional trajectories that were compared to those of controls. Results: The childhood IQ deficit displayed a stability until young adulthood. The delay in visual memory exhibited a non-linear two-stage trajectory: a lagging period during childhood followed by a recuperation period from adolescence until adulthood, as supported by a significant Group x Age Periods interaction. No data suggested deterioration between 7 and 22. Conclusion: In these offspring at genetic risk, the developmental trajectory of global IQ impairment may not apply to specific domains of cognition such as episodic memory. Different cognitive dysfunctions would mark different developmental courses. The shape of the trajectories might itself have a meaning and provide empirical leads for targeting the right dysfunction at the right time in future prevention research.	[Gingras, Nathalie; Roy, Marc-Andre; Merette, Chantal] Univ Laval, Fac Med, Laval, PQ, Canada; [Maziade, Michel; Rouleau, Nancie; Cellard, Caroline; Paccalet, Thomas; Moreau, Isabel; Gagnon, Valerie; Gingras, Nathalie; Gilbert, Elsa; Roy, Marc-Andre; Merette, Chantal] Ctr Rech Univ Laval Robert Giffard, Laval, PQ, Canada; [Rouleau, Nancie; Cellard, Caroline; Gagnon, Valerie; Gilbert, Elsa] Univ Laval, Ecole Psychol, Laval, PQ, Canada; [Battaglia, Marco] Univ Vita Salute San Raffaele, Acad Ctr Study Behav Plast, Milan, Italy; [Marino, Cecilia] Eugenio Medea Inst, Dept Child Psychiat, Bosisio Parini, Lecco, Italy	Laval University; Laval University; Laval University; Vita-Salute San Raffaele University; IRCCS Eugenio Medea	Maziade, M (corresponding author), Univ Laval, Fac Med, Laval, PQ, Canada.	michel.maziade@psa.ulaval.ca	Rouleau, Nancie/AAX-3231-2021; Paccalet, Thomas/F-9137-2014	Rouleau, Nancie/0000-0002-6602-8263; Marino, Cecilia/0000-0001-9308-5610; Maziade, Michel/0000-0001-6029-6702; Paccalet, Thomas/0000-0003-4955-2140	Canada Research Chair [950-200810]; Canadian Institute of Health Research [MOP-74430]; GSK	Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); GSK(GlaxoSmithKline)	Supported by by a Canada Research Chair (# 950-200810) in psychiatric genetics of which Maziade is the Chair, and by a Canadian Institute of Health Research grant (# MOP-74430). Maziade and Roy have been consultants for GlaxoSmithKline (GSK) and Eli Lilly and have received research funding from GSK, Eli Lilly and AstraZeneca that are not related to the material of this study. Rouleau, Cellard, Battaglia, Paccalet, Moreau, Gagnon, Marino, Gilbert and Merette have no financial support from pharmaceutical companies. The funding organizations had no role in the study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.	Aleman A, 1999, AM J PSYCHIAT, V156, P1358; BLISHEN BR, 1987, CAN REV SOC ANTHROP, V24, P465; Bora E, 2009, J AFFECT DISORDERS, V113, P1, DOI 10.1016/j.jad.2008.06.009; Braff DL, 2007, SCHIZOPHRENIA BULL, V33, P21, DOI 10.1093/schbul/sbl049; Byrne M, 1999, PSYCHOL MED, V29, P1161, DOI 10.1017/S0033291799001002; Cannon M, 2002, ARCH GEN PSYCHIAT, V59, P449, DOI 10.1001/archpsyc.59.5.449; Cannon TD, 2000, SCHIZOPHRENIA BULL, V26, P379, DOI 10.1093/oxfordjournals.schbul.a033460; Caspi A, 2003, SCHIZOPHR RES, V65, P87, DOI 10.1016/S0920-9964(03)00056-2; DelBello MP, 2001, BIPOLAR DISORD, V3, P325, DOI 10.1034/j.1399-5618.2001.30607.x; Dore Marie-Claire, 2007, Cogn Neuropsychiatry, V12, P511, DOI 10.1080/13546800701614098; Dore MC, 2009, J CLIN EXP NEUROPSYC, V31, P533, DOI 10.1080/13803390802317567; Erlenmeyer-Kimling L, 2000, AM J PSYCHIAT, V157, P1416, DOI 10.1176/appi.ajp.157.9.1416; Erlenmeyer-Kimling L, 2000, AM J MED GENET, V97, P65, DOI 10.1002/(SICI)1096-8628(200021)97:1<65::AID-AJMG9>3.0.CO;2-V; FARAONE SV, 1995, J ABNORM PSYCHOL, V104, P286, DOI 10.1037/0021-843X.104.2.286; Hans SL, 2004, SCHIZOPHRENIA BULL, V30, P303, DOI 10.1093/oxfordjournals.schbul.a007080; JONES P, 1994, LANCET, V344, P1398, DOI 10.1016/S0140-6736(94)90569-X; Kaiser MD, 2010, P NATL ACAD SCI US; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kelley K, 2007, J STAT SOFTW, V20, P1; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Klimes-Dougan B, 2006, BIOL PSYCHIAT, V60, P957, DOI 10.1016/j.biopsych.2006.03.031; Kraemer HC, 2000, AM J PSYCHIAT, V157, P163, DOI 10.1176/appi.ajp.157.2.163; Kremen WS, 2010, SCHIZOPHR RES, V118, P1, DOI 10.1016/j.schres.2010.01.009; Maziade M, 2008, ACTA PSYCHIAT SCAND, V117, P118, DOI 10.1111/j.1600-0447.2007.01125.x; Maziade M, 2005, MOL PSYCHIATR, V10, P486, DOI 10.1038/sj.mp.4001594; MAZIADE M, 1992, AM J PSYCHIAT, V149, P1674; MAZIADE M, 1995, AM J PSYCHIAT, V152, P1458; Maziade M, 2011, SCHIZOPHRENIA BULL, V37, P1218, DOI 10.1093/schbul/sbq026; Maziade M, 2009, SCHIZOPHRENIA BULL, V35, P919, DOI 10.1093/schbul/sbn058; Maziade M, 2009, EUR J HUM GENET, V17, P1034, DOI 10.1038/ejhg.2008.268; Merette C, 2008, AM J MED GENET B, V147B, P737, DOI 10.1002/ajmg.b.30673; Meyers J.E., 1996, REY COMPLEX FIGURE T; MURRAY RM, 1992, SCHIZOPHRENIA BULL, V18, P319, DOI 10.1093/schbul/18.2.319; Niemi LT, 2003, SCHIZOPHR RES, V60, P239, DOI 10.1016/S0920-9964(02)00234-7; Niemi LT, 2004, BRIT J PSYCHIAT, V185, P11, DOI 10.1192/bjp.185.1.11; Niendam TA, 2003, AM J PSYCHIAT, V160, P2060, DOI 10.1176/appi.ajp.160.11.2060; Osler M, 2007, SCHIZOPHR RES, V92, P132, DOI 10.1016/j.schres.2007.01.009; Owens DGC, 2006, PSYCHOL MED, V36, P1501; PARK S, 1995, ARCH GEN PSYCHIAT, V52, P821; Reichenberg A, 2010, AM J PSYCHIAT, V167, P160, DOI 10.1176/appi.ajp.2009.09040574; Roy MA, 1997, AM J PSYCHIAT, V154, P1726, DOI 10.1176/ajp.154.12.1726; Schretlen DJ, 2007, BIOL PSYCHIAT, V62, P179, DOI 10.1016/j.biopsych.2006.09.025; Seidman LJ, 2006, SCHIZOPHRENIA BULL, V32, P507, DOI 10.1093/schbul/sbj078; Seidman LJ, 2006, J CLIN EXP NEUROPSYC, V28, P225, DOI 10.1080/13803390500360471; Skelley SL, 2008, SCHIZOPHR RES, V105, P78, DOI 10.1016/j.schres.2008.05.027; Snitz BE, 2006, SCHIZOPHRENIA BULL, V32, P179, DOI 10.1093/schbul/sbi048; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; STEIGER JH, 1997, MULT APPL BK SER, P221; Szatmari P, 2007, AM J MED GENET B, V144B, P581, DOI 10.1002/ajmg.b.30426; Thomas MSC, 2009, J SPEECH LANG HEAR R, V52, P336, DOI 10.1044/1092-4388(2009/07-0144); Torres IJ, 2007, ACTA PSYCHIAT SCAND, V116, P17, DOI 10.1111/j.1600-0447.2007.01055.x; Weschler D., 1999, WESCHLER ABBREVIATED; WESCHLER D, 2005, ECHELLE INTELLIGENCE; WESCHLER D, 1997, ECHELLE INTELLIGENCE; Woodberry KA, 2008, AM J PSYCHIAT, V165, P579, DOI 10.1176/appi.ajp.2008.07081242	55	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19153	10.1371/journal.pone.0019153	http://dx.doi.org/10.1371/journal.pone.0019153			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559460	Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700080
J	Sousa, FL; Alves, RJ; Pereira-Leal, JB; Teixeira, M; Pereira, MM				Sousa, Filipa L.; Alves, Renato J.; Pereira-Leal, Jose B.; Teixeira, Miguel; Pereira, Manuela M.			A Bioinformatics Classifier and Database for Heme-Copper Oxygen Reductases	PLOS ONE			English	Article							NITRIC-OXIDE REDUCTASE; CYTOCHROME-C-OXIDASE; BAYESIAN PHYLOGENETIC INFERENCE; ACTIVE-SITE; PROTON TRANSLOCATION; TERMINAL OXIDASES; EVOLUTION; SEQUENCES; PROTEINS; MODELS	Background: Heme-copper oxygen reductases (HCOs) are the last enzymatic complexes of most aerobic respiratory chains, reducing dioxygen to water and translocating up to four protons across the inner mitochondrial membrane (eukaryotes) or cytoplasmatic membrane (prokaryotes). The number of completely sequenced genomes is expanding exponentially, and concomitantly, the number and taxonomic distribution of HCO sequences. These enzymes were initially classified into three different types being this classification recently challenged. Methodology: We reanalyzed the classification scheme and developed a new bioinformatics classifier for the HCO and Nitric oxide reductases (NOR), which we benchmark against a manually derived gold standard sequence set. It is able to classify any given sequence of subunit I from HCO and NOR with a global recall and precision both of 99.8%. We use this tool to classify this protein family in 552 completely sequenced genomes. Conclusions: We concluded that the new and broader data set supports three functional and evolutionary groups of HCOs. Homology between NORs and HCOs is shown and NORs closest relationship with C Type HCOs demonstrated. We established and made available a classification web tool and an integrated Heme-Copper Oxygen reductase and NOR protein database (www.evocell.org/hco).	[Sousa, Filipa L.; Teixeira, Miguel; Pereira, Manuela M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Alves, Renato J.; Pereira-Leal, Jose B.] Inst Gulbenkian Ciencias, Oeiras, Portugal	Universidade Nova de Lisboa; Instituto Gulbenkian de Ciencia	Sousa, FL (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal.	mpereira@itqb.unl.pt	Pereira-Leal, Jose/C-5616-2012; Sousa, Filipa/ACC-2848-2022; Teixeira, Miguel/A-9098-2011; Pereira, Manuela M./B-9029-2011; Sousa, Filipa/F-3812-2011; Teixeira, Miguel/M-1509-2019; Sousa, Filipa L./H-6192-2012	Sousa, Filipa/0000-0002-4084-1942; Teixeira, Miguel/0000-0003-4124-6237; Pereira, Manuela M./0000-0003-2033-4553; Teixeira, Miguel/0000-0003-4124-6237; Sousa, Filipa L./0000-0002-4075-1701; Alves, Renato/0000-0002-7212-0234; Pereira Leal, Jose/0000-0002-3111-7119	FCT-Fundacao para a Ciencia e a Tecnologia, Portuguese Funding agency [PTPC/Qui/66559/2006, PTPC/BIA-PRO/103310/2008, SFRH/BD/27972/2006]	FCT-Fundacao para a Ciencia e a Tecnologia, Portuguese Funding agency(Portuguese Foundation for Science and Technology)	This work was supported by FCT-Fundacao para a Ciencia e a Tecnologia, Portuguese Funding agency, projects PTPC/Qui/66559/2006 to MMP, PTPC/BIA-PRO/103310/2008 to MT and fellowships SFRH/BD/27972/2006 to FLS and FCG to RJA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BELL LC, 1992, J GEN MICROBIOL, V138, P437, DOI 10.1099/00221287-138-3-437; Branden G, 2006, BBA-BIOENERGETICS, V1757, P1052, DOI 10.1016/j.bbabio.2006.05.020; Brochier-Armanet C, 2009, MOL BIOL EVOL, V26, P285, DOI 10.1093/molbev/msn246; Buschmann S, 2010, SCIENCE, V329, P327, DOI 10.1126/science.1187303; Buse G, 1999, PROTEIN SCI, V8, P985, DOI 10.1110/ps.8.5.985; de Vries S, 2002, BIOCHEM SOC T, V30, P662, DOI 10.1042/bst0300662; Ducluzeau AL, 2009, TRENDS BIOCHEM SCI, V34, P9, DOI 10.1016/j.tibs.2008.10.005; FergusonMiller S, 1996, CHEM REV, V96, P2889, DOI 10.1021/cr950051s; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gennis RB, 1998, BBA-BIOENERGETICS, V1365, P241, DOI 10.1016/S0005-2728(98)00075-9; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Gribaldo S, 2009, TRENDS BIOCHEM SCI, V34, P375, DOI 10.1016/j.tibs.2009.04.002; Hao WL, 2006, J MOL EVOL, V62, P132, DOI 10.1007/s00239-005-0005-7; Hemp J, 2005, BIOCHEMISTRY-US, V44, P10766, DOI 10.1021/bi050464f; Hemp James, 2008, V45, P1, DOI 10.1007/400_2007_046; Hendriks J, 1998, J BIOENERG BIOMEMBR, V30, P15, DOI 10.1023/A:1020547225398; Hendriks JHM, 2002, BIOCHEMISTRY-US, V41, P2331, DOI 10.1021/bi0121050; Hino T, 2010, SCIENCE, V330, P1666, DOI 10.1126/science.1195591; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Keeling PJ, 2008, CURR BIOL, V18, pR345, DOI 10.1016/j.cub.2008.02.065; Konstantinov AA, 1997, P NATL ACAD SCI USA, V94, P9085, DOI 10.1073/pnas.94.17.9085; Michel H, 1998, ANNU REV BIOPH BIOM, V27, P329, DOI 10.1146/annurev.biophys.27.1.329; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nicholas KB., 1997, GENEDOC TOOL EDITING; Pereira MM, 2001, BBA-BIOENERGETICS, V1505, P185, DOI 10.1016/S0005-2728(01)00169-4; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SARASTE M, 1994, FEBS LETT, V341, P1, DOI 10.1016/0014-5793(94)80228-9; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SHAPLEIGH JP, 1985, J BACTERIOL, V163, P837, DOI 10.1128/JB.163.3.837-840.1985; Sigrist C.J., NUCL ACIDS RES, V38, pD161; Sousa FL, 2011, SEARCHING COMMON DEN; SVENSSON M, 1995, BIOCHEMISTRY-US, V34, P5252, DOI 10.1021/bi00015a040; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; VANDEROOST J, 1994, FEMS MICROBIOL LETT, V121, P1, DOI 10.1016/0378-1097(94)90137-6; Vanlerberghe GC, 1997, ANNU REV PLANT PHYS, V48, P703, DOI 10.1146/annurev.arplant.48.1.703; Verkhovskaya ML, 1997, P NATL ACAD SCI USA, V94, P10128, DOI 10.1073/pnas.94.19.10128; Zumft WG, 2005, J INORG BIOCHEM, V99, P194, DOI 10.1016/j.jinorgbio.2004.09.024	45	44	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19117	10.1371/journal.pone.0019117	http://dx.doi.org/10.1371/journal.pone.0019117			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559461	Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700067
J	Tang, B; Thornton-Wells, T; Askland, KD				Tang, Brady; Thornton-Wells, Tricia; Askland, Kathleen D.			Comparative Linkage Meta-Analysis Reveals Regionally-Distinct, Disparate Genetic Architectures: Application to Bipolar Disorder and Schizophrenia	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; EUROPEAN-ANCESTRY; SCAN METAANALYSIS; PROVIDES EVIDENCE; COMPLEX PEDIGREE; COMMON VARIANTS; RARE VARIANTS; INCREASE RISK; PUTATIVE LOCI	New high-throughput, population-based methods and next-generation sequencing capabilities hold great promise in the quest for common and rare variant discovery and in the search for ''missing heritability.'' However, the optimal analytic strategies for approaching such data are still actively debated, representing the latest rate-limiting step in genetic progress. Since it is likely a majority of common variants of modest effect have been identified through the application of tagSNP-based microarray platforms (i.e., GWAS), alternative approaches robust to detection of low-frequency (1-5% MAF) and rare (<1%) variants are of great importance. Of direct relevance, we have available an accumulated wealth of linkage data collected through traditional genetic methods over several decades, the full value of which has not been exhausted. To that end, we compare results from two different linkage meta-analysis methods-GSMA and MSP-applied to the same set of 13 bipolar disorder and 16 schizophrenia GWLS datasets. Interestingly, we find that the two methods implicate distinct, largely non-overlapping, genomic regions. Furthermore, based on the statistical methods themselves and our contextualization of these results within the larger genetic literatures, our findings suggest, for each disorder, distinct genetic architectures may reside within disparate genomic regions. Thus, comparative linkage meta-analysis (CLMA) may be used to optimize low-frequency and rare variant discovery in the modern genomic era.	[Tang, Brady] Brown Univ, Biostat Grad Program, Providence, RI 02912 USA; [Thornton-Wells, Tricia] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Askland, Kathleen D.] Brown Univ, Dept Psychiat & Human Behav, Butler Hosp, Warren Alpert Sch Med, Providence, RI 02912 USA	Brown University; Vanderbilt University; Brown University; Butler Hospital Rhode Island	Tang, B (corresponding author), Brown Univ, Biostat Grad Program, Providence, RI 02912 USA.	k.askland@gmail.com	Thornton-Wells, Tricia/C-3490-2012; Askland, Kathleen D./C-6479-2008; Thornton-Wells, Tricia/A-7852-2009	Thornton-Wells, Tricia/0000-0002-5467-2270; Askland, Kathleen/0000-0003-1467-8923	Kathleen Askland's National Institute of Mental Health (NIMH) [K08 MH085810-02]; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH085810] Funding Source: NIH RePORTER	Kathleen Askland's National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work is supported by Kathleen Askland's National Institute of Mental Health (NIMH) career development award, K08 MH085810-02. Brady Tang receives salary support as a research assistant from Dr. Askland's K08, and Tricia Thornton-Wells is a consultant under the same K08. There is no other funding supporting this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaerts M, 2009, HUM MUTAT, V30, P1139, DOI 10.1002/humu.21042; Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Anderson CA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000580; Athanasiu L, 2010, J PSYCHIATR RES, V44, P748, DOI 10.1016/j.jpsychires.2010.02.002; Badenhop R, 2002, MOL PSYCHIATR, V7, P851, DOI 10.1038/sj.mp.4001114; Badner JA, 2002, MOL PSYCHIATR, V7, P56, DOI 10.1038/sj/mp/4000922; Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; Baron M, 2001, AM J HUM GENET, V68, P299, DOI 10.1086/318212; Baum AE, 2008, MOL PSYCHIATR, V13, P466, DOI 10.1038/mp.2008.16; Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Bennett P, 2002, MOL PSYCHIATR, V7, P189, DOI 10.1038/sj.mp.4000957; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Borecki IB, 2008, ADV GENET, V60, P51, DOI 10.1016/S0065-2660(07)00403-8; Brzustowicz LM, 2000, SCIENCE, V288, P678, DOI 10.1126/science.288.5466.678; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; BYERLEY W, 2010, PSYCHIAT GENET; Cassidy F, 2007, AM J MED GENET B, V144B, P791, DOI 10.1002/ajmg.b.30524; Cheng R, 2006, MOL PSYCHIATR, V11, P252, DOI 10.1038/sj.mp.4001778; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Clark AG, 2005, GENOME RES, V15, P1463, DOI 10.1101/gr.4244005; Cooper-Casey K, 2005, MOL PSYCHIATR, V10, P651, DOI 10.1038/sj.mp.4001640; Curtis D, 2011, PSYCHIAT GENET, V21, P1, DOI 10.1097/YPG.0b013e3283413382; DeLisi LE, 2002, AM J PSYCHIAT, V159, P803, DOI 10.1176/appi.ajp.159.5.803; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Djurovic S, 2010, J AFFECT DISORDERS, V126, P312, DOI 10.1016/j.jad.2010.04.007; Egger M, 1997, BMJ-BRIT MED J, V315, P1371, DOI 10.1136/bmj.315.7119.1371; Etain B, 2006, MOL PSYCHIATR, V11, P685, DOI 10.1038/sj.mp.4001815; Fallin MD, 2004, AM J HUM GENET, V75, P204, DOI 10.1086/422474; Faraone SV, 2006, AM J PSYCHIAT, V163, P1760, DOI 10.1176/appi.ajp.163.10.1760; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Francks C, 2010, MOL PSYCHIATR, V15, P319, DOI 10.1038/mp.2008.100; Friddle C, 2000, AM J HUM GENET, V66, P205, DOI 10.1086/302697; Garver DL, 2001, SCHIZOPHR RES, V52, P145, DOI 10.1016/S0920-9964(01)00157-8; Guerra R, 2010, CH CRC MATH COMP BIO, P1; Gurling HMD, 2001, AM J HUM GENET, V68, P661, DOI 10.1086/318788; Hattori E, 2009, AM J MED GENET B, V150B, P1110, DOI 10.1002/ajmg.b.30941; Herzberg I, 2006, HUM MOL GENET, V15, P3146, DOI 10.1093/hmg/ddl254; Hindorff LA, 2009, CATALOG PUBLISHED GE; Holmans PA, 2009, MOL PSYCHIATR, V14, P786, DOI 10.1038/mp.2009.11; Hong KS, 2009, AM J MED GENET B, V150B, P647, DOI 10.1002/ajmg.b.30884; Hosking FJ, 2011, BRIT MED BULL, V97, P27, DOI 10.1093/bmb/ldq038; Huang J, 2010, AM J PSYCHIAT, V167, P1254, DOI 10.1176/appi.ajp.2010.09091335; Ikeda M, 2011, BIOL PSYCHIAT, V69, P472, DOI 10.1016/j.biopsych.2010.07.010; JSSLG, 2003, AM J MED GENET B, V120, P22; Kirov G, 2009, MOL PSYCHIATR, V14, P796, DOI 10.1038/mp.2008.33; Kirov G, 2009, HUM MOL GENET, V18, P1497, DOI 10.1093/hmg/ddp043; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LEE MT, 2010, MOL PSYCHIATR, DOI DOI 10.1038/MP.2010.43; Lencz T, 2007, MOL PSYCHIATR, V12, P572, DOI 10.1038/sj.mp.4001983; Lerer B, 2003, MOL PSYCHIATR, V8, P488, DOI 10.1038/sj.mp.4001322; Levinson DF, 2003, AM J HUM GENET, V73, P17, DOI 10.1086/376548; Levinson Douglas F, 2005, Curr Psychiatry Rep, V7, P143, DOI 10.1007/s11920-005-0012-9; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Lindholm E, 2001, AM J HUM GENET, V69, P96, DOI 10.1086/321288; Liu Y, 2011, MOL PSYCHIATR, V16, P2, DOI 10.1038/mp.2009.107; Marcheco-Teruel B, 2006, AM J MED GENET B, V141B, P833, DOI 10.1002/ajmg.b.30314; McClellan JM, 2007, BRIT J PSYCHIAT, V190, P194, DOI 10.1192/bjp.bp.106.025585; McInnis MG, 2003, MOL PSYCHIATR, V8, P288, DOI 10.1038/sj.mp.4001277; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Nothen Markus M, 2010, Dialogues Clin Neurosci, V12, P85; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Park N, 2004, MOL PSYCHIATR, V9, P1091, DOI 10.1038/sj.mp.4001541; Paunio T, 2001, HUM MOL GENET, V10, P3037, DOI 10.1093/hmg/10.26.3037; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; Province MA, 2001, AM J HUM GENET, V69, P660, DOI 10.1086/323316; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Ross J, 2008, PSYCHIAT GENET, V18, P191, DOI 10.1097/YPG.0b013e3283050aa5; Sanders AR, 2008, AM J PSYCHIAT, V165, P497, DOI 10.1176/appi.ajp.2007.07101573; Schulze TG, 2009, MOL PSYCHIATR, V14, P487, DOI 10.1038/mp.2008.134; Schwab SG, 2000, MOL PSYCHIATR, V5, P638, DOI 10.1038/sj.mp.4000791; Scott LJ, 2009, P NATL ACAD SCI USA, V106, P7501, DOI 10.1073/pnas.0813386106; Service S, 2006, AM J MED GENET B, V141B, P367, DOI 10.1002/ajmg.b.30323; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Shifman S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040028; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Straub RE, 2002, MOL PSYCHIATR, V7, P542, DOI 10.1038/sj.mp.4001051; Suarez BK, 2006, AM J HUM GENET, V78, P315, DOI 10.1086/500272; Sullivan PF, 2008, MOL PSYCHIATR, V13, P570, DOI 10.1038/mp.2008.25; Teltsh O, 2008, AM J MED GENET B, V147B, P209, DOI 10.1002/ajmg.b.30591; Thornton-Wells TA, 2004, TRENDS GENET, V20, P640, DOI 10.1016/j.tig.2004.09.007; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang K, 2010, AM J HUM GENET, V86, P730, DOI 10.1016/j.ajhg.2010.04.003; Wang KS, 2010, SCHIZOPHR RES, V124, P192, DOI 10.1016/j.schres.2010.09.002; Wijsman EM, 2003, MOL PSYCHIATR, V8, P695, DOI 10.1038/sj.mp.4001356; Wise LH, 1999, ANN HUM GENET, V63, P263, DOI 10.1046/j.1469-1809.1999.6330263.x; Zandi PP, 2007, MOL PSYCHIATR, V12, P630, DOI 10.1038/sj.mp.4002027; Zhang D, 2009, MOL PSYCHIATR, V14, P376, DOI 10.1038/mp.2008.144	92	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19073	10.1371/journal.pone.0019073	http://dx.doi.org/10.1371/journal.pone.0019073			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559500	gold, Green Published, Green Submitted			2022-12-27	WOS:000290024700060
J	Wang, Z; Yang, DH; Zhang, XJ; Li, T; Li, J; Tang, Y; Le, WD				Wang, Zheng; Yang, Dehua; Zhang, Xiaojie; Li, Ting; Li, Jia; Tang, Yu; Le, Weidong			Hypoxia-Induced Down-Regulation of Neprilysin by Histone Modification in Mouse Primary Cortical and Hippocampal Neurons	PLOS ONE			English	Article							AMYLOID-BETA PEPTIDE; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; GENE-EXPRESSION; CANCER-CELLS; A-BETA; DNA; METHYLATION; PROMOTER; 5-AZA-2'-DEOXYCYTIDINE	Amyloid beta-peptide (A beta) accumulation leads to neurodegeneration and Alzheimer's disease (AD). A beta metabolism is a dynamic process in the A beta production and clearance that requires neprilysin (NEP) and other enzymes to degrade A beta. It has been reported that NEP expression is significantly decreased in the brain of AD patients. Previously we have documented hypoxia is a risk factor for A beta generation in vivo and in vitro through increasing A beta generation by altering beta-cleavage and gamma-cleavage of APP and down-regulating NEP, and causing tau hyperphosphorylation. Here, we investigated the molecular mechanisms of hypoxia-induced down-regulation of NEP. We found a significant decrease in NEP expression at the mRNA and protein levels after hypoxic treatment in mouse primary cortical and hippocampal neurons. Chromatin immunoprecipitation (ChIP) assays and relative quantitative PCR (q-PCR) revealed an increase of histone H3-lysine9 demethylation (H3K9me2) and a decrease of H3 acetylation (H3-Ace) in the NEP promoter regions following hypoxia. In addition, we found that hypoxia caused up-regulation of histone methyl transferase (HMT) G9a and histone deacetylases (HDACs) HDAC-1. Decreased expression of NEP during hypoxia can be prevented by application with the epigenetic regulators 5-Aza-2'-deoxycytidine (5-Aza), HDACs inhibitor sodium valproate (VA), and siRNA-mediated knockdown of G9a or HDAC1. DNA methylation PCR data do not support that hypoxia affects the methylation of NEP promoters. This study suggests that hypoxia may down-regulate NEP by increasing H3K9me2 and decreasing H3-Ace modulation.	[Wang, Zheng; Yang, Dehua; Le, Weidong] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Inst Neurol, Shanghai 200030, Peoples R China; [Zhang, Xiaojie; Li, Ting; Li, Jia; Tang, Yu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Zhang, Xiaojie; Li, Ting; Li, Jia; Tang, Yu] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Le, Weidong] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Baylor College of Medicine	Wang, Z (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Inst Neurol, Shanghai 200030, Peoples R China.	weidongl@bcm.edu	Yang, Dehua/S-6156-2017; Yang, Dehua/M-5789-2019		Shanghai International Science and Technology Cooperation Project [10410712900]; National Basic Research Program of China [2007CB947904, 2010CB945200]; Chinese National Nature Science Foundation [30970925/30730096]; Shanghai Jiao Tong University School of Medicine [BXJ201013]	Shanghai International Science and Technology Cooperation Project; National Basic Research Program of China(National Basic Research Program of China); Chinese National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Jiao Tong University School of Medicine	This work was supported by the Shanghai International Science and Technology Cooperation Project (No. 10410712900; http://www.stcsm.gov.cn/structure/index.htm); the National Basic Research Program of China (2007CB947904 and 2010CB945200; http://www.973.gov.cn/English/Index.aspx); Chinese National Nature Science Foundation (No. 30970925/30730096; http://www.nsfc.gov.cn/Portal0) and by the the PhD Innovation Fund of Shanghai Jiao Tong University School of Medicine (BXJ201013; http://yjsy.shsmu.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolmaleky HM, 2006, HUM MOL GENET, V15, P3132, DOI 10.1093/hmg/ddl253; Anderson CJ, 2006, ONCOGENE, V25, P61, DOI 10.1038/sj.onc.1209011; Baiden-Amissah K, 1998, NEUROPATH APPL NEURO, V24, P346; Belyaev ND, 2009, EMBO REP, V10, P94, DOI 10.1038/embor.2008.222; Byrne JA, 2007, LAB INVEST, V87, P1138, DOI 10.1038/labinvest.3700677; Cacabelos Ramon, 2008, V448, P213, DOI 10.1007/978-1-59745-205-2_10; Campos ACE, 2007, NEOPLASIA, V9, P1111, DOI 10.1593/neo.07712; Carson JA, 2002, J NEUROCHEM, V81, P1, DOI 10.1046/j.1471-4159.2002.00855.x; Chen HB, 2006, CANCER RES, V66, P9009, DOI 10.1158/0008-5472.CAN-06-0101; Chen HB, 2010, CARCINOGENESIS, V31, P2136, DOI 10.1093/carcin/bgq197; Chen UL, 2009, BIOCHEM BIOPH RES CO, V378, P57, DOI 10.1016/j.bbrc.2008.10.173; Cho IH, 2008, BRAIN, V131, P3019, DOI 10.1093/brain/awn230; Du F, 2005, EUR J NEUROSCI, V22, P2422, DOI 10.1111/j.1460-9568.2005.04438.x; Fahrner JA, 2002, CANCER RES, V62, P7213; Fisk L, 2007, NEUROCHEM RES, V32, P1741, DOI 10.1007/s11064-007-9349-2; Fowler BA, 2004, BIOMETALS, V17, P567, DOI 10.1023/B:BIOM.0000045740.52182.9d; Hama E, 2005, MED HYPOTHESES, V65, P498, DOI 10.1016/j.mehy.2005.02.045; Hersh LB, 2008, CURR ALZHEIMER RES, V5, P225, DOI 10.2174/156720508783954703; Honig LS, 2005, NEUROLOGY, V64, P494, DOI 10.1212/01.WNL.0000150886.50187.30; ISHIMARU F, 1995, BLOOD, V85, P3199, DOI 10.1182/blood.V85.11.3199.bloodjournal85113199; Jacobsen JS, 2008, P NATL ACAD SCI USA, V105, P8754, DOI 10.1073/pnas.0710823105; Kilgore M, 2010, NEUROPSYCHOPHARMACOL, V35, P870, DOI 10.1038/npp.2009.197; Lee SH, 2009, ONCOGENE, V28, P184, DOI 10.1038/onc.2008.377; LI CW, 1995, J BIOL CHEM, V270, P5723, DOI 10.1074/jbc.270.11.5723; Li L, 2009, NEUROBIOL AGING, V30, P1091, DOI 10.1016/j.neurobiolaging.2007.10.011; Marr RA, 2003, J NEUROSCI, V23, P1992; Marr RA, 2004, J MOL NEUROSCI, V22, P5, DOI 10.1385/JMN:22:1-2:5; Maruyama M, 2005, ANN NEUROL, V57, P832, DOI 10.1002/ana.20494; Miners JS, 2006, J NEUROPATH EXP NEUR, V65, P1012, DOI 10.1097/01.jnen.0000240463.87886.9a; Morrison BE, 2007, CELL MOL LIFE SCI, V64, P2258, DOI 10.1007/s00018-007-7035-9; Nalivaeva NN, 2008, CURR ALZHEIMER RES, V5, P212, DOI 10.2174/156720508783954785; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nguyen CT, 2002, CANCER RES, V62, P6456; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Plattner F, 2006, J BIOL CHEM, V281, P25457, DOI 10.1074/jbc.M603469200; Qing H, 2008, J EXP MED, V205, P2781, DOI 10.1084/jem.20081588; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Scarpa S, 2003, FEBS LETT, V541, P145, DOI 10.1016/S0014-5793(03)00277-1; Schneider JA, 2003, NEUROLOGY, V60, P1082, DOI 10.1212/01.WNL.0000055863.87435.B2; Takebayashi S, 2001, BIOCHEM BIOPH RES CO, V288, P921, DOI 10.1006/bbrc.2001.5863; Wang SC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002698; Whang YE, 1998, P NATL ACAD SCI USA, V95, P5246, DOI 10.1073/pnas.95.9.5246; Yoder JA, 1997, J MOL BIOL, V270, P385, DOI 10.1006/jmbi.1997.1125; Zhang X, 2007, J BIOL CHEM, V282, P10873, DOI 10.1074/jbc.M608856200; Zhang X, 2010, EXP NEUROL, V223, P299, DOI 10.1016/j.expneurol.2009.07.033	45	77	86	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19229	10.1371/journal.pone.0019229	http://dx.doi.org/10.1371/journal.pone.0019229			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559427	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700105
J	Vibhuti, A; Gupta, K; Subramanian, H; Guo, Q; Ali, H				Vibhuti, Arpana; Gupta, Kshitij; Subramanian, Hariharan; Guo, Qiang; Ali, Hydar			Distinct and Shared Roles of beta-Arrestin-1 and beta-Arrestin-2 on the Regulation of C3a Receptor Signaling in Human Mast Cells	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; KAPPA-B ACTIVATION; DROSOPHILA NONVISUAL ARRESTIN; FC-EPSILON-RI; BETA-ARRESTIN; CHEMOKINE PRODUCTION; PEPTIDE CHEMOATTRACTANTS; CROSS-DESENSITIZATION; KINASE ACTIVATION; ERK1/2 ACTIVATION	Background: The complement component C3a induces degranulation in human mast cells via the activation of cell surface G protein coupled receptors (GPCR; C3aR). For most GPCRs, agonist-induced receptor phosphorylation leads to the recruitment of beta-arrestin-1/beta-arrestin-2; resulting in receptor desensitization and internalization. Activation of GPCRs also leads to ERK1/2 phosphorylation via two temporally distinct pathways; an early response that reflects G protein activation and a delayed response that is G protein independent but requires beta-arrestins. The role of b-arrestins on C3aR activation/regulation in human mast cells, however, remains unknown. Methodology/Principal Findings: We utilized lentivirus short hairpin (sh) RNA to stably knockdown the expression of beta-arrestin-1 and beta-arrrestin-2 in human mast cell lines, HMC-1 and LAD2 that endogenously expresses C3aR. Silencing beta-arrestin-2 attenuated C3aR desensitization, blocked agonist-induced receptor internalization and rendered the cells responsive to C3a for enhanced NF-kappa B activity as well as chemokine generation. By contrast, silencing beta-arrestin-1 had no effect on these responses but resulted in a significant decrease in C3a-induced mast cell degranulation. In shRNA control cells, C3a caused a transient ERK1/2 phosphorylation, which peaked at 5 min but disappeared by 10 min. Knockdown of beta-arrestin-1, beta-arrestin-2 or both enhanced the early response to C3a and rendered the cells responsive for ERK1/2 phosphorylation at later time points (10-30 min). Treatment of cells with pertussis toxin almost completely blocked both early and delayed C3a-induced ERK1/2 phosphorylation in beta-arrestin1/2 knockdown cells. Conclusion/Significance: This study demonstrates distinct roles for beta-arrestins-1 and beta-arrestins-2 on C3aR desensitization, internalization, degranulation, NF-kappa B activation and chemokine generation in human mast cells. It also shows that both beta-arrestin-1 and beta-arrestin-2 play a novel and shared role in inhibiting G protein-dependent ERK1/2 phosphorylation. These findings reveal a new level of complexity for C3aR regulation by beta-arrestins in human mast cells.	[Vibhuti, Arpana; Gupta, Kshitij; Subramanian, Hariharan; Guo, Qiang; Ali, Hydar] Univ Penn, Dept Pathol, Sch Dent Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Vibhuti, A (corresponding author), Univ Penn, Dept Pathol, Sch Dent Med, Philadelphia, PA 19104 USA.	alih@upenn.edu	Subramanian, Hariharan/AHC-5755-2022		National Institutes of Health [HL085774, AI080852]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI080852] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants HL085774 and AI080852. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed J, 2002, J BIOL CHEM, V277, P22685, DOI 10.1074/jbc.M110210200; Ahamed J, 2001, J IMMUNOL, V167, P3559, DOI 10.4049/jimmunol.167.7.3559; Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; Ali H, 2000, J IMMUNOL, V165, P7215, DOI 10.4049/jimmunol.165.12.7215; ALI H, 1994, J BIOL CHEM, V269, P24557; Barlic J, 2000, NAT IMMUNOL, V1, P227, DOI 10.1038/79767; Bhattacharya M, 2002, NAT CELL BIOL, V4, P547, DOI 10.1038/ncb821; BUTTERFIELD JH, 1989, INT ARCH ALLER A IMM, V89, P297, DOI 10.1159/000234963; Defea K, 2008, BRIT J PHARMACOL, V153, pS298, DOI 10.1038/sj.bjp.0707508; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Drouin SM, 2002, J IMMUNOL, V169, P5926, DOI 10.4049/jimmunol.169.10.5926; Fukuoka Y, 2008, J IMMUNOL, V180, P6307, DOI 10.4049/jimmunol.180.9.6307; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Ge H, 2006, CHEM SENSES, V31, P49, DOI 10.1093/chemse/bjj005; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; Hartmann K, 1997, BLOOD, V89, P2863, DOI 10.1182/blood.V89.8.2863; Humbles AA, 2000, NATURE, V406, P998, DOI 10.1038/35023175; Iikura M, 2007, LAB INVEST, V87, P971, DOI 10.1038/labinvest.3700663; Johnson EC, 2008, INSECT BIOCHEM MOLEC, V38, P1016, DOI 10.1016/j.ibmb.2008.09.003; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; Kubo Y, 2007, INFLAMM RES, V56, P70, DOI 10.1007/s00011-006-6064-4; Kuehn HS, 2007, IMMUNOL LETT, V113, P59, DOI 10.1016/j.imlet.2007.08.007; Lappalainen J, 2007, CLIN EXP ALLERGY, V37, P1404, DOI 10.1111/j.1365-2222.2007.02778.x; Lefkowitz RJ, 2004, CURR OPIN CELL BIOL, V16, P162, DOI 10.1016/j.ceb.2004.01.001; Liu LZ, 2007, GENETICS, V175, P1197, DOI 10.1534/genetics.106.068411; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; McNeil HP, 2007, J BIOL CHEM, V282, P20785, DOI 10.1074/jbc.R700017200; Oskeritzian CA, 2005, J ALLERGY CLIN IMMUN, V115, P1162, DOI 10.1016/j.jaci.2005.02.022; OSKERITZIAN CA, J EXP MED, V207, P465; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Raghuwanshi SK, 2008, J IMMUNOL, V180, P5699, DOI 10.4049/jimmunol.180.8.5699; Richardson RM, 1996, J BIOL CHEM, V271, P28717, DOI 10.1074/jbc.271.45.28717; RICHARDSON RM, 1995, BIOCHEMISTRY-US, V34, P14193, DOI 10.1021/bi00043a025; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Su YJ, 2005, J IMMUNOL, V175, P5396, DOI 10.4049/jimmunol.175.8.5396; Sun JY, 2008, P NATL ACAD SCI USA, V105, P17085, DOI 10.1073/pnas.0802701105; TIPPING M, EMBO J; TOMHAVE ED, 1994, J IMMUNOL, V153, P3267; Venkatesha RT, 2005, MOL IMMUNOL, V42, P581, DOI 10.1016/j.molimm.2004.09.009; Venkatesha RT, 2004, J BIOL CHEM, V279, P44606, DOI 10.1074/jbc.M408035200; Vines CM, 2002, J IMMUNOL, V169, P6760, DOI 10.4049/jimmunol.169.12.6760; WEI H, 2003, P NATL ACAD SCI US; WITHEROW DS, 2004, P NATL ACAD SCI US; Woolhiser MR, 2004, CLIN IMMUNOL, V110, P172, DOI 10.1016/j.clim.2003.11.007; Yang M, 2009, BIOCHEM J, V417, P287, DOI 10.1042/BJ20081561	49	42	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19585	10.1371/journal.pone.0019585	http://dx.doi.org/10.1371/journal.pone.0019585			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589858	Green Submitted, gold, Green Published			2022-12-27	WOS:000290531100019
J	Karjala, Z; Neal, D; Rohrer, J				Karjala, Zuzana; Neal, Diane; Rohrer, James			Association between HSV1 Seropositivity and Obesity: Data from the National Health and Nutritional Examination Survey, 2007-2008	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; INFECTION; TYPE-2; INFLAMMATION; RISK; FAT; MEN; SEROPREVALENCE; MANAGEMENT; ADENOVIRUS	Background: Herpes simplex virus (HSV) is among the most common sexually transmitted pathogens in the United States and worldwide. HSV has a high incidence of undetected cases. In addition, there is no treatment, and there is a lack of knowledge why disparities among populations exist. Research studies suggest that fat tissue may participate in body's immune responses, and the impact of obesity on susceptibility to HSV1 infection is not clear. The purpose of this study was to examine whether obesity is a risk factor for HSV1 infection using a large sample from the general population. Methods/Principal Findings: This cross-sectional study used data from the National Health and Examination and Nutritional Examination Survey (NHANES) from 2007-2008. Variables, gender, age, race/ethnicity, marital status, education, poverty level, and diabetes represented potential confounders and were included in analyses. The two-tailed Pearson's chi square, student's t test, and a multiple logistic regression analysis were applied to evaluate associations using a significance value of p <= 0.05. Adjusted odds ratios with 95% confidence interval represented the degree of these associations. The prevalence of HSV1 infection in US population between 20 and 49 years old was 60.3% (n = 1,536). In this study, having a BMI classified as the obese group (BMI 30-39.9) was significantly associated with HSV1 infection before [unadjusted OR = 1.74 (95% CI 1.20-2.51), p = 0.006] and after controlling for socio-demographic factors [adjusted OR = 1.50 (95% CI 1.06-2.13)], p = 0.026]. This association was stronger than three already established risk factors of age, female gender, and poverty level. Conclusions/Significance: This study provides evidence that obesity may play a role in the susceptibility to HSV1 infection. Findings from this study suggest that obesity should be considered when designing preventive measures for HSV1 infection. These results may also explain why some people acquire HSV1 infections and some do not. Further, these findings may justify an increased emphasis on the control and prevention of HSV1 transmission and other pathogens in overweight and obese populations.	[Karjala, Zuzana; Neal, Diane] Walden Univ, Minneapolis, MN USA; [Rohrer, James] Mayo Clin, Rochester, MN USA	Walden University; Mayo Clinic	Karjala, Z (corresponding author), Walden Univ, Minneapolis, MN USA.	zkarjala@yahoo.com	Sriwisit, Sukhumaphorn/G-1405-2011	rohrer, james/0000-0003-3074-1857				Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Arslan E, 2009, EUR J INTERN MED, V20, P695, DOI 10.1016/j.ejim.2009.07.013; Atkinson RL, 2005, INT J OBESITY, V29, P281, DOI 10.1038/sj.ijo.0802830; Bassols J, 2010, OBESITY, V18, P239, DOI 10.1038/oby.2009.250; Carr DJJ, 2006, CURR TOP MICROBIOL, V303, P47, DOI 10.1007/978-3-540-33397-5_3; *CDCP, 2009, NIIANES 2007 2008 PU; Centers for Disease Control and Prevention (CDCP), 2010, SEX TRANSM DIS SURV; Donoval BA, 2006, SEX TRANSM DIS, V33, P170, DOI 10.1097/01.olq.0000187203.27918.45; Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0; Fatahzadeh M, 2007, J AM ACAD DERMATOL, V57, P737, DOI 10.1016/j.jaad.2007.06.027; Fernaandez-Real JM, 2007, OBESITY, V15, P245, DOI 10.1038/oby.2007.541; Gabbert C, 2010, PEDIATRICS, V126, P721, DOI 10.1542/peds.2009-3362; Hill J, 2005, CLIN PERINATOL, V32, P657, DOI 10.1016/j.clp.2005.05.008; KALIMO KOK, 1983, INFECT IMMUN, V39, P24, DOI 10.1128/IAI.39.1.24-28.1983; Knezevic A, 2007, EMERG INFECT DIS, V13, P302, DOI 10.3201/eid1302.060907; Kopacova M, 2007, EUR J EPIDEMIOL, V22, P67, DOI 10.1007/s10654-006-9090-1; Krolczyk S, 2003, J CHILD NEUROL, V18, P356, DOI 10.1177/08830738030180050201; Kropp RY, 2006, PEDIATRICS, V117, P1955, DOI 10.1542/peds.2005-1778; Lutsey PL, 2009, DIABETIC MED, V26, P149, DOI 10.1111/j.1464-5491.2008.02632.x; Margetic S, 2002, INT J OBESITY, V26, P1407, DOI 10.1038/sj.ijo.0802142; Meisinger C, 2006, AM J CLIN NUTR, V84, P483, DOI 10.1093/ajcn/84.3.483; Myles TD, 2002, OBSTET GYNECOL, V100, P959, DOI 10.1016/S0029-7844(02)02323-2; Otero M, 2005, FEBS LETT, V579, P295, DOI 10.1016/j.febslet.2004.11.024; Pebody RG, 2004, SEX TRANSM INFECT, V80, P185, DOI 10.1136/sti.2003.005850; Pena KC, 2010, J CLIN MICROBIOL, V48, P150, DOI 10.1128/JCM.01336-09; Rantala A, 2010, EPIDEMIOL INFECT, V138, P1267, DOI 10.1017/S0950268809991452; Roberts CM, 2003, SEX TRANSM DIS, V30, P797, DOI 10.1097/01.OLQ.0000092387.58746.C7; Roivainen M, 2000, CIRCULATION, V101, P252, DOI 10.1161/01.CIR.101.3.252; Rupprecht HJ, 2001, CIRCULATION, V104, P25, DOI 10.1161/hc2601.091703; Schillinger JA, 2008, SEX TRANSM DIS, V35, P599, DOI 10.1097/OLQ.0b013e3181666fb1; Schwartz EJ, 2007, HUM VACCINES, V3, P231, DOI 10.4161/hv.4529; Smith JS, 2009, SEX TRANSM INFECT, V85, P92, DOI 10.1136/sti.2008.031815; Starr JR, 2001, CANCER RES, V61, P8459; *STATCORP LP, 2010, DAT AN SOFTW; Sun YH, 2005, DIABETES CARE, V28, P435, DOI 10.2337/diacare.28.2.435; Szucs TD, 2001, BMC INFECT DIS, V1, part. no., DOI 10.1186/1471-2334-1-5; Trovato GM, 2009, INT J OBESITY, V33, P1402, DOI 10.1038/ijo.2009.196; Wald A, 2005, ANN INTERN MED, V143, P707, DOI 10.7326/0003-4819-143-10-200511150-00007; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964	40	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19092	10.1371/journal.pone.0019092	http://dx.doi.org/10.1371/journal.pone.0019092			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589933	Green Published, gold, Green Submitted			2022-12-27	WOS:000290483600008
J	Cadotte, MW; Strauss, SY				Cadotte, Marc W.; Strauss, Sharon Y.			Phylogenetic Patterns of Colonization and Extinction in Experimentally Assembled Plant Communities	PLOS ONE			English	Article							ECOLOGICAL COMMUNITIES; RAIN-FOREST; DIVERSITY; NICHE; PRODUCTIVITY; NEUTRALITY; HISTORY; MODEL; SUBSTITUTION; COMPETITION	Background: Evolutionary history has provided insights into the assembly and functioning of plant communities, yet patterns of phylogenetic community structure have largely been based on non-dynamic observations of natural communities. We examined phylogenetic patterns of natural colonization, extinction and biomass production in experimentally assembled communities. Methodology/Principal Findings: We used plant community phylogenetic patterns two years after experimental diversity treatments (1, 2, 4, 8 or 32 species) were discontinued. We constructed a 5-gene molecular phylogeny and statistically compared relatedness of species that colonized or went extinct to remaining community members and patterns of aboveground productivity. Phylogenetic relatedness converged as species-poor plots were colonized and speciose plots experienced extinctions, but plots maintained more differences in composition than in phylogenetic diversity. Successful colonists tended to either be closely or distantly related to community residents. Extinctions did not exhibit any strong relatedness patterns. Finally, plots that increased in phylogenetic diversity also increased in community productivity, though this effect was inseparable from legume colonization, since these colonists tended to be phylogenetically distantly related. Conclusions: We found that successful non-legume colonists were typically found where close relatives already existed in the sown community; in contrast, successful legume colonists (on their own long branch in the phylogeny) resulted in plots that were colonized by distant relatives. While extinctions exhibited no pattern with respect to relatedness to sown plotmates, extinction plus colonization resulted in communities that converged to similar phylogenetic diversity values, while maintaining differences in species composition.	[Cadotte, Marc W.] Univ Toronto, Dept Biol Sci, Scarborough, ON M1C 1A4, Canada; [Strauss, Sharon Y.] Univ Calif Davis, Sect Ecol & Evolut, Davis, CA 95616 USA	University of Toronto; University Toronto Scarborough; University of California System; University of California Davis	Cadotte, MW (corresponding author), Univ Toronto, Dept Biol Sci, Scarborough, ON M1C 1A4, Canada.	mcadotte@utsc.utoronto.ca; systrauss@ucdavis.edu	Cadotte, Marc/AAG-8147-2020; Strauss, Sharon/J-1827-2012	Cadotte, Marc/0000-0002-5816-7693; Strauss, Sharon/0000-0002-6117-4085	NSF [DEB-0553768]; NSERC [386151]	NSF(National Science Foundation (NSF)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was indirectly funded by an NSF grant to the National Center for Ecological Analysis and Synthesis (DEB-0553768) and by an NSERC grant to MC (#386151). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bartelt-Ryser J, 2005, PERSPECT PLANT ECOL, V7, P27, DOI 10.1016/j.ppees.2004.11.002; Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Cadotte MW, 2010, DIVERS DISTRIB, V16, P892, DOI 10.1111/j.1472-4642.2010.00700.x; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Cadotte MW, 2007, P ROY SOC B-BIOL SCI, V274, P2739, DOI 10.1098/rspb.2007.0925; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cavender-Bares J, 2003, ECOLOGY, V84, P592, DOI 10.1890/0012-9658(2003)084[0592:IMAMPI]2.0.CO;2; Cavender-Bares J, 2006, ECOLOGY, V87, pS109, DOI 10.1890/0012-9658(2006)87[109:PSOFPC]2.0.CO;2; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Diemer Matthias, 1997, Bulletin of the Geobotanical Institute ETH, V63, P95; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fukami T, 2005, ECOL LETT, V8, P1283, DOI 10.1111/j.1461-0248.2005.00829.x; Fukami T, 2007, NATURE, V446, P436, DOI 10.1038/nature05629; Futuyma DJ, 2010, EVOLUTION, V64, P1865, DOI 10.1111/j.1558-5646.2010.00960.x; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Helmus MR, 2010, ECOL LETT, V13, P162, DOI 10.1111/j.1461-0248.2009.01411.x; Holt RD, 2006, TRENDS ECOL EVOL, V21, P531, DOI 10.1016/j.tree.2006.08.003; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kembel SW, 2009, ECOL LETT, V12, P949, DOI 10.1111/j.1461-0248.2009.01354.x; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Kraft NJB, 2007, AM NAT, V170, P271, DOI 10.1086/519400; Letcher SG, 2010, P ROY SOC B-BIOL SCI, V277, P97, DOI 10.1098/rspb.2009.0865; Levine JM, 2009, NATURE, V461, P254, DOI 10.1038/nature08251; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; MacDougall AS, 2009, J ECOL, V97, P609, DOI 10.1111/j.1365-2745.2009.01514.x; Maherali H, 2007, SCIENCE, V316, P1746, DOI 10.1126/science.1143082; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Petermann JS, 2010, ECOLOGY, V91, P408, DOI 10.1890/08-2304.1; Pfisterer AB, 2004, BASIC APPL ECOL, V5, P5, DOI 10.1078/1439-1791-00215; Posada D, 2001, SYST BIOL, V50, P580, DOI 10.1080/106351501750435121; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Scheffer M, 2006, P NATL ACAD SCI USA, V103, P6230, DOI 10.1073/pnas.0508024103; Silvertown J, 2001, J ECOL, V89, P428, DOI 10.1046/j.1365-2745.2001.00553.x; Silvertown J, 2006, ECOLOGY, V87, pS39, DOI 10.1890/0012-9658(2006)87[39:PATHOO]2.0.CO;2; Strauss SY, 2006, P NATL ACAD SCI USA, V103, P5841, DOI 10.1073/pnas.0508073103; Webb CO, 2006, ECOLOGY, V87, pS123, DOI 10.1890/0012-9658(2006)87[123:PSMSSA]2.0.CO;2; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; WEDIN D, 1993, ECOL MONOGR, V63, P199, DOI 10.2307/2937180	47	28	28	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19363	10.1371/journal.pone.0019363	http://dx.doi.org/10.1371/journal.pone.0019363			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573117	Green Submitted, Green Published, gold			2022-12-27	WOS:000290305600022
J	Sun, L; Han, X; He, SG				Sun, Le; Han, Xu; He, Shigang			Direction-Selective Circuitry in Rat Retina Develops Independently of GABAergic, Cholinergic and Action Potential Activity	PLOS ONE			English	Article							STARBURST AMACRINE CELLS; NICOTINIC ACETYLCHOLINE-RECEPTOR; DEVELOPING MAMMALIAN RETINA; OLFACTORY SENSORY MAP; GANGLION-CELLS; RABBIT RETINA; MOUSE RETINA; VISUAL EXPERIENCE; HIPPOCAMPAL-NEURONS; NEURAL ACTIVITY	The ON-OFF direction selective ganglion cells (DSGCs) in the mammalian retina code image motion by responding much more strongly to movement in one direction. They do so by receiving inhibitory inputs selectively from a particular sector of processes of the overlapping starburst amacrine cells, a type of retinal interneuron. The mechanisms of establishment and regulation of this selective connection are unknown. Here, we report that in the rat retina, the morphology, physiology of the ON-OFF DSGCs and the circuitry for coding motion directions develop normally with pharmacological blockade of GABAergic, cholinergic activity and/or action potentials for over two weeks from birth. With recent results demonstrating light independent formation of the retinal DS circuitry, our results strongly suggest the formation of the circuitry, i.e., the connections between the second and third order neurons in the visual system, can be genetically programmed, although emergence of direction selectivity in the visual cortex appears to require visual experience.	[Sun, Le; Han, Xu; He, Shigang] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS	Sun, L (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	shiganghe@moon.ibp.ac.cn			NSFC [30530280]; NSFC-NRF [30811140333]; National Basic Research Program of China [2007CB512208, 2006CB911003]	NSFC(National Natural Science Foundation of China (NSFC)); NSFC-NRF; National Basic Research Program of China(National Basic Research Program of China)	This project was supported by a NSFC key project grant (30530280), a NSFC-NRF grant (30811140333) and two grants of National Basic Research Program of China (2007CB512208 and 2006CB911003) to SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMTHOR FR, 1995, P NATL ACAD SCI USA, V92, P4002, DOI 10.1073/pnas.92.9.4002; BARLOW HB, 1963, SCIENCE, V139, P412, DOI 10.1126/science.139.3553.412; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BRECHA N, 1988, P NATL ACAD SCI USA, V85, P6187, DOI 10.1073/pnas.85.16.6187; Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; Cang JH, 2008, NEURON, V57, P511, DOI 10.1016/j.neuron.2007.12.025; Chan YC, 2008, VISION RES, V48, P2466, DOI 10.1016/j.visres.2008.08.010; Chen MG, 2009, J PHYSIOL-LONDON, V587, P819, DOI 10.1113/jphysiol.2008.161240; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; Diao L, 2004, J NEUROBIOL, V61, P236, DOI 10.1002/neu.20041; Elstrott J, 2008, NEURON, V58, P499, DOI 10.1016/j.neuron.2008.03.013; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Famiglietti EV, 2010, VISUAL NEUROSCI, V27, P19, DOI 10.1017/S0952523810000052; FAWCETT JW, 1984, P NATL ACAD SCI-BIOL, V81, P5589, DOI 10.1073/pnas.81.17.5589; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; GRASSE KL, 1990, VISUAL NEUROSCI, V4, P605, DOI 10.1017/S0952523800005800; Hausselt SE, 2007, PLOS BIOL, V5, P1474, DOI 10.1371/journal.pbio.0050185; Huberman AD, 2003, SCIENCE, V300, P994, DOI 10.1126/science.1080694; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Jones BW, 2003, J COMP NEUROL, V464, P1, DOI 10.1002/cne.10703; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Kim IJ, 2010, J NEUROSCI, V30, P1452, DOI 10.1523/JNEUROSCI.4779-09.2010; Lee S, 2006, NEURON, V51, P787, DOI 10.1016/j.neuron.2006.08.007; Li Y, 2006, NAT NEUROSCI, V9, P676, DOI 10.1038/nn1684; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Oesch N, 2005, NEURON, V47, P739, DOI 10.1016/j.neuron.2005.06.036; OMALLEY DM, 1992, J NEUROSCI, V12, P1394; OYSTER CW, 1967, SCIENCE, V155, P841, DOI 10.1126/science.155.3764.841; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; Ren L, 2010, DEV NEUROBIOL, V70, P397, DOI 10.1002/dneu.20777; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; Sherry DM, 2003, J COMP NEUROL, V465, P480, DOI 10.1002/cne.10838; Stacy RC, 2003, J COMP NEUROL, V456, P154, DOI 10.1002/cne.10509; Stellwagen D, 1999, NEURON, V24, P673, DOI 10.1016/S0896-6273(00)81121-6; STRYKER MP, 1986, J NEUROSCI, V6, P2117; Sun C, 2008, P NATL ACAD SCI USA, V105, P13638, DOI 10.1073/pnas.0807178105; Sun C, 2008, J NEUROPHYSIOL, V100, P3253, DOI 10.1152/jn.90303.2008; Sun WZ, 2006, J PHYSIOL-LONDON, V576, P197, DOI 10.1113/jphysiol.2006.115857; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; [谭洁 TAN Jie], 2010, [生物物理学报, Acta Biophysica Sinica], V26, P194; Vu TQ, 2000, J NEUROSCI, V20, P1414; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wei W, 2011, NATURE, V469, P402, DOI 10.1038/nature09600; Weng SJ, 2005, J PHYSIOL-LONDON, V562, P915, DOI 10.1113/jphysiol.2004.076695; WYATT HJ, 1976, SCIENCE, V191, P204, DOI 10.1126/science.1857; Yonehara K, 2011, NATURE, V469, P407, DOI 10.1038/nature09711; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; [张海涛 Zhang Haitao], 2010, [生物物理学报, Acta Biophysica Sinica], V26, P389; Zhang LL, 2006, J NEUROPHYSIOL, V95, P2404, DOI 10.1152/jn.00578.2005; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8; Zheng JJ, 2006, NAT NEUROSCI, V9, P363, DOI 10.1038/nn1644; Zheng JJ, 2004, NEURON, V44, P851, DOI 10.1016/j.neuron.2004.11.015; Zhou ZJ, 2001, J NEUROSCI, V21, P5158, DOI 10.1523/JNEUROSCI.21-14-05158.2001; Zhou ZJ, 1998, J NEUROSCI, V18, P4155; Zhou ZJ, 1996, P NATL ACAD SCI USA, V93, P8057, DOI 10.1073/pnas.93.15.8057	62	170	172	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19477	10.1371/journal.pone.0019477	http://dx.doi.org/10.1371/journal.pone.0019477			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573161	Green Published, gold, Green Submitted			2022-12-27	WOS:000290256400014
J	Roder, G; Rahier, M; Naisbit, RE				Roeder, Gregory; Rahier, Martine; Naisbit, Russell E.			Do Induced Responses Mediate the Ecological Interactions Between the Specialist Herbivores and Phytopathogens of an Alpine Plant?	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; LEAF BEETLE; NICOTIANA-ATTENUATA; INSECT HERBIVORES; PATHOGENS; DEFENSE; JASMONATE; ASTERACEAE; ELICITORS; TOBACCO	Plants are not passive victims of the myriad attackers that rely on them for nutrition. They have a suite of physical and chemical defences, and are even able to take advantage of the enemies of their enemies. These strategies are often only deployed upon attack, so may lead to indirect interactions between herbivores and phytopathogens. In this study we test for induced responses in wild populations of an alpine plant (Adenostyles alliariae) that possesses constitutive chemical defence (pyrrolizidine alkaloids) and specialist natural enemies (two species of leaf beetle, Oreina elongata and Oreina cacaliae, and the phytopathogenic rust Uromyces cacaliae). Plants were induced in the field using chemical elicitors of the jasmonic acid (JA) and salicylic acid (SA) pathways and monitored for one month under natural conditions. There was evidence for induced resistance, with lower probability and later incidence of attack by beetles in JA-induced plants and of rust infection in SA-induced plants. We also demonstrate ecological cross-effects, with reduced fungal attack following JA-induction, and a cost of SA-induction arising from increased beetle attack. As a result, there is the potential for negative indirect effects of the beetles on the rust, while in the field the positive indirect effect of the rust on the beetles appears to be over-ridden by direct effects on plant nutritional quality. Such interactions resulting from induced susceptibility and resistance must be considered if we are to exploit plant defences for crop protection using hormone elicitors or constitutive expression. More generally, the fact that induced defences are even found in species that possess constitutively-expressed chemical defence suggests that they may be ubiquitous in higher plants.	[Roeder, Gregory; Rahier, Martine] Univ Neuchatel, Lab Evolutionary Entomol, Inst Biol, CH-2000 Neuchatel, Switzerland; [Naisbit, Russell E.] Univ Fribourg, Unit Ecol & Evolut, Dept Biol, CH-1700 Fribourg, Switzerland	University of Neuchatel; University of Fribourg	Roder, G (corresponding author), Univ Neuchatel, Lab Evolutionary Entomol, Inst Biol, CH-2000 Neuchatel, Switzerland.	russell.naisbit@gmail.com	Naisbit, Russell E/B-9658-2011	Naisbit, Russell E/0000-0003-0190-9323; Roder, Gregory/0000-0002-7110-294X	Swiss National Science Foundation [31-64864.01]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The project was financed by Swiss National Science Foundation (grant 31-64864.01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2000, ECOLOGY, V81, P1804, DOI 10.1890/0012-9658(2000)081[1804:BACOIP]2.0.CO;2; [Anonymous], 2005, S PLUS 7 0 GUID STAT, V1; [Anonymous], 2001, DESIGN ANAL ECOLOGIC; Borer M, 2010, EVOLUTION, V64, P3629, DOI 10.1111/j.1558-5646.2010.01137.x; Borer M, 2010, MOL PHYLOGENET EVOL, V57, P703, DOI 10.1016/j.ympev.2010.08.017; Bostock RM, 1999, PHYSIOL MOL PLANT P, V55, P99, DOI 10.1006/pmpp.1999.0218; CUMMINS GB, 2003, ILLUSTRATED GENERA R; Dobler S, 1996, EVOLUTION, V50, P2373, DOI [10.2307/2410706, 10.1111/j.1558-5646.1996.tb03625.x]; Friedrich L, 1996, PLANT J, V10, P61, DOI 10.1046/j.1365-313X.1996.10010061.x; GAUMANN E, 1959, ROSTPILZE MITTELEURO, P218; Hagele BF, 1999, OIKOS, V85, P234, DOI 10.2307/3546489; Hagele BF, 2000, J EVOLUTION BIOL, V13, P131, DOI 10.1046/j.1420-9101.2000.00145.x; Halitschke R, 2000, OECOLOGIA, V124, P408, DOI 10.1007/s004420000389; HATCHER PE, 1995, BIOL REV, V70, P639, DOI 10.1111/j.1469-185X.1995.tb01655.x; Held M, 2005, ECOL APPL, V15, P1689, DOI 10.1890/03-5208; Hol WHG, 2002, J CHEM ECOL, V28, P1763, DOI 10.1023/A:1020557000707; Inbar M, 1998, J CHEM ECOL, V24, P135, DOI 10.1023/A:1022397130895; Kaplan I, 2007, ECOL LETT, V10, P977, DOI 10.1111/j.1461-0248.2007.01093.x; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Kessler A, 2002, ANNU REV PLANT BIOL, V53, P299, DOI 10.1146/annurev.arplant.53.100301.135207; Lawton KA, 1996, PLANT J, V10, P71, DOI 10.1046/j.1365-313X.1996.10010071.x; Lohse G.A., 1994, 3 SUPPLEMENTBAND KAT, V14; Margraf N, 2007, MOL ECOL, V16, P2333, DOI 10.1111/j.1365-294X.2007.03318.x; Mattocks A.R., 1986, CHEM TOXICOLOGY PYRR; Mauch-Mani B, 1998, ANN BOT-LONDON, V82, P535, DOI 10.1006/anbo.1998.0726; Preston CA, 2002, J CHEM ECOL, V28, P2343, DOI 10.1023/A:1021065703276; RODER G, 2007, THESIS U NEUCHATEL; Roder G, 2008, P ROY SOC B-BIOL SCI, V275, P879, DOI 10.1098/rspb.2007.1649; Roder G, 2007, OIKOS, V116, P1514, DOI [10.1111/j.2007.0030-1299.16057.x, 10.1111/j.0030-1299.2007.16057.x]; Smith JL, 2009, PEST MANAG SCI, V65, P497, DOI 10.1002/ps.1714; Stout MJ, 2006, ANNU REV ENTOMOL, V51, P663, DOI 10.1146/annurev.ento.51.110104.151117; Taylor JE, 2004, J EXP BOT, V55, P159, DOI 10.1093/jxb/erh053; Thaler JS, 2010, ECOLOGY, V91, P1075, DOI 10.1890/08-2347.1; Thaler JS, 1999, J CHEM ECOL, V25, P1597, DOI 10.1023/A:1020840900595; Turlings TCJ, 2004, ADVANCES IN INSECT CHEMICAL ECOLOGY, P21, DOI 10.1017/CBO9780511542664.003; Verdon A, 2007, ECOL ENTOMOL, V32, P62, DOI 10.1111/j.1365-2311.2006.00842.x; Wittstock U, 2002, CURR OPIN PLANT BIOL, V5, P300, DOI 10.1016/S1369-5266(02)00264-9	37	3	3	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19571	10.1371/journal.pone.0019571	http://dx.doi.org/10.1371/journal.pone.0019571			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573247	Green Published, gold			2022-12-27	WOS:000290224800035
J	Hunziker, L; Benitah, SA; Braun, KM; Jensen, K; McNulty, K; Butler, C; Potton, E; Nye, E; Boyd, R; Laurent, G; Glogauer, M; Wright, NA; Watt, FM; Janes, SM				Hunziker, Lukas; Aznar Benitah, Salvador; Braun, Kristin M.; Jensen, Kim; McNulty, Katrina; Butler, Colin; Potton, Elspeth; Nye, Emma; Boyd, Richard; Laurent, Geoff; Glogauer, Michael; Wright, Nick A.; Watt, Fiona M.; Janes, Sam M.			Rac1 Deletion Causes Thymic Atrophy	PLOS ONE			English	Article							EPITHELIAL PROGENITOR CELLS; STEM-CELLS; MEDULLARY EPITHELIUM; POSITIVE SELECTION; EPIDERMAL DELETION; MYC ACTIVATION; DIFFERENTIATION; MOUSE; EXPRESSION; PROLIFERATION	The thymic stroma supports T lymphocyte development and consists of an epithelium maintained by thymic epithelial progenitors. The molecular pathways that govern epithelial homeostasis are poorly understood. Here we demonstrate that deletion of Rac1 in Keratin 5/Keratin 14 expressing embryonic and adult thymic epithelial cells leads to loss of the thymic epithelial compartment. Rac1 deletion led to an increase in c-Myc expression and a generalized increase in apoptosis associated with a decrease in thymic epithelial proliferation. Our results suggest Rac1 maintains the epithelial population, and equilibrium between Rac1 and c-Myc may control proliferation, apoptosis and maturation of the thymic epithelial compartment. Understanding thymic epithelial maintenance is a step toward the dual goals of in vitro thymic epithelial cell culture and T cell differentiation, and the clinical repair of thymic damage from graft-versus-host-disease, chemotherapy or irradiation.	[Hunziker, Lukas; McNulty, Katrina; Butler, Colin; Potton, Elspeth; Laurent, Geoff; Janes, Sam M.] UCL, Ctr Resp Res, London, England; [Hunziker, Lukas] Univ Basel Hosp, CH-4031 Basel, Switzerland; [Aznar Benitah, Salvador] CRG, Barcelona, Spain; [Aznar Benitah, Salvador] UPF, Barcelona, Spain; [Braun, Kristin M.] Barts & London Queen Marys Sch Med & Dent, Ctr Cutaneous Res, London, England; [Jensen, Kim; Watt, Fiona M.] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge, England; [Nye, Emma] Canc Res UK, London Res Inst, Dept Expt Pathol, London, England; [Boyd, Richard] Monash Univ, Sch Med, Dept Pathol & Immunol, Melbourne, Vic 3004, Australia; [Glogauer, Michael] Univ Toronto, Fac Dent, Toronto, ON, Canada; [Wright, Nick A.] Canc Res UK, London Res Inst, Histopathol Unit, London, England; [Watt, Fiona M.] CR UK Cambridge Res Inst, Li Ka Shing Ctr, Cambridge, England	University of London; University College London; University of Basel; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; University of London; Queen Mary University London; University of Cambridge; Cancer Research UK; Monash University; University of Toronto; Cancer Research UK; CRUK Cambridge Institute	Hunziker, L (corresponding author), UCL, Ctr Resp Res, London, England.	s.janes@ucl.ac.uk	Jensen, Kim/F-5333-2014; Watt, Fiona/AHB-0226-2022; Glogauer, Michael/D-2504-2011; Wright, Nicholas/HHY-7227-2022; Aznar-Benitah, Salvador/F-4761-2016	Watt, Fiona/0000-0001-9151-5154; Aznar-Benitah, Salvador/0000-0002-9059-5049; Butler, Colin/0000-0003-4192-0519; Jensen, Kim/0000-0001-6569-1664; Glogauer, Michael/0000-0002-6248-5977; Wright, Nicholas/0000-0002-5525-3457; Hunziker, Lukas/0000-0003-0081-8518	Cancer Research UK; Swiss national foundation [PBBSB-108681]; Freiwillige Akademische Gesellschaft; Margarete und Walter Lichtenstein Stiftung; EuroStemCel; Department of Health's NIHR Biomedical Research Centre; Medical Research Council [G0800784B, G108/596, G0500502, G0800784] Funding Source: researchfish; MRC [G0500502, G108/596, G0800784] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Swiss national foundation(Swiss National Science Foundation (SNSF)); Freiwillige Akademische Gesellschaft; Margarete und Walter Lichtenstein Stiftung; EuroStemCel; Department of Health's NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	SAB, KMB, NW, and FMW were supported by Cancer Research UK (http://www.cancerresearchuk.org). LH was supported by the following grants: Swiss national foundation PBBSB-108681, the Freiwillige Akademische Gesellschaft and the Margarete und Walter Lichtenstein Stiftung. KMB was supported by EuroStemCell (http://www.eurostemcell.org/). KM is an MRC Clinical Training Fellow (http://www.mrc.ac.uk/index.htm). SMJ is a Wellcome Senior Fellow in Clinical Science (WT091730MA)(http://www.wellcome.ac.uk/). This work was partially undertaken at UCLH/UCL who received a proportion of funding from the Department of Health's NIHR Biomedical Research Centre's funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson G, 1997, EUR J IMMUNOL, V27, P1838, DOI 10.1002/eji.1830270803; Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0; Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3; Arvanitis C, 2006, SEMIN CANCER BIOL, V16, P313, DOI 10.1016/j.semcancer.2006.07.012; Benitah SA, 2005, SCIENCE, V309, P933, DOI 10.1126/science.1113579; Benitah SA, 2007, J INVEST DERMATOL, V127, P1555, DOI 10.1038/sj.jid.5700738; Bennett AR, 2002, IMMUNITY, V16, P803, DOI 10.1016/S1074-7613(02)00321-7; Blackburn CC, 1996, P NATL ACAD SCI USA, V93, P5742, DOI 10.1073/pnas.93.12.5742; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Candi E, 2007, CELL CYCLE, V6, P274, DOI 10.4161/cc.6.3.3797; Cantrell DA, 2003, IMMUNOL REV, V192, P122, DOI 10.1034/j.1600-065X.2003.00028.x; Conway SJ, 1997, DEVELOPMENT, V124, P505; Depreter MGL, 2008, P NATL ACAD SCI USA, V105, P961, DOI 10.1073/pnas.0711170105; Frye M, 2003, DEVELOPMENT, V130, P2793, DOI 10.1242/dev.00462; Ge Q, 2000, INT IMMUNOL, V12, P1127, DOI 10.1093/intimm/12.8.1127; Gebhardt A, 2006, J CELL BIOL, V172, P139, DOI 10.1083/jcb.200506057; Gill J, 2002, NAT IMMUNOL, V3, P635, DOI 10.1038/ni812; Glogauer M, 2003, J IMMUNOL, V170, P5652, DOI 10.4049/jimmunol.170.11.5652; Gomez M, 2000, NAT IMMUNOL, V1, P348, DOI 10.1038/79808; Gomez M, 2001, IMMUNITY, V15, P703, DOI 10.1016/S1074-7613(01)00235-7; Hare KJ, 1999, J IMMUNOL, V162, P3978; HOFFMANN MW, 1992, P NATL ACAD SCI USA, V89, P2526, DOI 10.1073/pnas.89.7.2526; HOLLANDER GA, 1995, NATURE, V373, P350, DOI 10.1038/373350a0; Hong KU, 2004, AM J PATHOL, V164, P577, DOI 10.1016/S0002-9440(10)63147-1; JANES SM, 2008, CELL RES; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Klug DB, 2002, J IMMUNOL, V169, P2842, DOI 10.4049/jimmunol.169.6.2842; Lind EF, 2001, J EXP MED, V194, P127, DOI 10.1084/jem.194.2.127; Lopez-Rovira T, 2005, J INVEST DERMATOL, V125, P1215, DOI 10.1111/j.0022-202X.2005.23956.x; Mainiero F, 2003, EUR J IMMUNOL, V33, P3038, DOI 10.1002/eji.200323931; Murphy MJ, 2005, TRENDS CELL BIOL, V15, P128, DOI 10.1016/j.tcb.2005.01.008; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; NEUBUSER A, 1995, DEV BIOL, V170, P701, DOI 10.1006/dbio.1995.1248; Oukka M, 1996, IMMUNITY, V4, P545, DOI 10.1016/S1074-7613(00)80481-1; Oukka M, 1997, EUR J IMMUNOL, V27, P855, DOI 10.1002/eji.1830270408; Rossi SW, 2007, EUR J IMMUNOL, V37, P2411, DOI 10.1002/eji.200737275; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Stappenbeck TS, 2000, DEVELOPMENT, V127, P2629; Su DM, 2000, J IMMUNOL, V164, P5753, DOI 10.4049/jimmunol.164.11.5753; Waikel RL, 2001, NAT GENET, V28, P165, DOI 10.1038/88889	43	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19292	10.1371/journal.pone.0019292	http://dx.doi.org/10.1371/journal.pone.0019292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559396	Green Published, gold			2022-12-27	WOS:000290024700126
J	Im, SH; Li, WH; Taghert, PH				Im, Seol Hee; Li, Weihua; Taghert, Paul H.			PDFR and CRY Signaling Converge in a Subset of Clock Neurons to Modulate the Amplitude and Phase of Circadian Behavior in Drosophila	PLOS ONE			English	Article							CRYPTOCHROME; PROTEIN; MUTATION; RECEPTOR; PERIOD; PHOTORECEPTOR; OSCILLATORS; EXPRESSION	Background: To synchronize their molecular rhythms, circadian pacemaker neurons must input both external and internal timing cues and, therefore, signal integration between sensory information and internal clock status is fundamental to normal circadian physiology. Methodology/Principal Findings: We demonstrate the specific convergence of clock-derived neuropeptide signaling with that of a deep brain photoreceptor. We report that the neuropeptide PDF receptor and the circadian photoreceptor CRYPTOCROME (CRY) are precisely co-expressed in a subset of pacemakers, and that these pathways together provide a requisite drive for circadian control of daily locomotor rhythms. These convergent signaling pathways influence the phase of rhythm generation, but also its amplitude. In the absence of both pathways, PER rhythms were greatly reduced in only those specific pacemakers that receive convergent inputs and PER levels remained high in the nucleus throughout the day. This suggested a large-scale dis-regulation of the pacemaking machinery. Behavioral rhythms were likewise disrupted: in light: dark conditions they were aberrant, and under constant dark conditions, they were lost. Conclusions/Significance: We speculate that the convergence of environmental and clock-derived signals may produce a coincident detection of light, synergistic responses to it, and thus more accurate and more efficient re-setting properties.	[Im, Seol Hee; Li, Weihua; Taghert, Paul H.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Im, SH (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	taghertp@pcg.wustl.edu		Im, Seol Hee/0000-0002-0777-3466	National Institutes of Health (NIH) [R01MH067122]; Korea Science and Engineering Foundation [M06-2004-000-10108]; NIH [NS057105]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from the National Institutes of Health (NIH) (R01MH067122) to P.H.T., a scholarship to S.H.I. from Korea Science and Engineering Foundation (M06-2004-000-10108), and a P30 NIH Neuroscience Blueprint Core Grant (#NS057105) to Washington University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrera NP, 2005, TRENDS PHARMACOL SCI, V26, P526, DOI 10.1016/j.tips.2005.08.003; Benito J, 2008, J BIOL RHYTHM, V23, P296, DOI 10.1177/0748730408318588; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; CURTIN KD, 1995, NEURON, V14, P365, DOI 10.1016/0896-6273(95)90292-9; Cusumano P, 2009, NAT NEUROSCI, V12, P1431, DOI 10.1038/nn.2429; Cyran SA, 2005, J NEUROSCI, V25, P5430, DOI 10.1523/JNEUROSCI.0263-05.2005; DIRCKSEN H, 1987, CELL TISSUE RES, V250, P377; Dolezelova E, 2007, GENETICS, V177, P329, DOI 10.1534/genetics.107.076513; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Helfrich-Forster C, 2009, J BIOL RHYTHM, V24, P259, DOI 10.1177/0748730409339614; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; Hyun S, 2005, NEURON, V48, P267, DOI 10.1016/j.neuron.2005.08.025; Im SH, 2010, J COMP NEUROL, V518, P1925, DOI 10.1002/cne.22311; Johard HAD, 2009, J COMP NEUROL, V516, P59, DOI 10.1002/cne.22099; Klarsfeld A, 2004, J NEUROSCI, V24, P1468, DOI 10.1523/JNEUROSCI.3661-03.2004; Knaden M, 2006, J EXP BIOL, V209, P26, DOI 10.1242/jeb.01976; Lear BC, 2005, NEURON, V48, P221, DOI 10.1016/j.neuron.2005.09.008; LEVINE JD, 2002, BMC NEUROSCI, V3; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; LIU X, 1992, J NEUROSCI, V12, P2735; Muller M, 2010, CURR BIOL, V20, P1368, DOI 10.1016/j.cub.2010.06.035; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Sheeba V, 2008, CRIT REV BIOCHEM MOL, V43, P37, DOI [10.1080/10409230701829128, 10.1080/10409230701829128 ]; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; vanVickle-Chavez SJ, 2007, J BIOL CHEM, V282, P10561, DOI 10.1074/jbc.M609314200; Vitaterna MH, 2006, P NATL ACAD SCI USA, V103, P9327, DOI 10.1073/pnas.0603601103; Yoshii T, 2008, J COMP NEUROL, V508, P952, DOI 10.1002/cne.21702; Yoshii T, 2009, J NEUROSCI, V29, P2597, DOI 10.1523/JNEUROSCI.5439-08.2009; Zhang LY, 2009, CURR BIOL, V19, P2050, DOI 10.1016/j.cub.2009.10.058	36	45	46	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18974	10.1371/journal.pone.0018974	http://dx.doi.org/10.1371/journal.pone.0018974			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559487	gold, Green Published, Green Submitted			2022-12-27	WOS:000290024700046
J	Pol, J; Vidova, V; Hyotylainen, T; Volny, M; Novak, P; Strohalm, M; Kostiainen, R; Havlicek, V; Wiedmer, SK; Holopainen, JM				Pol, Jaroslav; Vidova, Veronika; Hyotylainen, Tuulia; Volny, Michael; Novak, Petr; Strohalm, Martin; Kostiainen, Risto; Havlicek, Vladimir; Wiedmer, Susanne K.; Holopainen, Juha M.			Spatial Distribution of Glycerophospholipids in the Ocular Lens	PLOS ONE			English	Article							IMAGING MASS-SPECTROMETRY; MEMBRANE-PROTEINS; PORCINE LENS; IN-SITU; PHOSPHOLIPIDS; LIPIDS; AGE	Knowledge of the spatial distribution of lipids in the intraocular lens is important for understanding the physiology and biochemistry of this unique tissue and for gaining a better insight into the mechanisms underlying diseases of the lens. Following our previous study showing the spatial distribution of sphingolipids in the porcine lens, the current study used ultra performance liquid chromatography quadrupole time-of-flight mass spectrometry (UPLC-QTOFMS) to provide the whole lipidome of porcine lens and these studies were supplemented by matrix-assisted laser desorption ionization mass spectrometry imaging (MALDI MSI) of the lens using ultra-high resolution Fourier transform ion cyclotron resonance mass spectrometry (FTICR MS) to determine the spatial distribution of glycerophospholipids. Altogether 172 lipid species were identified with high confidence and their concentration was determined. Sphingomyelins, phosphatidylcholines, and phosphatidylethanolamines were the most abundant lipid classes. We then determined the spatial and concentration-dependent distributions of 20 phosphatidylcholines, 6 phosphatidylethanolamines, and 4 phosphatidic acids. Based on the planar molecular images of the lipids, we report the organization of fiber cell membranes within the ocular lens and suggest roles for these lipids in normal and diseased lenses.	[Pol, Jaroslav; Vidova, Veronika; Volny, Michael; Novak, Petr; Strohalm, Martin; Havlicek, Vladimir] Acad Sci Czech Republ, Inst Microbiol, Lab Mol Struct Characterizat, Prague, Czech Republic; [Pol, Jaroslav; Kostiainen, Risto] Univ Helsinki, Fac Pharm, Div Pharmaceut Chem, Helsinki, Finland; [Vidova, Veronika] Palacky Univ, Fac Sci, Dept Analyt Chem, CR-77147 Olomouc, Czech Republic; [Hyotylainen, Tuulia] VTT Tech Res Ctr Finland, Espoo, Finland; [Wiedmer, Susanne K.] Univ Helsinki, Dept Chem, Analyt Chem Lab, SF-00100 Helsinki, Finland; [Holopainen, Juha M.] Univ Helsinki, Dept Ophthalmol, Helsinki Eye Lab, Helsinki, Finland	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of Helsinki; Palacky University Olomouc; VTT Technical Research Center Finland; University of Helsinki; University of Helsinki	Pol, J (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Lab Mol Struct Characterizat, Prague, Czech Republic.	jaroslav.pol@gmail.com; juha.holopainen@hus.fi	Volny, Michael/B-5778-2008; Kostiainen, Risto K/B-5491-2008; Hyötyläinen, Tuulia/AAP-6266-2020; Novak, Petr/F-9655-2014; Havlicek, Vladimir/H-2626-2014	Volny, Michael/0000-0001-7456-5408; Novak, Petr/0000-0001-8688-529X; Havlicek, Vladimir/0000-0002-8614-7059; Kostiainen, Risto/0000-0003-2454-4574; Wiedmer, Susanne/0000-0002-3097-6165; Hyotylainen, Tuulia/0000-0002-1389-8302	Sigrid Juselius Foundation; Finnish Eye Foundation; Academy of Finland [122354]; University of Helsinki [2105060]; Ministry of Education, Youth, and Sports of the Czech Republic [LC07017]; Institutional Research Concept of the Institute of Microbiology; Academy of Sciences of the Czech Republic [AV0Z50200510]; EC; Czech Science Foundation [P206/10/P018]	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Eye Foundation; Academy of Finland(Academy of Finland); University of Helsinki; Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Institutional Research Concept of the Institute of Microbiology; Academy of Sciences of the Czech Republic(Czech Academy of Sciences); EC(European CommissionEuropean Commission Joint Research Centre); Czech Science Foundation(Grant Agency of the Czech Republic)	This work was supported by funding from the Sigrid Juselius Foundation (JMH), The Finnish Eye Foundation (JMH), the Academy of Finland (JP project No. 122354), research funds from the University of Helsinki (SKW: University of Helsinki project No. 2105060), the Ministry of Education, Youth, and Sports of the Czech Republic (LC07017), the Institutional Research Concept of the Institute of Microbiology, and the Academy of Sciences of the Czech Republic (AV0Z50200510). MV is supported by a Marie Curie IR Grant within the EC FP7 and by the Czech Science Foundation (Project P206/10/P018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altelaar AFM, 2007, NAT PROTOC, V2, P1185, DOI 10.1038/nprot.2007.117; Borchman D, 1989, Lens Eye Toxic Res, V6, P703; Borchman D, 2010, J LIPID RES, V51, P2473, DOI 10.1194/jlr.R004119; BYRDWELL WC, 1994, INVEST OPHTH VIS SCI, V35, P4333; Cantor RS, 1999, BIOPHYS J, V77, P2643, DOI 10.1016/S0006-3495(99)77098-0; Chughtai K, 2010, CHEM REV, V110, P3237, DOI 10.1021/cr100012c; Cornett DS, 2007, NAT METHODS, V4, P828, DOI 10.1038/NMETH1094; Deeley JM, 2008, BBA-MOL CELL BIOL L, V1781, P288, DOI 10.1016/j.bbalip.2008.04.002; Deeley JM, 2010, J LIPID RES, V51, P2753, DOI 10.1194/jlr.M007716; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; Ellis SR, 2010, J AM SOC MASS SPECTR, V21, P2095, DOI 10.1016/j.jasms.2010.09.003; Estrada R, 2004, J MASS SPECTROM, V39, P1531, DOI 10.1002/jms.759; Fletcher JS, 2009, ANALYST, V134, P2204, DOI 10.1039/b913575h; Grey AC, 2009, INVEST OPHTH VIS SCI, V50, P4319, DOI 10.1167/iovs.09-3522; Grey AC, 2009, J PROTEOME RES, V8, P3278, DOI 10.1021/pr800956y; Han J, 2006, INVEST OPHTH VIS SCI, V47, P2990, DOI 10.1167/iovs.05-1529; Heeren RMA, 2009, J AM SOC MASS SPECTR, V20, P1006, DOI 10.1016/j.jasms.2009.01.011; HUANG L, 2005, INVEST OPHTH VIS S S, V46, pNI427; LI LK, 1985, J LIPID RES, V26, P600; McDonnell LA, 2007, MASS SPECTROM REV, V26, P606, DOI 10.1002/mas.20124; MULDERS SM, 1995, J BIOL CHEM, V270, P9010, DOI 10.1074/jbc.270.15.9010; Ostrowski SG, 2004, SCIENCE, V305, P71, DOI 10.1126/science.1099791; Rujoi M, 2004, ANAL CHEM, V76, P1657, DOI 10.1021/ac0349680; Sane P, 2010, BBA-BIOMEMBRANES, V1798, P958, DOI 10.1016/j.bbamem.2010.01.011; Seeley EH, 2008, P NATL ACAD SCI USA, V105, P18126, DOI 10.1073/pnas.0801374105; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; van Leyen K, 1998, NATURE, V395, P392, DOI 10.1038/26500; Vidova V, 2010, J LIPID RES, V51, P2295, DOI 10.1194/jlr.M005488; Wiseman JM, 2006, ANGEW CHEM INT EDIT, V45, P7188, DOI 10.1002/anie.200602449; Wiseman JM, 2008, P NATL ACAD SCI USA, V105, P18120, DOI 10.1073/pnas.0801066105; Yappert MC, 2003, EXP EYE RES, V76, P725, DOI 10.1016/S0014-4835(03)00051-4	31	19	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19441	10.1371/journal.pone.0019441	http://dx.doi.org/10.1371/journal.pone.0019441			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559377	Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700172
J	Polyakov, P; Soussen, C; Duan, JB; Duval, JFL; Brie, D; Francius, G				Polyakov, Pavel; Soussen, Charles; Duan, Junbo; Duval, Jerome F. L.; Brie, David; Francius, Gregory			Automated Force Volume Image Processing for Biological Samples	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; ESCHERICHIA-COLI; BIOFILM FORMATION; MECHANICAL-PROPERTIES; CELL-WALL; NANOMECHANICAL PROPERTIES; MOLECULAR-INTERACTIONS; SURFACE-MORPHOLOGY; ELASTIC PROPERTIES; ROBUST STRATEGIES	Atomic force microscopy (AFM) has now become a powerful technique for investigating on a molecular level, surface forces, nanomechanical properties of deformable particles, biomolecular interactions, kinetics, and dynamic processes. This paper specifically focuses on the analysis of AFM force curves collected on biological systems, in particular, bacteria. The goal is to provide fully automated tools to achieve theoretical interpretation of force curves on the basis of adequate, available physical models. In this respect, we propose two algorithms, one for the processing of approach force curves and another for the quantitative analysis of retraction force curves. In the former, electrostatic interactions prior to contact between AFM probe and bacterium are accounted for and mechanical interactions operating after contact are described in terms of HertzHooke formalism. Retraction force curves are analyzed on the basis of the Freely Jointed Chain model. For both algorithms, the quantitative reconstruction of force curves is based on the robust detection of critical points (jumps, changes of slope or changes of curvature) which mark the transitions between the various relevant interactions taking place between the AFM tip and the studied sample during approach and retraction. Once the key regions of separation distance and indentation are detected, the physical parameters describing the relevant interactions operating in these regions are extracted making use of regression procedure for fitting experiments to theory. The flexibility, accuracy and strength of the algorithms are illustrated with the processing of two force-volume images, which collect a large set of approach and retraction curves measured on a single biological surface. For each force-volume image, several maps are generated, representing the spatial distribution of the searched physical parameters as estimated for each pixel of the force-volume image.	[Polyakov, Pavel; Francius, Gregory] Nancy Univ, CNRS, LCPME, UMR 7564, Vandoeuvre Les Nancy, France; [Soussen, Charles; Duan, Junbo; Brie, David] Nancy Univ, CNRS, CRAN, UMR 7039, Vandoeuvre Les Nancy, France; [Duval, Jerome F. L.] Nancy Univ, CNRS, LEM, UMR 7569, Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); National Office for Aerospace Studies & Research (ONERA); Universite de Lorraine	Polyakov, P (corresponding author), Nancy Univ, CNRS, LCPME, UMR 7564, Vandoeuvre Les Nancy, France.	david.brie@cran.uhp-nancy.fr; gregory.francius@lcpme.cnrs-nancy.fr	Soussen, Charles/AAC-8549-2019; Francius, Gregory/A-4246-2015; Francius, Gregory/P-6058-2019; Jerome, Duval/H-6421-2011; DUAN, Junbo/A-8795-2010	Soussen, Charles/0000-0002-6837-6755; Francius, Gregory/0000-0001-8533-9449; Francius, Gregory/0000-0001-8533-9449; Jerome, Duval/0000-0002-5458-3761; Polyakov, Pavel/0000-0001-9814-0842	Region Lorraine; Centre National de la Recherche Scientifique (CNRS) [246]; French program [ANR-07-JCJC-0024-01 PHYSCHEMBACT]	Region Lorraine(Region Grand-Est); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); French program	The development of algorithms to process force-volume images was supported by the Region Lorraine and by the Centre National de la Recherche Scientifique (CNRS) under Contract Projet Exploratoire Premier Soutien (PEPS 2008 No. 246). This work was financially supported by the French program ANR-07-JCJC-0024-01 PHYSCHEMBACT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A-Hassan E, 1998, BIOPHYS J, V74, P1564, DOI 10.1016/S0006-3495(98)77868-3; Abu-Lail NI, 2003, J MICROSC-OXFORD, V212, P217, DOI 10.1111/j.1365-2818.2003.01261.x; Alessandrini A, 2005, MEAS SCI TECHNOL, V16, pR65, DOI 10.1088/0957-0233/16/6/R01; Allison DG, 1998, FEMS MICROBIOL LETT, V167, P179, DOI 10.1016/S0378-1097(98)00386-3; Alsteens D, 2009, ACS NANO, V3, P1677, DOI 10.1021/nn900078p; Alsteens D, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/38/384005; ATTARD P, 1992, PHYS REV A, V46, P7959, DOI 10.1103/PhysRevA.46.7959; Beckmann MA, 2006, ULTRAMICROSCOPY, V106, P695, DOI 10.1016/j.ultramic.2006.02.006; Beloin C, 2008, CURR TOP MICROBIOL, V322, P249; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Bhushan B, 2006, ULTRAMICROSCOPY, V106, P755, DOI 10.1016/j.ultramic.2005.12.010; Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003; Camesano TA, 2002, BIOMACROMOLECULES, V3, P661, DOI 10.1021/bm015648y; CHEN S, 1989, INT J CONTROL, V50, P1873, DOI 10.1080/00207178908953472; Chen XX, 2009, CLIN HEMORHEOL MICRO, V43, P241, DOI 10.3233/CH-2009-1234; Clausen-Schaumann H, 2000, CURR OPIN CHEM BIOL, V4, P524, DOI 10.1016/S1367-5931(00)00126-5; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; Cross SE, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/38/384003; Cross SE, 2009, NAT NANOTECHNOL, V4, P72, DOI 10.1038/nnano.2009.036; Cui SX, 2009, POLYMER, V50, P930, DOI 10.1016/j.polymer.2008.12.012; Da Re S, 2007, APPL ENVIRON MICROB, V73, P3391, DOI 10.1128/AEM.02625-06; Danese PN, 2000, MOL MICROBIOL, V37, P424, DOI 10.1046/j.1365-2958.2000.02008.x; Dimitriadis EK, 2002, BIOPHYS J, V82, P2798, DOI 10.1016/S0006-3495(02)75620-8; Domke J, 2000, COLLOID SURFACE B, V19, P367, DOI 10.1016/S0927-7765(00)00145-4; Dufrene YF, 2001, ULTRAMICROSCOPY, V86, P113, DOI 10.1016/S0304-3991(00)00079-6; Dufrene YF, 2008, NAT REV MICROBIOL, V6, P674, DOI 10.1038/nrmicro1948; Dufrene YF, 2008, PFLUG ARCH EUR J PHY, V456, P237, DOI 10.1007/s00424-007-0413-1; Duval JFL, 2011, PHYS CHEM CHEM PHYS, V13, P1037, DOI 10.1039/c004243a; Ebenstein DM, 2006, NANO TODAY, V1, P26, DOI 10.1016/S1748-0132(06)70077-9; Ebner A, 2007, BIOCONJUGATE CHEM, V18, P1176, DOI 10.1021/bc070030s; Emerson RJ, 2004, APPL ENVIRON MICROB, V70, P6012, DOI 10.1128/AEM.70.10.6012-6022.2004; Engel A, 2000, NAT STRUCT BIOL, V7, P715, DOI 10.1038/78929; Engler AJ, 2007, METHOD CELL BIOL, V83, P521, DOI 10.1016/S0091-679X(07)83022-6; Fisher TE, 2000, NAT STRUCT BIOL, V7, P719; Francius G, 2006, MICROSC RES TECHNIQ, V69, P84, DOI 10.1002/jemt.20275; Francius G, 2008, ACS NANO, V2, P1921, DOI 10.1021/nn800341b; Francius G, 2008, ENVIRON MICROBIOL, V10, P1344, DOI 10.1111/j.1462-2920.2007.01551.x; Francius G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020066; Francius G, 2009, NAT PROTOC, V4, P939, DOI 10.1038/nprot.2009.65; Francius G, 2008, J BACTERIOL, V190, P7904, DOI 10.1128/JB.01116-08; Fung CKM, 2010, NANOMED-NANOTECHNOL, V6, P191, DOI 10.1016/j.nano.2009.05.008; Gaboriaud F, 2008, LANGMUIR, V24, P10988, DOI 10.1021/la800258n; Giesbers M, 2001, SURFACE FORCES STUDI; Greif D, 2010, ULTRAMICROSCOPY, V110, P1290, DOI 10.1016/j.ultramic.2010.06.004; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Heinisch JJ, 2010, NAT PROTOC, V5, P670, DOI 10.1038/nprot.2010.19; Hertz H., 1882, J ANGEW MATH, V92, P156, DOI [10.1515/9783112342404-004, DOI 10.1515/CRLL.1882.92.156, 10.1515/crll.1882.92.156]; Hinterdorfer P, 2006, NAT METHODS, V3, P347, DOI 10.1038/NMETH871; HOH JH, 1994, J CELL SCI, V107, P1105; Janovjak H, 2006, NEUROBIOL AGING, V27, P546, DOI 10.1016/j.neurobiolaging.2005.03.031; Janshoff A, 2000, ANGEW CHEM INT EDIT, V39, P3213; Jin H, 2010, BIOCHEM BIOPH RES CO, V391, P1698, DOI 10.1016/j.bbrc.2009.12.133; Jonas K, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-70; Kasas S, 2008, PFLUG ARCH EUR J PHY, V456, P13, DOI 10.1007/s00424-008-0448-y; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; La R, 2010, LIFE SCI, V86, P545, DOI 10.1016/j.lfs.2009.02.030; Landersjo C, 2002, BIOMACROMOLECULES, V3, P880, DOI 10.1021/bm020040q; Ledeboer NA, 2005, J BACTERIOL, V187, P3214, DOI 10.1128/JB.187.9.3214-3226.2005; Lee GJ, 2009, NANOTECH CONFERENCE & EXPO 2009, VOL 1, TECHNICAL PROCEEDINGS, P331; Lekka M, 2009, J PHYS CONF SER, V146, DOI 10.1088/1742-6596/146/1/012023; Lekka M, 2009, NAT NANOTECHNOL, V4, P72, DOI 10.1038/nnano.2009.004; Levy R, 2002, NANOTECHNOLOGY, V13, P33, DOI 10.1088/0957-4484/13/1/307; Lin DC, 2007, EXPRESS POLYM LETT, V1, P576, DOI 10.3144/expresspolymlett.2007.79; Lin DC, 2007, J BIOMECH ENG-T ASME, V129, P904, DOI 10.1115/1.2800826; Lin DC, 2007, J BIOMECH ENG-T ASME, V129, P430, DOI 10.1115/1.2720924; Lyklema J, 2005, FUND INTERFACE COLL, V4, P1; Mabbett AN, 2009, INT J MED MICROBIOL, V299, P53, DOI 10.1016/j.ijmm.2008.06.003; Malfatti F, 2009, AQUAT MICROB ECOL, V58, P1, DOI 10.3354/ame01355; McBride MJ, 2001, ANNU REV MICROBIOL, V55, P49, DOI 10.1146/annurev.micro.55.1.49; Melendez R, 1999, BIOPHYS J, V77, P1327, DOI 10.1016/S0006-3495(99)76982-1; MELENDEZHEVIA E, 1993, BIOCHEM J, V295, P477, DOI 10.1042/bj2950477; Mendez-Vilas A, 2006, ANTON LEEUW INT J G, V89, P373, DOI 10.1007/s10482-005-9041-y; Morris GA, 2008, CARBOHYD POLYM, V71, P101, DOI 10.1016/j.carbpol.2007.05.029; Mustata M, 2010, J NEUROSCI METH, V186, P35, DOI 10.1016/j.jneumeth.2009.10.021; NOVOTNY C, 1969, J BACTERIOL, V98, P1294, DOI 10.1128/JB.98.3.1294-1306.1969; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Ohshima H, 2008, J COLLOID INTERF SCI, V328, P3, DOI 10.1016/j.jcis.2008.08.009; Ortiz C, 1999, MACROMOLECULES, V32, P780, DOI 10.1021/ma981245n; PARANCHYCH W, 1988, ADV MICROB PHYSIOL, V29, P53, DOI 10.1016/S0065-2911(08)60346-X; Park S, 2005, BIOPHYS J, V89, P4330, DOI 10.1529/biophysj.104.053462; Radmacher M, 2002, METHOD CELL BIOL, V68, P67; Radmacher M, 1996, BIOPHYS J, V70, P556, DOI 10.1016/S0006-3495(96)79602-9; Ramachandran S, 2006, LANGMUIR, V22, P8156, DOI 10.1021/la0607499; Ribas F, 2000, J APPL MICROBIOL, V88, P704, DOI 10.1046/j.1365-2672.2000.01021.x; Rudoy D, 2010, J R STAT SOC C-APPL, V59, P573; Rutland MW, 2004, J ADHES SCI TECHNOL, V18, P1199, DOI 10.1163/1568561041581324; Schar-Zammaretti P, 2003, BIOPHYS J, V85, P4076, DOI 10.1016/S0006-3495(03)74820-6; Schar-Zammaretti P, 2002, ABSTR PAP AM CHEM S, V224, pU397; Sen S, 2010, J BIOMECH, V43, P45, DOI 10.1016/j.jbiomech.2009.09.008; Song J, 2008, MACROMOLECULES, V41, P6757, DOI 10.1021/ma800536y; Soussen C, 2010, FORCE CURVE SEGMENTA, P1; Sullivan MA, 2010, BIOMACROMOLECULES, V11, P1094, DOI 10.1021/bm100074p; Sun H, 2000, CURR BIOL, V10, P1143, DOI 10.1016/S0960-9822(00)00705-3; Tang W, 2010, COLLOID SURFACE B, V76, P1, DOI 10.1016/j.colsurfb.2009.09.039; TAO NJ, 1992, BIOPHYS J, V63, P1165, DOI 10.1016/S0006-3495(92)81692-2; Touhami A, 2003, LANGMUIR, V19, P4539, DOI 10.1021/la034136x; Touhami A, 2003, LANGMUIR, V19, P1745, DOI 10.1021/la026145w; Ulett GC, 2007, MICROBIOL-SGM, V153, P2321, DOI 10.1099/mic.0.2006/004648-0; Vadillo-Rodrigues V, 2004, APPL ENVIRON MICROB, V70, P5441, DOI 10.1128/AEM.70.9.5441-5446.2004; Vadillo-Rodriguez V, 2008, J BACTERIOL, V190, P4225, DOI 10.1128/JB.00132-08; Velegol SB, 2002, LANGMUIR, V18, P5256, DOI 10.1021/la011818g; Vinckier A, 1998, FEBS LETT, V430, P12, DOI 10.1016/S0014-5793(98)00592-4; Walch M, 2000, ULTRAMICROSCOPY, V82, P259, DOI 10.1016/S0304-3991(99)00135-7; Wei H, 2008, APPL SPECTROSC REV, V43, P111, DOI 10.1080/05704920701831254; Yao X, 2002, COLLOID SURFACE B, V23, P213, DOI 10.1016/S0927-7765(01)00249-1; Yuen SG, 2007, BAYESIAN CHANGEPOINT, P104; Zhao LM, 2005, BIOTECHNOL PROGR, V21, P292, DOI 10.1021/bp0497233	108	76	76	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18887	10.1371/journal.pone.0018887	http://dx.doi.org/10.1371/journal.pone.0018887			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559483	Green Submitted, gold, Green Published			2022-12-27	WOS:000290024700032
J	Rahim, S; Beauchamp, EM; Kong, YL; Brown, ML; Toretsky, JA; Uren, A				Rahim, Said; Beauchamp, Elspeth M.; Kong, Yali; Brown, Milton L.; Toretsky, Jeffrey A.; Ueren, Aykut			YK-4-279 Inhibits ERG and ETV1 Mediated Prostate Cancer Cell Invasion	PLOS ONE			English	Article							ETS TRANSCRIPTION FACTORS; TMPRSS2-ERG GENE FUSION; ANDROGEN RECEPTOR; RNA HELICASE; IN-VITRO; FREQUENCY; DIFFERENTIATION; ONCOPROTEIN; PROGRESSION; METASTASIS	Background: Genomic rearrangements involving the ETS family of transcription factors occur in 40-70% of prostate cancer cases. ERG and ETV1 are the most common ETS members observed in these genetic alterations. The high prevalence of these rearrangements and their biological significance represents a novel therapeutic target for the treatment of prostate cancer. Methods and Findings: We recently reported the development of YK-4-279, a small molecule inhibitor of EWS-FLI1 oncoprotein in Ewing's Sarcoma. Since ERG and ETV1 belong to the same class of ETS factors as FLI1, we tested the ability of YK-4-279 to inhibit biological functions of ERG and ETV1 proteins in prostate cancer. YK-4-279 inhibited ERG and ETV1 mediated transcriptional activity in a luciferase assay. YK-4-279 also decreased ERG and ETV1 downstream target mRNA and protein expression in ETV1-fusion positive LNCaP and ERG fusion positive VCaP cells. YK-4-279 reduced the motility of LNCaP cells in a scratch assay and the invasive phenotype of both LNCaP and VCaP cells in a HUVEC invasion assay. Fusion-negative PC3 cells were unresponsive to YK-4-279. SiRNA mediated ERG knockdown in VCaP cells resulted in a loss of drug responsiveness. Concurrently, transient ERG expression in PC-3 cells resulted in increased invasive potential, which was reduced by YK-4-279. Conclusion: These data demonstrate that YK-4-279 inhibits ERG and ETV1 biological activity in fusion-positive prostate cancer cells leading to decreased motility and invasion. Therefore, YK-4-279 may have an impact on metastasis in prostate cancer and it may be further evaluated for its clinical applications in prostate cancer in addition to Ewing's sarcoma.	[Rahim, Said; Beauchamp, Elspeth M.; Kong, Yali; Brown, Milton L.; Toretsky, Jeffrey A.; Ueren, Aykut] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA	Georgetown University	Rahim, S (corresponding author), Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA.	au26@georgetown.edu			Cancer Center [P30-CA051008]; Children's Cancer Foundation (Baltimore MD); Go4theGoal; Dani's Foundation; Alex's Lemonade Stand Foundation; Liddy Shriver Sarcoma Initiative; Burroughs Wellcome Clinical Scientist Award in Translational Research; NIH [R01CA133662, R01CA138212, R01CA108641]; NATIONAL CANCER INSTITUTE [T32CA009686, R01CA138212, P30CA051008, R01CA133662, R01CA108641] Funding Source: NIH RePORTER	Cancer Center; Children's Cancer Foundation (Baltimore MD); Go4theGoal; Dani's Foundation; Alex's Lemonade Stand Foundation; Liddy Shriver Sarcoma Initiative; Burroughs Wellcome Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was generously supported by the Cancer Center Support grant P30-CA051008 for use of Biacore Molecular Interaction Shared Resource. Support for the work also came from the Children's Cancer Foundation (Baltimore MD), Go4theGoal, Dani's Foundation, Alex's Lemonade Stand Foundation, Liddy Shriver Sarcoma Initiative, Burroughs Wellcome Clinical Scientist Award in Translational Research (JT), and the NIH R01CA133662 (JT), R01CA138212 (JT), R01CA108641 (AU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauchamp E, 2009, J BIOL CHEM, V284, P9074, DOI 10.1074/jbc.M806233200; Cai CM, 2009, CANCER RES, V69, P6027, DOI 10.1158/0008-5472.CAN-09-0395; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; de Launoit Y, 2006, BBA-REV CANCER, V1766, P79, DOI 10.1016/j.bbcan.2006.02.002; Demichelis F, 2007, ONCOGENE, V26, P4596, DOI 10.1038/sj.onc.1210237; Dewor M, 2007, FEBS LETT, V581, P4734, DOI 10.1016/j.febslet.2007.08.071; Erkizan HV, 2009, NAT MED, V15, P750, DOI 10.1038/nm.1983; Esquenet M, 1997, J STEROID BIOCHEM, V62, P391, DOI 10.1016/S0960-0760(97)00054-X; Fingleton B, 2006, FRONT BIOSCI-LANDMRK, V11, P479, DOI 10.2741/1811; Hermans KG, 2008, CANCER RES, V68, P7541, DOI 10.1158/0008-5472.CAN-07-5930; Jiang WG, 2009, MICROVASC RES, V77, P150, DOI 10.1016/j.mvr.2008.09.010; Keese CR, 2002, BIOTECHNIQUES, V33, P842, DOI 10.2144/02334rr01; Nam RK, 2007, CANCER BIOL THER, V6, P40, DOI 10.4161/cbt.6.1.3489; Nasca MR, 1999, J INVEST DERMATOL, V113, P720, DOI 10.1046/j.1523-1747.1999.00744.x; Rajput AB, 2007, J CLIN PATHOL, V60, P1238, DOI 10.1136/jcp.2006.043810; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Simbulan-Rosenthal CM, 2005, ONCOGENE, V24, P5443, DOI 10.1038/sj.onc.1208709; Soller MJ, 2006, GENE CHROMOSOME CANC, V45, P717, DOI 10.1002/gcc.20329; Sun C, 2008, ONCOGENE, V27, P5348, DOI 10.1038/onc.2008.183; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Toretsky JA, 2006, CANCER RES, V66, P5574, DOI 10.1158/0008-5472.CAN-05-3293; Tu JJ, 2007, MODERN PATHOL, V20, P921, DOI 10.1038/modpathol.3800903; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018	25	70	82	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19343	10.1371/journal.pone.0019343	http://dx.doi.org/10.1371/journal.pone.0019343			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559405	Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700143
J	Shaik, MM; Cendron, L; Percudani, R; Zanotti, G				Shaik, Md Munan; Cendron, Laura; Percudani, Riccardo; Zanotti, Giuseppe			The Structure of Helicobacter pylori HP0310 Reveals an Atypical Peptidoglycan Deacetylase	PLOS ONE			English	Article							CHITIN DEACETYLASE; DEUTEROMYCETE; RECOGNITION; ALIGNMENT; SYSTEM	Peptidoglycan deacetlyase (HP0310, HpPgdA) from the gram-negative pathogen Helicobacter pylori, has been indicated as the enzyme responsible for a peptidoglycan modification that counteracts the host immune response. HpPgdA has been cloned, purified and expressed in good yield in E. coli. It has been crystallized, its structure determined and activity tests in vitro performed. The enzyme, which belongs to the polysaccharide deacetylases protein family, is a homo-tetramer. The four polypeptide chains, each folded into a single domain characterized by a non-canonical TIM-barrel fold, are arranged around a four-fold symmetry axis. The active site, one per monomer, contains a heavy ion coordinated in a way similar to other deacetylases. However, the enzyme showed no in vitro activity on the typical polysaccharide substrates of peptidoglycan deacetylases. In striking contrast with the known peptidoglycan deacetylases, HpPgdA does not exhibit a solvent-accessible polysaccharide binding groove, suggesting that the enzyme binds a small molecule at the active site.	[Shaik, Md Munan; Cendron, Laura; Zanotti, Giuseppe] Univ Padua, Dept Biol Chem, Padua, Italy; [Cendron, Laura; Zanotti, Giuseppe] VIMM, Padua, Italy; [Percudani, Riccardo] Univ Parma, Dept Biochem & Mol Biol, I-43100 Parma, Italy	University of Padua; Veneto Institute Molecular Medicine; University of Parma	Shaik, MM (corresponding author), Univ Padua, Dept Biol Chem, Padua, Italy.	giuseppe.zanotti@unipd.it	cendron, Laura/A-5202-2014; percudani, riccardo/B-4872-2011	percudani, riccardo/0000-0001-8452-1062; Zanotti, Giuseppe/0000-0002-0945-6501; Cendron, Laura/0000-0002-0125-0461	University of Padua; CARIPARO	University of Padua; CARIPARO(Fondazione Cariparo)	This work was supported by the University of Padua. Md Shaik's position was supported by CARIPARO grants for foreign Students at the University of Padua. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BANNER DW, 1976, BIOCHEM BIOPH RES CO, V72, P146, DOI 10.1016/0006-291X(76)90972-4; Blair DE, 2005, P NATL ACAD SCI USA, V102, P15429, DOI 10.1073/pnas.0504339102; Blair DE, 2004, FEBS LETT, V570, P13, DOI 10.1016/j.febslet.2004.06.013; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Dickmanns A, 2006, ACTA CRYSTALLOGR D, V62, P262, DOI [10.1107/S0907444905041363, 10.1107/S0904777905041363]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Franco AT, 2009, MOL CELL PROTEOMICS, V8, P1947, DOI 10.1074/mcp.M900139-MCP200; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hekmat O, 2003, BIOCHEM J, V374, P369, DOI 10.1042/BJ20030204; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; KAMIO Y, 1987, J BACTERIOL, V169, P2881, DOI 10.1128/jb.169.6.2881-2884.1987; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Luthy L, 2002, J BIOL CHEM, V277, P10187, DOI 10.1074/jbc.M108993200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Patti GJ, 2008, J AM SOC MASS SPECTR, V19, P1467, DOI 10.1016/j.jasms.2008.06.020; Ramazzina I, 2008, J BIOL CHEM, V283, P23295, DOI 10.1074/jbc.M801195200; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Smith TG, 2007, PROTEOMICS, V7, P2240, DOI 10.1002/pmic.200600875; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tokuyasu K, 2000, BIOCHEMISTRY-US, V39, P8837, DOI 10.1021/bi0005355; Wang G, 2010, INFECT IMMUN, V78, P4660, DOI 10.1128/IAI.00307-10; Wang G, 2009, J BIOL CHEM, V284, P6790, DOI 10.1074/jbc.M808071200	31	17	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19207	10.1371/journal.pone.0019207	http://dx.doi.org/10.1371/journal.pone.0019207			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559431	Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700102
J	Litvintseva, AP; Carbone, I; Rossouw, J; Thakur, R; Govender, NP; Mitchell, TG				Litvintseva, Anastasia P.; Carbone, Ignazio; Rossouw, Jenny; Thakur, Rameshwari; Govender, Nelesh P.; Mitchell, Thomas G.			Evidence that the Human Pathogenic Fungus Cryptococcus neoformans var. grubii May Have Evolved in Africa	PLOS ONE			English	Article							POPULATION GENETIC-ANALYSIS; MULTILOCUS GENOTYPE DATA; MATING-TYPE; SEROTYPE-A; COLOPHOSPERMUM-MOPANE; COMPUTER-PROGRAM; RECOMBINATION; GATTII; INFERENCE; MODEL	Most of the species of fungi that cause disease in mammals, including Cryptococcus neoformans var. grubii (serotype A), are exogenous and non-contagious. Cryptococcus neoformans var. grubii is associated worldwide with avian and arboreal habitats. This airborne, opportunistic pathogen is profoundly neurotropic and the leading cause of fungal meningitis. Patients with HIV/AIDS have been ravaged by cryptococcosis - an estimated one million new cases occur each year, and mortality approaches 50%. Using phylogenetic and population genetic analyses, we present evidence that C. neoformans var. grubii may have evolved from a diverse population in southern Africa. Our ecological studies support the hypothesis that a few of these strains acquired a new environmental reservoir, the excreta of feral pigeons (Columba livia), and were globally dispersed by the migration of birds and humans. This investigation also discovered a novel arboreal reservoir for highly diverse strains of C. neoformans var. grubii that are restricted to southern Africa, the mopane tree (Colophospermum mopane). This finding may have significant public health implications because these primal strains have optimal potential for evolution and because mopane trees contribute to the local economy as a source of timber, folkloric remedies and the edible mopane worm.	[Litvintseva, Anastasia P.; Mitchell, Thomas G.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27706 USA; [Carbone, Ignazio] N Carolina State Univ, Dept Plant Pathol, Ctr Integrated Fungal Res, Raleigh, NC 27695 USA; [Rossouw, Jenny] Natl Inst Communicable Dis, Special Bacterial Pathogens Reference Unit, Johannesburg, South Africa; [Thakur, Rameshwari] Minist Hlth, Natl Hlth Lab, Dept Mycol, Gaborone, Botswana; [Govender, Nelesh P.] Natl Inst Communicable Dis, Mycol Reference Unit, Johannesburg, South Africa	Duke University; University of North Carolina; North Carolina State University; National Institute for Communicable Diseases (NICD); National Institute for Communicable Diseases (NICD)	Litvintseva, AP (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27706 USA.	litvi001@mc.duke.edu	Govender, Nelesh/ABI-6429-2020; Mitchell, Thomas G./A-2356-2008	Rossouw, Jennifer/0000-0003-2840-5563; Thakur, Rameshwari/0000-0002-6739-6383; Govender, Nelesh/0000-0001-7869-9462	U. S. Public Health Service NIH [5R01 AI 25783]; NIH [P30 AI 64518]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518, R01AI093257, R01AI025783] Funding Source: NIH RePORTER	U. S. Public Health Service NIH(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the U. S. Public Health Service NIH grant 5R01 AI 25783 and by a grant from the Duke University Center for AIDS Research, which is funded by NIH grant P30 AI 64518. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Aylor DL, 2006, BIOINFORMATICS, V22, P1399, DOI 10.1093/bioinformatics/btl136; Bovers M, 2008, FUNGAL GENET BIOL, V45, P400, DOI 10.1016/j.fgb.2007.12.004; Bui T, 2008, EUKARYOT CELL, V7, P1771, DOI 10.1128/EC.00097-08; Chayakulkeeree M, 2006, INFECT DIS CLIN N AM, V20, P507, DOI 10.1016/j.idc.2006.07.001; Chen JH, 2008, EMERG INFECT DIS, V14, P755, DOI 10.3201/eid1405.071312; Choi YH, 2010, FEMS YEAST RES, V10, P769, DOI 10.1111/j.1567-1364.2010.00648.x; CHUCK SL, 1989, NEW ENGL J MED, V321, P794, DOI 10.1056/NEJM198909213211205; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dromer F, 2007, PLOS MED, V4, P297, DOI 10.1371/journal.pmed.0040021; DRUMMOND AJ, 2010, GENEIOS PRO V 5 1; Eswaran V, 2005, J HUM EVOL, V49, P1, DOI 10.1016/j.jhevol.2005.02.006; EXCOFFIER L, 1992, GENETICS, V131, P479; Falush D, 2003, GENETICS, V164, P1567; Felsenstein J., 2004, INFERRING PHYLOGENIE, P664; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; FU YX, 1993, GENETICS, V133, P693; Grzimek B., 2004, GRZIMEKS ANIMAL LIFE; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Hempson GP, 2007, AUSTRAL ECOL, V32, P429, DOI 10.1111/j.1442-9993.2007.01712.x; Hiremath SS, 2008, MICROBIOL-SGM, V154, P1513, DOI 10.1099/mic.0.2007/015594-0; Idnurm A, 2005, NAT REV MICROBIOL, V3, P753, DOI 10.1038/nrmicro1245; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Lengeler KB, 2000, P NATL ACAD SCI USA, V97, P14455, DOI 10.1073/pnas.97.26.14455; Lin XR, 2005, NATURE, V434, P1017, DOI 10.1038/nature03448; LITTMAN ML, 1968, MYCOPATH MYCOL APPL, V35, P329, DOI 10.1007/BF02050749; Litvintseva AP, 2007, PLOS PATHOG, V3, P1109, DOI 10.1371/journal.ppat.0030114; Litvintseva AP, 2006, GENETICS, V172, P2223, DOI 10.1534/genetics.105.046672; Litvintseva AP, 2005, J CLIN MICROBIOL, V43, P556, DOI 10.1128/JCM.43.2.556-564.2005; Litvintseva AP, 2003, EUKARYOT CELL, V2, P1162, DOI 10.1128/EC.2.6.1162-1168.2003; Lyngso RB, 2008, LECT N BIOINFORMAT, V4955, P463; MADDISON WP, 1989, FOLIA PRIMATOL, V53, P190, DOI 10.1159/000156416; Mapaure I., 1994, Kirkia, V15, P1; Mashabane LG, 2001, S AFR J BOT, V67, P199, DOI 10.1016/S0254-6299(15)31120-0; Meyer W, 2009, MED MYCOL, V47, P561, DOI 10.1080/13693780902953886; Mirza SA, 2003, CLIN INFECT DIS, V36, P789, DOI 10.1086/368091; Mooney H.A., 2000, INVASIVE SPECIES CHA; Myers SR, 2003, GENETICS, V163, P375; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Ngamskulrungroj P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005862; Nielsen K, 2003, INFECT IMMUN, V71, P4831, DOI 10.1128/IAI.71.9.4831-4841.2003; NIELSEN K, 2007, EUKARYOT CELL; Nielsen K, 2007, ADV GENET, V57, P143, DOI 10.1016/S0065-2660(06)57004-X; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Perfect JR, 2005, FEMS IMMUNOL MED MIC, V45, P395, DOI 10.1016/j.femsim.2005.06.005; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Price EW, 2005, BIOINFORMATICS, V21, P402, DOI 10.1093/bioinformatics/bti003; Pritchard JK, 2000, GENETICS, V155, P945; RANDHAWA HS, 2008, MED MYCOL, P1; Sebego RJ, 2008, S AFR GEOGR J, V90, P41, DOI 10.1080/03736245.2008.9725310; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; STAIB F, 1989, MYCOSES, V32, P448, DOI 10.1111/j.1439-0507.1989.tb02280.x; Swofford David L., 1996, P407; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Templeton AR, 2005, YEARB PHYS ANTHROPOL, V48, P33, DOI 10.1002/ajpa.20351; TEMPLETON AR, 1983, EVOLUTION, V37, P221, DOI 10.1111/j.1558-5646.1983.tb05533.x; Venter F., 2002, PRETORIA S AFR; Vogel G, 2010, SCIENCE, V327, P811, DOI 10.1126/science.327.5967.811; Wright S, 1978, VARIABILITY NATURAL; Xu JP, 2000, MOL ECOL, V9, P1471, DOI 10.1046/j.1365-294x.2000.01021.x	62	75	77	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19688	10.1371/journal.pone.0019688	http://dx.doi.org/10.1371/journal.pone.0019688			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589919	Green Published, Green Submitted, gold			2022-12-27	WOS:000290483600022
J	Mi, Q; Constantine, G; Ziraldo, C; Solovyev, A; Torres, A; Namas, R; Bentley, T; Billiar, TR; Zamora, R; Puyana, JC; Vodovotz, Y				Mi, Qi; Constantine, Gregory; Ziraldo, Cordelia; Solovyev, Alexey; Torres, Andres; Namas, Rajaie; Bentley, Timothy; Billiar, Timothy R.; Zamora, Ruben; Puyana, Juan Carlos; Vodovotz, Yoram			A Dynamic View of Trauma/Hemorrhage-Induced Inflammation in Mice: Principal Drivers and Networks	PLOS ONE			English	Article							KERATINOCYTE-DERIVED CHEMOKINE; NECROSIS-FACTOR RECEPTORS; ENDOTHELIAL GROWTH-FACTOR; PLASMA CYTOKINE LEVELS; HEMORRHAGIC-SHOCK; SEVERE TRAUMA; SYSTEMIC INFLAMMATION; IMMUNE-RESPONSE; IN-SILICO; INJURY	Background: Complex biological processes such as acute inflammation induced by trauma/hemorrhagic shock/(T/HS) are dynamic and multi-dimensional. We utilized multiplexing cytokine analysis coupled with data-driven modeling to gain a systems perspective into T/HS. Methodology/Principal Findings: Mice were subjected to surgical cannulation trauma (ST) +/- hemorrhagic shock (HS; 25 mmHg), and followed for 1, 2, 3, or 4 h in each case. Serum was assayed for 20 cytokines and NO2-/NO3-. These data were analyzed using four data-driven methods (Hierarchical Clustering Analysis [HCA], multivariate analysis [MA], Principal Component Analysis [PCA], and Dynamic Network Analysis [DyNA]). Using HCA, animals subjected to ST vs. ST + HS could be partially segregated based on inflammatory mediator profiles, despite a large overlap. Based on MA, interleukin [IL]-12p40/p70 (IL-12.total), monokine induced by interferon-gamma (CXCL-9) [MIG], and IP-10 were the best discriminators between ST and ST/HS. PCA suggested that the inflammatory mediators found in the three main principal components in animals subjected to ST were IL-6, IL-10, and IL-13, while the three principal components in ST + HS included a large number of cytokines including IL-6, IL-10, keratinocyte-derived cytokine (CXCL-1) [KC], and tumor necrosis factor-alpha [TNF-alpha]. DyNA suggested that the circulating mediators produced in response to ST were characterized by a high degree of interconnection/complexity at all time points; the response to ST + HS consisted of different central nodes, and exhibited zero network density over the first 2 h with lesser connectivity vs. ST at all time points. DyNA also helped link the conclusions from MA and PCA, in that central nodes consisting of IP-10 and IL-12 were seen in ST, while MIG and IL-6 were central nodes in ST + HS. Conclusions/Significance: These studies help elucidate the dynamics of T/HS-induced inflammation, complementing other forms of dynamic mechanistic modeling. These methods should be applicable to the analysis of other complex biological processes.	[Mi, Qi] Univ Pittsburgh, Dept Sports Med & Nutr, Pittsburgh, PA 15260 USA; [Constantine, Gregory; Solovyev, Alexey] Univ Pittsburgh, Dept Math, Pittsburgh, PA 15260 USA; [Ziraldo, Cordelia; Torres, Andres; Namas, Rajaie; Billiar, Timothy R.; Zamora, Ruben; Puyana, Juan Carlos; Vodovotz, Yoram] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA; [Bentley, Timothy] Off Naval Res, Arlington, VA 22217 USA; [Mi, Qi; Constantine, Gregory; Puyana, Juan Carlos; Vodovotz, Yoram] Univ Pittsburgh, Ctr Inflammat & Regenerat Modeling, McGowan Inst Regenerat Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; United States Department of Defense; United States Navy; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mi, Q (corresponding author), Univ Pittsburgh, Dept Sports Med & Nutr, Pittsburgh, PA 15260 USA.	vodovotzy@upmc.edu	Namas, Rajaie/U-2206-2019	Namas, Rajaie/0000-0003-0353-895X	National Institutes of Health [P50-GM-53789, R33-HL-089082, RO1-HL-076157]; IBM; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076157, R33HL089082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM053789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IBM(International Business Machines (IBM)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants P50-GM-53789, R33-HL-089082, and RO1-HL-076157 and IBM Shared University Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Brand JM, 2003, SHOCK, V20, P213, DOI 10.1097/00024382-200309000-00003; Buchman TG, 2001, SHOCK, V16, P248, DOI 10.1097/00024382-200116040-00002; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; CHAUDRY IH, 1990, AM J PHYSIOL, V259, pR663, DOI 10.1152/ajpregu.1990.259.4.R663; Chow CC, 2005, SHOCK, V24, P74, DOI 10.1097/01.shk.0000168526.97716.f3; CINAT ME, 1994, J AM COLL SURGEONS, V179, P529; Cobb JP, 2004, LANCET, V363, P2076, DOI 10.1016/S0140-6736(04)16460-X; COBB JP, 2009, ANNSURG; Cohen MJ, 2009, CRIT CARE, V13, DOI 10.1186/cc8152; Delogu G., 1998, Annali Italiani di Chirurgia, V69, P15; DeLong WG, 2004, CLIN ORTHOP RELAT R, P57, DOI 10.1097/01.blo.0000130840.64528.1e; Dewar D, 2009, INJURY, V40, P912, DOI 10.1016/j.injury.2009.05.024; Diefenbach A, 1999, SCIENCE, V284, P951, DOI 10.1126/science.284.5416.951; DIPIRO JT, 1992, ADV NEUROIMMUNOL, V2, P55; Eckels P, 2008, SHOCK, V29, P17; Faist E, 1996, WORLD J SURG, V20, P454, DOI 10.1007/s002689900071; Fan Jie, 2010, Open Crit Care Med J, V2, P1; Frangen TM, 2008, SHOCK, V29, P462, DOI 10.1097/SHK.0b013e3181598a9d; Frink M, 2007, SHOCK, V28, P576, DOI 10.1097/shk.0b013e31814b8e0d; Hamaya Y, 2000, ANESTH ANALG, V90, P1177, DOI 10.1097/00000539-200005000-00034; Hardaway RM, 2006, MIL MED, V171, P278, DOI 10.7205/MILMED.171.4.278; Hensler T, 2002, J TRAUMA, V52, P962, DOI 10.1097/00005373-200205000-00023; Hierholzer C, 1998, J EXP MED, V187, P917, DOI 10.1084/jem.187.6.917; Hofstetter C, 2005, INT IMMUNOPHARMACOL, V5, P1519, DOI 10.1016/j.intimp.2005.04.008; Janes KA, 2006, NAT REV MOL CELL BIO, V7, P820, DOI 10.1038/nrm2041; Jarrar D, 1999, INT J MOL MED, V4, P575; Jin T, 2008, CYTOKINE, V44, P1, DOI 10.1016/j.cyto.2008.06.017; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Karakozis S, 2000, J SURG RES, V90, P109, DOI 10.1006/jsre.2000.5860; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Lagoa CE, 2006, SHOCK, V26, P592, DOI 10.1097/01.shk.0000232272.03602.0a; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Li NYK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002789; LI NYK, 2010, OTOLRHINOLLARYNGOL; Liu T, 2006, MOL CELL PROTEOMICS, V5, P1899, DOI 10.1074/mcp.M600068-MCP200; Lomas JL, 2003, SHOCK, V19, P358, DOI 10.1097/00024382-200304000-00011; Maier B, 2007, SHOCK, V28, P668, DOI 10.1097/shk.0b013e318123e64e; Marcu AC, 2007, J TRAUMA, V63, P662, DOI 10.1097/TA.0b013e31802e70d9; Martin C, 1997, CRIT CARE MED, V25, P1813, DOI 10.1097/00003246-199711000-00018; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Mcbee ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013277; McCloskey CA, 2004, SHOCK, V22, P380, DOI 10.1097/01.shk.0000140660.78744.bf; MCCLOSKEY CA, 2001, SHOCK S1, V15, P14; Mesarovic M. D., 2004, Systems Biology, V1, P19, DOI 10.1049/sb:20045010; Mi Q, 2010, PERS MED, V7, P549, DOI 10.2217/PME.10.45; Namas R, 2009, LIBYAN J MED, V4, P97, DOI 10.4176/090325; Namas R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008406; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; NATHAN C, 1991, J CELL BIOL, V113, P981, DOI 10.1083/jcb.113.5.981; Neugebauer EAM, 2001, SHOCK, V16, P252, DOI 10.1097/00024382-200116040-00003; Ombrellino M, 1999, LANCET, V354, P1446, DOI 10.1016/S0140-6736(99)02658-6; Peitzman A B, 1995, Curr Probl Surg, V32, P925, DOI 10.1016/S0011-3840(05)80008-5; Prince JM, 2006, MOL MED, V12, P88, DOI 10.2119/2006-00012.Prince; Procopio MA, 2001, ANESTH ANALG, V93, P460, DOI 10.1097/00000539-200108000-00044; Romagnani S, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2392; Rose S, 1998, LANGENBECK ARCH SURG, V383, P199, DOI 10.1007/s004230050119; Schinkel C, 1996, EUR J SURG, V162, P763; Schlag G, 1996, WORLD J SURG, V20, P406, DOI 10.1007/s002689900064; Shapiro NI, 2008, SHOCK, V29, P452, DOI 10.1097/SHK.0b013e31815072c1; SHIMADA M, 1993, J CRIT CARE, V8, P109, DOI 10.1016/0883-9441(93)90015-D; Smith RM, 1998, J ROY SOC MED, V91, P417, DOI 10.1177/014107689809100805; Sperry JL, 2008, J TRAUMA, V64, P572, DOI 10.1097/TA.0b013e3181650fdf; Stoiser B, 1998, EUR J CLIN INVEST, V28, P672; Tabata H, 1998, LAB ANIM-UK, V32, P143, DOI 10.1258/002367798780599983; Tjardes T, 2002, SHOCK, V17, P1, DOI 10.1097/00024382-200201000-00001; Torres A, 2009, SHOCK, V32, P172, DOI 10.1097/SHK.0b013e318193cc2b; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; VODOVOTZ Y, 2009, SYSTEMS BIOL DRUG DI; Vodovotz Y, 2006, IMMUNOL RES, V36, P237, DOI 10.1385/IR:36:1:237; Vodovotz Y, 2010, IMMUNOPHARM IMMUNOT, V32, P181, DOI 10.3109/08923970903369867; Vodovotz Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000014; Warren HS, 2009, MOL MED, V15, P220, DOI 10.2119/molmed.2009.00027; YANG R, 2006, MOLMED; Yano K, 2006, J EXP MED, V203, P1447, DOI 10.1084/jem.20060375; Zenati MS, 2002, J TRAUMA, V53, P232, DOI 10.1097/00005373-200208000-00007; Zuckerbraun BS, 2005, SHOCK, V23, P527, DOI 10.1097/01.shk.0000163206.22032.a1	78	75	77	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19424	10.1371/journal.pone.0019424	http://dx.doi.org/10.1371/journal.pone.0019424			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21573002	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000290440200007
J	Wagstaff, BJ; Barnerssoi, M; Roy-Engel, AM				Wagstaff, Bradley J.; Barnerssoi, Miriam; Roy-Engel, Astrid M.			Evolutionary Conservation of the Functional Modularity of Primate and Murine LINE-1 Elements	PLOS ONE			English	Article							OPEN READING FRAME; L1 RETROTRANSPOSITION; ORF1 PROTEIN; REVERSE-TRANSCRIPTASE; RIBONUCLEOPROTEIN-PARTICLES; ALU RETROTRANSPOSITION; CHAPERONE ACTIVITY; GENE-EXPRESSION; HUMAN GENOMES; ENDONUCLEASE	LINE-1 (L1) retroelements emerged in mammalian genomes over 80 million years ago with a few dominant subfamilies amplifying over discrete time periods that led to distinct human and mouse L1 lineages. We evaluated the functional conservation of L1 sequences by comparing retrotransposition rates of chimeric human-rodent L1 constructs to their parental L1 counterparts. Although amino acid conservation varies from similar to 35% to 63% for the L1 ORF1p and ORF2p, most human and mouse L1 sequences can be functionally exchanged. Replacing either ORF1 or ORF2 to create chimeric human-mouse L1 elements did not adversely affect retrotransposition. The mouse ORF2p retains retrotransposition-competency to support both Alu and L1 mobilization when any of the domain sequences we evaluated were substituted with human counterparts. However, the substitution of portions of the mouse cys-domain into the human ORF2p reduces both L1 retrotransposition and Alu trans-mobilization by 200-1000 fold. The observed loss of ORF2p function is independent of the endonuclease or reverse transcriptase activities of ORF2p and RNA interaction required for reverse transcription. In addition, the loss of function is physically separate from the cysteine-rich motif sequence previously shown to be required for RNP formation. Our data suggest an additional role of the less characterized carboxy-terminus of the L1 ORF2 protein by demonstrating that this domain, in addition to mediating RNP interaction(s), provides an independent and required function for the retroelement amplification process. Our experiments show a functional modularity of most of the LINE sequences. However, divergent evolution of interactions within L1 has led to non-reciprocal incompatibilities between human and mouse ORF2 cys-domain sequences.	[Wagstaff, Bradley J.; Barnerssoi, Miriam; Roy-Engel, Astrid M.] Tulane Univ, Hlth Sci Ctr, Tulane Canc Ctr, Dept Epidemiol, New Orleans, LA 70118 USA	Tulane University	Wagstaff, BJ (corresponding author), Tulane Univ, Hlth Sci Ctr, Tulane Canc Ctr, Dept Epidemiol, New Orleans, LA 70118 USA.	aengel@tulane.edu		Engel, Astrid/0000-0002-8884-4544	National Institutes of Health [R01GM079709A, NIH/NCRR P20 RR020152]; National Center for Research Resources [NCRR P20 RR020152]; Louisiana Cancer Research Consortium (LCRC); Tulane Cancer Center; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079709] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Louisiana Cancer Research Consortium (LCRC); Tulane Cancer Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health [R01GM079709A] and the National Center for Research Resources [NCRR P20 RR020152] awarded to AMR-E. Competitive Advantage Funds from the Louisiana Cancer Research Consortium (LCRC) were also awarded to AMR-E. BJW was supported by a Louisiana Cancer Research Consortium (LCRC) Fellowship and a Matching Funds Fellowship Award, 2006-2008 provide from the developmental funds of the Tulane Cancer Center. The Tulane Cancer COBRE CORE facility was supported by National Institutes NIH/NCRR P20 RR020152. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute Of General Medical Sciences, National Center for Research Resources or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An WF, 2006, P NATL ACAD SCI USA, V103, P18662, DOI 10.1073/pnas.0605300103; An WF, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-2; Basame S, 2006, J MOL BIOL, V357, P351, DOI 10.1016/j.jmb.2005.12.063; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Belancio VP, 2006, NUCLEIC ACIDS RES, V34, P1512, DOI 10.1093/nar/gkl027; Belgnaoui SM, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-13; Boissinot SP, 2001, MOL BIOL EVOL, V18, P2186, DOI 10.1093/oxfordjournals.molbev.a003765; BURTON FH, 1986, J MOL BIOL, V187, P291, DOI 10.1016/0022-2836(86)90235-4; Cabot EL, 1997, J MOL EVOL, V45, P412, DOI 10.1007/PL00006246; Cantrell MA, 2008, GENETICS, V178, P393, DOI 10.1534/genetics.107.080275; Casavant NC, 2000, GENETICS, V154, P1809; Clements AP, 1998, NUCLEIC ACIDS RES, V26, P3528, DOI 10.1093/nar/26.15.3528; Comeaux MS, 2009, GENOME RES, V19, P545, DOI 10.1101/gr.089789.108; Cost GJ, 2002, EMBO J, V21, P5899, DOI 10.1093/emboj/cdf592; DeBerardinis RJ, 1999, GENOMICS, V56, P317, DOI 10.1006/geno.1998.5729; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; DOMBROSKI BA, 1993, P NATL ACAD SCI USA, V90, P6513, DOI 10.1073/pnas.90.14.6513; Doucet AJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001150; El-Sawy M, 2005, J MOL BIOL, V354, P246, DOI 10.1016/j.jmb.2005.09.050; Ergun S, 2004, J BIOL CHEM, V279, P27753, DOI 10.1074/jbc.M312985200; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Furano AV, 2000, PROG NUCLEIC ACID RE, V64, P255, DOI 10.1016/S0079-6603(00)64007-2; Furano AV, 2004, TRENDS GENET, V20, P9, DOI 10.1016/j.tig.2003.11.006; Gasior SL, 2006, J MOL BIOL, V357, P1383, DOI 10.1016/j.jmb.2006.01.089; Goodier JL, 2004, HUM MOL GENET, V13, P1041, DOI 10.1093/hmg/ddh118; Han JS, 2004, NATURE, V429, P314, DOI 10.1038/nature02535; Hayward BE, 1997, GENETICS, V146, P641; Howell R, 1997, MOL BIOL EVOL, V14, P144, DOI 10.1093/oxfordjournals.molbev.a025747; Huang CRL, 2010, CELL, V141, P1171, DOI 10.1016/j.cell.2010.05.026; Hulme AE, 2007, GENE, V390, P199, DOI 10.1016/j.gene.2006.08.032; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Jones RB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001547; Khan H, 2006, GENOME RES, V16, P78, DOI 10.1101/gr.4001406; Khazina E, 2009, P NATL ACAD SCI USA, V106, P731, DOI 10.1073/pnas.0809964106; KOLOSHA VO, 1995, J BIOL CHEM, V270, P2868, DOI 10.1074/jbc.270.6.2868; Kroutter EN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000458; Kubo S, 2006, P NATL ACAD SCI USA, V103, P8036, DOI 10.1073/pnas.0601954103; Kulpa DA, 2005, HUM MOL GENET, V14, P3237, DOI 10.1093/hmg/ddi354; Kulpa DA, 2006, NAT STRUCT MOL BIOL, V13, P655, DOI 10.1038/nsmb1107; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Ling MM, 1997, ANAL BIOCHEM, V254, P157, DOI 10.1006/abio.1997.2428; Malik HS, 1999, MOL BIOL EVOL, V16, P793, DOI 10.1093/oxfordjournals.molbev.a026164; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Martin SL, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/45621; Martin SL, 1991, CURR OPIN GENET DEV, V1, P505, DOI 10.1016/S0959-437X(05)80199-6; Martin SL, 2005, J MOL BIOL, V348, P549, DOI 10.1016/j.jmb.2005.03.003; Martin SL, 2003, P NATL ACAD SCI USA, V100, P13815, DOI 10.1073/pnas.2336221100; Martin SL, 2001, MOL CELL BIOL, V21, P467, DOI 10.1128/MCB.21.2.467-475.2001; Mayorov VI, 1999, MAMM GENOME, V10, P724, DOI 10.1007/s003359901079; Mears ML, 2001, J MOL EVOL, V52, P51, DOI 10.1007/s002390010133; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; PASCALE E, 1990, P NATL ACAD SCI USA, V87, P9481, DOI 10.1073/pnas.87.23.9481; Perepelitsa-Belancio V, 2003, NAT GENET, V35, P363, DOI 10.1038/ng1269; Repanas K, 2007, NUCLEIC ACIDS RES, V35, P4914, DOI 10.1093/nar/gkm516; Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37; SCOTT A F, 1987, Genomics, V1, P113, DOI 10.1016/0888-7543(87)90003-6; Takahashi H, 2002, EMBO J, V21, P408, DOI 10.1093/emboj/21.3.408; Tamura M, 2007, GENE, V390, P221, DOI 10.1016/j.gene.2006.09.003; Wallace N, 2008, GENE, V419, P1, DOI 10.1016/j.gene.2008.04.007; Weichenrieder O, 2004, STRUCTURE, V12, P975, DOI 10.1016/j.str.2004.04.011; XING J, 2009, GENOME RES	62	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19672	10.1371/journal.pone.0019672	http://dx.doi.org/10.1371/journal.pone.0019672			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572950	Green Submitted, Green Published, gold			2022-12-27	WOS:000290440200020
J	Canchihuaman, FA; Garcia, PJ; Gloyd, SS; Holmes, KK				Canchihuaman, Fredy A.; Garcia, Patricia J.; Gloyd, Stephen S.; Holmes, King K.			An Interactive Internet-Based Continuing Education Course on Sexually Transmitted Diseases for Physicians and Midwives in Peru	PLOS ONE			English	Article							HEALTH INFORMATION; MEDICAL-STUDENTS; CME; KNOWLEDGE; COUNTRIES; EFFICACY	Background: Clinicians in developing countries have had limited access to continuing education (CE) outside major cities, and CE strategies have had limited impact on sustainable change in performance. New educational tools could improve CE accessibility and effectiveness. Methodology/Principal Findings: The objective of this study was to evaluate an interactive Internet-based CE course on Sexually Transmitted Diseases (STDs) management for clinicians in Peru. Participants included physicians and midwives in private practice drawn from a census of 10 Peruvian cities. The CE included a three-hour workshop for improving Internet skills, followed by a 22-hour online course on STD-syndrome-management, with subsequent educational support. The course used case-based clinical vignettes tailored to local STD problems. Knowledge and reported practices on STD management were assessed before, immediately after and at four months after completion of the course. Statistical analysis included parametric tests-linear regression multivariate analysis, paired t-test and repeated measures ANOVA using SPSS 14.0. Of 1,071 eligible clinicians, 510 agreed to participate, as did an additional 132 public sector clinicians. Of these 642 participants, 619 (96.4%) completed the course, and 596 (96.3%) took the four-month follow-up evaluation. Physician and midwife scores improved from 64.2% correct answers on the pre-test to 77.9% correct on the four-month follow-up test (p < 0.001). Most participants (95%) found the online course useful for their work needs. Self reported STD management practices did not change. Conclusions/Significance: Among physicians and midwives in Peru, an Internet-based CE course was feasible, acceptable with high participation rates, and led to sustained improvement in knowledge at four months. Further studies are needed to test it as a model for improving the training of physicians, midwives, and other health care providers.	[Canchihuaman, Fredy A.; Garcia, Patricia J.] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Lima, Peru; [Canchihuaman, Fredy A.; Gloyd, Stephen S.; Holmes, King K.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Canchihuaman, Fredy A.; Gloyd, Stephen S.; Holmes, King K.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Garcia, Patricia J.; Gloyd, Stephen S.; Holmes, King K.] Univ Washington, Ctr AIDS & STD, Seattle, WA 98195 USA; [Holmes, King K.] Univ Washington, Dept Med, Seattle, WA 98195 USA	Universidad Peruana Cayetano Heredia; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Canchihuaman, FA (corresponding author), Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Lima, Peru.	freancri@u.washington.edu	, Holmes/K-6215-2019		Wellcome Trust [059131/Z/99/Z, 078835/Z/05/Z, 078835/Z/05/B]; National Institutes of Health/NIAID STD Cooperative Research Center [AI31448]; University of Washington Center for AIDS Research [P30-AI27757]; NIH [D43-TW00007]; Peru ICOHRTA Network for AIDS/TB Research Training [U2-RTW007368, U2-RTW007374]; FOGARTY INTERNATIONAL CENTER [D43TW000007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI031448, U01AI031448, P30AI027757] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health/NIAID STD Cooperative Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Washington Center for AIDS Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Peru ICOHRTA Network for AIDS/TB Research Training; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Wellcome Trust-Burroughs Wellcome Fund Infectious Disease Initiative (059131/Z/99/Z, 078835/Z/05/Z, 078835/Z/05/B), the National Institutes of Health/NIAID STD Cooperative Research Center (AI31448), the University of Washington Center for AIDS Research (P30-AI27757), the NIH Fogarty International Center AIDS International Training and Research Program (grant D43-TW00007) and by the Peru ICOHRTA Network for AIDS/TB Research Training (grant U2-RTW007368, U2-RTW007374). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison JJ, 2005, AM J PREV MED, V28, P285, DOI 10.1016/j.amepre.2004.12.013; Alur P, 2002, MED TEACH, V24, P422, DOI 10.1080/01421590220145815; Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; Casebeer Linda, 2004, J Contin Educ Health Prof, V24, P68, DOI 10.1002/chp.1340240203; Casebeer L, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-42; Casebeer LL, 2003, J MED INTERNET RES, V5, DOI 10.2196/jmir.5.3.e20; Chandrasekhar CP, 2001, B WORLD HEALTH ORGAN, V79, P850; Chung S, 2004, ACAD EMERG MED, V11, P143, DOI 10.1197/j.aem.2003.09.012; Cook DA, 2008, JAMA-J AM MED ASSOC, V300, P1181, DOI 10.1001/jama.300.10.1181; Cook DA, 2007, TEACH LEARN MED, V19, P230, DOI 10.1080/10401330701366325; Cook DA, 2007, CLIN MED, V7, P37, DOI 10.7861/clinmedicine.7-1-37; Cook DA, 2010, MED EDUC, V44, P765, DOI 10.1111/j.1365-2923.2010.03723.x; Curran VR, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-10; Curran VR, 2005, MED EDUC, V39, P561, DOI 10.1111/j.1365-2929.2005.02173.x; DAVIS DA, 1992, JAMA-J AM MED ASSOC, V268, P1111, DOI 10.1001/jama.268.9.1111; Fordis M, 2005, JAMA-J AM MED ASSOC, V294, P1043, DOI 10.1001/jama.294.9.1043; Forsetlund L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003030.pub2; Garcia PJ, 2003, SEX TRANSM INFECT, V79, P403, DOI 10.1136/sti.79.5.403; Godlee F, 2004, LANCET, V364, P295, DOI 10.1016/S0140-6736(04)16681-6; Green LA, 2005, J AM BOARD FAM PRACT, V18, P541, DOI 10.3122/jabfm.18.6.541; Harden RM, 2005, J CONTIN EDUC HEALTH, V25, P43, DOI 10.1002/chp.8; Harris AD, 2006, J AM MED INFORM ASSN, V13, P16, DOI 10.1197/jamia.M1749; Hsieh Evelyn J., 2006, Rev Panam Salud Publica, V20, P223, DOI 10.1590/S1020-49892006000900002; Hsieh EJ, 2008, REV PANAM SALUD PUBL, V24, P271, DOI 10.1590/S1020-49892008001000007; Kerfoot BP, 2009, ANN SURG, V249, P744, DOI 10.1097/SLA.0b013e31819f6db8; McKimm J, 2003, BRIT MED J, V326, P870, DOI 10.1136/bmj.326.7394.870; Peabody JW, 2004, ANN INTERN MED, V141, P771, DOI 10.7326/0003-4819-141-10-200411160-00008; *PROY PREVEN, 2010, PREV COM ENF TRANSM; Raupach T, 2009, MED TEACH, V31, pE431, DOI 10.1080/01421590903095502; Rodrigues RJ, 2003, J MED INTERNET RES, V5, DOI 10.2196/jmir.5.1.e4; Stewart M, 2005, FAM MED, V37, P131; STIGMA, 2019, GUID MAN SEX TRANSM; Tian LC, 2007, AIDS, V21, pS137, DOI 10.1097/01.aids.0000304709.02412.3c; Tomasi E, 2004, B WORLD HEALTH ORGAN, V82, P867; US Department of Education Office of Planning Evaluation and Policy Development, 2009, EV EV BAS PRACT ONL; Voelker R, 2003, JAMA-J AM MED ASSOC, V290, P1700, DOI 10.1001/jama.290.13.1700; Wall TC, 2005, J MED INTERNET RES, V7, P25, DOI 10.2196/jmir.7.4.e48; Zary Nabil, 2006, BMC Med Educ, V6, P10, DOI 10.1186/1472-6920-6-10; Zbar RIS, 2001, PLAST RECONSTR SURG, V108, P460, DOI 10.1097/00006534-200108000-00029; Zimitat C, 2001, MED TEACH, V23, P117, DOI 10.1080/01421590120036538	40	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19318	10.1371/journal.pone.0019318	http://dx.doi.org/10.1371/journal.pone.0019318			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573054	Green Published, Green Submitted, gold			2022-12-27	WOS:000290386800009
J	Saridaki, A; Sapountzis, P; Harris, HL; Batista, PD; Biliske, JA; Pavlikaki, H; Oehler, S; Savakis, C; Braig, HR; Bourtzis, K				Saridaki, Aggeliki; Sapountzis, Panagiotis; Harris, Harriet L.; Batista, Philip D.; Biliske, Jennifer A.; Pavlikaki, Harris; Oehler, Stefan; Savakis, Charalambos; Braig, Henk R.; Bourtzis, Kostas			Wolbachia Prophage DNA Adenine Methyltransferase Genes in Different Drosophila-Wolbachia Associations	PLOS ONE			English	Article							CYTOPLASMIC INCOMPATIBILITY; BACTERIOPHAGE-WO; PARB PROTEIN; METHYLATION; EXPRESSION; INFECTION; SIMULANS; ENDOSYMBIONT; SEQUENCES; EVOLUTION	Wolbachia is an obligatory intracellular bacterium which often manipulates the reproduction of its insect and isopod hosts. In contrast, Wolbachia is an essential symbiont in filarial nematodes. Lately, Wolbachia has been implicated in genomic imprinting of host DNA through cytosine methylation. The importance of DNA methylation in cell fate and biology calls for in depth studing of putative methylation-related genes. We present a molecular and phylogenetic analysis of a putative DNA adenine methyltransferase encoded by a prophage in the Wolbachia genome. Two slightly different copies of the gene, met1 and met2, exhibit a different distribution over various Wolbachia strains. The met2 gene is present in the majority of strains, in wAu, however, it contains a frameshift caused by a 2 bp deletion. Phylogenetic analysis of the met2 DNA sequences suggests a long association of the gene with the Wolbachia host strains. In addition, our analysis provides evidence for previously unnoticed multiple infections, the detection of which is critical for the molecular elucidation of modification and/or rescue mechanism of cytoplasmic incompatibility.	[Saridaki, Aggeliki; Sapountzis, Panagiotis; Bourtzis, Kostas] Univ Ioannina, Dept Environm & Nat Resources Management, Agrinion, Greece; [Harris, Harriet L.; Batista, Philip D.; Biliske, Jennifer A.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Pavlikaki, Harris; Oehler, Stefan; Savakis, Charalambos; Bourtzis, Kostas] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Crete, Greece; [Pavlikaki, Harris] Technol Educ Inst Kalamata, Kalamata, Greece; [Oehler, Stefan; Savakis, Charalambos; Bourtzis, Kostas] Biomed Sci Res Ctr Alexander Fleming, Vari, Greece; [Savakis, Charalambos] Univ Crete, Sch Med, Iraklion, Crete, Greece; [Braig, Henk R.] Univ Bangor, Sch Biol Sci, Bangor, Gwynedd, Wales	University of Ioannina; University of Alberta; Foundation for Research & Technology - Hellas (FORTH); Technical Educational Institute Kalamata; Alexander Fleming Biomedical Sciences Research Center; University of Crete; Bangor University	Saridaki, A (corresponding author), Univ Ioannina, Dept Environm & Nat Resources Management, Agrinion, Greece.	kbourtz@uoi.gr	Braig, Henk/I-5477-2013	Braig, Henk/0000-0001-9592-1141; Sapountzis, Panagiotis/0000-0001-6286-3918	European Union [QLK3-2000-01079]; European Community [CSA-SA_REGPROT-2007-1]; BBSRC, United Kingdom; NSERC, Canada	European Union(European Commission); European Community(European Commission); BBSRC, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NSERC, Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported in part by the European Union grant QLK3-2000-01079 (to KB, HRB, CS, and Richard Stouthamer), by the European Community's Seventh Framework Programme CSA-SA_REGPROT-2007-1 (to KB), by BBSRC, United Kingdom (to HRB), and by the NSERC, Canada grant (to HLH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Blaisdell BE, 1996, P NATL ACAD SCI USA, V93, P5854, DOI 10.1073/pnas.93.12.5854; Bordenstein Seth R., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020043; Bordenstein SR, 2004, MOL BIOL EVOL, V21, P1981, DOI 10.1093/molbev/msh211; Bourtzis K, 1998, NATURE, V391, P852, DOI 10.1038/36017; Bourtzis K., 1994, Insect Molecular Biology, V3, P131, DOI 10.1111/j.1365-2583.1994.tb00160.x; Bourtzis K, 1996, GENETICS, V144, P1063; Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998; Clark ME, 2003, MECH DEVELOP, V120, P185, DOI 10.1016/S0925-4773(02)00424-0; Collier J, 2007, P NATL ACAD SCI USA, V104, P17111, DOI 10.1073/pnas.0708112104; Cordaux R, 2008, GENE, V409, P20, DOI 10.1016/j.gene.2007.10.035; Drummond AJ., 2010, GENEIOUS V5 3 3; Duron O, 2006, MOL ECOL, V15, P3061, DOI 10.1111/j.1365-294X.2006.02996.x; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Fujii Y, 2004, BIOCHEM BIOPH RES CO, V317, P1183, DOI 10.1016/j.bbrc.2004.03.164; Gavotte L, 2004, INSECT MOL BIOL, V13, P147, DOI 10.1111/j.0962-1075.2004.00471.x; Gavotte L, 2007, MOL BIOL EVOL, V24, P427, DOI 10.1093/molbev/msl171; GIORDANO R, 1995, GENETICS, V140, P1307; Grohmann E, 1997, MICROBIOL-UK, V143, P3889, DOI 10.1099/00221287-143-12-3889; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hattman S, 1997, NUCLEIC ACIDS RES, V25, P4385, DOI 10.1093/nar/25.21.4385; Heusipp G, 2007, INT J MED MICROBIOL, V297, P1, DOI 10.1016/j.ijmm.2006.10.002; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hoffmann AA, 1996, HEREDITY, V76, P1, DOI 10.1038/hdy.1996.1; HOFFMANN AA, 1986, EVOLUTION, V40, P692, DOI 10.1111/j.1558-5646.1986.tb00531.x; Hung MS, 1999, P NATL ACAD SCI USA, V96, P11940, DOI 10.1073/pnas.96.21.11940; Ishmael N, 2009, MICROBIOL-SGM, V155, P2211, DOI 10.1099/mic.0.027581-0; James AC, 2000, EVOLUTION, V54, P1661, DOI 10.1111/j.0014-3820.2000.tb00710.x; Johnson EP, 1999, J BACTERIOL, V181, P6010, DOI 10.1128/JB.181.19.6010-6018.1999; Kahng LS, 2001, J BACTERIOL, V183, P3065, DOI 10.1128/JB.183.10.3065-3075.2001; Kent BN, 2010, TRENDS MICROBIOL, V18, P173, DOI 10.1016/j.tim.2009.12.011; Klasson L, 2008, MOL BIOL EVOL, V25, P1877, DOI 10.1093/molbev/msn133; Klasson L, 2009, P NATL ACAD SCI USA, V106, P5725, DOI 10.1073/pnas.0810753106; Kunert N, 2003, DEVELOPMENT, V130, P5083, DOI 10.1242/dev.00716; Landmann F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000343; Lobner-Olesen A, 2005, CURR OPIN MICROBIOL, V8, P154, DOI 10.1016/j.mib.2005.02.009; Low DA, 2001, INFECT IMMUN, V69, P7197, DOI 10.1128/IAI.69.12.7197-7204.2001; Low DA, 2008, CURR OPIN MICROBIOL, V11, P106, DOI 10.1016/j.mib.2008.02.012; Lyko F, 2000, NATURE, V408, P538, DOI 10.1038/35046205; Lyko F, 2000, MECH DEVELOP, V95, P215, DOI 10.1016/S0925-4773(00)00325-7; Lynch KH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-599; Masui S, 2000, J MOL EVOL, V51, P491, DOI 10.1007/s002390010112; Masui S, 2001, BIOCHEM BIOPH RES CO, V283, P1099, DOI 10.1006/bbrc.2001.4906; Mercot H, 1998, NATURE, V391, P853, DOI 10.1038/36021; MERCOT H, 1995, GENETICS, V141, P1015; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Murphy KC, 2008, J BACTERIOL, V190, P438, DOI 10.1128/JB.01373-07; Murray NE, 2002, MICROBIOL-SGM, V148, P3, DOI 10.1099/00221287-148-1-3; Navajas M, 1998, HEREDITY, V80, P742, DOI 10.1046/j.1365-2540.1998.00349.x; Negri H, 2009, P ROY SOC B-BIOL SCI, V276, P2485, DOI 10.1098/rspb.2009.0324; ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699; Poinsot D, 1998, GENETICS, V150, P227; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pouillot F, 2007, MICROBIOL-SGM, V153, P2426, DOI 10.1099/mic.0.2007/005736-0; Reynolds KT, 2002, GENET RES, V80, P79, DOI 10.1017/S0016672302005827; Robertson GT, 2000, J BACTERIOL, V182, P3482, DOI 10.1128/JB.182.12.3482-3489.2000; ROUSSET F, 1995, P NATL ACAD SCI USA, V92, P6389, DOI 10.1073/pnas.92.14.6389; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sanogo YO, 2005, J MED ENTOMOL, V42, P789, DOI 10.1603/0022-2585(2005)042[0789:NEFBWO]2.0.CO;2; Saridaki A, 2010, CURR OPIN MICROBIOL, V13, P67, DOI 10.1016/j.mib.2009.11.005; Sinkins SP, 2005, NATURE, V436, P257, DOI 10.1038/nature03629; STERNBERG N, 1990, P NATL ACAD SCI USA, V87, P8070, DOI 10.1073/pnas.87.20.8070; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Tanaka K, 2009, APPL ENVIRON MICROB, V75, P5676, DOI 10.1128/AEM.01172-09; Unger E, 2001, TRANSGENIC RES, V10, P409, DOI 10.1023/A:1012032000383; Wion D, 2006, NAT REV MICROBIOL, V4, P183, DOI 10.1038/nrmicro1350; WRIGHT JD, 1978, J ULTRA MOL STRUCT R, V63, P79, DOI 10.1016/S0022-5320(78)80046-X; Wright R, 1997, J BACTERIOL, V179, P5869, DOI 10.1128/jb.179.18.5869-5877.1997; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Yamada R, 2011, INSECT MOL BIOL, V20, P75, DOI 10.1111/j.1365-2583.2010.01042.x; Zabalou S, 2004, GENETICS, V167, P827, DOI 10.1534/genetics.103.015990; Zabalou S, 2008, GENETICS, V178, P2145, DOI 10.1534/genetics.107.086488; Zhang JZ, 2006, VACCINE, V24, P2317, DOI 10.1016/j.vaccine.2005.11.044	75	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19708	10.1371/journal.pone.0019708	http://dx.doi.org/10.1371/journal.pone.0019708			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573076	Green Published, gold, Green Submitted			2022-12-27	WOS:000290305600041
J	van Gremberghe, I; Leliaert, F; Mergeay, J; Vanormelingen, P; Van der Gucht, K; Debeer, AE; Lacerot, G; De Meester, L; Vyverman, W				van Gremberghe, Ineke; Leliaert, Frederik; Mergeay, Joachim; Vanormelingen, Pieter; Van der Gucht, Katleen; Debeer, Ann-Eline; Lacerot, Gissell; De Meester, Luc; Vyverman, Wim			Lack of Phylogeographic Structure in the Freshwater Cyanobacterium Microcystis aeruginosa Suggests Global Dispersal	PLOS ONE			English	Article							16S RDNA SEQUENCES; GENETIC DIVERSITY; TOXIC CYANOBACTERIUM; MICROBIAL BIOGEOGRAPHY; SPATIOTEMPORAL CHANGES; NATURAL-POPULATIONS; SOFTWARE PACKAGE; SPACER SEQUENCES; LOCAL FACTORS; STRAINS	Background: Free-living microorganisms have long been assumed to have ubiquitous distributions with little biogeographic signature because they typically exhibit high dispersal potential and large population sizes. However, molecular data provide contrasting results and it is far from clear to what extent dispersal limitation determines geographic structuring of microbial populations. We aimed to determine biogeographical patterns of the bloom-forming freshwater cyanobacterium Microcystis aeruginosa. Being widely distributed on a global scale but patchily on a regional scale, this prokaryote is an ideal model organism to study microbial dispersal and biogeography. Methodology/Principal Findings: The phylogeography of M. aeruginosa was studied based on a dataset of 311 rDNA internal transcribed spacer (ITS) sequences sampled from six continents. Richness of ITS sequences was high (239 ITS types were detected). Genetic divergence among ITS types averaged 4% (maximum pairwise divergence was 13%). Preliminary analyses revealed nearly completely unresolved phylogenetic relationships and a lack of genetic structure among all sequences due to extensive homoplasy at multiple hypervariable sites. After correcting for this, still no clear phylogeographic structure was detected, and no pattern of isolation by distance was found on a global scale. Concomitantly, genetic differentiation among continents was marginal, whereas variation within continents was high and was mostly shared with all other continents. Similarly, no genetic structure across climate zones was detected. Conclusions/Significance: The high overall diversity and wide global distribution of common ITS types in combination with the lack of phylogeographic structure suggest that intercontinental dispersal of M. aeruginosa ITS types is not rare, and that this species might have a truly cosmopolitan distribution.	[van Gremberghe, Ineke; Vanormelingen, Pieter; Van der Gucht, Katleen; Debeer, Ann-Eline; Vyverman, Wim] Univ Ghent, Lab Protistol & Aquat Ecol, B-9000 Ghent, Belgium; [Leliaert, Frederik] Univ Ghent, Phycol Res Grp, B-9000 Ghent, Belgium; [Mergeay, Joachim; De Meester, Luc] Katholieke Univ Leuven, Lab Aquat Ecol & Evolutionary Biol, Leuven, Belgium; [Mergeay, Joachim] Res Inst Nat & Forest, Geraardsbergen, Belgium; [Lacerot, Gissell] Wageningen Univ, Dept Aquat Ecol & Water Qual Management, Wageningen, Netherlands; [Lacerot, Gissell] Univ Republica, Fac Ciencias, Secc Limnol, Montevideo, Uruguay	Ghent University; Ghent University; KU Leuven; Research Institute for Nature & Forest; Wageningen University & Research; Universidad de la Republica, Uruguay	van Gremberghe, I (corresponding author), Univ Ghent, Lab Protistol & Aquat Ecol, B-9000 Ghent, Belgium.	Wim.Vyverman@ugent.be	De Meester, Luc/F-3832-2015; Mergeay, Joachim/E-7670-2011; Leliaert, Frederik/A-9162-2009	De Meester, Luc/0000-0001-5433-6843; Mergeay, Joachim/0000-0002-6504-0551; Leliaert, Frederik/0000-0002-4627-7318; Lacerot, Gissell/0000-0002-9705-5715	BELSPO (Belgian Science Policy); European Commission - Research Directorate-General [EVK2-CT-1999-00046]; VLIR (Vlaamse Interuniversitaire Raad); NWO/WOTRO (The Netherlands Organisation for Scientific Research/Science for Global Development); FWO (Research Foundation Flanders) [G.0419.08]	BELSPO (Belgian Science Policy)(Belgian Federal Science Policy Office); European Commission - Research Directorate-General(European CommissionEuropean Commission Joint Research Centre); VLIR (Vlaamse Interuniversitaire Raad); NWO/WOTRO (The Netherlands Organisation for Scientific Research/Science for Global Development)(Netherlands Organization for Scientific Research (NWO)); FWO (Research Foundation Flanders)(FWO)	Sampling of lakes containing Microcystis was done in the framework of different projects: B-Blooms (EV/34) and B-Blooms2 (SD/TE/01A) nationally supported by BELSPO (Belgian Science Policy, www.belspo.be), BIOMAN "Biodiversity and human impact in shallow lakes'' (EVK2-CT-1999-00046) supported by the European Commission - Research Directorate-General, Aquatic Ecology project in Institutional Cooperation with Mekelle University supported by VLIR (Vlaamse Interuniversitaire Raad, www.vlir.be), SALGA "South American Lake Gradient Analysis'' supported by NWO/WOTRO (The Netherlands Organisation for Scientific Research/Science for Global Development) and other financiers see www.projectenaew.wur.nl/salga, and "Thermal adaptation and its interplay with biotic interactions across a latitude gradient'' (G.0419.08) supported by FWO (Research Foundation Flanders, www.fwo.be). FL, JM, and PV are indebted to the FWO for a postdoctoral fellowship grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Baurain D, 2002, J PHYCOL, V38, P384, DOI 10.1046/j.1529-8817.2002.01010.x; Belkhir K, 2004, GENETIX 4 05 LOGICIE; Bittencourt-Oliveira MD, 2001, J PHYCOL, V37, P810; BLACK WC, 1985, THEOR APPL GENET, V70, P491, DOI 10.1007/BF00305981; BOILEAU MG, 1992, J EVOLUTION BIOL, V5, P25, DOI 10.1046/j.1420-9101.1992.5010025.x; Boyer SL, 2001, MOL BIOL EVOL, V18, P1057, DOI 10.1093/oxfordjournals.molbev.a003877; Briand E, 2009, ISME J, V3, P419, DOI 10.1038/ismej.2008.121; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Brunberg AK, 2002, J PLANKTON RES, V24, P1247, DOI 10.1093/plankt/24.11.1247; Cadel-Six S, 2008, MOL BIOL EVOL, V25, P2031, DOI 10.1093/molbev/msn150; Casteleyn G, 2010, P NATL ACAD SCI USA, V107, P12952, DOI 10.1073/pnas.1001380107; Chen F, 2006, APPL ENVIRON MICROB, V72, P2239, DOI 10.1128/AEM.72.3.2239-2243.2006; Cho JC, 2000, APPL ENVIRON MICROB, V66, P5448, DOI 10.1128/AEM.66.12.5448-5456.2000; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dadheech PK, 2010, PHYCOLOGIA, V49, P361, DOI 10.2216/09-71.1; de Figueiredo DR, 2006, HYDROBIOLOGIA, V568, P145, DOI 10.1007/s10750-006-0196-y; De Rijk P, 2003, BIOINFORMATICS, V19, P299, DOI 10.1093/bioinformatics/19.2.299; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Figueredo CC, 2009, LIMNOLOGICA, V39, P264, DOI 10.1016/j.limno.2009.06.009; Figuerola J, 2003, GLOBAL ECOL BIOGEOGR, V12, P427, DOI 10.1046/j.1466-822X.2003.00043.x; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Foissner W, 2006, ACTA PROTOZOOL, V45, P111; Frangeul L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-274; Fraser C, 2009, SCIENCE, V323, P741, DOI 10.1126/science.1159388; Fu YX, 1997, GENETICS, V147, P915; Glockner FO, 2000, APPL ENVIRON MICROB, V66, P5053, DOI 10.1128/AEM.66.11.5053-5065.2000; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Green JL, 2008, SCIENCE, V320, P1039, DOI 10.1126/science.1153475; GUILLARD RR, 1972, J PHYCOL, V8, P10, DOI 10.1111/j.0022-3646.1972.00010.x; Haande S, 2008, HARMFUL ALGAE, V7, P692, DOI 10.1016/j.hal.2008.02.010; Haande S, 2007, ARCH MICROBIOL, V188, P15, DOI 10.1007/s00203-007-0219-8; Havel JE, 2006, BIOL INVASIONS, V8, P459, DOI 10.1007/s10530-005-6410-4; Hillebrand H, 2001, ECOGRAPHY, V24, P251, DOI 10.1034/j.1600-0587.2001.240302.x; HILLIS DM, 1992, J HERED, V83, P189, DOI 10.1093/oxfordjournals.jhered.a111190; Hoffmann L, 1996, HYDROBIOLOGIA, V336, P33, DOI 10.1007/BF00010817; Hugenholtz P, 2003, INT J SYST EVOL MICR, V53, P289, DOI 10.1099/ijs.0.02441-0; HUISMAN J, HARMFUL CYANOBACTERI; Humbert JF, 2005, MICROB ECOL, V49, P308, DOI 10.1007/s00248-004-0004-z; Ionescu D, 2010, FEMS MICROBIOL ECOL, V72, P103, DOI 10.1111/j.1574-6941.2010.00835.x; Iteman I, 2000, MICROBIOL-SGM, V146, P1275, DOI 10.1099/00221287-146-6-1275; Janse I, 2004, APPL ENVIRON MICROB, V70, P3979, DOI 10.1128/AEM.70.7.3979-3987.2004; Janse I, 2003, APPL ENVIRON MICROB, V69, P6634, DOI 10.1128/AEM.69.11.6634-6643.2003; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Jungblut AD, 2010, ISME J, V4, P191, DOI 10.1038/ismej.2009.113; Kaneko T, 2007, DNA RES, V14, P247, DOI 10.1093/dnares/dsm026; Kardinaal WEA, 2007, AQUAT MICROB ECOL, V48, P1, DOI 10.3354/ame048001; Kellogg CA, 2006, TRENDS ECOL EVOL, V21, P638, DOI 10.1016/j.tree.2006.07.004; Kingman J., 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Kristiansen J, 1996, HYDROBIOLOGIA, V336, P151, DOI 10.1007/BF00010829; KRISTIANSEN J, 1996, BIOGEOGRAPHY FRESHWA; Lepere Claire, 2000, Systematics and Geography of Plants, V70, P275, DOI 10.2307/3668646; Litvaitis MK, 2002, HYDROBIOLOGIA, V468, P135, DOI 10.1023/A:1015262621848; Lodders N, 2005, ENVIRON MICROBIOL, V7, P434, DOI 10.1111/j.1462-2920.2005.00730.x; Marshall WA, 1997, ECOGRAPHY, V20, P585, DOI 10.1111/j.1600-0587.1997.tb00427.x; Martiny AC, 2009, ENVIRON MICROBIOL, V11, P823, DOI 10.1111/j.1462-2920.2008.01803.x; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; McGregor Glenn B., 2000, Lakes and Reservoirs Research and Management, V5, P195, DOI 10.1046/j.1440-1770.2000.00115.x; Miller SR, 2007, APPL ENVIRON MICROB, V73, P4751, DOI 10.1128/AEM.02945-06; MULLINS TD, 1995, LIMNOL OCEANOGR, V40, P148, DOI 10.4319/lo.1995.40.1.0148; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Oberholster PJ, 2005, AFR J BIOTECHNOL, V4, P389; Otsuka S, 2001, INT J SYST EVOL MICR, V51, P873, DOI 10.1099/00207713-51-3-873; Otsuka S, 1999, FEMS MICROBIOL LETT, V172, P15, DOI 10.1111/j.1574-6968.1999.tb13443.x; Otsuka S, 1998, FEMS MICROBIOL LETT, V164, P119, DOI 10.1016/S0378-1097(98)00202-X; Padisak J., 1997, ARCH HYDROBIOL, V4, P563; Papke RT, 2003, ENVIRON MICROBIOL, V5, P650, DOI 10.1046/j.1462-2920.2003.00460.x; Parnell JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012919; Pearson T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-78; Pena A, 2010, ISME J, V4, P882, DOI 10.1038/ismej.2010.6; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Ramette A, 2007, MICROB ECOL, V53, P197, DOI 10.1007/s00248-005-5010-2; Rocap G, 2002, APPL ENVIRON MICROB, V68, P1180, DOI 10.1128/AEM.68.3.1180-1191.2002; ROUND F, ECOLOGY ALGAE; Rounge TB, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-141; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rudi K, 1997, APPL ENVIRON MICROB, V63, P2593, DOI 10.1128/AEM.63.7.2593-2599.1997; Rudi K, 1998, J BACTERIOL, V180, P3453, DOI 10.1128/JB.180.13.3453-3461.1998; Rudi K, 2002, J BACTERIOL, V184, P666, DOI 10.1128/JB.184.3.666-671.2002; Sabart M, 2009, ENV MICROBIOL REP, V1, P263, DOI 10.1111/j.1758-2229.2009.00042.x; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tanabe Y, 2007, MICROBIOL-SGM, V153, P3695, DOI 10.1099/mic.0.2007/010645-0; Tanabe Y, 2009, ENV MICROBIOL REP, V1, P575, DOI 10.1111/j.1758-2229.2009.00088.x; Templeton AR, 1998, MOL ECOL, V7, P381, DOI 10.1046/j.1365-294x.1998.00308.x; TEMPLETON AR, 1992, GENETICS, V132, P619; TEMPLETON AR, POPULATION GENETICS; Thompson JR, 2002, NUCLEIC ACIDS RES, V30, P2083, DOI 10.1093/nar/30.9.2083; Van der Gucht K, 2007, P NATL ACAD SCI USA, V104, P20404, DOI 10.1073/pnas.0707200104; van Gremberghe I, 2009, HYDROBIOLOGIA, V635, P147, DOI 10.1007/s10750-009-9907-5; VANGREMBERGHE I, 2011, GENETIC DIV IN PRESS; Vareli K, 2009, J ENVIRON MONITOR, V11, P1506, DOI 10.1039/b903093j; Verleyen E, 2009, OIKOS, V118, P1239, DOI 10.1111/j.1600-0706.2009.17575.x; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Vyverman W, 2007, ECOLOGY, V88, P1924, DOI 10.1890/06-1564.1; Wang GCY, 1996, MICROBIOL-SGM, V142, P1107, DOI 10.1099/13500872-142-5-1107; Wells RDS, 1999, J AQUAT PLANT MANAGE, V37, P49; Whitaker RJ, 2006, PHILOS T R SOC B, V361, P1975, DOI 10.1098/rstb.2006.1927; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Wilson AE, 2006, APPL ENVIRON MICROB, V72, P7386, DOI 10.1128/AEM.00834-06; Wu ZX, 2007, J INTEGR PLANT BIOL, V49, P262, DOI 10.1111/j.1744-7909.2007.00368.x; Wu ZX, 2008, HYDROBIOLOGIA, V596, P47, DOI 10.1007/s10750-007-9056-7; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yoshida M, 2008, J APPL MICROBIOL, V105, P407, DOI 10.1111/j.1365-2672.2008.03754.x; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; Zwart G, 1998, FEMS MICROBIOL ECOL, V25, P159, DOI 10.1016/S0168-6496(97)00092-5; Zwirglmaier K, 2008, ENVIRON MICROBIOL, V10, P147, DOI 10.1111/j.1462-2920.2007.01440.x	115	89	90	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19561	10.1371/journal.pone.0019561	http://dx.doi.org/10.1371/journal.pone.0019561			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573169	Green Published, Green Submitted, gold			2022-12-27	WOS:000290256400023
J	Switzer, WM; Jia, HW; Zheng, HQ; Tang, SH; Heneine, W				Switzer, William M.; Jia, Hongwei; Zheng, HaoQiang; Tang, Shaohua; Heneine, Walid			No Association of Xenotropic Murine Leukemia Virus-Related Viruses with Prostate Cancer	PLOS ONE			English	Article							XMRV INFECTION; BLOOD-DONORS; GENE-THERAPY; RETROVIRUS; SEQUENCES; ASSAY; CONTAMINATION; ANTIBODIES; MULTIPLE; TISSUE	Background: The association of the xenotropic murine leukemia virus-related virus (XMRV) with prostate cancer continues to receive heightened attention as studies report discrepant XMRV prevalences ranging from zero up to 23%. It is unclear if differences in the diagnostic testing, disease severity, geography, or other factors account for the discordant results. We report here the prevalence of XMRV in a population with well-defined prostate cancers and RNase L polymorphism. We used broadly reactive PCR and Western blot (WB) assays to detect infection with XMRV and related murine leukemia viruses (MLV). Methodology/Principal Findings: We studied specimens from 162 US patients diagnosed with prostate cancer with a intermediate to advanced stage (Gleason Scores of 5-10; moderate (46%) poorly differentiated tumors (54%)). Prostate tissue DNA was tested by PCR assays that detect XMRV and MLV variants. To exclude contamination with mouse DNA, we also designed and used a mouse-specific DNA PCR test. Detailed phylogenetic analysis was used to infer evolutionary relationships. RNase L typing showed that 9.3% were homozygous (QQ) for the R462Q RNase L mutation, while 45.6% and 45.1% were homozygous or heterozygous, respectively. Serologic testing was performed by a WB test. Three of 162 (1.9%) prostate tissue DNA were PCR-positive for XMRV and had undetectable mouse DNA. None was homozygous for the QQ mutation. Plasma from all three persons was negative for viral RNA by RT-PCR. All 162 patients were WB negative. Phylogenetic analysis inferred a distinct XMRV. Conclusions and Their Significance: We found a very low prevalence of XMRV in prostate cancer patients. Infection was confirmed by phylogenetic analysis and absence of contaminating mouse DNA. The finding of undetectable antibodies and viremia in all three patients may reflect latent infection. Our results do not support an association of XMRV or MLV variants with prostate cancer.	[Switzer, William M.; Jia, Hongwei; Zheng, HaoQiang; Tang, Shaohua; Heneine, Walid] Ctr Dis Control & Prevent, Branch Lab, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Switzer, WM (corresponding author), Ctr Dis Control & Prevent, Branch Lab, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.	bis3@cdc.gov			Centers for Disease Control and Prevention per annual appropriations of the United States Government	Centers for Disease Control and Prevention per annual appropriations of the United States Government(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding for the study was provided by the Centers for Disease Control and Prevention per annual appropriations of the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloia AL, 2010, CANC RES; Arnold RS, 2010, UROLOGY, V75, P755, DOI 10.1016/j.urology.2010.01.038; Busch MP, 2000, TRANSFUSION, V40, P443, DOI 10.1046/j.1537-2995.2000.40040443.x; DANIELSON BX, 2010, J INFECT DIS; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016; Garson JA, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-13; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; HENRICH TX, 2010, J INFECT DIS; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Hong P, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-224; Hue S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-111; Hussain AI, 2003, VIROLOGY, V309, P248, DOI 10.1016/S0042-6822(03)00070-9; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kim S, 2008, J VIROL, V82, P9964, DOI 10.1128/JVI.01299-08; Knouf EC, 2009, J VIROL, V83, P7353, DOI 10.1128/JVI.00546-09; Lerche NW, 1997, LAB ANIM SCI, V47, P263; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Matthews AL, 1999, TRANSPLANTATION, V67, P939, DOI 10.1097/00007890-199904150-00002; Mo ZN, 2009, PROSTATE, V69, P662, DOI 10.1002/pros.20907; Moorthy HK, 2008, INDIAN J UROL, V24, P295, DOI 10.4103/0970-1591.42608; Morse II H. C., 2007, MOUSE BIOMEDICAL RES, V2, P269; MURAD A, 2009, PROSTATE CANC PROSTA; Odedina Folakemi T, 2009, Infect Agent Cancer, V4 Suppl 1, pS2, DOI 10.1186/1750-9378-4-S1-S2; Qiu XX, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-68; Robinson MJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-108; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Sfanos KS, 2008, PROSTATE, V68, P306, DOI 10.1002/pros.20680; SHARMA P, 2010, C RETR OPP INF SAN F; Silverman RH, 2003, BIOCHEMISTRY-US, V42, P1805, DOI 10.1021/bi027147i; Switzer WM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-57; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; van Kuppeveld FJM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1018; Verhaegh G. W., 2010, PROSTATE; Wolfe ND, 2004, LANCET, V363, P932, DOI 10.1016/S0140-6736(04)15787-5	40	32	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19065	10.1371/journal.pone.0019065	http://dx.doi.org/10.1371/journal.pone.0019065			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573232	Green Published, gold			2022-12-27	WOS:000290224800015
J	Bos, N; Grinsted, L; Holman, L				Bos, Nick; Grinsted, Lena; Holman, Luke			Wax On, Wax Off: Nest Soil Facilitates Indirect Transfer of Recognition Cues between Ant Nestmates	PLOS ONE			English	Article							APIS-MELLIFERA; CUTICULAR HYDROCARBONS; HYMENOPTERA; EVOLUTION; QUEEN; WASP	Social animals use recognition cues to discriminate between group members and non-members. These recognition cues may be conceptualized as a label, which is compared to a neural representation of acceptable cue combinations termed the template. In ants and other social insects, the label consists of a waxy layer of colony-specific hydrocarbons on the body surface. Genetic and environmental differences between colony members may confound recognition and social cohesion, so many species perform behaviors that homogenize the odor label, such as mouth-to-mouth feeding and allogrooming. Here, we test for another mechanism of cue exchange: indirect transfer of cuticular hydrocarbons via the nest material. Using a combination of chemical analysis and behavioral experiments with Camponotus aethiops ants, we show that nest soil indirectly transfers hydrocarbons between ants and affects recognition behavior. We also found evidence that olfactory cues on the nest soil influence nestmate recognition, but this effect was not observed in all colonies. These results demonstrate that cuticular hydrocarbons deposited on the nest soil are important in creating uniformity in the odor label and may also contribute to the template.	[Bos, Nick; Grinsted, Lena; Holman, Luke] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Grinsted, Lena] Aarhus Univ, Dept Biol Sci, Aarhus, Denmark	University of Copenhagen; Aarhus University	Bos, N (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	nbos@bio.ku.dk	Holman, Luke/L-4392-2014; Bos, Nick/H-4903-2012; Grinsted, Aslak/J-9273-2012	Grinsted, Aslak/0000-0003-1634-6009; Grinsted, Lena/0000-0003-3904-3721; Bos, Nick/0000-0002-1982-1525	Marie Curie Intra-European Fellowship [235403]	Marie Curie Intra-European Fellowship(European Commission)	LH was supported by a Marie Curie Intra-European Fellowship (#235403; CHEMDOC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akino Toshiharu, 2008, Myrmecological News, V11, P173; Benabentos R, 2009, CURR BIOL, V19, P567, DOI 10.1016/j.cub.2009.02.037; BONAVITACOUGOURDAN A, 1987, J ENTOMOL SCI, V22, P1; Boomsma JJ, 2003, P NATL ACAD SCI USA, V100, P8799, DOI 10.1073/pnas.1430283100; Boulay R, 2001, BEHAV PROCESS, V55, P67, DOI 10.1016/S0376-6357(01)00163-2; Boulay R, 2000, ANIM BEHAV, V59, P1127, DOI 10.1006/anbe.2000.1408; Couvillon MJ, 2007, BIOL LETTERS, V3, P228, DOI 10.1098/rsbl.2006.0612; Couvillon MJ, 2009, J APICULT RES, V48, P225, DOI 10.3896/IBRA.1.48.4.01; CROZIER RH, 1979, BEHAV ECOL SOCIOBIOL, V4, P217, DOI 10.1007/BF00297645; D'Ettorre P, 2006, ANIM BEHAV, V71, P773, DOI 10.1016/j.anbehav.2005.05.014; d'Ettorre P, 2010, ANT ECOLOGY, P194; Darmaillacq AS, 2008, ANIM BEHAV, V76, P131, DOI 10.1016/j.anbehav.2008.02.006; Dietemann V, 2005, ANIM BEHAV, V69, P777, DOI 10.1016/j.anbehav.2004.07.006; Downs SG, 2000, BEHAV ECOL, V11, P326, DOI 10.1093/beheco/11.3.326; GAMBOA GJ, 1991, ETHOLOGY, V88, P109; Gardner A, 2010, EVOLUTION, V64, P25, DOI 10.1111/j.1558-5646.2009.00842.x; Guerrieri FJ, 2009, P ROY SOC B-BIOL SCI, V276, P2461, DOI 10.1098/rspb.2008.1860; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hefetz Abraham, 2007, Myrmecological News, V10, P59; Holman L, 2010, P ROY SOC B-BIOL SCI, V277, P3793, DOI 10.1098/rspb.2010.0984; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Lahav S, 1999, NATURWISSENSCHAFTEN, V86, P246, DOI 10.1007/s001140050609; Lenoir A, 2001, ANNU REV ENTOMOL, V46, P573, DOI 10.1146/annurev.ento.46.1.573; Lenoir A, 1999, INFORMATION PROCESSING IN SOCIAL INSECTS, P219; Lenoir A, 2009, J CHEM ECOL, V35, P913, DOI 10.1007/s10886-009-9669-6; Liebert AE, 2004, ANN ZOOL FENN, V41, P747; Martin SJ, 2009, INSECT SOC, V56, P375, DOI 10.1007/s00040-009-0035-z; McGlothlin JW, 2010, EVOLUTION, V64, P2558, DOI 10.1111/j.1558-5646.2010.01012.x; MESKALI M, 1995, INSECT SOC, V42, P347, DOI 10.1007/BF01242163; Nehring V, 2010, P ROYAL SOC B, P1; Oppelt A, 2009, J INSECT PHYSIOL, V55, P624, DOI 10.1016/j.jinsphys.2009.03.010; Ottoni EB, 2000, BEHAV RES METH INS C, V32, P446, DOI 10.3758/BF03200814; Ozaki M, 2005, SCIENCE, V309, P311, DOI 10.1126/science.1105244; REEVE HK, 1989, AM NAT, V133, P407, DOI 10.1086/284926; Sharp SP, 2005, NATURE, V434, P1127, DOI 10.1038/nature03522; Singer TL, 1996, J INSECT BEHAV, V9, P857, DOI 10.1007/BF02208974; SOROKER V, 1995, J CHEM ECOL, V21, P365, DOI 10.1007/BF02036724; Stroeymeyt N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012377; Tibbetts EA, 2002, P ROY SOC B-BIOL SCI, V269, P1423, DOI 10.1098/rspb.2002.2031; Torres CW, 2007, INSECT SOC, V54, P363, DOI 10.1007/s00040-007-0954-5; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; TURILLAZZI S, 1990, ETHOLOGY, V84, P47, DOI 10.1111/j.1439-0310.1990.tb00784.x; van Zweden JS, 2010, J EVOLUTION BIOL, V23, P1498, DOI 10.1111/j.1420-9101.2010.02020.x; van Zweden JS, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P222, DOI 10.1017/CBO9780511711909.012; van Zweden JS, 2009, J INSECT PHYSIOL, V55, P158, DOI 10.1016/j.jinsphys.2008.11.001	45	35	35	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19435	10.1371/journal.pone.0019435	http://dx.doi.org/10.1371/journal.pone.0019435			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559364	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000290024700170
J	Kim, KK; Singh, RK; Strongin, RM; Moore, RG; Brard, L; Lange, TS				Kim, Kyu Kwang; Singh, Rakesh K.; Strongin, Robert M.; Moore, Richard G.; Brard, Laurent; Lange, Thilo S.			Organometallic Iron(III)-Salophene Exerts Cytotoxic Properties in Neuroblastoma Cells via MAPK Activation and ROS Generation	PLOS ONE			English	Article							CANCER-CELLS; OXIDATIVE STRESS; DNA-BINDING; CLEAVING PROPERTIES; APOPTOSIS; COMPLEXES; TARGET; COPPER	The objective of the present study was to investigate the specific effects of Iron(III)-salophene (Fe-SP) on viability, morphology, proliferation, cell cycle progression, ROS generation and pro-apoptotic MAPK activation in neuroblastoma (NB) cells. A NCI-DTP cancer screen revealed that Fe-SP displayed high toxicity against cell lines of different tumor origin but not tumor type-specificity. In a viability screen Fe-SP exhibited high cytotoxicity against all three NB cell lines tested. The compound caused cell cycle arrest in G1 phase, suppression of cells progressing through S phase, morphological changes, disruption of the mitochondrial membrane depolarization potential, induction of apoptotic markers as well as p38 and JNK MAPK activation, DNA degradation, and elevated generation of reactive oxygen species (ROS) in SMS-KCNR NB cells. In contrast to Fe-SP, non-complexed salophene or Cu(II)-SP did not raise ROS levels in NB or SKOV-3 ovarian cancer control cells. Cytotoxicity of Fe-SP and activation of caspase-3, -7, PARP, pro-apoptotic p38 and JNK MAPK could be prevented by co-treatment with antioxidants suggesting ROS generation is the primary mechanism of cytotoxic action. We report here that Fe-SP is a potent growth-suppressing and cytotoxic agent for in vitro NB cell lines and, due to its high tolerance in previous animal toxicity studies, a potential therapeutic drug to treat NB tumors in vivo.	[Kim, Kyu Kwang; Singh, Rakesh K.; Moore, Richard G.; Lange, Thilo S.] Brown Univ, Women & Infants Hosp, Dept Obstet & Gynecol, Mol Therapeut Lab,Program Womens Oncol,Alpert Med, Providence, RI 02912 USA; [Strongin, Robert M.] Portland State Univ, Dept Chem, Portland, OR 97207 USA; [Brard, Laurent] So Illinois Univ, Sch Med, Dept Obstet & Gynecol, Div Gynecol Oncol, Springfield, IL 62794 USA; [Lange, Thilo S.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA	Brown University; Women & Infants Hospital Rhode Island; Portland State University; Southern Illinois University System; Southern Illinois University; Brown University	Kim, KK (corresponding author), Brown Univ, Women & Infants Hosp, Dept Obstet & Gynecol, Mol Therapeut Lab,Program Womens Oncol,Alpert Med, Providence, RI 02912 USA.	kkim@wihri.org; thilo_Lange@brown.edu	Strongin, Robert M./F-1026-2010	Brard, Laurent/0000-0003-0065-1826	NCI [1 RO1 CA136491-01]; Swim Across America; NATIONAL CANCER INSTITUTE [R01CA136491] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swim Across America; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	RGM is partially supported by NCI Grant #1 RO1 CA136491-01 and Grants from Swim Across America. RKS is partially supported by Grants from Swim Across America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CP, 2000, MED PEDIATR ONCOL, V35, P659, DOI 10.1002/1096-911X(20001201)35:6<659::AID-MPO38>3.0.CO;2-4; ATER JL, 2007, NELSON TXB PEDIAT, pCH498; BURROWS CJ, 1994, ACCOUNTS CHEM RES, V27, P295, DOI 10.1021/ar00046a002; Cerchiaro G, 2005, J INORG BIOCHEM, V99, P1433, DOI 10.1016/j.jinorgbio.2005.03.013; Goldsby Robert E, 2004, Paediatr Drugs, V6, P107, DOI 10.2165/00148581-200406020-00004; Gomes A, 2005, J BIOCHEM BIOPH METH, V65, P45, DOI 10.1016/j.jbbm.2005.10.003; Gupte A, 2009, CANCER TREAT REV, V35, P32, DOI 10.1016/j.ctrv.2008.07.004; Hettmer S, 2004, BRIT J CANCER, V91, P389, DOI 10.1038/sj.bjc.6601914; Hileman EO, 2004, CANCER CHEMOTH PHARM, V53, P209, DOI 10.1007/s00280-003-0726-5; Huang RL, 2005, BIOCHEM PHARMACOL, V69, P1009, DOI 10.1016/j.bcp.2005.01.001; Kang YH, 2008, J CELL PHYSIOL, V217, P23, DOI 10.1002/jcp.21470; Kim JS, 2008, INT J CANCER, V122, P672, DOI 10.1002/ijc.23158; Kim KK, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-72; Lange TS, 2008, DRUG DES DEV THER, V3, P1; Lange TS, 2010, CHEM BIOL DRUG DES, V76, P164, DOI 10.1111/j.1747-0285.2010.00988.x; Lange TS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002303; Mandal SS, 1997, BIOCONJUGATE CHEM, V8, P798, DOI 10.1021/bc970121x; Mansat-De Mas V, 1999, MOL PHARMACOL, V56, P867, DOI 10.1124/mol.56.5.867; Maris JM, 1999, J CLIN ONCOL, V17, P2264, DOI 10.1200/JCO.1999.17.7.2264; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Mazumder S, 2004, CURR CANCER DRUG TAR, V4, P65, DOI 10.2174/1568009043481669; Osone S, 2004, INT J CANCER, V112, P219, DOI 10.1002/ijc.20412; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Perez CA, 2000, J CLIN ONCOL, V18, P18, DOI 10.1200/JCO.2000.18.1.18; PETIT PX, 1995, J CELL BIOL, V130, P157, DOI 10.1083/jcb.130.1.157; Pochedly C, 1990, NEUROBLASTOMA TUMOR; ROSS RA, 1983, J NATL CANCER I, V71, P741; Routier S, 1999, NUCLEIC ACIDS RES, V27, P4160, DOI 10.1093/nar/27.21.4160; Routier S, 1997, BIOCONJUGATE CHEM, V8, P789, DOI 10.1021/bc970131y; Routier S, 1996, BIOORGAN MED CHEM, V4, P1185, DOI 10.1016/0968-0896(96)00082-X; Shapiro GI, 1999, J CLIN INVEST, V104, P1645, DOI 10.1172/JCI9054; Shrivastava HY, 2005, FREE RADICAL BIO MED, V38, P58, DOI 10.1016/j.freeradbiomed.2004.09.029; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tsai-Turton M, 2007, TOXICOL SCI, V98, P216, DOI 10.1093/toxsci/kfm087; Waris Gulam, 2006, J Carcinog, V5, P14; Woldemariam GA, 2008, J INORG BIOCHEM, V102, P740, DOI 10.1016/j.jinorgbio.2007.11.008	37	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19049	10.1371/journal.pone.0019049	http://dx.doi.org/10.1371/journal.pone.0019049			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559503	Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700056
J	Mizuki, F; Tanaka, A; Hirose, Y; Ohkuma, Y				Mizuki, Fumitaka; Tanaka, Aki; Hirose, Yutaka; Ohkuma, Yoshiaki			The HIRA Complex Subunit Hip3 Plays Important Roles in the Silencing of Meiosis-Specific Genes in Schizosaccharomyces pombe	PLOS ONE			English	Article							HISTONE CHAPERONE ASF1; RNA-POLYMERASE-II; FISSION YEAST; MESSENGER-RNA; BUDDING YEAST; TRANSCRIPTION; CHROMATIN; PROTEIN; METHYLATION; SUPPRESSION	Background: The control of gene expression is essential for growth and responses to environmental changes in various organisms. It is known that some meiosis-specific genes are silenced during mitosis and expressed upon nitrogen starvation in Schizosaccharomyces pombe. When the factors responsible for this regulation were studied, a hip3 mutant was isolated via discovery of a defect in the transcriptional repression of meiosis-specific genes. Hip3 is a subunit of the HIRA (histone regulatory complex A) complex, which consists of four subunits (Hip1, Hip3, Hip4 and Slm9) and acts as a histone chaperone that is independent of DNA replication. Methodology/Principal Findings: In a search for mutants, the meiosis-specific gene SPCC663.14c(+) was identified by screening for genes that are silenced during mitosis and induced upon nitrogen starvation. A reporter plasmid that expresses the ura4(+) gene driven by the SPCC663.14c(+) promoter was constructed. Screening for suppressor mutants was then carried out in nitrogen-rich medium without uracil. A mutant with a mutation in the hip3(+) gene was isolated and named hip3-1. This mutation alleviated the transcriptional repression of the ura4(+) gene on the reporter plasmid and of the endogenous SPCC663.14c(+) gene in the presence of nitrogen. A ChIP assay revealed that RNA polymerase II (Pol II) and TFIIE were enriched at the SPCC663.14c(+) locus, whereas the levels of histone H3 were decreased in hip3-1 cells. Intriguingly, histone H3 was heavily modified at the SPCC663.14c(+) locus in hip3-1 cells; these modifications included tri-methylation and acetylation of H3 lysine 9 (H3K9), mono-methylation of H3 arginine 2 (H3R2), and tri-methylation of H3 lysine 4 (H3K4). In addition, the tri-methylation of H3K9 and H3K4 were strongly elevated in hip3-1 mutants. Conclusions: Taken together, these results indicate that Hip3 plays important roles in the control of histone modifications at meiosis-specific gene loci and induces their transcriptional repression.	[Mizuki, Fumitaka; Tanaka, Aki; Hirose, Yutaka; Ohkuma, Yoshiaki] Toyama Univ, Lab Gene Regulat, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan	University of Toyama	Mizuki, F (corresponding author), Toyama Univ, Lab Gene Regulat, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan.	ohkumay@pha.u-toyama.ac.jp			Ministry of Educations, Culture, Sports, Science and Technology of Japan	Ministry of Educations, Culture, Sports, Science and Technology of Japan	This work was supported in part by grants from the Targeted Proteins Research Program and the Grants-in-Aid for Scientific Research from the Ministry of Educations, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013488; Anderson HE, 2009, MOL CELL BIOL, V29, P5158, DOI 10.1128/MCB.00698-09; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Blackwell C, 2004, MOL CELL BIOL, V24, P4309, DOI 10.1128/MCB.24.10.4309-4320.2004; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Fischer T, 2009, P NATL ACAD SCI USA, V106, P8998, DOI 10.1073/pnas.0813063106; Gasch AP, 2007, YEAST, V24, P961, DOI 10.1002/yea.1512; Greenall A, 2006, J BIOL CHEM, V281, P8732, DOI 10.1074/jbc.M512170200; Haraguchi N, 2007, J BIOL CHEM, V282, P2221, DOI 10.1074/jbc.M609430200; Hayashi K, 2005, GENES CELLS, V10, P207, DOI 10.1111/j.1365-2443.2005.00833.x; HUGHES DA, 1990, NATURE, V344, P355, DOI 10.1038/344355a0; Ito T, 2007, J BIOCHEM, V141, P609, DOI 10.1093/jb/mvm091; Kirmizis A, 2009, NAT STRUCT MOL BIOL, V16, P449, DOI 10.1038/nsmb.1569; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Malay AD, 2008, J BIOL CHEM, V283, P14022, DOI 10.1074/jbc.M800594200; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Mata J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r217; Mizuki F, 2007, GENES CELLS, V12, P35, DOI 10.1111/j.1365-2443.2006.01032.x; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Moshkin YM, 2009, MOL CELL, V35, P782, DOI 10.1016/j.molcel.2009.07.020; Nicolas E, 2007, NAT STRUCT MOL BIOL, V14, P372, DOI 10.1038/nsmb1239; Ohkuma Y, 1997, J BIOCHEM-TOKYO, V122, P481; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; SUGIMOTO A, 1991, GENE DEV, V5, P1990, DOI 10.1101/gad.5.11.1990; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tsukahara K, 1998, MOL CELL BIOL, V18, P4488, DOI 10.1128/MCB.18.8.4488; Tyler JK, 1999, CELL, V99, P443, DOI 10.1016/S0092-8674(00)81530-5; Urushiyama S, 1997, GENETICS, V147, P101; Vaissiere T, 2008, MUTAT RES-REV MUTAT, V659, P40, DOI 10.1016/j.mrrev.2008.02.004; Watanabe Y, 1997, NATURE, V386, P187, DOI 10.1038/386187a0; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Xue-Franzen YT, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-303; Yamamoto M, 1996, CELL STRUCT FUNCT, V21, P431, DOI 10.1247/csf.21.431; Yamane K, 2011, MOL CELL, V41, P56, DOI 10.1016/j.molcel.2010.12.009; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	39	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19442	10.1371/journal.pone.0019442	http://dx.doi.org/10.1371/journal.pone.0019442			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559379	Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700173
J	Morohashi, K; Sahara, H; Watashi, K; Iwabata, K; Sunoki, T; Kuramochi, K; Takakusagi, K; Miyashita, H; Sato, N; Tanabe, A; Shimotohno, K; Kobayashi, S; Sakaguchi, K; Sugawara, F				Morohashi, Kengo; Sahara, Hiroeki; Watashi, Koichi; Iwabata, Kazuki; Sunoki, Takashi; Kuramochi, Kouji; Takakusagi, Kaori; Miyashita, Hiroki; Sato, Noriyuki; Tanabe, Atsushi; Shimotohno, Kunitada; Kobayashi, Susumu; Sakaguchi, Kengo; Sugawara, Fumio			Cyclosporin A Associated Helicase-Like Protein Facilitates the Association of Hepatitis C Virus RNA Polymerase with Its Cellular Cyclophilin B	PLOS ONE			English	Article							ISOMERASE ACTIVITY; PHAGE DISPLAY; DRUG TARGET; IN-VITRO; REPLICATION; CALCINEURIN; IDENTIFICATION; ACTIVATION; RESISTANCE; INHIBITION	Background: Cyclosporin A (CsA) is well known as an immunosuppressive drug useful for allogeneic transplantation. It has been reported that CsA inhibits hepatitis C virus (HCV) genome replication, which indicates that cellular targets of CsA regulate the viral replication. However, the regulation mechanisms of HCV replication governed by CsA target proteins have not been fully understood. Principal Findings: Here we show a chemical biology approach that elucidates a novel mechanism of HCV replication. We developed a phage display screening to investigate compound-peptide interaction and identified a novel cellular target molecule of CsA. This protein, named CsA associated helicase-like protein (CAHL), possessed RNA-dependent ATPase activity that was negated by treatment with CsA. The downregulation of CAHL in the cells resulted in a decrease of HCV genome replication. CAHL formed a complex with HCV-derived RNA polymerase NS5B and host-derived cyclophilin B (CyPB), known as a cellular cofactor for HCV replication, to regulate NS5B-CyPB interaction. Conclusions: We found a cellular factor, CAHL, as CsA associated helicase-like protein, which would form trimer complex with CyPB and NS5B of HCV. The strategy using a chemical compound and identifying its target molecule by our phage display analysis is useful to reveal a novel mechanism underlying cellular and viral physiology.	[Morohashi, Kengo; Iwabata, Kazuki; Sunoki, Takashi; Kuramochi, Kouji; Takakusagi, Kaori; Kobayashi, Susumu; Sakaguchi, Kengo; Sugawara, Fumio] Tokyo Univ Sci, Genome & Drug Res Ctr, Chiba, Japan; [Sahara, Hiroeki; Tanabe, Atsushi] Azabu Univ, Sch Vet Med, Biol Lab, Kanagawa, Japan; [Watashi, Koichi] Natl Inst Infect Dis, Dept Virol 2, Shinjuku Ku, Tokyo 1628640, Japan; [Miyashita, Hiroki; Sato, Noriyuki] Sapporo Med Univ, Sch Med, Dept Pathol, Sapporo, Hokkaido, Japan; [Shimotohno, Kunitada] Chiba Inst Technol, Res Inst, Chiba, Japan	Tokyo University of Science; Azabu University; National Institute of Infectious Diseases (NIID); Sapporo Medical University; Chiba Institute of Technology	Morohashi, K (corresponding author), Tokyo Univ Sci, Genome & Drug Res Ctr, Chiba, Japan.	sahara@azabu-u.ac.jp	Morohashi, Kengo/C-5511-2014; Morohashi, Kengo/AAV-2545-2021	Tanabe, Atsushi/0000-0001-7651-3943; Kuramochi, Kouji/0000-0003-0571-9703	Promotion and Mutual Aid Corporation for Private Schools of Japan; Matching Fund; Grants-in-Aid for Scientific Research [22710219, 22390004] Funding Source: KAKEN	Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan); Matching Fund; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by The Promotion and Mutual Aid Corporation for Private Schools of Japan, Grant-in-Aid for Matching Fund Subsidy for Private Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki S, 2005, FEBS J, V272, P2132, DOI 10.1111/j.1742-4658.2005.04600.x; Aoki S, 2007, BIOCONJUGATE CHEM, V18, P1981, DOI 10.1021/bc700287V; Ariumi Y, 2007, J VIROL, V81, P13922, DOI 10.1128/JVI.01517-07; Bouchard R, 2006, J BIOL CHEM, V281, P30603, DOI 10.1074/jbc.M604604200; Braaten D, 2001, EMBO J, V20, P1300, DOI 10.1093/emboj/20.6.1300; CALNE RY, 1978, LANCET, V2, P1323; Chatterji U, 2009, J BIOL CHEM, V284, P16998, DOI 10.1074/jbc.M109.007625; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Fernandes F, 2007, HEPATOLOGY, V46, P1026, DOI 10.1002/hep.21809; Fischer G, 1998, FEBS LETT, V426, P17, DOI 10.1016/S0014-5793(98)00242-7; Flisiak R, 2009, HEPATOLOGY, V49, P1460, DOI 10.1002/hep.22835; FRUMAN DA, 1992, P NATL ACAD SCI USA, V89, P3686, DOI 10.1073/pnas.89.9.3686; Goh PY, 2004, J VIROL, V78, P5288, DOI 10.1128/JVI.78.10.5288-5298.2004; Hanoulle X, 2009, J BIOL CHEM, V284, P13589, DOI 10.1074/jbc.M809244200; Imai A, 2007, EUR J IMMUNOL, V37, P1730, DOI 10.1002/eji.200636392; Jangra RK, 2010, J VIROL, V84, P6615, DOI 10.1128/JVI.00417-10; Kanoh N, 2005, ANGEW CHEM INT EDIT, V44, P3559, DOI 10.1002/anie.200462370; Kuramochi K, 2005, BIOCONJUGATE CHEM, V16, P97, DOI 10.1021/bc0497970; Larrea E, 1996, HEPATOLOGY, V23, P210, DOI 10.1002/hep.510230203; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Liu Z, 2009, J VIROL, V83, P6554, DOI 10.1128/JVI.02550-08; Loor F, 2002, J MED CHEM, V45, P4613, DOI 10.1021/jm010987v; Makowski Lee, 2003, Human Genomics, V1, P41; Mandava S, 2004, PROTEOMICS, V4, P1439, DOI 10.1002/pmic.200300680; Morohashi K, 2005, BIOCHEM PHARMACOL, V70, P37, DOI 10.1016/j.bcp.2005.03.035; Okanami M, 1998, NUCLEIC ACIDS RES, V26, P2638, DOI 10.1093/nar/26.11.2638; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; Robida JM, 2007, J VIROL, V81, P5829, DOI 10.1128/JVI.02524-06; Rodi DJ, 2004, BIOINFORMATICS, V20, P3481, DOI 10.1093/bioinformatics/bth432; Rodi DJ, 2002, J MOL BIOL, V322, P1039, DOI 10.1016/S0022-2836(02)00844-6; Smith GP, 1997, CHEM REV, V97, P391, DOI 10.1021/cr960065d; Waldmeier PC, 2003, CURR MED CHEM, V10, P1485, DOI 10.2174/0929867033457160; Watashi K, 2003, MOL CELL BIOL, V23, P7498, DOI 10.1128/MCB.23.21.7498-7509.2003; Watashi K, 2003, HEPATOLOGY, V38, P1282, DOI 10.1053/jhep.2003.50449; Watashi K, 2005, MOL CELL, V19, P111, DOI 10.1016/j.molcel.2005.05.014; Yang F, 2008, J VIROL, V82, P5269, DOI 10.1128/JVI.02614-07	36	43	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18285	10.1371/journal.pone.0018285	http://dx.doi.org/10.1371/journal.pone.0018285			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559518	Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700009
J	Okada, Y; Imendra, KG; Miyazaki, T; Hotokezaka, H; Fujiyama, R; Toda, K				Okada, Yukio; Imendra, Kotapola G.; Miyazaki, Toshihiro; Hotokezaka, Hitoshi; Fujiyama, Rie; Toda, Kazuo			High Extracellular Ca2+ Stimulates Ca2+-Activated Cl- Currents in Frog Parathyroid Cells through the Mediation of Arachidonic Acid Cascade	PLOS ONE			English	Article							ION-CHANNEL REGULATION; PROTEIN-KINASE-C; CA2+-SENSING RECEPTOR; K+ CHANNELS; INSULIN-SECRETION; MAP KINASE; CALCIUM; MODULATION; ACTIVATION; PRODUCTS	Elevation of extracellular Ca2+ concentration induces intracellular Ca2+ signaling in parathyroid cells. The response is due to stimulation of the phospholipase C/Ca2+ pathways, but the direct mechanism responsible for the rise of intracellular Ca2+ concentration has remained elusive. Here, we describe the electrophysiological property associated with intracellular Ca2+ signaling in frog parathyroid cells and show that Ca2+-activated Cl- channels are activated by intracellular Ca2+ increase through an inositol 1,4,5-trisphophate (IP3)-independent pathway. High extracellular Ca2+ induced an outwardly-rectifying conductance in a dose-dependent manner (EC50 similar to 6 mM). The conductance was composed of an instantaneous time-independent component and a slowly activating time-dependent component and displayed a deactivating inward tail current. Extracellular Ca2+-induced and Ca2+ dialysis-induced currents reversed at the equilibrium potential of Cl- and were inhibited by niflumic acid (a specific blocker of Ca2+-activated Cl- channel). Gramicidin-perforated whole-cell recording displayed the shift of the reversal potential in extracellular Ca2+-induced current, suggesting the change of intracellular Cl- concentration in a few minutes. Extracellular Ca2+-induced currents displayed a moderate dependency on guanosine triphosphate (GTP). All blockers for phospholipase C, diacylglycerol (DAG) lipase, monoacylglycerol (MAG) lipase and lipoxygenase inhibited extracellular Ca2+-induced current. IP3 dialysis failed to induce conductance increase, but 2-arachidonoylglycerol (2-AG), arachidonic acid and 12S-hydroperoxy-5Z, 8Z, 10E, 14Z-eicosatetraenoic acid (12(S)-HPETE) dialysis increased the conductance identical to extracellular Ca2+-induced conductance. These results indicate that high extracellular Ca2+ raises intracellular Ca2+ concentration through the DAG lipase/lipoxygenase pathway, resulting in the activation of Cl- conductance.	[Okada, Yukio; Imendra, Kotapola G.; Miyazaki, Toshihiro; Hotokezaka, Hitoshi; Fujiyama, Rie; Toda, Kazuo] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Imendra, Kotapola G.] Univ Ruhuna, Fac Med, Dept Physiol, Galle, Sri Lanka	Nagasaki University; University Ruhuna	Okada, Y (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 852, Japan.	okada@nagasaki-u.ac.jp	Toda, Kazuo/A-7385-2013	Toda, Kazuo/0000-0002-8848-8017; Fujiyama, Rie/0000-0002-7305-0864	Japan Society for the Promotion of Science [14540630, 17570064, 20570073]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid (Nos. 14540630, 17570064 and 20570073) from Japan Society for the Promotion of Science to YO. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai M, 1998, J BIOL CHEM, V273, P21267, DOI 10.1074/jbc.273.33.21267; Barg S, 2001, J CELL SCI, V114, P2145; BOUDREAU A, 1994, ENDOCRINOLOGY, V135, P1109; BOURDEAU A, 1992, ENDOCRINOLOGY, V130, P1339, DOI 10.1210/en.130.3.1339; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brown EM, 1999, VITAM HORM, V55, P1; BROWN EM, 1991, PHYSIOL REV, V71, P371, DOI 10.1152/physrev.1991.71.2.371; BRUCE BR, 1979, AM J PHYSIOL, V236, pC15, DOI 10.1152/ajpcell.1979.236.1.C15; BUTTNER N, 1989, NATURE, V342, P553, DOI 10.1038/342553a0; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; CASTELLANO A, 1987, CELL CALCIUM, V8, P377, DOI 10.1016/0143-4160(87)90012-1; Chakrabarti SK, 2009, OBESITY, V17, P1657, DOI 10.1038/oby.2009.192; Chang WH, 2001, AM J PHYSIOL-ENDOC M, V281, pE180, DOI 10.1152/ajpendo.2001.281.1.E180; Dascal N, 2001, TRENDS ENDOCRIN MET, V12, P391, DOI 10.1016/S1043-2760(01)00475-1; DeCostanzo AJ, 2010, J NEUROSCI, V30, P1822, DOI 10.1523/JNEUROSCI.2168-09.2010; Exton JH, 1996, ANNU REV PHARMACOL, V36, P481, DOI 10.1146/annurev.pa.36.040196.002405; Gerasimenko O, 2005, CELL CALCIUM, V38, P201, DOI 10.1016/j.ceca.2005.06.025; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hammerland LG, 1998, MOL PHARMACOL, V53, P1083; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; JIA M, 1988, P NATL ACAD SCI USA, V85, P7236, DOI 10.1073/pnas.85.19.7236; Jia ZF, 2008, PFLUG ARCH EUR J PHY, V456, P857, DOI 10.1007/s00424-008-0444-2; KANAZIRSKA MPV, 1995, ENDOCRINOLOGY, V136, P2238, DOI 10.1210/en.136.5.2238; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; KIFOR O, 1992, J BONE MINER RES, V7, P1327; Kifor O, 1997, J BONE MINER RES, V12, P715, DOI 10.1359/jbmr.1997.12.5.715; Kifor O, 2001, AM J PHYSIOL-RENAL, V280, pF291, DOI 10.1152/ajprenal.2001.280.2.F291; KOMWATANA P, 1994, PFLUG ARCH EUR J PHY, V426, P320, DOI 10.1007/BF00374788; Li DQ, 2009, CELL METAB, V10, P309, DOI 10.1016/j.cmet.2009.08.011; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; LOPEZBARNEO J, 1983, J GEN PHYSIOL, V82, P269, DOI 10.1085/jgp.82.2.269; LOWE G, 1993, NATURE, V366, P283, DOI 10.1038/366283a0; Lu M, 2010, J MOL ENDOCRINOL, V44, P285, DOI 10.1677/JME-09-0138; Ma K, 2010, J CLIN ENDOCR METAB, V95, P887, DOI 10.1210/jc.2009-1102; McHenry CR, 1998, J SURG RES, V76, P37, DOI 10.1006/jsre.1998.5263; Mignen O, 2005, J PHYSIOL-LONDON, V564, P791, DOI 10.1113/jphysiol.2005.085704; Mignen O, 2009, J PHYSIOL-LONDON, V587, P4181, DOI 10.1113/jphysiol.2009.174193; Nemeth EF, 1998, P NATL ACAD SCI USA, V95, P4040, DOI 10.1073/pnas.95.7.4040; Okada Y, 2005, J EXP BIOL, V208, P4747, DOI 10.1242/jeb.01967; Qu ZQ, 2003, AM J PHYSIOL-RENAL, V285, pF326, DOI 10.1152/ajprenal.00034.2003; RACKE FK, 1993, J PHYSIOL-LONDON, V468, P141, DOI 10.1113/jphysiol.1993.sp019764; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; Rey O, 2005, J BIOL CHEM, V280, P22875, DOI 10.1074/jbc.M503455200; SAND O, 1981, ACTA PHYSIOL SCAND, V113, P45, DOI 10.1111/j.1748-1716.1981.tb06859.x; SASAYAMA Y, 1974, Annotationes Zoologicae Japonenses, V47, P232; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Valimaki S, 2003, J BIOL CHEM, V278, P49685, DOI 10.1074/jbc.M310595200; WICKMAN K, 1995, PHYSIOL REV, V75, P865, DOI 10.1152/physrev.1995.75.4.865; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yokoyama K, 2009, EXP PHYSIOL, V94, P847, DOI 10.1113/expphysiol.2009.046813	53	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19158	10.1371/journal.pone.0019158	http://dx.doi.org/10.1371/journal.pone.0019158			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559478	Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700083
J	Ryu, M; Chen, Y; Qi, JX; Liu, J; Fan, Z; Nam, G; Shi, Y; Cheng, H; Gao, GF				Ryu, Myongchol; Chen, Yong; Qi, Jianxun; Liu, Jun; Fan, Zheng; Nam, Gol; Shi, Yi; Cheng, Hao; Gao, George F.			LILRA3 Binds Both Classical and Non-Classical HLA Class I Molecules but with Reduced Affinities Compared to LILRB1/LILRB2: Structural Evidence	PLOS ONE			English	Article							INHIBITORY RECEPTOR; CRYSTAL-STRUCTURE; ACTIVATING RECEPTOR; CUTTING EDGE; LIR-1; PROTEIN; FAMILY; SPECIFICITY; EXPRESSION; SYSTEM	Structurally, Group 1 LILR (Leukocyte Immunogloblin (Ig)-Like Receptor, also known as Ig-like transcripts, ILT; Leukocyte Ig-like receptor, LIR; and CD85) members are very similar in terms of the HLAIs (human leukocyte antigen class I molecules) binding region and were hypothesized that they all bind to HLAIs. As one of the Group 1 LILRs, LILRA3 is the only secretory LILR and may greatly control the inhibitory immune response induced by LILRB1, LILRB2, and other HLA-binding LILR molecules like LILRA1. Nevertheless, little was known about the binding of LILRA3 to HLAIs. In this report, we present the crystal structure of the LILRA3 domain 1 (D1) and evaluate the D1 and D1D2 (domain 1 and domain 2) binding to classical and non-classical HLAIs using BIAcore (R) surface plasmon resonance analysis (SPR). We found that LILRA3 binds both classical HLA-A*0201 and non-classical HLA-G1 but with reduced affinities compared to either LILRB1 or LILRB2. The polymorphic amino acids and the LILRA3 D1 structure support this notion.	[Ryu, Myongchol; Chen, Yong; Qi, Jianxun; Liu, Jun; Fan, Zheng; Nam, Gol; Shi, Yi; Cheng, Hao; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Ryu, Myongchol; Chen, Yong; Liu, Jun; Nam, Gol; Shi, Yi; Cheng, Hao; Gao, George F.] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Ryu, Myongchol; Nam, Gol] State Acad Sci, Inst Microbiol, Pyongyang, North Korea; [Fan, Zheng] Chinese Acad Sci, Inst Microbiol, Core Facil, Beijing, Peoples R China; [Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences	Ryu, M (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.	gaof@im.ac.cn	Gao, George Fu/ABD-5229-2021; Qi, Jianxun/ABF-1646-2021		National 973 Project [2010CB911902]; National Natural Science Foundation of China (NSFC) Innovative Research Group [81021003]	National 973 Project(National Basic Research Program of China); National Natural Science Foundation of China (NSFC) Innovative Research Group(National Natural Science Foundation of China (NSFC))	This work is supported by a Special Grant for Protein Science of the National 973 Project (grant No. 2010CB911902). www.973.gov.cn/Default_3.aspx. GFG is a leading principal investigator of the National Natural Science Foundation of China (NSFC) Innovative Research Group (grant No. 81021003). www.nsfc.gov.cn/Portal0/default124.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allen RL, 2001, J IMMUNOL, V167, P5543, DOI 10.4049/jimmunol.167.10.5543; An HY, 2010, J RHEUMATOL, V37, P1596, DOI 10.3899/jrheum.091119; Andre P, 2001, NAT IMMUNOL, V2, P661, DOI 10.1038/90589; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bonetti A, 2009, J NEUROIMMUNOL, V208, P119, DOI 10.1016/j.jneuroim.2009.01.003; Borges L, 2003, BLOOD, V101, P1484, DOI 10.1182/blood-2002-05-1432; Borges L, 1997, J IMMUNOL, V159, P5192; Cao W, 2010, IMMUNOL REV, V234, P163, DOI 10.1111/j.0105-2896.2009.00867.x; Chapman TL, 1999, IMMUNITY, V11, P603, DOI 10.1016/S1074-7613(00)80135-1; Chapman TL, 2000, IMMUNITY, V13, P727, DOI 10.1016/S1074-7613(00)00071-6; Chen Y, 2007, PROTEIN EXPRES PURIF, V56, P253, DOI 10.1016/j.pep.2007.08.010; Chen Y, 2010, PROTEIN CELL, V1, P153, DOI 10.1007/s13238-010-0022-1; Chen Y, 2009, IUBMB LIFE, V61, P579, DOI 10.1002/iub.208; Chen Y, 2009, J MOL BIOL, V386, P841, DOI 10.1016/j.jmb.2009.01.006; Cheng H, 2011, J BIOL CHEM IN PRESS; Colonna M, 1999, J LEUKOCYTE BIOL, V66, P375, DOI 10.1002/jlb.66.3.375; Colonna M, 1998, J IMMUNOL, V160, P3096; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fanger NA, 1998, EUR J IMMUNOL, V28, P3423, DOI 10.1002/(SICI)1521-4141(199811)28:11<3423::AID-IMMU3423>3.0.CO;2-2; Gao GF, 2000, J BIOL CHEM, V275, P15232, DOI 10.1074/jbc.275.20.15232; Garner LI, 2006, PROTEIN EXPRES PURIF, V47, P490, DOI 10.1016/j.pep.2005.11.020; Gonen-Gross T, 2005, J IMMUNOL, V175, P4866, DOI 10.4049/jimmunol.175.8.4866; Jones DC, 2011, J IMMUNOL, V186, P2990, DOI 10.4049/jimmunol.1003078; Kabalak G, 2009, ARTHRITIS RHEUM-US, V60, P2923, DOI 10.1002/art.24804; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lepin EJM, 2000, EUR J IMMUNOL, V30, P3552, DOI 10.1002/1521-4141(200012)30:12<3552::AID-IMMU3552>3.0.CO;2-L; Liu J, 2010, J INFECT DIS, V202, P1171, DOI 10.1086/656315; McIntire RH, 2008, PLACENTA, V29, P631, DOI 10.1016/j.placenta.2008.04.007; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navarro F, 1999, EUR J IMMUNOL, V29, P277, DOI 10.1002/(SICI)1521-4141(199901)29:01<277::AID-IMMU277>3.0.CO;2-4; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Shiroishi M, 2006, J BIOL CHEM, V281, P10439, DOI 10.1074/jbc.M512305200; Shiroishi M, 2003, P NATL ACAD SCI USA, V100, P8856, DOI 10.1073/pnas.1431057100; Shiroishi M, 2006, P NATL ACAD SCI USA, V103, P16412, DOI 10.1073/pnas.0605228103; Shiroishi M, 2006, J BIOL CHEM, V281, P19536, DOI 10.1074/jbc.M603076200; Thomas R, 2010, CLIN REV ALLERG IMMU, V38, P159, DOI 10.1007/s12016-009-8148-8; Torkar M, 2000, EUR J IMMUNOL, V30, P3655, DOI 10.1002/1521-4141(200012)30:12<3655::AID-IMMU3655>3.0.CO;2-Y; Vitale M, 1999, INT IMMUNOL, V11, P29, DOI 10.1093/intimm/11.1.29; Wagtmann N, 1997, CURR BIOL, V7, P615, DOI 10.1016/S0960-9822(06)00263-6; Willcox BE, 2003, NAT IMMUNOL, V4, P913, DOI 10.1038/ni961; Willcox Benjamin E, 2002, BMC Struct Biol, V2, P6, DOI 10.1186/1472-6807-2-6; Young NT, 2001, IMMUNOGENETICS, V53, P270, DOI 10.1007/s002510100332	46	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19245	10.1371/journal.pone.0019245	http://dx.doi.org/10.1371/journal.pone.0019245			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559424	gold, Green Published, Green Submitted			2022-12-27	WOS:000290024700109
J	Tong, WC; Choi, CY; Karche, S; Holden, AV; Zhang, HG; Taggart, MJ				Tong, Wing-Chiu; Choi, Cecilia Y.; Karche, Sanjay; Holden, Arun V.; Zhang, Henggui; Taggart, Michael J.			A Computational Model of the Ionic Currents, Ca2+ Dynamics and Action Potentials Underlying Contraction of Isolated Uterine Smooth Muscle	PLOS ONE			English	Article							NA+/CA2+ EXCHANGER ISOFORMS; ACTIVATED CHLORIDE CHANNEL; SODIUM-CALCIUM EXCHANGER; SINGLE MYOMETRIAL CELLS; RAT MYOMETRIUM; K+-CHANNELS; T-TYPE; ELECTRICAL-ACTIVITY; POTASSIUM CHANNELS; ELECTROPHYSIOLOGICAL CHARACTERIZATION	Uterine contractions during labor are discretely regulated by rhythmic action potentials (AP) of varying duration and form that serve to determine calcium-dependent force production. We have employed a computational biology approach to develop a fuller understanding of the complexity of excitation-contraction (E-C) coupling of uterine smooth muscle cells (USMC). Our overall aim is to establish a mathematical platform of sufficient biophysical detail to quantitatively describe known uterine E-C coupling parameters and thereby inform future empirical investigations of physiological and pathophysiological mechanisms governing normal and dysfunctional labors. From published and unpublished data we construct mathematical models for fourteen ionic currents of USMCs: Ca2+ currents (L-and T-type), Na+ current, an hyperpolarization-activated current, three voltage-gated K+ currents, two Ca2+-activated K+ current, Ca2+-activated Cl current, non-specific cation current, Na+-Ca2+ exchanger, Na+-K+ pump and background current. The magnitudes and kinetics of each current system in a spindle shaped single cell with a specified surface area: volume ratio is described by differential equations, in terms of maximal conductances, electrochemical gradient, voltage-dependent activation/inactivation gating variables and temporal changes in intracellular Ca2+ computed from known Ca2+ fluxes. These quantifications are validated by the reconstruction of the individual experimental ionic currents obtained under voltage-clamp. Phasic contraction is modeled in relation to the time constant of changing [Ca2+](i). This integrated model is validated by its reconstruction of the different USMC AP configurations (spikes, plateau and bursts of spikes), the change from bursting to plateau type AP produced by estradiol and of simultaneous experimental recordings of spontaneous AP, [Ca2+](i) and phasic force. In summary, our advanced mathematical model provides a powerful tool to investigate the physiological ionic mechanisms underlying the genesis of uterine electrical E-C coupling of labor and parturition. This will furnish the evolution of descriptive and predictive quantitative models of myometrial electrogenesis at the whole cell and tissue levels.	[Tong, Wing-Chiu; Taggart, Michael J.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Tong, Wing-Chiu; Taggart, Michael J.] Univ Manchester, St Marys Hosp, Maternal & Fetal Hlth Res Ctr, Manchester M13 0JH, Lancs, England; [Choi, Cecilia Y.; Karche, Sanjay; Zhang, Henggui] Univ Manchester, Sch Phys & Astron, Manchester, Lancs, England; [Holden, Arun V.] Univ Leeds, Inst Membrane & Syst Biol, Leeds, W Yorkshire, England	Newcastle University - UK; University of Manchester; University of Manchester; University of Leeds	Tong, WC (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	henggui.zhang@manchester.ac.uk; michael.taggart@ncl.ac.uk	Kharche, Sanjay Ram/I-2130-2014; Zhang, Henggui/AAM-1043-2020; Zhang, Henggui/D-6712-2011	Kharche, Sanjay Ram/0000-0002-2634-4894; Taggart, Michael/0000-0002-9981-2783	MRC [G0900525, G0902091]; BBSRC [BBSRC/B/1678X]; EU Network of Excellence BioSim [LSHB-CT-2004-005137]; Medical Research Council [G0900525, G0902091] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU Network of Excellence BioSim; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work described here was supported by grants from MRC (G0900525 and G0902091, www.mrc.ac.uk), BBSRC (BBSRC/B/1678X, www.bbsrc.ac.uk), Tommy's (www.tommys.org) and EU Network of Excellence BioSim (LSHB-CT-2004-005137, http://biosim.fysik.dtu.dk:8080/biosim/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE Y, 1971, J PHYSIOL-LONDON, V214, P173, DOI 10.1113/jphysiol.1971.sp009426; AMEDEE T, 1987, J PHYSIOL-LONDON, V392, P253, DOI 10.1113/jphysiol.1987.sp016779; Angermann JE, 2006, J GEN PHYSIOL, V128, P73, DOI 10.1085/jgp.200609507; ANWER K, 1992, AM J PHYSIOL, V263, pC1049; ANWER K, 1993, AM J PHYSIOL, V265, pC976, DOI 10.1152/ajpcell.1993.265.4.C976; Arreola J, 1996, J GEN PHYSIOL, V108, P35, DOI 10.1085/jgp.108.1.35; Asokan KT, 2002, EUR J PHARMACOL, V455, P65, DOI 10.1016/S0014-2999(02)02487-1; Bao L, 2005, J GEN PHYSIOL, V126, P393, DOI 10.1085/jgp.200509346; BENGTSSON B, 1984, AM J PHYSIOL, V246, pC216, DOI 10.1152/ajpcell.1984.246.3.C216; Benkusky NA, 2000, J BIOL CHEM, V275, P27712; Blanks AM, 2007, J PHYSIOL-LONDON, V581, P915, DOI 10.1113/jphysiol.2007.132126; Brown A, 2007, AM J PHYSIOL-CELL PH, V292, pC832, DOI 10.1152/ajpcell.00268.2006; Bugg GJ, 2006, EUR J OBSTET GYN R B, V124, P37, DOI 10.1016/j.ejogrb.2005.04.015; Burdyga T, 2007, ANN NY ACAD SCI, V1101, P85, DOI 10.1196/annals.1389.002; Burdyga T, 2009, EUR J OBSTET GYN R B, V144, pS25, DOI 10.1016/j.ejogrb.2009.02.017; Bursztyn L, 2007, AM J PHYSIOL-CELL PH, V292, pC1816, DOI 10.1152/ajpcell.00478.2006; CAMPBELL DL, 1988, J PHYSIOL-LONDON, V403, P317, DOI 10.1113/jphysiol.1988.sp017251; CHANG DC, 1983, BIOPHYS J, V43, P149, DOI 10.1016/S0006-3495(83)84335-5; COLEMAN HA, 1987, PFLUG ARCH EUR J PHY, V410, P560, DOI 10.1007/BF00586540; CRICHTON CA, 1993, J PHYSIOL-LONDON, V465, P629, DOI 10.1113/jphysiol.1993.sp019697; CSAPO IA, 1963, J PHYSIOL-LONDON, V165, P575, DOI 10.1113/jphysiol.1963.sp007081; Curley Michael, 2004, Reprod Biol Endocrinol, V2, P67, DOI 10.1186/1477-7827-2-67; Ermentrout G. B., 2002, SIMULATING ANAL ANIM; ERULKAR SD, 1994, P ROY SOC B-BIOL SCI, V256, P59, DOI 10.1098/rspb.1994.0049; Esplin MS, 2003, AM J OBSTET GYNECOL, V188, P759, DOI 10.1067/mob.2003.166; Floyd RV, 2010, REPROD SCI, V17, P366, DOI 10.1177/1933719109355196; Garfield RE, 2007, SEMIN CELL DEV BIOL, V18, P289, DOI 10.1016/j.semcdb.2007.05.004; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Greenwood IA, 1996, PFLUG ARCH EUR J PHY, V432, P970, DOI 10.1007/s004240050224; GROVER AK, 1981, AM J PHYSIOL, V240, pC175, DOI 10.1152/ajpcell.1981.240.5.C175; Helguera G, 2002, BBA-GEN SUBJECTS, V1569, P59, DOI 10.1016/S0304-4165(01)00234-3; Hering J, 2004, J PHYSIOL-LONDON, V555, P331, DOI 10.1113/jphysiol.2003.054361; INOUE Y, 1991, AM J PHYSIOL, V260, pC658, DOI 10.1152/ajpcell.1991.260.3.C658; Inoue Y, 1999, CAN J PHYSIOL PHARM, V77, P447, DOI 10.1139/cjpp-77-6-447; INOUE Y, 1990, AM J OBSTET GYNECOL, V162, P1090, DOI 10.1016/0002-9378(90)91322-4; Iwamoto T, 1998, AM J PHYSIOL-CELL PH, V275, pC423, DOI 10.1152/ajpcell.1998.275.2.C423; Jeong JW, 2006, J ENDOCRINOL, V189, P473, DOI 10.1677/joe.1.06747; JMARI K, 1986, J PHYSIOL-LONDON, V380, P111, DOI 10.1113/jphysiol.1986.sp016275; Jones K, 2004, PFLUG ARCH EUR J PHY, V448, P36, DOI 10.1007/s00424-003-1224-7; Kamishima T, 1996, J PHYSIOL-LONDON, V492, P61, DOI 10.1113/jphysiol.1996.sp021289; KAWARABAYASHI T, 1994, CAMBRIDGE REV HUMAN, P148; Khan RN, 1998, HUM REPROD, V13, P208, DOI 10.1093/humrep/13.1.208; KHAN RN, 1993, P ROY SOC B-BIOL SCI, V251, P9, DOI 10.1098/rspb.1993.0002; Khan RN, 2001, EXP PHYSIOL, V86, P255, DOI 10.1113/eph8602181; Knock GA, 1999, J PHYSIOL-LONDON, V518, P769, DOI 10.1111/j.1469-7793.1999.0769p.x; Knock GA, 2001, BIOL REPROD, V64, P1526, DOI 10.1095/biolreprod64.5.1526; Knock GA, 1999, BRIT J PHARMACOL, V127, P1470, DOI 10.1038/sj.bjp.0702685; Kusaka M, 1995, BBA-BIOMEMBRANES, V1240, P196, DOI 10.1016/0005-2736(95)00191-3; Lammers WJEP, 2008, AM J PHYSIOL-REG I, V294, pR919, DOI 10.1152/ajpregu.00704.2007; LANDA JF, 1959, AM J PHYSIOL, V196, P905, DOI 10.1152/ajplegacy.1959.196.4.905; Lee SE, 2009, KOREAN J PHYSIOL PHA, V13, P241, DOI 10.4196/kjpp.2009.13.3.241; Levitsky DO, 2007, ANN NY ACAD SCI, V1099, P221, DOI 10.1196/annals.1387.063; LI ZP, 1994, J BIOL CHEM, V269, P17434; Linck B, 1998, AM J PHYSIOL-CELL PH, V274, pC415, DOI 10.1152/ajpcell.1998.274.2.C415; MANABE K, 1995, J PHYSIOL-LONDON, V487, P407, DOI 10.1113/jphysiol.1995.sp020889; Mankouri HW, 1998, J PHYSIOL-LONDON, V509P, p2P; Matharoo-Ball B, 2003, BIOL REPROD, V68, P2135, DOI 10.1095/biolreprod.102.010454; McCallum LA, 2011, J CELL MOL MED, V15, P577, DOI 10.1111/j.1582-4934.2010.01021.x; MCDONALD TF, 1994, PHYSIOL REV, V74, P365, DOI 10.1152/physrev.1994.74.2.365; MEISHERI KD, 1979, EUR J PHARMACOL, V60, P1, DOI 10.1016/0014-2999(79)90045-1; MERSHON JL, 1994, BIOL REPROD, V51, P993, DOI 10.1095/biolreprod51.5.993; Mironneau J, 1996, CELL CALCIUM, V20, P153, DOI 10.1016/S0143-4160(96)90104-9; Mitchell BF, 2009, AM J PHYSIOL-REG I, V297, pR525, DOI 10.1152/ajpregu.00153.2009; Miyoshi H, 2004, PFLUG ARCH EUR J PHY, V447, P457, DOI 10.1007/s00424-003-1175-z; MIYOSHI H, 1991, PFLUG ARCH EUR J PHY, V419, P386, DOI 10.1007/BF00371121; MOLLARD P, 1986, AM J PHYSIOL, V250, pC47, DOI 10.1152/ajpcell.1986.250.1.C47; Nakamura Y, 1999, J PHYSIOL-LONDON, V519, P203, DOI 10.1111/j.1469-7793.1999.0203o.x; NAKAO M, 1989, J GEN PHYSIOL, V94, P539, DOI 10.1085/jgp.94.3.539; Noble K, 2010, CELL CALCIUM, V47, P47, DOI 10.1016/j.ceca.2009.11.004; Ohkubo T, 2005, GYNECOL OBSTET INVES, V59, P80, DOI 10.1159/000082333; OHYA Y, 1989, AM J PHYSIOL, V257, pC408, DOI 10.1152/ajpcell.1989.257.2.C408; Okabe K, 1999, PFLUG ARCH EUR J PHY, V439, P76, DOI 10.1007/s004240051130; Okabe K, 1999, EUR J PHARMACOL, V376, P101, DOI 10.1016/S0014-2999(99)00353-2; Orio P, 2006, J GEN PHYSIOL, V127, P191, DOI 10.1085/jgp.200509370; Parkington HC, 1999, J PHYSIOL-LONDON, V514, P229, DOI 10.1111/j.1469-7793.1999.229af.x; Parkington HC, 2001, FRONT HORM RES, V27, P179; PEREZ GJ, 1993, AM J OBSTET GYNECOL, V168, P652, DOI 10.1016/0002-9378(93)90513-I; PIEDRASRENTERIA E, 1991, AM J PHYSIOL, V261, pC278, DOI 10.1152/ajpcell.1991.261.2.C278; Pierce SL, 2008, BIOL REPROD, V78, P1058, DOI 10.1095/biolreprod.107.066423; Quednau BD, 1997, AM J PHYSIOL-CELL PH, V272, pC1250, DOI 10.1152/ajpcell.1997.272.4.C1250; Rihana S, 2009, MED BIOL ENG COMPUT, V47, P665, DOI 10.1007/s11517-009-0433-4; SATOH H, 1995, GEN PHARMACOL-VASC S, V26, P1335, DOI 10.1016/0306-3623(95)00006-M; Serrano JR, 1999, J GEN PHYSIOL, V114, P185, DOI 10.1085/jgp.114.2.185; Shannon TR, 2004, BIOPHYS J, V87, P3351, DOI 10.1529/biophysj.104.047449; Shmigol A, 1998, PFLUG ARCH EUR J PHY, V437, P158, DOI 10.1007/s004240050761; Shmigol AV, 1998, J PHYSIOL-LONDON, V511, P803, DOI 10.1111/j.1469-7793.1998.803bg.x; Shmigol AV, 1999, J PHYSIOL-LONDON, V520, P153, DOI 10.1111/j.1469-7793.1999.00153.x; Smith RC, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-41; Song JF, 2009, BIOL REPROD, V80, P788, DOI 10.1095/biolreprod.108.071258; Song M, 1999, FEBS LETT, V460, P427, DOI 10.1016/S0014-5793(99)01394-0; SPERELAKIS N, 1992, MOL CELL BIOCHEM, V114, P79; STANDEN NB, 1982, PROC R SOC SER B-BIO, V217, P101, DOI 10.1098/rspb.1982.0097; Taggart M.J., 2007, NEW FRONTIERS SMOOTH, P523; Taggart MJ, 2007, SEMIN CELL DEV BIOL, V18, P296, DOI 10.1016/j.semcdb.2007.05.006; Taggart Michael John, 2007, BMC Pregnancy Childbirth, V7 Suppl 1, pS3, DOI 10.1186/1471-2393-7-S1-S3; Taggart MJ, 1997, CELL CALCIUM, V22, P333, DOI 10.1016/S0143-4160(97)90018-X; TAYLOR GS, 1969, LIFE SCI PT 1 PHYSI, V8, P769, DOI 10.1016/0024-3205(69)90268-9; TAYLOR GS, 1970, J GEN PHYSIOL, V56, P360, DOI 10.1085/jgp.56.3.360; TEZUKA N, 1995, AM J PHYSIOL-CELL PH, V269, pC1008, DOI 10.1152/ajpcell.1995.269.4.C1008; TURI A, 1992, BIOCHEM BIOPH RES CO, V188, P1191, DOI 10.1016/0006-291X(92)91357-V; Vance CJ, 2006, AM J OBSTET GYNECOL, V195, P1407, DOI 10.1016/j.ajog.2006.05.009; VIGNE P, 1988, J BIOL CHEM, V263, P8087; Wang SY, 1998, J GEN PHYSIOL, V112, P737, DOI 10.1085/jgp.112.6.737; Weber CR, 2001, J GEN PHYSIOL, V117, P119, DOI 10.1085/jgp.117.2.119; WEST TC, 1956, AM J PHYSIOL, V187, P333, DOI 10.1152/ajplegacy.1956.187.2.333; WILDE DW, 1988, BIOL REPROD, V38, P836, DOI 10.1095/biolreprod38.4.836; YAMAMOTO T, 1995, AM J PHYSIOL-CELL PH, V268, pC64, DOI 10.1152/ajpcell.1995.268.1.C64; Yoshino M, 1997, J GEN PHYSIOL, V110, P565, DOI 10.1085/jgp.110.5.565; YOUNG RC, 1993, AM J OBSTET GYNECOL, V169, P785, DOI 10.1016/0002-9378(93)90006-5; Young RC, 2009, REPROD SCI, V16, P734, DOI 10.1177/1933719109334965; Zhang J, 2010, REPROD SCI, V17, p78A; Zhou XB, 2000, J PHYSIOL-LONDON, V524, P339, DOI 10.1111/j.1469-7793.2000.t01-1-00339.x; Zhou XB, 2000, AM J PHYSIOL-CELL PH, V279, pC1751, DOI 10.1152/ajpcell.2000.279.6.C1751	113	55	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18685	10.1371/journal.pone.0018685	http://dx.doi.org/10.1371/journal.pone.0018685			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559514	gold, Green Published, Green Submitted			2022-12-27	WOS:000290024700019
J	Tucker, BA; Park, IH; Qi, SD; Klassen, HJ; Jiang, CH; Yao, J; Redenti, S; Daley, GQ; Young, MJ				Tucker, Budd A.; Park, In-Hyun; Qi, Sara D.; Klassen, Henry J.; Jiang, Caihui; Yao, Jing; Redenti, Stephen; Daley, George Q.; Young, Michael J.			Transplantation of Adult Mouse iPS Cell-Derived Photoreceptor Precursors Restores Retinal Structure and Function in Degenerative Mice	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; MACULAR DEGENERATION; PROGENITOR CELLS; HEAD INDUCTION; GENERATION; DIFFERENTIATION; EXPRESSION; PROMOTE; ROD	This study was designed to determine whether adult mouse induced pluripotent stem cells (iPSCs), could be used to produce retinal precursors and subsequently photoreceptor cells for retinal transplantation to restore retinal function in degenerative hosts. iPSCs were generated using adult dsRed mouse dermal fibroblasts via retroviral induction of the transcription factors Oct4, Sox2, KLF4 and c-Myc. As with normal mouse ES cells, adult dsRed iPSCs expressed the pluripotency genes SSEA1, Oct4, Sox2, KLF4, c-Myc and Nanog. Following transplantation into the eye of immunecompromised retinal degenerative mice these cells proceeded to form teratomas containing tissue comprising all three germ layers. At 33 days post-differentiation a large proportion of the cells expressed the retinal progenitor cell marker Pax6 and went on to express the photoreceptor markers, CRX, recoverin, and rhodopsin. When tested using calcium imaging these cells were shown to exhibit characteristics of normal retinal physiology, responding to delivery of neurotransmitters. Following subretinal transplantation into degenerative hosts differentiated iPSCs took up residence in the retinal outer nuclear layer and gave rise to increased electro retinal function as determined by ERG and functional anatomy. As such, adult fibroblast-derived iPSCs provide a viable source for the production of retinal precursors to be used for transplantation and treatment of retinal degenerative disease.	[Tucker, Budd A.; Jiang, Caihui; Redenti, Stephen] Univ Iowa, Dept Ophthalmol, Carver Coll Med, Inst Vis Res, Iowa City, IA 52242 USA; [Qi, Sara D.; Yao, Jing; Young, Michael J.] Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA USA; [Park, In-Hyun] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Park, In-Hyun] Dana Farber Canc Inst, Boston, MA 02115 USA; [Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Daley, George Q.] Childrens Hosp, Howard Hughes Med Inst, Harvard Stem Cell Inst, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Klassen, Henry J.] Univ Calif Irvine, Gavin Herbert Eye Inst, Sch Med, Dept Ophthalmol, Orange, CA 92668 USA; [Yao, Jing] Fudan Univ, Shanghai Med Sch, Eye & ENT Hosp, Dept Ophthalmol, Shanghai 200433, Peoples R China	University of Iowa; Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; University of California System; University of California Irvine; Fudan University	Tucker, BA (corresponding author), Univ Iowa, Dept Ophthalmol, Carver Coll Med, Inst Vis Res, Iowa City, IA 52242 USA.	budd-tucker@uiowa.edu		Tucker, Budd/0000-0003-2178-1742	National Institutes of Health (NIH); Foundation Fighting Blindness; Lincy and Discovery Eye Foundations; Research to Prevent Blindness	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); Lincy and Discovery Eye Foundations; Research to Prevent Blindness(Research to Prevent Blindness (RPB))	BAT is supported by grants from the National Institutes of Health (NIH) (DP2 new innovators award) and the Foundation Fighting Blindness; MJY is supported by grants from the Lincy and Discovery Eye Foundations and Research to Prevent Blindness; GQD is supported by grants from the NIH, and is an investigator of the Manton Center for Orphan Disease Research and the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2002, DEVELOPMENT, V129, P4975; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Choi M, 2009, NATURE, V461, DOI 10.1038/nature08493; Chopdar A, 2003, BRIT MED J, V326, P485, DOI 10.1136/bmj.326.7387.485; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Earnshaw SR, 2007, CLIN THER, V29, P2096, DOI 10.1016/j.clinthera.2007.09.001; Gonzalez F, 2009, P NATL ACAD SCI USA, V106, P8918, DOI 10.1073/pnas.0901471106; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Huerta JJ, 1997, NEUROSCI LETT, V232, P143, DOI 10.1016/S0304-3940(97)00595-8; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Ikeda H, 2005, P NATL ACAD SCI USA, V102, P11331, DOI 10.1073/pnas.0500010102; Jadhav AR, 2006, DEVELOPMENT, V133, P913, DOI 10.1242/dev.02245; Jiang CH, 2010, MOL VIS, V16, P983; Klassen HJ, 2004, INVEST OPHTH VIS SCI, V45, P4167, DOI 10.1167/iovs.04-0511; LAMB TM, 1993, SCIENCE, V262, P713, DOI 10.1126/science.8235591; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Lamba DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008763; Lamba DA, 2009, CELL STEM CELL, V4, P73, DOI 10.1016/j.stem.2008.10.015; Lee ES, 2006, INVEST OPHTH VIS SCI, V47, P2150, DOI 10.1167/iovs.05-0919; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Meyer JS, 2009, P NATL ACAD SCI US; Mitchell J, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-97; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; Osakada F, 2009, J CELL SCI, V122, P3169, DOI 10.1242/jcs.050393; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Pera EM, 2001, DEV CELL, V1, P655, DOI 10.1016/S1534-5807(01)00069-7; Reh TA, 2010, METHODS MOL BIOL, V636, P139, DOI 10.1007/978-1-60761-691-7_9; Schraermeyer U, 2001, CELL TRANSPLANT, V10, P673, DOI 10.3727/000000001783986215; Shao LJ, 2009, CELL RES, V19, P296, DOI 10.1038/cr.2009.20; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Sun W, 2002, NEUROREPORT, V13, P2421, DOI 10.1097/00001756-200212200-00009; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tomita M, 2005, STEM CELLS, V23, P1579, DOI 10.1634/stemcells.2005-0111; Tucker BA, 2009, ASS RES VISION OPHTH; Vugler A, 2008, EXP NEUROL, V214, P347, DOI 10.1016/j.expneurol.2008.09.007; Welstead GG, 2008, J VIS EXP	39	225	240	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18992	10.1371/journal.pone.0018992	http://dx.doi.org/10.1371/journal.pone.0018992			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559507	Green Published, gold			2022-12-27	WOS:000290024700047
J	Borgstrom, E; Lundin, S; Lundeberg, J				Borgstrom, Erik; Lundin, Sverker; Lundeberg, Joakim			Large Scale Library Generation for High Throughput Sequencing Authors and Affiliations	PLOS ONE			English	Article							CELL-LINES	Background: Large efforts have recently been made to automatethe sample preparation protocols for massively parallel sequencing in order to match the increasing instrument throughput. Still, the size selection through agarose gel electrophoresis separation is a labor-intensive bottleneck of these protocols. Methodology/Principal Findings: In this study a method for automatic library preparation and size selection on a liquid handling robot is presented. The method utilizes selective precipitation of certain sizes of DNA molecules on to paramagnetic beads for cleanup and selection after standard enzymatic reactions. Conclusions/Significance: The method is used to generate libraries for de novo and re-sequencing on the Illumina HiSeq 2000 instrument with a throughput of 12 samples per instrument in approximately 4 hours. The resulting output data show quality scores and pass filter rates comparable to manually prepared samples. The sample size distribution can be adjusted for each application, and are suitable for all high throughput DNA processing protocols seeking to control size intervals.	[Borgstrom, Erik; Lundin, Sverker; Lundeberg, Joakim] Sch Biotechnol, Royal Inst Technol KTH, Sci Life Lab, Div Gene Technol, Solna, Sweden	Royal Institute of Technology	Borgstrom, E (corresponding author), Sch Biotechnol, Royal Inst Technol KTH, Sci Life Lab, Div Gene Technol, Solna, Sweden.	Joakim.lundeberg@scilifelab.se	Palacios, Luis/GVT-3145-2022; Pages, Teresa/G-4244-2011	Pages, Teresa/0000-0002-4969-1522	Swedish research council; Knut and Alice Wallenberg Foundation	Swedish research council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was financially supported by grants from the Swedish research council and the Knut and Alice Wallenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bloom JS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-221; Farias-Hesson E, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/617469; Fuller CW, 2009, NAT BIOTECHNOL, V27, P1013, DOI 10.1038/nbt.1585; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Klevebring D, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/396808; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Lennon NJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r15; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Linnarsson S, 2010, EXP CELL RES, V316, P1339, DOI 10.1016/j.yexcr.2010.02.036; Lundin S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010029; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Pelak K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001111; Pettersson E, 2009, GENOMICS, V93, P105, DOI 10.1016/j.ygeno.2008.10.003; PONTEN J, 1967, INT J CANCER, V2, P434, DOI 10.1002/ijc.2910020505; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Wang X, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0003839, 10.1371/journal.pone.0002557]	17	117	118	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e19119	10.1371/journal.pone.0019119	http://dx.doi.org/10.1371/journal.pone.0019119			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21589638	Green Published, gold, Green Submitted			2022-12-27	WOS:000290019400031
J	Doretto, S; Malerba, M; Ramos, M; Ikrar, T; Kinoshita, C; De Mei, C; Tirotta, E; Xu, XM; Borrelli, E				Doretto, Sandrine; Malerba, Monica; Ramos, Maria; Ikrar, Taruna; Kinoshita, Chisato; De Mei, Claudia; Tirotta, Emanuele; Xu, Xiangmin; Borrelli, Emiliana			Oligodendrocytes as Regulators of Neuronal Networks during Early Postnatal Development	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; NMDA-RECEPTOR; DEVELOPING CEREBELLUM; NEURITE OUTGROWTH; SYNAPSE ELIMINATION; CORTICAL-NEURONS; AXONAL GROWTH; GRANULE CELLS; PLASTICITY; ABLATION	Oligodendrocytes are the glial cells responsible for myelin formation. Myelination occurs during the first postnatal weeks and, in rodents, is completed during the third week after birth. Myelin ensures the fast conduction of the nerve impulse; in the adult, myelin proteins have an inhibitory role on axon growth and regeneration after injury. During brain development, oligodendrocytes precursors originating in multiple locations along the antero-posterior axis actively proliferate and migrate to colonize the whole brain. Whether the initial interactions between oligodendrocytes and neurons might play a functional role before the onset of myelination is still not completely elucidated. In this article, we addressed this question by transgenically targeted ablation of proliferating oligodendrocytes during cerebellum development. Interestingly, we show that depletion of oligodendrocytes at postnatal day 1 (P1) profoundly affects the establishment of cerebellar circuitries. We observed an impressive deregulation in the expression of molecules involved in axon growth, guidance and synaptic plasticity. These effects were accompanied by an outstanding increase of neurofilament staining observed 4 hours after the beginning of the ablation protocol, likely dependent from sprouting of cerebellar fibers. Oligodendrocyte ablation modifies localization and function of ionotropic glutamate receptors in Purkinje neurons. These results show a novel oligodendrocyte function expressed during early postnatal brain development, where these cells participate in the formation of cerebellar circuitries, and influence its development.	[Doretto, Sandrine; Malerba, Monica; Ramos, Maria; Kinoshita, Chisato; De Mei, Claudia; Tirotta, Emanuele; Borrelli, Emiliana] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; [Doretto, Sandrine; Malerba, Monica; Ramos, Maria; Kinoshita, Chisato; De Mei, Claudia; Tirotta, Emanuele; Borrelli, Emiliana] Univ Calif Irvine, INSERM UCI U904, Irvine, CA 92717 USA; [Ikrar, Taruna; Xu, Xiangmin] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Doretto, S (corresponding author), Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA.	borrelli@uci.edu	Ikrar, Taruna/I-3357-2014; Kinoshita, Chisato/AAW-5116-2020; Borrelli, Emiliana/M-8994-2018	Kinoshita, Chisato/0000-0001-5877-0196; 	Institut National de la Sante et de la Recherche Medicale; ARSEP; ACI; UCI; NIH [DA-023700, DA-023700-04S1]; NATIONAL INSTITUTE ON DRUG ABUSE [K99DA023700, R00DA023700] Funding Source: NIH RePORTER	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); ARSEP; ACI; UCI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by the Institut National de la Sante et de la Recherche Medicale, ARSEP, ACI and UCI (to E. B.) and NIH (DA-023700 and DA-023700-04S1 to X. X.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesnik H, 2008, P NATL ACAD SCI USA, V105, P5597, DOI 10.1073/pnas.0800946105; Alcantara S, 2000, DEVELOPMENT, V127, P1359; Allen NJ, 2009, NATURE, V457, P675, DOI 10.1038/457675a; Bloch-Gallego E, 1999, J NEUROSCI, V19, P4407; Bomze HM, 2001, NAT NEUROSCI, V4, P38, DOI 10.1038/82881; BORRELLI E, 1989, NATURE, V339, P538, DOI 10.1038/339538a0; BORRELLI E, 1988, P NATL ACAD SCI USA, V85, P7572, DOI 10.1073/pnas.85.20.7572; Bouzioukh F, 2006, EUR J NEUROSCI, V23, P2247, DOI 10.1111/j.1460-9568.2006.04783.x; Cafferty WBJ, 2008, TRENDS NEUROSCI, V31, P215, DOI 10.1016/j.tins.2008.02.004; Caroni P, 2001, EMBO J, V20, P4332, DOI 10.1093/emboj/20.16.4332; CHEDOTAL A, 1993, DEV BRAIN RES, V76, P207, DOI 10.1016/0165-3806(93)90209-S; Collin L, 2004, P NATL ACAD SCI USA, V101, P325, DOI 10.1073/pnas.0305994101; Collin L, 2007, EXP CELL RES, V313, P2946, DOI 10.1016/j.yexcr.2007.05.003; Cull-Candy SG, 1998, NEUROPHARMACOLOGY, V37, P1369, DOI 10.1016/S0028-3908(98)00119-1; DELASSALLE A, 1981, J NEUROSCI RES, V6, P303, DOI 10.1002/jnr.490060305; Dent EW, 2004, J NEUROSCI, V24, P3002, DOI 10.1523/JNEUROSCI.4963-03.2004; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; FARRANT M, 1994, NATURE, V368, P335, DOI 10.1038/368335a0; Frey D, 2000, J CELL BIOL, V149, P1443, DOI 10.1083/jcb.149.7.1443; Goldowitz D, 2000, J NEUROSCI, V20, P4129; Hall BJ, 2008, TRENDS NEUROSCI, V31, P82, DOI 10.1016/j.tins.2007.11.010; Hu FH, 2004, SEMIN PERINATOL, V28, P371, DOI 10.1053/j.semperi.2004.10.001; Huang JK, 2005, SCIENCE, V310, P1813, DOI 10.1126/science.1118313; Hulo S, 2002, EUR J NEUROSCI, V15, P1976, DOI 10.1046/j.1460-9568.2002.02026.x; Jackson RE, 2009, CURR BIOL, V19, pR504, DOI 10.1016/j.cub.2009.04.055; KANEKO T, 1989, NEUROSCIENCE, V32, P79, DOI 10.1016/0306-4522(89)90109-7; Kano M, 1998, P NATL ACAD SCI USA, V95, P15724, DOI 10.1073/pnas.95.26.15724; Lin SC, 2005, NEURON, V46, P773, DOI 10.1016/j.neuron.2005.04.025; Liu BP, 2006, PHILOS T R SOC B, V361, P1593, DOI 10.1098/rstb.2006.1891; Mathis C, 2003, DEVELOPMENT, V130, P4709, DOI 10.1242/dev.00675; Mathis C, 2001, DEVELOPMENT, V128, P4881; Mathis C, 2000, J NEUROSCI, V20, P7698; Morando L, 2001, P NATL ACAD SCI USA, V98, P9954, DOI 10.1073/pnas.171098398; Peng YJ, 2010, J BIOL CHEM, V285, P24834, DOI 10.1074/jbc.M109.096537; PETRALIA RS, 1994, J NEUROSCI, V14, P667; RABACCHI S, 1992, SCIENCE, V256, P1823, DOI 10.1126/science.1352066; Rabacchi SA, 1999, J NEUROSCI, V19, P4437; Richardson WD, 2006, NAT REV NEUROSCI, V7, P11, DOI 10.1038/nrn1826; STRITTMATTER SM, 1995, CELL, V80, P445, DOI 10.1016/0092-8674(95)90495-6; Ultanir SK, 2007, P NATL ACAD SCI USA, V104, P19553, DOI 10.1073/pnas.0704031104; WATANABE M, 1994, J COMP NEUROL, V343, P513, DOI 10.1002/cne.903430402; Xu XM, 2010, J COMP NEUROL, V518, P389, DOI 10.1002/cne.22229; Xu XM, 2009, J NEUROSCI, V29, P70, DOI 10.1523/JNEUROSCI.4104-08.2009	44	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19849	10.1371/journal.pone.0019849	http://dx.doi.org/10.1371/journal.pone.0019849			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589880	Green Published, gold			2022-12-27	WOS:000290531100031
J	Sung, HJ; Ma, WZ; Starost, MF; Lago, CU; Lim, PK; Sack, MN; Kang, JG; Wang, PY; Hwang, PM				Sung, Ho Joong; Ma, Wenzhe; Starost, Matthew F.; Lago, Cory U.; Lim, Philip K.; Sack, Michael N.; Kang, Ju-Gyeong; Wang, Ping-yuan; Hwang, Paul M.			Ambient Oxygen Promotes Tumorigenesis	PLOS ONE			English	Article							P53 TUMOR-SUPPRESSOR; DNA-DAMAGE; MITOCHONDRIAL-FUNCTION; ANTIOXIDANT DEFENSE; LIFE-SPAN; CANCER; HYPEROXIA; MICE; REQUIREMENT; HYPOXIA	Oxygen serves as an essential factor for oxidative stress, and it has been shown to be a mutagen in bacteria. While it is well established that ambient oxygen can also cause genomic instability in cultured mammalian cells, its effect on de novo tumorigenesis at the organismal level is unclear. Herein, by decreasing ambient oxygen exposure, we report a similar to 50% increase in the median tumor-free survival time of p53-/- mice. In the thymus, reducing oxygen exposure decreased the levels of oxidative DNA damage and RAG recombinase, both of which are known to promote lymphomagenesis in p53-/- mice. Oxygen is further shown to be associated with genomic instability in two additional cancer models involving the APC tumor suppressor gene and chemical carcinogenesis. Together, these observations represent the first report directly testing the effect of ambient oxygen on de novo tumorigenesis and provide important physiologic evidence demonstrating its critical role in increasing genomic instability in vivo.	[Sung, Ho Joong; Ma, Wenzhe; Starost, Matthew F.; Lago, Cory U.; Lim, Philip K.; Sack, Michael N.; Kang, Ju-Gyeong; Wang, Ping-yuan; Hwang, Paul M.] NHLBI, Ctr Mol Med, NIH, Bethesda, MD 20892 USA; [Sung, Ho Joong] Eulji Univ, Coll Hlth Sci, Dept Biomed Lab Sci, Gyeonggi Do, South Korea	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Eulji University	Sung, HJ (corresponding author), NHLBI, Ctr Mol Med, NIH, Bldg 10, Bethesda, MD 20892 USA.	hwangp@mail.nih.gov	lim, philip/AAY-1053-2021	lim, philip/0000-0003-3947-090X	Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006051] Funding Source: NIH RePORTER	Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ejeh F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004630; Amornphimoltham P, 2008, CLIN CANCER RES, V14, P8094, DOI 10.1158/1078-0432.CCR-08-0703; [Anonymous], 2002, HIST PHIL LIFE SCI; Bardia A, 2008, MAYO CLIN PROC, V83, P23, DOI 10.4065/83.1.23; Braun RD, 2001, AM J PHYSIOL-HEART C, V280, pH2533, DOI 10.1152/ajpheart.2001.280.6.H2533; BRUYNINCKX WJ, 1978, NATURE, V274, P606, DOI 10.1038/274606a0; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Callicott RJ, 2006, COMPARATIVE MED, V56, P17; Cooper HS, 2005, MOL CARCINOGEN, V44, P31, DOI 10.1002/mc.20114; Das KC, 2004, AM J PHYSIOL-LUNG C, V286, pL87, DOI 10.1152/ajplung.00203.2002; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; FISCHER B, 1993, J REPROD FERTIL, V99, P673, DOI 10.1530/jrf.0.0990673; Galluzzo M, 2009, J CLIN INVEST, V119, P865, DOI 10.1172/JCI36579; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Heron-Milhavet L, 2004, ENDOCRINOLOGY, V145, P4667, DOI 10.1210/en.2003-1543; Hochachka PW, 1998, J EXP BIOL, V201, P1243; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Janne PA, 2000, NEW ENGL J MED, V342, P1960, DOI 10.1056/NEJM200006293422606; Kallen B, 2010, PEDIATRICS, V126, pE270, DOI 10.1542/peds.2009-3225; Kulkarni A, 2008, AM J PHYSIOL-LUNG C, V294, pL998, DOI 10.1152/ajplung.00004.2008; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Liao MJ, 1998, MOL CELL BIOL, V18, P3495, DOI 10.1128/MCB.18.6.3495; LINDENSCHMIDT RC, 1986, CANCER RES, V46, P1994; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; LUONGO C, 1994, CANCER RES, V54, P5947; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Olovnikov IA, 2009, SEMIN CANCER BIOL, V19, P32, DOI 10.1016/j.semcancer.2008.11.005; PACKER L, 1977, NATURE, V267, P423, DOI 10.1038/267423a0; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110; Patino WD, 2005, P NATL ACAD SCI USA, V102, P3423, DOI 10.1073/pnas.0408032102; Raa A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-23; Ryu CJ, 2006, CANCER CELL, V9, P109, DOI 10.1016/j.ccr.2006.01.004; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Spector LG, 2005, J PEDIATR-US, V147, P27, DOI 10.1016/j.jpeds.2005.03.008; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Stucker M, 2002, J PHYSIOL-LONDON, V538, P985, DOI 10.1013/jphysiol.2001.013067; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Sung HJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1003; Tu HC, 2009, P NATL ACAD SCI USA, V106, P1093, DOI 10.1073/pnas.0808173106; Uchida K, 1998, ZOOL SCI, V15, P703, DOI 10.2108/zsj.15.703; Unt E, 2008, J SPORT SCI MED, V7, P344; VAUPEL P, 1989, CANCER RES, V49, P6449; WEINBERG CR, 1987, RADIAT RES, V112, P381, DOI 10.2307/3577265; Welford SM, 2010, MOL CELL BIOL, V30, P4595, DOI 10.1128/MCB.01618-09	53	32	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19785	10.1371/journal.pone.0019785	http://dx.doi.org/10.1371/journal.pone.0019785			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589870	Green Published, Green Submitted, gold			2022-12-27	WOS:000290531100026
J	Dissing, BS; Nielsen, ME; Ersboll, BK; Frosch, S				Dissing, Bjorn S.; Nielsen, Michael E.; Ersboll, Bjarne K.; Frosch, Stina			Multispectral Imaging for Determination of Astaxanthin Concentration in Salmonids	PLOS ONE			English	Article							ATLANTIC SALMON; QUALITY; VISION; LIVE	Multispectral imaging has been evaluated for characterization of the concentration of a specific cartenoid pigment; astaxanthin. 59 fillets of rainbow trout, Oncorhynchus mykiss, were filleted and imaged using a rapid multispectral imaging device for quantitative analysis. The multispectral imaging device captures reflection properties in 19 distinct wavelength bands, prior to determination of the true concentration of astaxanthin. The samples ranged from 0.20 to 4.34 mu g per g fish. A PLSR model was calibrated to predict astaxanthin concentration from novel images, and showed good results with a RMSEP of 0.27. For comparison a similar model were built for normal color images, which yielded a RMSEP of 0.45. The acquisition speed of the multispectral imaging system and the accuracy of the PLSR model obtained suggest this method as a promising technique for rapid in-line estimation of astaxanthin concentration in rainbow trout fillets.	[Dissing, Bjorn S.; Ersboll, Bjarne K.] Tech Univ Denmark, Dept Informat & Math Modeling, Lyngby, Denmark; [Nielsen, Michael E.; Frosch, Stina] Tech Univ Denmark, Div Ind Food Technol, Natl Food Inst, Lyngby, Denmark	Technical University of Denmark; Technical University of Denmark	Dissing, BS (corresponding author), Tech Univ Denmark, Dept Informat & Math Modeling, Lyngby, Denmark.	bdi@imm.dtu.dk; sfr@aqua.dtu.dk	Nielsen, Michael Canova Engelbrecht/L-4911-2019	Nielsen, Michael Canova Engelbrecht/0000-0001-5044-4441; Ersboll, Bjarne Kjaer/0000-0003-1262-7890	Danish Food Industry Agency under The Ministry of Food, Agriculture and Fisheries [3304-FVFP-07-770-01]	Danish Food Industry Agency under The Ministry of Food, Agriculture and Fisheries	This study was supported by grant No 3304-FVFP-07-770-01 from The Danish Food Industry Agency under The Ministry of Food, Agriculture and Fisheries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON S, 2000, P 10 BIENN C INT I F; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brosnan T, 2004, J FOOD ENG, V61, P3, DOI 10.1016/S0260-8774(03)00183-3; Brown SD, 1995, APPL SPECTROSC, V49, pA14, DOI 10.1366/0003702953965876; BUCHWALD M, 1968, BIOCHEMISTRY-US, V7, P834, DOI 10.1021/bi00842a042; Carstensen J.M., 2006, 9 MED IM COMP COMP A; CLEMMENSEN LH, 2009, MACHINE VISION APPL; CLEMMESEN LH, 2006, MICCAI 06 WORKSH BIO, P15; Gomez DD, 2007, COMPUT VIS IMAGE UND, V106, P183, DOI 10.1016/j.cviu.2006.06.011; DISSING BS, 2009, P I EL EL ENG IEEE C; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Folkestad A, 2008, AQUACULTURE, V280, P129, DOI 10.1016/j.aquaculture.2008.04.037; FOLMHANSEN J, 1999, THESIS DTU R PETERSE; GOMEZ DD, 2005, THESIS DTU R PETERSE; GORMLEY TR, 1992, IRISH J AGR FOOD RES, V31, P199; GREEN AA, 1988, IEEE T GEOSCI REMOTE, V26, P65, DOI 10.1109/36.3001; Hansen ME, 2005, LECT NOTES COMPUT SC, V3540, P1228; Hansen ME, 2003, J MICROBIOL METH, V52, P221, DOI 10.1016/S0167-7012(02)00160-4; HANSEN ME, 2005, THESIS DTU R PETERSE; Hastie T., 2009, UNSUPERVISED LEARNIN; HEIA K, 2008, 38 W EUR FISH TECHN; Heia K, 2007, J FOOD SCI, V72, pE11, DOI 10.1111/j.1750-3841.2006.00212.x; MALETTI GM, 2003, THESIS DTU R PETERSE; Misimi E, 2007, J FOOD SCI, V72, pS30, DOI 10.1111/j.1750-3841.2006.00241.x; NIELSEN ME, 2005, 7 JOINT M 50 ANN ATL; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; QUEVEDO RA, 2008, FOOD BIOPROCESS TECH; Sivertsen AH, 2009, J FOOD ENG, V90, P317, DOI 10.1016/j.jfoodeng.2008.06.035; SIVERTSEN AH, 2008, INFOFISH INT, V3; Skjervold PO, 2001, AQUACULTURE, V194, P315, DOI 10.1016/S0044-8486(00)00531-7; SKREDE G, 1986, AQUACULTURE, V53, P279, DOI 10.1016/0044-8486(86)90358-3; SKREDE G, 1990, J FOOD SCI, V55, P361, DOI 10.1111/j.1365-2621.1990.tb06763.x; STONE M, 1977, BIOMETRIKA, V64, P29; Wyszecki G., 2000, COLOR SCI CONCEPTS M; ZHAO Y, 2005, 10 C INT COL ASS	35	52	55	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19032	10.1371/journal.pone.0019032	http://dx.doi.org/10.1371/journal.pone.0019032			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21573000	Green Published, gold, Green Submitted			2022-12-27	WOS:000290440200005
J	Lu, JB; Jiang, L; Yu, L; Sun, Q				Lu, Jianbo; Jiang, Lin; Yu, Lin; Sun, Que			Local Factors Determine Plant Community Structure on Closely Neighbored Islands	PLOS ONE			English	Article							COMPREHENSIVE FRAMEWORK; METACOMMUNITY STRUCTURE; INTERCONNECTED PONDS; SPATIAL PROCESSES; SPECIES RICHNESS; BETA-DIVERSITY; MODEL SYSTEMS; ECOLOGY; DISPERSAL; MATRICES	Despite the recent popularity of the metacommunity concept, ecologists have not evaluated the applicability of different metacommunity frameworks to insular organisms. We surveyed 50 closely spaced islands in the Thousand-Island Lake of China to examine the role of local (environmental) and regional (dispersal) factors in structuring woody plant assemblages (tree and shrub species) on these islands. By partitioning the variation in plant community structure into local and regional causes, we showed that local environmental conditions, specifically island morphometric characteristics, accounted for the majority of the variation in plant community structure among the studied islands. Spatial variables, representing the potential importance of species dispersal, explained little variation. We conclude that one metacommunity framework-species sorting-best characterizes these plant communities. This result reinforces the idea that the traditional approach of emphasizing the local perspective when studying ecological communities continues to hold its value.	[Lu, Jianbo] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Jiang, Lin] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Yu, Lin; Sun, Que] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	Hangzhou Normal University; University System of Georgia; Georgia Institute of Technology; Zhejiang University	Lu, JB (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Xiasha Campus, Hangzhou, Zhejiang, Peoples R China.	jianbo.lu63@gmail.com; lin.jiang@biology.gatech.edu	Jiang, Lin/K-5572-2019		Natural Science Foundation of China [30570320]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the Natural Science Foundation of China (grant no. 30570320). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beisner BE, 2006, ECOLOGY, V87, P2985, DOI 10.1890/0012-9658(2006)87[2985:TROEAS]2.0.CO;2; Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; Bell G, 2000, AM NAT, V155, P606, DOI 10.1086/303345; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Chase J.M., 2009, ECOLOGICAL NICHES LI; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; Chase JM, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P335; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Cottenie K, 2003, ECOLOGY, V84, P991, DOI 10.1890/0012-9658(2003)084[0991:ZMSRVL]2.0.CO;2; Cottenie K, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P189; Croll DA, 2005, SCIENCE, V307, P1959, DOI 10.1126/science.1108485; Davies KF, 2009, J ANIM ECOL, V78, P937, DOI 10.1111/j.1365-2656.2009.01559.x; Ding LiZhong, 2004, Biodiversity Science, V12, P473; [丁立仲 DING Lizhong], 2006, [浙江大学学报. 农业与生命科学版, Journal of Zhejiang University. Agriculture and Life Sciences], V32, P563; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Driscoll DA, 2009, ECOL MONOGR, V79, P485, DOI 10.1890/08-1114.1; Duivenvoorden JF, 2002, SCIENCE, V295, P636, DOI 10.1126/science.295.5555.636; Ellis AM, 2006, ECOLOGY, V87, P2582, DOI 10.1890/0012-9658(2006)87[2582:ETLMDO]2.0.CO;2; Gilbert B, 2004, P NATL ACAD SCI USA, V101, P7651, DOI 10.1073/pnas.0400814101; Gonzalez A, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P146; Griffith DA, 2006, ECOLOGY, V87, P2603, DOI 10.1890/0012-9658(2006)87[2603:SMIETF]2.0.CO;2; Guelat J, 2008, ECOLOGY, V89, P2033, DOI 10.1890/07-0905.1; Harrison S, 2008, ECOL LETT, V11, P969, DOI 10.1111/j.1461-0248.2008.01210.x; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Hubbell Stephen P., 2001, V32, pi; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jiang PeiKun, 1999, Journal of Zhejiang Forestry College, V16, P260; Kolasa J, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P212; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Li X. H., 2001, BIODIVERSITY SCI, V9, P68; LU J. B., 2005, CHINESE J APPL ECOLO, V16, P1672; MAC ARTHUR ROBERT H., 1967; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Michels E, 2001, HYDROBIOLOGIA, V442, P117, DOI 10.1023/A:1017549416362; Moser D, 2002, LANDSCAPE ECOL, V17, P657, DOI 10.1023/A:1021513729205; Mouquet N, 2003, AM NAT, V162, P544, DOI 10.1086/378857; Mouquet N., 2005, METACOMMUNITIES SPAT, P237; Myers JA, 2009, ECOL LETT, V12, P1250, DOI 10.1111/j.1461-0248.2009.01373.x; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Pringle RM, 2007, P NATL ACAD SCI USA, V104, P193, DOI 10.1073/pnas.0609840104; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Seifert, 2000, AUSTR GEOGRAPHICAL S, V38, P263, DOI [https://doi.org/10.1111/1467-8470.00115, DOI 10.1111/1467-8470.00115]; [孙雀 SUN Que], 2009, [生态学报, Acta Ecologica Sinica], V29, P2195; Sun Que, 2008, Shengwu Duoyangxing, V16, P1, DOI 10.3724/SP.J.1003.2008.07168; Svoray T, 2007, LANDSCAPE ECOL, V22, P105, DOI 10.1007/s10980-006-9004-3; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Urban MC, 2004, ECOLOGY, V85, P2971, DOI 10.1890/03-0631; Van der Gucht K, 2007, P NATL ACAD SCI USA, V104, P20404, DOI 10.1073/pnas.0707200104; Vitousek PM, 2002, J BIOGEOGR, V29, P573, DOI 10.1046/j.1365-2699.2002.00707.x; Wardle DA, 2002, J BIOGEOGR, V29, P583, DOI 10.1046/j.1365-2699.2002.00708.x; Wu J.G., 2007, LANDSCAPE ECOLOGY PA, V2nd; [张欣 ZHANG Xin], 2007, [生态学报, Acta Ecologica Sinica], V27, P424, DOI 10.1016/S1872-2032(07)60014-6; Zobel M, 1997, TRENDS ECOL EVOL, V12, P266, DOI 10.1016/S0169-5347(97)01096-3	58	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19762	10.1371/journal.pone.0019762	http://dx.doi.org/10.1371/journal.pone.0019762			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572960	Green Published, Green Submitted, gold			2022-12-27	WOS:000290440200026
J	Du, XN; Fleiss, B; Li, HF; D'angelo, B; Sun, YY; Zhu, CL; Hagberg, H; Levy, O; Mallard, C; Wang, XY				Du, Xiaonan; Fleiss, Bobbi; Li, Hongfu; D'angelo, Barbara; Sun, Yanyan; Zhu, Changlian; Hagberg, Henrik; Levy, Ofer; Mallard, Carina; Wang, Xiaoyang			Systemic Stimulation of TLR2 Impairs Neonatal Mouse Brain Development	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; ADULT HIPPOCAMPAL NEUROGENESIS; PROGENITOR-CELL PROLIFERATION; FOCAL CEREBRAL-ISCHEMIA; WHITE-MATTER INJURY; INNATE IMMUNITY; ISCHEMIA/REPERFUSION INJURY; LIPOTEICHOIC ACID; HYPOXIA-ISCHEMIA; PREMATURE-INFANT	Background: Inflammation is associated with perinatal brain injury but the underlying mechanisms are not completely characterized. Stimulation of Toll-like receptors (TLRs) through specific agonists induces inflammatory responses that trigger both innate and adaptive immune responses. The impact of engagement of TLR2 signaling pathways on the neonatal brain is still unclear. The aim of this study was to investigate the potential effect of a TLR2 agonist on neonatal brain development. Methodology/Principal Findings: Mice were injected intraperitoneally (i.p.) once a day from postnatal day (PND) 3 to PND11 with endotoxin-free saline, a TLR2 agonist Pam(3)CSK(4) (5 mg/kg) or Lipopolysaccharide (LPS, 0.3 mg/kg). Pups were sacrificed at PND12 or PND53 and brain, spleen and liver were collected and weighed. Brain sections were stained for brain injury markers. Long-term effects on memory function were assessed using the Trace Fear Conditioning test at PND50. After 9 days of Pam(3)CSK(4) administration, we found a decreased volume of cerebral gray matter, white matter in the forebrain and cerebellar molecular layer that was accompanied by an increase in spleen and liver weight at PND12. Such effects were not observed in Pam3CSK4-treated TLR 2-deficient mice. Pam3CSK4-treated mice also displayed decreased hippocampus neuronal density, and increased cerebral microglia density, while there was no effect on caspase-3 or general cell proliferation at PND12. Significantly elevated levels of IL-1 beta, IL-6, KC, and MCP-1 were detected after the first Pam3CSK4 injection in brain homogenates of PND3 mice. Pam(3)CSK(4) administration did not affect long-term memory function nor the volume of gray or white matter. Conclusions/Significance: Repeated systemic exposure to the TLR2 agonist Pam(3)CSK(4) can have a short-term negative impact on the neonatal mouse brain.	[Du, Xiaonan; Fleiss, Bobbi; D'angelo, Barbara; Hagberg, Henrik; Mallard, Carina; Wang, Xiaoyang] Univ Gothenburg, Dept Neurosci & Physiol, Perinatal Ctr, Gothenburg, Sweden; [Du, Xiaonan; Li, Hongfu; Sun, Yanyan; Zhu, Changlian; Wang, Xiaoyang] Zhengzhou Univ, Dept Pediat, Affiliated Hosp 3, Zhengzhou, Peoples R China; [Li, Hongfu; Sun, Yanyan; Zhu, Changlian] Univ Gothenburg, Ctr Brain Repair & Rehabil, Inst Neurosci & Physiol, Gothenburg, Sweden; [Hagberg, Henrik] Univ Gothenburg, Perinatal Ctr, Dept Obstet & Gynecol, Gothenburg, Sweden; [Hagberg, Henrik] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England; [Levy, Ofer] Harvard Univ, Sch Med, Boston, MA USA; [Levy, Ofer] Childrens Hosp Boston, Dept Med, Div Infect Dis, Boston, MA USA	University of Gothenburg; Zhengzhou University; University of Gothenburg; University of Gothenburg; Imperial College London; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Du, XN (corresponding author), Univ Gothenburg, Dept Neurosci & Physiol, Perinatal Ctr, Gothenburg, Sweden.	xiaoyang.wang@fysiologi.gu.se	Fleiss, Bobbi/F-9899-2011; Zhu, Changlian/AAN-6205-2020	Fleiss, Bobbi/0000-0001-7828-673X; Levy, Ofer/0000-0002-5859-1945; Zhu, Changlian/0000-0002-5029-6730; Mallard, Carina/0000-0001-8953-919X; Wang, Xiaoyang/0000-0001-9717-8160; Hagberg, Henrik/0000-0003-3962-1448	Swedish Medical Research Council [VR K2009-54X-21119-01-4, VR K2007-54x-14185-06-3, VR 2006-3396]; Wilhelm and Martina Lundgren [vet2-41/2010]; Signhild Engkvists Stiftelse; Linnea och Josef Carlssons stiftelse; National Natural Science Foundation of China [30973240]; Swedish governmental grants [ALFGBG2863]; Medical Research Council in United Kingdom [P19381]; Ahlen stiftelse; National Institutes of Health, USA [RO1 NIAID-AI067353-01A1]; EU [036534, HEALTH-F2-2009-241778]; 3M Drug Delivery Systems; VentiRx; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067353] Funding Source: NIH RePORTER; Medical Research Council [G0802853] Funding Source: researchfish; Action Medical Research [1764] Funding Source: researchfish; MRC [G0802853] Funding Source: UKRI	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Wilhelm and Martina Lundgren; Signhild Engkvists Stiftelse; Linnea och Josef Carlssons stiftelse; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Swedish governmental grants; Medical Research Council in United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ahlen stiftelse; National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU(European Commission); 3M Drug Delivery Systems(3M); VentiRx; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Action Medical Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Swedish Medical Research Council (VR K2009-54X-21119-01-4 to XW, VR K2007-54x-14185-06-3 to CM, VR 2006-3396 to HH), Wilhelm and Martina Lundgren (vet2-41/2010 to XW), Signhild Engkvists Stiftelse (to XW), Linnea och Josef Carlssons stiftelse (HH), National Natural Science Foundation of China (30973240 to XW), Swedish governmental grants to researchers in the public health service (ALFGBG2863 to HH) and Medical Research Council in United Kingdom (P19381 to HH). Ahlen stiftelse (CM), National Institutes of Health, USA (RO1 NIAID-AI067353-01A1 to OL). EU FP6, Neobrain (036534 to HH and CM) and the European Union (HEALTH-F2-2009-241778 to CM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; OL served as a consultant to MedImmune and Biosynexus. OL's laboratory receives material and/or sponsored research support from 3M Drug Delivery Systems and VentiRx. None of the other authors declare any conflicts.	Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Angelone DF, 2006, PEDIATR RES, V60, P205, DOI 10.1203/01.pdr.0000228319.10481.ea; Atkins AL, 2008, PHARMACOL BIOCHEM BE, V90, P481, DOI 10.1016/j.pbb.2008.04.007; Bizzarro MJ, 2005, PEDIATRICS, V116, P595, DOI 10.1542/peds.2005-0552; Bsibsi M, 2002, J NEUROPATH EXP NEUR, V61, P1013, DOI 10.1093/jnen/61.11.1013; Chau TA, 2009, NAT MED, V15, P641, DOI 10.1038/nm.1965; Dammann O, 1997, PEDIATR RES, V42, P1, DOI 10.1203/00006450-199707000-00001; Dean JM, 2009, NEUROSCIENCE, V160, P606, DOI 10.1016/j.neuroscience.2009.02.071; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Eklind S, 2004, DEV NEUROSCI-BASEL, V26, P61, DOI 10.1159/000080713; Favrais G, 2007, NEUROBIOL DIS, V25, P496, DOI 10.1016/j.nbd.2006.10.012; Gerlai R, 1998, BEHAV BRAIN RES, V95, P191, DOI 10.1016/S0166-4328(97)00144-7; Ha TZ, 2010, CARDIOVASC RES, V87, P694, DOI 10.1093/cvr/cvq116; Hagberg H, 1996, PEDIATR RES, V40, P603, DOI 10.1203/00006450-199610000-00015; Heldwein KA, 2003, J LEUKOCYTE BIOL, V74, P277, DOI 10.1189/jlb.0103026; Hoffmann O, 2007, J IMMUNOL, V178, P6476, DOI 10.4049/jimmunol.178.10.6476; Hua F, 2008, J NEUROIMMUNOL, V199, P75, DOI 10.1016/j.jneuroim.2008.05.009; Hua F, 2009, BRAIN RES, V1262, P100, DOI 10.1016/j.brainres.2009.01.018; Inder TE, 1999, ANN NEUROL, V46, P755, DOI 10.1002/1531-8249(199911)46:5<755::AID-ANA11>3.0.CO;2-0; Khashu M, 2006, PEDIATRICS, V117, P340, DOI 10.1542/peds.2005-0333; Kim JJ, 2006, NEUROSCI BIOBEHAV R, V30, P188, DOI 10.1016/j.neubiorev.2005.06.005; Laflamme N, 2001, J NEUROCHEM, V79, P648, DOI 10.1046/j.1471-4159.2001.00603.x; Lathia JD, 2008, J NEUROSCI, V28, P13978, DOI 10.1523/JNEUROSCI.2140-08.2008; Latz E, 2004, J IMMUNOL, V172, P2431, DOI 10.4049/jimmunol.172.4.2431; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Lehnardt S, 2006, J IMMUNOL, V177, P583, DOI 10.4049/jimmunol.177.1.583; Lehnardt S, 2007, J NEUROIMMUNOL, V190, P28, DOI 10.1016/j.jneuroim.2007.07.023; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Long EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005601; Mallard C, 2000, NEUROSCIENCE, V100, P327, DOI 10.1016/S0306-4522(00)00271-2; Mallard C, 2009, CLIN PERINATOL, V36, P763, DOI 10.1016/j.clp.2009.07.009; Mersmann J, 2010, CRIT CARE MED, V38, P903, DOI 10.1097/CCM.0b013e3181ce50e6; Messerschmidt A, 2005, AM J NEURORADIOL, V26, P1659; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Nadeau S, 2003, J NEUROSCI, V23, P5536, DOI 10.1523/jneurosci.23-13-05536.2003; Okun E, 2010, J NEUROCHEM, V114, P462, DOI 10.1111/j.1471-4159.2010.06778.x; PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189; Reddy K, 1998, PEDIATR RES, V43, P674, DOI 10.1203/00006450-199805000-00017; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Rousset CI, 2006, PEDIATR RES, V59, P428, DOI 10.1203/01.pdr.0000199905.08848.55; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Sellner J, 2009, J NEUROIMMUNOL, V206, P28, DOI 10.1016/j.jneuroim.2008.10.004; Sloane JA, 2010, P NATL ACAD SCI USA, V107, P11555, DOI 10.1073/pnas.1006496107; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Stoll BJ, 2002, NEW ENGL J MED, V347, P240, DOI 10.1056/NEJMoa012657; Strunk T, 2010, J MATERN FETAL NEONA; Strunk T, 2007, CURR OPIN INFECT DIS, V20, P370, DOI 10.1097/QCO.0b013e3281a7ec98; Strunk T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010111; Svedin P, 2009, DEV NEUROSCI-BASEL, V31, P427, DOI 10.1159/000232561; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Volpe JJ, 2011, INT J DEV NEUROS MAR; Volpe JJ, 2009, J CHILD NEUROL, V24, P1085, DOI 10.1177/0883073809338067; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Wang XY, 2007, BRAIN RES, V1144, P180, DOI 10.1016/j.brainres.2007.01.083; Wang XY, 2010, STROKE, V41, P2050, DOI 10.1161/STROKEAHA.110.589051; Wang XY, 2009, J CHILD NEUROL, V24, P1171, DOI 10.1177/0883073809338068; Wolfberg AJ, 2007, SEMIN FETAL NEONAT M, V12, P296, DOI 10.1016/j.siny.2007.01.021; Zhang JP, 2010, PEDIAT RES AUG, V2010; Ziegler G, 2007, BIOCHEM BIOPH RES CO, V359, P574, DOI 10.1016/j.bbrc.2007.05.157	59	63	67	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19583	10.1371/journal.pone.0019583	http://dx.doi.org/10.1371/journal.pone.0019583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573120	Green Submitted, Green Published, gold			2022-12-27	WOS:000290305600031
J	Hofmann, N; Wurm, R; Wagner, R				Hofmann, Nina; Wurm, Reinhild; Wagner, Rolf			The E. coli Anti-Sigma Factor Rsd: Studies on the Specificity and Regulation of Its Expression	PLOS ONE			English	Article							RNA-POLYMERASE HOLOENZYME; PHASE GENE-REGULATION; ESCHERICHIA-COLI; 6S RNA; H-NS; TRANSCRIPTION REGULATION; CORE ENZYME; FACTOR ASIA; T4 ASIA; PROMOTER	Background: Among the seven different sigma factors in E. coli sigma(70) has the highest concentration and affinity for the core RNA polymerase. The E. coli protein Rsd is regarded as an anti-sigma factor, inhibiting sigma(70)-dependent transcription at the onset of stationary growth. Although binding of Rsd to sigma(70) has been shown and numerous structural studies on Rsd have been performed the detailed mechanism of action is still unknown. Methodology/Principal Findings: We have performed studies to unravel the function and regulation of Rsd expression in vitro and in vivo. Cross-linking and affinity binding revealed that Rsd is able to interact with sigma(70), with the core enzyme of RNA polymerase and is able to form dimers in solution. Unexpectedly, we find that Rsd does also interact with sigma(38), the stationary phase-specific sigma factor. This interaction was further corroborated by gel retardation and footprinting studies with different promoter fragments and sigma(38)- or sigma(70)-containing RNA polymerase in presence of Rsd. Under competitive in vitro transcription conditions, in presence of both sigma factors, a selective inhibition of sigma(70)-dependent transcription was prevailing, however. Analysis of rsd expression revealed that the nucleoid-associated proteins H-NS and FIS, StpA and LRP bind to the regulatory region of the rsd promoters. Furthermore, the major promoter P2 was shown to be down-regulated in vivo by RpoS, the stationary phase-specific sigma factor and the transcription factor DksA, while induction of the stringent control enhanced rsd promoter activity. Most notably, the dam-dependent methylation of a cluster of GATC sites turned out to be important for efficient rsd transcription. Conclusions/Significance: The results contribute to a better understanding of the intricate mechanism of Rsd-mediated sigma factor specificity changes during stationary phase.	[Hofmann, Nina; Wurm, Reinhild; Wagner, Rolf] Univ Dusseldorf, Inst Phys Biol, D-4000 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Wagner, R (corresponding author), Univ Dusseldorf, Inst Phys Biol, D-4000 Dusseldorf, Germany.	r.wagner@rz.uni-duesseldorf.de			Grunderstiftung; Deutsche Forschungsgemeinschaft [WA 455/12]	Grunderstiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	N.H. was supported by a grant from the Grunderstiftung (http://www.unifreunde-duesseldorf.de/stiftungen/gruenderstiftung.php). The authors are grateful to the Deutsche Forschungsgemeinschaft for financial support (WA 455/12; http://www.dfg.de/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg A, 2008, MOL MICROBIOL, V67, P1223, DOI 10.1111/j.1365-2958.2008.06115.x; Aberg A, 2009, J BACTERIOL, V191, P3226, DOI 10.1128/JB.01410-08; Adelman K, 1997, J BIOL CHEM, V272, P27435, DOI 10.1074/jbc.272.43.27435; Bernardo LMD, 2006, MOL MICROBIOL, V60, P749, DOI 10.1111/j.1365-2958.2006.05129.x; Bordes P, 2000, MOL MICROBIOL, V35, P845, DOI 10.1046/j.1365-2958.2000.01758.x; BORUKHOV S, 1993, PROTEIN EXPRES PURIF, V4, P503, DOI 10.1006/prep.1993.1066; Bouffartigues E, 2007, NAT STRUCT MOL BIOL, V14, P441, DOI 10.1038/nsmb1233; BURGESS RR, 1975, BIOCHEMISTRY-US, V14, P4634, DOI 10.1021/bi00692a011; Campbell EA, 2008, CURR OPIN MICROBIOL, V11, P121, DOI 10.1016/j.mib.2008.02.016; Checroun C, 2004, NUCLEIC ACIDS RES, V32, P45, DOI 10.1093/nar/gkh155; Chen S, 2002, J MOL BIOL, V318, P1031, DOI 10.1016/S0022-2836(02)00187-0; Colland F, 1999, EMBO J, V18, P4049, DOI 10.1093/emboj/18.14.4049; Colland F, 2002, GENES CELLS, V7, P233, DOI 10.1046/j.1365-2443.2002.00517.x; Dorman CJ, 2009, ADV APPL MICROBIOL, V67, P47, DOI 10.1016/S0065-2164(08)01002-2; Geissen R, 2010, RNA BIOL, V7, P564, DOI 10.4161/rna.7.5.12969; GONZALEZ N, 1977, ARCH BIOCHEM BIOPHYS, V182, P404, DOI 10.1016/0003-9861(77)90521-5; Grigorova IL, 2006, P NATL ACAD SCI USA, V103, P5332, DOI 10.1073/pnas.0600828103; HAYATSU H, 1967, BIOCHEM BIOPH RES CO, V29, P556, DOI 10.1016/0006-291X(67)90521-9; Helmann JD, 1999, CURR OPIN MICROBIOL, V2, P135, DOI 10.1016/S1369-5274(99)80024-1; Hengge-Aronis R, 2002, CURR OPIN MICROBIOL, V5, P591, DOI 10.1016/S1369-5274(02)00372-7; HENGGEARONIS R, 1993, CELL, V72, P165, DOI 10.1016/0092-8674(93)90655-A; Hillebrand A, 2005, BIOL CHEM, V386, P523, DOI 10.1515/BC.2005.062; Hughes KT, 1998, ANNU REV MICROBIOL, V52, P231, DOI 10.1146/annurev.micro.52.1.231; IGARASHI K, 1991, J MOL BIOL, V218, P1, DOI 10.1016/0022-2836(91)90865-4; Ilag LL, 2004, STRUCTURE, V12, P269, DOI 10.1016/j.str.2004.01.007; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; Jishage M, 1999, J BACTERIOL, V181, P3768, DOI 10.1128/JB.181.12.3768-3776.1999; Jishage M, 1998, P NATL ACAD SCI USA, V95, P4953, DOI 10.1073/pnas.95.9.4953; JISHAGE M, 1995, J BACTERIOL, V177, P6832, DOI 10.1128/jb.177.23.6832-6835.1995; Kim EY, 2004, J MICROBIOL, V42, P103; KOLB A, 1995, NUCLEIC ACIDS RES, V23, P819, DOI 10.1093/nar/23.5.819; Kvaratskhelia M, 2002, J BIOL CHEM, V277, P16689, DOI 10.1074/jbc.M109914200; Lambert LJ, 2004, EMBO J, V23, P2952, DOI 10.1038/sj.emboj.7600312; Magnusson LU, 2007, J BACTERIOL, V189, P5193, DOI 10.1128/JB.00330-07; Maxam A M, 1980, Methods Enzymol, V65, P499; Minakhin L, 2003, J MOL BIOL, V326, P679, DOI 10.1016/S0022-2836(02)01442-0; Mitchell JE, 2007, J BACTERIOL, V189, P3489, DOI 10.1128/JB.00019-07; Munch R, 2003, NUCLEIC ACIDS RES, V31, P266, DOI 10.1093/nar/gkg037; Neusser T, 2008, BIOL CHEM, V389, P285, DOI 10.1515/BC.2008.023; Neusser T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-165; Nguyen LH, 1997, BIOCHEMISTRY-US, V36, P1748, DOI 10.1021/bi961175h; Nystrom T, 2004, MOL MICROBIOL, V54, P855, DOI 10.1111/j.1365-2958.2004.04342.x; Orsini G, 2001, J BIOL CHEM, V276, P19812, DOI 10.1074/jbc.M010105200; Oshima T, 2002, MOL MICROBIOL, V45, P673, DOI 10.1046/j.1365-2958.2002.03037.x; Patikoglou GA, 2007, J MOL BIOL, V372, P649, DOI 10.1016/j.jmb.2007.06.081; Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030; Pineda M, 2004, J MOL BIOL, V344, P1183, DOI 10.1016/j.jmb.2004.10.003; Piper SE, 2009, MOL BIOSYST, V5, P1943, DOI [10.1039/b904955j, 10.1039/B904955j]; Pul U, 2005, MOL MICROBIOL, V58, P864, DOI 10.1111/j.1365-2958.2005.04873.x; Pul U, 2007, J MOL BIOL, V366, P900, DOI 10.1016/j.jmb.2006.11.067; Pul U, 2010, MOL MICROBIOL, V75, P1495, DOI 10.1111/j.1365-2958.2010.07073.x; Rutherford ST, 2009, GENE DEV, V23, P236, DOI 10.1101/gad.1745409; Sharma UK, 2008, J BACTERIOL, V190, P3434, DOI 10.1128/JB.01792-07; Sharma UK, 2010, FEMS MICROBIOL REV, V34, P646, DOI 10.1111/j.1574-6976.2010.00223.x; Storz G, 2000, BACTERIAL STRESS RESPONSES, P47; TANAKA K, 1993, P NATL ACAD SCI USA, V90, P3511, DOI 10.1073/pnas.90.8.3511; Trotochaud AE, 2004, J BACTERIOL, V186, P4978, DOI 10.1128/JB.186.15.4978-4985.2004; Typas A, 2007, MOL MICROBIOL, V63, P1296, DOI 10.1111/j.1365-2958.2007.05601.x; Typas A, 2007, EMBO J, V26, P1569, DOI 10.1038/sj.emboj.7601629; Urbauer JL, 2002, P NATL ACAD SCI USA, V99, P1831, DOI 10.1073/pnas.032464699; Urbauer JL, 2001, J BIOL CHEM, V276, P41128, DOI 10.1074/jbc.M106400200; VANDERWOUDE MW, 1994, MOL MICROBIOL, V11, P605; VICENTE M, 1991, MOL MICROBIOL, V5, P2085, DOI 10.1111/j.1365-2958.1991.tb02137.x; Wassarman KM, 2007, MOL MICROBIOL, V65, P1425, DOI 10.1111/j.1365-2958.2007.05894.x; Wassarman KM, 2000, CELL, V101, P613, DOI 10.1016/S0092-8674(00)80873-9; Yuan AH, 2008, MOL MICROBIOL, V70, P1136, DOI 10.1111/j.1365-2958.2008.06462.x; ZACHARIAS M, 1990, NUCLEIC ACIDS RES, V18, P6271, DOI 10.1093/nar/18.21.6271	67	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19235	10.1371/journal.pone.0019235	http://dx.doi.org/10.1371/journal.pone.0019235			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573101	Green Published, gold, Green Submitted			2022-12-27	WOS:000290305600016
J	Cabibihan, JJ				Cabibihan, John-John			Patient-Specific Prosthetic Fingers by Remote Collaboration-A Case Study	PLOS ONE			English	Article							DIGITAL PROSTHESES; HAND; REPLANTATION; LIMB	The concealment of amputation through prosthesis usage can shield an amputee from social stigma and help improve the emotional healing process especially at the early stages of hand or finger loss. However, the traditional techniques in prosthesis fabrication defy this as the patients need numerous visits to the clinics for measurements, fitting and follow-ups. This paper presents a method for constructing a prosthetic finger through online collaboration with the designer. The main input from the amputee comes from the Computer Tomography (CT) data in the region of the affected and the non-affected fingers. These data are sent over the internet and the prosthesis is constructed using visualization, computer-aided design and manufacturing tools. The finished product is then shipped to the patient. A case study with a single patient having an amputated ring finger at the proximal interphalangeal joint shows that the proposed method has a potential to address the patient's psychosocial concerns and minimize the exposure of the finger loss to the public.	Natl Univ Singapore, Dept Elect & Comp Engn, Singapore 117548, Singapore	National University of Singapore	Cabibihan, JJ (corresponding author), Natl Univ Singapore, Dept Elect & Comp Engn, Singapore 117548, Singapore.	elecjj@nus.edu.sg		Cabibihan, John-John/0000-0001-5892-743X	Ministry of Education, Singapore [R-263-000-506-133]	Ministry of Education, Singapore(Ministry of Education, Singapore)	This work was supported by the Academic Research Fund Tier 1, Ministry of Education, Singapore under the project R-263-000-506-133. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALISON A, 1992, J HAND SURG-AM, V17A, P923, DOI 10.1016/0363-5023(92)90471-Z; Almond BS, 2011, J HAND THER, V24, P62, DOI 10.1016/j.jht.2010.04.003; Aydin C, 2007, J PROSTHET DENT, V97, P191, DOI 10.1016/j.prosdent.2007.02.008; Beris AE, 2010, ARCH ORTHOP TRAUM SU, V130, P1141, DOI 10.1007/s00402-009-1021-7; Bickel KD, 2008, J HAND SURG-AM, V33A, P1417, DOI 10.1016/j.jhsa.2008.07.001; CABIBIHAN JJ, 2010, Patent No. 61367723; Cabibihan JJ, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-16; Cabibihan JJ, 2009, INT J SOC ROBOT, V1, P29, DOI 10.1007/s12369-008-0008-9; Cabibihan JJ, 2009, LECT NOTES COMPUT SC, V5744, P73, DOI 10.1007/978-3-642-03983-6_11; DESMOND D, 2002, PROSTHET ORTHOT INT, V14, P19; Edin BB, 2008, BRAIN RES BULL, V75, P785, DOI 10.1016/j.brainresbull.2008.01.017; Friedman RM, 2008, EXP BRAIN RES, V191, P133, DOI 10.1007/s00221-008-1507-5; Gallagher P, 2001, J HEALTH PSYCHOL, V6, P85, DOI 10.1177/135910530100600107; Hattori Y, 2007, J HAND SURG-AM, V32A, P548, DOI 10.1016/j.jhsa.2007.01.019; Kini AY, 2010, PROSTHET ORTHOT INT, V34, P488, DOI 10.3109/03093646.2010.486391; Leow EL, 1997, PROSTHET ORTHOT INT, V21, P40; Leow MEL, 1999, PROSTHET ORTHOT INT, V23, P174; Molski M, 2007, J PLAST RECONSTR AES, V60, P748, DOI 10.1016/j.bjps.2007.03.009; Murray CD, 2005, J HEALTH PSYCHOL, V10, P425, DOI 10.1177/1359105305051431; PARKES CM, 1975, BRIT J PSYCHIAT, V127, P204, DOI 10.1192/bjp.127.3.204; Pawluk DTV, 1999, J BIOMECH ENG-T ASME, V121, P605, DOI 10.1115/1.2800860; Pereira BP, 1996, J HAND SURG-AM, V21A, P222, DOI 10.1016/S0363-5023(96)80104-3; Pillet J, 2001, J HAND SURG-BRIT EUR, V26, P523, DOI 10.1054/jhsb.2001.0658; Pilley MJ, 1999, J HAND SURG-BRIT EUR, V24B, P539, DOI 10.1054/jhsb.1999.0198; SABOLICH J, 2005, YOURE NOT ALONE STOR, P354; Serina ER, 1997, J BIOMECH, V30, P1035, DOI 10.1016/S0021-9290(97)00065-1; Shi DH, 2010, MICROSURG, V30, P380, DOI 10.1002/micr.20743; Soltanian H, 2003, HAND CLIN, V19, P177, DOI 10.1016/S0749-0712(02)00132-4; Thomas KF., 1994, PROSTHETIC REHABILIT; WILSON RL, 1983, ORTHOP CLIN N AM, V14, P851	30	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19508	10.1371/journal.pone.0019508	http://dx.doi.org/10.1371/journal.pone.0019508			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573246	Green Submitted, Green Published, gold			2022-12-27	WOS:000290224800032
J	Stanley, J; Carter, O; Forte, J				Stanley, Jody; Carter, Olivia; Forte, Jason			Color and Luminance Influence, but Can Not Explain, Binocular Rivalry Onset Bias	PLOS ONE			English	Article							ALTERNATIONS; DOMINANCE	When an observer is presented with dissimilar images to the right and left eye, the images will alternate every few seconds in a phenomenon known as binocular rivalry. During sustained viewing, the timing of these switches appears to be unpredictable. Recent research has suggested that the initial 'onset' period of rivalry is not random and may be different in its neural mechanism than subsequent dominance periods. It is known that differences in luminance and contrast have a significant influence on the average dominance during sustained rivalry and that perception of luminance can vary between individuals and across the visual field. We therefore investigated whether perception of luminance contrast plays a role in onset rivalry. Observers viewed rival targets of equal brightness for brief presentations in eight locations of the near periphery and reported the color that was first dominant in each location. Results show that minimizing differences in brightness and contrast yields a stronger pattern of onset dominance bias and reveals evidence of monocular dominance. The results suggest that both contrast and monocular dominance play a role in onset dominance, though neither can fully explain the effect.	[Stanley, Jody; Carter, Olivia; Forte, Jason] Univ Melbourne, Parkville, Vic 3052, Australia	University of Melbourne	Stanley, J (corresponding author), Univ Melbourne, Parkville, Vic 3052, Australia.	ocarter@unimelb.edu.au		Carter, Olivia/0000-0001-7708-6154; Forte, Jason/0000-0002-0668-885X	NHMRC (Australia) [628590]	NHMRC (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	The contribution of author Olivia Carter was supported by a Career Development Award from the NHMRC (Australia) 628590. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht J, 2002, J VISION, V2, DOI 10.1167/2.8.2; Anstis S. M., 1983, COLOUR VISION PHYSL, P155; BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; BLAKE R, 1992, VISUAL NEUROSCI, V8, P469, DOI 10.1017/S0952523800004971; Blake R, 2003, NEURON, V39, P869, DOI 10.1016/S0896-6273(03)00495-1; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brascamp JW, 2006, J VISION, V6, P1244, DOI 10.1167/6.11.8; Carter O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000343; Chen XC, 2004, CURR BIOL, V14, P1013, DOI 10.1016/j.cub.2004.05.042; Chong SC, 2006, VISION RES, V46, P1794, DOI 10.1016/j.visres.2005.10.031; CIE, 1932, COMM INT ECL P; CROVITZ HF, 1963, SCIENCE, V139, P596, DOI 10.1126/science.139.3555.596; Haynes JD, 2005, NATURE, V438, P496, DOI 10.1038/nature04169; Hohwy J, 2008, COGNITION, V108, P687, DOI 10.1016/j.cognition.2008.05.010; KAPLAN IT, 1964, J EXP PSYCHOL, V67, P22, DOI 10.1037/h0041379; Kim YJ, 2006, VISION RES, V46, P392, DOI 10.1016/j.visres.2005.08.009; KINGSMITH PE, 1994, VISION RES, V34, P885, DOI 10.1016/0042-6989(94)90039-6; Knapen T, 2009, J VISION, V9, DOI [10.1167/9.13.16, 10.1167/9.5.16]; Kovacs I, 1996, P NATL ACAD SCI USA, V93, P15508, DOI 10.1073/pnas.93.26.15508; LEAT SJ, 1984, PERCEPTION, V13, P351, DOI 10.1068/p130351; Leopold DA, 2002, NAT NEUROSCI, V5, P605, DOI 10.1038/nn0602-851; Lin ZC, 2009, PROG NEUROBIOL, V87, P195, DOI 10.1016/j.pneurobio.2008.09.002; Logothetis NK, 1998, PHILOS T R SOC B, V353, P1801, DOI 10.1098/rstb.1998.0333; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Macknik Stephen L, 2008, Adv Cogn Psychol, V3, P125, DOI 10.2478/v10053-008-0020-5; Moreno-Bote R, 2007, J NEUROPHYSIOL, V98, P1125, DOI 10.1152/jn.00116.2007; MUELLER TJ, 1989, BIOL CYBERN, V61, P223, DOI 10.1007/BF00198769; Pearson J, 2004, J VISION, V4, P196, DOI 10.1167/4.3.6; Pearson J, 2008, TRENDS COGN SCI, V12, P334, DOI 10.1016/j.tics.2008.05.006; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; SHETH B, 2008, EMOTIONAL AROUSAL VA; Silva MF, 2008, VISION RES, V48, P127, DOI 10.1016/j.visres.2007.10.018; Song C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006912; Sterzer P, 2009, TRENDS COGN SCI, V13, P310, DOI 10.1016/j.tics.2009.04.006; Sundareswara R, 2008, J VISION, V8, DOI 10.1167/8.5.12; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; Wilcke JC, 2009, BRAIN RES, V1305, P96, DOI 10.1016/j.brainres.2009.09.080; WOLFE JM, 1983, PERCEPTION, V12, P447, DOI 10.1068/p120447; Wunderlich K, 2005, NAT NEUROSCI, V8, P1595, DOI 10.1038/nn1554; Wyszecky G., 1982, COLOR SCI CONCEPTS M, DOI 10.1002/col.5080080421	40	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e18978	10.1371/journal.pone.0018978	http://dx.doi.org/10.1371/journal.pone.0018978			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573220	Green Published, Green Submitted, gold			2022-12-27	WOS:000290224800011
J	Vigouroux, Y; Mariac, C; De Mita, S; Pham, JL; Gerard, B; Kapran, I; Sagnard, F; Deu, M; Chantereau, J; Ali, A; Ndjeunga, J; Luong, V; Thuillet, AC; Saidou, AA; Bezancon, G				Vigouroux, Yves; Mariac, Cedric; De Mita, Stephane; Pham, Jean-Louis; Gerard, Bruno; Kapran, Issoufou; Sagnard, Fabrice; Deu, Monique; Chantereau, Jacques; Ali, Abdou; Ndjeunga, Jupiter; Luong, Viviane; Thuillet, Anne-Celine; Saidou, Abdoul-Aziz; Bezancon, Gilles			Selection for Earlier Flowering Crop Associated with Climatic Variations in the Sahel	PLOS ONE			English	Article							L. R. BR.; FOOD SECURITY; POPULATION-STRUCTURE; GENETIC DIVERSITY; INFERENCE; RAINFALL; AGRICULTURE; IMPACTS; PATTERN; NIGER	Climate changes will have an impact on food production and will require costly adaptive responses. Adapting to a changing environment will be particularly challenging in sub-Saharan Africa where climate change is expected to have a major impact. However, one important phenomenon that is often overlooked and is poorly documented is the ability of agro-systems to rapidly adapt to environmental variations. Such an adaptation could proceed by the adoption of new varieties or by the adaptation of varieties to a changing environment. In this study, we analyzed these two processes in one of the driest agro-ecosystems in Africa, the Sahel. We performed a detailed study in Niger where pearl millet is the main crop and covers 65% of the cultivated area. To assess how the agro-system is responding to recent recurrent drought, we analyzed samples of pearl millet landraces collected in the same villages in 1976 and 2003 throughout the entire cultivated area of Niger. We studied phenological and morphological differences in the 1976 and 2003 collections by comparing them over three cropping seasons in a common garden experiment. We found no major changes in the main cultivated varieties or in their genetic diversity. However, we observed a significant shift in adaptive traits. Compared to the 1976 samples, samples collected in 2003 displayed a shorter lifecycle, and a reduction in plant and spike size. We also found that an early flowering allele at the PHYC locus increased in frequency between 1976 and 2003. The increase exceeded the effect of drift and sampling, suggesting a direct effect of selection for earliness on this gene. We conclude that recurrent drought can lead to selection for earlier flowering in a major Sahelian crop. Surprisingly, these results suggest that diffusion of crop varieties is not the main driver of short term adaptation to climatic variation.	[Vigouroux, Yves; Mariac, Cedric; De Mita, Stephane; Pham, Jean-Louis; Luong, Viviane; Thuillet, Anne-Celine; Saidou, Abdoul-Aziz] Inst Rech Dev, Montpellier, France; [Vigouroux, Yves; Mariac, Cedric; Saidou, Abdoul-Aziz; Bezancon, Gilles] Inst Rech Dev, Niamey, Niger; [Gerard, Bruno; Ndjeunga, Jupiter] Int Ctr Res Semiarid Trop, Niamey, Niger; [Kapran, Issoufou] Inst Natl Rech Agron Niger, Niamey, Niger; [Sagnard, Fabrice; Deu, Monique; Chantereau, Jacques] Ctr Cooperat Int Rech Agron Dev, Montpellier, France; [Ali, Abdou] Ctr Reg AGHRYMET, Niamey, Niger; [Saidou, Abdoul-Aziz] Univ Abdou Moumouni, Niamey, Niger	Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); CIRAD	Vigouroux, Y (corresponding author), Inst Rech Dev, Montpellier, France.	yves.vigouroux@ird.fr	thuillet, anne-céline c/J-9836-2016; vigouroux, Yves/A-9056-2011; mariac, cedric/H-9868-2017; Gerard, Bruno/AAG-6592-2019	thuillet, anne-céline c/0000-0003-0774-2421; vigouroux, Yves/0000-0002-8361-6040; mariac, cedric/0000-0001-6439-115X; Gerard, Bruno/0000-0002-1079-7493	"Institut francais de la biodiversite" now "Fondation pour la Recherche sur la Biodiversite"; IRD; National Research Agency of France [ANR-07-JCJC-0116]; Agropolis Fondation	"Institut francais de la biodiversite" now "Fondation pour la Recherche sur la Biodiversite"; IRD; National Research Agency of France; Agropolis Fondation	This study was supported by the "Institut francais de la biodiversite" now "Fondation pour la Recherche sur la Biodiversite" (www.fondationbiodiversite.fr); by IRD (www.ird.fr); by the National Research Agency of France (ANR-07-JCJC-0116 to Y.V., www.agence-nationale-recherche.fr); by the Agropolis Fondation (http://www.agropolis-fondation.fr). The Ph.D. student, A.-A.S., is granted by IRD and Agropolis Fondation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2005, J APPL METEOROL, V44, P1691, DOI 10.1175/JAM2304.1; Allinne C, 2008, GENETICA, V133, P167, DOI 10.1007/s10709-007-9197-7; Bezancon G, 2009, GENET RESOUR CROP EV, V56, P223, DOI 10.1007/s10722-008-9357-3; Biasutti M, 2008, J CLIMATE, V21, P3471, DOI 10.1175/2007JCLI1896.1; Biasutti M, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL041303; BORGEL A, 1977, FIELD TRIP 1976 NIGE; Brown ME, 2008, SCIENCE, V319, P580, DOI 10.1126/science.1154102; Challinor AJ, 2009, J EXP BOT, V60, P2775, DOI 10.1093/jxb/erp062; Cook KH, 2008, NAT GEOSCI, V1, P647, DOI 10.1038/ngeo320; Falush D, 2003, GENETICS, V164, P1567; Foley JA, 2003, ECOSYSTEMS, V6, P524, DOI 10.1007/s10021-002-0227-0; Funk C, 2008, P NATL ACAD SCI USA, V105, P11081, DOI 10.1073/pnas.0708196105; Giannini A, 2003, SCIENCE, V302, P1027, DOI 10.1126/science.1089357; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Goudet J, 2002, FSTAT PROGRAM ESTIMA, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A111627; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; Howden SM, 2007, P NATL ACAD SCI USA, V104, P19691, DOI 10.1073/pnas.0701890104; Huelsenbeck JP, 2007, GENETICS, V175, P1787, DOI 10.1534/genetics.106.061317; Liu K., 2005, POWERMARKER NEW GENE; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Mariac C, 2006, THEOR APPL GENET, V113, P1003, DOI 10.1007/s00122-006-0360-9; Mariac C, 2006, THEOR APPL GENET, V114, P49, DOI 10.1007/s00122-006-0409-9; MARSHAL A, 1950, AGRON TROP, V5, P582; Morton JF, 2007, P NATL ACAD SCI USA, V104, P19680, DOI 10.1073/pnas.0701855104; Narisma GT, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028628; Ndjeunga J, 2002, EXP AGR, V38, P149, DOI 10.1017/S0014479702000224; Oumar I, 2008, THEOR APPL GENET, V117, P489, DOI 10.1007/s00122-008-0793-4; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Piao SL, 2010, NATURE, V467, P43, DOI 10.1038/nature09364; Pritchard JK, 2000, GENETICS, V155, P945; Saidou AA, 2009, GENETICS, V182, P899, DOI 10.1534/genetics.109.102756; Scarcelli N, 2007, P NATL ACAD SCI USA, V104, P16986, DOI 10.1073/pnas.0708209104; Sokal RR, 1995, BIOMETRY; Vigouroux Y, 2005, GENETICS, V169, P1617, DOI 10.1534/genetics.104.032086; Vigouroux Y, 2002, MOL BIOL EVOL, V19, P1251, DOI 10.1093/oxfordjournals.molbev.a004186; Wang JL, 2005, PHILOS T R SOC B, V360, P1395, DOI 10.1098/rstb.2005.1682; Wang JL, 2001, GENET RES, V78, P243, DOI 10.1017/S0016672301005286; Weir BS., 1996, GENETIC DATA ANAL	38	63	65	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19563	10.1371/journal.pone.0019563	http://dx.doi.org/10.1371/journal.pone.0019563			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573243	Green Published, gold			2022-12-27	WOS:000290224800034
J	Jacobson, EM; Concepcion, E; Ho, K; Kopp, P; Toniolo, JV; Tomer, Y				Jacobson, Eric M.; Concepcion, Erlinda; Ho, Kenneth; Kopp, Peter; Toniolo, Jussara Vono; Tomer, Yaron			cDNA Immunization of Mice with Human Thyroglobulin Generates Both Humoral and T Cell Responses: A Novel Model of Thyroid Autoimmunity	PLOS ONE			English	Article							RECEPTOR A-SUBUNIT; HASHIMOTOS-THYROIDITIS; GENE-TRANSFER; IN-VIVO; ANTITHYROGLOBULIN AUTOANTIBODIES; THYROTROPIN RECEPTOR; SKELETAL-MUSCLE; INTRAMUSCULAR INJECTION; GRAVES HYPERTHYROIDISM; DNA ELECTROTRANSFER	Thyroglobulin (Tg) represents one of the largest known self-antigens involved in autoimmunity. Numerous studies have implicated it in triggering and perpetuating the autoimmune response in autoimmune thyroid diseases (AITD). Indeed, traditional models of autoimmune thyroid disease, experimental autoimmune thyroiditis (EAT), are generated by immunizing mice with thyroglobulin protein in conjunction with an adjuvant, or by high repeated doses of Tg alone, without adjuvant. These extant models are limited in their experimental flexibility, i.e. the ability to make modifications to the Tg used in immunizations. In this study, we have immunized mice with a plasmid cDNA encoding the full-length human Tg (hTG) protein, in order to generate a model of Hashimoto's thyroiditis which is closer to the human disease and does not require adjuvants to breakdown tolerance. Human thyroglobulin cDNA was injected and subsequently electroporated into skeletal muscle using a square wave generator. Following hTg cDNA immunizations, the mice developed both B and T cell responses to Tg, albeit with no evidence of lymphocytic infiltration of the thyroid. This novel model will afford investigators the means to test various hypotheses which were unavailable with the previous EAT models, specifically the effects of hTg sequence variations on the induction of thyroiditis.	[Jacobson, Eric M.] Univ Cincinnati, Coll Med, Div Endocrinol, Cincinnati, OH 45221 USA; [Concepcion, Erlinda; Ho, Kenneth; Tomer, Yaron] Mt Sinai Sch Med, Dept Med, Div Endocrinol, New York, NY USA; [Kopp, Peter; Toniolo, Jussara Vono] Northwestern Univ, Div Endocrinol Metab & Mol Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Tomer, Yaron] James J Peters VA Med Ctr, Bronx, NY USA	University System of Ohio; University of Cincinnati; Icahn School of Medicine at Mount Sinai; Northwestern University; Feinberg School of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Jacobson, EM (corresponding author), Univ Cincinnati, Coll Med, Div Endocrinol, Cincinnati, OH 45221 USA.	Eric.Jacobson@uc.edu	Tomer, Yaron/GWU-8933-2022	Kopp, Peter A/0000-0001-5980-0529	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK061659, DK067555, DK073681, DK063024]; American Thyroid Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073681, R01DK063024, R01DK061659, R01DK067555] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Thyroid Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants DK061659, DK067555, DK073681 (to YT) and DK063024 (to PK) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). EMJ was supported by a grant from the American Thyroid Association (http://www.thyroid.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alimi E, 1998, EUR J IMMUNOL, V28, P201, DOI 10.1002/(SICI)1521-4141(199801)28:01<201::AID-IMMU201>3.0.CO;2-N; Ban Y, 2003, P NATL ACAD SCI USA, V100, P15119, DOI 10.1073/pnas.2434175100; BEISEL KW, 1982, IMMUNOGENETICS, V15, P427, DOI 10.1007/BF00364266; Berglund J, 1996, J INTERN MED, V239, P57, DOI 10.1046/j.1365-2796.1996.415757000.x; BERNARD NF, 1992, DIABETES, V41, P40, DOI 10.2337/diabetes.41.1.40; Bloquel C, 2004, J GENE MED, V6, pS11, DOI 10.1002/jgm.508; Cappelletti M, 2003, J GENE MED, V5, P324, DOI 10.1002/jgm.352; CHARREIRE J, 1989, ADV IMMUNOL, V46, P263, DOI 10.1016/S0065-2776(08)60656-2; Chen CR, 2007, ENDOCRINOLOGY, V148, P2375, DOI 10.1210/en.2006-1754; Chen CR, 2010, ENDOCRINOLOGY, V151, P4583, DOI 10.1210/en.2010-0321; Chen CR, 2004, ENDOCRINOLOGY, V145, P228, DOI 10.1210/en.2003-1134; CHRONOPOULOU E, 1994, CLIN EXP IMMUNOL, V98, P89; CREEMERS P, 1983, J EXP MED, V157, P559, DOI 10.1084/jem.157.2.559; DEVEY ME, 1989, CLIN EXP IMMUNOL, V77, P191; Donnelly JJ, 1997, ANNU REV IMMUNOL, V15, P617, DOI 10.1146/annurev.immunol.15.1.617; ELREHEWY M, 1981, EUR J IMMUNOL, V11, P146, DOI 10.1002/eji.1830110216; Flynn JC, 2004, CLIN EXP IMMUNOL, V137, P503, DOI 10.1111/j.1365-2249.2004.02553.x; FUKUMA N, 1991, AUTOIMMUNITY, V10, P291, DOI 10.3109/08916939109001903; FULLER BE, 1994, AUTOIMMUNITY, V19, P161, DOI 10.3109/08916939408995691; Guo J, 2003, CLIN EXP IMMUNOL, V132, P408, DOI 10.1046/j.1365-2249.2003.02170.x; Herweijer H, 2003, GENE THER, V10, P453, DOI 10.1038/sj.gt.3301983; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; HUREZ V, 1993, SCAND J IMMUNOL, V38, P190, DOI 10.1111/j.1365-3083.1993.tb01712.x; Jacobson EM, 2007, J AUTOIMMUN, V28, P85, DOI 10.1016/j.jaut.2007.02.006; Kim HJ, 2010, NATURE, V467, P328, DOI 10.1038/nature09370; Kong YCM, 1996, J EXP MED, V184, P1167, DOI 10.1084/jem.184.3.1167; KONG YCM, 1980, TRANSPLANT P, V12, P129; KONG YM, 1989, CLIN EXP IMMUNOL, V77, P428; Lu QL, 2003, GENE THER, V10, P131, DOI 10.1038/sj.gt.3301874; Mathiesen I, 1999, GENE THER, V6, P508, DOI 10.1038/sj.gt.3300847; MCINTOSH RS, 1994, BBA-MOL BASIS DIS, V1227, P171, DOI 10.1016/0925-4439(94)90091-4; McIntosh RS, 1996, J IMMUNOL, V157, P927; Menconi F, 2008, P NATL ACAD SCI USA, V105, P14034, DOI 10.1073/pnas.0806584105; Mir LM, 1999, P NATL ACAD SCI USA, V96, P4262, DOI 10.1073/pnas.96.8.4262; Mizutori Y, 2008, CLIN EXP IMMUNOL, V154, P305, DOI 10.1111/j.1365-2249.2008.03769.x; Mizutori Y, 2006, J AUTOIMMUN, V26, P32, DOI 10.1016/j.jaut.2005.08.008; Morris GP, 2003, CELL IMMUNOL, V226, P20, DOI 10.1016/j.cellimm.2003.11.002; Nagayama Y, 2002, J IMMUNOL, V168, P2789, DOI 10.4049/jimmunol.168.6.2789; Nakahara M, 2010, ENDOCRINOLOGY, V151, P4047, DOI 10.1210/en.2010-0315; ROITT IM, 1956, LANCET, V271, P820; ROITT IM, 1958, BIOCHEM J, V69, P248, DOI 10.1042/bj0690248; Sakai K, 2001, HUM MOL GENET, V10, P1379, DOI 10.1093/hmg/10.13.1379; Shulman S, 1971, Adv Immunol, V14, P85, DOI 10.1016/S0065-2776(08)60284-9; SILVERMAN DA, 1971, P SOC EXP BIOL MED, V138, P579; SIMON LL, 1985, CELL IMMUNOL, V94, P243, DOI 10.1016/0008-8749(85)90101-7; SOLLEVELD HA, 1985, AM J PATHOL, V119, P345; Stafford E A, 2000, Int Rev Immunol, V19, P501, DOI 10.3109/08830180009088510; STERNTHAL E, 1981, DIABETES, V30, P1058, DOI 10.2337/diabetes.30.12.1058; STULL SJ, 1988, CELL IMMUNOL, V117, P188, DOI 10.1016/0008-8749(88)90087-1; Sundick RS, 1996, EXP CLIN ENDOCR DIAB, V104, P4, DOI 10.1055/s-0029-1211668; Taguchi O, 1996, IMMUNOLOGY, V89, P13, DOI 10.1046/j.1365-2567.1996.d01-712.x; TOMAZIC V, 1976, IMMUNOLOGY, V30, P63; Tomer Y, 2003, AM J HUM GENET, V73, P736, DOI 10.1086/378588; Tomer Y, 2002, J CLIN ENDOCR METAB, V87, P404, DOI 10.1210/jc.87.1.404; Tomer Y, 1997, CLIN IMMUNOL IMMUNOP, V82, P3, DOI 10.1006/clin.1996.4243; Tomer Y, 2009, J AUTOIMMUN, V32, P231, DOI 10.1016/j.jaut.2009.02.007; Trezise AEO, 2002, DNA CELL BIOL, V21, P869, DOI 10.1089/104454902762053837; TUCKER WE, 1962, AM J CLIN PATHOL, V38, P70; TUNBRIDGE WMG, 1977, CLIN ENDOCRINOL, V7, P481, DOI 10.1111/j.1365-2265.1977.tb01340.x; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; van de Graaf SAR, 2001, J ENDOCRINOL, V170, P307, DOI 10.1677/joe.0.1700307; VITADELLO M, 1994, HUM GENE THER, V5, P11, DOI 10.1089/hum.1994.5.1-11; VLADUTIU AO, 1971, SCIENCE, V174, P1137, DOI 10.1126/science.174.4014.1137; Waisman A, 1996, NAT MED, V2, P899, DOI 10.1038/nm0896-899; Widera G, 2000, J IMMUNOL, V164, P4635, DOI 10.4049/jimmunol.164.9.4635; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; YANKAUCKAS MA, 1993, DNA CELL BIOL, V12, P771, DOI 10.1089/dna.1993.12.771	67	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19200	10.1371/journal.pone.0019200	http://dx.doi.org/10.1371/journal.pone.0019200			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559421	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700100
J	Li, DC; Ji, BH; Hwang, KC; Huang, YG				Li, Dechang; Ji, Baohua; Hwang, Keh-Chih; Huang, Yonggang			Strength of Hydrogen Bond Network Takes Crucial Roles in the Dissociation Process of Inhibitors from the HIV-1 Protease Binding Pocket	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DYNAMIC FORCE SPECTROSCOPY; SUBSTRATE-BINDING; FLAP TIPS; MECHANISM; ADHESION; MODEL; SIMULATIONS; EQUALITY; PATHWAYS	To understand the underlying mechanisms of significant differences in dissociation rate constant among different inhibitors for HIV-1 protease, we performed steered molecular dynamics (SMD) simulations to analyze the entire dissociation processes of inhibitors from the binding pocket of protease at atomistic details. We found that the strength of hydrogen bond network between inhibitor and the protease takes crucial roles in the dissociation process. We showed that the hydrogen bond network in the cyclic urea inhibitors AHA001/XK263 is less stable than that of the approved inhibitor ABT538 because of their large differences in the structures of the networks. In the cyclic urea inhibitor bound complex, the hydrogen bonds often distribute at the flap tips and the active site. In contrast, there are additional accessorial hydrogen bonds formed at the lateral sides of the flaps and the active site in the ABT538 bound complex, which take crucial roles in stabilizing the hydrogen bond network. In addition, the water molecule W301 also plays important roles in stabilizing the hydrogen bond network through its flexible movement by acting as a collision buffer and helping the rebinding of hydrogen bonds at the flap tips. Because of its high stability, the hydrogen bond network of ABT538 complex can work together with the hydrophobic clusters to resist the dissociation, resulting in much lower dissociation rate constant than those of cyclic urea inhibitor complexes. This study may provide useful guidelines for design of novel potent inhibitors with optimized interactions.	[Li, Dechang; Ji, Baohua; Hwang, Keh-Chih] Tsinghua Univ, Dept Engn Mech, Sch Aerosp, Beijing 100084, Peoples R China; [Ji, Baohua] Beijing Inst Technol, Dept Appl Mech, Biomech & Biomat Lab, Beijing 100081, Peoples R China; [Huang, Yonggang] Northwestern Univ, Dept Civil & Environm Engn, Evanston, IL USA	Tsinghua University; Beijing Institute of Technology; Northwestern University	Li, DC (corresponding author), Tsinghua Univ, Dept Engn Mech, Sch Aerosp, Beijing 100084, Peoples R China.	bhji@bit.edu.cn	HWANG, Keh-Chih/A-9989-2014; Li, Dechang/D-2766-2009; Li, Dechang/ABH-7349-2020; huang, yonggang/O-6236-2019; Huang, Yonggang/B-6998-2009; Ji, Baohua/B-6713-2008	Li, Dechang/0000-0002-9528-6851; Li, Dechang/0000-0002-9528-6851; Ji, Baohua/0000-0002-0092-6562	National Natural Science Foundation of China [10732050, 10872115, 11025208]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China through Grant Nos. 10732050, 10872115, and 11025208. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackbarow T, 2007, P NATL ACAD SCI USA, V104, P16410, DOI 10.1073/pnas.0705759104; Ala PJ, 1998, J BIOL CHEM, V273, P12325, DOI 10.1074/jbc.273.20.12325; Backbro K, 1997, J MED CHEM, V40, P898, DOI 10.1021/jm960588d; Bastug T, 2007, CHEM PHYS LETT, V436, P383, DOI 10.1016/j.cplett.2007.01.078; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chang CEA, 2007, CHEM BIOL DRUG DES, V69, P5, DOI 10.1111/j.1747-0285.2007.00464.x; Cheng YA, 2010, J MOL GRAPH MODEL, V29, P171, DOI 10.1016/j.jmgm.2010.05.009; Colizzi F, 2010, J AM CHEM SOC, V132, P7361, DOI 10.1021/ja100259r; Collin D, 2005, NATURE, V437, P231, DOI 10.1038/nature04061; Copeland R. A., 2004, ENZYMES PRACTICAL IN; Dudko OK, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.108101; Dudko OK, 2003, P NATL ACAD SCI USA, V100, P11378, DOI 10.1073/pnas.1534554100; Dudko OK, 2008, P NATL ACAD SCI USA, V105, P15755, DOI 10.1073/pnas.0806085105; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; FURFINE ES, 1992, BIOCHEMISTRY-US, V31, P7886, DOI 10.1021/bi00149a020; Grubmuller H, 1996, SCIENCE, V271, P997, DOI 10.1126/science.271.5251.997; Hamelberg D, 2005, J AM CHEM SOC, V127, P13778, DOI 10.1021/ja054338a; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hornak V, 2006, J AM CHEM SOC, V128, P2812, DOI 10.1021/ja058211x; Hornak V, 2006, P NATL ACAD SCI USA, V103, P915, DOI 10.1073/pnas.0508452103; Hulten J, 1997, J MED CHEM, V40, P885, DOI 10.1021/jm960728j; Hummer G, 2005, ACCOUNTS CHEM RES, V38, P504, DOI 10.1021/ar040148d; Hummer G, 2001, P NATL ACAD SCI USA, V98, P3658, DOI 10.1073/pnas.071034098; Hummer G, 2003, BIOPHYS J, V85, P5, DOI 10.1016/S0006-3495(03)74449-X; Jakalian A, 2000, J COMPUT CHEM, V21, P132, DOI 10.1002/(SICI)1096-987X(20000130)21:2<132::AID-JCC5>3.0.CO;2-P; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; KATZ RA, 1994, ANNU REV BIOCHEM, V63, P133, DOI 10.1146/annurev.bi.63.070194.001025; KEMPF DJ, 1995, P NATL ACAD SCI USA, V92, P2484, DOI 10.1073/pnas.92.7.2484; Keten S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.198301; Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/nmat2704, 10.1038/NMAT2704]; KOHL NE, 1988, P NATL ACAD SCI USA, V85, P4686, DOI 10.1073/pnas.85.13.4686; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; LAM PYS, 1994, SCIENCE, V263, P380, DOI 10.1126/science.8278812; Lemkul JA, 2010, J PHYS CHEM B, V114, P1652, DOI 10.1021/jp9110794; Li DC, 2009, INT J APPL MECH, V1, P113, DOI 10.1142/S1758825109000034; Li DC, 2010, J PHYS CHEM B, V114, P3060, DOI 10.1021/jp1005549; Li DC, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3148022; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Liphardt J, 2002, SCIENCE, V296, P1832, DOI 10.1126/science.1071152; Lu H, 1998, BIOPHYS J, V75, P662, DOI 10.1016/S0006-3495(98)77556-3; Markgren PO, 2002, J MED CHEM, V45, P5430, DOI 10.1021/jm0208370; Maschera B, 1996, J BIOL CHEM, V271, P33231, DOI 10.1074/jbc.271.52.33231; Morfill J, 2008, J MOL BIOL, V381, P1253, DOI 10.1016/j.jmb.2008.06.065; Neumann J, 2009, BIOPHYS J, V97, P1687, DOI 10.1016/j.bpj.2009.01.052; Pecht I, 1977, CHEM RELAXATION MOL; Pietrucci F, 2009, J AM CHEM SOC, V131, P11811, DOI 10.1021/ja903045y; Qin Z, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/42/425101; Root DD, 2006, BIOPHYS J, V90, P2852, DOI 10.1529/biophysj.105.071597; Sadiq SK, 2007, BIOCHEMISTRY-US, V46, P14865, DOI 10.1021/bi700864p; Scott WRP, 2000, STRUCTURE, V8, P1259, DOI 10.1016/S0969-2126(00)00537-2; Sheu SY, 2003, P NATL ACAD SCI USA, V100, P12683, DOI 10.1073/pnas.2133366100; Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Toth G, 2006, BIOCHEMISTRY-US, V45, P6606, DOI 10.1021/bi060188k; Tozzini V, 2005, CHEM PHYS LETT, V413, P123, DOI 10.1016/j.cplett.2005.07.075; Trylska J, 2007, BIOPHYS J, V92, P4179, DOI 10.1529/biophysj.106.100560; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; West DK, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2393232; Wiley AP, 2009, J CHEM THEORY COMPUT, V5, P1117, DOI 10.1021/ct800152d; Wittayanarakul K, 2008, J COMPUT CHEM, V29, P673, DOI 10.1002/jcc.20821; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P10791, DOI 10.1021/ja00102a057; Zhao Q, 2010, PHYS REV E, V86	64	31	31	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19268	10.1371/journal.pone.0019268	http://dx.doi.org/10.1371/journal.pone.0019268			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559397	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700119
J	Su, YW; Xie, TX; Sano, D; Myers, JN				Su, Ying-Wen; Xie, Tong-Xin; Sano, Daisuke; Myers, Jeffrey N.			IL-6 Stabilizes Twist and Enhances Tumor Cell Motility in Head and Neck Cancer Cells through Activation of Casein Kinase 2	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; NF-KAPPA-B; UP-REGULATION; MEDIATED DEGRADATION; TRANSCRIPTION FACTOR; CATALYTIC-SUBUNIT; BETA-CATENIN; IN-VITRO; CK2; PROTEIN	Background: Squamous cell carcinoma of the head and neck (SCCHN) is the seventh most common cancer worldwide. Unfortunately, the survival of patients with SCCHN has not improved in the last 40 years, and thus new targets for therapy are needed. Recently, elevations in serum level of interleukin 6 (IL-6) and expression of Twist in tumor samples were found to be associated with poor clinical outcomes in multiple types of cancer, including SCCHN. Although Twist has been proposed as a master regulator of epithelial-mesenchymal transition and metastasis in cancers, the mechanisms by which Twist levels are regulated post-translationally are not completely understood. Tumor progression is characterized by the involvement of cytokines and growth factors and Twist induction has been connected with a number of these signaling pathways including IL-6. Since many of the effects of IL-6 are mediated through activation of protein phosphorylation cascades, this implies that Twist expression must be under a tight control at the post-translational level in order to respond in a timely manner to external stimuli. Methodology/Principal Findings: Our data show that IL-6 increases Twist expression via a transcription-independent mechanism in many SCCHN cell lines. Further investigation revealed that IL-6 stabilizes Twist in SCCHN cell lines through casein kinase 2 (CK2) phosphorylation of Twist residues S18 and S20, and that this phosphorylation inhibits degradation of Twist. Twist phosphorylation not only increases its stability but also enhances cell motility. Thus, post-translational modulation of Twist contributes to its tumor-promoting properties. Conclusions/Significance: Our study shows Twist expression can be regulated at the post-translational level through phosphorylation by CK2, which increases Twist stability in response to IL-6 stimulation. Our findings not only provide novel mechanistic insights into post-translational regulation of Twist but also suggest that CK2 may be a viable therapeutic target in SCCHN.	[Su, Ying-Wen; Myers, Jeffrey N.] Univ Texas Houston, Grad Sch Biomed Sci, Program Canc Biol, Houston, TX 77030 USA; [Su, Ying-Wen; Xie, Tong-Xin; Sano, Daisuke; Myers, Jeffrey N.] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center	Su, YW (corresponding author), Univ Texas Houston, Grad Sch Biomed Sci, Program Canc Biol, Houston, TX 77030 USA.	jmyers@mdanderson.org	Sano, Daisuke/R-6591-2018	Sano, Daisuke/0000-0002-7686-4724	University of Texas MD Anderson Cancer Center [P50 CA097007]; National Institutes of Health Cancer Center [CA016672]; PANTHEON foundation; The Broudy "Commit to the Cure" foundation; NATIONAL CANCER INSTITUTE [P50CA097007, P30CA016672] Funding Source: NIH RePORTER	University of Texas MD Anderson Cancer Center; National Institutes of Health Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PANTHEON foundation; The Broudy "Commit to the Cure" foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by The University of Texas MD Anderson Cancer Center SPORE in Head and Neck Cancer grant P50 CA097007, the National Institutes of Health Cancer Center Support grant CA016672, and the PANTHEON and The Broudy "Commit to the Cure" foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed K, 2002, TRENDS CELL BIOL, V12, P226, DOI 10.1016/S0962-8924(02)02279-1; Allen C, 2007, CLIN CANCER RES, V13, P3182, DOI 10.1158/1078-0432.CCR-06-3047; ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000; Bourguignon LYW, 2010, J BIOL CHEM, V285, P36721, DOI 10.1074/jbc.M110.162305; Bromberg J, 2009, CANCER CELL, V15, P79, DOI 10.1016/j.ccr.2009.01.009; Brown MS, 2010, CLIN CANCER RES, V16, P2295, DOI 10.1158/1078-0432.CCR-09-3200; Buchou T, 2003, MOL CELL BIOL, V23, P908, DOI 10.1128/MCB.23.3.908-915.2003; Chen Z, 1999, CLIN CANCER RES, V5, P1369; Cheng GZ, 2008, J BIOL CHEM, V283, P14665, DOI 10.1074/jbc.M707429200; Colomiere M, 2009, BRIT J CANCER, V100, P134, DOI 10.1038/sj.bjc.6604794; Demontis S, 2006, CELL DEATH DIFFER, V13, P335, DOI 10.1038/sj.cdd.4401744; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; Duffy SA, 2008, CANCER-AM CANCER SOC, V113, P750, DOI 10.1002/cncr.23615; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Firulli BA, 2005, NAT GENET, V37, P373, DOI 10.1038/ng1525; Fuchs SY, 2000, J BIOL CHEM, V275, P12560, DOI 10.1074/jbc.275.17.12560; GAPANY M, 1995, MOL MED, V1, P659, DOI 10.1007/BF03401606; Gitelman I, 1997, DEV BIOL, V189, P205, DOI 10.1006/dbio.1997.8614; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; Hosono S, 2007, BRIT J CANCER, V96, P314, DOI 10.1038/sj.bjc.6603533; Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; Landesman-Bollag E, 2001, ONCOGENE, V20, P3247, DOI 10.1038/sj.onc.1204411; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Lou DY, 2008, MOL CELL BIOL, V28, P131, DOI 10.1128/MCB.01119-07; O-charoenrat P, 2004, CLIN CANCER RES, V10, P5792, DOI 10.1158/1078-0432.CCR-03-0317; Ou DL, 2008, ANTICANCER RES, V28, P1355; Pagano MA, 2004, BIOCHEM BIOPH RES CO, V321, P1040, DOI 10.1016/j.bbrc.2004.07.067; Piazza FA, 2006, BLOOD, V108, P1698, DOI 10.1182/blood-2005-11-013672; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Posner MR, 2007, NEW ENGL J MED, V357, P1705, DOI 10.1056/NEJMoa070956; Scaglioni PP, 2008, MOL CELL BIOCHEM, V316, P149, DOI 10.1007/s11010-008-9812-7; Schafer ZT, 2007, J CLIN INVEST, V117, P3660, DOI 10.1172/JCI34237; Schultz JD, 2010, ONCOL REP, V24, P1213, DOI 10.3892/or_00000974; SELDIN DC, 1995, SCIENCE, V267, P894, DOI 10.1126/science.7846532; Shinriki S, 2009, CLIN CANCER RES, V15, P5426, DOI 10.1158/1078-0432.CCR-09-0287; Singh S, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-47; Solares AM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-146; St-Denis NA, 2009, CELL MOL LIFE SCI, V66, P1817, DOI 10.1007/s00018-009-9150-2; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Trembley JH, 2010, BIOFACTORS, V36, P187, DOI 10.1002/biof.96; Vichalkovski A, 2010, ONCOGENE, V29, P3554, DOI 10.1038/onc.2010.115; Wallerand H, 2010, UROL ONCOL-SEMIN ORI, V28, P473, DOI 10.1016/j.urolonc.2008.12.018; Wang GX, 2005, MOL CELL BIOCHEM, V274, P77, DOI 10.1007/s11010-005-3077-1; Xu X, 1999, NAT GENET, V23, P118, DOI 10.1038/12729; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Zhou G, 2008, ONCOGENE, V27, P3527, DOI 10.1038/sj.onc.1211015	50	52	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19412	10.1371/journal.pone.0019412	http://dx.doi.org/10.1371/journal.pone.0019412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559372	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700161
J	Wang, LI; Lin, YS; Liu, KH; Jong, AY; Shen, WC				Wang, Lin-Ing; Lin, Yu-Sheng; Liu, Kung-Hung; Jong, Ambrose Y.; Shen, Wei-Chiang			Cryptococcus neoformans Mediator Protein Ssn8 Negatively Regulates Diverse Physiological Processes and Is Required for Virulence	PLOS ONE			English	Article							RNA-POLYMERASE-II; STRESS-INDUCED DESTRUCTION; CELL-WALL INTEGRITY; ALPHA-MATING TYPE; SACCHAROMYCES-CEREVISIAE; FILAMENTOUS GROWTH; INVASIVE GROWTH; YEAST MEDIATOR; TRANSCRIPTIONAL REGULATION; FUSARIUM-VERTICILLIOIDES	Cryptococcus neoformans is a ubiquitously distributed human pathogen. It is also a model system for studying fungal virulence, physiology and differentiation. Light is known to inhibit sexual development via the evolutionarily conserved white collar proteins in C. neoformans. To dissect molecular mechanisms regulating this process, we have identified the SSN8 gene whose mutation suppresses the light-dependent CWC1 overexpression phenotype. Characterization of sex-related phenotypes revealed that Ssn8 functions as a negative regulator in both heterothallic a-alpha mating and same-sex mating processes. In addition, Ssn8 is involved in the suppression of other physiological processes including invasive growth, and production of capsule and melanin. Interestingly, Ssn8 is also required for the maintenance of cell wall integrity and virulence. Our gene expression studies confirmed that deletion of SSN8 results in de-repression of genes involved in sexual development and melanization. Epistatic and yeast two hybrid studies suggest that C. neoformans Ssn8 plays critical roles downstream of the Cpk1 MAPK cascade and Ste12 and possibly resides at one of the major branches downstream of the Cwc complex in the light-mediated sexual development pathway. Taken together, our studies demonstrate that the conserved Mediator protein Ssn8 functions as a global regulator which negatively regulates diverse physiological and developmental processes and is required for virulence in C. neoformans.	[Wang, Lin-Ing; Lin, Yu-Sheng; Liu, Kung-Hung; Shen, Wei-Chiang] Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10764, Taiwan; [Jong, Ambrose Y.] Childrens Hosp Los Angeles, Div Hematol Oncol, Los Angeles, CA 90027 USA	National Taiwan University; Children's Hospital Los Angeles	Wang, LI (corresponding author), Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10764, Taiwan.	wcshen@ntu.edu.tw		SHEN, WEI-CHIANG/0000-0002-8921-1132; Wang, Lin-Ing/0000-0001-7916-9885	National Science Council [NSC96-2311-B-002-022-MY3, NSC99-2311-B-002-008-MY3]; Diseases Research and Education Center, Department of Health and National Taiwan University	National Science Council(Ministry of Science and Technology, Taiwan); Diseases Research and Education Center, Department of Health and National Taiwan University	This work has been funded by National Science Council Grants NSC96-2311-B-002-022-MY3 and NSC99-2311-B-002-008-MY3 (to WCS ). The authors also acknowledge the financial support provided by Infectious Diseases Research and Education Center, Department of Health and National Taiwan University (to LIW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alspaugh JA, 2000, MOL MICROBIOL, V36, P352, DOI 10.1046/j.1365-2958.2000.01852.x; Bahn YS, 2007, NAT REV MICROBIOL, V5, P57, DOI 10.1038/nrmicro1578; Baker LG, 2007, EUKARYOT CELL, V6, P855, DOI 10.1128/EC.00399-06; BALCIUNAS D, 1995, NUCLEIC ACIDS RES, V23, P4421, DOI 10.1093/nar/23.21.4421; Biddick R, 2005, CR BIOL, V328, P773, DOI 10.1016/j.crvi.2005.03.004; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; Blankenship JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000752; Bluhm BH, 2006, FUNGAL GENET BIOL, V43, P146, DOI 10.1016/j.fgb.2005.09.006; Borggrefe T, 2002, J BIOL CHEM, V277, P44202, DOI 10.1074/jbc.M207195200; Boube M, 2002, CELL, V110, P143, DOI 10.1016/S0092-8674(02)00830-9; Cai G, 2009, STRUCTURE, V17, P559, DOI 10.1016/j.str.2009.01.016; CARLSON M, 1984, GENETICS, V107, P19; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; Chadick JZ, 2005, TRENDS BIOCHEM SCI, V30, P264, DOI 10.1016/j.tibs.2005.03.001; Chang YC, 2001, P NATL ACAD SCI USA, V98, P3258, DOI 10.1073/pnas.061031998; Chang YW, 2004, MOL CELL, V15, P107, DOI 10.1016/j.molcel.2004.05.021; Chou S, 2006, MOL CELL BIOL, V26, P4794, DOI 10.1128/MCB.02053-05; Cohen TJ, 2003, EUKARYOT CELL, V2, P962, DOI 10.1128/EC.2.5.962-970.2003; Cooper KF, 1999, MOL CELL BIOL, V19, P3338; Cooper KF, 2002, EUKARYOT CELL, V1, P66, DOI 10.1128/EC.01.1.66-74.2002; Cullen PJ, 2000, P NATL ACAD SCI USA, V97, P13619, DOI 10.1073/pnas.240345197; Davidson RC, 2003, MOL MICROBIOL, V49, P469, DOI 10.1046/j.1365-2958.2003.03563.x; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Fuchs BB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000368; Fuchs BB, 2007, ANTIMICROB AGENTS CH, V51, P2929, DOI 10.1128/AAC.00121-07; Gagiano M, 2002, FEMS YEAST RES, V2, P433, DOI 10.1016/S1567-1356(02)00133-2; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Guglielmi B, 2004, NUCLEIC ACIDS RES, V32, P5379, DOI 10.1093/nar/gkh878; Hampsey M, 1998, MICROBIOL MOL BIOL R, V62, P465, DOI 10.1128/MMBR.62.2.465-503.1998; Hartmann HA, 1996, EMBO J, V15, P1632, DOI 10.1002/j.1460-2075.1996.tb00508.x; Helmy KY, 2006, CELL, V124, P915, DOI 10.1016/j.cell.2005.12.039; Hengartner CJ, 1998, MOL CELL, V2, P43, DOI 10.1016/S1097-2765(00)80112-4; Hirst M, 1999, MOL CELL, V3, P673, DOI 10.1016/S1097-2765(00)80360-3; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Hsueh YP, 2007, MOL BIOL CELL, V18, P3237, DOI 10.1091/mbc.E07-02-0133; Hsueh YP, 2009, EMBO J, V28, P1220, DOI 10.1038/emboj.2009.68; Hsueh YP, 2005, EUKARYOT CELL, V4, P147, DOI 10.1128/EC.4.1.147-155.2005; Idnurm A, 2005, PLOS BIOL, V3, P615, DOI 10.1371/journal.pbio.0030095; James P, 1996, GENETICS, V144, P1425; JAMES PG, 1990, CARBOHYD RES, V198, P23, DOI 10.1016/0008-6215(90)84273-W; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Krasley E, 2006, GENETICS, V172, P1477, DOI 10.1534/genetics.105.052266; KWONCHUNG KJ, 1982, A VAN LEEUW J MICROB, V48, P25, DOI 10.1007/BF00399484; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P602, DOI 10.1128/IAI.60.2.602-605.1992; Lin XR, 2006, ANNU REV MICROBIOL, V60, P69, DOI 10.1146/annurev.micro.60.080805.142102; Lin XR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000953; Lin XR, 2009, INFECT GENET EVOL, V9, P401, DOI 10.1016/j.meegid.2009.01.013; Lin XR, 2005, NATURE, V434, P1017, DOI 10.1038/nature03448; Linder T, 2004, J BIOL CHEM, V279, P49455, DOI 10.1074/jbc.M409046200; Liu L, 1999, INFECT IMMUN, V67, P6034, DOI 10.1128/IAI.67.11.6034-6039.1999; Liu OW, 2008, CELL, V135, P174, DOI 10.1016/j.cell.2008.07.046; Lu YK, 2005, MOL MICROBIOL, V56, P480, DOI 10.1111/j.1365-2958.2005.04549.x; Madhani HD, 1998, TRENDS GENET, V14, P151, DOI 10.1016/S0168-9525(98)01425-5; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; MOORE TDE, 1993, MOL CELL BIOL, V13, P1962, DOI 10.1128/MCB.13.3.1962; NEILSON JB, 1978, INFECT IMMUN, V20, P262, DOI 10.1128/IAI.20.1.262-266.1978; Nelson C, 2003, NATURE, V421, P187, DOI 10.1038/nature01243; Palecek SP, 2000, GENETICS, V156, P1005; Papamichos-Chronakis M, 2004, EMBO REP, V5, P368, DOI 10.1038/sj.embor.7400120; Rohde JR, 2000, MOL CELL BIOL, V20, P3880, DOI 10.1128/MCB.20.11.3880-3886.2000; RONCERO C, 1985, J BACTERIOL, V163, P1180, DOI 10.1128/JB.163.3.1180-1185.1985; Salas SD, 1996, J EXP MED, V184, P377, DOI 10.1084/jem.184.2.377; Shen WC, 2002, EUKARYOT CELL, V1, P366, DOI 10.1128/EC.1.3.366-377.2002; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shim WB, 2001, APPL ENVIRON MICROB, V67, P1607, DOI 10.1128/AEM.67.4.1607-1612.2001; Stanhill A, 1999, MOL CELL BIOL, V19, P7529; STRICH R, 1989, P NATL ACAD SCI USA, V86, P10018, DOI 10.1073/pnas.86.24.10018; Tang RJ, 2005, INFECT IMMUN, V73, P8219, DOI 10.1128/IAI.73.12.8219-8225.2005; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Urban M, 1996, MOL GEN GENET, V251, P31; Wang P, 2002, EUKARYOT CELL, V1, P257, DOI 10.1128/EC.1.2.257-272.2002; Wheeler RT, 2006, PLOS PATHOG, V2, P328, DOI 10.1371/journal.ppat.0020035; Wickes BL, 1996, P NATL ACAD SCI USA, V93, P7327, DOI 10.1073/pnas.93.14.7327; Wickes BL, 1997, MOL MICROBIOL, V26, P951, DOI 10.1046/j.1365-2958.1997.6322001.x; Yan J, 2000, IMMUNOPHARMACOLOGY, V46, P39, DOI 10.1016/S0162-3109(99)00157-5; Yeh YL, 2009, FUNGAL GENET BIOL, V46, P42, DOI 10.1016/j.fgb.2008.10.007; Zaragoza O, 2003, INFECT IMMUN, V71, P6155, DOI 10.1128/IAI.71.11.6155-6164.2003; Zarnack K, 2008, MOL MICROBIOL, V69, P1041, DOI 10.1111/j.1365-2958.2008.06345.x; Zhou XD, 2009, INT J ORAL SCI, V1, P1	82	9	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19162	10.1371/journal.pone.0019162	http://dx.doi.org/10.1371/journal.pone.0019162			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559476	gold, Green Published, Green Submitted			2022-12-27	WOS:000290024700085
J	Pelat, C; Falchi, A; Carrat, F; Mosnier, A; Bonmarin, I; Turbelin, C; Vaux, S; van der Werf, S; Cohen, JM; Lina, B; Blanchon, T; Hanslik, T				Pelat, Camille; Falchi, Alessandra; Carrat, Fabrice; Mosnier, Anne; Bonmarin, Isabelle; Turbelin, Clement; Vaux, Sophie; van der Werf, Sylvie; Cohen, Jean Marie; Lina, Bruno; Blanchon, Thierry; Hanslik, Thomas			Field Effectiveness of Pandemic and 2009-2010 Seasonal Vaccines against 2009-2010 A(H1N1) Influenza: Estimations from Surveillance Data in France	PLOS ONE			English	Article							VACCINATION; ILLNESS; HOSPITALIZATIONS; EFFICACY; PEOPLE; SYSTEM	Background: In this study, we assess how effective pandemic and trivalent 2009-2010 seasonal vaccines were in preventing influenza-like illness (ILI) during the 2009 A(H1N1) pandemic in France. We also compare vaccine effectiveness against ILI versus laboratory-confirmed pandemic A(H1N1) influenza, and assess the possible bias caused by using non-specific endpoints and observational data. Methodology and Principal Findings: We estimated vaccine effectiveness by using the following formula: VE = (PPV-PCV)/(PPV(1-PCV)) X 100%, where PPV is the proportion vaccinated in the population and PCV the proportion of vaccinated influenza cases. People were considered vaccinated three weeks after receiving a dose of vaccine. ILI and pandemic A(H1N1) laboratory-confirmed cases were obtained from two surveillance networks of general practitioners. During the epidemic, 99.7% of influenza isolates were pandemic A(H1N1). Pandemic and seasonal vaccine uptakes in the population were obtained from the National Health Insurance database and by telephonic surveys, respectively. Effectiveness estimates were adjusted by age and week. The presence of residual biases was explored by calculating vaccine effectiveness after the influenza period. The effectiveness of pandemic vaccines in preventing ILI was 52% (95% confidence interval: 30-69) during the pandemic and 33% (4-55) after. It was 86% (56-98) against confirmed influenza. The effectiveness of seasonal vaccines against ILI was 61% (56-66) during the pandemic and 19% (-10-41) after. It was 60% (41-74) against confirmed influenza. Conclusions: The effectiveness of pandemic vaccines in preventing confirmed pandemic A(H1N1) influenza on the field was high, consistently with published findings. It was significantly lower against ILI. This is unsurprising since not all ILI cases are caused by influenza. Trivalent 2009-2010 seasonal vaccines had a statistically significant effectiveness in preventing ILI and confirmed pandemic influenza, but were not better in preventing confirmed pandemic influenza than in preventing ILI. This lack of difference might be indicative of selection bias.	[Pelat, Camille; Falchi, Alessandra; Carrat, Fabrice; Turbelin, Clement; Blanchon, Thierry] UPMC Univ Paris 06, UMRS 707, Paris, France; [Pelat, Camille; Falchi, Alessandra; Carrat, Fabrice; Turbelin, Clement; Blanchon, Thierry; Hanslik, Thomas] INSERM, U707, Paris, France; [Carrat, Fabrice] Hop St Antoine, Unite Sante Publ, Assistance Publ Hop Paris, F-75571 Paris, France; [Mosnier, Anne; Cohen, Jean Marie] Grp Regionaux Observat Grippe, Reseau GROG, Paris, France; [Bonmarin, Isabelle; Vaux, Sophie] Inst Veille Sanit, St Maurice, France; [van der Werf, Sylvie] Inst Pasteur, Unit Mol Genet RNA Viruses, Natl Influenza Ctr No France, Dept Virol, Paris, France; [van der Werf, Sylvie] CNRS, URA3015, Paris, France; [van der Werf, Sylvie] Univ Paris Diderot, Paris, France; [Lina, Bruno] Hosp Civils Lyon, Virol Lab, Ctr Biol & Pathol Est, CNR Virus Influenzae Reg Sud, Bron, France; [Hanslik, Thomas] Hop Ambroise Pare, Serv Med Interne, Assistance Publ Hop Paris, Boulogne Billancourt, France; [Hanslik, Thomas] Univ Versailles St Quentin en Yvelines, Versailles, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Institute of Public Health Surveillance; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Universite Paris Saclay	Pelat, C (corresponding author), UPMC Univ Paris 06, UMRS 707, Paris, France.	pelat@u707.jussieu.fr	FALCHI, Alessandra/AAQ-8039-2020; BLANCHON, Thierry/AAK-6254-2020; lina, bruno/N-3663-2019; Carrat, Fabrice/AAU-8480-2020; LINA, bruno/M-4572-2014	lina, bruno/0000-0002-8959-2123; Carrat, Fabrice/0000-0002-8672-7918; van der WERF, Sylvie/0000-0002-1148-4456; Vaux, Sophie/0000-0001-6648-6320; Alessandra, FALCHI/0000-0003-0799-1460	Epiconcept society; GSK; Roche; Sanofi-Pasteur	Epiconcept society; GSK(GlaxoSmithKline); Roche(Roche Holding); Sanofi-Pasteur	This study was funded by a European Vaccine Manufacturers grant through the Epiconcept society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Several authors have competing interests, unrelated to the submitted study: SVDW has had a conference invitation from GSK; a research grant from GSK on an unrelated subject; joined patent from institution with GSK on an unrelated subject: vaccines against severe acute respiratory syndrome coronavirus (SARS-CoV) infection and their use in the prevention of SARS (patent US 2010/0233250 A1, published September 16 2010); travel grants for meetings from GSK; contributed to a clinical trial financed by Roche; is a member of the advisory committee on influenza of the French ministry of health; is a member of ESWI; is a member of the scientific committee of the GEIG; and is vice-president of the GROG network. BL has had paid consultancy and board membership (Roche, GSK, Novartis, BioCryst, MedImmune); has had research grants from Roche and Sanofi-Pasteur; and has received travel grants and honoraria for speaking or participation at meetings (Roche, Sanofi-Pasteur). TB has had a conference invitation from Roche in 2010 and is a member of the scientific committee of the GEIG. JMC has involvement in some epidemiological studies partially or fully granted by Roche and GSK, and travel grants from Roche for participation in scientific meetings. AM has a membership in the ministry of health advisory board on influenza; involvement in some epidemiological studies partially or fully granted by Roche and GSK; and travel grants from Roche for participation in scientific meetings. FC was a consultant for Novartis and GSK. The other authors have declared that no competing interests exist.	Laguna-Torres VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011719; BAXTER R, 2010, VACCINE; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; CARCIONE D, 2010, EUROSURVEILL, V15; Carlson SJ, 2010, VACCINE, V28, P6809, DOI 10.1016/j.vaccine.2010.08.051; Chowell G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008164; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; Eurich DT, 2008, AM J RESP CRIT CARE, V178, P527, DOI 10.1164/rccm.200802-282OC; Falchi A, 2009, J CLIN VIROL, V45, P265, DOI 10.1016/j.jcv.2009.05.004; FARRINGTON CP, 1993, INT J EPIDEMIOL, V22, P742, DOI 10.1093/ije/22.4.742; Fireman B, 2009, AM J EPIDEMIOL, V170, P650, DOI 10.1093/aje/kwp173; Furuse Y, 2010, J MED VIROL, V82, P1071, DOI 10.1002/jmv.21763; Halloran ME, 2001, AM J EPIDEMIOL, V154, P391, DOI 10.1093/aje/154.5.391; HANNOUN C, 1989, EUR J EPIDEMIOL, V5, P285, DOI 10.1007/BF00144828; HARDELID P, 2011, EUROSURVEILL, V16; *HAUT CONS SANT PU, 2009, REC SAN PRIOR INFL A; *HAUT CONS SANT PU, 2009, LIST PRIOR TARG GROU; Janjua NZ, 2010, CLIN INFECT DIS, V51, P1017, DOI 10.1086/656586; JEFFERIES S, 2011, EUROSURVEILL, V16; Johns MC, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010722, 10.1371/journal.pone.0015801]; Kawai N, 2003, VACCINE, V21, P4507, DOI 10.1016/S0264-410X(03)00508-5; Mangtani P, 2004, J INFECT DIS, V190, P1, DOI 10.1086/421274; Millot JL, 2002, OCCUP MED-OXFORD, V52, P281, DOI 10.1093/occmed/52.5.281; Nichol KL, 2008, ARCH PEDIAT ADOL MED, V162, P1113, DOI 10.1001/archpedi.162.12.1113; Ochiai H, 2009, VACCINE, V27, P7031, DOI 10.1016/j.vaccine.2009.09.067; Orellano PW, 2010, VACCINE, V28, P5288, DOI 10.1016/j.vaccine.2010.05.051; Orenstein EW, 2007, INT J EPIDEMIOL, V36, P623, DOI 10.1093/ije/dym021; ORENSTEIN WA, 1988, EPIDEMIOL REV, V10, P212, DOI 10.1093/oxfordjournals.epirev.a036023; ORENSTEIN WA, 1985, B WORLD HEALTH ORGAN, V63, P1055; Oshitani H, 2000, INFECT CONT HOSP EP, V21, P728, DOI 10.1086/501725; Plennevaux E, 2011, VACCINE, V29, P1569, DOI 10.1016/j.vaccine.2010.12.116; Puig-Barbera J, 2010, VACCINE, V28, P7460, DOI 10.1016/j.vaccine.2010.09.042; Rivetti D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004876.pub2; ROUSSET D, 2011, INFL OTH RE IN PRESS; Scharfstein DO, 2006, BIOSTATISTICS, V7, P615, DOI 10.1093/biostatistics/kxj031; Simpson CR, 2010, HEALTH TECHNOL ASSES, V14, P323, DOI 10.3310/hta14340-05; Skowronski DM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7297; Song JY, 2011, VACCINE, V29, P1395, DOI 10.1016/j.vaccine.2010.12.050; Valenciano M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000388; VALLERON AJ, 1986, AM J PUBLIC HEALTH, V76, P1289, DOI 10.2105/AJPH.76.11.1289; Vaux S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-30; Vu T, 2002, VACCINE, V20, P1831, DOI 10.1016/S0264-410X(02)00041-5; WICHMANN O, 2010, EUROSURVEILL, V15	43	22	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19621	10.1371/journal.pone.0019621	http://dx.doi.org/10.1371/journal.pone.0019621			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21573005	Green Published, gold, Green Submitted			2022-12-27	WOS:000290440200015
J	Soderberg, JAE; Birse, RT; Nassel, DR				Soderberg, Jeannette A. E.; Birse, Ryan T.; Nassel, Dick R.			Insulin Production and Signaling in Renal Tubules of Drosophila Is under Control of Tachykinin-Related Peptide and Regulates Stress Resistance	PLOS ONE			English	Article							EXTENDS LIFE-SPAN; CAENORHABDITIS-ELEGANS; LOCOMOTOR-ACTIVITY; OXIDATIVE STRESS; S6 KINASE; MALPIGHIAN TUBULE; SEXUAL-DIMORPHISM; INNATE IMMUNITY; BODY-SIZE; FRUIT-FLY	The insulin-signaling pathway is evolutionarily conserved in animals and regulates growth, reproduction, metabolic homeostasis, stress resistance and life span. In Drosophila seven insulin-like peptides (DILP1-7) are known, some of which are produced in the brain, others in fat body or intestine. Here we show that DILP5 is expressed in principal cells of the renal tubules of Drosophila and affects survival at stress. Renal (Malpighian) tubules regulate water and ion homeostasis, but also play roles in immune responses and oxidative stress. We investigated the control of DILP5 signaling in the renal tubules by Drosophila tachykinin peptide (DTK) and its receptor DTKR during desiccative, nutritional and oxidative stress. The DILP5 levels in principal cells of the tubules are affected by stress and manipulations of DTKR expression in the same cells. Targeted knockdown of DTKR, DILP5 and the insulin receptor dInR in principal cells or mutation of Dilp5 resulted in increased survival at either stress, whereas over-expression of these components produced the opposite phenotype. Thus, stress seems to induce hormonal release of DTK that acts on the renal tubules to regulate DILP5 signaling. Manipulations of S6 kinase and superoxide dismutase (SOD2) in principal cells also affect survival at stress, suggesting that DILP5 acts locally on tubules, possibly in oxidative stress regulation. Our findings are the first to demonstrate DILP signaling originating in the renal tubules and that this signaling is under control of stress-induced release of peptide hormone.	[Soderberg, Jeannette A. E.; Birse, Ryan T.; Nassel, Dick R.] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden	Stockholm University	Soderberg, JAE (corresponding author), Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden.	dnassel@zoologi.su.se			Swedish Research Council (VR) [621-2007-6500]	Swedish Research Council (VR)(Swedish Research Council)	This work was funded by the Swedish Research Council (VR, Grant 621-2007-6500; http://www.vr.se/) to D. R. Nassel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeghate E, 2001, PEPTIDES, V22, P99, DOI 10.1016/S0196-9781(00)00361-2; Albiston AL, 2011, REGUL PEPTIDES, V166, P83, DOI 10.1016/j.regpep.2010.09.003; Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Barcelo H, 2002, GENESIS, V34, P83, DOI 10.1002/gene.10132; Belgacem YH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000187; Belgacem YH, 2006, J NEUROBIOL, V66, P19, DOI 10.1002/neu.20193; Beyenbach KW, 2010, ANNU REV ENTOMOL, V55, P351, DOI 10.1146/annurev-ento-112408-085512; Birse RT, 2006, J NEUROBIOL, V66, P33, DOI 10.1002/neu.20189; Blumenthal EM, 2003, AM J PHYSIOL-CELL PH, V284, pC718, DOI 10.1152/ajpcell.00359.2002; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Cao C, 2001, CELL TISSUE RES, V304, P317, DOI 10.1007/s004410100367; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Cognigni P, 2011, CELL METAB, V13, P92, DOI 10.1016/j.cmet.2010.12.010; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Davies SA, 2009, GEN COMP ENDOCR, V162, P113, DOI 10.1016/j.ygcen.2008.09.012; Dionne MS, 2006, CURR BIOL, V16, P1977, DOI 10.1016/j.cub.2006.08.052; Dow JAT, 2009, J EXP BIOL, V212, P435, DOI 10.1242/jeb.024224; DRUCKER DJ, 1987, P NATL ACAD SCI USA, V84, P3434, DOI 10.1073/pnas.84.10.3434; Enell LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015780; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Garofalo RS, 2002, TRENDS ENDOCRIN MET, V13, P156, DOI 10.1016/S1043-2760(01)00548-3; Geminard C, 2006, DIABETES, V55, pS5, DOI 10.2337/db06-S001; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Giannakou ME, 2007, TRENDS BIOCHEM SCI, V32, P180, DOI 10.1016/j.tibs.2007.02.007; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Helfand SL, 2003, ANNU REV GENET, V37, P329, DOI 10.1146/annurev.genet.37.040103.095211; Helfand SL, 2003, BIOESSAYS, V25, P134, DOI 10.1002/bies.10225; Huang YQ, 2011, PEPTIDES, V32, P483, DOI 10.1016/j.peptides.2010.09.014; Ignell R, 2009, P NATL ACAD SCI USA, V106, P13070, DOI 10.1073/pnas.0813004106; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Kabil H, 2007, BIOGERONTOLOGY, V8, P201, DOI 10.1007/s10522-006-9065-3; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kaplan DD, 2008, GENE DEV, V22, P1877, DOI 10.1101/gad.1670508; Kawli T, 2008, NAT IMMUNOL, V9, P1415, DOI 10.1038/ni.1672; Kirby K, 2002, P NATL ACAD SCI USA, V99, P16162, DOI 10.1073/pnas.252342899; Kreneisz O, 2010, NEUROREPORT, V21, P1116, DOI 10.1097/WNR.0b013e3283409200; Lange AB, 2001, PEPTIDES, V22, P229, DOI 10.1016/S0196-9781(00)00386-7; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Lee KS, 2008, NAT CELL BIOL, V10, P468, DOI 10.1038/ncb1710; Martin I, 2009, FEBS LETT, V583, P2308, DOI 10.1016/j.febslet.2009.06.023; McGettigan J, 2005, INSECT BIOCHEM MOLEC, V35, P741, DOI 10.1016/j.ibmb.2005.02.017; MONNIER D, 1992, J BIOL CHEM, V267, P1298; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Okamoto N, 2009, DEV CELL, V17, P885, DOI 10.1016/j.devcel.2009.10.008; Poels J, 2009, PEPTIDES, V30, P545, DOI 10.1016/j.peptides.2008.10.012; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; REIHER W, 2011, J PROTEOME RES; Rosay P, 1997, J CELL SCI, V110, P1683; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sarafidis PA, 2008, CURR OPIN NEPHROL HY, V17, P450, DOI 10.1097/MNH.0b013e328305b994; Schmidt PT, 2000, PANCREAS, V20, P241, DOI 10.1097/00006676-200004000-00004; Siviter RJ, 2000, J BIOL CHEM, V275, P23273, DOI 10.1074/jbc.M002875200; Slaidina M, 2009, DEV CELL, V17, P874, DOI 10.1016/j.devcel.2009.10.009; Sonoda N, 2008, P NATL ACAD SCI USA, V105, P6614, DOI 10.1073/pnas.0710402105; Sozen MA, 1997, P NATL ACAD SCI USA, V94, P5207, DOI 10.1073/pnas.94.10.5207; Stergiopoulos K, 2009, PHYSIOL GENOMICS, V37, P1, DOI 10.1152/physiolgenomics.90360.2008; Styer KL, 2008, SCIENCE, V322, P460, DOI 10.1126/science.1163673; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; Terhzaz S, 2010, PHYSIOL GENOMICS, V41, P33, DOI 10.1152/physiolgenomics.00147.2009; Tettweiler G, 2005, GENE DEV, V19, P1840, DOI 10.1101/gad.1311805; Tiwari S, 2008, P NATL ACAD SCI USA, V105, P6469, DOI 10.1073/pnas.0711283105; Vanfleteren JR, 1996, J EXP ZOOL, V274, P93, DOI 10.1002/(SICI)1097-010X(19960201)274:2&lt;93::AID-JEZ2&gt;3.0.CO;2-8; Veenstra JA, 2008, CELL TISSUE RES, V334, P499, DOI 10.1007/s00441-008-0708-3; Wang J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r69; Winther AME, 2006, MOL CELL NEUROSCI, V31, P399, DOI 10.1016/j.mcn.2005.10.010; Winther AME, 2001, J EXP BIOL, V204, P1269; Wu Q, 2005, P NATL ACAD SCI USA, V102, P13289, DOI 10.1073/pnas.0501914102; Yang J, 2007, PHYSIOL GENOMICS, V30, P223, DOI 10.1152/physiolgenomics.00018.2007; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034	72	52	53	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19866	10.1371/journal.pone.0019866	http://dx.doi.org/10.1371/journal.pone.0019866			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572965	Green Submitted, Green Published, gold			2022-12-27	WOS:000290440200031
J	de Witte, L; Bobardt, MD; Chatterji, U; van Loenen, FB; Verjans, GMGM; Geijtenbeek, TBH; Gallay, PA				de Witte, Lot; Bobardt, Michael D.; Chatterji, Udayan; van Loenen, Freek B.; Verjans, Georges M. G. M.; Geijtenbeek, Teunis B. H.; Gallay, Philippe A.			HSV Neutralization by the Microbicidal Candidate C5A	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; DENDRITIC CELLS; SEXUAL TRANSMISSION; HIV-1 TRANSMISSION; DC-SIGN; INFECTION; TYPE-1; NONOXYNOL-9; METAANALYSIS	Genital herpes is a major risk factor in acquiring human immunodeficiency virus type-1 (HIV-1) infection and is caused by both Herpes Simplex virus type 1 (HSV-1) and HSV-2. The amphipathic peptide C5A, derived from the non-structural hepatitis C virus (HCV) protein 5A, was shown to prevent HIV-1 infection but neither influenza nor vesicular stomatitis virus infections. Here we investigated the antiviral function of C5A on HSV infections. C5A efficiently inhibited both HSV-1 and HSV-2 infection in epithelial cells in vitro as well as in an ex vivo epidermal infection model. C5A destabilized the integrity of the viral HSV membrane. Furthermore, drug resistant HSV strains were inhibited by this peptide. Notably, C5A-mediated neutralization of HSV-1 prevented HIV-1 transmission. An in vitro HIV-1 transmigration assay was developed using primary genital epithelial cells and HSV infection increased HIV-1 transmigration. Treatment with C5A abolished HIV-1 transmigration by preventing HSV infection and by preserving the integrity of the genital epithelium that was severely compromised by HSV infection. In conclusion, this study demonstrates that C5A represents a multipurpose microbicide candidate, which neutralizes both HIV-1 and HSV, and which may interfere with HIV-1 transmission through the genital epithelium.	[de Witte, Lot; Geijtenbeek, Teunis B. H.] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [Bobardt, Michael D.; Chatterji, Udayan; Gallay, Philippe A.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [van Loenen, Freek B.; Verjans, Georges M. G. M.] Erasmus MC, Dept Virol, Rotterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Scripps Research Institute; Erasmus University Rotterdam; Erasmus MC	de Witte, L (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	gallay@scripps.edu	de Witte, Lot/H-1499-2011; de Witte, Lot/GZG-9717-2022	de Witte, Lot/0000-0002-7235-9958; Verjans, Georges/0000-0002-2465-2674	United States Public Health Service [AI079782, AI078791]; Dutch Scientific Organization (NWO) [91204025, 91746367]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI079782, R21AI078791, R01AI087470, R21AI079782] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Dutch Scientific Organization (NWO)(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors acknowledge financial support from the United States Public Health Service grants no. AI079782 and AI078791 (P.A.G.) and the Dutch Scientific Organization (NWO) grants no. 91204025 and 91746367 (T.B.H.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreca C, 2004, J VIROL, V78, P8641, DOI 10.1128/JVI.78.16.8641-8653.2004; Bobardt MD, 2008, P NATL ACAD SCI USA, V105, P5525, DOI 10.1073/pnas.0801388105; Bobardt MD, 2007, J VIROL, V81, P395, DOI 10.1128/JVI.01303-06; Brass V, 2002, J BIOL CHEM, V277, P8130, DOI 10.1074/jbc.M111289200; Cheng G, 2008, P NATL ACAD SCI USA, V105, P3088, DOI 10.1073/pnas.0712380105; Coffin RS, 1998, GENE THER, V5, P718, DOI 10.1038/sj.gt.3300634; Cummins JE, 2007, ANTIMICROB AGENTS CH, V51, P1770, DOI 10.1128/AAC.01129-06; de Jong MAWP, 2008, J GEN VIROL, V89, P2398, DOI 10.1099/vir.0.2008/003129-0; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; Duan R, 2008, J INFECT DIS, V198, P659, DOI 10.1086/590668; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Kruse M, 2000, J VIROL, V74, P7127, DOI 10.1128/JVI.74.15.7127-7136.2000; Lin Q, 2011, J IMMUNOL, V186, P2087, DOI 10.4049/jimmunol.1002340; McFarland W, 1999, J INFECT DIS, V180, P1459, DOI 10.1086/315076; Mesquita PMM, 2008, J VIROL, V82, P6576, DOI 10.1128/JVI.00335-08; Mikloska Z, 2001, J VIROL, V75, P5958, DOI 10.1128/JVI.75.13.5958-5964.2001; Nicola AV, 2005, J VIROL, V79, P7609, DOI 10.1128/JVI.79.12.7609-7616.2005; NIRUTHISARD S, 1992, LANCET, V339, P1371, DOI 10.1016/0140-6736(92)91195-E; Patton DL, 2002, SEX TRANSM DIS, V29, P581, DOI 10.1097/00007435-200210000-00004; Phillips DM, 2000, CONTRACEPTION, V62, P149, DOI 10.1016/S0010-7824(00)00156-6; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Salio M, 1999, EUR J IMMUNOL, V29, P3245, DOI 10.1002/(SICI)1521-4141(199910)29:10<3245::AID-IMMU3245>3.3.CO;2-O; Stafford MK, 1998, J ACQ IMMUN DEF SYND, V17, P327, DOI 10.1097/00042560-199804010-00006; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Vanpouille C, 2010, J INFECT DIS, V201, P635, DOI 10.1086/650343; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002	29	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e18917	10.1371/journal.pone.0018917	http://dx.doi.org/10.1371/journal.pone.0018917			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573158	Green Published, gold, Green Submitted			2022-12-27	WOS:000290305600008
J	Loughlin, DT; Artlett, CM				Loughlin, Danielle T.; Artlett, Carol M.			Modification of Collagen by 3-Deoxyglucosone Alters Wound Healing through Differential Regulation of p38 MAP Kinase	PLOS ONE			English	Article							FIBROBLAST-MATRIX INTERACTIONS; ACTIVATED PROTEIN-KINASE; GROWTH-FACTOR; IN-VIVO; H-RAS; CELL-MIGRATION; VENOUS ULCERS; APOPTOSIS; PATHWAY; ASK1	Background: Wound healing is a highly dynamic process that requires signaling from the extracellular matrix to the fibroblasts for migration and proliferation, and closure of the wound. This rate of wound closure is impaired in diabetes, which may be due to the increased levels of the precursor for advanced glycation end products, 3-deoxyglucosone (3DG). Previous studies suggest a differential role for p38 mitogen-activated kinase (MAPK) during wound healing; whereby, p38 MAPK acts as a growth kinase during normal wound healing, but acts as a stress kinase during diabetic wound repair. Therefore, we investigated the signaling cross-talk by which p38 MAPK mediates wound healing in fibroblasts cultured on native collagen and 3DG-collagen. Methodology/Principal Findings: Using human dermal fibroblasts cultured on 3DG-collagen as a model of diabetic wounds, we demonstrated that p38 MAPK can promote either cell growth or cell death, and this was dependent on the activation of AKT and ERK1/2. Wound closure on native collagen was dependent on p38 MAPK phosphorylation of AKT and ERK1/2. Furthermore, proliferation and collagen production in fibroblasts cultured on native collagen was dependent on p38 MAPK regulation of AKT and ERK1/2. In contrast, 3DG-collagen decreased fibroblast migration, proliferation, and collagen expression through ERK1/2 and AKT downregulation via p38 MAPK. Conclusions/Significance: Taken together, the present study shows that p38 MAPK is a key signaling molecule that plays a significantly opposite role during times of cellular growth and cellular stress, which may account for the differing rates of wound closure seen in diabetic populations.	[Loughlin, Danielle T.; Artlett, Carol M.] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA	Drexel University	Loughlin, DT (corresponding author), Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA.	carol.artlett@drexelmed.edu			Department of Defense [WX81XWh-07-1-0450]; Dynamis Therapeutics, Inc.	Department of Defense(United States Department of Defense); Dynamis Therapeutics, Inc.	This work was funded by grants to C.M. Artlett from the Department of Defense WX81XWh-07-1-0450 and from Dynamis Therapeutics, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnesen SM, 2006, MECH AGEING DEV, V127, P726, DOI 10.1016/j.mad.2006.05.003; Asano Y, 2004, J IMMUNOL, V172, P7123, DOI 10.4049/jimmunol.172.11.7123; Blakytny R, 2006, DIABETIC MED, V23, P594, DOI 10.1111/j.1464-5491.2006.01773.x; Brunet A, 1996, SCIENCE, V272, P1652, DOI 10.1126/science.272.5268.1652; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen J, 2002, CIRC RES, V90, P1290, DOI 10.1161/01.RES.0000022161.42655.98; Chen J, 2001, P NATL ACAD SCI USA, V98, P7783, DOI 10.1073/pnas.141224398; Chen ZH, 1999, ONCOGENE, V18, P173, DOI 10.1038/sj.onc.1202276; Chiacchiera F, 2009, CELL DEATH DIFFER, V16, P1203, DOI 10.1038/cdd.2009.36; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Du J, 2004, CELL RES, V14, P148, DOI 10.1038/sj.cr.7290214; Du J, 2001, FREE RADICAL BIO MED, V31, P469, DOI 10.1016/S0891-5849(01)00611-6; Eckes B, 2000, MATRIX BIOL, V19, P325, DOI 10.1016/S0945-053X(00)00077-9; English J, 1999, EXP CELL RES, V253, P255, DOI 10.1006/excr.1999.4687; Estrada Y, 2009, PIGM CELL MELANOMA R, V22, P66, DOI 10.1111/j.1755-148X.2008.00520.x; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Harper EG, 2005, J CELL SCI, V118, P3471, DOI 10.1242/jcs.02475; Hasan A, 1997, J DERMATOL SCI, V16, P59, DOI 10.1016/S0923-1811(97)00622-1; Hatai T, 2000, J BIOL CHEM, V275, P26576, DOI 10.1074/jbc.M003412200; Hehenberger Karin, 1998, Wound Repair and Regeneration, V6, P135, DOI 10.1046/j.1524-475X.1998.60207.x; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; Huang Q, 2008, AM J PHYSIOL-CELL PH, V295, pC1647, DOI 10.1152/ajpcell.00322.2008; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kim BC, 2003, J CELL PHYSIOL, V195, P331, DOI 10.1002/jcp.10301; Kim MS, 2003, CANCER RES, V63, P5454; Li, 2000, Arterioscler Thromb Vasc Biol, V20, pE1; Liu QH, 2004, AM J PHYSIOL-HEART C, V286, pH2204, DOI 10.1152/ajpheart.01050.2003; Loots MAM, 1998, J INVEST DERMATOL, V111, P850, DOI 10.1046/j.1523-1747.1998.00381.x; Loots MAM, 1999, ARCH DERMATOL RES, V291, P93, DOI 10.1007/s004030050389; Loughlin DT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011093; Loughlin DT, 2009, WOUND REPAIR REGEN, V17, P739, DOI 10.1111/j.1524-475X.2009.00532.x; Matsumoto T, 1999, J BIOL CHEM, V274, P13954, DOI 10.1074/jbc.274.20.13954; MAUCH C, 1990, RHEUM DIS CLIN N AM, V16, P93; MEDICHERLA S, 2009, MAPK INHIBITION REDU, P91; Nemoto S, 1998, J BIOL CHEM, V273, P16415, DOI 10.1074/jbc.273.26.16415; PECORARO RE, 1990, DIABETES CARE, V13, P513, DOI 10.2337/diacare.13.5.513; Pozzi A, 2009, J AM SOC NEPHROL, V20, P2119, DOI 10.1681/ASN.2008080900; Raffetto JD, 2008, VASC ENDOVASC SURG, V42, P367, DOI 10.1177/1538574408316140; Saika S, 2004, INVEST OPHTH VIS SCI, V45, P100, DOI 10.1167/iovs.03-0700; Sassi-Gaha S, 2010, MATRIX BIOL, V29, P127, DOI 10.1016/j.matbio.2009.09.007; Shin I, 2005, J BIOL CHEM, V280, P14675, DOI 10.1074/jbc.M411625200; Stein W., 1989, CELL SHAPE DETERMINA; Grande MT, 2010, KIDNEY INT, V77, P509, DOI 10.1038/ki.2009.498; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Ye M, 2008, INVEST OPHTH VIS SCI, V49, P497, DOI 10.1167/iovs.07-0975; Zhang GY, 2009, EXP DERMATOL, V18, P947, DOI 10.1111/j.1600-0625.2009.00880.x; ZUMKELLER W, 1995, ANTICANCER RES, V15, P343	48	28	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e18676	10.1371/journal.pone.0018676	http://dx.doi.org/10.1371/journal.pone.0018676			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573155	Green Published, Green Submitted, gold			2022-12-27	WOS:000290305600005
J	Tinsley, JM; Fairclough, RJ; Storer, R; Wilkes, FJ; Potter, AC; Squire, SE; Powell, DS; Cozzoli, A; Capogrosso, RF; Lambert, A; Wilson, FX; Wren, SP; De Luca, A; Davies, KE				Tinsley, Jonathon M.; Fairclough, Rebecca J.; Storer, Richard; Wilkes, Fraser J.; Potter, Allyson C.; Squire, Sarah E.; Powell, Dave S.; Cozzoli, Anna; Capogrosso, Roberta F.; Lambert, Adam; Wilson, Francis X.; Wren, Stephen P.; De Luca, Annamaria; Davies, Kay E.			Daily Treatment with SMTC1100, a Novel Small Molecule Utrophin Upregulator, Dramatically Reduces the Dystrophic Symptoms in the mdx Mouse	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; UP-REGULATION; MICE; EXPRESSION; PATHOLOGY	Background: Duchenne muscular dystrophy (DMD) is a lethal, progressive muscle wasting disease caused by a loss of sarcolemmal bound dystrophin, which results in the death of the muscle fibers leading to the gradual depletion of skeletal muscle. There is significant evidence demonstrating that increasing levels of the dystrophin-related protein, utrophin, in mouse models results in sarcolemmal bound utrophin and prevents the muscular dystrophy pathology. The aim of this work was to develop a small molecule which increases the levels of utrophin in muscle and thus has therapeutic potential. Methodology and Principal Findings: We describe the in vivo activity of SMT C1100; the first orally bioavailable small molecule utrophin upregulator. Once-a-day daily-dosing with SMT C1100 reduces a number of the pathological effects of dystrophin deficiency. Treatment results in reduced pathology, better muscle physiology leading to an increase in overall strength, and an ability to resist fatigue after forced exercise; a surrogate for the six minute walk test currently recommended as the pivotal outcome measure in human trials for DMD. Conclusions and Significance: This study demonstrates proof-of-principle for the use of in vitro screening methods in allowing identification of pharmacological agents for utrophin transcriptional upregulation. The best compound identified, SMT C1100, demonstrated significant disease modifying effects in DMD models. Our data warrant the full evaluation of this compound in clinical trials in DMD patients.	[Tinsley, Jonathon M.; Storer, Richard; Wilkes, Fraser J.; Lambert, Adam; Wilson, Francis X.; Wren, Stephen P.] Summit plc, Abingdon, Oxon, England; [Fairclough, Rebecca J.; Potter, Allyson C.; Squire, Sarah E.; Powell, Dave S.; Davies, Kay E.] Univ Oxford, Dept Physiol Anat & Genet, MRC Funct Genom Unit, Oxford, England; [Cozzoli, Anna; Capogrosso, Roberta F.; De Luca, Annamaria] Univ Bari A Moro, Dept Pharmacobiol, Pharmacol Unit, Bari, Italy	University of Oxford; Universita degli Studi di Bari Aldo Moro	Tinsley, JM (corresponding author), Summit plc, Abingdon, Oxon, England.	Jon.Tinsley@summitplc.com; kay.davies@dpag.ox.ac.uk		Davies, Kelvin/0000-0001-7790-3003; De Luca, Annamaria/0000-0002-5652-7341	Medical Research Council; Muscular Dystrophy Campaign; Muscular Dystrophy Association USA; Association Francaise contre les Myopathies in Oxford; Telethon-Italy [GGP05130]; MRC [MC_U137761449] Funding Source: UKRI; Medical Research Council [MC_U137761449] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission); Muscular Dystrophy Association USA(Muscular Dystrophy Association); Association Francaise contre les Myopathies in Oxford; Telethon-Italy(Fondazione Telethon); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Covance for designing and conducting the safety evaluation programme for SMT C1100. For the study on exercised mdx mice we thank Dr. Karina Litvinova and Dr. Valeriana Sblendorio for assistance with the physiology and in vivo experiments, respectively, Dr. Antonella Liantonio for fura-2 microspectofluometry and Prof. Beatrice Nico for supervision on immunofluorescence and morphological studies. We acknowledge Charles J. Sherr, M.D., Ph.D., a Howard Hughes Medical Institute Investigator at St. Jude Children's Research Hospital, Memphis, USA, who developed the retroviral vector pSRalphaMSV-CDK4-tkneo used to generate the human DMD cell line provided by Vincent Mouly and Gillian Butler-Browne (Institute of Myology, Paris). We further acknowledge Prof. Steve Davies and Dr. Angela Russell (Chemistry Research Laboratories, Oxford University) who performed the initial pilot compound screens. We are grateful to the Medical Research Council, Muscular Dystrophy Campaign, Muscular Dystrophy Association USA and the Association Francaise contre les Myopathies for support of the work in Oxford. The support of Telethon-Italy (project GGP05130) for part of the work conducted in Bari is also gratefully acknowledged.	Amenta AR, 2011, P NATL ACAD SCI USA, V108, P762, DOI 10.1073/pnas.1013067108; Beroud C, 2007, HUM MUTAT, V28, P196, DOI 10.1002/humu.20428; Bogdanovich S, 2004, J MOL MED, V82, P102, DOI 10.1007/s00109-003-0484-1; Burdi R, 2009, J APPL PHYSIOL, V106, P1311, DOI 10.1152/japplphysiol.90985.2008; Cooper ST, 2003, NEUROLOGY, V61, P93, DOI 10.1212/01.WNL.0000069460.53438.38; De Luca A, 2003, J PHARMACOL EXP THER, V304, P453, DOI 10.1124/jpet.102.041343; De Luca A, 2008, NEUROBIOL DIS, V32, P243, DOI 10.1016/j.nbd.2008.07.009; Goemans N, 2010, NEUROMUSCULAR DISORD, V20, P639, DOI 10.1016/j.nmd.2010.07.139; Goyenvalle A, 2010, MOL THER, V18, P198, DOI 10.1038/mt.2009.248; Hirst R C, 2005, Acta Myol, V24, P209; Khurana TS, 2003, NAT REV DRUG DISCOV, V2, P379, DOI 10.1038/nrd1085; Krag TOB, 2004, P NATL ACAD SCI USA, V101, P13856, DOI 10.1073/pnas.0405972101; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mattei E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000774; McDonald CM, 2010, MUSCLE NERVE, V41, P500, DOI 10.1002/mus.21544; Miura P, 2006, TRENDS MOL MED, V12, P122, DOI 10.1016/j.molmed.2006.01.002; MORGAN JE, 1994, DEV BIOL, V162, P486, DOI 10.1006/dbio.1994.1103; Peter AK, 2008, J CELL BIOL, V183, P419, DOI 10.1083/jcb.200808027; Shrewsbury SB, 2010, NEUROMUSCULAR DISORD, V20, P639, DOI 10.1016/j.nmd.2010.07.140; Squire S, 2002, HUM MOL GENET, V11, P3333, DOI 10.1093/hmg/11.26.3333; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033	21	128	134	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19189	10.1371/journal.pone.0019189	http://dx.doi.org/10.1371/journal.pone.0019189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573153	Green Published, Green Submitted, gold			2022-12-27	WOS:000290305600014
J	Dobel, C; Junghofer, M; Gruber, T				Dobel, Christian; Junghoefer, Markus; Gruber, Thomas			The Role of Gamma-Band Activity in the Representation of Faces: Reduced Activity in the Fusiform Face Area in Congenital Prosopagnosia	PLOS ONE			English	Article							NEURAL MECHANISMS; PARIETAL CORTEX; REPETITION; BRAIN; RECOGNITION; RESPONSES; EEG; ACTIVATION; SYNCHRONY; ATTENTION	Background: Congenital prosopagnosia (CP) describes an impairment in face processing that is presumably present from birth. The neuronal correlates of this dysfunction are still under debate. In the current paper, we investigate high-frequent oscillatory activity in response to faces in persons with CP. Such neuronal activity is thought to reflect higher-level representations for faces. Methodology: Source localization of induced Gamma-Band Responses (iGBR) measured by magnetoencephalography (MEG) was used to establish the origin of oscillatory activity in response to famous and unknown faces which were presented in upright and inverted orientation. Persons suffering from congenital prosopagnosia (CP) were compared to matched controls. Principal Findings: Corroborating earlier research, both groups revealed amplified iGBR in response to upright compared to inverted faces predominately in a time interval between 170 and 330 ms and in a frequency range from 50-100 Hz. Oscillatory activity upon known faces was smaller in comparison to unknown faces, suggesting a "sharpening'' effect reflecting more efficient processing for familiar stimuli. These effects were seen in a wide cortical network encompassing temporal and parietal areas involved in the disambiguation of homogenous stimuli such as faces, and in the retrieval of semantic information. Importantly, participants suffering from CP displayed a strongly reduced iGBR in the left fusiform area compared to control participants. Conclusions: In sum, these data stress the crucial role of oscillatory activity for face representation and demonstrate the involvement of a distributed occipito-temporo-parietal network in generating iGBR. This study also provides the first evidence that persons suffering from an agnosia actually display reduced gamma band activity. Finally, the results argue strongly against the view that oscillatory activity is a mere epiphenomenon brought fourth by rapid eye-movements (micro saccades).	[Dobel, Christian; Junghoefer, Markus] Univ Munster, Otto Creutzfeldt Ctr, Inst Biomagnetism & Biosignalanal, Munster, Germany; [Gruber, Thomas] Univ Osnabruck, Inst Psychol, Osnabruck, Germany	University of Munster; University Osnabruck	Dobel, C (corresponding author), Univ Munster, Otto Creutzfeldt Ctr, Inst Biomagnetism & Biosignalanal, Munster, Germany.	cdobel@uni-muenster.de	Junghoefer, Markus/AAA-2892-2021	Junghoefer, Markus/0000-0002-8532-2986				Anaki D, 2007, NEUROIMAGE, V37, P1407, DOI 10.1016/j.neuroimage.2007.05.054; Avidan G, 2005, J COGNITIVE NEUROSCI, V17, P1150, DOI 10.1162/0898929054475145; Behrmann M, 2005, TRENDS COGN SCI, V9, P180, DOI 10.1016/j.tics.2005.02.011; Behrmann M, 2007, CEREB CORTEX, V17, P2354, DOI 10.1093/cercor/bhl144; Bentin S, 1999, NEUROREPORT, V10, P823, DOI 10.1097/00001756-199903170-00029; Bentin S, 2007, J COGNITIVE NEUROSCI, V19, P132, DOI 10.1162/jocn.2007.19.1.132; Bindemann M, 2008, VISION RES, V48, P2555, DOI 10.1016/j.visres.2008.09.001; Bosch-Bayard J, 2001, CLIN ELECTROENCEPHAL, V32, P47, DOI 10.1177/155005940103200203; Busch NA, 2006, NEUROIMAGE, V33, P1169, DOI 10.1016/j.neuroimage.2006.07.034; CORBETTA M, 1995, SCIENCE, V270, P802, DOI 10.1126/science.270.5237.802; DeGutis JM, 2007, J COGNITIVE NEUROSCI, V19, P1790, DOI 10.1162/jocn.2007.19.11.1790; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Dobel C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002326; Dobel C, 2007, CORTEX, V43, P718, DOI 10.1016/S0010-9452(08)70501-X; EVANS AC, 1993, STAT NEUROANATOMICAL; FAST K, 2004, VERFAHREN ERFASSUNG; Fiebach CJ, 2005, J NEUROSCI, V25, P3414, DOI 10.1523/JNEUROSCI.4107-04.2005; Fries P, 2008, NEURON, V58, P303, DOI 10.1016/j.neuron.2008.04.020; Garrido L, 2009, BRAIN, V132, P3443, DOI 10.1093/brain/awp271; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; GRUBER R, 2002, EUR J NEUROSCI, V19, P1073; Gruber T, 2008, BRAIN RES, V1196, P74, DOI 10.1016/j.brainres.2007.12.037; Gruber T, 2006, NEUROIMAGE, V29, P888, DOI 10.1016/j.neuroimage.2005.09.004; Gruber T, 2005, CEREB CORTEX, V15, P109, DOI 10.1093/cercor/bhh113; Gruber T, 2002, COGNITIVE BRAIN RES, V13, P377, DOI 10.1016/S0926-6410(01)00130-6; Harris AM, 2005, NEUROPSYCHOLOGIA, V43, P2125, DOI 10.1016/j.neuropsychologia.2005.03.017; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; Henson RNA, 2002, CEREB CORTEX, V12, P178, DOI 10.1093/cercor/12.2.178; Itier RJ, 2007, J COGNITIVE NEUROSCI, V19, P1815, DOI 10.1162/jocn.2007.19.11.1815; Jacques C, 2006, PSYCHOL SCI, V17, P485, DOI 10.1111/j.1467-9280.2006.01733.x; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Keil A, 1999, J NEUROSCI, V19, P7152, DOI 10.1523/JNEUROSCI.19-16-07152.1999; Kloth N, 2006, EUR J NEUROSCI, V24, P3317, DOI 10.1111/j.1460-9568.2006.05211.x; Kress T, 2003, BEHAV NEUROL, V14, P109, DOI 10.1155/2003/520476; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Leveroni CL, 2000, J NEUROSCI, V20, P878, DOI 10.1523/JNEUROSCI.20-02-00878.2000; LOBMAIER J, 2010, ADV COGN PS IN PRESS; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; Penny WD, 2005, NEUROIMAGE, V24, P350, DOI 10.1016/j.neuroimage.2004.08.034; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Schweinberger SR, 2004, NEUROREPORT, V15, P1501, DOI 10.1097/01.wnr.0000131675.00319.42; Schweinberger SR, 2007, BRAIN RES, V1184, P226, DOI 10.1016/j.brainres.2007.09.079; Shafritz KM, 2002, P NATL ACAD SCI USA, V99, P10917, DOI 10.1073/pnas.152694799; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Supp GG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000684; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; van Turennout M, 2003, CEREB CORTEX, V13, P381, DOI 10.1093/cercor/13.4.381; WARRINGTON EK, 1992, VISUAL OBJECT SPACE; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P74, DOI 10.1002/(SICI)1097-0193(1996)4:1<74::AID-HBM5>3.0.CO;2-M; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027; Zion-Golumbic E, 2008, NEUROIMAGE, V39, P1980, DOI 10.1016/j.neuroimage.2007.10.025; Zion-Golumbic E, 2007, CEREB CORTEX, V17, P1741, DOI 10.1093/cercor/bhl100	56	19	20	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19550	10.1371/journal.pone.0019550	http://dx.doi.org/10.1371/journal.pone.0019550			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573175	Green Submitted, Green Published, gold			2022-12-27	WOS:000290256400021
J	Lin, TC; Gombos, L; Neuner, A; Sebastian, D; Olsen, JV; Hrle, A; Benda, C; Schiebel, E				Lin, Tien-chen; Gombos, Linda; Neuner, Annett; Sebastian, Dominik; Olsen, Jesper V.; Hrle, Ajla; Benda, Christian; Schiebel, Elmar			Phosphorylation of the Yeast gamma-Tubulin Tub4 Regulates Microtubule Function	PLOS ONE			English	Article							SPINDLE POLE BODY; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; CELL-CYCLE; RING COMPLEX; PHOSPHOPROTEOME ANALYSIS; COMPONENT SPC110P; MASS-SPECTROMETRY; MITOTIC SPINDLE; SHUTTLE VECTORS	The yeast gamma-tubulin Tub4 is assembled with Spc97 and Spc98 into the small Tub4 complex. The Tub4 complex binds via the receptor proteins Spc72 and Spc110 to the spindle pole body (SPB), the functional equivalent of the mammalian centrosome, where the Tub4 complex organizes cytoplasmic and nuclear microtubules. Little is known about the regulation of the Tub4 complex. Here, we isolated the Tub4 complex with the bound receptors from yeast cells. Analysis of the purified Tub4 complex by mass spectrometry identified more than 50 phosphorylation sites in Spc72, Spc97, Spc98, Spc110 and Tub4. To examine the functional relevance of the phosphorylation sites, phospho-mimicking and non-phosphorylatable mutations in Tub4, Spc97 and Spc98 were analyzed. Three phosphorylation sites in Tub4 were found to be critical for Tub4 stability and microtubule organization. One of the sites is highly conserved in gamma-tubulins from yeast to human.	[Lin, Tien-chen; Gombos, Linda; Neuner, Annett; Sebastian, Dominik; Schiebel, Elmar] Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Allianz, D-6900 Heidelberg, Germany; [Olsen, Jesper V.; Hrle, Ajla; Benda, Christian] MPI Biochem, Martinsried, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Max Planck Society	Lin, TC (corresponding author), Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Allianz, D-6900 Heidelberg, Germany.	schiebel.elmar@zmbh.uni-heidelberg.de	Olsen, Jesper/ABH-4638-2020	Olsen, Jesper/0000-0002-4747-4938; Benda, Christian/0000-0001-5551-1332	German Research Council (DFG) [Schi-295/4-1]	German Research Council (DFG)(German Research Foundation (DFG))	The work of E.S. is supported by the grant Schi-295/4-1 of the German Research Council (DFG, http://www.dfg.de/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Aldaz H, 2005, NATURE, V435, P523, DOI 10.1038/nature03586; Alvarado-Kristensson M, 2009, NAT CELL BIOL, V11, P1081, DOI 10.1038/ncb1921; Araki Y, 2010, J CELL BIOL, V189, P41, DOI 10.1083/jcb.200910027; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Chen RH, 1996, SCIENCE, V274, P242, DOI 10.1126/science.274.5285.242; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Colornbie N, 2006, MOL BIOL CELL, V17, P272, DOI 10.1091/mbc.e05-08-0722; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Donaldson AD, 1996, J CELL BIOL, V132, P887, DOI 10.1083/jcb.132.5.887; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Friedman DB, 2001, J BIOL CHEM, V276, P17958, DOI 10.1074/jbc.M010461200; Fujita A, 2002, MOL BIOL CELL, V13, P2360, DOI 10.1091/mbc.02-01-0603; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Geissler S, 1996, EMBO J, V15, P3899, DOI 10.1002/j.1460-2075.1996.tb00764.x; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giddings TH, 2001, METHOD CELL BIOL, V67, P27; Gunawardane RN, 2000, J CELL BIOL, V151, P1513, DOI 10.1083/jcb.151.7.1513; Guthrie C., 1991, METHOD ENZYMOL, V194, P429; Hardwick KG, 1999, GENETICS, V152, P509; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Huisman SM, 2007, J CELL SCI, V120, P435, DOI 10.1242/jcs.03342; JACOBS CW, 1988, J CELL BIOL, V107, P1409, DOI 10.1083/jcb.107.4.1409; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jaspersen SL, 2004, DEV CELL, V7, P263, DOI 10.1016/j.devcel.2004.07.006; Knop M, 1998, EMBO J, V17, P3952, DOI 10.1093/emboj/17.14.3952; Knop M, 1997, EMBO J, V16, P1550, DOI 10.1093/emboj/16.7.1550; Knop M, 1997, EMBO J, V16, P6985, DOI 10.1093/emboj/16.23.6985; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kollman JM, 2008, MOL BIOL CELL, V19, P207, DOI 10.1091/mbc.E07-09-0879; Kollman JM, 2010, NATURE, V466, P879, DOI 10.1038/nature09207; Lau CK, 2004, EUKARYOT CELL, V3, P447, DOI 10.1128/EC.3.2.447-458.2004; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Marschall LG, 1996, J CELL BIOL, V134, P443, DOI 10.1083/jcb.134.2.443; MEGGIO F, 1994, CELL MOL BIOL RES, V40, P401; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Murphy SM, 1998, J CELL BIOL, V141, P663, DOI 10.1083/jcb.141.3.663; Nguyen T, 1998, MOL BIOL CELL, V9, P2201, DOI 10.1091/mbc.9.8.2201; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; ONeill EM, 1996, SCIENCE, V271, P209, DOI 10.1126/science.271.5246.209; Parry-Smith DJ, 1998, GENE, V221, pGC57, DOI 10.1016/S0378-1119(97)00650-1; Pereira G, 2000, MOL CELL, V6, P1, DOI 10.1016/S1097-2765(05)00017-1; Pereira G, 2005, MOL CELL, V19, P209, DOI 10.1016/j.molcel.2005.05.030; Pereira G, 1997, J CELL SCI, V110, P295; Pereira G, 1998, MOL BIOL CELL, V9, P775, DOI 10.1091/mbc.9.4.775; Santamaria A., 2010, MOL CELL PROTEOMICS; SAUNDERS WS, 1992, CELL, V70, P451, DOI 10.1016/0092-8674(92)90169-D; Seltzer V, 2007, PLANT J, V52, P322, DOI 10.1111/j.1365-313X.2007.03240.x; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; SIKORSKI RS, 1989, GENETICS, V122, P19; Sobel SG, 1995, J CELL BIOL, V131, P1775, DOI 10.1083/jcb.131.6.1775; Spang A, 1996, J CELL SCI, V109, P2229; Spang A, 1996, J CELL BIOL, V134, P429, DOI 10.1083/jcb.134.2.429; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Straight AF, 1997, SCIENCE, V277, P574, DOI 10.1126/science.277.5325.574; Sundberg HA, 1997, MOL BIOL CELL, V8, P2575, DOI 10.1091/mbc.8.12.2575; Tassin AM, 1998, J CELL BIOL, V141, P689, DOI 10.1083/jcb.141.3.689; Usui T, 2003, EMBO J, V22, P4779, DOI 10.1093/emboj/cdg459; Venkatram S, 2004, MOL BIOL CELL, V15, P2287, DOI 10.1091/mbc.E03-10-0728; Verollet C, 2006, J CELL BIOL, V172, P517, DOI 10.1083/jcb.200511071; Vinh DBN, 2002, MOL BIOL CELL, V13, P1144, DOI 10.1091/mbc.02-01-0607; Vogel J, 2001, DEV CELL, V1, P621, DOI 10.1016/S1534-5807(01)00073-9; Wiese C, 2000, NAT CELL BIOL, V2, P358, DOI 10.1038/35014051; Wiese C, 2006, J CELL SCI, V119, P4143, DOI 10.1242/jcs.03226	72	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19700	10.1371/journal.pone.0019700	http://dx.doi.org/10.1371/journal.pone.0019700			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573187	Green Published, gold, Green Submitted			2022-12-27	WOS:000290256400040
J	Mech, F; Thywissen, A; Guthke, R; Brakhage, AA; Figge, MT				Mech, Franziska; Thywissen, Andreas; Guthke, Reinhard; Brakhage, Axel A.; Figge, Marc Thilo			Automated Image Analysis of the Host-Pathogen Interaction between Phagocytes and Aspergillus fumigatus	PLOS ONE			English	Article							CONIDIA; SEGMENTATION; RECOGNITION; ALGORITHMS; INTENSITY	Aspergillus fumigatus is a ubiquitous airborne fungus and opportunistic human pathogen. In immunocompromised hosts, the fungus can cause life-threatening diseases like invasive pulmonary aspergillosis. Since the incidence of fungal systemic infections drastically increased over the last years, it is a major goal to investigate the pathobiology of A. fumigatus and in particular the interactions of A. fumigatus conidia with immune cells. Many of these studies include the activity of immune effector cells, in particular of macrophages, when they are confronted with conidia of A. fumigus wild-type and mutant strains. Here, we report the development of an automated analysis of confocal laser scanning microscopy images from macrophages coincubated with different A. fumigatus strains. At present, microscopy images are often analysed manually, including cell counting and determination of interrelations between cells, which is very time consuming and error-prone. Automation of this process overcomes these disadvantages and standardises the analysis, which is a prerequisite for further systems biological studies including mathematical modeling of the infection process. For this purpose, the cells in our experimental setup were differentially stained and monitored by confocal laser scanning microscopy. To perform the image analysis in an automatic fashion, we developed a ruleset that is generally applicable to phagocytosis assays and in the present case was processed by the software Definiens Developer XD. As a result of a complete image analysis we obtained features such as size, shape, number of cells and cell-cell contacts. The analysis reported here, reveals that different mutants of A. fumigatus have a major influence on the ability of macrophages to adhere and to phagocytose the respective conidia. In particular, we observe that the phagocytosis ratio and the aggregation behaviour of pksP mutant compared to wild-type conidia are both significantly increased.	[Mech, Franziska; Figge, Marc Thilo] HKI, Leibniz Inst Nat Prod Res & Infect Biol, Res Grp Appl Syst Biol, Jena, Germany; [Thywissen, Andreas; Brakhage, Axel A.] HKI, Leibniz Inst Nat Prod Res & Infect Biol, Dept Mol & Appl Microbiol, Jena, Germany; [Thywissen, Andreas; Brakhage, Axel A.; Figge, Marc Thilo] Univ Jena, Jena, Germany; [Guthke, Reinhard] HKI, Leibniz Inst Nat Prod Res & Infect Biol, Res Grp Syst Biol Bioinformat, Jena, Germany	Hans Knoll Institute (HKI); Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Hans Knoll Institute (HKI)	Mech, F (corresponding author), HKI, Leibniz Inst Nat Prod Res & Infect Biol, Res Grp Appl Syst Biol, Jena, Germany.	Thilo.Figge@hki-jena.de	Figge, Marc Thilo/J-7547-2017	Figge, Marc Thilo/0000-0002-4044-9166; Braun, Franziska/0000-0003-1027-8084	International Leibniz Research School (ILRS); BMBF; TMBWK	International Leibniz Research School (ILRS); BMBF(Federal Ministry of Education & Research (BMBF)); TMBWK	This work was supported by the International Leibniz Research School (ILRS: http://www.ilrs.hki-jena.de/) for Microbial and Biomolecular Interactions as part of the excellence graduate school Jena School for Microbial Communication (JSMC: http://www.jsmc.uni-jena.de/) and the "Pakt fur Forschung und Innovation'' of the BMBF (http://www.bmbf.de/) and TMBWK (http://www.thueringen.de/de/tmbwk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Baatz M, 2009, COMB CHEM HIGH T SCR, V12, P908, DOI 10.2174/138620709789383196; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Behnsen J, 2010, INFECT IMMUN, V78, P3585, DOI 10.1128/IAI.01353-09; Binnig G, 2002, EUROPHYSICS NEWS, V33; BRAKHAGE AA, 1995, J BACTERIOL, V177, P2781, DOI 10.1128/jb.177.10.2781-2788.1995; Brakhage AA, 2010, CURR OPIN MICROBIOL, V13, P409, DOI 10.1016/j.mib.2010.04.009; Bruns S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000873; Codina R, 2008, J INVEST ALLERG CLIN, V18, P156; Conchello JA, 2005, NAT METHODS, V2, P920, DOI 10.1038/NMETH815; Dagenais TRT, 2010, INFECT IMMUN, V78, P823, DOI 10.1128/IAI.00980-09; Dzyubachyk O, 2010, BIOINFORMATICS, V26, P2424, DOI 10.1093/bioinformatics/btq434; Fontaine T, 2010, FUNGAL GENET BIOL, V47, P707, DOI 10.1016/j.fgb.2010.04.006; Garrido A, 2000, PATTERN RECOGN, V33, P821, DOI 10.1016/S0031-3203(99)00091-6; de Ana SG, 2006, J INVEST ALLERG CLIN, V16, P357; Gonzalez R. C., 2008, DIGITAL IMAGE PROCES; HILDRETH EC, 1983, COMPUT VISION GRAPH, V22, P1, DOI 10.1016/0734-189X(83)90093-2; Ibrahim-Granet O, 2003, INFECT IMMUN, V71, P891, DOI 10.1128/IAI.71.2.891-903.2003; Jahn B, 2002, CELL MICROBIOL, V4, P793, DOI 10.1046/j.1462-5822.2002.00228.x; Latge JP, 2010, CELL MICROBIOL, V12, P863, DOI 10.1111/j.1462-5822.2010.01474.x; Latge JP, 2001, TRENDS MICROBIOL, V9, P382, DOI 10.1016/S0966-842X(01)02104-7; Luther K, 2007, CELL MICROBIOL, V9, P368, DOI 10.1111/j.1462-5822.2006.00796.x; Malpica N, 1997, CYTOMETRY, V28, P289, DOI 10.1002/(SICI)1097-0320(19970801)28:4<289::AID-CYTO3>3.0.CO;2-7; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Patel K, 2010, INT DRUG DISCOVERY, V5, P64; Schonmeyer R, 2011, INT J COMPUT ASS RAD, V6, P127, DOI 10.1007/s11548-010-0486-8; Shamir L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000974; Soille P., 2004, MORPHOLOGICAL IMAGE, DOI [10.1007/978-3-662-05088-0, DOI 10.1007/978-3-662-05088-0]; Sysko LR, 2010, CURR PROTOC CYTOM; Vogt A, 2009, DEV DYNAM, V238, P656, DOI 10.1002/dvdy.21892; Wahlby C, 2004, J MICROSC-OXFORD, V215, P67, DOI 10.1111/j.0022-2720.2004.01338.x; Yang YM, 1999, SIGIR'99: PROCEEDINGS OF 22ND INTERNATIONAL CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P42, DOI 10.1145/312624.312647; Zhou XB, 2006, IEEE SIGNAL PROC MAG, V23, P63, DOI 10.1109/MSP.2006.1628879	34	45	51	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19591	10.1371/journal.pone.0019591	http://dx.doi.org/10.1371/journal.pone.0019591			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573171	Green Published, Green Submitted, gold			2022-12-27	WOS:000290256400029
J	Ullrich, RT; Jikeli, JF; Diedenhofen, M; Bohm-Sturm, P; Unruh, M; Vollmar, S; Hoehn, M				Ullrich, Roland T.; Jikeli, Jan F.; Diedenhofen, Michael; Boehm-Sturm, Philipp; Unruh, Maike; Vollmar, Stefan; Hoehn, Mathias			In-Vivo Visualization of Tumor Microvessel Density and Response to Anti-Angiogenic Treatment by High Resolution MRI in Mice	PLOS ONE			English	Article							EXPERIMENTAL BRAIN-TUMORS; CONTRAST AGENTS; DIFFUSION; SIZE; RELAXATION; INHIBITOR	Purpose: Inhibition of angiogenesis has shown clinical success in patients with cancer. Thus, imaging approaches that allow for the identification of angiogenic tumors and the detection of response to anti-angiogenic treatment are of high clinical relevance. Experimental Design: We established an in vivo magnetic resonance imaging (MRI) approach that allows us to simultaneously image tumor microvessel density and tumor vessel size in a NSCLC model in mice. Results: Using microvessel density imaging we demonstrated an increase in microvessel density within 8 days after tumor implantation, while tumor vessel size decreased indicating a switch from macro-to microvessels during tumor growth. Moreover, we could monitor in vivo inhibition of angiogenesis induced by the angiogenesis inhibitor PTK787, resulting in a decrease of microvessel density and a slight increase in tumor vessel size. Conclusions: We present an in vivo imaging approach that allows us to monitor both tumor microvessel density and tumor vessel size in the tumor. Moreover, this approach enables us to assess, early-on, treatment effects on tumor microvessel density as well as on tumor vessel size. Thus, this imaging-based strategy of validating anti-angiogenic treatment effects has high potential in applications to preclinical and clinical trials.	[Ullrich, Roland T.; Jikeli, Jan F.; Diedenhofen, Michael; Boehm-Sturm, Philipp; Unruh, Maike; Vollmar, Stefan; Hoehn, Mathias] Max Planck Inst Neurol Res, Cologne, Germany; [Ullrich, Roland T.] Ctr Mol Med, Cologne, Germany; [Ullrich, Roland T.] Univ Hosp, Dept Internal Med 1, Cologne, Germany	Max Planck Society; University of Cologne; University of Cologne	Ullrich, RT (corresponding author), Max Planck Inst Neurol Res, Cologne, Germany.	ullrich@nf.mpg.de		Boehm-Sturm, Philipp/0000-0001-8777-4823	Deutsche Forschungsgemeinschaft [SFB 832]; European funds (project ENCITE) [HEALTH-F5-2008-201842]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European funds (project ENCITE)	This work was supported in part by a grant from the Deutsche Forschungsgemeinschaft through SFB 832 (to R.T.U.), and by European funds (project ENCITE) under the 7th Framework HEALTH-F5-2008-201842 (to M. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chenevert TL, 1997, CLIN CANCER RES, V3, P1457; Cizek J, 2004, NEUROIMAGE, V22, P434, DOI 10.1016/j.neuroimage.2004.01.016; Dennie J, 1998, MAGN RESON MED, V40, P793, DOI 10.1002/mrm.1910400602; Drevs J, 2002, CANCER RES, V62, P4015; Drevs J, 2007, J CLIN ONCOL, V25, P3045, DOI 10.1200/JCO.2006.07.2066; EIS M, 1995, MAGN RESON MED, V34, P835, DOI 10.1002/mrm.1910340608; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Hamstra DA, 2005, P NATL ACAD SCI USA, V102, P16759, DOI 10.1073/pnas.0508347102; Huang MQ, 2008, NMR BIOMED, V21, P1021, DOI 10.1002/nbm.1261; Ivy SP, 2009, NAT REV CLIN ONCOL, V6, P569, DOI 10.1038/nrclinonc.2009.130; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jensen JH, 2006, MAGN RESON MED, V56, P1145, DOI 10.1002/mrm.21052; Jensen JH, 2000, MAGNET RESON MED, V44, P224, DOI 10.1002/1522-2594(200008)44:2<224::AID-MRM9>3.0.CO;2-M; Kiselev VG, 1999, MAGN RESON MED, V41, P499, DOI 10.1002/(SICI)1522-2594(199903)41:3<499::AID-MRM12>3.0.CO;2-O; Kiselev VG, 2010, JOINT ANN M ISMRM ES; Lin CY, 2008, J CEREBR BLOOD F MET, V28, P1491, DOI 10.1038/jcbfm.2008.42; Schwarz AJ, 2003, MAGN RESON IMAGING, V21, P1191, DOI 10.1016/j.mri.2003.08.020; Tropres I, 2001, MAGN RESON MED, V45, P397, DOI 10.1002/1522-2594(200103)45:3<397::AID-MRM1052>3.0.CO;2-3; Ullrich RT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003908; Valonen PK, 2004, J MAGN RESON IMAGING, V19, P389, DOI 10.1002/jmri.20026; Wertman R, 2008, RADIOLOGY, V248, P799, DOI 10.1148/radiol.2483072093; Wong CI, 2009, J CLIN ONCOL, V27, P4718, DOI 10.1200/JCO.2008.21.7125; Wu EX, 2004, NMR BIOMED, V17, P507, DOI 10.1002/nbm.921; Zwick S, 2009, J MAGN RESON IMAGING, V29, P1125, DOI 10.1002/jmri.21710	25	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19592	10.1371/journal.pone.0019592	http://dx.doi.org/10.1371/journal.pone.0019592			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573168	gold, Green Published, Green Submitted			2022-12-27	WOS:000290256400030
J	Kesanakurti, D; Chetty, C; Bhoopathi, P; Lakka, SS; Gorantla, B; Tsung, AJ; Rao, JS				Kesanakurti, Divya; Chetty, Chandramu; Bhoopathi, Praveen; Lakka, Sajani S.; Gorantla, Bharathi; Tsung, Andrew J.; Rao, Jasti S.			Suppression of MMP-2 Attenuates TNF-alpha Induced NF-kappa B Activation and Leads to JNK Mediated Cell Death in Glioma	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; TUMOR-NECROSIS-FACTOR; FAS-INDUCED APOPTOSIS; C-JUN; SIGNAL-TRANSDUCTION; MOLECULAR-MECHANISMS; TERMINAL KINASE; PATHWAY; INHIBITION; RIP	Background: Abrogation of apoptosis for prolonged cell survival is essential in cancer progression. In our previous studies, we showed the MMP-2 downregulation induced apoptosis in cancer cell lines. Here, we attempt to investigate the exact molecular mechanism of how MMP-2 depletion leads to apoptosis in glioma xenograft cell lines. Methodology/Principal Findings: MMP-2 transcriptional suppression by MMP-2siRNA (pM) induces apoptosis associated with PARP, caspase-8 and -3 cleavage in human glioma xenograft cells 4910 and 5310. Western blotting and cytokine array showed significant decrease in the cellular and secreted levels of TNF-alpha with concomitant reduction in TNFR1, TRADD, TRAF2, RIP, IKK beta and pI kappa B alpha expression levels resulting in inhibition of p65 phosphorylation and nuclear translocation in pM-treated cells when compared to mock and pSV controls. In addition MMP-2 suppression led to elevated Fas-L, Fas and FADD expression levels along with increased p38 and JNK phosphorylation. The JNK-activity assay showed prolonged JNK activation in pM-transfected cells. Specific inhibition of p38 with SB203580 did not show any effect whereas inhibition of JNK phosphorylation with SP600125 notably reversed pM-induced cleavage of PARP, caspase-8 and -3, demonstrating a significant role of JNK in pM-induced cell death. Supplementation of rhMMP-2 counteracted the effect of pM by remarkably elevating TNF-alpha, TRADD, IKK beta and pI kappa B alpha expression and decreasing FADD, Fas-L, and phospho-JNK levels. The EMSA analysis indicated significant reversal of pM-inhibited NF-kappa B activity by rhMMP-2 treatment which rescued cells from pM-induced cell death. In vivo studies indicated that pM treatment diminished intracranial tumor growth and the immuno histochemical analysis showed decreased phospho-p65 and enhanced phospho-JNK levels that correlated with increased TUNEL-positive apoptotic cells in pM-treated tumor sections. Conclusion/Significance: In summary, our study implies a role of MMP-2 in the regulation of TNF-alpha mediated constitutive NF-kappa B activation and Fas-mediated JNK mediated apoptosis in glioma xenograft cells in vitro and in vivo.	[Kesanakurti, Divya; Chetty, Chandramu; Bhoopathi, Praveen; Lakka, Sajani S.; Gorantla, Bharathi; Rao, Jasti S.] Univ Illinois, Coll Med Peoria, Dept Canc Biol, Peoria, IL 61656 USA; [Kesanakurti, Divya; Chetty, Chandramu; Bhoopathi, Praveen; Lakka, Sajani S.; Gorantla, Bharathi; Rao, Jasti S.] Univ Illinois, Dept Pharmacol, Peoria, IL USA; [Tsung, Andrew J.; Rao, Jasti S.] Univ Illinois, Coll Med Peoria, Dept Neurosurg, Peoria, IL USA	University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria	Kesanakurti, D (corresponding author), Univ Illinois, Coll Med Peoria, Dept Canc Biol, Peoria, IL 61656 USA.	jsrao@uic.edu			N.I.N.D.S. [NS64535-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064535] Funding Source: NIH RePORTER	N.I.N.D.S.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by a grant from N.I.N.D.S., NS64535-01A1 (to JSR). The contents are solely the responsibility of the authors and do not necessarily represent the official views of National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcia RN, 2003, CELL IMMUNOL, V226, P78, DOI 10.1016/j.cellimm.2003.11.006; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chetty C, 2007, ONCOGENE, V26, P7675, DOI 10.1038/sj.onc.1210584; Chetty C, 2009, INT J CANCER, V124, P2468, DOI 10.1002/ijc.24209; Curtin JF, 2003, BRIT J CANCER, V89, P1950, DOI 10.1038/sj.bjc.6601393; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Demuth T, 2004, J NEURO-ONCOL, V70, P217, DOI 10.1007/s11060-004-2751-6; Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Giannini C, 2005, NEURO-ONCOLOGY, V7, P164, DOI 10.1215/S1152851704000821; Gibson S, 1999, J BIOL CHEM, V274, P10916, DOI 10.1074/jbc.274.16.10916; Gondi CS, 2009, INT J ONCOL, V35, P851, DOI 10.3892/ijo_00000399; Han SS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-97; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Huerta-Yepez S, 2006, CLIN IMMUNOL, V120, P297, DOI 10.1016/j.clim.2006.03.015; Jansen M, 2004, BRAIN RES REV, V45, P143, DOI 10.1016/j.brainresrev.2004.03.001; Jia L, 2008, PROSTATE, V68, P427, DOI 10.1002/pros.20716; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kim JW, 2000, ONCOGENE, V19, P4491, DOI 10.1038/sj.onc.1203796; Lin A, 2003, BIOESSAYS, V25, P17, DOI 10.1002/bies.10204; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Martinon F, 2000, FEBS LETT, V468, P134, DOI 10.1016/S0014-5793(00)01212-6; Micheau O, 1999, J BIOL CHEM, V274, P7987, DOI 10.1074/jbc.274.12.7987; Nupponen N. N., 2006, CURRENT DIAGNOSTIC P, V12, P394; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Qin YM, 2007, CELL MOL IMMUNOL, V4, P43; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Scaffidi C, 2000, J IMMUNOL, V164, P1236, DOI 10.4049/jimmunol.164.3.1236; Shimada K, 2004, CARCINOGENESIS, V25, P1089, DOI 10.1093/carcin/bgh130; Shimada K, 2003, PROSTATE, V55, P265, DOI 10.1002/pros.10227; Shrivastava P, 2004, MOL CELL BIOL, V24, P6763, DOI 10.1128/MCB.24.15.6763-6772.2004; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Tang FM, 2002, MOL CELL BIOL, V22, P8571, DOI 10.1128/MCB.22.24.8571-8579.2002; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Tsuchiya Y, 2010, MOL CELL, V39, P570, DOI 10.1016/j.molcel.2010.07.030; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Zhang SY, 2004, CARCINOGENESIS, V25, P2191, DOI 10.1093/carcin/bgh234	44	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19341	10.1371/journal.pone.0019341	http://dx.doi.org/10.1371/journal.pone.0019341			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573233	Green Published, gold, Green Submitted			2022-12-27	WOS:000290224800024
J	Cornil, CA; Ball, GF; Balthazart, J; Charlier, TD				Cornil, Charlotte A.; Ball, Gregory F.; Balthazart, Jacques; Charlier, Thierry D.			Organizing Effects of Sex Steroids on Brain Aromatase Activity in Quail	PLOS ONE			English	Article							MALE JAPANESE-QUAIL; SEXUALLY DIMORPHIC AROMATASE; IMMUNOREACTIVE CELLS; MESSENGER-RNA; PREOPTIC AREA; IMMUNOCYTOCHEMICAL LOCALIZATION; PERIAQUEDUCTAL GRAY; COTURNIX-JAPONICA; FEMALE QUAIL; RAT	Preoptic/hypothalamic aromatase activity (AA) is sexually differentiated in birds and mammals but the mechanisms controlling this sex difference remain unclear. We determined here (1) brain sites where AA is sexually differentiated and (2) whether this sex difference results from organizing effects of estrogens during ontogeny or activating effects of testosterone in adulthood. In the first experiment we measured AA in brain regions micropunched in adult male and female Japanese quail utilizing the novel strategy of basing the microdissections on the distribution of aromatase-immunoreactive cells. The largest sex difference was found in the medial bed nucleus of the stria terminalis (mBST) followed by the medial preoptic nucleus (POM) and the tuberal hypothalamic region. A second experiment tested the effect of embryonic treatments known to sex-reverse male copulatory behavior (i.e., estradiol benzoate [EB] or the aromatase inhibitor, Vorozole) on brain AA in gonadectomized adult males and females chronically treated as adults with testosterone. Embryonic EB demasculinized male copulatory behavior, while vorozole blocked demasculinization of behavior in females as previously demonstrated in birds. Interestingly, these treatments did not affect a measure of appetitive sexual behavior. In parallel, embryonic vorozole increased, while EB decreased AA in pooled POM and mBST, but the same effect was observed in both sexes. Together, these data indicate that the early action of estrogens demasculinizes AA. However, this organizational action of estrogens on AA does not explain the behavioral sex difference in copulatory behavior since AA is similar in testosterone-treated males and females that were or were not exposed to embryonic treatments with estrogens.	[Cornil, Charlotte A.; Balthazart, Jacques; Charlier, Thierry D.] Univ Liege, GIGA Neurosci, Liege, Belgium; [Ball, Gregory F.] Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD USA	University of Liege; Johns Hopkins University	Cornil, CA (corresponding author), Univ Liege, GIGA Neurosci, Liege, Belgium.	Charlotte.Cornil@ulg.ac.be	Cornil, Charlotte Anne/J-2462-2019; Charlier, Thierry/J-4668-2015	Cornil, Charlotte Anne/0000-0002-5536-7753; Ball, Gregory/0000-0002-4784-0520	National Institutes of Health (NIH/NIMH) [R01 MH50388]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH050388] Funding Source: NIH RePORTER	National Institutes of Health (NIH/NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Grant from the National Institutes of Health (NIH/NIMH R01 MH50388) to JB and GFB. CAC is a F.R.S.-FNRS Research Associate. TDC was a F.R.S.-FNRS Post-doctoral researcher and is a ULg Research Associate. F.R.S.-FNRS is the Belgian National Science Foundation: http://www1.frs-fnrs.be/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absil P, 2001, HORM BEHAV, V40, P369, DOI 10.1006/hbeh.2001.1702; ADKINS E K, 1975, Journal of Comparative and Physiological Psychology, V89, P61, DOI 10.1037/h0076406; ADKINS EK, 1972, J COMP PHYSIOL PSYCH, V81, P27, DOI 10.1037/h0033315; Adkins-Regan E, 2006, PHYSIOL BEHAV, V87, P82, DOI 10.1016/j.physbeh.2005.08.047; [Anonymous], 2008, SEX DIFFERENCES BRAI; [Anonymous], PHYSL REPRODUCTION, DOI DOI 10.1016/B978-012532104-4/50003-2; [Anonymous], 2011, J SEX MED, DOI DOI 10.1111/j.1743-6109.2011.02449.x; Aste N, 1998, J CHEM NEUROANAT, V14, P103, DOI 10.1016/S0891-0618(97)10023-0; Baillien M, 1997, J STEROID BIOCHEM, V63, P99, DOI 10.1016/S0960-0760(97)00080-0; Ball GF, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P855; BALTHAZART J, 1990, J NEUROENDOCRINOL, V2, P675, DOI 10.1111/j.1365-2826.1990.tb00464.x; BALTHAZART J, 1990, PHYSIOL BEHAV, V47, P83, DOI 10.1016/0031-9384(90)90045-6; Balthazart J, 2006, ENDOCRINOLOGY, V147, P359, DOI 10.1210/en.2005-0845; Balthazart J, 2004, PHYSIOL BEHAV, V83, P247, DOI 10.1016/j.physbeh.2004.08.025; Balthazart J, 1996, J CHEM NEUROANAT, V11, P147, DOI 10.1016/0891-0618(96)00149-4; BALTHAZART J, 1990, BRAIN RES, V514, P327, DOI 10.1016/0006-8993(90)91428-J; Balthazart J, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P1745; Balthazart J, 2003, EUR J NEUROSCI, V17, P1591, DOI 10.1046/j.1460-9568.2003.02598.x; BALTHAZART J, 1989, ARCH INT PHYSIOL BIO, V97, P465, DOI 10.3109/13813458909075078; BALTHAZART J, 1992, HORM BEHAV, V26, P179, DOI 10.1016/0018-506X(92)90041-S; Balthazart J, 2001, J NEUROENDOCRINOL, V13, P63, DOI 10.1046/j.1365-2826.2001.00598.x; Balthazart J, 2008, J EXP ZOOL PART A, V309A, P1; Balthazart J, 2006, TRENDS NEUROSCI, V29, P241, DOI 10.1016/j.tins.2006.03.004; Bao AM, 2010, NEUROSCIENTIST, V16, P550, DOI 10.1177/1073858410377005; BAYLE JD, 1974, J PHYSIOL-PARIS, V68, P219; Carere C, 2007, J COMP NEUROL, V500, P894, DOI 10.1002/cne.21210; Cornil CA, 2006, HORM BEHAV, V49, P45, DOI 10.1016/j.yhbeh.2005.05.003; Cornil CA, 2005, ENDOCRINOLOGY, V146, P3809, DOI 10.1210/en.2005-0441; Cornil CA, 2008, SOC NEUR ABSTR, V34, P994; Cornil CA, 2009, 13 ANN M SOC BEH NEU; Dickens M. J., 2010, Society for Neuroscience Abstract Viewer and Itinerary Planner, V40; Evrard HC, 2004, J COMP NEUROL, V473, P194, DOI 10.1002/cne.20068; FOIDART A, 1995, J CHEM NEUROANAT, V8, P267, DOI 10.1016/0891-0618(95)00054-B; FOIDART A, 1994, PHYSIOL BEHAV, V55, P453, DOI 10.1016/0031-9384(94)90100-7; Gu G, 2003, J COMP NEUROL, V460, P542, DOI 10.1002/cne.10677; Halem HA, 2001, J NEUROSCI, V21, P2474, DOI 10.1523/JNEUROSCI.21-07-02474.2001; Hojo Y, 2004, P NATL ACAD SCI USA, V101, P865, DOI 10.1073/pnas.2630225100; Hull EM, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P5; HUTCHISON RE, 1978, HORM BEHAV, V11, P363, DOI 10.1016/0018-506X(78)90038-7; Konkle ATM, 2011, J NEUROENDOCRINOL, V23, P424, DOI 10.1111/j.1365-2826.2011.02121.x; Loyd DR, 2006, J COMP NEUROL, V496, P723, DOI 10.1002/cne.20962; MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211; Martel KL, 2007, EUR J NEUROSCI, V26, P463, DOI 10.1111/j.1460-9568.2007.05651.x; Naftolin F, 1996, NEUROENDOCRINOLOGY, V63, P149, DOI 10.1159/000126951; PALKOVITS M, 1973, BRAIN RES, V59, P449, DOI 10.1016/0006-8993(73)90290-4; PAXINOS G, 1986, RAT BRAIN STEREOTAXI, pR8; Peterson RS, 2005, P ROY SOC B-BIOL SCI, V272, P2089, DOI 10.1098/rspb.2005.3181; Remage-Healey L, 2009, J NEUROENDOCRINOL, V21, P191, DOI 10.1111/j.1365-2826.2009.01820.x; Remage-Healey L, 2008, NAT NEUROSCI, V11, P1327, DOI 10.1038/nn.2200; Rohmann KN, 2007, DEV NEUROBIOL, V67, P1, DOI 10.1002/dneu.20303; ROSELLI CE, 1991, ENDOCRINOLOGY, V128, P1310, DOI 10.1210/endo-128-3-1310; Roselli CE, 1998, ENDOCRINOLOGY, V139, P3193, DOI 10.1210/en.139.7.3193; ROSELLI CE, 1995, J STEROID BIOCHEM, V52, P469, DOI 10.1016/0960-0760(94)00192-O; ROSELLI CE, 1984, ENDOCRINOLOGY, V114, P2183, DOI 10.1210/endo-114-6-2183; ROSELLI CE, 1985, ENDOCRINOLOGY, V117, P2471, DOI 10.1210/endo-117-6-2471; Roselli CE, 1997, BRAIN RES BULL, V44, P351, DOI 10.1016/S0361-9230(97)00214-1; Roselli CE, 2009, SEMIN REPROD MED, V27, P207, DOI 10.1055/s-0029-1216274; SACHS BD, 1967, SCIENCE, V157, P201, DOI 10.1126/science.157.3785.201; SCHLINGER BA, 1989, NEUROENDOCRINOLOGY, V49, P434, DOI 10.1159/000125149; SCHUMACHER M, 1987, BRAIN RES, V422, P137, DOI 10.1016/0006-8993(87)90548-8; SCHUMACHER M, 1986, BRAIN RES, V370, P285, DOI 10.1016/0006-8993(86)90483-X; SCHUMACHER M, 1983, PHYSIOL BEHAV, V30, P335, DOI 10.1016/0031-9384(83)90135-X; SCHUMACHER M, 1988, J ENDOCRINOL, V118, P127, DOI 10.1677/joe.0.1180127; SCHUMACHER M, 1989, HORM BEHAV, V23, P130, DOI 10.1016/0018-506X(89)90080-9; Seiwert CM, 1998, BRAIN BEHAV EVOLUT, V52, P61, DOI 10.1159/000006553; SIMERLY RB, 1984, J COMP NEUROL, V225, P151, DOI 10.1002/cne.902250202; STEIMER T, 1990, J NEUROBIOL, V21, P787, DOI 10.1002/neu.480210512; Thompson RR, 1998, BRAIN BEHAV EVOLUT, V51, P215; Voigt C, 2007, J CHEM NEUROANAT, V33, P75, DOI 10.1016/j.jchemneu.2006.12.004; Voigt C, 2011, GEN COMP ENDOCR, V170, P180, DOI 10.1016/j.ygcen.2010.10.003	70	34	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19196	10.1371/journal.pone.0019196	http://dx.doi.org/10.1371/journal.pone.0019196			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559434	Green Submitted, gold, Green Published			2022-12-27	WOS:000290024700097
J	Glas, J; Seiderer, J; Fries, C; Tillack, C; Pfennig, S; Weidinger, M; Beigel, F; Olszak, T; Lass, U; Goke, B; Ochsenkuhn, T; Wolf, C; Lohse, P; Muller-Myhsok, B; Diegelmann, J; Czamara, D; Brand, S				Glas, Juergen; Seiderer, Julia; Fries, Christoph; Tillack, Cornelia; Pfennig, Simone; Weidinger, Maria; Beigel, Florian; Olszak, Torsten; Lass, Ulrich; Goeke, Burkhard; Ochsenkuehn, Thomas; Wolf, Christiane; Lohse, Peter; Mueller-Myhsok, Bertram; Diegelmann, Julia; Czamara, Darina; Brand, Stephan			CEACAM6 Gene Variants in Inflammatory Bowel Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ALPHA-DEFENSIN EXPRESSION; INVASIVE ESCHERICHIA-COLI; ILEAL CROHNS-DISEASE; INTESTINAL INFLAMMATION; FRAMESHIFT MUTATION; SUSCEPTIBILITY LOCI; DENDRITIC CELLS; T-CELLS; ADHESION	Background: The carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) acts as a receptor for adherent-invasive E. coli (AIEC) and its ileal expression is increased in patients with Crohn's disease (CD). Given its contribution to the pathogenesis of CD, we aimed to investigate the role of genetic variants in the CEACAM6 region in patients with inflammatory bowel diseases (IBD). Methodology: In this study, a total of 2,683 genomic DNA samples (including DNA from 858 CD patients, 475 patients with ulcerative colitis (UC), and 1,350 healthy, unrelated controls) was analyzed for eight CEACAM6 SNPs (rs10415946, rs1805223 = p.Pro42Pro, rs4803507, rs4803508, rs11548735 = p.Gly239Val, rs7246116 = pHis260His, rs2701, rs10416839). In addition, a detailed haplotype analysis and genotype-phenotype analysis were performed. Overall, our genotype analysis did not reveal any significant association of the investigated CEACAM6 SNPs and haplotypes with CD or UC susceptibility, although certain CEACAM6 SNPs modulated CEACAM6 expression in intestinal epithelial cell lines. Despite its function as receptor of AIEC in ileal CD, we found no association of the CEACAM6 SNPs with ileal or ileocolonic CD. Moreover, there was no evidence of epistasis between the analyzed CEACAM6 variants and the main CD-associated NOD2, IL23R and ATG16L1 variants. Conclusions: This study represents the first detailed analysis of CEACAM6 variants in IBD patients. Despite its important role in bacterial attachment in ileal CD, we could not demonstrate a role for CEACAM6 variants in IBD susceptibility or regarding an ileal CD phenotype. Further functional studies are required to analyze if these gene variants modulate ileal bacterial attachment.	[Glas, Juergen; Seiderer, Julia; Fries, Christoph; Tillack, Cornelia; Pfennig, Simone; Weidinger, Maria; Beigel, Florian; Olszak, Torsten; Goeke, Burkhard; Ochsenkuehn, Thomas; Diegelmann, Julia; Brand, Stephan] Univ Munich, Dept Med Grosshadern 2, Munich, Germany; [Glas, Juergen; Fries, Christoph; Diegelmann, Julia] Univ Munich, Dept Prevent Dent & Periodontol, Munich, Germany; [Glas, Juergen] Rhein Westfal TH Aachen, Dept Human Genet, Aachen, Germany; [Olszak, Torsten] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol Hepatol & Endoscopy, Boston, MA 02115 USA; [Lass, Ulrich] TIB MOLBIOL Syntheselabor GmbH, Berlin, Germany; [Wolf, Christiane; Mueller-Myhsok, Bertram; Czamara, Darina] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Lohse, Peter] Univ Munich, Dept Clin Chem, Munich, Germany	University of Munich; University of Munich; RWTH Aachen University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Max Planck Society; University of Munich	Glas, J (corresponding author), Univ Munich, Dept Med Grosshadern 2, Munich, Germany.	stephan.brand@med.uni-muenchen.de	Müller-Myhsok, Bertram/A-3289-2013		Broad Medical Foundation [IBD-0126R2]; Ludwig-Maximilians-University Munich [422]; Robert-Bosch-Foundation; Else Kroener-Fresenius-Stiftung [81/08//EKMS08/01, P50/05/EKMS05/62]; DFG [BR 1912/5-1]; DCCV e.V.	Broad Medical Foundation; Ludwig-Maximilians-University Munich; Robert-Bosch-Foundation; Else Kroener-Fresenius-Stiftung; DFG(German Research Foundation (DFG)); DCCV e.V.	J. Glas was supported by a grant from the Broad Medical Foundation (IBD-0126R2). J. Seiderer and J. Diegelmann were supported by grants from the Ludwig-Maximilians-University Munich (FoeFoLe Nr. 422; Habilitationsstipendium, LMUExcellent to J.S. and Promotionsstipendium to J.D.); J. Seiderer was also supported by the Robert-Bosch-Foundation and the Else Kroener-Fresenius-Stiftung (81/08//EKMS08/01). S. Brand was supported by grants from the DFG (BR 1912/5-1), the Else Kroener-Fresenius-Stiftung (Else Kroener Fresenius Memorial Stipendium 2005; P50/05/EKMS05/62), by the Ludwig-Demling Grant 2007 from DCCV e.V., and by grants of Ludwig-Maximilians-University Munich (Excellence Initiative, Investment Funds 2008 and FFoLe program). U. Lass is a employee of TIB MOLBIOL Syntheselabor GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. TIB MOLBIOL Syntheselabor GmbH provided help with designing the FRET probes but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2007, NEW ENGL J MED, V357, P708, DOI 10.1056/NEJMcibr073420; Barnich N, 2007, J CLIN INVEST, V117, P1566, DOI 10.1172/JCI30504; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Boudeau J, 1999, INFECT IMMUN, V67, P4499, DOI 10.1128/IAI.67.9.4499-4509.1999; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Bresso F, 2007, INFLAMM BOWEL DIS, V13, P531, DOI 10.1002/ibd.20067; Callaghan M, 2008, GENES IMMUN, V9, P30, DOI 10.1038/sj.gene.6364442; Cario E, 2006, ANN NY ACAD SCI, V1072, P332, DOI 10.1196/annals.1326.006; Carvalho FA, 2009, J EXP MED, V206, P2179, DOI 10.1084/jem.20090741; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Dango S, 2008, LUNG CANCER, V60, P426, DOI 10.1016/j.lungcan.2007.11.015; de Chambrun GP, 2008, CURR OPIN GASTROEN, V24, P440, DOI 10.1097/MOG.0b013e3283023be5; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Glas JN, 2009, AM J GASTROENTEROL, V104, P1737, DOI 10.1038/ajg.2009.163; Glas J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000819; Glas J, 2009, AM J GASTROENTEROL, V104, P665, DOI 10.1038/ajg.2008.65; Glasser AL, 2001, INFECT IMMUN, V69, P5529, DOI 10.1128/IAI.69.9.5529-5537.2001; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Greicius G, 2003, J LEUKOCYTE BIOL, V74, P126, DOI 10.1189/jlb.1202594; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Han SU, 2008, ONCOGENE, V27, P675, DOI 10.1038/sj.onc.1210686; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; KHAN WN, 1992, GENOMICS, V14, P384, DOI 10.1016/S0888-7543(05)80230-7; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Martinez GJ, 2009, J BIOL CHEM, V284, P35283, DOI 10.1074/jbc.C109.078238; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; Mudter J, 2007, GUT, V56, P293, DOI 10.1136/gut.2005.090464; Muenzner P, 2005, J CELL BIOL, V170, P825, DOI 10.1083/jcb.200412151; Nagaishi T, 2006, ANN NY ACAD SCI, V1072, P155, DOI 10.1196/annals.1326.004; Nagaishi T, 2006, IMMUNITY, V25, P769, DOI 10.1016/j.immuni.2006.08.026; Obrink B, 1997, CURR OPIN CELL BIOL, V9, P616, DOI 10.1016/S0955-0674(97)80114-7; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rhodes JM, 2007, GUT, V56, P610, DOI 10.1136/gut.2006.111872; Roda G, 2009, INFLAMM BOWEL DIS, V15, P1775, DOI 10.1002/ibd.21023; Rolhion N, 2007, INFLAMM BOWEL DIS, V13, P1277, DOI 10.1002/ibd.20176; Schnitzler F, 2006, IMMUNOGENETICS, V58, P99, DOI 10.1007/s00251-005-0073-2; Seiderer J, 2006, SCAND J GASTROENTERO, V41, P1421, DOI 10.1080/00365520600703900; Seiderer J, 2006, INFLAMM BOWEL DIS, V12, P1114, DOI 10.1097/01.mib.0000235836.32176.5e; Silva MA, 2009, INFLAMM BOWEL DIS, V15, P436, DOI 10.1002/ibd.20660; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Simms LA, 2008, GUT, V57, P903, DOI 10.1136/gut.2007.142588; Sokol H, 2008, INFLAMM BOWEL DIS, V14, P858, DOI 10.1002/ibd.20392; Stanke F, 2010, HUM GENET, V127, P383, DOI 10.1007/s00439-009-0779-6; Sydora BC, 2007, INFLAMM BOWEL DIS, V13, P947, DOI 10.1002/ibd.20155; Thom I, 2009, ANTICANCER RES, V29, P249; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	56	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19319	10.1371/journal.pone.0019319	http://dx.doi.org/10.1371/journal.pone.0019319			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559399	Green Published, gold			2022-12-27	WOS:000290024700131
J	Tebben, J; Tapiolas, DM; Motti, CA; Abrego, D; Negri, AP; Blackall, LL; Steinberg, PD; Harder, T				Tebben, Jan; Tapiolas, Dianne M.; Motti, Cherie A.; Abrego, David; Negri, Andrew P.; Blackall, Linda L.; Steinberg, Peter D.; Harder, Tilmann			Induction of Larval Metamorphosis of the Coral Acropora millepora by Tetrabromopyrrole Isolated from a Pseudoalteromonas Bacterium	PLOS ONE			English	Article							BUILDING TUBE WORM; GREGARIOUS SETTLEMENT; MICROBIAL BIOFILMS; COLONIZATION; RECRUITMENT; ALGA; NEUROPEPTIDE; INHIBITION; SURFACES; ELEGANS	The induction of larval attachment and metamorphosis of benthic marine invertebrates is widely considered to rely on habitat specific cues. While microbial biofilms on marine hard substrates have received considerable attention as specific signals for a wide and phylogenetically diverse array of marine invertebrates, the presumed chemical settlement signals produced by the bacteria have to date not been characterized. Here we isolated and fully characterized the first chemical signal from bacteria that induced larval metamorphosis of acroporid coral larvae (Acropora millepora). The metamorphic cue was identified as tetrabromopyrrole (TBP) in four bacterial Pseudoalteromonas strains among a culture library of 225 isolates obtained from the crustose coralline algae Neogoniolithon fosliei and Hydrolithon onkodes. Coral planulae transformed into fully developed polyps within 6 h, but only a small proportion of these polyps attached to the substratum. The biofilm cell density of the four bacterial strains had no influence on the ratio of attached vs. non-attached polyps. Larval bioassays with ethanolic extracts of the bacterial isolates, as well as synthetic TBP resulted in consistent responses of coral planulae to various doses of TBP. The lowest bacterial density of one of the Pseudoalteromonas strains which induced metamorphosis was 7,000 cells mm(-2) in laboratory assays, which is on the order of 0.1-1% of the total numbers of bacteria typically found on such surfaces. These results, in which an actual cue from bacteria has been characterized for the first time, contribute significantly towards understanding the complex process of acroporid coral larval settlement mediated through epibiotic microbial biofilms on crustose coralline algae.	[Tebben, Jan; Steinberg, Peter D.; Harder, Tilmann] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Tapiolas, Dianne M.; Motti, Cherie A.; Abrego, David; Negri, Andrew P.; Blackall, Linda L.; Harder, Tilmann] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Steinberg, Peter D.] Sydney Inst Marine Sci, Mosman, Australia	University of New South Wales Sydney; Australian Institute of Marine Science; Sydney Institute of Marine Science	Tebben, J (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	t.harder@unsw.edu.au	Blackall, Linda Louise/AAC-4312-2020; Abrego, David/AAT-8120-2020; Blackall, Linda L/H-1947-2013; Motti, Cherie/A-2588-2012; Negri, Andrew P/G-9909-2017; Harder, Tilmann/B-6861-2008; Tebben, Jan/ABD-2247-2020	Blackall, Linda Louise/0000-0002-8848-7698; Abrego, David/0000-0003-3311-2730; Blackall, Linda L/0000-0002-8848-7698; Negri, Andrew P/0000-0003-1388-7395; Harder, Tilmann/0000-0003-3173-6806; Tebben, Jan/0000-0002-2780-2236; Steinberg, Peter/0000-0002-1781-0726; Motti, Cherie/0000-0002-3292-2785	German Research Foundation [HA 3496/5-1]; Australian Institute of Marine Science [2233]	German Research Foundation(German Research Foundation (DFG)); Australian Institute of Marine Science	T. Harder was partially supported by a Research Fellowship awarded by the German Research Foundation (HA 3496/5-1). Funding was also provided by the Australian Institute of Marine Science, Futures Project, Appropriation Fund 2233. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN RJ, 1974, MAR BIOL, V27, P281, DOI 10.1007/BF00394363; Bengtsson MM, 2010, AQUAT MICROB ECOL, V60, P71, DOI 10.3354/ame01409; CLARKE KR, 2006, PRIMERE V6 USER MANU; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Dreanno C, 2006, P NATL ACAD SCI USA, V103, P14396, DOI 10.1073/pnas.0602763103; Erwin P., 2008, P 11 INT COR REEF S, P1219; Erwin PM, 2010, CORAL REEFS, V29, P929, DOI 10.1007/s00338-010-0634-1; Hadfield MG, 2011, ANNU REV MAR SCI, V3, P453, DOI 10.1146/annurev-marine-120709-142753; Hay ME, 2009, ANNU REV MAR SCI, V1, P193, DOI 10.1146/annurev.marine.010908.163708; Hertiani T, 2010, BIOORGAN MED CHEM, V18, P1297, DOI 10.1016/j.bmc.2009.12.028; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Huang SY, 2003, MAR ECOL PROG SER, V260, P161, DOI 10.3354/meps260161; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hung OS, 2009, AQUAT BIOL, V4, P253, DOI 10.3354/ab00110; Iwao K, 2002, CORAL REEFS, V21, P127, DOI 10.1007/s00338-002-0219-8; JOHNSON CR, 1991, MAR ECOL PROG SER, V71, P143, DOI 10.3354/meps071143; LAATSCH H, 1989, MARINE BACTERIA, V1, P863; Leitz T, 1997, INVERTEBR REPROD DEV, V31, P109, DOI 10.1080/07924259.1997.9672569; MORSE DE, 1988, J EXP MAR BIOL ECOL, V116, P193, DOI 10.1016/0022-0981(88)90027-5; Muller WA, 2002, CAN J ZOOL, V80, P1755, DOI 10.1139/Z02-130; Negri AP, 2001, MAR ECOL PROG SER, V223, P121, DOI 10.3354/meps223121; Nylund GM, 2008, MAR ECOL PROG SER, V369, P39, DOI 10.3354/meps07577; Palmer M. H., 1967, STRUCTURE REACTIONS; PAWLIK JR, 1992, OCEANOGR MAR BIOL, V30, P273; PAWLIK JR, 1986, MAR BIOL, V91, P59, DOI 10.1007/BF00397571; PAWLIK JR, 1991, SCIENCE, V251, P421, DOI 10.1126/science.251.4992.421; Qian PY, 2007, MAR BIOTECHNOL, V9, P399, DOI 10.1007/s10126-007-9001-9; RASBAND WS, 2010, IMAGEJ V 1 43; Ritson-Williams R, 2010, CORAL REEFS, V29, P71, DOI 10.1007/s00338-009-0555-z; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Steinberg PD, 2002, J PHYCOL, V38, P621, DOI 10.1046/j.1529-8817.2002.02042.x; Swanson RL, 2004, BIOL BULL-US, V206, P161, DOI 10.2307/1543640; Thiyagarajan V, 2006, MICROB ECOL, V51, P431, DOI 10.1007/s00248-006-9041-0; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; Tsukamoto S, 1999, EUR J BIOCHEM, V264, P785, DOI 10.1046/j.1432-1327.1999.00642.x; Vermeij MJA, 2009, CORAL REEFS, V28, P987, DOI 10.1007/s00338-009-0535-3; Wang S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r126; Webster NS, 2004, APPL ENVIRON MICROB, V70, P1213, DOI 10.1128/AEM.70.2.1213-1221.2004; WOODIN SA, 1993, J CHEM ECOL, V19, P517, DOI 10.1007/BF00994322; YVIN JC, 1985, J NAT PROD, V48, P814, DOI 10.1021/np50041a018	40	149	157	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19082	10.1371/journal.pone.0019082	http://dx.doi.org/10.1371/journal.pone.0019082			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559509	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700062
J	Yang, RT; Lenaghan, SC; Wikswo, JP; Zhang, MJ				Yang, Ruoting; Lenaghan, Scott C.; Wikswo, John P.; Zhang, Mingjun			External Control of the GAL Network in S. cerevisiae: A View from Control Theory	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; SENSITIVITY-ANALYSIS; GLUCOSE REPRESSION; MODELS; SWITCH	While there is a vast literature on the control systems that cells utilize to regulate their own state, there is little published work on the formal application of control theory to the external regulation of cellular functions. This paper chooses the GAL network in S. cerevisiae as a well understood benchmark example to demonstrate how control theory can be employed to regulate intracellular mRNA levels via extracellular galactose. Based on a mathematical model reduced from the GAL network, we have demonstrated that a galactose dose necessary to drive and maintain the desired GAL genes' mRNA levels can be calculated in an analytic form. And thus, a proportional feedback control can be designed to precisely regulate the level of mRNA. The benefits of the proposed feedback control are extensively investigated in terms of stability and parameter sensitivity. This paper demonstrates that feedback control can both significantly accelerate the process to precisely regulate mRNA levels and enhance the robustness of the overall cellular control system.	[Yang, Ruoting; Lenaghan, Scott C.; Zhang, Mingjun] Univ Tennessee, Dept Mech Aerosp & Biomed Engn, Knoxville, TN 37996 USA; [Wikswo, John P.] Vanderbilt Univ, Vanderbilt Inst Integrat Biosyst Res & Educ, Dept Biomed Engn, Dept Mol Physiol & Biophys, Nashville, TN USA; [Wikswo, John P.] Vanderbilt Univ, Dept Phys & Astron, Nashville, TN USA	University of Tennessee System; University of Tennessee Knoxville; Vanderbilt University; Vanderbilt University	Yang, RT (corresponding author), Univ Tennessee, Dept Mech Aerosp & Biomed Engn, Knoxville, TN 37996 USA.	mjzhang@utk.edu		Lenaghan, Scott/0000-0002-7539-1726	National Academies Keck Futures Initiative; US Defense Threat Reduction Agency [HDTRA-09-1-0013]; NIH National Institute on Drug Abuse [RC2DA028981]; Vanderbilt Institute for Integrative Biosystems Research and Education; NATIONAL INSTITUTE ON DRUG ABUSE [RC2DA028981] Funding Source: NIH RePORTER	National Academies Keck Futures Initiative; US Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); NIH National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Vanderbilt Institute for Integrative Biosystems Research and Education; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors would like to thank the National Academies Keck Futures Initiative for its support of this research, as well as the US Defense Threat Reduction Agency (HDTRA-09-1-0013), the NIH National Institute on Drug Abuse (RC2DA028981), and the Vanderbilt Institute for Integrative Biosystems Research and Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett MR, 2008, NATURE; Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Bornholdt S, 2005, SCIENCE, V310, P449, DOI 10.1126/science.1119959; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cantone I, 2009, CELL, V137, P172, DOI 10.1016/j.cell.2009.01.055; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; de Atauri P., 2004, Systems Biology, V1, P28, DOI 10.1049/sb:20045013; Diep CQ, 2008, GENETICS, V178, P725, DOI 10.1534/genetics.107.074799; Draper N.R., 1998, APPL REGRESSION ANAL, P79; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Horak J, 1997, J BACTERIOL, V179, P1541, DOI 10.1128/jb.179.5.1541-1549.1997; JOHNSTON M, 1994, MOL CELL BIOL, V14, P3834, DOI 10.1128/MCB.14.6.3834; McLean JA, 2010, ELECTROSPRAY MALDI M, P411; Menolascina F, 2010, ATL GA US P 49 IEEE; Menolascina F, AUTOMATICA IN PRESS; Ramsey SA, 2006, NAT GENET, V38, P1082, DOI 10.1038/ng1869; Saltelli A, 1999, TECHNOMETRICS, V41, P39, DOI 10.2307/1270993; Saltelli A, 2000, STAT SCI, V15, P377, DOI 10.1214/ss/1009213004; Sobol IM, 2001, MATH COMPUT SIMULAT, V55, P271, DOI 10.1016/S0378-4754(00)00270-6; TRUMBLY RJ, 1992, MOL MICROBIOL, V6, P15, DOI 10.1111/j.1365-2958.1992.tb00832.x; Varma A, 1999, PARAMETERIC SENSITIV; Wikswo JP, 2006, IEE P-NANOBIOTECHNOL, V153, P81, DOI 10.1049/ip-nbt:20050045; Yano KI, 1997, P NATL ACAD SCI USA, V94, P1721, DOI 10.1073/pnas.94.5.1721	24	7	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19353	10.1371/journal.pone.0019353	http://dx.doi.org/10.1371/journal.pone.0019353			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559408	Green Published, gold			2022-12-27	WOS:000290024700145
J	Ashourian, P; Loewenstein, Y				Ashourian, Paymon; Loewenstein, Yonatan			Bayesian Inference Underlies the Contraction Bias in Delayed Comparison Tasks	PLOS ONE			English	Article							PERCEPTION; MOTION; INTEGRATION; EXPECTATIONS; CATEGORIES; COGNITION; JUDGMENT; MODEL	Delayed comparison tasks are widely used in the study of working memory and perception in psychology and neuroscience. It has long been known, however, that decisions in these tasks are biased. When the two stimuli in a delayed comparison trial are small in magnitude, subjects tend to report that the first stimulus is larger than the second stimulus. In contrast, subjects tend to report that the second stimulus is larger than the first when the stimuli are relatively large. Here we study the computational principles underlying this bias, also known as the contraction bias. We propose that the contraction bias results from a Bayesian computation in which a noisy representation of a magnitude is combined with a-priori information about the distribution of magnitudes to optimize performance. We test our hypothesis on choice behavior in a visual delayed comparison experiment by studying the effect of (i) changing the prior distribution and (ii) changing the uncertainty in the memorized stimulus. We show that choice behavior in both manipulations is consistent with the performance of an observer who uses a Bayesian inference in order to improve performance. Moreover, our results suggest that the contraction bias arises during memory retrieval/decision making and not during memory encoding. These results support the notion that the contraction bias illusion can be understood as resulting from optimality considerations.	[Ashourian, Paymon] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Loewenstein, Yonatan] Hebrew Univ Jerusalem, Dept Neurobiol, Edmond & Lily Safra Ctr Brain Sci, Interdisciplinary Ctr Neural Computat, Jerusalem, Israel; [Loewenstein, Yonatan] Hebrew Univ Jerusalem, Ctr Study Rat, Jerusalem, Israel	Massachusetts Institute of Technology (MIT); Hebrew University of Jerusalem; Hebrew University of Jerusalem	Ashourian, P (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	paymon@mit.edu; yonatan@huji.ac.il			National Institute for Psychobiology in Israel; Israel Science Foundation [868/08]	National Institute for Psychobiology in Israel; Israel Science Foundation(Israel Science Foundation)	This research was supported by grants from the National Institute for Psychobiology in Israel - founded by The Charles E. Smith Family - and from the Israel Science Foundation (grant No. 868/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; BERLINER JE, 1977, J ACOUST SOC AM, V61, P1577, DOI 10.1121/1.381471; Chalk M, 2010, J VISION, V10, DOI 10.1167/10.8.2; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Fechner G. T., 1860, ELEMENTE PSYCHOPHYSI; Griffiths TL, 2006, PSYCHOL SCI, V17, P767, DOI 10.1111/j.1467-9280.2006.01780.x; HELLSTROM A, 1985, PSYCHOL BULL, V97, P35, DOI 10.1037/0033-2909.97.1.35; Helson H, 1964, ADAPTATION LEVEL THE; HOLLINGWORTH HL, 2010, METHODS, V7, P461; HOSSEINI P, 2005, 2005 NEUR M PLANN WA; Huttenlocher J, 2000, J EXP PSYCHOL GEN, V129, P220, DOI 10.1037//0096-3445.129.2.220; Jacobs RA, 1999, VISION RES, V39, P3621, DOI 10.1016/S0042-6989(99)00088-7; Jazayeri M, 2010, NAT NEUROSCI, V13, P1020, DOI 10.1038/nn.2590; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; MARKS LE, 1993, J EXP PSYCHOL HUMAN, V19, P227, DOI 10.1037/0096-1523.19.2.227; Miller EK, 2002, PHILOS T R SOC B, V357, P1123, DOI 10.1098/rstb.2002.1099; PARDUCCI A, 1965, PSYCHOL REV, V72, P407, DOI 10.1037/h0022602; Poulton E.C., 1989, BIAS QUANTIFYING JUD; RAVIV O, 2009, J MOL NEUROSCIENC S1, V39, pS3; Schwartz E, 2008, 2008 NEUR M PLANN WA; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; Trommershauser J, 2005, J NEUROSCI, V25, P7169, DOI 10.1523/JNEUROSCI.1906-05.2005; van Ee R, 2003, J OPT SOC AM A, V20, P1398, DOI 10.1364/JOSAA.20.001398; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; Welchman AE, 2008, P NATL ACAD SCI USA, V105, P12087, DOI 10.1073/pnas.0804378105; Wilken P, 2004, J VISION, V4, P1120, DOI 10.1167/4.12.11; Yeshurun Y, 2008, VISION RES, V48, P1837, DOI 10.1016/j.visres.2008.05.008	28	59	59	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19551	10.1371/journal.pone.0019551	http://dx.doi.org/10.1371/journal.pone.0019551			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	763CL	21589867	Green Published, gold, Green Submitted			2022-12-27	WOS:000290531100017
J	Han, DH; Hancock, CR; Jung, SR; Higashida, K; Kim, SH; Holloszy, JO				Han, Dong-Ho; Hancock, Chad R.; Jung, Su Ryun; Higashida, Kazuhiko; Kim, Sang Hyun; Holloszy, John O.			Deficiency of the Mitochondrial Electron Transport Chain in Muscle Does Not Cause Insulin Resistance	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; RAT SKELETAL-MUSCLE; HIGH-FAT DIET; GLUCOSE-TRANSPORT; OXIDATIVE-PHOSPHORYLATION; GENE-EXPRESSION; IRON-DEFICIENCY; ACID OXIDATION; LIPID-CONTENT; IN-VITRO	Background: It has been proposed that muscle insulin resistance in type 2 diabetes is due to a selective decrease in the components of the mitochondrial electron transport chain and results from accumulation of toxic products of incomplete fat oxidation. The purpose of the present study was to test this hypothesis. Methodology/Principal Findings: Rats were made severely iron deficient, by means of an iron-deficient diet. Iron deficiency results in decreases of the iron containing mitochondrial respiratory chain proteins without affecting the enzymes of the fatty acid oxidation pathway. Insulin resistance was induced by feeding iron-deficient and control rats a high fat diet. Skeletal muscle insulin resistance was evaluated by measuring glucose transport activity in soleus muscle strips. Mitochondrial proteins were measured by Western blot. Iron deficiency resulted in a decrease in expression of iron containing proteins of the mitochondrial respiratory chain in muscle. Citrate synthase, a non-iron containing citrate cycle enzyme, and long chain acyl-CoA dehydrogenase (LCAD), used as a marker for the fatty acid oxidation pathway, were unaffected by the iron deficiency. Oleate oxidation by muscle homogenates was increased by high fat feeding and decreased by iron deficiency despite high fat feeding. The high fat diet caused severe insulin resistance of muscle glucose transport. Iron deficiency completely protected against the high fat diet-induced muscle insulin resistance. Conclusions/Significance: The results of the study argue against the hypothesis that a deficiency of the electron transport chain (ETC), and imbalance between the ETC and beta-oxidation pathways, causes muscle insulin resistance.	[Han, Dong-Ho; Hancock, Chad R.; Jung, Su Ryun; Higashida, Kazuhiko; Kim, Sang Hyun; Holloszy, John O.] Washington Univ, Div Geriatr & Nutr Sci, Dept Med, Sch Med, St Louis, MO 63130 USA	Washington University (WUSTL)	Han, DH (corresponding author), Washington Univ, Div Geriatr & Nutr Sci, Dept Med, Sch Med, St Louis, MO 63130 USA.	jhollosz@dom.wustl.edu	Hancock, Chad R./X-4803-2018	Hancock, Chad R./0000-0002-1578-5301	National Institutes of Health [AG000425, DK18986]; American Diabetes Association [DK070425]; Korean Research Foundation [KRF-2008-G00013]; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK070425, P30DK056341, R01DK018986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG000425, Z01AG000425, R01AG000425, R37AG000425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Korean Research Foundation(National Research Foundation of Korea); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by National Institutes of Health Grants AG000425 and DK18986. CRH was supported by an American Diabetes Association Mentor-Based Postdoctoral Fellowship and Individual National Research Service Award DK070425. SRJ was supported by an American Diabetes Association Mentor-Based Postdoctoral Fellowship and by Korean Research Foundation KRF-2008-G00013. KH was supported by a Research Fellow of the Japan Society for the Promotion of Science grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asmann YW, 2006, DIABETES, V55, P3309, DOI 10.2337/db05-1230; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Brown AE, 2008, AM J PHYSIOL-ENDOC M, V294, pE97, DOI 10.1152/ajpendo.00267.2007; CARTIER LJ, 1986, J BIOL CHEM, V261, P3827; De Feyter HM, 2008, EUR J ENDOCRINOL, V158, P643, DOI 10.1530/EJE-07-0756; De Feyter HM, 2008, FASEB J, V22, P3947, DOI 10.1096/fj.08-112318; DENTON RM, 1967, BIOCHEM J, V104, P416, DOI 10.1042/bj1040416; Dressel U, 2003, MOL ENDOCRINOL, V17, P2477, DOI 10.1210/me.2003-0151; Fisher JS, 2002, AM J PHYSIOL-ENDOC M, V282, pE18, DOI 10.1152/ajpendo.2002.282.1.E18; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRAYN KN, 1980, J LIPID RES, V21, P139; Garcia-Roves P, 2007, P NATL ACAD SCI USA, V104, P10709, DOI 10.1073/pnas.0704024104; Han DH, 2004, AM J PHYSIOL-ENDOC M, V286, pE347, DOI 10.1152/ajpendo.00434.2003; Han DH, 1997, DIABETES, V46, P1761, DOI 10.2337/diabetes.46.11.1761; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Hansen PA, 1998, J BIOL CHEM, V273, P26157, DOI 10.1074/jbc.273.40.26157; HANSEN PA, 1994, J APPL PHYSIOL, V76, P979, DOI 10.1152/jappl.1994.76.2.979; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; He J, 2001, DIABETES, V50, P817, DOI 10.2337/diabetes.50.4.817; HENRIKSEN EJ, 1991, ACTA PHYSIOL SCAND, V143, P381, DOI 10.1111/j.1748-1716.1991.tb09249.x; Hernandez-Alvarez MI, 2009, DIABETOLOGIA, V52, P1618, DOI 10.1007/s00125-009-1403-y; Hoeks J, 2008, FEBS LETT, V582, P510, DOI 10.1016/j.febslet.2008.01.013; Holloszy JO, 2009, AM J CLIN NUTR, V89, p463S, DOI 10.3945/ajcn.2008.26717C; Holmes BF, 1999, J APPL PHYSIOL, V87, P1990, DOI 10.1152/jappl.1999.87.5.1990; IJLST L, 1993, ANN CLIN BIOCHEM, V30, P293, DOI 10.1177/000456329303000311; Ishii K, 2009, NAT MED, V15, P259, DOI 10.1038/nm.1910; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kim JY, 2000, AM J PHYSIOL-REG I, V279, pR2057, DOI 10.1152/ajpregu.2000.279.6.R2057; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; MCLANE JA, 1981, AM J PHYSIOL, V241, pC47, DOI 10.1152/ajpcell.1981.241.1.C47; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; Musi N, 2001, AM J PHYSIOL-ENDOC M, V280, pE677, DOI 10.1152/ajpendo.2001.280.5.E677; Nair KS, 2008, DIABETES, V57, P1166, DOI 10.2337/db07-1556; Ojuka EO, 2000, J APPL PHYSIOL, V88, P1072, DOI 10.1152/jappl.2000.88.3.1072; PATTI ME, 2003, PNAS, V100, P104; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Ritov VB, 2010, AM J PHYSIOL-ENDOC M, V298, pE49, DOI 10.1152/ajpendo.00317.2009; ROSHOLT MN, 1994, AM J PHYSIOL, V266, pR95, DOI 10.1152/ajpregu.1994.266.1.R95; Sreekumar R, 2002, DIABETES, V51, P1913, DOI 10.2337/diabetes.51.6.1913; STORLIEN LH, 1986, AM J PHYSIOL, V251, pE576, DOI 10.1152/ajpendo.1986.251.5.E576; STORLIEN LH, 1991, DIABETES, V40, P280, DOI 10.2337/diabetes.40.2.280; Taylor R, 2004, NEW ENGL J MED, V350, P639, DOI 10.1056/NEJMp038239; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Wredenberg A, 2006, BIOCHEM BIOPH RES CO, V350, P202, DOI 10.1016/j.bbrc.2006.09.029; YOUNG DA, 1986, J BIOL CHEM, V261, P6049	52	52	53	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19739	10.1371/journal.pone.0019739	http://dx.doi.org/10.1371/journal.pone.0019739			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589859	Green Published, gold, Green Submitted			2022-12-27	WOS:000290531100025
J	Carrion, V; Donlan, CJ; Campbell, KJ; Lavoie, C; Cruz, F				Carrion, Victor; Donlan, C. Josh; Campbell, Karl J.; Lavoie, Christian; Cruz, Felipe			Archipelago-Wide Island Restoration in the Galapagos Islands: Reducing Costs of Invasive Mammal Eradication Programs and Reinvasion Risk	PLOS ONE			English	Article							FERAL GOATS; SEABIRDS; RATS	Invasive alien mammals are the major driver of biodiversity loss and ecosystem degradation on islands. Over the past three decades, invasive mammal eradication from islands has become one of society's most powerful tools for preventing extinction of insular endemics and restoring insular ecosystems. As practitioners tackle larger islands for restoration, three factors will heavily influence success and outcomes: the degree of local support, the ability to mitigate for non-target impacts, and the ability to eradicate non-native species more cost-effectively. Investments in removing invasive species, however, must be weighed against the risk of reintroduction. One way to reduce reintroduction risks is to eradicate the target invasive species from an entire archipelago, and thus eliminate readily available sources. We illustrate the costs and benefits of this approach with the efforts to remove invasive goats from the Galapagos Islands. Project Isabela, the world's largest island restoration effort to date, removed >140,000 goats from >500,000 ha for a cost of US$ 10.5 million. Leveraging the capacity built during Project Isabela, and given that goat reintroductions have been common over the past decade, we implemented an archipelago-wide goat eradication strategy. Feral goats remain on three islands in the archipelago, and removal efforts are underway. Efforts on the Galapagos Islands demonstrate that for some species, island size is no longer the limiting factor with respect to eradication. Rather, bureaucratic processes, financing, political will, and stakeholder approval appear to be the new challenges. Eradication efforts have delivered a suite of biodiversity benefits that are in the process of revealing themselves. The costs of rectifying intentional reintroductions are high in terms of financial and human resources. Reducing the archipelago-wide goat density to low levels is a technical approach to reducing reintroduction risk in the short-term, and is being complemented with a longer-term social approach focused on education and governance.	[Carrion, Victor; Campbell, Karl J.; Lavoie, Christian; Cruz, Felipe] Galapagos Natl Pk Serv, Galapagos, Ecuador; [Donlan, C. Josh] Adv Conservat Strategies, Midway, UT USA; [Donlan, C. Josh] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA; [Campbell, Karl J.; Lavoie, Christian; Cruz, Felipe] Charles Darwin Fdn, Quito, Ecuador; [Campbell, Karl J.] Univ Queensland, Sch Integrat Syst, Gatton, Qld, Australia; [Campbell, Karl J.] Isl Conservat, Santa Cruz, CA USA; [Lavoie, Christian] United Nations Dev Program, Quito, Ecuador	Cornell University; University of Queensland	Carrion, V (corresponding author), Galapagos Natl Pk Serv, Galapagos, Ecuador.	jdonlan@advancedconservation.org			GNPS; CDF; Charles Darwin Foundation (now Galapagos Conservancy); European Friends of Galapagos Organizations; Stewart Foundation; Merrill Foundation; Lindblad Expeditions [ECU/00/G31]; Galapagos Conservancy	GNPS; CDF; Charles Darwin Foundation (now Galapagos Conservancy); European Friends of Galapagos Organizations; Stewart Foundation; Merrill Foundation; Lindblad Expeditions; Galapagos Conservancy	Funding was provided by GNPS, CDF, Charles Darwin Foundation (now Galapagos Conservancy), European Friends of Galapagos Organizations, Stewart Foundation, Merrill Foundation and Lindblad Expeditions (Galapagos Conservation Fund) in collaboration with Project ECU/00/G31 "Control of Invasive Species in the Galapagos Archipelago'', a donation from the Global Environment Facility (GEF) to the Ecuadorian Government, represented by the Ministry of Environment. The authors also thank the Galapagos Conservancy for their support in financing this publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkrim J, 2007, CONSERV BIOL, V21, P719, DOI 10.1111/j.1523-1739.2007.00696.x; Aguirre-Munoz A, 2008, AMBIO, V37, P101, DOI 10.1579/0044-7447(2008)37[101:HCIMEF]2.0.CO;2; ALGAR D, 2010, J ROYAL SOC W AUSTR, V93; Atkinson R., 2008, GALAPAGOS REPORT 200, P121; BONNAUD E, 2011, BIOL INVASI IN PRESS; Campbell K, 2005, CONSERV BIOL, V19, P1362, DOI 10.1111/j.1523-1739.2005.00228.x; Campbell K, 2004, ORYX, V38, P328, DOI 10.1017/S0030605304000572; Campbell KJ, 2007, APPL ANIM BEHAV SCI, V102, P12, DOI 10.1016/j.applanim.2006.03.003; Campbell KJ, 2005, WILDLIFE RES, V32, P737, DOI 10.1071/WR05033; CAMPBELL KJ, 2007, THESIS U QUEENSLAND; Carrion V, 2007, BIODIVERS CONSERV, V16, P437, DOI 10.1007/s10531-005-5825-7; Cruz F, 2005, BIOL CONSERV, V121, P473, DOI 10.1016/j.biocon.2004.05.018; Cruz F, 2009, J WILDLIFE MANAGE, V73, P191, DOI 10.2193/2007-551; Donlan CJ, 2008, BIOL INVASIONS, V10, P1053, DOI 10.1007/s10530-007-9183-0; Donlan CJ, 2007, BIOL CONSERV, V138, P520, DOI 10.1016/j.biocon.2007.05.013; DONLAN CJ, 2010, TRENDS ECOL EVOL, V26, P624; DONLAN CJ, 2008, STATE WILD GLOBAL PO, P226; Howald G, 2007, CONSERV BIOL, V21, P1258, DOI 10.1111/j.1523-1739.2007.00755.x; *IS PROJ, 1997, PLAN PROT NO IS IS G; Jones HP, 2008, CONSERV BIOL, V22, P16, DOI 10.1111/j.1523-1739.2007.00859.x; KEEGAN DR, 1994, WILDLIFE SOC B, V22, P56; Keitt B., 2011, ISLAND INVASIVES ERA, P74; Lavoie C., 2007, THEMATIC ATLAS PROJE; Lavoie C, 2007, BIOL INVASIONS, V9, P139, DOI 10.1007/s10530-006-9011-y; McClelland P, 2002, NZ GEOGRAPHIC, V58, P86; Morrison SA, 2007, FRONT ECOL ENVIRON, V5, P271, DOI 10.1890/1540-9295(2007)5[271:FTDAEE]2.0.CO;2; OPPEL S, 2011, CONSERVATIO IN PRESS; Rainbolt Raymond E., 1999, Biological Invasions, V1, P363, DOI 10.1023/A:1010024429207; RAMSEY DSL, 2011, NZ J ECOL IN PRESS, V35; Rosenberg D.K., 1990, MONOGR SYST BOT MISS, V32, P169; Russell JC, 2008, WILDLIFE RES, V35, P215, DOI 10.1071/WR07032; SPRINGER K, 2011, ISLAND INVASIVES ERA; TAYLOR D, 1988, WILDLIFE SOC B, V16, P297; Towns DR, 2006, BIOL INVASIONS, V8, P863, DOI 10.1007/s10530-005-0421-z; TYE A, 2007, INFORM GALAPAGOS 200, P101; VEITCH CR, TURNING TIDE ERADICA	36	65	65	3	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e18835	10.1371/journal.pone.0018835	http://dx.doi.org/10.1371/journal.pone.0018835			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589656	gold, Green Published, Green Submitted			2022-12-27	WOS:000290483600002
J	Cuthbert, R; Taggart, MA; Prakash, V; Saini, M; Swarup, D; Upreti, S; Mateo, R; Chakraborty, SS; Deori, P; Green, RE				Cuthbert, Richard; Taggart, Mark A.; Prakash, Vibhu; Saini, Mohini; Swarup, Devendra; Upreti, Suchitra; Mateo, Rafael; Chakraborty, Soumya Sunder; Deori, Parag; Green, Rhys E.			Effectiveness of Action in India to Reduce Exposure of Gyps Vultures to the Toxic Veterinary Drug Diclofenac	PLOS ONE			English	Article							POPULATION DECLINES; RESIDUES; CARCASSES	Contamination of their carrion food supply with the non-steroidal anti-inflammatory drug diclofenac has caused rapid population declines across the Indian subcontinent of three species of Gyps vultures endemic to South Asia. The governments of India, Pakistan and Nepal took action in 2006 to prevent the veterinary use of diclofenac on domesticated livestock, the route by which contamination occurs. We analyse data from three surveys of the prevalence and concentration of diclofenac residues in carcasses of domesticated ungulates in India, carried out before and after the implementation of a ban on veterinary use. There was little change in the prevalence and concentration of diclofenac between a survey before the ban and one conducted soon after its implementation, with the percentage of carcasses containing diclofenac in these surveys estimated at 10.8 and 10.7%, respectively. However, both the prevalence and concentration of diclofenac had fallen markedly 7-31 months after the implementation of the ban, with the true prevalence in this third survey estimated at 6.5%. Modelling of the impact of this reduction in diclofenac on the expected rate of decline of the oriental white-backed vulture (Gyps bengalensis) in India indicates that the decline rate has decreased to 40% of the rate before the ban, but is still likely to be rapid (about 18% year(-1)). Hence, further efforts to remove diclofenac from vulture food are still needed if the future recovery or successful reintroduction of vultures is to be feasible.	[Cuthbert, Richard; Green, Rhys E.] Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; [Taggart, Mark A.; Mateo, Rafael] CSIC UCLM JCCM, IREC, Inst Invest Recursos Cineget, Ciudad Real, Spain; [Taggart, Mark A.] Univ Aberdeen, Dept Plant & Soil Sci, Sch Biol Sci, Aberdeen, Scotland; [Prakash, Vibhu; Chakraborty, Soumya Sunder; Deori, Parag] Bombay Nat Hist Soc, Bombay, Maharashtra, India; [Saini, Mohini; Swarup, Devendra; Upreti, Suchitra] Indian Vet Res Inst, Ctr Wildlife Conservat Management & Dis Surveilla, Izatnagar 243122, Uttar Pradesh, India; [Green, Rhys E.] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge, England	Royal Society for Protection of Birds; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; University of Aberdeen; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; University of Cambridge	Cuthbert, R (corresponding author), Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England.	reg29@cam.ac.uk	Mateo, Rafael/AAU-1480-2020; Mateo, Rafael/A-3117-2011	Mateo, Rafael/0000-0003-1307-9152; Mateo, Rafael/0000-0003-1307-9152; Taggart, Mark/0000-0002-0649-8490	Darwin Initiative of the United Kingdom government; Royal Society for the Protection of Birds (RSPB)	Darwin Initiative of the United Kingdom government; Royal Society for the Protection of Birds (RSPB)	This project was funded by the Darwin Initiative of the United Kingdom government http://darwin.defra.gov.uk/ and the Royal Society for the Protection of Birds (RSPB) http://www.rspb.org.uk. RC and REG are authors of the paper and members of the research staff of the Conservation Science Department of RSPB. Beyond this, the funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Arshad M, 2009, J ORNITHOL, V150, P495, DOI 10.1007/s10336-008-0368-9; Calix M., 2018, EUROPEAN RED LIST SA; Gilbert M, 2006, ORYX, V40, P388, DOI 10.1017/S0030605306001347; Green RE, 2004, J APPL ECOL, V41, P793, DOI 10.1111/j.0021-8901.2004.00954.x; Green RE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000686; Jackson AL, 2008, BIOL LETTERS, V4, P311, DOI 10.1098/rsbl.2008.0038; Kalbfleisch JG., 1985, PROBABILITY STAT INF, DOI 10.1007/978-1-4612-1096-2; Meteyer CU, 2005, J WILDLIFE DIS, V41, P707, DOI 10.7589/0090-3558-41.4.707; Naidoo V, 2009, REGUL TOXICOL PHARM, V53, P205, DOI 10.1016/j.yrtph.2009.01.010; Naidoo V, 2010, BIOL LETTERS, V6, P339, DOI 10.1098/rsbl.2009.0818; Oaks JL, 2004, NATURE, V427, P630, DOI 10.1038/nature02317; Pain DJ, 2008, BIRD CONSERV INT, V18, pS30, DOI 10.1017/S0959270908000324; Prakash V., 2007, J BOMBAY NAT HIST SO, V104, P129; Risebrough Robert W., 2006, Journal of the Bombay Natural History Society, V103, P239; Seigel S., 1988, NONPARAMETRIC STAT B; Shultz S, 2004, P ROY SOC B-BIOL SCI, V271, pS458, DOI 10.1098/rsbl.2004.0223; Swan G, 2006, PLOS BIOL, V4, P395, DOI 10.1371/journal.pbio.0040066; Swan GE, 2006, BIOL LETT-UK, V2, P279, DOI 10.1098/rsbl.2005.0425; Swarup D, 2007, ANIM CONSERV, V10, P192, DOI 10.1111/j.1469-1795.2006.00086.x; Taggart MA, 2007, ENVIRON INT, V33, P759, DOI 10.1016/j.envint.2007.02.010; Taggart MA, 2009, ENVIRON SCI TECHNOL, V43, P4561, DOI 10.1021/es9002026; [No title captured]	22	61	67	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19069	10.1371/journal.pone.0019069	http://dx.doi.org/10.1371/journal.pone.0019069			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589920	Green Published, gold, Green Submitted			2022-12-27	WOS:000290483600007
J	Piazzon, M; Larrinaga, AR; Santamaria, L				Piazzon, Martin; Larrinaga, Asier R.; Santamaria, Luis			Are Nested Networks More Robust to Disturbance? A Test Using Epiphyte-Tree, Comensalistic Networks	PLOS ONE			English	Article							VASCULAR EPIPHYTES; HOST PREFERENCES; PLANT; POLLINATION; SPECIALIZATION; BIODIVERSITY; DYNAMICS; FOREST; FRAGMENTATION; CONSEQUENCES	Recent research on ecological networks suggests that mutualistic networks are more nested than antagonistic ones and, as a result, they are more robust against chains of extinctions caused by disturbances. We evaluate whether mutualistic networks are more nested than comensalistic and antagonistic networks, and whether highly nested, host-epiphyte comensalistic networks fit the prediction of high robustness against disturbance. A review of 59 networks including mutualistic, antagonistic and comensalistic relationships showed that comensalistic networks are significantly more nested than antagonistic and mutualistic networks, which did not differ between themselves. Epiphyte-host networks from old-growth forests differed from those from disturbed forest in several topological parameters based on both qualitative and quantitative matrices. Network robustness increased with network size, but the slope of this relationship varied with nestedness and connectance. Our results indicate that interaction networks show complex responses to disturbances, which influence their topology and indirectly affect their robustness against species extinctions.	[Piazzon, Martin; Larrinaga, Asier R.; Santamaria, Luis] CSIC UIB, IMEDEA, Mediterranean Inst Adv Studies, Mallorca, Balearic Isl, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Barcelona	Piazzon, M (corresponding author), CSIC UIB, IMEDEA, Mediterranean Inst Adv Studies, C Miquel Marques 21, Mallorca, Balearic Isl, Spain.	martinpiazzon@gmail.com	Larrinaga, Asier/B-3826-2013; Santamaria, Luis/C-1438-2012	Larrinaga, Asier/0000-0001-6813-8784; Santamaria, Luis/0000-0002-5072-2912	Banco Bilbao Vizcaya Argentaria Foundation; CSIC, Spain	Banco Bilbao Vizcaya Argentaria Foundation; CSIC, Spain	This work was funded by the Banco Bilbao Vizcaya Argentaria Foundation. Martin Piazzon predoctoral grant is provided by JAE program (CSIC, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2008, PLOS BIOL, V6, P396, DOI 10.1371/journal.pbio.0060031; Alarcon R, 2008, OIKOS, V117, P1796, DOI 10.1111/j.0030-1299.2008.16987.x; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2006, SFI S SCI C, P143; Bascompte J, 2010, SCIENCE, V329, P765, DOI 10.1126/science.1194255; Benzing D.H., 1990, VASCULAR EPIPHYTES; BENZING DH, 1987, ANN MO BOT GARD, V74, P183, DOI 10.2307/2399394; Burgos E, 2007, J THEOR BIOL, V249, P307, DOI 10.1016/j.jtbi.2007.07.030; Burns KC, 2007, J ECOL, V95, P1142, DOI 10.1111/j.1365-2745.2007.01267.x; Burns KC, 2005, AUSTRAL ECOL, V30, P891; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Echeverria C, 2008, ECOL MODEL, V212, P439, DOI 10.1016/j.ecolmodel.2007.10.045; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Fortuna MA, 2006, ECOL LETT, V9, P278, DOI 10.1111/j.1461-0248.2005.00868.x; Gomes LGL, 2008, BIOL CONSERV, V141, P860, DOI 10.1016/j.biocon.2008.01.007; Gomez JM, 2010, NATURE, V465, P918, DOI 10.1038/nature09113; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Gotelli NJ, 2004, ECOSIM NULL MODELS S; Guimaraes PR, 2006, P ROY SOC B-BIOL SCI, V273, P2041, DOI 10.1098/rspb.2006.3548; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; JACKSON DA, 1995, ECOSCIENCE, V2, P297, DOI 10.1080/11956860.1995.11682297; JORDANO P, 1987, AM NAT, V129, P657, DOI 10.1086/284665; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Kreft H, 2004, J BIOGEOGR, V31, P1463, DOI 10.1111/j.1365-2699.2004.01083.x; Laube S, 2003, FUNCT ECOL, V17, P598, DOI 10.1046/j.1365-2435.2003.00760.x; Lopez-Villalobos A, 2008, PLANT ECOL, V198, P265, DOI 10.1007/s11258-008-9402-5; Mehltreter K, 2005, J TROP ECOL, V21, P651, DOI 10.1017/S0266467405002683; Okuyama T, 2008, ECOL LETT, V11, P208, DOI 10.1111/j.1461-0248.2007.01137.x; Olesen JM, 2008, ECOLOGY, V89, P1573, DOI 10.1890/07-0451.1; Ollerton J, 2007, P ROY SOC B-BIOL SCI, V274, P591, DOI 10.1098/rspb.2006.3758; Peres-Neto PR, 2001, OECOLOGIA, V129, P169, DOI 10.1007/s004420100720; Petanidou T, 2008, ECOL LETT, V11, P564, DOI 10.1111/j.1461-0248.2008.01170.x; Prado PI, 2004, J ANIM ECOL, V73, P1168, DOI 10.1111/j.0021-8790.2004.00891.x; R Development Core Team, 2007, R LANG ENV STAT COMP; Rodriguez-Cabal MA, 2007, BIOL CONSERV, V139, P195, DOI 10.1016/j.biocon.2007.06.014; Rodriguez-Girones MA, 2006, J BIOGEOGR, V33, P924, DOI 10.1111/j.1365-2699.2006.01444.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Santamaria L, 2007, PLOS BIOL, V5, P354, DOI 10.1371/journal.pbio.0050031; Snall T, 2005, ECOLOGY, V86, P106, DOI 10.1890/04-0531; Sole RV, 2001, P ROY SOC B-BIOL SCI, V268, P2039, DOI 10.1098/rspb.2001.1767; Taki H, 2007, BIODIVERS CONSERV, V16, P3147, DOI 10.1007/s10531-007-9168-4; Talley SM, 1996, ECOLOGY, V77, P1271, DOI 10.2307/2265596; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Thompson J. N., 2005, INTERSPEC INTERACT; Vazquez DP, 2009, ECOLOGY, V90, P2039, DOI 10.1890/08-1837.1; Vazquez DP, 2004, ECOLOGY, V85, P1251, DOI 10.1890/03-3112; Vazquez DP, 2002, AM NAT, V159, P606, DOI 10.1086/339991; Vazquez DP, 2004, ECOL MONOGR, V74, P281, DOI 10.1890/02-4055; Willson MF, 1996, REV CHIL HIST NAT, V69, P149; Zotz G, 2001, J EXP BOT, V52, P2067, DOI 10.1093/jexbot/52.364.2067	52	34	35	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19637	10.1371/journal.pone.0019637	http://dx.doi.org/10.1371/journal.pone.0019637			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589931	Green Submitted, Green Published, gold			2022-12-27	WOS:000290483600018
J	Guimaraes, AMS; Santos, AP; SanMiguel, P; Walter, T; Timenetsky, J; Messick, JB				Guimaraes, Ana M. S.; Santos, Andrea P.; SanMiguel, Phillip; Walter, Thomas; Timenetsky, Jorge; Messick, Joanne B.			Complete Genome Sequence of Mycoplasma suis and Insights into Its Biology and Adaption to an Erythrocyte Niche	PLOS ONE			English	Article							DEPENDENT GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; INTRAERYTHROCYTIC MALARIA PARASITE; GRAM-POSITIVE BACTERIA; RIBOSOMAL-RNA GENE; EPERYTHROZOON-SUIS; FUNCTIONAL-CHARACTERIZATION; HOMOLOGOUS RECOMBINATION; UREAPLASMA-UREALYTICUM; HAEMOBARTONELLA-FELIS; IMMUNOGENIC PROTEIN	Mycoplasma suis, the causative agent of porcine infectious anemia, has never been cultured in vitro and mechanisms by which it causes disease are poorly understood. Thus, the objective herein was to use whole genome sequencing and analysis of M. suis to define pathogenicity mechanisms and biochemical pathways. M. suis was harvested from the blood of an experimentally infected pig. Following DNA extraction and construction of a paired end library, whole-genome sequencing was performed using GS-FLX (454) and Titanium chemistry. Reads on paired-end constructs were assembled using GS De Novo Assembler and gaps closed by primer walking; assembly was validated by PFGE. Glimmer and Manatee Annotation Engine were used to predict and annotate protein-coding sequences (CDS). The M. suis genome consists of a single, 742,431 bp chromosome with low G+C content of 31.1%. A total of 844 CDS, 3 single copies, unlinked rRNA genes and 32 tRNAs were identified. Gene homologies and GC skew graph show that M. suis has a typical Mollicutes oriC. The predicted metabolic pathway is concise, showing evidence of adaptation to blood environment. M. suis is a glycolytic species, obtaining energy through sugars fermentation and ATP-synthase. The pentose-phosphate pathway, metabolism of cofactors and vitamins, pyruvate dehydrogenase and NAD(+) kinase are missing. Thus, ribose, NADH, NADPH and coenzyme A are possibly essential for its growth. M. suis can generate purines from hypoxanthine, which is secreted by RBCs, and cytidine nucleotides from uracil. Toxins orthologs were not identified. We suggest that M. suis may cause disease by scavenging and competing for host nutrients, leading to decreased life-span of RBCs. In summary, genome analysis shows that M. suis is dependent on host cell metabolism and this characteristic is likely to be linked to its pathogenicity. The prediction of essential nutrients will aid the development of in vitro cultivation systems.	[Guimaraes, Ana M. S.; Santos, Andrea P.; Messick, Joanne B.] Purdue Univ, Sch Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Guimaraes, Ana M. S.] Minist Educ, CAPES Fulbright Program, Brasilia, DF, Brazil; [SanMiguel, Phillip] Purdue Univ, Purdue Genom Core Facil, W Lafayette, IN 47907 USA; [Walter, Thomas] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Timenetsky, Jorge] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, BR-05508 Sao Paulo, Brazil	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Universidade de Sao Paulo	Guimaraes, AMS (corresponding author), Purdue Univ, Sch Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA.	anamsg@purdue.edu; jmessic@purdue.edu	Guimaraes, Ana M. S./N-5603-2016; SanMiguel, Phillip J/I-2196-2015; dos Santos, Andrea Pires/O-5371-2019	SanMiguel, Phillip J/0000-0002-3742-9527; dos Santos, Andrea Pires/0000-0002-1037-970X; Guimaraes, Ana/0000-0002-8261-5863	Hatch Act Formula Grant [IND020395]; Brazilian Ministerio da Educacao through Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fulbright Commission - Fulbright-Capes	Hatch Act Formula Grant; Brazilian Ministerio da Educacao through Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fulbright Commission - Fulbright-Capes	Funding support was provided from Hatch Act Formula Grant, project number - IND020395. Funding support for PhD studies was provided by the Brazilian Ministerio da Educacao through Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fulbright Commission - Fulbright-Capes Scholarship Program. CAPES-Fulbright Program, ID 167307/6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDULLAH KM, 1991, J BACTERIOL, V173, P5597, DOI 10.1128/jb.173.18.5597-5603.1991; Arutyunov DY, 2003, BIOCHEM BIOPH RES CO, V300, P149, DOI 10.1016/S0006-291X(02)02802-4; BAKER TA, 1992, ANNU REV GENET, V26, P447; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BenMenachem G, 1997, MICROBIOL-SGM, V143, P1933, DOI 10.1099/00221287-143-6-1933; Berent LM, 2003, INFECT IMMUN, V71, P3657, DOI 10.1128/IAI.71.6.3657-3662.2003; Bizarro CV, 2007, GENET MOL BIOL, V30, P190, DOI 10.1590/S1415-47572007000200005; BOYD DA, 1995, J BACTERIOL, V177, P2622, DOI 10.1128/jb.177.10.2622-2627.1995; BROWN DR, 2011, BERGEYS MANUAL SYSTE, P639; BROWNBACK A, 1981, VET MED SM ANIM CLIN, V76, P375; Caspersen K, 2002, INFECT IMMUN, V70, P1230, DOI 10.1128/IAI.70.3.1230-1234.2002; Chambaud I, 2001, NUCLEIC ACIDS RES, V29, P2145, DOI 10.1093/nar/29.10.2145; CHANG CJ, 1984, J BACTERIOL, V160, P488, DOI 10.1128/JB.160.1.488-490.1984; Chopra-Dewasthaly R, 2005, FEMS MICROBIOL LETT, V253, P89, DOI 10.1016/j.femsle.2005.09.021; Citti C, 2010, FUTURE MICROBIOL, V5, P1073, DOI 10.2217/FMB.10.71; Clark GW, 2010, BIOCHEM CELL BIOL, V88, P185, DOI [10.1139/o09-157, 10.1139/O09-157]; Commans S, 1999, FEMS MICROBIOL REV, V23, P335, DOI 10.1111/j.1574-6976.1999.tb00403.x; Cordova CMM, 2002, J BACTERIOL, V184, P5426, DOI 10.1128/JB.184.19.5426-5435.2002; D'Alessandro A, 2010, J PROTEOME RES, V9, P144, DOI 10.1021/pr900831f; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Downie MJ, 2008, INT J PARASITOL, V38, P203, DOI 10.1016/j.ijpara.2007.07.005; Downie MJ, 2008, EUKARYOT CELL, V7, P1231, DOI 10.1128/EC.00159-08; Hotopp JCD, 2006, PLOS GENET, V2, P208, DOI 10.1371/journal.pgen.0020021; Dybvig K, 2008, INFECT IMMUN, V76, P4000, DOI 10.1128/IAI.00516-08; EDWARD DGF, 1953, J GEN MICROBIOL, V8, P256, DOI 10.1099/00221287-8-2-256; Felder KM, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-18; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; FURNESS G, 1977, J INFECT DIS, V135, P507, DOI 10.1093/infdis/135.4.507; Groebel K, 2009, INFECT IMMUN, V77, P576, DOI 10.1128/IAI.00773-08; Guimaraes AMS, 2007, VET REC, V160, P50, DOI 10.1136/vr.160.2.50; HALDIMANN A, 1993, J GEN MICROBIOL, V139, P317, DOI 10.1099/00221287-139-2-317; HEINRITZI K, 1992, BERL MUNCH TIERARZTL, V105, P380; Henderson JP, 1997, VET REC, V140, P144, DOI 10.1136/vr.140.6.144; HENRY SC, 1979, J AM VET MED ASSOC, V174, P601; Hoelzle LE, 2007, FEMS IMMUNOL MED MIC, V49, P215, DOI 10.1111/j.1574-695X.2006.00184.x; Hsu T, 1998, INFECT IMMUN, V66, P4762, DOI 10.1128/IAI.66.10.4762-4766.1998; HU PC, 1987, INFECT IMMUN, V55, P1126, DOI 10.1128/IAI.55.5.1126-1131.1987; Iddar A, 2005, INT MICROBIOL, V8, P251; Iddar A, 2002, PROTEIN EXPRES PURIF, V25, P519, DOI 10.1016/S1046-5928(02)00032-3; Jaffe JD, 2004, GENOME RES, V14, P1447, DOI 10.1101/gr.2674004; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Lee SW, 2008, MICROBIOL-SGM, V154, P2571, DOI 10.1099/mic.0.2008/019208-0; Lewthwaite J, 1998, TRENDS MICROBIOL, V6, P426, DOI 10.1016/S0966-842X(98)01362-6; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MAEDE Y, 1978, JPN J VET SCI, V40, P203; MAEDE Y, 1978, JPN J VET SCI, V40, P141; MAYER M, 1921, ARCH SCHIFFS TROP HY, P115; McElhaney Ronald N., 1992, P231; Messick JB, 2000, CAN J MICROBIOL, V46, P1082, DOI 10.1139/cjm-46-11-1082; Messick JB, 2004, VET CLIN PATH, V33, P2, DOI 10.1111/j.1939-165X.2004.tb00342.x; MOULDER JW, 1974, BERGEYS MANUAL DETER, P882; Murray A W, 1970, Prog Nucleic Acid Res Mol Biol, V10, P87; Neimark H, 1997, FEMS MICROBIOL LETT, V156, P287, DOI 10.1111/j.1574-6968.1997.tb12742.x; Neimark H, 2001, INT J SYST EVOL MICR, V51, P891, DOI 10.1099/00207713-51-3-891; Nicolas MF, 2007, GENET MOL BIOL, V30, P202, DOI 10.1590/S1415-47572007000200006; OBERST RD, 1993, J VET DIAGN INVEST, V5, P351, DOI 10.1177/104063879300500308; Oshima K, 2004, NAT GENET, V36, P27, DOI 10.1038/ng1277; Papazisi L, 2003, MICROBIOL-SGM, V149, P2307, DOI 10.1099/mic.0.26427-0; Pei JM, 2001, TRENDS BIOCHEM SCI, V26, P275, DOI 10.1016/S0968-0004(01)01813-8; Pollack J. Dennis, 1992, P181; Pollack J. Dennis, 2002, OMICS A Journal of Integrative Biology, V6, P247, DOI 10.1089/15362310260256909; Pollack JD, 1997, CRIT REV MICROBIOL, V23, P269, DOI 10.3109/10408419709115140; Pollack JD, 2001, TRENDS MICROBIOL, V9, P169, DOI 10.1016/S0966-842X(01)01950-3; RAHMAN O, 2003, PROTEIN SCI, V12, P1652; Rahman O, 2008, WORLD J MICROB BIOT, V24, P2377, DOI 10.1007/s11274-008-9795-2; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; RENAUDIN J, 1995, J BACTERIOL, V177, P2870, DOI 10.1128/jb.177.10.2870-2877.1995; Rikihisa Y, 1997, J CLIN MICROBIOL, V35, P823, DOI 10.1128/JCM.35.4.823-829.1997; Ritzmann M, 2009, VET MICROBIOL, V133, P84, DOI 10.1016/j.vetmic.2008.06.015; ROTTEM S, 1980, BIOCHIM BIOPHYS ACTA, V604, P65, DOI 10.1016/0005-2736(80)90585-4; Sasaki Y, 2002, NUCLEIC ACIDS RES, V30, P5293, DOI 10.1093/nar/gkf667; Saurin W, 1996, MOL MICROBIOL, V22, P389; SCHILLING V, 1928, KLIN WOCHENSCHR, P1854; SPLITTER EJ, 1950, SCIENCE, V111, P513, DOI 10.1126/science.111.2889.513; Viratyosin W, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-38; WANKER EE, 1995, J CELL BIOL, V130, P29, DOI 10.1083/jcb.130.1.29; Yuan CL, 2009, AM J VET RES, V70, P890, DOI 10.2460/ajvr.70.7.890; Yuan CL, 2010, VET MICROBIOL, V142, P303, DOI 10.1016/j.vetmic.2009.10.022; Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263; ZACHARY JF, 1985, VET PATHOL, V22, P164, DOI 10.1177/030098588502200211; Zheng X, 2008, SCI CHINA SER C, V51, P182, DOI 10.1007/s11427-008-0017-9; ZINN GM, 1983, J AM VET MED ASSOC, V182, P369	82	36	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19574	10.1371/journal.pone.0019574	http://dx.doi.org/10.1371/journal.pone.0019574			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21573007	gold, Green Submitted, Green Published			2022-12-27	WOS:000290440200012
J	Yu, YQ; Zhao, F; Guan, SM; Chen, J				Yu, Yao-Qing; Zhao, Feng; Guan, Su-Min; Chen, Jun			Antisense-Mediated Knockdown of Na(V)1.8, but Not Na(V)1.9, Generates Inhibitory Effects on Complete Freund's Adjuvant-Induced Inflammatory Pain in Rat	PLOS ONE			English	Article							GATED SODIUM-CHANNELS; TETRODOTOXIN-RESISTANT; SENSORY NEURONS; NA+ CHANNELS; THERAPEUTIC TARGETS; UP-REGULATION; ION CHANNELS; EXPRESSION; CURRENTS; TRANSMISSION	Tetrodotoxin-resistant (TTX-R) sodium channels Na(V)1.8 and Na(V)1.9 in sensory neurons were known as key pain modulators. Comparing with the widely reported Na(V)1.8, roles of Na(V)1.9 on inflammatory pain are poorly studied by antisense-induced specific gene knockdown. Here, we used molecular, electrophysiological and behavioral methods to examine the effects of antisense oligodeoxynucleotide (AS ODN) targeting Na(V)1.8 and Na(V)1.9 on inflammatory pain. Following complete Freund's adjuvant (CFA) inflammation treatment, Na(V)1.8 and Na(V)1.9 in rat dorsal root ganglion (DRG) up-regulated mRNA and protein expressions and increased sodium current densities. Immunohistochemical data demonstrated that Na(V)1.8 mainly localized in medium and small-sized DRG neurons, whereas Na(V)1.9 only expressed in small-sized DRG neurons. Intrathecal (i.t.) delivery of AS ODN was used to down-regulate Na(V)1.8 or Na(V)1.9 expressions confirmed by immunohistochemistry and western blot. Unexpectedly, behavioral tests showed that only Na(V)1.8 AS ODN, but not Na(V)1.9 AS ODN could reverse CFA-induced heat and mechanical hypersensitivity. Our data indicated that TTX-R sodium channels Na(V)1.8 and Na(V)1.9 in primary sensory neurons played distinct roles in CFA-induced inflammatory pain and suggested that antisense oligodeoxynucleotide-mediated blocking of key pain modulator might point toward a potential treatment strategy against certain types of inflammatory pain.	[Yu, Yao-Qing; Zhao, Feng; Chen, Jun] Fourth Mil Med Univ, Inst Biomed Sci Pain, Xian 710032, Peoples R China; [Yu, Yao-Qing; Zhao, Feng; Chen, Jun] Fourth Mil Med Univ, Tangdu Hosp, Inst Funct Brain Disorders, Xian 710032, Peoples R China; [Guan, Su-Min] Fourth Mil Med Univ, Sch Stomatol, Xian 710032, Peoples R China; [Chen, Jun] Capital Med Univ, Inst Biomed Sci Pain, Beijing, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Capital Medical University	Yu, YQ (corresponding author), Fourth Mil Med Univ, Inst Biomed Sci Pain, Xian 710032, Peoples R China.	jchsmg@fmmu.edu.cn; junchen@fmmu.edu.cn	Chen, Jun/R-8412-2017; Yu, Yao-Qing/D-6163-2017	Chen, Jun/0000-0003-2637-8442; Yu, Yao-Qing/0000-0002-8047-9714	National Natural Science Foundation of China [30670692, 30770668, 81070899]; Natural Science Foundation of Beijing [KZ200510025016]; Military Health Foundation of PLA [06G095]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Military Health Foundation of PLA	This work was supported in part by the National Natural Science Foundation of China grants (30670692 and 30770668, 81070899), the Natural Science Foundation of Beijing (KZ200510025016) and Military Health Foundation of PLA (06G095) to J.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; Amaya F, 2000, MOL CELL NEUROSCI, V15, P331, DOI 10.1006/mcne.1999.0828; Amaya F, 2006, J NEUROSCI, V26, P12852, DOI 10.1523/JNEUROSCI.4015-06.2006; Baker MD, 2001, TRENDS PHARMACOL SCI, V22, P27, DOI 10.1016/S0165-6147(00)01585-6; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Benn SC, 2001, J NEUROSCI, V21, P6077, DOI 10.1523/JNEUROSCI.21-16-06077.2001; Berta T, 2008, MOL CELL NEUROSCI, V37, P196, DOI 10.1016/j.mcn.2007.09.007; Brussaard AB, 1997, J NEUROSCI METH, V71, P55, DOI 10.1016/S0165-0270(96)00126-4; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; Chen J, 1999, PAIN, V83, P67, DOI 10.1016/S0304-3959(99)00075-5; Chen J, 2010, PROG NEUROBIOL, V92, P151, DOI 10.1016/j.pneurobio.2010.06.006; Coste B, 2004, MOL CELL NEUROSCI, V26, P123, DOI 10.1016/j.mcn.2004.01.015; Coste B, 2007, J GEN PHYSIOL, V129, P57, DOI 10.1085/jgp.200609665; Cummins TR, 1997, J NEUROSCI, V17, P3503; Cummins TR, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0001.1999; Dib-Hajj S, 2002, TRENDS NEUROSCI, V25, P253, DOI 10.1016/S0166-2236(02)02150-1; Dib-Hajj SD, 1998, P NATL ACAD SCI USA, V95, P8963, DOI 10.1073/pnas.95.15.8963; Dib-Hajj SD, 2009, PAIN MED, V10, P1260, DOI 10.1111/j.1526-4637.2009.00719.x; Duan B, 2007, J NEUROSCI, V27, P11139, DOI 10.1523/JNEUROSCI.3364-07.2007; Ekberg J, 2006, INT J BIOCHEM CELL B, V38, P2005, DOI 10.1016/j.biocel.2006.06.008; Fukuoka T, 2008, J COMP NEUROL, V510, P188, DOI 10.1002/cne.21786; Glorioso JC, 2009, MOL THER, V17, P13, DOI 10.1038/mt.2008.213; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; Gould HJ, 1998, BRAIN RES, V802, P69, DOI 10.1016/S0006-8993(98)00568-X; Henry MA, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-56; Hillsley K, 2006, J PHYSIOL-LONDON, V576, P257, DOI 10.1113/jphysiol.2006.113597; Huang ZJ, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-20; Jarvis MF, 2007, P NATL ACAD SCI USA, V104, P8520, DOI 10.1073/pnas.0611364104; Joshi SK, 2006, PAIN, V123, P75, DOI 10.1016/j.pain.2006.02.011; Kurreck J, 2003, EUR J BIOCHEM, V270, P1628, DOI 10.1046/j.1432-1033.2003.03555.x; Lai J, 2002, PAIN, V95, P143, DOI 10.1016/S0304-3959(01)00391-8; Larsen HJ, 1999, BBA-GENE STRUCT EXPR, V1489, P159, DOI 10.1016/S0167-4781(99)00145-1; Leo S, 2010, BEHAV BRAIN RES, V208, P149, DOI 10.1016/j.bbr.2009.11.023; Mantegazza M, 2010, LANCET NEUROL, V9, P413, DOI 10.1016/S1474-4422(10)70059-4; Mogil JS, 2009, NAT REV NEUROSCI, V10, P283, DOI 10.1038/nrn2606; Parada CA, 2003, P NATL ACAD SCI USA, V100, P2923, DOI 10.1073/pnas.252777799; Patel VB, 2009, PAIN PHYSICIAN, V12, P345; Porreca F, 1999, P NATL ACAD SCI USA, V96, P7640, DOI 10.1073/pnas.96.14.7640; Priest BT, 2005, P NATL ACAD SCI USA, V102, P9382, DOI 10.1073/pnas.0501549102; RAGSDALE DS, 1994, SCIENCE, V265, P1724, DOI 10.1126/science.8085162; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Ritter AM, 2009, NEUROSCI LETT, V452, P28, DOI 10.1016/j.neulet.2008.12.051; Rogers M, 2006, SEMIN CELL DEV BIOL, V17, P571, DOI 10.1016/j.semcdb.2006.10.009; Rush AM, 2005, EUR J NEUROSCI, V22, P39, DOI 10.1111/j.1460-9568.2005.04186.x; Rush AM, 2006, P NATL ACAD SCI USA, V103, P8245, DOI 10.1073/pnas.0602813103; Scholz J, 2002, NAT NEUROSCI, V5, P1062, DOI 10.1038/nn942; STEIN C, 1988, PHARMACOL BIOCHEM BE, V31, P445, DOI 10.1016/0091-3057(88)90372-3; Tarnawa Istvan, 2007, Recent Pat CNS Drug Discov, V2, P57, DOI 10.2174/157488907779561754; Tate S, 1998, NAT NEUROSCI, V1, P653, DOI 10.1038/3652; Villarreal CF, 2005, NEUROSCI LETT, V386, P72, DOI 10.1016/j.neulet.2005.04.060; Yu YQ, 2005, NEUROSCI LETT, V381, P194, DOI 10.1016/j.neulet.2005.02.033	51	58	62	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19865	10.1371/journal.pone.0019865	http://dx.doi.org/10.1371/journal.pone.0019865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572961	Green Published, Green Submitted, gold			2022-12-27	WOS:000290440200030
J	Matthews, WJ				Matthews, William J.			Stimulus Repetition and the Perception of Time: The Effects of Prior Exposure on Temporal Discrimination, Judgment, and Production	PLOS ONE			English	Article							SUBJECTIVE DURATION; INTERNAL CLOCK; JUDGED LONGER; MEMORY; INFORMATION; INTENSITY; PROGRAM; HUMANS; LIGHTS; SOUNDS	It has been suggested that repeated stimuli have shorter subjective duration than novel items, perhaps because of a reduction in the neural response to repeated presentations of the same object. Five experiments investigated the effects of repetition on time perception and found further evidence that immediate repetition reduces apparent duration, consistent with the idea that subjective duration is partly based on neural coding efficiency. In addition, the experiments found (a) no effect of repetition on the precision of temporal discrimination, (b) that the effects of repetition disappeared when there was a modest lag between presentations, (c) that, across participants, the size of the repetition effect correlated with temporal discrimination, and (d) that the effects of repetition suggested by a temporal production task were the opposite of those suggested by temporal judgments. The theoretical and practical implications of these results are discussed.	Univ Essex, Dept Psychol, Colchester CO4 3SQ, Essex, England	University of Essex	Matthews, WJ (corresponding author), Univ Essex, Dept Psychol, Colchester CO4 3SQ, Essex, England.	will@essex.ac.uk			University of Essex; Experimental Psychology Society	University of Essex; Experimental Psychology Society	This research was partially funded by the University of Essex Research Promotion Fund and the Experimental Psychology Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan K., 1984, ANN NEW YORK ACAD SC, V423; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2002, HEURISTICS BIASES PS; Beckmann JS, 2009, J EXP PSYCHOL ANIM B, V35, P525, DOI 10.1037/a0015891; Brown SW, 1997, PERCEPT PSYCHOPHYS, V59, P1118, DOI 10.3758/BF03205526; BROWN SW, 1995, PERCEPT PSYCHOPHYS, V57, P105, DOI 10.3758/BF03211853; Buratto LG, 2009, Q J EXP PSYCHOL, V62, P1896, DOI 10.1080/17470210902883263; CHURCH RM, 1982, J EXP PSYCHOL ANIM B, V8, P165, DOI 10.1037/0097-7403.8.2.165; Danckert JA, 2005, BRAIN COGNITION, V59, P236, DOI 10.1016/j.bandc.2005.07.002; Droit-Volet S, 2010, EUR J COGN PSYCHOL, V22, P130, DOI 10.1080/09541440902738900; Eagleman DM, 2008, CURR OPIN NEUROBIOL, V18, P131, DOI 10.1016/j.conb.2008.06.002; Eagleman DM, 2009, PHILOS T R SOC B, V364, P1841, DOI 10.1098/rstb.2009.0026; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; GOLDSTON.S, 1974, PERCEPT MOTOR SKILL, V39, P63, DOI 10.2466/pms.1974.39.1.63; GOLDSTONE S, 1978, B PSYCHONOMIC SOC, V12, P83; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Hancock PA, 2010, ACTA PSYCHOL, V133, P170, DOI 10.1016/j.actpsy.2009.11.005; Hauser, 1996, EVOL COMMUN; Henson RN, 2004, NEUROIMAGE, V21, P1674, DOI 10.1016/j.neuroimage.2003.12.020; Henson RNA, 2003, NEUROPSYCHOLOGIA, V41, P263, DOI 10.1016/S0028-3932(02)00159-8; Jones LA, 2003, Q J EXP PSYCHOL-B, V56, P321, DOI 10.1080/02724990244000287; Jones LA, 2009, Q J EXP PSYCHOL, V62, P2171, DOI 10.1080/17470210902782200; KILLEEN PR, 1987, PSYCHOL REV, V94, P455, DOI 10.1037/0033-295X.94.4.455; Lander K, 2007, Q J EXP PSYCHOL, V60, P519, DOI 10.1080/17470210601117559; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Matthews WJ, 2007, PSYCHON B REV, V14, P989, DOI 10.3758/BF03194133; Matthews WJ, 2011, J EXP PSYCHOL HUMAN, V37, P303, DOI 10.1037/a0019961; Matthews WJ, 2011, BEHAV PROCESS, V86, P68, DOI 10.1016/j.beproc.2010.09.006; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Noguchi Y, 2006, CEREB CORTEX, V16, P1797, DOI 10.1093/cercor/bhj117; Ono F, 2005, CONSCIOUS COGN, V14, P474, DOI 10.1016/j.concog.2005.02.001; Ono F, 2008, PSYCHOL RES-PSYCH FO, V72, P61, DOI 10.1007/s00426-006-0073-3; Pariyadath V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001264; Pariyadath V, 2008, J VISION, V8, DOI 10.1167/8.16.11; PentonVoak IS, 1996, J EXP PSYCHOL ANIM B, V22, P307, DOI 10.1037/0097-7403.22.3.307; ROSEN S, 1992, PHILOS T ROY SOC B, V336, P367, DOI 10.1098/rstb.1992.0070; Seifried T, 2010, PSYCHOL RES-PSYCH FO, V74, P90, DOI 10.1007/s00426-008-0187-x; Stone JV, 1998, VISION RES, V38, P947, DOI 10.1016/S0042-6989(97)00301-5; THOMAS EAC, 1975, PERCEPT PSYCHOPHYS, V17, P363, DOI 10.3758/BF03199347; Treisman M, 1963, PSYCHOL MONOGRAPHS, V77; Tse PU, 2004, PERCEPT PSYCHOPHYS, V66, P1171, DOI 10.3758/BF03196844; Ulrich R, 2006, PSYCHOL RES-PSYCH FO, V70, P77, DOI 10.1007/S00426-004-0195-4; Wearden JH, 1999, BEHAV PROCESS, V45, P3, DOI 10.1016/S0376-6357(99)00006-6; Wearden JH, 1998, Q J EXP PSYCHOL-B, V51, P97; WITHERSPOON D, 1985, MEM COGNITION, V13, P101, DOI 10.3758/BF03197003; Xuan B, 2007, J VISION, V7, DOI 10.1167/7.10.2; ZAKAY D, 1993, PERCEPTION, V22, P91, DOI 10.1068/p220091; Zakay D, 1997, CURR DIR PSYCHOL SCI, V6, P12, DOI 10.1111/1467-8721.ep11512604; [No title captured]; [No title captured]	51	63	67	6	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19815	10.1371/journal.pone.0019815	http://dx.doi.org/10.1371/journal.pone.0019815			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	761GX	21573020	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000290386800037
J	Harvey, RM; Stroeher, UH; Ogunniyi, AD; Smith-Vaughan, HC; Leach, AJ; Paton, JC				Harvey, Richard M.; Stroeher, Uwe H.; Ogunniyi, Abiodun D.; Smith-Vaughan, Heidi C.; Leach, Amanda J.; Paton, James C.			A Variable Region within the Genome of Streptococcus pneumoniae Contributes to Strain-Strain Variation in Virulence	PLOS ONE			English	Article							A1 PROTEASE GENE; PNEUMOCOCCAL PILUS; PSAA MUTANTS; IRON UPTAKE; EXPRESSION; DIVERSITY; SEQUENCE; SEROTYPE; MITIS; IDENTIFICATION	The bacterial factors responsible for the variation in invasive potential between different clones and serotypes of Streptococcus pneumoniae are largely unknown. Therefore, the isolation of rare serotype 1 carriage strains in Indigenous Australian communities provided a unique opportunity to compare the genomes of non-invasive and invasive isolates of the same serotype in order to identify such factors. The human virulence status of non-invasive, intermediately virulent and highly virulent serotype 1 isolates was reflected in mice and showed that whilst both human non-invasive and highly virulent isolates were able to colonize the murine nasopharynx equally, only the human highly virulent isolates were able to invade and survive in the murine lungs and blood. Genomic sequencing comparisons between these isolates identified 8 regions >1 kb in size that were specific to only the highly virulent isolates, and included a version of the pneumococcal pathogenicity island 1 variable region (PPI-1v), phage-associated adherence factors, transporters and metabolic enzymes. In particular, a phage-associated endolysin, a putative iron/lead permease and an operon within PPI-1v exhibited niche-specific changes in expression that suggest important roles for these genes in the lungs and blood. Moreover, in vivo competition between pneumococci carrying PPI-1v derivatives representing the two identified versions of the region showed that the version of PPI-1v in the highly virulent isolates was more competitive than the version from the less virulent isolates in the nasopharyngeal tissue, blood and lungs. This study is the first to perform genomic comparisons between serotype 1 isolates with distinct virulence profiles that correlate between mice and humans, and has highlighted the important role that hypervariable genomic loci, such as PPI-1v, play in pneumococcal disease. The findings of this study have important implications for understanding the processes that drive progression from colonization to invasive disease and will help direct the development of novel therapeutic strategies.	[Harvey, Richard M.; Stroeher, Uwe H.; Ogunniyi, Abiodun D.; Paton, James C.] Univ Adelaide, Sch Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA, Australia; [Smith-Vaughan, Heidi C.; Leach, Amanda J.] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT 0909, Australia	University of Adelaide; Charles Darwin University; Menzies School of Health Research	Harvey, RM (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA, Australia.	james.paton@adelaide.edu.au	Paton, James C/A-9920-2008	Ogunniyi, Abiodun/0000-0001-9308-5629; Stroeher, Uwe/0000-0001-5705-7751	National Health and Medical Research Council (NHMRC) of Australia [565526, 627142]; Channel 7 Children's Research Foundation (CRF); Wellcome Trust	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Channel 7 Children's Research Foundation (CRF); Wellcome Trust(Wellcome TrustEuropean Commission)	This research was funded by Program Grant 565526 and Project Grant 627142 from the National Health and Medical Research Council (NHMRC) of Australia and a Channel 7 Children's Research Foundation (CRF) grant (www.crf.org.au). JCP is a NHMRC Australia Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Andrew Lawrence from the Women's and Children's Hospital, North Adelaide, South Australia, for the provision of strain 4496 in this study. We acknowledge BmG@S (the Bacterial Microarray Group at St. George's Hospital, University of London) for supply of the microarray slides and advice. We also acknowledge the use of the pneumococcal MLST database which is located at Imperial College London and is funded by the Wellcome Trust.	Aguiar SI, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-41; Antonio M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-198; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; AYOUBI P, 1991, J BACTERIOL, V173, P1617, DOI 10.1128/jb.173.5.1617-1622.1991; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Basset A, 2007, J CLIN MICROBIOL, V45, P1684, DOI 10.1128/JCM.00265-07; Bensing BA, 2001, INFECT IMMUN, V69, P1373, DOI 10.1128/IAI.69.3.1373-1380.2001; Berry AM, 2000, INFECT IMMUN, V68, P133, DOI 10.1128/IAI.68.1.133-140.2000; Berry AM, 1996, INFECT IMMUN, V64, P5255, DOI 10.1128/IAI.64.12.5255-5262.1996; BERRY AM, 1989, INFECT IMMUN, V57, P2324, DOI 10.1128/IAI.57.8.2324-2330.1989; Blomberg C, 2009, J INFECT DIS, V199, P1032, DOI 10.1086/597205; Brown JS, 2004, INFECT IMMUN, V72, P1587, DOI 10.1128/IAI.72.3.1587-1593.2004; Brown JS, 2002, INFECT IMMUN, V70, P4389, DOI 10.1128/IAI.70.8.4389-4398.2002; Brown JS, 2001, MOL MICROBIOL, V40, P572, DOI 10.1046/j.1365-2958.2001.02414.x; Bruckner R, 2004, INT J MED MICROBIOL, V294, P157, DOI 10.1016/j.ijmm.2004.06.019; Brueggemann AB, 2004, J INFECT DIS, V190, P1203, DOI 10.1086/423820; Brueggemann AB, 2003, J CLIN MICROBIOL, V41, P4966, DOI 10.1128/JCM.41.11.4966-4970.2003; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Busenlehner LS, 2003, FEMS MICROBIOL REV, V27, P131, DOI 10.1016/S0168-6445(03)00054-8; Camilli R, 2006, MICROBIOL-SGM, V152, P313, DOI 10.1099/mic.0.28417-0; CANVIN JR, 1995, J INFECT DIS, V172, P119, DOI 10.1093/infdis/172.1.119; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chiavolini D, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-14; Croucher NJ, 2009, J BACTERIOL, V191, P1480, DOI 10.1128/JB.01343-08; Dintilhac A, 1997, MOL MICROBIOL, V25, P727, DOI 10.1046/j.1365-2958.1997.5111879.x; Embry A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-80; Giammarinaro P, 2002, INFECT IMMUN, V70, P5454, DOI 10.1128/IAI.70.10.5454-5461.2002; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Henderson-Begg SK, 2009, INT J ANTIMICROB AG, V33, P364, DOI 10.1016/j.ijantimicag.2008.10.002; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; Hollands A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004102; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Hyams C, 2010, INFECT IMMUN, V78, P716, DOI 10.1128/IAI.01056-09; Khoo SK, 2007, J BIOL CHEM, V282, P19606, DOI 10.1074/jbc.M701703200; Kilian M, 1996, APMIS, V104, P321, DOI 10.1111/j.1699-0463.1996.tb00724.x; KILIAN M, 1979, INFECT IMMUN, V26, P143, DOI 10.1128/IAI.26.1.143-149.1979; Lau GW, 2001, MOL MICROBIOL, V40, P555, DOI 10.1046/j.1365-2958.2001.02335.x; Leimkugel J, 2005, J INFECT DIS, V192, P192, DOI 10.1086/431151; LeMessurier KS, 2006, MICROBIOL-SGM, V152, P305, DOI 10.1099/mic.0.28438-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACRINA FL, 1983, GENE, V25, P145; Mahdi LK, 2008, INFECT IMMUN, V76, P646, DOI 10.1128/IAI.01161-07; Martin B, 1995, DEV BIOL STAND, V85, P293; Martner A, 2009, INFECT IMMUN, V77, P3826, DOI 10.1128/IAI.00290-09; McAllister LJ, 2004, MOL MICROBIOL, V53, P889, DOI 10.1111/j.1365-2958.2004.04164.x; Melin M, 2010, INFECT IMMUN; Mitchell J, 2007, MOL MICROBIOL, V64, P844, DOI 10.1111/j.1365-2958.2007.05703.x; Mitchell J, 2009, INFECT IMMUN, V77, P3485, DOI 10.1128/IAI.01573-08; Morona JK, 2004, J INFECT DIS, V189, P1905, DOI 10.1086/383352; Munoz-Najar U, 1999, J BACTERIOL, V181, P2782, DOI 10.1128/JB.181.9.2782-2788.1999; Nunes S, 2008, CLIN MICROBIOL INFEC, V14, P82, DOI 10.1111/j.1469-0691.2007.01871.x; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Obert C, 2006, INFECT IMMUN, V74, P4766, DOI 10.1128/IAI.00316-06; Oggioni MR, 2003, MOL MICROBIOL, V49, P795, DOI 10.1046/j.1365-2958.2003.03596.x; Ogunniyi AD, 2002, MICROBIOL-SGM, V148, P2045, DOI 10.1099/00221287-148-7-2045; Orihuela CJ, 2009, J INFECT DIS, V200, P1180, DOI 10.1086/605649; Paterson GK, 2008, FEMS MICROBIOL LETT, V285, P170, DOI 10.1111/j.1574-6968.2008.01217.x; Poulsen K, 1996, INFECT IMMUN, V64, P3957, DOI 10.1128/IAI.64.10.3957-3966.1996; Quentin Y, 1999, J MOL BIOL, V287, P467, DOI 10.1006/jmbi.1999.2624; Romero P, 2009, J BACTERIOL, V191, P4854, DOI 10.1128/JB.01272-08; Romero P, 2009, APPL ENVIRON MICROB, V75, P1642, DOI 10.1128/AEM.02155-08; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sanchez CJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001044; Sandgren A, 2005, J INFECT DIS, V192, P791, DOI 10.1086/432513; Sandgren A, 2004, J INFECT DIS, V189, P785, DOI 10.1086/381686; Seo HS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001047; Shivshankar P, 2009, MOL MICROBIOL, V73, P663, DOI 10.1111/j.1365-2958.2009.06796.x; Silva NA, 2006, INFECT IMMUN, V74, P3513, DOI 10.1128/IAI.00079-06; Sjostrom K, 2007, P NATL ACAD SCI USA, V104, P12907, DOI 10.1073/pnas.0705589104; Sjostrom K, 2006, CLIN INFECT DIS, V42, P451, DOI 10.1086/499242; Smith BT, 1998, GENETICS, V148, P1599; Smith-Vaughan H, 2009, CLIN VACCINE IMMUNOL, V16, P218, DOI 10.1128/CVI.00283-08; Stroeher UH, 2007, J INFECT DIS, V196, P1820, DOI 10.1086/523107; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tseng HJ, 2002, INFECT IMMUN, V70, P1635, DOI 10.1128/IAI.70.3.1635-1639.2002; van der Ploeg JR, 2010, VIRUS GENES; Wani JH, 1996, INFECT IMMUN, V64, P3967, DOI 10.1128/IAI.64.10.3967-3974.1996; Weinberger DM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000476; WEISER JN, 1994, INFECT IMMUN, V62, P2582, DOI 10.1128/IAI.62.6.2582-2589.1994; Weiser JN, 2003, P NATL ACAD SCI USA, V100, P4215, DOI 10.1073/pnas.0637469100; Yaro S, 2006, CLIN INFECT DIS, V43, P693, DOI 10.1086/506940	82	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19650	10.1371/journal.pone.0019650	http://dx.doi.org/10.1371/journal.pone.0019650			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573186	gold, Green Published, Green Submitted			2022-12-27	WOS:000290256400038
J	Valente, MJ; Henrique, R; Costa, VL; Jeronimo, C; Carvalho, F; Bastos, ML; de Pinho, PG; Carvalho, M				Valente, Maria Joao; Henrique, Rui; Costa, Vera L.; Jeronimo, Carmen; Carvalho, Felix; Bastos, Maria L.; de Pinho, Paula Guedes; Carvalho, Marcia			A Rapid and Simple Procedure for the Establishment of Human Normal and Cancer Renal Primary Cell Cultures from Surgical Specimens	PLOS ONE			English	Article							HUMAN PROXIMAL TUBULE; IN-VITRO; CARCINOMA; NEPHROTOXICITY; RAT; INHIBITION; APOPTOSIS; KIDNEY; GROWTH; CLEAR	The kidney is a target organ for the toxicity of several xenobiotics and is also highly susceptible to the development of malignant tumors. In both cases, in vitro studies provide insight to cellular damage, and represent adequate models to study either the mechanisms underlying the toxic effects of several nephrotoxicants or therapeutic approaches in renal cancer. The development of efficient methods for the establishment of human normal and tumor renal cell models is hence crucial. In this study, a technically simple and rapid protocol for the isolation and culture of human proximal tubular epithelial cells and human renal tumor cells from surgical specimens is presented. Tumor and normal tissues were processed by using the same methodology, based on mechanical disaggregation of tissue followed by enzymatic digestion and cell purification by sequential sieving. The overall procedure takes roughly one hour. The resulting cell preparations have excellent viabilities and yield. Establishment of primary cultures from all specimens was achieved successfully. The origin of primary cultured cells was established through morphological evaluation. Normal cells purity was confirmed by immunofluorescent staining and reverse transcription-polymerase chain reaction analysis for expression of specific markers.	[Valente, Maria Joao; Carvalho, Felix; Bastos, Maria L.; de Pinho, Paula Guedes; Carvalho, Marcia] Univ Porto, Fac Farm, Dept Ciencias Biol, REQUIMTE,Lab Toxicol, P-4100 Oporto, Portugal; [Henrique, Rui] Portuguese Oncol Inst Porto, Dept Pathol, Oporto, Portugal; [Henrique, Rui; Jeronimo, Carmen] Univ Porto, Inst Biomed Sci Abel Salazar ICBAS, Dept Pathol & Mol Immunol, P-4100 Oporto, Portugal; [Henrique, Rui; Costa, Vera L.; Jeronimo, Carmen] Portuguese Oncol Inst Porto, Canc Epigenet Grp, Res Ctr, Oporto, Portugal; [Carvalho, Marcia] Univ Fernando Pessoa, Fac Hlth Sci, Oporto, Portugal	Universidade do Porto; Portuguese Institute of Oncology; Universidade do Porto; Portuguese Institute of Oncology; Universidade Fernando Pessoa	Valente, MJ (corresponding author), Univ Porto, Fac Farm, Dept Ciencias Biol, REQUIMTE,Lab Toxicol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	mjoao.pcv@gmail.com; mcarv@ufp.edu.pt	Jerónimo, Carmen/H-3284-2013; de Lourdes Bastos, Maria/D-8588-2013; Valente, Maria João/T-3646-2017; Carvalho, Félix/D-4914-2013; Valente, Maria João/M-9694-2019; Henrique, Rui Manuel Ferreira/I-2757-2013; de Pinho, P. Guedes/D-4847-2013; Carvalho, Marcia/D-5999-2013	Jerónimo, Carmen/0000-0003-4186-5345; de Lourdes Bastos, Maria/0000-0001-9895-503X; Valente, Maria João/0000-0001-6162-2426; Carvalho, Félix/0000-0003-3858-3494; Valente, Maria João/0000-0001-6162-2426; Henrique, Rui Manuel Ferreira/0000-0003-3171-4666; de Pinho, P. Guedes/0000-0002-7395-5700; Carvalho, Marcia/0000-0001-9884-4751				ANGLARD P, 1992, CANCER RES, V52, P348; Baer PC, 1997, KIDNEY INT, V52, P1321, DOI 10.1038/ki.1997.457; Bens M, 2008, PFLUG ARCH EUR J PHY, V457, P1, DOI 10.1007/s00424-008-0507-4; Bodmer D, 2002, HUM MOL GENET, V11, P2489, DOI 10.1093/hmg/11.20.2489; Carvalho M, 2002, ARCH TOXICOL, V76, P581, DOI 10.1007/s00204-002-0381-3; EBERT T, 1990, CANCER RES, V50, P5531; GERHARZ CD, 1993, AM J PATHOL, V142, P851; Glynne PA, 2000, METH MOLEC MED, V36, P197, DOI 10.1385/1-59259-216-3:197; Hawksworth Gabrielle M, 2005, Methods Mol Med, V107, P283; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Johnson DW, 1997, NEPHROLOGY, V3, P183; Kim FJ, 2008, J ENDOUROL, V22, P2361, DOI 10.1089/end.2008.9703; Kruidering M, 1997, J PHARMACOL EXP THER, V280, P638; Kuwana H, 2008, KIDNEY INT, V73, P430, DOI 10.1038/sj.ki.5002702; Lash LH, 2007, TOXICOL APPL PHARM, V221, P349, DOI 10.1016/j.taap.2007.03.023; Launonen V, 2001, P NATL ACAD SCI USA, V98, P3387, DOI 10.1073/pnas.051633798; Liu L, 2007, ARCH PATHOL LAB MED, V131, P1290; MCATEER JA, 1991, J TISSUE CULT METHOD, V13, P143; Mizutani Y, 2003, CLIN CANCER RES, V9, P1453; Park JG, 2004, METH MOLEC MED, V88, P111; Pfaller W, 1998, ENVIRON HEALTH PERSP, V106, P559, DOI 10.2307/3433806; Pittoggi C, 2008, INT BRAZ J UROL, V34, P492, DOI 10.1590/S1677-55382008000400012; Price KL, 2009, UROL RES, V37, P127, DOI 10.1007/s00240-009-0185-5; Qi W, 2007, NEPHROLOGY, V12, P155, DOI 10.1111/j.1440-1797.2007.00779.x; Schaaf GJ, 2001, CHEM-BIOL INTERACT, V134, P167, DOI 10.1016/S0009-2797(01)00151-X; Schwerdt G, 2007, TOXICOLOGY, V232, P57, DOI 10.1016/j.tox.2006.12.008; Terryn S, 2007, AM J PHYSIOL-RENAL, V293, pF476, DOI 10.1152/ajprenal.00363.2006; TUNE BM, 1980, KIDNEY INT, V18, P591, DOI 10.1038/ki.1980.177; Valente MJ, 2011, FOOD CHEM TOXICOL, V49, P86, DOI 10.1016/j.fct.2010.10.001; Vesey David A., 2009, V466, P19, DOI 10.1007/978-1-59745-352-3_2; WILSON PD, 1985, AM J PHYSIOL, V248, pF436, DOI 10.1152/ajprenal.1985.248.3.F436; Wu XX, 2000, CANCER RES, V60, P2912; Yang XMJ, 2005, CANCER RES, V65, P5628, DOI 10.1158/0008-5472.CAN-05-0533; Yusenko MV, 2010, INT J UROL, V17, P592, DOI 10.1111/j.1442-2042.2010.02558.x; ZBAR B, 1995, J UROLOGY, V153, P907, DOI 10.1016/S0022-5347(01)67601-8	35	35	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19337	10.1371/journal.pone.0019337	http://dx.doi.org/10.1371/journal.pone.0019337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573239	Green Published, gold, Green Submitted			2022-12-27	WOS:000290224800023
J	Villalta, JI; Galli, S; Iacaruso, MF; Arciuch, VGA; Poderoso, JJ; Jares-Erijman, EA; Pietrasanta, LI				Ignacio Villalta, Jorge; Galli, Soledad; Florencia Iacaruso, Maria; Antico Arciuch, Valeria Gabriela; Jose Poderoso, Juan; Andrea Jares-Erijman, Elizabeth; Isabel Pietrasanta, Lia			New Algorithm to Determine True Colocalization in Combination with Image Restoration and Time-Lapse Confocal Microscopy to Map Kinases in Mitochondria	PLOS ONE			English	Article								The subcellular localization and physiological functions of biomolecules are closely related and thus it is crucial to precisely determine the distribution of different molecules inside the intracellular structures. This is frequently accomplished by fluorescence microscopy with well-characterized markers and posterior evaluation of the signal colocalization. Rigorous study of colocalization requires statistical analysis of the data, albeit yet no single technique has been established as a standard method. Indeed, the few methods currently available are only accurate in images with particular characteristics. Here, we introduce a new algorithm to automatically obtain the true colocalization between images that is suitable for a wide variety of biological situations. To proceed, the algorithm contemplates the individual contribution of each pixel's fluorescence intensity in a pair of images to the overall Pearsons correlation and Manders' overlap coefficients. The accuracy and reliability of the algorithm was validated on both simulated and real images that reflected the characteristics of a range of biological samples. We used this algorithm in combination with image restoration by deconvolution and time-lapse confocal microscopy to address the localization of MEK1 in the mitochondria of different cell lines. Appraising the previously described behavior of Akt1 corroborated the reliability of the combined use of these techniques. Together, the present work provides a novel statistical approach to accurately and reliably determine the colocalization in a variety of biological images.	[Ignacio Villalta, Jorge; Florencia Iacaruso, Maria; Isabel Pietrasanta, Lia] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Ctr Microscopias Avanzadas, Buenos Aires, DF, Argentina; [Galli, Soledad; Andrea Jares-Erijman, Elizabeth] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Organ, CIHIDECAR,CONICET, RA-1428 Buenos Aires, DF, Argentina; [Antico Arciuch, Valeria Gabriela; Jose Poderoso, Juan] Univ Buenos Aires, Fac Med, Lab Oxygen Metab, Univ Hosp Jose de San Martin, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires	Villalta, JI (corresponding author), Univ Buenos Aires, Fac Med, Dept Fisiol, RA-1425 Buenos Aires, DF, Argentina.	eli@qo.fcen.uba.ar; lia@df.uba.ar		PIETRASANTA, LIA/0000-0002-2714-3162	Universidad de Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Max Planck Society	Universidad de Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Max Planck Society(Max Planck Society)	This work was supported by the Universidad de Buenos Aires, the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso M, 2004, J NEUROCHEM, V89, P248, DOI 10.1111/j.1471-4159.2004.02323.x; Arciuch VGA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007523; Barlow AL, 2010, MICROSC MICROANAL, V16, P710, DOI 10.1017/S143192761009389X; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bronfman FC, 2003, J NEUROSCI, V23, P3209; Comeau JWD, 2006, BIOPHYS J, V91, P4611, DOI 10.1529/biophysj.106.089441; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Craig EA, 2008, DEV DYNAM, V237, P3102, DOI 10.1002/dvdy.21750; Fletcher PA, 2010, BIOPHYS J, V99, P1996, DOI 10.1016/j.bpj.2010.07.006; Fukuda M, 1996, J BIOL CHEM, V271, P20024, DOI 10.1074/jbc.271.33.20024; Galli S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007541; Galli S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002379; Galmiche A, 2008, J BIOL CHEM, V283, P14857, DOI 10.1074/jbc.M709098200; Horgan AM, 2003, EXP CELL RES, V285, P208, DOI 10.1016/S0014-4827(03)00037-5; Jaaro H, 1997, P NATL ACAD SCI USA, V94, P3742, DOI 10.1073/pnas.94.8.3742; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lidke DS, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.064972; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; MANDERS EMM, 1992, J CELL SCI, V103, P857; Monick MM, 2008, J IMMUNOL, V180, P7485, DOI 10.4049/jimmunol.180.11.7485; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Poderoso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001443; Ramay HR, 2009, BIOPHYS J, V97, P443, DOI 10.1016/j.bpj.2009.04.062; Ramirez O, 2010, J MICROSC-OXFORD, V239, P173, DOI 10.1111/j.1365-2818.2010.03369.x; Sedarat F, 2004, J APPL PHYSIOL, V97, P1098, DOI 10.1152/japplphysiol.00089.2004; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SEGER R, 1992, J BIOL CHEM, V267, P14373; Yao Z, 2001, ONCOGENE, V20, P7588, DOI 10.1038/sj.onc.1204963; ZHENG CF, 1993, J BIOL CHEM, V268, P23933; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	30	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19031	10.1371/journal.pone.0019031	http://dx.doi.org/10.1371/journal.pone.0019031			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559502	Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700054
J	Koeva, M; Forsberg, EC; Stuart, JM				Koeva, Martina; Forsberg, E. Camilla; Stuart, Joshua M.			Computational Integration of Homolog and Pathway Gene Module Expression Reveals General Stemness Signatures	PLOS ONE			English	Article							SELF-RENEWAL; PROTEINS; CELLS; DIFFERENTIATION; ACETYLATION; NETWORKS; BINDING; KEGG; DNA	The stemness hypothesis states that all stem cells use common mechanisms to regulate self-renewal and multi-lineage potential. However, gene expression meta-analyses at the single gene level have failed to identify a significant number of genes selectively expressed by a broad range of stem cell types. We hypothesized that stemness may be regulated by modules of homologs. While the expression of any single gene within a module may vary from one stem cell type to the next, it is possible that the expression of the module as a whole is required so that the expression of different, yet functionally-synonymous, homologs is needed in different stem cells. Thus, we developed a computational method to test for stem cell-specific gene expression patterns from a comprehensive collection of 49 murine datasets covering 12 different stem cell types. We identified 40 individual genes and 224 stemness modules with reproducible and specific up-regulation across multiple stem cell types. The stemness modules included families regulating chromatin remodeling, DNA repair, and Wnt signaling. Strikingly, the majority of modules represent evolutionarily related homologs. Moreover, a score based on the discovered modules could accurately distinguish stem cell-like populations from other cell types in both normal and cancer tissues. This scoring system revealed that both mouse and human metastatic populations exhibit higher stemness indices than non-metastatic populations, providing further evidence for a stem cell-driven component underlying the transformation to metastatic disease.	[Koeva, Martina; Forsberg, E. Camilla; Stuart, Joshua M.] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Koeva, M (corresponding author), Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA.	jstuart@soe.ucsc.edu; cforsber@soe.ucsc.edu		Stuart, Joshua/0000-0002-2171-565X	California Institute for Regenerative Medicine; NSF; Sloan; Davis CRC Cancer Grant; Alfred P. Sloan Foundation	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NSF(National Science Foundation (NSF)); Sloan(Alfred P. Sloan Foundation); Davis CRC Cancer Grant; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	MK was supported by a California Institute for Regenerative Medicine Training grant. ECF is supported by a New Faculty Award from the California Institute for Regenerative Medicine. JMS was supported by grants from NSF, Sloan, Davis CRC Cancer Grant, and a fellowship from the Alfred P. Sloan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angelelli C, 2008, NUCLEIC ACIDS RES, V36, P915, DOI 10.1093/nar/gkm1114; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Chan KKK, 2009, STEM CELLS, V27, P2114, DOI 10.1002/stem.143; Chavez L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-314; Chen R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-548; Ficara F, 2008, CELL STEM CELL, V2, P484, DOI 10.1016/j.stem.2008.03.004; Fortunel NO, 2003, SCIENCE, V302, P393; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Hirst CE, 2006, DEV BIOL, V293, P90, DOI 10.1016/j.ydbio.2006.01.023; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Laurent A, 2008, INT J DEV BIOL, V52, P9, DOI 10.1387/ijdb.072304al; Ma KW, 2005, MOL CELL BIOL, V25, P3575, DOI 10.1128/MCB.25.9.3575-3582.2005; Mewes HW, 2006, NUCLEIC ACIDS RES, V34, pD169, DOI 10.1093/nar/gkj148; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Ramasamy A, 2008, PLOS MED, V5, P1320, DOI 10.1371/journal.pmed.0050184; Ravindranath A, 2008, CURR MOL MED, V8, P38; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Ruepp A, 2008, NUCLEIC ACIDS RES, V36, pD646, DOI 10.1093/nar/gkm936; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Sun Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003406; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yokota Y, 2002, J CELL PHYSIOL, V190, P21, DOI 10.1002/jcp.10042	31	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18968	10.1371/journal.pone.0018968	http://dx.doi.org/10.1371/journal.pone.0018968			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559491	Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700045
J	Lancichinetti, A; Radicchi, F; Ramasco, JJ; Fortunato, S				Lancichinetti, Andrea; Radicchi, Filippo; Ramasco, Jose J.; Fortunato, Santo			Finding Statistically Significant Communities in Networks	PLOS ONE			English	Article							COMPLEX NETWORKS; IDENTIFICATION; ORGANIZATION; HIERARCHIES	Community structure is one of the main structural features of networks, revealing both their internal organization and the similarity of their elementary units. Despite the large variety of methods proposed to detect communities in graphs, there is a big need for multi-purpose techniques, able to handle different types of datasets and the subtleties of community structure. In this paper we present OSLOM (Order Statistics Local Optimization Method), the first method capable to detect clusters in networks accounting for edge directions, edge weights, overlapping communities, hierarchies and community dynamics. It is based on the local optimization of a fitness function expressing the statistical significance of clusters with respect to random fluctuations, which is estimated with tools of Extreme and Order Statistics. OSLOM can be used alone or as a refinement procedure of partitions/covers delivered by other techniques. We have also implemented sequential algorithms combining OSLOM with other fast techniques, so that the community structure of very large networks can be uncovered. Our method has a comparable performance as the best existing algorithms on artificial benchmark graphs. Several applications on real networks are shown as well. OSLOM is implemented in a freely available software (http://www.oslom.org), and we believe it will be a valuable tool in the analysis of networks.	[Lancichinetti, Andrea; Ramasco, Jose J.; Fortunato, Santo] ISI, Complex Networks & Syst Lagrange Lab, Turin, Italy; [Lancichinetti, Andrea] Politecn Torino, Dept Phys, Turin, Italy; [Radicchi, Filippo] Northwestern Univ, Howard Hughes Med Inst, Evanston, IL USA; [Ramasco, Jose J.] UIB, CSIC, IFISC, Palma de Mallorca, Spain	Polytechnic University of Turin; Howard Hughes Medical Institute; Northwestern University; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC)	Lancichinetti, A (corresponding author), ISI, Complex Networks & Syst Lagrange Lab, Turin, Italy.	fortunato@isi.it	Fortunato, Santo/C-3586-2009; Fortunato, Santo/M-7912-2019; Ramasco, Jose Javier/F-2860-2010; Radicchi, Filippo/B-4407-2009	Fortunato, Santo/0000-0002-9039-4730; Fortunato, Santo/0000-0002-9039-4730; Ramasco, Jose Javier/0000-0003-2499-6095; Radicchi, Filippo/0000-0002-8352-1287	European Commission [238597]	European Commission(European CommissionEuropean Commission Joint Research Centre)	A.L. and S.F. gratefully acknowledge ICTeCollective. The project ICTeCollective acknowledges the financial support of the Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission, under FET-Open grant number 238597. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic L. A., 2005, 3 INT WORKSH LINK DI, P36, DOI DOI 10.1145/1134271.1134277; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; [Anonymous], 2006, P 12 ACM SIGKDD INT, DOI DOI 10.1145/1150402.1150467; Asur S, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P913; Backstrom L., 2006, P SIGKDD, P44, DOI DOI 10.1145/1150402.1150412; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Baumes J., 2005, IADIS AC, V5, P97; Bianconi G, 2009, P NATL ACAD SCI USA, V106, P11433, DOI 10.1073/pnas.0811511106; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Caldarelli G., 2007, SCALE FREE NETWORKS; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Clauset A, 2007, LECT NOTES COMPUT SC, V4503, P1; Condon A, 2001, RANDOM STRUCT ALGOR, V18, P116, DOI 10.1002/1098-2418(200103)18:2<116::AID-RSA1001>3.0.CO;2-2; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Dorogovtsev SN, 2002, ADV PHYS, V51, P1079, DOI 10.1080/00018730110112519; Evans TS, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016105; Flake GW, 2002, COMPUTER, V35, P66, DOI 10.1109/2.989932; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Good BH, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046106; Gregory S, 2007, LECT NOTES ARTIF INT, V4702, P91; Guimera R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.025101; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Holme P, 2003, BIOINFORMATICS, V19, P532, DOI 10.1093/bioinformatics/btg033; Hopcroft J, 2004, P NATL ACAD SCI USA, V101, P5249, DOI 10.1073/pnas.0307750100; Jonsson PF, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-2; Kovacs IA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012528; Krause AE, 2003, NATURE, V426, P282, DOI 10.1038/nature02115; LANCICHINETTI A, 2009, PHYS REV E 2, V80, DOI DOI 10.1103/PHYSREVE.80.056117; Lancichinetti A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011976; Lancichinetti A, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046110; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016118; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Leung IXY, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.066107; Lusseau D, 2004, P ROY SOC B-BIOL SCI, V271, pS477, DOI 10.1098/rsbl.2004.0225; McDaid A, 2010, 2010 INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM 2010), P112, DOI 10.1109/ASONAM.2010.77; Mellado JP, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/085010; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Mucha PJ, 2010, SCIENCE, V328, P876, DOI 10.1126/science.1184819; Nelson DL, 2004, BEHAV RES METH INS C, V36, P402, DOI 10.3758/BF03195588; Nepusz T, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016107; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, EUR PHYS J B, V38, P321, DOI 10.1140/epjb/e2004-00124-y; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Nowicki K., 2001, J AM STAT ASS, V96; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Pastor-Satorras R, 2004, EVOLUTION STRUCTURE; PIMM SL, 1979, THEOR POPUL BIOL, V16, P144, DOI 10.1016/0040-5809(79)90010-8; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Radicchi F, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.026102; Raghavan UN, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036106; Reichardt J, 2006, PHYSICA D, V224, P20, DOI 10.1016/j.physd.2006.09.009; Reichardt J, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.015102; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Rosvall M, 2010, ARXIV10100431; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; Simon H. A., 1962, P AM PHILOS SOC, V106, P467, DOI DOI 10.1080/14759550302804; Tan P. -N., 2005, INTRO DATA MINING, V1st; Zhang SH, 2007, PHYSICA A, V374, P483, DOI 10.1016/j.physa.2006.07.023	68	604	630	3	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18961	10.1371/journal.pone.0018961	http://dx.doi.org/10.1371/journal.pone.0018961			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559480	Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700043
J	Masliah, E; Rockenstein, E; Mante, M; Crews, L; Spencer, B; Adame, A; Patrick, C; Trejo, M; Ubhi, K; Rohn, TT; Mueller-Steiner, S; Seubert, P; Barbour, R; McConlogue, L; Buttini, M; Games, D; Schenk, D				Masliah, Eliezer; Rockenstein, Edward; Mante, Michael; Crews, Leslie; Spencer, Brian; Adame, Anthony; Patrick, Christina; Trejo, Margarita; Ubhi, Kiren; Rohn, Troy T.; Mueller-Steiner, Sarah; Seubert, Peter; Barbour, Robin; McConlogue, Lisa; Buttini, Manuel; Games, Dora; Schenk, Dale			Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease	PLOS ONE			English	Article							A-BETA COMPONENT; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; MOUSE MODEL; CEREBROSPINAL-FLUID; BILAYER CHARGE; IN-VITRO; AGGREGATION; PROTEIN; IMMUNOTHERAPY	Dementia with Lewy bodies (DLB) and Parkinson's Disease (PD) are common causes of motor and cognitive deficits and are associated with the abnormal accumulation of alpha-synuclein (alpha-syn). This study investigated whether passive immunization with a novel monoclonal alpha-syn antibody (9E4) against the C-terminus (CT) of alpha-syn was able to cross into the CNS and ameliorate the deficits associated with alpha-syn accumulation. In this study we demonstrate that 9E4 was effective at reducing behavioral deficits in the water maze, moreover, immunization with 9E4 reduced the accumulation of calpain-cleaved alpha-syn in axons and synapses and the associated neurodegenerative deficits. In vivo studies demonstrated that 9E4 traffics into the CNS, binds to cells that display alpha-syn accumulation and promotes alpha-syn clearance via the lysosomal pathway. These results suggest that passive immunization with monoclonal antibodies against the CT of alpha-syn may be of therapeutic relevance in patients with PD and DLB.	[Masliah, Eliezer; Rockenstein, Edward; Mante, Michael; Spencer, Brian; Adame, Anthony; Patrick, Christina; Trejo, Margarita; Ubhi, Kiren] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Masliah, Eliezer; Crews, Leslie] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Rohn, Troy T.] Boise State Univ, Dept Biol, Boise, ID 83725 USA; [Mueller-Steiner, Sarah; Seubert, Peter; Barbour, Robin; McConlogue, Lisa; Buttini, Manuel; Games, Dora; Schenk, Dale] ELAN Pharmaceut, San Francisco, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Idaho; Boise State University	Masliah, E (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	emasliah@ucsd.edu	Crews, Leslie/B-7584-2014	Crews, Leslie/0000-0003-0704-0067; Buttini, Manuel/0000-0003-1805-0279	National Institutes of Health (NIH) [AG 11385, AG 18840, AG 022074, NS 044233]; ELAN Pharmaceuticals; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG011385, R01AG011385, P01AG022074] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ELAN Pharmaceuticals; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by National Institutes of Health (NIH) grants AG 11385, AG 18840, AG 022074 and NS 044233 and by ELAN Pharmaceuticals. NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sarah Mueller-Steiner, Peter Seubert, Robin Barbour, Lisa McConlogue, Manuel Buttini, Dora Games and Dale Schenk are employed by ELAN Pharmaceuticals, who, in collaboration with the group at UCSD, were intellectually involved in the conception and execution of the in vitro and in vivo passive immunization experiments.	Benner EJ, 2004, P NATL ACAD SCI USA, V101, P9435, DOI 10.1073/pnas.0400569101; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; Bussiere T, 2004, AM J PATHOL, V165, P987, DOI 10.1016/S0002-9440(10)63360-3; Buttini M, 2005, J NEUROSCI, V25, P9096, DOI 10.1523/JNEUROSCI.1697-05.2005; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; CREWS L, 2010, PLOS ONE IN PRESS; Crews L, 2009, NEUROTOX RES, V16, P306, DOI 10.1007/s12640-009-9073-6; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Dickson DW, 2001, CURR OPIN NEUROL, V14, P423, DOI 10.1097/00019052-200108000-00001; Dufty BM, 2007, AM J PATHOL, V170, P1725, DOI 10.2353/ajpath.2007.061232; Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x; Emadi S, 2004, BIOCHEMISTRY-US, V43, P2871, DOI 10.1021/bi036281f; Fortin DL, 2005, J NEUROSCI, V25, P10913, DOI 10.1523/JNEUROSCI.2922-05.2005; Hashimoto M, 1999, NEUROREPORT, V10, P717, DOI 10.1097/00001756-199903170-00011; Hashimoto M, 2003, J NEUROCHEM, V85, P1468, DOI 10.1046/j.1471-4159.2003.01791.x; Hoyer W, 2004, BIOCHEMISTRY-US, V43, P16233, DOI 10.1021/bi048453u; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Iwatsubo T, 1996, AM J PATHOL, V148, P1517; Kim HY, 2009, J AM CHEM SOC, V131, P17482, DOI 10.1021/ja9077599; Koob AO, 2010, EXP NEUROL, V221, P267, DOI 10.1016/j.expneurol.2009.11.015; Kramer ML, 2007, J NEUROSCI, V27, P1405, DOI 10.1523/JNEUROSCI.4564-06.2007; Langston JW, 2006, ANN NEUROL, V59, P591, DOI 10.1002/ana.20834; Lansbury PT, 1999, P NATL ACAD SCI USA, V96, P3342, DOI 10.1073/pnas.96.7.3342; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee HJ, 2008, BIOCHEM BIOPH RES CO, V372, P423, DOI 10.1016/j.bbrc.2008.05.045; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee SJ, 2008, J MOL NEUROSCI, V34, P17, DOI 10.1007/s12031-007-0012-9; Lemere CA, 2006, REJUV RES, V9, P77, DOI 10.1089/rej.2006.9.77; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; McKeith IG, 2000, NEUROL CLIN, V18, P865, DOI 10.1016/S0733-8619(05)70230-9; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Noguchi-Shinohara M, 2009, BRAIN RES, V1251, P1, DOI 10.1016/j.brainres.2008.11.055; Pankiewicz J, 2006, EUR J NEUROSCI, V23, P2635, DOI 10.1111/j.1460-9568.2006.04805.x; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; de Laureto PP, 2006, BIOCHEMISTRY-US, V45, P11523, DOI 10.1021/bi052614s; Rhodes SL, 2011, ANN HUM GENET, V75, P195, DOI 10.1111/j.1469-1809.2010.00616.x; Rockenstein E, 2002, J NEUROSCI RES, V68, P568, DOI 10.1002/jnr.10231; Rockenstein E, 2001, J NEUROSCI RES, V66, P573, DOI 10.1002/jnr.1247; Rockenstein E, 2007, ADV DRUG DELIVER REV, V59, P1093, DOI 10.1016/j.addr.2007.08.013; ROEDER LM, 1982, J NEUROSCI RES, V8, P671, DOI 10.1002/jnr.490080412; Salem SA, 2007, BRAIN RES, V1170, P103, DOI 10.1016/j.brainres.2007.07.027; Schenk DB, 2005, NEURODEGENER DIS, V2, P255, DOI 10.1159/000090365; Sigurdsson EM, 2008, J ALZHEIMERS DIS, V15, P157; Sigurdsson EM, 2009, CURR ALZHEIMER RES, V6, P446, DOI 10.2174/156720509789207930; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Takeda A, 1998, LAB INVEST, V78, P1169; Takenouchi T, 2001, MOL CELL NEUROSCI, V17, P141, DOI 10.1006/mcne.2000.0923; Trojanowski JQ, 1998, ARCH NEUROL-CHICAGO, V55, P151, DOI 10.1001/archneur.55.2.151; Tsigelny IF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003135; Tsigelny IF, 2007, FEBS J, V274, P1862, DOI 10.1111/j.1742-4658.2007.05733.x; Tsigelny IF, 2008, NANOMED-NANOTECHNOL, V4, P350, DOI 10.1016/j.nano.2008.05.005; van Rooijen BD, 2009, BBA-BIOMEMBRANES, V1788, P1271, DOI 10.1016/j.bbamem.2009.03.010; van Rooijen BD, 2008, FEBS LETT, V582, P3788, DOI 10.1016/j.febslet.2008.10.009; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wolfgang WJ, 2005, P NATL ACAD SCI USA, V102, P11563, DOI 10.1073/pnas.0505321102; Xilouri M, 2008, AUTOPHAGY, V4, P917, DOI 10.4161/auto.6685; Xilouri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005515; Zhou C, 2004, MOL THER, V10, P1023, DOI 10.1016/j.ymthe.2004.08.019	63	307	341	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19338	10.1371/journal.pone.0019338	http://dx.doi.org/10.1371/journal.pone.0019338			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559417	Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700140
J	Nakamura, M; Fukami, M; Sugawa, F; Miyado, M; Nonomura, K; Ogata, T				Nakamura, Michiko; Fukami, Maki; Sugawa, Fumihiro; Miyado, Mami; Nonomura, Katsuya; Ogata, Tsutomu			Mamld1 Knockdown Reduces Testosterone Production and Cyp17a1 Expression in Mouse Leydig Tumor Cells	PLOS ONE			English	Article							CXORF6; HYPOSPADIAS; TESTIS; GENE; CANCER; FAMILY	Background: MAMLD1 is known to be a causative gene for hypospadias. Although previous studies have indicated that MAMLD1 mutations result in hypospadias primarily because of compromised testosterone production around the critical period for fetal sex development, the underlying mechanism(s) remains to be clarified. Furthermore, although functional studies have indicated a transactivation function of MAMLD1 for the non-canonical Notch target Hes3, its relevance to testosterone production remains unknown. To examine these matters, we performed Mamld1 knockdown experiments. Methodology/Principal Findings: Mamld1 knockdown was performed with two siRNAs, using mouse Leydig tumor cells (MLTCs). Mamld1 knockdown did not influence the concentrations of pregnenolone and progesterone but significantly reduced those of 17-OH pregnenolone, 17-OH progesterone, dehydroepiandrosterone, androstenedione, and testosterone in the culture media. Furthermore, Mamld1 knockdown significantly decreased Cyp17a1 expression, but did not affect expressions of other genes involved in testosterone biosynthesis as well as in insulin-like 3 production. Hes3 expression was not significantly altered. In addition, while 47 genes were significantly up-regulated (fold change >2.0x) and 38 genes were significantly down-regulated (fold change <0.5x), none of them was known to be involved in testosterone production. Cell proliferation analysis revealed no evidence for compromised proliferation of siRNA-transfected MLTCs. Conclusions/Significance: The results, in conjunction with the previous data, imply that Mamld1 enhances Cyp17a1 expression primarily in Leydig cells and permit to produce a sufficient amount of testosterone for male sex development, independently of the Hes3-related non-canonical Notch signaling.	[Nakamura, Michiko; Fukami, Maki; Sugawa, Fumihiro; Miyado, Mami; Ogata, Tsutomu] Natl Res Inst Child Hlth & Dev, Dept Mol Endocrinol, Tokyo, Japan; [Nakamura, Michiko; Nonomura, Katsuya] Hokkaido Univ, Grad Sch Med, Dept Renal & Genitourinary Surg, Sapporo, Hokkaido, Japan	National Center for Child Health & Development - Japan; Hokkaido University	Nakamura, M (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Mol Endocrinol, Tokyo, Japan.	tomogata@nch.go.jp	Fukami, Maki/ABE-4694-2020	Fukami, Maki/0000-0001-9971-4035; Ogata, Tsutomu/0000-0001-7178-9991	Ministry of Health, Labor and Welfare [H22-98]; Japan Society for the Promotion of Science (JSPS) [20390265, B-22791715]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [22132004 A01]; Grants-in-Aid for Scientific Research [22227002] Funding Source: KAKEN	Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grant for Research on Intractable Diseases (H22-98) from the Ministry of Health, Labor and Welfare (http://www.mhlw.go.jp/english/), and Grants-in-Aid for Scientific Research (B) (20390265) and for Young Scientists (B-22791715) from the Japan Society for the Promotion of Science (JSPS) (http://www.jsps.go.jp/english/), and by Grant-in-Aid for Scientific Research on Innovative Areas (22132004 A01) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann JC, 2008, WILLIAMS TXB ENDOCRI, V22, P783; ASCOLI M, 1978, P NATL ACAD SCI USA, V75, P99, DOI 10.1073/pnas.75.1.99; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Chen YG, 2010, EUR J MED GENET, V53, P122, DOI 10.1016/j.ejmg.2010.03.005; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Fukami M, 2008, J BIOL CHEM, V283, P5525, DOI 10.1074/jbc.M703289200; Fukami M, 2006, NAT GENET, V38, P1369, DOI 10.1038/ng1900; Hughes IA, 2008, EUR J ENDOCRINOL, V159, pS75, DOI 10.1530/EJE-08-0458; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kalfa N, 2008, EUR J ENDOCRINOL, V159, P453, DOI 10.1530/EJE-08-0085; Katoh M, 2007, INT J ONCOL, V31, P461; Lin L, 2008, SEX DEV, V2, P200, DOI 10.1159/000152036; Nef S, 1999, NAT GENET, V22, P295, DOI 10.1038/10364; Ogata T, 2009, HORM RES, V71, P245, DOI 10.1159/000208797; Panesar NS, 2003, STEROIDS, V68, P245, DOI 10.1016/S0039-128X(02)00183-6; REBOIS RV, 1982, J CELL BIOL, V94, P70, DOI 10.1083/jcb.94.1.70; Tang H, 2008, DEVELOPMENT, V135, P3745, DOI 10.1242/dev.024786	18	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19123	10.1371/journal.pone.0019123	http://dx.doi.org/10.1371/journal.pone.0019123			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559465	Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700069
J	Volstorf, J; Rieskamp, J; Stevens, JR				Volstorf, Jenny; Rieskamp, Joerg; Stevens, Jeffrey R.			The Good, the Bad, and the Rare: Memory for Partners in Social Interactions	PLOS ONE			English	Article							PRISONERS-DILEMMA; ENHANCED RECOGNITION; INDIRECT RECIPROCITY; DECISION-MAKING; FACES; COOPERATION; CHEATERS; EVOLUTION; GAME; PERSPECTIVE	For cooperation to evolve via direct reciprocity, individuals must track their partners' behavior to avoid exploitation. With increasing size of the interaction group, however, memory becomes error prone. To decrease memory effort, people could categorize partners into types, distinguishing cooperators and cheaters. We explored two ways in which people might preferentially track one partner type: remember cheaters or remember the rare type in the population. We assigned participants to one of three interaction groups which differed in the proportion of computer partners' types (defectors rare, equal proportion, or cooperators rare). We extended research on both hypotheses in two ways. First, participants experienced their partners repeatedly by interacting in Prisoner's Dilemma games. Second, we tested categorization of partners as cooperators or defectors in memory tests after a short and long retention interval (10 min and 1 week). Participants remembered rare partner types better than they remembered common ones at both retention intervals. We propose that the flexibility of responding to the environment suggests an ecologically rational memory strategy in social interactions.	[Volstorf, Jenny; Rieskamp, Joerg; Stevens, Jeffrey R.] Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Berlin, Germany; [Rieskamp, Joerg] Univ Basel, Dept Psychol, Basel, Switzerland	Max Planck Society; University of Basel	Volstorf, J (corresponding author), Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Berlin, Germany.	jevo@hrz.tu-chemnitz.de	Rieskamp, Joerg/D-4004-2013; Stevens, Jeffrey R/C-4619-2011	Rieskamp, Joerg/0000-0003-2632-8015; Stevens, Jeffrey R/0000-0003-2375-1360	Max Planck Society; Max Planck Research School on "Adapting Behavior in a Fundamentally Uncertain World"; Swiss National Science Foundation [100014_130191]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Max Planck Research School on "Adapting Behavior in a Fundamentally Uncertain World"; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The work on this article was supported by the Max Planck Society. J.V. received funding from the Max Planck Research School on "Adapting Behavior in a Fundamentally Uncertain World". J.R. was supported by a grant of the Swiss National Science Foundation No. 100014_130191. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Barclay P, 2008, COGNITION, V107, P817, DOI 10.1016/j.cognition.2007.11.013; Barclay P, 2006, HUM NATURE-INT BIOS, V17, P98, DOI 10.1007/s12110-006-1022-y; BATCHELDER WH, 1990, PSYCHOL REV, V97, P548, DOI 10.1037/0033-295X.97.4.548; Bayen UJ, 1996, J EXP PSYCHOL LEARN, V22, P197, DOI 10.1037/0278-7393.22.1.197; Bell R., 2009, EVOL PSYCHOL-US, V7, P317, DOI DOI 10.1177/147470490900700213; Bell R, 2010, COGNITION, V117, P261, DOI 10.1016/j.cognition.2010.08.020; Broder A, 2007, Z PSYCHOL, V215, P52, DOI 10.1027/0044-3409.215.1.52; Buchner A, 2009, EVOL HUM BEHAV, V30, P212, DOI 10.1016/j.evolhumbehav.2009.01.004; Cartwright J, 2000, EVOLUTION HUMAN BEHA; Chiappe D., 2004, EVOLUTIONARY PSYCHOL, V2, P108, DOI DOI 10.1177/147470490400200117; Cohen J., 1977, STAT POWER ANAL SOCI; COSMIDES L, 1989, ETHOL SOCIOBIOL, V10, P51, DOI 10.1016/0162-3095(89)90013-7; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Ebner NC, 2010, BEHAV RES METHODS, V42, P351, DOI 10.3758/BRM.42.1.351; Farrelly D, 2009, EVOLUTIONARY PSYCHOL, V6, P523; FREAN MR, 1994, P ROY SOC B-BIOL SCI, V257, P75, DOI 10.1098/rspb.1994.0096; Furlong EE, 2009, PSYCHOL SCI, V20, P11, DOI 10.1111/j.1467-9280.2008.02244.x; GIGERENZER G, 1992, COGNITION, V43, P127, DOI 10.1016/0010-0277(92)90060-U; Gigerenzer G., 2000, SIMPLE HEURISTICS MA; Haselton MG, 2000, J PERS SOC PSYCHOL, V78, P81, DOI 10.1037/0022-3514.78.1.81; Henrich J., 2007, WHY HUMANS COOPERATE; Hertwig R, 2001, BEHAV BRAIN SCI, V24, P383, DOI 10.1017/S0140525X01004149; Hunt R.R., 2006, DISTINCTIVENESS MEMO, P3, DOI [https://doi.org/10.1093/acprof:oso/9780195169669.003.0001, DOI 10.1093/ACPROF:OSO/9780195169669.003.0001, 10.1093/acprof:oso/9780195169669.003.0001]; Leimar O, 2001, P ROY SOC B-BIOL SCI, V268, P745, DOI 10.1098/rspb.2000.1573; Mealey L, 1996, ETHOL SOCIOBIOL, V17, P119, DOI 10.1016/0162-3095(95)00131-X; Mehl B, 2008, EVOL HUM BEHAV, V29, P35, DOI 10.1016/j.evolhumbehav.2007.08.001; Morey RD, 2008, TUTOR QUANT METHODS, V4, P61, DOI 10.20982/tqmp.04.2.p061; NOWAK MA, 1994, J THEOR BIOL, V168, P219, DOI 10.1006/jtbi.1994.1101; Oda R, 1997, EVOL HUM BEHAV, V18, P309, DOI 10.1016/S1090-5138(97)00014-7; Pachur T, 2009, PSYCHOL AGING, V24, P901, DOI 10.1037/a0017211; Restorff H, 1933, PSYCHOL FORSCH, V18, P299, DOI [DOI 10.1007/BF02409636, 10.1007/BF02409636]; Roberts G, 2008, P R SOC B, V275, P173, DOI 10.1098/rspb.2007.1134; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; SCHMIDT SR, 1991, MEM COGNITION, V19, P523, DOI 10.3758/BF03197149; Schneider W., 2002, E PRIME VERSION 20 C; Schneider W., 2002, E PRIME USERS GUIDE; Schooler LJ, 2005, BEHAV RES METHODS, V37, P3, DOI 10.3758/BF03206393; SCHULZ LS, 1971, J VERB LEARN VERB BE, V10, P322, DOI 10.1016/S0022-5371(71)80062-2; Shing YL, 2008, J EXP PSYCHOL GEN, V137, P495, DOI 10.1037/0096-3445.137.3.495; SIMON HA, 1956, PSYCHOL REV, V63, P129, DOI 10.1037/h0042769; Singer T, 2004, NEURON, V41, P653, DOI 10.1016/S0896-6273(04)00014-5; Slamecka JN, 1978, J EXPT PSYCHOL HUMAN, V4, P592; Stevens JR, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2010.00235; Stevens JR, 2005, ANNU REV ECOL EVOL S, V36, P499, DOI 10.1146/annurev.ecolsys.36.113004.083814; Todd PM, 2007, CURR DIR PSYCHOL SCI, V16, P167, DOI 10.1111/j.1467-8721.2007.00497.x; Trivers R, 1971, QUART REV BIOL, V46, P3; WIXTED JT, 1991, PSYCHOL SCI, V2, P409, DOI 10.1111/j.1467-9280.1991.tb00175.x	50	36	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18945	10.1371/journal.pone.0018945	http://dx.doi.org/10.1371/journal.pone.0018945			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	756OZ	21559490	Green Published, Green Accepted, gold			2022-12-27	WOS:000290024700040
J	Nitzsche, A; Paszkowski-Rogacz, M; Matarese, F; Janssen-Megens, EM; Hubner, NC; Schulz, H; de Vries, I; Ding, L; Huebner, N; Mann, M; Stunnenberg, HG; Buchholz, F				Nitzsche, Anja; Paszkowski-Rogacz, Maciej; Matarese, Filomena; Janssen-Megens, Eva M.; Hubner, Nina C.; Schulz, Herbert; de Vries, Ingrid; Ding, Li; Huebner, Norbert; Mann, Matthias; Stunnenberg, Hendrik G.; Buchholz, Frank			RAD21 Cooperates with Pluripotency Transcription Factors in the Maintenance of Embryonic Stem Cell Identity	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; CCCTC-BINDING FACTOR; DE-LANGE-SYNDROME; GENE-EXPRESSION; CHROMOSOME SEGREGATION; BAC TRANSGENEOMICS; SMC PROTEINS; RNAI SCREEN; NIPPED-B; CTCF	For self-renewal, embryonic stem cells (ESCs) require the expression of specific transcription factors accompanied by a particular chromosome organization to maintain a balance between pluripotency and the capacity for rapid differentiation. However, how transcriptional regulation is linked to chromosome organization in ESCs is not well understood. Here we show that the cohesin component RAD21 exhibits a functional role in maintaining ESC identity through association with the pluripotency transcriptional network. ChIP-seq analyses of RAD21 reveal an ESC specific cohesin binding pattern that is characterized by CTCF independent co-localization of cohesin with pluripotency related transcription factors Oct4, Nanog, Sox2, Esrrb and Klf4. Upon ESC differentiation, most of these binding sites disappear and instead new CTCF independent RAD21 binding sites emerge, which are enriched for binding sites of transcription factors implicated in early differentiation. Furthermore, knock-down of RAD21 causes expression changes that are similar to expression changes after Nanog depletion, demonstrating the functional relevance of the RAD21 - pluripotency transcriptional network association. Finally, we show that Nanog physically interacts with the cohesin or cohesin interacting proteins STAG1 and WAPL further substantiating this association. Based on these findings we propose that a dynamic placement of cohesin by pluripotency transcription factors contributes to a chromosome organization supporting the ESC expression program.	[Nitzsche, Anja; Paszkowski-Rogacz, Maciej; de Vries, Ingrid; Ding, Li; Buchholz, Frank] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Matarese, Filomena; Janssen-Megens, Eva M.; Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Dept Mol Biol, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Hubner, Nina C.; Mann, Matthias] Max Delbrueck Ctr Mol Med, Berlin, Germany; [Schulz, Herbert; Huebner, Norbert] Max Planck Inst Biochem, D-82152 Martinsried, Germany	Max Planck Society; Radboud University Nijmegen; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Max Planck Society	Nitzsche, A (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	buchholz@mpi-cbg.de	Mann, Matthias/A-3454-2013; Buchholz, Frank/B-4700-2017; Hubner, Nina C/C-4298-2008; Stunnenberg, Hendrik G./D-6875-2012	Mann, Matthias/0000-0003-1292-4799; Buchholz, Frank/0000-0002-4577-3344; Hubner, Nina C/0000-0002-7864-2877; Stunnenberg, Hendrik G./0000-0002-0066-1576	DFG [SPP1356]; DFG-SFB [655 BU1400/3-1]; EU [242129]; NGFN [01GS0859]	DFG(German Research Foundation (DFG)); DFG-SFB(German Research Foundation (DFG)); EU(European Commission); NGFN	This work was supported by the DFG SPP1356 'Pluripotency and cellular reprogramming'; DFG-SFB 655 BU1400/3-1 'Cells into tissues'; EU FP7 (242129) 'SyBoSS' and NGFN DiGtoP (01GS0859) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson S, 2008, CELL TISSUE RES, V331, P23, DOI 10.1007/s00441-007-0536-x; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Carretero M, 2010, CURR OPIN CELL BIOL, V22, P781, DOI 10.1016/j.ceb.2010.07.004; CHEESEMAN IM, 2005, SCI STKE, pP11, DOI DOI 10.1126/STKE.2662005P11; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; Dorsett D, 2009, CHROMOSOME RES, V17, P185, DOI 10.1007/s10577-009-9022-5; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gause M, 2008, BIOESSAYS, V30, P715, DOI 10.1002/bies.20787; Gerlich D, 2006, CURR BIOL, V16, P1571, DOI 10.1016/j.cub.2006.06.068; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hagstrom KA, 2003, NAT REV GENET, V4, P520, DOI 10.1038/nrg1110; Heidinger-Pauli JM, 2010, CURR BIOL, V20, P957, DOI 10.1016/j.cub.2010.04.018; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hou CH, 2010, P NATL ACAD SCI USA, V107, P3651, DOI 10.1073/pnas.0912087107; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kittler R, 2005, NAT METHODS, V2, P779, DOI 10.1038/nmeth1005-779; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Merkenschlager M, 2010, CURR OPIN GENET DEV, V20, P555, DOI 10.1016/j.gde.2010.05.007; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Nativio R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000739; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Onn I, 2008, ANNU REV CELL DEV BI, V24, P105, DOI 10.1146/annurev.cellbio.24.110707.175350; Panizza S, 2000, CURR BIOL, V10, P1557, DOI 10.1016/S0960-9822(00)00854-X; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; Peric-Hupkes D, 2008, CELL, V132, P925, DOI 10.1016/j.cell.2008.03.001; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Sekimata M, 2009, IMMUNITY, V31, P551, DOI 10.1016/j.immuni.2009.08.021; Stedman W, 2008, EMBO J, V27, P654, DOI 10.1038/emboj.2008.1; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; Tutter AV, 2009, J BIOL CHEM, V284, P3709, DOI 10.1074/jbc.M805677200; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Watrin E, 2006, CURR BIOL, V16, P863, DOI 10.1016/j.cub.2006.03.049; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Wendt KS, 2009, CHROMOSOME RES, V17, P201, DOI 10.1007/s10577-008-9017-7; Wood AJ, 2010, NAT REV GENET, V11, P391, DOI 10.1038/nrg2794; Xiong B, 2010, ANNU REV BIOCHEM, V79, P131, DOI 10.1146/annurev-biochem-061708-092640; Xu H., 2010, PLOS ONE, V5; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	57	89	91	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19470	10.1371/journal.pone.0019470	http://dx.doi.org/10.1371/journal.pone.0019470			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589869	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000290531100011
J	Voorman, A; Lumley, T; McKnight, B; Rice, K				Voorman, Arend; Lumley, Thomas; McKnight, Barbara; Rice, Kenneth			Behavior of QQ-Plots and Genomic Control in Studies of Gene-Environment Interaction	PLOS ONE			English	Article								Genome-wide association studies of gene-environment interaction (GxE GWAS) are becoming popular. As with main effects GWAS, quantile-quantile plots (QQ-plots) and Genomic Control are being used to assess and correct for population substructure. However, in G x E work these approaches can be seriously misleading, as we illustrate; QQ-plots may give strong indications of substructure when absolutely none is present. Using simulation and theory, we show how and why spurious QQ-plot inflation occurs in G x E GWAS, and how this differs from main-effects analyses. We also explain how simple adjustments to standard regression-based methods used in G x E GWAS can alleviate this problem.	[Voorman, Arend; Lumley, Thomas; McKnight, Barbara; Rice, Kenneth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Voorman, A (corresponding author), Univ Washington, Dept Biostat, Seattle, WA 98195 USA.	kenrice@u.washington.edu	Rice, Kenneth M/A-4150-2013	Rice, Kenneth M/0000-0001-5779-4495	NIH/NHLBI [T32 HL07183-34, R01 HL074745]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074745, T32HL007183] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was funded in part by NIH/NHLBI training grant T32 HL07183-34 and by research grant R01 HL074745. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cox D.R, 2006, PRINCIPLES STAT INFE; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Draper NR, 1998, APPL REGRESSION ANAL, P706, DOI 10.1002/9781118625590; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; GLAZER NL, 2010, GENOME WIDE IN PRESS; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Nolte IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006138; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; R Core Team, 2020, R LANG ENV STAT COMP; ROYALL RM, 1986, INT STAT REV, V54, P221, DOI 10.2307/1403146; StataCorp, 2021, STATA STAT SOFTWARE; Therneau T, 2009, SURVIVAL SURVIVAL AN; Thomas D, 2010, NAT REV GENET, V11, P259, DOI 10.1038/nrg2764; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Zeileis A., 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i10, DOI 10.18637/JSS.V011.I10]; Zeileis A, 2006, J STAT SOFTW, V16; Zhang F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003392	18	74	74	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19416	10.1371/journal.pone.0019416	http://dx.doi.org/10.1371/journal.pone.0019416			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589913	Green Submitted, Green Published, gold			2022-12-27	WOS:000290531100008
J	Koop, JAH; Huber, SK; Laverty, SM; Clayton, DH				Koop, Jennifer A. H.; Huber, Sarah K.; Laverty, Sean M.; Clayton, Dale H.			Experimental Demonstration of the Fitness Consequences of an Introduced Parasite of Darwin's Finches	PLOS ONE			English	Article							PHILORNIS-DOWNSI DIPTERA; SMALL GROUND FINCH; PEARLY-EYED THRASHERS; HEMATOPHAGOUS ECTOPARASITES; GROWTH; EXTINCTION; GEOSPIZA; MUSCIDAE; FLY; POPULATION	Background: Introduced parasites are a particular threat to small populations of hosts living on islands because extinction can occur before hosts have a chance to evolve effective defenses. An experimental approach in which parasite abundance is manipulated in the field can be the most informative means of assessing a parasite's impact on the host. The parasitic fly Philornis downsi, recently introduced to the Galapagos Islands, feeds on nestling Darwin's finches and other land birds. Several correlational studies, and one experimental study of mixed species over several years, reported that the flies reduce host fitness. Here we report the results of a larger scale experimental study of a single species at a single site over a single breeding season. Methodology/Principal Findings: We manipulated the abundance of flies in the nests of medium ground finches (Geospiza fortis) and quantified the impact of the parasites on nestling growth and fledging success. We used nylon nest liners to reduce the number of parasites in 24 nests, leaving another 24 nests as controls. A significant reduction in mean parasite abundance led to a significant increase in the number of nests that successfully fledged young. Nestlings in parasite-reduced nests also tended to be larger prior to fledging. Conclusions/Significance: Our results confirm that P. downsi has significant negative effects on the fitness of medium ground finches, and they may pose a serious threat to other species of Darwin's finches. These data can help in the design of management plans for controlling P. downsi in Darwin's finch breeding populations.	[Koop, Jennifer A. H.; Huber, Sarah K.; Clayton, Dale H.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Laverty, Sean M.] Univ Utah, Dept Math, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Koop, JAH (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	koop@utah.edu		Koop, Jennifer/0000-0002-5332-3618	National Science Foundation [DEB-0118794, DEB-0816877]; Society for the Study of Evolution; Division Of Environmental Biology [0816877] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Society for the Study of Evolution; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The work was supported by National Science Foundation (grants DEB-0118794 and DEB-0816877 to DHC) and the Society for the Study of Evolution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENDT WJ, 1985, AUK, V102, P281, DOI 10.2307/4086770; ARENDT WJ, 1985, AUK, V102, P270, DOI 10.2307/4086769; Atkinson CT, 2000, J WILDLIFE DIS, V36, P197, DOI 10.7589/0090-3558-36.2.197; BOAG PT, 1984, J ZOOL, V204, P413, DOI 10.1111/j.1469-7998.1984.tb02380.x; Causton CE, 2006, ANN ENTOMOL SOC AM, V99, P121, DOI 10.1603/0013-8746(2006)099[0121:AITAIF]2.0.CO;2; Charmantier A, 2004, EVOLUTION, V58, P203, DOI 10.1111/j.0014-3820.2004.tb01588.x; Christe P, 1996, BEHAV ECOL, V7, P127, DOI 10.1093/beheco/7.2.127; Cleaveland S., 2002, P139; COURI M S, 1985, Revista Brasileira de Entomologia, V29, P17; DODGE HR, 1971, STUDIA ENTOMOLOGIA, V14, P258; Dudaniec RY, 2007, BIOL CONSERV, V139, P325, DOI 10.1016/j.biocon.2007.07.006; Dudaniec RY, 2006, EMU, V106, P13, DOI 10.1071/MU04040; Dudaniec RY, 2006, AUSTRAL ECOL, V31, P88, DOI 10.1111/j.1442-9993.2006.01553.x; Dvorak M, 2004, ORYX, V38, P171, DOI 10.1017/S0030605304000316; Fessl B, 2002, IBIS, V144, P445, DOI 10.1046/j.1474-919X.2002.00076.x; Fessl B, 2006, BIOL CONSERV, V127, P55, DOI 10.1016/j.biocon.2005.07.013; Fessl B, 2006, PARASITOLOGY, V133, P739, DOI 10.1017/S0031182006001089; Fessl B., 2001, STUDIA DIPTEROLOGICA, V8, P317; Fessl B, 2010, PHILOS T R SOC B, V365, P1019, DOI 10.1098/rstb.2009.0288; Galligan TH, 2009, BIOL J LINN SOC, V98, P577, DOI 10.1111/j.1095-8312.2009.01309.x; Grant P. R., 1986, ECOLOGY EVOLUTION DA; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; Grant PR, 2005, BIOL CONSERV, V122, P499, DOI 10.1016/j.biocon.2004.09.001; GRANT PR, 1981, PROC R SOC SER B-BIO, V212, P403, DOI 10.1098/rspb.1981.0046; Huber SK, 2008, BIOL CONSERV, V141, P601, DOI 10.1016/j.biocon.2007.11.012; HurtrezBousses S, 1997, OECOLOGIA, V112, P514, DOI 10.1007/s004420050339; JACKSON JA, 1985, SIALIA, V7, P17; Lafferty KD, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P111; Lafferty KD, 2003, ECOL LETT, V6, P654, DOI 10.1046/j.1461-0248.2003.00480.x; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; MCCALLUM H, 1995, TRENDS ECOL EVOL, V10, P190, DOI 10.1016/S0169-5347(00)89050-3; Morrison BL, 2002, CONDOR, V104, P183, DOI 10.1650/0010-5422(2002)104[0183:FOHWNA]2.0.CO;2; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; O'Brien EL, 2001, J AVIAN BIOL, V32, P73, DOI 10.1034/j.1600-048X.2001.320110.x; O'Connor JA, 2010, ORYX, V44, P588, DOI 10.1017/S0030605310000086; O'Connor JA, 2010, J TROP ECOL, V26, P285, DOI 10.1017/S0266467409990678; O'Connor JA, 2010, BIODIVERS CONSERV, V19, P853, DOI 10.1007/s10531-009-9740-1; Parker PG, 2006, AUK, V123, P625, DOI 10.1642/0004-8038(2006)123[625:CMOTGI]2.0.CO;2; RICKLEFS RE, 1973, IBIS, V115, P177, DOI 10.1111/j.1474-919X.1973.tb02636.x; Simon A, 2004, PHYSIOL BIOCHEM ZOOL, V77, P492, DOI 10.1086/383512; Smith KF, 2006, CONSERV BIOL, V20, P1349, DOI 10.1111/j.1523-1739.2006.00524.x; Tarwater CE, 2009, ANIM BEHAV, V78, P1239, DOI 10.1016/j.anbehav.2009.07.040; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; WARNER RE, 1968, CONDOR, V70, P101, DOI 10.2307/1365954; Wiedenfeld David A., 2007, Pacific Conservation Biology, V13, P14; Wikelski M, 2004, ECOL SOC, V9	46	52	53	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19706	10.1371/journal.pone.0019706	http://dx.doi.org/10.1371/journal.pone.0019706			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589659	Green Published, gold			2022-12-27	WOS:000290483600025
J	Bishop, DVM; Anderson, M; Reid, C; Fox, AM				Bishop, Dorothy V. M.; Anderson, Mike; Reid, Corinne; Fox, Allison M.			Auditory Development between 7 and 11 Years: An Event-Related Potential (ERP) Study	PLOS ONE			English	Article							SYSTEM ACTIVITY; EVOKED POTENTIALS; THETA RESPONSE; MATURATION; COMPONENT; CHILDHOOD; ARTIFACTS; DYNAMICS; SPEECH; AGE	Background: There is considerable uncertainty about the time-course of central auditory maturation. On some indices, children appear to have adult-like competence by school age, whereas for other measures development follows a protracted course. Methodology: We studied auditory development using auditory event-related potentials (ERPs) elicited by tones in 105 children on two occasions two years apart. Just over half of the children were 7 years initially and 9 years at follow-up, whereas the remainder were 9 years initially and 11 years at follow-up. We used conventional analysis of peaks in the auditory ERP, independent component analysis, and time-frequency analysis. Principal Findings: We demonstrated maturational changes in the auditory ERP between 7 and 11 years, both using conventional peak measurements, and time-frequency analysis. The developmental trajectory was different for temporal vs. fronto-central electrode sites. Temporal electrode sites showed strong lateralisation of responses and no increase of low-frequency phase-resetting with age, whereas responses recorded from fronto-central electrode sites were not lateralised and showed progressive change with age. Fronto-central vs. temporal electrode sites also mapped onto independent components with differently oriented dipole sources in auditory cortex. A global measure of waveform shape proved to be the most effective method for distinguishing age bands. Conclusions/Significance: The results supported the idea that different cortical regions mature at different rates. The ICC measure is proposed as the best measure of 'auditory ERP age'.	[Bishop, Dorothy V. M.; Anderson, Mike; Fox, Allison M.] Univ Western Australia, Sch Psychol, Perth, WA 6009, Australia; [Reid, Corinne] Murdoch Univ, Sch Psychol, Perth, WA, Australia; [Bishop, Dorothy V. M.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Anderson, Mike; Reid, Corinne; Fox, Allison M.] Univ Western Australia, Neurocognit Dev Unit, Perth, WA 6009, Australia	University of Western Australia; Murdoch University; University of Oxford; University of Western Australia	Bishop, DVM (corresponding author), Univ Western Australia, Sch Psychol, Perth, WA 6009, Australia.	dorothy.bishop@psy.ox.ac.uk	Fox, Allison M/H-9218-2014	Fox, Allison M/0000-0001-5189-6271; reid, corinne/0000-0001-5252-041X; Bishop, Dorothy/0000-0002-2448-4033	Australian Research Council [DP0665616]; School of Psychology, University of Western Australia; Wellcome Trust [053335]	Australian Research Council(Australian Research Council); School of Psychology, University of Western Australia; Wellcome Trust(Wellcome TrustEuropean Commission)	Funding support was provided by the Australian Research Council DP0665616 (http://www.arc.gov.au/) and the School of Psychology, University of Western Australia. DB is supported by a Principal Research Fellowship affiliated with Wellcome Trust Programme Grant 053335 (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht R, 2000, CLIN NEUROPHYSIOL, V111, P2268, DOI 10.1016/S1388-2457(00)00464-8; Bishop DVM, 2007, DEVELOPMENTAL SCI, V10, P565, DOI 10.1111/j.1467-7687.2007.00619.x; BISHOP DV, 2010, DEVELOPMENTAL SCI, DOI DOI 10.1111/J.1467-7687.2010.00990.X; Bruneau N, 1997, PSYCHOPHYSIOLOGY, V34, P32, DOI 10.1111/j.1469-8986.1997.tb02413.x; Bruneau N., 1998, NEUROIMAGING CHILD N, P113, DOI 10.1007/978-3-642-95848-9_10; Burkard RF., 2007, AUDITORY EVOKED POTE; Ceponiene R, 1998, EVOKED POTENTIAL, V108, P345, DOI 10.1016/S0168-5597(97)00081-6; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2007, NEUROIMAGE, V34, P1443, DOI 10.1016/j.neuroimage.2006.11.004; Devous MD, 2006, J SPEECH LANG HEAR R, V49, P856, DOI 10.1044/1092-4388(2006/061); Fox AM, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-49; Gomes H, 2001, DEV BRAIN RES, V129, P147, DOI 10.1016/S0165-3806(01)00196-1; Holmes AE, 2004, EAR HEARING, V25, P397, DOI 10.1097/01.AUD.0000134553.60120.3A; Klimesch W, 2004, COGNITIVE BRAIN RES, V19, P302, DOI 10.1016/j.cogbrainres.2003.11.016; Kotecha R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004811; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Moore DR, 2010, PEDIATRICS, V126, pE382, DOI 10.1542/peds.2009-2826; MOORE DR, 2011, EAR HEARING, V32, P1; Morosan P, 2001, NEUROIMAGE, V13, P684, DOI 10.1006/nimg.2000.0715; Muller V, 2009, DEVELOPMENTAL SCI, V12, P839, DOI 10.1111/j.1467-7687.2009.00834.x; Ponton C, 2002, CLIN NEUROPHYSIOL, V113, P407, DOI 10.1016/S1388-2457(01)00733-7; Ponton CW, 2000, CLIN NEUROPHYSIOL, V111, P220, DOI 10.1016/S1388-2457(99)00236-9; Poulsen C, 2009, DEVELOPMENTAL SCI, V12, P220, DOI 10.1111/j.1467-7687.2008.00760.x; Scherg M, 1989, J Cogn Neurosci, V1, P336, DOI 10.1162/jocn.1989.1.4.336; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Shahin AJ, 2010, J NEUROPHYSIOL, V103, P218, DOI 10.1152/jn.00402.2009; Sharma A, 1997, EVOKED POTENTIAL, V104, P540, DOI 10.1016/S0168-5597(97)00050-6; Talarico M, 2007, AUDIOL NEURO-OTOL, V12, P13, DOI 10.1159/000096153; Tonnquist-Uhlen I, 2003, CLIN NEUROPHYSIOL, V114, P685, DOI 10.1016/S1388-2457(03)00005-1; Uhlhaas PJ, 2010, TRENDS COGN SCI, V14, P72, DOI 10.1016/j.tics.2009.12.002; WOLPAW JR, 1977, ELECTROEN CLIN NEURO, V43, P99, DOI 10.1016/0013-4694(77)90200-0; WOLPAW JR, 1975, ELECTROEN CLIN NEURO, V39, P609, DOI 10.1016/0013-4694(75)90073-5; Yordanova J, 1998, J PSYCHOPHYSIOL, V12, P113; Yordanova J, 1997, EVOKED POTENTIAL, V104, P418, DOI 10.1016/S0168-5597(97)00054-3	34	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e18993	10.1371/journal.pone.0018993	http://dx.doi.org/10.1371/journal.pone.0018993			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	761GX	21573058	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000290386800005
J	Flowers, MT; Paton, CM; O'Byrne, SM; Schiesser, K; Dawson, JA; Blaner, WS; Kendziorski, C; Ntambi, JM				Flowers, Matthew T.; Paton, Chad M.; O'Byrne, Sheila M.; Schiesser, Kevin; Dawson, John A.; Blaner, William S.; Kendziorski, Christina; Ntambi, James M.			Metabolic Changes in Skin Caused by Scd1 Deficiency: A Focus on Retinol Metabolism	PLOS ONE			English	Article							STEAROYL-COA DESATURASE; STRATUM-CORNEUM HYDRATION; TRANSEPIDERMAL WATER-LOSS; GENE-EXPRESSION; BARRIER FUNCTION; PROTECTS MICE; KERATINOCYTE PROLIFERATION; SEBACEOUS GLANDS; LIPID-METABOLISM; BINDING-PROTEIN	We previously reported that mice with skin-specific deletion of stearoyl-CoA desaturase-1 (Scd1) recapitulated the skin phenotype and hypermetabolism observed in mice with a whole-body deletion of Scd1. In this study, we first performed a diet-induced obesity experiment at thermoneutral temperature (33 degrees C) and found that skin-specific Scd1 knockout (SKO) mice still remain resistant to obesity. To elucidate the metabolic changes in the skin that contribute to the obesity resistance and skin phenotype, we performed microarray analysis of skin gene expression in male SKO and control mice fed a standard rodent diet. We identified an extraordinary number of differentially expressed genes that support the previously documented histological observations of sebaceous gland hypoplasia, inflammation and epidermal hyperplasia in SKO mice. Additionally, transcript levels were reduced in skin of SKO mice for genes involved in fatty acid synthesis, elongation and desaturation, which may be attributed to decreased abundance of key transcription factors including SREBP1c, ChREBP and LXR alpha. Conversely, genes involved in cholesterol synthesis were increased, suggesting an imbalance between skin fatty acid and cholesterol synthesis. Unexpectedly, we observed a robust elevation in skin retinol, retinoic acid and retinoic acid-induced genes in SKO mice. Furthermore, SEB-1 sebocytes treated with retinol and SCD inhibitor also display an elevation in retinoic acid-induced genes. These results highlight the importance of monounsaturated fatty acid synthesis for maintaining retinol homeostasis and point to disturbed retinol metabolism as a novel contributor to the Scd1 deficiency-induced skin phenotype.	[Flowers, Matthew T.; Paton, Chad M.; Schiesser, Kevin; Ntambi, James M.] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; [Flowers, Matthew T.; Paton, Chad M.; Ntambi, James M.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA; [Paton, Chad M.] W Virginia Univ, Div Anim & Nutr Sci, Morgantown, WV 26506 USA; [O'Byrne, Sheila M.; Blaner, William S.] Columbia Univ, Inst Human Nutr, New York, NY 10032 USA; [O'Byrne, Sheila M.; Blaner, William S.] Columbia Univ, Dept Med, New York, NY 10032 USA; [Dawson, John A.; Kendziorski, Christina] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; West Virginia University; Columbia University; Columbia University; University of Wisconsin System; University of Wisconsin Madison	Flowers, MT (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA.	mflowers@biochem.wisc.edu	Dawson, John/HDM-6702-2022		National Institutes of Health [R01DK062388, 667, R01DK079221]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062388, R01DK079221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant R01DK062388 (to J.M.N.), 667 and R01DK079221 to (W.S.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNER T, 1990, J INVEST DERMATOL, V95, P543, DOI 10.1111/1523-1747.ep12504896; Barua AB, 1998, MOL BIOTECHNOL, V10, P167, DOI 10.1007/BF02760863; Beaudoin GMJ, 2005, P NATL ACAD SCI USA, V102, P14653, DOI 10.1073/pnas.0507609102; Berry DC, 2007, PPAR RES, V2007, DOI 10.1155/2007/73256; Binczek E, 2007, BIOL CHEM, V388, P405, DOI 10.1515/BC.2007.046; BLANER WS, 1987, J BIOL CHEM, V262, P53; Bruford EA, 2008, NUCLEIC ACIDS RES, V36, pD445, DOI 10.1093/nar/gkm881; CHOUDHRY R, 1992, J ENDOCRINOL, V133, P467, DOI 10.1677/joe.0.1330467; Djalilian AR, 2006, J CLIN INVEST, V116, P1243, DOI 10.1172/JCI27186; Drake DR, 2008, J LIPID RES, V49, P4, DOI 10.1194/jlr.R700016-JLR200; ELIAS P M, 1987, Dermatologica (Basel), V175, P28; Elias PM, 2008, J LIPID RES, V49, P697, DOI 10.1194/jlr.R800002-JLR200; ELIAS PM, 1981, LAB INVEST, V44, P531; Everts HB, 2007, J INVEST DERMATOL, V127, P1593, DOI 10.1038/sj.jid.5700753; Feingold KR, 2009, J LIPID RES, V50, pS417, DOI 10.1194/jlr.R800039-JLR200; FEINGOLD KR, 1991, J INVEST DERMATOL, V96, P201, DOI 10.1111/1523-1747.ep12461153; Fisher GJ, 1996, FASEB J, V10, P1002, DOI 10.1096/fasebj.10.9.8801161; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Flowers JB, 2007, DIABETES, V56, P1228, DOI 10.2337/db06-1142; Flowers MI, 2009, BBA-MOL CELL BIOL L, V1791, P85, DOI 10.1016/j.bbalip.2008.12.011; Flowers MT, 2008, CURR OPIN LIPIDOL, V19, P248, DOI 10.1097/MOL.0b013e3282f9b54d; Fluhr JW, 2003, J INVEST DERMATOL, V120, P728, DOI 10.1046/j.1523-1747.2003.12134.x; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goren I, 2006, J INVEST DERMATOL, V126, P477, DOI 10.1038/sj.jid.5700063; GRUBAUER G, 1987, J LIPID RES, V28, P746; Hellemans K, 2003, J LIPID RES, V44, P280, DOI 10.1194/jlr.M200376-JLR200; House JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009837; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jennemann R, 2007, J BIOL CHEM, V282, P3083, DOI 10.1074/jbc.M610304200; Johnson EN, 1999, J INVEST DERMATOL, V112, P861, DOI 10.1046/j.1523-1747.1999.00595.x; JUGERT FK, 1994, J INVEST DERMATOL, V102, P970, DOI 10.1111/1523-1747.ep12384210; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kendziorski CM, 2003, STAT MED, V22, P3899, DOI 10.1002/sim.1548; Kurlandsky SB, 1996, J BIOL CHEM, V271, P15346, DOI 10.1074/jbc.271.26.15346; Lee SH, 2004, J LIPID RES, V45, P1674, DOI 10.1194/jlr.M400039-JLR200; Ma TH, 2002, J BIOL CHEM, V277, P17147, DOI 10.1074/jbc.M200925200; Man M, 2009, EXP DERMATOL, V18, P962, DOI 10.1111/j.1600-0625.2009.00882.x; Miyazaki M, 2001, J NUTR, V131, P2260, DOI 10.1093/jn/131.9.2260; Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Miyazaki M, 2009, BIOCHEM BIOPH RES CO, V380, P818, DOI 10.1016/j.bbrc.2009.01.183; Mizutani Y, 2009, BIOCHIMIE, V91, P784, DOI 10.1016/j.biochi.2009.04.001; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Nelson AM, 2008, J CLIN INVEST, V118, P1468, DOI 10.1172/JCI33869; Nelson AM, 2006, J INVEST DERMATOL, V126, P2178, DOI 10.1038/sj.jid.5700289; Nelson AM, 2009, DERM-ENDOCRINOL, V1, P177, DOI 10.4161/derm.1.3.8258; Newton MA, 2004, BIOSTATISTICS, V5, P155, DOI 10.1093/biostatistics/5.2.155; Newton MA, 2001, J COMPUT BIOL, V8, P37, DOI 10.1089/106652701300099074; Newton MA, 2007, ANN APPL STAT, V1, P85, DOI 10.1214/07-AOAS104; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; Ogawa K, 2005, J DERMATOL SCI, V40, P35, DOI 10.1016/j.jdermsci.2005.06.001; Oran A, 1997, BRIT J DERMATOL, V136, P519, DOI 10.1046/j.1365-2133.1997.6081584.x; Pares X, 2008, CELL MOL LIFE SCI, V65, P3936, DOI 10.1007/s00018-008-8591-3; R Development Core Team, 2005, R LANG ENV STAT COMP; Reichrath J, 2007, HORM METAB RES, V39, P71, DOI 10.1055/s-2007-958715; Rojek AM, 2007, P NATL ACAD SCI USA, V104, P3609, DOI 10.1073/pnas.0610894104; Romanowska M, 2008, J INVEST DERMATOL, V128, P110, DOI 10.1038/sj.jid.5700943; Romanowska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009701; Roos TC, 1998, PHARMACOL REV, V50, P315; Rowe JM, 2008, J INVEST DERMATOL, V128, P1866, DOI 10.1038/sj.jid.5701236; Sampath H, 2009, J BIOL CHEM, V284, P19961, DOI 10.1074/jbc.M109.014225; Schmuth M, 2008, J LIPID RES, V49, P499, DOI 10.1194/jlr.R800001-JLR200; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Schroder JM, 2006, CELL MOL LIFE SCI, V63, P469, DOI 10.1007/s00018-005-5364-0; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; SEIER AM, AM J PATHOL, V176, P246; SHAHIDULLAH M, 1969, BRIT J DERMATOL, V81, P722, DOI 10.1111/j.1365-2133.1969.tb15931.x; Shih MYS, 2009, J BIOL CHEM, V284, P4292, DOI 10.1074/jbc.M807503200; Skorija K, 2005, MOL ENDOCRINOL, V19, P855, DOI 10.1210/me.2004-0415; Smith KR, 2008, J LIPID RES, V49, P271, DOI 10.1194/jlr.R700015-JLR200; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sundberg JP, 2000, AM J PATHOL, V156, P2067, DOI 10.1016/S0002-9440(10)65078-X; Tamura K, 2009, CANCER RES, V69, P8133, DOI 10.1158/0008-5472.CAN-09-0775; Thompson Catherine C, 2009, Nucl Recept Signal, V7, pe010, DOI 10.1621/nrs.07010; Thorey IS, 2001, J BIOL CHEM, V276, P35818, DOI 10.1074/jbc.M104871200; Tsukada M, 2000, J INVEST DERMATOL, V115, P321, DOI 10.1046/j.1523-1747.2000.00066.x; Uchida Y, 2007, J BIOL CHEM, V282, P13211, DOI 10.1074/jbc.M611562200; Velasco P, 2009, J INVEST DERMATOL, V129, P2022, DOI 10.1038/jid.2008.447; WEI SH, 1995, J BIOL CHEM, V270, P866, DOI 10.1074/jbc.270.2.866; Wongsiriroj N, 2008, J BIOL CHEM, V283, P13510, DOI 10.1074/jbc.M800777200; Wu MH, 2009, AM J PATHOL, V175, P1041, DOI 10.2353/ajpath.2009.090241; Zheng Y, 1999, NAT GENET, V23, P268, DOI 10.1038/15446; Zheng Y, 2001, GENOMICS, V71, P182, DOI 10.1006/geno.2000.6429	87	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19734	10.1371/journal.pone.0019734	http://dx.doi.org/10.1371/journal.pone.0019734			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573029	Green Published, gold, Green Submitted			2022-12-27	WOS:000290386800035
J	Goerlich, KS; Witteman, J; Aleman, A; Martens, S				Goerlich, Katharina Sophia; Witteman, Jurriaan; Aleman, Andre; Martens, Sander			Hearing Feelings: Affective Categorization of Music and Speech in Alexithymia, an ERP Study	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; AUTOMATIC ACTIVATION; EMOTIONAL PROSODY; RECOGNITION; POTENTIALS; EXPRESSION; REACTIVITY; LANGUAGE; CONTEXT; CORTEX	Background: Alexithymia, a condition characterized by deficits in interpreting and regulating feelings, is a risk factor for a variety of psychiatric conditions. Little is known about how alexithymia influences the processing of emotions in music and speech. Appreciation of such emotional qualities in auditory material is fundamental to human experience and has profound consequences for functioning in daily life. We investigated the neural signature of such emotional processing in alexithymia by means of event-related potentials. Methodology: Affective music and speech prosody were presented as targets following affectively congruent or incongruent visual word primes in two conditions. In two further conditions, affective music and speech prosody served as primes and visually presented words with affective connotations were presented as targets. Thirty-two participants (16 male) judged the affective valence of the targets. We tested the influence of alexithymia on cross-modal affective priming and on N400 amplitudes, indicative of individual sensitivity to an affective mismatch between words, prosody, and music. Our results indicate that the affective priming effect for prosody targets tended to be reduced with increasing scores on alexithymia, while no behavioral differences were observed for music and word targets. At the electrophysiological level, alexithymia was associated with significantly smaller N400 amplitudes in response to affectively incongruent music and speech targets, but not to incongruent word targets. Conclusions: Our results suggest a reduced sensitivity for the emotional qualities of speech and music in alexithymia during affective categorization. This deficit becomes evident primarily in situations in which a verbalization of emotional information is required.	[Goerlich, Katharina Sophia; Aleman, Andre; Martens, Sander] Univ Groningen, Neuroimaging Ctr, Univ Med Ctr Groningen, Groningen, Netherlands; [Witteman, Jurriaan] Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands; [Witteman, Jurriaan] Leiden Univ, Ctr Linguist, Leiden, Netherlands	University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Goerlich, KS (corresponding author), Univ Groningen, Neuroimaging Ctr, Univ Med Ctr Groningen, Groningen, Netherlands.	K.Goerlich@med.umcg.nl	Aleman, Andre/E-1341-2012; Goerlich, Katharina S./J-6040-2016	Witteman, Jurriaan/0000-0003-3990-7569; Martens, Sander/0000-0001-8237-7984	European Science Foundation [044035001]	European Science Foundation(European Science Foundation (ESF)European Commission)	KG and AA were supported by a European Science Foundation EURYI grant (N.W.O. no. 044035001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aftanas L, 2004, INT J NEUROSCI, V114, P1443, DOI 10.1080/00207450490509230; Altenmuller E, 2002, NEUROPSYCHOLOGIA, V40, P2242, DOI 10.1016/S0028-3932(02)00107-0; Bagby RM, 2009, PERS INDIV DIFFER, V47, P413, DOI 10.1016/j.paid.2009.04.012; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P33, DOI 10.1016/0022-3999(94)90006-X; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Berthoz S, 2002, AM J PSYCHIAT, V159, P961, DOI 10.1176/appi.ajp.159.6.961; BERTHOZ S, 2005, EUROPEAN J PSYCHIAT, V20, P281; Bird G, 2010, BRAIN, V133, P1515, DOI 10.1093/brain/awq060; Boersma Paul, 1996, 132 I PHON SCI U AMS; Bostanov V, 2004, PSYCHOPHYSIOLOGY, V41, P259, DOI 10.1111/j.1469-8986.2003.00142.x; Chen J, 2008, NEUROSCI LETT, V445, P135, DOI 10.1016/j.neulet.2008.08.061; Daltrozzo J, 2009, J COGNITIVE NEUROSCI, V21, P1882, DOI 10.1162/jocn.2009.21113; Duan XJ, 2010, NEUROIMAGE, V52, P401, DOI 10.1016/j.neuroimage.2010.04.021; Fazio RH, 2001, COGNITION EMOTION, V15, P115, DOI 10.1080/02699930125908; FAZIO RH, 1986, J PERS SOC PSYCHOL, V50, P229, DOI 10.1037/0022-3514.50.2.229; Flores-Gutierrez EO, 2009, INT J PSYCHOPHYSIOL, V71, P43, DOI 10.1016/j.ijpsycho.2008.07.007; Franz M, 2004, AM J PSYCHIAT, V161, P728, DOI 10.1176/appi.ajp.161.4.728; Gundel H, 2004, J PSYCHOSOM RES, V56, P699, DOI 10.1016/S0022-3999(03)00124-7; Heaton P, 2009, ANN NY ACAD SCI, V1169, P318, DOI 10.1111/j.1749-6632.2009.04583.x; Hermans D, 2001, COGNITION EMOTION, V15, P143, DOI 10.1080/0269993004200033; Hill E, 2004, J AUTISM DEV DISORD, V34, P229, DOI 10.1023/B:JADD.0000022613.41399.14; Ilie G, 2006, MUSIC PERCEPT, V23, P319, DOI 10.1525/mp.2006.23.4.319; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; Klauer KC, 1997, J EXP PSYCHOL LEARN, V23, P246, DOI 10.1037/0278-7393.23.1.246; Klauer KC, 2003, PSYCHOLOGY OF EVALUATION, P7; Koelsch S, 2004, NAT NEUROSCI, V7, P302, DOI 10.1038/nn1197; Kooiman CG, 2002, J PSYCHOSOM RES, V53, P1083, DOI 10.1016/S0022-3999(02)00348-3; Kotz SA, 2007, BRAIN RES, V1151, P107, DOI 10.1016/j.brainres.2007.03.015; Kugel H, 2008, NEUROSCI LETT, V435, P40, DOI 10.1016/j.neulet.2008.02.005; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lane RD, 1996, PSYCHOSOM MED, V58, P203, DOI 10.1097/00006842-199605000-00002; Larsen JK, 2003, J PSYCHOSOM RES, V54, P533, DOI 10.1016/S0022-3999(02)00466-X; Logeswaran N, 2009, NEUROSCI LETT, V455, P129, DOI 10.1016/j.neulet.2009.03.044; Luminet O, 2006, J RES PERS, V40, P713, DOI 10.1016/j.jrp.2005.09.001; Lumley MA, 2007, J PERS ASSESS, V89, P230, DOI 10.1080/00223890701629698; Mantani T, 2005, BIOL PSYCHIAT, V57, P982, DOI 10.1016/j.biopsych.2005.01.047; MARIN MM, 2010, MUSIC ED, V1, P38; Meriau K, 2006, NEUROIMAGE, V33, P1016, DOI 10.1016/j.neuroimage.2006.07.031; Nater UM, 2006, INT J PSYCHOPHYSIOL, V62, P300, DOI 10.1016/j.ijpsycho.2006.05.011; Nemiah J.C., 1976, MODERN TRENDS PSYCHO, P430, DOI DOI 10.1016/J.IJNURSTU.2009.03.014; Pollatos O, 2008, PSYCHOPHYSIOLOGY, V45, P839, DOI 10.1111/j.1469-8986.2008.00674.x; Pouga L, 2010, HUM BRAIN MAPP, V31, P1469, DOI 10.1002/hbm.20953; PRKACHIN GC, 2008, PERSONALITY INDIVIDU, V46, P412; Reker M, 2010, CORTEX, V46, P658, DOI 10.1016/j.cortex.2009.05.008; Schirmer A, 2005, COGNITIVE BRAIN RES, V24, P442, DOI 10.1016/j.cogbrainres.2005.02.022; Schirmer A, 2002, COGNITIVE BRAIN RES, V14, P228, DOI 10.1016/S0926-6410(02)00108-8; Schirmer A, 2003, J COGNITIVE NEUROSCI, V15, P1135, DOI 10.1162/089892903322598102; Schneider W., 2002, E PRIME VERSION 20 C; Sollberger B, 2003, MUSIC PERCEPT, V20, P263, DOI 10.1525/mp.2003.20.3.263; Steinbeis N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002226; Steinbeis N, 2011, J COGNITIVE NEUROSCI, V23, P604, DOI 10.1162/jocn.2009.21383; Suslow T, 1998, EUR J PERSONALITY, V12, P433, DOI 10.1002/(SICI)1099-0984(199811/12)12:6<433::AID-PER320>3.0.CO;2-O; Suslow T, 2002, PERS INDIV DIFFER, V32, P541, DOI 10.1016/S0191-8869(01)00056-3; Suslow T, 2001, CAH PSYCHOL COGN, V20, P297; Swart M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005751; Taylor G.J., 1997, DISORDERS AFFECT REG; Taylor GJ, 2000, CAN J PSYCHIAT, V45, P134, DOI 10.1177/070674370004500203; Vermeulen N, 2006, COGNITION EMOTION, V20, P64, DOI 10.1080/02699930500304654; Vermeulen N, 2010, EUR J PERSONALITY, V24, P551, DOI 10.1002/per.758; Vorst HCM, 2001, PERS INDIV DIFFER, V30, P413, DOI 10.1016/S0191-8869(00)00033-7; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	61	38	42	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19501	10.1371/journal.pone.0019501	http://dx.doi.org/10.1371/journal.pone.0019501			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	761GX	21573026	Green Published, Green Submitted, gold			2022-12-27	WOS:000290386800017
J	Jaganathan, S; Yue, PB; Paladino, DC; Bogdanovic, J; Huo, Q; Turkson, J				Jaganathan, Soumya; Yue, Peibin; Paladino, David C.; Bogdanovic, Jelena; Huo, Qun; Turkson, James			A Functional Nuclear Epidermal Growth Factor Receptor, Src and Stat3 Heteromeric Complex in Pancreatic Cancer Cells	PLOS ONE			English	Article							DYNAMIC LIGHT-SCATTERING; GOLD NANOPARTICLE PROBES; NF-KAPPA-B; SIGNAL TRANSDUCER; GENE-REGULATION; EGF RECEPTOR; CYTOPLASMIC TRANSPORT; ADENOCARCINOMA CELLS; TRANSCRIPTION FACTOR; DRUG DISCOVERY	Evidence is presented for the nuclear presence of a functional heteromeric complex of epidermal growth factor (EGFR), Src and the Signal Transducer and Activator of Transcription (Stat) 3 proteins in pancreatic cancer cells. Stat3 remains nuclear and associated with Src or EGFR, respectively, upon the siRNA knockdown of EGFR or Src, demonstrating the resistance of the complex to the modulation of EGFR or Src alone. Significantly, chromatin immunoprecipitation (ChIP) analyses reveal the nuclear EGFR, Src and Stat3 complex is bound to the c-Myc promoter. The siRNA knockdown of EGFR or Src, or the pharmacological inhibition of Stat3 activity only marginally suppressed c-Myc expression. By contrast, the concurrent modulation of Stat3 and EGFR, or Stat3 and Src, or EGFR and Src strongly suppressed c-Myc expression, demonstrating that the novel nuclear heteromeric complex intricately regulates the c-Myc gene. The prevalence of the transcriptionally functional EGFR, Src, and Stat3 nuclear complex provides an additional and novel mechanism for supporting the pancreatic cancer phenotype and explains in part the insensitivity of pancreatic cancer cells to the inhibition of EGFR, Src or Stat3 alone.	[Jaganathan, Soumya; Yue, Peibin; Paladino, David C.; Turkson, James] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Bogdanovic, Jelena; Huo, Qun] Univ Cent Florida, NanoSci Technol Ctr, Orlando, FL 32816 USA; [Bogdanovic, Jelena; Huo, Qun] Univ Cent Florida, Dept Chem, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida	Jaganathan, S (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.	james.turkson@.ucf.edu	Yue, Peibin/J-9836-2015		National Cancer Institute [CA106439, CA128865]; Florida Department of Health Bankhead-Coley Foundation; World Gold Council; National Natural Science Foundation of China [20828006]; NATIONAL CANCER INSTITUTE [R01CA106439, R01CA128865] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Florida Department of Health Bankhead-Coley Foundation; World Gold Council; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute Grants CA106439 (JT) and CA128865 (JT), Florida Department of Health Bankhead-Coley Foundation (Bridge Grant) (HQ), partial support from World Gold Council (GROW Program) (HQ), and the National Natural Science Foundation of China Overseas Young Investigator Award (20828006) (HQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bild AH, 2002, EMBO J, V21, P3255, DOI 10.1093/emboj/cdf351; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Bognadovic J, 2010, P SPIE IN PRESS, V7674; Cao XM, 1996, MOL CELL BIOL, V16, P1595; COFFER PJ, 1995, BIOCHEM BIOPH RES CO, V210, P74, DOI 10.1006/bbrc.1995.1629; Dai Q, 2008, J AM CHEM SOC, V130, P8138, DOI 10.1021/ja801947e; Darnell JE, 2005, NAT MED, V11, P595, DOI 10.1038/nm0605-595; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DeArmond D, 2003, ONCOGENE, V22, P7781, DOI 10.1038/sj.onc.1206966; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Guo GG, 2002, J INTERF CYTOK RES, V22, P555, DOI 10.1089/10799900252982034; Hong OY, 2000, AM J PATHOL, V157, P1623, DOI 10.1016/S0002-9440(10)64800-6; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; Huo LF, 2010, P NATL ACAD SCI USA, V107, P16125, DOI 10.1073/pnas.1000743107; Huo Q, 2010, COLLOID SURFACE B, V78, P259, DOI 10.1016/j.colsurfb.2010.03.012; Jaganathan S, 2010, J PHARMACOL EXP THER, V333, P373, DOI 10.1124/jpet.109.162669; Jans H, 2009, ANAL CHEM, V81, P9425, DOI 10.1021/ac901822w; Jimeno A, 2008, CANCER RES, V68, P2841, DOI 10.1158/0008-5472.CAN-07-5200; Kawashima T, 2009, MOL CELL BIOL, V29, P1796, DOI 10.1128/MCB.01423-08; KORC M, 1986, P NATL ACAD SCI USA, V83, P5141, DOI 10.1073/pnas.83.14.5141; Liao HJ, 2007, MOL BIOL CELL, V18, P1064, DOI 10.1091/mbc.E06-09-0802; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Liu X, 2008, J AM CHEM SOC, V130, P2780, DOI 10.1021/ja711298b; Liu X, 2009, J IMMUNOL METHODS, V349, P38, DOI 10.1016/j.jim.2009.07.015; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Lo HW, 2006, J CELL BIOCHEM, V98, P1570, DOI 10.1002/jcb.20876; Lo HW, 2006, BREAST CANCER RES TR, V95, P211, DOI 10.1007/s10549-005-9011-0; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Ndubuisi MI, 1999, J BIOL CHEM, V274, P25499, DOI 10.1074/jbc.274.36.25499; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Scholz A, 2003, GASTROENTEROLOGY, V125, P891, DOI 10.1016/S0016-5085(03)01064-3; Sehgal PB, 2002, J BIOL CHEM, V277, P12067, DOI 10.1074/jbc.M200018200; Shao H, 2003, CANCER RES, V63, P3923; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Siddiquee KAZ, 2007, ACS CHEM BIOL, V2, P787, DOI 10.1021/cb7001973; Sinibaldi D, 2000, ONCOGENE, V19, P5419, DOI 10.1038/sj.onc.1203947; Thelemann A, 2005, MOL CELL PROTEOMICS, V4, P356, DOI 10.1074/mcp.M400118-MCP200; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; Trevino JG, 2006, AM J PATHOL, V168, P962, DOI 10.2353/ajpath.2006.050570; Trevino Jose G., 2006, Angiogenesis, V9, P101, DOI 10.1007/s10456-006-9038-9; Turkson J, 2001, J BIOL CHEM, V276, P45443, DOI 10.1074/jbc.M107527200; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Turkson J, 2004, EXPERT OPIN THER TAR, V8, P409, DOI 10.1517/14728222.8.5.409; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yue P, 2009, EXPERT OPIN INV DRUG, V18, P45, DOI 10.1517/13543780802565791 ; Zhang Y, 2000, J BIOL CHEM, V275, P24935, DOI 10.1074/jbc.M002383200; Zhao W, 2010, J BIOL CHEM     0831	51	70	72	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19605	10.1371/journal.pone.0019605	http://dx.doi.org/10.1371/journal.pone.0019605			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573184	Green Published, gold			2022-12-27	WOS:000290256400034
J	Fernandez-Brando, RJ; Bentancor, LV; Mejias, MP; Ramos, MV; Exeni, A; Exeni, C; Laso, MD; Exeni, R; Isturiz, MA; Palermo, MS				Fernandez-Brando, Romina J.; Bentancor, Leticia V.; Pilar Mejias, Maria; Victoria Ramos, Maria; Exeni, Andrea; Exeni, Claudia; del Carmen Laso, Maria; Exeni, Ramon; Isturiz, Martin A.; Palermo, Marina S.			Antibody Response to Shiga Toxins in Argentinean Children with Enteropathic Hemolytic Uremic Syndrome at Acute and Long-Term Follow-Up Periods	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; LINKED IMMUNOSORBENT ASSAYS; PROTECT MICE; RISK FACTOR; INFECTION; VEROCYTOTOXIN; DIARRHEA; STX2; LIPOPOLYSACCHARIDE; TRANSMISSION	Shiga toxin (Stx)-producing Escherichia coli (STEC) infection is associated with a broad spectrum of clinical manifestations that include diarrhea, hemorrhagic colitis, and hemolytic uremic syndrome (HUS). Systemic Stx toxemia is considered to be central to the genesis of HUS. Distinct methods have been used to evaluate anti-Stx response for immunodiagnostic or epidemiological analysis of HUS cases. The development of enzyme-linked immunosorbent assay (ELISA) and western blot (WB) assay to detect the presence of specific antibodies to Stx has introduced important advantages for serodiagnosis of HUS. However, application of these methods for seroepidemiological studies in Argentina has been limited. The aim of this work was to develop an ELISA to detect antibodies against the B subunit of Stx2, and a WB to evaluate antibodies against both subunits of Stx2 and Stx1, in order to analyze the pertinence and effectiveness of these techniques in the Argentinean population. We studied 72 normal healthy children (NHC) and 105 HUS patients of the urban pediatric population from the surrounding area of Buenos Aires city. Using the WB method we detected 67% of plasma from NHC reactive for Stx2, but only 8% for Stx1. These results are in agreement with the broad circulation of Stx2-expressing STEC in Argentina and the endemic behavior of HUS in this country. Moreover, the simultaneous evaluation by the two methods allowed us to differentiate acute HUS patients from NHC with a great specificity and accuracy, in order to confirm the HUS etiology when pathogenic bacteria were not isolated from stools.	[Fernandez-Brando, Romina J.; Bentancor, Leticia V.; Pilar Mejias, Maria; Victoria Ramos, Maria; Isturiz, Martin A.; Palermo, Marina S.] Acad Nacl Med Buenos Aires, Inst Invest Hematol, Div Inmunol, Buenos Aires, DF, Argentina; [Fernandez-Brando, Romina J.; Pilar Mejias, Maria; Isturiz, Martin A.; Palermo, Marina S.] Consejo Nacl Invest Cient & Tecn, Inst Leucemia Expt, RA-1033 Buenos Aires, DF, Argentina; [Exeni, Andrea] Hosp Austral, Serv Nefrol, Pilar, Buenos Aires, Argentina; [Exeni, Claudia; del Carmen Laso, Maria; Exeni, Ramon] Hosp Municipal Nino, Dept Nefrol, La Matanza, Buenos Aires, Argentina	Buenos Aires National Academy of Medicine; IIHEMA - Instituto de Investigaciones Hematologicas; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Austral University; Hospital Universitario Austral	Fernandez-Brando, RJ (corresponding author), Acad Nacl Med Buenos Aires, Inst Invest Hematol, Div Inmunol, Buenos Aires, DF, Argentina.	mspalermo@hematologia.anm.edu.ar			Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina [PICT 06/591]	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT)	This work was supported by PICT 06/591 from the Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina (to M. S. P). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRETT TJ, 1991, CURR MICROBIOL, V23, P189, DOI 10.1007/BF02092278; BITZAN M, 1993, EPIDEMIOL INFECT, V110, P183, DOI 10.1017/S0950268800068102; BITZAN M, 1991, J PEDIATR-US, V119, P380, DOI 10.1016/S0022-3476(05)82049-9; Bitzan M, 2009, KIDNEY INT, V75, pS62, DOI 10.1038/ki.2008.624; CAPRIOLI A, 1992, J INFECT DIS, V166, P154, DOI 10.1093/infdis/166.1.154; Cornick NA, 2002, J INFECT DIS, V186, P57, DOI 10.1086/341295; Creydt VP, 2004, BRAZ J MED BIOL RES, V37, P799, DOI 10.1590/S0100-879X2004000600004; Fraser ME, 2004, J BIOL CHEM, V279, P27511, DOI 10.1074/jbc.M401939200; HEAD SC, 1988, LANCET, V2, P751; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; Karmali MA, 2003, J INFECT DIS, V188, P1724, DOI 10.1086/379726; KARMALI MA, 1994, J CLIN MICROBIOL, V32, P1457, DOI 10.1128/JCM.32.6.1457-1463.1994; Karmali MA, 2003, J CLIN MICROBIOL, V41, P4930, DOI 10.1128/JCM.41.11.4930-4940.2003; KARMALI MA, 1989, CLIN MICROBIOL REV, V2, P15, DOI 10.1128/CMR.2.1.15-38.1989; KARMALI MA, 1983, LANCET, V1, P619, DOI 10.1016/s0140-6736(83)91795-6; Karmali MA, 2009, KIDNEY INT, V75, pS4, DOI 10.1038/ki.2008.608; Krautz-Peterson G, 2008, INFECT IMMUN, V76, P1931, DOI 10.1128/IAI.01282-07; Kulkarni H, 2002, COMP IMMUNOL MICROB, V25, P249, DOI 10.1016/S0147-9571(02)00011-5; Li YL, 2000, INFECT IMMUN, V68, P5090, DOI 10.1128/IAI.68.9.5090-5095.2000; LINDGREN SW, 1994, INFECT IMMUN, V62, P623, DOI 10.1128/IAI.62.2.623-631.1994; LOPEZ EL, 1989, J INFECT DIS, V160, P469, DOI 10.1093/infdis/160.3.469; Ludwig K, 2002, J CLIN MICROBIOL, V40, P1773, DOI 10.1128/JCM.40.5.1773-1782.2002; Ludwig K, 2002, J INFECT DIS, V186, P566, DOI 10.1086/341781; Ludwig K, 2001, J CLIN MICROBIOL, V39, P2272, DOI 10.1128/JCM.39.6.2272-2279.2001; Masana MO, 2010, J FOOD PROTECT, V73, P649, DOI 10.4315/0362-028X-73.4.649; OBRIEN AD, 1992, CURR TOP MICROBIOL, V180, P65; Palermo MS, 2009, EXPERT REV ANTI-INFE, V7, P697, DOI [10.1586/eri.09.49, 10.1586/ERI.09.49]; Reymond D, 1997, J CLIN MICROBIOL, V35, P609, DOI 10.1128/JCM.35.3.609-613.1997; Rivas M, 2006, FOODBORNE PATHOG DIS, V3, P88, DOI 10.1089/fpd.2006.3.88; Rivas M, 2006, MEDICINA-BUENOS AIRE, V66, P27; ROWE PC, 1993, EPIDEMIOL INFECT, V110, P9, DOI 10.1017/S0950268800050627; ROWE PC, 1994, J PEDIATR-US, V124, P21, DOI 10.1016/S0022-3476(94)70249-7; Serna A, 2008, CURR OPIN GASTROEN, V24, P38, DOI 10.1097/MOG.0b013e3282f2dfb8; Sheoran AS, 2003, INFECT IMMUN, V71, P3125, DOI 10.1128/IAI.71.6.3125-3130.2003; Smith MJ, 2006, VACCINE, V24, P4122, DOI 10.1016/j.vaccine.2006.02.035; Tzipori S, 2004, CLIN MICROBIOL REV, V17, P926, DOI 10.1128/CMR.17.4.926-941.2004; Wen SX, 2006, VACCINE, V24, P1142, DOI 10.1016/j.vaccine.2005.08.094; Werber D, 2008, CLIN INFECT DIS, V46, P1189, DOI 10.1086/587670; YAMADA S, 1993, MICROBIOL IMMUNOL, V37, P111, DOI 10.1111/j.1348-0421.1993.tb03187.x; YAMADA S, 1994, J CLIN MICROBIOL, V32, P955, DOI 10.1128/JCM.32.4.955-959.1994	40	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19136	10.1371/journal.pone.0019136	http://dx.doi.org/10.1371/journal.pone.0019136			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559455	gold, Green Published, Green Submitted			2022-12-27	WOS:000290024700074
J	Kapadia, D; Sadikovic, A; Vanloubbeeck, Y; Brockstedt, D; Fong, L				Kapadia, Dilnawaz; Sadikovic, Aida; Vanloubbeeck, Yannick; Brockstedt, Dirk; Fong, Lawrence			Interplay between CD8 alpha(+) Dendritic Cells and Monocytes in Response to Listeria monocytogenes Infection Attenuates T Cell Responses	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; IN-VIVO; IMMUNE-RESPONSES; INTERFERON-PRODUCTION; MONOCLONAL-ANTIBODY; MICE DEFICIENT; NITRIC-OXIDE; IFN-GAMMA; ACTIVATION; RESISTANCE	During the course of a microbial infection, different antigen presenting cells (APCs) are exposed and contribute to the ensuing immune response. CD8 alpha(+) dendritic cells (DCs) are an important coordinator of early immune responses to the intracellular bacteria Listeria monocytogenes (Lm) and are crucial for CD8(+) T cell immunity. In this study, we examine the contribution of different primary APCs to inducing immune responses against Lm. We find that CD8 alpha(+) DCs are the most susceptible to infection while plasmacytoid DCs are not infected. Moreover, CD8 alpha(+) DCs are the only DC subset capable of priming an immune response to Lm in vitro and are also the only APC studied that do so when transferred into beta 2 microglobulin deficient mice which lack endogenous cross-presentation. Upon infection, CD11b(+) DCs primarily secrete low levels of TNF alpha while CD8 alpha(+) DCs secrete IL-12 p70. Infected monocytes secrete high levels of TNFa and IL-12p70, cytokines associated with activated inflammatory macrophages. Furthermore, co-culture of infected CD8 alpha(+) DCs and CD11b(+) DCs with monocytes enhances production of IL-12 p70 and TNF alpha. However, the presence of monocytes in DC/T cell co-cultures attenuates T cell priming against Lm-derived antigens in vitro and in vivo. This suppressive activity of spleen-derived monocytes is mediated in part by both TNF alpha and inducible nitric oxide synthase (iNOS). Thus these monocytes enhance IL-12 production to Lm infection, but concurrently abrogate DC-mediated T cell priming.	[Kapadia, Dilnawaz; Sadikovic, Aida; Vanloubbeeck, Yannick; Fong, Lawrence] Univ Calif San Francisco, Dept Med, Div Hematol Oncol, San Francisco, CA 94143 USA; [Brockstedt, Dirk] Aduro Biotech, Berkeley, CA USA	University of California System; University of California San Francisco	Kapadia, D (corresponding author), Univ Calif San Francisco, Dept Med, Div Hematol Oncol, San Francisco, CA 94143 USA.	lfong@medicine.ucsf.edu			National Institutes of Health [CA R01 102303]; NATIONAL CANCER INSTITUTE [R01CA102303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health CA R01 102303. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dirk Brockstedt is an employee of Aduro Biotech and played a role in the design of the experiments and analysis.	Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Belz GT, 2005, J IMMUNOL, V175, P196, DOI 10.4049/jimmunol.175.1.196; Brockstedt DG, 2005, NAT MED, V11, P853, DOI 10.1038/nm1276; Brockstedt DG, 2004, P NATL ACAD SCI USA, V101, P13832, DOI 10.1073/pnas.0406035101; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Conlan JW, 1996, J MED MICROBIOL, V44, P295, DOI 10.1099/00222615-44-4-295; CONLAN JW, 1994, J EXP MED, V179, P259, DOI 10.1084/jem.179.1.259; Cossart P, 2008, MICROBES INFECT, V10, P1041, DOI 10.1016/j.micinf.2008.07.043; CZUPRYNSKI CJ, 1994, INFECT IMMUN, V62, P5161, DOI 10.1128/IAI.62.11.5161-5163.1994; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; DUNN PL, 1991, INFECT IMMUN, V59, P2892, DOI 10.1128/IAI.59.9.2892-2900.1991; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Humann J, 2010, J IMMUNOL, V184, P5172, DOI 10.4049/jimmunol.0903759; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Jiang J, 2003, J IMMUNOL, V171, P4352, DOI 10.4049/jimmunol.171.8.4352; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kang SJ, 2008, IMMUNITY, V29, P819, DOI 10.1016/j.immuni.2008.09.017; Kim TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004204; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Le Borgne M, 2006, IMMUNITY, V24, P191, DOI 10.1016/j.immuni.2006.01.005; Lu LN, 1996, J IMMUNOL, V157, P3577; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Merrick JC, 1997, AM J PATHOL, V151, P785; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Neuenhahn M, 2007, IMMUNOL LETT, V114, P66, DOI 10.1016/j.imlet.2007.09.007; Neuenhahn M, 2006, IMMUNITY, V25, P619, DOI 10.1016/j.immuni.2006.07.017; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Pron B, 2001, CELL MICROBIOL, V3, P331, DOI 10.1046/j.1462-5822.2001.00120.x; Ren GW, 2008, J IMMUNOL, V181, P3277, DOI 10.4049/jimmunol.181.5.3277; ROGERS HW, 1993, INFECT IMMUN, V61, P5090, DOI 10.1128/IAI.61.12.5090-5096.1993; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Steinman RM, 2007, EUR J IMMUNOL, V37, pS53, DOI 10.1002/eji.200737400; Tada Y, 2006, BRIT J DERMATOL, V154, P1180, DOI 10.1111/j.1365-2133.2006.07180.x; Tam MA, 2006, CELL MICROBIOL, V8, P1172, DOI 10.1111/j.1462-5822.2006.00700.x; Torres D, 2004, INFECT IMMUN, V72, P2131, DOI 10.1128/IAI.72.4.2131-2139.2004; Unanue ER, 1997, CURR OPIN IMMUNOL, V9, P35, DOI 10.1016/S0952-7915(97)80156-2; Zenewicz LA, 2007, MICROBES INFECT, V9, P1208, DOI 10.1016/j.micinf.2007.05.008; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	49	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19376	10.1371/journal.pone.0019376	http://dx.doi.org/10.1371/journal.pone.0019376			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559416	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700152
J	Petrini, K; Crabbe, F; Sheridan, C; Pollick, FE				Petrini, Karin; Crabbe, Frances; Sheridan, Carol; Pollick, Frank E.			The Music of Your Emotions: Neural Substrates Involved in Detection of Emotional Correspondence between Auditory and Visual Music Actions	PLOS ONE			English	Article							EVENT-RELATED FMRI; AUDIOVISUAL INTEGRATION; BRAIN-REGIONS; PICTURES; CHILDREN; SIGNALS; SPEECH; INSULA; CONNECTIVITY; ACTIVATION	In humans, emotions from music serve important communicative roles. Despite a growing interest in the neural basis of music perception, action and emotion, the majority of previous studies in this area have focused on the auditory aspects of music performances. Here we investigate how the brain processes the emotions elicited by audiovisual music performances. We used event-related functional magnetic resonance imaging, and in Experiment 1 we defined the areas responding to audiovisual (musician's movements with music), visual (musician's movements only), and auditory emotional (music only) displays. Subsequently a region of interest analysis was performed to examine if any of the areas detected in Experiment 1 showed greater activation for emotionally mismatching performances (combining the musician's movements with mismatching emotional sound) than for emotionally matching music performances (combining the musician's movements with matching emotional sound) as presented in Experiment 2 to the same participants. The insula and the left thalamus were found to respond consistently to visual, auditory and audiovisual emotional information and to have increased activation for emotionally mismatching displays in comparison with emotionally matching displays. In contrast, the right thalamus was found to respond to audiovisual emotional displays and to have similar activation for emotionally matching and mismatching displays. These results suggest that the insula and left thalamus have an active role in detecting emotional correspondence between auditory and visual information during music performances, whereas the right thalamus has a different role.	[Petrini, Karin; Crabbe, Frances; Sheridan, Carol; Pollick, Frank E.] Univ Glasgow, Dept Psychol, Glasgow, Lanark, Scotland	University of Glasgow	Petrini, K (corresponding author), Univ Glasgow, Dept Psychol, Glasgow, Lanark, Scotland.	karin@psy.gla.ac.uk	Pollick, Frank/F-3186-2011	Pollick, Frank/0000-0002-7212-4622; Petrini, Karin/0000-0001-5354-5600	Economic and Social Research Council (ESRC) [RES-060-25-0010]; ESRC [ES/E020933/1] Funding Source: UKRI; Economic and Social Research Council [ES/E020933/1] Funding Source: researchfish	Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	K.P. and F.E.P. are supported by a grant from the Economic and Social Research Council (ESRC) (RES-060-25-0010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; Baumgartner T, 2006, BRAIN RES, V1075, P151, DOI 10.1016/j.brainres.2005.12.065; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Buccino G, 2004, NEURON, V42, P323, DOI 10.1016/S0896-6273(04)00181-3; Bushara KO, 2001, J NEUROSCI, V21, P300, DOI 10.1523/JNEUROSCI.21-01-00300.2001; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; CALVERT GA, 2004, HDB MULTISENSORY PRO, P483; Chapin H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013812; Collignon O, 2008, BRAIN RES, V1242, P126, DOI 10.1016/j.brainres.2008.04.023; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Ethofer T, 2006, PROG BRAIN RES, V156, P345, DOI 10.1016/S0079-6123(06)56019-4; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Griffiths TD, 2004, J NEUROL NEUROSUR PS, V75, P344; Kirschner S, 2009, J EXP CHILD PSYCHOL, V102, P299, DOI 10.1016/j.jecp.2008.07.005; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; Koelsch S, 2005, NEUROIMAGE, V25, P1068, DOI 10.1016/j.neuroimage.2004.12.050; Koelsch S, 2010, TRENDS COGN SCI, V14, P131, DOI 10.1016/j.tics.2010.01.002; Komura Y, 2005, NAT NEUROSCI, V8, P1203, DOI 10.1038/nn1528; Kreifelts B, 2007, NEUROIMAGE, V37, P1445, DOI 10.1016/j.neuroimage.2007.06.020; Krumhansl CL, 1997, CAN J EXP PSYCHOL, V51, P336, DOI 10.1037/1196-1961.51.4.336; Leibenluft E, 2004, BIOL PSYCHIAT, V56, P225, DOI 10.1016/j.biopsych.2004.05.017; Menon V, 2005, NEUROIMAGE, V28, P175, DOI 10.1016/j.neuroimage.2005.05.053; Miller LM, 2005, J NEUROSCI, V25, P5884, DOI 10.1523/JNEUROSCI.0896-05.2005; MUFSON EJ, 1984, J COMP NEUROL, V227, P109, DOI 10.1002/cne.902270112; Musacchia G, 2007, P NATL ACAD SCI USA, V104, P15894, DOI 10.1073/pnas.0701498104; Naghavi HR, 2007, NEUROSCI LETT, V422, P77, DOI 10.1016/j.neulet.2007.06.009; Petrini K, 2010, BRAIN RES, V1323, P139, DOI 10.1016/j.brainres.2010.02.012; Saito DN, 2005, CEREB CORTEX, V15, P1750, DOI 10.1093/cercor/bhi052; Stewart L, 2006, BRAIN, V129, P2533, DOI 10.1093/brain/awl171; Vines BW, 2006, COGNITION, V101, P80, DOI 10.1016/j.cognition.2005.09.003; Wager TD, 2003, NEUROIMAGE, V18, P293, DOI 10.1016/S1053-8119(02)00046-0; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2	34	24	26	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19165	10.1371/journal.pone.0019165	http://dx.doi.org/10.1371/journal.pone.0019165			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	756OZ	21559468	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000290024700087
J	Masharani, UB; Maddux, BA; Li, XJ; Sakkas, GK; Mulligan, K; Schambelan, M; Goldfine, ID; Youngren, JF				Masharani, Umesh B.; Maddux, Betty A.; Li, Xiaojuan; Sakkas, Giorgos K.; Mulligan, Kathleen; Schambelan, Morris; Goldfine, Ira D.; Youngren, Jack F.			Insulin Resistance in Non-Obese Subjects Is Associated with Activation of the JNK Pathway and Impaired Insulin Signaling in Skeletal Muscle	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; TYPE-2 DIABETIC PARENTS; PROTEIN-KINASE-C; BETA-CELL; SERINE PHOSPHORYLATION; TRIGLYCERIDE CONTENT; GLUCOSE-TRANSPORT; ANGIOTENSIN-II; ABDOMINAL FAT; BODY-FAT	Background: The pathogenesis of insulin resistance in the absence of obesity is unknown. In obesity, multiple stress kinases have been identified that impair the insulin signaling pathway via serine phosphorylation of key second messenger proteins. These stress kinases are activated through various mechanisms related to lipid oversupply locally in insulin target tissues and in various adipose depots. Methodology/Principal Findings: To explore whether specific stress kinases that have been implicated in the insulin resistance of obesity are potentially contributing to insulin resistance in non-obese individuals, twenty healthy, non-obese, normoglycemic subjects identified as insulin sensitive or resistant were studied. Vastus lateralis muscle biopsies obtained during euglycemic, hyperinsulinemic clamp were evaluated for insulin signaling and for activation of stress kinase pathways. Total and regional adipose stores and intramyocellular lipids (IMCL) were assessed by DXA, MRI and (1)H-MRS. In muscle of resistant subjects, phosphorylation of JNK was increased (1.36 +/- 0.23 vs. 0.78 +/- 0.10 OD units, P < 0.05), while there was no evidence for activation of p38 MAPK or IKK beta. IRS-1 serine phosphorylation was increased (1.30 +/- 0.09 vs. 0.22 +/- 0.03 OD units, P < 0.005) while insulin-stimulated tyrosine phosphorylation decreased (10.97 +/- 0.95 vs. 0.89 +/- 0.50 OD units, P < 0.005). IMCL levels were twice as high in insulin resistant subjects (3.26 +/- 0.48 vs. 1.58 +/- 0.35% H(2)O peak, P < 0.05), who also displayed increased total fat and abdominal fat when compared to insulin sensitive controls. Conclusions: This is the first report demonstrating that insulin resistance in non-obese, normoglycemic subjects is associated with activation of the JNK pathway related to increased IMCL and higher total body and abdominal adipose stores. While JNK activation is consistent with a primary impact of muscle lipid accumulation on metabolic stress, further work is necessary to determine the relative contributions of the various mediators of impaired insulin signaling in this population.	[Masharani, Umesh B.; Maddux, Betty A.; Goldfine, Ira D.; Youngren, Jack F.] Univ Calif San Francisco, Dept Med, Ctr Diabet, San Francisco, CA 94143 USA; [Li, Xiaojuan] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA; [Sakkas, Giorgos K.; Mulligan, Kathleen; Schambelan, Morris] San Francisco Gen Hosp, Div Endocrinol, San Francisco, CA 94110 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center	Masharani, UB (corresponding author), Univ Calif San Francisco, Dept Med, Ctr Diabet, San Francisco, CA 94143 USA.	jack.youngren@ucsf.edu	Sakkas, Giorgos K./AAJ-4745-2021	Sakkas, Giorgos K./0000-0002-2462-995X	National Institutes of Health [R01DK59358]; CTSI NIH/NCRR UCSF-CTSI [UL1 RR024131]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059358] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSI NIH/NCRR UCSF-CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant R01DK59358 and CTSI NIH/NCRR UCSF-CTSI UL1 RR024131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Bandyopadhyay GK, 2005, DIABETES, V54, P2351, DOI 10.2337/diabetes.54.8.2351; Cai Y, 2000, BLOOD, V96, P2140, DOI 10.1182/blood.V96.6.2140.h8002140_2140_2148; Carey DG, 1996, DIABETES, V45, P633, DOI 10.2337/diabetes.45.5.633; Clausen JO, 1996, J CLIN INVEST, V98, P1195, DOI 10.1172/JCI118903; Conus F, 2007, APPL PHYSIOL NUTR ME, V32, P4, DOI [10.1139/H06-092, 10.1139/h06-092]; de Alvaro C, 2004, J BIOL CHEM, V279, P17070, DOI 10.1074/jbc.M312021200; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Diamond-Stanic Maggie K., 2010, Archives of Physiology and Biochemistry, V116, P88, DOI 10.3109/13813451003758703; DOHM GL, 1988, J CLIN INVEST, V82, P486, DOI 10.1172/JCI113622; Evans JL, 2005, ANTIOXID REDOX SIGN, V7, P1040, DOI 10.1089/ars.2005.7.1040; Ferrannini E, 1997, J CLIN INVEST, V100, P1166, DOI 10.1172/JCI119628; Folli F, 1997, J CLIN INVEST, V100, P2158, DOI 10.1172/JCI119752; Gan SK, 2003, OBES RES, V11, P1295, DOI 10.1038/oby.2003.176; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Johansen KL, 2003, KIDNEY INT, V63, P291, DOI 10.1046/j.1523-1755.2003.00704.x; Kitabchi AE, 2005, DIABETES, V54, P2404, DOI 10.2337/diabetes.54.8.2404; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Krssak M, 1999, DIABETOLOGIA, V42, P113, DOI 10.1007/s001250051123; Li XJ, 2008, MAGN RESON IMAGING, V26, P188, DOI 10.1016/j.mri.2007.06.006; Masharani U, 2009, METABOLISM, V58, P1602, DOI 10.1016/j.metabol.2009.05.012; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; NEWELLMORRIS LL, 1989, AM J CLIN NUTR, V50, P9, DOI 10.1093/ajcn/50.1.9; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Perseghin G, 1999, DIABETES, V48, P1600, DOI 10.2337/diabetes.48.8.1600; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Pirola L, 2004, DIABETOLOGIA, V47, P170, DOI 10.1007/s00125-003-1313-3; Rachek LI, 2007, ENDOCRINOLOGY, V148, P293, DOI 10.1210/en.2006-0998; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Sakkas GK, 2008, AM J PHYSIOL-REG I, V295, pR1721, DOI 10.1152/ajpregu.00935.2007; Schmitz-Peiffer C, 2002, ANN NY ACAD SCI, V967, P146; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sinha R, 2002, DIABETES, V51, P1022, DOI 10.2337/diabetes.51.4.1022; Solinas G, 2006, P NATL ACAD SCI USA, V103, P16454, DOI 10.1073/pnas.0607626103; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; Virkamaki A, 2001, DIABETES, V50, P2337, DOI 10.2337/diabetes.50.10.2337; Wei YZ, 2008, AM J PHYSIOL-REG I, V294, pR673, DOI 10.1152/ajpregu.00561.2007; White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952; White MF, 2006, CAN J PHYSIOL PHARM, V84, P725, DOI 10.1139/Y06-008; Youngren JF, 2007, CELL MOL LIFE SCI, V64, P873, DOI 10.1007/s00018-007-6359-9; Youngren JF, 2001, AM J PHYSIOL-ENDOC M, V280, pE528, DOI 10.1152/ajpendo.2001.280.3.E528	49	45	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19878	10.1371/journal.pone.0019878	http://dx.doi.org/10.1371/journal.pone.0019878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589939	gold, Green Submitted, Green Published			2022-12-27	WOS:000290483600034
J	Warren, RL; Holt, RA				Warren, Rene L.; Holt, Robert A.			Targeted Assembly of Short Sequence Reads	PLOS ONE			English	Article							SHORT DNA-SEQUENCES; GENOME; MAP	As next-generation sequence (NGS) production continues to increase, analysis is becoming a significant bottleneck. However, in situations where information is required only for specific sequence variants, it is not necessary to assemble or align whole genome data sets in their entirety. Rather, NGS data sets can be mined for the presence of sequence variants of interest by localized assembly, which is a faster, easier, and more accurate approach. We present TASR, a streamlined assembler that interrogates very large NGS data sets for the presence of specific variants by only considering reads within the sequence space of input target sequences provided by the user. The NGS data set is searched for reads with an exact match to all possible short words within the target sequence, and these reads are then assembled stringently to generate a consensus of the target and flanking sequence. Typically, variants of a particular locus are provided as different target sequences, and the presence of the variant in the data set being interrogated is revealed by a successful assembly outcome. However, TASR can also be used to find unknown sequences that flank a given target. We demonstrate that TASR has utility in finding or confirming genomic mutations, polymorphisms, fusions and integration events. Targeted assembly is a powerful method for interrogating large data sets for the presence of sequence variants of interest. TASR is a fast, flexible and easy to use tool for targeted assembly.	[Warren, Rene L.; Holt, Robert A.] British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Holt, Robert A.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	British Columbia Cancer Agency; Simon Fraser University	Warren, RL (corresponding author), British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada.	rwarren@bcgsc.ca	Holt, Robert A/C-3303-2009; Warren, Rene/R-7681-2016	Holt, Robert A/0000-0002-7259-1247; Warren, Rene/0000-0002-9890-2293				Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Freeman JD, 2009, GENOME RES, V19, P1817, DOI 10.1101/gr.092924.109; Goya R, 2010, BIOINFORMATICS, V26, P730, DOI 10.1093/bioinformatics/btq040; Jeck WR, 2007, BIOINFORMATICS, V23, P2942, DOI 10.1093/bioinformatics/btm451; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NAT BIOTECHNOL, V28, P57, DOI 10.1038/nbt.1596; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Nacu S, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-11; Nam RK, 2007, BRIT J CANCER, V97, P1690, DOI 10.1038/sj.bjc.6604054; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Stein LD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-207; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Warren RL, 2009, BIOINFORMATICS, V25, P458, DOI 10.1093/bioinformatics/btp010	18	21	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19816	10.1371/journal.pone.0019816	http://dx.doi.org/10.1371/journal.pone.0019816			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589938	gold, Green Submitted, Green Published			2022-12-27	WOS:000290483600031
J	Mackenzie, S; Schmermer, C; Charnley, A; Sim, D; Tah, V; Dumskyj, M; Nussey, S; Egan, C				Mackenzie, Sarah; Schmermer, Christian; Charnley, Amanda; Sim, Dawn; Tah, Vikas; Dumskyj, Martin; Nussey, Stephen; Egan, Catherine			SDOCT Imaging to Identify Macular Pathology in Patients Diagnosed with Diabetic Maculopathy by a Digital Photographic Retinal Screening Programme	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; TIME-DOMAIN; FLUORESCEIN ANGIOGRAPHY; THICKNESS MEASUREMENTS; FUNDUS PHOTOGRAPHY; LAYER THICKNESS; EYE DISEASE; EDEMA; RETINOPATHY; OPHTHALMOSCOPY	Introduction: Diabetic macular edema (DME) is an important cause of vision loss. England has a national systematic photographic retinal screening programme to identify patients with diabetic eye disease. Grading retinal photographs according to this national protocol identifies surrogate markers for DME. We audited a care pathway using a spectral-domain optical coherence tomography (SDOCT) clinic to identify macular pathology in this subset of patients. Methods: A prospective audit was performed of patients referred from screening with mild to moderate non-proliferative diabetic retinopathy (R1) and surrogate markers for diabetic macular edema (M1) attending an SDOCT clinic. The SDOCT images were graded by an ophthalmologist as SDOCT positive, borderline or negative. SDOCT positive patients were referred to the medical retina clinic. SDOCT negative and borderline patients were further reviewed in the SDOCT clinic in 6 months. Results: From a registered screening population of 17 551 patients with diabetes mellitus, 311 patients met the inclusion criteria between (March 2008 and September 2009). We analyzed images from 311 patients' SDOCT clinic episodes. There were 131 SDOCT negative and 12 borderline patients booked for revisit in the OCT clinic. Twenty-four were referred back to photographic screening for a variety of reasons. A total of 144 were referred to ophthalmology with OCT evidence of definite macular pathology requiring review by an ophthalmologist. Discussion: This analysis shows that patients with diabetes, mild to moderate non-proliferative diabetic retinopathy (R1) and evidence of diabetic maculopathy on non-stereoscopic retinal photographs (M1) have a 42.1% chance of having no macular edema on SDOCT imaging as defined by standard OCT definitions of DME when graded by a retinal specialist. SDOCT imaging is a useful adjunct to colour fundus photography in screening for referable diabetic maculopathy in our screening population.	[Mackenzie, Sarah; Sim, Dawn; Tah, Vikas; Egan, Catherine] Moorfields St Georges Hosp, London, England; [Schmermer, Christian; Charnley, Amanda; Dumskyj, Martin; Nussey, Stephen] St George Hosp, Dept Endocrinol, London, England	St Georges University London	Mackenzie, S (corresponding author), Moorfields St Georges Hosp, London, England.	sarah.mackenzie@moorfields.nhs.uk		Egan, Catherine/0000-0001-5593-1169				Aiello LP, 2010, OPHTHALMOLOGY, V117, P946, DOI 10.1016/j.ophtha.2009.10.002; Baskin DE, 2010, CURR OPIN OPHTHALMOL, V21, P172, DOI 10.1097/ICU.0b013e32833866ae; Beck RW, 2009, ARCH OPHTHALMOL-CHIC, V127, P245, DOI 10.1001/archophthalmol.2008.610; Broadbent DM, 1999, EYE, V13, P160, DOI 10.1038/eye.1999.43; Brown JC, 2004, ARCH OPHTHALMOL-CHIC, V122, P330, DOI 10.1001/archopht.122.3.330; Browning DJ, 2008, OPHTHALMOLOGY, V115, P1366, DOI 10.1016/j.ophtha.2007.12.004; Browning DJ, 2008, AM J OPHTHALMOL, V145, P889, DOI 10.1016/j.ajo.2008.01.007; Browning DJ, 2004, OPHTHALMOLOGY, V111, P712, DOI 10.1016/j.ophtha.2003.06.028; Bruce A, 2009, OPEN OPHTHALMOL J, V3, P10, DOI 10.2174/1874364100903010010; DANIS RP, 2006, DIABETIC RETINOPATHY, V124, P1701; Davis MD, 2008, INVEST OPHTH VIS SCI, V49, P1745, DOI 10.1167/iovs.07-1257; Emanuele N, 2009, J DIABETES COMPLICAT, V23, P323, DOI 10.1016/j.jdiacomp.2008.02.010; Fong DS, 1999, AM J OPHTHALMOL, V127, P137, DOI 10.1016/S0002-9394(98)00309-2; Forooghian F, 2008, INVEST OPHTH VIS SCI, V49, P4290, DOI 10.1167/iovs.08-2113; Glassman AR, 2009, INVEST OPHTH VIS SCI, V50, P560, DOI 10.1167/iovs.08-1881; HARDING SP, 1995, BMJ-BRIT MED J, V311, P1131, DOI 10.1136/bmj.311.7013.1131; Ho J, 2009, OPHTHALMOLOGY, V116, P1960, DOI 10.1016/j.ophtha.2009.03.034; International Council of Ophthalmology, INT CLIN DIAB RET DI; JAVITT JC, 1989, OPHTHALMOLOGY, V96, P255; Jittpoonkuson T, 2010, BRIT J OPHTHALMOL, V94, P1197, DOI 10.1136/bjo.2009.170589; Jyothi S, 2009, PRIM CARE DIABETES, V3, P67, DOI 10.1016/j.pcd.2009.05.005; Kim BY, 2006, AM J OPHTHALMOL, V142, P405, DOI 10.1016/j.ajo.2006.04.023; KINYOUN J, 1989, OPHTHALMOLOGY, V96, P746; KINYOUN JL, 1992, INVEST OPHTH VIS SCI, V33, P1888; LAMMER J, 2010, COMP 4 OPT COH TOM S, V10, P1; LEE VS, 1993, OPHTHALMOLOGY, V100, P1504; Leung CKS, 2008, INVEST OPHTH VIS SCI, V49, P4893, DOI 10.1167/iovs.07-1326; Massin P, 2006, ACTA OPHTHALMOL SCAN, V84, P466, DOI 10.1111/j.1600-0420.2006.00694.x; Moreira Rodrigo O., 2001, International Ophthalmology, V24, P331, DOI 10.1023/B:INTE.0000006784.52885.e9; *NAT HLTH SERV RET, NAT SCREEN PROGR DIA; *NAT I HLTH RES, 2007, 1703 SCAND, V85, P613; NATHAN DM, 1991, DIABETES CARE, V14, P26, DOI 10.2337/diacare.14.1.26; PATEL PJ, 2009, ACTA OPHTHALMOL 1021; PATEL PJ, 2009, ACTA OPHTHALMOL 1107; Patel PJ, 2009, INVEST OPHTH VIS SCI, V50, P5405, DOI 10.1167/iovs.09-3505; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; *ROYAL COLL OPHTH, 2005, GUID MAN DIAB RET LO; SADDA SR, 2006, OPHTHALMOL, V113; Sadda SR, 2006, OPHTHALMOLOGY, V113, P1187, DOI 10.1016/j.ophtha.2005.12.020; SCOTLAND GS, 2009, BR J OPHTHALMOL 1203; Scott IU, 2007, OPHTHALMOLOGY, V114, P1860, DOI 10.1016/j.ophtha.2007.05.062; Tangelder GJM, 2008, INVEST OPHTH VIS SCI, V49, P2627, DOI 10.1167/iovs.07-0820; van Dijk HW, 2010, INVEST OPHTH VIS SCI, V51, P3660, DOI 10.1167/iovs.09-5041; van Dijk HW, 2009, INVEST OPHTH VIS SCI, V50, P3404, DOI 10.1167/iovs.08-3143; VANDIJK HW, 2010, VISION RES      0827; Virgili G, 2007, INVEST OPHTH VIS SCI, V48, P4963, DOI 10.1167/iovs.06-1472; World Health Organization, DIAB PROGR; Yeung L, 2009, OPHTHALMOLOGY, V116, P1158, DOI 10.1016/j.ophtha.2008.12.063	48	43	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e14811	10.1371/journal.pone.0014811	http://dx.doi.org/10.1371/journal.pone.0014811			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573106	Green Published, Green Submitted, gold			2022-12-27	WOS:000290305600002
J	Wang, H; Zhou, XL; Lu, CY; Wu, J; Deng, XQ; Hong, LY				Wang, Hui; Zhou, Xiaolan; Lu, Ciyong; Wu, Jie; Deng, Xueqing; Hong, Lingyao			Problematic Internet Use in High School Students in Guangdong Province, China	PLOS ONE			English	Article							PROPOSED DIAGNOSTIC-CRITERIA; SUBSTANCE USE; NON-ADDICTS; ADOLESCENTS; PREVALENCE; EXPERIENCE; PROFILES	Background: Problematic Internet Use (PIU) is a growing problem in Chinese adolescents. There are many risk factors for PIU, which are found at school and at home. This study was designed to investigate the prevalence of PIU and to investigate the potential risk factors for PIU among high school students in China. Methodology/Principal Findings: A cross-sectional study was conducted. A total of 14,296 high school students were surveyed in four cities in Guangdong province. Problematic Internet Use was assessed by the 20-item Young Internet Addiction Test (YIAT). Information was also collected on demographics, family and school-related factors and Internet usage patterns. Of the 14,296 students, 12,446 were Internet users. Of those, 12.2% (1,515) were identified as problematic Internet users (PIUs). Generalized mixed-model regression revealed that there was no gender difference between PIUs and non-PIUs. High study-related stress, having social friends, poor relations with teachers and students and conflictive family relationships were risk factors for PIU. Students who spent more time on-line were more likely to develop PIU. The habits of and purposes for Internet usage were diverse, influencing the susceptibility to PIU. Conclusions/Significance: PIU is common among high school students, and risk factors are found at home and at school. Teachers and parents should pay close attention to these risk factors. Effective measures are needed to prevent the spread of this problem.	[Wang, Hui; Zhou, Xiaolan; Lu, Ciyong; Wu, Jie; Deng, Xueqing; Hong, Lingyao] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Wang, H (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China.	luciyong@mail.sysu.edu.cn			Guangdong Food and Drug Administration	Guangdong Food and Drug Administration	This research was supported by Guangdong Food and Drug Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beard KW, 2001, CYBERPSYCHOL BEHAV, V4, P377, DOI 10.1089/109493101300210286; Biglan A, 1999, J ABNORMAL CHILD PSY, V27, P194; Cao F, 2007, CHILD CARE HLTH DEV, V33, P275, DOI 10.1111/j.1365-2214.2006.00715.x; Chen SHWL, 2003, CHIN J PSYCHOL, V45; Chou C, 2000, COMPUT EDUC, V35, P65, DOI 10.1016/S0360-1315(00)00019-1; CNNIC, 2009, 24 CNNIC; CNNIC, 2010, CHIN AD INT US BEHAV; Davis RA, 2001, COMPUT HUM BEHAV, V17, P187, DOI 10.1016/S0747-5632(00)00041-8; Ghassemzadeh L, 2008, CYBERPSYCHOL BEHAV, V11, P731, DOI 10.1089/cpb.2007.0243; GRIFFITHS MD, 1991, J ADOLESCENCE, V14, P53, DOI 10.1016/0140-1971(91)90045-S; Hall A.S., 2001, J MENT HLTH COUNS, V23, P312, DOI DOI 10.1007/S11469-015-9622-6; Huang RL, 2009, FEATURES PREDICTORS, P485; Hur MH, 2006, CYBERPSYCHOL BEHAV, V9, P514, DOI 10.1089/cpb.2006.9.514; Jang KS, 2008, J SCHOOL HEALTH, V78, P165, DOI 10.1111/j.1746-1561.2007.00279.x; Kandell J.J., 1998, CYBERPSYCHOL BEHAV, V1, P11, DOI [10.1089/cpb.1998.1.11, DOI 10.1089/CPB.1998.1.11]; Khazaal Y, 2008, CYBERPSYCHOL BEHAV, V11, P703, DOI 10.1089/cpb.2007.0249; Kim K, 2006, INT J NURS STUD, V43, P185, DOI 10.1016/j.ijnurstu.2005.02.005; Ko CH, 2009, J ADOLESCENT HEALTH, V44, P598, DOI 10.1016/j.jadohealth.2008.11.011; Kraut R, 1998, AM PSYCHOL, V53, P1017, DOI 10.1037/0003-066X.53.9.1017; Lam LT, 2009, CYBERPSYCHOL BEHAV, V12, P551, DOI 10.1089/cpb.2009.0036; Leung L, 2007, CYBERPSYCHOL BEHAV, V10, P204, DOI 10.1089/cpb.2006.9967; Lin SSJ, 2002, COMPUT HUM BEHAV, V18, P411, DOI 10.1016/S0747-5632(01)00056-5; Milani L, 2009, CYBERPSYCHOL BEHAV, V12, P681, DOI 10.1089/cpb.2009.0071; Morahan-Martin J, 2000, COMPUT HUM BEHAV, V16, P13, DOI 10.1016/S0747-5632(99)00049-7; Ni XL, 2009, CYBERPSYCHOL BEHAV, V12, P327, DOI 10.1089/cpb.2008.0321; Norton EC, 1998, HEALTH ECON, V7, P439, DOI 10.1002/(SICI)1099-1050(199808)7:5<439::AID-HEC362>3.0.CO;2-9; OReilly M, 1996, CAN MED ASSOC J, V154, P1882; Shek DTL, 2008, THESCIENTIFICWORLDJO, V8, P776, DOI 10.1100/tsw.2008.104; Tao R, 2010, ADDICTION, V105, P556, DOI 10.1111/j.1360-0443.2009.02828.x; Tsai CC, 2001, CYBERPSYCHOL BEHAV, V4, P373, DOI 10.1089/109493101300210277; Tsitsika A, 2009, EUR J PEDIATR, V168, P655, DOI 10.1007/s00431-008-0811-1; Wang L., 2009, INT J MENT HEALTH AD, V7, P333, DOI [DOI 10.1007/S11469-008-9162-4, 10.1007/s11469-008-9162-4.]; Wu CS, 2007, CYBERPSYCHOL BEHAV, V10, P220, DOI 10.1089/cpb.2006.9965; Yang CK, 2005, CAN J PSYCHIAT, V50, P407, DOI 10.1177/070674370505000704; Yang SC, 2007, COMPUT HUM BEHAV, V23, P79, DOI 10.1016/j.chb.2004.03.037; Yen JY, 2007, CYBERPSYCHOL BEHAV, V10, P323, DOI 10.1089/cpb.2006.9948; Young K.S., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]	37	135	144	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19660	10.1371/journal.pone.0019660	http://dx.doi.org/10.1371/journal.pone.0019660			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	760DZ	21573073	Green Published, Green Submitted, gold			2022-12-27	WOS:000290305600040
J	Raghu, SV; Borst, A				Raghu, Shamprasad Varija; Borst, Alexander			Candidate Glutamatergic Neurons in the Visual System of Drosophila	PLOS ONE			English	Article							PLATE TANGENTIAL CELLS; INTRINSIC ELECTROPHYSIOLOGICAL CHARACTERISTICS; MOTION SENSITIVE INTERNEURONS; GAMMA-AMINOBUTYRIC-ACID; LOBULA PLATE; OPTIC LOBE; DESCENDING NEURONS; DETECTION CIRCUITS; OPTOMOTOR SYSTEM; HORIZONTAL CELLS	The visual system of Drosophila contains approximately 60,000 neurons that are organized in parallel, retinotopically arranged columns. A large number of these neurons have been characterized in great anatomical detail. However, studies providing direct evidence for synaptic signaling and the neurotransmitter used by individual neurons are relatively sparse. Here we present a first layout of neurons in the Drosophila visual system that likely release glutamate as their major neurotransmitter. We identified 33 different types of neurons of the lamina, medulla, lobula and lobula plate. Based on the previous Golgi-staining analysis, the identified neurons are further classified into 16 major subgroups representing lamina monopolar (L), transmedullary (Tm), transmedullary Y (TmY), Y, medulla intrinsic (Mi, Mt, Pm, Dm, Mi Am), bushy T (T), translobula plate (Tlp), lobula intrinsic (Lcn, Lt, Li), lobula plate tangential (LPTCs) and lobula plate intrinsic (LPi) cell types. In addition, we found 11 cell types that were not described by the previous Golgi analysis. This classification of candidate glutamatergic neurons fosters the future neurogenetic dissection of information processing in circuits of the fly visual system.	[Raghu, Shamprasad Varija; Borst, Alexander] Max Planck Inst Neurobiol, Dept Syst & Computat Neurobiol, Martinsried, Germany	Max Planck Society	Raghu, SV (corresponding author), Max Planck Inst Neurobiol, Dept Syst & Computat Neurobiol, Martinsried, Germany.	sham@neuro.mpg.de	Raghu, Shamprasad Varija/AAV-3044-2020		Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUSENWEIN B, 1992, CELL TISSUE RES, V267, P17, DOI 10.1007/BF00318687; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; BICKER G, 1988, J NEUROSCI, V8, P2108; Borst A, 1996, J COMPUT NEUROSCI, V3, P313, DOI 10.1007/BF00161091; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brotz TM, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-1; BUCHNER E, 1986, CELL TISSUE RES, V246, P57; BUCHNER E, 1984, J COMP PHYSIOL, V155, P471, DOI 10.1007/BF00611912; Busch S, 2009, J COMP NEUROL, V513, P643, DOI 10.1002/cne.21966; Buschbeck EK, 1996, J NEUROSCI, V16, P4563; Chiang AS, 2011, CURR BIOL, V21, P1, DOI 10.1016/j.cub.2010.11.056; Cully DF, 1996, J BIOL CHEM, V271, P20187, DOI 10.1074/jbc.271.33.20187; Daniels RW, 2008, J COMP NEUROL, V508, P131, DOI 10.1002/cne.21670; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; DOUGLASS JK, 1995, J NEUROSCI, V15, P5596; Duarte CB, 1999, J NEUROSCI RES, V58, P475, DOI 10.1002/(SICI)1097-4547(19991115)58:4<475::AID-JNR1>3.0.CO;2-O; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; Gao SY, 2008, NEURON, V60, P328, DOI 10.1016/j.neuron.2008.08.010; GILBERT C, 1995, J COMP NEUROL, V361, P285, DOI 10.1002/cne.903610207; GRONENBERG W, 1990, J COMP NEUROL, V302, P973, DOI 10.1002/cne.903020420; Haag J, 1997, J COMPUT NEUROSCI, V4, P349, DOI 10.1023/A:1008804117334; Haag J, 1999, J COMPUT NEUROSCI, V7, P213, DOI 10.1023/A:1008950515719; Haag J, 2002, J NEUROSCI, V22, P3227, DOI 10.1523/JNEUROSCI.22-08-03227.2002; Haag J, 2007, J NEUROSCI, V27, P1992, DOI 10.1523/JNEUROSCI.4393-06.2007; Hardie R.C., 1989, P235; HARDIE RC, 1987, J COMP PHYSIOL A, V161, P201, DOI 10.1007/BF00615241; Hasegawa E, 2011, DEVELOPMENT, V138, P983, DOI 10.1242/dev.058370; HAUSEN K, 1982, BIOL CYBERN, V46, P67, DOI 10.1007/BF00335352; HAUSEN K, 1982, BIOL CYBERN, V45, P143, DOI 10.1007/BF00335241; Hausen K., 1984, PHOTORECEPTION VISIO, P523, DOI [10.1007/978-1-4613-2743-1_15, DOI 10.1007/978-1-4613-2743-1_15]; HENGSTENBERG R, 1982, J COMP PHYSIOL, V149, P163, DOI 10.1007/BF00619211; HERTZ L, 1983, GLUTAMINE GLUTAMATE; HOMBERG U, 1989, CELL TISSUE RES, V258, P1, DOI 10.1007/BF00223139; JAN LY, 1976, J PHYSIOL-LONDON, V262, P215, DOI 10.1113/jphysiol.1976.sp011593; Joesch M, 2008, CURR BIOL, V18, P368, DOI 10.1016/j.cub.2008.02.022; Joesch M, 2010, NATURE, V468, P300, DOI 10.1038/nature09545; Kitamoto T, 1998, J BIOL CHEM, V273, P2706, DOI 10.1074/jbc.273.5.2706; Kolodziejczyk A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002110; LEA TJ, 1973, GEN PHARMACOL, V4, P351; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Luan HJ, 2006, NEURON, V52, P425, DOI 10.1016/j.neuron.2006.08.028; Meinertzhagen I. A., 1996, Society for Neuroscience Abstracts, V22, P655; MEYER EP, 1986, HISTOCHEMISTRY, V84, P207, DOI 10.1007/BF00495784; Morante J, 2008, CURR BIOL, V18, P553, DOI 10.1016/j.cub.2008.02.075; Nassel D.R., 1988, Journal of Chemical Neuroanatomy, V1, P311; NASSEL DR, 1983, COMP BIOCHEM PHYS C, V75, P259, DOI 10.1016/0742-8413(83)90190-1; NEAL MJ, 1992, NEUROCHEM INT, V20, P43, DOI 10.1016/0197-0186(92)90124-A; OMALLEY DM, 1992, J NEUROSCI, V12, P1394; POLLACK I, 1991, CELL TISSUE RES, V266, P391, DOI 10.1007/BF00318195; Raghu SV, 2007, J COMP NEUROL, V502, P598, DOI 10.1002/cne.21319; Raghu SV, 2011, J COMP NEUROL, V519, P162, DOI 10.1002/cne.22512; Raghu SV, 2009, J NEUROGENET, V23, P200, DOI 10.1080/01677060802471684; Ramaekers A, 2001, J COMP NEUROL, V438, P213, DOI 10.1002/cne.1310; Reiff DF, 2010, NAT NEUROSCI, V13, P973, DOI 10.1038/nn.2595; SCHAFER S, 1988, J COMP NEUROL, V268, P60, DOI 10.1002/cne.902680107; Schnell B, 2010, J NEUROPHYSIOL, V103, P1646, DOI 10.1152/jn.00950.2009; SCHURMANN FW, 1989, CELL TISSUE RES, V256, P399, DOI 10.1007/BF00218898; Schuster CM, 2006, CELL TISSUE RES, V326, P287, DOI 10.1007/s00441-006-0290-5; Scott EK, 2002, J COMP NEUROL, V454, P470, DOI 10.1002/cne.10467; Sinakevitch I, 2004, J COMP NEUROL, V468, P6, DOI 10.1002/cne.10929; Strausfeld N.J., 1976, P245; STRAUSFELD NJ, 1984, PHOTORECEPTION VISIO, P483; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; Stuart AE, 2007, PROG NEUROBIOL, V82, P202, DOI 10.1016/j.pneurobio.2007.03.006; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; USHERWOOD PN, 1968, J EXP BIOL, V49, P341; Volkner M, 2000, J NEUROCHEM, V75, P1791, DOI 10.1046/j.1471-4159.2000.0751791.x; Wertz A, 2008, J NEUROSCI, V28, P3131, DOI 10.1523/JNEUROSCI.5460-07.2008; Wertz A, 2009, J NEUROSCI, V29, P14993, DOI 10.1523/JNEUROSCI.3786-09.2009; Wertz A, 2009, J COMP PHYSIOL A, V195, P1107, DOI 10.1007/s00359-009-0481-0; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9	71	37	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19472	10.1371/journal.pone.0019472	http://dx.doi.org/10.1371/journal.pone.0019472			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573163	Green Submitted, Green Published, gold			2022-12-27	WOS:000290256400013
J	Stepanek, O; Brdicka, T; Angelisova, P; Horvath, O; Spicka, J; Stockbauer, P; Man, P; Horejsi, V				Stepanek, Ondrej; Brdicka, Tomas; Angelisova, Pavla; Horvath, Ondrej; Spicka, Jiri; Stockbauer, Petr; Man, Petr; Horejsi, Vaclav			Interaction of Late Apoptotic and Necrotic Cells with Vitronectin	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR; SERUM SPREADING FACTOR; MONOCLONAL-ANTIBODY; EPITHELIAL REPAIR; RECEPTOR; EXPRESSION; LOCALIZATION; CLEARANCE; INTEGRIN; NECROSIS	Background: Vitronectin is an abundant plasma glycoprotein identified also as a part of extracellular matrix. Vitronectin is substantially enriched at sites of injured, fibrosing, inflamed, and tumor tissues where it is believed to be involved in wound healing and tissue remodeling. Little is known about the mechanism of vitronectin localization into the damaged tissues. Methodology/Principal Findings: 2E12 antibody has been described to bind a subset of late apoptotic cells. Using immunoisolation followed by mass spectrometry, we identified the antigen recognized by 2E12 antibody as vitronectin. Based on flow cytometry, we described that vitronectin binds to the late apoptotic and necrotic cells in cell cultures in vitro as well as in murine thymus and spleen in vivo. Confocal microscopy revealed that vitronectin binds to an intracellular cytoplasmic structure after the membrane rupture. Conclusions/Significance: We propose that vitronectin could serve as a marker of membrane disruption in necrosis and apoptosis for flow cytometry analysis. Moreover, we suggest that vitronectin binding to dead cells may represent one of the mechanisms of vitronectin incorporation into the injured tissues.	[Stepanek, Ondrej; Brdicka, Tomas; Angelisova, Pavla; Horvath, Ondrej; Spicka, Jiri; Horejsi, Vaclav] Acad Sci Czech Republ, Inst Mol Genet, Prague, Czech Republic; [Stockbauer, Petr] Inst Hematol & Blood Transfus, CR-12820 Prague, Czech Republic; [Man, Petr] Acad Sci Czech Republ, Inst Microbiol, Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Institute of Hematology Prague; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Stepanek, O (corresponding author), Acad Sci Czech Republ, Inst Mol Genet, Prague, Czech Republic.	vaclav.horejsi@img.cas.cz	Horejsi, Vaclav/G-3113-2014; Stepanek, Ondrej/F-8882-2013; Brdicka, Tomas/G-6205-2014; Angelisova, Pavla/G-3131-2014; Man, Petr/H-2451-2014; Stepanek, Ondrej/AAG-3180-2020	Horejsi, Vaclav/0000-0003-4925-0142; Stepanek, Ondrej/0000-0002-2735-3311; Brdicka, Tomas/0000-0002-1560-4398; Man, Petr/0000-0002-1485-2197; Stepanek, Ondrej/0000-0002-2735-3311	Academy of Sciences of the Czech Republic [AV0Z50520514]; Center of Molecular and Cellular Immunology (Ministry of Education, Youth and Sports of the Czech Republic) [1M0506]; Academy of Sciences of the Czech Republic, P.S. [AVOZ50200510]; Faculty of Science, Charles University, Prague, Czech Republic;  [IGA-MZ 0002373601]	Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Center of Molecular and Cellular Immunology (Ministry of Education, Youth and Sports of the Czech Republic)(Ministry of Education, Youth & Sports - Czech Republic); Academy of Sciences of the Czech Republic, P.S.(Czech Academy of Sciences); Faculty of Science, Charles University, Prague, Czech Republic(Czech Republic Government); 	This work was supported in part by project No. AV0Z50520514 awarded by the Academy of Sciences of the Czech Republic, and by Center of Molecular and Cellular Immunology (project 1M0506, Ministry of Education, Youth and Sports of the Czech Republic). P.M. is supported from project No. AVOZ50200510 awarded by the Academy of Sciences of the Czech Republic, P.S. from grant IGA-MZ 0002373601, O.S. is a PhD student supported in part by Faculty of Science, Charles University, Prague, Czech Republic. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair JE, 2009, J BIOL CHEM, V284, P16922, DOI 10.1074/jbc.M808560200; AKIYAMA H, 1991, J NEUROIMMUNOL, V32, P19, DOI 10.1016/0165-5728(91)90067-H; Bafetti LM, 1998, J BIOL CHEM, V273, P143, DOI 10.1074/jbc.273.1.143; BASARA ML, 1985, CANCER RES, V45, P2487; BUJA LM, 1993, ARCH PATHOL LAB MED, V117, P1208; Carpagnano GE, 2003, RESPIRATION, V70, P154, DOI 10.1159/000070062; Cermakova P, 2007, FEBS J, V274, P3150, DOI 10.1111/j.1742-4658.2007.05847.x; Chen J, 2001, TOXICOL APPL PHARM, V171, P1, DOI 10.1006/taap.2000.9105; D'mello V, 2009, J BIOL CHEM, V284, P17030, DOI 10.1074/jbc.M109.010066; DAHLBACK K, 1988, ACTA DERM-VENEREOL, V68, P107; deBoer HC, 1995, J BIOL CHEM, V270, P30733, DOI 10.1074/jbc.270.51.30733; Ekmekci OB, 2006, CLIN CHIM ACTA, V368, P77, DOI 10.1016/j.cca.2005.12.015; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; Fay WP, 1999, BLOOD, V93, P1825, DOI 10.1182/blood.V93.6.1825.406k37_1825_1830; GLADSON CL, 1991, J CLIN INVEST, V88, P1924, DOI 10.1172/JCI115516; Gu JM, 2005, J CELL PHYSIOL, V204, P73, DOI 10.1002/jcp.20262; Habermann BF, 1993, CURR OPIN CELL BIOL, V5, P864, DOI 10.1016/0955-0674(93)90036-P; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; HAYMAN EG, 1983, P NATL ACAD SCI-BIOL, V80, P4003, DOI 10.1073/pnas.80.13.4003; HINTNER H, 1989, J INVEST DERMATOL, V93, P656, DOI 10.1111/1523-1747.ep12319824; Hoffmann PR, 2001, J CELL BIOL, V155, P649, DOI 10.1083/jcb.200108080; Hradcova M, 2002, LEUKEMIA RES, V26, P45, DOI 10.1016/S0145-2126(01)00097-2; Huang XZ, 1998, J CELL SCI, V111, P2189; Isik FF, 1998, J CELL PHYSIOL, V175, P149, DOI 10.1002/(SICI)1097-4652(199805)175:2<149::AID-JCP4>3.0.CO;2-O; Jang YC, 2000, SURGERY, V127, P696, DOI 10.1067/msy.2000.105858; Koukoulis GK, 2001, HUM PATHOL, V32, P1356, DOI 10.1053/hupa.2001.29675; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Lazar MH, 2004, AM J RESP CELL MOL, V31, P672, DOI 10.1165/rcmb.2004-0025OC; Lessard J, 2007, PROSTATE, V67, P808, DOI 10.1002/pros.20559; Man P, 2005, PROTEOMICS, V5, P113, DOI 10.1002/pmic.200400887; McCutcheon JC, 1998, J LEUKOCYTE BIOL, V64, P600, DOI 10.1002/jlb.64.5.600; Miyazaki T, 2004, J BIOL CHEM, V279, P44667, DOI 10.1074/jbc.M408101200; PARKER CJ, 1988, BLOOD, V71, P86; PODOR TJ, 1992, ANN NY ACAD SCI, V667, P173, DOI 10.1111/j.1749-6632.1992.tb51609.x; Podor TJ, 2002, J BIOL CHEM, V277, P7529, DOI 10.1074/jbc.M109675200; Preissner KT, 1998, THROMB RES, V89, P1, DOI 10.1016/S0049-3848(97)00298-3; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; REILLY JT, 1988, J CLIN PATHOL, V41, P1269, DOI 10.1136/jcp.41.12.1269; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; SAVILL J, 1990, NATURE, V343, P170, DOI 10.1038/343170a0; Schvartz I, 1999, INT J BIOCHEM CELL B, V31, P539, DOI 10.1016/S1357-2725(99)00005-9; Seiffert D, 1997, HISTOL HISTOPATHOL, V12, P787; Silva MT, 2008, APOPTOSIS, V13, P463, DOI 10.1007/s10495-008-0187-8; Stibrikova G, 2005, NEOPLASMA, V52, P18; TOMASINIJOHANSSON BR, 1994, EXP CELL RES, V214, P303, DOI 10.1006/excr.1994.1262; Tsuruta Y, 2007, J IMMUNOL, V179, P7079, DOI 10.4049/jimmunol.179.10.7079; vanAken BE, 1997, HISTOCHEM CELL BIOL, V107, P313, DOI 10.1007/s004180050116; Vermes I, 2000, J IMMUNOL METHODS, V243, P167, DOI 10.1016/S0022-1759(00)00233-7; VOLKER W, 1993, J HISTOCHEM CYTOCHEM, V41, P1823, DOI 10.1177/41.12.7504009	50	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19243	10.1371/journal.pone.0019243	http://dx.doi.org/10.1371/journal.pone.0019243			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573223	Green Published, gold			2022-12-27	WOS:000290224800019
J	Ahmed, SB; Ronksley, PE; Hemmelgarn, BR; Tsai, WH; Manns, BJ; Tonelli, M; Klarenbach, SW; Chin, R; Clement, FM; Hanly, PJ				Ahmed, Sofia B.; Ronksley, Paul E.; Hemmelgarn, Brenda R.; Tsai, Willis H.; Manns, Braden J.; Tonelli, Marcello; Klarenbach, Scott W.; Chin, Rick; Clement, Fiona M.; Hanly, Patrick J.			Nocturnal Hypoxia and Loss of Kidney Function	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; ALCOHOL-CONSUMPTION; ADMINISTRATIVE DATA; FUNCTION DECLINE; RENAL-FUNCTION; PROTEINURIA; DISEASE; MANAGEMENT; ASSOCIATION; DYSFUNCTION	Background: Although obstructive sleep apnea (OSA) is more common in patients with kidney disease, whether nocturnal hypoxia affects kidney function is unknown. Methods: We studied all adult subjects referred for diagnostic testing of sleep apnea between July 2005 and December 31 2007 who had serial measurement of their kidney function. Nocturnal hypoxia was defined as oxygen saturation (SaO2) below 90% for >= 12% of the nocturnal monitoring time. The primary outcome, accelerated loss of kidney function, was defined as a decline in estimated glomerular filtration rate (eGFR) >= 4 ml/min/1.73 m(2) per year. Results: 858 participants were included and followed for a mean study period of 2.1 years. Overall 374 (44%) had nocturnal hypoxia, and 49 (5.7%) had accelerated loss of kidney function. Compared to controls without hypoxia, patients with nocturnal hypoxia had a significant increase in the adjusted risk of accelerated kidney function loss (odds ratio (OR) 2.89, 95% confidence interval [CI] 1.25, 6.67). Conclusion: Nocturnal hypoxia was independently associated with an increased risk of accelerated kidney function loss. Further studies are required to determine whether treatment and correction of nocturnal hypoxia reduces loss of kidney function.	[Ahmed, Sofia B.; Hemmelgarn, Brenda R.; Tsai, Willis H.; Manns, Braden J.; Chin, Rick; Clement, Fiona M.; Hanly, Patrick J.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Ronksley, Paul E.; Hemmelgarn, Brenda R.; Tsai, Willis H.; Manns, Braden J.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Tonelli, Marcello; Klarenbach, Scott W.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Ahmed, Sofia B.; Ronksley, Paul E.; Hemmelgarn, Brenda R.; Manns, Braden J.; Tonelli, Marcello; Klarenbach, Scott W.; Chin, Rick; Clement, Fiona M.] Alberta Kidney Dis Network, Calgary, AB, Canada; [Ronksley, Paul E.; Tsai, Willis H.; Hanly, Patrick J.] Univ Calgary, Foothills Med Ctr, Sleep Ctr, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Alberta; University of Calgary	Ahmed, SB (corresponding author), Univ Calgary, Dept Med, Calgary, AB, Canada.	sofia.ahmed@albertahealthservices.ca	Tonelli, Marcello/B-3028-2009; Ahmed, Sofia/J-7876-2015; Klarenbach, Scott/E-7731-2013; Hemmelgarn, Brenda R./I-6894-2012; Manns, Braden J/I-8942-2012	Tonelli, Marcello/0000-0002-0846-3187; Klarenbach, Scott/0000-0002-8611-1056; Ronksley, Paul/0000-0002-3958-7561	Alberta Kidney Disease Network; Alberta Heritage Foundation for Medical Research; Calgary Health Region; Queen Elizabeth II Graduate Scholarship; Canadian Health Services Research Foundation; Alberta Health and Wellness; Universities of Alberta and Calgary	Alberta Kidney Disease Network; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Calgary Health Region; Queen Elizabeth II Graduate Scholarship; Canadian Health Services Research Foundation; Alberta Health and Wellness; Universities of Alberta and Calgary	This study was funded by the Alberta Kidney Disease Network and operating grants from the Alberta Heritage Foundation for Medical Research and the Calgary Health Region. SBA, BRH, MT and SWK are supported by the Alberta Heritage Foundation for Medical Research. PER is supported by a Queen Elizabeth II Graduate Scholarship. FC is supported by a Canadian Health Services Research Foundation and an Alberta Heritage Foundation for Medical Research post-doctoral fellowship. SBA, BRH, BJM and MT are supported by the Canadian Institute of Health Research. SBA, BRH, BJM, MT, SWK and PJH are supported by a joint initiative between Alberta Health and Wellness and the Universities of Alberta and Calgary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SB, 2005, HYPERTENSION, V46, P1316, DOI 10.1161/01.HYP.0000190819.07663.da; Ahmed SB, 2008, KIDNEY INT, V74, P370, DOI 10.1038/ki.2008.205; Austin PC, 2002, AM HEART J, V144, P290, DOI 10.1067/mhj.2002.123839; BAILEY RR, 1989, AUST NZ J MED, V19, P473, DOI 10.1111/j.1445-5994.1989.tb00310.x; Baumel MJ, 1997, AM J RESP CRIT CARE, V155, P9, DOI 10.1164/ajrccm.155.1.9001281; Bostrom KB, 2007, J HYPERTENS, V25, P779, DOI 10.1097/HJH.0b013e328017f6d5; Bratel T, 2003, RESP MED, V97, P308, DOI 10.1053/rmed.2002.1401; Casserly LF, 2001, KIDNEY INT, V60, P1484, DOI 10.1046/j.1523-1755.2001.00952.x; CHAUDHARY BA, 1988, SLEEP, V11, P69, DOI 10.1093/sleep/11.1.69; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Faulx MD, 2007, SLEEP, V30, P923, DOI 10.1093/sleep/30.7.923; Fine LG, 2008, KIDNEY INT, V74, P867, DOI 10.1038/ki.2008.350; Fine LG, 1998, KIDNEY INT, pS74; Fletcher EC, 1999, HYPERTENSION, V34, P309, DOI 10.1161/01.HYP.34.2.309; FLETCHER EC, 1993, J AM SOC NEPHROL, V4, P1111; Ghahramani N, 2011, NEPHROLOGY, V16, P219, DOI 10.1111/j.1440-1797.2010.01332.x; Gusbeth-Tatomir P, 2007, INT UROL NEPHROL, V39, P1217, DOI 10.1007/s11255-007-9262-2; Hanly PJ, 2001, NEW ENGL J MED, V344, P102, DOI 10.1056/NEJM200101113440204; Hemmelgarn BR, 2006, KIDNEY INT, V69, P2155, DOI 10.1038/sj.ki.5000270; Hemmelgarn BR, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-30; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Huzel Lisa, 2002, Can Respir J, V9, P407; Iseki K, 2008, HYPERTENS RES, V31, P249, DOI 10.1291/hypres.31.249; ISSA FG, 1993, AM REV RESPIR DIS, V148, P1023, DOI 10.1164/ajrccm/148.4_Pt_1.1023; KIMMEL PL, 1989, AM J MED, V86, P308, DOI 10.1016/0002-9343(89)90301-X; Kinebuchi SI, 2004, CLIN SCI, V107, P317, DOI 10.1042/CS20040074; Knight EL, 2003, NEPHROL DIAL TRANSPL, V18, P1549, DOI 10.1093/ndt/gfg228; Kokotailo RA, 2005, STROKE, V36, P1776, DOI 10.1161/01.STR.0000174293.17959.a1; Lee DS, 2005, MED CARE, V43, P182, DOI 10.1097/00005650-200502000-00012; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; Lin J, 2003, J AM SOC NEPHROL, V14, P2573, DOI 10.1097/01.ASN.0000088721.98173.4B; Manns BJ, 2001, CLIN INVEST MED, V24, P164; Mello P, 2004, AM J KIDNEY DIS, V44, P636, DOI 10.1053/j.ajkd.2004.06.014; Menon V, 2010, NEPHROL DIAL TRANSPL, V25, P3301, DOI 10.1093/ndt/gfq188; Mulgrew AT, 2007, ANN INTERN MED, V146, P157, DOI 10.7326/0003-4819-146-3-200702060-00004; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Ronksley PE, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-50; Schaeffner ES, 2005, ARCH INTERN MED, V165, P1048, DOI 10.1001/archinte.165.9.1048; SKLAR AH, 1988, ARCH INTERN MED, V148, P87, DOI 10.1001/archinte.148.1.87; SKLAR AH, 1989, NEPHRON, V51, P35, DOI 10.1159/000185239; Statistics Canada, 2006, COMM PROF VIS MIN PO; TU K, 2007, OPEN MED, V1, pE3; Vazquez JC, 2000, THORAX, V55, P302, DOI 10.1136/thorax.55.4.302; Wuerzner G, 2010, AM J KIDNEY DIS, V56, P303, DOI 10.1053/j.ajkd.2010.03.017; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080	46	91	99	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19029	10.1371/journal.pone.0019029	http://dx.doi.org/10.1371/journal.pone.0019029			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559506	Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700053
J	Amarnath, S; Chen, H; Foley, JE; Costanzo, CM; Sennesh, JD; Solomon, MA; Fowler, DH				Amarnath, Shoba; Chen, Hao; Foley, Jason E.; Costanzo, Carliann M.; Sennesh, Joel D.; Solomon, Michael A.; Fowler, Daniel H.			Host-Based Th2 Cell Therapy for Prolongation of Cardiac Allograft Viability	PLOS ONE			English	Article							REGULATORY T-CELLS; IN-VIVO; TRANSPLANTATION TOLERANCE; INFECTIOUS TOLERANCE; BLOOD-TRANSFUSIONS; GRAFT-REJECTION; RAPAMYCIN; CYCLOSPORINE; RECIPIENTS; SURVIVAL	Donor T cell transfusion, which is a long-standing approach to prevent allograft rejection, operates indirectly by alteration of host T cell immunity. We therefore hypothesized that adoptive transfer of immune regulatory host Th2 cells would represent a novel intervention to enhance cardiac allograft survival. Using a well-described rat cardiac transplant model, we first developed a method for ex vivo manufacture of rat host-type Th2 cells in rapamycin, with subsequent injection of such Th2. R cells prior to class I and class II disparate cardiac allografting. Second, we determined whether Th2. R cell transfer polarized host immunity towards a Th2 phenotype. And third, we evaluated whether Th2. R cell therapy prolonged allograft viability when used alone or in combination with a short-course of cyclosporine (CSA) therapy. We found that host-type Th2. R cell therapy prior to cardiac allografting: (1) reduced the frequency of activated T cells in secondary lymphoid organs; (2) shifted post-transplant cytokines towards a Th2 phenotype; and (3) prolonged allograft viability when used in combination with short-course CSA therapy. These results provide further support for the rationale to use "direct" host T cell therapy for prolongation of allograft viability as an alternative to "indirect" therapy mediated by donor T cell infusion.	[Amarnath, Shoba; Foley, Jason E.; Costanzo, Carliann M.; Fowler, Daniel H.] NCI, Expt Transplantat & Immunol Branch, NIH, Bethesda, MD 20892 USA; [Chen, Hao; Solomon, Michael A.] NIH, Ctr Clin, Bethesda, MD 20892 USA; [Chen, Hao] Fudan Univ, Huadong Hosp, Dept Cardiac Surg, Shanghai 200433, Peoples R China; [Sennesh, Joel D.] Inova Fairfax Hosp, Dept Pathol, Fairfax, VA USA; [Solomon, Michael A.] NHLBI, Cardiovasc & Pulm Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Fudan University; Inova Fairfax Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Amarnath, S (corresponding author), NCI, Expt Transplantat & Immunol Branch, NIH, Bethesda, MD 20892 USA.	samarnath@mail.nih.gov	amarnath, shoba/AAP-4391-2020	Solomon, Michael/0000-0001-7400-6614	Center for Cancer Research; National Cancer Institute; Critical Care Medicine Department; NATIONAL CANCER INSTITUTE [ZIASC010288, ZIABC011220] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL008094] Funding Source: NIH RePORTER	Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Critical Care Medicine Department; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CLINICAL CENTER	This work was supported by the Center for Cancer Research, National Cancer Institute, and Critical Care Medicine Department, Clinical Center Intramural Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007840; AMARNATH S, AUTOPHAGY, V6; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Cobbold SP, 2006, IMMUNOL REV, V213, P239, DOI 10.1111/j.1600-065X.2006.00428.x; COCHRUM K, 1981, TRANSPLANT P, V13, P1657; COOLEY DFO, 1983, TRANSPLANT P, V15; Deans KJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-280; Delfs MW, 2001, TRANSPLANTATION, V71, P606, DOI 10.1097/00007890-200103150-00005; Egidi MF, 2003, TRANSPLANTATION, V75, P572, DOI 10.1097/01.TP.0000046940.27269.43; Foley JE, 2005, J IMMUNOL, V175, P5732, DOI 10.4049/jimmunol.175.9.5732; FOWLER DH, 1994, J IMMUNOL, V152, P1004; Gao W, 2007, AM J TRANSPLANT, V7, P1722, DOI 10.1111/j.1600-6143.2007.01842.x; Golshayan D, 2007, BLOOD, V109, P827, DOI 10.1182/blood-2006-05-025460; Hackstein H, 2003, BLOOD, V101, P4457, DOI 10.1182/blood-2002-11-3370; Hall BM, 2007, TRANSPLANTATION, V83, P1075, DOI 10.1097/01.tp.0000259553.66185.2f; Illigens BM, 2009, EUR J IMMUNOL, V39, P3000, DOI 10.1002/eji.200838980; Isobe M, 1997, CIRCULATION, V96, P2247; Joffre O, 2008, NAT MED, V14, P88, DOI 10.1038/nm1688; Jung U, 2003, BLOOD, V102, P3439, DOI 10.1182/blood-2002-12-3936; Jung US, 2006, BIOL BLOOD MARROW TR, V12, P905, DOI 10.1016/j.bbmt.2006.05.014; Kang SM, 2007, AM J TRANSPLANT, V7, P1457, DOI 10.1111/j.1600-6143.2007.01829.x; Kataoka M, 2003, SURGERY, V134, P227, DOI 10.1067/msy.2003.226; Kataoka M, 2002, SURGERY, V132, P167, DOI 10.1067/msy.2002.125303; Ke BB, 2000, J IMMUNOL, V164, P5739, DOI 10.4049/jimmunol.164.11.5739; Khush KK, 2009, EXPERT OPIN EMERG DR, V14, P1, DOI [10.1517/14728210902791605, 10.1517/14728210902791605 ]; Kitade H, 2004, TRANSPLANTATION, V78, P1747, DOI 10.1097/01.TP.0000147788.23922.5B; Levine BL, 1997, J IMMUNOL, V159, P5921; Levy AE, 1997, TRANSPL IMMUNOL, V5, P83, DOI 10.1016/S0966-3274(97)80047-0; Li YS, 1998, TRANSPLANTATION, V66, P1387, DOI 10.1097/00007890-199811270-00021; Lucas JG, 2011, EXPERT OPIN PHARMACO, V12, P579, DOI 10.1517/14656566.2011.525219; Maes BD, 2004, TRANSPL P, V36, p40S, DOI 10.1016/j.transproceed.2004.01.038; Mariotti J, 2008, J IMMUNOL, V180, P89, DOI 10.4049/jimmunol.180.1.89; Mariotti J, 2008, BLOOD, V112, P4765, DOI 10.1182/blood-2008-05-154278; Onodera K, 1997, J IMMUNOL, V158, P1572; OPELZ G, 1979, TRANSPLANT P, V11, P145; Patel JK, 2004, TRANSPL P, V36, p323S, DOI 10.1016/j.transproceed.2004.01.039; Paulos CM, 2008, IMMUNOL RES, V42, P182, DOI 10.1007/s12026-008-8070-9; RAIMONDI G, J IMMUNOL, V184, P624; Schenk AD, 2008, AM J TRANSPLANT, V8, P1652, DOI 10.1111/j.1600-6143.2008.02302.x; SHAPIRA OM, 1993, J CLIN INVEST, V91, P388, DOI 10.1172/JCI116211; Stewart S, 2005, J HEART LUNG TRANSPL, V24, P1710, DOI 10.1016/j.healun.2005.03.019; WOODRUFF MFA, 1983, LANCET, V1, P1201; Yamada A, 2003, AM J TRANSPLANT, V3, P23, DOI 10.1034/j.1600-6143.2003.30105.x; YOKOYAMA H, 1995, J HEART LUNG TRANSPL, V14, P706; Young KJ, 2002, BLOOD, V100, P3408, DOI 10.1182/blood-2002-01-0235; Zhai Y, 1999, CRIT REV IMMUNOL, V19, P155	46	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18885	10.1371/journal.pone.0018885	http://dx.doi.org/10.1371/journal.pone.0018885			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559526	Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700031
J	Pinho, S; Simonsson, PR; Trevers, KE; Stower, MJ; Sherlock, WT; Khan, M; Streit, A; Sheng, GJ; Stern, CD				Pinho, Sonia; Simonsson, Pamela R.; Trevers, Katherine E.; Stower, Matthew J.; Sherlock, William T.; Khan, Mohsin; Streit, Andrea; Sheng, Guojun; Stern, Claudio D.			Distinct Steps of Neural Induction Revealed by Asterix, Obelix and TrkC, Genes Induced by Different Signals from the Organizer	PLOS ONE			English	Article							TRANSLATION INITIATION-FACTORS; PRIMITIVE STREAK FORMATION; MESSENGER-RNA EXPRESSION; IN-SITU HYBRIDIZATION; CHICK-EMBRYO; BMP INHIBITION; AVIAN EMBRYOS; XENOPUS-LAEVIS; SPEMANN ORGANIZER; RETINOIC ACID	The amniote organizer (Hensen's node) can induce a complete nervous system when grafted into a peripheral region of a host embryo. Although BMP inhibition has been implicated in neural induction, non-neural cells cannot respond to BMP antagonists unless previously exposed to a node graft for at least 5 hours before BMP inhibitors. To define signals and responses during the first 5 hours of node signals, a differential screen was conducted. Here we describe three early response genes: two of them, Asterix and Obelix, encode previously undescribed proteins of unknown function but Obelix appears to be a nuclear RNA-binding protein. The third is TrkC, a neurotrophin receptor. All three genes are induced by a node graft within 4-5 hours but they differ in the extent to which they are inducible by FGF: FGF is both necessary and sufficient to induce Asterix, sufficient but not necessary to induce Obelix and neither sufficient nor necessary for induction of TrkC. These genes are also not induced by retinoic acid, Noggin, Chordin, Dkk1, Cerberus, HGF/SF, Somatostatin or ionomycin-mediated Calcium entry. Comparison of the expression and regulation of these genes with other early neural markers reveals three distinct "epochs'', or temporal waves, of gene expression accompanying neural induction by a grafted organizer, which are mirrored by specific stages of normal neural plate development. The results are consistent with neural induction being a cascade of responses elicited by different signals, culminating in the formation of a patterned nervous system.	[Pinho, Sonia; Simonsson, Pamela R.; Trevers, Katherine E.; Stower, Matthew J.; Sherlock, William T.; Khan, Mohsin; Sheng, Guojun; Stern, Claudio D.] UCL, Dept Cell & Dev Biol, London, England; [Streit, Andrea] Kings Coll London, Dept Craniofacial Dev, London WC2R 2LS, England	University of London; University College London; University of London; King's College London	Pinho, S (corresponding author), Fac Med Porto, Serv Fisiol, Oporto, Portugal.	c.stern@ucl.ac.uk	Sheng, Guojun/G-8746-2013; Streit, Andrea/F-2683-2010; Stern, Claudio D/C-6265-2008; Sheng, Guojun/I-4900-2015; Sheng, Guojun/G-4116-2014; Stern, Claudio/AAZ-7381-2021	Stern, Claudio D/0000-0002-9907-889X; Stern, Claudio/0000-0002-9907-889X; Streit, Andrea/0000-0001-7664-7917; Khan, Mohsin/0000-0001-8028-2500	Medical Research Council; National Institutes of Health (USA) [R01MH60156]; Portuguese Foundation for Science and Technology (FCT); BBSRC; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060156] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [953782] Funding Source: researchfish; Medical Research Council [G0400559] Funding Source: researchfish; MRC [G0400559] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by grants from the Medical Research Council and the National Institutes of Health (USA) (R01MH60156). SP was part of the GABBA Programme, University of Porto and was supported by the Portuguese Foundation for Science and Technology (FCT). PRS was supported by a BBSRC quota studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albazerchi A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-25; Albazerchi A, 2007, DEV BIOL, V301, P489, DOI 10.1016/j.ydbio.2006.08.057; Baig MA, 1996, INT J DEV NEUROSCI, V14, P55, DOI 10.1016/0736-5748(95)00076-3; Battiste JL, 2000, MOL CELL, V5, P109, DOI 10.1016/S1097-2765(00)80407-4; BENNE R, 1978, J BIOL CHEM, V253, P3070; Bernd P, 1999, DEV BRAIN RES, V116, P205, DOI 10.1016/S0165-3806(99)00082-6; Bertocchini F, 2002, DEV CELL, V3, P735, DOI 10.1016/S1534-5807(02)00318-0; CHEN YP, 1992, P NATL ACAD SCI USA, V89, P10056, DOI 10.1073/pnas.89.21.10056; CHEN YP, 1992, DEV DYNAM, V195, P142, DOI 10.1002/aja.1001950209; Dale L, 1999, SEMIN CELL DEV BIOL, V10, P319, DOI 10.1006/scdb.1999.0308; DALE L, 1987, DEVELOPMENT, V100, P279; DALE L, 1992, DEVELOPMENT, V115, P573; de Almeida I, 2008, MECH DEVELOP, V125, P421, DOI 10.1016/j.mod.2008.02.002; Delaune E, 2005, DEVELOPMENT, V132, P299, DOI 10.1242/dev.01582; DEVER TE, 1994, J BIOL CHEM, V269, P3212; DIAS MS, 1990, ANAT RECORD, V228, P437, DOI 10.1002/ar.1092280410; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; Foley AC, 2000, DEVELOPMENT, V127, P3839; GALLERA J, 1969, J EMBRYOL EXP MORPH, V21, P105; GALLERA J, 1964, J EMBRYOL EXP MORPH, V12, P693; Gallera J., 1971, EXPERIENTIA, V26, P1953; GIBSON A, 2010, REGULATION PRO UNPUB; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; GURDON JB, 1987, DEVELOPMENT, V99, P285; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; HemmatiBrivanlou A, 1997, CELL, V88, P13, DOI 10.1016/S0092-8674(00)81853-X; KEELING PJ, 1995, MOL MICROBIOL, V17, P399; Kyrpides NC, 1998, P NATL ACAD SCI USA, V95, P224, DOI 10.1073/pnas.95.1.224; LAMB TM, 1993, SCIENCE, V262, P713, DOI 10.1126/science.8235591; Launay C, 1996, DEVELOPMENT, V122, P869; Linker C, 2004, DEVELOPMENT, V131, P5671, DOI 10.1242/dev.01445; Linker C, 2009, DEV BIOL, V327, P478, DOI 10.1016/j.ydbio.2008.12.034; LUTHER WOLFGANG, 1935, BIOL ZENTRALBL, V55, P114; Marchal L, 2009, P NATL ACAD SCI USA, V106, P17437, DOI 10.1073/pnas.0906352106; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; NEW DAT, 1955, J EMBRYOL EXP MORPH, V3, P326; Oppenheimer JM, 1936, J EXP ZOOL, V72, P409, DOI 10.1002/jez.1400720304; Oppenheimer JM, 1936, P SOC EXP BIOL MED, V34, P461; Papanayotou C, 2008, PLOS BIOL, V6, P109, DOI 10.1371/journal.pbio.0060002; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Rex M, 1997, DEV DYNAM, V209, P323, DOI 10.1002/(SICI)1097-0177(199707)209:3<323::AID-AJA7>3.3.CO;2-B; Sambrook J, 1989, MOL CLONING LABORATO; Sasai Y, 1996, EMBO J, V15, P4547, DOI 10.1002/j.1460-2075.1996.tb00832.x; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Sette M, 1997, EMBO J, V16, P1436, DOI 10.1093/emboj/16.6.1436; Sheng GJ, 2003, CELL, V115, P603, DOI 10.1016/S0092-8674(03)00927-9; Skromne I, 2001, DEVELOPMENT, V128, P2915; SMITH JC, 1989, DEVELOPMENT, V107, P149; SMITH JC, 1983, J EMBRYOL EXP MORPH, V78, P299; SMITH WC, 1993, NATURE, V361, P547, DOI 10.1038/361547a0; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Sorensen HP, 2001, IUBMB LIFE, V51, P321; Spemann Hans., 1924, ROUXS ARCH ENTW MECH, V100, P599, DOI 10.1007/BF02108133; Stern CD, 1998, CURR TOP DEV BIOL, V36, P223; Stern CD, 2005, DEVELOPMENT, V132, P2007, DOI 10.1242/dev.01794; STERN CD, 1981, ANAT EMBRYOL, V163, P245, DOI 10.1007/BF00315703; Stern Claudio D., 2008, V461, P265, DOI 10.1007/978-1-60327-483-8_18; STOREY KG, 1992, DEVELOPMENT, V114, P729; Streit A, 2000, NATURE, V406, P74, DOI 10.1038/35017617; STREIT A, 1995, DEVELOPMENT, V121, P813; Streit A, 1999, MECH DEVELOP, V85, P85, DOI 10.1016/S0925-4773(99)00085-4; Streit A, 1997, DEVELOPMENT, V124, P1191; Streit A, 1998, DEVELOPMENT, V125, P507; Streit A, 1999, MECH DEVELOP, V82, P51, DOI 10.1016/S0925-4773(99)00013-1; Streit A, 2001, METHODS, V23, P339, DOI 10.1006/meth.2000.1146; Streit A, 2008, METHOD CELL BIOL, V87, P3, DOI 10.1016/S0091-679X(08)00201-X; Tonegawa A, 1997, DEVELOPMENT, V124, P1975; UWANOGHO D, 1995, MECH DEVELOP, V49, P23, DOI 10.1016/0925-4773(94)00299-3; Waddington C. H., 1937, Archives de Biologie Liege, V48, P273; Waddington CH, 1934, J EXP BIOL, V11, P211; Waddington CH, 1932, PHILOS T R SOC LON B, V221, P179, DOI 10.1098/rstb.1932.0003; Waddington CH, 1933, ROUX ARCH DEV BIOL, V128, P522, DOI 10.1007/BF00649863; Waddington CH, 1930, NATURE, V125, P924, DOI 10.1038/125924b0; Waddington CH, 1933, J EXP BIOL, V10, P38; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Wilson SI, 2000, CURR BIOL, V10, P421, DOI 10.1016/S0960-9822(00)00431-0; Wilson SI, 2001, NATURE, V411, P325, DOI 10.1038/35077115; YAO LH, 1994, DEV BIOL, V165, P727, DOI 10.1006/dbio.1994.1288; Zhang C, 2000, PROTEINS, V40, P409, DOI 10.1002/1097-0134(20000815)40:3<409::AID-PROT60>3.0.CO;2-6; Zhang DM, 1996, DEV DYNAM, V205, P150, DOI 10.1002/(SICI)1097-0177(199602)205:2<150::AID-AJA6>3.0.CO;2-H; ZHANG DM, 1994, J NEUROBIOL, V25, P1517, DOI 10.1002/neu.480251205; Zhu L, 1999, CURR BIOL, V9, P931, DOI 10.1016/S0960-9822(99)80419-9	84	18	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19157	10.1371/journal.pone.0019157	http://dx.doi.org/10.1371/journal.pone.0019157			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559472	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700082
J	Winsel, S; Sommer, A; Eschenbrenner, J; Mittelstaedt, K; Klar, U; Hammer, S; Hoffmann, J				Winsel, Sebastian; Sommer, Anette; Eschenbrenner, Julia; Mittelstaedt, Kevin; Klar, Ulrich; Hammer, Stefanie; Hoffmann, Jens			Molecular Mode of Action and Role of TP53 in the Sensitivity to the Novel Epothilone Sagopilone (ZK-EPO) in A549 Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							FULLY SYNTHETIC EPOTHILONE; PIFITHRIN-ALPHA; PROLONGED MITOSIS; INDUCED APOPTOSIS; GENE-EXPRESSION; P53 FUNCTION; TUMOR-CELLS; PACLITAXEL; INACTIVATION; ARREST	Sagopilone, an optimized fully synthetic epothilone, is a microtubule-stabilizing compound that has shown high in vitro and in vivo activity against a broad range of human tumor models. We analyzed the differential mechanism of action of sagopilone in non-small cell lung cancer cell lines in vitro. Sagopilone inhibited proliferation of non-small cell lung cancer cell lines at lower nanomolar concentration. The treatment with sagopilone caused strong disturbances of cellular cytoskeletal organization. Two concentration-dependent phenotypes were observed. At 2.5 nM sagopilone or 4 nM paclitaxel an aneuploid phenotype occur whereas a mitotic arrest phenotype was induced by 40 nM sagopilone or paclitaxel. Interestingly, treatment with 2.5 nM of sagopilone effectively inhibited cell proliferation, but - compared to high concentrations (40 nM) - only marginally induced apoptosis. Treatment with a high versus a low concentration of sagopilone or paclitaxel regulates a non-overlapping set of genes, indicating that both phenotypes substantially differ from each other. Genes involved in G2/M phase transition and the spindle assembly checkpoint, like Cyclin B1 and BUBR1 were upregulated by treatment with 40 nM sagopilone. Unexpectedly, also genes involved in DNA damage response were upregulated under that treatment. In contrast, treatment of A549 cells with a low concentration of sagopilone revealed an upregulation of direct transcriptional target genes of TP53, like CDKN1A, MDM2, GADD45A, FAS. Knockdown of TP53, which inhibited the transcriptional induction of TP53 target genes, led to a significant increase in apoptosis induction in A549 cells when treated with a low concentration of sagopilone. The results indicate that activation of TP53 and its downstream effectors like CDKN1A by low concentrations of sagopilone is responsible for the relative apoptosis resistance of A549 cells and might represent a mechanism of resistance to sagopilone.	[Winsel, Sebastian; Sommer, Anette; Eschenbrenner, Julia; Mittelstaedt, Kevin; Klar, Ulrich; Hammer, Stefanie; Hoffmann, Jens] Bayer Healthcare, Global Drug Discovery, Berlin, Germany; [Winsel, Sebastian] Free Univ Berlin, Inst Chem Biochem, D-1000 Berlin, Germany; [Winsel, Sebastian] VTT Tech Res Ctr Finland, Turku, Finland; [Eschenbrenner, Julia] Tech Univ Berlin, Inst Biotechnol, Berlin, Germany; [Mittelstaedt, Kevin] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Hoffmann, Jens] Max Delbruck Ctr Mol Med, Berlin, Germany	Bayer AG; Bayer Healthcare Pharmaceuticals; Free University of Berlin; VTT Technical Research Center Finland; Technical University of Berlin; University of Melbourne; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Winsel, S (corresponding author), Bayer Healthcare, Global Drug Discovery, Berlin, Germany.	stefanie.hammer@bayer.com; jens.hoffmann@mdc-berlin.de	Sommer, Anette/T-7674-2019	Sommer, Anette/0000-0002-1576-3110; Hoffmann, Jens/0000-0003-3880-1658	Bayer Healthcare	Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals)	The work was funded by the Bayer Healthcare (www.bayerhealthcare.com). The funders had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript. All the authors are employees or former employees of the Bayer Healthcare. Grant support in detail: S. Winsel, J. Eschenbrenner, K. Mittelstaedt recieved commercial research grants from Bayer Healthcare; A. Sommer, U. Klar, S. Hammer, J. Hoffmann are current or former employes of Bayer Healthcare and hold patents on Bayer Healthcare as well as shares on Bayer.	Altaha R, 2004, INT J MOL MED, V14, P959; Aylon Y, 2007, CELL, V130, P597, DOI 10.1016/j.cell.2007.08.005; Bergstralh DT, 2004, J CHEMOTHERAPY, V16, P563, DOI 10.1179/joc.2004.16.6.563; Blagosklonny MV, 2007, CELL CYCLE, V6, P70, DOI 10.4161/cc.6.1.3682; Blagosklonny MV, 2006, CELL CYCLE, V5, P971, DOI 10.4161/cc.5.9.2711; Blagosklonny MV, 1999, INT J CANCER, V83, P151, DOI 10.1002/(SICI)1097-0215(19991008)83:2<151::AID-IJC1>3.0.CO;2-5; Cassinelli G, 2001, INT J CANCER, V92, P738, DOI 10.1002/1097-0215(20010601)92:5<738::AID-IJC1249>3.0.CO;2-2; Castedo M, 2002, J IMMUNOL METHODS, V265, P39, DOI 10.1016/S0022-1759(02)00069-8; Chen JG, 2003, CANCER RES, V63, P7891; Coate LE, 2009, LANCET ONCOL, V10, P1001, DOI 10.1016/S1470-2045(09)70155-X; Das S, 2008, CELL CYCLE, V7, P154, DOI 10.4161/cc.7.2.5236; Demidenko ZN, 2008, ONCOGENE, V27, P4402, DOI 10.1038/onc.2008.82; Fan SJ, 1998, CLIN CANCER RES, V4, P1047; FISCHER J, 2008, ESMO, V33; Gandhi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004576; Gazdar AF, 2009, NEW ENGL J MED, V361, P1018, DOI 10.1056/NEJMe0905763; Gudkov AV, 2005, BIOCHEM BIOPH RES CO, V331, P726, DOI 10.1016/j.bbrc.2005.03.153; Hammer S, 2010, CLIN CANCER RES, V16, P1452, DOI 10.1158/1078-0432.CCR-09-2455; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hawkins DS, 1996, CANCER RES, V56, P892; Heliez C, 2003, ONCOGENE, V22, P3260, DOI 10.1038/sj.onc.1206409; Hoagland MS, 2005, J PHARMACOL EXP THER, V314, P603, DOI 10.1124/jpet.105.084186; Hoffmann J, 2008, CANCER RES, V68, P5301, DOI 10.1158/0008-5472.CAN-08-0237; HORNER MJ, 2009, SEER CANC STAT REV; Horwitz Susan Band, 1993, Journal of the National Cancer Institute Monographs, V0, P55; Ioffe ML, 2004, PROSTATE, V61, P243, DOI 10.1002/pros.20108; Janicke RU, 2007, CELL CYCLE, V6, P407; Jin SF, 1997, EMBO J, V16, P6874, DOI 10.1093/emboj/16.22.6874; Kaji A, 2003, MOL CARCINOGEN, V37, P138, DOI 10.1002/mc.10130; Klar U, 2006, ANGEW CHEM INT EDIT, V45, P7942, DOI 10.1002/anie.200602785; Lichtner RB, 2001, P NATL ACAD SCI USA, V98, P11743, DOI 10.1073/pnas.171023398; Ling YH, 2000, ANTICANCER RES, V20, P693; Mozzetti S, 2008, CANCER RES, V68, P10197, DOI 10.1158/0008-5472.CAN-08-2091; Murphy PJM, 2004, J BIOL CHEM, V279, P30195, DOI 10.1074/jbc.M403539200; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; National Cancer Institute, GEN INF NONSM CELL L; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; OConnor PM, 1997, CANCER RES, V57, P4285; POPANDA O, 1992, BIOCHIM BIOPHYS ACTA, V1129, P155, DOI 10.1016/0167-4781(92)90480-N; Rigas JR, 2004, ONCOLOGIST, V9, P16, DOI 10.1634/theoncologist.9-suppl_2-16; Riley KJL, 2007, RNA, V13, P1825, DOI 10.1261/rna.673407; Schmid P, 2010, ANN ONCOL, V21, P633, DOI 10.1093/annonc/mdp491; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Seve Pascal, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P73, DOI 10.2174/1568011053352604; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sohn D, 2009, CELL DEATH DIFFER, V16, P869, DOI 10.1038/cdd.2009.17; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Suzuki A, 1999, ONCOGENE, V18, P1239, DOI 10.1038/sj.onc.1202409; Tomizawa Y, 1999, ONCOGENE, V18, P1007, DOI 10.1038/sj.onc.1202384; Torres K, 1998, CANCER RES, V58, P3620; Vikhanskaya F, 1998, EXP CELL RES, V241, P96, DOI 10.1006/excr.1998.4018; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Xu SQ, 2000, BIOCHEM BIOPH RES CO, V269, P179, DOI 10.1006/bbrc.2000.2247; Zuco V, 2008, NEOPLASIA, V10, P587, DOI 10.1593/neo.08262	54	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19273	10.1371/journal.pone.0019273	http://dx.doi.org/10.1371/journal.pone.0019273			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559393	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000290024700122
J	Yang, XH; Boateng, KA; Yuan, L; Wu, S; Baskin, TI; Makaroff, CA				Yang, Xiaohui; Boateng, Kingsley A.; Yuan, Li; Wu, Shuang; Baskin, Tobias I.; Makaroff, Christopher A.			The Radially Swollen 4 Separase Mutation of Arabidopsis thaliana Blocks Chromosome Disjunction and Disrupts the Radial Microtubule System in Meiocytes	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; MEIOSIS-I; CAENORHABDITIS-ELEGANS; ANAPHASE ONSET; ARM COHESION; CLEAVAGE; PROTEIN; PROPHASE; MITOSIS; CELLS	The caspase-family protease, separase, is required at the onset of anaphase to cleave the cohesin complex that joins replicated sister chromatids. However, in various eukaryotes, separase has acquired additional and distinct functions. A single amino-acid substitution in separase is responsible for phenotypes of the Arabidopsis thaliana mutant, radially swollen 4 (rsw4). This is a conditional mutant, resembling the wild type at the permissive temperature (similar to 20 degrees C) and expressing mutant phenotypes at the restrictive temperature (similar to 30 degrees C). Root cells in rsw4 at the restrictive temperature undergo nondisjunction and other indications of the loss of separase function. To determine to what extent separase activity remains at 30 degrees C, we examined the effect of the mutation on meiosis, where the effects of loss of separase activity through RNA interference are known; and in addition, we examined female gametophyte development. Here, we report that, at the restrictive temperature, replicated chromosomes in rsw4 meiocytes typically fail to disjoin and the cohesin complex remains at centromeres after metaphase. Meiotic spindles appear normal in rsw4 male meiocytes; however the mutation disrupts the radial microtubule system, which is replaced by asymmetric arrays. Surprisingly, female gametophyte development was relatively insensitive to loss of separase activity, through either rsw4 or RNAi. These effects confirm that phenotypes in rsw4 result from loss of separase activity and establish a role for separase in regulating cell polarization following male meiosis.	[Yang, Xiaohui; Boateng, Kingsley A.; Yuan, Li; Makaroff, Christopher A.] Miami Univ, Dept Chem & Biochem, Oxford, OH 45056 USA; [Wu, Shuang; Baskin, Tobias I.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA	University System of Ohio; Miami University; University of Massachusetts System; University of Massachusetts Amherst	Yang, XH (corresponding author), Miami Univ, Dept Chem & Biochem, Oxford, OH 45056 USA.	makaroca@muohio.edu	Wu, Shuang/M-1839-2013; Yuan, Li/D-6069-2015; Baskin, Tobias/W-5011-2019	Yuan, Li/0000-0003-1803-6661; Makaroff, Christopher/0000-0001-6237-1868	United States National Science Foundation [MCB-0718191]; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy [DE-FG-03ER15421]	United States National Science Foundation(National Science Foundation (NSF)); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE))	This work was supported by a grant (MCB-0718191)from the United States National Science Foundation to CAM and by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy through Grant DE-FG-03ER15421 (to TIB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bembenek JN, 2007, DEVELOPMENT, V134, P3837, DOI 10.1242/dev.011361; Brown RC, 2001, PROTOPLASMA, V215, P35, DOI 10.1007/BF01280302; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Cai X, 2003, J CELL SCI, V116, P2999, DOI 10.1242/jcs.00601; Christensen CA, 1997, SEX PLANT REPROD, V10, P49, DOI 10.1007/s004970050067; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Eijpe M, 2003, J CELL BIOL, V160, P657, DOI 10.1083/jcb.200212080; Fransz PF, 1996, PLANT J, V9, P421, DOI 10.1046/j.1365-313X.1996.09030421.x; Gimenez-Abian JF, 2004, CURR BIOL, V14, P1187, DOI 10.1016/j.cub.2004.06.052; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Higuchi T, 2005, NATURE, V433, P171, DOI 10.1038/nature03240; Katis VL, 2004, CURR BIOL, V14, P560, DOI 10.1016/j.cub.2004.03.001; Kitajima TS, 2003, EMBO J, V22, P5643, DOI 10.1093/emboj/cdg527; Lam WS, 2005, J CELL SCI, V118, P3037, DOI 10.1242/jcs.02443; Lee J, 2003, J CELL SCI, V116, P2781, DOI 10.1242/jcs.00495; Liu Z, 2006, PLANT CELL, V18, P1213, DOI 10.1105/tpc.105.036913; Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Otegui MS, 2004, PLANT CELL PHYSIOL, V45, pS10; Pandey R, 2005, J CELL SCI, V118, P733, DOI 10.1242/jcs.01663; Pasierbek P, 2001, GENE DEV, V15, P1349, DOI 10.1101/gad.192701; Queralt E, 2005, NAT CELL BIOL, V7, P930, DOI 10.1038/ncb1005-930; Rabitsch KP, 2003, DEV CELL, V4, P535, DOI 10.1016/S1534-5807(03)00086-8; Rappleye CA, 2002, DEV CELL, V2, P195, DOI 10.1016/S1534-5807(02)00114-4; Ross KJ, 1996, CHROMOSOME RES, V4, P507, DOI 10.1007/BF02261778; Shepard JL, 2007, GENE DEV, V21, P55, DOI 10.1101/gad.1470407; Siomos MF, 2001, CURR BIOL, V11, P1825, DOI 10.1016/S0960-9822(01)00588-7; STAIGER CJ, 1990, DEV BIOL, V138, P231, DOI 10.1016/0012-1606(90)90193-M; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Tinker-Kulberg RL, 1999, GENE DEV, V13, P1936, DOI 10.1101/gad.13.15.1936; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Wiedemeier AMD, 2002, DEVELOPMENT, V129, P4821; Wu S, 2010, DEVELOPMENT, V137, P953, DOI 10.1242/dev.041939; Xiong B, 2010, ANNU REV BIOCHEM, V79, P131, DOI 10.1146/annurev-biochem-061708-092640; YANG X, 2006, J CELL SCI, V19, P4025; Yang XH, 2009, PLANT PHYSIOL, V151, P323, DOI 10.1104/pp.109.140699; Yu HG, 2005, CELL, V123, P397, DOI 10.1016/j.cell.2005.09.014	44	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19459	10.1371/journal.pone.0019459	http://dx.doi.org/10.1371/journal.pone.0019459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559383	Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700183
J	Andersen, JH; Fallentin, N; Thomsen, JF; Mikkelsen, S				Andersen, Johan H.; Fallentin, Nils; Thomsen, Jane F.; Mikkelsen, Sigurd			Risk Factors for Neck and Upper Extremity Disorders among Computers Users and the Effect of Interventions: An Overview of Systematic Reviews	PLOS ONE			English	Review							CARPAL-TUNNEL-SYNDROME; MUSCULOSKELETAL DISORDERS; ERGONOMIC INTERVENTIONS; METHODOLOGICAL QUALITY; MEASUREMENT TOOL; OFFICE WORKERS; PAIN; SYMPTOMS; KEYBOARD; MOUSE	Background: To summarize systematic reviews that 1) assessed the evidence for causal relationships between computer work and the occurrence of carpal tunnel syndrome (CTS) or upper extremity musculoskeletal disorders (UEMSDs), or 2) reported on intervention studies among computer users/or office workers. Methodology/Principal Findings: PubMed, Embase, CINAHL and Web of Science were searched for reviews published between 1999 and 2010. Additional publications were provided by content area experts. The primary author extracted all data using a purpose-built form, while two of the authors evaluated the quality of the reviews using recommended standard criteria from AMSTAR; disagreements were resolved by discussion. The quality of evidence syntheses in the included reviews was assessed qualitatively for each outcome and for the interventions. Altogether, 1,349 review titles were identified, 47 reviews were retrieved for full text relevance assessment, and 17 reviews were finally included as being relevant and of sufficient quality. The degrees of focus and rigorousness of these 17 reviews were highly variable. Three reviews on risk factors for carpal tunnel syndrome were rated moderate to high quality, 8 reviews on risk factors for UEMSDs ranged from low to moderate/high quality, and 6 reviews on intervention studies were of moderate to high quality. The quality of the evidence for computer use as a risk factor for CTS was insufficient, while the evidence for computer use and UEMSDs was moderate regarding pain complaints and limited for specific musculoskeletal disorders. From the reviews on intervention studies no strong evidence based recommendations could be given. Conclusions/Significance: Computer use is associated with pain complaints, but it is still not very clear if this association is causal. The evidence for specific disorders or diseases is limited. No effective interventions have yet been documented.	[Andersen, Johan H.] Reg Hosp Herning, Danish Ramazzini Ctr, Dept Occupat Med, Herning, Denmark; [Fallentin, Nils] Liberty Mutual Res Inst Safety, Ctr Phys Ergon, Hopkinton, MA USA; [Thomsen, Jane F.; Mikkelsen, Sigurd] Univ Copenhagen, Dept Occupat & Environm Med, Bispebjerg Hosp, Copenhagen, Denmark	Aarhus University; Liberty Mutual Research Institute for Safety; Aarhus University; University of Copenhagen; Bispebjerg Hospital	Andersen, JH (corresponding author), Reg Hosp Herning, Danish Ramazzini Ctr, Dept Occupat Med, Herning, Denmark.	joande@rm.dk	Andersen, Johan Hviid/AAI-2086-2019	Andersen, Johan Hviid/0000-0003-1638-8276				Andersen JH, 2008, OCCUP ENVIRON MED, V65, P126, DOI 10.1136/oem.2007.033506; Andersen JH, 2003, JAMA-J AM MED ASSOC, V289, P2963, DOI 10.1001/jama.289.22.2963; Ariens GA, 2000, SCAND J WORK ENV HEA, V26, P7, DOI 10.5271/sjweh.504; Arvidsson I, 2006, INT J IND ERGONOM, V36, P613, DOI 10.1016/j.ergon.2006.03.002; BERGQVIST U, 1995, ERGONOMICS, V38, P754, DOI 10.1080/00140139508925147; BERGQVIST U, 1995, ERGONOMICS, V38, P763, DOI 10.1080/00140139508925148; BERNARD B, 1994, SCAND J WORK ENV HEA, V20, P417, DOI 10.5271/sjweh.1379; Boocock MG, 2007, OCCUP ENVIRON MED, V64, P291, DOI 10.1136/oem.2005.025593; Brandt LPA, 2004, SCAND J WORK ENV HEA, V30, P399, DOI 10.5271/sjweh.828; Brewer S, 2006, J OCCUP REHABIL, V16, P325, DOI 10.1007/s10926-006-9031-6; Conlon CF, 2008, OCCUP ENVIRON MED, V65, P311, DOI 10.1136/oem.2006.032243; Cote P, 2008, SPINE, V33, pS60, DOI 10.1097/BRS.0b013e3181643ee4; DEMBE A, 1996, OCCUPATION DIS SOCIA; Driessen MT, 2010, OCCUP ENVIRON MED, V67, P277, DOI 10.1136/oem.2009.047548; Egilman D, 1996, J OCCUP ENVIRON MED, V38, P1079, DOI 10.1097/00043764-199611000-00001; *EUR AG OCC SAF HL, 2008, WORK REL MUSC DIS PR; Fernstrom EAC, 1999, INT J IND ERGONOM, V23, P231, DOI 10.1016/S0169-8141(97)00058-9; Gerr F, 2004, J ELECTROMYOGR KINES, V14, P25, DOI 10.1016/j.jelekin.2003.09.014; Gerr F, 2006, J OCCUP REHABIL, V16, P265, DOI 10.1007/s10926-006-9037-0; Griffiths KL, 2007, J OCCUP REHABIL, V17, P743, DOI 10.1007/s10926-007-9108-x; Guyatt GH, BMJ, V336, P924; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P1049, DOI 10.1136/bmj.39493.646875.AE; Hadler NM, 1996, J OCCUP ENVIRON MED, V38, P469, DOI 10.1097/00043764-199605000-00007; HENDEE WR, 1987, JAMA-J AM MED ASSOC, V257, P1508; Hoogendoorn WE, 1999, SCAND J WORK ENV HEA, V25, P387, DOI 10.5271/sjweh.451; IJmker S, 2007, OCCUP ENVIRON MED, V64, P211, DOI 10.1136/oem.2006.026468; IJMKER S, 2010, OCCUP ENV MED   1102; Jensen C, 2003, SCAND J WORK ENV HEA, V29, P197, DOI 10.5271/sjweh.722; Kennedy CA, 2010, J OCCUP REHABIL, V20, P127, DOI 10.1007/s10926-009-9211-2; KNARDAHL S, 2008, 22 STAMI; Korhonen T, 2003, OCCUP ENVIRON MED, V60, P475, DOI 10.1136/oem.60.7.475; Kryger AI, 2003, OCCUP ENVIRON MED, V60, DOI 10.1136/oem.60.11.e14; Lassen CF, 2005, SCAND J WORK ENV HEA, V31, P122, DOI 10.5271/sjweh.859; Lassen CF, 2004, AM J IND MED, V46, P521, DOI 10.1002/ajim.20081; LEE W R, 1985, British Medical Journal, V291, P989; Leyshon R, 2010, WORK, V35, P335, DOI 10.3233/WOR-2010-0994; LUCIRE Y, 2003, CONSTRUCTING RSI BEL; MAEDA K, 1977, Journal of Human Ergology, V6, P193; Marcus M, 2002, AM J IND MED, V41, P236, DOI 10.1002/ajim.10067; *NAT RES COUNC, 2001, MUSC DIS WORKPL LOW, P492; OXMAN AD, 1994, BMJ-BRIT MED J, V309, P648, DOI 10.1136/bmj.309.6955.648; PALMER KT, 2007, OCCUP MED-OXFORD, V1, P57; Punnett L, 1999, OCCUP MED, V14, P113; Rempel DM, 2006, OCCUP ENVIRON MED, V63, P300, DOI 10.1136/oem.2005.022285; Richter JM, 2009, ERGONOMICS, V52, P1540, DOI 10.1080/00140130903199905; Sampson M, 2008, J CLIN EPIDEMIOL, V61, P748, DOI 10.1016/j.jclinepi.2007.10.009; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Shea BJ, 2009, J CLIN EPIDEMIOL, V62, P1013, DOI 10.1016/j.jclinepi.2008.10.009; Silverstein MA, 1996, J OCCUP ENVIRON MED, V38, P477, DOI 10.1097/00043764-199605000-00008; Thomsen JF, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-134; THOMSON LC, 2002, COCHRANE DB SYST REV; Tittiranonda P, 1999, OCCUP MED, V14, P17; van der Windt DAWM, 2000, OCCUP ENVIRON MED, V57, P433, DOI 10.1136/oem.57.7.433; van Rijn RM, 2009, SCAND J WORK ENV HEA, V35, P19, DOI 10.5271/sjweh.1306; Verhagen A P, 2007, Eura Medicophys, V43, P391; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0; Village J., 2005, Occupational Ergonomics, V5, P205; Visser B, 2006, J ELECTROMYOGR KINES, V16, P1, DOI 10.1016/j.jelekin.2005.06.005; Waersted M, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-79; Wahlstrom J, 2005, OCCUP MED-OXFORD, V55, P168, DOI 10.1093/occmed/kqi083; Wahlstrom J, 2004, OCCUP ENVIRON MED, V61, P523, DOI 10.1136/oem.2003.009563	61	65	67	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19691	10.1371/journal.pone.0019691	http://dx.doi.org/10.1371/journal.pone.0019691			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589875	Green Published, Green Submitted, gold			2022-12-27	WOS:000290531100022
J	Michalski, JP; Anderson, C; Beauvais, A; De Repentigny, Y; Kothary, R				Michalski, John-Paul; Anderson, Carrie; Beauvais, Ariane; De Repentigny, Yves; Kothary, Rashmi			The Proteolipid Protein Promoter Drives Expression outside of the Oligodendrocyte Lineage during Embryonic and Early Postnatal Development	PLOS ONE			English	Article							SOMA-RESTRICTED PRODUCTS; NERVOUS-SYSTEM MYELIN; DM-20 MESSENGER-RNA; TRANSGENIC MICE; PLP GENE; IN-VIVO; CELLS; MOUSE; NEURONS; PROGENITORS	The proteolipid protein (Plp) gene promoter is responsible for driving expression of one of the major components of myelin - PLP and its splice variant DM-20. Both products are classically thought to express predominantly in oligodendrocytes. However, accumulating evidence suggests Plp expression is more widespread than previously thought. In an attempt to create a mouse model for inducing oligodendrocyte-specific gene deletions, we have generated transgenic mice expressing a Cre recombinase cDNA under control of the mouse Plp promoter. We demonstrate Plp promoter driven Cre expression is restricted predominantly to mature oligodendrocytes of the central nervous system (CNS) at postnatal day 28. However, crosses into the Rosa26(LacZ) and mT/mG reporter mouse lines reveal robust and widespread Cre activity in neuronal tissues at E15.5 and E10.5 that is not strictly oligodendrocyte lineage specific. By P28, all CNS tissues examined displayed high levels of reporter gene expression well outside of defined white matter zones. Importantly, our study reinforces the emerging idea that Plp promoter activity is not restricted to the myelinating cell lineage, but rather, has widespread activity both during embryonic and early postnatal development in the CNS. Specificity of the promoter to the oligodendrocyte cell lineage, as shown through the use of a tamoxifen inducible Plp-CreER(t) line, occurs only at later postnatal stages. Understanding the temporal shift in Plp driven expression is of consequence when designing experimental models to study oligodendrocyte biology.	[Michalski, John-Paul; Anderson, Carrie; Beauvais, Ariane; De Repentigny, Yves; Kothary, Rashmi] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Michalski, John-Paul] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Kothary, Rashmi] Univ Ottawa, Dept Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa	Michalski, JP (corresponding author), Ottawa Hosp, Res Inst, Ottawa, ON, Canada.	rkothary@ohri.ca		Kothary, Rashmi/0000-0002-9239-7310	Multiple Sclerosis Society of Canada	Multiple Sclerosis Society of Canada	This work was supported by a grant from the Multiple Sclerosis Society of Canada to R.K. J-P.M. is supported by a Studentship from the Multiple Sclerosis Society of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bongarzone ER, 1999, J NEUROSCI, V19, P8349; CAMPAGNONI CW, 1992, J NEUROSCI RES, V33, P148, DOI 10.1002/jnr.490330119; Delaunay D, 2008, J NEUROSCI, V28, P2551, DOI 10.1523/JNEUROSCI.5497-07.2008; Dickinson PJ, 1997, J NEUROCYTOL, V26, P181, DOI 10.1023/A:1018584013739; Dickinson PJ, 1996, NEUROPATH APPL NEURO, V22, P188; Doerflinger NH, 2003, GENESIS, V35, P63, DOI 10.1002/gene.10154; Fuss B, 2001, MOL CELL NEUROSCI, V18, P221, DOI 10.1006/mcne.2001.1011; Fuss B, 2000, DEV BIOL, V218, P259, DOI 10.1006/dbio.1999.9574; Greenfield EA, 2006, J NEUROSCI RES, V83, P415, DOI 10.1002/jnr.20748; Guo FZ, 2009, J NEUROSCI, V29, P7256, DOI 10.1523/JNEUROSCI.5653-08.2009; IKENAKA K, 1992, J NEUROCHEM, V58, P2248, DOI 10.1111/j.1471-4159.1992.tb10970.x; Jacobs EC, 2004, NEUROCHEM RES, V29, P997, DOI 10.1023/B:NERE.0000021244.38279.c4; Jacobs EC, 2003, DEV NEUROSCI-BASEL, V25, P96, DOI 10.1159/000072259; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Klugmann M, 1997, NEURON, V18, P59, DOI 10.1016/S0896-6273(01)80046-5; Le Bras B, 2005, INT J DEV BIOL, V49, P209, DOI 10.1387/ijdb.041963bl; MACKLIN WB, 1987, J NEUROSCI RES, V18, P383, DOI 10.1002/jnr.490180302; Mallon BS, 2002, J NEUROSCI, V22, P876, DOI 10.1523/JNEUROSCI.22-03-00876.2002; Miller MJ, 2009, J NEUROSCI RES, V87, P2842, DOI 10.1002/jnr.22121; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nadon NL, 1997, INT J DEV NEUROSCI, V15, P285, DOI 10.1016/S0736-5748(97)00009-9; Nadon NL, 1998, DEV NEUROSCI-BASEL, V20, P533, DOI 10.1159/000017354; NAVE KA, 1987, P NATL ACAD SCI USA, V84, P5665, DOI 10.1073/pnas.84.16.5665; Pribyl TM, 1996, J NEUROIMMUNOL, V67, P125; Pribyl TM, 1996, J NEUROSCI RES, V45, P812; PUCKETT C, 1987, J NEUROSCI RES, V18, P511, DOI 10.1002/jnr.490180402; Sarret C, 2010, NEUROSCIENCE, V166, P522, DOI 10.1016/j.neuroscience.2009.12.047; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spassky N, 1998, J NEUROSCI, V18, P8331; TIMSIT S, 1995, J NEUROSCI, V15, P1012; TIMSIT SG, 1992, J NEUROCHEM, V58, P1172, DOI 10.1111/j.1471-4159.1992.tb09378.x; Tuason MC, 2008, J NEUROSCI, V28, P6895, DOI 10.1523/JNEUROSCI.4579-07.2008; WIGHT PA, 1993, J CELL BIOL, V123, P443, DOI 10.1083/jcb.123.2.443; Ye P, 2003, J NEUROSCI, V23, P4401	34	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19772	10.1371/journal.pone.0019772	http://dx.doi.org/10.1371/journal.pone.0019772			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572962	Green Submitted, gold, Green Published			2022-12-27	WOS:000290440200029
J	Bajwa, EK; Cremer, PC; Gong, MN; Zhai, RH; Su, L; Thompson, BT; Christiani, DC				Bajwa, Ednan K.; Cremer, Paul C.; Gong, Michelle N.; Zhai, Rihong; Su, Li; Thompson, B. Taylor; Christiani, David C.			An NFKB1 Promoter Insertion/Deletion Polymorphism Influences Risk and Outcome in Acute Respiratory Distress Syndrome among Caucasians	PLOS ONE			English	Article							NF-KAPPA-B; FACTOR GENE POLYMORPHISMS; LUNG INFLAMMATION; ARDS; SUSCEPTIBILITY; ASSOCIATION; MECHANISMS; MORTALITY; DISEASES; PATHWAY	Background: Nuclear factor-kappa B (NF-kappa B) is required for transcription of many pro-inflammatory genes and has been implicated in the pathogenesis of acute respiratory distress syndrome (ARDS). We hypothesized that a known functional polymorphism in the promoter of the NFKB1 gene may affect susceptibility to and outcome from ARDS. Methods: A case control study was conducted among a cohort of patients admitted to the intensive care unit (ICU) with risk factors for the development of ARDS. 379 patients with ARDS and 793 at-risk controls were studied. Patients were followed for 60 days with development of ARDS as a primary outcome; ARDS-related mortality and organ dysfunction were secondary outcomes. Results: Patients homozygous for the 4 base pair deletion in the promoter of NFKB1 (del/del) did not have an increased odds ratio (OR) of developing ARDS in unadjusted analysis but were more likely to develop ARDS in the presence of a significant interaction between the del/del genotype and age (OR 5.21, 95% CI 1.35-20.0). In multivariate analysis, patients with ARDS and the del/del genotype also had increased 60 day mortality (HR 1.54, 95% CI 1.01-2.36) and more severe daily organ dysfunction (P <.001) when compared to ARDS patients with other genotypes. Conclusion: The del/del genotype is associated with an age-dependent increase in odds of developing ARDS. Patients with the del/del genotype and ARDS also have increased hazard of 60 day mortality and more organ failure.	[Bajwa, Ednan K.; Cremer, Paul C.; Thompson, B. Taylor; Christiani, David C.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Pulm & Crit Care Unit,Dept Med, Boston, MA 02115 USA; [Gong, Michelle N.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Div Crit Care Med,Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Zhai, Rihong; Su, Li; Christiani, David C.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Harvard T.H. Chan School of Public Health	Bajwa, EK (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Pulm & Crit Care Unit,Dept Med, Boston, MA 02115 USA.	dchris@hsph.harvard.edu		Bajwa, Ednan/0000-0001-9026-1009	National Institutes of Health/National Heart, Lung and Blood Institute (NIH/NHLBI) [HL60710, HL67197, HL07874, ES0002]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060710, K23HL067197, T32HL007874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung and Blood Institute (NIH/NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by National Institutes of Health/National Heart, Lung and Blood Institute (NIH/NHLBI) grants HL60710, HL67197, HL07874, and ES0002 (http://www.nhlbi.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamzik M, 2007, INTENS CARE MED, V33, P1199, DOI 10.1007/s00134-007-0649-4; Albani D, 2009, AGE, V31, P155, DOI 10.1007/s11357-009-9092-5; Bajwa EK, 2007, CRIT CARE MED, V35, P1290, DOI 10.1097/01.CCM.0000260243.22758.4F; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Cheng DS, 2007, J IMMUNOL, V178, P6504, DOI 10.4049/jimmunol.178.10.6504; Christman JW, 2000, CHEST, V117, P1482, DOI 10.1378/chest.117.5.1482; Di Bona D, 2009, AGEING RES REV, V8, P36, DOI 10.1016/j.arr.2008.09.001; Gadjeva M, 2004, J IMMUNOL, V173, P5786, DOI 10.4049/jimmunol.173.9.5786; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gong MN, 2006, EUR RESPIR J, V27, P674, DOI 10.1183/09031936.06.00046405; Gong MN, 2005, EUR RESPIR J, V26, P382, DOI 10.1183/09031936.05.00000505; Han W, 2009, AM J PHYSIOL-LUNG C, V296, pL320, DOI 10.1152/ajplung.90485.2008; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hildebrand F, 2007, CYTOKINE, V37, P192, DOI 10.1016/j.cyto.2007.03.008; HUDSON LD, 1995, AM J RESP CRIT CARE, V151, P293, DOI 10.1164/ajrccm.151.2.7842182; Invidia L, 2010, BIOGERONTOLOGY, V11, P67, DOI 10.1007/s10522-009-9229-z; Karban AS, 2004, HUM MOL GENET, V13, P35, DOI 10.1093/hmg/ddh008; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Lasky-Su J, 2008, AM J HUM GENET, V82, P849, DOI 10.1016/j.ajhg.2008.01.018; Marik PE, 2001, J AM GERIATR SOC, V49, P5, DOI 10.1046/j.1532-5415.2001.49003.x; Marshall RP, 2002, CHEST, V121, p68S, DOI 10.1378/chest.121.3_suppl.68S; Mizgerd JP, 2003, AM J RESP CRIT CARE, V168, P810, DOI 10.1164/rccm.200303-412OC; Piantadosi CA, 2004, ANN INTERN MED, V141, P460, DOI 10.7326/0003-4819-141-6-200409210-00012; Schwartz MD, 1996, CRIT CARE MED, V24, P1285, DOI 10.1097/00003246-199608000-00004; Sheu CC, 2009, EUR RESPIR J, V33, P543, DOI 10.1183/09031936.00091308; Su L, 2009, INTENS CARE MED, V35, P1024, DOI 10.1007/s00134-009-1413-8; Zhai RH, 2007, CRIT CARE MED, V35, P893, DOI 10.1097/01.CCM.0000256845.92640.38	29	15	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19469	10.1371/journal.pone.0019469	http://dx.doi.org/10.1371/journal.pone.0019469			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573030	Green Published, gold, Green Submitted			2022-12-27	WOS:000290386800013
J	Kelley, AL; Karita, E; Sullivan, PS; Katangulia, F; Chomba, E; Carael, M; Telfair, J; Dunham, SM; Vwalika, CM; Kautzman, MG; Wall, KM; Allen, SA				Kelley, April L.; Karita, Etienne; Sullivan, Patrick S.; Katangulia, Francois; Chomba, Elwyn; Carael, Michel; Telfair, Joseph; Dunham, Steve M.; Vwalika, Cheswa M.; Kautzman, Michele G.; Wall, Kristin M.; Allen, Susan A.			Knowledge and Perceptions of Couples' Voluntary Counseling and Testing in Urban Rwanda and Zambia: A Cross-Sectional Household Survey	PLOS ONE			English	Article							HIV-SEROSTATUS DISCLOSURE; IMMUNODEFICIENCY-VIRUS TYPE-1; DAR-ES-SALAAM; DISCORDANT COUPLES; ANTENATAL CLINICS; SEXUAL PARTNERS; PREGNANT-WOMEN; CONDOM USE; TRANSMISSION; PREVENTION	Background: Most incident HIV infections in sub-Saharan Africa occur between cohabiting, discordant, heterosexual couples. Though couples' voluntary HIV counseling and testing (CVCT) is an effective, well-studied intervention in Africa < 1% of couples have been jointly tested. Methods: We conducted cross-sectional household surveys in Kigali, Rwanda (n = 600) and Lusaka, Zambia (n = 603) to ascertain knowledge, perceptions, and barriers to use of CVCT. Results: Compared to Lusaka, Kigali respondents were significantly more aware of HIV testing sites (79% vs. 56%); had greater knowledge of HIV serodiscordance between couples (83% vs. 43%); believed CVCT is good (96% vs. 72%); and were willing to test jointly (91% vs. 47%). Stigma, fear of partner reaction, and distance/cost/logistics were CVCT barriers. Conclusions: Though most respondents had positive attitudes toward CVCT, the majority were unaware that serodiscordance between cohabiting couples is possible. Future messages should target gaps in knowledge about serodiscordance, provide logistical information about CVCT services, and aim to reduce stigma and fear.	[Kelley, April L.; Karita, Etienne] Rwanda Zambia HIV Res Grp, Project San Francisco, Kigali, Rwanda; [Sullivan, Patrick S.; Wall, Kristin M.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Katangulia, Francois] Social Sci Syst Inc, Monitoring & Evaluation Management Serv SSS MEMS, Kigali, Rwanda; [Chomba, Elwyn; Dunham, Steve M.; Vwalika, Cheswa M.; Kautzman, Michele G.] Rwanda Zambia HIV Res Grp, Zambia Emory HIV Res Project, Lusaka, Zambia; [Carael, Michel] UNAIDS, Geneva, Switzerland; [Telfair, Joseph] Univ N Carolina, Dept Publ Hlth Res & Practice, Ctr Social Community & Hlth Res & Evaluat, Greensboro, NC 27412 USA; [Allen, Susan A.] Emory Univ, Dept Pathol & Lab Sci, Sch Med, Dept Epidemiol, Atlanta, GA 30322 USA; [Allen, Susan A.] Emory Univ, Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health; UNAIDS; University of North Carolina; University of North Carolina Greensboro; Emory University; Emory University; Rollins School Public Health	Kelley, AL (corresponding author), Rwanda Zambia HIV Res Grp, Project San Francisco, Kigali, Rwanda.	kmwall@emory.edu		Sullivan, Patrick Sean/0000-0002-7728-0587	National Institute of Mental Health (NIMH) [R01 MH66767]; Fogarty AIDS International Training and Research Program (AITRP) [FIC 2D43 TW001042]; Emory Center for AIDS Research (CFAR) [P30 AI050409]; International AIDS Vaccine Initiative; FOGARTY INTERNATIONAL CENTER [D43TW001042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066767] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Fogarty AIDS International Training and Research Program (AITRP)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Emory Center for AIDS Research (CFAR); International AIDS Vaccine Initiative; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by funding from the National Institute of Mental Health (NIMH) Grant No. R01 MH66767, Fogarty AIDS International Training and Research Program (AITRP) FIC 2D43 TW001042, the Emory Center for AIDS Research (CFAR) P30 AI050409, and the International AIDS Vaccine Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN S, 1992, BRIT MED J, V304, P1605, DOI 10.1136/bmj.304.6842.1605; ALLEN S, 1992, JAMA-J AM MED ASSOC, V268, P3338, DOI 10.1001/jama.268.23.3338; Allen S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-349; Angotti N, 2009, SOC SCI MED, V68, P2263, DOI 10.1016/j.socscimed.2009.02.041; Antelman G, 2001, AIDS, V15, P1865, DOI 10.1097/00002030-200109280-00017; Baiden F, 2007, J BIOSOC SCI, V39, P721, DOI 10.1017/S0021932006001829; Bakari JP, 2000, ANN NY ACAD SCI, V918, P64; Bentley ME, 1998, AIDS, V12, P1869, DOI 10.1097/00002030-199814000-00019; Bunnell RE, 2005, AIDS CARE, V17, P999, DOI 10.1080/09540120500100718; Bunnell R, 2008, AIDS, V22, P617, DOI 10.1097/QAD.0b013e3282f56b53; Castle S, 2003, HEALTH POLICY PLANN, V18, P146, DOI 10.1093/heapol/czg019; Centers for Disease Control (CDC), 2007, COUPL HIV COUNS TEST; CHOMBA E, 2007, J ACQUIR IMMUNE DEFI; Coates TJ, 2000, LANCET, V356, P103, DOI 10.1016/S0140-6736(00)02446-6; Conkling M, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-10; de Zoysa I, 1996, AIDS, V10 Suppl A, pS197, DOI 10.1097/00002030-199601001-00028; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Farquhar C, 2004, JAIDS-J ACQ IMM DEF, V37, P1620, DOI 10.1097/00126334-200412150-00016; Fylkesnes K, 2004, TROP MED INT HEALTH, V9, P566, DOI 10.1111/j.1365-3156.2004.01231.x; Gaillard P, 2002, AIDS, V16, P937, DOI 10.1097/00002030-200204120-00019; Gaillard P, 2000, AIDS, V14, P2341, DOI 10.1097/00002030-200010200-00015; Ginwalla SK, 2002, AIDS CARE, V14, P707, DOI 10.1080/0954012021000005533; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Grinstead OA, 2001, AIDS, V15, P1045, DOI 10.1097/00002030-200105250-00013; Hudson CP, 1996, INT J STD AIDS, V7, P302, DOI 10.1258/0956462961917906; *INSR, RWAND DEM HLTH SURV; KAMENGA M, 1991, AIDS, V5, P61, DOI 10.1097/00002030-199101000-00009; KEOGH P, 1994, SOC SCI MED, V38, P1047, DOI 10.1016/0277-9536(94)90221-6; King R, 2008, AIDS BEHAV, V12, P232, DOI 10.1007/s10461-007-9307-7; Lie GT, 1996, AIDS CARE, V8, P285, DOI 10.1080/09540129650125713; Maman S, 2003, AIDS BEHAV, V7, P373, DOI 10.1023/B:AIBE.0000004729.89102.d4; Maman S, 2001, AIDS CARE, V13, P595, DOI 10.1080/09540120120063223; Matovu JKB, 2007, TROP MED INT HEALTH, V12, P1315, DOI 10.1111/j.1365-3156.2007.01923.x; McKenna SL, 1997, AIDS, V11, pS103; Medley A, 2004, B WORLD HEALTH ORGAN, V82, P299; Mlay R, 2008, AIDS CARE, V20, P356, DOI 10.1080/09540120701561304; Msuya SE, 2008, AIDS CARE, V20, P700, DOI 10.1080/09540120701687059; Mutale W, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-347; Painter TM, 2001, SOC SCI MED, V53, P1397, DOI 10.1016/S0277-9536(00)00427-5; Pool R, 2001, AIDS CARE, V13, P605, DOI 10.1080/09540120120063232; Skurnick JH, 1998, CLIN INFECT DIS, V26, P855, DOI 10.1086/513929; Skurnick JH, 1998, AIDS EDUC PREV, V10, P493; Sweat M, 2000, LANCET, V356, P113, DOI 10.1016/S0140-6736(00)02447-8; SWEAT M, 1998, INT C AIDS, V12, P467; Trask SA, 2002, J VIROL, V76, P397, DOI 10.1128/JVI.76.1.397-405.2002; *UNAIDS, 2008, 2008 REP GLOB AIDS E; van Dyk AC, 2003, S AFR J PSYCHOL, V33, P118, DOI 10.1177/008124630303300207; VANDERSTRATEN A, 1995, AIDS, V9, P935, DOI 10.1097/00002030-199508000-00016; VANDERSTRATEN A, 1998, AIDS BEHAV, V2, P61, DOI DOI 10.1023/A:1022311424652; Were WA, 2006, JAIDS-J ACQ IMM DEF, V43, P91, DOI 10.1097/01.qai.0000225021.81384.28	50	33	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19573	10.1371/journal.pone.0019573	http://dx.doi.org/10.1371/journal.pone.0019573			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	761GX	21573068	Green Published, gold			2022-12-27	WOS:000290386800019
J	Rautiainen, A; Wernick, I; Waggoner, PE; Ausubel, JH; Kauppi, PE				Rautiainen, Aapo; Wernick, Iddo; Waggoner, Paul E.; Ausubel, Jesse H.; Kauppi, Pekka E.			A National and International Analysis of Changing Forest Density	PLOS ONE			English	Article								Like cities, forests grow by spreading out or by growing denser. Both inventories taken steadily by a single nation and other inventories gathered recently from many nations by the United Nations confirm the asynchronous effects of changing area and of density or volume per hectare. United States forests spread little after 1953, while growing density per hectare increased national volume and thus sequestered carbon. The 2010 United Nations appraisal of global forests during the briefer span of two decades after 1990 reveals a similar pattern: A slowing decline of area with growing volume means growing density in 68 nations encompassing 72% of reported global forest land and 68% of reported global carbon mass. To summarize, the nations were placed in 5 regions named for continents. During 1990-2010 national density grew unevenly, but nevertheless grew in all regions. Growing density was responsible for substantially increasing sequestered carbon in the European and North American regions, despite smaller changes in area. Density nudged upward in the African and South American regions as area loss outstripped the loss of carbon. For the Asian region, density grew in the first decade and fell slightly in the second as forest area expanded. The different courses of area and density disqualify area as a proxy for volume and carbon. Applying forestry methods traditionally used to measure timber volumes still offers a necessary route to measuring carbon stocks. With little expansion of forest area, managing for timber growth and density offered a way to increase carbon stocks.	[Rautiainen, Aapo; Kauppi, Pekka E.] Univ Helsinki, Fac Biosci, Helsinki, Finland; [Wernick, Iddo; Ausubel, Jesse H.] Rockefeller Univ, Program Human Environm, New York, NY 10021 USA; [Waggoner, Paul E.] Connecticut Agr Expt Stn, Dept Hort & Forestry, New Haven, CT 06504 USA	University of Helsinki; Rockefeller University; Connecticut Agricultural Experiment Station	Rautiainen, A (corresponding author), Univ Helsinki, Fac Biosci, Helsinki, Finland.	iwernick@rockefeller.edu		Rautiainen, Aapo/0000-0002-6885-215X	Rockefeller University; Academy of Finland [IFEE 1117822]; University of Helsinki [HENVI 470149031]	Rockefeller University; Academy of Finland(Academy of Finland); University of Helsinki	Funding for this work was provided by Rockefeller University, the Academy of Finland (IFEE 1117822), and the University of Helsinki (HENVI 470149031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel JH, 2008, P NATL ACAD SCI USA, V105, P12774, DOI 10.1073/pnas.0806099105; DeFries, 2009, MEASUREMENT MONITORI; Grainger A, 2008, P NATL ACAD SCI USA, V105, P818, DOI 10.1073/pnas.0703015105; KALACSKAA M, 2007, J ENVIRON MANAGE, V88, P348; Kauppi PE, 2006, P NATL ACAD SCI USA, V103, P17574, DOI 10.1073/pnas.0608343103; Kirilenko AP, 2007, P NATL ACAD SCI USA, V104, P19697, DOI 10.1073/pnas.0701424104; *MIN ENV FOR, 2008, STAT REP 2003, pCH7; Naesset E, 2008, REMOTE SENS ENVIRON, V112, P3079, DOI 10.1016/j.rse.2008.03.004; Sanchez-Azofeifa GA, 2009, ECOL APPL, V19, P480, DOI 10.1890/08-1149.1; SEDJO RA, 1984, FOREST ECOL MANAG, V9, P245, DOI 10.1016/0378-1127(84)90011-2; SEDJO RA, 1987, GLOBAL FOREST SECTOR, P7; SEDJO RA, 1986, SYSTEMS ANAL FORESTR, P55; Smith WB, 2009, WO78 USDA; *UN NAT FOOD AGR O, 2010, GLOB FOR RES ASS 201; *UNECE UNFAO, 2003, 27 UNECEUNFAO RUSS F; Victor DG, 2000, FOREIGN AFF, V79, P127, DOI 10.2307/20049972; Waggoner PE, 2001, POPUL DEV REV, V27, P239, DOI 10.1111/j.1728-4457.2001.00239.x; WAGGONER PE, 2009, 0929 RFF DF; Wernick IK, 2000, J FOREST, V98, P8; WERNICK IK, 2010, P NATL ACAD SCI USA, DOI DOI 10.1073/PNAS1008669107	20	40	40	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19577	10.1371/journal.pone.0019577	http://dx.doi.org/10.1371/journal.pone.0019577			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573125	Green Published, Green Submitted, gold			2022-12-27	WOS:000290305600030
J	Zurla, C; Lifland, AW; Santangelo, PJ				Zurla, Chiara; Lifland, Aaron W.; Santangelo, Philip J.			Characterizing mRNA Interactions with RNA Granules during Translation Initiation Inhibition	PLOS ONE			English	Article							MAMMALIAN STRESS GRANULES; NATURAL-PRODUCT PATEAMINE; P-BODIES; SACCHAROMYCES-CEREVISIAE; BINDING PROTEIN; CELL-MIGRATION; LOCALIZATION; DECAY; PHOSPHORYLATION; RECRUITMENT	When cells experience environmental stresses, global translational arrest is often accompanied by the formation of stress granules (SG) and an increase in the number of p-bodies (PBs), which are thought to play a crucial role in the regulation of eukaryotic gene expression through the control of mRNA translation and degradation. SGs and PBs have been extensively studied from the perspective of their protein content and dynamics but, to date, there have not been systematic studies on how they interact with native mRNA granules. Here, we demonstrate the use of live-cell hybridization assays with multiply-labeled tetravalent RNA imaging probes (MTRIPs) combined with immunofluorescence, as a tool to characterize the polyA+ and beta-actin mRNA distributions within the cytoplasm of epithelial cell lines, and the changes in their colocalization with native RNA granules including SGs, PBs and the RNA exosome during the inhibition of translational initiation. Translation initiation inhibition was achieved via the induction of oxidative stress using sodium arsenite, as well as through the use of Pateamine A, puromycin and cycloheximide. This methodology represents a valuable tool for future studies of mRNA trafficking and regulation within living cells.	[Zurla, Chiara] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; Emory Univ, Atlanta, GA 30322 USA	University System of Georgia; Georgia Institute of Technology; Emory University	Zurla, C (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	philip.santangelo@bme.gatech.edu			National Institutes of Health, through NIBIB [EB009455]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB009455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094198] Funding Source: NIH RePORTER	National Institutes of Health, through NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health R21 grant EB009455, through NIBIB (www.nibib.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizer A, 2008, MOL BIOL CELL, V19, P4154, DOI 10.1091/mbc.E08-05-0513; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Buchan JR, 2010, METHOD ENZYMOL, V470, P619, DOI 10.1016/S0076-6879(10)70025-2; Condeelis J, 2005, BIOL CELL, V97, P97; Dang YJ, 2006, J BIOL CHEM, V281, P32870, DOI 10.1074/jbc.M606149200; Dang YJ, 2009, J BIOL CHEM, V284, P23613, DOI 10.1074/jbc.M109.009985; Dormoy-Raclet V, 2007, MOL CELL BIOL, V27, P5365, DOI 10.1128/MCB.00113-07; Franks TM, 2007, GENE DEV, V21, P719, DOI 10.1101/gad.1494707; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Giles RV, 1998, NUCLEIC ACIDS RES, V26, P1567, DOI 10.1093/nar/26.7.1567; Grunwald D, 2008, METHOD ENZYMOL, V448, P553, DOI 10.1016/S0076-6879(08)02627-X; Ivanov PA, 2003, EXP CELL RES, V290, P227, DOI 10.1016/S0014-4827(03)00290-8; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kramer S, 2008, J CELL SCI, V121, P3002, DOI 10.1242/jcs.031823; Latham VM, 2001, CURR BIOL, V11, P1010, DOI 10.1016/S0960-9822(01)00291-3; Lin WJ, 2007, J BIOL CHEM, V282, P19958, DOI 10.1074/jbc.M702281200; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Lloyd BH, 2001, NUCLEIC ACIDS RES, V29, P3664, DOI 10.1093/nar/29.17.3664; Loschi M, 2009, J CELL SCI, V122, P3973, DOI 10.1242/jcs.051383; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; Mollet S, 2008, MOL BIOL CELL, V19, P4469, DOI 10.1091/mbc.E08-05-0499; Nadezhdina ES, 2010, BBA-MOL CELL RES, V1803, P361, DOI 10.1016/j.bbamcr.2009.12.004; Nielsen FC, 2002, J CELL SCI, V115, P2087; Oleynikov Y, 2003, CURR BIOL, V13, P199, DOI 10.1016/S0960-9822(03)00044-7; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Santangelo PJ, 2009, NAT METHODS, V6, P347, DOI [10.1038/nmeth.1316, 10.1038/NMETH.1316]; Stohr N, 2006, J CELL BIOL, V175, P527, DOI 10.1083/jcb.200608071; SUNDELL CL, 1991, SCIENCE, V253, P1275, DOI 10.1126/science.1891715; Thomas MG, 2005, MOL BIOL CELL, V16, P405, DOI 10.1091/mbc.E04-06-0516; Tyagi S, 2004, BIOPHYS J, V87, P4153, DOI 10.1529/biophysj.104.045153; UNSWORTH H, 2010, FASEB J; Yamagishi M, 2009, BIOCHEM BIOPH RES CO, V390, P750, DOI 10.1016/j.bbrc.2009.10.043; Yamagishi M, 2009, EXP CELL RES, V315, P1142, DOI 10.1016/j.yexcr.2009.02.009; Yamasaki S, 2007, J BIOL CHEM, V282, P30070, DOI 10.1074/jbc.M706273200; Yancy SL, 2005, TOXICOL SCI, V84, P278, DOI 10.1093/toxsci/kfi032	41	37	37	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19727	10.1371/journal.pone.0019727	http://dx.doi.org/10.1371/journal.pone.0019727			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573130	Green Submitted, gold, Green Published			2022-12-27	WOS:000290256400041
J	Dibra, D; Cutrera, J; Xia, XQ; Li, SL				Dibra, Denada; Cutrera, Jeffry; Xia, Xueqing; Li, Shulin			WSX1 Expression in Tumors Induces Immune Tolerance via Suppression of Effector Immune Cells	PLOS ONE			English	Article							I CYTOKINE RECEPTOR; CD8(+) T-CELLS; INDOLEAMINE 2,3-DIOXYGENASE; AUTOIMMUNE-DISEASES; COMPLETE REGRESSION; IL-27; INTERLEUKIN-27; ACTIVATION; ANTITUMOR; RESPONSES	Crosstalk between tumor cells and the cognate microenvironment plays a crucial role in tumor initiation and progression. However, only a few genes are known to affect such a crosstalk. This study reveals that WSX1 plays such a role when highly expressed in tumor cells. The expression of WSX1 in Lewis Lung Carcinoma (LLC) and the melanoma cell line AGS induces the death of T cells and inhibits the production of the effector cytokine IFN gamma from NK and T cells, resulting in the promotion of tumor growth. These pro-tumorigenic properties of WSX1 are independent of IL27. This key observation reveals a new pathway of tumor-host interaction, which will ultimately lead to better strategies in immune therapy to reverse tumor tolerance.	[Dibra, Denada; Cutrera, Jeffry; Xia, Xueqing; Li, Shulin] Univ Texas MD Anderson Canc Ctr, Pediat Res Dept, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Dibra, D (corresponding author), Univ Texas MD Anderson Canc Ctr, Pediat Res Dept, Houston, TX 77030 USA.	sli4@mdanderson.org	Li, Shulin/D-6478-2011		National Institutes of Health/National Cancer Institute (NIH/NCI) [RO1 CA098928]; NATIONAL CANCER INSTITUTE [R01CA142855, R01CA098928] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute (NIH/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by National Institutes of Health/National Cancer Institute (NIH/NCI) RO1 CA098928. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao YX, 2008, J IMMUNOL, V180, P922, DOI 10.4049/jimmunol.180.2.922; Chen Q, 2000, NATURE, V407, P916, DOI 10.1038/35038103; Chiyo M, 2005, INT J CANCER, V115, P437, DOI 10.1002/ijc.20848; Clayton A, 2008, J IMMUNOL, V180, P7249, DOI 10.4049/jimmunol.180.11.7249; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dibra D, 2009, CANCER RES, V69, P5505, DOI 10.1158/0008-5472.CAN-08-4311; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Hahne M, 1996, SCIENCE, V274, P1363, DOI 10.1126/science.274.5291.1363; Hamano S, 2003, IMMUNITY, V19, P657, DOI 10.1016/S1074-7613(03)00298-X; Hisada M, 2004, CANCER RES, V64, P1152, DOI 10.1158/0008-5472.CAN-03-2084; Ho MY, 2009, J IMMUNOL, V183, P6217, DOI 10.4049/jimmunol.0901272; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; Kaiser BK, 2007, NATURE, V447, P482, DOI 10.1038/nature05768; Kamiya S, 2004, J IMMUNOL, V173, P3871, DOI 10.4049/jimmunol.173.6.3871; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Mapara MY, 2004, J CLIN ONCOL, V22, P1136, DOI 10.1200/JCO.2004.10.041; Mellor AL, 2002, J IMMUNOL, V168, P3771, DOI 10.4049/jimmunol.168.8.3771; Mueller DL, 2010, NAT IMMUNOL, V11, P21, DOI 10.1038/ni.1817; Nagaraj S, 2007, NAT MED, V13, P828, DOI 10.1038/nm1609; Niedbala W, 2008, ANN RHEUM DIS, V67, P1474, DOI 10.1136/ard.2007.083360; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Oniki S, 2006, CANCER RES, V66, P6395, DOI 10.1158/0008-5472.CAN-05-4087; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Pradhan A, 2007, P NATL ACAD SCI USA, V104, P18502, DOI 10.1073/pnas.0702388104; Salcedo R, 2004, J IMMUNOL, V173, P7170, DOI 10.4049/jimmunol.173.12.7170; Salcedo R, 2009, J IMMUNOL, V182, P4328, DOI 10.4049/jimmunol.0800471; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Sauer KA, 2008, J IMMUNOL, V181, P6148, DOI 10.4049/jimmunol.181.9.6148; Schoenherr C, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-19; Shimizu M, 2006, J IMMUNOL, V176, P7317, DOI 10.4049/jimmunol.176.12.7317; Siebler J, 2008, J IMMUNOL, V180, P30, DOI 10.4049/jimmunol.180.1.30; Sprecher CA, 1998, BIOCHEM BIOPH RES CO, V246, P82, DOI 10.1006/bbrc.1998.8576; Strand S, 1996, NAT MED, V2, P1361, DOI 10.1038/nm1296-1361; Sugiyama N, 2008, ANN RHEUM DIS, V67, P1461, DOI 10.1136/ard.2007.077537; TANNER JW, 1995, J BIOL CHEM, V270, P6523, DOI 10.1074/jbc.270.12.6523; Thompson CB, 1997, IMMUNITY, V7, P445, DOI 10.1016/S1074-7613(00)80366-0; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Yamanaka A, 2004, J IMMUNOL, V172, P3590, DOI 10.4049/jimmunol.172.6.3590; Yoshimoto T, 2008, J IMMUNOL, V180, P6527, DOI 10.4049/jimmunol.180.10.6527	43	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19072	10.1371/journal.pone.0019072	http://dx.doi.org/10.1371/journal.pone.0019072			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559505	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700059
J	Geffen, E; Rowe, KC; Yom-Tov, Y				Geffen, Eli; Rowe, Kevin C.; Yom-Tov, Yoram			Reproductive Rates in Australian Rodents Are Related to Phylogeny	PLOS ONE			English	Article							LONG-TERM DYNAMICS; INTERSPECIFIC COMPETITION; ASYMMETRIC COMPETITION; HABITAT; RATTUS; HEATHLAND; COEXISTENCE; MECHANISM; RAINFALL; ECOLOGY	Background: The native rodents of Australia are commonly divided into two groups based on the time of their colonization of the Sahulian continent, which encompasses Australia, New Guinea, and the adjacent islands. The first group, the "old endemics,'' is a diverse assemblage of 34 genera that are descended from a single colonization of the continent during the Pliocene. A second group, the "new endemics,'' is composed of several native Rattus species that are descended from a single colonization during the Pleistocene. Finally, a third group is composed of three non-native species of Rattus and Mus introduced into Australia by humans over the last 200 years. Previous studies have claimed that the three groups differ in their reproductive rates and that this variation in rates is associated with the unique environmental conditions across Australia. We examined these hypotheses using phylogenetically controlled methods. Methodology and Results: We examined the relationship between the reproductive rates of the Australian rodents and the environmental variations across the continent, as well as the epoch of their colonization of the continent. Our results revealed no significant correlation with environmental variables but a significant association between colonization age and all the reproductive parameters examined. Discussion: Based on a larger phylogeny of the subfamily Murinae, we showed that significant differences in reproductive rates among colonization groups are shared with their closest relatives outside Sahul. Therefore, the lower reproductive rates in the old endemics are more likely to be the result of phylogenetic history and conservation of traits than an adaptation to the Australian environment. In the new endemics, we found a trend of increasing reproductive rates with diversification. We suggest that the differences in reproductive rates of the old endemic rodents and the native Rattus represent alternative adaptive strategies that have allowed them to utilize similar ecological niches across Australia.	[Geffen, Eli; Yom-Tov, Yoram] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Rowe, Kevin C.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA	Tel Aviv University; University of California System; University of California Berkeley	Geffen, E (corresponding author), Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel.	geffene@post.tau.ac.il		Rowe, Kevin Christopher/0000-0002-1215-9153	Israel Cohen Chair for Environmental Zoology	Israel Cohen Chair for Environmental Zoology	The Israel Cohen Chair for Environmental Zoology (to YYT) supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Aplin K.P., 2006, P707; Archer M, 1984, VERTEBRATE ZOOGEOGRA; Armstrong K.N., 2008, MAMMALS AUSTR, P470; BAVERSTOCK PR, 1986, GENETICA, V71, P11, DOI 10.1007/BF00123228; Breed B, 2007, AUSTRAL NAT HIST SER, P1; Cox MPG, 2000, AUSTRAL ECOL, V25, P375, DOI 10.1111/j.1442-9993.2000.tb00043.x; Dickman CR, 1999, WILDLIFE RES, V26, P389, DOI 10.1071/WR97057; Diniz JAF, 1998, EVOLUTION, V52, P1247, DOI 10.1111/j.1558-5646.1998.tb02006.x; Flannery T. F., 1995, MAMMALS SW PACIFIC M; FLANNERY TF, 1995, MAMMALS NEW GUINEA R; FORD HA, 1988, BEHAV ECOL SOCIOBIOL, V22, P239, DOI 10.1007/BF00299838; FOX BJ, 1989, AUST J ECOL, V14, P357, DOI 10.1111/j.1442-9993.1989.tb01444.x; Geffen E, 2000, BEHAV ECOL SOCIOBIOL, V47, P250, DOI 10.1007/s002650050662; GITTLEMAN JL, 1990, SYST ZOOL, V39, P227, DOI 10.2307/2992183; Hall Robert, 1998, P99; Heinsohn G, 1999, WILDLIFE RES, V26, P187, DOI 10.1071/WR98020; HIGGS P, 1993, AUST J ECOL, V18, P193, DOI 10.1111/j.1442-9993.1993.tb00443.x; Jackson S., 2003, AUSTR MAMMALS BIOL C; KEAST A, 1968, J ZOOL, V155, P185; Keast A., 1981, ECOLOGICAL BIOGEOGRA, P1891; Lecompte E, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-199; Leeper GW, 1971, AUSTR ENV, P12; Lindenmayer DB, 2000, J MAMMAL, V81, P787, DOI 10.1644/1545-1542(2000)081<0787:HFLCAM>2.3.CO;2; Luo J, 1996, AUST J ECOL, V21, P121, DOI 10.1111/j.1442-9993.1996.tb00593.x; Lydekker R, 1896, GEOGRAPHICAL HIST MA; Maddison W.P., 2010, MESQUITE MODULAR SYS; MADDISON WP, 1991, SYST ZOOL, V40, P304, DOI 10.2307/2992324; Madsen T, 1999, AUST J ECOL, V24, P80, DOI 10.1046/j.1442-9993.1999.00948.x; Maitz WE, 2001, OECOLOGIA, V128, P526, DOI 10.1007/s004420100689; Monamy V, 1999, J MAMMAL, V80, P232, DOI 10.2307/1383223; Morris DW, 2000, OIKOS, V91, P294, DOI 10.1034/j.1600-0706.2000.910210.x; Nix H, 1982, EVOLUTION FLORA FAUN, P47; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Orians GH, 2007, BIOL REV, V82, P393, DOI 10.1111/j.1469-185X.2007.00017.x; Pigram C. J., 1987, BMR Journal of Australian Geology & Geophysics, V10, P193; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Robins JH, 2007, MOL ECOL NOTES, V7, P717, DOI 10.1111/j.1471-8286.2007.01752.x; Rowe KC, 2008, MOL PHYLOGENET EVOL, V47, P84, DOI 10.1016/j.ympev.2008.01.001; Rowe KC, 2011, SYST BIOL, V60, P188, DOI 10.1093/sysbio/syq092; Rowley I., 1991, Oxford Ornithology Series, P22; Russell EM, 2004, BEHAV ECOL, V15, P831, DOI 10.1093/beheco/arh088; Steppan SJ, 2005, MOL PHYLOGENET EVOL, V37, P370, DOI 10.1016/j.ympev.2005.04.016; THOMPSON P, 1993, OIKOS, V67, P264, DOI 10.2307/3545471; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Wallace A. R., 1863, J ROYAL GEOGRAPHICAL, V33, P217, DOI DOI 10.2307/1798448; Watts CHS, 1981, RODENTS AUSTR; Weber M, 1904, SAUGETIERE EINFUHRUN; Wellesley-Whitehouse H, 1983, AUSTR MUSEUM COMPLET, P371; Woinarski J.C.Z., 1985, Proceedings of the Ecological Society of Australia, V14, P159; YOMTOV Y, 1985, OECOLOGIA, V66, P250, DOI 10.1007/BF00379862; YOMTOV Y, 1987, AUST WILDLIFE RES, V14, P319, DOI 10.1071/WR9870319	52	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19199	10.1371/journal.pone.0019199	http://dx.doi.org/10.1371/journal.pone.0019199			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559433	Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700099
J	Lee, SW; Song, YS; Lee, SY; Yoon, YG; Lee, SH; Park, BS; Yun, I; Choi, H; Kim, K; Chung, WT; Yoo, YH				Lee, Sung Won; Song, Yeon Suk; Lee, Sang Yeob; Yoon, Young Geol; Lee, Sang Hwa; Park, Bong Soo; Yun, Il; Choi, Hyantae; Kim, Kunhong; Chung, Won Tae; Yoo, Young Hyun			Downregulation of Protein Kinase CK2 Activity Facilitates Tumor Necrosis Factor-alpha-Mediated Chondrocyte Death through Apoptosis and Autophagy	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; CANCER-CELLS; HUMAN OSTEOARTHRITIS; GROWTH-PLATE; INDUCTION; CARTILAGE; DEGRADATION; MECHANISM; PHOSPHORYLATION; CLASSIFICATION	Despite the numerous studies of protein kinase CK2, little progress has been made in understanding its function in chondrocyte death. Our previous study first demonstrated that CK2 is involved in apoptosis of rat articular chondrocytes. Recent studies have suggested that CK2 downregulation is associated with aging. Thus examining the involvement of CK2 downregulation in chondrocyte death is an urgently required task. We undertook this study to examine whether CK2 downregulation modulates chondrocyte death. We first measured CK2 activity in articular chondrocytes of 6-, 21- and 30-month-old rats. Noticeably, CK2 activity was downregulated in chondrocytes with advancing age. To build an in vitro experimental system for simulating tumor necrosis factor (TNF)-alpha-induced cell death in aged chondrocytes with decreased CK2 activity, chondrocytes were co-treated with CK2 inhibitors and TNF-alpha. Viability assay demonstrated that CK2 inhibitors facilitated TNF-alpha-mediated chondrocyte death. Pulsed-field gel electrophoresis, nuclear staining, flow cytometry, TUNEL staining, confocal microscopy, western blot and transmission electron microscopy were conducted to assess cell death modes. The results of multiple assays showed that this cell death was mediated by apoptosis. Importantly, autophagy was also involved in this process, as supported by the appearance of a punctuate LC3 pattern and autophagic vacuoles. The inhibition of autophagy by silencing of autophage-related genes 5 and 7 as well as by 3-methyladenine treatment protected chondrocytes against cell death and caspase activation, indicating that autophagy led to the induction of apoptosis. Autophagic cells were observed in cartilage obtained from osteoarthritis (OA) model rats and human OA patients. Our findings indicate that CK2 down regulation facilitates TNF-alpha-mediated chondrocyte death through apoptosis and autophagy. It should be clarified in the future if autophagy observed is a consequence versus a cause of the degeneration in vivo.	[Lee, Sung Won; Chung, Won Tae] Dong A Univ, Dept Rheumatol, Coll Med, Pusan, South Korea; [Song, Yeon Suk; Lee, Sang Yeob; Yoon, Young Geol; Yoo, Young Hyun] Dong A Univ, Dept Anat & Cell Biol, Coll Med, Pusan, South Korea; [Song, Yeon Suk; Lee, Sang Yeob; Yoon, Young Geol; Yoo, Young Hyun] Dong A Univ, Mitochondria Hub Regulat Ctr, Coll Med, Pusan, South Korea; [Lee, Sang Hwa] Dong A Univ, Dept Microbiol, Coll Med, Pusan, South Korea; [Park, Bong Soo; Yun, Il] Pusan Natl Univ, Dept Oral Anat & Cell Biol, Coll Dent, Yangsan, South Korea; [Choi, Hyantae; Kim, Kunhong] Yonsei Univ, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea; [Choi, Hyantae; Kim, Kunhong] Yonsei Univ, Coll Med, Ctr Chron Metab Dis Res, Seoul, South Korea	Dong A University; Dong A University; Dong A University; Dong A University; Pusan National University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, SW (corresponding author), Dong A Univ, Dept Rheumatol, Coll Med, Pusan, South Korea.	yhyoo@dau.ac.kr		Lee, Sang Hwa/0000-0003-4792-1248; Yoon, Young Geol/0000-0003-4524-9531	Korean government (MEST) [2009-0093193, 2010-0001942, 2011-0001262, R01-2007-000-20100-0]	Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by National Research Foundation of Korea grant funded by the Korean government (MEST) (No. 2009-0093193, 2010-0001942, 2011-0001262 and R01-2007-000-20100-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; Aizawa T, 2001, J ORTHOP RES, V19, P785, DOI 10.1016/S0736-0266(00)00078-4; ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000; Almonte-Becerril M, 2010, APOPTOSIS, V15, P631, DOI 10.1007/s10495-010-0458-z; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Baehrecke EH, 2003, CELL DEATH DIFFER, V10, P940, DOI 10.1038/sj.cdd.4401280; Berry DL, 2007, CELL, V131, P1137, DOI 10.1016/j.cell.2007.10.048; Bohensky J, 2007, J CELL PHYSIOL, V213, P246, DOI 10.1002/jcp.21117; Bohensky J, 2007, AUTOPHAGY, V3, P207, DOI 10.4161/auto.3708; Bohensky J, 2009, ARTHRITIS RHEUM-US, V60, P1406, DOI 10.1002/art.24444; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Carames B, 2010, ARTHRITIS RHEUM-US, V62, P791, DOI 10.1002/art.27305; Cho TJ, 2003, ARTHRITIS RHEUM-US, V48, P2845, DOI 10.1002/art.11390; Csaki C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2850; Del Carlo Marcello Jr, 2008, Curr Rheumatol Rep, V10, P37; Farah M, 2003, AM J PHYSIOL-GASTR L, V285, pG919, DOI 10.1152/ajpgi.00205.2003; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; Galluzzi L, 2007, CELL DEATH DIFFER, V14, P1237, DOI 10.1038/sj.cdd.4402148; Goldring M. B., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P517; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hashimoto S, 1998, ARTHRITIS RHEUM-US, V41, P1266, DOI 10.1002/1529-0131(199807)41:7<1266::AID-ART18>3.0.CO;2-Y; Hashimoto S, 1998, ARTHRITIS RHEUM-US, V41, P1632, DOI 10.1002/1529-0131(199809)41:9<1632::AID-ART14>3.0.CO;2-A; Hunter T, 1997, TRENDS BIOCHEM SCI, V22, P18, DOI 10.1016/S0968-0004(96)10068-2; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Kim EK, 2009, GENE, V431, P55, DOI 10.1016/j.gene.2008.10.020; Kim HA, 2000, J RHEUMATOL, V27, P455; Kim KY, 2004, J PHARMACOL EXP THER, V308, P97, DOI 10.1124/jpet.103.058768; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kuhn K, 2001, ARTHRITIS RHEUM-US, V44, P1644, DOI 10.1002/1529-0131(200107)44:7<1644::AID-ART287>3.0.CO;2-S; Lee SW, 2008, ARTHRITIS RHEUM-US, V58, P790, DOI 10.1002/art.23220; Lee SW, 2004, ARTHRITIS RHEUM-US, V50, P534, DOI 10.1002/art.20052; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li PF, 2002, MOL CELL, V10, P247, DOI 10.1016/S1097-2765(02)00600-7; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; McElhinny JA, 1996, MOL CELL BIOL, V16, P899; Miwa M, 2000, OSTEOARTHR CARTILAGE, V8, P17, DOI 10.1053/joca.1999.0266; Pulsatelli L, 1999, J RHEUMATOL, V26, P1992; Rath PC, 1999, J CLIN IMMUNOL, V19, P350, DOI 10.1023/A:1020546615229; Ryu SW, 2006, FEBS LETT, V580, P988, DOI 10.1016/j.febslet.2006.01.028; Scaglioni PP, 2006, CELL, V126, P269, DOI 10.1016/j.cell.2006.05.041; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Shin S, 2005, EMBO J, V24, P3532, DOI 10.1038/sj.emboj.7600827; Srinivas V, 2006, AUTOPHAGY, V2, P215, DOI 10.4161/auto.2649; Srinivas V, 2009, CELL CYCLE, V8, P391, DOI 10.4161/cc.8.3.7545; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Wang DJ, 2009, CANCER RES, V69, P8200, DOI 10.1158/0008-5472.CAN-09-1976; Wang GX, 2005, MOL CELL BIOCHEM, V274, P201, DOI 10.1007/s11010-005-2952-0; Watanabe H, 2008, J CELL PHYSIOL, V216, P419, DOI 10.1002/jcp.21408	52	35	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19163	10.1371/journal.pone.0019163	http://dx.doi.org/10.1371/journal.pone.0019163			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559479	gold, Green Published, Green Submitted			2022-12-27	WOS:000290024700086
J	Mei, B; Li, F; Gu, YR; Cui, ZZ; Tsien, JZ				Mei, Bing; Li, Fei; Gu, Yiran; Cui, Zhenzhong; Tsien, Joe Z.			NMDA Receptors Are Not Required for Pattern Completion During Associative Memory Recall	PLOS ONE			English	Article							OLFACTORY MEMORY; SPATIAL MEMORY; NR1 KNOCKOUT; RETRIEVAL; CONSOLIDATION; ACQUISITION; ACTIVATION; CORTEX; MICE; ENHANCEMENT	Pattern completion, the ability to retrieve complete memories initiated by subsets of external cues, has been a major focus of many computation models. A previously study reports that such pattern completion requires NMDA receptors in the hippocampus. However, such a claim was derived from a non-inducible gene knockout experiment in which the NMDA receptors were absent throughout all stages of memory processes as well as animal's adult life. This raises the critical question regarding whether the previously described results were truly resulting from the requirement of the NMDA receptors in retrieval. Here, we have examined the role of the NMDA receptors in pattern completion via inducible knockout of NMDA receptors limited to the memory retrieval stage. By using two independent mouse lines, we found that inducible knockout mice, lacking NMDA receptor in either forebrain or hippocampus CA1 region at the time of memory retrieval, exhibited normal recall of associative spatial reference memory regardless of whether retrievals took place under full-cue or partial-cue conditions. Moreover, systemic antagonism of NMDA receptor during retention tests also had no effect on full-cue or partial-cue recall of spatial water maze memories. Thus, both genetic and pharmacological experiments collectively demonstrate that pattern completion during spatial associative memory recall does not require the NMDA receptor in the hippocampus or forebrain.	[Mei, Bing; Gu, Yiran] E China Normal Univ, Shanghai Inst Brain Funct Genom, Key Lab Brain Funct Genom, MOE, Shanghai 200062, Peoples R China; [Mei, Bing; Gu, Yiran] E China Normal Univ, STCSM, Shanghai 200062, Peoples R China; [Li, Fei] Jiao Tong Univ, Key Lab Childrens Environm Hlth, Shanghai Childrens Med Ctr, Dept Dev & Behav Pediat,Sch Med,MOE, Shanghai 200030, Peoples R China; [Li, Fei] Jiao Tong Univ, Shanghai Childrens Med Ctr, Sch Med, STCSM, Shanghai 200030, Peoples R China; [Gu, Yiran] Banna Biomed Res Inst, Xi Shuang Ban Na, Yunnan, Peoples R China; [Mei, Bing; Li, Fei; Cui, Zhenzhong; Tsien, Joe Z.] Georgia Hlth Sci Univ, Dept Neurol, Augusta, GA USA; [Mei, Bing; Li, Fei; Cui, Zhenzhong; Tsien, Joe Z.] Georgia Hlth Sci Univ, Brain & Behav Discovery Inst, Augusta, GA USA	East China Normal University; East China Normal University; Science & Technology Commission of Shanghai Municipality (STCSM); Shanghai Jiao Tong University; Science & Technology Commission of Shanghai Municipality (STCSM); Shanghai Jiao Tong University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Mei, B (corresponding author), E China Normal Univ, Shanghai Inst Brain Funct Genom, Key Lab Brain Funct Genom, MOE, Shanghai 200062, Peoples R China.	jtsien@georgiahealth.edu	/AAI-4103-2021		National Institutes of Health [MH06023, AG034663, AG025918]; National Natural Science Foundation of China [30870790, 81070876, 81000592]; Shanghai Commission of Science and Technology [10140900500, 09DZ2200900, 10DZ2272200, 10PJ1407500, 10JC1411200, 11ZZ38, 11ZZ103, 2010004]; Shanghai Jiaotong University; 973 Project [2009CB918402]; NATIONAL INSTITUTE ON AGING [R01AG025918, R01AG034663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee); Shanghai Jiaotong University; 973 Project(National Basic Research Program of China); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funds from National Institutes of Health (MH06023, AG034663, AG025918) (All to JZT), and was also supported by grants from National Natural Science Foundation of China (30870790, 81070876, 81000592) to BM and FL, from Shanghai Commission of Science and Technology (10140900500, 09DZ2200900, 10DZ2272200, 10PJ1407500, 10JC1411200, 11ZZ38, 11ZZ103, 2010004) to BM and FL and from Morning Star Rewarding Fund (Category B, 2011) of Shanghai Jiaotong University and from the 973 Project (2009CB918402) to FL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bast T, 2005, J NEUROSCI, V25, P5845, DOI 10.1523/JNEUROSCI.0698-05.2005; Brown R, 2004, CELL, V117, P3, DOI 10.1016/S0092-8674(04)00295-8; Chen X, 2005, NAT NEUROSCI, V8, P925, DOI 10.1038/nn1482; Cohen NJ, 1993, MEMORY AMNESIA HIPPO, pxii; Cui ZZ, 2005, EUR J NEUROSCI, V22, P755, DOI 10.1111/j.1460-9568.2005.04257.x; Cui ZZ, 2004, NEURON, V41, P781, DOI 10.1016/S0896-6273(04)00072-8; DEVAUGES V, 1991, BEHAV BRAIN RES, V43, P93, DOI 10.1016/S0166-4328(05)80056-7; Donchin O, 2002, J NEUROPHYSIOL, V88, P2114, DOI 10.1152/jn.2002.88.4.2114; Hetem LAB, 2000, PSYCHOPHARMACOLOGY, V152, P283, DOI 10.1007/s002130000511; Izquierdo LA, 2000, BEHAV BRAIN RES, V111, P93, DOI 10.1016/S0166-4328(00)00137-6; Jerman T, 2006, LEARN MEMORY, V13, P458, DOI 10.1101/lm.246906; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Lassalle JM, 2000, NEUROBIOL LEARN MEM, V73, P243, DOI 10.1006/nlme.1999.3931; Li F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015401; Liang K C, 1994, Chin J Physiol, V37, P201; Liu X, 2006, CURR OPIN NEUROBIOL, V16, P679, DOI 10.1016/j.conb.2006.09.003; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Matus-Amat P, 2004, J NEUROSCI, V24, P2431, DOI 10.1523/JNEUROSCI.1598-03.2004; Moulds ML, 2005, J TRAUMA STRESS, V18, P233, DOI 10.1002/jts.20022; Murchison CF, 2004, CELL, V117, P131, DOI 10.1016/S0092-8674(04)00259-4; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Niewoehner B, 2007, EUR J NEUROSCI, V25, P837, DOI 10.1111/j.1460-9568.2007.05312.x; Osan R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016507; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Rosenblum K, 1997, J NEUROSCI, V17, P5129; SARA SJ, 1985, ANN NY ACAD SCI, V444, P178, DOI 10.1111/j.1749-6632.1985.tb37588.x; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; Servatius RJ, 1996, BEHAV NEUROSCI, V110, P1040; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Takehara-Nishiuchi K, 2006, J NEUROSCI, V26, P5049, DOI 10.1523/JNEUROSCI.4381-05.2006; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Thompson RE, 2005, ANNU REV PSYCHOL, V56, P1, DOI 10.1146/annurev.psych.56.091103.070239; Tronel S, 2002, LEARN MEMORY, V9, P105, DOI 10.1101/lm.47802; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Wang HM, 2006, PROG NEUROBIOL, V79, P123, DOI 10.1016/j.pneurobio.2006.06.004; Wittenberg GM, 2002, TRENDS NEUROSCI, V25, P501, DOI 10.1016/S0166-2236(02)02231-2; Yasuda M, 2006, NEURON, V50, P309, DOI 10.1016/j.neuron.2006.03.035	37	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19326	10.1371/journal.pone.0019326	http://dx.doi.org/10.1371/journal.pone.0019326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559402	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700137
J	Saez, ME; Smani, T; Ramirez-Lorca, R; Diaz, I; Serrano-Rios, M; Ruiz, A; Ordonez, A				Saez, Maria E.; Smani, Tarik; Ramirez-Lorca, Reposo; Diaz, Ignacio; Serrano-Rios, Manuel; Ruiz, Agustin; Ordonez, Antonio			Association Analysis of Urotensin II Gene (UTS2) and Flanking Regions with Biochemical Parameters Related to Insulin Resistance	PLOS ONE			English	Article							RECEPTOR ANTAGONIST PALOSURAN; ACUTE MYOCARDIAL-INFARCTION; TYPE-2 DIABETES-MELLITUS; PERFUSED RAT PANCREAS; METABOLIC SYNDROME; ADMISSION HYPERGLYCEMIA; GLUCOSE-TOLERANCE; ORPHAN RECEPTOR; EXPRESSION; RISK	Background: Urotensin II (UII) is a potent vasoconstrictor peptide, which signals through a G-protein coupled receptor (GPCR) known as GPR14 or urotensin receptor (UTR). UII exerts a broad spectrum of actions in several systems such as vascular cell, heart muscle or pancreas, where it inhibits insulin release. Objective: Given the reported role of UII in insulin secretion, we have performed a genetic association analysis of the UTS2 gene and flanking regions with biochemical parameters related to insulin resistance (fasting glucose, glucose 2 hours after a glucose overload, fasting insulin and insulin resistance estimated as HOMA). Results and Conclusions: We have identified several polymorphisms associated with the analysed clinical traits, not only at the UTS2 gene, but also in thePER3 gene, located upstream from UTS2. Our results are compatible with a role for UII in glucose homeostasis and diabetes although we cannot rule out the possibility that PER3 gene may underlie the reported associations.	[Saez, Maria E.; Ramirez-Lorca, Reposo; Ruiz, Agustin] Neocodex, Dept Struct Genom, Seville, Spain; [Smani, Tarik; Diaz, Ignacio; Ordonez, Antonio] Univ Seville, CSIC, Hosp Univ Virgen Rocio, Inst Biomed Sevilla,Grp Fisiopathol Cardiovasc, Seville, Spain; [Serrano-Rios, Manuel] Univ Hosp Clin San Carlos, Biomed Res Fdn, Diabet Res Lab, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Hospital Clinico San Carlos	Saez, ME (corresponding author), Neocodex, Dept Struct Genom, Seville, Spain.	mesaez@neocodex.es	Ruiz, Agustin/G-5677-2012; Ruiz, Agustín/L-4469-2019; IBIS, CARDIOVASCULAR/P-3910-2015; Ordoñez, Antonio/G-9195-2018; Reposo, Ramirez-Lorca/D-7907-2014; Saez, Maria E/C-8093-2012; Hajami, Tarik Smani/D-5372-2016; Serrano Ríos, Manuel/E-4625-2019; Ramirez-Lorca, Reposo/A-5807-2012	Ruiz, Agustín/0000-0003-2633-2495; Ordoñez, Antonio/0000-0002-4344-8660; Hajami, Tarik Smani/0000-0002-1877-7438; Serrano Ríos, Manuel/0000-0002-3214-1444; Ramirez Lorca, Reposo/0000-0002-1594-0404; Saez, Maria/0000-0001-9299-2534	Centro para el Desarrollo Tecnologico Industrial (CDTI) [CENIT-2008 1004]; Ministerio de Ciencia e Innovacion; CIBER of Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Spain; Spanish Ministry MICINN [BFU2010-21043-C02-02, PS09-02287]; Red RECAVA [RD06-0014-0020]; Government of Andalucia [P08-CVI-3913; P09-CTS-4715]	Centro para el Desarrollo Tecnologico Industrial (CDTI); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); CIBER of Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Spain(Instituto de Salud Carlos III); Spanish Ministry MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Red RECAVA; Government of Andalucia	This work has been supported by grant CENIT-2008 1004 from the Centro para el Desarrollo Tecnologico Industrial (CDTI) and the Ministerio de Ciencia e Innovacion under the Ingenio 2010 program. The work by the Diabetes Research Laboratory, Biomedical Research Foundation, University Hospital Clinico San Carlos, Madrid, Spain (P.I: Manuel Serrano-Rios) is supported by CIBER of Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Spain. The Group of "Fisiopatologia Cardiovascular" is supported by funding from Spanish Ministry MICINN (BFU2010-21043-C02-02; PS09-02287) and Red RECAVA [RD06-0014-0020]; from the Government of Andalucia (CICE: [P08-CVI-3913; P09-CTS-4715]. Tarik Smani is a Researcher from "Fundacion Publica Andaluza Progreso y Salud". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainla T, 2005, DIABETIC MED, V22, P1321, DOI 10.1111/j.1464-5491.2005.01625.x; Ames RS, 1999, NATURE, V401, P282, DOI 10.1038/45809; Ando H, 2009, DIABETOLOGIA, V52, P329, DOI 10.1007/s00125-008-1194-6; Ando H, 2010, J GERONTOL A-BIOL, V65, P9, DOI 10.1093/gerona/glp160; Angeli F, 2010, CURR DIABETES REV, V6, P102, DOI 10.2174/157339910790909413; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chu LW, 2008, CANCER EPIDEM BIOMAR, V17, P3268, DOI 10.1158/1055-9965.EPI-08-0073; Clozel M, 2006, J PHARMACOL EXP THER, V316, P1115, DOI 10.1124/jpet.105.094821; Davenport AP, 2000, TRENDS PHARMACOL SCI, V21, P80, DOI 10.1016/S0165-6147(00)01449-8; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Gangwisch JE, 2009, OBES REV, V10, P37, DOI 10.1111/j.1467-789X.2009.00663.x; Gayan J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-326; Genuth S, 2003, DIABETES CARE, V26, P3160; Gruson D, 2010, PEPTIDES, V31, P1326, DOI 10.1016/j.peptides.2010.04.009; Gruson D, 2010, J CLIN HYPERTENS, V12, P653, DOI 10.1111/j.1751-7176.2010.00336.x; Guess J, 2009, INTEGR CANCER THER, V8, P329, DOI 10.1177/1534735409352029; Jiang Z, 2008, INT J BIOL SCI, V4, P96; Kolman L, 2009, AM J CARDIOL, V104, P470, DOI 10.1016/j.amjcard.2009.04.006; Kosiborod M, 2005, CIRCULATION, V111, P3078, DOI 10.1161/CIRCULATIONAHA.104.517839; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Liu Fang, 2010, Shengli Xuebao, V62, P129; Lorenzo C, 2001, DIABETES CARE, V24, P2059, DOI 10.2337/diacare.24.12.2059; Marco J, 2008, PEPTIDES, V29, P852, DOI 10.1016/j.peptides.2007.08.025; Martinez-Larrad MT, 2005, MED CLIN-BARCELONA, V125, P481; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Milvidaite I, 2007, MEDICINA-LITHUANIA, V43, P935, DOI 10.3390/medicina43120121; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Nishihama K, 2007, INT J MOL MED, V19, P129; Oguri M, 2009, ATHEROSCLEROSIS, V206, P486, DOI 10.1016/j.atherosclerosis.2009.02.037; Ong KL, 2005, CARDIOVASC DRUG THER, V19, P65, DOI 10.1007/s10557-005-6899-x; Ong KL, 2008, PEPTIDES, V29, P859, DOI 10.1016/j.peptides.2007.06.003; Ong KL, 2006, PEPTIDES, V27, P1659, DOI 10.1016/j.peptides.2006.02.008; Papadopoulos P, 2008, PEPTIDES, V29, P764, DOI 10.1016/j.peptides.2007.09.012; Petursson P, 2007, INT J CARDIOL, V116, P315, DOI 10.1016/j.ijcard.2006.04.043; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ross B, 2010, AM J PHYSIOL-REG I, V298, pR1156, DOI 10.1152/ajpregu.00706.2009; Schiele F, 2006, DIABETIC MED, V23, P1370, DOI 10.1111/j.1464-5491.2006.02000.x; SHERIDAN MA, 1987, GEN COMP ENDOCR, V66, P405, DOI 10.1016/0016-6480(87)90251-6; Sidharta PN, 2006, CLIN PHARMACOL THER, V80, P246, DOI 10.1016/j.clpt.2006.05.013; Sidharta PN, 2009, BRIT J CLIN PHARMACO, V68, P502, DOI 10.1111/j.1365-2125.2009.03480.x; Silvestre R, 2004, EUR J ENDOCRINOL, V151, P803, DOI 10.1530/eje.0.1510803; Silvestre RA, 2001, HORM METAB RES, V33, P379, DOI 10.1055/s-2001-15414; Silvestre RA, 2009, REGUL PEPTIDES, V153, P37, DOI 10.1016/j.regpep.2008.11.008; Stranders I, 2004, ARCH INTERN MED, V164, P982, DOI 10.1001/archinte.164.9.982; Suguro T, 2008, CLIN SCI, V115, P327, DOI 10.1042/CS20080014; Sun Hong-xia, 2002, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V24, P223; Suzuki S, 2004, PEPTIDES, V25, P1803, DOI 10.1016/j.peptides.2004.03.030; Tan Yu-Jie, 2006, Zhonghua Fu Chan Ke Za Zhi, V41, P732; Thalib L, 2010, CLIN MED RES; Tooke JE, 2000, J INTERN MED, V247, P425, DOI 10.1046/j.1365-2796.2000.00671.x; Totsune K, 2003, CLIN SCI, V104, P1, DOI 10.1042/CS20020271; Tzanidis A, 2003, CIRC RES, V93, P246, DOI 10.1161/01.RES.0000084382.64418.BC; Vaudry H, 2010, ANN NY ACAD SCI, V1200, P53, DOI 10.1111/j.1749-6632.2010.05514.x; Vogt L, 2010, HYPERTENSION, V55, P1206, DOI 10.1161/HYPERTENSIONAHA.109.149559; Wenyi Z, 2003, DIABETOLOGIA, V46, P972, DOI 10.1007/s00125-003-1145-1; Yi L, 2006, J INT MED RES, V34, P272, DOI 10.1177/147323000603400306; Zhu Fang, 2002, Zhonghua Yi Xue Za Zhi, V82, P1473	57	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19327	10.1371/journal.pone.0019327	http://dx.doi.org/10.1371/journal.pone.0019327			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559414	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700138
J	Wang, YF; Broderick, P; Matakidou, A; Eisen, T; Houlston, RS				Wang, Yufei; Broderick, Peter; Matakidou, Athena; Eisen, Timothy; Houlston, Richard S.			Chromosome 15q25 (CHRNA3-CHRNA5) Variation Impacts Indirectly on Lung Cancer Risk	PLOS ONE			English	Article							SUSCEPTIBILITY LOCUS; NICOTINE DEPENDENCE; SMOKING; ASSOCIATION; VARIANTS; SMOKERS; GENES	Genetic variants at the 15q25 CHRNA5-CHRNA3 locus have been shown to influence lung cancer risk however there is controversy as to whether variants have a direct carcinogenic effect on lung cancer risk or impact indirectly through smoking behavior. We have performed a detailed analysis of the 15q25 risk variants rs12914385 and rs8042374 with smoking behavior and lung cancer risk in 4,343 lung cancer cases and 1,479 controls from the Genetic Lung Cancer Predisposition Study (GELCAPS). A strong association between rs12914385 and rs8042374, and lung cancer risk was shown, odds ratios (OR) were 1.44, (95% confidence interval (CI): 1.29-1.62, P = 3.69x10(-10)) and 1.35 (95% CI: 1.18-1.55, P = 9.99x10(-6)) respectively. Each copy of risk alleles at rs12914385 and rs8042374 was associated with increased cigarette consumption of 1.0 and 0.9 cigarettes per day (CPD) (P = 5.18x10(-5) and P = 5.65x10(-3)). These genetically determined modest differences in smoking behavior can be shown to be sufficient to account for the 15q25 association with lung cancer risk. To further verify the indirect effect of 15q25 on the risk, we restricted our analysis of lung cancer risk to never-smokers and conducted a meta-analysis of previously published studies of lung cancer risk in never-smokers. Never-smoker studies published in English were ascertained from PubMed stipulating - lung cancer, risk, genome-wide association, candidate genes. Our study and five previously published studies provided data on 2,405 never-smoker lung cancer cases and 7,622 controls. In the pooled analysis no association has been found between the 15q25 variation and lung cancer risk (OR = 1.09, 95% CI: 0.94-1.28). This study affirms the 15q25 association with smoking and is consistent with an indirect link between genotype and lung cancer risk.	[Wang, Yufei; Broderick, Peter; Houlston, Richard S.] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [Matakidou, Athena; Eisen, Timothy] Univ Cambridge, Dept Oncol, Cambridge, England	University of London; Institute of Cancer Research - UK; University of Cambridge	Wang, YF (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England.	richard.houlston@icr.ac.uk		Houlston, Richard/0000-0002-5268-0242; Broderick, Peter/0000-0002-8348-5829	Cancer Research UK [C1298/A8780, C1298/A8362]; Allan J Lerner Fund; NHS; Sanofi-Anventis	Cancer Research UK(Cancer Research UK); Allan J Lerner Fund; NHS; Sanofi-Anventis	This work was supported by Cancer Research UK (C1298/A8780 and C1298/A8362-Bobby Moore Fund for Cancer Research UK) who provided principal funding for this study. Athena Matakidou was the recipient of a clinical research fellowship from the Allan J Lerner Fund. The authors are also grateful to the National Cancer Research Network, Helen Rollason Heal Cancer Charity and Sanofi-Aventis. They acknowledge NHS funding for the Royal Marsden Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work was partially supported by commercial funder Sanofi-Anventis. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The commercial funder Sanofi-Aventis has declared that no competing interests exist.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; [Anonymous], NAT GENET, V42, P441; Bermejo JL, 2005, CANCER EPIDEM BIOMAR, V14, P1738, DOI 10.1158/1055-9965.EPI-05-0201; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Broderick P, 2009, CANCER RES, V69, P6633, DOI 10.1158/0008-5472.CAN-09-0680; Broms U, 2006, TWIN RES HUM GENET, V9, P64, DOI 10.1375/183242706776403046; DOLL R, 1978, J EPIDEMIOL COMMUN H, V32, P303, DOI 10.1136/jech.32.4.303; Eisen T, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-244; Falvella FS, 2009, CLIN CANCER RES, V15, P1837, DOI 10.1158/1078-0432.CCR-08-2107; Falvella FS, J NATL CANC I, V102, P1366; Flanders WD, 2003, CANCER RES, V63, P6556; Freathy RM, 2009, HUM MOL GENET, V18, P2922, DOI 10.1093/hmg/ddp216; Galvan A, 2010, CARCINOGENESIS, V31, P331, DOI 10.1093/carcin/bgp282; Gorber SC, 2009, NICOTINE TOB RES, V11, P12, DOI 10.1093/ntr/ntn010; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Le Marchand L, 2008, CANCER RES, V68, P9137, DOI 10.1158/0008-5472.CAN-08-2271; Li XJ, 2005, LUNG CANCER, V47, P301, DOI 10.1016/j.lungcan.2004.07.048; Lips EH, 2010, INT J EPIDEMIOL, V39, P563, DOI 10.1093/ije/dyp288; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Pettiti D, 1994, METAANALYSIS DECISIO; Saccone NL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001053; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Shiraishi K, 2009, CARCINOGENESIS, V30, P65, DOI 10.1093/carcin/bgn257; Spitz MR, 2008, J NATL CANCER I, V100, DOI 10.1093/jnci/djn363; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Truong T, J NATL CANC I, V102, P959; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Weiss RB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000125	31	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19085	10.1371/journal.pone.0019085	http://dx.doi.org/10.1371/journal.pone.0019085			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559498	Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700063
J	Yan, Y; Cui, HC; Jiang, SS; Huang, YH; Huang, XH; Wei, SN; Xu, WY; Qin, QW				Yan, Yang; Cui, Huachun; Jiang, Songshan; Huang, Youhua; Huang, Xiaohong; Wei, Shina; Xu, Weiyi; Qin, Qiwei			Identification of a Novel Marine Fish Virus, Singapore Grouper Iridovirus-Encoded MicroRNAs Expressed in Grouper Cells by Solexa Sequencing	PLOS ONE			English	Article							SPOTTED GROUPER; GENE-EXPRESSION; GENOMICS; CLONING; PCR; RNA	Background: MicroRNAs (miRNAs) are ubiquitous non-coding RNAs that regulate gene expression at the post-transcriptional level. An increasing number of studies has revealed that viruses can also encode miRNAs, which are proposed to be involved in viral replication and persistence, cell-mediated antiviral immune response, angiogenesis, and cell cycle regulation. Singapore grouper iridovirus (SGIV) is a pathogenic iridovirus that has severely affected grouper aquaculture in China and Southeast Asia. Comprehensive knowledge about the related miRNAs during SGIV infection is helpful for understanding the infection and the pathogenic mechanisms. Methodology/Principal Findings: To determine whether SGIV encoded miRNAs during infection, a small RNA library derived from SGIV-infected grouper (GP) cells was constructed and sequenced by Illumina/Solexa deep-sequencing technology. We recovered 6,802,977 usable reads, of which 34,400 represented small RNA sequences encoded by SGIV. Sixteen novel SGIV-encoded miRNAs were identified by a computational pipeline, including a miRNA that shared a similar sequence to herpesvirus miRNA HSV2-miR-H4-5p, which suggests miRNAs are conserved in far related viruses. Generally, these 16 miRNAs are dispersed throughout the SGIV genome, whereas three are located within the ORF057L region. Some SGIV-encoded miRNAs showed marked sequence and length heterogeneity at their 39 and/or 59 end that could modulate their functions. Expression levels and potential biological activities of these viral miRNAs were examined by stem-loop quantitative RT-PCR and luciferase reporter assay, respectively, and 11 of these viral miRNAs were present and functional in SGIV-infected GP cells. Conclusions: Our study provided a genome-wide view of miRNA production for iridoviruses and identified 16 novel viral miRNAs. To the best of our knowledge, this is the first experimental demonstration of miRNAs encoded by aquatic animal viruses. The results provide a useful resource for further in-depth studies on SGIV infection and iridovirus pathogenesis.	[Yan, Yang; Cui, Huachun; Jiang, Songshan; Xu, Weiyi] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Youhua; Huang, Xiaohong; Wei, Shina; Qin, Qiwei] Chinese Acad Sci, S China Sea Inst Oceanol, Key Lab Marine Bioresources Sustainable Utilizat, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS	Yan, Y (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	qinqw@scsio.ac.cn			Natural Science Foundation of China [30725027, 30930070]; Chinese Academy of Sciences [KZCX2-YW-BR-08, KZCX2-EW-Q213]; National Basic Research Program of China (973) [2006CB101802]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China (973)(National Basic Research Program of China)	This work was supported by the grants from the Natural Science Foundation of China (30725027, 30930070), the Knowledge Innovation Program of Chinese Academy of Sciences (KZCX2-YW-BR-08, KZCX2-EW-Q213) and the National Basic Research Program of China (973)(2006CB101802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio O, 2006, J VIROL, V80, P1376, DOI 10.1128/JVI.80.3.1376-1384.2006; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Barth S, 2008, NUCLEIC ACIDS RES, V36, P666, DOI 10.1093/nar/gkm1080; Bennasser Yamina, 2004, Retrovirology, V1, P43, DOI 10.1186/1742-4690-1-43; Boss IW, 2010, CURR OPIN MICROBIOL, V13, P540, DOI 10.1016/j.mib.2010.05.017; Burnside J, 2006, J VIROL, V80, P8778, DOI 10.1128/JVI.00831-06; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cai Xuezhong, 2006, PLoS Pathogens, V2, P236, DOI 10.1371/journal.ppat.0020023; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012745; Chen X, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r78; Chinchar VG, 2002, ARCH VIROL, V147, P447, DOI 10.1007/s007050200000; Choy EYW, 2008, J EXP MED, V205, P2551, DOI 10.1084/jem.20072581; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Dolken L, 2007, J VIROL, V81, P13771, DOI 10.1128/JVI.01313-07; Dunn W, 2005, CELL MICROBIOL, V7, P1684, DOI 10.1111/j.1462-5822.2005.00598.x; Ghosh Z, 2009, NUCLEIC ACIDS RES, V37, P1035, DOI 10.1093/nar/gkn1004; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Grassmann R, 2008, BBA-GENE REGUL MECH, V1779, P706, DOI 10.1016/j.bbagrm.2008.05.005; GRAVELL M, 1965, ANN NY ACAD SCI, V126, P555, DOI 10.1111/j.1749-6632.1965.tb14302.x; Grey F, 2005, J VIROL, V79, P12095, DOI 10.1128/JVI.79.18.12095-12099.2005; Grey F, 2007, PLOS PATHOG, V3, P1593, DOI 10.1371/journal.ppat.0030163; Gupta A, 2006, NATURE, V442, P82, DOI 10.1038/nature04836; Huang XH, 2008, BIOCHEM BIOPH RES CO, V373, P140, DOI 10.1016/j.bbrc.2008.06.003; Iyer LA, 2006, VIRUS RES, V117, P156, DOI 10.1016/j.virusres.2006.01.009; Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo AKF, 2007, P NATL ACAD SCI USA, V104, P16164, DOI 10.1073/pnas.0702896104; Qin QW, 2003, DIS AQUAT ORGAN, V53, P1, DOI 10.3354/dao053001; Qin QW, 2001, J VIROL METHODS, V98, P17, DOI 10.1016/S0166-0934(01)00350-0; Rachamadugu R, 2009, VIRUS GENES, V39, P301, DOI 10.1007/s11262-009-0397-3; Samols MA, 2005, J VIROL, V79, P9301, DOI 10.1128/JVI.79.14.9301-9305.2005; Scaria V, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-68; Schafer A, 2007, VIROLOGY, V364, P21, DOI 10.1016/j.virol.2007.03.029; Song WJ, 2004, J VIROL, V78, P12576, DOI 10.1128/JVI.78.22.12576-12590.2004; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; Tang S, 2008, P NATL ACAD SCI USA, V105, P10931, DOI 10.1073/pnas.0801845105; Tang S, 2009, J VIROL, V83, P1433, DOI 10.1128/JVI.01723-08; Teng Y, 2008, VIROLOGY, V377, P39, DOI 10.1016/j.virol.2008.04.011; Umbach JL, 2010, J VIROL, V84, P1189, DOI 10.1128/JVI.01712-09; Umbach JL, 2010, J VIROL, V84, P695, DOI 10.1128/JVI.02013-09; Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wan QJ, 2010, ARCH VIROL, V155, P351, DOI 10.1007/s00705-010-0594-3; Williams T, 2005, ADV VIRUS RES, V65, P173, DOI 10.1016/S0065-3527(05)65006-3; Xia HP, 2010, J BIOL CHEM, V285, P36995, DOI 10.1074/jbc.M110.133744; Xia LQ, 2010, VIRUS RES, V147, P30, DOI 10.1016/j.virusres.2009.09.015; Xia LQ, 2009, ARCH VIROL, V154, P1409, DOI 10.1007/s00705-009-0457-y; Yao YX, 2007, J VIROL, V81, P7164, DOI 10.1128/JVI.00112-07; Zhu JY, 2009, J VIROL, V83, P3333, DOI 10.1128/JVI.01689-08; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	53	38	43	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19148	10.1371/journal.pone.0019148	http://dx.doi.org/10.1371/journal.pone.0019148			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559453	Green Submitted, gold, Green Published			2022-12-27	WOS:000290024700077
J	Lang, SLC; Iverson, SJ; Bowen, WD				Lang, Shelley L. C.; Iverson, Sara J.; Bowen, W. Don			The Influence of Reproductive Experience on Milk Energy Output and Lactation Performance in the Grey Seal (Halichoerus grypus)	PLOS ONE			English	Article							HYDROGEN-ISOTOPE-DILUTION; MAMMARY-GLAND; GRAY SEALS; BREEDING COLONIES; 1ST REPRODUCTION; CELL POPULATION; BODY CONDITION; ELEPHANT SEAL; LITTER SIZE; GUINEA-PIG	Although evidence from domestic and laboratory species suggests that reproductive experience plays a critical role in the development of aspects of lactation performance, whether reproductive experience may have a significant influence on milk energy transfer to neonates in wild populations has not been directly investigated. We compared maternal energy expenditures and pup growth and energy deposition over the course of lactation between primiparous and fully-grown, multiparous grey seal (Halichoerus grypus) females to test whether reproductive experience has a significant influence on lactation performance. Although there was no difference between primiparous females in milk composition and, thus, milk energy content at either early or peak lactation primiparous females had a significantly lower daily milk energy output than multiparous females indicating a reduced physiological capacity for milk secretion. Primiparous females appeared to effectively compensate for lower rates of milk production through an increased nursing effort and, thus, achieved the same relative rate of milk energy transfer to pups as multiparous females. There was no difference between primiparous and multiparous females in the proportion of initial body energy stores mobilised to support the costs of lactation. Although primiparous females allocated a greater proportion of energy stores to maternal maintenance versus milk production than multiparous females, the difference was not sufficient to result in significant differences in the efficiency of energy transfer to pups. Thus, despite a lower physiological capacity for milk production, primiparous females weaned pups of the same relative size and condition as multiparous females without expending proportionally more energy. Although reproductive experience does not significantly affect the overall lactation performance of grey seals, our results suggest that increases in mammary gland capacity with reproductive experience may play a significant role in the age-related increases in neonatal growth rates and weaning masses observed in other free-ranging mammals.	[Lang, Shelley L. C.; Iverson, Sara J.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Bowen, W. Don] Bedford Inst Oceanog, Populat Ecol Div, Dartmouth, NS, Canada	Dalhousie University; Bedford Institute of Oceanography; Fisheries & Oceans Canada	Lang, SLC (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	Shelley.Lang@Dal.Ca	Bowen, William/AAE-7204-2022; Bowen, William/D-2758-2012	Bowen, William/0000-0001-8334-5677; Iverson, Sara/0000-0003-2842-4094	Canadian Department of Fisheries and Oceans; Natural Science and Engineering Research Council (NSERC); Dalhousie Graduate Studies Fellowship	Canadian Department of Fisheries and Oceans; Natural Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Dalhousie Graduate Studies Fellowship	This research was supported by the Canadian Department of Fisheries and Oceans, Natural Science and Engineering Research Council (NSERC) grants to SJI and WDB and a Dalhousie Graduate Studies Fellowship to SLCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PJ, 1995, MOL ECOL, V4, P653, DOI 10.1111/j.1365-294X.1995.tb00266.x; ANDERSON RR, 1983, J DAIRY SCI, V66, P29, DOI 10.3168/jds.S0022-0302(83)81749-4; Becker CD, 1998, OIKOS, V81, P81, DOI 10.2307/3546470; Blaxter K, 1989, ENERGY METABOLISM AN; Bowen WD, 2006, J ANIM ECOL, V75, P1340, DOI 10.1111/j.1365-2656.2006.01157.x; BOWEN WD, 1992, J ZOOL, V227, P607, DOI 10.1111/j.1469-7998.1992.tb04418.x; Bowen WD, 1998, PHYSIOL ZOOL, V71, P329, DOI 10.1086/515921; Broussard DR, 2003, J ANIM ECOL, V72, P212, DOI 10.1046/j.1365-2656.2003.00691.x; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; Cowie A, 1980, HORMONAL CONTROL LAC; CURIO E, 1983, IBIS, V125, P400, DOI 10.1111/j.1474-919X.1983.tb03130.x; DEROCHER AE, 1994, J ZOOL, V234, P527, DOI 10.1111/j.1469-7998.1994.tb04863.x; FISCHBECK KL, 1987, J NUTR, V117, P1967, DOI 10.1093/jn/117.11.1967; FORSLUND P, 1995, TRENDS ECOL EVOL, V10, P374, DOI 10.1016/S0169-5347(00)89141-7; FOWLER PA, 1990, J REPROD FERTIL, V89, P367, DOI 10.1530/jrf.0.0890367; GOMENDIO M, 1989, J REPROD FERTIL, V87, P529; Gonzalez-Mariscal Gabriela, 2002, P215; Hall AJ, 2001, J ANIM ECOL, V70, P138; Hennighausen L, 1998, GENE DEV, V12, P449, DOI 10.1101/gad.12.4.449; Hoffman PC, 1997, J ANIM SCI, V75, P836; HORWITZ W, 2000, OFFICIAL METHODS ANA, pCH33; IVERSON SJ, 1993, PHYSIOL ZOOL, V66, P61, DOI 10.1086/physzool.66.1.30158287; Jacquot JJ, 1998, J MAMMAL, V79, P312, DOI 10.2307/1382867; KENAGY GJ, 1989, OECOLOGIA, V78, P269, DOI 10.1007/BF00377166; King RH, 1997, LIVEST PROD SCI, V47, P169, DOI 10.1016/S0301-6226(96)01404-2; KNIGHT CH, 1984, J DAIRY RES, V51, P29, DOI 10.1017/S0022029900023293; Knight CH, 2000, LIVEST PROD SCI, V66, P169, DOI 10.1016/S0301-6226(00)00224-4; KOZLOWSKI J, 1992, TRENDS ECOL EVOL, V7, P15, DOI 10.1016/0169-5347(92)90192-E; Kunkele J, 1997, PHYSIOL ZOOL, V70, P571; Kunkele J, 2000, CAN J ZOOL, V78, P300, DOI 10.1139/cjz-78-2-300; Lambert KG, 2005, PHYSIOL BEHAV, V84, P799, DOI 10.1016/j.physbeh.2005.03.012; Lang SLC, 2011, MAR MAMMAL SCI, V27, pE153, DOI 10.1111/j.1748-7692.2010.00443.x; Lang SLC, 2009, ECOLOGY, V90, P2513, DOI 10.1890/08-1386.1; Limmer B, 2009, ANIM BEHAV, V77, P1095, DOI 10.1016/j.anbehav.2009.01.015; McMahon CR, 2005, P ROY SOC B-BIOL SCI, V272, P923, DOI 10.1098/rspb.2004.3038; Mellish JAE, 1999, PHYSIOL BIOCHEM ZOOL, V72, P677, DOI 10.1086/316708; Michel P, 2003, J ZOOL, V261, P427, DOI 10.1017/S0952836903004291; Miller N, 2006, J DAIRY SCI, V89, P4669, DOI 10.3168/jds.S0022-0302(06)72517-6; Mysterud A, 2002, OIKOS, V97, P177, DOI 10.1034/j.1600-0706.2002.970203.x; Newton I, 1989, LIFETIME REPROD BIRD; Noren SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P269, DOI 10.1086/528777; Numan M, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1921; Oftedal O. T., 1995, HDB MILK COMPOSITION, P790; Oftedal O.T., 1987, APPROACHES MARINE MA, P67; ORTIZ CL, 1978, PHYSIOL ZOOL, V51, P166, DOI 10.1086/physzool.51.2.30157864; Pomeroy PP, 2000, ETHOLOGY, V106, P899, DOI 10.1046/j.1439-0310.2000.00610.x; REILLY JJ, 1990, J APPL PHYSIOL, V69, P885, DOI 10.1152/jappl.1990.69.3.885; Rogowitz GL, 1996, AM ZOOL, V36, P197; Tanaka I, 1997, AM J PRIMATOL, V42, P331, DOI 10.1002/(SICI)1098-2345(1997)42:4<331::AID-AJP8>3.3.CO;2-8; TOPPER YJ, 1980, PHYSIOL REV, V60, P1049, DOI 10.1152/physrev.1980.60.4.1049; VONDERHAAR BK, 1978, CANCER RES, V38, P4059; WADA H, 1959, J DAIRY SCI, V42, P1198, DOI 10.3168/jds.S0022-0302(59)90712-X; Wagner KU, 2002, DEVELOPMENT, V129, P1377; Wang De-Hua, 1996, Acta Zoologica Sinica, V42, P140; Wartella J, 2003, PHYSIOL BEHAV, V79, P373, DOI 10.1016/S0031-9384(03)00150-1; Weladji RB, 2002, OECOLOGIA, V131, P79, DOI 10.1007/s00442-001-0864-6; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; YANG H, 1989, ANIM PROD, V48, P181, DOI 10.1017/S0003356100003901	58	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19487	10.1371/journal.pone.0019487	http://dx.doi.org/10.1371/journal.pone.0019487			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589918	Green Published, gold			2022-12-27	WOS:000290483600013
J	Meng, X; Zaidi, Q				Meng, Xin; Zaidi, Qasim			Visual Effects of Haptic Feedback Are Large but Local	PLOS ONE			English	Article							3-DIMENSIONAL SHAPE; PERCEPTION; TOUCH; VISION; SURFACES; TEXTURES; OBJECTS; SENSES	Vision generally provides reliable predictions for touch and motor-control, but some classes of stimuli evoke visual illusions. Using haptic feedback on virtual 3-D surfaces, we tested the function of touch in such cases. Our experiments show that in the perception of 3-D shapes from texture cues, haptic information can dominate vision in some cases, changing percepts qualitatively from convex to concave and concave to slant. The effects take time to develop, do not outlive the cessation of the feedback, are attenuated by distance, and drastically reduced by gaps in the surface. These dynamic shifts in qualitative perceived shapes could be invaluable in neural investigations that test whether haptic feedback modifies selective activation of neurons or changes the shape-tuning of neurons responsible for percepts of 3-D shapes.	[Meng, Xin; Zaidi, Qasim] SUNY Coll Optometry, Grad Ctr Vis Res, New York, NY 10010 USA	State University of New York (SUNY) System; SUNY Optometry	Meng, X (corresponding author), SUNY Coll Optometry, Grad Ctr Vis Res, New York, NY 10010 USA.	qz@sunyopt.edu			National Institute of Health [EY07556, EY13312]; NATIONAL EYE INSTITUTE [R01EY013312, R01EY007556, R29EY007556] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institute of Health grants EY07556 and EY13312 to Q. Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WJ, 2004, NAT NEUROSCI, V7, P1057, DOI 10.1038/nn1312; Amedi A, 2001, NAT NEUROSCI, V4, P324, DOI 10.1038/85201; BERKELEY G, 1702, ESSAY NEW THEORY VIS; Blake R, 2004, PSYCHOL SCI, V15, P397, DOI 10.1111/j.0956-7976.2004.00691.x; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Ernst MO, 2000, NAT NEUROSCI, V3, P69, DOI 10.1038/71140; Griffiths AF, 1998, PERCEPTION, V27, P799, DOI 10.1068/p270799; HELLER MA, 1992, PERCEPTION, V21, P655, DOI 10.1068/p210655; James TW, 2002, NEUROPSYCHOLOGIA, V40, P1706, DOI 10.1016/S0028-3932(02)00017-9; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; Li A, 2004, J VISION, V4, P860, DOI 10.1167/4.10.3; Li A, 2003, VISION RES, V43, P2741, DOI 10.1016/j.visres.2003.07.001; Li A, 2000, VISION RES, V40, P217, DOI 10.1016/S0042-6989(99)00169-8; Lunghi C, 2010, CURR BIOL, V20, pR143, DOI 10.1016/j.cub.2009.12.015; MAUNSELL JHR, 1991, VISUAL NEUROSCI, V7, P561, DOI 10.1017/S095252380001035X; Newell FN, 2001, PSYCHOL SCI, V12, P37, DOI 10.1111/1467-9280.00307; ROCK I, 1964, SCIENCE, V143, P594, DOI 10.1126/science.143.3606.594; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Violentyev A, 2005, NEUROREPORT, V16, P1107, DOI 10.1097/00001756-200507130-00015; Yamane Y, 2008, NAT NEUROSCI, V11, P1352, DOI 10.1038/nn.2202; ZAIDI Q, 2011, VISUAL INFE IN PRESS	23	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19877	10.1371/journal.pone.0019877	http://dx.doi.org/10.1371/journal.pone.0019877			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	761YU	21572964	Green Published, gold			2022-12-27	WOS:000290440200032
J	Clyde, K; Glaunsinger, BA				Clyde, Karen; Glaunsinger, Britt A.			Deep Sequencing Reveals Direct Targets of Gammaherpesvirus-Induced mRNA Decay and Suggests That Multiple Mechanisms Govern Cellular Transcript Escape	PLOS ONE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; AU-RICH ELEMENTS; GENE-EXPRESSION; HOST SHUTOFF; GENOTOXIC STRESS; LYTIC INFECTION; C-MYC; PROTEIN; KSHV; PATHOGENESIS	One characteristic of lytic infection with gammaherpesviruses, including Kaposi's sarcoma-associated herpesvirus (KSHV), Epstein-Barr virus (EBV) and murine herpesvirus 68 (MHV68), is the dramatic suppression of cellular gene expression in a process known as host shutoff. The alkaline exonuclease proteins (KSHV SOX, MHV-68 muSOX and EBV BGLF5) have been shown to induce shutoff by destabilizing cellular mRNAs. Here we extend previous analyses of cellular mRNA abundance during lytic infection to characterize the effects of SOX and muSOX, in the absence of other viral genes, utilizing deep sequencing technology (RNA-seq). Consistent with previous observations during lytic infection, the majority of transcripts are downregulated in cells expressing either SOX or muSOX, with muSOX acting as a more potent shutoff factor than SOX. Moreover, most cellular messages fall into the same expression class in both SOX- and muSOX-expressing cells, indicating that both factors target similar pools of mRNAs. More abundant mRNAs are more efficiently downregulated, suggesting a concentration effect in transcript targeting. However, even among highly expressed genes there are mRNAs that escape host shutoff. Further characterization of select escapees reveals multiple mechanisms by which cellular genes can evade downregulation. While some mRNAs are directly refractory to SOX, the steady state levels of others remain unchanged, presumably as a consequence of downstream effects on mRNA biogenesis. Collectively, these studies lay the framework for dissecting the mechanisms underlying the susceptibility of mRNA to destruction during lytic gammaherpesvirus infection.	[Clyde, Karen; Glaunsinger, Britt A.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Clyde, K (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	glaunsinger@berkeley.edu			Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease Award; Ruth L. Kirschstein National Research Service [F32AI080082]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI080082] Funding Source: NIH RePORTER	Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease Award(Burroughs Wellcome Fund); Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this work was provided by the Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease Award (http://www.bwfund.org/page.php?mode=privateview&pageID=105) to B.A.G. and the Ruth L. Kirschstein National Research Service Award (F32AI080082) to K.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibes A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-9; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BAER MR, 1992, BLOOD, V79, P1319; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Buisson M, 2009, J MOL BIOL, V391, P717, DOI 10.1016/j.jmb.2009.06.034; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Chandriani S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000811; Clyde K, 2010, ADV VIRUS RES, V78, P1, DOI 10.1016/S0065-3527(10)78001-5; Covarrubias S, 2009, J VIROL, V83, P9554, DOI 10.1128/JVI.01051-09; Cuenin S, 2008, ONCOGENE, V27, P387, DOI 10.1038/sj.onc.1210635; Deng HY, 2002, BLOOD, V100, P1919, DOI 10.1182/blood-2002-01-0015; Dixon DA, 2001, J CLIN INVEST, V108, P1657, DOI 10.1172/JCI200112973; Ebrahimi B, 2003, J GEN VIROL, V84, P99, DOI 10.1099/vir.0.18639-0; GANEM D, 2007, FIELDS VIROLOGY; Ganem D, 2010, J CLIN INVEST, V120, P939, DOI 10.1172/JCI40567; Glaunsinger B, 2005, J VIROL, V79, P7396, DOI 10.1128/JVI.79.12.7396-7401.2005; Glaunsinger B, 2004, J EXP MED, V200, P391, DOI 10.1084/jem.20031881; Glaunsinger B, 2004, MOL CELL, V13, P713, DOI 10.1016/S1097-2765(04)00091-7; Hollams EM, 2002, NEUROCHEM RES, V27, P957, DOI 10.1023/A:1020992418511; Kasprzyk A, 2004, GENOME RES, V14, P160, DOI 10.1101/gr.1645104; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee YJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000107; Mages J, 2008, J CELL MOL MED, V12, P1974, DOI 10.1111/j.1582-4934.2008.00235.x; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McCormick C, 2005, SCIENCE, V307, P739, DOI 10.1126/science.1105779; MODROW S, 1983, J GEN VIROL, V64, P37, DOI 10.1099/0022-1317-64-1-37; Roan F, 2002, VIROLOGY, V301, P293, DOI 10.1006/viro.2002.1582; Rowe M, 2007, P NATL ACAD SCI USA, V104, P3366, DOI 10.1073/pnas.0611128104; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; Seko Y, 2006, AUTOIMMUN REV, V5, P299, DOI 10.1016/j.autrev.2005.10.013; SHYU AB, 1989, GENE DEV, V3, P60, DOI 10.1101/gad.3.1.60; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Voynow JA, 2006, AM J RESP CELL MOL, V34, P661, DOI 10.1165/rcmb.2006-0035SF; Wilkinson DE, 2003, IUBMB LIFE, V55, P451, DOI 10.1080/15216540310001612237; WISDOM R, 1991, GENE DEV, V5, P232, DOI 10.1101/gad.5.2.232; Zuo J, 2008, J VIROL, V82, P2385, DOI 10.1128/JVI.01946-07	38	37	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19655	10.1371/journal.pone.0019655	http://dx.doi.org/10.1371/journal.pone.0019655			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573023	gold, Green Published			2022-12-27	WOS:000290386800029
J	Fong, DH; Xiong, B; Hwang, JY; Berghuis, AM				Fong, Desiree H.; Xiong, Bing; Hwang, Jiyoung; Berghuis, Albert M.			Crystal Structures of Two Aminoglycoside Kinases Bound with a Eukaryotic Protein Kinase Inhibitor	PLOS ONE			English	Article							PRELIMINARY CRYSTALLOGRAPHIC ANALYSIS; ANTIBIOTIC-RESISTANCE; KINETIC MECHANISM; PHOSPHOTRANSFERASE; SELECTIVITY; ENZYME; SUBSTRATE; BINDING; POTENT; IIIA	Antibiotic resistance is recognized as a growing healthcare problem. To address this issue, one strategy is to thwart the causal mechanism using an adjuvant in partner with the antibiotic. Aminoglycosides are a class of clinically important antibiotics used for the treatment of serious infections. Their usefulness has been compromised predominantly due to drug inactivation by aminoglycoside-modifying enzymes, such as aminoglycoside phosphotransferases or kinases. These kinases are structurally homologous to eukaryotic Ser/Thr and Tyr protein kinases and it has been shown that some can be inhibited by select protein kinase inhibitors. The aminoglycoside kinase, APH(3')-IIIa, can be inhibited by CKI-7, an ATP- competitive inhibitor for the casein kinase 1. We have determined that CKI-7 is also a moderate inhibitor for the atypical APH(9)-Ia. Here we present the crystal structures of CKI-7-bound APH(3')-IIIa and APH(9)-Ia, the first structures of a eukaryotic protein kinase inhibitor in complex with bacterial kinases. CKI-7 binds to the nucleotide-binding pocket of the enzymes and its binding alters the conformation of the nucleotide-binding loop, the segment homologous to the glycine-rich loop in eurkaryotic protein kinases. Comparison of these structures with the CKI-7-bound casein kinase 1 reveals features in the binding pockets that are distinct in the bacterial kinases and could be exploited for the design of a bacterial kinase specific inhibitor. Our results provide evidence that an inhibitor for a subset of APHs can be developed in order to curtail resistance to aminoglycosides.	[Fong, Desiree H.; Hwang, Jiyoung; Berghuis, Albert M.] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Fong, Desiree H.; Berghuis, Albert M.] McGill Univ, Grp Rech GRASP, Montreal, PQ, Canada; [Xiong, Bing; Berghuis, Albert M.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Fong, DH (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	albert.berghuis@mcgill.ca	Xiong, Bing/B-8849-2008; Berghuis, Albert M/A-6495-2008; Xiong, Bin/L-7560-2019	Xiong, Bing/0000-0001-9776-8136; Xiong, Bin/0000-0001-9776-8136; Berghuis, Albert/0000-0002-2663-025X	Canadian Institutes of Health Research [MOP-13107]; Natural Sciences and Engineering Research Council of Canada; Canada Research Chair in Structural Biology	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair in Structural Biology	This work was supported by an operating grant from the Canadian Institutes of Health Research awarded to AMB (MOP-13107; http://www.cihr-irsc.gc.ca/). Support for the X8C synchrotron beamline was in part received from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/). AMB is the recipient of a Canada Research Chair in Structural Biology (http://www.chairs-chaires.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akritopoulou-Zanze I, 2009, DRUG DISCOV TODAY, V14, P291, DOI 10.1016/j.drudis.2008.12.002; ALLINGER NL, 1977, J AM CHEM SOC, V99, P8127, DOI 10.1021/ja00467a001; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burk DL, 2002, PHARMACOL THERAPEUT, V93, P283, DOI 10.1016/S0163-7258(02)00197-3; Burk DL, 2001, BIOCHEMISTRY-US, V40, P8756, DOI 10.1021/bi010504p; Burkert U., 1982, MOL MECH, DOI 10.1002/jcc.540040420; Cherry M, 2004, CURR MED CHEM, V11, P663, DOI 10.2174/0929867043455792; CHIJIWA T, 1989, J BIOL CHEM, V264, P4924; Daigle DM, 1997, J BIOL CHEM, V272, P24755, DOI 10.1074/jbc.272.40.24755; Daigle DM, 1999, CHEM BIOL, V6, P11, DOI 10.1016/S1074-5521(99)80016-7; De Pascale G, 2010, CHEMBIOCHEM, V11, P1325, DOI 10.1002/cbic.201000067; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fong DH, 2010, J BIOL CHEM, V285, P9545, DOI 10.1074/jbc.M109.038364; Fong DH, 2009, ANTIMICROB AGENTS CH, V53, P3049, DOI 10.1128/AAC.00062-09; Fong DH, 2004, ACTA CRYSTALLOGR D, V60, P1897, DOI 10.1107/S0907444904019390; Fong DH, 2002, EMBO J, V21, P2323, DOI 10.1093/emboj/21.10.2323; Gao F, 2006, J MED CHEM, V49, P5273, DOI 10.1021/jm060732n; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; Hon WC, 1997, CELL, V89, P887, DOI 10.1016/S0092-8674(00)80274-3; Huang DZ, 2010, BIOINFORMATICS, V26, P198, DOI 10.1093/bioinformatics/btp650; Johnson LN, 2009, Q REV BIOPHYS, V42, P1, DOI 10.1017/S0033583508004745; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lemke CT, 2005, ACTA CRYSTALLOGR F, V61, P606, DOI 10.1107/S1744309105016301; Liao JJL, 2007, J MED CHEM, V50, P409, DOI 10.1021/jm0608107; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MCKAY GA, 1994, BIOCHEMISTRY-US, V33, P6936, DOI 10.1021/bi00188a024; MCKAY GA, 1995, J BIOL CHEM, V270, P24686, DOI 10.1074/jbc.270.42.24686; Nurizzo D, 2003, J MOL BIOL, V327, P491, DOI 10.1016/S0022-2836(03)00121-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; SHAW KJ, 1993, MICROBIOL REV, V57, P138, DOI 10.1128/MMBR.57.1.138-163.1993; Sowadski JM, 1999, PHARMACOL THERAPEUT, V82, P157, DOI 10.1016/S0163-7258(98)00054-0; Therrien C, 2000, FEMS MICROBIOL REV, V24, P251, DOI 10.1111/j.1574-6976.2000.tb00541.x; Thompson PR, 1999, J BIOL CHEM, V274, P30697, DOI 10.1074/jbc.274.43.30697; Thompson PR, 1996, CHEM BIOL, V3, P747, DOI 10.1016/S1074-5521(96)90251-3; Toth M, 2010, PROTEIN SCI, V19, P1565, DOI 10.1002/pro.437; Vakulenko SB, 2003, CLIN MICROBIOL REV, V16, P430, DOI 10.1128/CMR.16.3.430-450.2003; Xu RM, 1996, P NATL ACAD SCI USA, V93, P6308, DOI 10.1073/pnas.93.13.6308; Young PG, 2009, J BACTERIOL, V191, P4133, DOI 10.1128/JB.00149-09	42	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19589	10.1371/journal.pone.0019589	http://dx.doi.org/10.1371/journal.pone.0019589			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573013	gold, Green Submitted, Green Published			2022-12-27	WOS:000290386800021
J	Grumelli, S; Lu, B; Peterson, L; Maeno, T; Gerard, C				Grumelli, Sandra; Lu, Bao; Peterson, Leif; Maeno, Toshitaka; Gerard, Craig			CD46 Protects against Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							MEMBRANE COFACTOR PROTEIN; T-CELLS; RETINOIC ACID; LUNG-FUNCTION; EXPRESSION; ACTIVATION; EMPHYSEMA; INFLAMMATION; MACROPHAGE; INDUCTION	Background: Chronic obstructive pulmonary disease and emphysema develops in 15% of ex-smokers despite sustained quitting, while 10% are free of emphysema or severe lung obstruction. The cause of the incapacity of the immune system to clear the inflammation in the first group remains unclear. Methods and Findings: We searched genes that were protecting ex-smokers without emphysema, using microarrays on portions of human lungs surgically removed; we found that loss of lung function in patients with chronic obstructive pulmonary disease and emphysema was associated with a lower expression of CD46 and verified this finding by qRT-PCR and flow cytometry. Also, there was a significant association among decreased CD46(+) cells with decreased CD4(+)T cells, apoptosis mediator CD95 and increased CD8(+)T cells that were protecting patients without emphysema or severe chronic obstructive pulmonary disease. CD46 not only regulates the production of T regulatory cells, which suppresses CD8(+)T cell proliferation, but also the complement cascade by degradation of C3b. These results were replicated in the murine smoking model, which showed increased C5a (produced by C3b) that suppressed IL12 mediated bias to T helper 1 cells and elastin co-precipitation with C3b, suggesting that elastin could be presented as an antigen. Thus, using ELISA from elastin peptides, we verified that 43% of the patients with severe early onset of chronic obstructive pulmonary disease tested positive for IgG to elastin in their serum compared to healthy controls. Conclusions: These data suggest that higher expression of CD46 in the lungs of ex-smoker protects them from emphysema and chronic obstructive pulmonary disease by clearing the inflammation impeding the proliferation of CD8(+)T cells and necrosis, achieved by production of T regulatory cells and degradation of C3b; restraining the complement cascade favors apoptosis over necrosis, protecting them from autoimmunity and chronic inflammation.	[Grumelli, Sandra; Maeno, Toshitaka] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Grumelli, Sandra] Univ Catolica Cordoba, Ctr Invest Med Resp, Cordoba, Argentina; [Peterson, Leif] Baylor Coll Med, Dept Med, Chron Dis Prevent & Res Program, Houston, TX 77030 USA; [Lu, Bao; Gerard, Craig] Harvard Univ, Childrens Hosp, Sch Med, Div Pulm, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Catholic University of Cordoba; Baylor College of Medicine; Harvard University; Boston Children's Hospital; Harvard Medical School	Grumelli, S (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA.	sgrumelli@yahoo.com		Peterson, Leif/0000-0002-1187-0883	National Heart, Lung and Blood Institute	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The funding provided by the National Heart, Lung and Blood Institute made this study possible. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn JF, 2010, ANNU REV PHYSIOL, V72, P495, DOI 10.1146/annurev-physiol-021909-135926; Anthonisen NR, 2002, AM J RESP CRIT CARE, V166, P675, DOI 10.1164/rccm.2112096; Cai XZ, 2003, AM J PHYSIOL-LUNG C, V285, pL1263, DOI 10.1152/ajplung.00274.2002; Cai XZ, 2002, J INTERF CYTOK RES, V22, P1175, DOI 10.1089/10799900260475687; Cosio MG, 1999, AM J RESP CRIT CARE, V160, pS21, DOI 10.1164/ajrccm.160.supplement_1.7; Cottin V, 2009, EUR RESPIR J, V33, P219, DOI 10.1183/09031936.00140208; Curtis Jeffrey L, 2007, Proc Am Thorac Soc, V4, P512, DOI 10.1513/pats.200701-002FM; De Sanctis JB, 2009, RECENT PATENTS INFLA, V3, P149, DOI 10.2174/187221309788489814; Devaux P, 1999, EUR J IMMUNOL, V29, P815; Di Stefano A, 2009, CLIN EXP IMMUNOL, V157, P316, DOI 10.1111/j.1365-2249.2009.03965.x; Doe C, 2010, CHEST, V138, P1140, DOI 10.1378/chest.09-3058; Fernandez-Salas E, 2002, MOL CELL BIOL, V22, P3610, DOI 10.1128/MCB.22.11.3610-3620.2002; Gianni M, 1997, BLOOD, V89, P1001, DOI 10.1182/blood.V89.3.1001; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; Greene CM, 2010, AM J RESP CRIT CARE, V181, P31, DOI 10.1164/rccm.200904-0545OC; GROSSO LE, 1993, ARCH BIOCHEM BIOPHYS, V305, P401, DOI 10.1006/abbi.1993.1438; Grumelli S, 2004, PLOS MED, V1, P75, DOI 10.1371/journal.pmed.0010008; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; He JP, 2000, J EXP MED, V191, P1605, DOI 10.1084/jem.191.9.1605; Huber-Lang M, 2002, AM J PATHOL, V161, P1849, DOI 10.1016/S0002-9440(10)64461-6; Inoue T, 2001, Hinyokika Kiyo, V47, P321; Jani TS, 2009, CELL RES, V19, P358, DOI 10.1038/cr.2008.314; Katsanou V, 2005, MOL CELL, V19, P777, DOI 10.1016/j.molcel.2005.08.007; Kemper C, 2003, NATURE, V421, P388, DOI 10.1038/nature01315; Lai KC, 2008, MOL CANCER RES, V6, P1431, DOI 10.1158/1541-7786.MCR-08-0141; Lane N, 2010, CLIN SCI, V119, P75, DOI 10.1042/CS20100033; Lee SH, 2007, NAT MED, V13, P567, DOI 10.1038/nm1583; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Madani A, 2001, EUR RESPIR J, V18, P720, DOI 10.1183/09031936.01.00255701; Maeno T, 2007, J IMMUNOL, V178, P8090, DOI 10.4049/jimmunol.178.12.8090; Matikainen S, 1996, BLOOD, V88, P114; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pauwels R, 2001, EUR RESPIR J, V18, P901, DOI 10.1183/09031936.01.0027401; Richards A, 2003, P NATL ACAD SCI USA, V100, P12966, DOI 10.1073/pnas.2135497100; Rochat-Steiner V, 2000, J EXP MED, V192, P1165, DOI 10.1084/jem.192.8.1165; Saetta M, 2002, AM J RESP CRIT CARE, V165, P1404, DOI 10.1164/rccm.2107139; Shapiro SD, 1999, AM J RESP CRIT CARE, V160, pS29, DOI 10.1164/ajrccm.160.supplement_1.9; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Skokowa J, 2005, J IMMUNOL, V174, P3041, DOI 10.4049/jimmunol.174.5.3041; Sprent J, 2002, IMMUNOL REV, V185, P126, DOI 10.1034/j.1600-065X.2002.18512.x; Uppaluri R, 1997, AM J RESP CRIT CARE, V156, P248, DOI 10.1164/ajrccm.156.1.9606093; Wang ZD, 2000, J EXP MED, V192, P1587, DOI 10.1084/jem.192.11.1587; Wood AM, 2010, OCCUP ENVIRON MED, V67, P556, DOI 10.1136/oem.2009.047589; Xu JS, 2006, J BIOL CHEM, V281, P38894, DOI 10.1074/jbc.M609339200; YAMAMOTO K, 1994, MOL CELL BIOL, V14, P4342, DOI 10.1128/MCB.14.7.4342; Zou CB, 2007, NAT MED, V13, P1078, DOI 10.1038/nm1625	48	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e18785	10.1371/journal.pone.0018785	http://dx.doi.org/10.1371/journal.pone.0018785			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573156	Green Submitted, Green Published, gold			2022-12-27	WOS:000290305600006
J	Rudolph, AE; Latkin, C; Crawford, ND; Jones, KC; Fuller, CM				Rudolph, Abby E.; Latkin, Carl; Crawford, Natalie D.; Jones, Kandice C.; Fuller, Crystal M.			Does Respondent Driven Sampling Alter the Social Network Composition and Health-Seeking Behaviors of Illicit Drug Users Followed Prospectively?	PLOS ONE			English	Article							HIV RISK BEHAVIORS; INJECTION-DRUG; HIDDEN POPULATIONS; INTERVENTION; AIDS; OUTREACH; PREVENTION; PATTERNS; PROGRAM; COCAINE	Respondent driven sampling (RDS) was originally developed to sample and provide peer education to injection drug users at risk for HIV. Based on the premise that drug users' social networks were maintained through sharing rituals, this peer-driven approach to disseminate educational information and reduce risk behaviors capitalizes and expands upon the norms that sustain these relationships. Compared with traditional outreach interventions, peer-driven interventions produce greater reductions in HIV risk behaviors and adoption of safer behaviors over time, however, control and intervention groups are not similarly recruited. As peer-recruitment may alter risk networks and individual risk behaviors over time, such comparison studies are unable to isolate the effect of a peer-delivered intervention. This analysis examines whether RDS recruitment (without an intervention) is associated with changes in health-seeking behaviors and network composition over 6 months. New York City drug users (N = 618) were recruited using targeted street outreach (TSO) and RDS (2006-2009). 329 non-injectors (RDS = 237; TSO = 92) completed baseline and 6-month surveys ascertaining demographic, drug use, and network characteristics. Chi-square and t-tests compared RDS- and TSO-recruited participants on changes in HIV testing and drug treatment utilization and in the proportion of drug using, sex, incarcerated and social support networks over the follow-up period. The sample was 66% male, 24% Hispanic, 69% black, 62% homeless, and the median age was 35. At baseline, the median network size was 3, 86% used crack, 70% used cocaine, 40% used heroin, and in the past 6 months 72% were tested for HIV and 46% were enrolled in drug treatment. There were no significant differences by recruitment strategy with respect to changes in health-seeking behaviors or network composition over 6 months. These findings suggest no association between RDS recruitment and changes in network composition or HIV risk, which supports prior findings from prospective HIV behavioral surveillance and intervention studies.	[Rudolph, Abby E.; Latkin, Carl] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Crawford, Natalie D.; Jones, Kandice C.; Fuller, Crystal M.] New York Acad Med, Ctr Urban Epidemiol Studies, New York, NY USA; [Crawford, Natalie D.; Fuller, Crystal M.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; New York Academy of Medicine; Columbia University	Rudolph, AE (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	abby.rudolph@gmail.com		Rudolph, Abby/0000-0003-1786-3307	National Institute on Drug Abuse [R01 DA019964-01, T32 DA007282]; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007282, R01DA019964] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the National Institute on Drug Abuse (R01 DA019964-01, T32 DA007282). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MD, 1996, J DRUG ISSUES, V26, P619, DOI 10.1177/002204269602600307; Barrington C, 2009, SOC SCI MED, V68, P2037, DOI 10.1016/j.socscimed.2009.03.009; BOOTH R, 1991, AM J DRUG ALCOHOL AB, V17, P337, DOI 10.3109/00952999109027557; Booth RE, 1996, DRUG ALCOHOL DEPEN, V42, P11, DOI 10.1016/0376-8716(96)01257-4; Booth RE, 2011, AM J PUBLIC HEALTH, V101, P336, DOI 10.2105/AJPH.2009.172304; Borders TF, 2008, ADDICTION, V103, P800, DOI 10.1111/j.1360-0443.2008.02159.x; Broadhead RS, 2006, INT J DRUG POLICY, V17, P379, DOI 10.1016/j.drugpo.2006.06.001; Broadhead RS, 1999, PUBLIC HEALTH, V113, P42; Broadhead RS, 2002, SOC SCI MED, V55, P235, DOI 10.1016/S0277-9536(01)00167-8; BROADHEAD RS, 1994, SOC PROBL, V41, P473, DOI 10.1525/sp.1994.41.3.03x0449g; BUX DA, 1993, HOSP COMMUNITY PSYCH, V44, P1066; CAMACHO LM, 1995, AM J ADDICTION, V4, P49; COLEMAN JS, 1959, SOC APPL ANTHR, V17, P28; Colon H M, 1993, P R Health Sci J, V12, P27; COLON HM, 1992, BRIT J ADDICT, V87, P585; Costenbader EC, 2006, ADDICTION, V101, P1003, DOI 10.1111/j.1360-0443.2006.01431.x; Cottler L B, 1998, Public Health Rep, V113 Suppl 1, P31; Coyle S L, 1998, Public Health Rep, V113 Suppl 1, P19; Curry AD, 2003, J URBAN HEALTH, V80, P482, DOI 10.1093/jurban/jtg049; Deering K. N., 2009, AIDS PATIENT CARE ST; DEREN S, 1995, AIDS EDUC PREV, V7, P379; DEREN S, 1995, J DRUG ISSUES, V25, P57, DOI 10.1177/002204269502500105; FRIEDMAN SR, 1992, BRIT J ADDICT, V87, P393; Gile KJ, 2010, SOCIOL METHODOL, V40, P285, DOI 10.1111/j.1467-9531.2010.01223.x; He HO, 1996, J DRUG ISSUES, V26, P649, DOI 10.1177/002204269602600309; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Heckathorn DD, 1999, SOCIOL FOCUS, V32, P159, DOI [DOI 10.1080/00380237.1999.10571133, 10.1080/00380237.1999.10571133]; Hoffmann JP, 1997, DRUG ALCOHOL DEPEN, V46, P41, DOI 10.1016/S0376-8716(97)00038-0; KLOVDAHL AS, 1994, SOC SCI MED, V38, P79, DOI 10.1016/0277-9536(94)90302-6; Kotranski L, 1998, AIDS EDUC PREV, V10, P19; Latkin C, 1996, J ACQ IMMUN DEF SYND, V13, P273, DOI 10.1097/00042560-199611010-00010; LATKIN C, 1995, DRUG ALCOHOL DEPEN, V38, P1, DOI 10.1016/0376-8716(94)01082-V; Latkin CA, 1999, AM J DRUG ALCOHOL AB, V25, P463, DOI 10.1081/ADA-100101873; LAUMANN EO, 1993, J HEALTH SOC BEHAV, V34, P7, DOI 10.2307/2137301; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; McCoy CB, 2001, SUBST USE MISUSE, V36, P49, DOI 10.1081/JA-100000228; Neaigus A, 1990, AIDS Educ Prev, V2, P253; Neaigus A, 1998, Public Health Rep, V113 Suppl 1, P140; Pilowsky DJ, 2007, SUBST USE MISUSE, V42, P1629, DOI 10.1080/10826080701205372; Rhodes F, 1996, CLAR SYMP, P207; Robinson WT, 2006, J URBAN HEALTH, V83, pI29, DOI 10.1007/s11524-006-9100-3; Rudolph AE, 2011, ANN EPIDEMIOL, V21, P280, DOI 10.1016/j.annepidem.2010.11.007; Scott G, 2008, INT J DRUG POLICY, V19, P42, DOI 10.1016/j.drugpo.2007.11.014; Semaan Salaam, 2002, AIDS Reviews, V4, P213; Sergeyev B, 1999, J DRUG ISSUES, V29, P777, DOI 10.1177/002204269902900403; SIEGAL HA, 1995, AIDS EDUC PREV, V7, P308; STEPHENS RC, 1991, AM J PUBLIC HEALTH, V81, P568, DOI 10.2105/AJPH.81.5.568; Stevens SJ, 1998, WOMEN HEALTH, V27, P25, DOI 10.1300/J013v27n01_03; SUFIAN M, 1991, Journal of Addictive Diseases, V10, P89, DOI 10.1300/J069v10n04_07; Tobin KE, 2011, ADDICTION, V106, P366, DOI 10.1111/j.1360-0443.2010.03146.x; WATTERS JK, 1989, SOC PROBL, V36, P416, DOI 10.1525/sp.1989.36.4.03a00070; WECHSBERG WM, 1994, EVAL PROGRAM PLANN, V17, P371, DOI 10.1016/0149-7189(94)90037-X; WEEKS MR, 2002, AIDS BEHAV, V6, P193, DOI DOI 10.1023/A:1015457400897; WEEKS RM, 2002, AIDS BEHAV, V6, P193; Williams CT, 2007, AM J PREV MED, V32, pS203, DOI 10.1016/j.amepre.2007.02.006	56	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19615	10.1371/journal.pone.0019615	http://dx.doi.org/10.1371/journal.pone.0019615			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	760DZ	21573122	Green Published, gold, Green Submitted			2022-12-27	WOS:000290305600036
J	Alami, S; Boutron, I; Desjeux, D; Hirschhorn, M; Meric, G; Rannou, F; Poiraudeau, S				Alami, Sophie; Boutron, Isabelle; Desjeux, Dominique; Hirschhorn, Monique; Meric, Gwendoline; Rannou, Francois; Poiraudeau, Serge			Patients' and Practitioners' Views of Knee Osteoarthritis and Its Management: A Qualitative Interview Study	PLOS ONE			English	Article							OF-LIFE; GENERAL-PRACTITIONERS; RHEUMATOID-ARTHRITIS; PRIMARY-CARE; DISABILITY; IMPACT; HIP	Purpose: To identify the views of patients and care providers regarding the management of knee osteoarthritis (OA) and to reveal potential obstacles to improving health care strategies. Methods: We performed a qualitative study based on semi-structured interviews of a stratified sample of 81 patients (59 women) and 29 practitioners (8 women, 11 general practitioners [GPs], 6 rheumatologists, 4 orthopedic surgeons, and 8 [4 GPs] delivering alternative medicine). Results: Two main domains of patient views were identified: one about the patient-physician relationship and the other about treatments. Patients feel that their complaints are not taken seriously. They also feel that practitioners act as technicians, paying more attention to the knee than to the individual, and they consider that not enough time is spent on information and counseling. They have negative perceptions of drugs and a feeling of medical uncertainty about OA, which leads to less compliance with treatment and a switch to alternative medicine. Patients believe that knee OA is an inevitable illness associated with age, that not much can be done to modify its evolution, that treatments are of little help, and that practitioners have not much to propose. They express unrealistic fears about the impact of knee OA on daily and social life. Practitioners' views differ from those of patients. Physicians emphasize the difficulty in elaborating treatment strategies and the need for a tool to help in treatment choice. Conclusions: This qualitative study suggests several ways to improve the patient-practitioner relationship and the efficacy of treatment strategies, by increasing their acceptability and compliance. Providing adapted and formalized information to patients, adopting more global assessment and therapeutic approaches, and dealing more accurately with patients' paradoxal representation of drug therapy are main factors of improvement that should be addressed.	[Alami, Sophie; Boutron, Isabelle] Univ Paris 05, AP HP, Ctr Epidemiol Clin, Paris, France; [Meric, Gwendoline] Pfizer, Paris, France; [Rannou, Francois; Poiraudeau, Serge] Univ Paris 05, AP HP, Serv Reeduc & Readaptat Appareil Locomoteur & Pat, INSERM,IFR Handicap 25, Paris, France	Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Pfizer; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Alami, S (corresponding author), Univ Paris 05, AP HP, Ctr Epidemiol Clin, Paris, France.	serge.poiraudeau@cch.aphp.fr	POIRAUDEAU, SERGE/P-5301-2016	Boutron, Isabelle/0000-0002-5263-6241; , ALAMI/0000-0002-2999-8551; Poiraudeau, Serge/0000-0002-1988-9124	Pfizer	Pfizer(Pfizer)	This work was funded by Pfizer. The funders had no role in study design, data collection, data analysis, decision to publish, writing the manuscript.	Alami S, 2009, METHODES QUALITATIVE; BADLEY EM, 1994, J RHEUMATOL, V21, P505; Barbour V, 2007, PLOS MED, V4, P1283, DOI 10.1371/journal.pmed.0040258; Boutron I, 2008, OSTEOARTHR CARTILAGE, V16, P1024, DOI 10.1016/j.joca.2008.01.001; Desjeux D., 2002, ITINERARY METHOD COM; Fainzang S, 2001, MEDICAMENTS SOC PATI; Glaser B.G., 1968, DISCOV GROUNDED THEO; GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009; Hewlett S, 2001, ANN RHEUM DIS, V60, P928, DOI 10.1136/ard.60.10.928; KUZEL AJ, 1992, RES METH PR, V3, P31; Lam CLK, 2000, FAM PRACT, V17, P159, DOI 10.1093/fampra/17.2.159; LAPLANTE MP, 1991, MILBANK Q, V69, P55, DOI 10.2307/3350158; Ramond A, 2010, FAM PRACT, V2010; Rosemann T, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-48; Salaffi F, 2005, AGING CLIN EXP RES, V17, P255; Strauss AL, 1990, BASICS QUALITATIVE G; Taponier S, 1999, ITINERARY METHOD APP; The Food and Drug Administration, 2006, PAT REP OUTC MEAS US; TUGWELL P, 1990, ARCH INTERN MED, V150, P59, DOI 10.1001/archinte.150.1.59; van der Waal JM, 2005, QUAL LIFE RES, V14, P795, DOI 10.1007/s11136-004-0801-3; vanderGeest S, 1996, ANNU REV ANTHROPOL, V25, P153, DOI 10.1146/annurev.anthro.25.1.153; Wylde V, 2006, MUSCULOSKELET CARE, V4, P152, DOI 10.1002/msc.86; Xie F, 2006, OSTEOARTHR CARTILAGE, V14, P224, DOI 10.1016/j.joca.2005.09.009	23	76	76	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19634	10.1371/journal.pone.0019634	http://dx.doi.org/10.1371/journal.pone.0019634			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573185	gold, Green Published, Green Submitted			2022-12-27	WOS:000290256400036
J	Liang, G; Ahlqvist, K; Pannem, R; Posern, G; Massoumi, R				Liang, Gang; Ahlqvist, Kristofer; Pannem, Rajeswararao; Posern, Guido; Massoumi, Ramin			Serum Response Factor Controls CYLD Expression via MAPK Signaling Pathway	PLOS ONE			English	Article							TUMOR-SUPPRESSOR CYLD; NF-KAPPA-B; DEPENDENT GENE-EXPRESSION; NEGATIVE REGULATION; CELL-PROLIFERATION; MULTIPLE-MYELOMA; GROWTH-FACTORS; BINDING SITE; IN-VIVO; KINASE	Tumor suppressor gene CYLD is a deubiquitinating enzyme which negatively regulates various signaling pathways by removing the lysine 63-linked polyubiquitin chains from several specific substrates. Loss of CYLD in different types of tumors leads to either cell survival or proliferation. In this study we demonstrate that lack of CYLD expression in CYLD-/- MEFs increases proliferation rate of these cells compared to CYLD+/+ in a serum concentration dependent manner without affecting cell survival. The reduced proliferation rate in CYLD+/+ in the presence of serum was due to the binding of serum response factor (SRF) to the serum response element identified in the CYLD promoter for the up-regulation of CYLD levels. The serum regulated recruitment of SRF to the CYLD promoter was dependent on p38 mitogen-activated protein kinase (MAPK) activity. Elimination of SRF by siRNA or inhibition of p38 MAPK reduced the expression level of CYLD and increased cell proliferation. These results show that SRF acts as a positive regulator of CYLD expression, which in turn reduces the mitogenic activation of serum for aberrant proliferation of MEF cells.	[Liang, Gang; Ahlqvist, Kristofer; Pannem, Rajeswararao; Massoumi, Ramin] Lund Univ, UMAS, Dept Lab Med, Malmo, Sweden; [Posern, Guido] Max Planck Inst Biochem, Dept Mol Biol, AG Regulat Gene Express, D-82152 Martinsried, Germany	Lund University; Skane University Hospital; Max Planck Society	Liang, G (corresponding author), Lund Univ, UMAS, Dept Lab Med, Malmo, Sweden.	Ramin.Massoumi@med.lu.se	Massoumi, Ramin/AAG-4786-2019	Massoumi, Ramin/0000-0001-8875-6440	Swedish Society for Medical Research; Swedish Cancer Foundation; Swedish Medical Research Council; Crafoordska Foundation; Royal Physiographic Society in Lund; U-MAS Research Foundations; ERC	Swedish Society for Medical Research; Swedish Cancer Foundation; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Crafoordska Foundation; Royal Physiographic Society in Lund; U-MAS Research Foundations; ERC(European Research Council (ERC)European Commission)	This work was supported by the Swedish Society for Medical Research, Swedish Cancer Foundation, Swedish Medical Research Council, Crafoordska Foundation, Royal Physiographic Society in Lund, U-MAS Research Foundations and ERC starting independent researcher grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An J, 2008, CANCER CELL, V14, P394, DOI 10.1016/j.ccr.2008.10.007; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Costello CM, 2005, PLOS MED, V2, P771, DOI 10.1371/journal.pmed.0020199; Davis FJ, 2003, J BIOL CHEM, V278, P20047, DOI 10.1074/jbc.M209998200; Descot A, 2008, MOL CELL BIOL, V28, P6171, DOI 10.1128/MCB.00303-08; Descot A, 2009, MOL CELL, V35, P291, DOI 10.1016/j.molcel.2009.07.015; GAUTHIERROUVIERE C, 1991, CELL REGUL, V2, P575, DOI 10.1091/mbc.2.7.575; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Heidenreich O, 1999, J BIOL CHEM, V274, P14434, DOI 10.1074/jbc.274.20.14434; Hellerbrand C, 2007, CARCINOGENESIS, V28, P21, DOI 10.1093/carcin/bgl081; HILL CS, 1995, EMBO J, V14, P5037, DOI 10.1002/j.1460-2075.1995.tb00186.x; Hirai Y, 2004, INT J ONCOL, V24, P977; Hutti JE, 2009, MOL CELL, V34, P461, DOI 10.1016/j.molcel.2009.04.031; JANKNECHT R, 1992, EMBO J, V11, P1045, DOI 10.1002/j.1460-2075.1992.tb05143.x; Janknecht R, 1997, EMBO J, V16, P1620, DOI 10.1093/emboj/16.7.1620; JOHANSEN FE, 1995, BBA-REV CANCER, V1242, P1, DOI 10.1016/0304-419X(94)00014-S; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Koegel H, 2009, J CLIN INVEST, V119, P899, DOI 10.1172/JCI37771; Koga T, 2008, J BIOL CHEM, V283, P12546, DOI 10.1074/jbc.M710518200; Lim JH, 2007, IMMUNITY, V27, P349, DOI 10.1016/j.immuni.2007.07.011; MARAIS RM, 1992, EMBO J, V11, P97, DOI 10.1002/j.1460-2075.1992.tb05032.x; Massoumi R, TRENDS BIOCH SCI, V35, P392; Massoumi R, 2007, BIOESSAYS, V29, P1203, DOI 10.1002/bies.20677; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Massoumi R, 2009, J EXP MED, V206, P221, DOI 10.1084/jem.20082044; McDonald OG, 2006, J CLIN INVEST, V116, P36, DOI 10.1172/JCI26505; Milyavsky M, 2007, CANCER CELL, V11, P133, DOI 10.1016/j.ccr.2006.11.022; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; MIRANTI CK, 1995, MOL CELL BIOL, V15, P3672; Montagne J, 1996, DEVELOPMENT, V122, P2589; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; Poser S, 2000, EMBO J, V19, P4955, DOI 10.1093/emboj/19.18.4955; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Regamey A, 2003, J EXP MED, V198, P1959, DOI 10.1084/jem.20031187; Reiley W, 2005, MOL CELL BIOL, V25, P3886, DOI 10.1128/MCB.25.10.3886-3895.2005; Reiley W, 2004, J BIOL CHEM, V279, P55161, DOI 10.1074/jbc.M411049200; RIVERA VM, 1993, MOL CELL BIOL, V13, P6260, DOI 10.1128/MCB.13.10.6260; Ronkina N, NUCL ACIDS RES; Sara A, 2009, EMBO J; Schratt G, 2001, MOL CELL BIOL, V21, P2933, DOI 10.1128/MCB.21.8.2933-2943.2001; Soulez M, 1996, MOL CELL BIOL, V16, P6065; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; TREISMAN R, 1986, CELL, V46, P567, DOI 10.1016/0092-8674(86)90882-2; Xue L, 2007, DEV CELL, V13, P446, DOI 10.1016/j.devcel.2007.07.012; Yoshida H, 2005, J BIOL CHEM, V280, P41111, DOI 10.1074/jbc.M509526200	48	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19613	10.1371/journal.pone.0019613	http://dx.doi.org/10.1371/journal.pone.0019613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573132	gold, Green Published			2022-12-27	WOS:000290256400035
J	Meunier, J; Delemont, O; Lucas, C				Meunier, Joel; Delemont, Olivier; Lucas, Christophe			Recognition in Ants: Social Origin Matters	PLOS ONE			English	Article							NEST-MATE RECOGNITION; CUTICULAR HYDROCARBONS; SEX ALLOCATION; DIVERSITY; COLONIES; WORKERS; SIZE; AGGRESSION; EVOLUTION; CONFLICT	The ability of group members to discriminate against foreigners is a keystone in the evolution of sociality. In social insects, colony social structure (number of queens) is generally thought to influence abilities of resident workers to discriminate between nestmates and non-nestmates. However, whether social origin of introduced individuals has an effect on their acceptance in conspecific colonies remains poorly explored. Using egg-acceptance bioassays, we tested the influence of social origin of queen-laid eggs on their acceptance by foreign workers in the ant Formica selysi. We showed that workers from both single-and multiple-queen colonies discriminated against foreign eggs from single-queen colonies, whereas they surprisingly accepted foreign eggs from multiple-queen colonies. Chemical analyses then demonstrated that social origins of eggs and workers could be discriminated on the basis of their chemical profiles, a signal generally involved in nestmate discrimination. These findings provide the first evidence in social insects that social origins of eggs interfere with nestmate discrimination and are encoded by chemical signatures.	[Meunier, Joel; Lucas, Christophe] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Meunier, Joel] Univ Basel, Inst Zool, CH-4051 Basel, Switzerland; [Delemont, Olivier] Univ Lausanne, Inst Police Sci, Ecole Sci Criminelles, Lausanne, Switzerland; [Lucas, Christophe] Univ Tours, CNRS, Inst Rech Biol Insecte, UMR 6035, Tours, France	University of Lausanne; University of Basel; University of Lausanne; Centre National de la Recherche Scientifique (CNRS); Universite de Tours	Meunier, J (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland.	joel.meunier@unibas.ch	meunier, joël/E-5376-2010; Meunier, Joël/A-1067-2017; Lucas, Christophe/A-4186-2011	Meunier, Joël/0000-0001-6893-2064; Lucas, Christophe/0000-0003-2839-7583; Delemont, Olivier/0000-0002-4122-7231	University of Lausanne; Swiss National Science Foundation	University of Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	University of Lausanne and Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison J, 1986, STAT ANAL COMPOSITIO, DOI DOI 10.1007/978-94-009-4109-0; BAGNERES AG, 1991, J CHEM ECOL, V17, P1641, DOI 10.1007/BF00984695; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909; Chapuisat M, 2004, EVOLUTION, V58, P1064, DOI 10.1111/j.0014-3820.2004.tb00440.x; Cini A, 2009, BIOL LETTERS, V5, P459, DOI 10.1098/rsbl.2009.0140; Crozier R.H., 1996, EVOLUTION SOCIAL INS; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; DETTORRE G, 2010, ANT ECOLOGY; Endler A, 2006, BEHAV ECOL SOCIOBIOL, V59, P490, DOI 10.1007/s00265-005-0073-0; Endler A, 2004, P NATL ACAD SCI USA, V101, P2945, DOI 10.1073/pnas.0308447101; Errard C, 2008, INSECT SOC, V55, P115, DOI 10.1007/s00040-008-0979-4; Florane CB, 2004, J CHEM ECOL, V30, P2559, DOI 10.1007/s10886-004-7950-2; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Heinze J, 1996, ETHOLOGY, V102, P510; Helantera H, 2007, BEHAV ECOL SOCIOBIOL, V61, P1143, DOI 10.1007/s00265-006-0327-5; Helantera H, 2009, BEHAV ECOL SOCIOBIOL, V63, P573, DOI 10.1007/s00265-008-0692-3; Holzer B, 2008, OECOLOGIA, V157, P717, DOI 10.1007/s00442-008-1101-3; Ichinose K, 2010, INSECT SOC, V57, P453, DOI 10.1007/s00040-010-0103-4; Lenoir A, 2001, ANNU REV ENTOMOL, V46, P573, DOI 10.1146/annurev.ento.46.1.573; Lin YK, 2010, SOCIOBIOLOGY, V56, P39; Lucas C, 2002, BIOL J LINN SOC, V75, P249, DOI 10.1111/j.1095-8312.2002.tb01425.x; Lucas C, 2005, J INSECT PHYSIOL, V51, P1148, DOI 10.1016/j.jinsphys.2005.06.003; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Martin SJ, 2009, INSECT SOC, V56, P375, DOI 10.1007/s00040-009-0035-z; Martin SJ, 2002, NATURE, V415, P163, DOI 10.1038/415163a; Martin SJ, 2008, J INSECT PHYSIOL, V54, P700, DOI 10.1016/j.jinsphys.2008.01.010; Martin SJ, 2011, P ROY SOC B-BIOL SCI, V278, P496, DOI 10.1098/rspb.2010.1047; MCCARTHY ED, 1968, ANAL CHEM, V40, P1475, DOI 10.1021/ac60266a021; Meunier J, 2009, J EVOLUTION BIOL, V22, P1906, DOI 10.1111/j.1420-9101.2009.01805.x; Meunier J, 2011, ANIM BEHAV, V81, P163, DOI 10.1016/j.anbehav.2010.09.029; Meunier J, 2010, BEHAV ECOL SOCIOBIOL, V64, P1655, DOI 10.1007/s00265-010-0979-z; Moore D, 2010, BEHAV ECOL SOCIOBIOL, V64, P1011, DOI 10.1007/s00265-010-0916-1; Nelson D.R., 1978, Advances in Insect Physiology, V13, P1, DOI 10.1016/S0065-2806(08)60263-5; POMONIS JG, 1980, J CHEM ECOL, V6, P965, DOI 10.1007/BF00994653; PROVOST E, 1990, BEHAVIOUR, V115, P114, DOI 10.1163/156853990X00310; PROVOST E, 1994, J CHEM ECOL, V20, P2985, DOI 10.1007/BF02098404; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ratnieks FLW, 2006, ANNU REV ENTOMOL, V51, P581, DOI 10.1146/annurev.ento.51.110104.151003; RATNIEKS FLW, 1995, AM NAT, V145, P969, DOI 10.1086/285779; RATNIEKS FLW, 1989, NATURE, V342, P796, DOI 10.1038/342796a0; Reber A, 2008, ECOL LETT, V11, P682, DOI 10.1111/j.1461-0248.2008.01177.x; Reber A, 2010, ANIM BEHAV, V79, P467, DOI 10.1016/j.anbehav.2009.11.030; Ross KG, 1998, P NATL ACAD SCI USA, V95, P14232, DOI 10.1073/pnas.95.24.14232; Rosset H, 2006, CURR BIOL, V16, P328, DOI 10.1016/j.cub.2005.12.036; Rosset H, 2007, ANIM BEHAV, V74, P951, DOI 10.1016/j.anbehav.2006.11.028; Rosset H, 2007, EVOL ECOL, V21, P577, DOI 10.1007/s10682-006-9139-3; Schwander T, 2005, BEHAV ECOL SOCIOBIOL, V59, P215, DOI 10.1007/s00265-005-0027-6; Soroker V, 2003, INSECT SOC, V50, P212, DOI 10.1007/s00040-003-0669-1; Steiger S, 2007, P R SOC B, V274, P2211, DOI 10.1098/rspb.2007.0656; van Zweden JS, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P222, DOI 10.1017/CBO9780511711909.012; VANDERMEER MK, 1998, PHEROMONE COMMUNICAT, P79	51	17	17	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19347	10.1371/journal.pone.0019347	http://dx.doi.org/10.1371/journal.pone.0019347			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573235	Green Published, gold, Green Submitted			2022-12-27	WOS:000290224800025
J	Poot, M; Badea, A; Williams, RW; Kas, MJ				Poot, Martin; Badea, Alexandra; Williams, Robert W.; Kas, Martien J.			Identifying Human Disease Genes through Cross-Species Gene Mapping of Evolutionary Conserved Processes	PLOS ONE			English	Article							CORPUS-CALLOSUM; INTERSTITIAL DELETION; MENTAL-RETARDATION; MB DELETION; MICRODELETION SYNDROME; DEVELOPMENTAL DELAY; REGION 1Q44; MOUSE-BRAIN; AGENESIS; BOY	Background: Understanding complex networks that modulate development in humans is hampered by genetic and phenotypic heterogeneity within and between populations. Here we present a method that exploits natural variation in highly diverse mouse genetic reference panels in which genetic and environmental factors can be tightly controlled. The aim of our study is to test a cross-species genetic mapping strategy, which compares data of gene mapping in human patients with functional data obtained by QTL mapping in recombinant inbred mouse strains in order to prioritize human disease candidate genes. Methodology: We exploit evolutionary conservation of developmental phenotypes to discover gene variants that influence brain development in humans. We studied corpus callosum volume in a recombinant inbred mouse panel (C57BL/6J6 x DBA/2J, BXD strains) using high-field strength MRI technology. We aligned mouse mapping results for this neuro-anatomical phenotype with genetic data from patients with abnormal corpus callosum (ACC) development. Principal Findings: From the 61 syndromes which involve an ACC, 51 human candidate genes have been identified. Through interval mapping, we identified a single significant QTL on mouse chromosome 7 for corpus callosum volume with a QTL peak located between 25.5 and 26.7 Mb. Comparing the genes in this mouse QTL region with those associated with human syndromes (involving ACC) and those covered by copy number variations (CNV) yielded a single overlap, namely HNRPU in humans and Hnrpul1 in mice. Further analysis of corpus callosum volume in BXD strains revealed that the corpus callosum was significantly larger in BXD mice with a B genotype at the Hnrpul1 locus than in BXD mice with a D genotype at Hnrpul1 (F = 22.48, p < 9.87*10(-5)). Conclusion: This approach that exploits highly diverse mouse strains provides an efficient and effective translational bridge to study the etiology of human developmental disorders, such as autism and schizophrenia.	[Poot, Martin] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Badea, Alexandra] Duke Univ, Med Ctr, Ctr Vivo Microscopy, Durham, NC USA; [Williams, Robert W.] Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [Kas, Martien J.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurosci & Pharmacol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Duke University; University of Tennessee System; University of Tennessee Health Science Center; Utrecht University; Utrecht University Medical Center	Poot, M (corresponding author), Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands.	m.j.h.kas@umcutrecht.nl	Poot, Martin/F-9427-2010; Kas, Martien J./G-8269-2018; Badea, Alexandra/ABC-8324-2020; Badea, Alexandra/S-6052-2016; Williams, Robert W./H-8789-2016	Kas, Martien J./0000-0002-4471-8618; Badea, Alexandra/0000-0001-6621-4560; Badea, Alexandra/0000-0001-6621-4560; Williams, Robert W./0000-0001-8924-4447	Netherlands Organization for Scientific Research (NWO) [91786327]; NCRR [U24 RR021760, P41 RR005959]; NIAAA [U01AA13499, AA17590]; NIDA [P20DA21131]; NCI [U24 CA092656]; NATIONAL CANCER INSTITUTE [U24CA092656] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR021760, P41RR005959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA017590, U01AA013499, U01AA016662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P20DA021131] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by a ZonMW VIDI-grant (91786327) from The Netherlands Organization for Scientific Research (NWO) to Dr. Martien Kas. The authors also benefited from support from NCRR U24 RR021760, NIAAA U01AA13499 and AA17590, NIDA P20DA21131, NCRR P41 RR005959 and NCI U24 CA092656. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrieux J, 2008, EUR J MED GENET, V51, P172, DOI 10.1016/j.ejmg.2007.12.002; Badea A, 2007, NEUROIMAGE, V37, P683, DOI 10.1016/j.neuroimage.2007.05.046; Badea A, 2009, NEUROIMAGE, V45, P1067, DOI 10.1016/j.neuroimage.2009.01.021; Badea A, 2009, CURR OPIN NEUROL, V22, P379, DOI 10.1097/WCO.0b013e32832d9b86; Barkovich AJ, 2009, BRAIN, V132, P3199, DOI 10.1093/brain/awp247; Boland E, 2007, AM J HUM GENET, V81, P292, DOI 10.1086/519999; Caliebe A, 2010, EUR J MED GENET, V53, P179, DOI 10.1016/j.ejmg.2010.04.001; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Donahoo ALS, 2009, SEMIN PEDIATR NEUROL, V16, P127, DOI 10.1016/j.spen.2009.07.003; Doron KW, 2008, CORTEX, V44, P1023, DOI 10.1016/j.cortex.2008.03.007; Freitag CM, 2009, BIOL PSYCHIAT, V66, P316, DOI 10.1016/j.biopsych.2009.03.011; Gazzaniga MS, 2005, NAT REV NEUROSCI, V6, P653, DOI 10.1038/nrn1723; Inglis PN, 2006, TRENDS GENET, V22, P491, DOI 10.1016/j.tig.2006.07.006; Johnson GA, 2007, NEUROIMAGE, V37, P82, DOI 10.1016/j.neuroimage.2007.05.013; Kirchhoff M, 2009, AM J MED GENET A, V149A, P894, DOI 10.1002/ajmg.a.32814; Koutnikova H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000591; Lalani SR, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-8; MALSEN AJD, 2009, BIOL PSYCHIAT, V66, P1123; Masurel-Paulet A, 2009, AM J MED GENET A, V149A, P1504, DOI 10.1002/ajmg.a.32904; Nagamani SCS, 2009, EUR J HUM GENET, V17, P573, DOI 10.1038/ejhg.2008.220; Najm J, 2008, NAT GENET, V40, P1065, DOI 10.1038/ng.194; Namavar Y, 2011, BRAIN, V134, P143, DOI 10.1093/brain/awq287; Orellana C, 2009, CYTOGENET GENOME RES, V127, P5, DOI 10.1159/000279261; Papa FT, 2008, AM J MED GENET A, V146A, P1994, DOI 10.1002/ajmg.a.32413; PLOMIN R, 1991, BEHAV GENET, V21, P99, DOI 10.1007/BF01066330; Poot M, 2007, AM J MED GENET A, V143A, P1038, DOI 10.1002/ajmg.a.31690; Poot M, 2010, EUR J HUM GENET, V18, P39, DOI 10.1038/ejhg.2009.120; Poot M, 2008, EUR J MED GENET, V51, P689, DOI 10.1016/j.ejmg.2008.07.001; Richards LJ, 2004, CLIN GENET, V66, P276, DOI 10.1111/j.1399-0004.2004.00354.x; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Schell-Apacik CC, 2008, AM J MED GENET A, V146A, P2501, DOI 10.1002/ajmg.a.32476; Sharief AA, 2008, NEUROIMAGE, V39, P136, DOI 10.1016/j.neuroimage.2007.08.028; Sharief AA, 2006, MAGN RESON MED, V56, P717, DOI 10.1002/mrm.21026; Sherr EH, 2005, NEUROLOGY, V65, P1496, DOI 10.1212/01.wnl.0000183066.09239.b6; Stevenson DA, 2004, CLIN DYSMORPHOL, V13, P103, DOI 10.1097/00019605-200404000-00010; SWANK RT, 1973, SCIENCE, V181, P1249, DOI 10.1126/science.181.4106.1249; TAYLOR BA, 1976, GENETICS, V83, P373; Tempesta S, 2008, EUR J MED GENET, V51, P639, DOI 10.1016/j.ejmg.2008.07.010; van Bever Y, 2005, AM J MED GENET A, V135A, P91, DOI 10.1002/ajmg.a.30695; van Bon BWM, 2008, J MED GENET, V45, P346, DOI 10.1136/jmg.2007.055830; Wang JT, 2003, NEUROINFORMATICS, V1, P299, DOI 10.1385/NI:1:4:299; Zaghloul NA, 2010, TRENDS GENET, V26, P168, DOI 10.1016/j.tig.2010.01.006	42	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e18612	10.1371/journal.pone.0018612	http://dx.doi.org/10.1371/journal.pone.0018612			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21572526	Green Published, gold, Green Submitted			2022-12-27	WOS:000290224800004
J	Shelswell, KJ; Beatty, JT				Shelswell, Kristopher John; Beatty, J. Thomas			Coordinated, Long-Range, Solid Substrate Movement of the Purple Photosynthetic Bacterium Rhodobacter capsulatus	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; TWITCHING MOTILITY; GLIDING MOTILITY; SWARMING MOTILITY; RHODOPSEUDOMONAS-CAPSULATA; SURFACE; GENE; SYSTEM; GROWTH; ULTRASTRUCTURE	The long-range movement of Rhodobacter capsulatus cells in the glass-agar interstitial region of borosilicate Petri plates was found to be due to a subset of the cells inoculated into plates. The macroscopic appearance of plates indicated that a small group of cells moved in a coordinated manner to form a visible satellite cluster of cells. Satellite clusters were initially separated from the point of inoculation by the absence of visible cell density, but after 20 to 24 hours this space was colonized by cells apparently shed from a group of cells moving away from the point of inoculation. Cell movements consisted of flagellum-independent and flagellum-dependent motility contributions. Flagellum-independent movement occurred at an early stage, such that satellite clusters formed after 12 to 24 hours. Subsequently, after 24 to 32 hours, a flagellum-dependent dispersal of cells became visible, extending laterally outward from a line of flagellum-independent motility. These modes of taxis were found in several environmental isolates and in a variety of mutants, including a strain deficient in the production of the R. capsulatus acyl-homoserine lactone quorum-sensing signal. Although there was great variability in the direction of movement in illuminated plates, cells were predisposed to move toward broad spectrum white light. This predisposition was increased by the use of square plates, and a statistical analysis indicated that R. capsulatus is capable of genuine phototaxis. Therefore, the variability in the direction of cell movement was attributed to optical effects on light waves passing through the plate material and agar medium.	[Shelswell, Kristopher John; Beatty, J. Thomas] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Shelswell, KJ (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada.	j.beatty@ubc.ca			Canadian Natural Sciences and Engineering Research Council [2796]; Canada Council for the Arts	Canadian Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Council for the Arts	Funding was provided by Discovery Grant 2796 from the Canadian Natural Sciences and Engineering Research Council, http://www.nserc-crsng.gc.ca/Index_eng.asp, and a Killam Research Fellowship (to JTB) from the Canada Council for the Arts, http://www.canadacouncil.ca/prizes/killam/xy127235773746406250.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage JP, 1999, ADV MICROB PHYSIOL, V41, P229, DOI 10.1016/S0065-2911(08)60168-X; Bartnikas TB, 2002, MICROBIOL-SGM, V148, P825, DOI 10.1099/00221287-148-3-825; BEATTY JT, 1981, ARCH MICROBIOL, V129, P335, DOI 10.1007/BF00406457; Berg HC, 2005, CURR BIOL, V15, pR599, DOI 10.1016/j.cub.2005.07.042; BLAIR DF, 1995, ANNU REV MICROBIOL, V49, P489, DOI 10.1146/annurev.mi.49.100195.002421; Brahamsha B., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P59; BURCHARD RP, 1981, ANNU REV MICROBIOL, V35, P497, DOI 10.1146/annurev.mi.35.100181.002433; Burrows LL, 2005, MOL MICROBIOL, V57, P878, DOI 10.1111/j.1365-2958.2005.04703.x; Cabello P, 2004, J BIOL CHEM, V279, P45485, DOI 10.1074/jbc.M404417200; Caiazza NC, 2005, J BACTERIOL, V187, P7351, DOI 10.1128/JB.187.21.7351-7361.2005; DALDAL F, 1988, J BACTERIOL, V170, P2388, DOI 10.1128/jb.170.5.2388-2391.1988; Fraser GM, 1999, CURR OPIN MICROBIOL, V2, P630, DOI 10.1016/S1369-5274(99)00033-8; GODCHAUX W, 1991, J BACTERIOL, V173, P7607, DOI 10.1128/jb.173.23.7607-7614.1991; GORSKI L, 1993, ARCH MICROBIOL, V169, P121; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Haselkorn R, 2001, PHOTOSYNTH RES, V70, P43, DOI 10.1023/A:1013883807771; HENRICHSEN J, 1972, BACTERIOL REV, V36, P478, DOI 10.1128/MMBR.36.4.478-503.1972; HENRICHSEN J, 1975, ACTA PATH MICRO IM B, V83, P179; Hunnicutt DW, 2001, J BACTERIOL, V183, P4167, DOI 10.1128/JB.183.14.4167-4175.2001; Jarrell KF, 2008, NAT REV MICROBIOL, V6, P466, DOI 10.1038/nrmicro1900; Jones BV, 2004, INFECT IMMUN, V72, P3941, DOI 10.1128/IAI.72.7.3941-3950.2004; Kearns DB, 1998, P NATL ACAD SCI USA, V95, P11957, DOI 10.1073/pnas.95.20.11957; Kearns DB, 2001, J BACTERIOL, V183, P763, DOI 10.1128/JB.183.2.763-767.2001; Kleinbaum DG, 1998, APPL REGRESSION ANAL, p[xviii, 798]; Lancero H, 2004, MICROBIOL-SGM, V150, P4085, DOI 10.1099/mic.0.27381-0; Lang AS, 2002, J BACTERIOL, V184, P913, DOI 10.1128/jb.184.4.913-918.2002; LEBLANC HN, 1993, J GEN MICROBIOL, V139, P101, DOI 10.1099/00221287-139-1-101; Lindum PW, 1998, J BACTERIOL, V180, P6384; Liu HL, 2001, MICROBIOL-SGM, V147, P3215, DOI 10.1099/00221287-147-12-3215; MARRS B, 1974, P NATL ACAD SCI USA, V71, P971, DOI 10.1073/pnas.71.3.971; Martinez A, 1999, J BACTERIOL, V181, P7331; MATSUYAMA T, 1995, J BACTERIOL, V177, P987, DOI 10.1128/jb.177.4.987-991.1995; Mauriello EMF, 2010, MICROBIOL MOL BIOL R, V74, P229, DOI 10.1128/MMBR.00043-09; McBride MJ, 2001, ANNU REV MICROBIOL, V55, P49, DOI 10.1146/annurev.micro.55.1.49; Neu TR, 1996, MICROBIOL REV, V60, P151, DOI 10.1128/MMBR.60.1.151-166.1996; Niehus E, 2002, MICROBIOL-SGM, V148, P3827, DOI 10.1099/00221287-148-12-3827; PAISLEY JW, 1982, J CLIN MICROBIOL, V15, P61, DOI 10.1128/JCM.15.1.61-63.1982; PARKINSON JS, 1993, CELL, V73, P857, DOI 10.1016/0092-8674(93)90267-T; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; RUSHING BG, 2000, PHOTOSENSORY BEHAV; Schaefer AL, 2002, J BACTERIOL, V184, P6515, DOI 10.1128/JB.184.23.6515-6521.2002; Semmler ABT, 1999, MICROBIOL-SGM, V145, P2863, DOI 10.1099/00221287-145-10-2863; Semmler ABT, 2000, MICROBIOL-UK, V146, P1321, DOI 10.1099/00221287-146-6-1321; Shelswell KJ, 2005, J BACTERIOL, V187, P5040, DOI 10.1128/JB.187.14.5040-5043.2005; SHI WY, 1993, P NATL ACAD SCI USA, V90, P3378, DOI 10.1073/pnas.90.8.3378; Skerker JM, 2001, P NATL ACAD SCI USA, V98, P6901, DOI 10.1073/pnas.121171698; Sperandio V, 2002, MOL MICROBIOL, V43, P809, DOI 10.1046/j.1365-2958.2002.02803.x; Stanier RY, 1942, J BACTERIOL, V44, P405, DOI 10.1128/JB.44.4.405-412.1942; STEPHENS LJ, 2004, ADV STAT DEMYSTIFIED, pR12; Strnad H, 2010, J BACTERIOL, V192, P3545, DOI 10.1128/JB.00366-10; Tomich M, 2007, NAT REV MICROBIOL, V5, P363, DOI 10.1038/nrmicro1636; WEAVER PF, 1975, ARCH MICROBIOL, V105, P207, DOI 10.1007/BF00447139; Wu JG, 1997, MOL MICROBIOL, V24, P233, DOI 10.1046/j.1365-2958.1997.3281691.x; Youderian P, 1998, CURR BIOL, V8, pR408, DOI 10.1016/S0960-9822(98)70264-7	54	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19646	10.1371/journal.pone.0019646	http://dx.doi.org/10.1371/journal.pone.0019646			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573194	gold, Green Submitted, Green Published			2022-12-27	WOS:000290224800042
J	Shui, GH; Stebbins, JW; Lam, BD; Cheong, WF; Lam, SM; Gregoire, F; Kusonoki, J; Wenk, MR				Shui, Guanghou; Stebbins, Jeffrey William; Lam, Buu Duyen; Cheong, Wei Fun; Lam, Sin Man; Gregoire, Francine; Kusonoki, Jun; Wenk, Markus R.			Comparative Plasma Lipidome between Human and Cynomolgus Monkey: Are Plasma Polar Lipids Good Biomarkers for Diabetic Monkeys?	PLOS ONE			English	Article							INSULIN-RESISTANCE; GANGLIOSIDE GM3; GLYCEMIC CONTROL; MICE; SENSITIVITY; MITOCHONDRIA; RECEPTOR; FAT; INHIBITION; CERAMIDE	Background: Non-human primates (NHP) are now being considered as models for investigating human metabolic diseases including diabetes. Analyses of cholesterol and triglycerides in plasma derived from NHPs can easily be achieved using methods employed in humans. Information pertaining to other lipid species in monkey plasma, however, is lacking and requires comprehensive experimental analysis. Methodologies/Principal Findings: We examined the plasma lipidome from 16 cynomolgus monkey, Macaca fascicularis, using liquid chromatography coupled with mass spectrometry (LC/MS). We established novel analytical approaches, which are based on a simple gradient elution, to quantify polar lipids in plasma including (i) glycerophospholipids (phosphatidylcholine, PC; phosphatidylethanolamine, PE; phosphatidylinositol, PI; phosphatidylglycerol, PG; phosphatidylserine, PS; phosphatidic acid, PA); (ii) sphingolipids (sphingomyelin, SM; ceramide, Cer; Glucocyl-ceramide, GluCer; ganglioside mannoside 3, GM3). Lipidomic analysis had revealed that the plasma of human and cynomolgus monkey were of similar compositions, with PC, SM, PE, LPC and PI constituting the major polar lipid species present. Human plasma contained significantly higher levels of plasmalogen PE species (p < 0.005) and plasmalogen PC species (p < 0.0005), while cynomolgus monkey had higher levels of polyunsaturated fatty acyls (PUFA) in PC, PE, PS and PI. Notably, cynomolgus monkey had significantly lower levels of glycosphingolipids, including GluCer (p < 0.0005) and GM(3) (p < 0.0005), but higher level of Cer (p < 0.0005) in plasma than human. We next investigated the biochemical alterations in blood lipids of 8 naturally occurring diabetic cynomolgus monkeys when compared with 8 healthy controls. Conclusions: For the first time, we demonstrated that the plasma of human and cynomolgus monkey were of similar compositions, but contained different mol distribution of individual molecular species. Diabetic monkeys exhibited decreased levels of sphingolipids, which are microdomain-associated lipids and are thought to be associated with insulin sensitivity. Significant increases in PG species, which are precursors for cardiolipin biosynthesis in mitochondria, were found in fasted diabetic monkeys (n = 8).	[Shui, Guanghou; Lam, Buu Duyen; Cheong, Wei Fun; Wenk, Markus R.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Shui, Guanghou] Natl Univ Singapore, Inst Life Sci, Singapore 117595, Singapore; [Lam, Sin Man; Wenk, Markus R.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biol Sci, Singapore 117595, Singapore; [Stebbins, Jeffrey William; Gregoire, Francine; Kusonoki, Jun] Lilly Singapore Ctr Drug Discovery Pte Ltd, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Shui, GH (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore.	bchsgh@nus.edu.sg	Wenk, Markus Rene/D-1441-2014	Lam, Sin Man/0000-0001-9037-904X; Shui, Guanghou/0000-0002-1621-9643	Singapore National Research Foundation [2007-04]	Singapore National Research Foundation(National Research Foundation, Singapore)	This work was supported by the Singapore National Research Foundation under CRP Award No. 2007-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; ANDERSON EJ, 2009, J CLIN INVEST; Bijl N, 2009, HEPATOLOGY, V50, P1431, DOI 10.1002/hep.23175; Chan R, 2008, J VIROL, V82, P11228, DOI 10.1128/JVI.00981-08; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Chen H, 2010, ENDOCRINOLOGY, V151, P3115, DOI 10.1210/en.2009-1366; Chen SL, 2008, MOL MICROBIOL, V68, P1061, DOI 10.1111/j.1365-2958.2008.06216.x; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Choo HJ, 2006, DIABETOLOGIA, V49, P784, DOI 10.1007/s00125-006-0170-2; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136; Goldfine H, 2010, PROG LIPID RES, V49, P493, DOI 10.1016/j.plipres.2010.07.003; Gross RW, 2007, METHOD ENZYMOL, V433, P73, DOI 10.1016/S0076-6879(07)33004-8; Guan XL, 2006, FASEB J, V20, P1152, DOI 10.1096/fj.05-5362com; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Inokuchi J, 2010, FEBS LETT, V584, P1864, DOI 10.1016/j.febslet.2009.10.012; Kabayama K, 2007, P NATL ACAD SCI USA, V104, P13678, DOI 10.1073/pnas.0703650104; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Langeveld M, 2008, J CLIN ENDOCR METAB, V93, P845, DOI 10.1210/jc.2007-1702; Maasen J A, 2008, Minerva Med, V99, P241; MANCUSO DJ, 2010, J BIOL CHEM; Matheson A, 2010, DIABETES-METAB RES, V26, P150, DOI 10.1002/dmrr.1068; NAKANO M, 1993, MECH AGEING DEV, V66, P243, DOI 10.1016/0047-6374(93)90011-F; Yuji OA, 2007, EXP MOL PATHOL, V83, P73, DOI 10.1016/j.yexmp.2007.02.007; Paccalet T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010055; Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027; Pickersgill L, 2007, J BIOL CHEM, V282, P12583, DOI 10.1074/jbc.M611157200; QUEHENBERGER O, 2010, J LIPID RES; Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135; Shui GH, 2007, J LIPID RES, V48, P1976, DOI 10.1194/jlr.M700060-JLR200; Shui G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011956; Shui GH, 2010, MOL BIOSYST, V6, P1008, DOI 10.1039/b913353d; Tagami S, 2002, J BIOL CHEM, V277, P3085, DOI 10.1074/jbc.M103705200; Taguchi R, 2005, J CHROMATOGR B, V823, P26, DOI 10.1016/j.jchromb.2005.06.005; Toufektsian MC, 2011, J NUTR, V141, P37, DOI 10.3945/jn.110.127225; van Eijk M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004723; Wagner JD, 2010, J PHARMACOL EXP THER, V333, P844, DOI 10.1124/jpet.110.166736; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; Zhao HM, 2007, DIABETES, V56, P1210, DOI 10.2337/db06-0719; Zhao ZW, 2010, J LIPID RES, V51, P652, DOI 10.1194/jlr.D001503	43	49	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19731	10.1371/journal.pone.0019731	http://dx.doi.org/10.1371/journal.pone.0019731			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573191	Green Submitted, Green Published, gold			2022-12-27	WOS:000290224800043
J	Smerc, A; Sodja, E; Legisa, M				Smerc, Andreja; Sodja, Eva; Legisa, Matic			Posttranslational Modification of 6-phosphofructo-1-kinase as an Important Feature of Cancer Metabolism	PLOS ONE			English	Article							INHIBITION-RESISTANT FORM; ASPERGILLUS-NIGER; SACCHAROMYCES-CEREVISIAE; AEROBIC GLYCOLYSIS; 2-PROMOTER SYSTEM; PHOSPHOFRUCTOKINASE; EXPRESSION; GENE; PROTEIN; AKT	Background: Human cancers consume larger amounts of glucose compared to normal tissues with most being converted and excreted as lactate despite abundant oxygen availability (Warburg effect). The underlying higher rate of glycolysis is therefore at the root of tumor formation and growth. Normal control of glycolytic allosteric enzymes appears impaired in tumors; however, the phenomenon has not been fully resolved. Methodology/Principal Findings: In the present paper, we show evidence that the native 85-kDa 6-phosphofructo-1-kinase (PFK1), a key regulatory enzyme of glycolysis that is normally under the control of feedback inhibition, undergoes posttranslational modification. After proteolytic cleavage of the C-terminal portion of the enzyme, an active, shorter 47-kDa fragment was formed that was insensitive to citrate and ATP inhibition. In tumorigenic cell lines, only the short fragments but not the native 85-kDa PFK1 were detected by immunoblotting. Similar fragments were detected also in a tumor tissue that developed in mice after the subcutaneous infection with tumorigenic B16-F10 cells. Based on limited proteolytic digestion of the rabbit muscle PFK-M, an active citrate inhibition-resistant shorter form was obtained, indicating that a single posttranslational modification step was possible. The exact molecular masses of the active shorter PFK1 fragments were determined by inserting the truncated genes constructed from human muscle PFK1 cDNA into a pfk null E. coli strain. Two E. coli transformants encoding for the modified PFK1s of 45,551 Da and 47,835 Da grew in glucose medium. The insertion of modified truncated human pfkM genes also stimulated glucose consumption and lactate excretion in stable transfectants of non-tumorigenic human HEK cell, suggesting the important role of shorter PFK1 fragments in enhancing glycolytic flux. Conclusions/Significance: Posttranslational modification of PFK1 enzyme might be the pivotal factor of deregulated glycolytic flux in tumors that in combination with altered signaling mechanisms essentially supports fast proliferation of cancer cells.	[Smerc, Andreja; Sodja, Eva; Legisa, Matic] Natl Inst Chem, Dept Biotechnol, Ljubljana, Slovenia	National Institute of Chemistry - Slovenia	Smerc, A (corresponding author), Natl Inst Chem, Dept Biotechnol, Ljubljana, Slovenia.	matic.legisa@ki.si			Slovenian Research Agency [J4-9606, 1000-07-310027]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This research was funded by the Slovenian Research Agency (Contract No. J4-9606 and 1000-07-310027; http://www.arrs.gov.si/sl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Banaszak K, 2011, J MOL BIOL, V407, P284, DOI 10.1016/j.jmb.2011.01.019; Barnes DJ, 2005, CANCER RES, V65, P8912, DOI 10.1158/0008-5472.CAN-05-0076; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Capuder M, 2009, J BIOTECHNOL, V144, P51, DOI 10.1016/j.jbiotec.2009.04.004; Cheng JQ, 1997, ONCOGENE, V14, P2793, DOI 10.1038/sj.onc.1201121; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DUNAWAY GA, 1983, MOL CELL BIOCHEM, V52, P75; DUNAWAY GA, 1988, BIOCHEM J, V251, P677, DOI 10.1042/bj2510677; Edelmann A, 2000, EUR J BIOCHEM, V267, P4825, DOI 10.1046/j.1432-1327.2000.01540.x; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; ELSON A, 1990, GENOMICS, V7, P47, DOI 10.1016/0888-7543(90)90517-X; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Emmerling M, 1999, METAB ENG, V1, P117, DOI 10.1006/mben.1998.0109; ETO K, 1994, BIOCHEM BIOPH RES CO, V198, P990, DOI 10.1006/bbrc.1994.1141; Garber K, 2006, SCIENCE, V312, P1158, DOI 10.1126/science.312.5777.1158; Hauf J, 2000, ENZYME MICROB TECH, V26, P688, DOI 10.1016/S0141-0229(00)00160-5; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Huang LE, 2008, CELL DEATH DIFFER, V15, P672, DOI 10.1038/sj.cdd.4402302; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; KASHIWAYA Y, 1994, J BIOL CHEM, V269, P25502; Kemp RG, 2002, BIOCHEMISTRY-US, V41, P9426, DOI 10.1021/bi020110d; Legisa M, 2007, BIOTECHNOL LETT, V29, P181, DOI 10.1007/s10529-006-9235-z; Leite TC, 2011, FEBS LETT, V585, P92, DOI 10.1016/j.febslet.2010.11.009; LIM PS, 1990, J INFECT DIS, V162, P1263, DOI 10.1093/infdis/162.6.1263; Lovingshimer MR, 2006, PROTEIN EXPRES PURIF, V46, P475, DOI 10.1016/j.pep.2005.09.015; Lu X, 2010, J BIOL CHEM, V285, P9317, DOI 10.1074/jbc.C110.104448; Marin-Hernandez A, 2006, FEBS J, V273, P1975, DOI 10.1111/j.1742-4658.2006.05214.x; Mathupala SP, 2009, SEMIN CANCER BIOL, V19, P17, DOI 10.1016/j.semcancer.2008.11.006; Mesojednik S, 2005, APPL ENVIRON MICROB, V71, P1425, DOI 10.1128/AEM.71.3.1425-1432.2005; Mlakar T, 2006, APPL ENVIRON MICROB, V72, P4515, DOI 10.1128/AEM.00539-06; NAKAJIMA H, 1994, BIOCHEM J, V303, P449, DOI 10.1042/bj3030449; Paliouras M, 2008, TUMOR BIOL, V29, P63, DOI 10.1159/000135686; Paliouras M, 2008, BIOL CHEM, V389, P773, DOI 10.1515/BC.2008.072; POORMAN RA, 1984, NATURE, V309, P467, DOI 10.1038/309467a0; REINHART GD, 1980, BIOCHEMISTRY-US, V19, P1491, DOI 10.1021/bi00548a036; Sambrook J., MOL CLONING LAB MANU; SHARMA PM, 1990, J BIOL CHEM, V265, P9006; STAAL GEJ, 1987, CANCER RES, V47, P5047; Swietach P, 2007, CANCER METAST REV, V26, P299, DOI 10.1007/s10555-007-9064-0; Tevz G, 2010, APPL MICROBIOL BIOT, V87, P1657, DOI 10.1007/s00253-010-2642-z; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson JE, 2004, J CLIN ONCOL, V22, P4217, DOI 10.1200/jco.2004.01.103; Usenik A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015447; VORA S, 1985, BIOCHEM J, V229, P333, DOI 10.1042/bj2290333; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; YAMASAKI T, 1991, GENE, V104, P277, DOI 10.1016/0378-1119(91)90262-A; Yeung SJ, 2008, CELL MOL LIFE SCI, V65, P3981, DOI 10.1007/s00018-008-8224-x	50	31	32	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19645	10.1371/journal.pone.0019645	http://dx.doi.org/10.1371/journal.pone.0019645			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573193	gold, Green Published, Green Submitted			2022-12-27	WOS:000290224800041
J	Chen, HY; Poon, A; Yeung, C; Helms, C; Pons, J; Bowcock, AM; Kwok, PY; Liao, W				Chen, Haoyan; Poon, Annie; Yeung, Celestine; Helms, Cynthia; Pons, Jennifer; Bowcock, Anne M.; Kwok, Pui-Yan; Liao, Wilson			A Genetic Risk Score Combining Ten Psoriasis Risk Loci Improves Disease Prediction	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; REVEALS ASSOCIATION; EXTENDED HAPLOTYPE; HLA-C; VARIANTS; ONSET; IDENTIFICATION; ARTHRITIS; TRAF3IP2	Psoriasis is a chronic, immune-mediated skin disease affecting 2-3% of Caucasians. Recent genetic association studies have identified multiple psoriasis risk loci; however, most of these loci contribute only modestly to disease risk. In this study, we investigated whether a genetic risk score (GRS) combining multiple loci could improve psoriasis prediction. Two approaches were used: a simple risk alleles count (cGRS) and a weighted (wGRS) approach. Ten psoriasis risk SNPs were genotyped in 2815 case-control samples and 858 family samples. We found that the total number of risk alleles in the cases was significantly higher than in controls, mean 13.16 (SD 1.7) versus 12.09 (SD 1.8), p = 4.577 x 10(-40). The wGRS captured considerably more risk than any SNP considered alone, with a psoriasis OR for high-low wGRS quartiles of 10.55 (95% CI 7.63-14.57), p = 2.010 x 10(-65). To compare the discriminatory ability of the GRS models, receiver operating characteristic curves were used to calculate the area under the curve (AUC). The AUC for wGRS was significantly greater than for cGRS (72.0% versus 66.5%, p = 2.13 x 10(-8)). Additionally, the AUC for HLA-C alone (rs10484554) was equivalent to the AUC for all nine other risk loci combined (66.2% versus 63.8%, p = 0.18), highlighting the dominance of HLA-C as a risk locus. Logistic regression revealed that the wGRS was significantly associated with two subphenotypes of psoriasis, age of onset (p = 4.91 x 10(-6)) and family history (p = 0.020). Using a liability threshold model, we estimated that the 10 risk loci account for only 11.6% of the genetic variance in psoriasis. In summary, we found that a GRS combining 10 psoriasis risk loci captured significantly more risk than any individual SNP and was associated with early onset of disease and a positive family history. Notably, only a small fraction of psoriasis heritability is captured by the common risk variants identified to date.	[Poon, Annie; Yeung, Celestine; Pons, Jennifer; Kwok, Pui-Yan] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Poon, Annie; Yeung, Celestine; Pons, Jennifer; Kwok, Pui-Yan] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Chen, Haoyan; Kwok, Pui-Yan; Liao, Wilson] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [Helms, Cynthia; Bowcock, Anne M.] Washington Univ, Sch Med, Dept Genet, Div Human Genet, St Louis, MO 63110 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Washington University (WUSTL)	Chen, HY (corresponding author), Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA.	liaowi@derm.ucsf.edu	Kwok, Pui-Yan/F-7725-2014	Kwok, Pui-Yan/0000-0002-5087-3059; Bowcock, Anne/0000-0001-8691-9090	Dermatology Foundation; National Institutes of Health [K08AR057763, R01AR050266]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR057763, R01AR050266] Funding Source: NIH RePORTER	Dermatology Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Financial support for this study was provided, in part, by the Dermatology Foundation to WL and by the National Institutes of Health to WL (K08AR057763) and AB (R01AR050266). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2010, AM HEART J, V160, P250, DOI 10.1016/j.ahj.2010.05.031; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Capon F, 2008, HUM MOL GENET, V17, P1938, DOI 10.1093/hmg/ddn091; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chang M, 2008, GENES IMMUN, V9, P176, DOI 10.1038/sj.gene.6364451; Cornelis MC, 2009, ANN INTERN MED, V150, P541, DOI 10.7326/0003-4819-150-8-200904210-00008; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Duffin KC, 2008, J RHEUMATOL, V35, P1449; ELDER JT, 1994, ARCH DERMATOL, V130, P216, DOI 10.1001/archderm.130.2.216; Elder JT, 2001, ARCH DERMATOL, V137, P1447; Ellinghaus E, 2010, NAT GENET, V42, P991, DOI 10.1038/ng.689; Enerback C, 1997, ACTA DERM-VENEREOL, V77, P273; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Gudjonsson JE, 2002, J INVEST DERMATOL, V118, P362, DOI 10.1046/j.0022-202x.2001.01656.x; HENSELER T, 1985, J AM ACAD DERMATOL, V13, P450, DOI 10.1016/S0190-9622(85)70188-0; Henseler T, 1998, ARCH DERMATOL RES, V290, P463, DOI 10.1007/s004030050338; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huffmeier U, 2010, NAT GENET, V42, P996, DOI 10.1038/ng.688; Li YH, 2009, J INVEST DERMATOL, V129, P629, DOI 10.1038/jid.2008.297; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Mallon E, 2000, BRIT J DERMATOL, V143, P1177, DOI 10.1046/j.1365-2133.2000.03885.x; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Nair RP, 2008, J INVEST DERMATOL, V128, P1653, DOI 10.1038/sj.jid.5701255; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Pawitan Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007969; Piccolo Stephen R, 2009, BMC Proc, V3 Suppl 7, pS46; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roberson EDO, 2010, TRENDS GENET, V26, P415, DOI 10.1016/j.tig.2010.06.006; Schafer T, 2006, DERMATOLOGY, V212, P327, DOI 10.1159/000092283; SchmittEgenolf M, 1996, J INVEST DERMATOL, V106, P711, DOI 10.1111/1523-1747.ep12345600; SCHMITTEGENOLF M, 1993, J INVEST DERMATOL, V100, P749, DOI 10.1111/1523-1747.ep12476080; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Stuart PE, 2010, NAT GENET, V42, P1000, DOI 10.1038/ng.693; Weedon MN, 2006, PLOS MED, V3, P1877, DOI 10.1371/journal.pmed.0030374; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819	41	63	69	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19454	10.1371/journal.pone.0019454	http://dx.doi.org/10.1371/journal.pone.0019454			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559375	Green Published, gold			2022-12-27	WOS:000290024700180
J	Ciabattini, A; Pettini, E; Fiorino, F; Prota, G; Pozzi, G; Medaglini, D				Ciabattini, Annalisa; Pettini, Elena; Fiorino, Fabio; Prota, Gennaro; Pozzi, Gianni; Medaglini, Donata			Distribution of Primed T Cells and Antigen-Loaded Antigen Presenting Cells Following Intranasal Immunization in Mice	PLOS ONE			English	Article							LYMPH-NODES; DENDRITIC CELLS; L-SELECTIN; MIGRATION; TRAFFICKING; CD4(+); EXPRESSION; GENERATION; INDUCTION; INTEGRIN	Priming of T cells is a key event in vaccination, since it bears a decisive influence on the type and magnitude of the immune response. T-cell priming after mucosal immunization via the nasal route was studied by investigating the distribution of antigen-loaded antigen presenting cells (APCs) and primed antigen-specific T cells. Nasal immunization studies were conducted using the model protein antigen ovalbumin (OVA) plus CpG oligodeoxynucleotide adjuvant. Trafficking of antigen-specific primed T cells was analyzed in vivo after adoptive transfer of OVA-specific transgenic T cells in the presence or absence of fingolimod, a drug that causes lymphocytes sequestration within lymph nodes. Antigen-loaded APCs were observed in mediastinal lymph nodes, draining the respiratory tract, but not in distal lymph nodes. Antigen-specific proliferating T cells were first observed within draining lymph nodes, and later in distal iliac and mesenteric lymph nodes and in the spleen. The presence at distal sites was due to migration of locally primed T cells as shown by fingolimod treatment that caused a drastic reduction of proliferated T cells in non-draining lymph nodes and an accumulation of extensively divided T cells within draining lymph nodes. Homing of nasally primed T cells in distal iliac lymph nodes was CD62L-dependent, while entry into mesenteric lymph nodes depended on both CD62L and alpha 4 beta 7, as shown by in vivo antibody-mediated inhibition of T-cell trafficking. These data, elucidating the trafficking of antigen-specific primed T cells to non-draining peripheral and mucosa-associated lymph nodes following nasal immunization, provide relevant insights for the design of vaccination strategies based on mucosal priming.	[Ciabattini, Annalisa; Pettini, Elena; Fiorino, Fabio; Prota, Gennaro; Pozzi, Gianni; Medaglini, Donata] Univ Siena, Dipartimento Biotecnol, Lab Microbiol Mol & Biotecnol LAMMB, I-53100 Siena, Italy	University of Siena	Ciabattini, A (corresponding author), Univ Siena, Dipartimento Biotecnol, Lab Microbiol Mol & Biotecnol LAMMB, Via Laterina 8, I-53100 Siena, Italy.	medaglini@unisi.it	Pozzi, Gianni/Q-2713-2018; Pettini, Elena/R-4188-2018; Medaglini, Donata/R-1149-2018; Ciabattini, Annalisa/Q-2721-2018	Pozzi, Gianni/0000-0002-9557-4714; Pettini, Elena/0000-0002-0308-7127; Medaglini, Donata/0000-0003-1729-7325; Ciabattini, Annalisa/0000-0002-4585-7783; Fiorino, Fabio/0000-0002-1440-8061	Commission of the European Communities [LSHP-CT-2003-503240]; "European Vaccines and Microbicides Enterprise" (EUROPRISE) [037611]; "Azione Concertata Italiana per lo Sviluppo di un Vaccino HIV/AIDS" (ICAV) of the Istituto Superiore di Sanita [45G.27]	Commission of the European Communities(European Commission); "European Vaccines and Microbicides Enterprise" (EUROPRISE); "Azione Concertata Italiana per lo Sviluppo di un Vaccino HIV/AIDS" (ICAV) of the Istituto Superiore di Sanita	This study has been carried out with the financial support from the Commission of the European Communities, Sixth Framework Programme, contract LSHP-CT-2003-503240, "Mucosal Vaccines for Poverty-Related Diseases'' (MUVAPRED), and contract 037611 "European Vaccines and Microbicides Enterprise" (EUROPRISE) and from "Azione Concertata Italiana per lo Sviluppo di un Vaccino HIV/AIDS" (ICAV) of the Istituto Superiore di Sanita contract no. 45G.27. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; BRADLEY LM, 1994, J EXP MED, V180, P2401, DOI 10.1084/jem.180.6.2401; Brandtzaeg P, 2008, MUCOSAL IMMUNOL, V1, P31, DOI 10.1038/mi.2007.9; Brandtzaeg P, 2009, SCAND J IMMUNOL, V70, P505, DOI 10.1111/j.1365-3083.2009.02319.x; Brinkman CC, 2008, J IMMUNOL, V181, P1814, DOI 10.4049/jimmunol.181.3.1814; Caccamo N, 2006, EUR J IMMUNOL, V36, P2681, DOI 10.1002/eji.200636220; Catron DM, 2006, J EXP MED, V203, P1045, DOI 10.1084/jem.20051954; Ciabattini A, 2008, INFECT IMMUN, V76, P5817, DOI 10.1128/IAI.00793-08; Ciabattini A, 2010, VACCINE, V28, P1226, DOI 10.1016/j.vaccine.2009.11.021; Dutt S, 2005, BLOOD, V106, P4009, DOI 10.1182/blood-2005-06-2339; Enioutina EY, 2008, VACCINE, V26, P601, DOI 10.1016/j.vaccine.2007.11.084; Enioutina EY, 2009, J IMMUNOL, V182, P4296, DOI 10.4049/jimmunol.0804344; Estcourt MJ, 2005, EUR J IMMUNOL, V35, P2532, DOI 10.1002/eji.200535184; Galli G, 2009, P NATL ACAD SCI USA, V106, P3877, DOI 10.1073/pnas.0813390106; Gunn MD, 1998, P NATL ACAD SCI USA, V95, P258, DOI 10.1073/pnas.95.1.258; Halle S, 2009, J EXP MED, V206, P2593, DOI 10.1084/jem.20091472; HAMANN A, 1994, J IMMUNOL, V152, P3282; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Jakubzick C, 2008, J IMMUNOL METHODS, V337, P121, DOI 10.1016/j.jim.2008.07.005; Johansson-Lindbom B, 2007, IMMUNOL REV, V215, P226, DOI 10.1111/j.1600-065X.2006.00482.x; Kaufman DR, 2009, CLIN EXP IMMUNOL, V157, P165, DOI 10.1111/j.1365-2249.2009.03927.x; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Kozlowski PA, 1997, INFECT IMMUN, V65, P1387, DOI 10.1128/IAI.65.4.1387-1394.1997; KRAAL G, 1995, AM J PATHOL, V147, P763; Lan YY, 2005, AM J TRANSPLANT, V5, P2649, DOI 10.1111/j.1600-6143.2005.01085.x; LARSEN CP, 1990, J EXP MED, V172, P1483, DOI 10.1084/jem.172.5.1483; Legge KL, 2003, IMMUNITY, V18, P265, DOI 10.1016/S1074-7613(03)00023-2; Lu S, 2009, CURR OPIN IMMUNOL, V21, P346, DOI 10.1016/j.coi.2009.05.016; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; McCluskie MJ, 2002, FEMS IMMUNOL MED MIC, V32, P179, DOI 10.1016/S0928-8244(01)00305-4; McHeyzer-Williams LJ, 2009, CURR OPIN IMMUNOL, V21, P266, DOI 10.1016/j.coi.2009.05.010; Mora JR, 2006, TRENDS IMMUNOL, V27, P235, DOI 10.1016/j.it.2006.03.007; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Pettini E, 2009, METHODS, V49, P340, DOI 10.1016/j.ymeth.2009.03.026; Reines I, 2009, J INVEST DERMATOL, V129, P1954, DOI 10.1038/jid.2008.454; Song JH, 2009, J IMMUNOL, V182, P6851, DOI 10.4049/jimmunol.0803568; Sprent J, 2001, CURR OPIN IMMUNOL, V13, P248, DOI 10.1016/S0952-7915(00)00211-9; STREETER PR, 1988, NATURE, V331, P41, DOI 10.1038/331041a0; Vendetti S, 2009, METHODS, V49, P334, DOI 10.1016/j.ymeth.2009.04.018; Wagner N, 1998, EUR J IMMUNOL, V28, P3832, DOI 10.1002/(SICI)1521-4141(199811)28:11<3832::AID-IMMU3832>3.0.CO;2-J; Warnock RA, 1998, J EXP MED, V187, P205, DOI 10.1084/jem.187.2.205; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016	46	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19346	10.1371/journal.pone.0019346	http://dx.doi.org/10.1371/journal.pone.0019346			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559409	Green Submitted, gold, Green Published			2022-12-27	WOS:000290024700144
J	de Herve, MGD; Durali, D; Dembele, B; Giuliani, M; Tran, TA; Azzarone, B; Eid, P; Tardieu, M; Delfraissy, JF; Taoufik, Y				de Herve, Marie-Ghislaine de Goer; Durali, Deniz; Dembele, Bamory; Giuliani, Massimo; Tu-Anh Tran; Azzarone, Bruno; Eid, Pierre; Tardieu, Marc; Delfraissy, Jean-Francois; Taoufik, Yassine			Interferon-Alpha Triggers B Cell Effector 1 (Be1) Commitment	PLOS ONE			English	Article							IFN-ALPHA; T-CELLS; STAT4 ACTIVATION; GAMMA PRODUCTION; VIRAL-INFECTION; NATURAL-KILLER; TH2 CELLS; EXPRESSION; RESPONSES; IL-12	B-cells can contribute to the pathogenesis of autoimmune diseases not only through auto-antibody secretion but also via cytokine production. Therapeutic depletion of B-cells influences the functions and maintenance of various T-cell subsets. The mechanisms governing the functional heterogeneity of B-cell subsets as cytokine-producing cells are poorly understood. B-cells can differentiate into two functionally polarized effectors, one (B-effector-1-cells) producing a Th-1-like cytokine pattern and the other (Be2) producing a Th-2-like pattern. IL-12 and IFN-gamma play a key role in Be1 polarization, but the initial trigger of Be1 commitment is unclear. Type-I-interferons are produced early in the immune response and prime several processes involved in innate and adaptive responses. Here, we report that IFN-alpha triggers a signaling cascade in resting human naive B-cells, involving STAT4 and T-bet, two key IFN-gamma gene imprinting factors. IFN-alpha primed naive B-cells for IFN-gamma production and increased IFN-gamma gene responsiveness to IL-12. IFN-gamma continues this polarization by re-inducing T-bet and up-regulating IL-12R beta 2 expression. IFN-alpha and IFN-gamma therefore pave the way for the action of IL-12. These results point to a coordinated action of IFN-alpha, IFN-gamma and IL-12 in Be1 polarization of naive B-cells, and may provide new insights into the mechanisms by which type-I-interferons favor autoimmunity.	[de Herve, Marie-Ghislaine de Goer; Durali, Deniz; Dembele, Bamory; Tu-Anh Tran; Tardieu, Marc; Delfraissy, Jean-Francois; Taoufik, Yassine] INSERM, U1012, Le Kremlin Bicetre, France; [de Herve, Marie-Ghislaine de Goer; Durali, Deniz; Dembele, Bamory; Tu-Anh Tran; Tardieu, Marc; Delfraissy, Jean-Francois; Taoufik, Yassine] Univ Paris Sud, Le Kremlin Bicetre, France; [de Herve, Marie-Ghislaine de Goer; Taoufik, Yassine] Hop Bicetre, Unite Immunol Biol, Le Kremlin Bicetre, France; [Durali, Deniz] GEBI, Vaccine Technol Lab, TUBITAK Marmara Res Ctr, Gebze, Turkey; [Giuliani, Massimo; Azzarone, Bruno; Eid, Pierre] INSERM, U542, Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Gebze Technical University; Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK); Institut National de la Sante et de la Recherche Medicale (Inserm)	de Herve, MGD (corresponding author), INSERM, U1012, Le Kremlin Bicetre, France.	yassine.taoufik@bct.aphp.fr	Azzarone, Bruno/AAH-9251-2019; DURALI, Deniz/Y-6325-2019	Azzarone, Bruno/0000-0002-5962-3849; DEMBELE, Bamory/0000-0002-6165-9090; TRAN, Tu-Anh/0000-0001-6587-1876				Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; AGRAWAL S, 2011, J CLIN IMMUNOL; Airoldi I, 2000, J IMMUNOL, V165, P6880, DOI 10.4049/jimmunol.165.12.6880; Bekeredjian-Ding I, 2007, J IMMUNOL, V178, P2803, DOI 10.4049/jimmunol.178.5.2803; Bouaziz JD, 2008, IMMUNOL REV, V224, P201, DOI 10.1111/j.1600-065X.2008.00661.x; Cho SS, 1996, J IMMUNOL, V157, P4781; Cousens LP, 1997, P NATL ACAD SCI USA, V94, P634, DOI 10.1073/pnas.94.2.634; Durali D, 2003, BLOOD, V102, P4084, DOI 10.1182/blood-2003-02-0518; Farrar JD, 2000, NAT IMMUNOL, V1, P65, DOI 10.1038/76932; Farrar JD, 2000, J BIOL CHEM, V275, P2693, DOI 10.1074/jbc.275.4.2693; Harris DP, 2005, J IMMUNOL, V175, P7103, DOI 10.4049/jimmunol.175.11.7103; Harris DP, 2005, J IMMUNOL, V174, P6781, DOI 10.4049/jimmunol.174.11.6781; Harris DP, 2000, NAT IMMUNOL, V1, P475, DOI 10.1038/82717; Hermann P, 1998, J IMMUNOL, V161, P2011; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; LEUNG S, 1995, MOL CELL BIOL, V15, P1312; Lund FE, 2008, CURR OPIN IMMUNOL, V20, P332, DOI 10.1016/j.coi.2008.03.003; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Ma XJ, 1996, J EXP MED, V183, P147, DOI 10.1084/jem.183.1.147; Miyagi T, 2007, J EXP MED, V204, P2383, DOI 10.1084/jem.20070401; Mizoguchi A, 2006, J IMMUNOL, V176, P705, DOI 10.4049/jimmunol.176.2.705; Nguyen KB, 2002, SCIENCE, V297, P2063, DOI 10.1126/science.1074900; PARRONCHI P, 1992, J IMMUNOL, V149, P2977; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Pistoia V, 1997, IMMUNOL TODAY, V18, P343, DOI 10.1016/S0167-5699(97)01080-3; Rogge L, 1998, J IMMUNOL, V161, P6567; Ruprecht CR, 2006, EUR J IMMUNOL, V36, P810, DOI 10.1002/eji.200535744; Sanz I, 2007, FRONT BIOSCI-LANDMRK, V12, P2546, DOI 10.2741/2254; Stasi R, 2010, SEMIN HEMATOL, V47, P170, DOI 10.1053/j.seminhematol.2010.01.010; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Zimmerer JM, 2007, J IMMUNOL, V178, P4832, DOI 10.4049/jimmunol.178.8.4832	33	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19366	10.1371/journal.pone.0019366	http://dx.doi.org/10.1371/journal.pone.0019366			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559410	Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700150
J	Huang, PP; Khan, I; Suhail, MSA; Malkmus, S; Yaksh, TL				Huang, Polly P.; Khan, Imran; Suhail, Mohammed S. A.; Malkmus, Shelle; Yaksh, Tony L.			Spinal Botulinum Neurotoxin B: Effects on Afferent Transmitter Release and Nociceptive Processing	PLOS ONE			English	Article							SUBSTANCE-P RELEASE; LIGHT-CHAIN PROTEASE; INTRATHECAL MORPHINE; TACTILE ALLODYNIA; NEUROPATHIC PAIN; NERVE LIGATION; FORMALIN TEST; DORSAL-HORN; RAT; RECEPTOR	Botulinum neurotoxin B (BoNT-B) mediates proteolytic cleavage of VAMP I/II (synaptobrevins I/II), which prevents vesicle-membrane fusion and blocks neurotransmitter release. In the present study, we investigated the effects of BoNT-B on neurotransmitter release in vivo from spinal primary afferent sensory fibers and the effects of this blockade on nociception. With intrathecally (IT) delivered BoNT-B in C57B/l6 mice, we characterized the effects of such block on the release of substance P (SP) from spinal afferent nociceptors (as measured by neurokinin-1 receptor, NK1-R, internalization), spinal neuronal activation (as indicated by spinal C-Fos expression) and nociceptive behavior after intraplantar (IPLT) formalin. In addition, we investigated the effect of IT BoNT-B on spinal nerve ligation-induced tactile allodynia. A single percutaneous IT injection of BoNT-B 0.5 U at 2 or 5 days prior to IPLT formalin reduced NK1-R internalization and C-Fos expression. These effects correlated with BoNT-B cleavage of VAMPI/II protein in tissue lysate. IT BoNT-B also produced a corresponding reduction in phase 2 of formalin-evoked flinching behavior for over 30 days after IT injection. In mice with spinal nerve ligation (SNL), tactile allodynia was observed, which was attenuated by IT BoNT-B 0.5 U over the next 15 days, as compared to vehicle animals. These effects were observed without effects upon motor function. The specificity of the IT BoNT-B effect is indicated by: i) IT co-injection of BoNT-B and anti-BoNTB antibody prevented effects on SP release, and ii) IT BoNT-B 50 U in the Sprague Dawley rats showed no effect on formalin-evoked flinching or SNL-induced tactile allodynia, which is consistent with rat resistance to BoNT-B. IT BoNT-B blocks transmitter release from spinal primary afferents, and attenuates inflammatory nociceptive response and spinal nerve injury-induced neuropathic pain, in the absence of motor impairment. These observations provide an initial assessment of the ability of IT BoNT-B to regulate spinal nociceptive processing.	[Huang, Polly P.] Univ Calif San Diego, Dept Biol Sci, La Jolla, CA 92093 USA; [Khan, Imran] US FDA, Dept Hlth & Human Serv, Bethesda, MD 20014 USA; [Suhail, Mohammed S. A.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Malkmus, Shelle; Yaksh, Tony L.] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; US Food & Drug Administration (FDA); University of California System; University of California San Diego; University of California System; University of California San Diego	Huang, PP (corresponding author), Univ Calif San Diego, Dept Biol Sci, La Jolla, CA 92093 USA.	tyaksh@ucsd.edu	Yaksh, Tony/D-4119-2009		National Institutes of Health, Bethesda, MD [NIH-DA02110]; Solstice Neurosciences; National Institutes of Health [DA02110]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002110] Funding Source: NIH RePORTER	National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Solstice Neurosciences; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by funding from the National Institutes of Health: NIH-DA02110, Bethesda, MD (TLY); Solstice Neurosciences, 701 Gateway Boulevard, Suite 250, South San Francisco, CA 94080. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; A portion of the funds and drugs used in this work was supplied by Solstice Neuroscience and by the National Institutes of Health (DA02110). The support by Solstice did not involve any compensation for consulting nor any restriction on the publication of the results or on the contents of this manuscript. The authors have no patent position associated with this product or research. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abbadie C, 1997, PAIN, V69, P101, DOI 10.1016/S0304-3959(96)03285-X; Antonucci F, 2008, J NEUROSCI, V28, P3689, DOI 10.1523/JNEUROSCI.0375-08.2008; Bleakman D, 2006, SEMIN CELL DEV BIOL, V17, P592, DOI 10.1016/j.semcdb.2006.10.008; Chaplan SR, 1997, J PHARMACOL EXP THER, V280, P829; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Coderre TJ, 2005, J NEUROCHEM, V94, P1131, DOI 10.1111/j.1471-4159.2005.03263.x; de Paiva A, 1999, P NATL ACAD SCI USA, V96, P3200, DOI 10.1073/pnas.96.6.3200; DICKENSON A, 1990, PAIN, V43, P353, DOI 10.1016/0304-3959(90)90032-9; Dong M, 2003, J CELL BIOL, V162, P1293, DOI 10.1083/jcb.200305098; Durham PL, 2004, HEADACHE, V44, P35, DOI 10.1111/j.1526-4610.2004.04007.x; Eisenach JC, 2010, PAIN, V149, P417, DOI 10.1016/j.pain.2010.02.028; FENSTERMACHER J, 1988, ANN NY ACAD SCI, V531, P29, DOI 10.1111/j.1749-6632.1988.tb51416.x; Garry EM, 2003, MOL CELL NEUROSCI, V24, P10, DOI 10.1016/S1044-7431(03)00134-9; Henry JL, 1999, J NEUROSCI, V19, P6588; Hughes DI, 2007, J NEUROSCI, V27, P2035, DOI 10.1523/JNEUROSCI.5401-06.2007; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Juzans P, 1996, NEUROMUSCULAR DISORD, V6, P177, DOI 10.1016/0960-8966(96)00041-7; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Kondo I, 2005, J NEUROSCI, V25, P3651, DOI 10.1523/JNEUROSCI.0252-05.2005; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Kozaki S, 1998, MICROB PATHOGENESIS, V25, P91, DOI 10.1006/mpat.1998.0214; Larsson M, 2009, MOL NEUROBIOL, V40, P260, DOI 10.1007/s12035-009-8086-8; Linninger AA, 2008, J BIOMECH, V41, P2176, DOI 10.1016/j.jbiomech.2008.04.025; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luvisetto S, 2006, BRAIN RES, V1082, P124, DOI 10.1016/j.brainres.2006.01.117; MANTYH PW, 1995, P NATL ACAD SCI USA, V92, P2622, DOI 10.1073/pnas.92.7.2622; Marvizon JCG, 2003, NEUROSCIENCE, V118, P535, DOI 10.1016/S0306-4522(02)00977-6; MCMAHON HT, 1992, J BIOL CHEM, V267, P21338; Meunier FA, 2002, J PHYSIOL-PARIS, V96, P105, DOI 10.1016/S0928-4257(01)00086-9; Montal M, 2009, TOXICON, V54, P565, DOI 10.1016/j.toxicon.2008.11.018; Montecucco C, 1995, Q REV BIOPHYS, V28, P423, DOI 10.1017/S0033583500003292; Morris JL, 2001, AM J PHYSIOL-HEART C, V281, pH2124, DOI 10.1152/ajpheart.2001.281.5.H2124; Nicholson C, 1999, STRUCTURE EXTRACELLU; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SCHIAVO G, 1994, J BIOL CHEM, V269, P20213; Sorkin LS, 2009, NEUROTHERAPEUTICS, V6, P609, DOI 10.1016/j.nurt.2009.07.007; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Todd AJ, 2003, EUR J NEUROSCI, V17, P13, DOI 10.1046/j.1460-9568.2003.02406.x; Urban LA, 2000, TRENDS PHARMACOL SCI, V21, P462; Verderio C, 2004, NEURON, V41, P599, DOI 10.1016/S0896-6273(04)00077-7; Welch MJ, 2000, TOXICON, V38, P245, DOI 10.1016/S0041-0101(99)00153-1; YAKSH TL, 1980, NATURE, V286, P155, DOI 10.1038/286155a0; Yaksh TL, 2001, J APPL PHYSIOL, V90, P2386, DOI 10.1152/jappl.2001.90.6.2386; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9; Yaksh TL, 2004, ANESTH ANALG, V98, P1536, DOI 10.1213/01.ANE.0000122638.41130.BF; YAKSH TL, 1986, PHARMACOL BIOCHEM BE, V25, P483, DOI 10.1016/0091-3057(86)90028-6; Yaksh TL, 1999, P NATL ACAD SCI USA, V96, P7680, DOI 10.1073/pnas.96.14.7680; YAMAMOTO T, 1991, LIFE SCI, V49, P1955, DOI 10.1016/0024-3205(91)90637-Q; Yasaka T, 2010, PAIN, V151, P475, DOI 10.1016/j.pain.2010.08.008	50	32	33	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19126	10.1371/journal.pone.0019126	http://dx.doi.org/10.1371/journal.pone.0019126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559464	Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700070
J	Kajiya, M; Komatsuzawa, H; Papantonakis, A; Seki, M; Makihira, S; Ouhara, K; Kusumoto, Y; Murakami, S; Taubman, MA; Kawai, T				Kajiya, Mikihito; Komatsuzawa, Hitoshi; Papantonakis, Annatoula; Seki, Makoto; Makihira, Seicho; Ouhara, Kazuhisa; Kusumoto, Yutaka; Murakami, Shinya; Taubman, Martin A.; Kawai, Toshihisa			Aggregatibacter actinomycetemcomitans Omp29 Is Associated with Bacterial Entry to Gingival Epithelial Cells by F-Actin Rearrangement	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; PATHOGEN ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; EXPERIMENTAL PERIODONTAL-DISEASE; INFLAMMATORY BONE-RESORPTION; BLOOD-BRAIN-BARRIER; ESCHERICHIA-COLI; PORPHYROMONAS-GINGIVALIS; YERSINIA-ENTEROCOLITICA; BACTEROIDES-GINGIVALIS; JUNCTIONAL EPITHELIUM	The onset and progressive pathogenesis of periodontal disease is thought to be initiated by the entry of Aggregatibacter actinomycetemcomitans (Aa) into periodontal tissue, especially gingival epithelium. Nonetheless, the mechanism underlying such bacterial entry remains to be clarified. Therefore, this study aimed to investigate the possible role of Aa outer membrane protein 29 kD (Omp29), a homologue of E. coli OmpA, in promoting bacterial entry into gingival epithelial cells. To accomplish this, Omp29 expression vector was incorporated in an OmpA-deficient mutant of E. coli. Omp29(+)/OmpA(-) 2 E. coli demonstrated 22-fold higher entry into human gingival epithelial line cells (OBA9) than Omp29(-)/OmpA(-) E. coli. While the entry of Aa and Omp29(+)/OmpA(-) E. coli into OBA9 cells were inhibited by anti-Omp29 antibody, their adherence to OBA9 cells was not inhibited. Stimulation of OBA9 cells with purified Omp29 increased the phosphorylation of focal adhesion kinase (FAK), a pivotal cell-signaling molecule that can up-regulate actin rearrangement. Furthermore, Omp29 increased the formation of F-actin in OBA9 cells. The internalization of Omp29-coated beads and the entry of Aa into OBA9 were partially inhibited by treatment with PI3-kinase inhibitor (Wortmannin) and Rho GTPases inhibitor (EDIN), both known to convey FAK-signaling to actin-rearrangement. These results suggest that Omp29 is associated with the entry of Aa into gingival epithelial cells by up-regulating F-actin rearrangement via the FAK signaling pathway.	[Kajiya, Mikihito; Papantonakis, Annatoula; Seki, Makoto; Makihira, Seicho; Ouhara, Kazuhisa; Taubman, Martin A.; Kawai, Toshihisa] Forsyth Inst, Dept Immunol, Boston, MA USA; [Kajiya, Mikihito; Kawai, Toshihisa] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA; [Komatsuzawa, Hitoshi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oral Microbiol, Kagoshima 890, Japan; [Kusumoto, Yutaka] Osaka Ohtani Univ, Fac Pharm, Immunol Lab, Osaka, Japan; [Murakami, Shinya] Osaka Univ, Grad Sch Dent, Dept Periodontol, Div Oral Biol & Dis Control, Osaka, Japan	Harvard University; Forsyth Institute; Harvard University; Harvard School of Dental Medicine; Kagoshima University; Osaka University	Kajiya, M (corresponding author), Forsyth Inst, Dept Immunol, Boston, MA USA.	tkawai@forsyth.org	Ouhara, Kazuhisa/G-5251-2019; Komatsuzawa, Hitoshi/AAC-7731-2019; Kajiya, Mikihito/A-4288-2018	Kajiya, Mikihito/0000-0001-6652-0007	National Institute of Dental and Craniofacial Research [DE-03420, DE-18499, DE-19917]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE003420, R01DE019917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE003420, R01DE018499] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The study reported herein was supported in part by grants DE-03420, DE-18499 and DE-19917 from the National Institute of Dental and Craniofacial Research (http://www.nidcr.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakawa R, 2003, MOL MICROBIOL, V50, P1125, DOI 10.1046/j.1365-2958.2003.03748.x; BREMER E, 1986, FEMS MICROBIOL LETT, V33, P173, DOI 10.1016/0378-1097(86)90232-6; Brissette CA, 1999, ORAL MICROBIOL IMMUN, V14, P137, DOI 10.1034/j.1399-302X.1999.140301.x; Cary LA, 1999, HISTOL HISTOPATHOL, V14, P1001, DOI 10.14670/HH-14.1001; CHRISTERSSON LA, 1987, J PERIODONTOL, V58, P540, DOI 10.1902/jop.1987.58.8.540; Fives-Taylor P, 1995, Adv Dent Res, V9, P55; Fives-Taylor PM, 1999, PERIODONTOL 2000, V20, P136, DOI 10.1111/j.1600-0757.1999.tb00161.x; FLUGEL A, 1994, J BIOL CHEM, V269, P29732; Henderson B, 2003, ANNU REV MICROBIOL, V57, P29, DOI 10.1146/annurev.micro.57.030502.090908; Kachlany SC, 2010, J DENT RES, V89, P561, DOI 10.1177/0022034510363682; Kawai T, 1998, CLIN DIAGN LAB IMMUN, V5, P11, DOI 10.1128/CDLI.5.1.11-17.1998; Kawai T, 2000, J IMMUNOL, V164, P2102, DOI 10.4049/jimmunol.164.4.2102; Komatsuzawa H, 2002, GENE, V288, P195, DOI 10.1016/S0378-1119(02)00500-0; Komatsuzawa H, 1999, INFECT IMMUN, V67, P942, DOI 10.1128/IAI.67.2.942-945.1999; Kusumoto Y, 2004, J PERIODONTOL, V75, P370, DOI 10.1902/jop.2004.75.3.370; Li L, 2004, ORAL MICROBIOL IMMUN, V19, P16, DOI 10.1046/j.0902-0055.2003.00102.x; Matsuyama T, 2005, INFECT IMMUN, V73, P1044, DOI 10.1128/IAI.73.2.1044-1051.2005; Meyer DH, 1997, CRIT REV ORAL BIOL M, V8, P389, DOI 10.1177/10454411970080040301; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Prasadarao NV, 1996, INFECT IMMUN, V64, P154, DOI 10.1128/IAI.64.1.154-160.1996; Prasadarao NV, 1996, INFECT IMMUN, V64, P146, DOI 10.1128/IAI.64.1.146-153.1996; Rolhion N, 2005, J BACTERIOL, V187, P2286, DOI 10.1128/JB.187.7.2286-2296.2005; ROMANOWSKI AW, 1988, J PERIODONTAL RES, V23, P81, DOI 10.1111/j.1600-0765.1988.tb01338.x; SAGLIE FR, 1988, J PERIODONTOL, V59, P259, DOI 10.1902/jop.1988.59.4.259; Schmid Y, 2004, INFECT IMMUN, V72, P6780, DOI 10.1128/IAI.72.12.6780-6789.2004; Schreiner HC, 2003, P NATL ACAD SCI USA, V100, P7295, DOI 10.1073/pnas.1237223100; Shimoji Y, 1999, P NATL ACAD SCI USA, V96, P9857, DOI 10.1073/pnas.96.17.9857; SLOTS J, 1986, J CLIN PERIODONTOL, V13, P570, DOI 10.1111/j.1600-051X.1986.tb00849.x; Soulas C, 2000, J IMMUNOL, V165, P2335, DOI 10.4049/jimmunol.165.5.2335; SUGAI M, 1990, BIOCHEM BIOPH RES CO, V173, P92, DOI 10.1016/S0006-291X(05)81026-5; TAKATA T, 1988, J PERIODONTOL, V59, P823, DOI 10.1902/jop.1988.59.12.823; Valverde P, 2005, J DENT RES, V84, P488, DOI 10.1177/154405910508400603; Valverde P, 2004, J BONE MINER RES, V19, P155, DOI 10.1359/JBMR.0301213; WILSON ME, 1995, INFECT IMMUN, V63, P1062, DOI 10.1128/IAI.63.3.1062-1069.1995; Xie Y, 2004, FEMS IMMUNOL MED MIC, V42, P271, DOI 10.1016/j.femsim.2004.09.001	36	28	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18287	10.1371/journal.pone.0018287	http://dx.doi.org/10.1371/journal.pone.0018287			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559515	Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700010
J	Kallas, A; Pook, M; Maimets, M; Zimmermann, K; Maimets, T				Kallas, Ade; Pook, Martin; Maimets, Martti; Zimmermann, Kuelli; Maimets, Toivo			Nocodazole Treatment Decreases Expression of Pluripotency Markers Nanog and Oct4 in Human Embryonic Stem Cells	PLOS ONE			English	Article							ROCK INHIBITOR; SELF-RENEWAL; HISTONE H3; TRANSCRIPTIONAL REGULATION; RNA INTERFERENCE; ES CELLS; DIFFERENTIATION; TAXOL; P53; PACLITAXEL	Nocodazole is a known destabiliser of microtubule dynamics and arrests cell-cycle at the G2/M phase. In the context of the human embryonic stem cell (hESC) it is important to understand how this arrest influences the pluripotency of cells. Here we report for the first time the changes in the expression of transcription markers Nanog and Oct4 as well as SSEA-3 and SSEA-4 in human embryonic cells after their treatment with nocodazole. Multivariate permeabilised-cell flow cytometry was applied for characterising the expression of Nanog and Oct4 during different cell cycle phases. Among untreated hESC we detected Nanog-expressing cells, which also expressed Oct4, SSEA-3 and SSEA-4. We also found another population expressing SSEA-4, but without Nanog, Oct4 and SSEA-3 expression. Nocodazole treatment resulted in a decrease of cell population positive for all four markers Nanog, Oct4, SSEA-3, SSEA-4. Nocodazole-mediated cell-cycle arrest was accompanied by higher rate of apoptosis and upregulation of p53. Twenty-four hours after the release from nocodazole block, the cell cycle of hESC normalised, but no increase in the expression of transcription markers Nanog and Oct4 was detected. In addition, the presence of ROCK-2 inhibitor Y-27632 in the medium had no effect on increasing the expression of pluripotency markers Nanog and Oct4 or decreasing apoptosis or the level of p53. The expression of SSEA-3 and SSEA-4 increased in Nanog-positive cells after wash-out of nocodazole in the presence and in the absence of Y-27632. Our data show that in hESC nocodazole reversible blocks cell cycle, which is accompanied by irreversible loss of expression of pluripotency markers Nanog and Oct4.	[Kallas, Ade; Pook, Martin; Maimets, Martti; Zimmermann, Kuelli; Maimets, Toivo] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia	University of Tartu	Kallas, A (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Ulikooli 18, EE-50090 Tartu, Estonia.	ade@ebc.ee	Pook, Martin/Q-9707-2019; Kallas, Ade/H-2498-2012; Maimets, Toivo/E-9268-2017; Pook, Martin/G-3467-2017; Kallas-Kivi, Ade/F-2411-2017	Maimets, Toivo/0000-0001-6461-3365; Pook, Martin/0000-0002-8386-0203; Kallas-Kivi, Ade/0000-0002-0536-5020; Maimets, Martti/0000-0001-7343-2769	Estonian Ministry of Education and Science [SF0180100s08]; Estonian Science Foundation [7578]	Estonian Ministry of Education and Science(Ministry of Education and Research, Estonia); Estonian Science Foundation	This study was supported by grant no. SF0180100s08 of the Estonian Ministry of Education and Science, and Estonian Science Foundation (no. 7578). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aladjem MI, 1998, CURR BIOL, V8, P145, DOI 10.1016/S0960-9822(98)70061-2; Becker KA, 2010, J CELL PHYSIOL, V222, P103, DOI 10.1002/jcp.21925; Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776; Becker KA, 2007, J CELL PHYSIOL, V210, P517, DOI 10.1002/jcp.20903; Braithwaite AW, 2005, CARCINOGENESIS, V26, P1161, DOI 10.1093/carcin/bgi091; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chen GK, 2010, CELL STEM CELL, V7, P240, DOI 10.1016/j.stem.2010.06.017; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Claassen DA, 2009, MOL REPROD DEV, V76, P722, DOI 10.1002/mrd.21021; Darr H, 2006, DEVELOPMENT, V133, P1193, DOI 10.1242/dev.02286; DONALDSON KL, 1994, INT J CANCER, V57, P847, DOI 10.1002/ijc.2910570614; Edel MJ, 2010, GENE DEV, V24, P561, DOI 10.1101/gad.1876710; Gauthaman K, 2010, STEM CELL REV REP, V6, P86, DOI [10.1007/s12015-010-9166-x, 10.1007/s12015-009-9107-8]; Giannakakou P, 2001, ONCOGENE, V20, P3806, DOI 10.1038/sj.onc.1204487; Goto H, 2002, GENES CELLS, V7, P11, DOI 10.1046/j.1356-9597.2001.00498.x; HAKOMORI S, 1983, JNCI-J NATL CANCER I, V71, P231; Hay DC, 2004, STEM CELLS, V22, P225, DOI 10.1634/stemcells.22-2-225; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hoffman LM, 2005, STEM CELL REV, V1, P139, DOI 10.1385/SCR:1:2:139; Hyslop L, 2005, STEM CELLS, V23, P1035, DOI 10.1634/stemcells.2005-0080; Jordan MA, 1996, CANCER RES, V56, P816; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; Krutzik PO, 2005, J IMMUNOL, V175, P2357, DOI 10.4049/jimmunol.175.4.2357; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Li XY, 2009, HUM REPROD, V24, P580, DOI 10.1093/humrep/den404; Martin-Ibanez R, 2008, HUM REPROD, V23, P2744, DOI 10.1093/humrep/den316; Matin MM, 2004, STEM CELLS, V22, P659, DOI 10.1634/stemcells.22-5-659; Michalakis J, 2007, ANN SURG ONCOL, V14, P1220, DOI 10.1245/s10434-006-9305-4; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pakzad M, 2010, STEM CELL REV REP, V6, P96, DOI 10.1007/s12015-009-9103-z; Qin H, 2007, J BIOL CHEM, V282, P5842, DOI 10.1074/jbc.M610464200; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Sena G, 1999, CYTOMETRY, V37, P113, DOI 10.1002/(SICI)1097-0320(19991001)37:2<113::AID-CYTO4>3.0.CO;2-M; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Stewart MH, 2006, NAT METHODS, V3, P807, DOI 10.1038/nmeth939; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Teperek-Tkacz M, 2010, CELL CYCLE, V9, P4674, DOI 10.4161/cc.9.23.14023; Torres K, 1998, CANCER RES, V58, P3620; Trounson A, 2006, ENDOCR REV, V27, P208, DOI 10.1210/er.2005-0016; Vallier L, 2009, STEM CELLS, V27, P2655, DOI 10.1002/stem.199; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; WOODS CM, 1995, MOL MED, V1, P506, DOI 10.1007/BF03401588; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zaehres H, 2005, STEM CELLS, V23, P299, DOI 10.1634/stemcells.2004-0252; Zeineddine D, 2006, DEV CELL, V11, P535, DOI 10.1016/j.devcel.2006.07.013	48	19	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19114	10.1371/journal.pone.0019114	http://dx.doi.org/10.1371/journal.pone.0019114			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559451	Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700066
J	Salehi-Had, H; Roh, MI; Giani, A; Hisatomi, T; Nakao, S; Kim, IK; Gragoudas, ES; Vavvas, D; Guccione, S; Miller, JW				Salehi-Had, Hani; Roh, Mi In; Giani, Andrea; Hisatomi, Toshio; Nakao, Shintaro; Kim, Ivana K.; Gragoudas, Evangelos S.; Vavvas, Demetrios; Guccione, Samira; Miller, Joan W.			Utilizing Targeted Gene Therapy with Nanoparticles Binding Alpha v Beta 3 for Imaging and Treating Choroidal Neovascularization	PLOS ONE			English	Article							MACULAR DEGENERATION; INTEGRIN ALPHA(V)BETA(3); PHOTODYNAMIC THERAPY; RETINAL NEOVASCULARIZATION; VISUAL IMPAIRMENT; TUMOR-REGRESSION; CELL-SURVIVAL; ANGIOGENESIS; DELIVERY; MODEL	Purpose: The integrin avb3 is differentially expressed on neovascular endothelial cells. We investigated whether a novel intravenously injectable avb3 integrin-ligand coupled nanoparticle (NP) can target choroidal neovascular membranes (CNV) for imaging and targeted gene therapy. Methods: CNV lesions were induced in rats using laser photocoagulation. The utility of NP for in vivo imaging and gene delivery was evaluated by coupling the NP with a green fluorescing protein plasmid (NP-GFPg). Rhodamine labeling (Rd-NP) was used to localize NP in choroidal flatmounts. Rd-NP-GFPg particles were injected intravenously on weeks 1, 2, or 3. In the treatment arm, rats received NP containing a dominant negative Raf mutant gene (NP-ATP mu-Raf) on days 1, 3, and 5. The change in CNV size and leakage, and TUNEL positive cells were quantified. Results: GFP plasmid expression was seen in vivo up to 3 days after injection of Rd-NP-GFPg. Choroidal flatmounts confirmed the localization of the NP and the expression of GFP plasmid in the CNV. Treating the CNV with NP-ATP mu-Raf decreased the CNV size by 42% (P < 0.001). OCT analysis revealed that the reduction of CNV size started on day 5 and reached statistical significance by day 7. Fluorescein angiography grading showed significantly less leakage in the treated CNV (P < 0.001). There were significantly more apoptotic (TUNEL-positive) nuclei in the treated CNV. Conclusion: Systemic administration of avb3 targeted NP can be used to label the abnormal blood vessels of CNV for imaging. Targeted gene delivery with NP-ATP mu-Raf leads to a reduction in size and leakage of the CNV by induction of apoptosis in the CNV.	[Salehi-Had, Hani; Roh, Mi In; Giani, Andrea; Hisatomi, Toshio; Nakao, Shintaro; Kim, Ivana K.; Gragoudas, Evangelos S.; Vavvas, Demetrios; Miller, Joan W.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol,Angiogenesis Lab, Boston, MA 02115 USA; [Guccione, Samira] Stanford Univ, Lucas Ctr, Radiol Sci Lab, Palo Alto, CA 94304 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Stanford University	Salehi-Had, H (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol,Angiogenesis Lab, Boston, MA 02115 USA.	guccione@stanford.edu	; Giani, Andrea/L-5926-2017	Miller, Joan/0000-0003-2046-3996; Vavvas, Demetrios/0000-0002-8622-6478; Roh, Miin/0000-0003-3346-754X; Hisatomi, Toshio/0000-0003-2552-9595; Giani, Andrea/0000-0003-0682-1945; Kim, Ivana/0000-0003-0310-6129	Research to Prevent Blindness (NY); Neovascular Research Fund; AMD Center of Excellence	Research to Prevent Blindness (NY)(Research to Prevent Blindness (RPB)); Neovascular Research Fund; AMD Center of Excellence	This work was supported by: Research to Prevent Blindness (NY) Unrestricted Grant to the Harvard Department of Ophthalmology and Neovascular Research Fund; AMD Center of Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERINSTEIN A, 1995, J VIROL, V69, P2664, DOI 10.1128/JVI.69.4.2664-2666.1995; Blinder KJ, 2003, AM J OPHTHALMOL, V136, P407, DOI 10.1016/S0002-9394(03)00223-X; Bressler NM, 2009, OPHTHALMOLOGY, V116, pS15, DOI 10.1016/j.ophtha.2009.06.048; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; BROOKS PC, 1995, J CLIN INVEST, V96, P1815, DOI 10.1172/JCI118227; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; DAMATO RJ, 1995, OPHTHALMOLOGY, V102, P1261, DOI 10.1016/S0161-6420(95)30876-7; FERRIS FL, 1984, ARCH OPHTHALMOL-CHIC, V102, P1640; Friedlander M, 1996, P NATL ACAD SCI USA, V93, P9764, DOI 10.1073/pnas.93.18.9764; Gaudana R, 2010, AAPS J, V12, P348, DOI 10.1208/s12248-010-9183-3; Gaudreault J, 2005, INVEST OPHTH VIS SCI, V46, P726, DOI 10.1167/iovs.04-0601; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Guccione S, 2004, IEEE ENG MED BIOL, V23, P50, DOI 10.1109/MEMB.2004.1360408; Hammes HP, 1996, NAT MED, V2, P529, DOI 10.1038/nm0596-529; HEIDECKER G, 1990, MOL CELL BIOL, V10, P2503, DOI 10.1128/MCB.10.6.2503; Honda S, 2009, GRAEF ARCH CLIN EXP, V247, P515, DOI 10.1007/s00417-008-1010-5; Hood JD, 2002, SCIENCE, V296, P2404, DOI 10.1126/science.1070200; Huser M, 2001, EMBO J, V20, P1940, DOI 10.1093/emboj/20.8.1940; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Kamizuru H, 2001, INVEST OPHTH VIS SCI, V42, P2664; Kobayashi H, 2006, NANOMEDICINE-UK, V1, P17, DOI 10.2217/17435889.1.1.17; Kumar CC, 2000, ADV EXP MED BIOL, V476, P169; Luna J, 1996, LAB INVEST, V75, P563; Marneros AG, 2007, FASEB J, V21, P3809, DOI 10.1096/fj.07-8422com; Nakazawa T, 2006, MOL VIS, V12, P867; Ning A, 2008, CAN J OPHTHALMOL, V43, P683, DOI 10.3129/i08-145; Pascolini D, 2004, OPHTHAL EPIDEMIOL, V11, P67, DOI 10.1076/opep.11.2.67.28158; Renno RZ, 2004, ARCH OPHTHALMOL-CHIC, V122, P1002, DOI 10.1001/archopht.122.7.1002; ROBBINS SG, 1994, INVEST OPHTH VIS SCI, V35, P3475; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P2743, DOI 10.1167/iovs.02-1246; Scatena MT, 2002, TRENDS CARDIOVAS MED, V12, P83, DOI 10.1016/S1050-1738(01)00151-7; Seddon Johanna M., 2004, International Ophthalmology Clinics, V44, P17, DOI 10.1097/00004397-200404440-00004; She HC, 2007, INVEST OPHTH VIS SCI, V48, P2268, DOI 10.1167/iovs.06-0979; Singh SR, 2009, GENE THER, V16, P645, DOI 10.1038/gt.2008.185; Stromblad S, 1996, CHEM BIOL, V3, P881, DOI 10.1016/S1074-5521(96)90176-3; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; Tang Renhong, 2009, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V34, P762; Thomson H, 2009, NANOMEDICINE-UK, V4, P599, DOI 10.2217/nnm.09.43; Tucker Gordon C, 2003, Curr Opin Investig Drugs, V4, P722; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Yancopoulos GD, 1998, CELL, V93, P661, DOI 10.1016/S0092-8674(00)81426-9; Zacks DN, 2002, INVEST OPHTH VIS SCI, V43, P2384; Zambarakji HJ, 2006, INVEST OPHTH VIS SCI, V47, P2623, DOI 10.1167/iovs.05-0855	45	20	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18864	10.1371/journal.pone.0018864	http://dx.doi.org/10.1371/journal.pone.0018864			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559527	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700029
J	Zhao, ZY; Chen, Y; Wang, J; Sternberg, P; Freeman, ML; Grossniklaus, HE; Cai, JY				Zhao, Zhenyang; Chen, Yan; Wang, Jian; Sternberg, Paul; Freeman, Michael L.; Grossniklaus, Hans E.; Cai, Jiyang			Age-Related Retinopathy in NRF2-Deficient Mice	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NRF2; MACULAR DEGENERATION; CHOROIDAL NEOVASCULARIZATION; FUNDUS AUTOFLUORESCENCE; RETINAL DEGENERATION; GEOGRAPHIC ATROPHY; OXIDATIVE STRESS; BRUCHS MEMBRANE; DRUSEN; AUTOPHAGY	Background: Cumulative oxidative damage is implicated in the pathogenesis of age-related macular degeneration (AMD). Nuclear factor erythroid 2-related factor 2 (NRF2) is a transcription factor that plays key roles in retinal antioxidant and detoxification responses. The purposes of this study were to determine whether NRF2-deficient mice would develop AMD-like retinal pathology with aging and to explore the underlying mechanisms. Methods and Findings: Eyes of both wild type and Nrf2(-/-) mice were examined in vivo by fundus photography and electroretinography (ERG). Structural changes of the outer retina in aged animals were examined by light and electron microscopy, and immunofluorescence labeling. Our results showed that Nrf2(-/-) mice developed age-dependent degenerative pathology in the retinal pigment epithelium (RPE). Drusen-like deposits, accumulation of lipofuscin, spontaneous choroidal neovascularization (CNV) and sub-RPE deposition of inflammatory proteins were present in Nrf2(-/-) mice after 12 months. Accumulation of autophagy-related vacuoles and multivesicular bodies was identified by electron microcopy both within the RPE and in Bruch's membrane of aged Nrf2(-/-) mice. Conclusions: Our data suggest that disruption of Nfe2l2 gene increased the vulnerability of outer retina to age-related degeneration. NRF2-deficient mice developed ocular pathology similar to cardinal features of human AMD and deregulated autophagy is likely a mechanistic link between oxidative injury and inflammation. The Nrf2(-/-) mice can provide a novel model for mechanistic and translational research on AMD.	[Zhao, Zhenyang; Chen, Yan; Wang, Jian; Sternberg, Paul; Cai, Jiyang] Vanderbilt Univ, Med Ctr, Vanderbilt Eye Inst, Nashville, TN 37203 USA; [Freeman, Michael L.] Vanderbilt Univ, Med Ctr, Dept Radiat Oncol, Nashville, TN USA; [Grossniklaus, Hans E.] Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA	Vanderbilt University; Vanderbilt University; Emory University	Zhao, ZY (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Eye Inst, Nashville, TN 37203 USA.	jiyang.cai@vanderbilt.edu	Zhao, Zhenyang/N-3321-2015	Zhao, Zhenyang/0000-0002-1701-3751; Freeman, Michael/0000-0003-1881-366X	International Retinal Research Foundation; Research to Prevent Blindness, Inc.; NIH [EY019706, EY07892, EY08126, CA115556, EY018715]; NATIONAL CANCER INSTITUTE [R01CA115556] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R29EY007892, P30EY008126, R01EY007892, K99EY019706, R21EY018715] Funding Source: NIH RePORTER	International Retinal Research Foundation; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by International Retinal Research Foundation, an unrestricted department grant from Research to Prevent Blindness, Inc. and NIH grants EY019706, EY07892, EY08126, CA115556 and EY018715. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert DM, 2010, ARCH OPHTHALMOL-CHIC, V128, P212, DOI 10.1001/archophthalmol.2009.395; Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Burk RF, 2008, FREE RADICAL BIO MED, V44, P1617, DOI 10.1016/j.freeradbiomed.2008.01.016; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Coleman HR, 2008, LANCET, V372, P1835, DOI 10.1016/S0140-6736(08)61759-6; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Curcio CA, 1999, ARCH OPHTHALMOL-CHIC, V117, P329, DOI 10.1001/archopht.117.3.329; DILORETO D, 1994, CURR EYE RES, V13, P157, DOI 10.3109/02713689409042411; Greco T, 2010, J ALZHEIMERS DIS, V20, pS427, DOI 10.3233/JAD-2010-100519; GREEN WR, 1993, OPHTHALMOLOGY, V100, P1519; GREEN WR, 1996, OPHTHALMIC PATHOLOGY, P1025; Hageman GS, 1999, FASEB J, V13, P477, DOI 10.1096/fasebj.13.3.477; Handa James T., 2007, International Ophthalmology Clinics, V47, P15, DOI 10.1097/IIO.0b013e31802bd546; HERIOT WJ, 1984, OPHTHALMOLOGY, V91, P1603; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Holz FG, 2001, INVEST OPHTH VIS SCI, V42, P1051; Hwang JC, 2006, INVEST OPHTH VIS SCI, V47, P2655, DOI 10.1167/iovs.05-1027; Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103; Innamorato NG, 2008, J IMMUNOL, V181, P680, DOI 10.4049/jimmunol.181.1.680; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Justilien V, 2007, INVEST OPHTH VIS SCI, V48, P4407, DOI 10.1167/iovs.07-0432; Katsuoka F, 2005, MOL CELL BIOL, V25, P8044, DOI 10.1128/MCB.25.18.8044-8051.2005; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Klein R, 2007, OPHTHALMOLOGY, V114, P253, DOI 10.1016/j.ophtha.2006.10.040; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Leiser SF, 2010, MOL CELL BIOL, V30, P871, DOI 10.1128/MCB.01145-09; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Li J, 2001, BRIT J OPHTHALMOL, V85, P287, DOI 10.1136/bjo.85.3.287; Lotery A, 2007, HUM GENET, V122, P219, DOI 10.1007/s00439-007-0406-3; Lukinova N, 2009, INVEST OPHTH VIS SCI, V50, P1440, DOI 10.1167/iovs.08-2545; Malek G, 2005, P NATL ACAD SCI USA, V102, P11900, DOI 10.1073/pnas.0503015102; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; McLeod DS, 2009, INVEST OPHTH VIS SCI, V50, P4982, DOI 10.1167/iovs.09-3639; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Mullins RF, 2001, EYE, V15, P390, DOI 10.1038/eye.2001.142; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Ni MW, 2010, TOXICOL SCI, V116, P590, DOI 10.1093/toxsci/kfq126; Osburn WO, 2008, MUTAT RES-REV MUTAT, V659, P31, DOI 10.1016/j.mrrev.2007.11.006; Pearson KJ, 2008, P NATL ACAD SCI USA, V105, P2325, DOI 10.1073/pnas.0712162105; POLLACK A, 1986, ARCH OPHTHALMOL-CHIC, V104, P1372, DOI 10.1001/archopht.1986.01050210126039; Rojo AI, 2010, GLIA, V58, P588, DOI 10.1002/glia.20947; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Sakaguchi H, 2002, EXP EYE RES, V74, P547, DOI 10.1006/exer.2002.1186; Solbach U, 1997, RETINA-J RET VIT DIS, V17, P385; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Spraul CW, 1997, ARCH OPHTHALMOL-CHIC, V115, P267, DOI 10.1001/archopht.1997.01100150269022; Uno K, 2010, EXP EYE RES, V90, P493, DOI 10.1016/j.exer.2009.12.012; von Ruckmann A, 1999, GRAEF ARCH CLIN EXP, V237, P1, DOI 10.1007/s004170050186; Wakabayashi N, 2010, ANTIOXID REDOX SIGN, V13, P1649, DOI 10.1089/ars.2010.3216; Walter P, 1999, GRAEF ARCH CLIN EXP, V237, P962, DOI 10.1007/s004170050331; Wang AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004160; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Xu HP, 2008, EXP EYE RES, V87, P319, DOI 10.1016/j.exer.2008.06.012; Zhu H, 2008, CARDIOVASC TOXICOL, V8, P115, DOI 10.1007/s12012-008-9020-4	62	213	224	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19456	10.1371/journal.pone.0019456	http://dx.doi.org/10.1371/journal.pone.0019456			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559389	gold, Green Submitted, Green Published			2022-12-27	WOS:000290024700182
J	Baveewo, S; Ssali, F; Karamagi, C; Kalyango, JN; Hahn, JA; Ekoru, K; Mugyenyi, P; Katabira, E				Baveewo, Steven; Ssali, Francis; Karamagi, Charles; Kalyango, Joan N.; Hahn, Judith A.; Ekoru, Kenneth; Mugyenyi, Peter; Katabira, Elly			Validation of World Health Organisation HIV/AIDS Clinical Staging in Predicting Initiation of Antiretroviral Therapy and Clinical Predictors of Low CD4 Cell Count in Uganda	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; LYMPHOCYTE COUNT; POPULATION; NEED	Introduction: The WHO clinical guidelines for HIV/AIDS are widely used in resource limited settings to represent the gold standard of CD4 counts for antiviral therapy initiation. The utility of the WHO-defined stage 1 and 2 clinical factors used in WHO HIV/AIDS clinical staging in predicting low CD4 cell count has not been established in Uganda. Although the WHO staging has shown low sensitivity for predicting CD4 < 200cells/mm(3), it has not been evaluated at for CD4 cut-offs of < 250cells/mm(3) or < 350 cells/mm(3). Objective: To validate the World Health Organisation HIV/AIDS clinical staging in predicting initiation of antiretroviral therapy in a low-resource setting and to determine the clinical predictors of low CD4 cell count in Uganda. Results: Data was collected on 395 participants from the Joint Clinical Research Centre, of whom 242 (61.3%) were classified as in stages 1 and 2 and 262 (68%) were females. Participants had a mean age of 36.8 years (SD 8.5). We found a significant inverse correlation between the CD4 lymphocyte count and WHO clinical stages. The sensitivity the WHO clinical staging at CD4 cell count of 250 cells/mm(3) and 350cells/mm(3) was 53.5% and 49.1% respectively. Angular cheilitis, papular pruritic eruptions and recurrent upper respiratory tract infections were found to be significant predictors of low CD4 cell count among participants in WHO stage 1 and 2. Conclusion: The WHO HIV/AIDS clinical staging guidelines have a low sensitivity and about half of the participants in stages 1 and 2 would be eligible for ART initiation if they had been tested for CD4 count. Angular cheilitis and papular pruritic eruptions and recurrent upper respiratory tract infections may be used, in addition to the WHO staging, to improve sensitivity in the interim, as access to CD4 machines increases in Uganda.	[Baveewo, Steven; Karamagi, Charles; Kalyango, Joan N.; Ekoru, Kenneth] Makerere Univ, Clin Epidemiol Unit, Coll Hlth Sci, Kampala, Uganda; [Kalyango, Joan N.] Makerere Univ, Dept Pharm, Coll Hlth Sci, Kampala, Uganda; [Katabira, Elly] Makerere Univ, Dept Med, Coll Hlth Sci, Kampala, Uganda; [Ssali, Francis; Mugyenyi, Peter] Joint Clin Res Ctr Kampala, Kampala, Uganda; [Hahn, Judith A.] Univ Calif San Francisco, San Francisco Gen Hosp, San Francisco, CA USA; [Baveewo, Steven] Makerere Univ Univ Calif Los Angeles Univ Calif S, Kampala, Uganda	Makerere University; Makerere University; Makerere University; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Baveewo, S (corresponding author), Makerere Univ, Clin Epidemiol Unit, Coll Hlth Sci, Kampala, Uganda.	baveewosteven@yahoo.co.uk	Hahn, Judith/J-5813-2014	Hahn, Judith/0000-0002-2697-8264				Athan E, 2010, AIDS, V24, P1887, DOI 10.1097/QAD.0b013e32833b25ed; Badri M, 2004, AIDS, V18, P1159, DOI 10.1097/00002030-200405210-00009; Costello C, 2005, JAIDS-J ACQ IMM DEF, V39, P242; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Hulley SB, 2007, DESIGNING CLIN RES; Jaffar Shabbar, 2008, AIDS Res Ther, V5, P4, DOI 10.1186/1742-6405-5-4; Kagaayi J, 2007, AIDS, V21, P1208, DOI 10.1097/QAD.0b013e32810c8dce; Kamya Moses R, 2004, Afr Health Sci, V4, P94; Kaplan JE, 2003, CLIN INFECT DIS, V37, P951, DOI 10.1086/377606; MARTINSON N, 2005, 3 INT AIDS SOC C HIV; McGrath N, 2007, AIDS, V21, pS105, DOI 10.1097/01.aids.0000299417.69432.65; Miiro G, 2010, TROP MED INT HEALTH, V15, P396, DOI 10.1111/j.1365-3156.2010.02471.x; Morpeth SC, 2007, AIDS RES HUM RETROV, V23, P1230, DOI 10.1089/aid.2007.0053; Spacek LA, 2003, AIDS, V17, P1311, DOI 10.1097/00002030-200306130-00005; Torpey K, 2009, INT J STD AIDS, V20, P395, DOI 10.1258/ijsa.2008.008333; UGANDA MH, 2003, NAT ANT TREATM CAR G; UNAIDS, 2008, REP GLOB AIDS EP; WHO, 2006, GUID ANT THER HIV IN; WHO Expert Committee on Problems Related to Alcohol Consumption World Health Organization, 2007, WHO GLOB CONS M IND, P19; World Health Organization (WHO), 2005, INT WHO CLIN STAG HV, P513	20	15	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19089	10.1371/journal.pone.0019089	http://dx.doi.org/10.1371/journal.pone.0019089			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589912	Green Submitted, gold, Green Published			2022-12-27	WOS:000290531100004
J	Bridges, M; Heron, EA; O'Dushlaine, C; Segurado, R; Morris, D; Corvin, A; Gill, M; Pinto, C				Bridges, Michael; Heron, Elizabeth A.; O'Dushlaine, Colm; Segurado, Ricardo; Morris, Derek; Corvin, Aiden; Gill, Michael; Pinto, Carlos		ISC	Genetic Classification of Populations Using Supervised Learning	PLOS ONE			English	Article							NETWORKS	There are many instances in genetics in which we wish to determine whether two candidate populations are distinguishable on the basis of their genetic structure. Examples include populations which are geographically separated, case-control studies and quality control (when participants in a study have been genotyped at different laboratories). This latter application is of particular importance in the era of large scale genome wide association studies, when collections of individuals genotyped at different locations are being merged to provide increased power. The traditional method for detecting structure within a population is some form of exploratory technique such as principal components analysis. Such methods, which do not utilise our prior knowledge of the membership of the candidate populations. are termed unsupervised. Supervised methods, on the other hand are able to utilise this prior knowledge when it is available. In this paper we demonstrate that in such cases modern supervised approaches are a more appropriate tool for detecting genetic differences between populations. We apply two such methods, (neural networks and support vector machines) to the classification of three populations (two from Scotland and one from Bulgaria). The sensitivity exhibited by both these methods is considerably higher than that attained by principal components analysis and in fact comfortably exceeds a recently conjectured theoretical limit on the sensitivity of unsupervised methods. In particular, our methods can distinguish between the two Scottish populations, where principal components analysis cannot. We suggest, on the basis of our results that a supervised learning approach should be the method of choice when classifying individuals into predefined populations, particularly in quality control for large scale genome wide association studies.	[Bridges, Michael] Univ Cambridge, Cavendish Lab, Astrophys Grp, Cambridge CB3 0HE, England; [Heron, Elizabeth A.; O'Dushlaine, Colm; Segurado, Ricardo; Morris, Derek; Corvin, Aiden; Gill, Michael; Pinto, Carlos] Trinity Coll Dublin, Neuropsychiat Genet Res Grp, Dept Psychiat, Dublin, Ireland	University of Cambridge; Trinity College Dublin	Bridges, M (corresponding author), Univ Cambridge, Cavendish Lab, Astrophys Grp, Cambridge CB3 0HE, England.	capinto@tcd.ie	macedo, antónio/AFQ-1571-2022; Heron, Elizabeth Ann/HCI-9636-2022; Morris, Derek/AAW-8343-2021; Fanous, Ayman H/O-1263-2017; McQuillin, Andrew/C-1623-2008; O'Donovan, Michael C/P-7005-2018; Williams, Hywel/AAL-2440-2021; macedo santos, antónio/M-5737-2013; Visscher, Peter/ABB-6151-2020; macedo, antónio/AFQ-1570-2022; Ruderfer, Douglas M/M-5795-2016; Segurado, Ricardo/K-6116-2014; Morley, Christopher P/K-1907-2014	macedo, antónio/0000-0003-2180-2718; Heron, Elizabeth Ann/0000-0003-2219-4005; Morris, Derek/0000-0002-3413-570X; McQuillin, Andrew/0000-0003-1567-2240; O'Donovan, Michael C/0000-0001-7073-2379; Williams, Hywel/0000-0001-7758-0312; macedo santos, antónio/0000-0003-2180-2718; Visscher, Peter/0000-0002-2143-8760; macedo, antónio/0000-0003-2180-2718; Ruderfer, Douglas M/0000-0002-2365-386X; Toncheva, Draga/0000-0002-7451-6363; Gill, Michael/0000-0003-0206-5337; Newton-Bishop, Julia/0000-0001-9147-6802; Corvin, Aiden/0000-0001-6717-4089; Segurado, Ricardo/0000-0002-3547-6733; Middleton, Frank/0000-0002-3107-7188; lichtenstein, paul/0000-0003-3037-5287; Walters, James/0000-0002-6980-4053; Morley, Christopher P/0000-0003-0185-7148; Quested, Digby/0000-0001-6155-3336	Wellcome Trust; Science Foundation Ireland; UK Science and Technology Research Council; Cambridge Centre for High Performance Computing; Medical Research Council [G0801418B] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); UK Science and Technology Research Council; Cambridge Centre for High Performance Computing; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project has not been directly funded by any agency. The authors employed on research contracts are supported by the Wellcome Trust (http://www.wellcome.ac.uk), Science Foundation Ireland (http://www.sfi.ie), and the UK Science and Technology Research Council (http://www.stfc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; We thank the individuals and families who contributed data to the International Schizophrenia Consortium. We are grateful to the reviewers for their constructive comments. We thank the members of the Statistical Genetics Unit in the Neuropsychiatric Genetics Group for helpful comments and advice at all stages of this work. We acknowledge Anthony Ryan for reviewing and commenting on this manuscript. The authors would like to acknowledge support from the Cambridge Centre for High Performance Computing where this work was carried out, and also to Stuart Rankin for computational assistance. Additionally we acknowledge Steve Gull for useful discussions and for the use of MemSys in this application.	Baik J, 2006, J MULTIVARIATE ANAL, V97, P1382, DOI 10.1016/j.jmva.2005.08.003; BAILERJONES C, 2001, AUTOMATED DATA ANAL; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Curtis D, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-49; JAYNES E, 2003, PROBABILITY THEOR LO; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; LESHNO M, 1993, NEURAL NETWORKS, V6, P861, DOI 10.1016/S0893-6080(05)80131-5; Motsinger-Reif AA, 2008, BIODATA MIN, V1, DOI 10.1186/1756-0381-1-3; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; North BV, 2003, ANN HUM GENET, V67, P348, DOI 10.1046/j.1469-1809.2003.00030.x; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Penco S, 2005, ANN HUM GENET, V69, P693, DOI 10.1111/j.1529-8817.2005.00206.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; SERETTI A, 2004, BMC MED GENET, V5, P27; Skilling J., 1999, QUANTIFIED MAXIMUM E	18	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e14802	10.1371/journal.pone.0014802	http://dx.doi.org/10.1371/journal.pone.0014802			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589856	Green Published, gold, Green Submitted			2022-12-27	WOS:000290531100001
J	Mahn, F; Hullemann, P; Gockel, U; Brosz, M; Freynhagen, R; Tolle, TR; Baron, R				Mahn, Friederike; Huellemann, Philipp; Gockel, Ulrich; Brosz, Mathias; Freynhagen, Rainer; Toelle, Thomas R.; Baron, Ralf			Sensory Symptom Profiles and Co-Morbidities in Painful Radiculopathy	PLOS ONE			English	Article							LOW-BACK-PAIN; NEUROPATHIC PAIN; RADICULAR PAIN; QUESTIONNAIRE; DEGENERATION; EXPRESSION; DEPRESSION; DISC	Painful radiculopathies (RAD) and classical neuropathic pain syndromes (painful diabetic polyneuropathy, postherpetic neuralgia) show differences how the patients express their sensory perceptions. Furthermore, several clinical trials with neuropathic pain medications failed in painful radiculopathy. Epidemiological and clinical data of 2094 patients with painful radiculopathy were collected within a cross sectional survey (painDETECT) to describe demographic data and co-morbidities and to detect characteristic sensory abnormalities in patients with RAD and compare them with other neuropathic pain syndromes. Common co-morbidities in neuropathic pain (depression, sleep disturbance, anxiety) do not differ considerably between the three conditions. Compared to other neuropathic pain syndromes touch-evoked allodynia and thermal hyperalgesia are relatively uncommon in RAD. One distinct sensory symptom pattern (sensory profile), i.e., severe painful attacks and pressure induced pain in combination with mild spontaneous pain, mild mechanical allodynia and thermal hyperalgesia, was found to be characteristic for RAD. Despite similarities in sensory symptoms there are two important differences between RAD and other neuropathic pain disorders: (1) The paucity of mechanical allodynia and thermal hyperalgesia might be explained by the fact that the site of the nerve lesion in RAD is often located proximal to the dorsal root ganglion. (2) The distinct sensory profile found in RAD might be explained by compression-induced ectopic discharges from a dorsal root and not necessarily by nerve damage. These differences in pathogenesis might explain why medications effective in DPN and PHN failed to demonstrate efficacy in RAD.	[Mahn, Friederike; Huellemann, Philipp; Baron, Ralf] Univ Klinikum Schleswig Holstein, Sekt Neurol Schmerzforsch & Therapie, Neurol Klin, Kiel, Germany; [Gockel, Ulrich] CASQUAR GmbH, Comp Assoziierte Qualitatssicherung & Rehabil For, Bochum, Germany; [Brosz, Mathias] StatConsult GmbH, Magdeburg, Germany; [Freynhagen, Rainer] Benedictus Krankenhaus Tutzing, Zentrum Anasthesiol Intensivmed Schmerztherapie &, Tutzing, Germany; [Toelle, Thomas R.] Tech Univ Munich, Neurol Klin, Munich, Germany	University of Kiel; Schleswig Holstein University Hospital; Technical University of Munich	Mahn, F (corresponding author), Univ Klinikum Schleswig Holstein, Sekt Neurol Schmerzforsch & Therapie, Neurol Klin, Campus Kiel, Kiel, Germany.	r.baron@neurologie.uni-kiel.de		Freynhagen, Rainer/0000-0002-3759-1508	Pfizer Germany; Pfizer at 450 outpatient centers throughout Germany	Pfizer Germany(Pfizer); Pfizer at 450 outpatient centers throughout Germany	This research was supported by a grant from Pfizer Germany. Data were collected within the PainDetect project, which was funded by Pfizer at 450 outpatient centers throughout Germany. The funder had no role in study design, analysis, decision to publish, or preparation of the manuscript. The lead investigators (RB, RF, TRT) designed the study in collaboration with the DFNS. MB is statistician at StatConsult GmbH, Germany. StatConsult maintains painDETECT, and supports research technically as well as statistically. UG was an employee of Pfizer Germany in the past twelve years. UG developed, programmed and supported the technical devices.	Baron R, 2010, PAIN, V150, P420, DOI 10.1016/j.pain.2010.04.013; Baron R, 2009, PAIN, V146, P34, DOI 10.1016/j.pain.2009.06.001; Bogduk N, 2009, PAIN, V147, P17, DOI 10.1016/j.pain.2009.08.020; Daniel HC, 2008, EUR J PAIN, V12, P731, DOI 10.1016/j.ejpain.2007.11.006; Freynhagen R, 2008, PAIN, V135, P65, DOI 10.1016/j.pain.2007.05.004; Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488; HOWE JF, 1977, PAIN, V3, P25, DOI 10.1016/0304-3959(77)90033-1; Junker U, 2008, CURR MED RES OPIN, V24, P1797, DOI 10.1185/03007990802121059; Khoromi S, 2005, J PAIN, V6, P829, DOI 10.1016/j.jpain.2005.08.002; Khoromi S, 2007, PAIN, V130, P66, DOI 10.1016/j.pain.2006.10.029; LaCroix-Fralish ML, 2006, ANESTHESIOLOGY, V104, P1283, DOI 10.1097/00000542-200606000-00025; Linton SJ, 2000, SPINE, V25, P1148, DOI 10.1097/00007632-200005010-00017; Lowe B, 2004, J AFFECT DISORDERS, V81, P61, DOI 10.1016/S0165-0327(03)00198-8; Manchikanti Laxmaiah, 2002, Pain Physician, V5, P149; Merskey H., 1994, CLASSIFICATION CHRON, V2nd ed; Meyer T, 2007, SPINE, V32, P2380, DOI 10.1097/BRS.0b013e3181557955; Moldovan M, 2009, BRAIN, V132, P511, DOI 10.1093/brain/awn332; Nakata M, 2008, MUSCLE NERVE, V37, P721, DOI 10.1002/mus.21031; Palmgren T, 1996, SPINE, V21, P1301, DOI 10.1097/00007632-199606010-00004; Shamji MF, 2009, SPINE, V34, P648, DOI 10.1097/BRS.0b013e318197f013; SMYTH MJ, 1958, J BONE JOINT SURG AM, V40, P1401, DOI 10.2106/00004623-195840060-00016; SULLIVAN MJL, 1992, PAIN, V50, P5, DOI 10.1016/0304-3959(92)90107-M; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Wu G, 2002, J NEUROSCI, V22, P7746	24	60	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e18018	10.1371/journal.pone.0018018	http://dx.doi.org/10.1371/journal.pone.0018018			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573064	Green Published, gold, Green Submitted			2022-12-27	WOS:000290386800002
J	Turk, S; Verlaine, O; Gerards, T; Zivec, M; Humljan, J; Sosic, I; Amoroso, A; Zervosen, A; Luxen, A; Joris, B; Gobec, S				Turk, Samo; Verlaine, Olivier; Gerards, Thomas; Zivec, Matej; Humljan, Jan; Sosic, Izidor; Amoroso, Ana; Zervosen, Astrid; Luxen, Andre; Joris, Bernard; Gobec, Stanislav			New Noncovalent Inhibitors of Penicillin-Binding Proteins from Penicillin-Resistant Bacteria	PLOS ONE			English	Article							BETA-LACTAM RESISTANCE; STAPHYLOCOCCUS-AUREUS; CRYSTAL-STRUCTURE	Background: Penicillin-binding proteins (PBPs) are well known and validated targets for antibacterial therapy. The most important clinically used inhibitors of PBPs beta-lactams inhibit transpeptidase activity of PBPs by forming a covalent penicilloyl-enzyme complex that blocks the normal transpeptidation reaction; this finally results in bacterial death. In some resistant bacteria the resistance is acquired by active-site distortion of PBPs, which lowers their acylation efficiency for beta-lactams. To address this problem we focused our attention to discovery of novel noncovalent inhibitors of PBPs. Methodology/Principal Findings: Our in-house bank of compounds was screened for inhibition of three PBPs from resistant bacteria: PBP2a from Methicillin-resistant Staphylococcus aureus (MRSA), PBP2x from Streptococcus pneumoniae strain 5204, and PBP5fm from Enterococcus faecium strain D63r. Initial hit inhibitor obtained by screening was then used as a starting point for computational similarity searching for structurally related compounds and several new noncovalent inhibitors were discovered. Two compounds had promising inhibitory activities of both PBP2a and PBP2x 5204, and good in-vitro antibacterial activities against a panel of Gram-positive bacterial strains. Conclusions: We found new noncovalent inhibitors of PBPs which represent important starting points for development of more potent inhibitors of PBPs that can target penicillin-resistant bacteria.	[Turk, Samo; Zivec, Matej; Humljan, Jan; Sosic, Izidor; Gobec, Stanislav] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia; [Verlaine, Olivier; Amoroso, Ana; Joris, Bernard] Univ Liege, Ctr Prot Engn, Liege, Belgium; [Gerards, Thomas; Zervosen, Astrid; Luxen, Andre] Univ Liege, Organ Chem Lab, Liege, Belgium; [Humljan, Jan] Lek Pharmaceut DD, Menges, Slovenia	University of Ljubljana; University of Liege; University of Liege; Novartis	Turk, S (corresponding author), Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia.	gobecs@ffa.uni-lj.si	Turk, Samo/C-3905-2012; Turk, Samo/ABD-5492-2021	Turk, Samo/0000-0003-2044-7670; Turk, Samo/0000-0003-2044-7670; Sosic, Izidor/0000-0002-3370-4587; Gobec, Stanislav/0000-0002-9678-3083				ADAM M, 1990, BIOCHEM J, V270, P525, DOI 10.1042/bj2700525; Carapito R, 2006, J BIOL CHEM, V281, P1771, DOI 10.1074/jbc.M511506200; Chambers HF, 1997, CLIN MICROBIOL REV, V10, P781, DOI 10.1128/CMR.10.4.781; Clinical and Laboratory Standards Institute (CLSI), 2009, METHODS DILUTION ANT, V8th ed.; Dessen A, 2001, J BIOL CHEM, V276, P45106, DOI 10.1074/jbc.M107608200; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; *ESCMID, 2003, E DIS; Feng BY, 2006, NAT PROTOC, V1, P550, DOI 10.1038/nprot.2006.77; Humljan J, 2008, J MED CHEM, V51, P7486, DOI 10.1021/jm800762u; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; LAKAYE B, 1994, BIOCHEM J, V300, P141, DOI 10.1042/bj3000141; Lemaire S, 2009, ANTIMICROB AGENTS CH, V53, P2289, DOI 10.1128/AAC.01135-08; Lim D, 2002, NAT STRUCT BIOL, V9, P870, DOI 10.1038/nsb858; Macheboeuf P, 2007, NAT CHEM BIOL, V3, P565, DOI 10.1038/nchembio.2007.21; Macheboeuf P, 2006, FEMS MICROBIOL REV, V30, P673, DOI 10.1111/j.1574-6976.2006.00024.x; Miguet L, 2009, J MED CHEM, V52, P5926, DOI 10.1021/jm900625q; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Rarey M, 2001, J COMPUT AID MOL DES, V15, P497, DOI 10.1023/A:1011144622059; Sauvage E, 2002, CELL MOL LIFE SCI, V59, P1223, DOI 10.1007/s00018-002-8500-0; SCHWYZER R, 1954, HELV CHIM ACTA, V37, P155, DOI 10.1002/hlca.19540370119; Shoichet BK, 2006, DRUG DISCOV TODAY, V11, P607, DOI 10.1016/j.drudis.2006.05.014; Toney JH, 1998, ANAL BIOCHEM, V255, P113, DOI 10.1006/abio.1997.2458; Wilke MS, 2005, CURR OPIN MICROBIOL, V8, P525, DOI 10.1016/j.mib.2005.08.016; Wu SW, 2001, J BACTERIOL, V183, P2417, DOI 10.1128/JB.183.8.2417-2424.2001; Zervosen A, 2004, ANTIMICROB AGENTS CH, V48, P961, DOI 10.1128/AAC.48.3.961-969.2004	25	29	30	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19418	10.1371/journal.pone.0019418	http://dx.doi.org/10.1371/journal.pone.0019418			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573060	gold, Green Submitted, Green Published			2022-12-27	WOS:000290386800012
J	Kajla, MK; Shi, L; Li, B; Luckhart, S; Li, JY; Paskewitz, SM				Kajla, Mayur K.; Shi, Lei; Li, Bin; Luckhart, Shirley; Li, Jianyong; Paskewitz, Susan M.			A New Role for an Old Antimicrobial: Lysozyme c-1 Can Function to Protect Malaria Parasites in Anopheles Mosquitoes	PLOS ONE			English	Article							PLASMODIUM-BERGHEI; SEPHADEX BEADS; GAMBIAE; MELANIZATION; LAMININ; DETERMINANT; ACTIVATION; INVASION; SURFACE; BINDS	Background: Plasmodium requires an obligatory life stage in its mosquito host. The parasites encounter a number of insults while journeying through this host and have developed mechanisms to avoid host defenses. Lysozymes are a family of important antimicrobial immune effectors produced by mosquitoes in response to microbial challenge. Methodology/Principal Findings: A mosquito lysozyme was identified as a protective agonist for Plasmodium. Immunohistochemical analyses demonstrated that Anopheles gambiae lysozyme c-1 binds to oocysts of Plasmodium berghei and Plasmodium falciparum at 2 and 5 days after infection. Similar results were observed with Anopheles stephensi and P. falciparum, suggesting wide occurrence of this phenomenon across parasite and vector species. Lysozyme c-1 did not bind to cultured ookinetes nor did recombinant lysozyme c-1 affect ookinete viability. dsRNA-mediated silencing of LYSC-1 in Anopheles gambiae significantly reduced the intensity and the prevalence of Plasmodium berghei infection. We conclude that this host antibacterial protein directly interacts with and facilitates development of Plasmodium oocysts within the mosquito. Conclusions/Significance: This work identifies mosquito lysozyme c-1 as a positive mediator of Plasmodium development as its reduction reduces parasite load in the mosquito host. These findings improve our understanding of parasite development and provide a novel target to interrupt parasite transmission to human hosts.	[Kajla, Mayur K.; Shi, Lei; Li, Bin; Paskewitz, Susan M.] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; [Shi, Lei] Univ Wisconsin, Sch Med & Publ Hlth, Sect Allergy Pulm & Crit Care, Dept Med, Madison, WI 53706 USA; [Li, Bin] Univ Calif Davis, Microbiol Sect, Coll Biol Sci, Davis, CA 95616 USA; [Luckhart, Shirley] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Li, Jianyong] Virginia Tech, Dept Biochem, Blacksburg, VA USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Davis; University of California System; University of California Davis; Virginia Polytechnic Institute & State University	Kajla, MK (corresponding author), Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA.	paskewit@entomology.wisc.edu			NIH [AI037083]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037083] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant AI037083 to SP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adini A, 1999, PARASITOLOGY, V119, P331, DOI 10.1017/S0031182099004874; Ahmed AM, 2002, OIKOS, V97, P371, DOI 10.1034/j.1600-0706.2002.970307.x; Arrighi RBG, 2005, J EXP BIOL, V208, P2497, DOI 10.1242/jeb.01664; Bedoya RJU, 2005, INSECT MOL BIOL, V14, P89, DOI 10.1111/j.1365-2583.2004.00534.x; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Callewaert L, 2010, J BIOSCIENCES, V35, P127, DOI 10.1007/s12038-010-0015-5; Castillo JC, 2006, INSECT BIOCHEM MOLEC, V36, P891, DOI 10.1016/j.ibmb.2006.08.010; CHUN JD, 1995, J INVERTEBR PATHOL, V66, P11, DOI 10.1006/jipa.1995.1054; CLARKE AJ, 1992, CAN J MICROBIOL, V38, P85, DOI 10.1139/m92-014; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; Dessens JT, 2003, MOL MICROBIOL, V49, P319, DOI 10.1046/j.1365-2958.2003.03566.x; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Gandhe AS, 2007, INSECT BIOCHEM MOLEC, V37, P655, DOI 10.1016/j.ibmb.2007.03.013; Gao Y, 2000, INSECT MOL BIOL, V9, P553, DOI 10.1046/j.1365-2583.2000.00216.x; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; Hultmark D., 1996, Experientia Supplementum (Basel), V75, P87; Kajla MK, 2010, COMP BIOCHEM PHYS B, V155, P201, DOI 10.1016/j.cbpb.2009.11.012; Kotsyfakis M, 2005, MOL MICROBIOL, V57, P171, DOI 10.1111/j.1365-2958.2005.04664.x; Li B, 2005, GENE, V360, P131, DOI 10.1016/j.gene.2005.07.001; Li B, 2006, J INSECT PHYSIOL, V52, P936, DOI 10.1016/j.jinsphys.2006.06.002; Mahairaki V, 2005, MOL BIOCHEM PARASIT, V140, P119, DOI 10.1016/j.molbiopara.2004.11.012; MEIS JFGM, 1989, PARASITOL RES, V76, P13, DOI 10.1007/BF00931065; Moss JM, 1997, ARCH BIOCHEM BIOPHYS, V348, P49, DOI 10.1006/abbi.1997.0365; Nacer A, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-33; Nakimbugwe D, 2006, INT J FOOD MICROBIOL, V108, P355, DOI 10.1016/j.ijfoodmicro.2005.11.021; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; Park PW, 1996, J INVEST DERMATOL, V106, P1075, DOI 10.1111/1523-1747.ep12339292; Paskewitz SM, 1999, INSECT MOL BIOL, V8, P329, DOI 10.1046/j.1365-2583.1999.83124.x; Paskewitz SM, 1998, EXP PARASITOL, V90, P34, DOI 10.1006/expr.1998.4305; REDDY JT, 1990, J INSECT PHYSIOL, V36, P397, DOI 10.1016/0022-1910(90)90057-M; Rodrigues J, 2010, SCIENCE, V329, P1353, DOI 10.1126/science.1190689; SALAZAR CE, 1993, NUCLEIC ACIDS RES, V21, P4147, DOI 10.1093/nar/21.17.4147; Surachetpong W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000366; Vlachou D, 2005, CURR BIOL, V15, P1185, DOI 10.1016/j.cub.2005.06.044; Vlachou D, 2001, MOL BIOCHEM PARASIT, V112, P229, DOI 10.1016/S0166-6851(00)00371-6; WINGER LA, 1988, PARASITE IMMUNOL, V10, P193, DOI 10.1111/j.1365-3024.1988.tb00214.x; Yu KH, 2002, DEV COMP IMMUNOL, V26, P707, DOI 10.1016/S0145-305X(02)00027-7	39	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19649	10.1371/journal.pone.0019649	http://dx.doi.org/10.1371/journal.pone.0019649			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573077	Green Submitted, gold, Green Published			2022-12-27	WOS:000290305600039
J	Oliveira, FL; Brand, C; Paula, AA; Arcanjo, KD; Hsu, DK; Liu, FT; Takiya, CM; Borojevic, R; Chammas, R; El-Cheikh, MC				Oliveira, Felipe L.; Brand, Camila; Paula, Adelzon A.; Arcanjo, Katia D.; Hsu, Daniel K.; Liu, Fu-Tong; Takiya, Christina M.; Borojevic, Radovan; Chammas, Roger; El-Cheikh, Marcia C.			Lack of Galectin-3 Disturbs Mesenteric Lymph Node Homeostasis and B Cell Niches in the Course of Schistosoma mansoni Infection	PLOS ONE			English	Article							EXPERIMENTAL MURINE SCHISTOSOMIASIS; T-CELL; IMMUNE; LYMPHOCYTES; MACROPHAGES; EXPRESSION; DIFFERENTIATION; RESPONSES; INCREASE; GLYCANS	Galectin-3 is a beta-galactoside-binding protein that has been shown to regulate pathophysiological processes, including cellular activation, differentiation and apoptosis. Recently, we showed that galectin-3 acts as a potent inhibitor of B cell differentiation into plasma cells. Here, we have investigated whether galectin-3 interferes with the lymphoid organization of B cell compartments in mesenteric lymph nodes (MLNs) during chronic schistosomiasis, using WT and galectin-3(-/-) mice. Schistosoma mansoni synthesizes GalNAc beta 1-4(Fuc alpha 1-3) GlcNAc(Lac-DiNAc) structures (N-acetylgalactosamine beta 1-4 N-acetylglucosamine), which are known to interact with galectin-3 and elicit an intense humoral response. Antigens derived from the eggs and adult worms are continuously drained to MLNs and induce a polyclonal B cell activation. In the present work, we observed that chronically-infected galectin-3(-/-) mice exhibited a significant reduced amount of macrophages and B lymphocytes followed by drastic histological changes in B lymphocyte and plasma cell niches in the MLNs. The lack of galectin-3 favored an increase in the lymphoid follicle number, but made follicular cells more susceptible to apoptotic stimuli. There were an excessive quantity of apoptotic bodies, higher number of annexin V+/PI- cells, and reduced clearance of follicular apoptotic cells in the course of schistosomiasis. Here, we observed that galectin-3 was expressed in nonlymphoid follicular cells and its absence was associated with severe damage to tissue architecture. Thus, we convey new information on the role of galectin-3 in regulation of histological events associated with B lymphocyte and plasma cell niches, apoptosis, phagocytosis and cell cycle properties in the MLNs of mice challenged with S. mansoni.	[Oliveira, Felipe L.; Brand, Camila; Paula, Adelzon A.; Arcanjo, Katia D.; Borojevic, Radovan; El-Cheikh, Marcia C.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Proliferacao & Diferenciacao Celular, Rio De Janeiro, Brazil; [Hsu, Daniel K.; Liu, Fu-Tong] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA; [Takiya, Christina M.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Patol Celular, Rio De Janeiro, Brazil; [Chammas, Roger] Univ Sao Paulo, Fac Med, Dept Radiol & Oncol, Expt Oncol Lab, Sao Paulo, Brazil; [Chammas, Roger] Inst Canc Estado Sao Paulo, Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro; University of California System; University of California Davis; Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo	Oliveira, FL (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Proliferacao & Diferenciacao Celular, Rio De Janeiro, Brazil.	felipe@histo.ufrj.br; marcia@histo.ufrj.br	Oliveira, Felipe L/H-9902-2012; Liu, FU-TONG/A-5749-2019; Borojevic, Radovan/V-8500-2019; Chammas, Roger/A-8004-2011; Takiya, Christina/AAU-5959-2021; Brand, Camila/D-8873-2014	Liu, FU-TONG/0000-0002-3354-1001; Borojevic, Radovan/0000-0002-2393-7280; Chammas, Roger/0000-0003-0342-8726; Takiya, Christina/0000-0002-8019-628X; Leite de Oliveira, Felipe/0000-0001-6193-1616	Conselho Nacional de Pesquisa e Desenvolvimento (CNPq) [472553/2008-9]; Fundacoes de Amparo a Pesquisa do Estado do Rio de Janeiro e de Sao Paulo (FAPERJ); FAPESP; Associacao Paul Ehrlich de Biologia Celular Aplicada a Medicina (APABCAM)	Conselho Nacional de Pesquisa e Desenvolvimento (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacoes de Amparo a Pesquisa do Estado do Rio de Janeiro e de Sao Paulo (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Associacao Paul Ehrlich de Biologia Celular Aplicada a Medicina (APABCAM)	This work was supported by Conselho Nacional de Pesquisa e Desenvolvimento (CNPq - 472553/2008-9); Fundacoes de Amparo a Pesquisa do Estado do Rio de Janeiro e de Sao Paulo (FAPERJ and FAPESP) and Associacao Paul Ehrlich de Biologia Celular Aplicada a Medicina (APABCAM). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2004, J IMMUNOL, V172, P493, DOI 10.4049/jimmunol.172.1.493; Angelin-Duclos C, 2000, J IMMUNOL, V165, P5462, DOI 10.4049/jimmunol.165.10.5462; Benson MJ, 2007, CURR OPIN IMMUNOL, V19, P275, DOI 10.1016/j.coi.2007.04.009; BOROJEVIC R, 1992, MEM I OSWALDO CRUZ, V87, P171, DOI 10.1590/S0074-02761992000800026; Breuilh L, 2007, INFECT IMMUN, V75, P5148, DOI 10.1128/IAI.02006-06; Colnot C, 1998, IMMUNOLOGY, V94, P290, DOI 10.1046/j.1365-2567.1998.00517.x; Dietz AB, 2000, BIOCHEM BIOPH RES CO, V275, P731, DOI 10.1006/bbrc.2000.3372; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; El-Cheikh MC, 1998, IMMUNOBIOLOGY, V199, P51, DOI 10.1016/S0171-2985(98)80063-6; ELCHEIKH MC, 1994, BRAZ J MED BIOL RES, V27, P1605; ELCHEIKH MC, 1990, INFECT IMMUN, V58, P816, DOI 10.1128/IAI.58.3.816-821.1990; GRZYCH JM, 1991, J IMMUNOL, V146, P1322; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Hoyer KK, 2004, AM J PATHOL, V164, P893, DOI 10.1016/S0002-9440(10)63177-X; Hsu DK, 2000, AM J PATHOL, V156, P1073, DOI 10.1016/S0002-9440(10)64975-9; Joo HG, 2001, J LEUKOCYTE BIOL, V69, P555; Karlsson MCI, 2003, J EXP MED, V198, P333, DOI 10.1084/jem.20030684; KRAAL G, 1987, SCAND J IMMUNOL, V26, P653, DOI 10.1111/j.1365-3083.1987.tb02301.x; Lenzi HL, 1996, BRAZ J MED BIOL RES, V29, P19; LIU FT, 1995, AM J PATHOL, V147, P1016; Lundy SK, 2001, INFECT IMMUN, V69, P271, DOI 10.1128/IAI.69.1.271-280.2001; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Miyake Y, 2007, J CLIN INVEST, V117, P2268, DOI 10.1172/JCI31990; Montalvao F, 2010, EUR J IMMUNOL, V40, P417, DOI 10.1002/eji.200939606; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Nakamura M, 1996, EUR J IMMUNOL, V26, P1211, DOI 10.1002/eji.1830260604; Nyame AK, 2003, EXP PARASITOL, V104, P1, DOI 10.1016/S0014-4894(03)00110-3; Oliveira FL, 2007, J LEUKOCYTE BIOL, V82, P300, DOI 10.1189/jlb.1206747; Oliveira FL, 2009, GLYCOBIOLOGY, V19, P1248, DOI 10.1093/glycob/cwp120; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Sano H, 2000, J IMMUNOL, V165, P2156, DOI 10.4049/jimmunol.165.4.2156; Sano H, 2003, J CLIN INVEST, V112, P389, DOI 10.1172/JCI200317592; Smith J P, 1998, Dev Immunol, V6, P285, DOI 10.1155/1998/38923; van den Berg TK, 2004, J IMMUNOL, V173, P1902, DOI 10.4049/jimmunol.173.3.1902; Villa-Verde DMS, 2002, EUR J IMMUNOL, V32, P1434, DOI 10.1002/1521-4141(200205)32:5<1434::AID-IMMU1434>3.0.CO;2-M; VINDELOV LL, 1980, CANCER RES, V40, P4295; Willard-Mack CL, 2006, TOXICOL PATHOL, V34, P409, DOI 10.1080/01926230600867727; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737	41	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19216	10.1371/journal.pone.0019216	http://dx.doi.org/10.1371/journal.pone.0019216			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573150	Green Published, Green Submitted, gold			2022-12-27	WOS:000290305600015
J	Boegsted, M; Holst, JM; Fogd, K; Falgreen, S; Sorensen, S; Schmitz, A; Bukh, A; Johnsen, HE; Nyegaard, M; Dybkaer, K				Boegsted, Martin; Holst, Johanne M.; Fogd, Kirsten; Falgreen, Steffen; Sorensen, Suzette; Schmitz, Alexander; Bukh, Anne; Johnsen, Hans E.; Nyegaard, Mette; Dybkaer, Karen			Generation of a Predictive Melphalan Resistance Index by Drug Screen of B-Cell Cancer Cell Lines	PLOS ONE			English	Article							CHONDROITIN SULFATE; HEPARAN-SULFATE; CHEMOSENSITIVITY; EXPRESSION; TARGET; BIOINFORMATICS; LYMPHOMA; PATHWAY	Background: Recent reports indicate that in vitro drug screens combined with gene expression profiles (GEP) of cancer cell lines may generate informative signatures predicting the clinical outcome of chemotherapy. In multiple myeloma (MM) a range of new drugs have been introduced and now challenge conventional therapy including high dose melphalan. Consequently, the generation of predictive signatures for response to melphalan may have a clinical impact. The hypothesis is that melphalan screens and GEPs of B-cell cancer cell lines combined with multivariate statistics may provide predictive clinical information. Materials and Methods: Microarray based GEPs and a melphalan growth inhibition screen of 59 cancer cell lines were downloaded from the National Cancer Institute database. Equivalent data were generated for 18 B-cell cancer cell lines. Linear discriminant analyses (LDA), sparse partial least squares (SPLS) and pairwise comparisons of cell line data were used to build resistance signatures from both cell line panels. A melphalan resistance index was defined and estimated for each MM patient in a publicly available clinical data set and evaluated retrospectively by Cox proportional hazards and Kaplan-Meier survival analysis. Principal Findings: Both cell line panels performed well with respect to internal validation of the SPLS approach but only the B-cell panel was able to predict a significantly higher risk of relapse and death with increasing resistance index in the clinical data sets. The most sensitive and resistant cell lines, MOLP-2 and RPMI-8226 LR5, respectively, had high leverage, which suggests their differentially expressed genes to possess important predictive value. Conclusion: The present study presents a melphalan resistance index generated by analysis of a B-cell panel of cancer cell lines. However, the resistance index needs to be functionally validated and correlated to known MM biomarkers in independent data sets in order to better understand the mechanism underlying the preparedness to melphalan resistance.	[Boegsted, Martin; Holst, Johanne M.; Fogd, Kirsten; Falgreen, Steffen; Sorensen, Suzette; Schmitz, Alexander; Bukh, Anne; Johnsen, Hans E.; Nyegaard, Mette; Dybkaer, Karen] Aarhus Univ Hosp, Dept Haematol, Aalborg Hosp, Sci & Innovat Ctr, Aalborg, Denmark	Aalborg University; Aalborg University Hospital; Aarhus University	Boegsted, M (corresponding author), Aarhus Univ Hosp, Dept Haematol, Aalborg Hosp, Sci & Innovat Ctr, Aalborg, Denmark.	martin.boegsted@rn.dk	Nyegaard, Mette/M-3379-2019; Nyegaard, Mette/G-4443-2012	Nyegaard, Mette/0000-0003-4973-8543; Nyegaard, Mette/0000-0003-4973-8543; Johnsen, Hans Erik/0000-0001-8253-2913; Bogsted, Martin/0000-0001-9192-1814; Dybkaer, Karen/0000-0003-2488-435X	MSCNET; EU; CHEPRE; The Danish Agency for Science, Technology and Innovation; Det Obelske Familiefond and Karen Elise Jensen Fonden	MSCNET; EU(European Commission); CHEPRE; The Danish Agency for Science, Technology and Innovation; Det Obelske Familiefond and Karen Elise Jensen Fonden	The research is supported by MSCNET, a translational program studying cancer stem cells in multiple myeloma supported by the EU FP6, and CHEPRE, a program studying chemosensitivity in malignant lymphoma by genomic signatures supported by The Danish Agency for Science, Technology and Innovation, as well as Det Obelske Familiefond and Karen Elise Jensen Fonden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahdesmaki M, 2010, ANN APPL STAT, V4, P503, DOI 10.1214/09-AOAS277; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], REGRESSION MODELLING, DOI DOI 10.1200/JCO.2017.76.1155; Baggerly KA, 2009, ANN APPL STAT, V3, P1309, DOI 10.1214/09-AOAS291; Barlogie B, 2006, NEW ENGL J MED, V354, P1021, DOI 10.1056/NEJMoa053583; BELLAMY WT, 1991, CANCER RES, V51, P995; Blade Joan, 1998, British Journal of Haematology, V102, P1115, DOI 10.1046/j.1365-2141.1998.00930.x; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; BOYD MR, 1995, DRUG DEVELOP RES, V34, P91, DOI 10.1002/ddr.430340203; Bret C, 2009, BRIT J HAEMATOL, V145, P350, DOI 10.1111/j.1365-2141.2009.07633.x; Burr ML, 2011, P NATL ACAD SCI USA, V108, P2034, DOI 10.1073/pnas.1016229108; Chen Q, 2005, BLOOD, V106, P698, DOI 10.1182/blood-2004-11-4286; Child JA, 2003, NEW ENGL J MED, V348, P1875, DOI 10.1056/NEJMoa022340; Chun H, 2010, J R STAT SOC B, V72, P3, DOI 10.1111/j.1467-9868.2009.00723.x; Coombes KR, 2007, NAT MED, V13, P1276, DOI 10.1038/nm1107-1276b; Dutta-Simmons J, 2009, BLOOD, V114, P2699, DOI 10.1182/blood-2008-12-194290; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GOLDMANLEIKIN RE, 1989, J LAB CLIN MED, V113, P335; GRUBBS FE, 1950, ANN MATH STAT, V21, P27, DOI 10.1214/aoms/1177729885; Havaleshko DM, 2007, MOL CANCER THER, V6, P578, DOI 10.1158/1535-7163.MCT-06-0497; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kimura T, 2003, CANCER SCI, V94, P431, DOI 10.1111/j.1349-7006.2003.tb01460.x; Lee JK, 2007, P NATL ACAD SCI USA, V104, P13086, DOI 10.1073/pnas.0610292104; Leisch F., 2003, CHANCE, V16, P46; Liedtke C, 2010, BREAST CANCER RES TR, V121, P301, DOI 10.1007/s10549-009-0445-7; Mehra S, 2002, GENE CHROMOSOME CANC, V33, P225, DOI 10.1002/gcc.10025; Messick TE, 2009, J CELL BIOL, V187, P319, DOI 10.1083/jcb.200908074; MONKS A, 1991, J NATL CANCER I, V83, P757, DOI 10.1093/jnci/83.11.757; RAPRAEGER A, 1985, J BIOL CHEM, V260, P1046; SAMUELS BL, 1995, J CLIN ONCOL, V13, P1786, DOI 10.1200/JCO.1995.13.7.1786; Sato T, 2003, J BIOL CHEM, V278, P3063, DOI 10.1074/jbc.M208886200; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Shen CL, 2005, J BIOL CHEM, V280, P35967, DOI 10.1074/jbc.M505220200; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Subramanian J, 2010, NAT REV CLIN ONCOL, V7, P327, DOI 10.1038/nrclinonc.2010.60; Tan YM, 2008, CANCER LETT, V271, P1, DOI 10.1016/j.canlet.2008.04.036; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Yarde DN, 2009, CANCER RES, V69, P9367, DOI 10.1158/0008-5472.CAN-09-2616; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458	41	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19322	10.1371/journal.pone.0019322	http://dx.doi.org/10.1371/journal.pone.0019322			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559449	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700133
J	Farnelid, H; Andersson, AF; Bertilsson, S; Abu Al-Soud, W; Hansen, LH; Sorensen, S; Steward, GF; Hagstrom, A; Riemann, L				Farnelid, Hanna; Andersson, Anders F.; Bertilsson, Stefan; Abu Al-Soud, Waleed; Hansen, Lars H.; Sorensen, Soren; Steward, Grieg F.; Hagstrom, Ake; Riemann, Lasse			Nitrogenase Gene Amplicons from Global Marine Surface Waters Are Dominated by Genes of Non-Cyanobacteria	PLOS ONE			English	Article							CHESAPEAKE BAY; NIFH GENE; DIVERSITY; DISTRIBUTIONS; AMPLIFICATION; SEA; MICROORGANISMS; TRICHODESMIUM; ASSEMBLAGES; TRANSCRIPTS	Cyanobacteria are thought to be the main N-2-fixing organisms (diazotrophs) in marine pelagic waters, but recent molecular analyses indicate that non-cyanobacterial diazotrophs are also present and active. Existing data are, however, restricted geographically and by limited sequencing depths. Our analysis of 79,090 nitrogenase (nifH) PCR amplicons encoding 7,468 unique proteins from surface samples (ten DNA samples and two RNA samples) collected at ten marine locations worldwide provides the first in-depth survey of a functional bacterial gene and yield insights into the composition and diversity of the nifH gene pool in marine waters. Great divergence in nifH composition was observed between sites. Cyanobacteria-like genes were most frequent among amplicons from the warmest waters, but overall the data set was dominated by nifH sequences most closely related to non-cyanobacteria. Clusters related to Alpha-, Beta-, Gamma-, and Delta-Proteobacteria were most common and showed distinct geographic distributions. Sequences related to anaerobic bacteria (nifH Cluster III) were generally rare, but preponderant in cold waters, especially in the Arctic. Although the two transcript samples were dominated by unicellular cyanobacteria, 42% of the identified non-cyanobacterial nifH clusters from the corresponding DNA samples were also detected in cDNA. The study indicates that non-cyanobacteria account for a substantial part of the nifH gene pool in marine surface waters and that these genes are at least occasionally expressed. The contribution of non-cyanobacterial diazotrophs to the global N-2 fixation budget cannot be inferred from sequence data alone, but the prevalence of non-cyanobacterial nifH genes and transcripts suggest that these bacteria are ecologically significant.	[Farnelid, Hanna; Hagstrom, Ake; Riemann, Lasse] Linnaeus Univ, Dept Nat Sci, Kalmar, Sweden; [Andersson, Anders F.] KTH Royal Inst Technol, Sch Biotechnol, Sci Life Lab, Stockholm, Sweden; [Bertilsson, Stefan] Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden; [Abu Al-Soud, Waleed; Hansen, Lars H.; Sorensen, Soren] Univ Copenhagen, Dept Biol, Microbiol Sect, Copenhagen, Denmark; [Steward, Grieg F.] Univ Hawaii, Sch Ocean & Earth Sci & Technol, Dept Oceanog, Honolulu, HI 96822 USA; [Riemann, Lasse] Univ Copenhagen, Marine Biol Lab, Dept Biol, DK-3000 Helsingor, Denmark	Linnaeus University; Royal Institute of Technology; Uppsala University; University of Copenhagen; University of Hawaii System; University of Copenhagen	Farnelid, H (corresponding author), Linnaeus Univ, Dept Nat Sci, Kalmar, Sweden.	lriemann@bio.ku.dk	Abu Al-Soud, Waleed/AAH-3477-2021; Andersson, Anders/J-9310-2019; Hagström, Åke/Q-9257-2019; Abu Al-Soud, Waleed/K-4408-2014; Sørensen, Søren J/J-5015-2014; Steward, Grieg F./D-9768-2011; Riemann, Lasse/J-7091-2014; Sørensen, Søren Johannes/N-2120-2019; Abu Al-Soud, Waleed/K-4408-2014	Abu Al-Soud, Waleed/0000-0002-1143-9233; Andersson, Anders/0000-0002-3627-6899; Abu Al-Soud, Waleed/0000-0002-1143-9233; Sørensen, Søren J/0000-0001-6227-9906; Steward, Grieg F./0000-0001-5988-0522; Riemann, Lasse/0000-0001-9207-2543; Sørensen, Søren Johannes/0000-0001-6227-9906; Abu Al-Soud, Waleed/0000-0002-1488-4826; Hestbjerg Hansen, Lars/0000-0003-0027-1524	Swedish (FORMAS) [217-2006-342, 621-205-4710, VR 2009-3784, 2008-1293]; Danish Research Council [FNU09-066396]; American Research Council (US NSF) [OCE 08-26650, EF 04-24599]	Swedish (FORMAS)(Swedish Research Council Formas); Danish Research Council(Det Frie Forskningsrad (DFF)); American Research Council (US NSF)(National Science Foundation (NSF))	This work was supported by the Swedish (FORMAS, http://www.formas.se/, 217-2006-342 to L.R., VR, http://www.vr.se/, 621-205-4710 to A.H., and VR 2009-3784 and 2008-1293 to S.B.), Danish (FNU09-066396 to L.R.), and American (US NSF, http://www.nsf.gov/, OCE 08-26650 and EF 04-24599 to G.F.S.) Research Councils. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2004, NATURE, V430, P551, DOI 10.1038/nature02649; Affourtit J, 2001, MICROBIAL ECOL, V41, P114; [Anonymous], 2008, MICROBIAL ECOLOGY OC; Beja O, 2002, NATURE, V415, P630, DOI 10.1038/415630a; Berg OG, 2002, MOL BIOL EVOL, V19, P2265, DOI 10.1093/oxfordjournals.molbev.a004050; Bird C, 2005, APPL ENVIRON MICROB, V71, P2079, DOI 10.1128/AEM.71.4.2079-2085.2005; Bostrom KH, 2007, J PLANKTON RES, V29, P391, DOI 10.1093/plankt/fbm019; Braun ST, 1999, FEMS MICROBIOL ECOL, V28, P273, DOI 10.1016/S0168-6496(98)00132-9; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; Carpenter EJ, 1999, MAR ECOL PROG SER, V185, P273, DOI 10.3354/meps185273; CHAO A, 1984, SCAND J STAT, V11, P265; Chien YT, 1996, J BACTERIOL, V178, P143, DOI 10.1128/jb.178.1.143-148.1996; Church MJ, 2008, LIMNOL OCEANOGR, V53, P63, DOI 10.4319/lo.2008.53.1.0063; Church MJ, 2005, AQUAT MICROB ECOL, V38, P3, DOI 10.3354/ame038003; Church MJ, 2005, APPL ENVIRON MICROB, V71, P5362, DOI 10.1128/AEM.71.9.5362-5370.2005; Diallo MD, 2008, FEMS MICROBIOL ECOL, V65, P220, DOI 10.1111/j.1574-6941.2008.00545.x; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Farnelid H, 2010, AQUAT MICROB ECOL, V61, P105, DOI 10.3354/ame01440; Farnelid H, 2009, ENV MICROBIOL REP, V1, P145, DOI 10.1111/j.1758-2229.2009.00021.x; Foster RA, 2009, LIMNOL OCEANOGR, V54, P219, DOI 10.4319/lo.2009.54.1.0219; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Goto M, 2005, FEMS MICROBIOL LETT, V246, P33, DOI 10.1016/j.femsle.2005.03.042; Hamilton AK, 2008, LIMNOL OCEANOGR, V53, P922, DOI 10.4319/lo.2008.53.3.0922; Hewson I, 2007, ISME J, V1, P78, DOI 10.1038/ismej.2007.5; Hewson I, 2007, AQUAT MICROB ECOL, V46, P15, DOI 10.3354/ame046015; Horner-Devine MC, 2008, SCIENCE, V320, P757, DOI 10.1126/science.1147012; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Jenkins BD, 2004, APPL ENVIRON MICROB, V70, P1767, DOI 10.1128/AEM.70.3.1767-1776.2004; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Langlois RJ, 2008, APPL ENVIRON MICROB, V74, P1922, DOI 10.1128/AEM.01720-07; Langlois RJ, 2005, APPL ENVIRON MICROB, V71, P7910, DOI 10.1128/AEM.71.12.7910-7919.2005; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lin WC, 2004, APPL ENVIRON MICROB, V70, P2525, DOI 10.1128/AEM.70.4.2525-2528.2004; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Man-Aharonovich D, 2007, ENVIRON MICROBIOL, V9, P2354, DOI 10.1111/j.1462-2920.2007.01353.x; Moisander PH, 2008, ISME J, V2, P954, DOI 10.1038/ismej.2008.51; Moisander PH, 2007, ENVIRON MICROBIOL, V9, P1823, DOI 10.1111/j.1462-2920.2007.01304.x; Moisander PH, 2010, SCIENCE, V327, P1512, DOI 10.1126/science.1185468; Oelze J, 1996, ARCH MICROBIOL, V165, P219, DOI 10.1007/s002030050319; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Pommier T, 2005, AQUAT MICROB ECOL, V41, P79, DOI 10.3354/ame041079; Riemann L, 2010, AQUAT MICROB ECOL, V61, P225, DOI 10.3354/ame01431; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Sicking C, 2005, J BACTERIOL, V187, P92, DOI 10.1128/JB.187.1.92-98.2005; Sorensen T., 1948, K DAN VIDENSK SELSK, V5, P1; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TURK A, 2011, ISME J, DOI DOI 10.1038/ISMEJ.2010.205; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Zehr JP, 2008, SCIENCE, V322, P1110, DOI 10.1126/science.1165340; Zehr JP, 2007, P NATL ACAD SCI USA, V104, P17807, DOI 10.1073/pnas.0701017104; Zehr JP, 2003, BIOTECHNIQUES, V35, P996, DOI 10.2144/03355st08; Zehr JP, 2003, ENVIRON MICROBIOL, V5, P539, DOI 10.1046/j.1462-2920.2003.00451.x; ZEHR JP, 1989, APPL ENVIRON MICROB, V55, P2522, DOI 10.1128/AEM.55.10.2522-2526.1989; Zehr JP, 2001, METHOD MICROBIOL, V30, P271, DOI 10.1016/S0580-9517(01)30049-1; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063	62	132	136	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19223	10.1371/journal.pone.0019223	http://dx.doi.org/10.1371/journal.pone.0019223			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559425	Green Published, gold			2022-12-27	WOS:000290024700104
J	Miggins, M; Hasan, A; Hohmann, S; Southwick, F; Casella, G; Schain, D; Liu, HZ; Bihorac, A; Moldawer, L; Efron, P; Ang, D				Miggins, Makesha; Hasan, Anjum; Hohmann, Samuel; Southwick, Frederick; Casella, George; Schain, Denise; Liu, Huazhi; Bihorac, Azra; Moldawer, Lyle; Efron, Philip; Ang, Darwin			The Potential Influence of Common Viral Infections Diagnosed during Hospitalization among Critically Ill Patients in the United States	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; INTENSIVE-CARE-UNIT; ACTIVE CYTOMEGALOVIRUS-INFECTION; SURGICAL-PATIENTS; VENTILATION; MORTALITY; TYPE-1; REACTIVATION; DISEASE	Viruses are the most common source of infection among immunocompetent individuals, yet they are not considered a clinically meaningful risk factor among the critically ill. This work examines the association of viral infections diagnosed during the hospital stay or not documented as present on admission to the outcomes of ICU patients with no evidence of immunosuppression on admission. This is a population-based retrospective cohort study of University HealthSystem Consortium (UHC) academic centers in the U. S. from the years 2006 to 2009. The UHC is an alliance of over 90% of the non-profit academic medical centers in the U. S. A total of 209,695 critically ill patients were used in this analysis. Eight hospital complications were examined. Patients were grouped into four cohorts: absence of infection, bacterial infection only, viral infection only, and bacterial and viral infection during same hospital admission. Viral infections diagnosed during hospitalization significantly increased the risk of all complications. There was also a seasonal pattern for viral infections. Specific viruses associated with poor outcomes included influenza, RSV, CMV, and HSV. Patients who had both viral and bacterial infections during the same hospitalization had the greatest risk of mortality RR 6.58, 95% CI (5.47, 7.91); multi-organ failure RR 8.25, 95% CI (7.50, 9.07); and septic shock RR 271.2, 95% CI (188.0, 391.3). Viral infections may play a significant yet unrecognized role in the outcomes of ICU patients. They may serve as biological markers or play an active role in the development of certain adverse complications by interacting with coincident bacterial infection.	[Miggins, Makesha; Liu, Huazhi; Moldawer, Lyle; Efron, Philip; Ang, Darwin] Univ Florida, Dept Surg, Gainesville, FL 32611 USA; [Hasan, Anjum; Southwick, Frederick; Schain, Denise] Univ Florida, Dept Infect Dis, Gainesville, FL USA; [Hohmann, Samuel] Univ HealthSyst Consortium, Gainesville, FL USA; [Casella, George] Univ Florida, Dept Stat, Gainesville, FL 32611 USA; [Bihorac, Azra] Univ Florida, Dept Anesthesiol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Miggins, M (corresponding author), Univ Florida, Dept Surg, Gainesville, FL 32611 USA.	darwin.ang@surgery.ufl.edu	Ang, Darwin/AIA-3852-2022; Bihorac, Azra/Q-6500-2016	Bihorac, Azra/0000-0002-5745-2863; Moldawer, Lyle/0000-0002-9041-9838	NCI NIH HHS [T32 CA106493] Funding Source: Medline; NIGMS NIH HHS [K23 GM087709] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA106493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K23GM087709] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahlbom A, 2005, EUR J EPIDEMIOL, V20, P563, DOI 10.1007/s10654-005-4410-4; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Beadling C, 2004, CURR OPIN INFECT DIS, V17, P185, DOI 10.1097/00001432-200406000-00003; Bruynseels P, 2003, LANCET, V362, P1536, DOI 10.1016/S0140-6736(03)14740-X; Cameron RJ, 2006, INTENS CARE MED, V32, P1022, DOI 10.1007/s00134-006-0202-x; Centers for Disease Control and Prevention, 2010, OV BRFSS 2010; Chiche L, 2009, CRIT CARE MED, V37, P1850, DOI 10.1097/CCM.0b013e31819ffea6; Cook CH, 1998, AM J SURG, V176, P357, DOI 10.1016/S0002-9610(98)00205-0; Cook CH, 2003, CRIT CARE MED, V31, P1923, DOI 10.1097/01.CCM.0000070222.11325.C4; Couch Robert B., 1997, American Journal of Medicine, V102, P2, DOI 10.1016/S0002-9343(97)00003-X; da Silva AR, 2007, BRAZ J INFECT DIS, V11, P163, DOI 10.1590/S1413-86702007000100034; Hament JM, 1999, FEMS IMMUNOL MED MIC, V26, P189, DOI 10.1111/j.1574-695X.1999.tb01389.x; Heininger A, 2001, CRIT CARE MED, V29, P541, DOI 10.1097/00003246-200103000-00012; Jaber S, 2005, CHEST, V127, P233, DOI 10.1378/chest.127.1.233; Kalil AC, 2009, CRIT CARE MED, V37, P2350, DOI 10.1097/CCM.0b013e3181a3aa43; Limaye AP, 2008, JAMA-J AM MED ASSOC, V300, P413, DOI 10.1001/jama.300.4.413; Luyt CE, 2008, CURR OPIN CRIT CARE, V14, P605, DOI 10.1097/MCC.0b013e32830f1e12; Luyt CE, 2007, AM J RESP CRIT CARE, V175, P935, DOI 10.1164/rccm.200609-1322OC; Ong GM, 2004, J MED VIROL, V72, P121, DOI 10.1002/jmv.10524; Papazian L, 1996, ANESTHESIOLOGY, V84, P280, DOI 10.1097/00000542-199602000-00005; PORTEOUS C, 1984, CRIT CARE MED, V12, P626, DOI 10.1097/00003246-198408000-00003; ROTHMAN KJ, 1976, AM J EPIDEMIOL, V104, P587, DOI 10.1093/oxfordjournals.aje.a112335; Stollenwerk N, 2008, CRIT CARE, V12, DOI 10.1186/cc6917; van den Brink JW, 2004, J CLIN VIROL, V30, P68, DOI 10.1016/j.jcv.2003.09.003; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964; Ziemann M, 2008, CRIT CARE MED, V36, P3145, DOI 10.1097/CCM.0b013e31818f3fc4	26	21	22	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18890	10.1371/journal.pone.0018890	http://dx.doi.org/10.1371/journal.pone.0018890			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21573031	Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700034
J	Mochizuki, H; Toda, H; Ando, M; Kurusu, M; Tomoda, T; Furukubo-Tokunaga, K				Mochizuki, Hiroaki; Toda, Hirofumi; Ando, Mai; Kurusu, Mitsuhiko; Tomoda, Toshifumi; Furukubo-Tokunaga, Katsuo			Unc-51/ATG1 Controls Axonal and Dendritic Development via Kinesin-Mediated Vesicle Transport in the Drosophila Brain	PLOS ONE			English	Article							BODY NEURONAL MORPHOGENESIS; INHIBITS CELL-GROWTH; CAENORHABDITIS-ELEGANS; C-ELEGANS; MUSHROOM BODIES; SERINE/THREONINE KINASE; EXPRESSION PATTERNS; DEPENDENT TRANSPORT; UNC-51-LIKE KINASE; FASCICLIN-II	Background: Members of the evolutionary conserved Ser/Thr kinase Unc-51 family are key regulatory proteins that control neural development in both vertebrates and invertebrates. Previous studies have suggested diverse functions for the Unc-51 protein, including axonal elongation, growth cone guidance, and synaptic vesicle transport. Methodology/Principal Findings: In this work, we have investigated the functional significance of Unc-51-mediated vesicle transport in the development of complex brain structures in Drosophila. We show that Unc-51 preferentially accumulates in newly elongating axons of the mushroom body, a center of olfactory learning in flies. Mutations in unc-51 cause disintegration of the core of the developing mushroom body, with mislocalization of Fasciclin II (Fas II), an IgG-family cell adhesion molecule important for axonal guidance and fasciculation. In unc-51 mutants, Fas II accumulates in the cell bodies, calyx, and the proximal peduncle. Furthermore, we show that mutations in unc-51 cause aberrant overshooting of dendrites in the mushroom body and the antennal lobe. Loss of unc-51 function leads to marked accumulation of Rab5 and Golgi components, whereas the localization of dendrite-specific proteins, such as Down syndrome cell adhesion molecule (DSCAM) and No distributive disjunction (Nod), remains unaltered. Genetic analyses of kinesin light chain (Klc) and unc-51 double heterozygotes suggest the importance of kinesin-mediated membrane transport for axonal and dendritic development. Moreover, our data demonstrate that loss of Klc activity causes similar axonal and dendritic defects in mushroom body neurons, recapitulating the salient feature of the developmental abnormalities caused by unc-51 mutations. Conclusions/Significance: Unc-51 plays pivotal roles in the axonal and dendritic development of the Drosophila brain. Unc-51-mediated membrane vesicle transport is important in targeted localization of guidance molecules and organelles that regulate elongation and compartmentalization of developing neurons.	[Mochizuki, Hiroaki; Toda, Hirofumi; Ando, Mai; Furukubo-Tokunaga, Katsuo] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Kurusu, Mitsuhiko] Grad Univ Adv Studies, Struct Biol Ctr, Natl Inst Genet, Shizuoka, Japan; [Kurusu, Mitsuhiko] Grad Univ Adv Studies, Dept Genet, Shizuoka, Japan; [Toda, Hirofumi; Tomoda, Toshifumi] Beckman Res Inst City Hope, Div Neurosci, Duarte, CA USA	University of Tsukuba; Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; City of Hope; Beckman Research Institute of City of Hope	Mochizuki, H (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	furukubo-tokunaga.gm@u.tsukuba.ac.jp	Toda, Hirofumi/U-3521-2018	Toda, Hirofumi/0000-0002-6247-2826	Rose Hills Foundation; Ministry of Education, Culture, Sports, Science and Technology, Japan [20570196, 20700319]	Rose Hills Foundation; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Rose Hills Foundation (http://www.rosehillsfoundation.org/) to T.T. and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (www.mext.go.jp/english/) to K.F.T. (No. 20570196) and to M.K. (No. 20700319). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2003, MECH DEVELOP, V120, P1113, DOI 10.1016/j.mod.2003.08.007; Allen J, 2009, DEV BIOL, V327, P4, DOI 10.1016/j.ydbio.2008.12.013; Andersen R, 2005, J NEUROSCI, V25, P8878, DOI 10.1523/JNEUROSCI.2005-05.2005; Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250; Chen GC, 2008, AUTOPHAGY, V4, P37, DOI 10.4161/auto.5141; Clark IE, 1997, DEVELOPMENT, V124, P461; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Gindhart JG, 1998, J CELL BIOL, V141, P443, DOI 10.1083/jcb.141.2.443; Guzik BW, 2004, CURR OPIN CELL BIOL, V16, P443, DOI 10.1016/j.ceb.2004.06.002; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Hirokawa N, 2004, CURR OPIN NEUROBIOL, V14, P564, DOI 10.1016/j.conb.2004.08.011; Honjo K, 2005, J NEUROSCI, V25, P7905, DOI 10.1523/JNEUROSCI.2135-05.2005; Honjo K, 2009, J NEUROSCI, V29, P852, DOI 10.1523/JNEUROSCI.1315-08.2009; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Ito K, 1997, CELL TISSUE RES, V290, P1, DOI 10.1007/s004410050901; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; Kohsaka H, 2007, J CELL BIOL, V179, P1289, DOI 10.1083/jcb.200705154; Kurusu M, 2000, P NATL ACAD SCI USA, V97, P2140, DOI 10.1073/pnas.040564497; Kurusu M, 2002, DEVELOPMENT, V129, P409; Kurusu M, 2008, MOL CELL NEUROSCI, V38, P53, DOI 10.1016/j.mcn.2008.01.015; Lai T, 2004, DEVELOPMENT, V131, P5991, DOI 10.1242/dev.01457; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lee SB, 2007, EMBO REP, V8, P360, DOI 10.1038/sj.embor.7400917; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Levy-Strumpf N, 2007, NAT NEUROSCI, V10, P161, DOI 10.1038/nn1835; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Masse NY, 2009, CURR BIOL, V19, pR700, DOI 10.1016/j.cub.2009.06.026; MCINTIRE SL, 1992, NEURON, V8, P307, DOI 10.1016/0896-6273(92)90297-Q; OGURA K, 1994, GENE DEV, V8, P2389, DOI 10.1101/gad.8.20.2389; Ogura K, 1997, GENE DEV, V11, P1801, DOI 10.1101/gad.11.14.1801; Ogura K, 2006, DEVELOPMENT, V133, P3441, DOI 10.1242/dev.02503; Okazaki N, 2000, MOL BRAIN RES, V85, P1, DOI 10.1016/S0169-328X(00)00218-7; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Pulipparacharuvil S, 2005, J CELL SCI, V118, P3663, DOI 10.1242/jcs.02502; Recacha R, 2009, STRUCTURE, V17, P21, DOI 10.1016/j.str.2008.10.014; Reuter JE, 2003, DEVELOPMENT, V130, P1203, DOI 10.1242/dev.00319; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Sakamoto R, 2005, MOL BIOL CELL, V16, P483, DOI 10.1091/mbc.E04-07-0553; Sann S, 2009, TRENDS CELL BIOL, V19, P317, DOI 10.1016/j.tcb.2009.05.001; Satoh D, 2008, NAT CELL BIOL, V10, P1164, DOI 10.1038/ncb1776; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Shen W, 2009, J CELL BIOL, V187, P71, DOI 10.1083/jcb.200907109; Shi L, 2007, J NEUROSCI, V27, P6723, DOI 10.1523/JNEUROSCI.1517-07.2007; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Toda H, 2008, GENE DEV, V22, P3292, DOI 10.1101/gad.1734608; Tomoda T, 2004, GENE DEV, V18, P541, DOI 10.1101/gad.1151204; Tomoda T, 1999, NEURON, V24, P833, DOI 10.1016/S0896-6273(00)81031-4; Wairkar YP, 2009, J NEUROSCI, V29, P517, DOI 10.1523/JNEUROSCI.3848-08.2009; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Watari-Goshima N, 2007, NAT NEUROSCI, V10, P169, DOI 10.1038/nn1834; Wolf FW, 1998, NEURON, V20, P655, DOI 10.1016/S0896-6273(00)81006-5; Yang JSJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003504; YANG MY, 1995, NEURON, V15, P45; Ye B, 2007, CELL, V130, P717, DOI 10.1016/j.cell.2007.06.032; Zhang J, 2007, GENETICS, V176, P1307, DOI 10.1534/genetics.106.066761; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144; Zheng Y, 2008, NAT CELL BIOL, V10, P1172, DOI 10.1038/ncb1777; Zhou X, 2007, P NATL ACAD SCI USA, V104, P5842, DOI 10.1073/pnas.0701402104	66	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19632	10.1371/journal.pone.0019632	http://dx.doi.org/10.1371/journal.pone.0019632			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589871	Green Submitted, Green Published, gold			2022-12-27	WOS:000290531100021
J	Pepper, DJ; Marais, S; Wilkinson, RJ; Bhaijee, F; De Azevedo, V; Meintjes, G				Pepper, Dominique J.; Marais, Suzaan; Wilkinson, Robert J.; Bhaijee, Feriyl; De Azevedo, Virginia; Meintjes, Graeme			Barriers to Initiation of Antiretrovirals during Antituberculosis Therapy in Africa	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; SOUTH-AFRICA; TUBERCULOSIS; CHALLENGES; MORTALITY; EPIDEMIC; GENDER; DURBAN; CARE; ART	Background: In the developing world, the principal cause of death among HIV-infected patients is tuberculosis (TB). The initiation of antiretroviral therapy (ART) during TB therapy significantly improves survival, however it is not known which barriers prevent eligible TB patients from initiating life-saving ART. Method: Setting. A South African township clinic with integrated tuberculosis and HIV services. Design. Logistic regression analyses of a prospective cohort of HIV-1 infected adults (>= 18 years) who commenced TB therapy, were eligible for ART, and were followed for 6 months. Findings: Of 100 HIV-1 infected adults eligible for ART during TB therapy, 90 TB patients presented to an ART clinic for assessment, 66 TB patients initiated ART, and 15 TB patients died. 34% of eligible TB patients (95% CI: 25-43%) did not initiate ART. Male gender and younger age (< 36 years) were associated with failure to initiate ART (adjusted odds ratios of 3.7 [95% CI: 1.25-10.95] and 3.3 [95% CI: 1.12-9.69], respectively). Death during TB therapy was associated with a CD4+ count < 100 cells/mL. Conclusion: In a clinic with integrated services for tuberculosis and HIV, one-third of eligible TB patients - particularly young men - did not initiate ART. Strategies are needed to promote ART initiation during TB therapy, especially among young men.	[Pepper, Dominique J.; Marais, Suzaan; Wilkinson, Robert J.; Bhaijee, Feriyl; Meintjes, Graeme] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Marais, Suzaan; Wilkinson, Robert J.; Meintjes, Graeme] GF Jooste Hosp, Infect Dis Unit, Cape Town, South Africa; [Marais, Suzaan; Wilkinson, Robert J.; Meintjes, Graeme] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [Wilkinson, Robert J.; Meintjes, Graeme] Univ London Imperial Coll Sci Technol & Med, Div Med, London SW7 2AZ, England; [Wilkinson, Robert J.] MRC Natl Inst Med Res, London, England; [De Azevedo, Virginia] City Hlth, Cape Town, South Africa	University of Cape Town; University of Cape Town; Imperial College London; MRC National Institute for Medical Research	Pepper, DJ (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.	dominiquepepper@gmail.com	Marais, Suzaan/AAG-2750-2019	Marais, Suzaan/0000-0002-8050-9610; Wilkinson, Robert/0000-0002-2753-1800; Meintjes, Graeme/0000-0003-1196-4414	Perinatal HIV Research Unit; US Agency for International Development; President's Emergency Plan for AIDS Relief; Wellcome Trust [081667, 084323, 088316]; Fogarty International Center South Africa (NIH/FIC) [1U2RTW007373-01A1, 1U2RTW007370]; FOGARTY INTERNATIONAL CENTER [U2RTW007370, U2RTW007373] Funding Source: NIH RePORTER; Medical Research Council [MC_U117588499] Funding Source: researchfish	Perinatal HIV Research Unit; US Agency for International Development(United States Agency for International Development (USAID)); President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Fogarty International Center South Africa (NIH/FIC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Perinatal HIV Research Unit, the US Agency for International Development, and the President's Emergency Plan for AIDS Relief (to DJP and SM); Wellcome Trust (RJW and GM, WT 081667, 084323 and 088316). The data analysis was supported by a Fogarty International Center South Africa TB/AIDS Training Award (NIH/FIC 1U2RTW007373-01A1, 1U2RTW007370). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam MA, 2009, SAMJ S AFR MED J, V99, P661; Bassett IV, 2009, JAIDS-J ACQ IMM DEF, V51, P135, DOI 10.1097/QAI.0b013e3181a44ef2; *BUS TRUST DPLG, 2007, KHAYEL NOD EC DEV PR; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Cornell M, 2009, TROP MED INT HEALTH, V14, P722, DOI 10.1111/j.1365-3156.2009.02290.x; Desilva MB, 2009, AIDS CARE, V21, P70, DOI 10.1080/09540120802017636; *ETR NET S AFR, 2010, EL TUB REG; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Kranzer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013801; Lawn SD, 2011, CURR OPIN INFECT DIS, V24, P34, DOI 10.1097/QCO.0b013e3283420f76; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; Medicins Sans Frontieres, 2007, REP INT TB HIV SERV; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; Pepper DJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-83; Prins M, 2005, AIDS, V19, P357, DOI 10.1097/01.aids.0000161765.75663.27; *S AFR DEP HLTH, 2009, S AFR CLIN GUID MAN; South African Department of Health, 2004, S AFR NAT TUB CONTR; *STOP TB PARTN, 2009, TUB COUNTR; UNAIDS, 2008, REP GLOB AIDS EP; Van Damme W, 2006, AIDS, V20, P653, DOI 10.1097/01.aids.0000216364.44409.b1; Veinot TC, 2006, J ADOLESCENT HEALTH, V38, P261, DOI 10.1016/j.jadohealth.2005.03.008; *WHO, 2007, GLOB TUB DAT PROF S; Zachariah R, 2009, TROP MED INT HEALTH, V14, P713, DOI 10.1111/j.1365-3156.2009.02291.x	25	23	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19484	10.1371/journal.pone.0019484	http://dx.doi.org/10.1371/journal.pone.0019484			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589868	gold, Green Submitted, Green Published			2022-12-27	WOS:000290531100012
J	Raju, I; Kumarasamy, A; Abraham, EC				Raju, Ilangovan; Kumarasamy, Anbarasu; Abraham, Edathara C.			Multiple Aggregates and Aggresomes of C-Terminal Truncated Human alpha A-Crystallins in Mammalian Cells and Protection by alpha B-Crystallin	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; HUMAN LENS CRYSTALLINS; CHAPERONE ACTIVITY; BOVINE; DEGRADATION; CHAIN; OLIGOMERIZATION; ACCUMULATION; CLEAVAGE; REGION	Background: Cleavage of 11 (alpha A162), 5 (alpha A168) and 1 (alpha A172) residues from the C-terminus of alpha A-crystallin creates structurally and functionally different proteins. The formation of these post-translationally modified alpha A-crystallins is enhanced in diabetes. In the present study, the fate of the truncated alpha A-crystallins expressed in living mammalian cells in the presence and absence of native alpha A- or alpha B-crystallin has been studied by laser scanning confocal microscopy (LSM). Methodology/Principal Findings: YFP tagged alpha Awt, alpha A162, alpha A168 and alpha A172, were individually transfected or co-transfected with CFP tagged alpha Awt or alpha Bwt, expressed in HeLa cells and studied by LSM. Difference in protein aggregation was not caused by different level of alpha-crystallin expression because Western blotting results showed nearly same level of expression of the various alpha-crystallins. The FRET-acceptor photo-bleaching protocol was followed to study in situ protein-protein interaction. alpha A172 interacted with alpha Awt and alpha Bwt better than alpha A168 and alpha A162, interaction of alpha Bwt being two-fold stronger than that of alpha Awt. Furthermore, aggresomes were detected in cells individually expressing alpha A162 and alpha A168 constructs and co-expression with alpha Bwt significantly sequestered the aggresomes. There was no sequestration of aggresomes with alpha Awt co-expression with the truncated constructs, alpha A162 and alpha A168. Double immunocytochemistry technique was used for co-localization of gamma-tubulin with alpha A-crystallin to demonstrate the perinuclear aggregates were aggresomes. Conclusions/Significance: alpha A172 showed the strongest interaction with both alpha Awt and alpha Bwt. Native alpha B-crystallin provided protection to partially unfolded truncated alpha A-crystallins whereas native alpha A-crystallin did not. Aggresomes were detected in cells expressing alpha A162 and alpha A168 and alpha Bwt co-expression with these constructs diminished the aggresome formation. Co-localization of gamma-tubulin in perinuclear aggregates validates for aggresomes.	[Raju, Ilangovan; Abraham, Edathara C.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Kumarasamy, Anbarasu] Bharathidasan Univ, Dept Biotechnol, Tiruchirappalli, India	University of Arkansas System; University of Arkansas Medical Sciences; Bharathidasan University	Raju, I (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	ecabraham@uams.edu	Kumarasamy, Anbarasu/K-4703-2015	Kumarasamy, Anbarasu/0000-0002-1666-6742	National Institutes of Health [EY11352]; NATIONAL EYE INSTITUTE [R01EY011352] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by grant EY11352 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Aziz A, 2007, BIOCHEMISTRY-US, V46, P2510, DOI 10.1021/bi0618722; Colvis C, 2002, ARCH BIOCHEM BIOPHYS, V397, P319, DOI 10.1006/abbi.2001.2669; DEJONG WW, 1975, FEBS LETT, V58, P310, DOI 10.1016/0014-5793(75)80286-9; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; Heir R, 2006, EMBO REP, V7, P1252, DOI 10.1038/sj.embor.7400823; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; INGOLIA TD, 1982, P NATL ACAD SCI-BIOL, V79, P2360, DOI 10.1073/pnas.79.7.2360; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Jones RJ, 2007, AM J PHYSIOL-HEART C, V292, pH2634, DOI 10.1152/ajpheart.01247.2006; Junn E, 2002, J BIOL CHEM, V277, P47870, DOI 10.1074/jbc.M203159200; Kallur LS, 2008, MOL CELL BIOCHEM, V308, P85, DOI 10.1007/s11010-007-9615-2; Kaneko M, 2010, J NEUROSCI, V30, P3924, DOI 10.1523/JNEUROSCI.2422-09.2010; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lund AL, 1996, EXP EYE RES, V63, P661, DOI 10.1006/exer.1996.0160; Ma JY, 2001, P NATL ACAD SCI USA, V98, P14955, DOI 10.1073/pnas.011578098; Ma ZX, 1998, EXP EYE RES, V67, P21, DOI 10.1006/exer.1998.0482; MIESBAUER LR, 1994, J BIOL CHEM, V269, P12494; Muqit MMK, 2004, HUM MOL GENET, V13, P117, DOI 10.1093/hmg/ddh012; Rajan S, 2006, BIOCHEMISTRY-US, V45, P15684, DOI 10.1021/bi060705z; Rao PV, 1995, BBA-GEN SUBJECTS, V1245, P439, DOI 10.1016/0304-4165(95)00125-5; Sha YB, 2009, MOL CELL BIOL, V29, P116, DOI 10.1128/MCB.00829-08; SHEN D, 2010, CELL BIOCH IN PRESS; Takemoto LJ, 1998, EXP EYE RES, V66, P263, DOI 10.1006/exer.1997.0411; TAKEMOTO LJ, 1995, CURR EYE RES, V14, P837, DOI 10.3109/02713689508995806; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Thampi P, 2003, BIOCHEMISTRY-US, V42, P11857, DOI 10.1021/bi030129w; Thampi P, 2002, INVEST OPHTH VIS SCI, V43, P3265; VANDEROU.FJ, 1974, EUR J BIOCHEM, V49, P157; VANDEROU.FJ, 1973, EUR J BIOCHEM, V39, P207; WANG KY, 1994, J BIOL CHEM, V269, P13601; Zaarur N, 2008, J BIOL CHEM, V283, P27575, DOI 10.1074/jbc.M802216200; Zobel ATC, 2003, HUM MOL GENET, V12, P1609, DOI 10.1093/hmg/ddg173	34	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19876	10.1371/journal.pone.0019876	http://dx.doi.org/10.1371/journal.pone.0019876			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589881	Green Published, gold, Green Submitted			2022-12-27	WOS:000290531100033
J	Barbour, AB; Allen, MS; Frazer, TK; Sherman, KD				Barbour, Andrew B.; Allen, Michael S.; Frazer, Thomas K.; Sherman, Krista D.			Evaluating the Potential Efficacy of Invasive Lionfish (Pterois volitans) Removals	PLOS ONE			English	Article							INDO-PACIFIC LIONFISH; CORAL-REEF FISH; MARINE NURSERIES; EAST-COAST; RECRUITMENT; MANAGEMENT; MANGROVES; DISPERSAL	The lionfish, Pterois volitans (Linnaeus) and Pterois miles (Bennett), invasion of the Western Atlantic Ocean, Caribbean Sea and Gulf of Mexico has the potential to alter aquatic communities and represents a legitimate ecological concern. Several local removal programs have been initiated to control this invasion, but it is not known whether removal efforts can substantially reduce lionfish numbers to ameliorate these concerns. We used an age-structured population model to evaluate the potential efficacy of lionfish removal programs and identified critical data gaps for future studies. We used high and low estimates for uncertain parameters including: length at 50% vulnerability to harvest (L-vul), instantaneous natural mortality (M), and the Goodyear compensation ratio (CR). The model predicted an annual exploitation rate between 35 and 65% would be required to cause recruitment overfishing on lionfish populations for our baseline parameter estimates for M and CR (0.5 and 15). Lionfish quickly recovered from high removal rates, reaching 90% of unfished biomass six years after a 50-year simulated removal program. Quantifying lionfish natural mortality and the size-selective vulnerability to harvest are the most important knowledge gaps for future research. We suggest complete eradication of lionfish through fishing is unlikely, and substantial reduction of adult abundance will require a long-term commitment and may be feasible only in small, localized areas where annual exploitation can be intense over multiple consecutive years.	[Barbour, Andrew B.; Allen, Michael S.; Frazer, Thomas K.] Univ Florida, Sch Forest Resources & Conservat, Fisheries & Aquat Sci Program, Gainesville, FL 32611 USA; [Sherman, Krista D.] Bahamas Natl Trust, Nassau, Bahamas	State University System of Florida; University of Florida	Barbour, AB (corresponding author), Univ Florida, Sch Forest Resources & Conservat, Fisheries & Aquat Sci Program, Gainesville, FL 32611 USA.	snook@ufl.edu		Barbour, Andrew/0000-0003-1405-4897	NOAA National Sea Grant College; National Science Foundation [DGE-0802270]; NOAA; NOAA National Centers for Coastal Ocean Science; National Marine Fisheries Service's Southeast Fisheries Science Center; University of Florida	NOAA National Sea Grant College; National Science Foundation(National Science Foundation (NSF)); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); NOAA National Centers for Coastal Ocean Science; National Marine Fisheries Service's Southeast Fisheries Science Center; University of Florida(University of Florida)	This publication was supported by a grant from the NOAA National Sea Grant College Program, and the National Science Foundation Graduate Research Fellowship under grant No. DGE-0802270 to ABB, the NOAA Aquatic Invasive Species Program, the NOAA National Centers for Coastal Ocean Science, and the National Marine Fisheries Service's Southeast Fisheries Science Center. Publication of this article was funded, in part, by the University of Florida Open-Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AJ, 2006, MAR ECOL PROG SER, V318, P287, DOI 10.3354/meps318287; Adams AJ, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P185, DOI 10.1007/978-90-481-2406-0_6; Ahrenholz DW, 2010, ENVIRON BIOL FISH, V88, P305, DOI 10.1007/s10641-010-9647-4; Albins MA, 2008, MAR ECOL PROG SER, V367, P233, DOI 10.3354/meps07620; Allen MS, 2009, FISH RES, V95, P260, DOI 10.1016/j.fishres.2008.09.028; [Anonymous], 2009, NOAA TECHNICAL MEMOR; AQUILARPERERA A, 2010, AQ INV S1, V5, P9; Barbour AB, 2010, MAR ECOL PROG SER, V401, P291, DOI 10.3354/meps08373; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Beck MW., 2003, ISSUES ECOL, V11, P1; BOTSFORD LW, 1981, AM NAT, V117, P38, DOI 10.1086/283685; BOTSFORD LW, 1981, J MATH BIOL, V12, P265, DOI 10.1007/BF00276917; BOTSFORD LW, 1979, P 13 EUR MAR BIOL S, V13, P73; CONNELL SD, 1991, J EXP MAR BIOL ECOL, V151, P271, DOI 10.1016/0022-0981(91)90129-K; Dahlgren CP, 2006, MAR ECOL PROG SER, V312, P291, DOI 10.3354/meps312291; DAVIS JE, 2003, NONNATIVE SPECIES MO; Freshwater DW, 2009, MAR BIOL, V156, P1213, DOI 10.1007/s00227-009-1163-8; Goodwin NB, 2006, CAN J FISH AQUAT SCI, V63, P494, DOI 10.1139/f05-234; Goodyear C.P., 1980, P253; Goodyear C. Philip, 1993, Canadian Special Publication of Fisheries and Aquatic Sciences, V120, P67; Green SJ, 2009, CORAL REEFS, V28, P107, DOI 10.1007/s00338-008-0446-8; Hamner RM, 2007, J FISH BIOL, V71, P214, DOI 10.1111/j.1095-8649.2007.01575.x; Harding EK, 2001, CONSERV BIOL, V15, P1114, DOI 10.1046/j.1523-1739.2001.0150041114.x; Hare JA, 2003, NOAA TECH MEMO NOS N; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Johnson LE, 1996, ECOLOGY, V77, P1686, DOI 10.2307/2265774; Kimball ME, 2004, MAR ECOL PROG SER, V283, P269, DOI 10.3354/meps283269; MACE PM, 1994, CAN J FISH AQUAT SCI, V51, P110, DOI 10.1139/f94-013; Maljkovic A, 2008, CORAL REEFS, V27, P501, DOI 10.1007/s00338-008-0372-9; Morris, 2009, THESIS N CAROLINA ST; Morris JA, 2011, SCI MAR, V75, P147, DOI 10.3989/scimar.2011.75n1147; Morris JA, 2011, BIOL INVASIONS, V13, P7, DOI 10.1007/s10530-010-9786-8; Morris JA, 2009, ENVIRON BIOL FISH, V86, P389, DOI 10.1007/s10641-009-9538-8; Mueller GA, 2005, FISHERIES, V30, P10, DOI 10.1577/1548-8446(2005)30[10:PFRANF]2.0.CO;2; Mumby PJ, 2004, NATURE, V427, P533, DOI 10.1038/nature02286; Myers RA, 1999, CAN J FISH AQUAT SCI, V56, P2404, DOI 10.1139/cjfas-56-12-2404; Nagelkerken I, 2002, MAR ECOL PROG SER, V244, P299, DOI 10.3354/meps244299; POTTS JC, P 63 GULF C IN PRESS; Schofield Pamela J., 2009, Aquatic Invasions, V4, P473; SCHOFIELD PJ, 2010, PTEROIS VOLITANS MIL; Serbesoff-King K, 2003, J AQUAT PLANT MANAGE, V41, P98; SHULMAN MJ, 1987, MAR ECOL PROG SER, V39, P233, DOI 10.3354/meps039233; Walters CJ., 2020, FISHERIES ECOLOGY MA, DOI [10.2307/j.ctv10vm1f6, DOI 10.2307/J.CTV10VM1F6]; Whitfield, 2009, P GULF CARIB FISH I, V29, P409; Whitfield PE, 2002, MAR ECOL PROG SER, V235, P289, DOI 10.3354/meps235289	45	137	148	2	183	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19666	10.1371/journal.pone.0019666	http://dx.doi.org/10.1371/journal.pone.0019666			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572951	Green Submitted, Green Published, gold			2022-12-27	WOS:000290440200019
J	So, AY; Jung, JW; Lee, S; Kim, HS; Kang, KS				So, Ah-Young; Jung, Ji-Won; Lee, Seunghee; Kim, Hyung-Sik; Kang, Kyung-Sun			DNA Methyltransferase Controls Stem Cell Aging by Regulating BMI1 and EZH2 through MicroRNAs	PLOS ONE			English	Article							HUMAN CANCER-CELLS; HISTONE DEACETYLASE; HUMAN FIBROBLASTS; PROSTATE-CANCER; BREAST-CANCER; LUNG-CANCER; IN-VITRO; GENE; DIFFERENTIATION; METHYLATION	Epigenetic regulation of gene expression is well known mechanism that regulates cellular senescence of cancer cells. Here we show that inhibition of DNA methyltransferases (DNMTs) with 5-azacytidine (5-AzaC) or with specific small interfering RNA (siRNA) against DNMT1 and 3b induced the cellular senescence of human umbilical cord blood-derived multipotent stem cells (hUCB-MSCs) and increased p16(INK4A) and p21(CIP1/WAF1) expression. DNMT inhibition changed histone marks into the active forms and decreased the methylation of CpG islands in the p16(INK4A) and p21(CIP1/WAF1) promoter regions. Enrichment of EZH2, the key factor that methylates histone H3 lysine 9 and 27 residues, was decreased on the p16(INK4A) and p21(CIP1/WAF1) promoter regions. We found that DNMT inhibition decreased expression levels of Polycomb-group (PcG) proteins and increased expression of microRNAs (miRNAs), which target PcG proteins. Decreased CpG island methylation and increased levels of active histone marks at genomic regions encoding miRNAs were observed after 5-AzaC treatment. Taken together, DNMTs have a critical role in regulating the cellular senescence of hUCB-MSCs through controlling not only the DNA methylation status but also active/inactive histone marks at genomic regions of PcG-targeting miRNAs and p16(INK4A) and p21(CIP1/WAF1) promoter regions.	[So, Ah-Young; Lee, Seunghee; Kim, Hyung-Sik; Kang, Kyung-Sun] Seoul Natl Univ, Adult Stem Cell Res Ctr, Coll Vet Med, Seoul, South Korea; [So, Ah-Young; Lee, Seunghee; Kim, Hyung-Sik; Kang, Kyung-Sun] Seoul Natl Univ, Dept Vet Publ Hlth, Coll Vet Med, Seoul, South Korea; [So, Ah-Young; Lee, Seunghee; Kim, Hyung-Sik; Kang, Kyung-Sun] Seoul Natl Univ, Res Inst Vet Sci, Coll Vet Med, Seoul, South Korea; [Jung, Ji-Won] Korea Natl Inst Hlth, Div Intractable Dis, Ctr Biomed Sci, Chungbuk, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science	So, AY (corresponding author), Seoul Natl Univ, Adult Stem Cell Res Ctr, Coll Vet Med, Seoul, South Korea.	kangpub@snu.ac.kr	Kang, Kyung-Sun/G-6205-2013		National Research Foundation of Korea (NRF) [2010-0020265]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (NRF) (MEST, 2010-0020265). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia A, 2001, GYNECOL ONCOL, V82, P299, DOI 10.1006/gyno.2001.6284; Allan LA, 2000, MOL CELL BIOL, V20, P1291, DOI 10.1128/MCB.20.4.1291-1298.2000; Balzer E, 2010, DEVELOPMENT, V137, P891, DOI 10.1242/dev.042895; Banerjee S, 2010, EXP CELL RES, V316, P172, DOI 10.1016/j.yexcr.2009.08.011; Barh D, 2010, CURR ONCOL, V17, P70; Benetti R, 2008, NAT STRUCT MOL BIOL, V15, P268, DOI 10.1038/nsmb.1399; Braconi C, 2010, HEPATOLOGY, V51, P881, DOI 10.1002/hep.23381; Casillas MA, 2003, MOL CELL BIOCHEM, V252, P33, DOI 10.1023/A:1025548623524; Chen Chun-ling, 2005, Zhonghua Fu Chan Ke Za Zhi, V40, P770; Cheng H., 2010, MOL BIOL REP; Datta J, 2003, J CELL BIOCHEM, V88, P855, DOI 10.1002/jcb.10457; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fabbri M, 2010, ADV GENET, V70, P87, DOI [10.1016/S0065-2660(10)70004-3, 10.1016/B978-0-12-380866-0.60004-6]; Fandy TE, 2009, CURR MED CHEM, V16, P2075, DOI 10.2174/092986709788612738; Fang JY, 2004, CHINESE MED J-PEKING, V117, P99; Fang JY, 2002, WORLD J GASTROENTERO, V8, P400, DOI 10.3748/wjg.v8.i3.400; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Hernandez-Munoz I, 2005, MOL CELL BIOL, V25, P11047, DOI 10.1128/MCB.25.24.11047-11058.2005; Huang XP, 2010, CIRCULATION, V122, P2419, DOI 10.1161/CIRCULATIONAHA.110.955971; HUPKES M, 2011, BIOCH BIOPHYS ACTA; IMAM JS, ONCOGENE; Jin BL, 2009, CANCER RES, V69, P7412, DOI 10.1158/0008-5472.CAN-09-0116; Jori FP, 2005, J CELL BIOCHEM, V94, P645, DOI 10.1002/jcb.20315; Jorl FP, 2005, CELL DEATH DIFFER, V12, P65, DOI 10.1038/sj.cdd.4401499; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Jung JW, 2010, CELL MOL LIFE SCI, V67, P1165, DOI 10.1007/s00018-009-0242-9; Jung JW, 2005, CANCER LETT, V225, P199, DOI 10.1016/j.canlet.2004.11.029; KOMASHKO VM, EPIGENETICS, V5; Lee S, 2009, CELL PROLIFERAT, V42, P711, DOI 10.1111/j.1365-2184.2009.00633.x; LEE S, CELL MOL LIFE SCI; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lehmann U, 2008, J PATHOL, V214, P17, DOI 10.1002/path.2251; Li Y, 2010, CURR MED CHEM, V17, P2141, DOI 10.2174/092986710791299966; Lin TS, 2005, CANCER LETT, V226, P77, DOI 10.1016/j.canlet.2004.12.031; Lopatina N, 2002, J CELL BIOCHEM, V84, P324, DOI 10.1002/jcb.10015; MAHPATRA S, ETHN DIS, V20; Majumder S, 2002, J BIOL CHEM, V277, P16048, DOI 10.1074/jbc.M111662200; Milutinovic S, 2000, J BIOL CHEM, V275, P6353, DOI 10.1074/jbc.275.9.6353; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Noonan EJ, 2009, ONCOGENE, V28, P1714, DOI 10.1038/onc.2009.19; Orciani M, 2011, J BIOL REG HOMEOS AG, V25, P115; Park JR, 2008, CELL PROLIFERAT, V41, P859, DOI 10.1111/j.1365-2184.2008.00565.x; Patra SK, 2002, MOL CARCINOGEN, V33, P163, DOI 10.1002/mc.10033; Pignolo RJ, 2008, AGING CELL, V7, P23, DOI 10.1111/j.1474-9726.2007.00350.x; Robert MF, 2003, NAT GENET, V33, P61, DOI 10.1038/ng1068; Rong QF, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-36; ROSCA AM, 2011, STEM CELLS DEV; Saito Y, 2006, CELL CYCLE, V5, P2220, DOI 10.4161/cc.5.19.3340; Schneider-Stock R, 2007, IDRUGS, V10, P557; Seo KW, 2009, BIOCHEM BIOPH RES CO, V384, P120, DOI 10.1016/j.bbrc.2009.04.094; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Shin JY, 2000, CANCER RES, V60, P262; Soleimani M, 2010, INT J DEV BIOL, V54, P1295, DOI 10.1387/ijdb.092999ms; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Su Yu, 2009, Yichuan, V31, P1087, DOI 10.3724/SP.J.1005.2009.01087; Takeuchi S, 2010, CANCER RES, V70, P9381, DOI 10.1158/0008-5472.CAN-10-0801; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Valeri N, 2009, MAMM GENOME, V20, P573, DOI 10.1007/s00335-009-9206-5; VINKEN M, TOXICOL IN VITRO, V24, P445; VRBA L, PLOS ONE, V5, pE8697; WAKITANI S, 1995, MUSCLE NERVE, V18, P1417, DOI 10.1002/mus.880181212; Wang HJ, EUR J CANC, V46, P2295; Woodbury D, 2002, J NEUROSCI RES, V69, P908, DOI 10.1002/jnr.10365; XU C, EUR J CANC; Xu WR, 2004, EXP BIOL MED, V229, P623, DOI 10.1177/153537020422900706; Young JI, 2001, J BIOL CHEM, V276, P19610, DOI 10.1074/jbc.M009470200; Yuan Yan, 2005, Zhonghua Xinxueguanbing Zazhi, V33, P170; Zardo G, 2005, CELL RES, V15, P679, DOI 10.1038/sj.cr.7290337; Zhou S, 2008, AGING CELL, V7, P335, DOI 10.1111/j.1474-9726.2008.00377.x	69	121	128	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19503	10.1371/journal.pone.0019503	http://dx.doi.org/10.1371/journal.pone.0019503			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572997	Green Published, Green Submitted, gold			2022-12-27	WOS:000290440200009
J	Spear, GT; Kendrick, SR; Chen, HY; Thomas, TT; Bahk, M; Balderas, R; Ghosh, S; Weinberg, A; Landay, AL				Spear, Gregory T.; Kendrick, Sabrina R.; Chen, Hua Y.; Thomas, Tin T.; Bahk, Mieoak; Balderas, Robert; Ghosh, Santosh; Weinberg, Aaron; Landay, Alan L.			Multiplex Immunoassay of Lower Genital Tract Mucosal Fluid from Women Attending an Urban STD Clinic Shows Broadly Increased IL1 beta and Lactoferrin	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; BACTERIAL-VAGINOSIS; INNATE IMMUNITY; INFLAMMATORY CYTOKINES; PREGNANT-WOMEN; CERVICAL-MUCUS; ACTIVATION; MARKERS; PROTEIN; CELLS	Background: More than one million new cases of sexually transmitted diseases (STDs) occur each day. The immune responses and inflammation induced by STDs and other frequent non-STD microbial colonizations (i.e. Candida and bacterial vaginosis) can have serious pathologic consequences in women including adverse pregnancy outcomes, infertility and increased susceptibility to infection by other pathogens. Understanding the types of immune mediators that are elicited in the lower genital tract by these infections/colonizations can give important insights into the innate and adaptive immune pathways that are activated and lead to strategies for preventing pathologic effects. Methodology/Principal Findings: 32 immune mediators were measured by multiplexed immunoassays to assess the immune environment of the lower genital tract mucosa in 84 women attending an urban STD clinic. IL-3, IL-1 beta, VEGF, angiogenin, IL-8, beta 2Defensin and beta 3Defensin were detected in all subjects, Interferon-a was detected in none, while the remaining mediators were detected in 40% to 93% of subjects. Angiogenin, VEGF, FGF, IL-9, IL-7, lymphotoxin-alpha and IL-3 had not been previously reported in genital mucosal fluid from women. Strong correlations were observed between levels of TNF-alpha, IL-1 beta and IL-6, between chemokines IP-10 and MIG and between myeloperoxidase, IL-8 and G-CSF. Samples from women with any STD/colonization had significantly higher levels of IL-8, IL-3, IL-7, IL-1 beta, lactoferrin and myeloperoxidase. IL-1 beta and lactoferrin were significantly increased in gonorrhea, Chlamydia, cervicitis, bacterial vaginosis and trichomoniasis. Conclusions/Significance: These studies show that mucosal fluid in general appears to be an environment that is rich in immune mediators. Importantly, IL-1 beta and lactoferrin are biomarkers for STDs/colonizations providing insights into immune responses and pathogenesis at this mucosal site.	[Spear, Gregory T.; Landay, Alan L.] Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA; [Kendrick, Sabrina R.; Thomas, Tin T.; Bahk, Mieoak] John H Stroger Jr Hosp Cook Cty, Dept Med, Chicago, IL USA; [Kendrick, Sabrina R.] Ruth M Rothstein CORE Ctr, Chicago, IL USA; [Chen, Hua Y.] Univ Illinois, Div Epidemiol & Biostat, Chicago, IL USA; [Balderas, Robert] BD Biosci, San Diego, CA USA; [Ghosh, Santosh; Weinberg, Aaron] Case Sch Dent Med, Dept Biol Sci, Cleveland, OH USA	Rush University; John H Stroger Junior Hospital Cook County; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Case Western Reserve University	Spear, GT (corresponding author), Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA.	gspear@rush.edu	Ghosh, Santosh K/I-5461-2019	Ghosh, Santosh K/0000-0001-5669-7853; Weinberg, Aaron/0000-0002-9960-7181	Rush University Translational Science Consortium; NIH [P01HD40539]; BD Biosciences; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD040539] Funding Source: NIH RePORTER	Rush University Translational Science Consortium; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BD Biosciences; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Financial support for this work was provided by a Rush University Translational Science Consortium Pilot award and by NIH Grant P01HD40539. BD Biosciences is also a funder since it provided the salary of author RB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, except that author RB had a role in the conceiving and designing of the experiments, and in the interpretation of the results.	Agrawal T, 2009, CLIN MICROBIOL INFEC, V15, P50, DOI 10.1111/j.1469-0691.2008.02113.x; Capitini CM, 2009, J INTERN MED, V266, P141, DOI 10.1111/j.1365-2796.2009.02085.x; Cole AM, 2001, J IMMUNOL, V167, P623, DOI 10.4049/jimmunol.167.2.623; Culhane JF., 2007, AM J OBSTET GYNECOL, V196; Cummins JE, 2006, AIDS RES HUM RETROV, V22, P788, DOI 10.1089/aid.2006.22.788; Farnaud S, 2003, MOL IMMUNOL, V40, P395, DOI 10.1016/S0161-5890(03)00152-4; Frantz S, 2005, CIRC RES, V96, P15, DOI 10.1161/01.RES.0000153188.68898.ac; Ghosh SK, 2007, CLIN CHEM, V53, P757, DOI 10.1373/clinchem.2006.081430; Goldenherg RL, 2000, AM J OBSTET GYNECOL, V182, P631, DOI 10.1067/mob.2000.104211; Hedges SR, 1998, J INFECT DIS, V178, P742, DOI 10.1086/515372; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Imseis HM, 1997, J SOC GYNECOL INVEST, V4, P90, DOI 10.1016/S1071-5576(97)00003-8; Keller MJ, 2006, AM J REPROD IMMUNOL, V56, P356, DOI 10.1111/j.1600-0897.2006.00436.x; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; Lieberman JA, 2008, CLIN VACCINE IMMUNOL, V15, P49, DOI 10.1128/CVI.00216-07; Loetscher P, 2001, J BIOL CHEM, V276, P2986, DOI 10.1074/jbc.M005652200; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mattsby-Baltzer I, 1998, ACTA OBSTET GYN SCAN, V77, P701, DOI 10.1034/j.1600-0412.1998.770701.x; Mayaud P, 2004, SEX TRANSM INFECT, V80, P174, DOI 10.1136/sti.2002.004101; Novak RM, 2007, CLIN VACCINE IMMUNOL, V14, P1102, DOI 10.1128/CVI.00386-06; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Rein MF, 1996, SEX TRANSM DIS, V23, P517, DOI 10.1097/00007435-199611000-00014; Sawada M, 2006, INT J GYNECOL OBSTET, V92, P117, DOI 10.1016/j.ijgo.2005.10.004; Simhan HN, 2007, AM J OBSTET GYNECOL, V196, P59, DOI 10.1016/j.ajog.2006.08.035; Sobel JD, 1998, AM J OBSTET GYNECOL, V178, P203, DOI 10.1016/S0002-9378(98)80001-X; SOUKKA T, 1992, FEMS MICROBIOL LETT, V90, P223, DOI 10.1111/j.1574-6968.1992.tb05156.x; St John Elizabeth, 2007, Curr HIV/AIDS Rep, V4, P22, DOI 10.1007/s11904-007-0004-y; Sulak PJ, 2003, SEMIN REPROD MED, V21, P399; Trifonova RT, 2007, BIOMARKERS, V12, P608, DOI 10.1080/13547500701600670; van der Strate BWA, 2001, ANTIVIR RES, V52, P225, DOI 10.1016/S0166-3542(01)00195-4; Wald A, 2003, J INFECT DIS, V188, P1345, DOI 10.1086/379043; Ward PP, 2005, CELL MOL LIFE SCI, V62, P2540, DOI 10.1007/s00018-005-5369-8; WIRA CR, 2010, AM J REPROD IMMUNOL	34	36	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19560	10.1371/journal.pone.0019560	http://dx.doi.org/10.1371/journal.pone.0019560			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572958	Green Published, gold, Green Submitted			2022-12-27	WOS:000290440200011
J	Di Paola, R; Caporarello, N; Marucci, A; Dimatteo, C; Iadicicco, C; Del Guerra, S; Prudente, S; Sudano, D; Miele, C; Parrino, C; Piro, S; Beguinot, F; Marchetti, P; Trischitta, V; Frittitta, L				Di Paola, Rosa; Caporarello, Nunzia; Marucci, Antonella; Dimatteo, Claudia; Iadicicco, Claudia; Del Guerra, Silvia; Prudente, Sabrina; Sudano, Dora; Miele, Claudia; Parrino, Cristina; Piro, Salvatore; Beguinot, Francesco; Marchetti, Piero; Trischitta, Vincenzo; Frittitta, Lucia			ENPP1 Affects Insulin Action and Secretion: Evidences from In Vitro Studies	PLOS ONE			English	Article							MEMBRANE GLYCOPROTEIN PC-1; AMINO-ACID POLYMORPHISM; PANCREATIC BETA-CELLS; DEPENDENT DIABETES-MELLITUS; AFFECTS GLUCOSE-METABOLISM; RECEPTOR SUBSTRATE-1; ENDOPLASMIC-RETICULUM; K121Q POLYMORPHISM; RESISTANCE; MUSCLE	The aim of this study was to deeper investigate the mechanisms through which ENPP1, a negative modulator of insulin receptor (IR) activation, plays a role on insulin signaling, insulin secretion and eventually glucose metabolism. ENPP1 cDNA (carrying either K121 or Q121 variant) was transfected in HepG2 liver-, L6 skeletal muscle-and INS1E beta-cells. Insulin-induced IR-autophosphorylation (HepG2, L6, INS1E), Akt-Ser(473), ERK1/2-Thr(202)/Tyr(204) and GSK3-beta Ser(9) phosphorylation (HepG2, L6), PEPCK mRNA levels (HepG2) and 2-deoxy-D-glucose uptake (L6) was studied. GLUT 4 mRNA (L6), insulin secretion and caspase-3 activation (INS1E) were also investigated. Insulin-induced IR-autophosphorylation was decreased in HepG2-K, L6-K, INS1E-K (20%, 52% and 11% reduction vs. untransfected cells) and twice as much in HepG2-Q, L6-Q, INS1E-Q (44%, 92% and 30%). Similar data were obtained with Akt-Ser(473), ERK1/2-Thr(202)/Tyr(204) and GSK3-beta Ser(9) in HepG2 and L6. Insulin-induced reduction of PEPCK mRNA was progressively lower in untransfected, HepG2-K and HepG2-Q cells (65%, 54%, 23%). Insulin-induced glucose uptake in untransfected L6 (60% increase over basal), was totally abolished in L6-K and L6-Q cells. GLUT 4 mRNA was slightly reduced in L6-K and twice as much in L6-Q (13% and 25% reduction vs. untransfected cells). Glucose-induced insulin secretion was 60% reduced in INS1E-K and almost abolished in INS1E-Q. Serum deficiency activated caspase-3 by two, three and four folds in untransfected INS1E, INS1E-K and INS1E-Q. Glyburide-induced insulin secretion was reduced by 50% in isolated human islets from homozygous QQ donors as compared to those from KK and KQ individuals. Our data clearly indicate that ENPP1, especially when the Q121 variant is operating, affects insulin signaling and glucose metabolism in skeletal muscle-and liver-cells and both function and survival of insulin secreting beta-cells, thus representing a strong pathogenic factor predisposing to insulin resistance, defective insulin secretion and glucose metabolism abnormalities.	[Di Paola, Rosa; Marucci, Antonella; Dimatteo, Claudia; Trischitta, Vincenzo] IRCCS Casa Sollievo Sofferenza, Res Unit Diabet & Endocrine Dis, San Giovanni Rotondo, Italy; [Caporarello, Nunzia; Sudano, Dora; Parrino, Cristina; Frittitta, Lucia] Univ Catania, Sch Med, Garibaldi Hosp, Unit Endocrinol,Dept Clin & Mol Biomed, Catania, Italy; [Iadicicco, Claudia; Miele, Claudia; Beguinot, Francesco] Univ Napoli Federico II, CNR, Ist Endocrinol & Oncol Sperimentale, Naples, Italy; [Iadicicco, Claudia; Miele, Claudia; Beguinot, Francesco] Univ Napoli Federico II, Dipartimento Biol & Patol Cellulare & Mol, Naples, Italy; [Del Guerra, Silvia; Marchetti, Piero] Univ Pisa, Dept Endocrinol & Metab, Pisa, Italy; [Prudente, Sabrina; Trischitta, Vincenzo] IRCCS Casa Sollievo Sofferenza, Mendel Lab, San Giovanni Rotondo, Italy; [Piro, Salvatore] Univ Catania, Sch Med, Garibaldi Hosp, Unit Internal Med,Dept Clin & Mol Biomed, Catania, Italy; [Trischitta, Vincenzo] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy	IRCCS Casa Sollievo Della Sofferenza; University of Catania; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; University of Naples Federico II; University of Pisa; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; University of Catania; Sapienza University Rome	Di Paola, R (corresponding author), IRCCS Casa Sollievo Sofferenza, Res Unit Diabet & Endocrine Dis, San Giovanni Rotondo, Italy.	r.dipaola@operapadrepio.it; v.trischitta@operapadrepio.it; lfritti@unict.it	frittitta, lucia/AAA-4733-2019; frittitta, Lucia/J-2334-2012; Di Paola, Rosa/G-7813-2011; Parrino, Cristina/H-4009-2018; Trischitta, Vincenzo/K-1487-2016; marucci, antonella/B-8722-2017; Piro, Salvatore/H-9353-2012; Prudente, Sabrina/H-2886-2016; Parrino, Cristina/ABA-7496-2020; Piro, Salvatore/P-7585-2019; Marchetti, Piero/J-7439-2013	frittitta, lucia/0000-0002-7941-5828; Di Paola, Rosa/0000-0001-5837-9111; Parrino, Cristina/0000-0002-1367-6208; Trischitta, Vincenzo/0000-0003-1174-127X; marucci, antonella/0000-0001-8131-8317; Piro, Salvatore/0000-0002-1781-0902; Prudente, Sabrina/0000-0001-9220-8981; Parrino, Cristina/0000-0002-1367-6208; Piro, Salvatore/0000-0002-1781-0902; Marchetti, Piero/0000-0003-4907-0635; Caporarello, Nunzia/0000-0002-3183-2868	Italian Ministry of Health [RC2008 RC2009 RC2010, RC2009 RC2011, RF05ED01]; Italian Ministry of University and Research [RBNE01N4Z9_009]; Telethon [E1239, GGP02423]; Fondazione Roma "Sostegno alla ricerca scientifica biomedica''; European Community [201681, RBIP0689BS, 115005]; Telethon, Italy	Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Telethon(Fondazione Telethon); Fondazione Roma "Sostegno alla ricerca scientifica biomedica''(Fondazione Roma); European Community(European Commission); Telethon, Italy(Fondazione Telethon)	This research was supported by Italian Ministry of Health Grants: RC2008 RC2009 RC2010 (R.D.P.), RC2009 RC2011 (V.T.), RF05ED01 (R.D.P.); Italian Ministry of University and Research Grant: RBNE01N4Z9_009; Telethon Grants: E1239 (V.T.) and GGP02423 (R.D.P.); Fondazione Roma "Sostegno alla ricerca scientifica biomedica 2008'' (V.T.); European Community's PREPOBEDIA 201681 (F.B.) and FIRB RBIP0689BS (F.B.). The financial support of Telethon, Italy, to F.B. is also gratefully acknowledged. P.M. and S.D.G. are supported in part by the European Community, project IMIDIA, N. 115005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate N, 2003, J CLIN ENDOCR METAB, V88, P5927, DOI 10.1210/jc.2003-030453; Almind K, 1996, J CLIN INVEST, V97, P2569, DOI 10.1172/JCI118705; Andreozzi F, 2008, ARTERIOSCL THROM VAS, V28, P1355, DOI 10.1161/ATVBAHA.108.162883; Anello M, 2004, AM J PHYSIOL-ENDOC M, V287, pE602, DOI 10.1152/ajpendo.00320.2003; Aspinwall CA, 2000, J BIOL CHEM, V275, P22331, DOI 10.1074/jbc.M909647199; Bacci S, 2011, DIABETES, V60, P1000, DOI 10.2337/db10-1300; Bacci S, 2009, ARTERIOSCL THROM VAS, V29, P1678, DOI 10.1161/ATVBAHA.109.189191; Baratta R, 2008, DIABETES, V57, P3360, DOI 10.2337/db07-1830; Belfiore A, 1996, MOL ENDOCRINOL, V10, P1318, DOI 10.1210/me.10.11.1318; Bernal-Mizrachi E, 2004, J CLIN INVEST, V114, P928, DOI 10.1172/JCI200420016; Chin CN, 2009, EUR J PHARMACOL, V606, P17, DOI 10.1016/j.ejphar.2009.01.016; Clark J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012333; CLAUSEN JO, 1995, LANCET, V346, P397, DOI 10.1016/S0140-6736(95)92779-4; Costanzo BV, 2001, DIABETES, V50, P831, DOI 10.2337/diabetes.50.4.831; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Dong HJ, 2005, DIABETES, V54, P367, DOI 10.2337/diabetes.54.2.367; Frittitta L, 1998, DIABETES, V47, P1095, DOI 10.2337/diabetes.47.7.1095; Frittitta L, 1997, DIABETOLOGIA, V40, P282, DOI 10.1007/s001250050675; Goldfine ID, 2008, ENDOCR REV, V29, P62, DOI 10.1210/er.2007-0004; Grarup N, 2006, DIABETOLOGIA, V49, P2097, DOI 10.1007/s00125-006-0353-x; Hribal ML, 2000, J CLIN ENDOCR METAB, V85, P2004, DOI 10.1210/jc.85.5.2004; Kahn C Ronald, 2003, Exp Diabesity Res, V4, P169, DOI 10.1155/EDR.2003.169; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Liang J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000882; Liew CW, 2010, J CLIN INVEST, V120, P2876, DOI 10.1172/JCI36849; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; Maddux BA, 2006, AM J PHYSIOL-ENDOC M, V290, pE746, DOI 10.1152/ajpendo.00298.2005; MADDUX BA, 1995, NATURE, V373, P448, DOI 10.1038/373448a0; Maddux BA, 2000, DIABETES, V49, P13, DOI 10.2337/diabetes.49.1.13; Maedler K, 2005, J CLIN ENDOCR METAB, V90, P501, DOI 10.1210/jc.2004-0699; Marchetti P, 2007, DIABETOLOGIA, V50, P2486, DOI 10.1007/s00125-007-0816-8; Marchetti P, 2002, DIABETES, V51, P1419, DOI 10.2337/diabetes.51.5.1419; Marucci A, 2009, J MOL MED, V87, P139, DOI 10.1007/s00109-008-0429-9; Miele C, 2003, J BIOL CHEM, V278, P47376, DOI 10.1074/jbc.M301088200; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Oriente F, 2011, DIABETES, V60, P138, DOI 10.2337/db10-0860; Otani K, 2004, AM J PHYSIOL-ENDOC M, V286, pE41, DOI 10.1152/ajpendo.00533.2001; Parker JC, 2004, LIFE SCI, V75, P1479, DOI 10.1016/j.lfs.2004.03.015; Pizzuti A, 1999, DIABETES, V48, P1881, DOI 10.2337/diabetes.48.9.1881; Porzio O, 1999, J CLIN INVEST, V104, P357, DOI 10.1172/JCI5870; Prudente S, 2005, DIABETES, V54, P2807, DOI 10.2337/diabetes.54.9.2807; Prudente S, 2010, DIABETOLOGIA, V53, P1354, DOI 10.1007/s00125-010-1749-1; Prudente S, 2009, J CLIN ENDOCR METAB, V94, P190, DOI 10.1210/jc.2008-1365; Prudente S, 2009, NAT REV ENDOCRINOL, V5, P682, DOI 10.1038/nrendo.2009.215; Raciti GA, 2010, DIABETOLOGIA, V53, P955, DOI 10.1007/s00125-010-1676-1; Stentz Frankie B., 2007, Genomics Proteomics & Bioinformatics, V5, P216, DOI 10.1016/S1672-0229(08)60009-1; Stolerman ES, 2008, DIABETES, V57, P1971, DOI 10.2337/db08-0266; Stumvoll M, 2001, DIABETES, V50, P882, DOI 10.2337/diabetes.50.4.882; Teno S, 1999, DIABETES RES CLIN PR, V45, P25, DOI 10.1016/S0168-8227(99)00056-X; Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; WARRAM JH, 1990, ANN INTERN MED, V113, P909, DOI 10.7326/0003-4819-113-12-909; Zhou HH, 2009, EUR J PHARMACOL, V616, P346, DOI 10.1016/j.ejphar.2009.06.057	54	28	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19462	10.1371/journal.pone.0019462	http://dx.doi.org/10.1371/journal.pone.0019462			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573217	Green Published, gold, Green Submitted			2022-12-27	WOS:000290256400012
J	Millioni, R; Tolin, S; Puricelli, L; Sbrignadello, S; Fadini, GP; Tessari, P; Arrigoni, G				Millioni, Renato; Tolin, Serena; Puricelli, Lucia; Sbrignadello, Stefano; Fadini, Gian Paolo; Tessari, Paolo; Arrigoni, Giorgio			High Abundance Proteins Depletion vs Low Abundance Proteins Enrichment: Comparison of Methods to Reduce the Plasma Proteome Complexity	PLOS ONE			English	Article							HUMAN SERUM; BIOMARKER DISCOVERY; GEL-ELECTROPHORESIS; MASS-SPECTROMETRY; LIGAND LIBRARIES; ALBUMIN; STRATEGIES; PREFRACTIONATION; COMBINATORIAL; REMOVAL	Background: To date, the complexity of the plasma proteome exceeds the analytical capacity of conventional approaches to isolate lower abundance proteins that may prove to be informative biomarkers. Only complex multistep separation strategies have been able to detect a substantial number of low abundance proteins (< 100 ng/ml). The first step of these protocols is generally the depletion of high abundance proteins by the use of immunoaffinity columns or, alternatively, the enrichment of by the use of solid phase hexapeptides ligand libraries. Methodology/Principal Findings: Here we present a direct comparison of these two approaches. Following either approach, the plasma sample was further fractionated by SCX chromatography and analyzed by RP-LC-MS/MS with a Q-TOF mass spectrometer. The depletion of the 20 most abundant plasma proteins allowed the identification of about 25% more proteins than those detectable following low abundance proteins enrichment. The two datasets are partially overlapping and the identified proteins belong to the same order of magnitude in terms of plasma concentration. Conclusions/Significance: Our results show that the two approaches give complementary results. However, the enrichment of low abundance proteins has the great advantage of obtaining much larger amount of material that can be used for further fractionations and analyses and emerges also as a cheaper and technically simpler approach. Collectively, these data indicate that the enrichment approach seems more suitable as the first stage of a complex multi-step fractionation protocol.	[Millioni, Renato; Puricelli, Lucia; Sbrignadello, Stefano; Fadini, Gian Paolo; Tessari, Paolo] Univ Padua, Dept Clin & Expt Med, Div Metab, Padua, Italy; [Tolin, Serena] Univ Padua, Dept Agr Biotechnol, Padua, Italy; [Tolin, Serena; Tessari, Paolo; Arrigoni, Giorgio] VIMM, Padua, Italy; [Sbrignadello, Stefano] CNR, Inst Biomed Engn, Padua, Italy; [Arrigoni, Giorgio] Univ Padua, Dept Biol Chem, Padua, Italy	University of Padua; University of Padua; Veneto Institute Molecular Medicine; Consiglio Nazionale delle Ricerche (CNR); University of Padua	Millioni, R (corresponding author), Univ Padua, Dept Clin & Expt Med, Div Metab, Padua, Italy.	millionirenato@gmail.com	Millioni, Renato/ABG-1799-2020; Fadini, Gian Paolo/M-4575-2019; Avogaro, Angelo/S-3808-2016; Arrigoni, Giorgio/A-3535-2014	Fadini, Gian Paolo/0000-0002-6510-2097; Arrigoni, Giorgio/0000-0002-4103-2733; Sbrignadello, Stefano/0000-0002-3795-2887; Tessari, Paolo/0000-0002-4570-9238	University of Padua [CPDA082784/08]; European Foundation for the Study of Diabetes (EFSD)/Eli Lilly; FSE [2105/201/9/2215/2009]	University of Padua; European Foundation for the Study of Diabetes (EFSD)/Eli Lilly(Eli Lilly); FSE(European Social Fund (ESF))	This work was supported by the University of Padua (CPDA082784/08 to GA). GPF is supported by a European Foundation for the Study of Diabetes (EFSD)/Eli Lilly grant. RM and LP are supported by a FSE (2105/201/9/2215/2009) grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2003, PROTEOMICS, V3, P1980, DOI 10.1002/pmic.200300465; Bandow JE, 2010, PROTEOMICS, V10, P1416, DOI 10.1002/pmic.200900431; BELLEI E, 2010, AMINO ACIDS; Beseme O, 2010, ELECTROPHORESIS, V31, P2697, DOI 10.1002/elps.201000188; Boschetti E, 2008, J PROTEOMICS, V71, P255, DOI 10.1016/j.jprot.2008.05.002; Castagna A, 2005, J PROTEOME RES, V4, P1917, DOI 10.1021/pr050153r; Chen YY, 2005, ELECTROPHORESIS, V26, P2117, DOI 10.1002/elps.200410381; Chromy BA, 2004, J PROTEOME RES, V3, P1120, DOI 10.1021/pr049921p; Colantonio DA, 2005, PROTEOMICS, V5, P3831, DOI 10.1002/pmic.200401235; Desrosiers RR, 2007, CELL BIOCHEM BIOPHYS, V49, P182, DOI 10.1007/s12013-007-0048-z; Echan LA, 2005, PROTEOMICS, V5, P3292, DOI 10.1002/pmic.200401228; Ernoult E, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/927917; Gong Y, 2006, J PROTEOME RES, V5, P1379, DOI 10.1021/pr0600024; Govorukhina NI, 2003, J CHROMATOGR A, V1009, P171, DOI 10.1016/S0021-9673(03)00921-X; Granger J, 2005, PROTEOMICS, V5, P4713, DOI 10.1002/pmic.200401331; Guerrier L, 2006, J CHROMATOGR B, V833, P33, DOI 10.1016/j.jchromb.2005.12.048; Guerrier L, 2007, J PROTEOME RES, V6, P4290, DOI 10.1021/pr0703371; Hoffman SA, 2007, J CHROMATOGR B, V849, P43, DOI 10.1016/j.jchromb.2006.10.069; Liu Tao, 2007, Methods Mol Biol, V359, P107; Liu T, 2006, MOL CELL PROTEOMICS, V5, P1899, DOI 10.1074/mcp.M600068-MCP200; Liumbruno G, 2010, J PROTEOMICS, V73, P483, DOI 10.1016/j.jprot.2009.06.010; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Magagnotti C, 2010, CLIN CHEM LAB MED, V48, P531, DOI 10.1515/CCLM.2010.109; Millioni R, 2008, AMINO ACIDS, V34, P507, DOI 10.1007/s00726-007-0556-6; Omenn GS, 2005, PROTEOMICS, V5, P3226, DOI 10.1002/pmic.200500358; Pernemalm M, 2008, J PROTEOME RES, V7, P2712, DOI 10.1021/pr700821k; Polaskova V, 2010, ELECTROPHORESIS, V31, P471, DOI 10.1002/elps.200900286; Qian WJ, 2008, MOL CELL PROTEOMICS, V7, P1963, DOI 10.1074/mcp.M800008-MCP200; Quero C, 2004, PROTEOMICS, V4, P303, DOI 10.1002/pmic.200300630; Rai AJ, 2005, PROTEOMICS, V5, P3262, DOI 10.1002/pmic.200401245; Roche S, 2009, J PROTEOMICS, V72, P945, DOI 10.1016/j.jprot.2009.03.008; Roux-Dalvai F, 2008, MOL CELL PROTEOMICS, V7, P2254, DOI 10.1074/mcp.M800037-MCP200; Schenk S, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-41; Sennels L, 2007, J PROTEOME RES, V6, P4055, DOI 10.1021/pr070339l; Shen YF, 2005, PROTEOMICS, V5, P4034, DOI 10.1002/pmic.200401246; Stempfer R, 2008, ELECTROPHORESIS, V29, P4316, DOI 10.1002/elps.200800211; Tu CJ, 2005, J PROTEOME RES, V4, P1265, DOI 10.1021/pr0497529; Vasudev NS, 2008, PROTEOMICS, V8, P5074, DOI 10.1002/pmic.200800497; Ye HG, 2010, MOL CELL BIOCHEM, V343, P91, DOI 10.1007/s11010-010-0502-x; Zheng XY, 2009, J CHROMATOGR A, V1216, P3538, DOI 10.1016/j.chroma.2009.01.063; Zolotarjova N, 2005, PROTEOMICS, V5, P3304, DOI 10.1002/pmic.200402021	41	113	116	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19603	10.1371/journal.pone.0019603	http://dx.doi.org/10.1371/journal.pone.0019603			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573190	Green Published, gold, Green Submitted			2022-12-27	WOS:000290224800038
J	Jham, BC; Ma, T; Hu, JD; Chaisuparat, R; Friedman, ER; Pandolfi, PP; Schneider, A; Sodhi, A; Montaner, S				Jham, Bruno C.; Ma, Tao; Hu, Jiadi; Chaisuparat, Risa; Friedman, Eitan R.; Pandolfi, Pier Paolo; Schneider, Abraham; Sodhi, Akrit; Montaner, Silvia			Amplification of the Angiogenic Signal through the Activation of the TSC/mTOR/HIF Axis by the KSHV vGPCR in Kaposi's Sarcoma	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; ENDOTHELIAL GROWTH-FACTOR; VASCULAR-PERMEABILITY FACTOR; PARACRINE NEOPLASIA; TUBEROUS SCLEROSIS; CHEMOKINE RECEPTOR; TUMOR ANGIOGENESIS; FACTOR EXPRESSION; VIRAL ONCOGENE; HERPESVIRUS	Background: Kaposi's sarcoma (KS) is a vascular neoplasm characterized by the dysregulated expression of angiogenic and inflammatory cytokines. The driving force of the KS lesion, the KSHV-infected spindle cell, secretes elevated levels of vascular endothelial growth factor (VEGF), essential for KS development. However, the origin of VEGF in this tumor remains unclear. Methodology/Principal Findings: Here we report that the KSHV G protein-coupled receptor (vGPCR) upregulates VEGF in KS through an intricate paracrine mechanism. The cytokines secreted by the few vGPCR-expressing tumor cells activate in neighboring cells multiple pathways (including AKT, ERK, p38 and IKK beta) that, in turn, converge on TSC1/2, promoting mTOR activation, HIF upregulation, and VEGF secretion. Conditioned media from vGPCR-expressing cells lead to an mTOR-dependent increase in HIF-1 alpha and HIF-2 alpha protein levels and VEGF upregulation. In a mouse allograft model for KS, specific inhibition of the paracrine activation of mTOR in non-vGPCR-expressing cells was sufficient to inhibit HIF upregulation in these cells, and abolished the ability of the vGPCR-expressing cells to promote tumor formation in vivo. Similarly, pharmacologic inhibition of HIF in this model blocked VEGF secretion and also lead to tumor regression. Conclusions/Significance: Our findings provide a compelling explanation for how the few tumor cells expressing vGPCR can contribute to the dramatic amplification of VEGF secretion in KS, and further provide a molecular mechanism for how cytokine dysregulation in KS fuels angiogenesis and tumor development. These data further suggest that activation of HIF by vGPCR may be a vulnerable target for the treatment of patients with KS.	[Jham, Bruno C.; Ma, Tao; Hu, Jiadi; Chaisuparat, Risa; Friedman, Eitan R.; Schneider, Abraham; Montaner, Silvia] Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA; [Montaner, Silvia] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Schneider, Abraham; Montaner, Silvia] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Canc Genet Program, Dept Med,Med Sch, Boston, MA 02215 USA; [Sodhi, Akrit] Johns Hopkins Univ, Wilmer Eye Inst, Johns Hopkins Sch Med, Baltimore, MD 21218 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Johns Hopkins University; Johns Hopkins Medicine	Jham, BC (corresponding author), Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA.	smontaner@umaryland.edu	Jham, Bruno/F-1596-2013; Schneider, Abraham/AAR-5941-2021	Pandolfi, Pier Paolo/0000-0002-5352-5295	National Cancer Institute, National Institutes of Health [R01CA119911]; CNPq-Brazil; NATIONAL CANCER INSTITUTE [R01CA119911] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant R01CA119911 (National Cancer Institute, National Institutes of Health). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Gary S. Hayward for kindly providing the specific antibody recognizing KSHV vGPCR. BCJ is a recipient of a predoctoral fellowship from the CNPq-Brazil. We thank Xin Wang for her help with the immunohistochemistry experiments.	Arvanitakis L, 1997, NATURE, V385, P347, DOI 10.1038/385347a0; Bais C, 2003, CANCER CELL, V3, P131, DOI 10.1016/S1535-6108(03)00024-2; Bais C, 1998, NATURE, V391, P86, DOI 10.1038/34193; Brinkmann MM, 2003, J VIROL, V77, P9346, DOI 10.1128/JVI.77.17.9346-9358.2003; Brown LF, 1996, AM J PATHOL, V148, P1065; Cai QL, 2006, PLOS PATHOG, V2, P1002, DOI 10.1371/journal.ppat.0020116; Cai Q, 2007, J VIROL, V81, P10413, DOI 10.1128/JVI.00611-07; Campistol JM, 2004, TRANSPLANTATION, V77, P760, DOI 10.1097/01.TP.0000115344.18025.0B; Carroll PA, 2006, J VIROL, V80, P10802, DOI 10.1128/JVI.00673-06; Catrina SB, 2006, CLIN CANCER RES, V12, P4506, DOI 10.1158/1078-0432.CCR-05-2473; Cesarman E, 2000, J EXP MED, V191, P417, DOI 10.1084/jem.191.3.417; Cesarman E, 1996, J VIROL, V70, P8218, DOI 10.1128/JVI.70.11.8218-8223.1996; Cornali E, 1996, AM J PATHOL, V149, P1851; Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guo HG, 2003, J VIROL, V77, P2631, DOI 10.1128/JVI.77.4.2631-2639.2003; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jensen KK, 2005, J IMMUNOL, V174, P3686, DOI 10.4049/jimmunol.174.6.3686; Jham BC, 2010, J CELL BIOCHEM, V110, P1, DOI 10.1002/jcb.22524; Lee DF, 2007, CELL CYCLE, V6, P3011, DOI 10.4161/cc.6.24.5085; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Li Y, 2003, J BIOL CHEM, V278, P13663, DOI 10.1074/jbc.M300862200; Liu L, 2002, J BIOL CHEM, V277, P13745, DOI 10.1074/jbc.M110480200; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Martin D, 2008, ONCOGENE, V27, P1844, DOI [10.1038/sj.onc.1210817, 10.1038/onc.2009.351]; Masood R, 1997, P NATL ACAD SCI USA, V94, P979, DOI 10.1073/pnas.94.3.979; McCormick C, 2005, SCIENCE, V307, P739, DOI 10.1126/science.1105779; Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888; Montaner S, 2006, CANCER RES, V66, P168, DOI 10.1158/0008-5472.CAN-05-1026; Montaner S, 2003, CANCER CELL, V3, P23, DOI 10.1016/S1535-6108(02)00237-4; Montaner S, 2004, BLOOD, V104, P2903, DOI 10.1182/blood-2003-12-4436; Nakamura S, 1997, J IMMUNOL, V158, P4992; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Rey S, 2010, CARDIOVASC RES, V86, P236, DOI 10.1093/cvr/cvq045; ROSENBERG ZF, 1988, ANN NY ACAD SCI, V546, P164, DOI 10.1111/j.1749-6632.1988.tb21631.x; Sakakibara S, 2009, J VIROL, V83, P2140, DOI 10.1128/JVI.01871-08; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Shin YC, 2008, CANCER RES, V68, P1751, DOI 10.1158/0008-5472.CAN-07-2766; Sodhi A, 2000, CANCER RES, V60, P4873; Sodhi A, 2006, CANCER CELL, V10, P133, DOI 10.1016/j.ccr.2006.05.026; Stallone G, 2005, NEW ENGL J MED, V352, P1317, DOI 10.1056/NEJMoa042831; Sun Q, 2006, ONCOGENE, V25, P2717, DOI 10.1038/sj.onc.1209298; Tomlinson CC, 2004, J VIROL, V78, P1918, DOI 10.1128/JVI.78.4.1918-1927.2004; WEINDEL K, 1992, BIOCHEM BIOPH RES CO, V183, P1167, DOI 10.1016/S0006-291X(05)80313-4; Yang TY, 2000, J EXP MED, V191, P445, DOI 10.1084/jem.191.3.445; Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105	47	47	48	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19103	10.1371/journal.pone.0019103	http://dx.doi.org/10.1371/journal.pone.0019103			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559457	Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700065
J	Joshi, DC; Bakowska, JC				Joshi, Dinesh C.; Bakowska, Joanna C.			SPG20 Protein Spartin Associates with Cardiolipin via Its Plant-Related Senescence Domain and Regulates Mitochondrial Ca2+ Homeostasis	PLOS ONE			English	Article							HEREDITARY SPASTIC PARAPLEGIA; ALPHA-SYNUCLEIN; TROYER-SYNDROME; OXIDATIVE STRESS; CELL-DEATH; CALCIUM; MEMBRANE; IDENTIFICATION; TRANSLOCATION; LOCALIZATION	Hereditary spastic paraplegias (HSPs) are a group of neurological disorders characterized clinically by spasticity of lower limbs and pathologically by degeneration of the corticospinal tract. Troyer syndrome is an autosomal recessive HSP caused by a frameshift mutation in the spartin (SPG20) gene. Previously, we established that this mutation results in a lack of expression of the truncated mutant spartin protein. Spartin is involved in many cellular processes and associates with several intracellular organelles, including mitochondria. Spartin contains a conserved plant-related senescence domain at its C-terminus. However, neither the function of this domain nor the roles of spartin in mitochondrial physiology are currently known. In this study, we determined that the plant-related senescence domain of spartin interacts with cardiolipin but not with two other major mitochondrial phospholipids, phosphatidylcholine and phosphatidylethanolamine. We also found that knockdown of spartin by small interfering RNA in a human neuroblastoma cell line resulted in depolarization of the mitochondrial membrane. In addition, depletion of spartin resulted in a significant decrease in both mitochondrial calcium uptake and mitochondrial membrane potential in cells treated with thapsigargin. Our results suggest that impairment of mitochondrial calcium uptake might contribute to the neurodegeneration of long corticospinal axons and the pathophysiology of Troyer syndrome.	[Joshi, Dinesh C.; Bakowska, Joanna C.] Loyola Univ Chicago, Dept Mol Pharmacol & Therapeut, Maywood, IL USA	Loyola University Chicago	Joshi, DC (corresponding author), Loyola Univ Chicago, Dept Mol Pharmacol & Therapeut, Maywood, IL USA.	jbakowska@lumc.edu		Joshi, Dinesh/0000-0003-1158-7890	National Institutes of Health [K22NS050137]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K22NS050137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (grant number K22NS050137 to J.C.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aromolaran AS, 2007, AM J PHYSIOL-CELL PH, V293, pC106, DOI 10.1152/ajpcell.00543.2006; Atorino L, 2003, J CELL BIOL, V163, P777, DOI 10.1083/jcb.200304112; Bakowska JC, 2005, BIOCHEM BIOPH RES CO, V334, P1042, DOI 10.1016/j.bbrc.2005.06.201; Bakowska JC, 2008, ARCH NEUROL-CHICAGO, V65, P520, DOI 10.1001/archneur.65.4.520; Bakowska JC, 2007, MOL BIOL CELL, V18, P1683, DOI 10.1091/mbc.E06-09-0833; Cabiscol E, 2002, J BIOL CHEM, V277, P44531, DOI 10.1074/jbc.M206525200; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Casari G, 2001, CURR OPIN GENET DEV, V11, P336, DOI 10.1016/S0959-437X(00)00199-4; Chen JS, 2002, J CELL BIOCHEM, V86, P784, DOI 10.1002/jcb.10266; Ciccarelli FD, 2003, GENOMICS, V81, P437, DOI 10.1016/S0888-7543(03)00011-9; Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200; Cole NB, 2008, EXP CELL RES, V314, P2076, DOI 10.1016/j.yexcr.2008.03.012; Crosby AH, 2002, AM J HUM GENET, V71, P1009, DOI 10.1086/344206; CROSS HE, 1967, ARCH NEUROL-CHICAGO, V16, P473, DOI 10.1001/archneur.1967.00470230025003; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; deKroon AIPM, 1997, BBA-BIOMEMBRANES, V1325, P108, DOI 10.1016/S0005-2736(96)00240-4; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Duchen Michael R., 2004, Molecular Aspects of Medicine, V25, P365, DOI 10.1016/j.mam.2004.03.001; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Eastman SW, 2009, J CELL BIOL, V184, P881, DOI 10.1083/jcb.200808041; Edwards TL, 2009, BIOCHEM J, V423, P31, DOI 10.1042/BJ20082398; FARKAS DL, 1989, BIOPHYS J, V56, P1053, DOI 10.1016/S0006-3495(89)82754-7; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gizatullina ZZ, 2006, ANN NEUROL, V59, P407, DOI 10.1002/ana.20754; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hansen JJ, 2002, AM J HUM GENET, V70, P1328, DOI 10.1086/339935; Hooper C, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-72; JOSHI DC, 2011, J VIS EXP IN PRESS; Kerbiriou M, 2007, BBA-MOL BASIS DIS, V1772, P1236, DOI 10.1016/j.bbadis.2007.10.004; Koshkin V, 2000, BIOCHEM J, V347, P687, DOI 10.1042/0264-6021:3470687; Kruman II, 1999, J NEUROCHEM, V72, P529, DOI 10.1046/j.1471-4159.1999.0720529.x; Li WW, 2007, NEUROREPORT, V18, P1543, DOI 10.1097/WNR.0b013e3282f03db4; Lu J, 2006, J NEUROCHEM, V98, P1908, DOI 10.1111/j.1471-4159.2006.04008.x; Majumder PK, 2000, J BIOL CHEM, V275, P21793, DOI 10.1074/jbc.C000048200; Manfredi G, 2005, MITOCHONDRION, V5, P77, DOI 10.1016/j.mito.2005.01.002; Manfredi G, 2002, METHODS, V26, P317, DOI 10.1016/S1046-2023(02)00037-3; Marks JD, 2005, J NEUROSCI, V25, P6561, DOI 10.1523/JNEUROSCI.1450-05.2005; Mehta B, 2008, J GEN PHYSIOL, V132, P339, DOI 10.1085/jgp.200810043; Milakovic T, 2006, J BIOL CHEM, V281, P34785, DOI 10.1074/jbc.M603845200; Milewska M, 2009, J NEUROCHEM, V111, P1022, DOI 10.1111/j.1471-4159.2009.06382.x; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Patel H, 2002, NAT GENET, V31, P347, DOI 10.1038/ng937; Ramakrishnan M, 2003, BIOCHEMISTRY-US, V42, P12919, DOI 10.1021/bi035048e; Renvoise B, 2010, MOL BIOL CELL, V21, P3293, DOI 10.1091/mbc.E09-10-0879; Robay D, 2006, EXP CELL RES, V312, P2764, DOI 10.1016/j.yexcr.2006.05.003; Rogers TB, 1995, BIOSCIENCE REP, V15, P341, DOI 10.1007/BF01788366; Shavali S, 2008, NEUROSCI LETT, V439, P125, DOI 10.1016/j.neulet.2008.05.005; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; TSIEN RY, 1981, NATURE, V290, P527, DOI 10.1038/290527a0; Wolins NE, 2005, J BIOL CHEM, V280, P19146, DOI 10.1074/jbc.M500978200; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zhao KS, 2004, J BIOL CHEM, V279, P34682, DOI 10.1074/jbc.M402999200	54	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19290	10.1371/journal.pone.0019290	http://dx.doi.org/10.1371/journal.pone.0019290			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559443	Green Submitted, gold, Green Published			2022-12-27	WOS:000290024700125
J	Liu, CH; Li, L; Chen, Z; Wang, Q; Hu, YL; Zhu, BL; Woo, PCY				Liu, Cui Hua; Li, Ling; Chen, Zhi; Wang, Qi; Hu, Yong Liang; Zhu, Baoli; Woo, Patrick C. Y.			Characteristics and Treatment Outcomes of Patients with MDR and XDR Tuberculosis in a TB Referral Hospital in Beijing: A 13-Year Experience	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; RISK-FACTORS	Background: Information on treatment outcomes among hospitalized patients with multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) are scarce in China. Methodology/Principal Findings: We conducted this retrospective study to analyze the characteristics and treatment outcomes in MDR- and XDR-TB patients in the 309 Hospital in Beijing, China during 1996-2009. Socio-demographic and clinical data were retrieved from medical records and analyzed. Logistic regression analysis was performed to identify risk factors associated with poor treatment outcomes and Cox proportional hazards regression model was further used to determine risk factors associated with death in TB patients. Among the 3,551 non-repetitive hospitalized TB patients who had drug susceptibility testing (DST) results, 716 (20.2%) had MDR-TB and 51 (1.4%) had XDR-TB. A total of 3,270 patients who had medical records available were used for further analyses. Treatment success rates (cured and treatment completed) were 90.9%, 53.4% and 29.2% for patients with non-MDR-TB, patients with MDR-TB excluding XDR-TB and patients with XDR-TB, respectively. Independent risk factors associated with poor treatment outcomes in MDR-TB patients included being a migrant (adjusted OR = 1.77), smear-positivity at treatment onset (adjusted OR = 1.94) and not receiving 3 or more potentially effective drugs (adjusted OR = 3.87). Independent risk factors associated with poor treatment outcomes in XDR-TB patients were smear-positivity at treatment onset (adjusted OR = 10.42) and not receiving 3 or more potentially effective drugs (adjusted OR = 14.90). The independent risk factors associated with death in TB patients were having chronic obstructive pulmonary disease (adjusted HR = 5.25) and having hypertension (adjusted HR = 4.31). Conclusions/Significance: While overall satisfactory treatment success for non-MDR-TB patients was achieved, more intensive efforts should be made to better manage MDR-and XDR-TB cases in order to improve their treatment outcomes and to minimize further emergence of so-called totally drug-resistant TB cases.	[Liu, Cui Hua; Wang, Qi; Zhu, Baoli] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Liu, Cui Hua; Chen, Zhi; Hu, Yong Liang] 309 Hosp, Inst TB Res, Beijing, Peoples R China; [Li, Ling] So Med Univ, Inst Genet Engn, Guangzhou, Guangdong, Peoples R China; [Woo, Patrick C. Y.] Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Southern Medical University - China; University of Hong Kong	Liu, CH (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.	cuihualiu@gmail.com; zhubaoli@im.ac.cn; pcywoo@hkucc.hku.hk	Woo, Patrick Chiu Yat/C-4449-2009	Woo, Patrick Chiu Yat/0000-0001-9401-1832	309 Hospital, Beijing, China [09QD01]; State Key Development Program for Basic Research of China, China [2009CB522605]; Chinese Academy of Sciences [KSCX2-EW-J-6, KSCX2-YW-R-164]	309 Hospital, Beijing, China; State Key Development Program for Basic Research of China, China(State Key Development Program for Basic Research of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This research project received funding from the Start-up Grant of the 309 Hospital, Beijing, China (09QD01) and the State Key Development Program for Basic Research of China, China (2009CB522605). This work was supported by the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-J-6 and KSCX2-YW-R-164). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beijing Municipal Bureau of Statistics, 2007, BEIJ STAT YB 2007; Bonilla Cesar A, 2008, PLoS One, V3, pe2957, DOI 10.1371/journal.pone.0002957; Centers for Disease Control and Prevention, 2006, MMWR-MORBID MORTAL W, V55, P1176; Chan ED, 2008, CURR OPIN INFECT DIS, V21, P587, DOI 10.1097/QCO.0b013e328319bce6; Chen XY, 2004, LANCET, V364, P417; Cox HS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001126; Dheda K, 2010, LANCET, V375, P1798, DOI 10.1016/S0140-6736(10)60492-8; Eker B, 2008, EMERG INFECT DIS, V14, P1700, DOI 10.3201/eid1411.080729; Fan H, 2010, PLOS ONE, V5; Franke MF, 2008, CLIN INFECT DIS, V46, P1844, DOI 10.1086/588292; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Jain A, 2008, FEMS IMMUNOL MED MIC, V53, P145, DOI 10.1111/j.1574-695X.2008.00400.x; Jeon CY, 2008, CLIN INFECT DIS, V46, P42, DOI 10.1086/524017; Jia ZW, 2008, EMERG INFECT DIS, V14, P1413, DOI [10.3201/1409.071543, 10.3201/eid1409.071543]; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Kim DH, 2008, AM J RESP CRIT CARE, V178, P1075, DOI 10.1164/rccm.200801-132OC; Kliiman K, 2009, EUR RESPIR J, V33, P1085, DOI 10.1183/09031936.00155708; Lai CC, 2008, CLIN INFECT DIS, V47, pE57, DOI 10.1086/591702; Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640; Leimane V, 2005, LANCET, V365, P318, DOI 10.1016/S0140-6736(05)17786-1; Lew W, 2008, ANN INTERN MED, V149, P123, DOI 10.7326/0003-4819-149-2-200807150-00008; LoBue P, 2009, CURR OPIN INFECT DIS, V22, P167, DOI 10.1097/QCO.0b013e3283229fab; Migliori GB, 2008, EUR RESPIR J, V31, P904, DOI 10.1183/09031936.00159807; Shah NS, 2008, JAMA-J AM MED ASSOC, V300, P2153, DOI 10.1001/jama.300.18.2153; Shean KP, 2008, INT J TUBERC LUNG D, V12, P1182; Vashakidze L, 2009, INT J TUBERC LUNG D, V13, P1148; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; Wei XL, 2009, TROP MED INT HEALTH, V14, P754, DOI 10.1111/j.1365-3156.2009.02286.x; WHO, 2010, MULT EXT DRUG RES TU; [WHO IUATLD], 2009, 4 WHO IUATLD; World Health Organization, 2008, WHOHTMTB2008402; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7; Zhao M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004370	35	42	48	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19399	10.1371/journal.pone.0019399	http://dx.doi.org/10.1371/journal.pone.0019399			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559362	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700158
J	Losada, L; Varga, JJ; Hostetler, J; Radune, D; Kim, M; Durkin, S; Schneewind, O; Nierman, WC				Losada, Liliana; Varga, John J.; Hostetler, Jessica; Radune, Diana; Kim, Maria; Durkin, Scott; Schneewind, Olaf; Nierman, William C.			Genome Sequencing and Analysis of Yersina pestis KIM D27, an Avirulent Strain Exempt from Select Agent Regulation	PLOS ONE			English	Article							BACILLUS-ANTHRACIS; PASTEURELLA PESTIS; IDENTIFICATION; REPEATS; PLAGUE	Yersinia pestis is the causative agent of the plague. Y. pestis KIM 10+ strain was passaged and selected for loss of the 102 kb pgm locus, resulting in an attenuated strain, KIM D27. In this study, whole genome sequencing was performed on KIM D27 in order to identify any additional differences. Initial assemblies of 454 data were highly fragmented, and various bioinformatic tools detected between 15 and 465 SNPs and INDELs when comparing both strains, the vast majority associated with A or T homopolymer sequences. Consequently, Illumina sequencing was performed to improve the quality of the assembly. Hybrid sequence assemblies were performed and a total of 56 validated SNP/INDELs and 5 repeat differences were identified in the D27 strain relative to published KIM 10+ sequence. However, further analysis showed that 55 of these SNP/INDELs and 3 repeats were errors in the KIM 10+ reference sequence. We conclude that both 454 and Illumina sequencing were required to obtain the most accurate and rapid sequence results for Y. pestis KIMD27. SNP and INDELS calls were most accurate when both Newbler and CLC Genomics Workbench were employed. For purposes of obtaining high quality genome sequence differences between strains, any identified differences should be verified in both the new and reference genomes.	[Losada, Liliana; Varga, John J.; Hostetler, Jessica; Radune, Diana; Kim, Maria; Durkin, Scott; Nierman, William C.] J Craig Venter Inst, Rockville, MD USA; [Schneewind, Olaf] Univ Chicago, Chicago, IL 60637 USA; [Nierman, William C.] George Washington Univ, Washington, DC USA	J. Craig Venter Institute; University of Chicago; George Washington University	Losada, L (corresponding author), J Craig Venter Inst, Rockville, MD USA.	llosada@jcvi.org	Varga, John J/I-8130-2012	Varga, John J/0000-0002-4868-1971	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200900007C]	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in whole with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under contract number HHSN272200900007C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; BRUBAKER RR, 1969, J BACTERIOL, V98, P1404, DOI 10.1128/JB.98.3.1404-1406.1969; Buchrieser C, 1999, INFECT IMMUN, V67, P4851, DOI 10.1128/IAI.67.9.4851-4861.1999; Carniel E, 2001, MICROBES INFECT, V3, P561, DOI 10.1016/S1286-4579(01)01412-5; Chen PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012397; Conrad TM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r118; Darling AE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000128; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; Easton J, 2009, RARE INFECT MAY HAVE; FINEGOLD MJ, 1968, AM J PATHOL, V53, P99; Forman S, 2006, MICROBIOL-SGM, V152, P3399, DOI 10.1099/mic.0.29224-0; ITEMAN I, 1993, INFECT IMMUN, V61, P2717, DOI 10.1128/IAI.61.6.2717-2722.1993; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; Kuroda M, 2010, J CLIN MICROBIOL, V48, P2821, DOI 10.1128/JCM.00137-10; Kurtz S, 1999, BIOINFORMATICS, V15, P426, DOI 10.1093/bioinformatics/15.5.426; Kurtz S, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P228; Lahteenmaki K, 1998, INFECT IMMUN, V66, P5755; Lillard JW, 1997, GENE, V193, P13, DOI 10.1016/S0378-1119(97)00071-1; Losada L, 2010, GENOME BIOL EVOL, V2, P102, DOI 10.1093/gbe/evq003; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Paauw A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008240; Perry RD, 2008, CURR PROTOC MICROBIO; Pop M, 2004, BRIEF BIOINFORM, V5, P237, DOI 10.1093/bib/5.3.237; Read TD, 2002, SCIENCE, V296, P2028, DOI 10.1126/science.1071837; Schutzer SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002058; Sjodin A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011556	29	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19054	10.1371/journal.pone.0019054	http://dx.doi.org/10.1371/journal.pone.0019054			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559501	Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700057
J	Wansleeben, C; van Gurp, L; Feitsma, H; Kroon, C; Rieter, E; Verberne, M; Guryev, V; Cuppen, E; Meijlink, F				Wansleeben, Carolien; van Gurp, Leon; Feitsma, Harma; Kroon, Carla; Rieter, Ester; Verberne, Marlies; Guryev, Victor; Cuppen, Edwin; Meijlink, Frits			An ENU-Mutagenesis Screen in the Mouse: Identification of Novel Developmental Gene Functions	PLOS ONE			English	Article							BLOOD-VESSEL DEVELOPMENT; ETHYL-N-NITROSOUREA; LUNG DEVELOPMENT; BRANCHING MORPHOGENESIS; MUTATIONS; DROSOPHILA; DEFECTS; DELTA; MICE; TRAFFICKING	Background: Mutagenesis screens in the mouse have been proven useful for the identification of novel gene functions and generation of interesting mutant alleles. Here we describe a phenotype-based screen for recessive mutations affecting embryonic development. Methodology/Principal Findings: Mice were mutagenized with N-ethyl-N-nitrosurea (ENU) and following incrossing the offspring, embryos were analyzed at embryonic day 10.5. Mutant phenotypes that arose in our screen include cardiac and nuchal edema, neural tube defects, situs inversus of the heart, posterior truncation and the absence of limbs and lungs. We isolated amongst others novel mutant alleles for Dll1, Ptprb, Plexin-B2, Fgf10, Wnt3a, Ncx1, Scrib(Scrib, Scribbled homolog [Drosophila]) and Sec24b. We found both nonsense alleles leading to severe protein truncations and mutants with single-amino acid substitutions that are informative at a molecular level. Novel findings include an ectopic neural tube in our Dll1 mutant and lung defects in the planar cell polarity mutants for Sec24b and Scrib. Conclusions/Significance: Using a forward genetics approach, we have generated a number of novel mutant alleles that are linked to disturbed morphogenesis during development.	Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands; [Rieter, Ester] Univ Med Ctr Utrecht, Dept Cell Biol, Utrecht, Netherlands; [Rieter, Ester] Univ Med Ctr Utrecht, Inst Biomembranes, Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Wansleeben, C (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	f.meijlink@hubrecht.eu	Cuppen, Edwin/H-2389-2016; Cuppen, Edwin/F-5696-2011; van Gurp, Leon/M-1218-2016	Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542; van Gurp, Leon/0000-0002-6281-5964; Guryev, Victor/0000-0002-5810-6022; Feitsma, Harma/0000-0002-8173-7164	Dutch government [03038]	Dutch government	This work was supported by a grant from the Dutch government (BSIK program 03038, Stem Cells in Development and Disease) to FM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumer S, 2006, BLOOD, V107, P4754, DOI 10.1182/blood-2006-01-0141; Beier DR, 2004, GENETICA, V122, P65, DOI 10.1007/s10709-004-1437-5; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; Beverdam A, 2001, DEVELOPMENT, V128, P3975; Brown SDM, 2001, CURR OPIN GENET DEV, V11, P268, DOI 10.1016/S0959-437X(00)00189-1; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Chapman DL, 1998, NATURE, V391, P695, DOI 10.1038/35624; Ching YH, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-106; D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; Deng SH, 2007, J NEUROSCI, V27, P6333, DOI 10.1523/JNEUROSCI.5381-06.2007; Dominguez MG, 2007, P NATL ACAD SCI USA, V104, P3243, DOI 10.1073/pnas.0611510104; Friedel RH, 2007, J NEUROSCI, V27, P3921, DOI 10.1523/JNEUROSCI.4710-06.2007; Garcia-Garcia MJ, 2005, P NATL ACAD SCI USA, V102, P5913, DOI 10.1073/pnas.0501071102; Herron BJ, 2002, NAT GENET, V30, P185, DOI 10.1038/ng812; Hirschberg A, 2010, MOL CELL BIOL, V30, P764, DOI 10.1128/MCB.01458-09; HITOTSUMACHI S, 1985, P NATL ACAD SCI USA, V82, P6619, DOI 10.1073/pnas.82.19.6619; Justice MJ, 1999, HUM MOL GENET, V8, P1955, DOI 10.1093/hmg/8.10.1955; Kasarskis A, 1998, P NATL ACAD SCI USA, V95, P7485, DOI 10.1073/pnas.95.13.7485; Li CG, 2002, DEV BIOL, V248, P68, DOI 10.1006/dbio.2002.0729; Loscertales M, 2008, DEVELOPMENT, V135, P1365, DOI 10.1242/dev.010504; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Moore KA, 2005, DEV DYNAM, V232, P268, DOI 10.1002/dvdy.20237; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Parks AL, 2006, GENETICS, V174, P1947, DOI 10.1534/genetics.106.061630; Przemeck GKH, 2003, DEVELOPMENT, V130, P3, DOI 10.1242/dev.00176; Rida PCG, 2009, SEMIN CELL DEV BIOL, V20, P978, DOI 10.1016/j.semcdb.2009.02.007; Saburi S, 2008, NAT GENET, V40, P1010, DOI 10.1038/ng.179; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Shimizu K, 1999, J BIOL CHEM, V274, P32961, DOI 10.1074/jbc.274.46.32961; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; Teppner I, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-68; Wansleeben C, 2010, INT J DEV BIOL, V54, P1465, DOI 10.1387/ijdb.093051cw; Wansleeben C, 2010, DEVELOPMENT, V137, P1067, DOI 10.1242/dev.041434; Weber JS, 2000, GENESIS, V26, P230, DOI 10.1002/(SICI)1526-968X(200004)26:4<230::AID-GENE20>3.0.CO;2-S; Winderlich M, 2009, J CELL BIOL, V185, P657, DOI 10.1083/jcb.200811159; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; Yates L, 2009, BIOCHEM SOC T, V37, P838, DOI 10.1042/BST0370838; Yates LL, 2010, HUM MOL GENET, V19, P2251, DOI 10.1093/hmg/ddq104; Zarbalis K, 2004, PLOS BIOL, V2, P1177, DOI 10.1371/journal.pbio.0020219	43	26	26	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19357	10.1371/journal.pone.0019357	http://dx.doi.org/10.1371/journal.pone.0019357			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559415	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700147
J	Hu, Y; Mathema, B; Jiang, WL; Kreiswirth, B; Wang, WB; Xu, BA				Hu, Yi; Mathema, Barun; Jiang, Weili; Kreiswirth, Barry; Wang, Weibing; Xu, Biao			Transmission Pattern of Drug-Resistant Tuberculosis and Its Implication for Tuberculosis Control in Eastern Rural China	PLOS ONE			English	Article							TREATMENT-FAILURE PATIENTS; MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR CHARACTERIZATION; NOSOCOMIAL TRANSMISSION; PREVALENCE; STRAINS; GENOTYPE; COUNTIES; TB	Objective: Transmission patterns of drug-resistant Mycobacterium tuberculosis (MTB) may be influenced by differences in socio-demographics, local tuberculosis (TB) endemicity and efficaciousness of TB control programs. This study aimed to investigate the impact of DOTS on the transmission of drug-resistant TB in eastern rural China. Methods: We conducted a cross-sectional study of all patients diagnosed with drug-resistant TB over a one-year period in two rural Chinese counties with varying lengths of DOTS implementation. Counties included Deqing, with over 11 years' DOTS implementation and Guanyun, where DOTS was introduced 1 year prior to start of this study. We combined demographic, clinical and epidemiologic information with IS6110-based restricted fragment length polymorphism (RFLP) and Spoligotyping analysis of MTB isolates. In addition, we conducted DNA sequencing of resistance determining regions to first-line anti-tuberculosis agents. Results: Of the 223 drug-resistant isolates, 73(32.7%) isolates were identified with clustered IS6110RFLP patterns. The clustering proportion among total drug-resistant TB was higher in Guanyun than Deqing (26/101. vs. 47/122; p, 0.04), but not significantly different among the 53 multidrug-resistant isolates (10/18. vs. 24/35; p, 0.35). Patients with cavitary had increased risk of clustering in both counties. In Guanyun, patients with positive smear test or previous treatment history had a higher clustering proportion. Beijing genotype and isolates resistant to isoniazid and/or rifampicin were more likely to be clustered. Of the 73 patients with clustered drug-resistant isolates, 71.2% lived in the same or neighboring villages. Epidemiological link (household and social contact) was confirmed in 12.3% of the clustered isolates. Conclusion: Transmission of drug-resistant TB in eastern rural China is characterized by small clusters and limited geographic spread. Our observations highlight the need for supplementing DOTS with additional strategies, including active case finding at the village level, effective treatment for patients with cavities and drug susceptibility testing for patients at increased risk for drug-resistance.	[Hu, Yi; Jiang, Weili; Wang, Weibing; Xu, Biao] Fudan Univ, Key Lab Publ Hlth Safety, Minist Educ, Shanghai 200433, Peoples R China; [Hu, Yi; Jiang, Weili; Wang, Weibing; Xu, Biao] Fudan Univ, Dept Epidemiol, Sch Publ Hlth, Shanghai 200433, Peoples R China; [Mathema, Barun; Kreiswirth, Barry] Publ Hlth Res Inst, TB Ctr, Newark, NJ USA	Fudan University; Fudan University	Hu, Y (corresponding author), Fudan Univ, Key Lab Publ Hlth Safety, Minist Educ, Shanghai 200433, Peoples R China.	bxu@shmu.edu.cn		Mathema, Barun/0000-0003-2772-479X	National Natural Science Foundation of China [30771843, 30901223]; Shanghai Leading Academic Discipline Project [B118]; National Key Project for Infectious Disease [2008ZX10003-010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); National Key Project for Infectious Disease	This study was supported by two grants (PI, Biao Xu, No. 30771843; PI, Yi Hu, No. 30901223) from National Natural Science Foundation of China, Shanghai Leading Academic Discipline Project (No. B118) and National Key Project for Infectious Disease (No. 2008ZX10003-010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadia E, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-122; Agerton T, 1997, JAMA-J AM MED ASSOC, V278, P1073, DOI 10.1001/jama.278.13.1073; Ano H, 2008, INT J TUBERC LUNG D, V12, P1300; Aristimuno L, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-90; Basu S, 2007, LANCET, V370, P1500, DOI 10.1016/S0140-6736(07)61636-5; Cohn DL, 1997, CLIN INFECT DIS, V24, pS121, DOI 10.1093/clinids/24.Supplement_1.S121; COHN ML, 1970, AM REV RESPIR DIS, V102, P97; D'souza DTB, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-211; Drobniewski F, 2002, EMERG INFECT DIS, V8, P1320, DOI 10.3201/eid0811.020507; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Hu Y, 2011, EPIDEMIOL INFECT, V139, P130, DOI 10.1017/S0950268810000890; Hu Y, 2010, INT J TUBERC LUNG D, V14, P210; Hu Y, 2008, MICROB DRUG RESIST, V14, P227, DOI 10.1089/mdr.2008.0823; Hu Y, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-43; Kelly PM, 2005, INT J TUBERC LUNG D, V9, P81; Li GL, 2010, BIOMED ENVIRON SCI, V23, P188, DOI 10.1016/S0895-3988(10)60051-7; Li X, 2007, J INFECT DIS, V195, P864, DOI 10.1086/511985; Mohammadi A., 2008, Eastern Mediterranean Health Journal, V14, P1238; Mokrousov I, 2008, J CLIN MICROBIOL, V46, P3576, DOI 10.1128/JCM.00414-08; Ohata Ritsuko, 2004, Kekkaku, V79, P47; Park YK, 2005, J MICROBIOL METH, V63, P165, DOI 10.1016/j.mimet.2005.03.002; Phyu S, 2009, J CLIN MICROBIOL, V47, P335, DOI 10.1128/JCM.01812-08; Pritchard AJ, 2003, EPIDEMIOL INFECT, V130, P481, DOI 10.1017/S0950268803008367; Quitugua TN, 2002, J CLIN MICROBIOL, V40, P2716, DOI 10.1128/JCM.40.8.2716-2724.2002; Resch SC, 2006, PLOS MED, V3, P1048, DOI 10.1371/journal.pmed.0030241; Sun YJ, 2007, INT J TUBERC LUNG D, V11, P436; Telles MAS, 2005, INT J TUBERC LUNG D, V9, P970; Valcheva V, 2008, J CLIN MICROBIOL, V46, P3005, DOI 10.1128/JCM.00437-08; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Varela G, 2008, J MED MICROBIOL, V57, P1518, DOI 10.1099/jmm.0.2008/001917-0; Vitol I, 2006, INFECT GENET EVOL, V6, P491, DOI 10.1016/j.meegid.2006.03.003; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; World Health Organization (WHO), 2008, WHO IUATLD GLOB PROJ; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7	34	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19548	10.1371/journal.pone.0019548	http://dx.doi.org/10.1371/journal.pone.0019548			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589863	Green Published, Green Submitted, gold			2022-12-27	WOS:000290531100016
J	Cai, K; Qi, DF; Hou, XW; Wang, OM; Chen, J; Deng, B; Qian, LH; Liu, XL; Le, YY				Cai, Kun; Qi, Dongfei; Hou, Xinwei; Wang, Oumei; Chen, Juan; Deng, Bo; Qian, Lihua; Liu, Xiaolong; Le, Yingying			MCP-1 Upregulates Amylin Expression in Murine Pancreatic beta Cells through ERK/JNK-AP1 and NF-kappa B Related Signaling Pathways Independent of CCR2	PLOS ONE			English	Article							ISLET AMYLOID POLYPEPTIDE; MONOCYTE CHEMOATTRACTANT PROTEIN-1; DEPENDENT DIABETES-MELLITUS; AORTIC SMOOTH-MUSCLE; INSULIN-RESISTANCE; ADIPOSE-TISSUE; SKELETAL-MUSCLE; OBESE SUBJECTS; WEIGHT-LOSS; IN-VIVO	Background: Amylin is the most abundant component of islet amyloid implicated in the development of type 2 diabetes. Plasma amylin levels are elevated in individuals with obesity and insulin resistance. Monocyte chemoattractant protein-1 (MCP-1, CCL2) is involved in insulin resistance of obesity and type 2 diabetes. We investigated the effect of MCP-1 on amylin expression and the underlying mechanisms with murine pancreatic beta-cell line MIN6 and pancreatic islets. Methodology/Principal Findings: We found that MCP-1 induced amylin expression at transcriptional level and increased proamylin and intermediate forms of amylin at protein level in MIN6 cells and islets. However, MCP-1 had no effect on the expressions of proinsulin 1 and 2, as well as prohormone convertase (PC) 1/3 and PC2, suggesting that MCP-1 specifically induces amylin expression in beta-cells. Mechanistic studies showed that although there is no detectable CCR2 mRNA in MIN6 cells and islets, pretreatment of MIN6 cells with pertussis toxin inhibited MCP-1 induced amylin expression, suggesting that alternative Gi-coupled receptor(s) mediates the inductive effect of MCP-1. MCP-1 rapidly induced ERK1/2 and JNK phosphorylation. Inhibitors for MEK1/2 (PD98059), JNK (SP600125) or AP1 (curcumin) significantly inhibited MCP-1-induced amylin mRNA expression. MCP-1 failed to induce amylin expression in pancreatic islets isolated from Fos knockout mice. EMSA showed that JNK and ERK1/2 were involved in MCP-1-induced AP1 activation. These results suggest that MCP-1 induces murine amylin expression through AP1 activation mediated by ERK1/2 or JNK. Further studies showed that treatment of MIN6 cells with NF-kappa B inhibitor or overexpression of I kappa B alpha dominant-negative construct in MIN6 cells significantly inhibited MCP-1-induced amylin expression, suggesting that NF-kappa B related signaling also participates in MCP-1-induced murine amylin expression. Conclusions/Significance: MCP-1 induces amylin expression through ERK1/2/JNK-AP1 and NF-kappa B related signaling pathways independent of CCR2. Amylin upregulation by MCP-1 may contribute to elevation of plasma amylin in obesity and insulin resistance.	[Cai, Kun; Qi, Dongfei; Hou, Xinwei; Wang, Oumei; Chen, Juan; Deng, Bo; Qian, Lihua; Le, Yingying] Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Key Lab Nutr & Metab,Inst Nutr Sci, Shanghai, Peoples R China; [Liu, Xiaolong] Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Mol Cell Biol Lab, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Cai, K (corresponding author), Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Key Lab Nutr & Metab,Inst Nutr Sci, Shanghai, Peoples R China.	yyle@sibs.ac.cn	Qi, Dongfei/L-9548-2015; Le, Yingying/L-9785-2017; Qi, Dongfei/M-1050-2015; wang, oumei/P-5528-2015	Qi, Dongfei/0000-0001-9104-978X; Le, Yingying/0000-0002-7990-3899; Qi, Dongfei/0000-0001-9104-978X; 	National Basic Research Program of China (973 Program) [2011CB504002]; National Natural Science Foundation of China [30870931]; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences [SIBS2008006]; Science and Technology Commission of Shanghai Municipality [03JC14079, 04DZ14007]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Institutes for Biological Sciences(Chinese Academy of Sciences); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by grants from the National Basic Research Program of China (973 Program) (2011CB504002), the National Natural Science Foundation of China (30870931); the One Hundred Talents Program of Chinese Academy of Sciences; the Chief Scientist Program of Shanghai Institutes for Biological Sciences (SIBS2008006), Chinese Academy of Sciences; and the Science and Technology Commission of Shanghai Municipality (03JC14079, 04DZ14007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anguiano M, 2002, BIOCHEMISTRY-US, V41, P11338, DOI 10.1021/bi020314u; Cai K, 2011, DIABETOLOGIA, V54, P617, DOI 10.1007/s00125-010-1972-9; Cambien B, 2001, BLOOD, V97, P359, DOI 10.1182/blood.V97.2.359; Casas S, 2007, DIABETES, V56, P2284, DOI 10.2337/db07-0178; Cheung AT, 1998, ENDOCRINOLOGY, V139, P4928, DOI 10.1210/en.139.12.4928; Christiansen T, 2005, INT J OBESITY, V29, P146, DOI 10.1038/sj.ijo.0802839; CLARK A, 1990, DIABETOLOGIA, V33, P285, DOI 10.1007/BF00403322; Clark A, 2004, DIABETOLOGIA, V47, P157, DOI 10.1007/s00125-003-1304-4; COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628; Ding WQ, 2001, AM J PHYSIOL-ENDOC M, V281, pE938, DOI 10.1152/ajpendo.2001.281.5.E938; ENOKI S, 1992, DIABETES RES CLIN PR, V15, P97, DOI 10.1016/0168-8227(92)90074-2; ERIKSSON J, 1992, DIABETOLOGIA, V35, P291, DOI 10.1007/BF00400933; Hahm ER, 2002, CANCER LETT, V184, P89, DOI 10.1016/S0304-3835(02)00170-2; Harsimran K, 2009, DIABETES VASC DIS RE, V6, P288, DOI 10.1177/1479164109346364; Heesen M, 1996, J NEUROSCI RES, V45, P382; Herder C, 2006, DIABETOLOGIA, V49, P921, DOI 10.1007/s00125-006-0190-y; Hoppener JWM, 2000, NEW ENGL J MED, V343, P411; Huang CJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE1656, DOI 10.1152/ajpendo.00318.2007; HUANG HJS, 1992, HYPERTENSION, V19, pI101, DOI 10.1161/01.HYP.19.1_Suppl.I101; Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405; Jaikaran ETAS, 2001, BBA-MOL BASIS DIS, V1537, P179, DOI 10.1016/S0925-4439(01)00078-3; KAHN SE, 1990, DIABETES, V39, P634, DOI 10.2337/diabetes.39.5.634; Kahn SE, 1999, DIABETES, V48, P241, DOI 10.2337/diabetes.48.2.241; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kim CS, 2006, INT J OBESITY, V30, P1347, DOI 10.1038/sj.ijo.0803259; LANG CH, 1992, ENDOCRINOLOGY, V130, P43, DOI 10.1210/en.130.1.43; Lee Yong-Ho, 2005, Curr Diab Rep, V5, P70; LEIGHTON B, 1988, NATURE, V335, P632, DOI 10.1038/335632a0; Macfarlane WM, 2000, J BIOL CHEM, V275, P15330, DOI 10.1074/jbc.M908045199; Marzban L, 2005, MOL ENDOCRINOL, V19, P2154, DOI 10.1210/me.2004-0407; Marzban L, 2005, ENDOCRINOLOGY, V146, P1808, DOI 10.1210/en.2004-1175; Marzban L, 2003, EXP GERONTOL, V38, P347, DOI 10.1016/S0531-5565(03)00004-4; Matveyenko AV, 2006, DIABETES, V55, P2106, DOI 10.2337/db05-1672; Mirzabekov TA, 1996, J BIOL CHEM, V271, P1988, DOI 10.1074/jbc.271.4.1988; OHSAWA H, 1989, BIOCHEM BIOPH RES CO, V160, P961, DOI 10.1016/0006-291X(89)92529-1; Piemonti L, 2003, DIABETES CARE, V26, P2883, DOI 10.2337/diacare.26.10.2883; PORTE D, 1989, DIABETES, V38, P1333, DOI 10.2337/diabetes.38.11.1333; Qi DF, 2010, AM J PHYSIOL-ENDOC M, V298, pE99, DOI 10.1152/ajpendo.00242.2009; Reinehr T, 2007, OBESITY, V15, P2006, DOI 10.1038/oby.2007.239; SANKE T, 1991, DIABETOLOGIA, V34, P129, DOI 10.1007/BF00500385; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Schecter AD, 2004, J LEUKOCYTE BIOL, V75, P1079, DOI 10.1189/jlb.0903421; Schecter AD, 1997, J BIOL CHEM, V272, P28568, DOI 10.1074/jbc.272.45.28568; Sell H, 2006, ENDOCRINOLOGY, V147, P2458, DOI 10.1210/en.2005-0969; Sell H, 2007, CURR OPIN LIPIDOL, V18, P258, DOI 10.1097/MOL.0b013e3281338546; Sell H, 2009, P NUTR SOC, V68, P378, DOI 10.1017/S0029665109990218; Sodhi A, 2002, J INTERF CYTOK RES, V22, P517, DOI 10.1089/10799900252981990; SOWA R, 1990, DIABETOLOGIA, V33, P118, DOI 10.1007/BF00401051; Tateya S, 2010, ENDOCRINOLOGY, V151, P971, DOI 10.1210/en.2009-0926; Viedt C, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015609.31253.7F; Viedt C, 2002, ARTERIOSCL THROM VAS, V22, P914, DOI 10.1161/01.ATV.0000019009.73586.7F; Wang OM, 2008, ENDOCRINOLOGY, V149, P672, DOI 10.1210/en.2007-0106; Wang XM, 2008, NAT IMMUNOL, V9, P794, DOI 10.1038/ni.1614; Weber CK, 2000, GASTROENTEROLOGY, V119, P1209, DOI 10.1053/gast.2000.19458; Werle M, 2002, CARDIOVASC RES, V56, P284, DOI 10.1016/S0008-6363(02)00600-4; WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881; WESTERMARK P, 1989, DIABETES RES CLIN PR, V7, P219, DOI 10.1016/0168-8227(89)90008-9; Young MR, 2003, TRENDS MOL MED, V9, P36, DOI 10.1016/S1471-4914(02)00009-6; Zhang N, 2003, AM J TRANSPLANT, V3, P1230, DOI 10.1046/j.1600-6143.2003.00215.x; Zhao HL, 2003, DIABETES, V52, P2759, DOI 10.2337/diabetes.52.11.2759; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465; Zhou C, 2004, J REPROD IMMUNOL, V63, P1, DOI 10.1016/j.jri.2004.03.002; Zhou HY, 2011, CURR DRUG TARGETS, V12, P332, DOI 10.2174/138945011794815356	64	42	47	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19559	10.1371/journal.pone.0019559	http://dx.doi.org/10.1371/journal.pone.0019559			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589925	Green Published, Green Submitted, gold			2022-12-27	WOS:000290483600016
J	Negri, AP; Hoogenboom, MO				Negri, Andrew P.; Hoogenboom, Mia O.			Water Contamination Reduces the Tolerance of Coral Larvae to Thermal Stress	PLOS ONE			English	Article							GREAT-BARRIER-REEF; SCLERACTINIAN CORALS; CLIMATE-CHANGE; HEAVY-METALS; TEMPERATURE; COPPER; SETTLEMENT; METAMORPHOSIS; FERTILIZATION; DISPERSAL	Coral reefs are highly susceptible to climate change, with elevated sea surface temperatures (SST) posing one of the main threats to coral survival. Successful recruitment of new colonies is important for the recovery of degraded reefs following mortality events. Coral larvae require relatively uncontaminated substratum on which to metamorphose into sessile polyps, and the increasing pollution of coastal waters therefore constitutes an additional threat to reef resilience. Here we develop and analyse a model of larval metamorphosis success for two common coral species to quantify the interactive effects of water pollution (copper contamination) and SST. We identify thresholds of temperature and pollution that prevent larval metamorphosis, and evaluate synergistic interactions between these stressors. Our analyses show that halving the concentration of Cu can protect corals from the negative effects of a 2-3 degrees C increase in SST. These results demonstrate that effective mitigation of local impacts can reduce negative effects of global stressors.	[Negri, Andrew P.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Hoogenboom, Mia O.] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	Australian Institute of Marine Science; University of Glasgow	Negri, AP (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	a.negri@aims.gov.au	Hoogenboom, Mia O/D-3664-2012; Negri, Andrew P/G-9909-2017	Hoogenboom, Mia O/0000-0003-3709-6344; Negri, Andrew P/0000-0003-1388-7395	Australian Institute of Marine Science	Australian Institute of Marine Science	This research was funded by the Australian Institute of Marine Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AIMS, 2010, SEA TEMP MON PROGR; Apte SC, 2009, DEV EARTH ENV SCI, V9, P321, DOI 10.1016/S1571-9197(08)00409-6; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; BAIRD AH, 2006, TEMPERATURE TOLERANC, P38; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; BERENBAUM MC, 1989, PHARMACOL REV, V41, P93; Berkelmans R, 1999, CORAL REEFS, V18, P219, DOI 10.1007/s003380050186; Bidwell JR, 1998, MAR ECOL PROG SER, V163, P259, DOI 10.3354/meps163259; Bielmyer GK, 2010, AQUAT TOXICOL, V97, P125, DOI 10.1016/j.aquatox.2009.12.021; CAIRNS J, 1975, HYDROBIOLOGIA, V47, P135, DOI 10.1007/BF00036747; Campbell P.G.C., 1995, METAL SPECIATION BIO, P45; Connolly SR, 2010, ECOLOGY, V91, P3572, DOI 10.1890/10-0143.1; Dunne RP, 2010, CORAL REEFS, V29, P145, DOI 10.1007/s00338-009-0569-6; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Graham EM, 2008, CORAL REEFS, V27, P529, DOI 10.1007/s00338-008-0361-z; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; Heyward AJ, 2010, CORAL REEFS, V29, P631, DOI 10.1007/s00338-009-0578-5; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; HOWARD LS, 1984, OCEANOGR MAR BIOL, V22, P195; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jones RJ, 2004, MAR ECOL PROG SER, V284, P133, DOI 10.3354/meps284133; Jones RJ, 2003, MAR ECOL PROG SER, V251, P153, DOI 10.3354/meps251153; Jones RJ, 2007, MAR POLLUT BULL, V54, P905, DOI 10.1016/j.marpolbul.2007.02.018; Lesser MP, 1997, CORAL REEFS, V16, P187, DOI 10.1007/s003380050073; LI RC, 1993, ANTIMICROB AGENTS CH, V37, P523, DOI 10.1128/AAC.37.3.523; Lough J., 2007, CLIMATE CHANGE GREAT, P15; MCCONCHIE DM, 1988, J COASTAL RES, V4, P37; Mendes JM, 2002, MAR ECOL PROG SER, V227, P241, DOI 10.3354/meps227241; Michel A, 2004, ENVIRON TOXICOL CHEM, V23, P1074, DOI 10.1897/03-256; Miller K, 2003, CORAL REEFS, V22, P99, DOI 10.1007/s00338-003-0290-9; Negri A, 2005, MAR POLLUT BULL, V51, P370, DOI 10.1016/j.marpolbul.2004.10.053; Negri A, 2009, J ENVIRON MANAGE, V90, pS31, DOI 10.1016/j.jenvman.2008.06.009; Negri AP, 2001, MAR ENVIRON RES, V51, P17, DOI 10.1016/S0141-1136(00)00029-5; Negri AP, 2002, MAR POLLUT BULL, V44, P111, DOI 10.1016/S0025-326X(01)00128-X; Negri AP, 2000, MAR POLLUT BULL, V41, P420, DOI 10.1016/S0025-326X(00)00139-9; NEGRI AP, LIMNOL OCEA IN PRESS; NOAA, 2009, COR REEF CONS PROGR; Nozawa Y, 2007, MAR BIOL, V152, P1181, DOI 10.1007/s00227-007-0765-2; Nystrom M, 2001, MAR BIOL, V138, P1225; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; R Core Team, 2018, R LANG ENV STAT COMP; *REEF PLAN, 2009, REEF WAT QUAL PROT P; REICHELT AJ, 1994, AUST J MAR FRESH RES, V45, P1237, DOI 10.1071/MF9941237; Reichelt-Brushett AJ, 2000, MAR POLLUT BULL, V41, P385, DOI 10.1016/S0025-326X(00)00131-4; Riegl BM, 2009, ECOL MODEL, V220, P192, DOI 10.1016/j.ecolmodel.2008.09.022; Rodriguez-Lanetty M, 2009, MOL ECOL, V18, P5101, DOI 10.1111/j.1365-294X.2009.04419.x; Roth L, 2010, MAR ECOL PROG SER, V411, P73, DOI 10.3354/meps08640; Sokolova IM, 2008, CLIM RES, V37, P181, DOI 10.3354/cr00764; SOLI AL, 1989, LIMNOL OCEANOGR, V34, P239, DOI 10.4319/lo.1989.34.1.0239; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Tallarida RJ, 2006, J PHARMACOL EXP THER, V319, P1, DOI 10.1124/jpet.106.104117; United States Environmental Protection Agency (USEPA), 2003, UPD AMB WAT IN PRESS; van Woesik R, 2006, ECOL LETT, V9, P390, DOI 10.1111/j.1461-0248.2006.00886.x; Venn AA, 2009, AQUAT TOXICOL, V93, P188, DOI 10.1016/j.aquatox.2009.05.003; Wagner DE, 2010, MAR ECOL PROG SER, V408, P65, DOI 10.3354/meps08584; Watson GJ, 2008, INVERTEBR REPROD DEV, V52, P101, DOI 10.1080/07924259.2008.9652277; Wolstenholme JK, 2004, MAR BIOL, V144, P567, DOI 10.1007/s00227-003-1209-2; Wooldridge SA, 2009, MAR POLLUT BULL, V58, P745, DOI 10.1016/j.marpolbul.2008.12.013; Yakovleva IM, 2009, MAR ECOL PROG SER, V378, P105, DOI 10.3354/meps07857	60	70	71	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19703	10.1371/journal.pone.0019703	http://dx.doi.org/10.1371/journal.pone.0019703			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589934	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000290483600023
J	Hu, QA; Hollunder, J; Niehl, A; Korner, CJ; Gereige, D; Windels, D; Arnold, A; Kuiper, M; Vazquez, F; Pooggin, M; Heinlein, M				Hu, Quanan; Hollunder, Jens; Niehl, Annette; Korner, Camilla Julie; Gereige, Dalya; Windels, David; Arnold, Andreas; Kuiper, Martin; Vazquez, Franck; Pooggin, Mikhail; Heinlein, Manfred			Specific Impact of Tobamovirus Infection on the Arabidopsis Small RNA Profile	PLOS ONE			English	Article							TOBACCO-MOSAIC-VIRUS; TRANS-ACTING SIRNAS; SMALL SILENCING RNAS; DNA METHYLATION; VIRAL SUPPRESSORS; PLANT DEVELOPMENT; REPLICATION PROTEIN; ANTIVIRAL IMMUNITY; ARGONAUTE PROTEINS; BIOGENESIS	Tobamoviruses encode a silencing suppressor that binds small RNA (sRNA) duplexes in vitro and supposedly in vivo to counteract antiviral silencing. Here, we used sRNA deep-sequencing combined with transcriptome profiling to determine the global impact of tobamovirus infection on Arabidopsis sRNAs and their mRNA targets. We found that infection of Arabidopsis plants with Oilseed rape mosaic tobamovirus causes a global size-specific enrichment of miRNAs, ta-siRNAs, and other phased siRNAs. The observed patterns of sRNA enrichment suggest that in addition to a role of the viral silencing suppressor, the stabilization of sRNAs might also occur through association with unknown host effector complexes induced upon infection. Indeed, sRNA enrichment concerns primarily 21-nucleotide RNAs with a 5 '-terminal guanine. Interestingly, ORMV infection also leads to accumulation of novel miRNA-like sRNAs from miRNA precursors. Thus, in addition to canonical miRNAs and miRNA*s, miRNA precursors can encode additional sRNAs that may be functional under specific conditions like pathogen infection. Virus-induced sRNA enrichment does not correlate with defects in miRNA-dependent ta-siRNA biogenesis nor with global changes in the levels of mRNA and ta-siRNA targets suggesting that the enriched sRNAs may not be able to significantly contribute to the normal activity of pre-loaded RISC complexes. We conclude that tobamovirus infection induces the stabilization of a specific sRNA pool by yet unknown effector complexes. These complexes may sequester viral and host sRNAs to engage them in yet unknown mechanisms involved in plant: virus interactions.	[Hu, Quanan; Korner, Camilla Julie; Windels, David; Arnold, Andreas; Vazquez, Franck; Pooggin, Mikhail; Heinlein, Manfred] Univ Basel, Inst Bot, Dept Plant Physiol, Zurich Basel Plant Sci Ctr, CH-4056 Basel, Switzerland; [Hollunder, Jens] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Hollunder, Jens] Univ Ghent, Dept Plant Biotechnol & Genet, B-9000 Ghent, Belgium; [Niehl, Annette; Gereige, Dalya; Heinlein, Manfred] Univ Strasbourg, Inst Biol Mol Plantes, CNRS, UPR 2357, Strasbourg, France; [Kuiper, Martin] Norwegian Univ Sci & Technol, Dept Biol, N-7034 Trondheim, Norway	University of Basel; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Norwegian University of Science & Technology (NTNU)	Hu, QA (corresponding author), Univ Basel, Inst Bot, Dept Plant Physiol, Zurich Basel Plant Sci Ctr, Hebelstr 1, CH-4056 Basel, Switzerland.	manfred.heinlein@ibmp-cnrs.unistra.fr	Kuiper, Martin/AAM-7279-2020; Hollunder, Jens/G-6588-2016; david, windels/C-1112-2013; Vazquez, Franck/B-9849-2013	Kuiper, Martin/0000-0002-1171-9876; Hollunder, Jens/0000-0003-3234-6762; Vazquez, Franck/0000-0002-7967-3798; Pooggin, Mikhail/0000-0003-2308-393X; Hu, Quan'An/0000-0002-0295-3820	Human Frontier Science Program Organization [RGP0022/2006]; Swiss National Science Foundation [3100A0-111916, 31003A-124940, 31003A-122469, 31003A-127514, PZ00P3-126329]	Human Frontier Science Program Organization(Human Frontier Science Program); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank the Functional Genomics Center Zurich for providing the resources for RNA profiling using Affimetrix oligonucleotide arrays. This work was supported with financial support by the Human Frontier Science Program Organization (RGP0022/2006) and the Swiss National Science Foundation grants 3100A0-111916 and 31003A-124940 to M.H., 31003A-122469 and 31003A-127514 to M.M.P., and PZ00P3-126329) to F.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no competing interests exist.	Addo-Quaye C, 2009, RNA, V15, P2112, DOI 10.1261/rna.1774909; Akbergenov R, 2006, NUCLEIC ACIDS RES, V34, P462, DOI 10.1093/nar/gkj447; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bazzini AA, 2007, P NATL ACAD SCI USA, V104, P12157, DOI 10.1073/pnas.0705114104; Blevins T, 2006, NUCLEIC ACIDS RES, V34, P6233, DOI 10.1093/nar/gkl886; Bologna NG, 2009, EMBO J, V28, P3646, DOI 10.1038/emboj.2009.292; Boutet S, 2003, CURR BIOL, V13, P843, DOI 10.1016/S0960-9822(03)00293-8; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Buck KW, 1999, PHILOS T R SOC B, V354, P613, DOI 10.1098/rstb.1999.0413; Charon C, 2010, MOL PLANT, V3, P729, DOI 10.1093/mp/ssq037; Chellappan P, 2010, NUCLEIC ACIDS RES, V38, P6883, DOI 10.1093/nar/gkq590; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Csorba T, 2009, ADV VIRUS RES, V75, P35, DOI 10.1016/S0065-3527(09)07502-2; Csorba T, 2007, J VIROL, V81, P11768, DOI 10.1128/JVI.01230-07; Diaz-Pendon JA, 2008, ANNU REV PHYTOPATHOL, V46, P303, DOI 10.1146/annurev.phyto.46.081407.104746; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Ding XS, 2004, MOL PLANT MICROBE IN, V17, P583, DOI 10.1094/MPMI.2004.17.6.583; Donaire L, 2009, VIROLOGY, V392, P203, DOI 10.1016/j.virol.2009.07.005; Dunoyer P, 2010, SCIENCE, V328, P912, DOI 10.1126/science.1185880; Endres MW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000729; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Havecker ER, 2010, PLANT CELL, V22, P321, DOI 10.1105/tpc.109.072199; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; KIELLANDBRANDT MC, 1974, J MOL BIOL, V87, P489, DOI 10.1016/0022-2836(74)90099-0; Kubota K, 2003, J VIROL, V77, P11016, DOI 10.1128/JVI.77.20.11016-11026.2003; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Kurihara Y, 2007, J GEN VIROL, V88, P2347, DOI 10.1099/vir.0.82994-0; Lakatos L, 2006, EMBO J, V25, P2768, DOI 10.1038/sj.emboj.7601164; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LEWANDOWSKI DJ, 1993, MOL PLANT MICROBE IN, V6, P157, DOI 10.1094/MPMI-6-157; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Lindow M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-119; Mallory A, 2010, PLANT CELL, V22, P3879, DOI 10.1105/tpc.110.080671; Martinez G, 2010, MOL PLANT PATHOL, V11, P347, DOI [10.1111/J.1364-3703.2009.00608.X, 10.1111/j.1364-3703.2009.00608.x]; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Navarro L, 2008, SCIENCE, V321, P964, DOI 10.1126/science.1159505; Pantaleo V, 2010, VIROLOGY, V408, P49, DOI 10.1016/j.virol.2010.09.001; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Pelisson A, 2007, J VIROL, V81, P1951, DOI 10.1128/JVI.01980-06; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Qi XP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004971; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Schwab R, 2009, EMBO J, V28, P3633, DOI 10.1038/emboj.2009.334; Soosaar JLM, 2005, NAT REV MICROBIOL, V3, P789, DOI 10.1038/nrmicro1239; Szittya G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000838; Tagami Y, 2007, DNA RES, V14, P227, DOI 10.1093/dnares/dsm022; Takeda A, 2008, PLANT CELL PHYSIOL, V49, P493, DOI 10.1093/pcp/pcn043; Varallyay E, 2010, EMBO J, V29, P3507, DOI 10.1038/emboj.2010.215; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Vazquez F, 2008, NUCLEIC ACIDS RES, V36, P6429, DOI 10.1093/nar/gkn670; Vazquez F, 2010, TRENDS PLANT SCI, V15, P337, DOI 10.1016/j.tplants.2010.04.001; Vogler H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000038; Vogler H, 2007, J VIROL, V81, P10379, DOI 10.1128/JVI.00727-07; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Wu QF, 2010, CELL HOST MICROBE, V8, P12, DOI 10.1016/j.chom.2010.06.009; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; YANG JH, 2010, NUCL ACIDS RES; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Zhang WX, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r81; Zheng XW, 2007, EMBO J, V26, P1691, DOI 10.1038/sj.emboj.7601603; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	83	45	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19549	10.1371/journal.pone.0019549	http://dx.doi.org/10.1371/journal.pone.0019549			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572953	Green Published, Green Submitted, gold			2022-12-27	WOS:000290440200010
J	Qiu, LH; Rivera-Perez, JA; Xu, ZS				Qiu, Linghua; Rivera-Perez, Jaime A.; Xu, Zuoshang			A Non-Specific Effect Associated with Conditional Transgene Expression Based on Cre-loxP Strategy in Mice	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MEDIATED RECOMBINATION; DISEASE PROGRESSION; DNA RECOMBINATION; DOUBLE REPORTER; NERVOUS-SYSTEM; MOTOR-NEURONS; CELL ABLATION; MOUSE; PROGRANULIN	Transgenes flanked by loxP sites have been widely used to generate transgenic mice where the transgene expression can be controlled spatially and temporally by Cre recombinase. Data from this approach has led to important conclusions in cancer, neurodevelopment and neurodegeneration. Using this approach to conditionally express micro RNAs (miRNAs) in mice, we found that Cre-mediated recombination in neural progenitor cells caused microcephaly in five of our ten independent transgenic lines. This effect was not associated with the types or the quantity of miRNAs being expressed, nor was it associated with specific target knockdown. Rather, it was correlated with the presence of multiple tandem transgene copies and inverted (head-to-head or tail-to-tail) transgene repeats. The presence of these inverted repeats caused a high level of cell death in the ventricular zone of the embryonic brain, where Cre was expressed. Therefore, results from this Cre-loxP approach to generate inducible transgenic alleles must be interpreted with caution and conclusions drawn in previous reports may need reexamination.	[Qiu, Linghua; Xu, Zuoshang] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Rivera-Perez, Jaime A.; Xu, Zuoshang] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; [Xu, Zuoshang] Univ Massachusetts, Sch Med, Neurosci Program, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Qiu, LH (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	Zuoshang.xu@umassmed.edu		Rivera-Perez, Jaime/0000-0001-5776-6291	National Institute of Neurological Disorders and Stroke and National Center for Research Resources [RO1NS048145, R21NS062230, R21RR024395, RC1NS068391]; Diabetes Endocrinology Research Center [DK32520]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR024395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS062230, R01NS048145, RC1NS068391] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke and National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Center for Research Resources (NCRR)); Diabetes Endocrinology Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants (RO1NS048145, R21NS062230, R21RR024395, RC1NS068391) from the National Institute of Neurological Disorders and Stroke and National Center for Research Resources. Core resources were supported by the Diabetes Endocrinology Research Center grant DK32520. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2010, AM J PATHOL, V177, P311, DOI 10.2353/ajpath.2010.090915; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Brockschnieder D, 2004, MOL CELL BIOL, V24, P7636, DOI 10.1128/MCB.24.17.7636-7642.2004; Coumoul X, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni100; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Fritsch L, 2004, EMBO REP, V5, P178, DOI 10.1038/sj.embor.7400064; GIBSON GE, 1988, ARCH NEUROL-CHICAGO, V45, P836, DOI 10.1001/archneur.1988.00520320022009; GORDON JW, 1985, GENE, V33, P121, DOI 10.1016/0378-1119(85)90087-3; Gregoire D, 2008, P NATL ACAD SCI USA, V105, P14492, DOI 10.1073/pnas.0807484105; Grieshammer U, 1998, DEV BIOL, V197, P234, DOI 10.1006/dbio.1997.8859; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Huang ZJ, 2002, GENESIS, V32, P209, DOI 10.1002/gene.10054; JAENISCH R, 1988, SCIENCE, V240, P1468, DOI 10.1126/science.3287623; Kamei K, 2006, GENESIS, V44, P177, DOI 10.1002/dvg.20199; Kayasuga Y, 2007, BEHAV BRAIN RES, V185, P110, DOI 10.1016/j.bbr.2007.07.020; LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232; Leppanen P, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000013; Lewandoski M, 1997, NAT GENET, V17, P223, DOI 10.1038/ng1097-223; Liu J, 2007, GENESIS, V45, P259, DOI 10.1002/dvg.20282; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lo ACY, 2004, TRANSGENIC RES, V13, P119, DOI 10.1023/B:TRAG.0000026072.01351.10; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Lobsiger CS, 2009, P NATL ACAD SCI USA, V106, P4465, DOI 10.1073/pnas.0813339106; Matsumura H, 2004, BIOCHEM BIOPH RES CO, V321, P275, DOI 10.1016/j.bbrc.2004.06.139; Matsumura H, 2007, NAT METHODS, V4, P23, DOI 10.1038/NMETH973; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; Mills AA, 2001, TRENDS GENET, V17, P331, DOI 10.1016/S0168-9525(01)02321-6; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861; Otsuji T, 2008, J MOL BIOL, V378, P328, DOI 10.1016/j.jmb.2008.01.065; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; Qiu LH, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-77; Streicher JM, 2010, J MOL CELL CARDIOL, V49, P88, DOI 10.1016/j.yjmcc.2010.01.021; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wang LJ, 2009, NEUROBIOL DIS, V35, P234, DOI 10.1016/j.nbd.2009.05.002; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yin FF, 2010, FASEB J, V24, P4639, DOI 10.1096/fj.10-161471; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zhong ZH, 2009, J CLIN INVEST, V119, P3437, DOI 10.1172/JCI38476; Zhu Y, 2010, J BIOL CHEM, V285, P26005, DOI 10.1074/jbc.M110.139196	41	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e18778	10.1371/journal.pone.0018778	http://dx.doi.org/10.1371/journal.pone.0018778			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572998	gold, Green Published, Green Submitted			2022-12-27	WOS:000290440200003
J	Cabral, A; Stassen, JHM; Seidl, MF; Bautor, J; Parker, JE; Van den Ackerveken, G				Cabral, Adriana; Stassen, Joost H. M.; Seidl, Michael F.; Bautor, Jaqueline; Parker, Jane E.; Van den Ackerveken, Guido			Identification of Hyaloperonospora arabidopsidis Transcript Sequences Expressed during Infection Reveals Isolate-Specific Effectors	PLOS ONE			English	Article							DOWNY MILDEW RESISTANCE; PATHOGEN CLADOSPORIUM-FULVUM; PERONOSPORA-PARASITICA; DISEASE SUSCEPTIBILITY; CELL-DEATH; PLANT; AVIRULENCE; GENES; PROTEINS; LOCUS	Biotrophic plant pathogens secrete effector proteins that are important for infection of the host. The aim of this study was to identify effectors of the downy mildew pathogen Hyaloperonospora arabidopsidis (Hpa) that are expressed during infection of its natural host Arabidopsis thaliana. Infection-related transcripts were identified from Expressed Sequence Tags (ESTs) derived from leaves of the susceptible Arabidopsis Ws eds1-1 mutant inoculated with the highly virulent Hpa isolate Waco9. Assembly of 6364 ESTs yielded 3729 unigenes, of which 2164 were Hpa-derived. From the translated Hpa unigenes, 198 predicted secreted proteins were identified. Of these, 75 were found to be Hpa-specific and six isolate Waco9-specific. Among 42 putative effectors identified there were three Elicitin-like proteins, 16 Cysteine-rich proteins and 18 host-translocated RXLR effectors. Sequencing of alleles in different Hpa isolates revealed that five RXLR genes show signatures of diversifying selection. Thus, EST analysis of Hpa-infected Arabidopsis is proving to be a powerful method for identifying pathogen effector candidates expressed during infection. Delivery of the Waco9-specific protein RXLR29 in planta revealed that this effector can suppress PAMP-triggered immunity and enhance disease susceptibility. We propose that differences in host colonization can be conditioned by isolate-specific effectors.	[Cabral, Adriana; Stassen, Joost H. M.; Van den Ackerveken, Guido] Univ Utrecht, Dept Plant Microbe Interact, Dept Biol, Utrecht, Netherlands; [Seidl, Michael F.; Van den Ackerveken, Guido] Ctr BioSyst Genom CBSG, Wageningen, Netherlands; [Bautor, Jaqueline; Parker, Jane E.] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Cologne, Germany	Utrecht University; Centre for BioSystems Genomics; Max Planck Society	Cabral, A (corresponding author), Univ Utrecht, Dept Plant Microbe Interact, Dept Biol, Utrecht, Netherlands.	parker@mpipz.mpg.de; g.vandenackerveken@uu.nl	Seidl, Michael F./ABD-6042-2021; Cabral, Adriana/AAX-3284-2021; Van den Ackerveken, Guido/B-8568-2011	Van den Ackerveken, Guido/0000-0002-0183-8978; Seidl, Michael F/0000-0002-5218-2083; Stassen, Joost/0000-0001-5483-325X	Alexander von Humboldt Foundation; The Netherlands Organization for Scientific Research (NWO); ERA-NET Plant Genomics 'Effectoromics' consortium	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); The Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); ERA-NET Plant Genomics 'Effectoromics' consortium	This work was funded by the Alexander von Humboldt Foundation to Jane Parker, by a VIDI innovational research grant from The Netherlands Organization for Scientific Research (NWO) to Guido Van den Ackerveken, and grants within the ERA-NET Plant Genomics 'Effectoromics' consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Abramovitch RB, 2003, EMBO J, V22, P60, DOI 10.1093/emboj/cdg006; Aguileta G, 2009, INFECT GENET EVOL, V9, P656, DOI 10.1016/j.meegid.2009.03.010; Alfano JR, 2009, MOL PLANT PATHOL, V10, P805, DOI 10.1111/j.1364-3703.2009.00588.x; Alfano JR, 2000, P NATL ACAD SCI USA, V97, P4856, DOI 10.1073/pnas.97.9.4856; Allen RL, 2008, MOL PLANT PATHOL, V9, P511, DOI 10.1111/J.1364-3703.2008.00481.X; Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; BAXTER L, SCIENCE IN PRESS; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bittner-Eddy P, 1999, MOL PLANT MICROBE IN, V12, P792, DOI 10.1094/MPMI.1999.12.9.792; Bittner-Eddy PD, 2003, MOL PLANT PATHOL, V4, P501, DOI 10.1046/J.1364-3703.2003.00194.X; Boissy G, 1999, PROTEIN SCI, V8, P1191, DOI 10.1110/ps.8.6.1191; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Bos JIB, 2010, P NATL ACAD SCI USA, V107, P9909, DOI 10.1073/pnas.0914408107; Botella MA, 1998, PLANT CELL, V10, P1847, DOI 10.1105/tpc.10.11.1847; Catanzariti AM, 2006, PLANT CELL, V18, P243, DOI 10.1105/tpc.105.035980; DebRoy S, 2004, P NATL ACAD SCI USA, V101, P9927, DOI 10.1073/pnas.0401601101; Dong SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005556; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; Eisenhaber B, 2003, PLANT PHYSIOL, V133, P1691, DOI 10.1104/pp.103.023580; Fan J, 2008, PLANT J, V53, P393, DOI 10.1111/j.1365-313X.2007.03303.x; Gan PHP, 2009, MOL GENET GENOMICS, V281, P565, DOI 10.1007/s00438-009-0431-0; Gijzen M, 2006, PHYTOCHEMISTRY, V67, P1800, DOI 10.1016/j.phytochem.2005.12.008; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Guo M, 2009, MOL PLANT MICROBE IN, V22, P1069, DOI 10.1094/MPMI-22-9-1069; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; HOLUB EB, 1994, MOL PLANT MICROBE IN, V7, P223, DOI 10.1094/MPMI-7-0223; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jiang RHY, 2006, MOL BIOL EVOL, V23, P338, DOI 10.1093/molbev/msj039; JOOSTEN MHAJ, 1994, NATURE, V367, P384, DOI 10.1038/367384a0; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kale SD, 2010, CELL, V142, P284, DOI 10.1016/j.cell.2010.06.008; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Kim MG, 2005, CELL, V121, P749, DOI 10.1016/j.cell.2005.03.025; KOCH E, 1990, PLANT CELL, V2, P437, DOI 10.1105/tpc.2.5.437; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Luderer R, 2002, MOL MICROBIOL, V45, P875, DOI 10.1046/j.1365-2958.2002.03060.x; McDowell JM, 1998, PLANT CELL, V10, P1861, DOI 10.1105/tpc.10.11.1861; Mikes V, 1998, BIOCHEM BIOPH RES CO, V245, P133, DOI 10.1006/bbrc.1998.8341; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; NEI M, 1986, MOL BIOL EVOL, V3, P418; NESPOULOUS C, 1992, PLANTA, V186, P551, DOI 10.1007/BF00198035; Nielsen H, 1997, Int J Neural Syst, V8, P581, DOI 10.1142/S0129065797000537; O'Connell RJ, 2006, NEW PHYTOL, V171, P699, DOI 10.1111/j.1469-8137.2006.01829.x; Panabieres F, 1997, MYCOL RES, V101, P1459, DOI 10.1017/S0953756297004413; Parker JE, 1996, PLANT CELL, V8, P2033, DOI 10.1105/tpc.8.11.2033; Parker JE, 1997, PLANT CELL, V9, P879, DOI 10.1105/tpc.9.6.879; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Qutob D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005066; Randall TA, 2005, MOL PLANT MICROBE IN, V18, P229, DOI 10.1094/MPMI-18-0229; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P224, DOI 10.1093/nar/gkg076; Rodrigues ML, 2006, BBA-PROTEINS PROTEOM, V1764, P110, DOI 10.1016/j.bbapap.2005.09.008; Shan WX, 2004, MOL PLANT MICROBE IN, V17, P394, DOI 10.1094/MPMI.2004.17.4.394; Sierra R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009847; Slusarenko AJ, 2003, MOL PLANT PATHOL, V4, P159, DOI 10.1046/j.1364-3703.2003.00166.x; Sohn KH, 2007, PLANT CELL, V19, P4077, DOI 10.1105/tpc.107.054262; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Staden R, 2000, Methods Mol Biol, V132, P115; Stergiopoulos I, 2007, MOL PLANT MICROBE IN, V20, P1271, DOI 10.1094/MPMI-20-10-1271; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tian MY, 2004, J BIOL CHEM, V279, P26370, DOI 10.1074/jbc.M400941200; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Torto-Alalibo TA, 2007, MOL PLANT MICROBE IN, V20, P781, DOI 10.1094/MPMI-20-7-0781; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Van Damme M, 2005, MOL PLANT MICROBE IN, V18, P583, DOI 10.1094/MPMI-18-0583; van der Biezen EA, 2000, MOL PLANT MICROBE IN, V13, P895, DOI 10.1094/MPMI.2000.13.8.895; van der Biezen EA, 2002, PLANT J, V29, P439, DOI 10.1046/j.0960-7412.2001.01229.x; van Esse HP, 2007, MOL PLANT MICROBE IN, V20, P1092, DOI 10.1094/MPMI-20-9-1092; van Poppel PMJA, 2008, MOL PLANT MICROBE IN, V21, P1460, DOI 10.1094/MPMI-21-11-1460; VANKAN JAL, 1991, MOL PLANT MICROBE IN, V4, P52, DOI 10.1094/MPMI-4-052; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	82	44	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19328	10.1371/journal.pone.0019328	http://dx.doi.org/10.1371/journal.pone.0019328			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573066	gold, Green Published, Green Accepted			2022-12-27	WOS:000290386800010
J	Liu, XJ; Lin, H; Tang, Q; Li, C; Yang, ST; Wang, ZC; Wang, CJ; He, Q; Cao, B; Feng, ZQ; Guan, XH; Zhu, J				Liu, Xinjian; Lin, Hong; Tang, Qi; Li, Chen; Yang, Songtao; Wang, Zhongcan; Wang, Changjun; He, Qing; Cao, Brian; Feng, Zhenqing; Guan, Xiaohong; Zhu, Jin			Characterization of a Human Antibody Fragment Fab and Its Calcium Phosphate Nanoparticles that Inhibit Rabies Virus Infection with Vaccine	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODY; DRUG-DELIVERY; GLYCOPROTEIN; COMBINATION; PROTEINS; COCKTAIL; LIBRARY	Recombinant antibody phage display technology has been used to mimic many aspects of the processes that govern the generation and selection of high-affinity natural human antibodies in the human immune system, especially for infectious disease prophylaxis. An anti-rabies virus immunized phage-display Fab library was constructed from peripheral blood lymphocytes from vaccinated volunteers. The immunized antibody library, with a diversity of 6.7x10(8), was used to select and produce antibodies that bound to rabies virus glycoprotein. After five rounds of immobilized fixed rabies virion panning, four unique DNA sequences were found in the higher binding clones, and only one, Fab094, showed neutralization activity. Fab094 components were analyzed by ELISA, immunoprecipitation and immunofluorescent staining. ELISA and immunofluorescence showed that Fab094 bound specifically to rabies virions. Immunoprecipitation and mass spectrometry showed that Fab094 reacted with rabies virus glycoprotein. To improve the penetration power of Fab094 antibodies, we developed Fab094 calcium phosphate nanoparticles (Fab094-CPNPs) and tested their efficacy. The rapid fluorescent focus inhibition test indicated that the neutralizing antibody titers of Fab094 and Fab094-CPNPs were reached at 200.17 IU/Kg and 246.12 IU/Kg, respectively. These findings were confirmed in vivo in a Kunming mouse challenge model. Our results demonstrate that human Fab094 and Fab094-CPNPs are efficacious candidate drugs to replace rabies immunoglobulin in post-exposure prophylaxis (PEP).	[Liu, Xinjian; Lin, Hong; Tang, Qi; Li, Chen; He, Qing; Feng, Zhenqing; Guan, Xiaohong; Zhu, Jin] Nanjing Med Univ, Minist Hlth, Key Lab Antibody Tech, Nanjing, Peoples R China; [Wang, Zhongcan; Wang, Changjun; Zhu, Jin] Huadong Med Inst Biotech, Nanjing, Peoples R China; [Lin, Hong; Cao, Brian] Van Andel Inst, Antibody Technol Lab, Grand Rapids, MI USA; [Yang, Songtao] Acad Mil Med Sci, Vet Inst, Changchun, Peoples R China; [Liu, Xinjian] Nanjing Med Univ, Dept Pathol, Nanjing, Peoples R China	Nanjing Medical University; Van Andel Institute; Academy of Military Medical Sciences - China; Nanjing Medical University	Liu, XJ (corresponding author), Nanjing Med Univ, Minist Hlth, Key Lab Antibody Tech, Nanjing, Peoples R China.	xiaohongguan1@163.com; zjsimmons@yahoo.com.cn			National High Technology Research and Development Program of China (863 Program) [2007AA02Z418]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by the National High Technology Research and Development Program of China (863 Program) (grant no. 2007AA02Z418). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; Ando T, 2005, MICROBIOL IMMUNOL, V49, P311, DOI 10.1111/j.1348-0421.2005.tb03735.x; Bakker ABH, 2005, J VIROL, V79, P9062, DOI 10.1128/JVI.79.14.9062-9068.2005; Barbas C.F., 2004, PHAGE DISPLAY LAB MA; Bourhy H., 1990, LAB METHODS RABIES D, P191; Cai K, 2008, MICROBES INFECT, V10, P548, DOI 10.1016/j.micinf.2008.02.008; Cho KJ, 2008, CLIN CANCER RES, V14, P1310, DOI 10.1158/1078-0432.CCR-07-1441; de Kruif J, 2007, ANNU REV MED, V58, P359, DOI 10.1146/annurev.med.58.061705.145053; DIETZSCHOLD B, 1990, J VIROL, V64, P3804, DOI 10.1128/JVI.64.8.3804-3809.1990; Feyssaguet M, 2007, VACCINE, V25, P2244, DOI 10.1016/j.vaccine.2006.12.012; Goudsmit J, 2006, J INFECT DIS, V193, P796, DOI 10.1086/500470; Harper A, 1996, WHO, V12, P1; Houimel M, 2009, VACCINE, V27, P4648, DOI 10.1016/j.vaccine.2009.05.055; MEBATSION T, 1995, J VIROL, V69, P1444, DOI 10.1128/JVI.69.3.1444-1451.1995; MESLIN FX, 2001, PROSPECTS IMMUNIZATI, P15; [明平刚 MING Pinggang], 2006, [中国生物制品学杂志, Chinese Journal of Biologicals], V19, P217; Prosniak M, 2003, J INFECT DIS, V188, P53, DOI 10.1086/375247; Ray K, 2001, CLIN EXP IMMUNOL, V125, P94, DOI 10.1046/j.1365-2249.2001.01515.x; Redwan ERM, 2009, COMP IMMUNOL MICROB, V32, P9, DOI 10.1016/j.cimid.2007.11.004; Sloan SE, 2007, VACCINE, V25, P2800, DOI 10.1016/j.vaccine.2006.12.031; Stayton PS, 2000, J CONTROL RELEASE, V65, P203, DOI 10.1016/S0168-3659(99)00236-9; Wagner S, 2010, BIOMATERIALS, V31, P2388, DOI 10.1016/j.biomaterials.2009.11.093; WHO, 2005, WHO TECH REP SER, V931, P1; WHO, 2004, WHO TECHN REP SER; Wilde H, 2003, CLIN INFECT DIS, V37, P96, DOI 10.1086/375605	25	10	13	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19848	10.1371/journal.pone.0019848	http://dx.doi.org/10.1371/journal.pone.0019848			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573024	Green Published, gold, Green Submitted			2022-12-27	WOS:000290386800038
J	Hoadley, KD; Szmant, AM; Pyott, SJ				Hoadley, Kenneth D.; Szmant, Alina M.; Pyott, Sonja J.			Circadian Clock Gene Expression in the Coral Favia fragum over Diel and Lunar Reproductive Cycles	PLOS ONE			English	Article							RHYTHMS; PATTERNS; SYNCHRONIZATION; CRYPTOCHROMES; COMPONENTS; ROLES	Natural light cycles synchronize behavioral and physiological cycles over varying time periods in both plants and animals. Many scleractinian corals exhibit diel cycles of polyp expansion and contraction entrained by diel sunlight patterns, and monthly cycles of spawning or planulation that correspond to lunar moonlight cycles. The molecular mechanisms for regulating such cycles are poorly understood. In this study, we identified four molecular clock genes (cry1, cry2, clock and cycle) in the scleractinian coral, Favia fragum, and investigated patterns of gene expression hypothesized to be involved in the corals' diel polyp behavior and lunar reproductive cycles. Using quantitative PCR, we measured fluctuations in expression of these clock genes over both diel and monthly spawning timeframes. Additionally, we assayed gene expression and polyp expansion-contraction behavior in experimental corals in normal light: dark (control) or constant dark treatments. Well-defined and reproducible diel patterns in cry1, cry2, and clock expression were observed in both field-collected and the experimental colonies maintained under control light: dark conditions, but no pattern was observed for cycle. Colonies in the control light: dark treatment also displayed diel rhythms of tentacle expansion and contraction. Experimental colonies in the constant dark treatment lost diel patterns in cry1, cry2, and clock expression and displayed a diminished and less synchronous pattern of tentacle expansion and contraction. We observed no pattern in cry1, cry2, clock, or cycle expression correlated with monthly spawning events suggesting these genes are not involved in the entrainment of reproductive cycles to lunar light cycles in F. fragum. Our results suggest a molecular clock mechanism, potentially similar to that in described in fruit flies, exists within F. fragum.	[Hoadley, Kenneth D.; Szmant, Alina M.; Pyott, Sonja J.] Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28401 USA; [Szmant, Alina M.] Univ N Carolina, Ctr Marine Sci, Wilmington, NC 28401 USA	University of North Carolina; University of North Carolina Wilmington; University of North Carolina; University of North Carolina Wilmington	Hoadley, KD (corresponding author), Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28401 USA.	pyotts@uncw.edu	Pyott, Sonja/AAW-8789-2020	Hoadley, Kenneth/0000-0002-9287-181X; Pyott, Sonja/0000-0001-7750-2437	UNC Wilmington Center for Marine Science; UNC Wilmington Academic Affairs; UNC Wilmington; AWARE Foundation	UNC Wilmington Center for Marine Science; UNC Wilmington Academic Affairs; UNC Wilmington; AWARE Foundation	The authors acknowledge the following funding sources: UNC Wilmington Center for Marine Science Pilot Project to SJP and AMS; UNC Wilmington Academic Affairs funding to AMS for support of coral reef research; Friends of UNC Wilmington to SJP; Project AWARE Foundation grant to KDH; and funding from UNC Wilmington to SJP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N., 1939, PALAO TROP BIOL STN, V1, P651; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Boden MJ, 2006, REPRODUCTION, V132, P379, DOI 10.1530/rep.1.00614; Brady AK, 2009, CORAL REEFS, V28, P677, DOI 10.1007/s00338-009-0498-4; Caldelas I, 2003, NEUROSCIENCE, V116, P583, DOI 10.1016/S0306-4522(02)00654-1; Challet E, 2003, BIOL CHEM, V384, P711, DOI 10.1515/BC.2003.079; Challet E, 2010, J COMP PHYSIOL B, V180, P631, DOI 10.1007/s00360-010-0451-4; Chong NW, 2003, J NEUROCHEM, V85, P851, DOI 10.1046/j.1471-4159.2003.01723.x; Dolatshad H, 2006, HUM REPROD, V21, P68, DOI 10.1093/humrep/dei313; Dolatshad H, 2009, REPROD FERT DEVELOP, V21, P1, DOI 10.1071/RD08223; Hardin PE, 2009, SLEEP BIOL RHYTHMS, V7, P235, DOI 10.1111/j.1479-8425.2009.00412.x; HARDIN PE, 1992, EMBO J, V11, P1; HARDIN PE, 1992, P NATL ACAD SCI USA, V89, P11711, DOI 10.1073/pnas.89.24.11711; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; Honma S, 1998, BIOCHEM BIOPH RES CO, V250, P83, DOI 10.1006/bbrc.1998.9275; JOKIEL PL, 1985, MAR BIOL, V88, P167, DOI 10.1007/BF00397164; Kawaguti S., 1948, Bulletin of the Oceanographical Institute of Taiwan, VNo. 4, P65; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; KUHL M, 1995, MAR ECOL PROG SER, V117, P159, DOI 10.3354/meps117159; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; LASKER HR, 1979, BIOL BULL, V156, P196, DOI 10.2307/1541043; Levy O, 2007, SCIENCE, V318, P467, DOI 10.1126/science.1145432; Levy O, 2011, SCIENCE, V331, P175, DOI 10.1126/science.1196419; Lin CT, 2005, CRYPTOCHROMES, V6; Looby P, 2005, TRENDS GENET, V21, P46, DOI 10.1016/j.tig.2004.11.012; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; Reitzel AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012805; Sandrelli F, 2008, INSECT MOL BIOL, V17, P447, DOI 10.1111/j.1365-2583.2008.00832.x; SEBENS KP, 1977, MAR BIOL, V43, P247, DOI 10.1007/BF00402317; SWEENEY BM, 1976, BIOL BULL, V151, P236, DOI 10.2307/1540717; SZMANTFROELICH A, 1985, B MAR SCI, V37, P880; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; Vize PD, 2009, BIOL BULL-US, V216, P131; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Xu Y, 2003, EMBO J, V22, P2117, DOI 10.1093/emboj/cdg168; Yonge C. M., 1940, Scientific Reports Great Barrier Reef Expedition 1928-29 London, V1, P353; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zhu HS, 2001, MOL VIS, V7, P210	39	43	44	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19755	10.1371/journal.pone.0019755	http://dx.doi.org/10.1371/journal.pone.0019755			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573070	Green Submitted, gold, Green Published			2022-12-27	WOS:000290305600044
J	Iacobaeus, E; Amoudruz, P; Strom, M; Khademi, M; Brundin, L; Hillert, J; Kockum, I; Malmstrom, V; Olsson, T; Tham, E; Piehl, F				Iacobaeus, Ellen; Amoudruz, Petra; Strom, Mikael; Khademi, Mohsen; Brundin, Lou; Hillert, Jan; Kockum, Ingrid; Malmstrom, Vivianne; Olsson, Tomas; Tham, Emma; Piehl, Fredrik			The Expression of VEGF-A Is Down Regulated in Peripheral Blood Mononuclear Cells of Patients with Secondary Progressive Multiple Sclerosis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; T-CELLS; DIAGNOSTIC-CRITERIA; ALZHEIMERS-DISEASE; ANGIOGENIC FACTORS; NERVOUS-SYSTEM; BRAIN; BETA; NEUROINFLAMMATION	Background: Most patients with relapsing-remitting multiple sclerosis (RRMS) eventually enter a secondary progressive (SPMS) phase, characterized by increasing neurological disability. The mechanisms underlying transition to SPMS are unknown and effective treatments and biomarkers are lacking. Vascular endothelial growth factor-A (VEGF-A) is an angiogenic factor with neuroprotective effects that has been associated with neurodegenerative diseases. SPMS has a prominent neurodegenerative facet and we investigated a possible role for VEGF-A during transition from RRMS to SPMS. Methodology/Principal Findings: VEGF-A mRNA expression in peripheral blood mononuclear (PBMC) and cerebrospinal fluid (CSF) cells from RRMS (n = 128), SPMS (n = 55) and controls (n = 116) were analyzed using real time PCR. We demonstrate reduced expression of VEGF-A mRNA in MS CSF cells compared to controls (p<0.001) irrespective of disease course and expression levels are restored by natalizumab treatment(p<0.001). VEGF-A was primarily expressed in monocytes and our CSF findings in part may be explained by effects on relative monocyte proportions. However, VEGF-A mRNA expression was also down regulated in the peripheral compartment of SPMS (p<0.001), despite unchanged monocyte counts, demonstrating a particular phenotype differentiating SPMS from RRMS and controls. A possible association of allelic variability in the VEGF-A gene to risk of MS was also studied by genotyping for six single nucleotide polymorphisms (SNPs) in MS (n = 1114) and controls (n = 1234), which, however, did not demonstrate any significant association between VEGF-A alleles and risk of MS. Conclusions/Significance: Expression of VEGF-A in CSF cells is reduced in MS patients compared to controls irrespective of disease course. In addition, SPMS patients display reduced VEGF-A mRNA expression in PBMC, which distinguish them from RRMS and controls. This indicates a possible role for VEGF-A in the mechanisms regulating transition to SPMS. Decreased levels of PBMC VEGF-A mRNA expression should be further evaluated as a biomarker for SPMS.	[Iacobaeus, Ellen; Strom, Mikael; Khademi, Mohsen; Brundin, Lou; Kockum, Ingrid; Olsson, Tomas; Piehl, Fredrik] Karolinska Inst Solna, Ctr Mol Med, Dept Clin Neurosci, Neuroimmunol Unit, Stockholm, Sweden; [Amoudruz, Petra; Malmstrom, Vivianne] Karolinska Inst Solna, Ctr Mol Med, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Hillert, Jan] Karolinska Inst Solna, Ctr Mol Med, Dept Clin Neurosci, Multiple Sclerosis Res Grp, Stockholm, Sweden; [Tham, Emma] Karolinska Univ Hosp, Dept Clin Genet, Solna, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Iacobaeus, E (corresponding author), Karolinska Inst Solna, Ctr Mol Med, Dept Clin Neurosci, Neuroimmunol Unit, Stockholm, Sweden.	Ellen.Iacobaeus@karolinska.se	Kockum, Ingrid/O-8781-2018; Piehl, Fredrik/E-3451-2013	Kockum, Ingrid/0000-0002-0867-4726; Brundin, Lou/0000-0003-4408-7817; Tham, Emma/0000-0001-6079-164X; Khademi, Mohsen/0000-0003-0801-1444; Olsson, Tomas/0000-0002-2938-1877	European Union [LSHM-CT-2005-018637, LSHG-CT-2005019015]; Swedish Research Council; Swedish Society for Medical Research; Swedish Brain Foundation; Nils and Bibbi Jenssens Foundation; Montel Williams' MS Foundation; GV80 Foundation; Soderberg Foundation; Swedish Association of Persons with Neurological Disabilities; BiogenIdec Sweden AB	European Union(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society for Medical Research; Swedish Brain Foundation; Nils and Bibbi Jenssens Foundation; Montel Williams' MS Foundation; GV80 Foundation; Soderberg Foundation; Swedish Association of Persons with Neurological Disabilities; BiogenIdec Sweden AB	This study was supported by the 6th Framework Program of the European Union, NeuroproMiSe, LSHM-CT-2005-018637 and EURATools, LSHG-CT-2005019015, the Swedish Research Council, the Swedish Society for Medical Research, the Swedish Brain Foundation, the Nils and Bibbi Jenssens Foundation, the Montel Williams' MS Foundation, the GV80 Foundation, the Soderberg Foundation, the Swedish Association of Persons with Neurological Disabilities, and an unrestricted research grant from BiogenIdec Sweden AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; Balashov KE, 1997, P NATL ACAD SCI USA, V94, P599, DOI 10.1073/pnas.94.2.599; Bergh FT, 2004, J NEUROIMMUNOL, V146, P176, DOI 10.1016/j.jneuroim.2003.10.037; Boneschi FM, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002127.pub2; Cepok S, 2001, BRAIN, V124, P2169, DOI 10.1093/brain/124.11.2169; Coles AJ, 2006, J NEUROL, V253, P98, DOI 10.1007/s00415-005-0934-5; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Croll SD, 2004, EXP NEUROL, V187, P388, DOI 10.1016/j.expneurol.2004.02.010; De Almodovar CR, 2009, PHYSIOL REV, V89, P607, DOI 10.1152/physrev.00031.2008; Del Bo R, 2009, J NEUROL SCI, V283, P66, DOI 10.1016/j.jns.2009.02.318; Eriksson M, 2003, MULT SCLER J, V9, P260, DOI 10.1191/1352458503ms914oa; Farez MF, 2009, NAT IMMUNOL, V10, P958, DOI 10.1038/ni.1775; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Graumann U, 2003, BRAIN PATHOL, V13, P554, DOI 10.1111/j.1750-3639.2003.tb00485.x; Hamzaoui K, 2009, J NEUROIMMUNOL, V213, P148, DOI 10.1016/j.jneuroim.2009.05.005; Ingram G, 2010, BRAIN, V133, P1602, DOI 10.1093/brain/awq085; Kirk SL, 2003, J AUTOIMMUN, V21, P353, DOI 10.1016/S0896-8411(03)00139-2; Kivisakk P, 2009, NEUROLOGY, V72, P1922, DOI 10.1212/WNL.0b013e3181a8266f; Kozak T, 2002, J NEUROL, V249, P1088, DOI 10.1007/s00415-002-0800-7; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; LAMBRECHTS D, 2008, J MED GENET; Lopez-Diego RS, 2008, NAT REV DRUG DISCOV, V7, P909, DOI 10.1038/nrd2358; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; Manoonkitiwongsa PS, 2004, J CEREBR BLOOD F MET, V24, P693, DOI 10.1097/01.WCB.0000126236.54306.21; Mor F, 2004, J IMMUNOL, V172, P4618, DOI 10.4049/jimmunol.172.7.4618; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Proescholdt MA, 2002, J NEUROPATH EXP NEUR, V61, P914, DOI 10.1093/jnen/61.10.914; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Rosenstein JM, 2004, EXP NEUROL, V187, P246, DOI 10.1016/j.expneurol.2004.01.022; Rovaris M, 2006, LANCET NEUROL, V5, P343, DOI 10.1016/S1474-4422(06)70410-0; Salzer J, 2010, MULT SCLER J, V16, P287, DOI 10.1177/1352458509359725; Seabrook TJ, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-95; SEABROOK TJ, J NEUROINFLAMMATION, V7, P95; Sellebjerg F, 2009, NEUROLOGY, V73, P2003, DOI 10.1212/WNL.0b013e3181c5b457; Shahbazi M, 2002, J AM SOC NEPHROL, V13, P260, DOI 10.1681/ASN.V131260; Storkebaum E, 2005, NAT NEUROSCI, V8, P85, DOI 10.1038/nn1360; Su JJ, 2006, J NEUROL SCI, V243, P21, DOI 10.1016/j.jns.2005.11.006; Tarkowski E, 2002, NEUROBIOL AGING, V23, P237, DOI 10.1016/S0197-4580(01)00285-8; Teunissen CE, 2009, NEUROLOGY, V72, P1322, DOI 10.1212/WNL.0b013e3181a0fe3f; Tham E, 2006, SCAND J IMMUNOL, V64, P609, DOI 10.1111/j.1365-3083.2006.01851.x; Vogt J, 2009, ANN NEUROL, V66, P310, DOI 10.1002/ana.21719; Yang SP, 2004, NEUROBIOL AGING, V25, P283, DOI 10.1016/S0197-4580(03)00111-8; Zacchigna S, 2008, NAT REV NEUROSCI, V9, P169, DOI 10.1038/nrn2336	46	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19138	10.1371/journal.pone.0019138	http://dx.doi.org/10.1371/journal.pone.0019138			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573104	Green Submitted, Green Published, gold			2022-12-27	WOS:000290305600012
J	Hiraoka, M; Ichihara, K; Zhu, WR; Ma, JH; Shimada, S				Hiraoka, Masanori; Ichihara, Kensuke; Zhu, Wenrong; Ma, Jiahai; Shimada, Satoshi			Culture and Hybridization Experiments on an Ulva Clade Including the Qingdao Strain Blooming in the Yellow Sea	PLOS ONE			English	Article							GREEN-TIDE; MACROALGAL BLOOMS; RAPID EVOLUTION; FLOATING ULVA; CHLOROPHYTA; CHLAMYDOMONAS; ULVOPHYCEAE; AQUACULTURE; CHINA; ALGAE	In the summer of 2008, immediately prior to the Beijing Olympics, a massive green tide of the genus Ulva covered the Qingdao coast of the Yellow Sea in China. Based on molecular analyses using the nuclear encoded rDNA internal transcribed spacer (ITS) region, the Qingdao strains dominating the green tide were reported to be included in a single phylogenetic clade, currently regarded as a single species. On the other hand, our detailed phylogenetic analyses of the clade, using a higher resolution DNA marker, suggested that two genetically separate entities could be included within the clade. However, speciation within the Ulva clade has not yet been examined. We examined the occurrence of an intricate speciation within the clade, including the Qingdao strains, via combined studies of culture, hybridization and phylogenetic analysis. The two entities separated by our phylogenetic analyses of the clade were simply distinguished as U. linza and U. prolifera morphologically by the absence or presence of branches in cultured thalli. The inclusion of sexual strains and several asexual strains were found in each taxon. Hybridizations among the sexual strains also supported the separation by a partial gamete incompatibility. The sexually reproducing Qingdao strains crossed with U. prolifera without any reproductive boundary, but a complete reproductive isolation to U. linza occurred by gamete incompatibility. The results demonstrate that the U. prolifera group includes two types of sexual strains distinguishable by crossing affinity to U. linza. Species identification within the Ulva clade requires high resolution DNA markers and/or hybridization experiments and is not possible by reliance on the ITS markers alone.	[Hiraoka, Masanori] Kochi Univ, Usa Marine Biol Inst, Kochi 780, Japan; [Ichihara, Kensuke] Hokkaido Univ, Grad Sch Sci, Dept Nat Hist Sci, Kita Ku, Sapporo, Hokkaido, Japan; [Zhu, Wenrong] Xianshan Xuwen Seaweed Dev Co Ltd, Ningbo, Peoples R China; [Ma, Jiahai] Shanghai Ocean Univ, Shanghai, Peoples R China; [Shimada, Satoshi] Ochanomizu Univ, Grad Sch Humanities & Sci, Div Nat Appl Sci, Bunkyo Ku, Tokyo 112, Japan	Kochi University; Hokkaido University; Shanghai Ocean University; Ochanomizu University	Hiraoka, M (corresponding author), Kochi Univ, Usa Marine Biol Inst, Kochi 780, Japan.	mhiraoka@kochi-u.ac.jp	Hiraoka, Masanori/AAE-4937-2022	Hiraoka, Masanori/0000-0002-1733-6796; Shimada, Satoshi/0000-0003-4810-4303				Bliding C., 1963, OPERA BOT, V8, P1; BRATEN T, 1971, J CELL SCI, V9, P621; BURROW EM, 1991, SEAWEEDS BRIT ISLES, V2; Coleman AW, 2009, MOL PHYLOGENET EVOL, V50, P197, DOI 10.1016/j.ympev.2008.10.008; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferris PJ, 1997, P NATL ACAD SCI USA, V94, P8634, DOI 10.1073/pnas.94.16.8634; Ferris PJ, 2005, PLANT CELL, V17, P597, DOI 10.1105/tpc.104.028035; FLETCHER RL, 1996, ECOL STUD, V123, P7; Hayden HS, 2004, PHYCOLOGIA, V43, P364, DOI 10.2216/i0031-8884-43-4-364.1; Hiraoka M, 2004, HYDROBIOLOGIA, V512, P239, DOI 10.1023/B:HYDR.0000020332.12641.a2; Hiraoka M, 2003, PHYCOLOGIA, V42, P275, DOI 10.2216/i0031-8884-42-3-275.1; Hu CM, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005561; KOEMAN R P T, 1984, Cryptogamie Algologie, V5, P21; KOEMAN R P T, 1982, Cryptogamie Algologie, V3, P37; Leliaert F, 2009, MOL PHYLOGENET EVOL, V53, P122, DOI 10.1016/j.ympev.2009.06.004; Leliaert F, 2009, PHYCOL RES, V57, P147, DOI 10.1111/j.1440-1835.2009.00532.x; Leskinen E, 2004, MOL ECOL, V13, P2257, DOI 10.1111/j.1365-294X.2004.02219.x; Liu DY, 2010, MAR POLLUT BULL, V60, P1423, DOI 10.1016/j.marpolbul.2010.05.015; Liu DY, 2009, MAR POLLUT BULL, V58, P888, DOI 10.1016/j.marpolbul.2009.01.013; Liu F, 2010, J APPL PHYCOL, V22, P531, DOI 10.1007/s10811-009-9489-7; LOVLIE A, 1976, NATURE, V263, P779, DOI 10.1038/263779a0; Maggs C.A., 2007, GREEN SEAWEEDS BRITA, P80; Malta EJ, 1999, EUR J PHYCOL, V34, P443, DOI 10.1080/09541449910001718801; Miyamura Shinichi, 2004, Cytologia (Tokyo), V69, P197, DOI 10.1508/cytologia.69.197; Morand P, 2005, J COASTAL RES, V21, P1009, DOI 10.2112/04-700A.1; Muller T, 2007, RNA, V13, P1469, DOI 10.1261/rna.617107; Nelson TA, 2003, BOT MAR, V46, P263, DOI 10.1515/BOT.2003.024; Nelson TA, 2008, ECOLOGY, V89, P1287, DOI 10.1890/07-0494.1; O'Kelly CJ, 2010, J PHYCOL, V46, P728, DOI 10.1111/j.1529-8817.2010.00860.x; Pang SJ, 2010, MAR ENVIRON RES, V69, P207, DOI 10.1016/j.marenvres.2009.10.007; Raffaelli DG, 1998, OCEANOGR MAR BIOL<D>, V36, P97; Raven J. A., 2003, WATER AIR SOIL POLL, V3, P7, DOI DOI 10.1023/A:1022167722654; Shimada S, 2010, COAST MAR SCI, V34, P117; Shimada S, 2008, J APPL PHYCOL, V20, P979, DOI 10.1007/s10811-007-9296-y; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Taylor R, 2001, BOT MAR, V44, P327, DOI 10.1515/BOT.2001.042; Wang JF, 2010, AQUAT BOT, V93, P25, DOI 10.1016/j.aquabot.2010.03.001; Zhang XW, 2010, J APPL PHYCOL, V22, P173, DOI 10.1007/s10811-009-9437-6	39	57	61	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19371	10.1371/journal.pone.0019371	http://dx.doi.org/10.1371/journal.pone.0019371			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573216	gold, Green Submitted, Green Published			2022-12-27	WOS:000290256400008
J	Stoimenov, I; Schultz, N; Gottipati, P; Helleday, T				Stoimenov, Ivaylo; Schultz, Niklas; Gottipati, Ponnari; Helleday, Thomas			Transcription Inhibition by DRB Potentiates Recombinational Repair of UV Lesions in Mammalian Cells	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; REPLICATION FORK PROGRESSION; NUCLEOTIDE EXCISION-REPAIR; HOMOLOGOUS RECOMBINATION; P-TEFB; XERODERMA-PIGMENTOSUM; H2AX PHOSPHORYLATION; DNA-REPAIR; CHO-CELLS; CYCLE	Homologous recombination (HR) is intricately associated with replication, transcription and DNA repair in all organisms studied. However, the interplay between all these processes occurring simultaneously on the same DNA molecule is still poorly understood. Here, we study the interplay between transcription and HR during ultraviolet light (UV)-induced DNA damage in mammalian cells. Our results show that inhibition of transcription with 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) increases the number of UV-induced DNA lesions (gamma H2AX, 53BP1 foci formation), which correlates with a decrease in the survival of wild type or nucleotide excision repair defective cells. Furthermore, we observe an increase in RAD51 foci formation, suggesting HR is triggered in response to an increase in UV-induced DSBs, while inhibiting transcription. Unexpectedly, we observe that DRB fails to sensitise HR defective cells to UV treatment. Thus, increased RAD51 foci formation correlates with increased cell death, suggesting the existence of a futile HR repair of UV-induced DSBs which is linked to transcription inhibition.	[Stoimenov, Ivaylo; Schultz, Niklas; Helleday, Thomas] Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden; [Gottipati, Ponnari; Helleday, Thomas] Univ Oxford, Gray Inst Radiat Oncol & Biol, Oxford, England	Stockholm University; University of Oxford	Stoimenov, I (corresponding author), Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden.	helleday@gmt.su.se	Helleday, Thomas/D-5224-2013; Schultz, Niklas/AFQ-8244-2022	Gottipati, Ponnari/0000-0002-3596-5633; Helleday, Thomas/0000-0002-7384-092X; Stoimenov, Ivaylo/0000-0002-2133-7396	Swedish Cancer Society; Swedish Children's Cancer Foundation; Swedish Research Council; Swedish Pain Relief Foundation; Medical Research Council; MRC [G0700730] Funding Source: UKRI; Medical Research Council [G0700730] Funding Source: researchfish	Swedish Cancer Society(Swedish Cancer Society); Swedish Children's Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Pain Relief Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Swedish Cancer Society, Swedish Children's Cancer Foundation, Swedish Research Council, and Swedish Pain Relief Foundation and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; Arnaudeau C, 2001, J MOL BIOL, V307, P1235, DOI 10.1006/jmbi.2001.4564; AUBRECHT J, 1995, CARCINOGENESIS, V16, P2841, DOI 10.1093/carcin/16.11.2841; BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; CALDECOTT K, 1991, MUTAT RES, V255, P111, DOI 10.1016/0921-8777(91)90046-R; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chavez S, 2000, EMBO J, V19, P5824, DOI 10.1093/emboj/19.21.5824; Chavez S, 1997, GENE DEV, V11, P3459, DOI 10.1101/gad.11.24.3459; CHRISTIANS FC, 1992, MUTAT RES, V274, P93, DOI 10.1016/0921-8777(92)90056-9; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; FULLER LF, 1988, MUTAT RES, V193, P109, DOI 10.1016/0167-8817(88)90041-7; Gottipati P, 2008, MOL CELL BIOL, V28, P154, DOI 10.1128/MCB.00816-07; Gottipati P, 2009, MUTAGENESIS, V24, P203, DOI 10.1093/mutage/gen072; Helleday T, 1998, CARCINOGENESIS, V19, P973, DOI 10.1093/carcin/19.6.973; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Hendriks G, 2008, DNA REPAIR, V7, P1330, DOI 10.1016/j.dnarep.2008.04.015; Hendriks G, 2010, CURR BIOL, V20, P170, DOI 10.1016/j.cub.2009.11.061; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Lehmann AR, 2001, GENE DEV, V15, P15, DOI 10.1101/gad.859501; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Lundin C, 2002, MOL CELL BIOL, V22, P5869, DOI 10.1128/MCB.22.16.5869-5878.2002; Marti TM, 2006, P NATL ACAD SCI USA, V103, P9891, DOI 10.1073/pnas.0603779103; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Prado F, 2005, EMBO J, V24, P1267, DOI 10.1038/sj.emboj.7600602; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Saleh-Gohari N, 2004, NUCLEIC ACIDS RES, V32, P3683, DOI 10.1093/nar/gkh703; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Savolainen L, 2009, NUCLEIC ACIDS RES, V37, P405, DOI 10.1093/nar/gkn971; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; SMITH KC, 1987, MUTAT RES, V183, P1, DOI 10.1016/0167-8817(87)90039-3; Stoimenov I, 2011, MUTAT RES-FUND MOL M, V706, P1, DOI 10.1016/j.mrfmmm.2010.10.012; Theron T, 2005, MOL CELL BIOL, V25, P8368, DOI 10.1128/MCB.25.18.8368-8378.2005; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wada T, 1998, EMBO J, V17, P7395, DOI 10.1093/emboj/17.24.7395; WANG YY, 1988, MOL CELL BIOL, V8, P196, DOI 10.1128/MCB.8.1.196; WEBER CA, 1988, MOL CELL BIOL, V8, P1137, DOI 10.1128/MCB.8.3.1137; Wellinger RE, 2006, MOL CELL BIOL, V26, P3327, DOI 10.1128/MCB.26.8.3327-3334.2006; Wilson PF, 2010, DNA REPAIR, V9, P737, DOI 10.1016/j.dnarep.2010.03.009; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8	42	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19492	10.1371/journal.pone.0019492	http://dx.doi.org/10.1371/journal.pone.0019492			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573160	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000290256400015
J	Elshire, RJ; Glaubitz, JC; Sun, Q; Poland, JA; Kawamoto, K; Buckler, ES; Mitchell, SE				Elshire, Robert J.; Glaubitz, Jeffrey C.; Sun, Qi; Poland, Jesse A.; Kawamoto, Ken; Buckler, Edward S.; Mitchell, Sharon E.			A Robust, Simple Genotyping-by-Sequencing (GBS) Approach for High Diversity Species	PLOS ONE			English	Article							MAIZE; GENERATION; MAP; ASSOCIATION; PLANT	Advances in next generation technologies have driven the costs of DNA sequencing down to the point that genotyping-by-sequencing (GBS) is now feasible for high diversity, large genome species. Here, we report a procedure for constructing GBS libraries based on reducing genome complexity with restriction enzymes (REs). This approach is simple, quick, extremely specific, highly reproducible, and may reach important regions of the genome that are inaccessible to sequence capture approaches. By using methylation-sensitive REs, repetitive regions of genomes can be avoided and lower copy regions targeted with two to three fold higher efficiency. This tremendously simplifies computationally challenging alignment problems in species with high levels of genetic diversity. The GBS procedure is demonstrated with maize (IBM) and barley (Oregon Wolfe Barley) recombinant inbred populations where roughly 200,000 and 25,000 sequence tags were mapped, respectively. An advantage in species like barley that lack a complete genome sequence is that a reference map need only be developed around the restriction sites, and this can be done in the process of sample genotyping. In such cases, the consensus of the read clusters across the sequence tagged sites becomes the reference. Alternatively, for kinship analyses in the absence of a reference genome, the sequence tags can simply be treated as dominant markers. Future application of GBS to breeding, conservation, and global species and population surveys may allow plant breeders to conduct genomic selection on a novel germplasm or species without first having to develop any prior molecular tools, or conservation biologists to determine population structure without prior knowledge of the genome or diversity in the species.	[Elshire, Robert J.; Glaubitz, Jeffrey C.; Kawamoto, Ken; Buckler, Edward S.; Mitchell, Sharon E.] Cornell Univ, Inst Genom Divers, Ithaca, NY 14853 USA; [Sun, Qi] Cornell Univ, Computat Biol Serv Unit, Ithaca, NY USA; [Poland, Jesse A.] ARS, Hard Winter Wheat Genet Res Unit, USDA, Manhattan, KS USA; [Buckler, Edward S.] ARS, Plant Soil & Nutr Res Unit, USDA, Ithaca, NY USA	Cornell University; Cornell University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Elshire, RJ (corresponding author), Cornell Univ, Inst Genom Divers, Ithaca, NY 14853 USA.	sem30@cornell.edu	Buckler, Edward/GPS-4932-2022; Buckler, Edward/L-7651-2019	Buckler, Edward/0000-0002-3100-371X; Elshire, Robert/0000-0003-1753-6920; Poland, Jesse/0000-0002-7856-1399	National Science Foundation [0820619, 0965342]; United States Department of Agriculture/National Institute of Food and Agriculture; Direct For Biological Sciences [0965342] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture/National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by National Science Foundation awards 0820619 and 0965342, and the United States Department of Agriculture/National Institute of Food and Agriculture, Barley Coordinated Agriculture Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andolfatto P, 2011, GENOME RES, V21, P610, DOI 10.1101/gr.115402.110; Aquadro CF, 2001, CURR OPIN GENET DEV, V11, P627, DOI 10.1016/S0959-437X(00)00245-8; Arteaga-Vazquez MA, 2010, CURR OPIN GENET DEV, V20, P156, DOI 10.1016/j.gde.2010.01.008; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Buckler ES, 2006, CURR OPIN PLANT BIOL, V9, P172, DOI 10.1016/j.pbi.2006.01.013; Clark RM, 2006, NAT GENET, V38, P594, DOI 10.1038/ng1784; Costa JM, 2001, THEOR APPL GENET, V103, P415, DOI 10.1007/s001220100622; Craig DW, 2008, NAT METHODS, V5, P887, DOI 10.1038/NMETH.1251; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Fedurco M, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj023; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Gore M, 2007, CROP SCI, V47, pS135, DOI 10.2135/cropsci2007.02.0085tpg; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; Lee M, 2002, PLANT MOL BIOL, V48, P453, DOI 10.1023/A:1014893521186; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; LI WH, 1991, GENETICS, V129, P513; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Messing J, 2006, CURR OPIN PLANT BIOL, V9, P157, DOI 10.1016/j.pbi.2006.01.009; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Przeworski M, 2000, TRENDS GENET, V16, P296, DOI 10.1016/S0168-9525(00)02030-8; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Salvi S, 2007, P NATL ACAD SCI USA, V104, P11376, DOI 10.1073/pnas.0704145104; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Springer NM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000734; Szucs P, 2009, PLANT GENOME-US, V2, P134, DOI [10.3835/plantgenome2008.01.005, 10.3835/plantgenome2008.01.0005]; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; Zhao ZM, 2006, GENETICS, V174, P399, DOI 10.1534/genetics.106.060301	37	3716	3861	32	936	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19379	10.1371/journal.pone.0019379	http://dx.doi.org/10.1371/journal.pone.0019379			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573248	Green Published, gold, Green Submitted			2022-12-27	WOS:000290224800026
J	Newcombe, V; Chatfield, D; Outtrim, J; Vowler, S; Manktelow, A; Cross, J; Scoffings, D; Coleman, M; Hutchinson, P; Coles, J; Carpenter, TA; Pickard, J; Williams, G; Menon, D				Newcombe, Virginia; Chatfield, Doris; Outtrim, Joanne; Vowler, Sarah; Manktelow, Anne; Cross, Justin; Scoffings, Daniel; Coleman, Martin; Hutchinson, Peter; Coles, Jonathan; Carpenter, T. Adrian; Pickard, John; Williams, Guy; Menon, David			Mapping Traumatic Axonal Injury Using Diffusion Tensor Imaging: Correlations with Functional Outcome	PLOS ONE			English	Article							SEVERE HEAD-INJURY; BRAIN-INJURY; MR-IMAGES; SCALE; DISEASE; LESIONS; BURDEN; STATE	Background: Traumatic brain injury is a major cause of morbidity and mortality worldwide. Ameliorating the neurocognitive and physical deficits that accompany traumatic brain injury would be of substantial benefit, but the mechanisms that underlie them are poorly characterized. This study aimed to use diffusion tensor imaging to relate clinical outcome to the burden of white matter injury. Methodology/Principal Findings: Sixty-eight patients, categorized by the Glasgow Outcome Score, underwent magnetic resonance imaging at a median of 11.8 months (range 6.6 months to 3.7 years) years post injury. Control data were obtained from 36 age-matched healthy volunteers. Mean fractional anisotropy, apparent diffusion coefficient (ADC), and eigenvalues were obtained for regions of interest commonly affected in traumatic brain injury. In a subset of patients where conventional magnetic resonance imaging was completely normal, diffusion tensor imaging was able to detect clear abnormalities. Significant trends of increasing ADC with worse outcome were noted in all regions of interest. In the white matter regions of interest worse clinical outcome corresponded with significant trends of decreasing fractional anisotropy. Conclusions/Significance: This study found that clinical outcome was related to the burden of white matter injury, quantified by diffusivity parameters late after traumatic brain injury. These differences were seen even in patients with the best outcomes and patients in whom conventional magnetic resonance imaging was normal, suggesting that diffusion tensor imaging can detect subtle injury missed by other techniques. An improved in vivo understanding of the pathology of traumatic brain injury, including its distribution and extent, may enhance outcome evaluation and help to provide a mechanistic basis for deficits that remain unexplained by other approaches.	[Newcombe, Virginia; Chatfield, Doris; Outtrim, Joanne; Manktelow, Anne; Coles, Jonathan; Menon, David] Univ Cambridge, Univ Div Anaesthesia, Cambridge, England; [Newcombe, Virginia; Chatfield, Doris; Outtrim, Joanne; Manktelow, Anne; Coleman, Martin; Hutchinson, Peter; Coles, Jonathan; Carpenter, T. Adrian; Pickard, John; Williams, Guy; Menon, David] Univ Cambridge, Dept Clin Neurosci, Wolfson Brain Imaging Ctr, Cambridge, England; [Vowler, Sarah] Univ Cambridge, Ctr Appl Med Stat, Dept Publ Hlth & Primary Care, Cambridge, England; [Cross, Justin; Scoffings, Daniel] Univ Cambridge, Addenbrookes Hosp, Dept Radiol, Cambridge CB2 2QQ, England; [Hutchinson, Peter; Pickard, John] Univ Cambridge, Acad Neurosurg Unit, Dept Clin Neurosci, Cambridge, England	University of Cambridge; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Newcombe, V (corresponding author), Univ Cambridge, Univ Div Anaesthesia, Cambridge, England.	vfjn2@wbic.cam.ac.uk	Scoffings, Daniel/AAA-1649-2022; Scoffings, Daniel/GLS-1219-2022	Outtrim, Joanne/0000-0001-8118-6430; Newcombe, Virginia/0000-0001-6044-9035; Williams, Guy/0000-0001-5223-6654; Coles, Jonathan/0000-0003-4013-679X	Medical Research Council (UK) [G9439390 ID 65883]; UK National Institute of Health Research Biomedical Research Centre at Cambridge; UK Department of Health; Gates Cambridge Trust; Overseas Research Studentship; NIHR Cambridge Biomedical Research Centre; Academy of Medical Sciences/Health Foundation; Royal College of Anaesthetists; Evelyn Trust; Medical Research Council [G0001354B, G0001354, G9439390, G0001237, G1000183B, G0600986] Funding Source: researchfish; National Institute for Health Research [ACF-2009-14-007, NF-SI-0508-10327] Funding Source: researchfish; MRC [G9439390, G0001237, G0600986] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK National Institute of Health Research Biomedical Research Centre at Cambridge(National Institute for Health Research (NIHR)); UK Department of Health; Gates Cambridge Trust; Overseas Research Studentship; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Academy of Medical Sciences/Health Foundation; Royal College of Anaesthetists; Evelyn Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Medical Research Council (UK) Program Grant (Acute brain injury: heterogeneity of mechanisms, therapeutic targets and outcome effects [G9439390 ID 65883]), the UK National Institute of Health Research Biomedical Research Centre at Cambridge, and the Technology Platform funding provided by the UK Department of Health. VN was supported by the Gates Cambridge Trust and an Overseas Research Studentship. JC and DS are supported by the NIHR Cambridge Biomedical Research Centre. PJH is supported by an Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship. JPC is supported by a Clinician Scientist Award from the Academy of Medical Sciences/Health Foundation. DKM is supported by the BOC Professorship of the Royal College of Anaesthetists and the Evelyn Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Greenberg G, 2008, ARCH PHYS MED REHAB, V89, pS45, DOI 10.1016/j.apmr.2008.08.211; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; JENNETT B, 1976, LANCET, V1, P1031; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mannion RJ, 2007, J NEUROTRAUM, V24, P128, DOI 10.1089/neu.2006.0127; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Newcombe VFJ, 2010, J NEUROL NEUROSUR PS, V81, P552, DOI 10.1136/jnnp.2009.196246; NIOGI SN, 2008, AJNR AM J NEURORADIO; Patrick PD, 2007, BRAIN INJURY, V21, P63, DOI 10.1080/02699050601111401; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; SIDAROS A, 2007, BRAIN; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Yanagawa Y, 2000, J TRAUMA, V49, P272, DOI 10.1097/00005373-200008000-00013; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	28	63	68	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19214	10.1371/journal.pone.0019214	http://dx.doi.org/10.1371/journal.pone.0019214			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573228	Green Submitted, gold, Green Published			2022-12-27	WOS:000290224800017
J	Velthuis, AGJ; Mourits, MCM; Saatkamp, HW; de Koeijer, AA; Elbers, ARW				Velthuis, Annet G. J.; Mourits, Monique C. M.; Saatkamp, Helmut W.; de Koeijer, Aline A.; Elbers, Armin R. W.			Financial Evaluation of Different Vaccination Strategies for Controlling the Bluetongue Virus Serotype 8 Epidemic in the Netherlands in 2008	PLOS ONE			English	Article							SHEEP; VACCINES; CATTLE; FIELD	Background: Bluetongue (BT) is a vector-borne disease of ruminants caused by bluetongue virus that is transmitted by biting midges (Culicoides spp.). In 2006, the introduction of BTV serotype 8 (BTV-8) caused a severe epidemic in Western and Central Europe. The principal effective veterinary measure in response to BT was believed to be vaccination accompanied by other measures such as movement restrictions and surveillance. As the number of vaccine doses available at the start of the vaccination campaign was rather uncertain, the Dutch Ministry of Agriculture, Nature and Food Quality and the Dutch agricultural industry wanted to evaluate several different vaccination strategies. This study aimed to rank eight vaccination strategies based on their efficiency (i.e. net costs in relation to prevented losses or benefits) for controlling the bluetongue virus serotype 8 epidemic in 2008. Methodology/Principal Findings: An economic model was developed that included the Dutch professional cattle, sheep and goat sectors together with the hobby farms. Strategies were evaluated based on the least cost - highest benefit frontier, the benefit-cost ratio and the total net returns. Strategy F, where all adult sheep at professional farms in the Netherlands would be vaccinated was very efficient at lowest costs, whereas strategy D, where additional to all adult sheep at professional farms also all adult cattle in the four Northern provinces would be vaccinated, was also very efficient but at a little higher costs. Strategy C, where all adult sheep and cattle at professional farms in the whole of the Netherlands would be vaccinated was also efficient but again at higher costs. Conclusions/Significance: This study demonstrates that a financial analysis differentiates between vaccination strategies and indicates important decision rules based on efficiency.	[Velthuis, Annet G. J.; Mourits, Monique C. M.; Saatkamp, Helmut W.] Wageningen Univ, Wageningen, Netherlands	Wageningen University & Research	Velthuis, AGJ (corresponding author), Wageningen Univ, Wageningen, Netherlands.	Annet.Velthuis@wur.nl		Mourits, Monique/0000-0001-5213-2927; Velthuis, Annet/0000-0002-5869-8144	joint commission on cattle health and quality (DKR) of the Product Boards for Livestock and Meat (PVV) and the Dutch Dairy Board (PZ); Dutch Ministry of Agriculture, Nature and Food Quality	joint commission on cattle health and quality (DKR) of the Product Boards for Livestock and Meat (PVV) and the Dutch Dairy Board (PZ); Dutch Ministry of Agriculture, Nature and Food Quality	This study was funded by the joint commission on cattle health and quality (DKR) of the Product Boards for Livestock and Meat (PVV) and the Dutch Dairy Board (PZ) and by the Dutch Ministry of Agriculture, Nature and Food Quality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backx A, 2007, VET REC, V161, P591, DOI 10.1136/vr.161.17.591; Barkema HW, 2001, TIJDSCHR DIERGENEESK, V126, P158; BARTELS C, 2008, BLUETONGUE INFECT DA, P1; Belli P., 2001, WORLD BANK I DEV STU; BERENDS IBC, 2008, MEMO MATCHING VWA DA, P1; Bruckner L, 2009, SCHWEIZ ARCH TIERH, V151, P101, DOI 10.1024/0036-7281.151.3.101; *BUND ERN LANDW VE, 2009, MULL IMPF GEG BLAUZ; Conraths FJ, 2009, EMERG INFECT DIS, V15, P433, DOI 10.3201/eid1503.081210; *CVI, 2010, SIT; Elbers ARW, 2010, VACCINE, V28, P2473, DOI 10.1016/j.vaccine.2010.01.047; Elbers ARW, 2008, PREV VET MED, V87, P31, DOI 10.1016/j.prevetmed.2008.06.003; Elbers ARW, 2009, PREV VET MED, V92, P1, DOI 10.1016/j.prevetmed.2009.08.007; Eschbaumer M, 2009, VACCINE, V27, P4169, DOI 10.1016/j.vaccine.2009.04.056; European Council, 2008, OFF J EUR COMM L, VL214, P66; European Council, 2000, OFF J L, V327, P74; Gethmann J, 2009, VACCINE, V27, P4118, DOI 10.1016/j.vaccine.2009.04.072; Kuijk H, 2008, TIJDSCHR DIERGENEESK, V133, P1006; *LEI, 2008, 2008048 LEI; OIE, 2005, TERR AN HLTH COD, V14th; Palisade-Corporation, 2010, RISK; Santman-Berends IMGA, 2011, VET MICROBIOL, V148, P183, DOI 10.1016/j.vetmic.2010.09.010; Savini G, 2008, COMP IMMUNOL MICROB, V31, P101, DOI 10.1016/j.cimid.2007.07.006; Szmaragd C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009353; Velthuis AGJ, 2010, PREV VET MED, V93, P294, DOI 10.1016/j.prevetmed.2009.11.007; VELTHUIS AGJ, 2009, FOOD EC ACTA AGR SCA, V6, P31; Verwoerd D. W., 2004, Infectious diseases of livestock. Volume Two, P1201; Wackerlin R, 2010, VACCINE, V28, P4348, DOI 10.1016/j.vaccine.2010.04.055	27	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19612	10.1371/journal.pone.0019612	http://dx.doi.org/10.1371/journal.pone.0019612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573195	Green Published, gold			2022-12-27	WOS:000290224800040
J	Chatterjee, C; Kumar, S; Chakraborty, S; Tan, YW; Leung, KY; Sivaraman, J; Mok, YK				Chatterjee, Chiradip; Kumar, Sundramurthy; Chakraborty, Smarajit; Tan, Yih Wan; Leung, Ka Yin; Sivaraman, J.; Mok, Yu-Keung			Crystal Structure of the Heteromolecular Chaperone, AscE-AscG, from the Type III Secretion System in Aeromonas hydrophila	PLOS ONE			English	Article							PROTEIN; COMPLEX; BINDING; REGIONS; CRYSTALLOGRAPHY; ALIGNMENT; DISORDER; MODELS; FOLD	Background: The putative needle complex subunit AscF forms a ternary complex with the chaperones AscE and AscG in the type III secretion system of Aeromonas hydrophila so as to avoid premature assembly. Previously, we demonstrated that the C-terminal region of AscG (residues 62-116) in the hetero-molecular chaperone, AscE-AscG, is disordered and susceptible to limited protease digestion. Methodology/Principal Findings: Here, we report the crystal structure of the ordered AscG(1-61) region in complex with AscE at 2.4 angstrom resolution. Helices alpha(2) and alpha(3) of AscE in the AscE-AscG(1-61) complex assumes a helix-turn-helix conformation in an anti-parallel fashion similar to that in apo AscE. However, in the presence of AscG, an additional N-terminal helix alpha 1 in AscE (residues 4-12) is observed. PscG or YscG in the crystal structures of PscE-PscF-PscG or YscE-YscF-YscG, respectively, assumes a typical tetratricopeptide repeat (TPR) fold with three TPR repeats and one C-terminal capping helix. By comparison, AscG in AscE-AscG(1-61) comprises three anti-parallel helices that resembles the N-terminal TPR repeats in the corresponding region of PscG or YscG in PscE-PscF-PscG or YscE-YscF-YscG. Thermal denaturation of AscE-AscG and AscE-AscG(1-61) complexes demonstrates that the C-terminal disordered region does not contribute to the thermal stability of the overall complex. Conclusion/Significance: The N-terminal region of the AscG in the AscE-AscG complex is ordered and assumes a structure similar to those in the corresponding regions of PscE-PscG-PscF or YscE-YscF-YscG complexes. While the C-terminal region of AscG in the AscE-AscG complex is disordered and will assume its structure only in the presence of the substrate AscF. We hypothesize that AscE act as a chaperone of the chaperone to keep AscG in a stable but partially disordered state for interaction with AscF.	[Chatterjee, Chiradip; Kumar, Sundramurthy; Chakraborty, Smarajit; Tan, Yih Wan; Leung, Ka Yin; Sivaraman, J.; Mok, Yu-Keung] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	National University of Singapore	Chatterjee, C (corresponding author), Republ Polytech, Sch Appl Sci, Singapore, Singapore.	dbsmokh@nus.edu.sg	Sivaraman, J/H-8028-2012; Mok, Yu Keung/H-8019-2012	Mok, Yu Keung/0000-0002-2829-4878; J, Sivaraman/0000-0001-9781-5326	Biomedical Research Council (BMRC) of the Agency for Science Technology and Research (A*STAR) of Singapore [07/1/21/19/495]; Natural Science and Engineering Research Council (NSERC) [372373-2010]; Trinity [0488]	Biomedical Research Council (BMRC) of the Agency for Science Technology and Research (A*STAR) of Singapore(Agency for Science Technology & Research (A*STAR)); Natural Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Trinity	This work was supported by a grant from the Biomedical Research Council (BMRC) of the Agency for Science Technology and Research (A*STAR) of Singapore to YKM (07/1/21/19/495), a Natural Science and Engineering Research Council (NSERC) Discovery Grant (372373-2010) and a Trinity Western Startup Grant (0488) to KYL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin B, 1996, GENUS AEROMONAS, P197; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Birtalan S, 2001, NAT STRUCT BIOL, V8, P974, DOI 10.1038/nsb1101-974; Birtalan SC, 2002, MOL CELL, V9, P971, DOI 10.1016/S1097-2765(02)00529-4; Bourhis JM, 2004, VIRUS RES, V99, P157, DOI 10.1016/j.virusres.2003.11.007; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buttner CR, 2008, J MOL BIOL, V375, P997, DOI 10.1016/j.jmb.2007.11.009; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Edqvist PJ, 2006, MOL MICROBIOL, V59, P31, DOI 10.1111/j.1365-2958.2005.04923.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Finlay BB, 1997, SCIENCE, V276, P718, DOI 10.1126/science.276.5313.718; Gugolya Z, 2003, FEBS LETT, V535, P66, DOI 10.1016/S0014-5793(02)03859-0; Janda JM, 2001, MOL MED MICROBIOLOGY, P1237; Job V, 2010, J BIOL CHEM, V285, P23222, DOI 10.1074/jbc.M110.111278; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lunelli M, 2009, P NATL ACAD SCI USA, V106, P9661, DOI 10.1073/pnas.0812900106; Moraes TF, 2008, CURR OPIN STRUC BIOL, V18, P1; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phan J, 2005, PROTEIN SCI, V14, P2759, DOI 10.1110/ps.051706105; Quinaud M, 2005, J BIOL CHEM, V280, P36293, DOI 10.1074/jbc.M508089200; Quinaud M, 2007, P NATL ACAD SCI USA, V104, P7803, DOI 10.1073/pnas.0610098104; Rodgers L, 2008, J BIOL CHEM, V283, P20857, DOI 10.1074/jbc.M802339200; RUIZSANZ J, 1995, BIOCHEMISTRY-US, V34, P1695, DOI 10.1021/bi00005a026; Sha J, 2007, MICROB PATHOGENESIS, V43, P127, DOI 10.1016/j.micpath.2007.05.002; Sierra JC, 2007, MICROB PATH IN PRESS; Sippl MJ, 2008, BIOINFORMATICS, V24, P872, DOI 10.1093/bioinformatics/btn040; Sippl MJ, 2008, BIOINFORMATICS, V24, P426, DOI 10.1093/bioinformatics/btm622; Sun P, 2008, J MOL BIOL, V377, P819, DOI 10.1016/j.jmb.2007.12.067; Tan YW, 2008, PROTEIN SCI, V17, P1748, DOI 10.1110/ps.036798.108; Tan YW, 2009, PROTEIN SCI, V18, P1724, DOI 10.1002/pro.187; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thune Ronald L., 1993, Annual Review of Fish Diseases, V3, P37, DOI 10.1016/0959-8030(93)90028-A; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; Vilches S, 2007, MICROB PATH IN PRESS; Weeks CM, 2002, Z KRISTALLOGR, V217, P686, DOI 10.1524/zkri.217.12.686.20659; Yip CK, 2006, TRENDS BIOCHEM SCI, V31, P223, DOI 10.1016/j.tibs.2006.02.005; Yu HB, 2004, INFECT IMMUN, V72, P1248, DOI 10.1128/IAI.72.3.1248-1256.2004; Yu HB, 2007, PROTEOMICS, V7, P436, DOI 10.1002/pmic.200600396	45	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19208	10.1371/journal.pone.0019208	http://dx.doi.org/10.1371/journal.pone.0019208			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559439	gold, Green Submitted, Green Published			2022-12-27	WOS:000290024700103
J	Cherezova, L; Burnside, KL; Rose, TM				Cherezova, Lidia; Burnside, Kellie L.; Rose, Timothy M.			Conservation of Complex Nuclear Localization Signals Utilizing Classical and Non-Classical Nuclear Import Pathways in LANA Homologs of KSHV and RFHV	PLOS ONE			English	Article							SARCOMA-ASSOCIATED-HERPESVIRUS; IMMUNODEFICIENCY-VIRUS TYPE-1; KAPOSIS-SARCOMA; STRUCTURAL BASIS; BINDING PROTEIN; TUMOR-CELLS; REV PROTEIN; HNRNP A1; LATENCY; ANTIGEN	ORF73 latency-associated nuclear antigen (LANA) of the Kaposi's sarcoma-associated herpesvirus (KSHV) is targeted to the nucleus of infected cells where it binds to chromatin and mediates viral episome persistence, interacts with cellular proteins and plays a role in latency and tumorigenesis. A structurally related LANA homolog has been identified in the retroperitoneal fibromatosis herpesvirus (RFHV), the macaque homolog of KSHV. Here, we report the evolutionary and functional conservation of a novel bi-functional nuclear localization signal (NLS) in KSHV and RFHV LANA. N-terminal peptides from both proteins were fused to EGFP or double EGFP fusions to examine their ability to induce nuclear transport of a heterologous protein. In addition, GST-pull down experiments were used to analyze the ability of LANA peptides to interact with members of the karyopherin family of nuclear transport receptors. Our studies revealed that both LANA proteins contain an N-terminal arginine/glycine (RG)-rich domain spanning a conserved chromatin-binding motif, which binds directly to importin beta 1 in a RanGTP-sensitive manner and serves as an NLS in the importin beta 1-mediated non-classical nuclear import pathway. Embedded within this domain is a conserved lysine/arginine-(KR)-rich bipartite motif that binds directly to multiple members of the importin a family of nuclear import adaptors in a RanGTP-insensitive manner and serves as an NLS in the classical importin alpha/beta-mediated nuclear import pathway. The positioning of a classical bipartite kr-NLS embedded within a non-classical rg-NLS is a unique arrangement in these viral proteins, whose nuclear localization is critical to their functionality and to the virus life cycle. The ability to interact with multiple import receptors provides alternate pathways for nuclear localization of LANA. Since different import receptors can import cargo to distinct subnuclear compartments, a multifunctional NLS may provide LANA with an increased ability to interact with different nuclear components in its multifunctional role to maintain viral latency.	[Cherezova, Lidia] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Cherezova, Lidia; Burnside, Kellie L.; Rose, Timothy M.] Seattle Childrens Res Inst, Ctr Childhood Infect & Prematur Res, Seattle, WA USA; [Rose, Timothy M.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle	Cherezova, L (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	timothy.rose@seattlechildrens.org			National Center for Research Resource (NCRR) [RR13154]; National Institute for Dental and Craniofacial Research (NIDCR) [DE016826]; National Institutes of Health (NIH); National Institute of Dental and Craniofacial Research [DE07023]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR013154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007023, R21DE016826] Funding Source: NIH RePORTER	National Center for Research Resource (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute for Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by Public Health Service grants to T.M.R. from the National Center for Research Resource (NCRR) (RR13154) and the National Institute for Dental and Craniofacial Research (NIDCR) (DE016826), National Institutes of Health (NIH), and to K.L.B. who received support from the Cross-Disciplinary Dental Science Research Training Grant DE07023 from the National Institute of Dental and Craniofacial Research. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of NCRR, NIDCR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBINDER RF, 1991, J VIROL, V65, P1466, DOI 10.1128/JVI.65.3.1466-1478.1991; Antman K, 2000, NEW ENGL J MED, V342, P1027, DOI 10.1056/NEJM200004063421407; Arnold M, 2006, J BIOL CHEM, V281, P20883, DOI 10.1074/jbc.M602189200; Ballestas ME, 1999, SCIENCE, V284, P641, DOI 10.1126/science.284.5414.641; Barbera AJ, 2004, J VIROL, V78, P294, DOI 10.1128/JVI.78.1.294-301.2004; Bian XL, 2007, J VIROL, V81, P2899, DOI 10.1128/JVI.01850-06; Boulikas Teni, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P193; Bruce AG, 2006, J GEN VIROL, V87, P3529, DOI 10.1099/vir.0.82339-0; Burnside KL, 2006, VIROLOGY, V354, P103, DOI 10.1016/j.virol.2006.06.022; Cingolani G, 2002, MOL CELL, V10, P1345, DOI 10.1016/S1097-2765(02)00727-X; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Corredor AG, 2009, J VIROL, V83, P12842, DOI 10.1128/JVI.01613-09; Cotter MA, 1999, VIROLOGY, V264, P254, DOI 10.1006/viro.1999.9999; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Fagerlund R, 2005, J BIOL CHEM, V280, P15942, DOI 10.1074/jbc.M500814200; Fontes MRM, 2003, J BIOL CHEM, V278, P27981, DOI 10.1074/jbc.M303275200; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Forwood JK, 2001, BIOCHEMISTRY-US, V40, P5208, DOI 10.1021/bi002732+; Friborg J, 1999, NATURE, V402, P889, DOI 10.1038/47266; Fujimuro M, 2005, J VIROL, V79, P10429, DOI 10.1128/JVI.79.16.10429-10441.2005; Ganem D, 2006, ANNU REV PATHOL-MECH, V1, P273, DOI 10.1146/annurev.pathol.1.110304.100133; Garber AC, 2001, J VIROL, V75, P7882, DOI 10.1128/JVI.75.17.7882-7892.2001; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Harel A, 2003, MOL BIOL CELL, V14, P4387, DOI 10.1091/mbc.E03-05-0275; Henderson BR, 1997, J MOL BIOL, V274, P693, DOI 10.1006/jmbi.1997.1420; Hogarth CA, 2006, DEV DYNAM, V235, P253, DOI 10.1002/dvdy.20569; Hosokawa K, 2008, NEUROSCIENCE, V157, P864, DOI 10.1016/j.neuroscience.2008.09.045; Huber J, 1998, EMBO J, V17, P4114, DOI 10.1093/emboj/17.14.4114; Ito S, 2000, VIROLOGY, V266, P110, DOI 10.1006/viro.1999.0054; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Johnson-Saliba M, 2000, FEBS LETT, V467, P169, DOI 10.1016/S0014-5793(00)01142-X; Kedes DH, 1997, J CLIN INVEST, V100, P2606, DOI 10.1172/JCI119804; Kellam P, 1997, J Hum Virol, V1, P19; Kitamura R, 2006, J VIROL, V80, P1979, DOI 10.1128/JVI.80.4.1979-1991.2006; Knapp AA, 2009, VIROLOGY, V383, P60, DOI 10.1016/j.virol.2008.09.037; Kurnari G, 2007, J MOL BIOL, V367, P1294, DOI 10.1016/j.jmb.2007.01.026; Kurisaki A, 2001, MOL BIOL CELL, V12, P1079, DOI 10.1091/mbc.12.4.1079; Lam MHC, 2001, BIOCHEM BIOPH RES CO, V282, P629, DOI 10.1006/bbrc.2001.4607; Lan K, 2004, J VIROL, V78, P6585, DOI 10.1128/JVI.78.12.6585-6594.2004; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Le Roux LG, 2003, J VIROL, V77, P2330, DOI 10.1128/JVI.77.4.2330-2337.2003; Lee DCY, 1999, J BIOL CHEM, V274, P29031, DOI 10.1074/jbc.274.41.29031; Leslie DM, 2004, MOL CELL BIOL, V24, P8487, DOI 10.1128/MCB.24.19.8487-8503.2004; Liang SH, 1999, J BIOL CHEM, V274, P32699, DOI 10.1074/jbc.274.46.32699; Lin CY, 2000, J BIOL CHEM, V275, P37815, DOI 10.1074/jbc.M002470200; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Melen K, 2003, J BIOL CHEM, V278, P28193, DOI 10.1074/jbc.M303571200; Moore JD, 1999, J CELL BIOL, V144, P213, DOI 10.1083/jcb.144.2.213; Moroianu J, 1998, J CELL BIOCHEM, V70, P231; Mosammaparast N, 2002, J BIOL CHEM, V277, P862, DOI 10.1074/jbc.M106845200; Mosammaparast N, 2001, J CELL BIOL, V153, P251, DOI 10.1083/jcb.153.2.251; Nagoshi E, 1999, MOL BIOL CELL, V10, P2221, DOI 10.1091/mbc.10.7.2221; Nakahara S, 2006, CANCER RES, V66, P9995, DOI 10.1158/0008-5472.CAN-06-1772; Narayanan U, 2002, HUM MOL GENET, V11, P1785, DOI 10.1093/hmg/11.15.1785; Palmeri D, 1999, MOL CELL BIOL, V19, P1218; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Piolot T, 2001, J VIROL, V75, P3948, DOI 10.1128/JVI.75.8.3948-3959.2001; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; Radkov SA, 2000, NAT MED, V6, P1121, DOI 10.1038/80459; Rainbow L, 1997, J VIROL, V71, P5915, DOI 10.1128/JVI.71.8.5915-5921.1997; Rao MRKS, 2006, J MOL BIOL, V364, P637, DOI 10.1016/j.jmb.2006.09.007; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Sakakida Y, 2005, J BIOL CHEM, V280, P13272, DOI 10.1074/jbc.M413236200; Schickling O, 2001, CELL DEATH DIFFER, V8, P1157, DOI 10.1038/sj.cdd.4400928; Schwam DR, 2000, J VIROL, V74, P8532, DOI 10.1128/JVI.74.18.8532-8540.2000; Shinohara H, 2002, J VIROL, V76, P12917, DOI 10.1128/JVI.76.24.12917-12924.2002; SIOMI H, 1995, J CELL BIOL, V129, P551, DOI 10.1083/jcb.129.3.551; Siomi MC, 1997, J CELL BIOL, V138, P1181, DOI 10.1083/jcb.138.6.1181; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Tiganis T, 1997, J BIOL CHEM, V272, P21548, DOI 10.1074/jbc.272.34.21548; Truant R, 1998, MOL CELL BIOL, V18, P1449, DOI 10.1128/MCB.18.3.1449; Truant R, 1999, MOL CELL BIOL, V19, P1210; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; WEIGHARDT F, 1995, J CELL SCI, V108, P545; Wodrich H, 2006, J VIROL, V80, P9608, DOI 10.1128/JVI.00850-06; Wong LY, 2004, J VIROL, V78, P10074, DOI 10.1128/JVI.78.18.10074-10085.2004; Xiao Z, 2000, J BIOL CHEM, V275, P23425, DOI 10.1074/jbc.C000345200; Yeung PL, 2006, BIOCHEM BIOPH RES CO, V348, P13, DOI 10.1016/j.bbrc.2006.06.163; ZACKSENHAUS E, 1993, MOL CELL BIOL, V13, P4588, DOI 10.1128/MCB.13.8.4588	81	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18920	10.1371/journal.pone.0018920	http://dx.doi.org/10.1371/journal.pone.0018920			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559489	Green Submitted, gold, Green Published			2022-12-27	WOS:000290024700036
J	Jin, QE; Chen, HY; Luo, AP; Ding, F; Liu, ZH				Jin, Qing'e; Chen, Hongyan; Luo, Aiping; Ding, Fang; Liu, Zhihua			S100A14 Stimulates Cell Proliferation and Induces Cell Apoptosis at Different Concentrations via Receptor for Advanced Glycation End Products (RAGE)	PLOS ONE			English	Article							NEURITE OUTGROWTH; CANCER; PROTEINS; SURVIVAL; GROWTH; ACTIVATION; EXPRESSION; AMPHOTERIN; S100A8/A9; MIGRATION	S100A14 is an EF-hand containing calcium-binding protein of the S100 protein family that exerts its biological effects on different types of cells. However, exact extracellular roles of S100A14 have not been clarified yet. Here we investigated the effects of S100A14 on esophageal squamous cell carcinoma (ESCC) cell lines. Results demonstrated that low doses of extracellular S100A14 stimulate cell proliferation and promote survival in KYSE180 cells through activating ERK1/2 MAPK and NF-kappa B signaling pathways. Immunoprecipitation assay showed that S100A14 binds to receptor for advanced glycation end products (RAGE) in KYSE180 cells. Inhibition of RAGE signaling by different approaches including siRNA for RAGE, overexpression of a dominant-negative RAGE construct or a RAGE antagonist peptide (AmphP) significantly blocked S100A14-induced effects, suggesting that S100A14 acts via RAGE ligation. Furthermore, mutation of the N-EF hand of S100A14 (E39A, E45A) virtually reduced 10 mg/ml S100A14-induced cell proliferation and ERK1/2 activation. However, high dose (80 mg/ml) of S100A14 causes apoptosis via the mitochondrial pathway with activation of caspase-3, caspase-9, and poly(ADP-ribose) polymerase. High dose S100A14 induces cell apoptosis is partially in a RAGE-dependent manner. This is the first study to demonstrate that S100A14 binds to RAGE and stimulates RAGE-dependent signaling cascades, promoting cell proliferation or triggering cell apoptosis at different doses.	[Jin, Qing'e] Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Jin, QE (corresponding author), Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China.	liuzh@cicams.ac.cn			National Natural Science Foundation of China [30721001, 81000954]; National Basic Research Program of China [2011CB504205]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (30721001, 81000954) and National Basic Research Program of China (2011CB504205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam PJ, 2003, J BIOL CHEM, V278, P6482, DOI 10.1074/jbc.M210184200; Arumugam T, 2004, J BIOL CHEM, V279, P5059, DOI 10.1074/jbc.M310124200; Arumugam T, 2005, CLIN CANCER RES, V11, P5356, DOI 10.1158/1078-0432.CCR-05-0092; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Businaro R, 2006, J NEUROSCI RES, V83, P897, DOI 10.1002/jnr.20785; Cecil DL, 2005, J IMMUNOL, V175, P8296, DOI 10.4049/jimmunol.175.12.8296; Chen HY, 2009, CANCER RES, V69, P3451, DOI 10.1158/0008-5472.CAN-08-4231; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Donato R, 2007, CURR MOL MED, V7, P711, DOI 10.2174/156652407783220688; Emberley ED, 2004, BIOCHEM CELL BIOL, V82, P508, DOI 10.1139/O04-052; Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X; Fuentes MK, 2007, DIS COLON RECTUM, V50, P1230, DOI 10.1007/s10350-006-0850-5; Ghavami S, 2004, J LEUKOCYTE BIOL, V76, P169, DOI 10.1189/jlb.0903435; Ghavami S, 2008, J LEUKOCYTE BIOL, V83, P1484, DOI 10.1189/jlb.0607397; Ghavami S, 2008, BBA-MOL CELL RES, V1783, P297, DOI 10.1016/j.bbamcr.2007.10.015; Han Yaling, 2002, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V19, P455; Heizmann C. W., 2007, V45, P93; Hermani A, 2005, EXP CELL RES, V312, P184, DOI 10.1016/j.yexcr.2005.10.013; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hsieh HL, 2004, BIOCHEM BIOPH RES CO, V316, P949, DOI 10.1016/j.bbrc.2004.02.135; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Huttunen HJ, 2002, CANCER RES, V62, P4805; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Ismail TM, 2010, J BIOL CHEM, V285, P914, DOI 10.1074/jbc.M109.010892; Lavoie C, 2002, MOL ENDOCRINOL, V16, P2462, DOI 10.1210/me.2002-0079; Leclerc E, 2007, J BIOL CHEM, V282, P31317, DOI 10.1074/jbc.M703951200; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Logsdon CD, 2007, CURR MOL MED, V7, P777, DOI 10.2174/156652407783220697; Luo AP, 2004, ONCOGENE, V23, P1291, DOI 10.1038/sj.onc.1207218; Pietas A, 2002, GENOMICS, V79, P513, DOI 10.1006/geno.2002.6744; Rincon M, 2009, IMMUNOL REV, V228, P212, DOI 10.1111/j.1600-065X.2008.00744.x; Salama I, 2008, EJSO-EUR J SURG ONC, V34, P357, DOI 10.1016/j.ejso.2007.04.009; Schmidt-Hansen B, 2004, J BIOL CHEM, V279, P24498, DOI 10.1074/jbc.M400441200; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Smirnov DA, 2005, CANCER RES, V65, P4993, DOI 10.1158/0008-5472.CAN-04-4330; Sorci G, 2004, J CELL PHYSIOL, V199, P274, DOI 10.1002/jcp.10462; Sorci G, 2003, MOL CELL BIOL, V23, P4870, DOI 10.1128/MCB.23.14.4870-4881.2003; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Vincent AM, 2007, ENDOCRINOLOGY, V148, P548, DOI 10.1210/en.2006-0073; Wang HY, 2010, ONCOL REP, V23, P45, DOI 10.3892/or_00000604; Yammani RR, 2006, ARTHRITIS RHEUM-US, V54, P2901, DOI 10.1002/art.22042; Yao R, 2007, ANTICANCER RES, V27, P3051; Zhang LY, 2006, CLIN CANCER RES, V12, P1639, DOI 10.1158/1078-0432.CCR-05-1858; Zhang S, 2005, ONCOGENE, V24, P4401, DOI 10.1038/sj.onc.1208663	46	66	73	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19375	10.1371/journal.pone.0019375	http://dx.doi.org/10.1371/journal.pone.0019375			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559403	Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700151
J	Tuttelmann, F; Simoni, M; Kliesch, S; Ledig, S; Dworniczak, B; Wieacker, P; Ropke, A				Tuettelmann, Frank; Simoni, Manuela; Kliesch, Sabine; Ledig, Susanne; Dworniczak, Bernd; Wieacker, Peter; Roepke, Albrecht			Copy Number Variants in Patients with Severe Oligozoospermia and Sertoli-Cell-Only Syndrome	PLOS ONE			English	Article							MALE-INFERTILITY; GENE; POLYMORPHISMS; FAMILY; MEN; AZOOSPERMIA; CHROMOSOME; EXCRETION; CLONING; H2B	A genetic origin is estimated in 30% of infertile men with the common phenotypes of oligo-or azoospermia, but the pathogenesis of spermatogenic failure remains frequently obscure. To determine the involvement of Copy Number Variants (CNVs) in the origin of male infertility, patients with idiopathic severe oligozoospermia (N = 89), Sertoli-cell-only syndrome (SCOS, N = 37)) and controls with normozoospermia (N = 100) were analysed by array-CGH using the 244A/400K array sets (Agilent Technologies). The mean number of CNVs and the amount of DNA gain/loss were comparable between all groups. Ten recurring CNVs were only found in patients with severe oligozoospermia, three only in SCOS and one CNV in both groups with spermatogenic failure but not in normozoospermic men. Sex-chromosomal, mostly private CNVs were significantly overrepresented in patients with SCOS. CNVs found several times in all groups were analysed in a case-control design and four additional candidate genes and two regions without known genes were associated with SCOS (P<1 x 10(-3)). In conclusion, by applying array-CGH to study male infertility for the first time, we provide a number of candidate genes possibly causing or being risk factors for the men's spermatogenic failure. The recurring, patient-specific and private, sex-chromosomal CNVs as well as those associated with SCOS are candidates for further, larger case-control and re-sequencing studies.	[Tuettelmann, Frank; Ledig, Susanne; Dworniczak, Bernd; Wieacker, Peter; Roepke, Albrecht] Univ Munster, Inst Human Genet, D-4400 Munster, Germany; [Simoni, Manuela] Univ Modena & Reggio Emilia, Dept Med Endocrinol Metab & Geriatr, Modena, Italy; [Kliesch, Sabine] Univ Munster, Dept Clin Androl, Ctr Reprod Med & Androl, Munster, Germany	University of Munster; Universita di Modena e Reggio Emilia; University of Munster	Tuttelmann, F (corresponding author), Univ Munster, Inst Human Genet, D-4400 Munster, Germany.	frank.tuettelmann@ukmuenster.de	Tüttelmann, Frank/ABH-8185-2020; Simoni, Manuela/A-9600-2013	Tüttelmann, Frank/0000-0003-2745-9965; Simoni, Manuela/0000-0002-2133-4304	Deutsche Forschungsgemeinschaft Research Unit [FOR 1041, TU 298/1-1]	Deutsche Forschungsgemeinschaft Research Unit(German Research Foundation (DFG))	The study was supported by the Deutsche Forschungsgemeinschaft Research Unit 'Germ Cell Potential' (FOR 1041, grant TU 298/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aston KI, 2010, HUM REPROD, V25, P1383, DOI 10.1093/humrep/deq081; Aston KI, 2009, J ANDROL, V30, P711, DOI 10.2164/jandrol.109.007971; Boulard M, 2006, MOL CELL BIOL, V26, P1518, DOI 10.1128/MCB.26.4.1518-1526.2006; Burgoyne P S, 1984, Symp Soc Exp Biol, V38, P349; Chen YT, 2003, GENOMICS, V82, P628, DOI 10.1016/S0888-7543(03)00183-6; Churikov D, 2004, GENOMICS, V84, P745, DOI 10.1016/j.ygeno.2004.06.001; Fanciulli M, 2010, CLIN GENET, V77, P201, DOI 10.1111/j.1399-0004.2009.01342.x; Ferlin A, 2007, REPROD BIOMED ONLINE, V14, P734, DOI 10.1016/S1472-6483(10)60677-3; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Foresta C, 2005, J CLIN ENDOCR METAB, V90, P152, DOI 10.1210/jc.2004-1469; Gure AO, 2002, INT J CANCER, V101, P448, DOI 10.1002/ijc.10634; Guttman JA, 1999, ANAT RECORD, V254, P418, DOI 10.1002/(SICI)1097-0185(19990301)254:3<418::AID-AR13>3.0.CO;2-C; Huang WJ, 2008, SEX DEV, V2, P251, DOI 10.1159/000152041; Jakobsson J, 2006, J CLIN ENDOCR METAB, V91, P687, DOI 10.1210/jc.2005-1643; Jelinic P, 2006, PLOS BIOL, V4, P1910, DOI 10.1371/journal.pbio.0040355; Juul A, 2009, J CLIN ENDOCR METAB, V94, P1005, DOI 10.1210/jc.2008-1984; Kim J, 2010, MOL CELL BIOL, V30, P1582, DOI 10.1128/MCB.01605-09; Kohn M, 2004, EUR J HUM GENET, V12, P29, DOI 10.1038/sj.ejhg.5201085; Kouprina N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000359; Ledig S, 2010, HUM REPROD, V25, P2637, DOI 10.1093/humrep/deq167; Ledig S, 2010, SEX DEV, V4, P225, DOI 10.1159/000314958; LEDIG S, 2010, FERTIL STERIL, V4, P213; Lee J, 2009, J CELL MOL MED, V13, P1942, DOI 10.1111/j.1582-4934.2009.00830.x; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; McLachlan RI, 2010, J CLIN ENDOCR METAB, V95, P1013, DOI 10.1210/jc.2009-1925; Nishimune Y, 2006, J ANDROL, V27, P326, DOI 10.2164/jandrol.05162; Nuti F, 2008, REPROD BIOMED ONLINE, V16, P504, DOI 10.1016/S1472-6483(10)60457-9; Pan JY, 2009, DEV BIOL, V330, P167, DOI 10.1016/j.ydbio.2009.03.022; Radhakrishnan Y, 2009, BIOL REPROD, V81, P647, DOI 10.1095/biolreprod.109.077545; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sasaki M, 2005, GENOMICS, V85, P641, DOI 10.1016/j.ygeno.2005.01.003; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Sutton KA, 2004, DEV BIOL, V274, P426, DOI 10.1016/j.ydbio.2004.07.031; Tuttelmann F, 2007, REPROD BIOMED ONLINE, V15, P643, DOI 10.1016/s1472-6483(10)60531-7; Tuttelmann F, 2010, ANDROLOGY: MALE REPRODUCTIVE HEALTH AND DYSFUNCTION, THIRD EDITION, P87, DOI 10.1007/978-3-540-78355-8_4; Tuttelmann F, 2006, ASIAN J ANDROL, V8, P235, DOI 10.1111/j.1745-7262.2006.00131.x; TUTTELMANN F, 2010, INT J ANDROL    0628; VanAssche E, 1996, HUM REPROD, V11, P1, DOI 10.1093/humrep/11.suppl_4.1; Vincent MC, 2002, J ANDROL, V23, P45; Vincent MC, 2002, J ANDROL, V23, P18, DOI 10.1002/j.1939-4640.2002.tb02597.x; World Health Organization (WHO), 1999, WHO LAB MANUAL EXAMI, V4th; Yan W, 2009, MOL CELL ENDOCRINOL, V306, P24, DOI 10.1016/j.mce.2009.03.003; Yang QS, 2002, BIOCHEM GENET, V40, P1, DOI 10.1023/A:1014565320998	43	93	98	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19426	10.1371/journal.pone.0019426	http://dx.doi.org/10.1371/journal.pone.0019426			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559371	Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700166
J	Vikan, JR; Fossoy, F; Huhta, E; Moksnes, A; Roskaft, E; Stokke, BG				Vikan, Johan Reinert; Fossoy, Frode; Huhta, Esa; Moksnes, Arne; Roskaft, Eivin; Stokke, Bard Gunnar			Outcomes of Brood Parasite-Host Interactions Mediated by Egg Matching: Common Cuckoos Cuculus canorus versus Fringilla Finches	PLOS ONE			English	Article							COEVOLUTIONARY ARMS-RACE; LOCAL ADAPTATION; BEHAVIORAL-RESPONSES; COLOR PATTERNS; SITE-TENACITY; GENE FLOW; EVOLUTION; POPULATIONS; MONTIFRINGILLA; REJECTION	Background: Antagonistic species often interact via matching of phenotypes, and interactions between brood parasitic common cuckoos (Cuculus canorus) and their hosts constitute classic examples. The outcome of a parasitic event is often determined by the match between host and cuckoo eggs, giving rise to potentially strong associations between fitness and egg phenotype. Yet, empirical efforts aiming to document and understand the resulting evolutionary outcomes are in short supply. Methods/Principal Findings: We used avian color space models to analyze patterns of egg color variation within and between the cuckoo and two closely related hosts, the nomadic brambling (Fringilla montifringilla) and the site fidelic chaffinch (F. coelebs). We found that there is pronounced opportunity for disruptive selection on brambling egg coloration. The corresponding cuckoo host race has evolved egg colors that maximize fitness in both sympatric and allopatric brambling populations. By contrast, the chaffinch has a more bimodal egg color distribution consistent with the evolutionary direction predicted for the brambling. Whereas the brambling and its cuckoo host race show little geographical variation in their egg color distributions, the chaffinch's distribution becomes increasingly dissimilar to the brambling's distribution towards the core area of the brambling cuckoo host race. Conclusion: High rates of brambling gene flow is likely to cool down coevolutionary hot spots by cancelling out the selection imposed by a patchily distributed cuckoo host race, thereby promoting a matching equilibrium. By contrast, the site fidelic chaffinch is more likely to respond to selection from adapting cuckoos, resulting in a markedly more bimodal egg color distribution. The geographic variation in the chaffinch's egg color distribution could reflect a historical gradient in parasitism pressure. Finally, marked cuckoo egg polymorphisms are unlikely to evolve in these systems unless the hosts evolve even more exquisite egg recognition capabilities than currently possessed.	[Vikan, Johan Reinert; Fossoy, Frode; Moksnes, Arne; Roskaft, Eivin; Stokke, Bard Gunnar] Norwegian Univ Sci & Technol NTNU, Dept Biol, Trondheim, Norway; [Huhta, Esa] Finnish Forest Res Inst, Rovaniemi Res Stn, Rovaniemi, Finland	Norwegian University of Science & Technology (NTNU); Natural Resources Institute Finland (Luke)	Vikan, JR (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Biol, Trondheim, Norway.	johanrei@bio.ntnu.no	Røskaft, Eivin/N-7476-2019; Fossoy, Frode/O-3073-2017	Røskaft, Eivin/0000-0003-0262-8443; Fossoy, Frode/0000-0002-7535-9574	European Community [RITA-CT-2006-025969]	European Community(European Commission)	This work was supported by the European Community - LAPBIAT project RITA-CT-2006-025969. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON M, 1980, J ANIM ECOL, V49, P175, DOI 10.2307/4282; Aviles JM, 2006, J EVOLUTION BIOL, V19, P1901, DOI 10.1111/j.1420-9101.2006.01166.x; Aviles JM, 2011, J EVOLUTION BIOL, V24, P314, DOI 10.1111/j.1420-9101.2010.02168.x; Aviles JM, 2010, J EVOLUTION BIOL, V23, P293, DOI 10.1111/j.1420-9101.2009.01898.x; Aviles JM, 2008, P ROY SOC B-BIOL SCI, V275, P2345, DOI 10.1098/rspb.2008.0720; Baker ECS, 1942, CUCKOO PROBLEMS; Benkman CW, 2003, AM NAT, V162, P182, DOI 10.1086/376580; BLOW WL, 1950, POULTRY SCI, V29, P381, DOI 10.3382/ps.0290381; BROOKE MD, 1988, NATURE, V335, P630; Chance EP., 1940, TRUTH CUCKOO; Clayton DH, 1999, AM NAT, V154, P261, DOI 10.1086/303237; COLLIAS EC, 1993, AUK, V110, P683, DOI 10.2307/4088624; Cramp S., 1994, BIRDS W PALEARCTIC; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; DAVIES NB, 1989, J ANIM ECOL, V58, P207, DOI 10.2307/4995; DAVIES NB, 1989, J ANIM ECOL, V58, P225, DOI 10.2307/4996; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; DIECKMANN U, 1995, J THEOR BIOL, V176, P91, DOI 10.1006/jtbi.1995.0179; DYBDAHL MF, 1995, P ROY SOC B-BIOL SCI, V260, P99, DOI 10.1098/rspb.1995.0065; Dybdahl MF, 2003, TRENDS ECOL EVOL, V18, P523, DOI 10.1016/S0169-5347(03)00223-4; Endler JA, 2005, EVOLUTION, V59, P1795, DOI 10.1111/j.0014-3820.2005.tb01827.x; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; Enemar Anders, 2004, Ornis Svecica, V14, P63; Fransson T., 2008, SWEDISH BIRD RINGING; FRY CH, 1988, BIRDS AFRICA; Furrer R., 2009, FIELDS TOOLS SPATIAL; Gandon S, 2002, ECOL LETT, V5, P246, DOI 10.1046/j.1461-0248.2002.00305.x; Gandon S, 1996, P ROY SOC B-BIOL SCI, V263, P1003, DOI 10.1098/rspb.1996.0148; Garant D, 2007, FUNCT ECOL, V21, P434, DOI 10.1111/j.1365-2435.2006.01228.x; Gavrilets S, 1997, J THEOR BIOL, V186, P527, DOI 10.1006/jtbi.1997.0426; Gavrilets S, 1998, J THEOR BIOL, V191, P415, DOI 10.1006/jtbi.1997.0615; Gibbs HL, 2000, NATURE, V407, P183, DOI 10.1038/35025058; Glue D, 1984, BRIT TRUST ORNITHOLO, V5, P134; Hagemeijer W., 1997, EBCC ATLAS EUROPEAN; Hanifin CT, 2008, PLOS BIOL, V6, P471, DOI 10.1371/journal.pbio.0060060; HILDEN O, 1982, Ornis Fennica, V59, P20; Hoeksema JD, 2008, AM NAT, V171, P275, DOI 10.1086/527496; Hogstad O, 2000, ORNIS FENNICA, V77, P97; Hogstad O, 2005, IBIS, V147, P77, DOI [10.1111/j.1474-919X.2004.00338.x, 10.1111/j.1474-919x.2004.00338]; HOYT DF, 1979, AUK, V96, P73; Kilner RM, 2006, BIOL REV, V81, P383, DOI 10.1017/S1464793106007044; Kruger O, 2007, PHILOS T R SOC B, V362, P1873, DOI 10.1098/rstb.2006.1849; Lahti DC, 2008, AUK, V125, P796, DOI 10.1525/auk.2008.07033; Lahti DC, 2005, P NATL ACAD SCI USA, V102, P18057, DOI 10.1073/pnas.0508930102; Legendre P., 2012, NUMERICAL ECOLOGY; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; LINDSTROM A, 1987, ORNIS FENNICA, V64, P50; Lindstrom A, 2005, OIKOS, V110, P155, DOI 10.1111/j.0030-1299.2005.13828.x; Lively CM, 1999, AM NAT, V153, pS34, DOI 10.1086/303210; Malchevsky A. S., 1987, CUCKOO ITS HOSTS; Matsuura K, 2009, CURR BIOL, V19, P30, DOI 10.1016/j.cub.2008.11.030; Mielke PW, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-69813-7; MIKKONEN AV, 1983, ORNIS SCAND, V14, P36, DOI 10.2307/3676248; Minka TP, 2009, MAPS DRAW GEOGRAPHIC; MOKSNES A, 1995, J ZOOL, V236, P625, DOI 10.1111/j.1469-7998.1995.tb02736.x; MOKSNES A, 1991, BEHAVIOUR, V116, P64, DOI 10.1163/156853990X00365; MONTELL J, 1917, ACTA SOC FAUNA FLORA, V44, P135; Nash DR, 2008, SCIENCE, V319, P88, DOI 10.1126/science.1149180; Nuismer SL, 2005, EVOLUTION, V59, P2073; Numerov A.D., 2003, INTERSPECIFIC INTRAS; OIEN IJ, 1995, BEHAV ECOL, V6, P166, DOI 10.1093/beheco/6.2.166; Oksanen J, 2022, COMMUNITY ECOLOGY PA; Paradis E, 1998, J ANIM ECOL, V67, P518, DOI 10.1046/j.1365-2656.1998.00215.x; PICMAN J, 1989, AUK, V106, P577; Reiss PT, 2010, BIOMETRICS, V66, P636, DOI 10.1111/j.1541-0420.2009.01300.x; Roskaft E, 2002, BEHAVIOUR, V139, P613, DOI 10.1163/15685390260136735; ROTHSTEIN SI, 1990, ANNU REV ECOL SYST, V21, P481, DOI 10.1146/annurev.es.21.110190.002405; Rothstein SI, 1998, OX ORN SER, V9, P419; Servedio MR, 2003, EVOLUTION, V57, P1164; Soler JJ, 2001, ECOL LETT, V4, P470, DOI 10.1046/j.1461-0248.2001.00247.x; Soler JJ, 1999, EVOLUTION, V53, P947, DOI 10.1111/j.1558-5646.1999.tb05388.x; Stoddard MC, 2008, AM NAT, V171, P755, DOI 10.1086/587526; Stokke BG, 2007, EVOLUTION, V61, P2212, DOI 10.1111/j.1558-5646.2007.00176.x; Stokke BG, 2004, ETHOLOGY, V110, P459, DOI 10.1111/j.1439-0310.2004.00978.x; Stokke BG, 2002, EVOLUTION, V56, P199; Swynnerton C.F.M., 1918, IBIS, V6, P127, DOI DOI 10.1111/J.1474-919X.1918.TB00774.X; Takasu F, 2003, EVOL ECOL RES, V5, P345; Takasu Fugo, 2005, Ornithological Science, V4, P65, DOI 10.2326/osj.4.65; Thompson JN, 2002, INTEGR COMP BIOL, V42, P381, DOI 10.1093/icb/42.2.381; Vikan JR, 2009, ETHOLOGY, V115, P840, DOI 10.1111/j.1439-0310.2009.01679.x; Vikan JR, 2010, EVOL ECOL, V24, P1141, DOI 10.1007/s10682-010-9360-y; VIRKKALA R, 1989, ANN ZOOL FENN, V26, P277; Wasenius E., 1936, Ornis Fennica, V13, P147; WEI R, 1992, POULTRY SCI, V71, P406, DOI 10.3382/ps.0710406; Yang CC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010816; Zangerl AR, 2003, EVOLUTION, V57, P806, DOI 10.1111/j.0014-3820.2003.tb00292.x	87	16	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19288	10.1371/journal.pone.0019288	http://dx.doi.org/10.1371/journal.pone.0019288			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559400	Green Published, gold			2022-12-27	WOS:000290024700124
J	von Levetzow, C; Jiang, XH; Gwye, Y; von Levetzow, G; Hung, L; Cooper, A; Hsu, JHR; Lawlor, ER				von Levetzow, Cornelia; Jiang, Xiaohua; Gwye, Ynnez; von Levetzow, Gregor; Hung, Long; Cooper, Aaron; Hsu, Jessie Hao-Ru; Lawlor, Elizabeth R.			Modeling Initiation of Ewing Sarcoma in Human Neural Crest Cells	PLOS ONE			English	Article							STEM-CELLS; EWS/FLI1 EXPRESSION; GENE-EXPRESSION; IN-VIVO; DIFFERENTIATION; PROLIFERATION; TUMORS; FAMILY; TRANSFORMATION; FIBROBLASTS	Ewing sarcoma family tumors (ESFT) are aggressive bone and soft tissue tumors that express EWS-ETS fusion genes as driver mutations. Although the histogenesis of ESFT is controversial, mesenchymal (MSC) and/or neural crest (NCSC) stem cells have been implicated as cells of origin. For the current study we evaluated the consequences of EWS-FLI1 expression in human embryonic stem cell-derived NCSC (hNCSC). Ectopic expression of EWS-FLI1 in undifferentiated hNCSC and their neuro-mesenchymal stem cell (hNC-MSC) progeny was readily tolerated and led to altered expression of both well established as well as novel EWS-FLI1 target genes. Importantly, whole genome expression profiling studies revealed that the molecular signature of established ESFT is more similar to hNCSC than any other normal tissue, including MSC, indicating that maintenance or reactivation of the NCSC program is a feature of ESFT pathogenesis. Consistent with this hypothesis, EWS-FLI1 induced hNCSC genes as well as the polycomb proteins BMI-1 and EZH2 in hNC-MSC. In addition, up-regulation of BMI-1 was associated with avoidance of cellular senescence and reversible silencing of p16. Together these studies confirm that, unlike terminally differentiated cells but consistent with bone marrow-derived MSC, NCSC tolerate expression of EWS-FLI1 and ectopic expression of the oncogene initiates transition to an ESFT-like state. In addition, to our knowledge this is the first demonstration that EWS-FLI1-mediated induction of BMI-1 and epigenetic silencing of p16 might be critical early initiating events in ESFT tumorigenesis.	[von Levetzow, Cornelia; von Levetzow, Gregor; Hsu, Jessie Hao-Ru; Lawlor, Elizabeth R.] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [von Levetzow, Cornelia; von Levetzow, Gregor; Hsu, Jessie Hao-Ru; Lawlor, Elizabeth R.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Jiang, Xiaohua; Gwye, Ynnez; Hung, Long; Cooper, Aaron] Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA 90027 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Children's Hospital Los Angeles	von Levetzow, C (corresponding author), Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA.	elawlor@med.umich.edu	jiang, cynthia xiaohua/F-7580-2017	jiang, cynthia xiaohua/0000-0002-7372-4961; Cooper, Aaron/0000-0003-4588-2513	CIRM [RS1-00249, R01 CA134604, U01 CA114757, SU2C-AACR-IRG1309, T2-00005, T1-00004]; NATIONAL CANCER INSTITUTE [R01CA134604, U01CA114757] Funding Source: NIH RePORTER	CIRM(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant support for this work was provided by CIRM SEED Grant RS1-00249, R01 CA134604, U01 CA114757, SU2C-AACR-IRG1309, and by CIRM Training Grants T2-00005 (to CvL and XJ) and T1-00004 (to JH-RH). Philanthropic support from the My Brother Joey, T. J. Martell and Bogart Foundations is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Braunreiter CL, 2006, CELL CYCLE, V5, P2753, DOI 10.4161/cc.5.23.3505; CAVAZZANA AO, 1987, AM J PATHOL, V127, P507; Chinnasamy D, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-14; Coles EG, 2008, STEM CELLS, V26, P2237, DOI 10.1634/stemcells.2008-0133; Crawford YG, 2004, CANCER CELL, V5, P263, DOI 10.1016/S1535-6108(04)00023-6; Deneen B, 2001, ONCOGENE, V20, P6731, DOI 10.1038/sj.onc.1204875; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Douglas D, 2008, CANCER RES, V68, P6507, DOI 10.1158/0008-5472.CAN-07-6152; Feldhahn N, 2007, J EXP MED, V204, P1157, DOI 10.1084/jem.20062662; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Hancock JD, 2008, CELL CYCLE, V7, P250, DOI 10.4161/cc.7.2.5229; Hu-Lieskovan S, 2005, CANCER RES, V65, P4633, DOI 10.1158/0008-5472.CAN-04-2857; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang HY, 2005, J CLIN ONCOL, V23, P548, DOI 10.1200/JCO.2005.02.081; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jiang XH, 2009, STEM CELLS DEV, V18, P1059, DOI 10.1089/scd.2008.0362; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kauer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005415; Knezevich SR, 1998, HUM PATHOL, V29, P289, DOI 10.1016/S0046-8177(98)90049-1; Kovar H, 2010, GENOME MED, V2, DOI 10.1186/gm129; Lawlor ER, 2006, CANCER RES, V66, P4591, DOI 10.1158/0008-5472.CAN-05-3826; Le Douarin NM, 2008, CELL CYCLE, V7, P1013, DOI 10.4161/cc.7.8.5641; Lessnick SL, 2002, CANCER CELL, V1, P393, DOI 10.1016/S1535-6108(02)00056-9; Miyagawa Y, 2008, MOL CELL BIOL, V28, P2125, DOI 10.1128/MCB.00740-07; Morikawa S, 2009, BIOCHEM BIOPH RES CO, V379, P1114, DOI 10.1016/j.bbrc.2009.01.031; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; Novak P, 2009, CANCER RES, V69, P5251, DOI 10.1158/0008-5472.CAN-08-4977; OREGAN S, 1995, J NEUROCHEM, V64, P69; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Rajasekhar Vinagolu K., 2009, P285, DOI 10.1007/978-1-60327-227-8_24; Richter GHS, 2009, P NATL ACAD SCI USA, V106, P5324, DOI 10.1073/pnas.0810759106; Riggi N, 2008, CANCER RES, V68, P2176, DOI 10.1158/0008-5472.CAN-07-1761; Riggi N, 2007, CANCER LETT, V254, P1, DOI 10.1016/j.canlet.2006.12.009; Riggi N, 2010, GENE DEV, V24, P916, DOI 10.1101/gad.1899710; Riggi N, 2009, EXPERT REV ANTICANC, V9, P1025, DOI 10.1586/ERA.09.81; Smith KS, 2003, MOL CELL, V12, P393, DOI 10.1016/S1097-2765(03)00277-6; Staege MS, 2004, CANCER RES, V64, P8213, DOI 10.1158/0008-5472.CAN-03-4059; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Torchia EC, 2007, MOL CELL BIOL, V27, P7918, DOI 10.1128/MCB.00099-07; Yang S, 2008, GENE THER, V15, P1411, DOI 10.1038/gt.2008.90; Zou JH, 2005, MOL CELL BIOL, V25, P6235, DOI 10.1128/MCB.25.14.6235-6246.2005; Zwerner JP, 2003, EXP CELL RES, V290, P414, DOI 10.1016/S0014-4827(03)00371-9	44	109	112	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19305	10.1371/journal.pone.0019305	http://dx.doi.org/10.1371/journal.pone.0019305			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559395	Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700129
J	Zhang, L; Bhasin, M; Schor-Bardach, R; Wang, XE; Collins, MP; Panka, D; Putheti, P; Signoretti, S; Alsop, DC; Libermann, T; Atkins, MB; Mier, JW; Goldberg, SN; Bhatt, RS				Zhang, Liang; Bhasin, Manoj; Schor-Bardach, Rachel; Wang, Xiaoen; Collins, Michael P.; Panka, David; Putheti, Prabhakar; Signoretti, Sabina; Alsop, David C.; Libermann, Towia; Atkins, Michael B.; Mier, James W.; Goldberg, S. Nahum; Bhatt, Rupal S.			Resistance of Renal Cell Carcinoma to Sorafenib Is Mediated by Potentially Reversible Gene Expression	PLOS ONE			English	Article							ANTIANGIOGENIC THERAPY; CANCER; MICROARRAYS; SUMMARIES; BIOLOGY; GROWTH; TUMORS	Purpose: Resistance to antiangiogenic therapy is an important clinical problem. We examined whether resistance occurs at least in part via reversible, physiologic changes in the tumor, or results solely from stable genetic changes in resistant tumor cells. Experimental Design: Mice bearing two human RCC xenografts were treated with sorafenib until they acquired resistance. Resistant 786-O cells were harvested and reimplanted into naive mice. Mice bearing resistant A498 cells were subjected to a 1 week treatment break. Sorafenib was then again administered to both sets of mice. Tumor growth patterns, gene expression, viability, blood vessel density, and perfusion were serially assessed in treated vs control mice. Results: Despite prior resistance, reimplanted 786-O tumors maintained their ability to stabilize on sorafenib in sequential reimplantation steps. A transcriptome profile of the tumors revealed that the gene expression profile of tumors upon reimplantation reapproximated that of the untreated tumors and was distinct from tumors exhibiting resistance to sorafenib. In A498 tumors, revascularization was noted with resistance and cessation of sorafenib therapy and tumor perfusion was reduced and tumor cell necrosis enhanced with re-exposure to sorafenib. Conclusions: In two RCC cell lines, resistance to sorafenib appears to be reversible. These results support the hypothesis that resistance to VEGF pathway therapy is not solely the result of a permanent genetic change in the tumor or selection of resistant clones, but rather is due to a great extent to reversible changes that likely occur in the tumor and/or its microenvironment.	[Zhang, Liang; Panka, David; Atkins, Michael B.; Mier, James W.; Bhatt, Rupal S.] Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02215 USA; [Bhasin, Manoj; Libermann, Towia] Beth Israel Deaconess Med Ctr, Div Interdisciplinary Med & Biotechnol, Boston, MA 02215 USA; [Bhasin, Manoj] Beth Israel Deaconess Med Ctr, Genom & Prote Ctr, Boston, MA 02215 USA; [Schor-Bardach, Rachel; Wang, Xiaoen; Alsop, David C.; Goldberg, S. Nahum] Beth Israel Deaconess Med Ctr, Dept Radiol, Boston, MA 02215 USA; [Schor-Bardach, Rachel; Goldberg, S. Nahum] Hadassah Hebrew Univ, Med Ctr, Dept Radiol, Jerusalem, Israel; [Collins, Michael P.; Signoretti, Sabina] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Putheti, Prabhakar] Beth Israel Deaconess Med Ctr, Dept Surg, Transplant Inst, Boston, MA 02215 USA; [Putheti, Prabhakar] Beth Israel Deaconess Med Ctr, Dept Med, Transplant Inst, Boston, MA 02215 USA; [Signoretti, Sabina] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Bhatt, Rupal S.] Dana Farber Harvard Canc Ctr, Kidney Canc Program, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute	Zhang, L (corresponding author), Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02215 USA.	rbhatt@bidmc.harvard.edu	Alsop, David C/J-5764-2013; Goldberg, S. Nahum/AAV-4526-2020	Alsop, David C/0000-0002-8206-1995; Bhasin, Manoj/0000-0001-5172-420X; Collins, Michael/0000-0002-1806-6775; Libermann, Towia/0000-0002-4006-8179	DF/HCC Kidney Cancer SPORE [2 P50 CA101942]; National Comprehensive Cancer Network, Jenkintown, PA; NATIONAL CANCER INSTITUTE [K08CA138900, P50CA101942] Funding Source: NIH RePORTER	DF/HCC Kidney Cancer SPORE; National Comprehensive Cancer Network, Jenkintown, PA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by DF/HCC Kidney Cancer SPORE: 2 P50 CA101942, a Career Development Award (RB), and the National Comprehensive Cancer Network, Jenkintown, PA (JM). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop DC, 1996, J CEREBR BLOOD F MET, V16, P1236, DOI 10.1097/00004647-199611000-00019; Bhatt R.S., 2010, P 101 ANN M AM ASS C; Bhatt RS, 2010, MOL CANCER THER, V9, P2793, DOI 10.1158/1535-7163.MCT-10-0477; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Hammers HJ, 2010, MOL CANCER THER, V9, P1525, DOI 10.1158/1535-7163.MCT-09-1106; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang D, 2010, CANCER RES, V70, P1063, DOI 10.1158/0008-5472.CAN-09-3965; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Janne PA, 2005, J CLIN ONCOL, V23, P3227, DOI 10.1200/JCO.2005.09.985; Jones J, 2007, CLIN CANCER RES, V13, p685S, DOI 10.1158/1078-0432.CCR-06-1867; Kaelin WG, 2005, BIOCHEM BIOPH RES CO, V338, P627, DOI 10.1016/j.bbrc.2005.08.165; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Mizukami Y, 2005, NAT MED, V11, P992, DOI 10.1038/nm1294; MOTZER RJ, 2011, J CLIN ONCOL S7, V29; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; Rini BI, 2009, J CLIN ONCOL, V27, P4462, DOI 10.1200/JCO.2008.21.7034; Sabir A, 2008, AM J ROENTGENOL, V191, P133, DOI 10.2214/AJR.07.2848; Sablin MP, 2009, J UROLOGY, V182, P29, DOI 10.1016/j.juro.2009.02.119; Schor-Bardach R, 2009, RADIOLOGY, V251, P731, DOI 10.1148/radiol.2521081059; Simon R, 2007, CANCER INFORM, V3, P11; Sneath P.H.A., 1973, NUMERICAL TAXONOMY; Tamaskar I, 2008, J UROLOGY, V179, P8186; Tang TC, 2010, NEOPLASIA, V12, P928, DOI 10.1593/neo.10804; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Zama IN, 2010, CANCER-AM CANCER SOC, V116, P5400, DOI 10.1002/cncr.25583	34	46	47	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19144	10.1371/journal.pone.0019144	http://dx.doi.org/10.1371/journal.pone.0019144			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559452	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700075
J	Lewis, SL; Feighner, BH; Loschen, WA; Wojcik, RA; Skora, JF; Coberly, JS; Blazes, DL				Lewis, Sheri L.; Feighner, Brian H.; Loschen, Wayne A.; Wojcik, Richard A.; Skora, Joseph F.; Coberly, Jacqueline S.; Blazes, David L.			SAGES: A Suite of Freely-Available Software Tools for Electronic Disease Surveillance in Resource-Limited Settings	PLOS ONE			English	Article							INFECTIOUS-DISEASES; EPIDEMICS; SYSTEMS	Public health surveillance is undergoing a revolution driven by advances in the field of information technology. Many countries have experienced vast improvements in the collection, ingestion, analysis, visualization, and dissemination of public health data. Resource-limited countries have lagged behind due to challenges in information technology infrastructure, public health resources, and the costs of proprietary software. The Suite for Automated Global Electronic bioSurveillance (SAGES) is a collection of modular, flexible, freely-available software tools for electronic disease surveillance in resource-limited settings. One or more SAGES tools may be used in concert with existing surveillance applications or the SAGES tools may be used en masse for an end-to-end biosurveillance capability. This flexibility allows for the development of an inexpensive, customized, and sustainable disease surveillance system. The ability to rapidly assess anomalous disease activity may lead to more efficient use of limited resources and better compliance with World Health Organization International Health Regulations.	[Lewis, Sheri L.; Feighner, Brian H.; Loschen, Wayne A.; Wojcik, Richard A.; Skora, Joseph F.; Coberly, Jacqueline S.] Johns Hopkins Univ, Appl Phys Lab, Natl Secur Technol Dept, Laurel, MD USA; [Blazes, David L.] Armed Forces Hlth Surveillance Ctr, Div GEIS Operat, Silver Spring, MD USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	Lewis, SL (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Natl Secur Technol Dept, Laurel, MD USA.	Sheri.Lewis@jhuapl.edu			Armed Forces Health Surveillance Center	Armed Forces Health Surveillance Center	Funding for this work has been provided by the Armed Forces Health Surveillance Center (http://www.afhsc.mil). The funders had no role in the study design, data collection and analysis, or decision to publish. The funders did review the manuscript prior to submission.	[Anonymous], PRINCIPLES PRACTICE; Ashar R, 2010, J BIOMED INFORM, V43, P332, DOI 10.1016/j.jbi.2009.11.009; Binder S, 1999, SCIENCE, V284, P1311, DOI 10.1126/science.284.5418.1311; BUEHLER JW, 2004, MMWR RR, V5, P1; *CDC, 2007, MMWR-MORBID MORTAL W, V58, P804; CHRETIEN JP, 2008, PLOS MED, V5; Feighner BH, 2009, MIL MED, V174, P557, DOI 10.7205/MILMED-D-04-6108; G Soto, 2007, BMC P, V2; HAPPELLEWIS S, 2003, JHU APPL PHYS LAB TE, V24, P354; Hollingsworth TD, 2007, EMERG INFECT DIS, V13, P1288, DOI 10.3201/eid1309.070081; JAJOSKY RA, 2004, BMC PUBLIC HLTH, V4; KLAUCKE DN, 1988, MMWR S5, V37, P1; Lombardo J, 2003, J URBAN HEALTH, V80, pI32; Lombardo Joseph S, 2004, MMWR Suppl, V53, P159; LOMBARDO JS, 2007, DIS SURVEILLANCE PUB, P1; Loschen Wayne, 2007, AMIA Annu Symp Proc, P483; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Sosin DM, 2003, J URBAN HEALTH, V80, pI8; World Health Organization, 2007, WORLD HLTH REP 2007; World Health Organization (WHO), 2016, INT HLTH REG 2005	20	41	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19750	10.1371/journal.pone.0019750	http://dx.doi.org/10.1371/journal.pone.0019750			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572957	Green Published, Green Submitted, gold			2022-12-27	WOS:000290440200024
J	Wu, K; Taki, Y; Sato, K; Sassa, Y; Inoue, K; Goto, R; Okada, K; Kawashima, R; He, Y; Evans, AC; Fukuda, H				Wu, Kai; Taki, Yasuyuki; Sato, Kazunori; Sassa, Yuko; Inoue, Kentaro; Goto, Ryoi; Okada, Ken; Kawashima, Ryuta; He, Yong; Evans, Alan C.; Fukuda, Hiroshi			The Overlapping Community Structure of Structural Brain Network in Young Healthy Individuals	PLOS ONE			English	Article							CORTICAL THICKNESS; NEURONAL OSCILLATIONS; ANATOMICAL NETWORKS; COMPLEX NETWORKS; CORTEX; ATLAS; ORGANIZATION; MECHANISM; FREQUENCY; PATHWAYS	Community structure is a universal and significant feature of many complex networks in biology, society, and economics. Community structure has also been revealed in human brain structural and functional networks in previous studies. However, communities overlap and share many edges and nodes. Uncovering the overlapping community structure of complex networks remains largely unknown in human brain networks. Here, using regional gray matter volume, we investigated the structural brain network among 90 brain regions (according to a predefined anatomical atlas) in 462 young, healthy individuals. Overlapped nodes between communities were defined by assuming that nodes (brain regions) can belong to more than one community. We demonstrated that 90 brain regions were organized into 5 overlapping communities associated with several well-known brain systems, such as the auditory/language, visuospatial, emotion, decision-making, social, control of action, memory/learning, and visual systems. The overlapped nodes were mostly involved in an inferior-posterior pattern and were primarily related to auditory and visual perception. The overlapped nodes were mainly attributed to brain regions with higher node degrees and nodal efficiency and played a pivotal role in the flow of informa- tion through the structural brain network. Our results revealed fuzzy boundaries between communities by identifying overlapped nodes and provided new insights into the understanding of the relationship between the structure and function of the human brain. This study provides the first report of the overlapping community structure of the structural network of the human brain.	[Wu, Kai; Taki, Yasuyuki; Sato, Kazunori; Inoue, Kentaro; Goto, Ryoi; Okada, Ken; Fukuda, Hiroshi] Tohoku Univ, Dept Nucl Med & Radiol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Taki, Yasuyuki; Sassa, Yuko; Kawashima, Ryuta] Tohoku Univ, Div Dev Cognit Neurosci, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Kawashima, Ryuta] Tohoku Univ, Dept Funct Brain Imaging, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [He, Yong] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Evans, Alan C.] McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada	Tohoku University; Tohoku University; Tohoku University; Beijing Normal University; McGill University	Wu, K (corresponding author), Tohoku Univ, Dept Nucl Med & Radiol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan.	kai.wu.22@gmail.com	Evans, Alan C/B-2373-2013; Wu, Kai/C-5362-2011; He, Yong/C-2161-2009; He, Yong/Q-5756-2018; wu, kai/G-1229-2014	Evans, Alan C/0000-0003-3841-6098; Wu, Kai/0000-0003-4467-1597; wu, kai/0000-0003-4467-1597	Ministry of Education, Culture, Sports, Science and Technology [22103501, 23240056]; Tohoku University	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tohoku University	This study was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology (22103501 and 23240056) and the 2007 Tohoku University Global COE Program "Global Nano-Biomedical Engineering Education and Research Network Centre''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Alm PA, 2004, J COMMUN DISORD, V37, P325, DOI 10.1016/j.jcomdis.2004.03.001; Barton RA, 2000, NATURE, V405, P1055, DOI 10.1038/35016580; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Baumes J, 2005, LECT NOTES COMPUT SC, V3495, P27; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; Evans TS, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016105; Farkas IJ, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/180; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; Fransson P, CEREB CORTE IN PRESS; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gazzaniga M. S., 2009, COGNITIVE NEUROSCIEN; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goel V, 1998, J COGNITIVE NEUROSCI, V10, P293, DOI 10.1162/089892998562744; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Graziano MSA, 2001, NEURON, V29, P4, DOI 10.1016/S0896-6273(01)00174-X; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; He Y, 2009, BRAIN, V132, P3366, DOI 10.1093/brain/awp089; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; HIKOSAKA K, 1988, J NEUROPHYSIOL, V60, P1615, DOI 10.1152/jn.1988.60.5.1615; Honey CJ, 2010, NEUROIMAGE, V52, P766, DOI 10.1016/j.neuroimage.2010.01.071; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Jeannerod M., 1997, COGNITIVE NEUROSCIEN; Kaiser M, 2004, BIOL CYBERN, V90, P311, DOI 10.1007/s00422-004-0479-1; Kayser C, 2009, HEARING RES, V258, P80, DOI 10.1016/j.heares.2009.02.011; Knauff M, 2003, J COGNITIVE NEUROSCI, V15, P559, DOI 10.1162/089892903321662949; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lerch JP, 2006, NEUROIMAGE, V31, P993, DOI 10.1016/j.neuroimage.2006.01.042; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Macaluso E, 2000, SCIENCE, V289, P1206, DOI 10.1126/science.289.5482.1206; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; Marchand WR, 2008, NEUROREPORT, V19, P957, DOI 10.1097/WNR.0b013e328302c873; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mechelli A, 2005, J NEUROSCI, V25, P8303, DOI 10.1523/JNEUROSCI.0357-05.2005; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Meunier D., 2009, FRONT NEUROINFORM, V30, DOI [10.3389/neuro.11.037.2009, 10.3389/neuro.11.037.2009.eCollection2009]; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Morgan VL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006660; Nepusz T, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016107; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Nicosia V, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/03/P03024; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Recanzone GH, 2009, HEARING RES, V258, P89, DOI 10.1016/j.heares.2009.04.009; Salvador R, 2008, NEUROIMAGE, V39, P279, DOI 10.1016/j.neuroimage.2007.08.018; Sanabria-Diaz G, 2010, NEUROIMAGE, V50, P1497, DOI 10.1016/j.neuroimage.2010.01.028; Sato K, 2003, NEURAL NETWORKS, V16, P1301, DOI 10.1016/j.neunet.2003.06.004; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Schroeder CE, 2005, CURR OPIN NEUROBIOL, V15, P454, DOI 10.1016/j.conb.2005.06.008; Shen HW, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/07/P07042; Shen HW, 2009, PHYSICA A, V388, P1706, DOI 10.1016/j.physa.2008.12.021; Stam CJ, 2010, INT J PSYCHOPHYSIOL, V77, P186, DOI 10.1016/j.ijpsycho.2010.06.024; Talairach J., 1988, COPLANAR STEREOTAXIC; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Wu K, HUM BRAIN M IN PRESS; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhang SH, 2007, PHYSICA A, V374, P483, DOI 10.1016/j.physa.2006.07.023; Zhu W, NEUROBIOLOG IN PRESS	86	44	44	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19608	10.1371/journal.pone.0019608	http://dx.doi.org/10.1371/journal.pone.0019608			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573111	gold, Green Published, Green Submitted			2022-12-27	WOS:000290305600035
J	Querings, S; Altmuller, J; Ansen, S; Zander, T; Seidel, D; Gabler, F; Peifer, M; Markert, E; Stemshorn, K; Timmermann, B; Saal, B; Klose, S; Ernestus, K; Scheffler, M; Engel-Riedel, W; Stoelben, E; Brambilla, E; Wolf, J; Nurnberg, P; Thomas, RK				Querings, Silvia; Altmueller, Janine; Ansen, Sascha; Zander, Thomas; Seidel, Danila; Gabler, Franziska; Peifer, Martin; Markert, Eva; Stemshorn, Kathryn; Timmermann, Bernd; Saal, Beate; Klose, Stefan; Ernestus, Karen; Scheffler, Matthias; Engel-Riedel, Walburga; Stoelben, Erich; Brambilla, Elisabeth; Wolf, Juergen; Nuernberg, Peter; Thomas, Roman K.			Benchmarking of Mutation Diagnostics in Clinical Lung Cancer Specimens	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; EGFR MUTATIONS; GENE-MUTATIONS; KRAS MUTATION; GEFITINIB; POLYMERASE; SYSTEM; SAMPLES; TUMORS	Treatment of EGFR-mutant non-small cell lung cancer patients with the tyrosine kinase inhibitors erlotinib or gefitinib results in high response rates and prolonged progression-free survival. Despite the development of sensitive mutation detection approaches, a thorough validation of these in a clinical setting has so far been lacking. We performed, in a clinical setting, a systematic validation of dideoxy 'Sanger' sequencing and pyrosequencing against massively parallel sequencing as one of the most sensitive mutation detection technologies available. Mutational annotation of clinical lung tumor samples revealed that of all patients with a confirmed response to EGFR inhibition, only massively parallel sequencing detected all relevant mutations. By contrast, dideoxy sequencing missed four responders and pyrosequencing missed two responders, indicating a dramatic lack of sensitivity of dideoxy sequencing, which is widely applied for this purpose. Furthermore, precise quantification of mutant alleles revealed a low correlation (r(2) = 0.27) of histopathological estimates of tumor content and frequency of mutant alleles, thereby questioning the use of histopathology for stratification of specimens for individual analytical procedures. Our results suggest that enhanced analytical sensitivity is critically required to correctly identify patients responding to EGFR inhibition. More broadly, our results emphasize the need for thorough evaluation of all mutation detection approaches against massively parallel sequencing as a prerequisite for any clinical implementation.	[Querings, Silvia; Seidel, Danila; Gabler, Franziska; Peifer, Martin; Saal, Beate; Thomas, Roman K.] Max Planck Gesell, Klaus Joachim Zulch Labs, Max Planck Inst Neurol Res, Cologne, Germany; [Querings, Silvia; Seidel, Danila; Gabler, Franziska; Peifer, Martin; Saal, Beate; Thomas, Roman K.] Univ Cologne, Fac Med, Cologne, Germany; [Querings, Silvia; Seidel, Danila; Gabler, Franziska; Wolf, Juergen; Thomas, Roman K.] Univ Cologne, Ctr Integrated Oncol Koln Bonn, Lab Translat Canc Genom, Cologne, Germany; [Altmueller, Janine; Stemshorn, Kathryn; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, Cologne, Germany; [Ansen, Sascha; Zander, Thomas; Scheffler, Matthias; Wolf, Juergen; Thomas, Roman K.] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany; [Ansen, Sascha; Zander, Thomas; Scheffler, Matthias; Wolf, Juergen; Thomas, Roman K.] Univ Hosp Cologne, Ctr Integrated Oncol Koln Bonn, Cologne, Germany; [Markert, Eva; Ernestus, Karen] Hosp Merheim, Inst Pathol, Cologne, Germany; [Timmermann, Bernd] Max Planck Inst Mol Genet, Berlin, Germany; [Engel-Riedel, Walburga] Lung Clin Merheim, Dept Med Oncol, Cologne, Germany; [Klose, Stefan] Pneumol Gemeinschaftpraxis Dr HP Wagner Dr St Kos, Chemnitz, Germany; [Stoelben, Erich] Lung Clin Merheim, Dept Thorac Surg, Cologne, Germany; [Brambilla, Elisabeth] Univ Grenoble 1, CHU Grenoble Hop Michallon, INSERM, Dept Pathol,Inst Albert Bonniot,U823, Grenoble, France	Max Planck Society; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; Max Planck Society; CHU Grenoble Alpes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Querings, S (corresponding author), Max Planck Gesell, Klaus Joachim Zulch Labs, Max Planck Inst Neurol Res, Cologne, Germany.	nini@nf.mpg.de	Scheffler, Matthias/AAC-1656-2019; Seidel, Danila/Y-6795-2018; Brambilla, Elisabeth MP/L-8796-2013	Seidel, Danila/0000-0003-4388-3117; Peifer, Martin/0000-0002-5243-5503; Scheffler, Matthias/0000-0002-9031-1368; Altmuller, Janine/0000-0003-4372-1521	German Cancer Aid as part of the Centers of Excellence in Oncology program; Federal German Ministry of Science and Education (BMBF) [01GS08100, 01GS08101]; AstraZeneca; Roche; Boehringer Ingelheim; JohnsonJohnson; Lilly; Merck; Atlas Biolabs; Sanofi-Aventis	German Cancer Aid as part of the Centers of Excellence in Oncology program; Federal German Ministry of Science and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); AstraZeneca(AstraZeneca); Roche(Roche Holding); Boehringer Ingelheim(Boehringer Ingelheim); JohnsonJohnson(Johnson & JohnsonJohnson & Johnson USA); Lilly(Eli Lilly); Merck(Merck & Company); Atlas Biolabs; Sanofi-Aventis(Sanofi-Aventis)	This work was supported by the German Cancer Aid as part of the Centers of Excellence in Oncology program to the Center of Integrated Oncology Koln - Bonn and by the Federal German Ministry of Science and Education (BMBF) as part of the National Genome Research Network program (NGFNplus, grants 01GS08100 and 01GS08101) to Jurgen Wolf, Peter Nurnberg and Roman Thomas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Roman K. Thomas received research support from AstraZeneca and received lecture or consultancy fees from Roche, Boehringer Ingelheim, Johnson&Johnson, AstraZeneca, Lilly, Merck, Atlas Biolabs and Sanofi-Aventis. Jurgen Wolf received research support and served as a consultant to Roche and AstraZeneca. Research support mentioned in this section was not used for conducting this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Asano H, 2006, CLIN CANCER RES, V12, P43, DOI 10.1158/1078-0432.CCR-05-0934; Brevet M, 2010, J MOL DIAGN, V12, P169, DOI 10.2353/jmoldx.2010.090140; Cappuzzo F, 2007, J CLIN ONCOL, V25, P2248, DOI 10.1200/JCO.2006.09.4300; Droege M, 2008, J BIOTECHNOL, V136, P3, DOI 10.1016/j.jbiotec.2008.03.021; Dufort S, 2009, ANAL BIOCHEM, V391, P166, DOI 10.1016/j.ab.2009.05.027; FELLEYBOSCO E, 1991, NUCLEIC ACIDS RES, V19, P2913, DOI 10.1093/nar/19.11.2913; Flaherty KT, N ENGL J MED, V363, P809; Fong PC, 2010, J CLIN ONCOL, V28, P2512, DOI 10.1200/JCO.2009.26.9589; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Fukui T, 2008, CLIN CANCER RES, V14, P4751, DOI 10.1158/1078-0432.CCR-07-5207; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Miyazawa H, 2008, CANCER SCI, V99, P595, DOI 10.1111/j.1349-7006.2007.00706.x; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Molina-Vila MA, 2008, J THORAC ONCOL, V3, P1224, DOI 10.1097/JTO.0b013e318189f579; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Nomoto K, 2006, AM J CLIN PATHOL, V126, P608, DOI 10.1309/N5PQNGW2QKMX09X7; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; Oh YH, 2010, J MOL DIAGN, V12, P644, DOI 10.2353/jmoldx.2010.090208; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pan QL, 2005, J MOL DIAGN, V7, P396, DOI 10.1016/S1525-1578(10)60569-7; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Poehlmann A, 2007, PATHOL RES PRACT, V203, P489, DOI 10.1016/j.prp.2007.06.001; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Rosell R, 2011, CLIN CANCER RES, V17, P1160, DOI 10.1158/1078-0432.CCR-10-2158; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Smith GD, 2008, J CLIN PATHOL, V61, P487, DOI 10.1136/jcp.2007.051425; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736; Uramoto H, 2007, BRIT J CANCER, V96, P857, DOI 10.1038/sj.bjc.6603665	33	96	96	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19601	10.1371/journal.pone.0019601	http://dx.doi.org/10.1371/journal.pone.0019601			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573178	Green Published, Green Submitted, gold			2022-12-27	WOS:000290256400033
J	Tripathi, SC; Matta, A; Kaur, J; Grigull, J; Chauhan, SS; Thakar, A; Shukla, NK; Duggal, R; Choudhary, AR; DattaGupta, S; Sharma, MC; Ralhan, R; Siu, KWM				Tripathi, Satyendra Chandra; Matta, Ajay; Kaur, Jatinder; Grigull, Jorg; Chauhan, Shyam Singh; Thakar, Alok; Shukla, Nootan Kumar; Duggal, Ritu; Choudhary, Ajoy Roy; DattaGupta, Siddhartha; Sharma, Mehar Chand; Ralhan, Ranju; Siu, K. W. Michael			Overexpression of Prothymosin Alpha Predicts Poor Disease Outcome in Head and Neck Cancer	PLOS ONE			English	Article							MULTIDIMENSIONAL LIQUID-CHROMATOGRAPHY; TANDEM MASS-SPECTROMETRY; ORAL PREMALIGNANT LESIONS; SQUAMOUS-CELL CARCINOMA; BREAST-CANCER; PROGNOSTIC-SIGNIFICANCE; BLADDER-CANCER; HISTONE H1; IN-VITRO; N-MYC	Background: In our recent study, tissue proteomic analysis of oral pre-malignant lesions (OPLs) and normal oral mucosa led to the identification of a panel of biomarkers, including prothymosin alpha (PTMA), to distinguish OPLs from histologically normal oral tissues. This study aimed to determine the clinical significance of PTMA overexpression in oral squamous cell hyperplasia, dysplasia and head and neck squamous cell carcinoma (HNSCC). Methodology: Immunohistochemistry of PTMA protein was performed in HNSCCs (n = 100), squamous cell hyperplasia (n = 116), dysplasia (n = 50) and histologically normal oral tissues (n = 100). Statistical analysis was carried out to determine the association of PTMA overexpression with clinicopathological parameters and disease prognosis over 7 years for HNSCC patients. Results: Our immunohistochemical analysis demonstrated significant overexpression of nuclear PTMA in squamous cell hyperplasia (63.8%), dysplasia (50%) and HNSCC (61%) in comparison with oral normal mucosa (p(trend)< 0.001). Chi-square analysis showed significant association of nuclear PTMA with advanced tumor stages (III+IV). Kaplan Meier survival analysis indicated reduced disease free survival (DFS) in HNSCC patients (p < 0.001; median survival 11 months). Notably, Cox-multivariate analysis revealed nuclear PTMA as an independent predictor of poor prognosis of HNSCC patients (p < 0.001, Hazard's ratio, HR = 5.2, 95% CI = 2.3-11.8) in comparison with the histological grade, T-stage, nodal status and tumor stage. Conclusions: Nuclear PTMA may serve as prognostic marker in HNSCC to determine the subset of patients that are likely to show recurrence of the disease.	[Tripathi, Satyendra Chandra; Kaur, Jatinder; Chauhan, Shyam Singh] All India Inst Med Sci, Dept Biochem, New Delhi 110029, India; [Matta, Ajay; Ralhan, Ranju; Siu, K. W. Michael] York Univ, Dept Chem, Toronto, ON M3J 2R7, Canada; [Tripathi, Satyendra Chandra; Ralhan, Ranju; Siu, K. W. Michael] York Univ, Ctr Res Mass Spectrometry, Toronto, ON M3J 2R7, Canada; [Grigull, Jorg] York Univ, Dept Math & Stat, Toronto, ON M3J 2R7, Canada; [Thakar, Alok] All India Inst Med Sci, Dept Otorhinolaryngol, New Delhi 110029, India; [Shukla, Nootan Kumar] All India Inst Med Sci, Dept Surg, Dr BRA Inst Rotary Canc Hosp, New Delhi 110029, India; [Duggal, Ritu; Choudhary, Ajoy Roy] All India Inst Med Sci, Ctr Dent Educ & Res, New Delhi 110029, India; [DattaGupta, Siddhartha; Sharma, Mehar Chand] All India Inst Med Sci, Dept Pathol, New Delhi 110029, India; [Ralhan, Ranju] Mt Sinai Hosp, Joseph & Mildred Sonshine Family Ctr Head & Neck, Toronto, ON M5G 1X5, Canada; [Ralhan, Ranju] Mt Sinai Hosp, Dept Otolaryngol Head & Neck Surg, Toronto, ON M5G 1X5, Canada; [Ralhan, Ranju] Mt Sinai Hosp, Alex & Simona Shnaider Lab Mol Oncol, Toronto, ON M5G 1X5, Canada; [Ralhan, Ranju] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Ralhan, Ranju] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada	All India Institute of Medical Sciences (AIIMS) New Delhi; York University - Canada; York University - Canada; York University - Canada; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; DR. B.R.A. Institute Rotary Cancer Hospital; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Tripathi, SC (corresponding author), All India Inst Med Sci, Dept Biochem, New Delhi 110029, India.	rralhan@mtsinai.on.ca; kwmsiu@yorku.ca	MATTA, AJAY/AFT-2977-2022; Thakar, Alok/V-7701-2019; Tripathi, Satyendra Chandra/L-9352-2017; Bhurji, Jatinder K/B-6767-2013	Tripathi, Satyendra Chandra/0000-0003-3917-9645; Kaur, Jatinder/0000-0003-1650-0707	Indian Council of Medical Research (ICMR), New Delhi, India; Joseph and Mildred Sonshine Centre for Head and Neck Diseases; Temmy Latner/Dynacare Family Foundation, Canada; Canadian Institutes of Health Research (CIHR); International Science and Technology Partnerships Canada (ISTP Canada); Department of Biotechnology (DBT), India	Indian Council of Medical Research (ICMR), New Delhi, India(Indian Council of Medical Research (ICMR)); Joseph and Mildred Sonshine Centre for Head and Neck Diseases; Temmy Latner/Dynacare Family Foundation, Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); International Science and Technology Partnerships Canada (ISTP Canada); Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India)	SCT is supported by a Senior Research Fellowship from Indian Council of Medical Research (ICMR), New Delhi, India. AM is recipient of MITACS Accelerate Fellow. RR gratefully acknowledges support from Joseph and Mildred Sonshine Centre for Head and Neck Diseases and Temmy Latner/Dynacare Family Foundation, Canada. RR and KWMS acknowledge funding from the Canadian Institutes of Health Research (CIHR), International Science and Technology Partnerships Canada (ISTP Canada) and Department of Biotechnology (DBT), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora S, 2005, MOL CARCINOGEN, V42, P97, DOI 10.1002/mc.20048; Ben-Yosef T, 1998, ONCOGENE, V17, P165, DOI 10.1038/sj.onc.1201939; Bettendorf O, 2004, ORAL ONCOL, V40, P110, DOI 10.1016/j.oraloncology.2003.08.010; DOSIL M, 1993, EXP CELL RES, V204, P94, DOI 10.1006/excr.1993.1013; EILERS M, 1991, EMBO J, V10, P133, DOI 10.1002/j.1460-2075.1991.tb07929.x; Franceschi S, 2000, INT J CANCER, V85, P787, DOI 10.1002/(SICI)1097-0215(20000315)85:6&lt;787::AID-IJC8&gt;3.0.CO;2-6; Garnier M, 1997, J NEUROSCI, V17, P4591; Hapke S, 2003, BIOL CHEM, V384, P1073, DOI 10.1515/BC.2003.120; HARITOS AA, 1984, P NATL ACAD SCI-BIOL, V81, P1008, DOI 10.1073/pnas.81.4.1008; Hunter KD, 2005, NAT REV CANCER, V5, P127, DOI 10.1038/nrc1549; Jayalekshmi PA, 2009, BRIT J CANCER, V100, P848, DOI 10.1038/sj.bjc.6604907; Jiang XJ, 2003, SCIENCE, V299, P223, DOI 10.1126/science.1076807; Jou YC, 2009, UROLOGY, V74, P951, DOI 10.1016/j.urology.2008.11.060; Karetsou Z, 1998, NUCLEIC ACIDS RES, V26, P3111, DOI 10.1093/nar/26.13.3111; Karetsou Z, 2004, FEBS LETT, V577, P496, DOI 10.1016/j.febslet.2004.09.091; Kobayashi T, 2006, CANCER RES, V66, P3137, DOI 10.1158/0008-5472.CAN-05-2112; Lal A, 2005, EMBO J, V24, P1852, DOI 10.1038/sj.emboj.7600661; Letsas KP, 2006, NEOPLASMA, V53, P92; Letsas KP, 2005, PATHOL INT, V55, P694, DOI 10.1111/j.1440-1827.2005.01899.x; Leys CM, 2007, SURGERY, V141, P41, DOI 10.1016/j.surg.2006.05.009; Magdalena C, 2000, BRIT J CANCER, V82, P584, DOI 10.1054/bjoc.1999.0968; Martini PGV, 2001, ENDOCRINOLOGY, V142, P3493, DOI 10.1210/en.142.8.3493; Maserejian NN, 2006, CANCER EPIDEM BIOMAR, V15, P774, DOI 10.1158/1055-9965.EPI-05-0842; Matta A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-169; Matta A, 2008, J PROTEOME RES, V7, P2078, DOI 10.1021/pr7007797; Matta A, 2009, INT J CANCER, V125, P1398, DOI 10.1002/ijc.24517; Moore SR, 2000, ORAL DIS, V6, P191; Neville BW, 2002, CA-CANCER J CLIN, V52, P195, DOI 10.3322/canjclin.52.4.195; Orre RS, 2001, J BIOL CHEM, V276, P1794, DOI 10.1074/jbc.M008560200; PAPAMARCAKI T, 1994, FEBS LETT, V345, P71, DOI 10.1016/0014-5793(94)00439-0; Pineiro A, 2000, PEPTIDES, V21, P1433, DOI 10.1016/S0196-9781(00)00288-6; Ralhan R, 2008, MOL CELL PROTEOMICS, V7, P1162, DOI 10.1074/mcp.M700500-MCP200; Ralhan R, 2009, J PROTEOME RES, V8, P300, DOI 10.1021/pr800501j; Reibel J, 2003, CRIT REV ORAL BIOL M, V14, P47, DOI 10.1177/154411130301400105; Rodriguez P, 1998, BIOCHEM J, V331, P753, DOI 10.1042/bj3310753; Romani L, 2007, ANN NY ACAD SCI, V1112, P326, DOI 10.1196/annals.1415.002; Saleh A, 2010, ORAL ONCOL, V46, P379, DOI 10.1016/j.oraloncology.2010.02.022; Sankaranarayanan R, 1998, ANTICANCER RES, V18, P4779; Sasaki H, 2001, CANCER LETT, V168, P191, DOI 10.1016/S0304-3835(01)00540-7; Sasaki H, 2001, SURG TODAY, V31, P936, DOI 10.1007/s005950170040; Shiwa M, 2003, BIOCHEM BIOPH RES CO, V309, P18, DOI 10.1016/S0006-291X(03)01520-1; Smith Elaine M, 2010, Infect Agent Cancer, V5, P4, DOI 10.1186/1750-9378-5-4; SMITH EM, 2010, CANC CAUSES CONTROL; Suzuki S, 2006, PROSTATE, V66, P463, DOI 10.1002/pros.20385; Traub F, 2006, LAB INVEST, V86, P246, DOI 10.1038/labinvest.3700385; Tsai YS, 2009, UROLOGY, V73, P188, DOI 10.1016/j.urology.2008.05.031; Tzai TS, 2006, UROLOGY, V67, P294, DOI 10.1016/j.urology.2005.08.034; Wang F, 2009, CURR OPIN PHARMACOL, V9, P389, DOI 10.1016/j.coph.2009.06.005; Warnakulasuriya KAAS, 2007, J ORAL PATHOL MED, V36, P63, DOI 10.1111/j.1600-0714.2007.00496.x; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Wu CG, 1997, BRIT J CANCER, V76, P1199, DOI 10.1038/bjc.1997.533; Wu CL, 1997, LIFE SCI, V61, P2091, DOI 10.1016/S0024-3205(97)00882-5; Yang CH, 2004, EXP CELL RES, V298, P197, DOI 10.1016/j.yexcr.2004.04.008	53	27	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19213	10.1371/journal.pone.0019213	http://dx.doi.org/10.1371/journal.pone.0019213			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573209	Green Submitted, Green Published, gold			2022-12-27	WOS:000290256400004
J	Heim, NA; Peters, SE				Heim, Noel A.; Peters, Shanan E.			Regional Environmental Breadth Predicts Geographic Range and Longevity in Fossil Marine Genera	PLOS ONE			English	Article							LATITUDINAL DIVERSITY GRADIENT; SPECIES LONGEVITY; ABUNDANCE; PATTERNS; EXTINCTION; DISPERSAL; AREA; AGE; SPECIATION; ENDEMISM	Background: Geographic range is a good indicator of extinction susceptibility in fossil marine species and higher taxa. The widely-recognized positive correlation between geographic range and taxonomic duration is typically attributed to either accumulating geographic range with age or an extinction buffering effect, whereby cosmopolitan taxa persist longer because they are reintroduced by dispersal from remote source populations after local extinction. The former hypothesis predicts that all taxa within a region should have equal probabilities of extinction regardless of global distributions while the latter predicts that cosmopolitan genera will have greater survivorship within a region than endemics within the same region. Here we test the assumption that all taxa within a region have equal likelihoods of extinction. Methodology/Principal Findings: We use North American and European occurrences of marine genera from the Paleobiology Database and the areal extent of marine sedimentary cover in North America to show that endemic and cosmopolitan fossil marine genera have significantly different range-duration relationships and that broad geographic range and longevity are both predicted by regional environmental breadth. Specifically, genera that occur outside of the focal region are significantly longer lived and have larger geographic ranges and environmental breadths within the focal region than do their endemic counterparts, even after controlling for differences in sampling intensity. Analyses of the number of paleoenvironmental zones occupied by endemic and cosmopolitan genera suggest that the number of paleoenvironmental zones occupied is a key factor of geographic range that promotes genus survivorship. Conclusions/Significance: Wide environmental tolerances within a single region predict both broad geographic range and increased longevity in marine genera over evolutionary time. This result provides a specific driving mechanism for the spatial and temporal distributions of marine genera at regional and global scales and is consistent with the niche-breadth hypothesis operating on macroevolutionary timescales.	[Heim, Noel A.; Peters, Shanan E.] Univ Wisconsin, Dept Geosci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Heim, NA (corresponding author), Univ Wisconsin, Dept Geosci, Madison, WI 53706 USA.	nheim@wisc.edu	Peters, Shanan E/A-5620-2013; Heim, Noel/A-1497-2009; Heim, Noel A,/GRO-2700-2022	Peters, Shanan E/0000-0002-3346-4317; Heim, Noel/0000-0002-4528-345X	American Chemical Society; United States Geological Survey; National Science Foundation [EAR 0819931]; Directorate For Geosciences [0819931] Funding Source: National Science Foundation	American Chemical Society(American Chemical Society); United States Geological Survey(United States Geological Survey); National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was funded by the American Chemical Society Petroleum Research Fund, the United States Geological Survey, and The National Science Foundation EAR 0819931. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; ANDERSON S, 1994, Q REV BIOL, V69, P451, DOI 10.1086/418743; [Anonymous], 2010, R LANG ENV STAT COMP; Benton MJ, 2001, GEOL J, V36, P211, DOI 10.1002/gj.877.abs; Bivand RS, 2008, USE R, P1; Brett CE, 2007, PALAIOS, V22, P228, DOI 10.2110/palo.2005.p05-028r; Brown J. H., 1995, MACROECOLOGY; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; BURGMAN MA, 1989, AM NAT, V133, P228, DOI 10.1086/284912; Carotenuto F, 2010, PALEOBIOLOGY, V36, P399, DOI 10.1666/09059.1; CHILDS OE, 1985, AAPG BULL, V69, P173; Crampton JS, 2010, PALEOBIOLOGY, V36, P204, DOI 10.1666/09010.1; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Foote M, 2008, PALEOBIOLOGY, V34, P421, DOI 10.1666/08023.1; Gaston KJ, 1997, J ANIM ECOL, V66, P579, DOI 10.2307/5951; GASTON KJ, 1994, ECOGRAPHY, V17, P198, DOI 10.1111/j.1600-0587.1994.tb00094.x; Gaston KJ, 2003, STRUCTURE DYNAMICS G; Goldberg EE, 2005, AM NAT, V165, P623, DOI 10.1086/430012; Gregory RD, 2000, OIKOS, V88, P515, DOI 10.1034/j.1600-0706.2000.880307.x; HANSEN TA, 1980, PALEOBIOLOGY, V6, P193, DOI 10.1017/S0094837300006758; Harnik PG, 2010, P ROY SOC B-BIOL SCI, V277, P3427, DOI 10.1098/rspb.2010.0628; Heim NA, 2008, PALEOBIOLOGY, V34, P195, DOI 10.1666/0094-8373(2008)034[0195:ANBMFQ]2.0.CO;2; Heim NA, 2011, GEOL SOC AM BULL, V123, P620, DOI 10.1130/B30215.1; Hubbell Stephen P., 2001, V32, pi; Hughes JB, 2000, OECOLOGIA, V123, P375, DOI 10.1007/s004420051024; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; JABLONSKI D, 1986, SCIENCE, V231, P129, DOI 10.1126/science.231.4734.129; JABLONSKI D, 1987, SCIENCE, V238, P360, DOI 10.1126/science.238.4825.360; Jablonski D, 2003, P ROY SOC B-BIOL SCI, V270, P401, DOI 10.1098/rspb.2002.2243; Jablonski D, 2007, PALAEONTOLOGY, V50, P87, DOI 10.1111/j.1475-4983.2006.00615.x; JACKSON JBC, 1974, AM NAT, V108, P541, DOI 10.1086/282933; Jansson R, 2003, P ROY SOC B-BIOL SCI, V270, P583, DOI 10.1098/rspb.2002.2283; Kammer TW, 1997, GEOLOGY, V25, P219, DOI 10.1130/0091-7613(1997)025<0219:SLAAFO>2.3.CO;2; Kidwell SM, 2001, SCIENCE, V294, P1091, DOI 10.1126/science.1064539; Liow LH, 2007, GLOBAL ECOL BIOGEOGR, V16, P117, DOI 10.1111/j.1466-8238.2006.00269.x; MAC ARTHUR ROBERT H., 1967; Miller AI, 1997, PALEOBIOLOGY, V23, P410, DOI 10.1017/S0094837300019813; Miller AI, 2009, SCIENCE, V326, P1106, DOI 10.1126/science.1180061; Olszewski T, 1999, PALEOBIOLOGY, V25, P226, DOI 10.1017/S009483730002652X; Payne JL, 2007, P NATL ACAD SCI USA, V104, P10506, DOI 10.1073/pnas.0701257104; Peters SE, 2010, PALEOBIOLOGY, V36, P61, DOI 10.1666/0094-8373-36.1.61; Peters SE, 2006, J GEOL, V114, P391, DOI 10.1086/504176; Powell MG, 2007, PALEOBIOLOGY, V33, P530, DOI 10.1666/07011.1; Powell MG, 2009, J GEOL, V117, P585, DOI 10.1086/605777; ROY K, 1994, P NATL ACAD SCI USA, V91, P8871, DOI 10.1073/pnas.91.19.8871; Roy K, 2009, P ROY SOC B-BIOL SCI, V276, P1485, DOI 10.1098/rspb.2008.1232; RUSSELL MP, 1988, PALEOBIOLOGY, V14, P322, DOI 10.1017/S0094837300012070; SALVADOR A, 1985, AAPG BULL, V69, P181; SEPKOSKI JJ, 1981, NATURE, V293, P435, DOI 10.1038/293435a0; SEPKOSKI JJ, 1988, PALEOBIOLOGY, V14, P221, DOI 10.1017/S0094837300011969; Thornhill DJ, 2008, MOL ECOL, V17, P5104, DOI 10.1111/j.1365-294X.2008.03970.x; Tomasovych A, 2009, PALEOBIOLOGY, V35, P94, DOI 10.1666/08024.1; VERMEIJ GJ, 1987, EVOLUTION, V41, P1046, DOI 10.1111/j.1558-5646.1987.tb05875.x; Willis J.C., 1922, AGE AREA STUDY GEOGR; [No title captured]; [No title captured]	56	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e18946	10.1371/journal.pone.0018946	http://dx.doi.org/10.1371/journal.pone.0018946			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573226	Green Submitted, Green Published, gold			2022-12-27	WOS:000290224800008
J	Eshima, N; Tokumaru, O; Hara, S; Bacal, K; Korematsu, S; Tabata, M; Karukaya, S; Yasui, Y; Okabe, N; Matsuishi, T				Eshima, Nobuoki; Tokumaru, Osamu; Hara, Shohei; Bacal, Kira; Korematsu, Seigo; Tabata, Minoru; Karukaya, Shigeru; Yasui, Yoshinori; Okabe, Nobuhiko; Matsuishi, Toyojiro			Sex- and Age-Related Differences in Morbidity Rates of 2009 Pandemic Influenza A H1N1 Virus of Swine Origin in Japan	PLOS ONE			English	Article							IMMUNE-RESPONSES; UNITED-STATES; INFECTION; HUMANS; TRANSMISSION; EMERGENCE; GENDER	Background: The objective of the present study was to determine whether the morbidity rates of the 2009 pandemic influenza A H1N1 virus (pdmH1N1) varied by age and/or sex. Methods and Findings: Retrospective analysis of 2,024,367 cases of pdmH1N1 was performed using the national surveillance data from influenza sentinel points in Japan. The male-to-female morbidity ratios (M/F ratios) in nineteen age groups were estimated as the primary outcome. The M/F ratios for pdmH1N1 influenza were: >1 in age groups <20 years and >= 80 years (p<0.001); <1 in age groups 20-79 years (p<0.001). This data suggests that males <20 years of age may be more likely to suffer from pdmH1N1 influenza than females in the same age categories. When the infection pattern for pdmH1N1 was compared with that of seasonal influenza outbreaks between 2000 and 2008, the M/F ratio for pdmH1N1 influenza was higher in ages 3-29 years and lower in ages 40-79 years. Because the present study was based on the national surveillance, it was impossible to estimate the morbidity rate for the Japanese population. It is also likely that the data did not capture asymptomatic or mild infections. Conclusions: Although exposure to the pdmH1N1 virus is assumed to be similar in both boys and girls, M/F ratios were >1 in those younger than 20 years. The subsequent reversal of the M/F ratio in the adult generation could be due to several possibilities, including: greater immunity among adult males, more asymptomatic infections among males, less reporting of illness by males, or differences in exposure to the virus and probability of visiting a clinic. These results suggest that the infection and virulence patterns of pdmH1N1 are more complex than previously considered.	[Eshima, Nobuoki] Oita Univ, Fac Med, Dept Biostat, Yufu City, Oita, Japan; [Tokumaru, Osamu] Oita Univ, Fac Med, Dept Neurophysiol, Yufu City, Oita, Japan; [Hara, Shohei] Yomiuri Shimbun Osaka Newspaper, Osaka, Japan; [Bacal, Kira] Univ Auckland, Med Programme Directorate, Fac Med & Hlth Sci, Auckland 1, New Zealand; [Korematsu, Seigo] Oita Univ, Fac Med, Dept Pediat, Yufu City, Oita, Japan; [Tabata, Minoru] Osaka Prefecture Univ, Dept Math Sci, Grad Sch Engn, Sakai, Osaka 591, Japan; [Karukaya, Shigeru; Matsuishi, Toyojiro] Kurume Univ, Sch Med, Dept Pediat, Kurume, Fukuoka 830, Japan; [Yasui, Yoshinori; Okabe, Nobuhiko] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan	Oita University; Oita University; University of Auckland; Oita University; Osaka Metropolitan University; Kurume University; National Institute of Infectious Diseases (NIID)	Eshima, N (corresponding author), Oita Univ, Fac Med, Dept Biostat, Yufu City, Oita, Japan.	ostokuma@oita-u.ac.jp	Tokumaru, Osamu/AAN-3055-2020; Tabata, Minoru/X-5682-2018	Tabata, Minoru/0000-0003-3876-7437	Japan Ministry of Education, Culture, Sports, Science and Technology [22500260]; Grants-in-Aid for Scientific Research [22500260] Funding Source: KAKEN	Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded in part by a Grant-in-Aid for Scientific Research (C) #22500260 to NE from the Japan Ministry of Education, Culture, Sports, Science and Technology (www.jsps.go.jp/english/e-grants/grants.html). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carr MJ, 2009, J CLIN VIROL, V45, P196, DOI 10.1016/j.jcv.2009.06.001; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Ding N, 2009, VIRUS GENES, V39, P293, DOI 10.1007/s11262-009-0393-7; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; Engler RJM, 2008, ARCH INTERN MED, V168, P2405, DOI 10.1001/archinternmed.2008.513; Eshima N, 2009, J CLIN VIROL, V45, P135, DOI 10.1016/j.jcv.2009.03.012; Faix DJ, 2009, NEW ENGL J MED, V361, P728, DOI 10.1056/NEJMc0904264; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Glezen WP, 2006, J CLIN VIROL, V37, P237, DOI 10.1016/j.jcv.2006.08.020; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Klein SL, 2010, LANCET INFECT DIS, V10, P338, DOI 10.1016/S1473-3099(10)70049-9; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; May RC, 2007, BIOESSAYS, V29, P795, DOI 10.1002/bies.20614; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; MIYOSHI I, 1981, NATURE, V294, P770, DOI 10.1038/294770a0; Noymer A, 2000, POPUL DEV REV, V26, P565, DOI 10.1111/j.1728-4457.2000.00565.x; Odaira F, 2009, EURO SURVEILL, V14; Peiris JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/j.jcv.2009.06.006; Picone O, 2005, PRENATAL DIAG, V25, P34, DOI 10.1002/pd.944; Sikora C, 2010, J CLIN VIROL, V49, P90, DOI 10.1016/j.jcv.2010.06.015; Stensballe L, 2004, SCAND J INFECT DIS, V36, P291, DOI 10.1080/00365540410019589; Wang TE, 2010, EPIDEMIOLOGY, V21, P726, DOI 10.1097/EDE.0b013e3181e94274; *WHO DEP GEND WOM, 2007, ADDR SEX GEND EP PRO; World Health Organaization, 2009, WKLY EPIDEMIOLOGICAL, V84, P249; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	26	49	50	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19409	10.1371/journal.pone.0019409	http://dx.doi.org/10.1371/journal.pone.0019409			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559366	gold, Green Submitted, Green Published			2022-12-27	WOS:000290024700160
J	Gilbert, AE; Karagiannis, P; Dodev, T; Koers, A; Lacy, K; Josephs, DH; Takhar, P; Geh, JLC; Healy, C; Harries, M; Acland, KM; Rudman, SM; Beavil, RL; Blower, PJ; Beavil, AJ; Gould, HJ; Spicer, J; Nestle, FO; Karagiannis, SN				Gilbert, Amy E.; Karagiannis, Panagiotis; Dodev, Tihomir; Koers, Alexander; Lacy, Katie; Josephs, Debra H.; Takhar, Pooja; Geh, Jenny L. C.; Healy, Ciaran; Harries, Mark; Acland, Katharine M.; Rudman, Sarah M.; Beavil, Rebecca L.; Blower, Philip J.; Beavil, Andrew J.; Gould, Hannah J.; Spicer, James; Nestle, Frank O.; Karagiannis, Sophia N.			Monitoring the Systemic Human Memory B Cell Compartment of Melanoma Patients for Anti-Tumor IgG Antibodies	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; METASTATIC MELANOMA; BREAST-CANCER; T-CELLS; RESPONSES; ANTIGENS; IMMUNOTHERAPY; MECHANISMS; MULTIPLE; SURVIVAL	Melanoma, a potentially lethal skin cancer, is widely thought to be immunogenic in nature. While there has been much focus on T cell-mediated immune responses, limited knowledge exists on the role of mature B cells. We describe an approach, including a cell-based ELISA, to evaluate mature IgG antibody responses to melanoma from human peripheral blood B cells. We observed a significant increase in antibody responses from melanoma patients (n = 10) to primary and metastatic melanoma cells compared to healthy volunteers (n = 10) (P < 0.0001). Interestingly, we detected a significant reduction in antibody responses to melanoma with advancing disease stage in our patient cohort (n = 21) (P < 0.0001). Overall, 28% of melanoma patient-derived B cell cultures (n = 1,800) compared to 2% of cultures from healthy controls (n = 600) produced antibodies that recognized melanoma cells. Lastly, a patient-derived melanoma-specific monoclonal antibody was selected for further study. This antibody effectively killed melanoma cells in vitro via antibody-mediated cellular cytotoxicity. These data demonstrate the presence of a mature systemic B cell response in melanoma patients, which is reduced with disease progression, adding to previous reports of tumor-reactive antibodies in patient sera, and suggesting the merit of future work to elucidate the clinical relevance of activating humoral immune responses to cancer.	[Gilbert, Amy E.; Karagiannis, Panagiotis; Lacy, Katie; Josephs, Debra H.; Nestle, Frank O.; Karagiannis, Sophia N.] Kings Coll London, Cutaneous Med & Immunotherapy Unit, Div Genet & Mol Med, NIHR Biomed Res Ctr Guys & St Thomass Hosp, London WC2R 2LS, England; [Gilbert, Amy E.; Karagiannis, Panagiotis; Lacy, Katie; Josephs, Debra H.; Nestle, Frank O.; Karagiannis, Sophia N.] Kings Coll London, Sch Med, St Johns Inst Dermatol, Guys Hosp, London WC2R 2LS, England; [Dodev, Tihomir; Takhar, Pooja; Beavil, Rebecca L.; Beavil, Andrew J.; Gould, Hannah J.] Kings Coll London, Randall Div Cell & Mol Biophys, MRC & Asthma UK Ctr Allerg Mech Asthma, London WC2R 2LS, England; [Dodev, Tihomir; Takhar, Pooja; Beavil, Rebecca L.; Beavil, Andrew J.; Gould, Hannah J.] Kings Coll London, Div Asthma Allergy & Lung Biol, MRC & Asthma UK Ctr Allerg Mech Asthma, London WC2R 2LS, England; [Koers, Alexander; Blower, Philip J.] Kings Coll London, Div Imaging Sci, Sch Med, Rayne Inst,St Thomass Hosp, London WC2R 2LS, England; [Geh, Jenny L. C.; Healy, Ciaran; Acland, Katharine M.] Guys Hosp, Skin Tumour Unit, Guys & St Thomass NHS Trust, St Johns Inst Dermatol, London SE1 9RT, England; [Harries, Mark] Guys & St Thomass NHS Fdn Trust, London, England; [Rudman, Sarah M.; Spicer, James] Kings Coll London, Guys Hosp, Div Canc Studies, Dept Acad Oncol, London WC2R 2LS, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Gilbert, AE (corresponding author), Kings Coll London, Cutaneous Med & Immunotherapy Unit, Div Genet & Mol Med, NIHR Biomed Res Ctr Guys & St Thomass Hosp, London WC2R 2LS, England.	frank.nestle@kcl.ac.uk; sophia.karagiannis@kcl.ac.uk	Karagiannis, Sophia/H-1097-2011; Geh, Jenny/F-1031-2018; Blower, Phil/GSD-5552-2022	Karagiannis, Sophia/0000-0002-4100-7810; Geh, Jenny/0000-0001-7031-3844; Beavil, Andrew/0000-0002-0768-122X; Blower, Philip/0000-0001-6290-1590; Spicer, James/0000-0003-3732-8491; Gould, Hannah/0000-0003-0411-688X; Karagiannis, Panagiotis/0000-0001-6459-7561	Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; St. Thomas's NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust, UK; CR UK/EPSRC/MRC/NIHR KCL/UCL Comprehensive Cancer Imaging Centre [C1519/A10331]; Cancer Research UK [C30122/A11527]; Mary Dunhill Trust; CR UK/NIHR in England/DoH for Scotland; Wales and Northern Ireland Experimental Cancer Medicine Centre (FON); Overseas Research Students Award Scheme (AEG); MRC [G0501494] Funding Source: UKRI; Medical Research Council [G1000758B, G0501494, G1000758, G0600698B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish	Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); St. Thomas's NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust, UK; CR UK/EPSRC/MRC/NIHR KCL/UCL Comprehensive Cancer Imaging Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Cancer Research UKEngineering & Physical Sciences Research Council (EPSRC)); Cancer Research UK(Cancer Research UK); Mary Dunhill Trust(Dunhill Medical Trust); CR UK/NIHR in England/DoH for Scotland(Cancer Research UK); Wales and Northern Ireland Experimental Cancer Medicine Centre (FON); Overseas Research Students Award Scheme (AEG); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's, and St. Thomas's NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust, UK (AEG, PK, TD, AK, KL, PT, FON, SNK) (http://www.guysandstthomas.nhs.uk/healthprof/researchanddevelopment/biomedicalresearch/biomedhome.aspx); CR UK/EPSRC/MRC/NIHR KCL/UCL Comprehensive Cancer Imaging Centre (C1519/A10331) (DHJ, PJB, JS, SNK) (http://www.cancerimagingcentre.org.uk/); Cancer Research UK (C30122/A11527) (DHJ) (http://www.cancerresearchuk.org/); Mary Dunhill Trust (FON) (http://www.dunhillmedical.org.uk/page_viewer.asp?page=welcome & pid=8); CR UK/NIHR in England/DoH for Scotland, Wales and Northern Ireland Experimental Cancer Medicine Centre (FON) (http://www.ecmcnetwork.org.uk/network-centres/london-kcl/); and the Overseas Research Students Award Scheme (AEG) (http://www.orsas.ac.uk/). The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Andreu P, 2010, CANCER CELL, V17, P121, DOI 10.1016/j.ccr.2009.12.019; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Besser MJ, 2010, CLIN CANCER RES, V16, P2646, DOI 10.1158/1078-0432.CCR-10-0041; Bouaziz J-D, EUROPEAN J IMMUNOLOG, V40, P2686; CAI XH, 1995, P NATL ACAD SCI USA, V92, P6537, DOI 10.1073/pnas.92.14.6537; Campoli MR, 2004, CRITICAL REV IMMUNOL, V24, P30; Carpenter EL, 2009, CLIN CANCER RES, V15, P4277, DOI 10.1158/1078-0432.CCR-09-0537; Chen YT, 1998, P NATL ACAD SCI USA, V95, P6919, DOI 10.1073/pnas.95.12.6919; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Cummins DL, 2006, MAYO CLIN PROC, V81, P500, DOI 10.4065/81.4.500; DiLillo DJ, 2010, J IMMUNOL, V184, P4006, DOI 10.4049/jimmunol.0903009; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Glennie MJ, 2007, MOL IMMUNOL, V44, P3823, DOI 10.1016/j.molimm.2007.06.151; Gril B, 2008, JNCI-J NATL CANCER I, V100, P1092, DOI 10.1093/jnci/djn216; Hodi FS, 2006, CLIN CANCER RES, V12, P673, DOI 10.1158/1078-0432.CCR-05-2616; Hodi FS, N ENGL J MED, V363, P711; Houghton AN, 2001, CURR OPIN IMMUNOL, V13, P134, DOI 10.1016/S0952-7915(00)00195-3; Huang SKS, 1998, J INVEST DERMATOL, V111, P662, DOI 10.1046/j.1523-1747.1998.00354.x; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Kalialis LV, 2009, MELANOMA RES, V19, P275, DOI 10.1097/CMR.0b013e32832eabd5; Karagiannis P, 2009, CANCER IMMUNOL IMMUN, V58, P915, DOI 10.1007/s00262-008-0607-1; Karagiannis SN, 2003, EUR J IMMUNOL, V33, P1030, DOI 10.1002/eji.200323185; Karagiannis SN, 2007, J IMMUNOL, V179, P2832, DOI 10.4049/jimmunol.179.5.2832; KIRKWOOD JM, 1990, CANCER IMMUNOL IMMUN, V32, P228, DOI 10.1007/BF01741705; Kirkwood JM, 2006, CLIN CANCER RES, V16, P1042; Kirkwood JM, 2008, J CLIN ONCOL, V26, P3445, DOI 10.1200/JCO.2007.14.6423; Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071; Lanzavecchia A, 2007, CURR OPIN BIOTECH, V18, P523, DOI 10.1016/j.copbio.2007.10.011; Lee PP, 1999, NAT MED, V5, P677, DOI 10.1038/9525; Lens MB, 2004, BRIT J DERMATOL, V150, P179, DOI 10.1111/j.1365-2133.2004.05708.x; LEWIS MG, 1969, BMJ-BRIT MED J, V3, P547, DOI 10.1136/bmj.3.5670.547; Marincola FM, 2003, TRENDS IMMUNOL, V24, P335, DOI 10.1016/S1471-4906(03)00116-9; MITTELMAN A, 1992, P NATL ACAD SCI USA, V89, P466, DOI 10.1073/pnas.89.2.466; Nestle FO, 2007, DERMATOLOGY; Perez DG, 2009, CANCER-AM CANCER SOC, V115, P119, DOI 10.1002/cncr.23987; Pinna D, 2009, EUR J IMMUNOL, V39, P1260, DOI 10.1002/eji.200839129; PUNT CJA, 1994, CANCER IMMUNOL IMMUN, V38, P225, DOI 10.1007/s002620050058; Qin ZH, 1998, NAT MED, V4, P627, DOI 10.1038/nm0598-627; Restifo NP, 1996, J NATL CANCER I, V88, P100, DOI 10.1093/jnci/88.2.100; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; SAHIN U, 1995, P NATL ACAD SCI USA, V92, P11810, DOI 10.1073/pnas.92.25.11810; Schadendorf D, 2006, ANN ONCOL, V17, P563, DOI 10.1093/annonc/mdj138; Schadendorf D, 2009, ANN ONCOL, V20, P41, DOI 10.1093/annonc/mdp253; Shimbo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010566; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Stockert E, 1998, J EXP MED, V187, P1349, DOI 10.1084/jem.187.8.1349; Stove C, 2003, J INVEST DERMATOL, V121, P802, DOI 10.1046/j.1523-1747.2003.12522.x; Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405; Takahashi T, 1999, J INVEST DERMATOL, V112, P205, DOI 10.1046/j.1523-1747.1999.00493.x; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Vajdic CM, 2009, CANCER EPIDEM BIOMAR, V18, P2297, DOI 10.1158/1055-9965.EPI-09-0278; Vence L, 2007, P NATL ACAD SCI USA, V104, P20884, DOI 10.1073/pnas.0710557105; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Wewetzer K, 1996, J IMMUNOL METHODS, V191, P171, DOI 10.1016/0022-1759(96)00018-X; Wistuba II, 1999, CLIN CANCER RES, V5, P991; YAMAGUCHI H, 1987, P NATL ACAD SCI USA, V84, P2416, DOI 10.1073/pnas.84.8.2416; YEILDING NM, 1992, INT J CANCER, V52, P967, DOI 10.1002/ijc.2910520623; Yuan JD, 2008, P NATL ACAD SCI USA, V105, P20410, DOI 10.1073/pnas.0810114105; ZHANG H, 1995, CANCER RES, V55, P3584	60	48	50	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19330	10.1371/journal.pone.0019330	http://dx.doi.org/10.1371/journal.pone.0019330			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559411	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700139
J	Inbar, S; Neeman, E; Avraham, R; Benish, M; Rosenne, E; Ben-Eliyahu, S				Inbar, Shelly; Neeman, Elad; Avraham, Roi; Benish, Marganit; Rosenne, Ella; Ben-Eliyahu, Shamgar			Do Stress Responses Promote Leukemia Progression? An Animal Study Suggesting a Role for Epinephrine and Prostaglandin-E-2 through Reduced NK Activity	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; ENDOTHELIAL GROWTH-FACTOR; ACUTE MYELOID-LEUKEMIA; PROSTATE-CANCER CELLS; CHRONIC LYMPHOCYTIC-LEUKEMIA; BETA-ADRENERGIC ANTAGONIST; CLASS-I MOLECULES; QUALITY-OF-LIFE; TUMOR-METASTASIS; SIGNAL-TRANSDUCTION	In leukemia patients, stress and anxiety were suggested to predict poorer prognosis. Oncological patients experience ample physiological and psychological stress, potentially leading to increased secretion of stress factors, including epinephrine, corticosteroids, and prostaglandins. Here we tested whether environmental stress and these stress factors impact survival of leukemia-challenged rats, and studied mediating mechanisms. F344 rats were administered with a miniscule dose of 60 CRNK-16 leukemia cells, and were subjected to intermittent forced swim stress or to administration of physiologically relevant doses of epinephrine, prostaglandin-E-2 or corticosterone. Stress and each stress factor, and/or their combinations, doubled mortality rates when acutely applied simultaneously with, or two or six days after tumor challenge. Acute administration of the beta-adrenergic blocker nadolol diminished the effects of environmental stress, without affecting baseline survival rates. Prolonged beta-adrenergic blockade or COX inhibition (using etodolac) also increased baseline survival rates, possibly by blocking tumor-related or normal levels of catecholamines and prostaglandins. Searching for mediating mechanisms, we found that each of the stress factors transiently suppressed NK activity against CRNK-16 and YAC-1 lines on a per NK basis. In contrast, the direct effects of stress factors on CRNK-16 proliferation, vitality, and VEGF secretion could not explain or even contradicted the in vivo survival findings. Overall, it seems that environmental stress, epinephrine, and prostaglandins promote leukemia progression in rats, potentially through suppressing cell mediated immunity. Thus, patients with hematological malignancies, which often exhibit diminished NK activity, may benefit from extended beta-blockade and COX inhibition.	[Inbar, Shelly; Neeman, Elad; Avraham, Roi; Benish, Marganit; Rosenne, Ella; Ben-Eliyahu, Shamgar] Tel Aviv Univ, Dept Psychol, Neuroimmunol Res Unit, IL-69978 Tel Aviv, Israel	Tel Aviv University	Inbar, S (corresponding author), Tel Aviv Univ, Dept Psychol, Neuroimmunol Res Unit, IL-69978 Tel Aviv, Israel.	shamgar@post.tau.ac.il	Ben-Eliyahu, Shamgar/AAE-5444-2020	Ben-Eliyahu, Shamgar/0000-0003-3832-0678; Avraham, Roi/0000-0002-9098-3885	National Institutes of Health/National Cancer Institute (NIH/NCI) [CA125456]; Israel-USA bi-national Science Foundation [2005331]; NATIONAL CANCER INSTITUTE [R01CA125456] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute (NIH/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Israel-USA bi-national Science Foundation(US-Israel Binational Science Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health/National Cancer Institute (NIH/NCI) grant # CA125456 (SBE), and a grant from the Israel-USA bi-national Science Foundation # 2005331 (SBE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algarra I, 1997, INT J CLIN LAB RES, V27, P95, DOI 10.1007/BF02912442; Antoni MH, 2006, NAT REV CANCER, V6, P240, DOI 10.1038/nrc1820; Avraham R, 2006, CANCER IMMUNOL IMMUN, V55, P1348, DOI 10.1007/s00262-006-0139-5; Avraham R, 2010, BRAIN BEHAV IMMUN, V24, P952, DOI 10.1016/j.bbi.2010.03.010; BARLOZZARI T, 1985, J IMMUNOL, V134, P2783; BAXEVANIS CN, 1993, CANCER-AM CANCER SOC, V72, P491, DOI 10.1002/1097-0142(19930715)72:2<491::AID-CNCR2820720227>3.0.CO;2-1; Beglinger LJ, 2007, J INT NEUROPSYCH SOC, V13, P172, DOI 10.1017/S1355617707070208; Ben-Eliyahu S, 1999, INT J CANCER, V80, P880; BenEliyahu S, 1996, NAT MED, V2, P457, DOI 10.1038/nm0496-457; BENELIYAHU S, 1991, BRAIN BEHAV IMMUN, V5, P193, DOI 10.1016/0889-1591(91)90016-4; BENELIYAHU S, 2007, BRAIN BEHAV IMMUN; Benish M, 2008, ANN SURG ONCOL, V15, P2042, DOI 10.1245/s10434-008-9890-5; BERKELHAMMER J, 1982, CANCER RES, V42, P3157; Binstadt BA, 1997, IMMUNOL REV, V155, P197, DOI 10.1111/j.1600-065X.1997.tb00952.x; Burshtyn DN, 1996, IMMUNITY, V4, P77, DOI 10.1016/S1074-7613(00)80300-3; Calcagni E, 2006, ANN NY ACAD SCI, V1069, P62, DOI 10.1196/annals.1351.006; CALLEWAERT DM, 1991, FEBS LETT, V285, P108, DOI 10.1016/0014-5793(91)80736-M; Chakraborti AK, 2010, CURR MED CHEM, V17, P1563, DOI 10.2174/092986710790979980; CHAMBERS WH, 1992, J IMMUNOL, V148, P3658; COLON EA, 1991, PSYCHOSOMATICS, V32, P420, DOI 10.1016/S0033-3182(91)72045-8; Costello RT, 2002, BLOOD, V99, P3661, DOI 10.1182/blood.V99.10.3661; CRARY B, 1983, J IMMUNOL, V131, P1178; DHABHAR F, 1996, J IMMUNOL, V15, P1638; Dhabhar FS, 2010, BRAIN BEHAV IMMUN, V24, P127, DOI 10.1016/j.bbi.2009.09.004; Dhabhar FS, 2003, ANN NY ACAD SCI, V992, P205, DOI 10.1111/j.1749-6632.2003.tb03151.x; Dunn AJ, 2000, ANN NY ACAD SCI, V917, P608, DOI 10.1111/j.1749-6632.2000.tb05426.x; Elenkov IJ, 2006, NEUROIMMUNOMODULAT, V13, P257, DOI 10.1159/000104853; Fehder W P, 1999, CRNA, V10, P124; GIGUERE V, 1983, BIOCHEM BIOPH RES CO, V110, P456, DOI 10.1016/0006-291X(83)91171-3; Glasner A, 2010, J IMMUNOL, V184, P2449, DOI 10.4049/jimmunol.0903301; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Grulke N, 2005, BONE MARROW TRANSPL, V35, P1107, DOI 10.1038/sj.bmt.1704971; Haim S, 2003, J ENDOCRINOL INVEST, V26, P1013, DOI 10.1007/BF03348201; HUCKER HB, 1996, PHARM EXPT THERAPEUT, V153, P237; Jetschmann JU, 1997, J NEUROIMMUNOL, V74, P159, DOI 10.1016/S0165-5728(96)00221-4; Karre K, 2002, SCAND J IMMUNOL, V55, P221, DOI 10.1046/j.1365-3083.2002.01053.x; Karre K, 2002, SCIENCE, V295, P2029, DOI 10.1126/science.1070538; Kiecolt-Glaser JK, 2002, J PSYCHOSOM RES, V53, P873, DOI 10.1016/S0022-3999(02)00309-4; Kishikawa H, 1997, TOXICOL APPL PHARM, V147, P180, DOI 10.1006/taap.1997.8308; KUMAR V, 1979, J IMMUNOL, V123, P1832; LANDMANN R, 1992, EUR J CLIN INVEST, V22, P30; Leibson PJ, 1997, IMMUNITY, V6, P655, DOI 10.1016/S1074-7613(00)80441-0; Letilovic T, 2006, CANCER-AM CANCER SOC, V107, P925, DOI 10.1002/cncr.22086; LEUNG KH, 1984, J IMMUNOL, V132, P1445; Levin TT, 2007, GEN HOSP PSYCHIAT, V29, P251, DOI 10.1016/j.genhosppsych.2007.01.014; LIPPMAN M, 1976, CANCER RES, V36, P4602; Lowdell MW, 2002, BRIT J HAEMATOL, V117, P821, DOI 10.1046/j.1365-2141.2002.03495.x; Lutgendorf SK, 2000, CANCER, V89, P1402, DOI 10.1002/1097-0142(20000915)89:6<1402::AID-CNCR26>3.3.CO;2-8; Lutgendorf SK, 2003, CLIN CANCER RES, V9, P4514; Ma WY, 2008, NEUROSCI LETT, V437, P165, DOI 10.1016/j.neulet.2008.02.072; Melamed R, 2005, BRAIN BEHAV IMMUN, V19, P114, DOI 10.1016/j.bbi.2004.07.004; Menetrier-Caux C, 1999, BRIT J CANCER, V79, P119, DOI 10.1038/sj.bjc.6690021; Montgomery C, 2003, J PSYCHOSOM RES, V54, P289, DOI 10.1016/S0022-3999(02)00396-3; Nance DM, 2007, BRAIN BEHAV IMMUN, V21, P736, DOI 10.1016/j.bbi.2007.03.008; Nieborowska-Skorska M, 2006, CANCER RES, V66, P4108, DOI 10.1158/0008-5472.CAN-05-1584; Nielsen NR, 2008, J INTERN MED, V263, P192, DOI 10.1111/j.1365-2796.2007.01826.x; Page GG, 2008, J NEUROIMMUNOL, V193, P113, DOI 10.1016/j.jneuroim.2007.10.023; PAGE GG, 1994, BRAIN BEHAV IMMUN, V8, P241, DOI 10.1006/brbi.1994.1022; PARK PG, 1995, CANCER RES, V55, P3504; PAWELEC G, 1995, LEUKEMIA LYMPHOMA, V18, P471, DOI 10.3109/10428199509059647; Pierson BA, 1996, BLOOD, V88, P2279, DOI 10.1182/blood.V88.6.2279.bloodjournal8862279; Prieto JM, 2005, J CLIN ONCOL, V23, P6063, DOI 10.1200/JCO.2005.05.751; Rasmussen HN, 2009, ANN BEHAV MED, V37, P239, DOI 10.1007/s12160-009-9111-x; Reiche EMV, 2004, LANCET ONCOL, V5, P617, DOI 10.1016/S1470-2045(04)01597-9; Rettori V, 2009, ANN NY ACAD SCI, V1153, P35, DOI 10.1111/j.1749-6632.2008.03968.x; REYNOLDS CW, 1984, J IMMUNOL, V132, P534; Rolstad B, 2001, IMMUNOL REV, V181, P149, DOI 10.1034/j.1600-065X.2001.1810112.x; Ryan JC, 2000, METH MOL B, V121, P283; Sanders VM, 1995, ADV NEUROIMMUNOL, V5, P283, DOI 10.1016/0960-5428(95)00019-X; Saul AN, 2005, JNCI-J NATL CANCER I, V97, P1760, DOI 10.1093/jnci/dji401; SCHMID I, 1992, CYTOMETRY, V13, P204, DOI 10.1002/cyto.990130216; Schuch G, 2002, BLOOD, V100, P4622, DOI 10.1182/blood.V100.13.4622; Shakhar G, 1998, J IMMUNOL, V160, P3251; Shakhar G, 2003, J NEUROIMMUNOL, V138, P83, DOI 10.1016/S0165-5728(03)00118-8; Shakhar G, 2007, ANN SURG ONCOL, V14, P841, DOI 10.1245/s10434-006-9078-9; Shang ZJ, 2009, J ORAL PATHOL MED, V38, P371, DOI 10.1111/j.1600-0714.2008.00691.x; SIMON WE, 1984, JNCI-J NATL CANCER I, V73, P313, DOI 10.1093/jnci/73.2.313; Sood AK, 2006, CLIN CANCER RES, V12, P369, DOI 10.1158/1078-0432.CCR-05-1698; Sood AK, 2010, J CLIN INVEST, V120, P1515, DOI 10.1172/JCI40802; Specht C, 2001, INT J CANCER, V91, P705, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1066>3.0.CO;2-J; Steiner K, 2006, LEUKEMIA, V20, P2076, DOI 10.1038/sj.leu.2404391; Tajima F, 1996, LEUKEMIA, V10, P478; TALMADGE JE, 1982, J NATL CANCER I, V69, P975; TOFT P, 1992, APMIS, V100, P593, DOI 10.1111/j.1699-0463.1992.tb03971.x; Uotila P, 1996, CANCER IMMUNOL IMMUN, V43, P1; Vazquez S, 2006, CANCER CHEMOTH PHARM, V58, P50, DOI 10.1007/s00280-005-0130-4; WojtowiczPraga S, 1997, J IMMUNOTHER, V20, P165, DOI 10.1097/00002371-199705000-00001; Wong HPS, 2009, DIGESTION, V80, P209, DOI 10.1159/000231898; Xie YF, 2002, IMMUNOBIOLOGY, V206, P345, DOI 10.1078/0171-2985-00185; Yakar I, 2003, ANN SURG ONCOL, V10, P469, DOI 10.1245/ASO.2003.08.017; Yang EV, 2006, CANCER RES, V66, P10357, DOI 10.1158/0008-5472.CAN-06-2496; Yang EV, 2009, BRAIN BEHAV IMMUN, V23, P267, DOI 10.1016/j.bbi.2008.10.005; Yano A, 2006, CLIN CANCER RES, V12, P6012, DOI 10.1158/1078-0432.CCR-06-0749; Yano A, 2006, CLIN CANCER RES, V12, P3003, DOI 10.1158/1078-0432.CCR-05-2085; Zhao XY, 2000, NAT MED, V6, P703, DOI 10.1038/76287	95	80	81	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19246	10.1371/journal.pone.0019246	http://dx.doi.org/10.1371/journal.pone.0019246			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559428	gold, Green Submitted, Green Published			2022-12-27	WOS:000290024700110
J	Panasiti, MS; Pavone, EF; Merla, A; Aglioti, SM				Panasiti, Maria Serena; Pavone, Enea Francesco; Merla, Arcangelo; Aglioti, Salvatore Maria			Situational and Dispositional Determinants of Intentional Deceiving	PLOS ONE			English	Article							EVERYDAY LIFE; GAME; DISHONESTY; DECEPTION; PERSONALITY; COOPERATION; PUNISHMENT; MOTIVATION; RESPONSES; EVOLUTION	Does opportunity make the thief or are people dispositionally prone to deceive? The interaction between personality and the circumstances surrounding deception is crucial to understand what promotes dishonesty in our society. Due to its inherent spontaneity and sociality, deceptive behaviour may be hardly reproducible in experimental settings. We developed a novel paradigm in the form of an interactive game where participants can choose whether to lie to another person in situations of loss vs. gain, and of no-reputation-risk vs. reputation-risk linked to the disclosure of their deceptive behaviour to others. Thus, our ecological paradigm allowed subjects to spontaneously decide when to lie and face the challenge of deceiving others. In the case of loss, participants lied to reverse the outcome in their favour. Deception was lower in the reputation-risk condition where personality traits concerning social interactions also played an important role. The results suggest that deception is definitely promoted by unfavourable events, and that maintaining one's own reputation encourages honesty, particularly in socially inclined individuals.	[Panasiti, Maria Serena; Pavone, Enea Francesco; Aglioti, Salvatore Maria] Univ Roma La Sapienza, Dept Psychol, Rome, Italy; [Panasiti, Maria Serena; Pavone, Enea Francesco; Aglioti, Salvatore Maria] IRCCS Santa Lucia Fdn, Rome, Italy; [Merla, Arcangelo] Univ G DAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [Merla, Arcangelo] Univ G DAnnunzio, Inst Adv Biomed Technol, Chieti, Italy	Sapienza University Rome; IRCCS Santa Lucia; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Panasiti, MS (corresponding author), Univ Roma La Sapienza, Dept Psychol, Rome, Italy.	mariaserena.panasiti@uniroma1.it; salvatoremaria.aglioti@uniroma1.it	Panasiti, Maria Serena/J-5893-2016; Aglioti, Salvatore M/E-9829-2012	Panasiti, Maria Serena/0000-0002-3149-8855; Pavone, Enea Francesco/0000-0002-8263-3594; Aglioti, Salvatore Maria/0000-0001-8175-7563	Ministero Istruzione Universita e Ricerca; Sapienza University of Rome; IRCCS Fondazione Santa Lucia, Rome	Ministero Istruzione Universita e Ricerca(Ministry of Education, Universities and Research (MIUR)); Sapienza University of Rome; IRCCS Fondazione Santa Lucia, Rome	S.M.A. is funded by Ministero Istruzione Universita e Ricerca (Progetti di Ricerca di Interesse Nazionale, PRIN), Sapienza University of Rome and by IRCCS Fondazione Santa Lucia, Rome. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio DM, 2006, SOC COGN AFFECT NEUR, V1, P26, DOI 10.1093/scan/nsl002; Bandura A., 1986, SOCIAL FDN THOUGHT A; Blanchard EA, 1991, PSYCHOL SCI, V2, P101; Caprara G. V., 2005, RICERCHE PSICOLOGIA, V28, P67; Christie R., 1970, STUDIES MACHIAVELLIA; Cloninger C. R., 1994, TEMPERAMENT CHARACTE; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; DePaulo BM, 1996, J PERS SOC PSYCHOL, V70, P979, DOI 10.1037/0022-3514.70.5.979; Dunton BC, 1997, PERS SOC PSYCHOL B, V23, P316, DOI 10.1177/0146167297233009; Ganis G, 2009, SOC NEUROSCI, V4, P465, DOI 10.1080/17470910802507660; Gino F, 2009, PSYCHOL SCI, V20, P1153, DOI 10.1111/j.1467-9280.2009.02421.x; Gozna LF, 2001, PERS INDIV DIFFER, V31, P1203, DOI 10.1016/S0191-8869(00)00219-1; Greene JD, 2009, P NATL ACAD SCI USA, V106, P12506, DOI 10.1073/pnas.0900152106; Haley KJ, 2005, EVOL HUM BEHAV, V26, P245, DOI 10.1016/j.evolhumbehav.2005.01.002; Helbing D, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/083005; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Izuma K, 2008, NEURON, V58, P284, DOI 10.1016/j.neuron.2008.03.020; Kashy DA, 1996, J PERS SOC PSYCHOL, V70, P1037, DOI 10.1037/0022-3514.70.5.1037; Kurzban R, 2007, EVOL HUM BEHAV, V28, P75, DOI 10.1016/j.evolhumbehav.2006.06.001; Mazar N, 2008, J MARKETING RES, V45, P633, DOI 10.1509/jmkr.45.6.633; McLeod BA, 2008, PERS INDIV DIFFER, V45, P591, DOI 10.1016/j.paid.2008.06.015; Mead NL, 2009, J EXP SOC PSYCHOL, V45, P594, DOI 10.1016/j.jesp.2009.02.004; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Monteith MJ, 1996, BASIC APPL SOC PSYCH, V18, P267, DOI 10.1207/s15324834basp1803_2; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Nyberg D., 1993, VANISHED TRUTH TRUTH; Paulhus D. L., 1998, MANUAL PAULHUS DECEP; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Plant EA, 1998, J PERS SOC PSYCHOL, V75, P811, DOI 10.1037/0022-3514.75.3.811; Seth AK, 2006, NEUROIMAGE, V32, P465, DOI 10.1016/j.neuroimage.2006.02.050; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; Sip KE, 2008, TRENDS COGN SCI, V12, P48, DOI 10.1016/j.tics.2007.11.008; Sip KE, 2010, NEUROPSYCHOLOGIA, V48, P3619, DOI 10.1016/j.neuropsychologia.2010.08.013; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003	36	22	22	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19465	10.1371/journal.pone.0019465	http://dx.doi.org/10.1371/journal.pone.0019465			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	756OZ	21559381	gold, Green Published			2022-12-27	WOS:000290024700187
J	Wikman, A; Wardle, J; Steptoe, A				Wikman, Anna; Wardle, Jane; Steptoe, Andrew			Quality of Life and Affective Well-Being in Middle-Aged and Older People with Chronic Medical Illnesses: A Cross-Sectional Population Based Study	PLOS ONE			English	Article							FUNCTIONAL IMPAIRMENT; CANCER-PATIENTS; RESPONSE SHIFT; HEART-FAILURE; MENTAL-HEALTH; DEPRESSION; DISEASE; MORTALITY; QUESTIONNAIRE; METAANALYSIS	Background: There has been considerable research into the impact of chronic illness on health-related quality of life. However, few studies have assessed the impact of different chronic conditions on general quality of life (QOL). The objective of this paper was to compare general (rather than health-related) QOL and affective well-being in middle aged and older people across eight chronic illnesses. Methods and Findings: This population-based, cross-sectional study involved 11,523 individuals aged 50 years and older, taking part in wave 1 of the English Longitudinal Study of Ageing. General QOL was assessed using the CASP-19, happiness was evaluated using two items drawn from the GHQ-12, and depression was measured with the CES-D. Analysis of covariance and logistic regression, adjusting for age, gender and wealth, were performed. General QOL was most impaired in people with stroke (mean 37.56, CI 36.73-38.39), and least in those reporting cancer (mean 41.78, CI 41.12-42.44, respectively), compared with no illness (mean 44.15, CI 43.92-44.39). Stroke (mean 3.65, CI 3.58-3.73) was also associated with the greatest reduction in positive well-being whereas diabetes (mean 3.81, CI 3.76-3.86) and cancer were least affected (3.85, CI 3.79-3.91), compared with no illness (mean 3.97, CI 3.95-4.00). Depression was significantly elevated in all conditions, but was most common in chronic lung disease (OR 3.04, CI 2.56-3.61), with more modest elevations in those with osteoarthritis (OR 2.08, CI 1.84-2.34) or cancer (OR 2.07, CI 1.69-2.54). Multiple co-morbidities were associated with greater decrements in QOL and affective well-being. Conclusion: The presence of chronic illness is associated with impairments in broader aspects of QOL and affective wellbeing, but different conditions vary in their impact. Further longitudinal work is needed to establish the temporal links between chronic illness and impairments in QOL and affective well-being.	[Wikman, Anna; Steptoe, Andrew] UCL, Dept Epidemiol & Publ Hlth, Psychobiol Grp, London, England; [Wikman, Anna] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Wardle, Jane] UCL, Dept Epidemiol & Publ Hlth, Hlth Behav Res Ctr, London, England	University of London; University College London; Karolinska Institutet; University of London; University College London	Wikman, A (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Psychobiol Grp, London, England.	anna.wikman@ki.se	Steptoe, Andrew/Y-2440-2019	Steptoe, Andrew/0000-0001-7808-4943	National Institute on Aging in the United States [2RO1AG7644-01A1, 2RO1AG017644]; consortium of UK government departments; NATIONAL INSTITUTE ON AGING [R01AG017644] Funding Source: NIH RePORTER; British Heart Foundation [RG/10/005/28296] Funding Source: researchfish	National Institute on Aging in the United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); consortium of UK government departments; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation)	The data for this study were made available through the UK Data Archive. The English Longitudinal Study of Ageing (ELSA) was developed by a team of researchers based at University College London, the Institute of Fiscal Studies and the National Centre for Social Research. The funding is provided by the National Institute on Aging in the United States (grants 2RO1AG7644-01A1 and 2RO1AG017644) and a consortium of UK government departments coordinated by the Office for National Statistics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The developers and funders of ELSA and the Archive do not bear any responsibility for the analyses or interpretations presented here.	Alonso J, 2004, QUAL LIFE RES, V13, P283, DOI 10.1023/B:QURE.0000018472.46236.05; Banks J, 2003, HLTH WEALTH LIFESTYL, P71; Beckett M, 2000, AM J EPIDEMIOL, V151, P315, DOI 10.1093/oxfordjournals.aje.a010208; Carver CS, 2004, HEALTH PSYCHOL, V23, P595, DOI 10.1037/0278-6133.23.6.595; Chida Y, 2008, PSYCHOSOM MED, V70, P741, DOI 10.1097/PSY.0b013e31818105ba; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; Crimmins EM, 2011, J GERONTOL B-PSYCHOL, V66, P75, DOI 10.1093/geronb/gbq088; Dolan P, 2005, HEALTH ECON, V14, P197, DOI 10.1002/hec.924; Erens B, 1999, HLTH SURVEY ENGLAND, V2; Falachetti E, 2007, HLTH SURVEY ENGLAND, V2, P41; Fogel RW, 1997, PHILOS T R SOC B, V352, P1905, DOI 10.1098/rstb.1997.0177; Freedman VA, 2004, DEMOGRAPHY, V41, P417, DOI 10.1353/dem.2004.0022; Freedman VA, 2002, JAMA-J AM MED ASSOC, V288, P3137, DOI 10.1001/jama.288.24.3137; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Hobbs FDR, 2002, EUR HEART J, V23, P1867, DOI 10.1053/euhj.2002.3255; Hopman WM, 2009, CHRONIC DIS CAN, V29, P108; Huang CQ, 2010, AGE AGEING, V39, P23, DOI 10.1093/ageing/afp187; Hunt SM, 1986, MEASURING HLTH STATU; Hyde M, 2003, AGING MENT HEALTH, V7, P186, DOI 10.1080/1360786031000101157; Juenger J, 2002, HEART, V87, P235, DOI 10.1136/heart.87.3.235; Kahneman D, 2006, J ECON PERSPECT, V20, P3, DOI 10.1257/089533006776526030; Katon W, 2007, GEN HOSP PSYCHIAT, V29, P147, DOI 10.1016/j.genhosppsych.2006.11.005; LYONS RA, 1994, J EPIDEMIOL COMMUN H, V48, P388, DOI 10.1136/jech.48.4.388; Marmot M, 2003, HLTH WEALTH LIFESTYL; Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338; Nussbaum MC., 1993, QUALITY LIFE; PAGANINIHILL A, 1993, AM J EPIDEMIOL, V138, P101, DOI 10.1093/oxfordjournals.aje.a116832; Piazza JR, 2007, J GERONTOL B-PSYCHOL, V62, pP313, DOI 10.1093/geronb/62.6.P313; Pinquart M, 2010, PSYCHOL MED, V40, P1797, DOI 10.1017/S0033291709992285; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Satin JR, 2009, CANCER-AM CANCER SOC, V115, P5349, DOI 10.1002/cncr.24561; Schwartz CE, 1999, SOC SCI MED, V48, P1531, DOI 10.1016/S0277-9536(99)00047-7; Singer MA, 1999, QUAL LIFE RES, V8, P687, DOI 10.1023/A:1008917016998; Singh JA, 2005, J AM GERIATR SOC, V53, P108, DOI 10.1111/j.1532-5415.2005.53020.x; Sprangers MAG, 2000, J CLIN EPIDEMIOL, V53, P895, DOI 10.1016/S0895-4356(00)00204-3; Sprangers MAG, 1999, SOC SCI MED, V48, P1507, DOI 10.1016/S0277-9536(99)00045-3; Steffick DE., 2000, DOCUMENTATION AFFECT; STEWART AL, 1989, JAMA-J AM MED ASSOC, V262, P907, DOI 10.1001/jama.262.7.907; Taylor R, 2003, HLTH WEALTH LIFESTYL, P357; Vodermaier A, 2009, JNCI-J NATL CANCER I, V101, P1464, DOI 10.1093/jnci/djp336; Walker AE, 2007, CHRONIC ILLN, V3, P202, DOI 10.1177/1742395307081504; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wee HL, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-93; Werneke U, 2000, PSYCHOL MED, V30, P823, DOI 10.1017/S0033291799002287; Wiggins RD, 2008, SOC INDIC RES, V89, P61, DOI 10.1007/s11205-007-9220-5; Zeiss AM, 1996, PSYCHOL AGING, V11, P572, DOI 10.1037/0882-7974.11.4.572	46	110	111	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18952	10.1371/journal.pone.0018952	http://dx.doi.org/10.1371/journal.pone.0018952			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	756OZ	21559485	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700041
J	Hu, TS; Gimferrer, I; Simmons, A; Wiest, D; Alberola-Ila, J				Hu, Taishan; Gimferrer, Idoia; Simmons, Amie; Wiest, David; Alberola-Ila, Jose			The Ras/MAPK Pathway Is Required for Generation of iNKT Cells	PLOS ONE			English	Article							NEGATIVE SELECTION; CUTTING EDGE; INNATE; SAP; DIFFERENTIATION; ACTIVATION; MATURATION; THYMOCYTES; INDUCTION	iNKT cells derive from CD4(+)CD8(+)DP thymocytes, and are selected by thymocyte-thymocyte interactions through signals from their invariant V alpha 14-J alpha 18 TCR and from the costimulatory molecules SLAMF1 and SLAMF6. Genetic studies have demonstrated the contribution of different signaling pathways to this process. Surprisingly, current models imply that the Ras/MAPK pathway, one of the critical mediators of conventional alpha beta T cell positive selection, is not necessary for iNKT cell development. Using mice defective at different levels of this pathway our results refute this paradigm, and demonstrate that Ras, and its downstream effectors Egr-1 and Egr-2 are required for positive selection of iNKT cells. Interestingly our results also show that there are differences in the contributions of several of these molecules to the development of iNKT and conventional alpha beta T cells.	[Hu, Taishan; Gimferrer, Idoia; Simmons, Amie; Alberola-Ila, Jose] Oklahoma Med Res Fdn, Immunobiol & Canc Res Program, Oklahoma City, OK 73104 USA; [Wiest, David] Fox Chase Canc Ctr, Immune Cell Dev & Host Def Program, Philadelphia, PA USA; [Alberola-Ila, Jose] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA	Oklahoma Medical Research Foundation; Fox Chase Cancer Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Hu, TS (corresponding author), Oklahoma Med Res Fdn, Immunobiol & Canc Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	alberolaj@omrf.org	Lin, Zongli/L-6084-2019	alberola-ila, Jose/0000-0003-2439-553X; Wiest, David/0000-0002-0792-3188	NIH/NIAID [AI059302]; AHA [0855002F]; Spanish Education and Science Department; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081314, R01AI059302, R21AI088546] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); AHA(American Heart Association); Spanish Education and Science Department; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants AI059302 (NIH/NIAID) and 0855002F (AHA) to JAI. IG was supported in part by a grant from the Spanish Education and Science Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberola-Ila J, 2003, IMMUNOL REV, V191, P79, DOI 10.1034/j.1600-065X.2003.00012.x; AlberolaIla J, 1996, J EXP MED, V184, P9, DOI 10.1084/jem.184.1.9; ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; Alonzo ES, 2010, J IMMUNOL, V184, P1268, DOI 10.4049/jimmunol.0903218; Bain G, 2001, NAT IMMUNOL, V2, P165, DOI 10.1038/84273; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Bettini M, 2002, J IMMUNOL, V169, P1713, DOI 10.4049/jimmunol.169.4.1713; Borowski C, 2005, J EXP MED, V201, P833, DOI 10.1084/jem.20050339; Carter JH, 2007, J IMMUNOL, V178, P6796, DOI 10.4049/jimmunol.178.11.6796; Chung B, 2005, J IMMUNOL, V174, P3153, DOI 10.4049/jimmunol.174.6.3153; Eberl G, 1999, J IMMUNOL, V163, P4091; Felices M, 2008, J IMMUNOL, V180, P3007, DOI 10.4049/jimmunol.180.5.3007; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Godfrey DI, 2007, NAT REV IMMUNOL, V7, P505, DOI 10.1038/nri2116; Godfrey DI, 2010, NAT IMMUNOL, V11, P197, DOI 10.1038/ni.1841; Griewank K, 2007, IMMUNITY, V27, P751, DOI 10.1016/j.immuni.2007.08.020; Hernandez-Hoyos G, 2005, METHOD ENZYMOL, V392, P199, DOI 10.1016/S0076-6879(04)92012-5; Hu TS, 2010, NAT IMMUNOL, V11, P435, DOI 10.1038/ni.1865; Kronenberg M, 2007, CURR OPIN IMMUNOL, V19, P186, DOI 10.1016/j.coi.2007.02.009; Lauritsen JPH, 2008, J IMMUNOL, V181, P7778, DOI 10.4049/jimmunol.181.11.7778; Lazarevic V, 2009, NAT IMMUNOL, V10, P306, DOI 10.1038/ni.1696; Liu Y, 2006, J IMMUNOL METHODS, V312, P34, DOI 10.1016/j.jim.2006.02.009; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; Nichols KE, 2005, NAT MED, V11, P340, DOI 10.1038/nm1189; Pasquier B, 2005, J EXP MED, V201, P695, DOI 10.1084/jem.20042432; Shao H, 1997, J EXP MED, V185, P731, DOI 10.1084/jem.185.4.731; Stanic AK, 2004, J IMMUNOL, V172, P2265, DOI 10.4049/jimmunol.172.4.2265; Stankovic S, 2011, IMMUNOL CELL BIOL, V89, P294, DOI 10.1038/icb.2010.93; SWAN KA, 1995, EMBO J, V14, P276, DOI 10.1002/j.1460-2075.1995.tb07001.x; Taillebourg E, 2002, GENESIS, V32, P112, DOI 10.1002/gene.10062; Taniguchi M, 2010, INT IMMUNOL, V22, P1, DOI 10.1093/intimm/dxp104; Verykokakis M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009303; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Xi HK, 2004, J IMMUNOL, V172, P964, DOI 10.4049/jimmunol.172.2.964	34	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19890	10.1371/journal.pone.0019890	http://dx.doi.org/10.1371/journal.pone.0019890			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572967	Green Submitted, Green Published, gold			2022-12-27	WOS:000290440200033
J	MacKenzie, BR; Eero, M; Ojaveer, H				MacKenzie, Brian R.; Eero, Margit; Ojaveer, Henn			Could Seals Prevent Cod Recovery in the Baltic Sea?	PLOS ONE			English	Article							GADUS-MORHUA; HALICHOERUS-GRYPUS; CLIMATE-CHANGE; SOUTHERN GULF; ECOSYSTEM; FISH; RECRUITMENT; ATLANTIC; VARIABILITY; COLLAPSE	Fish populations are increasingly affected by multiple human and natural impacts including exploitation, eutrophication, habitat alteration and climate change. As a result many collapsed populations may have to recover in ecosystems whose structure and functioning differ from those in which they were formerly productive and supported sustainable fisheries. Here we investigate how a cod (Gadus morhua) population in the Baltic Sea whose biomass was reduced due to a combination of high exploitation and deteriorating environmental conditions might recover and develop in the 21st century in an ecosystem that likely will change due to both the already started recovery of a cod predator, the grey seal Halichoerus grypus, and projected climate impacts. Simulation modelling, assuming increased seal predation, fishing levels consistent with management plan targets and stable salinity, shows that the cod population could reach high levels well above the long-term average. Scenarios with similar seal and fishing levels but with 15% lower salinity suggest that the Baltic will still be able to support a cod population which can sustain a fishery, but biomass and yields will be lower. At present knowledge of cod and seal interactions, seal predation was found to have much lower impact on cod recovery, compared to the effects of exploitation and salinity. These results suggest that dual management objectives (recovery of both seal and cod populations) are realistic but success in achieving these goals will also depend on how climate change affects cod recruitment.	[MacKenzie, Brian R.; Eero, Margit] Tech Univ Denmark DTU Aqua, Natl Inst Aquat Resources, Charlottenlund, Denmark; [MacKenzie, Brian R.] Univ Copenhagen, Dept Biol, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark; [Ojaveer, Henn] Univ Tartu, Estonian Marine Inst, Parnu, Estonia	Technical University of Denmark; University of Copenhagen; University of Tartu; Estonian Marine Institute	MacKenzie, BR (corresponding author), Tech Univ Denmark DTU Aqua, Natl Inst Aquat Resources, Charlottenlund, Denmark.	brm@aqua.dtu.dk	Eero, Margit/AAK-2845-2021; MacKenzie, Brian R./T-9379-2019; Ojaveer, Henn/K-2160-2016	Eero, Margit/0000-0002-1848-0597; MacKenzie, Brian R./0000-0002-4798-0363; Ojaveer, Henn/0000-0003-2742-6063	Census of Marine Life-History of Marine Animal Populations (CoML-HMAP; Sloan Foundation); EU [266445]; Estonian Ministry of Education and Research [SF0180005s10]; European Community [217246]; Danish National Science Foundation; Danish National Research Foundation (Dansk Grundforskningsfond)	Census of Marine Life-History of Marine Animal Populations (CoML-HMAP; Sloan Foundation)(Alfred P. Sloan Foundation); EU(European Commission); Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); European Community(European Commission); Danish National Science Foundation(Danmarks Grundforskningsfond); Danish National Research Foundation (Dansk Grundforskningsfond)(Danmarks Grundforskningsfond)	We thank the Census of Marine Life-History of Marine Animal Populations (CoML-HMAP; Sloan Foundation), EU UNCOVER project (BRM), and Estonian Ministry of Education and Research (grant no. SF0180005s10 to HO) for support. DTU Aqua (BRM, ME) has received funding from the European Community's Seventh Framework Programme (FP/2007-2013) under grant agreement no 217246 made with the joint Baltic Sea research and development programme BONUS, and from the Danish National Science Foundation (ECOSUPPORT project). We thank the Danish National Research Foundation (Dansk Grundforskningsfond) for support to the Center for Macroecology, Evolution and Climate, University of Copenhagen. The study contributes to the EU FP7 project VECTORS (266445). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CNK, 2008, NATURE, V452, P835, DOI 10.1038/nature06851; BACC, 2007, INT C GOTH SWED MAY; Bakun A, 2006, PROG OCEANOGR, V68, P271, DOI 10.1016/j.pocean.2006.02.004; Bastardie F, 2010, FISH RES, V101, P188, DOI 10.1016/j.fishres.2009.10.009; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Bundy A, 2009, PROG OCEANOGR, V81, P188, DOI 10.1016/j.pocean.2009.04.010; Caddy JF, 2004, REV FISH BIOL FISHER, V14, P43, DOI 10.1007/s11160-004-3770-2; Cardoso A. C., 2010, JRC SCI TECHNICAL RE; Casini M, 2009, P NATL ACAD SCI USA, V106, P197, DOI 10.1073/pnas.0806649105; Chassot E, 2009, MAR ECOL PROG SER, V379, P279, DOI 10.3354/meps07897; Chouinard GA, 2005, CAN J FISH AQUAT SCI, V62, P1991, DOI 10.1139/f05-107; Commission of the european communities (EC), 2009, GREEN PAP REF COMM F; EERO M, 2010, ECOL APPL IN PRESS; Eero M, 2008, CAN J FISH AQUAT SCI, V65, P2728, DOI 10.1139/F08-176; EILOLA K, 2010, 1012010 SMHI; ELMGREN R, 1989, AMBIO, V18, P326; Fulton EA, 2010, J MARINE SYST, V81, P171, DOI 10.1016/j.jmarsys.2009.12.012; HAMMOND PS, 2006, GREY SEAL DIET COMP; Hansson S, 2007, AMBIO, V36, P265, DOI 10.1579/0044-7447(2007)36[265:MBSFUC]2.0.CO;2; Harding KC, 1999, AMBIO, V28, P619; Heikinheimo O, 2008, BOREAL ENVIRON RES, V13, P457; HELCOM, 2007, HELCOM BALT SEA ACT; HILBORN R, 1992; Hinrichsen HH, 2009, ICES J MAR SCI, V66, P101, DOI 10.1093/icesjms/fsn207; HOLLING C. S., 1959, CANADIAN ENT, V91, P293; *ICES, 2006, 2006OCC12 ICES CM; *ICES, 2008, 2008ACOM ICES CM, V6, P220; *ICES, 2010, ICES ADV BALT SEA EC, P25; *ICES, 2009, 2009ACOM ICES CM, V53, P1; *ICES, 2010, 2010ACOM ICES CM, V54, P1; *ICES, 2008, 2008ACOM ICES CM, P44; *ICES, 2007, 2007ACFM ICES CM, V25, P1; *ICES, 2009, REP ICES BALT FISH A; *ICES, 2007, 2007RMC ICES CM, P8; *ICES, 2010, 2010SSGRSP ICES CM, V2, P1; *ICES, 2005, 2005ACFM ICES CM, P19; *ICES, 2010, 2010ACOM ICES CM, V10, P1; *ICES, 2007, 2007ACFM ICES CM, V5, P1; Kempf A, 2008, MAR ECOL PROG SER, V367, P295, DOI 10.3354/meps07555; Koster F.W, 2009, J NW ATLANTIC FISHER, V41, P205, DOI DOI 10.2960/J.V41.M636; Koster FW, 2000, ICES J MAR SCI, V57, P310, DOI 10.1006/jmsc.1999.0528; Koster FW, 2005, ICES J MAR SCI, V62, P1408, DOI 10.1016/j.icesjms.2005.05.004; Kramer AM, 2010, J ANIM ECOL, V79, P633, DOI 10.1111/j.1365-2656.2009.01657.x; Lindegren M, 2010, P ROY SOC B-BIOL SCI, V277, P2121, DOI 10.1098/rspb.2010.0353; Lindstrom U, 2009, DEEP-SEA RES PT II, V56, P2068, DOI 10.1016/j.dsr2.2008.11.017; Lotze HK, 2009, TRENDS ECOL EVOL, V24, P254, DOI 10.1016/j.tree.2008.12.004; Lundstrom K., 2007, NAMMCO Scientific Publications, V6, P177; LUNDSTROM K, 2010, ICES J MAR IN PRESS, P67; MacKenzie BR, 2002, CAN J FISH AQUAT SCI, V59, P173, DOI 10.1139/F01-201; MacKenzie BR, 2004, ECOLOGY, V85, P784, DOI 10.1890/02-0780; MacKenzie BR, 2007, FISH RES, V87, P106, DOI 10.1016/j.fishres.2007.07.003; Mackenzie BR, 2007, GLOBAL CHANGE BIOL, V13, P1348, DOI 10.1111/j.1365-2486.2007.01369.x; MacKenzie BR, 2009, CONSERV LETT, V2, P25, DOI 10.1111/j.1755-263X.2008.00039.x; Murawski SA, 2010, ICES J MAR SCI, V67, P1830, DOI 10.1093/icesjms/fsq125; Neumann T, 2010, J MARINE SYST, V81, P213, DOI 10.1016/j.jmarsys.2009.12.001; Ojaveer H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012467; Osterblom H, 2010, MAR POLICY, V34, P1290, DOI 10.1016/j.marpol.2010.05.007; Osterblom H, 2007, ECOSYSTEMS, V10, P877, DOI 10.1007/s10021-007-9069-0; Pohl C., 2008, STATE EVOLUTION BALT, P367; Rick TC, 2008, HUMAN IMPACTS ON ANCIENT MARINE ECOSYSTEMS: A GLOBAL PERSPECTIVE, P1; Rindorf A, 2005, J EXP MAR BIOL ECOL, V324, P1, DOI 10.1016/j.jembe.2005.04.013; Smout S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010761; SODERBERG S, 1975, P S SEAL BALT JUN 4; Sparholt H, 1996, ICES J MAR SCI, V53, P771, DOI 10.1006/jmsc.1996.0098; Sparholt Henrik, 1994, Dana, V10, P131; Swain DP, 2008, CAN J FISH AQUAT SCI, V65, P2315, DOI 10.1139/F08-175; Thrush SF, 2010, ANNU REV MAR SCI, V2, P419, DOI 10.1146/annurev-marine-120308-081129; Uzars D, 2000, ICES J MAR SCI, V57, P324, DOI 10.1006/jmsc.1999.0527; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	69	30	30	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e18998	10.1371/journal.pone.0018998	http://dx.doi.org/10.1371/journal.pone.0018998			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573062	Green Published, Green Submitted, gold			2022-12-27	WOS:000290386800006
J	Wohlfart, S; Khalansky, AS; Gelperina, S; Maksimenko, O; Bernreuther, C; Glatzel, M; Kreuter, J				Wohlfart, Stefanie; Khalansky, Alexander S.; Gelperina, Svetlana; Maksimenko, Olga; Bernreuther, Christian; Glatzel, Markus; Kreuter, Joerg			Efficient Chemotherapy of Rat Glioblastoma Using Doxorubicin-Loaded PLGA Nanoparticles with Different Stabilizers	PLOS ONE			English	Article							POLY(BUTYL CYANOACRYLATE) NANOPARTICLES; ANGIOGENESIS; INHIBITION; TUMORS; ACID)	Background: Chemotherapy of glioblastoma is largely ineffective as the blood-brain barrier (BBB) prevents entry of most anticancer agents into the brain. For an efficient treatment of glioblastomas it is necessary to deliver anti-cancer drugs across the intact BBB. Poly(lactic-co-glycolic acid) (PLGA) nanoparticles coated with poloxamer 188 hold great promise as drug carriers for brain delivery after their intravenous injection. In the present study the anti-tumour efficacy of the surfactant-coated doxorubicin-loaded PLGA nanoparticles against rat glioblastoma 101/8 was investigated using histological and immunohistochemical methods. Methodology: The particles were prepared by a high-pressure solvent evaporation technique using 1% polyvinylalcohol (PLGA/PVA) or human serum albumin (PLGA/HSA) as stabilizers. Additionally, lecithin-containing PLGA/HSA particles (Dox-Lecithin-PLGA/HSA) were prepared. For evaluation of the antitumour efficacy the glioblastoma-bearing rats were treated intravenously with the doxorubicin-loaded nanoparticles coated with poloxamer 188 using the following treatment regimen: 362.5 mg/kg on day 2, 5 and 8 after tumour implantation; doxorubicin and poloxamer 188 solutions were used as controls. On day 18, the rats were sacrificed and the antitumour effect was determined by measurement of tumour size, necrotic areas, proliferation index, and expression of GFAP and VEGF as well as Isolectin B4, a marker for the vessel density. Conclusion: The results reveal a considerable anti-tumour effect of the doxorubicin-loaded nanoparticles. The overall best results were observed for Dox-Lecithin-PLGA/HSA. These data demonstrate that the poloxamer 188-coated PLGA nanoparticles enable delivery of doxorubicin across the blood-brain barrier in the therapeutically effective concentrations.	[Wohlfart, Stefanie; Kreuter, Joerg] Goethe Univ Frankfurt, Inst Pharmaceut Technol, Frankfurt, Germany; [Khalansky, Alexander S.] Inst Human Morphol, Moscow, Russia; [Gelperina, Svetlana; Maksimenko, Olga] Nanosyst Ltd, Moscow, Russia; [Bernreuther, Christian; Glatzel, Markus] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany	Goethe University Frankfurt; Russian Academy of Medical Sciences; Research Institute of Human Morphology; University of Hamburg; University Medical Center Hamburg-Eppendorf	Wohlfart, S (corresponding author), Goethe Univ Frankfurt, Inst Pharmaceut Technol, Frankfurt, Germany.	Kreuter@em.uni-frankfurt.de	Gelperina, Svetlana/T-9112-2019; Glatzel, Markus/V-8844-2019; Maksimenko, Olga Olegovna/T-1267-2018; Glatzel, Markus/G-3356-2011	Gelperina, Svetlana/0000-0003-1113-6715; Glatzel, Markus/0000-0002-7720-8817; Maksimenko, Olga Olegovna/0000-0002-1230-4680; Glatzel, Markus/0000-0002-7720-8817; Khalansky, Aleksandr S/0000-0002-2575-7523	INTAS (International Association) [00-838]; DFG (Deutsche Forschungsgemeinschaft); Goethe/University Frankfurt of the University Clinics Hamburg	INTAS (International Association)(INTAS); DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Goethe/University Frankfurt of the University Clinics Hamburg	This study was supported in part (S.G and O.M.) by residual funds from INTAS (International Association for the promotion of cooperation with scientists from the new independent states of the former Soviet Union, Brussels, Belgium, Grant 00-838) and by travel grants for A.S.K. and S.G. by the DFG (Deutsche Forschungsgemeinschaft). All studies in Frankfurt and Hamburg including the work of A.S.K. were supported by the regular department funds of Goethe/University Frankfurt of the University Clinics Hamburg. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambruosi A, 2006, J DRUG TARGET, V14, P97, DOI 10.1080/10611860600636135; Barker FG, 1996, CANCER, V77, P1161, DOI 10.1002/(SICI)1097-0142(19960315)77:6<1161::AID-CNCR24>3.0.CO;2-Z; Brat DJ, 2002, ADV ANAT PATHOL, V9, P24, DOI 10.1097/00125480-200201000-00004; BREM S, 1972, J NATL CANCER I, V48, P347; Ding H, 2010, P NATL ACAD SCI USA, V107, P18143, DOI 10.1073/pnas.1003919107; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Frank PG, 2000, J LIPID RES, V41, P853; Fujita Manabu, 2006, Angiogenesis, V9, P183, DOI 10.1007/s10456-006-9046-9; Gelperina SE, 2002, TOXICOL LETT, V126, P131, DOI 10.1016/S0378-4274(01)00456-8; Gelperina S, 2010, EUR J PHARM BIOPHARM, V74, P157, DOI 10.1016/j.ejpb.2009.09.003; GERDES J, 1984, J IMMUNOL, V133, P1710; HAMAYA K, 1985, ACTA MED OKAYAMA, V39, P453; Hekmatara T, 2009, CLIN NEUROPATHOL, V28, P153; Kreuter J, 2001, ADV DRUG DELIVER REV, V47, P65, DOI 10.1016/S0169-409X(00)00122-8; Kreuter J, 2008, TUMORI J, V94, P271; Lee BS, 2006, BIOCONJUGATE CHEM, V17, P317, DOI 10.1021/bc0502457; Petri B, 2007, J CONTROL RELEASE, V117, P51, DOI 10.1016/j.jconrel.2006.10.015; Roullin VG, 2002, EUR J PHARM BIOPHARM, V53, P293, DOI 10.1016/S0939-6411(02)00011-5; Schoch G, 2006, PLOS MED, V3, P236, DOI 10.1371/journal.pmed.0030014; Steiniger SCJ, 2004, INT J CANCER, V109, P759, DOI 10.1002/ijc.20048; Ulbrich K, 2011, J DRUG TARGET, V19, P125, DOI 10.3109/10611861003734001; Veronese SM, 1995, ANTICANCER RES, V15, P2717; VERRECCHIA T, 1993, J BIOMED MATER RES, V27, P1019, DOI 10.1002/jbm.820270807; Weidner N, 2000, HUM PATHOL, V31, P403, DOI 10.1053/hp.2000.6724; Wohlfart S, 2009, J NANONEUROSCI, V1, P144; Zensi A, 2009, J CONTROL RELEASE; Zhirnov AE, 2005, BBA-BIOMEMBRANES, V1720, P73, DOI 10.1016/j.bbamem.2005.11.010	27	119	131	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19121	10.1371/journal.pone.0019121	http://dx.doi.org/10.1371/journal.pone.0019121			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573151	Green Published, Green Submitted, gold			2022-12-27	WOS:000290305600011
J	Banni, M; Negri, A; Mignone, F; Boussetta, H; Viarengo, A; Dondero, F				Banni, Mohamed; Negri, Alessandro; Mignone, Flavio; Boussetta, Hamadi; Viarengo, Aldo; Dondero, Francesco			Gene Expression Rhythms in the Mussel Mytilus galloprovincialis (Lam.) across an Annual Cycle	PLOS ONE			English	Article							OYSTER CRASSOSTREA-GIGAS; REAL-TIME PCR; MESSENGER-RNA; MOLECULAR-CLONING; CHITINASE; REPRODUCTION; PROTEIN; TOOL; SPERMATOGENESIS; MATURATION	Seasonal environmental changes may affect the physiology of Mytilus galloprovincialis (Lam.), an intertidal filter-feeder bivalve occurring commonly in Mediterranean and Atlantic coastal areas. We investigated seasonal variations in relative transcript abundance of the digestive gland and the mantle (gonads) of males and females. To identify gene expression trends - in terms of relative mRNA abundance-we used a medium-density cDNA microarray (1.7 K probes) in dual-color competitive hybridization analyses. Hierarchical clustering of digestive gland microarray data showed two main branches, distinguishing profiles associated with the "hot'' months (May-August) from the other months. Genes involved in chitin metabolism, associated with mussel nutrition and digestion showed higher mRNA levels during summer. Moreover, we found different gene transcriptomic patterns in the digestive glands of males when compared to females, during the four stages of mussel gonadal development. Microarray data from gonadal transcripts also displayed clear patterns during the different developmental phases respect to the resting period (stage I) with peak relative mRNA abundance at the ripe phase (stage III) for both sexes. These data showed a clear temporal pattern in transcriptomic profiles of mussels sampled over an annual cycle. Physiological response to thermal variation, food availability, and reproductive status across months may contribute to variation in relative mRNA abundance.	[Banni, Mohamed; Negri, Alessandro; Viarengo, Aldo; Dondero, Francesco] Univ Piemonte Orientale Vercelli Novara Alessandr, Dept Environm & Life Sci, Alessandria, Italy; [Banni, Mohamed; Boussetta, Hamadi] Sousse Univ, ISA, Lab Biochem & Environm Toxicol, Chott Mariem, Tunisia; [Mignone, Flavio] Univ Milan, Dept Struct Chem & Inorgan Stereochem, Milan, Italy	University of Eastern Piedmont Amedeo Avogadro; Universite de Sousse; Universite de Tunis-El-Manar; Institut Salah Azaiez; University of Milan	Banni, M (corresponding author), Univ Piemonte Orientale Vercelli Novara Alessandr, Dept Environm & Life Sci, Alessandria, Italy.	francesco.dondero@mfn.unipmn.it	Banni, Mohamed/M-2144-2014; Dondero, Francesco/J-1528-2012	Banni, Mohamed/0000-0001-9764-0343; Viarengo, Aldo/0000-0002-1557-6526; Dondero, Francesco/0000-0001-7945-3712	European FP7 Integrated Project MEECE2 [212085]; Ministere de l'Enseignement Superieur et de la Recherche Scientifique, Republique de Tunisia	European FP7 Integrated Project MEECE2; Ministere de l'Enseignement Superieur et de la Recherche Scientifique, Republique de Tunisia	This work was funded by a grant from the European FP7 Integrated Project MEECE2 (contract n. 212085) and a grant from the Ministere de l'Enseignement Superieur et de la Recherche Scientifique, Republique de Tunisia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Au HK, 2005, ANN NY ACAD SCI, V1042, P177, DOI 10.1196/annals.1338.020; Badariotti F, 2007, DEV COMP IMMUNOL, V31, P559, DOI 10.1016/j.dci.2006.09.002; Badariotti F, 2006, J BIOL CHEM, V281, P29583, DOI 10.1074/jbc.M605687200; Banni M, 2007, BIOMARKERS, V12, P369, DOI 10.1080/13547500701217061; Banni M, 2009, COMP BIOCHEM PHYS C, V149, P414, DOI 10.1016/j.cbpc.2008.09.017; Bouchut A, 2006, INT J PARASITOL, V36, P175, DOI 10.1016/j.ijpara.2005.09.009; Boutet I, 2008, GENE, V407, P130, DOI 10.1016/j.gene.2007.10.005; Chikhaoui MA, 2008, CR BIOL, V331, P389, DOI 10.1016/j.crvi.2008.03.005; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Craft JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008875; Cummins J M, 2000, Hum Reprod, V15 Suppl 2, P92; D'haeseleer P, 2005, NAT BIOTECHNOL, V23, P1499, DOI 10.1038/nbt1205-1499; Dalziel AC, 2009, MOL ECOL, V18, P4997, DOI 10.1111/j.1365-294X.2009.04427.x; Dellali M, 2001, COMP BIOCHEM PHYS C, V130, P227, DOI 10.1016/S1532-0456(01)00245-9; Dondero F, 2005, GENE, V345, P259, DOI 10.1016/j.gene.2004.11.031; Dondero F, 2006, AQUAT TOXICOL, V78, pS13, DOI 10.1016/j.aquatox.2006.02.025; Dondero F, 2010, SCI TOTAL ENVIRON, V408, P3775, DOI 10.1016/j.scitotenv.2010.03.040; Dumollard R, 2004, DEVELOPMENT, V131, P3057, DOI 10.1242/dev.01181; Dunbar Emily J., 2009, Minnesota Department of Natural Resources Summaries of Wildlife Research Findings, V2008, P13; Durkin CA, 2009, EUKARYOT CELL, V8, P1038, DOI 10.1128/EC.00079-09; Etchian OA, 2004, COMP BIOCHEM PHYS B, V139, P287, DOI 10.1016/j.cbpc.2004.08.006; Farcy E, 2008, MAR ENVIRON RES, V66, P300, DOI 10.1016/j.marenvres.2008.04.006; Farcy E, 2009, CELL STRESS CHAPERON, V14, P371, DOI 10.1007/s12192-008-0091-8; Gracey AY, 2008, CURR BIOL, V18, P1501, DOI 10.1016/j.cub.2008.08.049; HAKE LE, 1990, DEVELOPMENT, V110, P249; Hecht N B, 1988, Prog Clin Biol Res, V267, P291; Hines A, 2007, ANAL BIOCHEM, V369, P175, DOI 10.1016/j.ab.2007.06.008; Ivanina AV, 2009, AQUAT TOXICOL, V91, P245, DOI 10.1016/j.aquatox.2008.11.016; KENNEDY BP, 1985, EXP CELL RES, V158, P445, DOI 10.1016/0014-4827(85)90468-9; Khan MA, 2006, J AGR FOOD CHEM, V54, P2236, DOI 10.1021/jf051587+; KURANDA MJ, 1991, J BIOL CHEM, V266, P19758; Lester SE, 2007, ECOLOGY, V88, P2229, DOI 10.1890/06-1784.1; Li GP, 2010, J AGR FOOD CHEM, V58, P7831, DOI 10.1021/jf101526c; Liu JX, 2008, GENE EXPR PATTERNS, V8, P237, DOI 10.1016/j.gep.2007.12.004; LOWE DM, 1982, J MAR BIOL ASSOC UK, V62, P133, DOI 10.1017/S0025315400020166; Matocq MD, 2009, MOL ECOL, V18, P2310, DOI 10.1111/j.1365-294X.2009.04172.x; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Moraga D, 2005, COMP BIOCHEM PHYS C, V141, P151, DOI 10.1016/j.cca.2005.05.014; Motta PM, 2000, HUM REPROD, V15, P78; Muttray AF, 2008, MAR ENVIRON RES, V66, P412, DOI 10.1016/j.marenvres.2008.06.004; Osada M, 2004, MOL REPROD DEV, V67, P273, DOI 10.1002/mrd.20020; PEARL LH, 2001, ADV PROTEIN CHEM; Petrovic S, 2004, MAR POLLUT BULL, V49, P713, DOI 10.1016/j.marpolbul.2004.05.004; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Place SP, 2008, MAR ECOL PROG SER, V356, P1, DOI 10.3354/meps07354; Ramalho-Santos J, 2009, HUM REPROD UPDATE, V15, P553, DOI 10.1093/humupd/dmp016; Riginos C, 2003, MOL BIOL EVOL, V20, P200, DOI 10.1093/molbev/msg021; Sekimoto T, 2010, MOL CELL, V37, P79, DOI 10.1016/j.molcel.2009.12.015; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Suchanek T.H., 1992, MUSSEL MYTILUS ECOLO, P87; Suzuki M, 2002, J HISTOCHEM CYTOCHEM, V50, P1081, DOI 10.1177/002215540205000810; Tachu B, 2008, INFECT IMMUN, V76, P221, DOI 10.1128/IAI.00701-07; Venier P, 2006, MUTAT RES-FUND MOL M, V602, P121, DOI 10.1016/j.mrfmmm.2006.08.007; Viarengo A, 2007, COMP BIOCHEM PHYS C, V146, P281, DOI 10.1016/j.cbpc.2007.04.011; Viarengo A, 2000, CELL MOL BIOL, V46, P407; Xu W, 2009, COMP BIOCHEM PHYS B, V154, P143, DOI 10.1016/j.cbpb.2009.05.012	60	86	86	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e18904	10.1371/journal.pone.0018904	http://dx.doi.org/10.1371/journal.pone.0018904			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573210	gold, Green Submitted, Green Published			2022-12-27	WOS:000290256400003
J	Baumeister, S; Wiesner, J; Reichenberg, A; Hintz, M; Bietz, S; Harb, OS; Roos, DS; Kordes, M; Friesen, J; Matuschewski, K; Lingelbach, K; Jomaa, H; Seeber, F				Baumeister, Stefan; Wiesner, Jochen; Reichenberg, Armin; Hintz, Martin; Bietz, Sven; Harb, Omar S.; Roos, David S.; Kordes, Maximilian; Friesen, Johannes; Matuschewski, Kai; Lingelbach, Klaus; Jomaa, Hassan; Seeber, Frank			Fosmidomycin Uptake into Plasmodium and Babesia-Infected Erythrocytes Is Facilitated by Parasite-Induced New Permeability Pathways	PLOS ONE			English	Article							1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE; METHYLERYTHRITOL PHOSPHATE-PATHWAY; ISOPRENOID BIOSYNTHESIS; IN-VITRO; PHOSPHONIC ACID; MYCOBACTERIUM-TUBERCULOSIS; METABOLIC PATHWAYS; ANTIMALARIAL-DRUGS; FALCIPARUM; RESISTANCE	Background: Highly charged compounds typically suffer from low membrane permeability and thus are generally regarded as sub-optimal drug candidates. Nonetheless, the highly charged drug fosmidomycin and its more active methyl-derivative FR900098 have proven parasiticidal activity against erythrocytic stages of the malaria parasite Plasmodium falciparum. Both compounds target the isoprenoid biosynthesis pathway present in bacteria and plastid-bearing organisms, like apicomplexan parasites. Surprisingly, the compounds are inactive against a range of apicomplexans replicating in nucleated cells, including Toxoplasma gondii. Methodology/Principal Findings: Since non-infected erythrocytes are impermeable for FR90098, we hypothesized that these drugs are taken up only by erythrocytes infected with Plasmodium. We provide evidence that radiolabeled FR900098 accumulates in theses cells as a consequence of parasite-induced new properties of the host cell, which coincide with an increased permeability of the erythrocyte membrane. Babesia divergens, a related parasite that also infects human erythrocytes and is also known to induce an increase in membrane permeability, displays a similar susceptibility and uptake behavior with regard to the drug. In contrast, Toxoplasma gondii-infected cells do apparently not take up the compounds, and the drugs are inactive against the liver stages of Plasmodium berghei, a mouse malaria parasite. Conclusions/Significance: Our findings provide an explanation for the observed differences in activity of fosmidomycin and FR900098 against different Apicomplexa. These results have important implications for future screens aimed at finding new and safe molecular entities active against P. falciparum and related parasites. Our data provide further evidence that parasite-induced new permeability pathways may be exploited as routes for drug delivery.	[Baumeister, Stefan; Bietz, Sven; Lingelbach, Klaus; Seeber, Frank] Univ Marburg, Fachbereich Biol, D-3550 Marburg, Germany; [Wiesner, Jochen; Reichenberg, Armin; Hintz, Martin; Jomaa, Hassan] Univ Giessen Klinikum, Inst Klin Immunol & Transfus Med, D-6300 Giessen, Germany; [Wiesner, Jochen; Reichenberg, Armin; Hintz, Martin; Jomaa, Hassan] Marburg GmbH, Giessen, Germany; [Harb, Omar S.; Roos, David S.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Kordes, Maximilian; Friesen, Johannes; Matuschewski, Kai] Max Planck Inst Infect Biol, Parasitol Unit, Berlin, Germany; [Seeber, Frank] Robert Koch Inst, Fachgebiet Parasitol 16, D-1000 Berlin, Germany	Philipps University Marburg; University Hospital of Giessen & Marburg; University Hospital of Giessen & Marburg; University of Pennsylvania; Max Planck Society; Robert Koch Institute	Baumeister, S (corresponding author), Univ Marburg, Fachbereich Biol, D-3550 Marburg, Germany.	seeberf@rki.de	Kordes, Maximilian/AAE-9646-2019	Kordes, Maximilian/0000-0002-5715-0881; Harb, Omar/0000-0003-4446-6200; Baumeister, Stefan/0000-0002-7784-3474; Matuschewski, Kai/0000-0001-6147-8591; Seeber, Frank/0000-0002-2271-3699; Roos, David Siker/0000-0001-6725-4089	Deutsche Forschungsgemeinschaft [SFB 593, SE622/4-3, WI 2050/2-1]; European Commission [018834]; EviMalaR network of excellence	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); EviMalaR network of excellence	This study was supported by the Deutsche Forschungsgemeinschaft (grants SFB 593 to S.B. and K.L., SE622/4-3 to F.S., and WI 2050/2-1 to J.W.) and by a grant from the European Commission to H.J. (Integrated Project #018834) and via the EviMalaR network of excellence to K.L. and K.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhalil A, 2007, CELL MICROBIOL, V9, P851, DOI 10.1111/j.1462-5822.2006.00834.x; Baumeister S, 2006, MOL MICROBIOL, V60, P493, DOI 10.1111/j.1365-2958.2006.05112.x; Baumeister S, 2010, PROTOPLASMA, V240, P3, DOI 10.1007/s00709-009-0090-3; Biagini GA, 2003, ANTIMICROB AGENTS CH, V47, P2584, DOI 10.1128/AAC.47.8.2584-2589.2003; Borrmann S, 2005, ANTIMICROB AGENTS CH, V49, P3749, DOI 10.1128/AAC.49.9.3749-3754.2005; Borrmann S, 2004, J INFECT DIS, V189, P901, DOI 10.1086/381785; Borrmann S, 2006, ANTIMICROB AGENTS CH, V50, P2713, DOI 10.1128/AAC.00392-06; Brown AC, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-78; Bruna-Romero O, 2001, INT J PARASITOL, V31, P1499, DOI 10.1016/S0020-7519(01)00265-X; Caspi R, 2010, NUCLEIC ACIDS RES, V38, pD473, DOI 10.1093/nar/gkp875; Cassera MB, 2004, J BIOL CHEM, V279, P51749, DOI 10.1074/jbc.M408360200; Clastre M, 2007, EXP PARASITOL, V116, P375, DOI 10.1016/j.exppara.2007.02.002; Cooper B, 1998, ARCH BIOCHEM BIOPHYS, V353, P356, DOI 10.1006/abbi.1998.0626; Deng LS, 2009, J MED CHEM, V52, P6539, DOI 10.1021/jm9012592; Dharia NV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r21; Dhiman RK, 2005, J BACTERIOL, V187, P8395, DOI 10.1128/JB.187.24.8395-8402.2005; Dobson PD, 2008, NAT REV DRUG DISCOV, V7, P205, DOI 10.1038/nrd2438; Dobson PD, 2009, DRUG DISCOV TODAY, V14, P31, DOI 10.1016/j.drudis.2008.10.011; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Eisenreich W, 2004, CELL MOL LIFE SCI, V61, P1401, DOI 10.1007/s00018-004-3381-z; Ershov YV, 2002, J BACTERIOL, V184, P5045, DOI 10.1128/JB.184.18.5045-5051.2002; Fouts AE, 2007, INFECT IMMUN, V75, P634, DOI 10.1128/IAI.01228-06; Friesen J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001058; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Gero AM, 2003, CURR PHARM DESIGN, V9, P867, DOI 10.2174/1381612033455233; Giessmann D, 2008, CHEM BIODIVERS, V5, P643, DOI 10.1002/cbdv.200890060; GINSBURG H, 1987, BIOSCIENCE REP, V7, P455, DOI 10.1007/BF01116501; GORENFLOT A, 1991, PARASITOL RES, V77, P3, DOI 10.1007/BF00934377; Grauvogel C, 2007, J MOL EVOL, V65, P725, DOI 10.1007/s00239-007-9053-5; Harb OS, 2004, EUKARYOT CELL, V3, P663, DOI 10.1128/EC.3.3.663-674.2004; Henriksson LM, 2006, ACTA CRYSTALLOGR D, V62, P807, DOI 10.1107/S0907444906019196; Hill DA, 2007, P NATL ACAD SCI USA, V104, P1063, DOI 10.1073/pnas.0610353104; Holstein SA, 2004, LIPIDS, V39, P293, DOI 10.1007/s11745-004-1233-3; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; KAMIYA T, 1980, Patent No. 4206156; Kirk K, 2001, PHYSIOL REV, V81, P495, DOI 10.1152/physrev.2001.81.2.495; KUEMMERLE HP, 1985, INT J CLIN PHARM TH, V23, P521; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Ling Y, 2005, J MED CHEM, V48, P3130, DOI 10.1021/jm040132t; Lisk G, 2008, ANTIMICROB AGENTS CH, V52, P2346, DOI 10.1128/AAC.00057-08; Lizundia R, 2009, ANTIMICROB AGENTS CH, V53, P1213, DOI 10.1128/AAC.00126-08; Missinou MA, 2002, LANCET, V360, P1941, DOI 10.1016/S0140-6736(02)11860-5; Moudy R, 2001, J BIOL CHEM, V276, P41492, DOI 10.1074/jbc.M106154200; MURAKAWA T, 1982, ANTIMICROB AGENTS CH, V21, P224, DOI 10.1128/AAC.21.2.224; Muregi FW, 2010, DRUG DEVELOP RES, V71, P20, DOI 10.1002/ddr.20345; Odom AR, 2010, MOL BIOCHEM PARASIT, V170, P108, DOI 10.1016/j.molbiopara.2009.12.001; OHLER E, 1995, SYNTHESIS-STUTTGART, P539; Olliaro P, 2009, CLIN PHARMACOL THER, V85, P584, DOI 10.1038/clpt.2009.51; Paley SM, 2002, BIOINFORMATICS, V18, P715, DOI 10.1093/bioinformatics/18.5.715; PASVOL G, 1978, ANN TROP MED PARASIT, V72, P87, DOI 10.1080/00034983.1978.11719283; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prudencio M, 2009, CELL MICROBIOL, V11, P1492, DOI 10.1111/j.1462-5822.2009.01342.x; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Sakamoto Y, 2003, BIOSCI BIOTECH BIOCH, V67, P2030, DOI 10.1271/bbb.67.2030; Sangari FJ, 2010, P NATL ACAD SCI USA, V107, P14081, DOI 10.1073/pnas.1001962107; Seeber F, 1996, GENE, V169, P39, DOI 10.1016/0378-1119(95)00786-5; Seeber F, 2010, INT REV CEL MOL BIO, V281, P161, DOI 10.1016/S1937-6448(10)81005-6; Silvie O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000086; Sivakumar T., 2008, Journal of Protozoology Research, V18, P71; Staines HM, 2007, INT J PARASITOL, V37, P475, DOI 10.1016/j.ijpara.2006.12.013; Staines HM, 2005, COMB CHEM HIGH T SCR, V8, P81, DOI 10.2174/1386207053328138; Staines HM, 2000, BBA-BIOMEMBRANES, V1463, P88, DOI 10.1016/S0005-2736(99)00187-X; Stead AMW, 2001, MOL PHARMACOL, V59, P1298, DOI 10.1124/mol.59.5.1298; Stelter K, 2007, PROTIST, V158, P119, DOI 10.1016/j.protis.2006.09.003; Tarun AS, 2008, P NATL ACAD SCI USA, V105, P305, DOI 10.1073/pnas.0710780104; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; TSUCHIYA T, 1982, EUR J DRUG METAB PH, V7, P59, DOI 10.1007/BF03189544; Wang WX, 2010, P NATL ACAD SCI USA, V107, P11189, DOI 10.1073/pnas.1000264107; Wang WX, 2010, P NATL ACAD SCI USA, V107, P4522, DOI 10.1073/pnas.0911087107; Wiesner J, 2000, EXP PARASITOL, V96, P182, DOI 10.1006/expr.2000.4566; Wiesner J, 2007, ARCH PHARM, V340, P667, DOI 10.1002/ardp.200700069; Woo YH, 2006, BIOORGAN MED CHEM, V14, P2375, DOI 10.1016/j.bmc.2005.11.012; Zintl A, 2003, CLIN MICROBIOL REV, V16, P622, DOI 10.1128/CMR.16.4.622-636.2003	74	59	59	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19334	10.1371/journal.pone.0019334	http://dx.doi.org/10.1371/journal.pone.0019334			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573242	Green Published, Green Submitted, gold			2022-12-27	WOS:000290224800022
J	Hanson, JL; Chandra, A; Wolfe, BL; Pollak, SD				Hanson, Jamie L.; Chandra, Amitabh; Wolfe, Barbara L.; Pollak, Seth D.			Association between Income and the Hippocampus	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; NORMAL BRAIN-DEVELOPMENT; ENVIRONMENTAL ENRICHMENT; COGNITIVE-DEVELOPMENT; SOCIOECONOMIC-STATUS; CHILDHOOD POVERTY; NIH MRI; STRESS; RATS; REGISTRATION	Facets of the post-natal environment including the type and complexity of environmental stimuli, the quality of parenting behaviors, and the amount and type of stress experienced by a child affects brain and behavioral functioning. Poverty is a type of pervasive experience that is likely to influence biobehavioral processes because children developing in such environments often encounter high levels of stress and reduced environmental stimulation. This study explores the association between socioeconomic status and the hippocampus, a brain region involved in learning and memory that is known to be affected by stress. We employ a voxel-based morphometry analytic framework with region of interest drawing for structural brain images acquired from participants across the socioeconomic spectrum (n = 317). Children from lower income backgrounds had lower hippocampal gray matter density, a measure of volume. This finding is discussed in terms of disparities in education and health that are observed across the socioeconomic spectrum.	[Hanson, Jamie L.; Pollak, Seth D.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; [Hanson, Jamie L.; Pollak, Seth D.] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Chandra, Amitabh] Harvard Univ, Harvard Kennedy Sch Govt, Cambridge, MA 02138 USA; [Wolfe, Barbara L.] Univ Wisconsin, Dept Econ, Madison, WI 53706 USA; [Wolfe, Barbara L.] Univ Wisconsin, Dept Populat Hlth Sci, Madison, WI USA; [Wolfe, Barbara L.] Univ Wisconsin, Inst Res Poverty, Madison, WI USA; [Wolfe, Barbara L.] Univ Wisconsin, Dept Publ Affairs, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Harvard University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Hanson, JL (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.	jlhanson5@wisc.edu; wolfe@lafollette.wisc.edu	Pollak, Seth D/G-2345-2011; Hanson, Jamie/B-9420-2014	Hanson, Jamie/0000-0002-0469-8886; Wolfe, Barbara/0000-0002-8803-9019	US National Institute on Drug Abuse [DA028087]; US National Institute of Mental Health [MH61285, MH68858]; Children's Bureau of the Administration on Children, Youth and Families as part of the Child Neglect Research Consortium; Russell Sage Foundation; University of Wisconsin-Madison Graduate School; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068858, R01MH061285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA028087] Funding Source: NIH RePORTER	US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Children's Bureau of the Administration on Children, Youth and Families as part of the Child Neglect Research Consortium; Russell Sage Foundation; University of Wisconsin-Madison Graduate School; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the US National Institute on Drug Abuse (Grant DA028087 to JLH), the US National Institute of Mental Health (Grants MH61285 and MH68858 to SDP) and the Children's Bureau of the Administration on Children, Youth and Families as part of the Child Neglect Research Consortium. This project was also supported by the Russell Sage Foundation and the University of Wisconsin-Madison Graduate School grants to BLW. The authors also thank the Russell Sage Foundation for their support of Health and SES working group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER NE, 1994, AM PSYCHOL, V49, P15, DOI 10.1037/0003-066X.49.1.15; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Biegler R, 2001, P NATL ACAD SCI USA, V98, P6941, DOI 10.1073/pnas.121034798; Busatto Geraldo F, 2008, Expert Rev Neurother, V8, P1691, DOI 10.1586/14737175.8.11.1691; Evans AC, 2006, NEUROIMAGE, V30, P184, DOI 10.1016/j.neuroimage.2005.09.068; Evans GW, 2007, PSYCHOL SCI, V18, P953, DOI 10.1111/j.1467-9280.2007.02008.x; Farah MJ, 2008, DEVELOPMENTAL SCI, V11, P793, DOI 10.1111/j.1467-7687.2008.00688.x; Farah MJ, 2006, BRAIN RES, V1110, P166, DOI 10.1016/j.brainres.2006.06.072; FIALA BA, 1978, EXP NEUROL, V59, P372, DOI 10.1016/0014-4886(78)90229-7; Gianaros PJ, 2007, NEUROIMAGE, V35, P795, DOI 10.1016/j.neuroimage.2006.10.045; GREEN EJ, 1986, J NEUROPHYSIOL, V55, P739, DOI 10.1152/jn.1986.55.4.739; GREENOUGH WT, 1992, MINN SYM CHILD PSYCH, V24, P155; GREENOUGH WT, 1973, EXP NEUROL, V41, P371, DOI 10.1016/0014-4886(73)90278-1; Hackman DA, 2009, TRENDS COGN SCI, V13, P65, DOI 10.1016/j.tics.2008.11.003; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Lupien SJ, 2007, BRAIN COGNITION, V65, P209, DOI 10.1016/j.bandc.2007.02.007; McEwen BS, 2010, ANN NY ACAD SCI, V1204, pE38, DOI 10.1111/j.1749-6632.2010.05568.x; McEwen BS, 2001, ANN NY ACAD SCI, V933, P265, DOI 10.1111/j.1749-6632.2001.tb05830.x; McLoyd V C, 1990, New Dir Child Dev, P49; Meaney Michael J, 2005, Dialogues Clin Neurosci, V7, P103; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; MOFFITT TE, 1981, J ABNORM PSYCHOL, V90, P152, DOI 10.1037/0021-843X.90.2.152; Raizada RDS, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/neuro.09.003.2010; Rao H, 2010, NEUROIMAGE, V49, P1144, DOI 10.1016/j.neuroimage.2009.07.003; Soffie M, 1999, BEHAV BRAIN RES, V101, P37, DOI 10.1016/S0166-4328(98)00139-9; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Tottenham N, 2010, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.068.2009; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Waber DP, 2007, J INT NEUROPSYCH SOC, V13, P729, DOI 10.1017/S1355617707070841; Whitwell JL, 2007, PARKINSONISM RELAT D, V13, pS406, DOI 10.1016/S1353-8020(08)70039-7; Wilke M, 2008, NEUROIMAGE, V41, P903, DOI 10.1016/j.neuroimage.2008.02.056; WILL BE, 1977, J COMP PHYSIOL PSYCH, V91, P33, DOI 10.1037/h0077306; Williams Leanne M, 2008, Expert Rev Neurother, V8, P1049, DOI 10.1586/14737175.8.7.1049; Yassa MA, 2009, NEUROIMAGE, V44, P319, DOI 10.1016/j.neuroimage.2008.09.016	37	186	190	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e18712	10.1371/journal.pone.0018712	http://dx.doi.org/10.1371/journal.pone.0018712			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	759EZ	21573231	Green Submitted, gold, Green Published			2022-12-27	WOS:000290224800005
J	Lusebrink, J; Schildgen, V; Tillmann, RL; Wittleben, F; Bohmer, A; Muller, A; Schildgen, O				Luesebrink, Jessica; Schildgen, Verena; Tillmann, Ramona Liza; Wittleben, Felix; Boehmer, Anne; Mueller, Andreas; Schildgen, Oliver			Detection of Head-to-Tail DNA Sequences of Human Bocavirus in Clinical Samples	PLOS ONE			English	Article							PARVOVIRUS MINUTE VIRUS; REPLICATIVE-FORM DNA; ROLLING CIRCLE MODEL; PROTEIN NS1; MICE; ORIGIN; INFECTIONS; INITIATION; CELLS	Parvoviruses are single stranded DNA viruses that replicate in a so called "rolling-hairpin" mechanism, a variant of the rolling circle replication known for bacteriophages like phi X174. The replication intermediates of parvoviruses thus are concatemers of head-to-head or tail-to-tail structure. Surprisingly, in case of the novel human bocavirus, neither head-to-head nor tail-to-tail DNA sequences were detected in clinical isolates; in contrast head-to-tail DNA sequences were identified by PCR and sequencing. Thereby, the head-to-tail sequences were linked by a novel sequence of 54 bp of which 20 bp also occur as conserved structures of the palindromic ends of parvovirus MVC which in turn is a close relative to human bocavirus.	[Luesebrink, Jessica; Schildgen, Verena; Tillmann, Ramona Liza; Wittleben, Felix; Boehmer, Anne; Schildgen, Oliver] Klinikum Privaten Univ Witten Herdecke, Inst Pathol, Kliniken Stadt Koln gGmbH, Cologne, Germany; [Mueller, Andreas] Univ Hosp Bonn, Dept Paediat, Bonn, Germany	University of Cologne; University of Bonn	Lusebrink, J (corresponding author), Klinikum Privaten Univ Witten Herdecke, Inst Pathol, Kliniken Stadt Koln gGmbH, Cologne, Germany.	schildgeno@kliniken-koeln.de	Schildgen, Oliver/D-5327-2014	Schildgen, Oliver/0000-0003-4297-9627; Wittleben, Felix/0000-0002-1561-8271	Deutsche Lungenstiftung e.V. (Hannover, Germany); Else Kroner-Fresenius Stiftung (Bad Homburg, Germany); Deutsche Gesellschaft fur Padiatrische Infektiologie (DGPI) (Bremen, Germany)	Deutsche Lungenstiftung e.V. (Hannover, Germany); Else Kroner-Fresenius Stiftung (Bad Homburg, Germany); Deutsche Gesellschaft fur Padiatrische Infektiologie (DGPI) (Bremen, Germany)	This work was partially supported by unrestricted research grants from the Deutsche Lungenstiftung e.V. (Hannover, Germany), the Else Kroner-Fresenius Stiftung (Bad Homburg, Germany), and the Research Award 2009 from the Deutsche Gesellschaft fur Padiatrische Infektiologie (DGPI) (Bremen, Germany) to O.S. and A.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Baldauf AQ, 1997, J VIROL, V71, P971, DOI 10.1128/JVI.71.2.971-980.1997; BERNS KI, 1990, MICROBIOL REV, V54, P316, DOI 10.1128/MMBR.54.3.316-329.1990; Bohmer A, 2009, J VIROL METHODS, V158, P199, DOI 10.1016/j.jviromet.2009.02.010; CHEN AY, VIROLOGY, V403, P145; CHEN KC, 1988, J VIROL, V62, P3807, DOI 10.1128/JVI.62.10.3807-3813.1988; CHOW BD, J CLIN VIROL, V47, P143; Chow BDW, 2009, CLIN LAB MED, V29, P695, DOI 10.1016/j.cll.2009.07.010; Cotmore SF, 2005, J VIROL, V79, P2287, DOI 10.1128/JVI.79.4.2287-2300.2005; COTMORE SF, 1989, J VIROL, V63, P1002, DOI 10.1128/JVI.63.2.1002-1006.1989; Cotmore SF, 1998, J VIROL, V72, P8477, DOI 10.1128/JVI.72.11.8477-8484.1998; Cotmore SF, 2000, J VIROL, V74, P1332, DOI 10.1128/JVI.74.3.1332-1341.2000; COTMORE SF, 1993, J VIROL, V67, P1579, DOI 10.1128/JVI.67.3.1579-1589.1993; Cotmore SF, 2007, J VIROL, V81, P13015, DOI 10.1128/JVI.01703-07; Dijkman R, 2009, J VIROL, V83, P7739, DOI 10.1128/JVI.00614-09; DOERMANN AH, 1973, ANNU REV GENET, V7, P325, DOI 10.1146/annurev.ge.07.120173.001545; FAUST EA, 1982, NUCLEIC ACIDS RES, V10, P4181, DOI 10.1093/nar/10.14.4181; Gao GP, 2003, P NATL ACAD SCI USA, V100, P6081, DOI 10.1073/pnas.0937739100; Hirt B, 2000, CONTRIB MICROBIOL, V4, P163; Kahn J, 2008, CURR OPIN PEDIATR, V20, P62, DOI 10.1097/MOP.0b013e3282f3f518; KAPOOR A, J INFECT DIS, V201, P1633; KOCZOT FJ, 1973, P NATL ACAD SCI USA, V70, P215, DOI 10.1073/pnas.70.1.215; Lindner J, 2008, INTERVIROLOGY, V51, P116, DOI 10.1159/000137411; Schildgen O, 2008, CLIN MICROBIOL REV, V21, P291, DOI 10.1128/CMR.00030-07; SCHRODER CH, 1973, J MOL BIOL, V79, P599, DOI 10.1016/0022-2836(73)90066-1; Sun YN, 2009, J VIROL, V83, P3956, DOI 10.1128/JVI.02569-08; TATTERSALL P, 1976, NATURE, V263, P106, DOI 10.1038/263106a0; Tattersall P., 2006, EVOLUTION PARVOVIRUS, P5; Volz S, 2007, J CLIN VIROL, V40, P229, DOI 10.1016/j.jcv.2007.07.017; Willwand K, 1998, J BIOL CHEM, V273, P1165, DOI 10.1074/jbc.273.2.1165	30	51	57	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19457	10.1371/journal.pone.0019457	http://dx.doi.org/10.1371/journal.pone.0019457			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573237	Green Submitted, Green Published, gold			2022-12-27	WOS:000290224800030
J	Luquero, FJ; Banga, CN; Remartinez, D; Palma, PP; Baron, E; Grais, RF				Luquero, Francisco J.; Banga, Cunhate Na; Remartinez, Daniel; Palma, Pedro Pablo; Baron, Emanuel; Grais, Rebeca F.			Cholera Epidemic in Guinea-Bissau (2008): The Importance of "Place"	PLOS ONE			English	Article							RISK; VACCINATION; AREA	Background: As resources are limited when responding to cholera outbreaks, knowledge about where to orient interventions is crucial. We describe the cholera epidemic affecting Guinea-Bissau in 2008 focusing on the geographical spread in order to guide prevention and control activities. Methodology/Principal Findings: We conducted two studies: 1) a descriptive analysis of the cholera epidemic in Guinea-Bissau focusing on its geographical spread (country level and within the capital); and 2) a cross-sectional study to measure the prevalence of houses with at least one cholera case in the most affected neighbourhood of the capital (Bairro Bandim) to detect clustering of households with cases (cluster analysis). All cholera cases attending the cholera treatment centres in Guinea-Bissau who fulfilled a modified World Health Organization clinical case definition during the epidemic were included in the descriptive study. For the cluster analysis, a sample of houses was selected from a satellite photo (Google Earth (TM)); 140 houses (and the four closest houses) were assessed from the 2,202 identified structures. We applied K-functions and Kernel smoothing to detect clustering. We confirmed the clustering using Kulldorff's spatial scan statistic. A total of 14,222 cases and 225 deaths were reported in the country (AR = 0.94%, CFR = 1.64%). The more affected regions were Biombo, Bijagos and Bissau (the capital). Bairro Bandim was the most affected neighborhood of the capital (AR = 4.0). We found at least one case in 22.7% of the houses (95% CI: 19.5-26.2) in this neighborhood. The cluster analysis identified two areas within Bairro Bandim at highest risk: a market and an intersection where runoff accumulates waste (p < 0.001). Conclusions/Significance: Our analysis allowed for the identification of the most affected regions in Guinea-Bissau during the 2008 cholera outbreak, and the most affected areas within the capital. This information was essential for making decisions on where to reinforce treatment and to guide control and prevention activities.	[Luquero, Francisco J.; Baron, Emanuel; Grais, Rebeca F.] Epicentre, Paris, France; [Luquero, Francisco J.] European Ctr Dis Prevent & Control ECDC, EPIET, Stockholm, Sweden; [Banga, Cunhate Na] Minist Hlth, Dept Epidemiol, Bissau, Guinea Bissau; [Remartinez, Daniel; Palma, Pedro Pablo] Med Sin Fronteras, Barcelona, Spain	European Centre for Disease Prevention & Control	Luquero, FJ (corresponding author), Epicentre, Paris, France.	fluquero@epicentre.msf.org		Freeman Grais, Rebecca/0000-0002-5037-8218	Medecins Sans Frontieres	Medecins Sans Frontieres	This research was funded by Medecins Sans Frontieres. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AABY P, 1997, PROSPECTIVE COMMUNIT, P276; Ali M, 2002, SOC SCI MED, V55, P1015, DOI 10.1016/S0277-9536(01)00230-1; Ali M, 2002, HEALTH PLACE, V8, P201, DOI 10.1016/S1353-8292(01)00043-0; Ali Mohammad, 2006, Int J Health Geogr, V5, P45, DOI 10.1186/1476-072X-5-45; Bompangue D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000436; Cavailler P, 2006, VACCINE, V24, P4890, DOI 10.1016/j.vaccine.2005.10.006; Chevallier E, 2004, EUR J PUBLIC HEALTH, V14, P274, DOI 10.1093/eurpub/14.3.274; Coulombier D, 2002, Med Trop (Mars), V62, P391; Deen JL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000173; DIGGLE P., 1985, APPL STAT-J ROY ST C, V34, P138, DOI DOI 10.2307/2347366; DIGGLE PJ, 1991, BIOMETRICS, V47, P1155, DOI 10.2307/2532668; Griffith DC, 2006, AM J TROP MED HYG, V75, P973, DOI 10.4269/ajtmh.2006.75.973; KULLDORFF M., 2010, SOFTWARE SPATIAL SPA; Lucas MES, 2005, NEW ENGL J MED, V352, P757, DOI 10.1056/NEJMoa043323; *MED SAN FRONT, 2004, CHOL GUID; Myaux J, 1997, HEALTH PLACE, V3, P181, DOI 10.1016/S1353-8292(97)00013-0; Osei FB, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-44; R Core Team, 2018, R LANG ENV STAT COMP; Sasaki S, 2008, AM J TROP MED HYG, V79, P414, DOI 10.4269/ajtmh.2008.79.414; Sur D, 2009, LANCET, V374, P1694, DOI 10.1016/S0140-6736(09)61297-6; Waldman EA, 2002, J HEALTH POPUL NUTR, V20, P85; *WHO, 2008, CHOL GUIN BISS; *WHO, 2008, COUNTR HLTH SYST FAC; WHO, 2004, CHOL OUTBR ASS OUTBR; WHO, 2006, WKLY EPIDEMIOL REC, V81, P297; *WORK GROUP MORT E, 2007, EMERG THEMES EPIDEMI, V1, P4; Zuckerman JN, 2007, LANCET INFECT DIS, V7, P521, DOI 10.1016/S1473-3099(07)70138-X; 2004, MMWR MORB MORTAL WKL, V53, P783	28	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19005	10.1371/journal.pone.0019005	http://dx.doi.org/10.1371/journal.pone.0019005			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21572530	Green Published, gold, Green Submitted			2022-12-27	WOS:000290224800013
J	Yang, AC; Tsai, SJ; Hong, CJ; Wang, C; Chen, TJ; Liou, YJ; Peng, CK				Yang, Albert C.; Tsai, Shih-Jen; Hong, Chen-Jee; Wang, Cynthia; Chen, Tai-Jui; Liou, Ying-Jay; Peng, Chung-Kang			Clustering Heart Rate Dynamics Is Associated with beta-Adrenergic Receptor Polymorphisms: Analysis by Information-Based Similarity Index	PLOS ONE			English	Article							LEFT-VENTRICULAR FUNCTION; POWER SPECTRUM ANALYSIS; RATE-VARIABILITY; SYMBOLIC DYNAMICS; BETA(2)-ADRENERGIC RECEPTOR; ADRENOCEPTOR POLYMORPHISMS; PERIOD VARIABILITY; GENE POLYMORPHISMS; NONLINEAR INDEXES; FRACTAL ANALYSIS	Background: Genetic polymorphisms in the gene encoding the beta-adrenergic receptors (beta-AR) have a pivotal role in the functions of the autonomic nervous system. Using heart rate variability (HRV) as an indicator of autonomic function, we present a bottom-up genotype-phenotype analysis to investigate the association between beta-AR gene polymorphisms and heart rate dynamics. Methods: A total of 221 healthy Han Chinese adults (59 males and 162 females, aged 33.6 +/- 10.8 years, range 19 to 63 years) were recruited and genotyped for three common beta-AR polymorphisms: beta(1)-AR Ser49Gly, beta(2)-AR Arg16Gly and beta(2)-AR Gln27Glu. Each subject underwent two hours of electrocardiogram monitoring at rest. We applied an information-based similarity (IBS) index to measure the pairwise dissimilarity of heart rate dynamics among study subjects. Results: With the aid of agglomerative hierarchical cluster analysis, we categorized subjects into major clusters, which were found to have significantly different distributions of beta(2)-AR Arg16Gly genotype. Furthermore, the non-randomness index, a nonlinear HRV measure derived from the IBS method, was significantly lower in Arg16 homozygotes than in Gly16 carriers. The non-randomness index was negatively correlated with parasympathetic-related HRV variables and positively correlated with those HRV indices reflecting a sympathovagal shift toward sympathetic activity. Conclusions: We demonstrate a bottom-up categorization approach combining the IBS method and hierarchical cluster analysis to detect subgroups of subjects with HRV phenotypes associated with beta-AR polymorphisms. Our results provide evidence that beta(2)-AR polymorphisms are significantly associated with the acceleration/deceleration pattern of heart rate oscillation, reflecting the underlying mode of autonomic nervous system control.	[Yang, Albert C.] Chu Tung Vet Hosp, Dept Psychiat, Hsin Chu Cty, Taiwan; [Yang, Albert C.; Peng, Chung-Kang] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Chungli 32054, Taiwan; [Yang, Albert C.; Tsai, Shih-Jen; Hong, Chen-Jee; Liou, Ying-Jay] Natl Yang Ming Univ, Sch Med, Div Psychiat, Taipei 112, Taiwan; [Tsai, Shih-Jen; Hong, Chen-Jee; Liou, Ying-Jay] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Hong, Chen-Jee] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Wang, Cynthia] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Chen, Tai-Jui] I Shou Univ, Kaohsiung, Taiwan; [Chen, Tai-Jui] E DA Hosp, Kaohsiung, Taiwan; [Peng, Chung-Kang] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Margret & HA Rey Inst Nonlinear Dynam Med, Boston, MA 02215 USA	National Central University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Princeton University; I Shou University; E-Da Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Yang, AC (corresponding author), Chu Tung Vet Hosp, Dept Psychiat, Hsin Chu Cty, Taiwan.	ccyang@physionet.org; sjtsai@vghtpe.gov.tw	Peng, Chung-Kang/N-1308-2019; Tsai, Shih-Jen/AAK-7944-2020; Peng, Chung-Kang/E-1489-2011	Peng, Chung-Kang/0000-0003-3666-9833; Tsai, Shih-Jen/0000-0002-9987-022X; Peng, Chung-Kang/0000-0003-3666-9833; Wang, Cynthia/0000-0001-9565-9585	Taipei Veterans General Hospital, Taiwan [V97ER3-003, V98ER3-004, V99ER3-004, V97C1-132]; National Science Council (NSC) of Taiwan [NSC 95-2314-B-075-111]; NSC	Taipei Veterans General Hospital, Taiwan(Taipei Veterans General Hospital); National Science Council (NSC) of Taiwan(Ministry of Science and Technology, Taiwan); NSC(Ministry of Science and Technology, Taiwan)	This work was supported by grants V97ER3-003, V98ER3-004, V99ER3-004, and V97C1-132 from Taipei Veterans General Hospital, Taiwan; the National Science Council (NSC) of Taiwan (NSC 95-2314-B-075-111); and the NSC support for the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Antelmi I, 2004, AM J CARDIOL, V93, P381, DOI 10.1016/j.amjcard.2003.09.065; Bengtsson K, 2001, CIRCULATION, V104, P187, DOI 10.1161/01.CIR.104.2.187; Bleecker ER, 2007, LANCET, V370, P2118, DOI 10.1016/S0140-6736(07)61906-0; Busjahn A, 1998, AM J CARDIOL, V81, P755, DOI 10.1016/S0002-9149(97)01019-9; Camm AJ, 1996, CIRCULATION, V93, P1043; Cheng D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007733; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Dishy V, 2001, NEW ENGL J MED, V345, P1030, DOI 10.1056/NEJMoa010819; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Goldberger JJ, 2001, CIRCULATION, V103, P1977; Grandy SA, 2004, AM J PHYSIOL-HEART C, V287, pH1029, DOI 10.1152/ajpheart.00814.2003; Guzzetti S, 2005, CIRCULATION, V112, P465, DOI 10.1161/CIRCULATIONAHA.104.518449; Ho KKL, 1997, CIRCULATION, V96, P842; HO YL, 2011, PLOS ONE IN PRESS; Huikuri HV, 2000, CIRCULATION, V101, P47, DOI 10.1161/01.CIR.101.1.47; Humma LM, 2001, AM J CARDIOL, V88, P1034, DOI 10.1016/S0002-9149(01)01986-5; KATONA PG, 1975, J APPL PHYSIOL, V39, P801, DOI 10.1152/jappl.1975.39.5.801; Kupper NHM, 2004, CIRCULATION, V110, P2792, DOI 10.1161/01.CIR.0000146334.96820.6E; KURTHS J, 1995, CHAOS, V5, P88, DOI 10.1063/1.166090; Lohse MJ, 2004, TRENDS MOL MED, V10, P55, DOI 10.1016/j.molmed.2003.12.004; Maestri R, 2005, COMPUT CARDIOL, V32, P981; Maestri R, 2007, J CARDIOVASC ELECTR, V18, P425, DOI 10.1111/j.1540-8167.2007.00728.x; Makikallio TH, 1997, AM J CARDIOL, V80, P779; Makikallio TH, 1999, AM J CARDIOL, V83, P836, DOI 10.1016/S0002-9149(98)01076-5; MALLIANI A, 1994, BRIT HEART J, V71, P1; Masuo K, 2005, AM J HYPERTENS, V18, P1009, DOI 10.1016/j.amjhyper.2005.01.006; Masuo K, 2005, CIRCULATION, V111, P3429, DOI 10.1161/CIRCULATIONAHA.104.519652; Matsunaga T, 2007, AM HEART J, V154, P759, DOI 10.1016/j.ahj.2007.03.053; Matsunaga T, 2009, J HYPERTENS, V27, P305, DOI 10.1097/HJH.0b013e32831ac967; Mietus JE, 2002, HEART, V88, P378, DOI 10.1136/heart.88.4.378; Neumann SA, 2005, PSYCHOSOM MED, V67, P168, DOI 10.1097/01.psy.0000155671.90861.c2; Newton-Cheh C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S7; Peng CK, 2007, CHAOS, V17, DOI 10.1063/1.2716147; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; PENG CK, 1992, NATURE, V356, P168, DOI 10.1038/356168a0; POMERANZ B, 1985, AM J PHYSIOL, V248, pH151, DOI 10.1152/ajpheart.1985.248.1.H151; Porta A, 2001, IEEE T BIO-MED ENG, V48, P1282, DOI 10.1109/10.959324; Ranade K, 2002, AM J HUM GENET, V70, P935, DOI 10.1086/339621; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Singh JP, 1999, CIRCULATION, V99, P2251, DOI 10.1161/01.CIR.99.17.2251; Sinnreich R, 1999, HUM GENET, V105, P654, DOI 10.1007/s004390051158; Snyder EM, 2006, J PHYSIOL-LONDON, V571, P121, DOI 10.1113/jphysiol.2005.098558; Su SY, 2009, AM J CARDIOL, V104, P1748, DOI 10.1016/j.amjcard.2009.07.063; Tapanainen JM, 2002, AM J CARDIOL, V90, P347, DOI 10.1016/S0002-9149(02)02488-8; Taylor JA, 1998, CIRCULATION, V98, P547, DOI 10.1161/01.CIR.98.6.547; Tibby SM, 2003, CRIT CARE MED, V31, P2059, DOI 10.1097/01.CCM.0000069539.65980.58; Tien YJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-155; Wang Xiaoling, 2005, Am J Cardiol, V96, P1166, DOI 10.1016/j.amjcard.2005.06.050; Wessel N, 2000, PHYS REV E, V61, P733, DOI 10.1103/PhysRevE.61.733; Wilk JB, 2006, ANN HUM GENET, V70, P566, DOI 10.1111/j.1469-1809.2005.00258.x; Yang ACC, 2005, J COMPUT BIOL, V12, P1103, DOI 10.1089/cmb.2005.12.1103; Yang ACC, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.108103; Yang ACC, 2003, PHYSICA A, V329, P473, DOI 10.1016/S0378-4371(03)00622-8; Yang AC, 2010, AM J MED GENET B, V153B, P1024, DOI 10.1002/ajmg.b.31069; Yeh RG, 2007, BIOMED ENG-APP BAS C, V19, P303, DOI 10.1142/S1016237207000409; Yeragani VK, 2000, DEPRESS ANXIETY, V12, P67, DOI 10.1002/1520-6394(2000)12:2<67::AID-DA2>3.0.CO;2-C	58	13	14	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19232	10.1371/journal.pone.0019232	http://dx.doi.org/10.1371/journal.pone.0019232			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573230	Green Submitted, Green Published, gold			2022-12-27	WOS:000290224800018
J	Colson, P; Gimenez, G; Boyer, M; Fournous, G; Raoult, D				Colson, Philippe; Gimenez, Gregory; Boyer, Mickael; Fournous, Ghislain; Raoult, Didier			The Giant Cafeteria roenbergensis Virus That Infects a Widespread Marine Phagocytic Protist Is a New Member of the Fourth Domain of Life	PLOS ONE			English	Article							DNA VIRUSES; SEQUENCE; EVOLUTION; GENES; CLASSIFICATION; SOFTWARE; FAMILIES; DATABASE; LESSONS; ORIGIN	Background: A recent work has provided strong arguments in favor of a fourth domain of Life composed of nucleocytoplasmic large DNA viruses (NCLDVs). This hypothesis was supported by phylogenetic and phyletic analyses based on a common set of proteins conserved in Eukarya, Archaea, Bacteria, and viruses, and implicated in the functions of information storage and processing. Recently, the genome of a new NCLDV, Cafeteria roenbergensis virus (CroV), was released. The present work aimed to determine if CroV supports the fourth domain of Life hypothesis. Methods: A consensus phylogenetic tree of NCLDVs including CroV was generated from a concatenated alignment of four universal proteins of NCLDVs. Some features of the gene complement of CroV and its distribution along the genome were further analyzed. Phylogenetic and phyletic analyses were performed using the previously identified common set of informational genes present in Eukarya, Archaea, Bacteria, and NCLDVs, including CroV. Findings: Phylogenetic reconstructions indicated that CroV is clearly related to the Mimiviridae family. The comparison between the gene repertoires of CroV and Mimivirus showed similarities regarding the gene contents and genome organization. In addition, the phyletic clustering based on the comparison of informational gene repertoire between Eukarya, Archaea, Bacteria, and NCLDVs unambiguously classified CroV with other NCLDVs and clearly included it in a fourth domain of Life. Taken together, these data suggest that Mimiviridae, including CroV, may have inherited a common gene content probably acquired from a common Mimiviridae ancestor. Conclusions: This further analysis of the gene repertoire of CroV consolidated the fourth domain of Life hypothesis and contributed to outline a functional pan-genome for giant viruses infecting phagocytic protistan grazers.	[Colson, Philippe; Gimenez, Gregory; Boyer, Mickael; Fournous, Ghislain; Raoult, Didier] Univ Mediterranee, Fac Med & Pharm, CNRS, IRD 3R198,URMITE,UMR 6236, Marseille, France; [Colson, Philippe; Raoult, Didier] CHU Timone, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Colson, P (corresponding author), Univ Mediterranee, Fac Med & Pharm, CNRS, IRD 3R198,URMITE,UMR 6236, Marseille, France.	didier.raoult@gmail.com	Boyer, Mickaël/F-6608-2013; RAOULT, Didier/A-8434-2008; Colson, Philippe/P-6355-2014	Boyer, Mickaël/0000-0001-5384-1151; RAOULT, Didier/0000-0002-0633-5974; Colson, Philippe/0000-0001-6285-0308				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Boyer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015530; Boyer M, 2010, INTERVIROLOGY, V53, P310, DOI 10.1159/000312916; Boyer M, 2009, P NATL ACAD SCI USA, V106, P21848, DOI 10.1073/pnas.0911354106; Claverie JM, 2009, NAT REV MICROBIOL, V7, DOI 10.1038/nrmicro2108-c3; Dagan T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-118; Delaroque N, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-110; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EVANS DH, 1988, J VIROL, V62, P367, DOI 10.1128/JVI.62.2.367-375.1988; Filee J, 2007, TRENDS GENET, V23, P10, DOI 10.1016/j.tig.2006.11.002; Fischer D, 1999, BIOINFORMATICS, V15, P759, DOI 10.1093/bioinformatics/15.9.759; Fischer Matthias G, 2010, Proc Natl Acad Sci U S A, V107, P19508, DOI 10.1073/pnas.1007615107; Forterre P, 2010, INTERVIROLOGY, V53, P362, DOI 10.1159/000312921; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Iyer LA, 2006, VIRUS RES, V117, P156, DOI 10.1016/j.virusres.2006.01.009; Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001; Koonin EV, 2010, INTERVIROLOGY, V53, P284, DOI 10.1159/000312913; Koonin EV, 2009, NAT REV MICROBIOL, V7, DOI 10.1038/nrmicro2108-c5; La Scola B, 2003, SCIENCE, V299, P2033; La Scola B, 2008, NATURE, V455, P100, DOI 10.1038/nature07218; La Scola B, 2010, INTERVIROLOGY, V53, P344, DOI 10.1159/000312919; Massana R, 2007, ENVIRON MICROBIOL, V9, P2660, DOI 10.1111/j.1462-2920.2007.01378.x; McLysaght A, 2003, P NATL ACAD SCI USA, V100, P15655, DOI 10.1073/pnas.2136653100; Moreira D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-12; Moreira D, 2009, NAT REV MICROBIOL, V7, P306, DOI 10.1038/nrmicro2108; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Puigbo P, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-38; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Raoult D, 2008, NAT REV MICROBIOL, V6, P315, DOI 10.1038/nrmicro1858; Raoult D, 2007, CLIN INFECT DIS, V45, P95, DOI 10.1086/518608; Raoult D, 2010, INTERVIROLOGY, V53, P321, DOI 10.1159/000312917; Raoult D, 2009, NAT REV MICROBIOL, V7, DOI 10.1038/nrmicro2108-c6; Shackelton LA, 2004, TRENDS MICROBIOL, V12, P458, DOI 10.1016/j.tim.2004.08.005; Suhre K, 2005, J VIROL, V79, P14095, DOI 10.1128/JVI.79.22.14095-14101.2005; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Thomas V, 2010, INTERVIROLOGY, V53, P254, DOI 10.1159/000312910; Van Etten JL, 2010, ANNU REV MICROBIOL, V64, P83, DOI 10.1146/annurev.micro.112408.134338; Yutin N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-223	42	49	51	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18935	10.1371/journal.pone.0018935	http://dx.doi.org/10.1371/journal.pone.0018935			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559486	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700039
J	Kanazawa, H; Fujimoto, Y; Teratani, T; Iwasaki, J; Kasahara, N; Negishi, K; Tsuruyama, T; Uemoto, S; Kobayashi, E				Kanazawa, Hiroyuki; Fujimoto, Yasuhiro; Teratani, Takumi; Iwasaki, Junji; Kasahara, Naoya; Negishi, Kouji; Tsuruyama, Tatsuaki; Uemoto, Shinji; Kobayashi, Eiji			Bone Marrow-Derived Mesenchymal Stem Cells Ameliorate Hepatic Ischemia Reperfusion Injury in a Rat Model	PLOS ONE			English	Article							IN-VIVO; LIVER-TRANSPLANTATION; DIFFERENTIATION; THERAPY	Background: Ischemia-reperfusion (I/R) injury associated with living donor liver transplantation impairs liver graft regeneration. Mesenchymal stem cells (MSCs) are potential cell therapeutic targets for liver disease. In this study, we demonstrate the impact of MSCs against hepatic I/R injury and hepatectomy. Methodology/Principal Findings: We used a new rat model in which major hepatectomy with I/R injury was performed. Male Lewis rats were separated into two groups: an MSC group given MSCs after reperfusion as treatment, and a Control group given phosphate-buffered saline after reperfusion as placebo. The results of liver function tests, pathologic changes in the liver, and the remnant liver regeneration rate were assessed. The fate of transplanted MSCs in the luciferase-expressing rats was examined by in vivo luminescent imaging. The MSC group showed peak luciferase activity of transplanted MSCs in the remnant liver 24 h after reperfusion, after which luciferase activity gradually declined. The elevation of serum alanine transaminase levels was significantly reduced by MSC injection. Histopathological findings showed that vacuolar change was lower in the MSC group compared to the Control group. In addition, a significantly lower percentage of TUNEL-positive cells was observed in the MSC group compared with the controls. Remnant liver regeneration rate was accelerated in the MSC group. Conclusions/Significance: These data suggest that MSC transplantation provides trophic support to the I/R-injured liver by inhibiting hepatocellular apoptosis and by stimulating regeneration.	[Kanazawa, Hiroyuki; Fujimoto, Yasuhiro; Teratani, Takumi; Iwasaki, Junji; Kasahara, Naoya; Negishi, Kouji; Kobayashi, Eiji] Jichi Med Univ, Ctr Dev Adv Med Technol, Div Dev Adv Treatment, Yakushiji City, Tochigi, Japan; [Kanazawa, Hiroyuki; Iwasaki, Junji; Tsuruyama, Tatsuaki] Kyoto Univ Hosp, Dept Diagnost Pathol, Kyoto 606, Japan; [Uemoto, Shinji] Kyoto Univ, Grad Sch Med, Dept Hepatopancreatobiliary Surg & Transplantat, Kyoto, Japan	Jichi Medical University; Kyoto University; Kyoto University	Kanazawa, H (corresponding author), Jichi Med Univ, Ctr Dev Adv Med Technol, Div Dev Adv Treatment, Yakushiji City, Tochigi, Japan.	kagoshimakurobuta@hotmail.com						Azoulay D, 1996, ANN SURG, V224, P737, DOI 10.1097/00000658-199612000-00009; Baertschiger RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006657; Banas A, 2008, STEM CELLS, V26, P2705, DOI 10.1634/stemcells.2008-0034; Banas A, 2007, DEV DYNAM, V236, P3228, DOI 10.1002/dvdy.21330; Banas A, 2007, HEPATOLOGY, V46, P219, DOI 10.1002/hep.21704; Ben-Haim M, 2001, LIVER TRANSPLANT, V7, P948, DOI 10.1053/jlts.2001.29033; Dahlke MH, 2009, TRANSPLANTATION, V88, P614, DOI 10.1097/TP.0b013e3181b4425a; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Forte A, 2008, J CELL PHYSIOL, V217, P789, DOI 10.1002/jcp.21559; Fujishiro J, 2005, NEPHROL DIAL TRANSPL, V20, P1385, DOI 10.1093/ndt/gfh783; Goss JA, 1997, TRANSPLANTATION, V64, P871, DOI 10.1097/00007890-199709270-00014; Hakamata Y, 2006, TRANSPLANTATION, V81, P1179, DOI 10.1097/01.tp.0000203137.06587.4a; Inoue H, 2005, BIOCHEM BIOPH RES CO, V329, P288, DOI 10.1016/j.bbrc.2005.01.132; Inoue S, 2004, TRANSPLANTATION, V77, P997, DOI 10.1097/01.TP.0000118404.66106.E8; Lam SP, 2010, LIVER TRANSPLANT, V16, P1195, DOI 10.1002/lt.22136; Meer C, 1976, CIRC SHOCK, V3, P191; Oyagi S, 2006, J HEPATOL, V44, P742, DOI 10.1016/j.jhep.2005.10.026; Parekkadan B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000941; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Sato Y, 2005, BLOOD, V106, P756, DOI 10.1182/blood-2005-02-0572; SUZUKI S, 1991, TRANSPLANTATION, V52, P978, DOI 10.1097/00007890-199112000-00008; Tsai PC, 2009, LIVER TRANSPLANT, V15, P484, DOI 10.1002/lt.21715; van Poll D, 2008, HEPATOLOGY, V47, P1634, DOI 10.1002/hep.22236; Wang YJ, 2009, BIOCHEM BIOPH RES CO, V390, P1309, DOI 10.1016/j.bbrc.2009.10.143; Yadav SS, 1998, TRANSPLANTATION, V65, P1433, DOI 10.1097/00007890-199806150-00004; Zhang D, 2011, PLOS ONE, V2	26	142	163	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19195	10.1371/journal.pone.0019195	http://dx.doi.org/10.1371/journal.pone.0019195			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559442	Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700096
J	Nakajima, K; Yokoyama, K; Koizumi, T; Koizumi, A; Asakura, T; Terada, T; Masuda, K; Ito, K; Shimizu-Ibuka, A; Misaka, T; Abe, K				Nakajima, Ken-ichiro; Yokoyama, Kanako; Koizumi, Taichi; Koizumi, Ayako; Asakura, Tomiko; Terada, Tohru; Masuda, Katsuyoshi; Ito, Keisuke; Shimizu-Ibuka, Akiko; Misaka, Takumi; Abe, Keiko			Identification and Modulation of the Key Amino Acid Residue Responsible for the pH Sensitivity of Neoculin, a Taste-Modifying Protein	PLOS ONE			English	Article							SWEET PROTEIN; PURIFICATION; CURCULIN; STABILITY; PRINCIPLE; RECEPTOR; FRUIT	Neoculin occurring in the tropical fruit of Curculigo latifolia is currently the only protein that possesses both a sweet taste and a taste-modifying activity of converting sourness into sweetness. Structurally, this protein is a heterodimer consisting of a neoculin acidic subunit (NAS) and a neoculin basic subunit (NBS). Recently, we found that a neoculin variant in which all five histidine residues are replaced with alanine elicits intense sweetness at both neutral and acidic pH but has no taste-modifying activity. To identify the critical histidine residue(s) responsible for this activity, we produced a series of His-to-Ala neoculin variants and evaluated their sweetness levels using cell-based calcium imaging and a human sensory test. Our results suggest that NBS His11 functions as a primary pH sensor for neoculin to elicit taste modification. Neoculin variants with substitutions other than His-to-Ala were further analyzed to clarify the role of the NBS position 11 in the taste-modifying activity. We found that the aromatic character of the amino acid side chain is necessary to elicit the pH-dependent sweetness. Interestingly, since the His-to-Tyr variant is a novel taste-modifying protein with alternative pH sensitivity, the position 11 in NBS can be critical to modulate the pH-dependent activity of neoculin. These findings are important for understanding the pH-sensitive functional changes in proteinaceous ligands in general and the interaction of taste receptor-taste substance in particular.	[Nakajima, Ken-ichiro; Koizumi, Taichi; Koizumi, Ayako; Asakura, Tomiko; Ito, Keisuke; Shimizu-Ibuka, Akiko; Misaka, Takumi; Abe, Keiko] Univ Tokyo, Dept Appl Biol Chem, Tokyo, Japan; [Yokoyama, Kanako] Tokyo Univ Agr, Dept Nutr Sci, Tokyo, Japan; [Terada, Tohru; Abe, Keiko] Univ Tokyo, Grad Sch Agr & Life Sci, Agr Bioinformat Res Unit, Tokyo, Japan; [Masuda, Katsuyoshi] Suntory Inst Bioorgan Res, Osaka 618, Japan; [Abe, Keiko] Kanagawa Acad Sci & Technol, Food Safety & Reliabil Project, Kawasaki, Kanagawa, Japan	University of Tokyo; Tokyo University of Agriculture; University of Tokyo; Suntory Holdings Ltd; Kanagawa Academy Science & Technology	Nakajima, K (corresponding author), Univ Tokyo, Dept Appl Biol Chem, Tokyo, Japan.	aka7308@mail.ecc.u-tokyo.ac.jp	Terada, Tohru/W-2956-2019; Ito, Keisuke/J-5926-2013	Terada, Tohru/0000-0002-7091-0646; SHIMIZU-IBUKA, Akiko/0000-0002-5310-9216; Nakajima, Ken-ichiro/0000-0003-1932-418X; Ito, Keisuke/0000-0002-8719-9635; Misaka, Takumi/0000-0002-9547-5767	Research and Development Program for New Bio-industry Initiatives of the Bio-oriented Technology Research Advancement Institution; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan [21880015, 19300248, 20688015, 21658046, 20380183]; Nisshin Seifun Foundation	Research and Development Program for New Bio-industry Initiatives of the Bio-oriented Technology Research Advancement Institution; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nisshin Seifun Foundation	This study was performed with a grant from the Research and Development Program for New Bio-industry Initiatives of the Bio-oriented Technology Research Advancement Institution. This work was also supported by the Nisshin Seifun Foundation (to K. N.), by the Japan Society for the Promotion of Science Research Fellowship for Young Scientists (to A. K.), by Grant-in-aid for Research Activity Start-up 21880015 (to K. N.), and by Grants-in-aid for Scientific Research 19300248 (to T. A.), 20688015 and 21658046 (to T. M.) and 20380183 (to K. A.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cui M, 2006, CURR PHARM DESIGN, V12, P4591, DOI 10.2174/138161206779010350; Koizumi A, 2007, BIOCHEM BIOPH RES CO, V358, P585, DOI 10.1016/j.bbrc.2007.04.171; KURIHARA Y, 1992, CRIT REV FOOD SCI, V32, P231, DOI 10.1080/10408399209527598; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Maehashi K, 1998, BIOSCI BIOTECH BIOCH, V62, P605, DOI 10.1271/bbb.62.605; Masuda T, 2001, J AGR FOOD CHEM, V49, P4937, DOI 10.1021/jf010404q; MING D, 1994, FEBS LETT, V355, P106, DOI 10.1016/0014-5793(94)01184-2; MORRIS JA, 1972, BIOCHIM BIOPHYS ACTA, V261, P114, DOI 10.1016/0304-4165(72)90320-0; Nakajima KI, 2008, FASEB J, V22, P2323, DOI 10.1096/fj.07-100289; Nakajima K, 2006, APPL ENVIRON MICROB, V72, P3716, DOI 10.1128/AEM.72.5.3716-3723.2006; NIRASAWA S, 1994, EUR J BIOCHEM, V223, P989, DOI 10.1111/j.1432-1033.1994.tb19077.x; Shirasuka Y, 2004, BIOSCI BIOTECH BIOCH, V68, P1403, DOI 10.1271/bbb.68.1403; Suzuki M, 2004, FEBS LETT, V573, P135, DOI 10.1016/j.febslet.2004.07.073; THEERASILP S, 1988, J BIOL CHEM, V263, P11536; VANDERWEL H, 1989, CHEM SENSES, V14, P75; VANDERWEL H, 1972, EUR J BIOCHEM, V31, P221; YAMASHITA H, 1990, J BIOL CHEM, V265, P15770; YAMASHITA H, 1995, CHEM SENSES, V20, P239, DOI 10.1093/chemse/20.2.239; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001	19	12	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19448	10.1371/journal.pone.0019448	http://dx.doi.org/10.1371/journal.pone.0019448			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559382	gold, Green Published, Green Submitted			2022-12-27	WOS:000290024700177
J	Simpson, LA; Miller, WC; Eng, JJ				Simpson, Lisa A.; Miller, William C.; Eng, Janice J.			Effect of Stroke on Fall Rate, Location and Predictors: A Prospective Comparison of Older Adults with and without Stroke	PLOS ONE			English	Article							CONFIDENCE ABC SCALE; 6-MINUTE WALK TEST; RISK-FACTORS; ELDERLY PERSONS; PREVENTION TRIALS; INJURY PREVENTION; GO TEST; BALANCE; COMMUNITY; REHABILITATION	Background: The literature suggests that stroke is a major risk factor for falls, but there is a lack of prospective, controlled studies which quantify fall-risk after stroke. The purpose of this study was to compare the rates, location and predictors among individuals recently discharged home from stroke rehabilitation to age and sex matched controls. Methodology/Principal Findings: A sample of 80 people with stroke and 90 controls received baseline assessments of balance, mobility and balance confidence. Falls were recorded prospectively over 13 months for both groups. Group differences in fall rates and contribution of clinical measures to falls were determined using negative binomial regression. Fall location was compared between groups using x 2 statistics. The rate of falls for individuals with stroke was 1.77 times the rate for the control group. People with stroke were more likely to fall at home. Poorer balance (Berg Balance Scale) was associated with greater falls for both stroke and control groups (incidence rate ratio [IRR]: 0.908 and IRR: 0.877 respectively). A faster Timed Up and Go Test was associated with greater falls for the stroke group (IRR: 0.955) while better walking endurance (Six Minute Walk Test) was associated with greater falls for the controls (IRR: 1.004). Balance confidence was not an independent predictor in either group. Conclusions: Individuals recently discharged home are at greater risk of falling than individuals without stroke. Attention to home environment is warranted. Balance function can predict falls for both people with stroke and age and sex matched controls. Increased mobility may increase exposure to fall opportunities.	[Simpson, Lisa A.] Univ British Columbia, Grad Program Rehabil Sci, Vancouver, BC V5Z 1M9, Canada; [Miller, William C.] Univ British Columbia, Dept Occupat Sci & Occupat Therapy, Vancouver, BC V5Z 1M9, Canada; [Eng, Janice J.] Univ British Columbia, Dept Phys Therapy, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Simpson, LA (corresponding author), Univ British Columbia, Grad Program Rehabil Sci, Vancouver, BC V5Z 1M9, Canada.	bcmiller@telus.net	Miller, William/S-7407-2019	Eng, Janice/0000-0002-2093-0788	Heart and Stroke Foundation of BC; Heart and Stroke Foundation of Yukon; Canadian Institutes of Health Research [CIHR MSH-63617, CIHR MSH-76731]; Michael Smith Foundation of Health Research	Heart and Stroke Foundation of BC; Heart and Stroke Foundation of Yukon; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation of Health Research(Michael Smith Foundation for Health Research)	This study was funded by a grant-in-aid from the Heart and Stroke Foundation of BC and Yukon. The authors are also grateful for salary support from the Canadian Institutes of Health Research to JJE (CIHR MSH-63617) and WCM (CIHR MSH-76731) and the Michael Smith Foundation of Health Research (JJE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburn A, 2008, AGE AGEING, V37, P270, DOI 10.1093/ageing/afn066; Batchelor F, 2010, STROKE, V41, P1715, DOI 10.1161/STROKEAHA.109.570390; Beninato M, 2009, PHYS THER, V89, P816, DOI 10.2522/ptj.20080160; BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; Berg WP, 1997, AGE AGEING, V26, P261, DOI 10.1093/ageing/26.4.261; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Donaldson MG, 2009, AGE AGEING, V38, P151, DOI 10.1093/ageing/afn279; FORSTER A, 1995, BRIT MED J, V311, P83, DOI 10.1136/bmj.311.6997.83; JACOBS JW, 1977, ANN INTERN MED, V86, P40, DOI 10.7326/0003-4819-86-1-40; Jorgensen H S, 1999, Phys Med Rehabil Clin N Am, V10, P887; Jorgensen L, 2002, STROKE, V33, P542, DOI 10.1161/hs0202.102375; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; Lamb SE, 2003, STROKE, V34, P494, DOI 10.1161/01.STR.0000053444.00582.B7; Long J.S., 2006, REGRESSION MODELS CA; Mackintosh SFH, 2005, CLIN REHABIL, V19, P441, DOI 10.1191/0269215505cr796oa; Mackintosh SF, 2006, ARCH PHYS MED REHAB, V87, P1583, DOI 10.1016/j.apmr.2006.09.004; Myers AM, 1998, J GERONTOL A-BIOL, V53, pM287, DOI 10.1093/gerona/53A.4.M287; Newman AB, 2006, JAMA-J AM MED ASSOC, V295, P2018, DOI 10.1001/jama.295.17.2018; OLOUGHLIN JL, 1993, AM J EPIDEMIOL, V137, P342, DOI 10.1093/oxfordjournals.aje.a116681; Pang MYC, 2008, OSTEOPOROSIS INT, V19, P919, DOI 10.1007/s00198-007-0519-5; Persson CU, 2011, J REHABIL MED, V43, P348, DOI 10.2340/16501977-0677; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; Ramnemark A, 1998, OSTEOPOROSIS INT, V8, P92, DOI 10.1007/s001980050053; Robertson MC, 2005, J GERONTOL A-BIOL, V60, P530, DOI 10.1093/gerona/60.4.530; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; SPEECHLEY M, 1991, J AM GERIATR SOC, V39, P46, DOI 10.1111/j.1532-5415.1991.tb05905.x; Steffen TM, 2002, PHYS THER, V82, P128, DOI 10.1093/ptj/82.2.128; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Wagner Laura M, 2009, BMC Geriatr, V9, P46, DOI 10.1186/1471-2318-9-46; Watanabe Y, 2005, INT J REHABIL RES, V28, P149, DOI 10.1097/00004356-200506000-00008; Weerdesteyn V, 2008, J REHABIL RES DEV, V45, P1195, DOI 10.1682/JRRD.2007.09.0145; Whitney JC, 2005, AGE AGEING, V34, P567, DOI 10.1093/ageing/afi178; Yiannakoulias N, 2003, SOC SCI MED, V57, P2065, DOI 10.1016/S0277-9536(03)00081-9	34	115	120	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19431	10.1371/journal.pone.0019431	http://dx.doi.org/10.1371/journal.pone.0019431			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	756OZ	21559367	gold, Green Published, Green Submitted			2022-12-27	WOS:000290024700169
J	Liou, JW; Gu, MH; Chen, YK; Chen, WY; Chen, YC; Tseng, YH; Hung, YJ; Chang, HH				Liou, Je-Wen; Gu, Ming-Hui; Chen, Yen-Kai; Chen, Wen-Yi; Chen, Yi-Cheng; Tseng, Yao-Hsuan; Hung, Yu-Jiun; Chang, Hsin-Hou			Visible Light Responsive Photocatalyst Induces Progressive and Apical-Terminus Preferential Damages on Escherichia coli Surfaces	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; BACTERICIDAL ACTIVITY; STATIONARY-PHASE; MEMBRANE; DOMAINS; VISUALIZATION; LOCALIZATION; SULBACTAM; WATER; TIO2	Background: Recent research shows that visible-light responsive photocatalysts have potential usage in antimicrobial applications. However, the dynamic changes in the damage to photocatalyzed bacteria remain unclear. Methodology/Principal Findings: Facilitated by atomic force microscopy, this study analyzes the visible-light driven photocatalyst-mediated damage of Escherichia coli. Results show that antibacterial properties are associated with the appearance of hole-like structures on the bacteria surfaces. Unexpectedly, these hole-like structures were preferentially induced at the apical terminus of rod shaped E. coli cells. Differentiating the damages into various levels and analyzing the percentage of damage to the cells showed that photocatalysis was likely to elicit sequential damages in E. coli cells. The process began with changing the surface properties on bacterial cells, as indicated in surface roughness measurements using atomic force microscopy, and holes then formed at the apical terminus of the cells. The holes were then subsequently enlarged until the cells were totally transformed into a flattened shape. Parallel experiments indicated that photocatalysis-induced bacterial protein leakage is associated with the progression of hole-like damages, further suggesting pore formation. Control experiments using ultraviolet light responsive titanium-dioxide substrates also obtained similar observations, suggesting that this is a general phenomenon of E. coli in response to photocatalysis. Conclusion/Significance: The photocatalysis-mediated localization-preferential damage to E. coli cells reveals the weak points of the bacteria. This might facilitate the investigation of antibacterial mechanism of the photocatalysis.	[Liou, Je-Wen; Chen, Yen-Kai; Chen, Wen-Yi] Tzu Chi Univ, Dept Biochem, Hualien, Taiwan; [Liou, Je-Wen; Chen, Yi-Cheng; Hung, Yu-Jiun; Chang, Hsin-Hou] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Liou, Je-Wen; Chang, Hsin-Hou] Natl Dong Hwa Univ, Nanotechnol Res Ctr, Hualien, Taiwan; [Gu, Ming-Hui; Chen, Yi-Cheng] Tzu Chi Univ, Dept Lab Med & Biotechnol, Hualien, Taiwan; [Tseng, Yao-Hsuan] Natl Taiwan Univ Sci & Technol, Dept Chem Engn, Taipei, Taiwan; [Chang, Hsin-Hou] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan	Tzu Chi University; Tzu Chi University; National Dong Hwa University; Tzu Chi University; National Taiwan University of Science & Technology; Tzu Chi University	Liou, JW (corresponding author), Tzu Chi Univ, Dept Biochem, Hualien, Taiwan.	hhchang@mail.tcu.edu.tw	Liou, Je-Wen/ABB-2157-2020; Chang, Hsin-Hou/B-6225-2012	Liou, Je-Wen/0000-0002-6181-7263; Chang, Hsin-Hou/0000-0002-8731-3485	National Science Council of Taiwan ROC [94-2120-M-259-003, 95-2314-B-320-009-MY3, 95-2120-M-259-003]; Ministry of Economic Affairs, Taiwan, ROC [98-EC-17-A-19-S2-0111]; Tzu-Chi University [TCIRP 95002-02, TCIRP 96004-01, TCIRP 98001-01, TCRPP 99020-01]; Tzu-Chi University Center for Biomedical Nanotechnology	National Science Council of Taiwan ROC(Ministry of Science and Technology, Taiwan); Ministry of Economic Affairs, Taiwan, ROC(Ministry of Economic Affairs, Taiwan); Tzu-Chi University; Tzu-Chi University Center for Biomedical Nanotechnology	This work was supported by National Science Council of Taiwan ROC under grant no. 94-2120-M-259-003, 95-2314-B-320-009-MY3 and 95-2120-M-259-003, and Ministry of Economic Affairs, Taiwan, ROC under grant no. 98-EC-17-A-19-S2-0111, and Tzu-Chi University under grant no. TCIRP 95002-02, TCIRP 9600401, TCIRP 98001-01 and TCRPP 99020-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank the support from Tzu-Chi University Center for Biomedical Nanotechnology.	Alley SH, 2008, BIOPHYS J, V94, P2938, DOI 10.1529/biophysj.107.118380; Bantar C, 2008, DIAGN MICR INFEC DIS, V61, P309, DOI 10.1016/j.diagmicrobio.2008.02.014; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Braga PC, 1998, ANTIMICROB AGENTS CH, V42, P18, DOI 10.1128/AAC.42.1.18; Buynak JD, 2007, ACS CHEM BIOL, V2, P602, DOI 10.1021/cb700182u; Cabeen MT, 2007, J CELL BIOL, V179, P381, DOI 10.1083/jcb.200708001; Cheng CL, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-7; Chou PW, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2357879; Christensen H, 1999, MOL MICROBIOL, V31, P1561, DOI 10.1046/j.1365-2958.1999.01304.x; da Silva A, 2003, BBA-MOL CELL RES, V1643, P95, DOI 10.1016/j.bbamcr.2003.10.001; DIEDRICH DL, 1974, J BACTERIOL, V119, P1006, DOI 10.1128/JB.119.3.1006-1018.1974; Fishov I, 1999, MOL MICROBIOL, V32, P1166, DOI 10.1046/j.1365-2958.1999.01425.x; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Herbert D, 1996, ANTIMICROB AGENTS CH, V40, P2296, DOI 10.1128/AAC.40.10.2296; Kau JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014289; Kau JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004167; LEGRINI O, 1993, CHEM REV, V93, P671, DOI 10.1021/cr00018a003; Li A, 2007, BBA-BIOMEMBRANES, V1768, P411, DOI 10.1016/j.bbamem.2006.12.010; Liou JW, 2002, BIOCHEMISTRY-US, V41, P8535, DOI 10.1021/bi025962s; Maness PC, 1999, APPL ENVIRON MICROB, V65, P4094; Margolin W, 2009, CURR BIOL, V19, pR812, DOI 10.1016/j.cub.2009.06.033; Mascio CTM, 2007, ANTIMICROB AGENTS CH, V51, P4255, DOI 10.1128/AAC.00824-07; Meincken A, 2005, ANTIMICROB AGENTS CH, V49, P4085, DOI 10.1128/AAC.49.10.4085-4092.2005; Mileykovskaya E, 2000, J BACTERIOL, V182, P1172, DOI 10.1128/JB.182.4.1172-1175.2000; Mileykovskaya E, 2007, MOL MICROBIOL, V64, P1419, DOI 10.1111/j.1365-2958.2007.05766.x; Mingorance J, 2010, TRENDS MICROBIOL, V18, P348, DOI 10.1016/j.tim.2010.06.001; Mitoraj D, 2007, PHOTOCH PHOTOBIO SCI, V6, P642, DOI 10.1039/b617043a; Mukhopadhyay R, 2008, BIOPHYS J, V95, P1034, DOI 10.1529/biophysj.107.126920; Rasmussen JP, 2008, ENVIRON TOXICOL, V23, P36, DOI 10.1002/tox.20311; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Scheuring S, 2010, MOL MICROBIOL, V75, P1327, DOI 10.1111/j.1365-2958.2010.07064.x; Shapiro L, 2002, SCIENCE, V298, P1942, DOI 10.1126/science.1072163; Treschev SY, 2008, APPL CATAL B-ENVIRON, V79, P8, DOI 10.1016/j.apcatb.2007.09.046; Tsai TM, 2010, J CHEM TECHNOL BIOT, V85, P1642, DOI 10.1002/jctb.2476; Tseng YH, 2006, NANOTECHNOLOGY, V17, P2490, DOI 10.1088/0957-4484/17/10/009; Wong MS, 2006, APPL ENVIRON MICROB, V72, P6111, DOI 10.1128/AEM.02580-05; Wong MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010394; Wu PG, 2010, BIOMATERIALS, V31, P7526, DOI 10.1016/j.biomaterials.2010.06.032; Yang L, 2006, ANAL CHEM, V78, P7341, DOI 10.1021/ac0604890; Young KD, 2003, MOL MICROBIOL, V49, P571, DOI 10.1046/j.1365-2958.2003.03607.x	41	29	29	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19982	10.1371/journal.pone.0019982	http://dx.doi.org/10.1371/journal.pone.0019982			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589873	Green Submitted, Green Published, gold			2022-12-27	WOS:000290531100036
J	Rachlis, BS; Mills, EJ; Cole, DC				Rachlis, Beth S.; Mills, Edward J.; Cole, Donald C.			Livelihood Security and Adherence to Antiretroviral Therapy in Low and Middle Income Settings: A Systematic Review	PLOS ONE			English	Review							HIV-INFECTED INDIVIDUALS; HIV/AIDS PATIENTS; MEDICATION ADHERENCE; BARRIERS; NONADHERENCE; DETERMINANTS; FACILITATORS; HAART; AIDS; PREDICTORS	Introduction: We sought to examine the association between livelihood security and adherence to antiretroviral therapy (ARVs) in low-and middle-income countries (LIMC). Methods: Performing a systematic review, we searched, independently and in duplicate, 7 electronic databases and 2 conference websites for quantitative surveys that examined the association between indicators of livelihood security and adherence to ARVs in LIMC between 2000-2010. Criteria for relevance were applied to complete papers (quantitative study with estimates of associations) and quality assessment was conducted on those deemed relevant. We performed three regressions to measure the association between each type of livelihood and adherence. Results: Twenty original studies and 6 conference abstracts were included, the majority from Africa (n = 16). Seventeen studies and 3 conference abstracts were cross-sectional and 3 studies and 3 abstracts were prospective clinical cohort studies, with considerable variation in quality for studies of each design type. Among the diverse populations represented, we observed considerable variation in associations between measurements of livelihood indicators and increasingly accepted adherence measures, irrespective of study design or quality. A financial capital indicator, financial constraints/payment for ARV medication, was more commonly associated with non-adherence (3/5 studies). A human capital indicator, educational level, was most commonly associated with adherence (11/20 studies). Discussion: Additional better quality research examining livelihood security is required to inform provision of optimal supports for adherence and mitigation of the impacts of HIV/AIDS.	[Rachlis, Beth S.; Cole, Donald C.] Univ Toronto, Div Epidemiol, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Mills, Edward J.] Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada	University of Toronto; University of Ottawa	Rachlis, BS (corresponding author), Univ Toronto, Div Epidemiol, Dalla Lana Sch Publ Hlth, 100 Coll St, Toronto, ON, Canada.	beth.rachlis@utoronto.ca	Cole, Donald C/K-1040-2013	Cole, Donald C/0000-0002-1009-603X				ABAH IO, 2006, AIDS 2006 16 INT AID; Aboubacrine SA, 2007, INT J STD AIDS, V18, P741, DOI 10.1258/095646207782212243; Altice FL, 2001, J ACQ IMMUN DEF SYND, V28, P47, DOI 10.1097/00042560-200109010-00008; Anema Aranka, 2009, Curr HIV/AIDS Rep, V6, P224, DOI 10.1007/s11904-009-0030-z; [Anonymous], CRIT APPR SKILLS PRO; Au JT, 2006, AIDS, V20, P2116, DOI 10.1097/01.aids.0000247580.16073.1b; Bandura A., 1997, SELF EFFICACY EXERCI; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Berg KM, 2006, JAIDS-J ACQ IMM DEF, V43, pS79, DOI 10.1097/01.qai.0000248337.97814.66; Birbeck GL, 2009, AM J TROP MED HYG, V80, P669, DOI 10.4269/ajtmh.2009.80.669; Bonolo P. de F., 2005, AIDS, V19, pS5, DOI 10.1097/01.aids.0000191484.84661.2b; Boyer S, 2009, B WORLD HEALTH ORGAN, V87, P279, DOI 10.2471/BLT.07.049643; Byakika-Tusiime J, 2005, INT J STD AIDS, V16, P38, DOI 10.1258/0956462052932548; Carlucci JG, 2008, JAIDS-J ACQ IMM DEF, V47, P615, DOI 10.1097/QAI.0b013e318165dc25; CARNEY B, 1998, DEP INT DEV NAT RES; Castro A, 2005, PLOS MED, V2, P1217, DOI 10.1371/journal.pmed.0020338; Cauldbeck Mary B, 2009, AIDS Res Ther, V6, P7, DOI 10.1186/1742-6405-6-7; Chijioke AN, 2006, AFRICAN J HLTH SCI, V13, P13; DAHAB M, 2006, AIDS 2006 16 INT AID; DANIEL OJ, 2004, 15 INT AIDS C THAIL; DARDER M, 2004, 15 INT AIDS C 2004; de Waal A, 2003, LANCET, V362, P1234, DOI 10.1016/S0140-6736(03)14548-5; Diabate S, 2007, AIDS, V21, P1799, DOI 10.1097/QAD.0b013e3282a5667b; Drimie S., 2006, AIDS, poverty, and hunger: challenges and responses. Highlights of the International Conference on HIV/AIDS and Food and Nutrition Security, Durban, South Africa, 14-16 April, 2005, P283, DOI 10.2499/0896297586CH15; ELASHA BO, 2005, 17 ASS IMP AD CLIM C; Ellis F, 2003, WORLD DEV, V31, P1495, DOI 10.1016/S0305-750X(03)00111-6; Erah PO, 2008, AFR J PHARM PHARMACO, V2, P145; Silva MCF, 2009, REV INST MED TROP SP, V51, P135, DOI 10.1590/S0036-46652009000300003; Gavian S., 2006, AIDS, poverty, and hunger: challenges and responses. Highlights of the International Conference on HIV/AIDS and Food and Nutrition Security, Durban, South Africa, 14-16 April, 2005, P221, DOI 10.2499/0896297586CH12; Hogg RS, 1997, LANCET, V349, P1294, DOI 10.1016/S0140-6736(05)62505-6; Ickovics JR, 2002, AIDS CARE, V14, P309, DOI 10.1080/09540120220123685; Iliyasu Z, 2005, Niger J Med, V14, P290; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; *JOINT UN PROGR HI, 2009, REP GLOB AIDS PAND; Kalichman SC, 1999, J GEN INTERN MED, V14, P267, DOI 10.1046/j.1525-1497.1999.00334.x; Katrak Persis, 2004, BMC Med Res Methodol, V4, P22, DOI 10.1186/1471-2288-4-22; Kumarasamy N, 2005, AIDS PATIENT CARE ST, V19, P526, DOI 10.1089/apc.2005.19.526; Laniece I, 2003, AIDS, V17, pS103, DOI 10.1097/00002030-200317003-00014; Liu HH, 2001, ANN INTERN MED, V134, P968, DOI 10.7326/0003-4819-134-10-200105150-00011; LOEVINSOHN M, 2003, 2 RENEWAL; Malangu NG, 2008, S AFR FAM PRACT, V50, P49, DOI 10.1080/20786204.2008.10873763; Mannheimer SB, 2005, AIDS CARE, V17, P10, DOI 10.1080/09540120412331305098; Masanjala W, 2007, SOC SCI MED, V64, P1032, DOI 10.1016/j.socscimed.2006.10.009; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Mondloch MV, 2001, CAN MED ASSOC J, V165, P174; Moss AR, 2004, CLIN INFECT DIS, V39, P1190, DOI 10.1086/424008; Nachega JB, 2004, AIDS RES HUM RETROV, V20, P1053, DOI 10.1089/aid.2004.20.1053; Nachega JB, 2010, CURR OPIN HIV AIDS, V5, P70, DOI 10.1097/COH.0b013e328333ad61; NAIK E, 2009, IND J SEX TRANSMIT D, V40, P23; Nam SL, 2008, SOC SCI MED, V67, P301, DOI 10.1016/j.socscimed.2008.03.042; Ncama BP, 2008, INT J NURS STUD, V45, P1757, DOI 10.1016/j.ijnurstu.2008.06.006; Nemes MIB, 2004, AIDS, V18, pS15, DOI 10.1097/00002030-200406003-00004; Norman A, 2007, AM J PUBLIC HEALTH, V97, P1775, DOI 10.2105/AJPH.2005.082511; Orrell C, 2003, AIDS, V17, P1369, DOI 10.1097/00002030-200306130-00011; Pinheiro CAT, 2002, BRAZ J MED BIOL RES, V35, P1173, DOI 10.1590/S0100-879X2002001000010; Ramadhani HO, 2007, CLIN INFECT DIS, V45, P1492, DOI 10.1086/522991; Remien RH, 2003, AIDS BEHAV, V7, P61, DOI 10.1023/A:1022513507669; Sanjobo N, 2008, SAHARA J-J SOC ASP H, V5, P136, DOI 10.1080/17290376.2008.9724912; Sarna A, 2008, INDIAN J MED RES, V127, P28; SEELEY J, 2002, THINKING LIVELIHOOD; SHAH B, 2006, AIDS 2006 16 INT AID; Shelton JD, 2007, LANCET, V370, P1809, DOI 10.1016/S0140-6736(07)61755-3; SIDLE J, 2007, 4 IAS C HIV PATH TRE; Stout BD, 2004, AIDS PATIENT CARE ST, V18, P297, DOI 10.1089/108729104323076034; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Talam N C, 2008, East Afr J Public Health, V5, P74; Tuller DM, 2010, AIDS BEHAV, V14, P778, DOI 10.1007/s10461-009-9533-2; *UK DEP DEV, 2004, SUST LIV GUID SHEETS; Unge C, 2008, AIDS CARE, V20, P146, DOI 10.1080/09540120701513677; Uzochukwu BSC, 2009, HEALTH POLICY PLANN, V24, P189, DOI 10.1093/heapol/czp006; Vandenbroucke JP, 2007, PLOS MED, V4, P1628, DOI 10.1371/journal.pmed.0040297; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Wagner G, 2004, JAIDS-J ACQ IMM DEF, V35, P203, DOI 10.1097/00126334-200402010-00016; Wang XQ, 2007, AIDS, V21, pS149, DOI 10.1097/01.aids.0000304711.87164.99; Ware NC, 2009, PLOS MED, V6, P39, DOI 10.1371/journal.pmed.1000011; WARLEY E, 2006, AIDS 2006 16 INT AID; Watt MH, 2009, SOC SCI MED, V68, P1793, DOI 10.1016/j.socscimed.2009.02.037; Weiser S, 2003, JAIDS-J ACQ IMM DEF, V34, P281, DOI 10.1097/00126334-200311010-00004; Weiser SD, 2009, JAIDS-J ACQ IMM DEF, V52, P342, DOI 10.1097/QAI.0b013e3181b627c2; Weiser SD, 2009, J GEN INTERN MED, V24, P14, DOI 10.1007/s11606-008-0824-5; *WHO, 2008, PRIOR INT HIV AIDS P; Williams M, 2007, W INDIAN MED J, V56, P270; Wood E, 2003, AIDS, V17, P711, DOI 10.1097/00002030-200303280-00009; *WORLD BANK, COUNTR CLASS TABL	85	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e18948	10.1371/journal.pone.0018948	http://dx.doi.org/10.1371/journal.pone.0018948			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	763CL	21589911	Green Published, Green Submitted, gold			2022-12-27	WOS:000290531100002
J	Belenky, P; Stebbins, R; Bogan, KL; Evans, CR; Brenner, C				Belenky, Peter; Stebbins, Rebecca; Bogan, Katrina L.; Evans, Charles R.; Brenner, Charles			Nrt1 and Tna1-Independent Export of NAD(+) Precursor Vitamins Promotes NAD(+) Homeostasis and Allows Engineering of Vitamin Production	PLOS ONE			English	Article							LIFE-SPAN EXTENSION; SACCHAROMYCES-CEREVISIAE; NICOTINAMIDE RIBOSIDE; CALORIE RESTRICTION; DIPHOSPHOPYRIDINE NUCLEOTIDE; MULTIDRUG TRANSPORTER; GENE; IDENTIFICATION; BIOSYNTHESIS; RESISTANCE	NAD(+) is both a co-enzyme for hydride transfer enzymes and a substrate of sirtuins and other NAD(+) consuming enzymes. NAD(+) biosynthesis is required for two different regimens that extend lifespan in yeast. NAD(+) is synthesized from tryptophan and the three vitamin precursors of NAD(+): nicotinic acid, nicotinamide and nicotinamide riboside. Supplementation of yeast cells with NAD(+) precursors increases intracellular NAD(+) levels and extends replicative lifespan. Here we show that both nicotinamide riboside and nicotinic acid are not only vitamins but are also exported metabolites. We found that the deletion of the nicotinamide riboside transporter, Nrt1, leads to increased export of nicotinamide riboside. This discovery was exploited to engineer a strain to produce high levels of extracellular nicotinamide riboside, which was recovered in purified form. We further demonstrate that extracellular nicotinamide is readily converted to extracellular nicotinic acid in a manner that requires intracellular nicotinamidase activity. Like nicotinamide riboside, export of nicotinic acid is elevated by the deletion of the nicotinic acid transporter, Tna1. The data indicate that NAD(+) metabolism has a critical extracellular element in the yeast system and suggest that cells regulate intracellular NAD(+) metabolism by balancing import and export of NAD(+) precursor vitamins.	[Belenky, Peter; Stebbins, Rebecca; Bogan, Katrina L.; Brenner, Charles] Dartmouth Med Sch, Dept Genet, Lebanon, NH USA; [Belenky, Peter; Stebbins, Rebecca; Bogan, Katrina L.; Brenner, Charles] Dartmouth Med Sch, Dept Biochem, Lebanon, NH USA; [Belenky, Peter; Stebbins, Rebecca; Bogan, Katrina L.; Brenner, Charles] Dartmouth Med Sch, Norris Cotton Canc Ctr, Lebanon, NH USA; [Bogan, Katrina L.; Brenner, Charles] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA; [Bogan, Katrina L.; Brenner, Charles] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Evans, Charles R.] Univ Michigan, Nutr & Obes Res Ctr, Ann Arbor, MI 48109 USA	Dartmouth College; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; University of Iowa; University of Iowa; University of Michigan System; University of Michigan	Belenky, P (corresponding author), Dartmouth Med Sch, Dept Genet, Lebanon, NH USA.	charles-brenner@uiowa.edu	Brenner, Charles/D-6339-2014	Brenner, Charles/0000-0002-4955-3226; Evans, Charles/0000-0001-6698-5330; Stebbins, Rebecca/0000-0002-3663-1360; Belenky, Peter/0000-0002-1682-945X	National Science Foundation [MCB-0822581]; National Institutes of Health [DK089503]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089503] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grant MCB-0822581 from the National Science Foundation and by a generous gift from the Roy J. Carver Trust. Metabolomic assays were made possible by utilization of Core Services supported by grant DK089503 from the National Institutes of Health awarded to Charles K. Burant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Belenky P, 2009, J BIOL CHEM, V284, P158, DOI 10.1074/jbc.M807976200; Belenky PA, 2008, J BIOL CHEM, V283, P8075, DOI 10.1074/jbc.C800021200; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Bieganowski P, 2003, J BIOL CHEM, V278, P33049, DOI 10.1074/jbc.M302257200; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Bogan KL, 2009, J BIOL CHEM, V284, P34861, DOI 10.1074/jbc.M109.056689; Brachmann CB, 1998, YEAST, V14, P115; Evans Charles, 2010, BMC Chemical Biology, V10, P2, DOI 10.1186/1472-6769-10-2; FRANCHETTI P, 2004, CHEMINFORM, V35, P4655; Ghislain M, 2002, YEAST, V19, P215, DOI 10.1002/yea.810; Golin J, 2007, BIOCHEM BIOPH RES CO, V356, P1, DOI 10.1016/j.bbrc.2007.02.011; Klebl F, 2000, FEBS LETT, V481, P86, DOI 10.1016/S0014-5793(00)01959-1; Kolaczkowska A, 2008, FEBS LETT, V582, P977, DOI 10.1016/j.febslet.2008.02.045; Kolodziejska-Huben M, 2002, J LABELLED COMPD RAD, V45, P1005, DOI 10.1002/jlcr.617; Llorente B, 2000, FEBS LETT, V475, P237, DOI 10.1016/S0014-5793(00)01698-7; Lu SP, 2010, BBA-PROTEINS PROTEOM, V1804, P1567, DOI 10.1016/j.bbapap.2009.09.030; Lu SP, 2009, J BIOL CHEM, V284, P17110, DOI 10.1074/jbc.M109.004010; Prasad R., 2006, Infectious Disorders - Drug Targets, V6, P69, DOI 10.2174/187152606784112164; PREISS J, 1958, J BIOL CHEM, V233, P488; PREISS J, 1958, J BIOL CHEM, V233, P493; Sasaki Y, 2006, J NEUROSCI, V26, P8484, DOI 10.1523/JNEUROSCI.2320-06.2006; Tempel W, 2007, PLOS BIOL, V5, P2220, DOI 10.1371/journal.pbio.0050263; Vargas RC, 2004, ANTIMICROB AGENTS CH, V48, P2531, DOI 10.1128/AAC.48.7.2531-2537.2004; WICKERHAM LJ, 1946, J BACTERIOL, V52, P293, DOI 10.1128/JB.52.3.293-301.1946; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yang T, 2007, J MED CHEM, V50, P6458, DOI 10.1021/jm701001c	28	23	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19710	10.1371/journal.pone.0019710	http://dx.doi.org/10.1371/journal.pone.0019710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589930	Green Published, Green Submitted, gold			2022-12-27	WOS:000290483600026
J	Chappell, JM; Lohe, MA; von Smekal, L; Iqbal, A; Abbott, D				Chappell, James M.; Lohe, Max A.; von Smekal, Lorenz; Iqbal, Azhar; Abbott, Derek			A Precise Error Bound for Quantum Phase Estimation	PLOS ONE			English	Article							ALGORITHMS	Quantum phase estimation is one of the key algorithms in the field of quantum computing, but up until now, only approximate expressions have been derived for the probability of error. We revisit these derivations, and find that by ensuring symmetry in the error definitions, an exact formula can be found. This new approach may also have value in solving other related problems in quantum computing, where an expected error is calculated. Expressions for two special cases of the formula are also developed, in the limit as the number of qubits in the quantum computer approaches infinity and in the limit as the extra added qubits to improve reliability goes to infinity. It is found that this formula is useful in validating computer simulations of the phase estimation procedure and in avoiding the overestimation of the number of qubits required in order to achieve a given reliability. This formula thus brings improved precision in the design of quantum computers.	[Chappell, James M.; Lohe, Max A.] Univ Adelaide, Sch Chem & Phys, Adelaide, SA, Australia; [von Smekal, Lorenz] Tech Univ Darmstadt, Inst Kernphys, Darmstadt, Germany; [Iqbal, Azhar; Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia	University of Adelaide; Technical University of Darmstadt; University of Adelaide	Chappell, JM (corresponding author), Univ Adelaide, Sch Chem & Phys, Adelaide, SA, Australia.	james.m.chappell@adelaide.edu.au	Lohe, Max/C-3193-2012; Iqbal, Azhar/E-8749-2011; Abbott, Derek/E-8352-2011	Lohe, Max/0000-0002-5214-2225; Iqbal, Azhar/0000-0002-5221-9384; Abbott, Derek/0000-0002-0945-2674				Abramowitz M., 1964, HDB MATH FUNCTIONS F; Imre S, 2002, ISIT: 2002 IEEE INTERNATIONAL SYMPOSIUM ON INFORMATION THEORY, PROCEEDINGS, P43, DOI 10.1109/ISIT.2002.1023315; Mosca M., 1999, THESIS U OXFORD; Nielsen MA., 2002, QUANTUM COMPUTATION; Shor PW, 1997, SIAM J COMPUT, V26, P1484, DOI [10.1137/S0097539795293172, 10.1137/S0036144598347011]	6	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19663	10.1371/journal.pone.0019663	http://dx.doi.org/10.1371/journal.pone.0019663			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21573006	Green Submitted, Green Published, gold			2022-12-27	WOS:000290440200018
J	Krupovic, M; Forterre, P				Krupovic, Mart; Forterre, Patrick			Microviridae Goes Temperate: Microvirus-Related Proviruses Reside in the Genomes of Bacteroidetes	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; MOLECULAR CHARACTERIZATION; PHAGE INTEGRATION; TAILED VIRUSES; DNA; PROTEIN; DIVERSITY; EVOLUTION; BACTERIOPHAGE; BIOGEOGRAPHY	The Microviridae comprises icosahedral lytic viruses with circular single-stranded DNA genomes. The family is divided into two distinct groups based on genome characteristics and virion structure. Viruses infecting enterobacteria belong to the genus Microvirus, whereas those infecting obligate parasitic bacteria, such as Chlamydia, Spiroplasma and Bdellovibrio, are classified into a subfamily, the Gokushovirinae. Recent metagenomic studies suggest that members of the Microviridae might also play an important role in marine environments. In this study we present the identification and characterization of Microviridae-related prophages integrated in the genomes of species of the Bacteroidetes, a phylum not previously known to be associated with microviruses. Searches against metagenomic databases revealed the presence of highly similar sequences in the human gut. This is the first report indicating that viruses of the Microviridae lysogenize their hosts. Absence of associated integrase-coding genes and apparent recombination with dif-like sequences suggests that Bacteroidetes-associated microviruses are likely to rely on the cellular chromosome dimer resolution machinery. Phylogenetic analysis of the putative major capsid proteins places the identified proviruses into a group separate from the previously characterized microviruses and gokushoviruses, suggesting that the genetic diversity and host range of bacteriophages in the family Microviridae is wider than currently appreciated.	[Krupovic, Mart; Forterre, Patrick] Inst Pasteur, Dept Microbiol, Unite Biol Mol Gene Chez Extremophiles, Paris, France; [Forterre, Patrick] Univ Paris 11, CNRS, Inst Genet & Microbiol, UMR 8621, Orsay, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Krupovic, M (corresponding author), Inst Pasteur, Dept Microbiol, Unite Biol Mol Gene Chez Extremophiles, Paris, France.	krupovic@pasteur.fr	Krupovic, Mart/ABD-6255-2021; Krupovic, Mart/I-4209-2012	Krupovic, Mart/0000-0001-5486-0098; Krupovic, Mart/0000-0001-5486-0098	European Molecular Biology Organization [ALTF 347-2010]	European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	This work was supported by the European Molecular Biology Organization (Long-Term Fellowship ALTF 347-2010 to MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; AZUMA J, 1980, J BIOCHEM, V88, P525, DOI 10.1093/oxfordjournals.jbchem.a132999; Brentlinger KL, 2002, J BACTERIOL, V184, P1089, DOI 10.1128/jb.184.4.1089-1094.2002; Carnoy C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006531; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Cherwa JE, 2011, VIROLOGY, V411, P9, DOI 10.1016/j.virol.2010.12.026; Chipman PR, 1998, STRUCTURE, V6, P135, DOI 10.1016/S0969-2126(98)00016-1; Clarke IN, 2004, J BACTERIOL, V186, P7571, DOI 10.1128/JB.186.22.7571-7574.2004; Cortez D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001166; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Das B, 2011, P NATL ACAD SCI USA, V108, P2516, DOI 10.1073/pnas.1017061108; Desnues C, 2008, NATURE, V452, P340, DOI 10.1038/nature06735; Downes J, 2006, INT J SYST EVOL MICR, V56, P609, DOI 10.1099/ijs.0.63888-0; Duncan MJ, 2003, CRIT REV ORAL BIOL M, V14, P175, DOI 10.1177/154411130301400303; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fane B., 2006, BACTERIOPHAGES, P129; Fane BA, 2003, ADV PROTEIN CHEM, V64, P259; Garner SA, 2004, VIRUS GENES, V28, P207, DOI 10.1023/B:VIRU.0000016860.53035.f3; Held NL, 2009, ENVIRON MICROBIOL, V11, P457, DOI 10.1111/j.1462-2920.2008.01784.x; Hendrickson H, 2007, MOL MICROBIOL, V64, P42, DOI 10.1111/j.1365-2958.2007.05596.x; Huber KE, 2002, NATURE, V417, P656, DOI 10.1038/nature00782; ILYINA TV, 1992, NUCLEIC ACIDS RES, V20, P3279, DOI 10.1093/nar/20.13.3279; Ip SCY, 2003, EMBO J, V22, P6399, DOI 10.1093/emboj/cdg589; Jalasvuori M, 2010, J BACTERIOL, V192, P3231, DOI 10.1128/JB.00124-10; Kim KH, 2008, APPL ENVIRON MICROB, V74, P5975, DOI 10.1128/AEM.01275-08; Krupovic M, 2008, VIROLOGY, V375, P292, DOI 10.1016/j.virol.2008.01.043; Krupovic M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-236; Krupovic M, 2011, BIOCHEM SOC T, V39, P82, DOI 10.1042/BST0390082; Krupovic M, 2010, J VIROL, V84, P12476, DOI 10.1128/JVI.01489-10; Krupovic M, 2010, J MOL BIOL, V397, P144, DOI 10.1016/j.jmb.2010.01.037; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Liu BL, 2000, J VIROL, V74, P3464, DOI 10.1128/JVI.74.8.3464-3469.2000; Lopez-Bueno A, 2009, SCIENCE, V326, P858, DOI 10.1126/science.1179287; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McDaniel LD, 2006, J MAR BIOL ASSOC UK, V86, P517, DOI 10.1017/S0025315406013427; MCKENNA R, 1992, NATURE, V355, P137, DOI 10.1038/355137a0; McLeod SM, 2004, MOL MICROBIOL, V54, P935, DOI 10.1111/j.1365-2958.2004.04309.x; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; O'Sullivan LA, 2002, APPL ENVIRON MICROB, V68, P201, DOI 10.1128/AEM.68.1.201-210.2002; Ohkuma M, 2002, BIOSCI BIOTECH BIOCH, V66, P78, DOI 10.1271/bbb.66.78; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Read TD, 2003, NUCLEIC ACIDS RES, V31, P2134, DOI 10.1093/nar/gkg321; REITER WD, 1989, NUCLEIC ACIDS RES, V17, P1907, DOI 10.1093/nar/17.5.1907; Rohwer F, 2009, NATURE, V459, P207, DOI 10.1038/nature08060; Rokyta DR, 2006, J BACTERIOL, V188, P1134, DOI 10.1128/JB.188.3.1134-1142.2006; Ruboyianes MV, 2009, J VIROL, V83, P9952, DOI 10.1128/JVI.01077-09; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; SHAH HN, 1998, MICROBIOLOGY MICROBI, P1305; Srinivasiah S, 2008, RES MICROBIOL, V159, P349, DOI 10.1016/j.resmic.2008.04.010; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TUCKER KP, 2010, ISME J IN PRESS; Val ME, 2005, MOL CELL, V19, P559, DOI 10.1016/j.molcel.2005.07.002; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Yates J, 2006, MOL MICROBIOL, V59, P1754, DOI 10.1111/j.1365-2958.2005.05033.x	58	81	83	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19893	10.1371/journal.pone.0019893	http://dx.doi.org/10.1371/journal.pone.0019893			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572966	Green Published, Green Submitted, gold			2022-12-27	WOS:000290440200034
J	Deng, KY; Chu, TG				Deng, Kuiying; Chu, Tianguang			Action Being Character: A Promising Perspective on the Solution Concept of Game Theory	PLOS ONE			English	Article							ECONOMIC MAN; COOPERATION; DYNAMICS; BEHAVIOR	The inconsistency of predictions from solution concepts of conventional game theory with experimental observations is an enduring question. These solution concepts are based on the canonical rationality assumption that people are exclusively self-regarding utility maximizers. In this article, we think this assumption is problematic and, instead, assume that rational economic agents act as if they were maximizing their implicit utilities, which turns out to be a natural extension of the canonical rationality assumption. Implicit utility is defined by a player's character to reflect his personal weighting between cooperative, individualistic, and competitive social value orientations. The player who actually faces an implicit game chooses his strategy based on the common belief about the character distribution for a general player and the self-estimation of his own character, and he is not concerned about which strategies other players will choose and will never feel regret about his decision. It is shown by solving five paradigmatic games, the Dictator game, the Ultimatum game, the Prisoner's Dilemma game, the Public Goods game, and the Battle of the Sexes game, that the framework of implicit game and its corresponding solution concept, implicit equilibrium, based on this alternative assumption have potential for better explaining people's actual behaviors in social decision making situations.	[Deng, Kuiying; Chu, Tianguang] Peking Univ, State Key Lab Turbulence & Complex Syst, Coll Engn, Beijing 100871, Peoples R China; [Chu, Tianguang] Peking Univ, Key Lab Machine Percept, Minist Educ, Beijing 100871, Peoples R China	Peking University; Peking University	Deng, KY (corresponding author), Peking Univ, State Key Lab Turbulence & Complex Syst, Coll Engn, Beijing 100871, Peoples R China.	chutg@pku.edu.cn	Chu, Tianguang/C-3521-2012		National Natural Science Foundation of China (NSFC) [60974064, 60736022]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (NSFC) under grant Nos. 60974064 and 60736022 (http://www.nsfc.gov.cn/Portal0/default124.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER CG, 1978, AM J PHYS, V46, P199, DOI 10.1119/1.11165; Ahn TK, 2001, PUBLIC CHOICE, V106, P137, DOI 10.1023/A:1005219123532; [Anonymous], 1995, EVOLUTIONARY GAME TH; Bolton GE, 2000, AM ECON REV, V90, P166, DOI 10.1257/aer.90.1.166; Camerer CF, 2006, SCIENCE, V311, P47, DOI 10.1126/science.1110600; Colman AM, 2003, BEHAV BRAIN SCI, V26, P139, DOI 10.1017/S0140525X03000050; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Eckel CC, 1998, ECON J, V108, P726, DOI 10.1111/1468-0297.00311; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Fehr E, 2007, ANNU REV SOCIOL, V33, P43, DOI 10.1146/annurev.soc.33.040406.131812; FRANK RH, 1993, J ECON PERSPECT, V7, P159, DOI 10.1257/jep.7.2.159; Gintis H, 2007, BEHAV BRAIN SCI, V30, P1, DOI 10.1017/S0140525X07000581; Hauert C, 2006, P R SOC B, V273, P2565, DOI 10.1098/rspb.2006.3600; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Hoffman E, 1996, AM ECON REV, V86, P653; Jensen K, 2007, SCIENCE, V318, P107, DOI 10.1126/science.1145850; Murnighan JK, 2001, GAME ECON BEHAV, V37, P388, DOI 10.1006/game.2001.0847; Nowak MA, 2004, SCIENCE, V303, P793, DOI 10.1126/science.1093411; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; RABIN M, 1993, AM ECON REV, V83, P1281; Rose J, 2007, PSYCHOL REP, V101, P803, DOI 10.2466/PR0.101.3.803-815; ROTH AE, 1991, AM ECON REV, V81, P1068; SALLY D, 1995, RATION SOC, V7, P58, DOI 10.1177/1043463195007001004; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Sugden R, 2000, ECON PHILOS, V16, P175, DOI 10.1017/S0266267100000213; Van Lange PAM, 1999, J PERS SOC PSYCHOL, V77, P337, DOI 10.1037/0022-3514.77.2.337	29	0	0	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19014	10.1371/journal.pone.0019014	http://dx.doi.org/10.1371/journal.pone.0019014			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	761GX	21573055	gold, Green Published, Green Submitted			2022-12-27	WOS:000290386800007
J	Pachathundikandi, SK; Brandt, S; Madassery, J; Backert, S				Pachathundikandi, Suneesh Kumar; Brandt, Sabine; Madassery, Joseph; Backert, Steffen			Induction of TLR-2 and TLR-5 Expression by Helicobacter pylori Switches cagPAI-Dependent Signalling Leading to the Secretion of IL-8 and TNF-alpha	PLOS ONE			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTORS; EPITHELIAL-CELLS; GENE-EXPRESSION; IV SECRETION; CAGA; ACTIVATION; IMMUNITY; RECOGNITION; INFECTION	Helicobacter pylori is the causative agent for developing gastritis, gastric ulcer, and even gastric cancer. Virulent strains carry the cag pathogenicity island (cagPAI) encoding a type-IV secretion system (T4SS) for injecting the CagA protein. However, mechanisms of sensing this pathogen through Toll-like receptors (TLRs) and downstream signalling pathways in the development of different pathologies are widely unclear. Here, we explored the involvement of TLR-2 and TLR-5 in THP-1 cells and HEK293 cell lines ( stably transfected with TLR-2 or TLR-5) during infection with wild-type H. pylori and isogenic cagPAI mutants. H. pylori triggered enhanced TLR-2 and TLR-5 expression in THP-1, HEK293-TLR2 and HEK293-TLR5 cells, but not in the HEK293 control. In addition, IL-8 and TNF-alpha cytokine secretion in THP-1 cells was induced in a cagPAI-dependent manner. Furthermore, we show that HEK293 cells are not competent for the uptake of T4SS-delivered CagA, and are therefore ideally suited for studying TLR signalling in the absence of T4SS functions. HEK293 control cells, which do not induce TLR-2 and TLR-5 expression during infection, only secreted cytokines in small amounts, in agreement with T4SS functions being absent. In contrast, HEK293-TLR2 and HEK293-TLR5 cells were highly competent for inducing the secretion of IL-8 and TNF-alpha cytokines in a cagPAI-independent manner, suggesting that the expression of TLR-2 or TLR-5 has profoundly changed the capability to trigger pro-inflammatory signalling upon infection. Using phospho-specific antibodies and luciferase reporter assays, we further demonstrate that H. pylori induces IRAK-1 and I kappa B phosphorylation in a TLR-dependent manner, and this was required for activation of transcription factor NF-kappa B. Finally, NF-kappa B activation in HEK293-TLR2 and HEK293-TLR5 cells was confirmed by expressing p65-GFP which was translocated from the cytoplasm into the nucleus. These data indicate that H. pylori-induced expression of TLR-2 and TLR-5 can qualitatively shift cagPAI-dependent to cagPAI-independent pro-inflammatory signalling pathways with possible impact on the outcome of H. pylori-associated diseases.	[Pachathundikandi, Suneesh Kumar; Brandt, Sabine; Backert, Steffen] Otto Von Guericke Univ, Inst Med Microbiol, Magdeburg, Germany; [Pachathundikandi, Suneesh Kumar; Madassery, Joseph] Univ Calicut, Dept Biotechnol, Calicut, Kerala, India	Otto von Guericke University; University of Calicut	Pachathundikandi, SK (corresponding author), Otto Von Guericke Univ, Inst Med Microbiol, Magdeburg, Germany.	Steffen.Backert@ucd.ie	Brandt, Sabine/ABE-9674-2020		DAAD; Deutsche Forschungsgemeinschaft DFG [Ba1671/8-1]; National Institute of Diabetes and Digestive and Kidney Diseases [R56DK064371]; University College Dublin [R11408]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK064371] Funding Source: NIH RePORTER	DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University College Dublin; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work of SKP was supported by a DAAD Fellowship. The work of SBA is supported through grants from the Deutsche Forschungsgemeinschaft DFG grant (Ba1671/8-1), from the National Institute of Diabetes and Digestive and Kidney Diseases (R56DK064371) and from University College Dublin (R11408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Atherton JC, 2009, J CLIN INVEST, V119, P2475, DOI 10.1172/JCI38605; Backert S, 2004, INFECT IMMUN, V72, P1043, DOI 10.1128/IAI.72.2.1043-1056.2004; Backert S, 2010, TRENDS MICROBIOL, V18, P479, DOI 10.1016/j.tim.2010.08.003; Backert S, 2010, HELICOBACTER, V15, P163, DOI 10.1111/j.1523-5378.2010.00759.x; Backhed F, 2003, J INFECT DIS, V187, P829; Bauer B, 2005, INFECT IMMUN, V73, P4643, DOI 10.1128/IAI.73.8.4643-4652.2005; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Brandt S, 2005, P NATL ACAD SCI USA, V102, P9300, DOI 10.1073/pnas.0409873102; Contestabile A, 2005, J BIOL CHEM, V280, P33541, DOI 10.1074/jbc.M413323200; D'Elios MM, 2004, MICROBES INFECT, V6, P1395, DOI 10.1016/j.micinf.2004.10.001; Ding SZ, 2005, HELICOBACTER, V10, P193, DOI 10.1111/j.1523-5378.2005.00311.x; Foster SL, 2009, CLIN IMMUNOL, V130, P7, DOI 10.1016/j.clim.2008.08.015; Fukata M, 2008, ONCOGENE, V27, P234, DOI 10.1038/sj.onc.1210908; Gewirtz AT, 2004, J INFECT DIS, V189, P1914, DOI 10.1086/386289; Gieseler S, 2005, MICROBES INFECT, V7, P437, DOI 10.1016/j.micinf.2004.11.018; Graham DY, 2004, GUT, V53, P1235, DOI 10.1136/gut.2003.037499; Hatakeyama M, 2008, CURR OPIN MICROBIOL, V11, P30, DOI 10.1016/j.mib.2007.12.003; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jimenez-Soto LF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000684; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kawahara Tsukasa, 2001, Journal of Medical Investigation, V48, P190; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kollewe C, 2004, J BIOL CHEM, V279, P5227, DOI 10.1074/jbc.M309251200; Kurtoglu E, 2004, WORLD J GASTROENTERO, V10, P2113, DOI 10.3748/wjg.v10.i14.2113; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Lamb A, 2009, EMBO REP, V10, P1242, DOI 10.1038/embor.2009.210; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maeda S, 2001, J BIOL CHEM, V276, P44856, DOI 10.1074/jbc.M105381200; Mandell L, 2004, INFECT IMMUN, V72, P6446, DOI 10.1128/IAI.72.11.6446-6454.2004; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Moese S, 2004, INFECT IMMUN, V72, P3646, DOI 10.1128/IAI.72.6.3646-3649.2004; Moese S, 2002, INFECT IMMUN, V70, P4687, DOI 10.1128/IAI.70.8.4687-4691.2002; Ogawa T, 2003, FEMS IMMUNOL MED MIC, V36, P1, DOI 10.1016/S0928-8244(03)00093-2; Pedron T, 2008, CELL HOST MICROBE, V3, P344, DOI 10.1016/j.chom.2008.05.010; Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857; Rad R, 2007, GASTROENTEROLOGY, V133, P150, DOI 10.1053/j.gastro.2007.04.071; Rad R, 2009, GASTROENTEROLOGY, V136, P2247, DOI 10.1053/j.gastro.2009.02.066; Rothenbacher D, 2003, MICROBES INFECT, V5, P693, DOI 10.1016/S1286-4579(03)00111-4; Sayi A, 2011, J IMMUNOL, V186, P878, DOI 10.4049/jimmunol.1002269; Schmausser B, 2004, CLIN EXP IMMUNOL, V136, P521, DOI 10.1111/j.1365-2249.2004.02464.x; Schmid JA, 2000, J BIOL CHEM, V275, P17035, DOI 10.1074/jbc.M000291200; Selbach M, 2003, EMBO J, V22, P515, DOI 10.1093/emboj/cdg050; Selbach M, 2002, J BIOL CHEM, V277, P6775, DOI 10.1074/jbc.C100754200; Shaykhiev R, 2007, J LEUKOCYTE BIOL, V82, P1, DOI 10.1189/jlb.0207096; Smith MF, 2003, J BIOL CHEM, V278, P32552, DOI 10.1074/jbc.M305536200; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tato CM, 2002, INFECT IMMUN, V70, P3311, DOI 10.1128/IAI.70.7.3311-3317.2002; Torok AM, 2005, INFECT IMMUN, V73, P1523, DOI 10.1128/IAI.73.3.1523-1531.2005; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Watanabe T, 2010, J CLIN INVEST, V120, P1645, DOI 10.1172/JCI39481; Wessler S, 2008, TRENDS MICROBIOL, V16, P397, DOI 10.1016/j.tim.2008.05.005; Yokota SI, 2007, FEMS IMMUNOL MED MIC, V51, P140, DOI 10.1111/j.1574-695X.2007.00288.x; Yokota S, 2010, INFECT IMMUN, V78, P468, DOI 10.1128/IAI.00903-09; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	60	71	72	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19614	10.1371/journal.pone.0019614	http://dx.doi.org/10.1371/journal.pone.0019614			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573018	Green Published, gold, Green Submitted			2022-12-27	WOS:000290386800024
J	Myllymaki, SM; Teravainen, TP; Manninen, A				Myllymaki, Satu Marja; Teravainen, Terhi Piritta; Manninen, Aki			Two Distinct Integrin-Mediated Mechanisms Contribute to Apical Lumen Formation in Epithelial Cells	PLOS ONE			English	Article							BASOLATERAL PLASMA-MEMBRANE; SPINDLE ORIENTATION; RHO-FAMILY; MATRIX ADHESION; LIGAND-BINDING; CYST FORMATION; SMALL GTPASES; MDCK CELLS; CDC42 GEF; IN-VITRO	Background: Formation of apical compartments underlies the morphogenesis of most epithelial organs during development. The extracellular matrix (ECM), particularly the basement membrane (BM), plays an important role in orienting the apico-basal polarity and thereby the positioning of apical lumens. Integrins have been recognized as essential mediators of matrix-derived polarity signals. The importance of beta 1-integrins in epithelial polarization is well established but the significance of the accompanying alpha-subunits have not been analyzed in detail. Principal Findings: Here we demonstrate that two distinct integrin-dependent pathways regulate formation of apical lumens to ensure robust apical membrane biogenesis under different microenvironmental conditions; 1) alpha 2 beta 1- and alpha 6 beta 4-integrins were required to establish a basal cue that depends on Rac1-activity and guides apico-basal cell polarization. 2) alpha 3 beta 1-integrins were implicated in positioning of mitotic spindles in cysts, a process that is essential for Cdc42-driven epithelial hollowing. Significance: Identification of the separate processes driven by particular integrin receptors clarifies the functional hierarchies between the different integrins co-expressed in epithelial cells and provides valuable insight into the complexity of cell-ECM interactions thereby guiding future studies addressing the molecular basis of epithelial morphogenesis during development and disease.	[Myllymaki, Satu Marja; Teravainen, Terhi Piritta; Manninen, Aki] Univ Oulu, Bioctr Oulu, Oulu Ctr Cell Matrix Res, Dept Med Biochem & Mol Biol, Oulu, Finland	University of Oulu	Myllymaki, SM (corresponding author), Univ Oulu, Bioctr Oulu, Oulu Ctr Cell Matrix Res, Dept Med Biochem & Mol Biol, Oulu, Finland.	aki.manninen@oulu.fi	Manninen, Aki/AAC-8067-2019	Manninen, Aki/0000-0002-6263-8101; Myllymaki, Satu-Marja/0000-0003-0521-5062	Academy of Finland [114330]; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was supported by an Academy of Finland Grant to A.M. (114330) and by the Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar N, 2006, J CELL BIOL, V173, P781, DOI 10.1083/jcb.200601059; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; CHEN FA, 1991, J EXP MED, V173, P1111, DOI 10.1084/jem.173.5.1111; Clark EA, 1998, J CELL BIOL, V142, P573, DOI 10.1083/jcb.142.2.573; Cohen D, 2001, TRAFFIC, V2, P556, DOI 10.1034/j.1600-0854.2001.20805.x; Coucouvanis E, 1999, DEVELOPMENT, V126, P535; Cox EA, 2001, MOL BIOL CELL, V12, P265, DOI 10.1091/mbc.12.2.265; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Ferletta M, 1999, J CELL SCI, V112, P1; Friedrichs J, 2007, J BIOL CHEM, V282, P29375, DOI 10.1074/jbc.M701867200; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Hall AB, 2006, IMMUNITY, V24, P305, DOI 10.1016/j.immuni.2006.02.005; HALL DE, 1990, J CELL BIOL, V110, P2175, DOI 10.1083/jcb.110.6.2175; Hodivala-Dilke KM, 1998, J CELL BIOL, V142, P1357, DOI 10.1083/jcb.142.5.1357; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Jou TS, 1998, J CELL BIOL, V142, P85, DOI 10.1083/jcb.142.1.85; Kim Y, 2009, J CELL BIOL, V184, P309, DOI 10.1083/jcb.200806067; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Manninen A, 2005, MOL CELL BIOL, V25, P10087, DOI 10.1128/MCB.25.22.10087-10096.2005; Martin-Belmonte F, 2008, CURR OPIN CELL BIOL, V20, P227, DOI 10.1016/j.ceb.2008.01.001; Martin-Belmonte F, 2008, CURR BIOL, V18, P507, DOI 10.1016/j.cub.2008.02.076; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Matlin KS, 2003, METHODS, V30, P235, DOI 10.1016/S1046-2023(03)00030-6; Meder D, 2005, J CELL BIOL, V168, P303, DOI 10.1083/jcb.200407072; Merdek KD, 2007, J BIOL CHEM, V282, P30322, DOI 10.1074/jbc.M703156200; Mills KR, 2004, P NATL ACAD SCI USA, V101, P3438, DOI 10.1073/pnas.0400443101; Musch A, 2001, EMBO J, V20, P2171, DOI 10.1093/emboj/20.9.2171; Nguyen BP, 2001, J BIOL CHEM, V276, P43860, DOI 10.1074/jbc.M103404200; Nievers MG, 1998, J CELL SCI, V111, P1659; Nievers MG, 2000, J CELL SCI, V113, P963; O'Brien LE, 2001, NAT CELL BIOL, V3, P831, DOI 10.1038/ncb0901-831; OJAKIAN GK, 1988, J CELL BIOL, V107, P2377, DOI 10.1083/jcb.107.6.2377; Qin Y, 2010, J CELL BIOL, V189, P661, DOI 10.1083/jcb.201002097; Rasband W., 2006, IMAGEJ; REINSCH S, 1994, J CELL BIOL, V126, P1509, DOI 10.1083/jcb.126.6.1509; Rodriguez-Fraticelli AE, 2010, J CELL BIOL, V189, P725, DOI 10.1083/jcb.201002047; Rogers KK, 2003, KIDNEY INT, V63, P1632, DOI 10.1046/j.1523-1755.2003.00902.x; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Schuck S, 2004, P NATL ACAD SCI USA, V101, P4912, DOI 10.1073/pnas.0401285101; SCHWIMMER R, 1995, J CELL SCI, V108, P2487; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Torkko JM, 2008, J CELL SCI, V121, P1193, DOI 10.1242/jcs.015495; Wang ZM, 1999, J CELL SCI, V112, P2925; Yu W, 2005, MOL BIOL CELL, V16, P433, DOI 10.1091/mbc.e04-05-0435; Yu W, 2003, MOL BIOL CELL, V14, P748, DOI 10.1091/mbc.E02-06-0350; Yu W, 2008, EMBO REP, V9, P923, DOI 10.1038/embor.2008.135; Zegers MMP, 2003, TRENDS CELL BIOL, V13, P169, DOI 10.1016/S0962-8924(03)00036-9; Zhang F, 2003, J CELL BIOL, V163, P177, DOI 10.1083/jcb.200304065; Zhou H, 2005, J BIOL CHEM, V280, P10624, DOI 10.1074/jbc.M411900200	54	40	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19453	10.1371/journal.pone.0019453	http://dx.doi.org/10.1371/journal.pone.0019453			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573123	gold, Green Published, Green Submitted			2022-12-27	WOS:000290305600026
J	Ren, XF; Meng, FD; Yin, JC; Li, GX; Li, XL; Wang, C; Herrler, G				Ren, Xiaofeng; Meng, Fandan; Yin, Jiechao; Li, Guangxing; Li, Xunliang; Wang, Chao; Herrler, Georg			Action Mechanisms of Lithium Chloride on Cell Infection by Transmissible Gastroenteritis Coronavirus	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; CASPASE-DEPENDENT APOPTOSIS; BRONCHITIS VIRUS; CULTURED-CELLS; REPLICATION; DIAMMONIUM; EXPRESSION; INDUCTION; PCR	Transmissible gastroenteritis virus (TGEV) is a porcine coronavirus. Lithium chloride (LiCl) has been found to be effective against several DNA viruses, such as Herpes simplex virus and vaccinia virus. Recently, we and others have reported the inhibitory effect of LiCl on avian infectious bronchitis coronavirus (IBV) infection, an RNA virus. In the current study, the action mechanism of LiCl on cell infection by TGEV was investigated. Plaque assays and 3-(4,5)-dimethylthiahiazo(-z-y1)-3,5di-phenyl tetrazoliumbromide (MTT) assays showed that the cell infection by TGEV was inhibited in a dose-dependent manner, when LiCl was added to virus-infected cells; the cell infection was not affected when either cells or viruses were pretreated with the drug. The inhibition of TGEV infection in vitro by LiCl was observed at different virus doses and with different cell lines. The inhibitory effect of LiCl against TGEV infection and transcription was confirmed by RT-PCR and real-time PCR targeting viral S and 3CL-protease genes. The time-of-addition effect of the drug on TGEV infection indicated that LiCl acted on the initial and late stage of TGEV infection. The production of virus was not detected at 36 h post-infection due to the drug treatment. Moreover, immunofluorescence (IF) and flow cytometry analyses based on staining of Annexin V and propidium iodide staining of nuclei indicated that early and late cell apoptosis induced by TGEV was inhibited efficiently. The ability of LiCl to inhibit apoptosis was investigated by IF analysis of caspase-3 expression. Our data indicate that LiCl inhibits TGEV infection by exerting an anti-apoptotic effect. The inhibitory effect of LiCl was also observed with porcine epidemic diarrhea coronavirus. Together with other reports concerning the inhibitory effect of lithium salts on IBV in cell culture, our results indicate that LiCl may be a potent agent against porcine and avian coronaviruses.	[Ren, Xiaofeng; Meng, Fandan; Li, Guangxing; Li, Xunliang; Wang, Chao] NE Agr Univ, Coll Vet Med, Harbin, Peoples R China; [Yin, Jiechao] NE Agr Univ, Coll Life Sci, Harbin, Peoples R China; [Herrler, Georg] Tierarztlichen Hsch Hannover, Inst Virol, D-3000 Hannover, Germany	Northeast Agricultural University - China; Northeast Agricultural University - China; University of Veterinary Medicine Hannover, Foundation	Ren, XF (corresponding author), NE Agr Univ, Coll Vet Med, Harbin, Peoples R China.	rxfemail@yahoo.com.cn			National Natural Science Foundation of China [30972195, 30700590]; Heilongjiang Provincial University [1155-NCET-005]; Ministry of Education of the People's Republic of China; Deutsche Forschungsgemeinschaft [SFB 621, TPB7]; Ministry of Education of China [NO706019]; Northeast Agricultural University, China [CXZ008-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Provincial University; Ministry of Education of the People's Republic of China(Ministry of Education, China); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ministry of Education of China(Ministry of Education, China); Northeast Agricultural University, China	The work of X.R. is funded by the National Natural Science Foundation of China (30972195; 30700590), the Program for New Century Excellent Talents at the Heilongjiang Provincial University (1155-NCET-005), and the New Century Excellent Talents program from the Ministry of Education of the People's Republic of China. The work of G.H. was supported by Deutsche Forschungsgemeinschaft (SFB 621, TPB7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the support of the Cultivation Fund of the Key Scientific and Technical Innovation Project, Ministry of Education of China (NO706019) and Northeast Agricultural University, China (CXZ008-1).	AO Z, 2006, LIVEST POULT IND, V191, P50; Baba Chiaki, 2005, Antiviral Chemistry & Chemotherapy, V16, P33; BAI W, 2005, FUJIAN J ANIM HUSBAN, V27, P34; BURLESON FG, 1992, VIROLOGY LAB MANUAL, P74; Choi HJ, 2009, ANTIVIR RES, V81, P77, DOI 10.1016/j.antiviral.2008.10.002; Eleouet JF, 1998, J VIROL, V72, P4918, DOI 10.1128/JVI.72.6.4918-4924.1998; ENJUANES L, 1992, VET MICROBIOL, V33, P249, DOI 10.1016/0378-1135(92)90053-V; GEBAUER F, 1991, VIROLOGY, V183, P225, DOI 10.1016/0042-6822(91)90135-X; Harrison SM, 2007, AVIAN PATHOL, V36, P109, DOI 10.1080/03079450601156083; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; LAUDE H, 1993, VET RES, V24, P125; Li J, 2009, AVIAN PATHOL, V38, P215, DOI 10.1080/03079450902912184; Liu C, 2001, J VIROL, V75, P6402, DOI 10.1128/JVI.75.14.6402-6409.2001; Liu Y, 2003, J VIROL, V77, P11952, DOI 10.1128/JVI.77.22.11952-11963.2003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mizutani T, 2004, BIOCHEM BIOPH RES CO, V319, P1228, DOI 10.1016/j.bbrc.2004.05.107; Moreno JL, 2008, J VIROL, V82, P3882, DOI 10.1128/JVI.02622-07; Muller V, 2007, PHYTOTHER RES, V21, P970, DOI 10.1002/ptr.2198; Musial BL, 2004, AM J HEALTH-SYST PH, V61, P1365, DOI 10.1093/ajhp/61.13.1365; Ni ZJ, 2004, CURR OPIN DRUG DISC, V7, P446; Penzes Z, 2001, VIRUS GENES, V23, P105, DOI 10.1023/A:1011147832586; Ren XF, 2008, VIRUS RES, V137, P220, DOI 10.1016/j.virusres.2008.07.023; Rothfuss O, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1082; Saif L.J., 1999, DIS SWINE, P295; Schwegmann-Wessels C, 2006, DEUT TIERARZTL WOCH, V113, P157; Schwegmann-Wessels C, 2003, J VIROL, V77, P11846, DOI 10.1128/JVI.77.21.11846-11848.2003; SKINNER GRB, 1980, MED MICROBIOL IMMUN, V168, P139, DOI 10.1007/BF02121762; SPAAN W, 1988, J GEN VIROL, V69, P2939, DOI 10.1099/0022-1317-69-12-2939; Sui XW, 2010, ANTIVIR RES, V85, P346, DOI 10.1016/j.antiviral.2009.10.014; Suzuki K, 2008, VET MICROBIOL, V129, P390, DOI 10.1016/j.vetmic.2007.11.034; Wang S, 2003, HEBEI ANIM HUSB VET, V19, P38; Wei Y, 2001, SHANGHAI J ANIM HUSB, V4, P37; Wu CY, 2004, P NATL ACAD SCI USA, V101, P10012, DOI 10.1073/pnas.0403596101; Yang CW, 2007, ANTIMICROB AGENTS CH, V51, P3924, DOI 10.1128/AAC.00408-07; ZIAIE Z, 1989, BIOCHEM BIOPH RES CO, V160, P1073, DOI 10.1016/S0006-291X(89)80112-3	35	42	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e18669	10.1371/journal.pone.0018669	http://dx.doi.org/10.1371/journal.pone.0018669			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573100	Green Submitted, Green Published, gold			2022-12-27	WOS:000290305600004
J	Saddic, LA; Wirt, S; Vogel, H; Felsher, DW; Sage, J				Saddic, Louis A.; Wirt, Stacey; Vogel, Hannes; Felsher, Dean W.; Sage, Julien			Functional Interactions between Retinoblastoma and c-MYC in a Mouse Model of Hepatocellular Carcinoma	PLOS ONE			English	Article							GROWTH-FACTOR-ALPHA; CELL-CYCLE CONTROL; TUMOR-SUPPRESSOR; HEPATITIS-B; GENOMIC INSTABILITY; TRANSGENIC MICE; PRB/E2F PATHWAY; ABERRANT PLOIDY; LIVER-CANCER; STEM-CELLS	Inactivation of the RB tumor suppressor and activation of the MYC family of oncogenes are frequent events in a large spectrum of human cancers. Loss of RB function and MYC activation are thought to control both overlapping and distinct cellular processes during cell cycle progression. However, how these two major cancer genes functionally interact during tumorigenesis is still unclear. Here, we sought to test whether loss of RB function would affect cancer development in a mouse model of c-MYC-induced hepatocellular carcinoma (HCC), a deadly cancer type in which RB is frequently inactivated and c-MYC often activated. We found that RB inactivation has minimal effects on the cell cycle, cell death, and differentiation features of liver tumors driven by increased levels of c-MYC. However, combined loss of RB and activation of c-MYC led to an increase in polyploidy in mature hepatocytes before the development of tumors. There was a trend for decreased survival in double mutant animals compared to mice developing c-MYC-induced tumors. Thus, loss of RB function does not provide a proliferative advantage to c-MYC-expressing HCC cells but the RB and c-MYC pathways may cooperate to control the polyploidy of mature hepatocytes.	[Saddic, Louis A.; Wirt, Stacey; Sage, Julien] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Saddic, Louis A.; Wirt, Stacey; Sage, Julien] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Vogel, Hannes; Felsher, Dean W.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Felsher, Dean W.] Stanford Univ, Dept Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Saddic, LA (corresponding author), Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.	julsage@stanford.edu		Vogel, Otto Hannes/0000-0002-0960-3508	Lucile Packard Foundation for Children's Health; NIH-NCI [RO1 CA114102]; NATIONAL CANCER INSTITUTE [R01CA114102, T32CA009302] Funding Source: NIH RePORTER	Lucile Packard Foundation for Children's Health; NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Lucile Packard Foundation for Children's Health and NIH-NCI RO1 CA114102 (J.S.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouElella A, 1996, MODERN PATHOL, V9, P95; Beer S, 2004, PLOS BIOL, V2, P1785, DOI 10.1371/journal.pbio.0020332; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Burkhart DL, 2010, MOL CELL BIOL, V30, P1729, DOI 10.1128/MCB.00952-09; Caldwell S, 2009, J GASTROENTEROL, V44, P96, DOI 10.1007/s00535-008-2258-6; Calvisi DF, 2004, GASTROENTEROLOGY, V126, P1374, DOI 10.1053/j.gastro.2004.02.014; Celton-Morizur S, 2010, ADV EXP MED BIOL, V676, P123; Chen DN, 2009, NATURE, V462, P925, DOI 10.1038/nature08544; Cimini D, 2008, BBA-REV CANCER, V1786, P32, DOI 10.1016/j.bbcan.2008.05.003; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Conner EA, 2003, BIOCHEM BIOPH RES CO, V302, P114, DOI 10.1016/S0006-291X(03)00125-6; Dang CV, 1999, MOL CELL BIOL, V19, P1; Deshpande A, 2006, CURR MOL MED, V6, P809; Edamoto Y, 2003, INT J CANCER, V106, P334, DOI 10.1002/ijc.11254; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Felsher DW, 1999, P NATL ACAD SCI USA, V96, P3940, DOI 10.1073/pnas.96.7.3940; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Giuriato S, 2006, P NATL ACAD SCI USA, V103, P16266, DOI 10.1073/pnas.0608017103; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harrington EA, 1998, P NATL ACAD SCI USA, V95, P11945, DOI 10.1073/pnas.95.20.11945; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; HO VM, 2009, ONCOGENE; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Hsieh YH, 2007, MOL CANCER RES, V5, P1063, DOI 10.1158/1541-7786.MCR-07-0098; Iavarone A, 2004, NATURE, V432, P1040, DOI 10.1038/nature03068; Junttila MR, 2010, NATURE, V468, P567, DOI 10.1038/nature09526; Kaposi-Novak P, 2009, CANCER RES, V69, P2775, DOI 10.1158/0008-5472.CAN-08-3357; Kawate S, 1999, ONCOLOGY-BASEL, V57, P157, DOI 10.1159/000012024; Khidr L, 2006, ONCOGENE, V25, P5210, DOI 10.1038/sj.onc.1209612; Kim JW, 2010, CANCER RES, V70, P4820, DOI 10.1158/0008-5472.CAN-10-0659; KIM YJ, 2009, CANC LETT; Knudsen ES, 2008, NAT REV CANCER, V8, P714, DOI 10.1038/nrc2401; Knudsen ES, 2006, CURR MOL MED, V6, P749; Laurent-Puig P, 2006, ONCOGENE, V25, P3778, DOI 10.1038/sj.onc.1209547; Lund AH, 2004, GENE DEV, V18, P2315, DOI 10.1101/gad.1232504; MACHIDA K, 2009, J VIROL; MacPherson D, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-9; MANNING AL, 2010, GENES DEV; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; Mayer RJ, 2006, BIOCHEM SOC T, V34, P746, DOI 10.1042/BST0340746; Mayhew CN, 2007, GASTROENTEROLOGY, V133, P976, DOI 10.1053/j.gastro.2007.06.025; Mayhew CN, 2005, CANCER RES, V65, P4568, DOI 10.1158/0008-5472.CAN-04-4221; McGivern DR, 2009, ANNU REV PATHOL-MECH, V4, P399, DOI 10.1146/annurev.pathol.4.110807.092202; McMahon BJ, 2009, HEPATOLOGY, V49, pS45, DOI 10.1002/hep.22898; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; MURAKAMI H, 1993, CANCER RES, V53, P1719; Nguyen DX, 2005, J CELL BIOCHEM, V94, P870, DOI 10.1002/jcb.20375; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Park SG, 2006, J BIOL CHEM, V281, P31770, DOI 10.1074/jbc.M603194200; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Roskams T, 2006, ONCOGENE, V25, P3818, DOI 10.1038/sj.onc.1209558; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Sage J, 2010, GENE DEV, V24, P1329, DOI 10.1101/gad.1948010; SANDGREN EP, 1989, ONCOGENE, V4, P715; Santoni-Rugiu E, 2000, MOL CELL BIOL, V20, P3497, DOI 10.1128/MCB.20.10.3497-3509.2000; Santoni-Rugiu E, 1998, CANCER RES, V58, P123; Sargent LM, 1999, AM J PATHOL, V154, P1047, DOI 10.1016/S0002-9440(10)65357-6; Sears RC, 2002, J BIOL CHEM, V277, P11617, DOI 10.1074/jbc.R100063200; Shachaf CM, 2008, CANCER RES, V68, P5132, DOI 10.1158/0008-5472.CAN-07-6192; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Sherman M, 2010, SEMIN LIVER DIS, V30, P3, DOI 10.1055/s-0030-1247128; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Skapek SX, 2006, ONCOGENE, V25, P5268, DOI 10.1038/sj.onc.1209710; Srinivasan SV, 2007, J BIOL CHEM, V282, P23867, DOI 10.1074/jbc.M700542200; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Thomas DM, 2003, CANCER BIOL THER, V2, P124, DOI 10.4161/cbt.2.2.235; Thomas MB, 2010, J CLIN ONCOL, V28, P3994, DOI 10.1200/JCO.2010.28.7805; VANHARN T, 2010, GENES DEV; Wang WH, 2008, J BIOL CHEM, V283, P25455, DOI 10.1074/jbc.M801934200; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WILLIAMS BO, 1994, EMBO J, V13, P4251, DOI 10.1002/j.1460-2075.1994.tb06745.x; Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104; Yamashita T, 2008, CANCER RES, V68, P1451, DOI 10.1158/0008-5472.CAN-07-6013; Zheng L, 2002, ADV CANCER RES, V85, P13, DOI 10.1016/S0065-230X(02)85002-3; Zheng L, 2002, CANCER RES, V62, P2498	78	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19758	10.1371/journal.pone.0019758	http://dx.doi.org/10.1371/journal.pone.0019758			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573126	Green Published, Green Submitted, gold			2022-12-27	WOS:000290305600045
J	Mullaly, SC; Burrows, K; Antignano, F; Zaph, C				Mullaly, Sarah C.; Burrows, Kyle; Antignano, Frann; Zaph, Colby			Assessing the Role of CD103 in Immunity to an Intestinal Helminth Parasite	PLOS ONE			English	Article							REGULATORY T-CELLS; RETINOIC-ACID; DENDRITIC CELLS; TRICHURIS-MURIS; E-CADHERIN; INFECTION; DIFFERENTIATION; EXPRESSION; INTEGRIN; MICE	Background: In the intestine, the integrin CD103 is expressed on a subset of T regulatory (T(reg)) cells and a population of dendritic cells (DCs) that produce retinoic acid and promote immune homeostasis. However, the role of CD103 during intestinal helminth infection has not been tested. Methodology/Principal Findings: We demonstrate that CD103 is dispensable for the development of protective immunity to the helminth parasite Trichuris muris. While we observed an increase in the frequency of CD103(+) DCs in the lamina propria (LP) following acute high-dose infection with Trichuris, lack of CD103 had no effect on the frequency of CD11c(+) DCs in the LP or mesenteric lymph nodes (mLN). CD103-deficient (CD103(-/-)) mice develop a slightly increased and earlier T cell response but resolve infection with similar kinetics to control mice. Similarly, low-dose chronic infection of CD103(-/-) mice with Trichuris resulted in no significant difference in immunity or parasite burden. Absence of CD103 also had no effect on the frequency of CD4(+) CD25(+) Foxp3(+) Treg cells in the mLN or LP. Conclusions/Significance: These results suggest that CD103 is dispensable for intestinal immunity during helminth infection. Furthermore, lack of CD103 had no effect on DC or Treg recruitment or retention within the large intestine.	[Mullaly, Sarah C.; Burrows, Kyle; Antignano, Frann; Zaph, Colby] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada; [Zaph, Colby] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Mullaly, SC (corresponding author), Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada.	colby@brc.ubc.ca		Burrows, Kyle/0000-0001-5371-3512; Zaph, Colby/0000-0002-9889-9848; Antignano, Frann/0000-0003-0502-5330	Canadian Institutes of Health Research [MSH-95368, MOP-89773, MOP-106623]; Canada Foundation for Innovation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This work was supported by the Canadian Institutes of Health Research (www.cihr.ca) (MSH-95368, MOP-89773, and MOP-106623) and the Canada Foundation for Innovation (www.innovation.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annacker O, 2005, J EXP MED, V202, P1051, DOI 10.1084/jem.20040662; Artis D, 2004, P NATL ACAD SCI USA, V101, P13596, DOI 10.1073/pnas.0404034101; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Cliffe LJ, 2004, ADV PARASIT, V57, P255, DOI 10.1016/S0065-308X(04)57004-5; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; ELSE KJ, 1991, IMMUNOLOGY, V72, P508; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Johansson-Lindbom B, 2007, IMMUNOL REV, V215, P226, DOI 10.1111/j.1600-065X.2006.00482.x; Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761; Lehmann J, 2002, P NATL ACAD SCI USA, V99, P13031, DOI 10.1073/pnas.192162899; LOCKSLEY RM, 1993, SCIENCE, V261, P1448, DOI 10.1126/science.8367726; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nair MG, 2008, J IMMUNOL, V181, P4709, DOI 10.4049/jimmunol.181.7.4709; Schon MP, 1999, J IMMUNOL, V162, P6641; Siddiqui KRR, 2010, IMMUNITY, V32, P557, DOI 10.1016/j.immuni.2010.03.017; Suffia I, 2005, J IMMUNOL, V174, P5444, DOI 10.4049/jimmunol.174.9.5444; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Svensson M, 2008, MUCOSAL IMMUNOL, V1, P38, DOI 10.1038/mi.2007.4; Van den Bossche J, 2009, BLOOD, V114, P4664, DOI 10.1182/blood-2009-05-221598; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Wurbel MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016442	31	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19580	10.1371/journal.pone.0019580	http://dx.doi.org/10.1371/journal.pone.0019580			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573179	Green Published, Green Submitted, gold			2022-12-27	WOS:000290256400028
J	Veen, T; Faulks, J; Rodriguez-Munoz, R; Tregenza, T				Veen, Thor; Faulks, Joseph; Rodriguez-Munoz, Rolando; Tregenza, Tom			Premating Reproductive Barriers between Hybridising Cricket Species Differing in Their Degree of Polyandry	PLOS ONE			English	Article							CONSPECIFIC SPERM PRECEDENCE; GRYLLUS-FULTONI ORTHOPTERA; IN-FIELD CRICKETS; SEXUAL SELECTION; MATE CHOICE; MATING-BEHAVIOR; GENE EXCHANGE; ALLOPATRIC POPULATIONS; RAPID EVOLUTION; FEMALE CHOICE	Understanding speciation hinges on understanding how reproductive barriers arise between incompletely isolated populations. Despite their crucial role in speciation, prezygotic barriers are relatively poorly understood and hard to predict. We use two closely related cricket species, Gryllus bimaculatus and G. campestris, to experimentally investigate premating barriers during three sequential mate choice steps. Furthermore, we experimentally show a significant difference in polyandry levels between the two species and subsequently test the hypothesis that females of the more polyandrous species, G. bimaculatus, will be less discriminating against heterospecific males and hence hybridise more readily. During close-range mating behaviour experiments, males showed relatively weak species discrimination but females discriminated very strongly. In line with our predictions, this discrimination is asymmetric, with the more polyandrous G. bimaculatus mating heterospecifically and G. campestris females never mating heterospecifically. Our study shows clear differences in the strength of reproductive isolation during the mate choice process depending on sex and species, which may have important consequences for the evolution of reproductive barriers.	[Veen, Thor; Faulks, Joseph; Rodriguez-Munoz, Rolando; Tregenza, Tom] Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Penryn, Cornwall, England; [Veen, Thor] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V5Z 1M9, Canada	University of Exeter; University of British Columbia	Veen, T (corresponding author), Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Penryn, Cornwall, England.	veen@biodiversity.ubc.ca	Tregenza, Tom/B-1078-2014	Tregenza, Tom/0000-0003-4182-2222	Netherlands Organisation for Scientific Research; NSERC-CREATE; Natural Environment Research Council; Natural Environment Research Council [NE/H02249X/1, NE/E005403/1] Funding Source: researchfish; NERC [NE/H02249X/1] Funding Source: UKRI	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NSERC-CREATE; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	TV was supported by a Rubicon grant from the Netherlands Organisation for Scientific Research and the NSERC-CREATE Training Program in Biodiversity Research. RR-M and TT were supported by grants from the Natural Environment Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMO SA, 1994, ANIM BEHAV, V47, P857, DOI 10.1006/anbe.1994.1117; ARNOLD ML, 1992, ANNU REV ECOL SYST, V23, P237, DOI 10.1146/annurev.es.23.110192.001321; Arnqvist G, 2000, P NATL ACAD SCI USA, V97, P10460, DOI 10.1073/pnas.97.19.10460; Arnqvist Goran, 2005, pUnpaginated; Birge LM, 2010, J INSECT BEHAV, V23, P268, DOI 10.1007/s10905-010-9213-0; Boughman JW, 2001, NATURE, V411, P944, DOI 10.1038/35082064; Bretman A, 2005, MOL ECOL, V14, P2169, DOI 10.1111/j.1365-294X.2005.02556.x; Bretman A, 2009, MOL ECOL, V18, P3340, DOI 10.1111/j.1365-294X.2009.04301.x; Coyne J.A., 2004, SPECIATION; Crawley M.J., 2007, R BOOK; Gangwere S. K., 1992, EOS-Revista Espanola de Entomologia, V68, P51; Gavrilets S, 2005, EVOL ECOL, V19, P167, DOI 10.1007/s10682-004-7916-4; Gavrilets S, 2000, NATURE, V403, P886, DOI 10.1038/35002564; Gray DA, 2005, BEHAV ECOL, V16, P201, DOI 10.1093/beheco/arh144; Gray DA, 2000, P NATL ACAD SCI USA, V97, P14449, DOI 10.1073/pnas.97.26.14449; HARRISON RG, 1985, EVOLUTION, V39, P244, DOI 10.1111/j.1558-5646.1985.tb05664.x; HARRISON RG, 1983, EVOLUTION, V37, P245, DOI 10.1111/j.1558-5646.1983.tb05534.x; Hedwig B, 2005, J EXP BIOL, V208, P915, DOI 10.1242/jeb.01452; Howard DJ, 1998, EVOLUTION, V52, P511, DOI 10.1111/j.1558-5646.1998.tb01650.x; Izzo AS, 2011, ANIM BEHAV, V81, P259, DOI 10.1016/j.anbehav.2010.10.015; Jang Y, 2006, J EVOLUTION BIOL, V19, P459, DOI 10.1111/j.1420-9101.2005.01014.x; Jang Y, 2007, ETHOLOGY, V113, P87, DOI 10.1111/j.1439-0310.2006.01304.x; Jang Y, 2006, BEHAV ECOL SOCIOBIOL, V60, P150, DOI 10.1007/s00265-005-0151-3; Kirkpatrick M, 2002, AM NAT, V159, pS22, DOI 10.1086/338370; Lemmon EM, 2010, EVOLUTION, V64, P1748, DOI 10.1111/j.1558-5646.2010.00955.x; Leonard AS, 2009, ANIM BEHAV, V77, P151, DOI 10.1016/j.anbehav.2008.09.029; Linder HP, 1996, OECOLOGIA, V108, P85, DOI 10.1007/BF00333218; Maroja LS, 2009, BIOL J LINN SOC, V97, P390, DOI 10.1111/j.1095-8312.2009.01201.x; Mendelson TC, 2007, EVOLUTION, V61, P2596, DOI 10.1111/j.1558-5646.2007.00220.x; Mendelson TC, 2002, GENETICA, V116, P301, DOI 10.1023/A:1021244812270; Mullen SP, 2007, EVOLUTION, V61, P223, DOI 10.1111/j.1558-5646.2007.00019.x; Munoz AG, 2010, J EVOLUTION BIOL, V23, P1312, DOI 10.1111/j.1420-9101.2010.02001.x; ORR HA, 1995, GENETICS, V139, P1805; Orr MR, 1996, EVOLUTION, V50, P704, DOI 10.1111/j.1558-5646.1996.tb03880.x; Pardo J.E., 1993, Zoologica Baetica, V4, P113; Parker GA, 1998, PHILOS T R SOC B, V353, P261, DOI 10.1098/rstb.1998.0208; Pfennig KS, 1998, P ROY SOC B-BIOL SCI, V265, P1743, DOI 10.1098/rspb.1998.0497; Pfennig KS, 2000, BEHAV ECOL, V11, P220, DOI 10.1093/beheco/11.2.220; Price CSC, 1997, NATURE, V388, P663, DOI 10.1038/41753; Price T, 2007, SPECIATION BIRDS; Price TD, 2002, EVOLUTION, V56, P2083; R Core Team, 2018, R LANG ENV STAT COMP; Ramsey J, 2003, EVOLUTION, V57, P1520, DOI 10.1111/j.0014-3820.2003.tb00360.x; Rodriguez-Munoz R, 2010, SCIENCE, V328, P1269, DOI 10.1126/science.1188102; Ross CL, 2002, EVOLUTION, V56, P2296, DOI 10.1111/j.0014-3820.2002.tb00153.x; ROST R, 1987, BEHAV ECOL SOCIOBIOL, V21, P279, DOI 10.1007/BF00299965; Ryan MJ, 2003, AM NAT, V161, P380, DOI 10.1086/367588; RYAN MJ, 1993, PHILOS T ROY SOC B, V340, P187, DOI 10.1098/rstb.1993.0057; Seehausen O, 1998, BEHAV ECOL SOCIOBIOL, V42, P1, DOI 10.1007/s002650050405; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; Simmons LW, 2001, EVOLUTION, V55, P1386, DOI 10.1111/j.0014-3820.2001.tb00660.x; Simmons LW, 1996, P ROY SOC B-BIOL SCI, V263, P1305, DOI 10.1098/rspb.1996.0191; Svedin N, 2008, P ROY SOC B-BIOL SCI, V275, P735, DOI 10.1098/rspb.2007.0967; THORSON J, 1982, J COMP PHYSIOL, V146, P361, DOI 10.1007/BF00612706; Tregenza T, 1998, EVOLUTION, V52, P1726, DOI [10.1111/j.1558-5646.1998.tb02252.x, 10.2307/2411345]; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Veen T, 2001, NATURE, V411, P45, DOI 10.1038/35075000; Veen T, 2009, BEHAV ECOL SOCIOBIOL, V63, P329, DOI 10.1007/s00265-008-0665-6; VONHORMANNHECK S, 1995, Z TIERPSYCHOL, V14, P137; Ward PI, 2007, ADV STUD BEHAV, V37, P343, DOI 10.1016/S0065-3454(07)37007-1; Wirtz P, 1999, ANIM BEHAV, V58, P1, DOI 10.1006/anbe.1999.1144; Zuk Marlene, 1997, P89, DOI 10.1017/CBO9780511721946.006	62	14	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19531	10.1371/journal.pone.0019531	http://dx.doi.org/10.1371/journal.pone.0019531			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573165	Green Submitted, Green Published, gold			2022-12-27	WOS:000290256400018
J	Yang, LF; Zhang, J; Ho, B; Ding, JL				Yang, Lifeng; Zhang, Jing; Ho, Bow; Ding, Jeak Ling			Histidine-Mediated pH-Sensitive Regulation of M-Ficolin:GlcNAc Binding Activity in Innate Immunity Examined by Molecular Dynamics Simulations	PLOS ONE			English	Article							PATTERN-RECOGNITION MOLECULES; C-REACTIVE PROTEIN; LECTIN-COMPLEMENT PATHWAY; CONSTANT-PH; FICOLINS; METHODOLOGY; KYOTORPHIN; BACTERIA; ADHESION; CLONING	Background: M-ficolin, a pathogen recognition molecule in the innate immune system, binds sugar residues including N-acetyl-D-glucosamine (GlcNAc), which is displayed on invading microbes and on apoptotic cells. The cis and trans Asp282-Cys283 peptide bond in the M-ficolin, which was found to occur at neutral and acidic pH in crystal structures, has been suggested to represent binding and non-binding activity, respectively. A detailed understanding of the pH-dependent conformational changes in M-ficolin and pH-mediated discrimination mechanism of GlcNAc-binding activity are crucial to both immune-surveillance and clearance of apoptotic cells. Methodology/Principal Findings: By immunodetection analysis, we found that the pH-sensitive binding of GlcNAc is regulated by a conformational equilibrium between the active and inactive states of M-ficolin. We performed constant pH molecular dynamics (MD) simulation at a series of pH values to explore the pH effect on the cis-trans isomerization of the Asp282-Cys283 peptide bond in the M-ficolin fibrinogen-like domain (FBG). Analysis of the hydrogen bond occupancy of wild type FBG compared with three His mutants (H251A, H284A and H297A) corroborates that His284 is indispensible for pH-dependent binding. H251A formed new but weaker hydrogen bonds with GlcNAc. His297, unlike the other two His mutants, is more dependent on the solution pH and also contributes to cis-trans isomerization of the Asp282-Cys283 peptide bond in weak basic solution. Conclusions/Significance: Constant pH MD simulation indicated that the cis active isomer of Asp282-Cys283 peptide bond was predominant around neutral pH while the trans bond gradually prevailed towards acidic environment. The protonation of His284 was found to be associated with the trans-to-cis isomerization of Asp282-Cys283 peptide bond which dominantly regulates the GlcNAc binding. Our MD simulation approach provides an insight into the pH-sensitive proteins and hence, ligand binding activity.	[Yang, Lifeng; Ding, Jeak Ling] SMA, Singapore, Singapore; [Yang, Lifeng; Zhang, Jing; Ding, Jeak Ling] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Zhang, Jing] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn NGS, Singapore 117548, Singapore; [Ho, Bow] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117595, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Yang, LF (corresponding author), SMA, Singapore, Singapore.	dbsdjl@nus.edu.sg	Zhang, Jing/E-4844-2013; Ding, Jeak/H-8057-2012	Zhang, Jing/0000-0003-0391-7298; 	Singapore-MIT Alliance; Ministry of Education (MoE) [T208B3109]	Singapore-MIT Alliance; Ministry of Education (MoE)	This work was financed by the Singapore-MIT Alliance (Computational Systems Biology) and the Ministry of Education (MoE, T208B3109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, AMBER 10; Baptista AM, 2002, J CHEM PHYS, V117, P4184, DOI 10.1063/1.1497164; Baptista AM, 2002, J CHEM PHYS, V116, P7766, DOI 10.1063/1.1465399; Baptista AM, 1997, PROTEINS, V27, P523, DOI 10.1002/(SICI)1097-0134(199704)27:4<523::AID-PROT6>3.0.CO;2-B; Borjesson U, 2001, J CHEM PHYS, V114, P9706, DOI 10.1063/1.1370959; Borjesson U, 2004, J PHYS CHEM B, V108, P13551, DOI 10.1021/jp037841n; Burgi R, 2002, PROTEINS, V47, P469, DOI 10.1002/prot.10046; Campos SRR, 2010, J PHYS CHEM B, V114, P12692, DOI 10.1021/jp104753t; Chen JH, 2008, CURR OPIN STRUC BIOL, V18, P140, DOI 10.1016/j.sbi.2008.01.003; Chen YZ, 2007, COMPUT PHYS COMMUN, V177, P210, DOI 10.1016/j.cpc.2007.02.095; Dlugosz M, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.021915; Dlugosz M, 2004, CHEM PHYS, V302, P161, DOI 10.1016/j.chemphys.2004.03.031; Endo Y, 1996, GENOMICS, V36, P515, DOI 10.1006/geno.1996.0497; Endo Y, 2007, IMMUNOBIOLOGY, V212, P371, DOI 10.1016/j.imbio.2006.11.014; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; Fujita T, 2004, IMMUNOL REV, V198, P185, DOI 10.1111/j.0105-2896.2004.0123.x; Garlatti V, 2007, J BIOL CHEM, V282, P35814, DOI 10.1074/jbc.M705741200; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; Gout E, 2010, J BIOL CHEM, V285, P6612, DOI 10.1074/jbc.M109.065854; Honore C, 2008, MOL IMMUNOL, V45, P2782, DOI 10.1016/j.molimm.2008.02.005; Khandogin J, 2005, BIOPHYS J, V89, P141, DOI 10.1529/biophysj.105.061341; Krarup A, 2005, INFECT IMMUN, V73, P1052, DOI 10.1128/IAI.73.2.1052-1060.2005; Krarup A, 2004, J BIOL CHEM, V279, P47513, DOI 10.1074/jbc.M407161200; Kyte J., 1995, STRUCTURE PROTEIN CH; Liu B, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001059; Liu Y, 2005, J IMMUNOL, V175, P3150, DOI 10.4049/jimmunol.175.5.3150; Lynch NJ, 2004, J IMMUNOL, V172, P1198, DOI 10.4049/jimmunol.172.2.1198; Ma YG, 2004, J BIOL CHEM, V279, P25307, DOI 10.1074/jbc.M400701200; Machuqueiro M, 2006, J PHYS CHEM B, V110, P2927, DOI 10.1021/jp056456q; Machuqueiro M, 2008, PROTEINS, V72, P289, DOI 10.1002/prot.21923; Machuqueiro M, 2007, BIOPHYS J, V92, P1836, DOI 10.1529/biophysj.106.092445; Machuqueiro M, 2010, J PHYS CHEM B, V114, P11659, DOI 10.1021/jp104418g; Machuqueiro M, 2009, J AM CHEM SOC, V131, P12586, DOI 10.1021/ja808463e; Marnell L, 2005, CLIN IMMUNOL, V117, P104, DOI 10.1016/j.clim.2005.08.004; Matsushita M, 2001, IMMUNOL REV, V180, P78, DOI 10.1034/j.1600-065X.2001.1800107.x; Meng YL, 2010, J CHEM THEORY COMPUT, V6, P1401, DOI 10.1021/ct900676b; Mongan J, 2005, CURR OPIN STRUC BIOL, V15, P157, DOI 10.1016/j.sbi.2005.02.002; Mongan J, 2004, J COMPUT CHEM, V25, P2038, DOI 10.1002/jcc.20139; Ng PML, 2007, EMBO J, V26, P3431, DOI 10.1038/sj.emboj.7601762; Runza VL, 2008, IMMUNOBIOLOGY, V213, P297, DOI 10.1016/j.imbio.2007.10.009; Srivastava J, 2008, P NATL ACAD SCI USA, V105, P14436, DOI 10.1073/pnas.0805163105; Srivastava J, 2007, PHYSIOLOGY, V22, P30, DOI 10.1152/physiol.00035.2006; Sugimoto R, 1998, J BIOL CHEM, V273, P20721, DOI 10.1074/jbc.273.33.20721; Swails JM, 2009, J PHYS CHEM B, V113, P1192, DOI 10.1021/jp806906x; Tanio M, 2008, J SYNCHROTRON RADIAT, V15, P243, DOI 10.1107/S0909049507054325; Tanio M, 2007, J BIOL CHEM, V282, P3889, DOI 10.1074/jbc.M608627200; Tanio M, 2006, ACTA CRYSTALLOGR F, V62, P652, DOI 10.1107/S1744309106019786; Tanio M, 2009, BIOCHEM J, V417, P485, DOI 10.1042/BJ20081640; Teh C, 2000, IMMUNOLOGY, V101, P225, DOI 10.1046/j.1365-2567.2000.00099.x; Thiel S, 2007, MOL IMMUNOL, V44, P3875, DOI 10.1016/j.molimm.2007.06.005; Tjong H, 2008, BIOPHYS J, V95, P2601, DOI 10.1529/biophysj.107.127746; Wittenborn T, 2010, J INNATE IMMUN, V2, P167, DOI 10.1159/000218324; Woods G, 2005, GLYCAM WEB; Zhang J, 2010, J IMMUNOL, V185, P6899, DOI 10.4049/jimmunol.1001225; Zhang J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000282	55	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19647	10.1371/journal.pone.0019647	http://dx.doi.org/10.1371/journal.pone.0019647			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573188	gold, Green Published, Green Submitted			2022-12-27	WOS:000290256400037
J	Craney, A; Tahlan, K; Andrews, D; Nodwell, J				Craney, Arryn; Tahlan, Kapil; Andrews, David; Nodwell, Justin			Bacterial Transmembrane Proteins that Lack N-Terminal Signal Sequences	PLOS ONE			English	Article							TAIL-ANCHORED PROTEINS; ESCHERICHIA-COLI; STREPTOMYCES-COELICOLOR; MEMBRANE INSERTION; SEC TRANSLOCON; RECOGNITION; MECHANISMS; SECRETION; PATHWAYS; CHANNEL	Tail-anchored membrane proteins (TAMPs), a class of proteins characterized by their lack of N-terminal signal sequence and Sec-independent membrane targeting, play critical roles in apoptosis, vesicle trafficking and other vital processes in eukaryotic organisms. Until recently, this class of membrane proteins has been unknown in bacteria. Here we present the results of bioinformatic analysis revealing proteins that are superficially similar to eukaryotic TAMPs in the bacterium Streptomyces coelicolor. We demonstrate that at least four of these proteins are bona fide membrane-spanning proteins capable of targeting to the membrane in the absence of their N-terminus and the C-terminal membrane-spanning domain is sufficient for membrane targeting. Several of these proteins, including a serine/threonine kinase and the SecE component of the Sec translocon, are widely conserved in bacteria.	[Craney, Arryn; Tahlan, Kapil; Andrews, David; Nodwell, Justin] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada	McMaster University	Craney, A (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.	nodwellj@mcmaster.ca		Andrews, David/0000-0002-9266-7157	Canadian Institutes for Health Research [MOP-57684]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes for Health Research grant #MOP-57684. http://www.cihr-irsc.gc.ca/e/193.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Borgese N, 2010, TRAFFIC, V11, P877, DOI 10.1111/j.1600-0854.2010.01068.x; Dong HJ, 2009, CURR MICROBIOL, V59, P336, DOI 10.1007/s00284-009-9439-2; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; EICHLER J, 2010, TRENDS BIOCHEM SCI, V29, P3; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; Flett F, 1997, FEMS MICROBIOL LETT, V155, P223, DOI 10.1111/j.1574-6968.1997.tb13882.x; Gold VAM, 2007, MOL MEMBR BIOL, V24, P387, DOI 10.1080/09687680701416570; HAGEGE J, 1993, J BACTERIOL, V175, P5529; High S, 2004, BIOCHEM SOC T, V32, P659, DOI 10.1042/BST0320659; Huang J, 2005, MOL MICROBIOL, V58, P1276, DOI 10.1111/j.1365-2958.2005.04879.x; Hudson ME, 2002, J BACTERIOL, V184, P4920, DOI 10.1128/JB.184.17.4920-4924.2002; JEONG SM, 1993, MOL MICROBIOL, V10, P133, DOI 10.1111/j.1365-2958.1993.tb00910.x; Keiser T, 2000, PRACTICAL STREPTOMYC; Kim BH, 2001, MOL MICROBIOL, V41, P665, DOI 10.1046/j.1365-2958.2001.02544.x; Kol S, 2008, J BIOL CHEM, V283, P31269, DOI 10.1074/jbc.R800029200; KONTINEN VP, 1996, J BIOCH, V1130, P1124; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Molloy MP, 2000, EUR J BIOCHEM, V267, P2871, DOI 10.1046/j.1432-1327.2000.01296.x; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Niegowski D, 2007, CELL MOL LIFE SCI, V64, P2564, DOI 10.1007/s00018-007-7174-z; NISHIYAMA K, 1992, J BIOL CHEM, V267, P7170; Papanikou E, 2007, NAT REV MICROBIOL, V5, P839, DOI 10.1038/nrmicro1771; PUTTIKHUNT C, 1995, MOL GEN GENET, V247, P118, DOI 10.1007/BF00425829; Rusch SL, 2007, BBA-BIOMEMBRANES, V1768, P5, DOI 10.1016/j.bbamem.2006.08.013; Shen K, 2010, P NATL ACAD SCI USA, V107, P7698, DOI 10.1073/pnas.1002968107; Stroud RM, 1999, CURR OPIN STRUC BIOL, V9, P754, DOI 10.1016/S0959-440X(99)00040-8; SUN J, 1999, MICROBIOL, V3, P2221; Sureka K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008590; Valent QA, 2001, ANTON LEEUW INT J G, V79, P17, DOI 10.1023/A:1010256109582; Veenendaal AKJ, 2004, BBA-MOL CELL RES, V1694, P81, DOI 10.1016/j.bbamcr.2004.02.009; VONHEIJNE J, 1992, J MOL BIOL, V225, P487; Wattenberg BW, 2007, BIOSCIENCE REP, V27, P385, DOI 10.1007/s10540-007-9061-0; Yi L, 2003, BIOCHEMISTRY-US, V42, P10537, DOI 10.1021/bi034309h	36	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19421	10.1371/journal.pone.0019421	http://dx.doi.org/10.1371/journal.pone.0019421			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573234	Green Published, gold, Green Submitted			2022-12-27	WOS:000290224800028
J	Batard, E; Jamme, F; Villette, S; Jacqueline, C; de la Cochetiere, MF; Caillon, J; Refregiers, M				Batard, Eric; Jamme, Frederic; Villette, Sandrine; Jacqueline, Cedric; de la Cochetiere, Marie-France; Caillon, Jocelyne; Refregiers, Matthieu			Diffusion of Ofloxacin in the Endocarditis Vegetation Assessed with Synchrotron Radiation UV Fluorescence Microspectrocopy	PLOS ONE			English	Article							CARDIAC VEGETATIONS; PENETRATION; CIPROFLOXACIN; PEFLOXACIN; EFFICACY; BIOFILMS	The diffusion of antibiotics in endocarditis vegetation bacterial masses has not been described, although it may influence the efficacy of antibiotic therapy in endocarditis. The objective of this work was to assess the diffusion of ofloxacin in experimental endocarditis vegetation bacterial masses using synchrotron-radiation UV fluorescence microspectroscopy. Streptococcal endocarditis was induced in 5 rabbits. Three animals received an unique IV injection of 150 mg/kg ofloxacin, and 2 control rabbits were left untreated. Two fluorescence microscopes were coupled to a synchrotron beam for excitation at 275 nm. A spectral microscope collected fluorescence spectra between 285 and 550 nm. A second, full field microscope was used with bandpass filters at 510-560 nm. Spectra of ofloxacin-treated vegetations presented higher fluorescence between 390 and 540 nm than control. Full field imaging showed that ofloxacin increased fluorescence between 510 and 560 nm. Ofloxacin diffused into vegetation bacterial masses, although it accumulated in their immediate neighborhood. Fluorescence images additionally suggested an ofloxacin concentration gradient between the vegetation peripheral and central areas. In conclusion, ofloxacin diffuses into vegetation bacterial masses, but it accumulates in their immediate neighborhood. Synchrotron radiation UV fluorescence microscopy is a new tool for assessment of antibiotic diffusion in the endocarditis vegetation bacterial masses.	[Batard, Eric; Jacqueline, Cedric; de la Cochetiere, Marie-France; Caillon, Jocelyne] Univ Nantes, Therapeut Clin & Expt Infect EA3826, Nantes, France; [Jamme, Frederic; Refregiers, Matthieu] Synchrotron Soleil, Disco Beamline, St Aubin, France; [Jamme, Frederic] INRA, CEPIA, F-44026 Nantes, France; [Villette, Sandrine] CNRS, Ctr Biophys Mol UPR 4301, Orleans, France	Nantes Universite; SOLEIL Synchrotron; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC)	Batard, E (corresponding author), Univ Nantes, Therapeut Clin & Expt Infect EA3826, Nantes, France.	eric.batard@chu-nantes.fr	CAILLON, Jocelyne/AAF-8179-2020; Réfrégiers, Matthieu/AAE-2075-2022; Jacqueline, Cédric/G-5650-2010; JAMME, Frederic/E-2170-2011; Réfrégiers, Matthieu/A-4249-2011	Jacqueline, Cédric/0000-0001-9606-5930; JAMME, Frederic/0000-0002-7398-7868; Réfrégiers, Matthieu/0000-0002-3281-2308; Batard, Eric/0000-0002-1927-228X	Synchrotron SOLEIL [20090085, 20090754]	Synchrotron SOLEIL	This work was partly funded by Synchrotron SOLEIL (grants #20090085 and #20090754). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Batard E, 2010, APPL SPECTROSC, V64, P901, DOI 10.1366/000370210792081172; CREMIEUX AC, 1989, J INFECT DIS, V159, P938, DOI 10.1093/infdis/159.5.938; Drakopoulos AI, 1997, ANAL CHIM ACTA, V354, P197, DOI 10.1016/S0003-2670(97)00465-0; FANTIN B, 1994, ANTIMICROB AGENTS CH, V38, P432, DOI 10.1128/AAC.38.3.432; FOWLER VG, 2009, PRINCIPLES PRACTICE, P1067; Giuliani A, 2009, J SYNCHROTRON RADIAT, V16, P835, DOI 10.1107/S0909049509034049; JAMME F, 2010, MICROSC MICROANAL, V25, P1; Jefferson KK, 2005, ANTIMICROB AGENTS CH, V49, P2467, DOI 10.1128/AAC.49.6.2467-2473.2005; KAATZ GW, 1990, ANTIMICROB AGENTS CH, V34, P257, DOI 10.1128/AAC.34.2.257; Lefort AS, 2003, ANTIMICROB AGENTS CH, V47, P216, DOI 10.1128/AAC.47.1.216-222.2003; MERTES PM, 1992, ANTIMICROB AGENTS CH, V36, P2493, DOI 10.1128/AAC.36.11.2493; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; Papadakis JA, 2000, CHEMOTHERAPY, V46, P116, DOI 10.1159/000007265; Pautke C, 2010, J ANAT, V217, P76, DOI 10.1111/j.1469-7580.2010.01237.x; Saleh-Mghir A, 1999, ANTIMICROB AGENTS CH, V43, P115, DOI 10.1128/AAC.43.1.115; Stewart PS, 2009, ANTIMICROB AGENTS CH, V53, P3505, DOI 10.1128/AAC.01728-08; Stone G, 2002, ANTIMICROB AGENTS CH, V46, P2458, DOI 10.1128/AAC.46.8.2458-2461.2002; Wagnieres GA, 1998, PHOTOCHEM PHOTOBIOL, V68, P603	18	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19440	10.1371/journal.pone.0019440	http://dx.doi.org/10.1371/journal.pone.0019440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559378	Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700171
J	Bilitchenko, L; Liu, A; Cheung, S; Weeding, E; Xia, B; Leguia, M; Anderson, JC; Densmore, D				Bilitchenko, Lesia; Liu, Adam; Cheung, Sherine; Weeding, Emma; Xia, Bing; Leguia, Mariana; Anderson, J. Christopher; Densmore, Douglas			Eugene - A Domain Specific Language for Specifying and Constraining Synthetic Biological Parts, Devices, and Systems	PLOS ONE			English	Article							STANDARD; NETWORK; DESIGN	Background: Synthetic biological systems are currently created by an ad-hoc, iterative process of specification, design, and assembly. These systems would greatly benefit from a more formalized and rigorous specification of the desired system components as well as constraints on their composition. Therefore, the creation of robust and efficient design flows and tools is imperative. We present a human readable language (Eugene) that allows for the specification of synthetic biological designs based on biological parts, as well as provides a very expressive constraint system to drive the automatic creation of composite Parts (Devices) from a collection of individual Parts. Results: We illustrate Eugene's capabilities in three different areas: Device specification, design space exploration, and assembly and simulation integration. These results highlight Eugene's ability to create combinatorial design spaces and prune these spaces for simulation or physical assembly. Eugene creates functional designs quickly and cost-effectively. Conclusions: Eugene is intended for forward engineering of DNA-based devices, and through its data types and execution semantics, reflects the desired abstraction hierarchy in synthetic biology. Eugene provides a powerful constraint system which can be used to drive the creation of new devices at runtime. It accomplishes all of this while being part of a larger tool chain which includes support for design, simulation, and physical device assembly.	[Bilitchenko, Lesia] Calif State Polytech Univ Pomona, Dept Comp Sci, Pomona, CA 91768 USA; [Liu, Adam; Xia, Bing] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Cheung, Sherine] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Weeding, Emma] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA; [Leguia, Mariana; Anderson, J. Christopher] Univ Calif Berkeley, Calif Inst Quantitat Biol Res QB3, Dept Bioengn, Berkeley, CA 94720 USA; [Anderson, J. Christopher] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Densmore, Douglas] Boston Univ, Dept Elect & Comp Engn, Boston, MA 02215 USA	California State University System; California State Polytechnic University Pomona; University of California System; University of California Berkeley; University of California System; University of California San Diego; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Boston University	Bilitchenko, L (corresponding author), Calif State Polytech Univ Pomona, Dept Comp Sci, Pomona, CA 91768 USA.	dougd@bu.edu	Densmore, Douglas/AAC-7059-2020	Leguia, Mariana/0000-0002-7297-0263	Synthetic Biology Engineering Research Center; Joint BioEnergy Institute; Coalition to Diversify Computing; Center for Hybrid Embedded Software Systems; California Institute for Quantitative Biosciences	Synthetic Biology Engineering Research Center; Joint BioEnergy Institute; Coalition to Diversify Computing; Center for Hybrid Embedded Software Systems; California Institute for Quantitative Biosciences	Synthetic Biology Engineering Research Center (www.synberc.org), the Joint BioEnergy Institute (www.jbei.org), the Coalition to Diversify Computing (http://www.cdc-computing.org), the Center for Hybrid Embedded Software Systems (CHESS) (http://chess.eecs.berkeley.edu), and the California Institute for Quantitative Biosciences (http://qb3.org). The funders' broad goals are reflected in the study design and the types of data collected and analyzed. They did not have any role in the decision to publish, or in preparation of the manuscript.	[Anonymous], 2009, Nat Biotechnol, V27, P1071, DOI 10.1038/nbt1209-1071; Arkin A, 2008, NAT BIOTECHNOL, V26, P771, DOI 10.1038/nbt0708-771; Ashenden PJ, 2008, DESIGNERS GUIDE VHDL, p[xxii, 909]; Beal J, 2008, SASOW 2008: SECOND IEEE INTERNATIONAL CONFERENCE ON SELF-ADAPTIVE AND SELF-ORGANIZING SYSTEMS WORKSHOPS, PROCEEDINGS, P284, DOI 10.1109/SASOW.2008.14; Bhatia S, 2011, METHODS ENZYMOLOGY; Bickford JH, 1998, HDB BOLTS BOLTED JOI, p[x, 911]; Bilitchenko L, 2011, EUGENE LANGUAGE SYNT; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Chandran Deepak, 2009, J Biol Eng, V3, P19, DOI 10.1186/1754-1611-3-19; Chinnery D, 2002, CLOSING GAP ASIC CUS, p[xiv, 407]; Czar MJ, 2009, NUCLEIC ACIDS RES, V37, pW40, DOI 10.1093/nar/gkp361; Densmore D, 2009, 5 R TAP CEL DIV COMP; Densmore D, RULE BASED CONSTRAIN, P557; Densmore D., NUCL ACIDS RES, V38, P2607; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Hill AD, 2008, BIOINFORMATICS, V24, P2551, DOI 10.1093/bioinformatics/btn468; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Karwowski W, 2006, HDB STANDARDS GUIDEL, p[xvii, 623]; Keutzer K, 2000, IEEE T COMPUT AID D, V19, P1523, DOI 10.1109/43.898830; Leguia M, 2011, METHODS ENZYMOLOGY; Lloyd CM, 2004, PROG BIOPHYS MOL BIO, V85, P433, DOI 10.1016/j.pbiomolbio.2004.01.004; Lucks JB, 2008, CURR OPIN MICROBIOL, V11, P567, DOI 10.1016/j.mib.2008.10.002; Palnitkar S, 2003, VERILOG HDL GUIDE DE, p[xlii, 450]; Pedersen M, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2008.0516.focus; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Sangiovanni-Vincentelli A, 2007, P IEEE, V95, P467, DOI 10.1109/JPROC.2006.890107; Scott ML, 2009, PROGRAMMING LANGUAGE PRAGMATICS, 3RD EDITION, P1; Smith LP, 2009, BIOINFORMATICS, V25, P2452, DOI 10.1093/bioinformatics/btp401; Smolke CD, 2009, NAT BIOTECHNOL, V27, P1099, DOI 10.1038/nbt1209-1099; STEVENSON D, 1981, COMPUTER, V14, P51, DOI 10.1109/C-M.1981.220377; Tuttle LM, 2005, BIOPHYS J, V89, P3873, DOI 10.1529/biophysj.105.064204; Weeding E, 2010, BRIEFINGS BIOINFORMA	34	86	103	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18882	10.1371/journal.pone.0018882	http://dx.doi.org/10.1371/journal.pone.0018882			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559524	gold, Green Submitted, Green Published			2022-12-27	WOS:000290024700030
J	Srivastava, P; Mehrotra, S; Tiwary, P; Chakravarty, J; Sundar, S				Srivastava, Pankaj; Mehrotra, Sanjana; Tiwary, Puja; Chakravarty, Jaya; Sundar, Shyam			Diagnosis of Indian Visceral Leishmaniasis by Nucleic Acid Detection Using PCR	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; KALA-AZAR PATIENTS; CLINICAL-SAMPLES; NASBA-OLIGOCHROMATOGRAPHY; OLIGOC-TEST; STRIP TEST; IDENTIFICATION; BLOOD; DONOVANI; SUDAN	Background: PCR based diagnosis for Visceral Leishmaniasis (VL), despite numerous published primers, remains far from being applied in the field. The present study was planned to design a Leishmania specific diagnostic assay and to evaluate its sensitivity and specificity on a sample size, which to the best of our knowledge is the largest ever screened in one study. Methods: Leishmania specific primers were developed using 18S rRNA gene and their sensitivity was evaluated on 500 parasitologically confirmed patients with VL and 25 Post Kala-azar Dermal Leishmaniasis (PKDL) patients. Specificity was calculated on 250 healthy endemic controls, 250 healthy non endemic controls and 250 non leishmanial diseases like malaria. Results: Our PCR assay had a sensitivity of 87.8% (95% CI: 84.1-89.8) using 200 mu L of patient's peripheral-blood. Specificity was absolute in non-endemic healthy controls and in subjects with different diseases while in endemic controls it was 84% (95% CI: 78.9-88.0). Its overall specificity was 94.6% (95% CI-92.8-96.1). Conclusions: The PCR assay developed is sensitive enough to detect the 18S rRNA gene in an amount equivalent to a single parasite or less in a one million human cell environment. The high sensitivity of this PCR diagnostic test with relatively non-invasive peripheral blood sampling method opens up the possibility of its deployment in field for the routine diagnosis of VL.	[Srivastava, Pankaj; Mehrotra, Sanjana; Tiwary, Puja; Chakravarty, Jaya; Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Dept Med, Infect Dis Res Lab, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU)	Srivastava, P (corresponding author), Banaras Hindu Univ, Inst Med Sci, Dept Med, Infect Dis Res Lab, Varanasi 221005, Uttar Pradesh, India.	drshyamsundar@hotmail.com	TIWARY, PUJA/F-3395-2012	TIWARY, PUJA/0000-0002-8180-2739	Indian Council for Medical Research and NIAID, NIH TMRC [1P50AI074321]; Council of Scientific and Industrial Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI074321] Funding Source: NIH RePORTER	Indian Council for Medical Research and NIAID, NIH TMRC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by Indian Council for Medical Research and NIAID, NIH TMRC Grant No. 1P50AI074321 for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank KAMRC, Sitaram Memorial Trust, Muzaffarpur, Bihar, India, for their constant support in conducting this study. Author SM is thankful to Council of Scientific and Industrial Research for financial support.	Adhya S, 1995, T ROY SOC TROP MED H, V89, P622, DOI 10.1016/0035-9203(95)90416-6; Basiye FL, 2010, TROP MED INT HEALTH, V15, P806, DOI 10.1111/j.1365-3156.2010.02548.x; Chiurillo MA, 2001, AM J TROP MED HYG, V65, P573; CHULAY JD, 1983, AM J TROP MED HYG, V32, P475, DOI 10.4269/ajtmh.1983.32.475; Deborggraeve S, 2008, J INFECT DIS, V198, P1565, DOI 10.1086/592509; Dujardin J C, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS81, DOI 10.1016/S0035-9203(02)90056-8; le Fichoux Y, 1999, J CLIN MICROBIOL, V37, P1953, DOI 10.1128/JCM.37.6.1953-1957.1999; Maurya R, 2005, J CLIN MICROBIOL, V43, P3038, DOI 10.1128/JCM.43.7.3038-3041.2005; Minodier P, 1997, J CLIN MICROBIOL, V35, P2551, DOI 10.1128/JCM.35.10.2551-2555.1997; Mugasa CM, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-13; Noyes HA, 1998, J CLIN MICROBIOL, V36, P2877, DOI 10.1128/JCM.36.10.2877-2881.1998; Ramos A, 1996, EXP PARASITOL, V82, P242, DOI 10.1006/expr.1996.0031; Reithinger R, 2007, J CLIN MICROBIOL, V45, P21, DOI 10.1128/JCM.02029-06; Saad AA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000776; Salotra P, 2001, J CLIN MICROBIOL, V39, P849, DOI 10.1128/JCM.39.3.849-854.2001; Schonian G, 2003, DIAGN MICR INFEC DIS, V47, P349, DOI 10.1016/S0732-8893(03)00093-2; SMYTH AJ, 1992, PARASITOLOGY, V105, P183, DOI 10.1017/S0031182000074096; Sundar S, 1998, LANCET, V351, P563, DOI 10.1016/S0140-6736(97)04350-X; Sundar S, 2006, T ROY SOC TROP MED H, V100, P533, DOI 10.1016/j.trstmh.2005.08.018; Sundar S, 2002, CLIN DIAGN LAB IMMUN, V9, P951, DOI 10.1128/CDLI.9.5.951-958.2002; Topno RK, 2010, AM J TROP MED HYG, V83, P502, DOI 10.4269/ajtmh.2010.09-0345; VANEYS GJJM, 1992, MOL BIOCHEM PARASIT, V51, P133, DOI 10.1016/0166-6851(92)90208-2; Zijlstra EE, 2001, TROP MED INT HEALTH, V6, P108, DOI 10.1046/j.1365-3156.2001.00680.x	23	44	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19304	10.1371/journal.pone.0019304	http://dx.doi.org/10.1371/journal.pone.0019304			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559398	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700128
J	Wong, RCB; Ibrahim, A; Fong, H; Thompson, N; Lock, LF; Donovan, PJ				Wong, Raymond Ching-Bong; Ibrahim, Abel; Fong, Helen; Thompson, Noelle; Lock, Leslie F.; Donovan, Peter J.			L1TD1 Is a Marker for Undifferentiated Human Embryonic Stem Cells	PLOS ONE			English	Article							ORF1 PROTEIN; RNA INTERFERENCE; LINE-1 RETROTRANSPOSITION; TRANSPOSABLE ELEMENT; CHAPERONE ACTIVITY; HUMAN BLASTOCYSTS; SELF-RENEWAL; IN-VITRO; DIFFERENTIATION; BINDING	Background: Human embryonic stem cells (hESC) are stem cells capable of differentiating into cells representative of the three primary embryonic germ layers. There has been considerable interest in understanding the mechanisms regulating stem cell pluripotency, which will ultimately lead to development of more efficient methods to derive and culture hESC. In particular, Oct4, Sox2 and Nanog are transcription factors known to be important in maintenance of hESC. However, many of the downstream targets of these transcription factors are not well characterized. Furthermore, it remains unknown whether additional novel stem cell factors are involved in the establishment and maintenance of the stem cell state. Methodology/Principal Findings: Here we show that a novel gene, L1TD1 (also known as FLJ10884 or ECAT11), is abundantly expressed in undifferentiated hESC. Differentiation of hESC via embryoid body (EB) formation or BMP4 treatment results in the rapid down-regulation of L1TD1 expression. Furthermore, populations of undifferentiated and differentiated hESC were sorted using the stem cell markers SSEA4 and TRA160. Our results show that L1TD1 is enriched in the SSEA4-positive or TRA160-positive population of hESC. Using chromatin immunoprecipitation we found enriched association of Nanog to the predicted promoter region of L1TD1. Furthermore, siRNA-mediated knockdown of Nanog in hESC also resulted in downregulation of L1TD1 expression. Finally, using luciferase reporter assay we demonstrated that Nanog can activate the L1TD1 upstream promoter region. Altogether, these results provide evidence that L1TD1 is a downstream target of Nanog. Conclusion/Significance: Taken together, our results suggest that L1TD1 is a downstream target of Nanog and represents a useful marker for identifying undifferentiated hESC.	[Wong, Raymond Ching-Bong; Ibrahim, Abel; Fong, Helen; Thompson, Noelle; Lock, Leslie F.; Donovan, Peter J.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Lock, Leslie F.; Donovan, Peter J.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Wong, Raymond Ching-Bong; Ibrahim, Abel; Fong, Helen; Thompson, Noelle; Lock, Leslie F.; Donovan, Peter J.] Univ Calif Irvine, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Wong, RCB (corresponding author), Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA.	pdonovan@uci.edu		Wong, Raymond Ching-Bong/0000-0002-8092-9455; Maheswara Reddy, Emani/0000-0002-3455-1818	California Institute of Regenerative Medicine [T1-00008, TG2-01152, RCI-00110]; University of California; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); University of California(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the California Institute of Regenerative Medicine (http://www.cirm.ca.gov/; T1-00008 for RC-BW and HF, TG2-01152 for NT, RCI-00110 to PJD) and the University of California Irvine startup funds to LFL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Goodier JL, 2007, MOL CELL BIOL, V27, P6469, DOI 10.1128/MCB.00332-07; Hohenstein KA, 2008, STEM CELLS, V26, P1436, DOI 10.1634/stemcells.2007-0857; Hohjoh H, 1997, EMBO J, V16, P6034, DOI 10.1093/emboj/16.19.6034; HOLMES SE, 1992, J BIOL CHEM, V267, P19765; Hyslop L, 2005, STEM CELLS, V23, P1035, DOI 10.1634/stemcells.2005-0080; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kohler EE, 2011, BLOOD, V117, P1761, DOI 10.1182/blood-2010-07-295261; Kolosha VO, 2003, J BIOL CHEM, V278, P8112, DOI 10.1074/jbc.M210487200; Laslett AL, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-12; Levine AJ, 2006, DEVELOPMENT, V133, P209, DOI 10.1242/dev.02192; Martin SL, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/45621; Martin SL, 2005, J MOL BIOL, V348, P549, DOI 10.1016/j.jmb.2005.03.003; Martin SL, 2001, MOL CELL BIOL, V21, P467, DOI 10.1128/MCB.21.2.467-475.2001; MATHIAS SL, 1991, SCIENCE, V254, P1808, DOI 10.1126/science.1722352; Matin MM, 2004, STEM CELLS, V22, P659, DOI 10.1634/stemcells.22-5-659; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wong RCB, 2007, STEM CELLS DEV, V16, P989, DOI 10.1089/scd.2007.0057; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Zeng WH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000559; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	32	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19355	10.1371/journal.pone.0019355	http://dx.doi.org/10.1371/journal.pone.0019355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559406	Green Published, gold			2022-12-27	WOS:000290024700146
J	Garbelli, A; Beermann, S; Di Cicco, G; Dietrich, U; Maga, G				Garbelli, Anna; Beermann, Sandra; Di Cicco, Giulia; Dietrich, Ursula; Maga, Giovanni			A Motif Unique to the Human Dead-Box Protein DDX3 Is Important for Nucleic Acid Binding, ATP Hydrolysis, RNA/DNA Unwinding and HIV-1 Replication	PLOS ONE			English	Article							RNA HELICASE; FAMILY	DEAD-box proteins are enzymes endowed with nucleic acid-dependent ATPase, RNA translocase and unwinding activities. The human DEAD-box protein DDX3 has been shown to play important roles in tumor proliferation and viral infections. In particular, DDX3 has been identified as an essential cofactor for HIV-1 replication. Here we characterized a set of DDX3 mutants biochemically with respect to nucleic acid binding, ATPase and helicase activity. In particular, we addressed the functional role of a unique insertion between motifs I and la of DDX3 and provide evidence for its implication in nucleic acid binding and HIV-1 replication. We show that human DDX3 lacking this domain binds HIV-1 RNA with lower affinity. Furthermore, a specific peptide ligand for this insertion selected by phage display interferes with HIV-1 replication after transduction into HelaP4 cells. Besides broadening our understanding of the structure-function relationships of this important protein, our results identify a specific domain of DDX3 which may be suited as target for antiviral drugs designed to inhibit cellular cofactors for HIV-1 replication.	[Garbelli, Anna; Di Cicco, Giulia; Maga, Giovanni] CNR, Inst Mol Genet, I-27100 Pavia, Italy; [Beermann, Sandra; Dietrich, Ursula] Georg Speyer Haus Inst Biomed Res, Frankfurt, Germany	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR)	Garbelli, A (corresponding author), CNR, Inst Mol Genet, I-27100 Pavia, Italy.	maga@igm.cnr.it	Dietrich, Ursula/AAD-5704-2020; Maga, Giovanni/C-5409-2009	Maga, Giovanni/0000-0001-8092-1552; Dietrich, Ursula/0000-0003-2491-4758	Italian Association for Cancer Research [AIRC-IG2008-2010-4538]; Italian National Interest Research Project [PRIN2007_N7KYCY]; Italian National AIDS Programme Research Project [40H26]; European Commission [LSHP-CT-2006-037257]	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Italian National Interest Research Project; Italian National AIDS Programme Research Project; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work has been partially supported by an Italian Association for Cancer Research Grant (AIRC-IG2008-2010-4538) to GM, by an Italian National Interest Research Project (PRIN2007_N7KYCY) to GM, by an Italian National AIDS Programme Research Project (40H26) to GM and by the European Commission FP6 Project Excellent-Hit (LSHP-CT-2006-037257) to GM and UD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhaleem M, 2003, GENOMICS, V81, P618, DOI 10.1016/S0888-7543(03)00049-1; Ariumi Y, 2007, J VIROL, V81, P13922, DOI 10.1128/JVI.01517-07; Chen YF, 2008, P NATL ACAD SCI USA, V105, P20203, DOI 10.1073/pnas.0811075106; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Franca R, 2007, PROTEINS, V67, P1128, DOI 10.1002/prot.21433; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; Hilbert M, 2009, BIOL CHEM, V390, P1237, DOI 10.1515/BC.2009.135; Hogbom M, 2007, J MOL BIOL, V372, P150, DOI 10.1016/j.jmb.2007.06.050; Kalverda AP, 2009, J MOL BIOL, V385, P843, DOI 10.1016/j.jmb.2008.09.048; Kikuma T, 2004, J BIOL CHEM, V279, P20692, DOI 10.1074/jbc.M400231200; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kwong AD, 2005, NAT REV DRUG DISCOV, V4, P845, DOI 10.1038/nrd1853; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; Liu F, 2008, P NATL ACAD SCI USA, V105, P20209, DOI 10.1073/pnas.0811115106; LIU J, 2011, J NEUROIMMUNE PHARM; Maga G, 2008, J MED CHEM, V51, P6635, DOI 10.1021/jm8008844; Schutz P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012791; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Tarn WY, 2009, RNA BIOL, V6, P17, DOI 10.4161/rna.6.1.7440; von Moeller H, 2009, NAT STRUCT MOL BIOL, V16, P247, DOI 10.1038/nsmb.1561; Wang HF, 2009, J VIROL, V83, P5815, DOI 10.1128/JVI.00011-09; Yang Q, 2007, MOL CELL, V28, P253, DOI 10.1016/j.molcel.2007.08.016; Yedavalli VSRK, 2008, J MED CHEM, V51, P5043, DOI 10.1021/jm800332m; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029	24	54	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19810	10.1371/journal.pone.0019810	http://dx.doi.org/10.1371/journal.pone.0019810			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589879	gold, Green Published, Green Submitted			2022-12-27	WOS:000290531100028
J	Portelli, G; Ruffier, F; Roubieu, FL; Franceschini, N				Portelli, Geoffrey; Ruffier, Franck; Roubieu, Frederic L.; Franceschini, Nicolas			Honeybees' Speed Depends on Dorsal as Well as Lateral, Ventral and Frontal Optic Flows	PLOS ONE			English	Article							FLIGHT SPEED; VISUAL CONTROL; GROUND SPEED; BEES; VISION; HEIGHT; COMPENSATION; ORGANIZATION; NAVIGATION; DROSOPHILA	Flying insects use the optic flow to navigate safely in unfamiliar environments, especially by adjusting their speed and their clearance from surrounding objects. It has not yet been established, however, which specific parts of the optical flow field insects use to control their speed. With a view to answering this question, freely flying honeybees were trained to fly along a specially designed tunnel including two successive tapering parts: the first part was tapered in the vertical plane and the second one, in the horizontal plane. The honeybees were found to adjust their speed on the basis of the optic flow they perceived not only in the lateral and ventral parts of their visual field, but also in the dorsal part. More specifically, the honeybees' speed varied monotonically, depending on the minimum cross-section of the tunnel, regardless of whether the narrowing occurred in the horizontal or vertical plane. The honeybees' speed decreased or increased whenever the minimum cross-section decreased or increased. In other words, the larger sum of the two opposite optic flows in the horizontal and vertical planes was kept practically constant thanks to the speed control performed by the honeybees upon encountering a narrowing of the tunnel. The previously described ALIS ("AutopiLot using an Insect-based vision System'') model nicely matches the present behavioral findings. The ALIS model is based on a feedback control scheme that explains how honeybees may keep their speed proportional to the minimum local cross-section of a tunnel, based solely on optic flow processing, without any need for speedometers or rangefinders. The present behavioral findings suggest how flying insects may succeed in adjusting their speed in their complex foraging environments, while at the same time adjusting their distance not only from lateral and ventral objects but also from those located in their dorsal visual field.	[Portelli, Geoffrey; Ruffier, Franck; Roubieu, Frederic L.; Franceschini, Nicolas] Univ Aix Marseille 2, Biorobot Dept, Inst Movement Sci, CNRS, F-13284 Marseille 07, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Portelli, G (corresponding author), Univ Aix Marseille 2, Biorobot Dept, Inst Movement Sci, CNRS, F-13284 Marseille 07, France.	franck.ruffier@univmed.fr	RUFFIER, Franck/G-4797-2013	RUFFIER, Franck/0000-0002-7854-1275	CNRS (Life Science; Information and Engineering Science and Technology); Aix-Marseille University; French Defense Agency (DGA) [05 34 022]; French Agency for Research (ANR); European Space Agency (ESA) [08-6303b]; European Commission [237940]	CNRS (Life Science; Information and Engineering Science and Technology)(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille University; French Defense Agency (DGA); French Agency for Research (ANR)(French National Research Agency (ANR)); European Space Agency (ESA)(European Space Agency); European Commission(European CommissionEuropean Commission Joint Research Centre)	This research was supported by CNRS (Life Science; Information and Engineering Science and Technology), Aix-Marseille University, the French Defense Agency (DGA, 05 34 022), the French Agency for Research (ANR, EVA project), the European Space Agency (ESA) under contract no 08-6303b and the European Commission via the CURVACE project. The project CURVACE acknowledges the financial support of the Future and Emerging Technologies (FET) program within the Seventh Framework Program for Research of the European Commission, under FETOpen grant number 237940. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird E, 2005, J EXP BIOL, V208, P3895, DOI 10.1242/jeb.01818; BAIRD E, 2007, THESIS AUSTR NATL U; Baird E, 2006, LECT NOTES COMPUT SC, V4095, P40; Baird E, 2010, J EXP BIOL, V213, P1625, DOI 10.1242/jeb.038802; Barron A, 2006, J EXP BIOL, V209, P978, DOI 10.1242/jeb.02085; Beyeler A, 2009, AUTON ROBOT, V27, P201, DOI 10.1007/s10514-009-9139-6; BISHOP LG, 1970, J COMP PHYSIOL A, V70, P374; Boeddeker N, 2010, P ROY SOC B-BIOL SCI, V277, P1209, DOI 10.1098/rspb.2009.1928; Brinkworth RSA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000555; Buchner E., 1984, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, V74, P561; COLLETT T, 1993, VISUAL MOTION ITS RO, P239; Conroy J, 2009, AUTON ROBOT, V27, P189, DOI 10.1007/s10514-009-9140-0; DAVID CT, 1979, PHYSIOL ENTOMOL, V4, P209, DOI 10.1111/j.1365-3032.1979.tb00197.x; DAVID CT, 1982, J COMP PHYSIOL, V147, P485, DOI 10.1007/BF00612014; DAVID CT, 1978, PHYSIOL ENTOMOL, V3, P191, DOI 10.1111/j.1365-3032.1978.tb00148.x; Eckert MP, 2001, MOTION VISION, P333; Fadamiro HY, 1998, J INSECT BEHAV, V11, P549, DOI 10.1023/A:1022367430354; FRANCESCHINI N, 1992, PHILOS T R SOC B, V337, P283, DOI 10.1098/rstb.1992.0106; Franceschini N., 2009, FUTURA, V3, P15; Franceschini N, 2007, CURR BIOL, V17, P329, DOI 10.1016/j.cub.2006.12.032; Fry SN, 2009, J EXP BIOL, V212, P1120, DOI 10.1242/jeb.020768; HENGSTENBERG R, 1988, J COMP PHYSIOL A, V163, P151, DOI 10.1007/BF00612425; HENGSTENBERG R, 1992, P 20 GOTT NEUR C; HENGSTENBERG R, 2001, P INV VIS C; KAISER W, 1974, J COMP PHYSIOL, V89, P391, DOI 10.1007/BF00695355; KENNEDY JS, 1951, PHILOS T ROY SOC B, V235, P163, DOI 10.1098/rstb.1951.0003; KIRCHNER WH, 1989, NATURWISSENSCHAFTEN, V76, P281, DOI 10.1007/BF00368643; KOENDERINK JJ, 1986, VISION RES, V26, P161, DOI 10.1016/0042-6989(86)90078-7; Krapp HG, 1998, J NEUROPHYSIOL, V79, P1902, DOI 10.1152/jn.1998.79.4.1902; KUENEN LPS, 1982, PHYSIOL ENTOMOL, V7, P193, DOI 10.1111/j.1365-3032.1982.tb00289.x; MARTIN N, 1994, INTELLIGENT VEHICLES, P381; MENZEL R, 1973, J COMP PHYSIOL, V82, P135, DOI 10.1007/BF00696149; Menzel Randolf, 1991, P262; Netter T, 2002, 2002 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-3, PROCEEDINGS, P129, DOI 10.1109/IRDS.2002.1041376; PICHON JM, 1989, MOBILE ROBOTS 4, V1195, P44; Portelli G, 2010, J PHYSIOL-PARIS, V104, P27, DOI 10.1016/j.jphysparis.2009.11.011; Portelli G, 2010, J COMP PHYSIOL A, V196, P307, DOI 10.1007/s00359-010-0510-z; REICHARDT W, 1957, Z NATURFORSCH PT B, V12, P448, DOI 10.1515/znb-1957-0707; REICHARDT W, 1969, PROCESSING OPTICAL D, P465; Ruffier F, 2005, ROBOT AUTON SYST, V50, P177, DOI 10.1016/j.robot.2004.09.016; Ruffier F, 2003, PROC SPIE, V5119, P1, DOI 10.1117/12.498193; Ruffier F, 2008, 2008 IEEE/RSJ INTERNATIONAL CONFERENCE ON ROBOTS AND INTELLIGENT SYSTEMS, VOLS 1-3, CONFERENCE PROCEEDINGS, P1266, DOI 10.1109/IROS.2008.4651089; SANTOSVICTOR J, 1995, INT J COMPUT VISION, V14, P159, DOI 10.1007/BF01418981; Schilstra C, 1999, J EXP BIOL, V202, P1481; Serres J, 2008, AUTON ROBOT, V25, P103, DOI 10.1007/s10514-007-9069-0; Serres JR, 2008, NATURWISSENSCHAFTEN, V95, P1181, DOI 10.1007/s00114-008-0440-6; Srinivasan MV, 2004, ANNU REV NEUROSCI, V27, P679, DOI 10.1146/annurev.neuro.27.070203.144343; SRINIVASAN MV, 1991, VISUAL NEUROSCI, V6, P519, DOI 10.1017/S095252380000136X; Srinivasan MV, 1996, J EXP BIOL, V199, P237; Taylor GK, 2007, ADV INSECT PHYSIOL, V34, P231, DOI 10.1016/S0065-2806(07)34005-8; VALETTE F, 2010, P IEEE INT C ROB AUT, P2253; Van Hateren JH, 1999, J EXP BIOL, V202, P1491; Zar JH, 1999, BIOSTATISTICAL ANAL; Zeil J, 1996, J EXP BIOL, V199, P245; Zeil J, 2008, CURR BIOL, V18, pR320, DOI 10.1016/j.cub.2008.02.017; ZHANG SW, 1990, VISUAL NEUROSCI, V4, P379, DOI 10.1017/S0952523800004582	56	41	41	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19486	10.1371/journal.pone.0019486	http://dx.doi.org/10.1371/journal.pone.0019486			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589861	Green Submitted, Green Published, gold			2022-12-27	WOS:000290531100013
J	Tang, YT; Li, SJ; Kao, HY; Tsai, SJ; Wang, HC				Tang, Yi-Tsung; Li, Shuo-Jang; Kao, Hung-Yu; Tsai, Shaw-Jenq; Wang, Hei-Chia			Using Unsupervised Patterns to Extract Gene Regulation Relationships for Network Construction	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; INFORMATION; SYSTEM	Background: The gene expression is usually described in the literature as a transcription factor X that regulates the target gene Y. Previously, some studies discovered gene regulations by using information from the biomedical literature and most of them require effort of human annotators to build the training dataset. Moreover, the large amount of textual knowledge recorded in the biomedical literature grows very rapidly, and the creation of manual patterns from literatures becomes more difficult. There is an increasing need to automate the process of establishing patterns. Methodology/Principal Findings: In this article, we describe an unsupervised pattern generation method called AutoPat. It is a gene expression mining system that can generate unsupervised patterns automatically from a given set of seed patterns. The high scalability and low maintenance cost of the unsupervised patterns could help our system to extract gene expression from PubMed abstracts more precisely and effectively. Conclusions/Significance: Experiments on several regulators show reasonable precision and recall rates which validate AutoPat's practical applicability. The conducted regulation networks could also be built precisely and effectively. The system in this study is available at http://ikmbio.csie.ncku.edu.tw/AutoPat/.	[Tang, Yi-Tsung; Li, Shuo-Jang; Kao, Hung-Yu] Natl Cheng Kung Tainan, Dept Comp Sci & Informat Engn, Tainan, Taiwan; [Tsai, Shaw-Jenq] Natl Cheng Kung Univ, Coll Med, Dept Physiol, Tainan 70101, Taiwan; [Wang, Hei-Chia] Natl Cheng Kung Univ, Inst Informat Management, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University	Tang, YT (corresponding author), Natl Cheng Kung Tainan, Dept Comp Sci & Informat Engn, Tainan, Taiwan.	p7895125@mail.ncku.edu.tw	Tsai, Shaw-Jenq/AAG-6569-2019	TSAI, SHAW-JENQ/0000-0002-3569-5813	National Science Council of Taiwan [NSC97-2627-B-006-003]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This paper was supported in part by National Science Council of Taiwan under Contract NSC97-2627-B-006-003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaschke C, 2001, Genome Inform, V12, P123; BUYKO E, 2008, TESTING DIFFERENT AC, P21; Chiang JH, 2004, BIOINFORMATICS, V20, P120, DOI 10.1093/bioinformatics/btg369; Chowdhary R, 2009, BIOINFORMATICS, V25, P1536, DOI 10.1093/bioinformatics/btp245; Fundel K, 2007, BIOINFORMATICS, V23, P365, DOI 10.1093/bioinformatics/btl616; HAHN U, 2009, FEASIBLE ROBUST AUTO, P37; Hoffmann R, 2004, NAT GENET, V36, P664, DOI 10.1038/ng0704-664; Huang ML, 2004, BIOINFORMATICS, V20, P3604, DOI 10.1093/bioinformatics/bth451; Jelier R, 2005, BIOINFORMATICS, V21, P2049, DOI 10.1093/bioinformatics/bti268; Jenssen TK, 2001, NAT GENET, V28, P21, DOI 10.1038/88213; Kim S, 2008, NUCLEIC ACIDS RES, V36, pW411, DOI 10.1093/nar/gkn281; Klein D, 2003, 41ST ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P423, DOI 10.3115/1075096.1075150; Klein D, 2002, ADV NEUR IN, V14, P35; Muller HM, 2004, PLOS BIOL, V2, P1984, DOI 10.1371/journal.pbio.0020309; NEDELLEC C, 2005, P ICML05 WORKSH LEAR; Ozgur A, 2008, BIOINFORMATICS, V24, pI277, DOI 10.1093/bioinformatics/btn182; Ono T, 2001, BIOINFORMATICS, V17, P155, DOI 10.1093/bioinformatics/17.2.155; Pyysalo S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S3-S6; Rodriguez-Penagos C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-293; Saric J, 2006, BIOINFORMATICS, V22, P645, DOI 10.1093/bioinformatics/bti597; SARIC J, 2004, EXTRACTING REGULATOR, P191; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Stapley B J, 2000, Pac Symp Biocomput, P529; Tanabe L, 2002, BIOINFORMATICS, V18, P1124, DOI 10.1093/bioinformatics/18.8.1124; van der Eijk CC, 2004, J AM SOC INF SCI TEC, V55, P436, DOI 10.1002/asi.10392	25	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19633	10.1371/journal.pone.0019633	http://dx.doi.org/10.1371/journal.pone.0019633			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21573008	Green Published, Green Submitted, gold			2022-12-27	WOS:000290440200016
J	Xia, Q; Zhou, LF; Liu, DC; Chen, Z; Chen, F				Xia, Qi; Zhou, LinFu; Liu, Dongcheng; Chen, Zhi; Chen, Feng			Relationship between TNF-< alpha > Gene Promoter Polymorphisms and Outcomes of Hepatitis B Virus Infections: A Meta-Analysis	PLOS ONE			English	Article							ALPHA TNF-ALPHA; ASSOCIATION OF-238G/A; TUMOR; REGION; CLEARANCE	Background: The clearance of hepatitis B virus (HBV) is a complex process which may be influenced by many factors polymorphisms in the tumor necrosis factor < alpha > (TNF-< alpha >) gene promoter. However, previous reports regarding the relationship between polymorphisms in the TNF-< alpha > promoter and HBV clearance have been inconsistent. Therefore, we performed a meta-analysis on a large population to address this inconsistency. Methods: A meta-analysis was performed to examine the association between TNF-< alpha > promoter polymorphisms (-1031T/C, -863C/A, -857C/T, -308G/A and-238G/A) and chronic hepatitis B infection. Odds ratio (OR) and its 95% confidence interval (CI) were used. Results: Twelve studies were chosen in our meta-analysis, involving 2,754 chronic HBV infection cases and 1,630 HBV clearance cases. The data showed that TNF-< alpha >-863 CC genotype was significantly associated with HBV clearance (-863 CC vs. AA: OR, 0.64; 95% CI, [0.42, 0.97]; p = 0.04) while patients carrying -308 GG genotype had a significantly increased risk of HBV persistence compared with those with GA or AA genotype (GG vs. GA+AA: OR, 1.35; 95% CI, [1.08, 1.70]; p = 0.01). For the other polymorphisms, no association with HBV infection outcome was found. Conclusions: The data showed that polymorphisms -863 A and -308 G in the TNF-< alpha > gene promoter region might be risk factors for HBV persistence. Furthermore, ethnicity might play an important role in HBV infection outcome, leading to conflicting results. More studies on individuals from various ethnic groups will be necessary to determine the role of TNF-< alpha > promoter polymorphisms in the outcome of HBV infection.	[Xia, Qi; Liu, Dongcheng; Chen, Zhi; Chen, Feng] Zhejiang Univ, State Key Lab Infect Dis Diag & Treatment, Coll Med, Affiliated Hosp 1, Zhejiang, Peoples R China; [Zhou, LinFu] Zhejiang Univ, Dept Biochem, Coll Med, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Xia, Q (corresponding author), Zhejiang Univ, State Key Lab Infect Dis Diag & Treatment, Coll Med, Affiliated Hosp 1, Zhejiang, Peoples R China.	zjuchenfeng@gmail.com			National Basic Research Program (973 Program) [2007CB512905]; National Natural Science Fund [30771918]; State ST Projects [2008ZX10002-007]	National Basic Research Program (973 Program)(National Basic Research Program of China); National Natural Science Fund(National Natural Science Foundation of China (NSFC)); State ST Projects	The work was supported by the National Basic Research Program (973 Program) (2007CB512905), National Natural Science Fund (30771918), the State S&T Projects (11th Five Year) (2008ZX10002-007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham LJ, 1999, J LEUKOCYTE BIOL, V66, P562, DOI 10.1002/jlb.66.4.562; Bozkaya H, 2000, HEPATO-GASTROENTEROL, V47, P1675; Bradham CA, 1998, AM J PHYSIOL-GASTR L, V275, pG387, DOI 10.1152/ajpgi.1998.275.3.G387; Chen DQ, 2010, J MED VIROL, V82, P371, DOI 10.1002/jmv.21716; Cheong JY, 2006, J GASTROEN HEPATOL, V21, P1163, DOI 10.1111/j.1440-1746.2006.04304.x; CHEONG JYC, 2005, KOREAN J MED, V68, P619; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hohler T, 1998, CLIN EXP IMMUNOL, V111, P579; Kamali-Sarvestani E, 2005, CANCER LETT, V223, P113, DOI 10.1016/j.canlet.2004.09.025; Kim Gwang Ha, 2005, Korean Journal of Internal Medicine, V20, P191; Kim YJ, 2003, HUM MOL GENET, V12, P2541, DOI 10.1093/hmg/ddg262; Koziel MJ, 1999, SEMIN LIVER DIS, V19, P157, DOI 10.1055/s-2007-1007107; Kummee P, 2007, J VIRAL HEPATITIS, V14, P841, DOI 10.1111/j.1365-2893.2007.00880.x; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Li HQ, 2005, WORLD J GASTROENTERO, V11, P5213; Li HQ, 2006, BIOMED ENVIRON SCI, V19, P133; Lu LP, 2004, WORLD J GASTROENTERO, V10, P1810; MANTEL N, 1959, J NATL CANCER I, V22, P719; Niro GA, 2005, LIVER INT, V25, P1175, DOI 10.1111/j.1478-3231.2005.01166.x; Puro R, 2007, J VIROL, V81, P7351, DOI 10.1128/JVI.00554-07; Skoog T, 1999, HUM MOL GENET, V8, P1443, DOI 10.1093/hmg/8.8.1443; Somi M H, 2006, Indian J Gastroenterol, V25, P14; Ribeiro CSS, 2007, MEM I OSWALDO CRUZ, V102, P435, DOI 10.1590/S0074-02762007005000043; Tokushige K, 2000, AM J GASTROENTEROL, V95, P2040; WAN PQ, 2010, POLYMORPHISMS GENE P, V32, P381; Wang FS, 2003, WORLD J GASTROENTERO, V9, P641, DOI 10.3748/wjg.v9.i4.641; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195; Xing PeiXiang, 2007, Journal of Shandong University (Health Sciences), V45, P1229; ZHANG PA, 2004, WORLD CHIN J DIGESTO, V12, P2086; Zheng MH, 2010, INT J INFECT DIS, V14, pE580, DOI 10.1016/j.ijid.2009.08.010	31	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19606	10.1371/journal.pone.0019606	http://dx.doi.org/10.1371/journal.pone.0019606			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572952	Green Published, gold, Green Submitted			2022-12-27	WOS:000290440200013
J	LaBarre, P; Hawkins, KR; Gerlach, J; Wilmoth, J; Beddoe, A; Singleton, J; Boyle, D; Weigl, B				LaBarre, Paul; Hawkins, Kenneth R.; Gerlach, Jay; Wilmoth, Jared; Beddoe, Andrew; Singleton, Jered; Boyle, David; Weigl, Bernhard			A Simple, Inexpensive Device for Nucleic Acid Amplification without Electricity-Toward Instrument-Free Molecular Diagnostics in Low-Resource Settings	PLOS ONE			English	Article							MEDIATED ISOTHERMAL AMPLIFICATION; RAPID DETECTION; REVERSE-TRANSCRIPTION; DNA AMPLIFICATION; LAMP; ASSAY; TECHNOLOGIES; VIRUS; HIV-1	Background: Molecular assays targeted to nucleic acid (NA) markers are becoming increasingly important to medical diagnostics. However, these are typically confined to wealthy, developed countries; or, to the national reference laboratories of developing-world countries. There are many infectious diseases that are endemic in low-resource settings (LRS) where the lack of simple, instrument-free, NA diagnostic tests is a critical barrier to timely treatment. One of the primary barriers to the practicality and availability of NA assays in LRS has been the complexity and power requirements of polymerase chain reaction (PCR) instrumentation (another is sample preparation). Methodology/Principal Findings: In this article, we investigate the hypothesis that an electricity-free heater based on exothermic chemical reactions and engineered phase change materials can successfully incubate isothermal NA amplification assays. We assess the heater's equivalence to commercially available PCR instruments through the characterization of the temperature profiles produced, and a minimal method comparison. Versions of the prototype for several different isothermal techniques are presented. Conclusions/Significance: We demonstrate that an electricity-free heater based on exothermic chemical reactions and engineered phase change materials can successfully incubate isothermal NA amplification assays, and that the results of those assays are not significantly different from ones incubated in parallel in commercially available PCR instruments. These results clearly suggest the potential of the non-instrumented nucleic acid amplification (NINA) heater for molecular diagnostics in LRS. When combined with other innovations in development that eliminate power requirements for sample preparation, cold reagent storage, and readout, the NINA heater will comprise part of a kit that should enable electricity-free NA testing for many important analytes.	[LaBarre, Paul; Hawkins, Kenneth R.; Gerlach, Jay; Wilmoth, Jared; Beddoe, Andrew; Singleton, Jered; Boyle, David; Weigl, Bernhard] PATH, Seattle, WA 98121 USA		LaBarre, P (corresponding author), PATH, Seattle, WA 98121 USA.	plabarr@path.org	Gerlach, Jay/GOJ-7886-2022		United States Agency for International Development; National Institutes of Health, National Institute of Biomedical Imaging and Bioengineering [1U54EB007949-01]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB007949] Funding Source: NIH RePORTER	United States Agency for International Development(United States Agency for International Development (USAID)); National Institutes of Health, National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	PATH is a nonprofit international health agency that designs and develops appropriate and affordable technologies to solve health problems, especially in developing countries. This work, such as the technology described in this paper, is supported by grants from the United States Agency for International Development, the National Institutes of Health, National Institute of Biomedical Imaging and Bioengineering Grant 1U54EB007949-01, other governments, and private foundations. Since the authors do not manufacture or distribute products themselves, they work with private-sector collaborators willing to work on products for these types of markets. Support for this project is made possible by the generous support of the American people through the United States Agency for International Development (USAID) under the terms of the HealthTech Cooperative Agreement # GPH-A-00-01-00005-00. The contents are the responsibility of PATH and do not necessarily reflect the views of USAID or the US Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade TPD, 2009, J FISH DIS, V32, P911, DOI 10.1111/j.1365-2761.2009.01072.x; Andresen D, 2009, EXPERT REV MOL DIAGN, V9, P645, DOI 10.1586/ERM.09.46; BOYLE DS, 2009, CLIN CHEM, V55, P1891; BURGESS DH, 2006, NATURE LONDON S, V1; Curtis KA, 2008, J VIROL METHODS, V151, P264, DOI 10.1016/j.jviromet.2008.04.011; Curtis KA, 2009, J MED VIROL, V81, P966, DOI 10.1002/jmv.21490; Dominguez M, 2010, INT J TUBERC LUNG D, V14, P1468; Fang RD, 2009, J CLIN MICROBIOL, V47, P845, DOI 10.1128/JCM.01528-08; Fujino M, 2005, J MED VIROL, V76, P406, DOI 10.1002/jmv.20371; Han ET, 2007, J CLIN MICROBIOL, V45, P2521, DOI 10.1128/JCM.02117-06; Hatano B, 2010, JPN J INFECT DIS, V63, P36; Hill J, 2008, J CLIN MICROBIOL, V46, P2800, DOI 10.1128/JCM.00152-08; Ihira M, 2007, J CLIN VIROL, V39, P22, DOI 10.1016/j.jcv.2007.02.001; Lai JJ, 2007, LANGMUIR, V23, P7385, DOI 10.1021/la062527g; Lee SY, 2008, SENSOR ACTUAT B-CHEM, V133, P493, DOI 10.1016/j.snb.2008.03.008; Mabey D, 2004, NAT REV MICROBIOL, V2, P231, DOI 10.1038/nrmicro841; Mori Y, 2001, BIOCHEM BIOPH RES CO, V289, P150, DOI 10.1006/bbrc.2001.5921; Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9; Morisset D, 2008, EUR FOOD RES TECHNOL, V227, P1287, DOI 10.1007/s00217-008-0850-x; Morshed MG, 2007, FEMS IMMUNOL MED MIC, V49, P184, DOI 10.1111/j.1574-695X.2006.00191.x; Neumaier M, 1998, CLIN CHEM, V44, P12; Ngom B, 2010, ANAL BIOANAL CHEM, V397, P1113, DOI 10.1007/s00216-010-3661-4; NIEMZ A, 2010, TRENDS BIOT IN PRESS; Nimitphak T, 2010, MOL CELL PROBE, V24, P1, DOI 10.1016/j.mcp.2009.09.004; Njiru ZK, 2008, INT J PARASITOL, V38, P589, DOI 10.1016/j.ijpara.2007.09.006; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Paris DH, 2008, T ROY SOC TROP MED H, V102, P1239, DOI 10.1016/j.trstmh.2008.04.040; Peeling RW, 2006, NAT REV MICROBIOL, V4, P909, DOI 10.1038/nrmicro1555; Poon LLM, 2006, CLIN CHEM, V52, P303; Rafael Maria E, 2006, Nature, V444 Suppl 1, P39, DOI 10.1038/nature05445; Rigano LA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-176; Thai HTC, 2004, J CLIN MICROBIOL, V42, P1956, DOI 10.1128/JCM.42.5.1956-1961.2004; Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57; Tucker JD, 2010, LANCET INFECT DIS, V10, P381, DOI 10.1016/S1473-3099(10)70092-X; Urdea Mickey, 2006, Nature, V444 Suppl 1, P73, DOI 10.1038/nature05448; Weigl BH, 2009, EXPERT REV MED DEVIC, V6, P461, DOI [10.1586/erd.09.31, 10.1586/ERD.09.31]; Weigl B, 2008, LAB CHIP, V8, P1999, DOI 10.1039/b811314a; Wu WJ, 2009, CLIN LAB MED, V29, P673, DOI 10.1016/j.cll.2009.07.005; Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064; 2010, FACTORS AFFECTING QU	40	107	114	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19738	10.1371/journal.pone.0019738	http://dx.doi.org/10.1371/journal.pone.0019738			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573065	Green Published, gold			2022-12-27	WOS:000290386800036
J	Dheekollu, J; Wiedmer, A; Hayden, J; Speicher, D; Gotter, AL; Yen, T; Lieberman, PM				Dheekollu, Jayaraju; Wiedmer, Andreas; Hayden, James; Speicher, David; Gotter, Anthony L.; Yen, Tim; Lieberman, Paul M.			Timeless Links Replication Termination to Mitotic Kinase Activation	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; DNA-REPLICATION; AURORA-A; S-PHASE; SCHIZOSACCHAROMYCES-POMBE; CHECKPOINT RESPONSE; INTERACTING PROTEIN; HISTONE H3; CELL-CYCLE; COMPLEX	The mechanisms that coordinate the termination of DNA replication with progression through mitosis are not completely understood. The human Timeless protein (Tim) associates with S phase replication checkpoint proteins Claspin and Tipin, and plays an important role in maintaining replication fork stability at physical barriers, like centromeres, telomeres and ribosomal DNA repeats, as well as at termination sites. We show here that human Tim can be isolated in a complex with mitotic entry kinases CDK1, Auroras A and B, and Polo-like kinase (Plk1). Plk1 bound Tim directly and colocalized with Tim at a subset of mitotic structures in M phase. Tim depletion caused multiple mitotic defects, including the loss of sister-chromatid cohesion, loss of mitotic spindle architecture, and a failure to exit mitosis. Tim depletion caused a delay in mitotic kinase activity in vivo and in vitro, as well as a reduction in global histone H3 S10 phosphorylation during G2/M phase. Tim was also required for the recruitment of Plk1 to centromeric DNA and formation of catenated DNA structures at human centromere alpha satellite repeats. Taken together, these findings suggest that Tim coordinates mitotic kinase activation with termination of DNA replication.	[Dheekollu, Jayaraju; Wiedmer, Andreas; Hayden, James; Speicher, David; Lieberman, Paul M.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Gotter, Anthony L.] Merk Res Labs, West Point, PA USA; [Yen, Tim] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	The Wistar Institute; Fox Chase Cancer Center	Dheekollu, J (corresponding author), Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA.	Lieberman@wistar.org		Yen, Tim/0000-0003-2159-0997	National Institutes of Health (NIH) [RO1 CA093606]; Wistar Institute Cancer Center [5 P30 CA 010815-41]; NATIONAL CANCER INSTITUTE [P30CA010815, R01CA093606] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wistar Institute Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this study was provided by National Institutes of Health (NIH) RO1 CA093606 to PML and the Wistar Institute Cancer Center Core Grant 5 P30 CA 010815-41. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers T, 2000, Nucleic Acids Res, V28, pe6, DOI 10.1093/nar/28.2.e6; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Barr AR, 2007, J CELL SCI, V120, P2987, DOI 10.1242/jcs.013136; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Biswas S, 2008, MOL CELL BIOL, V28, P6844, DOI 10.1128/MCB.01235-08; Burkhalter MD, 2004, MOL CELL, V15, P409, DOI 10.1016/j.molcel.2004.06.024; Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; Chan RC, 2003, NATURE, V423, P1002, DOI 10.1038/nature01697; Chini CCS, 2004, DNA REPAIR, V3, P1033, DOI 10.1016/j.dnarep.2004.03.001; Chou DM, 2006, P NATL ACAD SCI USA, V103, P18143, DOI 10.1073/pnas.0609251103; Conti C, 2007, CELL CYCLE, V6, P2760, DOI 10.4161/cc.6.22.4932; Dalgaard JZ, 2000, CELL, V102, P745, DOI 10.1016/S0092-8674(00)00063-5; Deng Z, 2009, MOL CELL, V35, P403, DOI 10.1016/j.molcel.2009.06.025; Dheekollu J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001257; Egel R, 2004, CURR BIOL, V14, pR915, DOI 10.1016/j.cub.2004.10.012; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Errico A, 2007, P NATL ACAD SCI USA, V104, P14929, DOI 10.1073/pnas.0706347104; Gotter AL, 2003, J MOL BIOL, V331, P167, DOI 10.1016/S0022-2836(03)00633-8; Gotter AL, 2007, J MOL BIOL, V366, P36, DOI 10.1016/j.jmb.2006.10.097; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Hodgson B, 2007, MOL BIOL CELL, V18, P3894, DOI 10.1091/mbc.E07-05-0500; Hwang JY, 2008, DNA REPAIR, V7, P1426, DOI 10.1016/j.dnarep.2008.05.006; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Karisson-Rosenthal C, 2006, TRENDS CELL BIOL, V16, P285, DOI 10.1016/j.tcb.2006.04.002; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kemp MG, 2010, J BIOL CHEM, V285, P16562, DOI 10.1074/jbc.M110.110304; King MC, 2008, CELL, V134, P427, DOI 10.1016/j.cell.2008.06.022; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; Kondratov RV, 2007, TRENDS CELL BIOL, V17, P311, DOI 10.1016/j.tcb.2007.07.001; Krings G, 2004, P NATL ACAD SCI USA, V101, P14085, DOI 10.1073/pnas.0406037101; Kunitoku N, 2003, DEV CELL, V5, P853, DOI 10.1016/S1534-5807(03)00364-2; Labib K, 2007, EMBO REP, V8, P346, DOI 10.1038/sj.embor.7400940; Lee MG, 2006, METHODS, V40, P327, DOI 10.1016/j.ymeth.2006.07.030; Leman AR, 2010, J CELL SCI, V123, P660, DOI 10.1242/jcs.057984; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Macurek L, 2009, CANCER RES, V69, P4555, DOI 10.1158/0008-5472.CAN-09-0142; Matos J, 2008, CELL, V135, P662, DOI 10.1016/j.cell.2008.10.026; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; McFarlane RJ, 2010, CELL CYCLE, V9, P700, DOI 10.4161/cc.9.4.10676; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Noguchi E, 2004, MOL CELL BIOL, V24, P8342, DOI 10.1128/MCB.24.19.8342-8355.2004; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Pebernard S, 2008, EMBO J, V27, P3011, DOI 10.1038/emboj.2008.220; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Potts PR, 2007, NAT STRUCT MOL BIOL, V14, P581, DOI 10.1038/nsmb1259; Prasanth SG, 2004, EMBO J, V23, P2651, DOI 10.1038/sj.emboj.7600255; Rush BL, 2006, J BIOL RHYTHM, V21, P272, DOI 10.1177/0748730406290416; Schueler MG, 2006, ANNU REV GENOM HUM G, V7, P301, DOI 10.1146/annurev.genom.7.080505.115613; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Smith MM, 2002, CURR OPIN CELL BIOL, V14, P279, DOI 10.1016/S0955-0674(02)00331-9; Taylor SS, 2001, J CELL SCI, V114, P4385; Tourriere H, 2007, DNA REPAIR, V6, P900, DOI 10.1016/j.dnarep.2007.02.004; Trenz K, 2008, EMBO J, V27, P876, DOI 10.1038/emboj.2008.29; Tsvetkov L, 2005, J BIOL CHEM, V280, P11943, DOI 10.1074/jbc.M413514200; Unsal-Kacmaz K, 2005, MOL CELL BIOL, V25, P3109, DOI 10.1128/MCB.25.8.3109-3116.2005; Unsal-Kacmaz K, 2007, MOL CELL BIOL, V27, P3131, DOI 10.1128/MCB.02190-06; Urtishak KA, 2008, J BIOL CHEM; Vagnarelli P, 2004, CHROMOSOMA, V113, P211, DOI 10.1007/s00412-004-0307-3; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Yoo HY, 2004, CELL, V117, P575, DOI 10.1016/S0092-8674(04)00417-9; Yoshizawa-Sugata N, 2007, J BIOL CHEM, V282, P2729, DOI 10.1074/jbc.M605596200	65	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19596	10.1371/journal.pone.0019596	http://dx.doi.org/10.1371/journal.pone.0019596			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573113	Green Published, gold, Green Submitted			2022-12-27	WOS:000290305600033
J	Frost, D; Meechoovet, B; Wang, T; Gately, S; Giorgetti, M; Shcherbakova, I; Dunckley, T				Frost, Danielle; Meechoovet, Bessie; Wang, Tong; Gately, Stephen; Giorgetti, Marco; Shcherbakova, Irina; Dunckley, Travis			beta-Carboline Compounds, Including Harmine, Inhibit DYRK1A and Tau Phosphorylation at Multiple Alzheimer's Disease-Related Sites	PLOS ONE			English	Article							DOWN-SYNDROME; FUNCTIONAL-LINK; PROTEIN; BINDING; MICE; HYPERPHOSPHORYLATION; CELLS	Harmine, a beta-carboline alkaloid, is a high affinity inhibitor of the dual specificity tyrosine phosphorylation regulated kinase 1A (DYRK1A) protein. The DYRK1A gene is located within the Down Syndrome Critical Region (DSCR) on chromosome 21. We and others have implicated DYRK1A in the phosphorylation of tau protein on multiple sites associated with tau pathology in Down Syndrome and in Alzheimer's disease (AD). Pharmacological inhibition of this kinase may provide an opportunity to intervene therapeutically to alter the onset or progression of tau pathology in AD. Here we test the ability of harmine, and numerous additional beta-carboline compounds, to inhibit the DYRK1A dependent phosphorylation of tau protein on serine 396, serine 262/serine 356 (12E8 epitope), and threonine 231 in cell culture assays and in vitro phosphorylation assays. Results demonstrate that the beta-carboline compounds (1) potently reduce the expression of all three phosphorylated forms of tau protein, and (2) inhibit the DYRK1A catalyzed direct phosphorylation of tau protein on serine 396. By assaying several beta-carboline compounds, we define certain chemical groups that modulate the affinity of this class of compounds for inhibition of tau phosphorylation.	[Frost, Danielle; Meechoovet, Bessie; Dunckley, Travis] Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ USA; [Wang, Tong; Gately, Stephen] Translat Genom Res Inst, Scottsdale, AZ USA; [Giorgetti, Marco; Shcherbakova, Irina] MediProPharma Inc, Salt Lake City, UT USA; [Frost, Danielle; Meechoovet, Bessie; Dunckley, Travis] Arizona Alzheimers Res Consortium, Phoenix, AZ USA	Translational Genomics Research Institute; Translational Genomics Research Institute	Frost, D (corresponding author), Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ USA.	tdunckley@tgen.org			Arizona Alzheimer's Research Consortium; MediProPharma, Inc.;  [R21AG029576];  [K01AG024079];  [P30AG19610]; NATIONAL INSTITUTE ON AGING [K01AG024079, P30AG019610, R21AG029576] Funding Source: NIH RePORTER	Arizona Alzheimer's Research Consortium; MediProPharma, Inc.; ; ; ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by R21AG029576, K01AG024079, P30AG19610 to TD, the Arizona Alzheimer's Research Consortium, and a charitable contribution to TGen from the Louis Charitable Trust. Studies of MPP-021 and MPP-313 were supported by MediProPharma, Inc. MediProPharma provided information about compound solubility and IC50 data to assist in compound dosing. Aside from this, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KJ, 2006, NEUROBIOL DIS, V22, P463, DOI 10.1016/j.nbd.2005.12.006; Alonso AD, 2010, J BIOL CHEM, V285, P30851, DOI 10.1074/jbc.M110.110957; Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Arib O, 2010, EUR J PHARMACOL, V629, P47, DOI 10.1016/j.ejphar.2009.12.012; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Azorsa DO, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-25; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Du W, 1997, BRAIN RES, V770, P26, DOI 10.1016/S0006-8993(97)00606-9; Glennon RA, 2000, DRUG ALCOHOL DEPEN, V60, P121, DOI 10.1016/S0376-8716(99)00148-9; Gockler N, 2009, FEBS J, V276, P6324, DOI 10.1111/j.1742-4658.2009.07346.x; GUSTKE N, 1992, FEBS LETT, V307, P199, DOI 10.1016/0014-5793(92)80767-B; Herraiz T, 2010, FOOD CHEM TOXICOL, V48, P839, DOI 10.1016/j.fct.2009.12.019; Jayaprakash V, 2008, BIOORG MED CHEM LETT, V18, P6362, DOI 10.1016/j.bmcl.2008.10.084; Kimura R, 2007, HUM MOL GENET, V16, P15, DOI 10.1093/hmg/ddl437; Vazquez-Higuera JL, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-129; Mandelkow EM, 1996, ANN NY ACAD SCI, V777, P96, DOI 10.1111/j.1749-6632.1996.tb34407.x; Park J, 2007, MOL CELL NEUROSCI, V36, P270, DOI 10.1016/j.mcn.2007.07.007; PIMPINELLA G, 1995, NEUROSCI LETT, V189, P121, DOI 10.1016/0304-3940(95)11469-D; Ryoo SR, 2008, J NEUROCHEM, V104, P1333, DOI 10.1111/j.1471-4159.2007.05075.x; Ryoo SR, 2007, J BIOL CHEM, V282, P34850, DOI 10.1074/jbc.M707358200; Wegiel J, 2008, ACTA NEUROPATHOL, V116, P391, DOI 10.1007/s00401-008-0419-6; Yang YJ, 2008, EUR J PHARMACOL, V587, P57, DOI 10.1016/j.ejphar.2008.03.050	22	125	129	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19264	10.1371/journal.pone.0019264	http://dx.doi.org/10.1371/journal.pone.0019264			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573099	gold, Green Published, Green Submitted			2022-12-27	WOS:000290305600017
J	Raz, T; Kapranov, P; Lipson, D; Letovsky, S; Milos, PM; Thompson, JF				Raz, Tal; Kapranov, Philipp; Lipson, Doron; Letovsky, Stan; Milos, Patrice M.; Thompson, John F.			Protocol Dependence of Sequencing-Based Gene Expression Measurements	PLOS ONE			English	Article							HISTONE MESSENGER-RNA; MAMMALIAN TRANSCRIPTOMES; AMPLIFICATION-FREE; CELL-LINE; SEQ; SAMPLES; DIFFERENTIATION; QUANTIFICATION; PLATFORMS; LEUKEMIA	RNA Seq provides unparalleled levels of information about the transcriptome including precise expression levels over a wide dynamic range. It is essential to understand how technical variation impacts the quality and interpretability of results, how potential errors could be introduced by the protocol, how the source of RNA affects transcript detection, and how all of these variations can impact the conclusions drawn. Multiple human RNA samples were used to assess RNA fragmentation, RNA fractionation, cDNA synthesis, and single versus multiple tag counting. Though protocols employing polyA RNA selection generate the highest number of non-ribosomal reads and the most precise measurements for coding transcripts, such protocols were found to detect only a fraction of the non-ribosomal RNA in human cells. PolyA RNA excludes thousands of annotated and even more unannotated transcripts, resulting in an incomplete view of the transcriptome. Ribosomal-depleted RNA provides a more cost-effective method for generating complete transcriptome coverage. Expression measurements using single tag counting provided advantages for assessing gene expression and for detecting short RNAs relative to multi-read protocols. Detection of short RNAs was also hampered by RNA fragmentation. Thus, this work will help researchers choose from among a range of options when analyzing gene expression, each with its own advantages and disadvantages.	[Raz, Tal; Kapranov, Philipp; Lipson, Doron; Letovsky, Stan; Milos, Patrice M.; Thompson, John F.] Helicos BioSci, Applicat Methods & Collaborat Grp, Cambridge, MA USA		Raz, T (corresponding author), Helicos BioSci, Applicat Methods & Collaborat Grp, Cambridge, MA USA.	jthompson@helicosbio.com		Thompson, John/0000-0001-8568-3311	National Human Genetics Research Institute (NHGRI) at the National Institutes of Health [R01 HG004144, RC2 HG005598]; Helicos BioSciences; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005598, R01HG004144] Funding Source: NIH RePORTER	National Human Genetics Research Institute (NHGRI) at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Helicos BioSciences; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This publication was made possible by grants R01 HG004144 and RC2 HG005598 from the National Human Genetics Research Institute (NHGRI) at the National Institutes of Health. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NHGRI. The remainder of funding was provided by Helicos BioSciences and its authors, as employees, helped design the experiments and prepare the manuscript.	Armour CD, 2009, NAT METHODS, V6, P647, DOI [10.1038/NMETH.1360, 10.1038/nmeth.1360]; Asmann YW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-531; BAUMBACH LL, 1987, BIOCHEMISTRY-US, V26, P6178, DOI 10.1021/bi00393a034; Blencowe BJ, 2009, GENE DEV, V23, P1379, DOI 10.1101/gad.1788009; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; Canales RD, 2006, NAT BIOTECHNOL, V24, P1115, DOI 10.1038/nbt1236; Carninci P, 2009, NAT METHODS, V6, P711, DOI 10.1038/nmeth1009-711; Chepelev I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp507; Djebali S, 2008, NAT METHODS, V5, P629, DOI 10.1038/nmeth.1216; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; Goren A, 2010, NAT METHODS, V7, P47, DOI [10.1038/NMETH.1404, 10.1038/nmeth.1404]; Hart C, 2010, METHOD ENZYMOL, V472, P407, DOI 10.1016/S0076-6879(10)72002-4; Heap GA, 2010, HUM MOL GENET, V19, P122, DOI 10.1093/hmg/ddp473; Kapranov P, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-149; Kapranov P, 2010, NATURE, V466, P642, DOI 10.1038/nature09190; KLEIN E, 1976, INT J CANCER, V18, P421, DOI 10.1002/ijc.2910180405; Lipson D, 2009, NAT BIOTECHNOL, V27, P652, DOI 10.1038/nbt.1551; Mamanova L, 2010, NAT METHODS, V7, P130, DOI [10.1038/NMETH.1417, 10.1038/nmeth.1417]; Mane SP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-264; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagaike T, 2005, J BIOL CHEM, V280, P19721, DOI 10.1074/jbc.M500804200; Oshlack A, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-14; Ozsolak F, 2010, NAT METHODS, V7, P619, DOI [10.1038/NMETH.1480, 10.1038/nmeth.1480]; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Plessy C, 2010, NAT METHODS, V7, P528, DOI [10.1038/NMETH.1470, 10.1038/nmeth.1470]; Rosenkranz R, 2008, GENOMICS, V92, P187, DOI 10.1016/j.ygeno.2008.05.011; Sam LT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017305; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Sullivan KD, 2009, RNA, V15, P459, DOI 10.1261/rna.1205409; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu ZJ, 2010, GENOME RES, V20, P1730, DOI 10.1101/gr.108217.110	37	66	70	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19287	10.1371/journal.pone.0019287	http://dx.doi.org/10.1371/journal.pone.0019287			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573114	Green Submitted, Green Published, gold			2022-12-27	WOS:000290305600020
J	Torres-Diaz, C; Gomez-Gonzalez, S; Stotz, GC; Torres-Morales, P; Paredes, B; Perez-Millaqueo, M; Gianoli, E				Torres-Diaz, Cristian; Gomez-Gonzalez, Susana; Stotz, Gisela C.; Torres-Morales, Patricio; Paredes, Brayam; Perez-Millaqueo, Matias; Gianoli, Ernesto			Extremely Long-Lived Stigmas Allow Extended Cross-Pollination Opportunities in a High Andean Plant	PLOS ONE			English	Article							HIGH TEMPERATE ANDES; POLLEN LIMITATION; CENTRAL CHILE; SELF-FERTILIZATION; INSECT POLLINATION; MT-OLYMPOS; ALPINE; COMMUNITY; ECOLOGY; CONSEQUENCES	High-elevation ecosystems are traditionally viewed as environments in which predominantly autogamous breeding systems should be selected because of the limited pollinator availability. Chaetanthera renifolia (Asteraceae) is an endemic monocarpic triennial herb restricted to a narrow altitudinal range within the high Andes of central Chile (3300-3500 m a.s.l.), just below the vegetation limit. This species displays one of the larger capitulum within the genus. Under the reproductive assurance hypothesis, and considering its short longevity (monocarpic triennial), an autogamous breeding system and low levels of pollen limitation would be predicted for C. renifolia. In contrast, considering its large floral size, a xenogamous breeding system, and significant levels of pollen limitation could be expected. In addition, the increased pollination probability hypothesis predicts prolonged stigma longevity for high alpine plants. We tested these alternative predictions by performing experimental crossings in the field to establish the breeding system and to measure the magnitude of pollen limitation in two populations of C. renifolia. In addition, we measured the stigma longevity in unpollinated and open pollinated capitula, and pollinator visitation rates in the field. We found low levels of self-compatibility and significant levels of pollen limitation in C. renifolia. Pollinator visitation rates were moderate (0.047-0.079 visits per capitulum per 30 min). Although pollinator visitation rate significantly differed between populations, they were not translated into differences in achene output. Finally, C. renifolia stigma longevity of unpollinated plants was extremely long and significantly higher than that of open pollinated plants (26.3 +/- 2.8 days vs. 10.1 +/- 2.2, respectively), which gives support to the increased pollination probability hypothesis for high-elevation flowering plants. Our results add to a growing number of studies that show that xenogamous breeding systems and mechanisms to increase pollination opportunities can be selected in high-elevation ecosystems.	[Torres-Diaz, Cristian; Gomez-Gonzalez, Susana] Univ Bio Bio, Dept Ciencias Basicas, LGB, Chillan, Chile; [Torres-Diaz, Cristian; Stotz, Gisela C.; Torres-Morales, Patricio; Paredes, Brayam; Perez-Millaqueo, Matias; Gianoli, Ernesto] Univ Concepcion, Dept Bot, Concepcion, Chile; [Gianoli, Ernesto] Pontificia Univ Catolica Chile, CASEB, Santiago, Chile; [Gianoli, Ernesto] Univ La Serena, Dept Biol, La Serena, Chile	Universidad del Bio-Bio; Universidad de Concepcion; Pontificia Universidad Catolica de Chile; Universidad de La Serena	Torres-Diaz, C (corresponding author), Univ Bio Bio, Dept Ciencias Basicas, LGB, Chillan, Chile.	crtorres@ubiobio.cl	Gómez-González, Susana/AAL-2631-2021; GOMEZ-GONZALEZ, SUSANA/J-7637-2018; Torres, Patricio/D-2405-2010; Stotz, Gisela/E-2197-2017; Gianoli, Ernesto/A-7984-2015	Gómez-González, Susana/0000-0002-3779-8701; GOMEZ-GONZALEZ, SUSANA/0000-0002-3779-8701; Stotz, Gisela/0000-0001-8687-7361; Gianoli, Ernesto/0000-0003-4246-8640	FONDECYT [3090020]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	The study was supported FONDECYT-3090020 project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo MTK, 2006, ACTA OECOL, V30, P248, DOI 10.1016/j.actao.2006.05.006; ARROYO MTK, 1982, AM J BOT, V69, P82, DOI 10.2307/2442833; ARROYO MTK, 1985, PLANT SYST EVOL, V149, P187, DOI 10.1007/BF00983305; ARROYO MTK, 1981, J ECOL, V69, P205, DOI 10.2307/2259826; ARROYO MTK, 1990, BIOL APPROACHES EVOL, P205; Ashman T. L., 1996, FLORAL BIOL STUDIES, P112, DOI DOI 10.1007/978-1-4613-1165-2_5; Barrett S.C.H., 1990, BIOL APPROACHES EVOL, P229, DOI DOI 10.1016/B978-0-12-402960-6.50019-6; BILLINGS WD, 1968, BIOL REV, V43, P481, DOI 10.1111/j.1469-185X.1968.tb00968.x; Bingham RA, 1998, NATURE, V391, P238, DOI 10.1038/34564; Blionis GJ, 2002, PLANT SYST EVOL, V232, P89, DOI 10.1007/s006060200029; Blionis GJ, 2001, ECOGRAPHY, V24, P696, DOI 10.1034/j.1600-0587.2001.240608.x; BLISS L. C., 1962, ARCTIC, V15, P117; Bliss L. C., 1971, ANNU REV ECOL SYST, V2, P405, DOI [10.1146/annurev.es.02.110171.002201, DOI 10.1146/ANNUREV.ES.02.110171.002201]; Bu HY, 2008, PLANT ECOL, V195, P87, DOI 10.1007/s11258-007-9301-1; CABRERA AL, 1937, REV MUSEO PLATA B, V1, P87; Cavieres LA, 2000, REV CHIL HIST NAT, V73, P331; DAVIS A, 2009, THESIS LUDWIG MAXIMI; Di Castri F, 1976, BIOCLIMATOLOGIA CHIL; Fabbro T, 2004, FLORA, V199, P70, DOI 10.1078/0367-2530-00128; FAEGRI K, 1979, P244; Fitting H., 1909, Z BOT, V1, P1; Garcia-Camacho R, 2009, ARCT ANTARCT ALP RES, V41, P103, DOI [10.1657/1938-4246(08-028)[GARCIA-CAMACHO]2.0.CO;2, 10.1657/1523-0430-41.1.103]; HERRERA CM, 1987, OIKOS, V50, P79, DOI 10.2307/3565403; HOCKING B, 1968, OIKOS, V19, P359, DOI 10.2307/3565022; KEARNS CA, 1994, AM J BOT, V81, P1091, DOI 10.2307/2445470; KEVAN PG, 1972, J ECOL, V60, P831, DOI 10.2307/2258569; Kudo Gaku, 1999, Plant Species Biology, V14, P181, DOI 10.1046/j.1442-1984.1999.00012.x; Larson BMH, 2000, BIOL J LINN SOC, V69, P503, DOI 10.1111/j.1095-8312.2000.tb01221.x; LLOYD DG, 1992, INT J PLANT SCI, V153, P370, DOI 10.1086/297041; LLOYD DG, 1992, INT J PLANT SCI, V153, P358, DOI 10.1086/297040; Mamayev, 1972, PINACEAE URALE TYPES; Mani M.S., 1962, INTRO HIGH ALTITUDE; Medan D, 2002, ARCT ANTARCT ALP RES, V34, P233, DOI 10.2307/1552480; MOLDENKE A R, 1979, Phytologia, V42, P349; Muller H, 1881, ALPENBLUMEN IHRE BEF; Norden N, 2009, FUNCT ECOL, V23, P203, DOI 10.1111/j.1365-2435.2008.01477.x; Primack R.B., 1978, New Zealand Journal of Ecology, V1, P66; PRIMACK RB, 1985, ANNU REV ECOL SYST, V16, P15, DOI 10.1146/annurev.es.16.110185.000311; PRIMACK RB, 1983, NEW ZEAL J BOT, V21, P317, DOI 10.1080/0028825X.1983.10428561; Richards A.J, 1997, PLANT BREEDING SYSTE; Santibanez F, 1990, ATLAS AGROCLIMATICO; SCHEMSKE DW, 1985, EVOLUTION, V39, P41, DOI [10.2307/2408515, 10.1111/j.1558-5646.1985.tb04078.x]; STEAD AD, 1992, PLANT GROWTH REGUL, V11, P13, DOI 10.1007/BF00024427; Stebbins G, 1950, VARIATION EVOLUTION, DOI [10.7312/steb94536, DOI 10.7312/STEB94536]; Torices R, 2010, OECOLOGIA, V164, P949, DOI 10.1007/s00442-010-1715-0; Torres-Diaz C, 2007, REV CHIL HIST NAT, V80, P455, DOI 10.4067/S0716-078X2007000400007; TOTLAND O, 1993, CAN J BOT, V71, P1072, DOI 10.1139/b93-124; Totland O, 2001, ECOLOGY, V82, P2233, DOI 10.1890/0012-9658(2001)082[2233:EDPLAS]2.0.CO;2; Totland O, 2001, AM J BOT, V88, P1011, DOI 10.2307/2657082; Utelli AB, 2000, OIKOS, V89, P461, DOI 10.1034/j.1600-0706.2000.890305.x; Wirth LR, 2010, AM J BOT, V97, P899, DOI 10.3732/ajb.0900297	51	34	40	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19497	10.1371/journal.pone.0019497	http://dx.doi.org/10.1371/journal.pone.0019497			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573159	gold, Green Published, Green Submitted			2022-12-27	WOS:000290256400016
J	Signorini, A; Segre, AM; Polgreen, PM				Signorini, Alessio; Segre, Alberto Maria; Polgreen, Philip M.			The Use of Twitter to Track Levels of Disease Activity and Public Concern in the US during the Influenza A H1N1 Pandemic	PLOS ONE			English	Article							SALES; SURVEILLANCE; REMEDIES	Twitter is a free social networking and micro-blogging service that enables its millions of users to send and read each other's "tweets," or short, 140-character messages. The service has more than 190 million registered users and processes about 55 million tweets per day. Useful information about news and geopolitical events lies embedded in the Twitter stream, which embodies, in the aggregate, Twitter users' perspectives and reactions to current events. By virtue of sheer volume, content embedded in the Twitter stream may be useful for tracking or even forecasting behavior if it can be extracted in an efficient manner. In this study, we examine the use of information embedded in the Twitter stream to (1) track rapidly-evolving public sentiment with respect to H1N1 or swine flu, and (2) track and measure actual disease activity. We also show that Twitter can be used as a measure of public interest or concern about health-related events. Our results show that estimates of influenza-like illness derived from Twitter chatter accurately track reported disease levels.	[Signorini, Alessio; Segre, Alberto Maria] Univ Iowa, Dept Comp Sci, Iowa City, IA 52242 USA; [Polgreen, Philip M.] Univ Iowa, Dept Epidemiol, Coll Publ Hlth, Iowa City, IA 52242 USA; [Polgreen, Philip M.] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Signorini, A (corresponding author), Univ Iowa, Dept Comp Sci, Iowa City, IA 52242 USA.	philip-polgreen@uiowa.edu	Segre, Alberto M/B-1734-2009	Polgreen, Philip/0000-0002-0630-5898	National Institutes of Health [NIAID K01 AI75089, NIAID-R21-AI081164]; Robert Wood Johnson Foundation Pioneer Portfolio; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081164, K01AI075089] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Foundation Pioneer Portfolio; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this research was provided by a National Institutes of Health Career Award NIAID K01 AI75089 (PMP), by the National Institutes of Health grant NIAID-R21-AI081164 (AMS, PMP), and by the Robert Wood Johnson Foundation Pioneer Portfolio. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biever C, 2010, NEW SCI, V207, P14, DOI 10.1016/S0262-4079(10)61833-7; *CDCP, 2010, OV INFL SURV US; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cooper Crystale Purvis, 2005, J Med Internet Res, V7, pe36, DOI 10.2196/jmir.7.3.e36; Cristianini Nello, 2000, INTRO SUPPORT VECTOR; Dailey L, 2007, J AM MED INFORM ASSN, V14, P626, DOI 10.1197/jamia.M2328; Davies GR, 2003, CLIN MICROBIOL INFEC, V9, P858, DOI 10.1046/j.1469-0691.2003.00693.x; Drucker H, 1997, ADV NEUR IN, V9, P155; Espino Jeremy U, 2003, AMIA Annu Symp Proc, P215; Giles J, 2010, NEW SCI, V206, P20; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Hogan WR, 2003, J AM MED INFORM ASSN, V10, P555, DOI 10.1197/jamia.M1377; Irvin CB, 2003, ANN EMERG MED, V41, P447, DOI 10.1067/mem.2003.104; KOSTKOVA P, 2010, POTENTIAL TWITTER EA; LAMPOS V, 2010, TRACKING FLU PANDEMI; LENAWAY DD, 1995, PUBLIC HEALTH REP, V110, P333; LORICA B, 2010, TWITTER NUMBERS OREI; Magruder SF, 2003, J HOPKINS APL TECH D, V24, P349; *NLM NIH, 2006, NLM TECHN B MLA 2006; *PEAR AN, 2009, TWITT STUD AUG 2009; Polgreen PM, 2008, CLIN INFECT DIS, V47, P1443, DOI 10.1086/593098; Polgreen PM, 2007, CLIN INFECT DIS, V44, P272, DOI 10.1086/510427; SAKAKI T, 2010, EARTHQUAKE SHAKES TW; STROUP DF, 1988, STAT MED, V7, P1045, DOI 10.1002/sim.4780071006; Suyama J, 2003, ACAD EMERG MED, V10, P753, DOI 10.1111/j.1553-2712.2003.tb00070.x; Thompson WW, 2006, J INFECT DIS, V194, pS82, DOI 10.1086/507558; VANRIJSBERGEN CJ, 1980, 5587 BRIT LIB RES DE; Weiss S. M., 1991, COMPUTER SYSTEMS LEA; WELLIVER RC, 1979, PEDIATR RES, V13, P1015, DOI 10.1203/00006450-197909000-00014; Yuan Christine M, 2004, MMWR Suppl, V53, P56; 2010, STREAMING API DOCUME; 2010, PLANE HUDSON PHOTOGR	32	677	695	8	198	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19467	10.1371/journal.pone.0019467	http://dx.doi.org/10.1371/journal.pone.0019467			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573238	gold, Green Submitted, Green Published			2022-12-27	WOS:000290224800031
J	Tamez, PA; Liu, H; Wickrema, A; Haldar, K				Tamez, Pamela A.; Liu, Hui; Wickrema, Amittha; Haldar, Kasturi			P. falciparum Modulates Erythroblast Cell Gene Expression in Signaling and Erythrocyte Production Pathways	PLOS ONE			English	Article							PROTEINS; MALARIA; ERYTHROPOIESIS; VIRULENCE; REVEALS	Global, genomic responses of erythrocytes to infectious agents have been difficult to measure because these cells are enucleated. We have previously demonstrated that in vitro matured, nucleated erythroblast cells at the orthochromatic stage can be efficiently infected by the human malaria parasite Plasmodium falciparum. We now show that infection of orthochromatic cells induces change in 609 host genes. 592 of these transcripts are up-regulated and associated with metabolic and chaperone pathways unique to P. falciparum infection, as well as a wide range of signaling pathways that are also induced in related apicomplexan infections of mouse hepatocytes or human fibroblast cells. Our data additionally show that polychromatophilic cells, which precede the orthochromatic stage and are not infected when co-cultured with P. falciparum, up-regulate a small set of genes, at least two of which are associated with pathways of hematopoiesis and/or erythroid cell development. These data support the idea that P. falciparum affects erythropoiesis at multiple stages during erythroblast differentiation. Further P. falciparum may modulate gene expression in bystander erythroblasts and thus influence pathways of erythrocyte development. This study provides a benchmark of the host erythroblast cell response to infection by P. falciparum.	[Tamez, Pamela A.; Haldar, Kasturi] Univ Notre Dame, Ctr Rare & Neglected Dis, Dept Biol Sci, South Bend, IN USA; [Liu, Hui; Wickrema, Amittha] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Notre Dame; University of Chicago	Tamez, PA (corresponding author), Univ Notre Dame, Ctr Rare & Neglected Dis, Dept Biol Sci, South Bend, IN USA.	khaldar@nd.edu	Haldar, Kasturi/C-6685-2014	Tamez, Pamela/0000-0001-9005-4560	NIH [R01 HL 079397, R01 069630, P01 HL 078826, HL069630]; Giving Tree Foundation [NIH:RO1CA98550]; Northwestern University Dept. Microbiology-Immunology [T32 AI007476]; American Heart Association [0425607Z]; NATIONAL CANCER INSTITUTE [R01CA098550] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069630, P01HL078826, R01HL079397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007476] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Giving Tree Foundation; Northwestern University Dept. Microbiology-Immunology; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported in part by grants to KH (NIH: R01 HL 079397, R01 069630, P01 HL 078826), to AW (NIH:RO1CA98550, Giving Tree Foundation), and to PT (Institutional National Research Service Award at Northwestern University Dept. Microbiology-Immunology (T32 AI007476), the American Heart Association (0425607Z), and NIH Research Supplements to Promote Diversity in Health-Related Research (HL069630)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, WORLD MAL REP 2009; Bei AK, 2010, J INFECT DIS, V202, P1722, DOI 10.1086/657157; Blader IJ, 2001, J BIOL CHEM, V276, P24223, DOI 10.1074/jbc.M100951200; Casals-Pascual C, 2006, BLOOD, V108, P2569, DOI 10.1182/blood-2006-05-018697; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; DEMAST Q, 1995, HAEMATOLOGICA, V95, P1068; Elagib KE, 2004, MOL CELL BIOL, V24, P7779, DOI 10.1128/MCB.24.17.7779-7794.2004; Haldar K, 2009, HEMATOL-AM SOC HEMAT, V2009, P87, DOI DOI 10.1182/ASHEDUCATI0N-2009.1.87; Harrison T, 2003, SCIENCE, V301, P1734, DOI 10.1126/science.1089324; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Kang JA, 2008, J BIOL CHEM, V283, P6997, DOI 10.1074/jbc.M706712200; Kim DW, 2000, ONCOGENE, V19, P5498, DOI 10.1038/sj.onc.1203945; Kulzer S, 2010, CELL MICROBIOL, V12, P1398, DOI 10.1111/j.1462-5822.2010.01477.x; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lodish H, 2010, IUBMB LIFE, V62, P492, DOI 10.1002/iub.322; Lovegrove FE, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-295; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Mishra SK, 2009, NAT REV NEUROL, V5, P189, DOI 10.1038/nrneurol.2009.23; PASVOL G, 1983, CIBA F SYMP, V94, P174; Prentice AM, 2007, FOOD NUTR BULL, V28, pS524, DOI 10.1177/15648265070284S406; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; RUSTEN LS, 1996, BLOOD, V87; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Skorokhod OA, 2010, BLOOD, V116, P4328, DOI 10.1182/blood-2010-03-272781; Tamez PA, 2009, BLOOD, V114, P3652, DOI 10.1182/blood-2009-07-231894; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Tasanee P, 2007, INT J PARASITOL, V37, P1551, DOI 10.1016/j.ijpara.2007.05.009; van Ooij C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000084; WICKRAMASINGHE SN, 1987, BRIT J HAEMATOL, V66, P295, DOI 10.1111/j.1365-2141.1987.tb06913.x; Zhu J, 2001, BLOOD, V98, P2563, DOI 10.1182/blood.V98.8.2563	30	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19307	10.1371/journal.pone.0019307	http://dx.doi.org/10.1371/journal.pone.0019307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573240	gold, Green Submitted, Green Published			2022-12-27	WOS:000290224800021
J	DeAngelis, KM; Allgaier, M; Chavarria, Y; Fortney, JL; Hugenholtz, P; Simmons, B; Sublette, K; Silver, WL; Hazen, TC				DeAngelis, Kristen M.; Allgaier, Martin; Chavarria, Yaucin; Fortney, Julian L.; Hugenholtz, Phillip; Simmons, Blake; Sublette, Kerry; Silver, Whendee L.; Hazen, Terry C.			Characterization of Trapped Lignin-Degrading Microbes in Tropical Forest Soil	PLOS ONE			English	Article							PHOSPHORUS AVAILABILITY; IRON REDUCTION; DIVERSITY; PRETREATMENT; DEGRADATION; PEROXIDASE; BACTERIA; SOLUBILIZATION; POPULATIONS; NITROGEN	Lignin is often the most difficult portion of plant biomass to degrade, with fungi generally thought to dominate during late stage decomposition. Lignin in feedstock plant material represents a barrier to more efficient plant biomass conversion and can also hinder enzymatic access to cellulose, which is critical for biofuels production. Tropical rain forest soils in Puerto Rico are characterized by frequent anoxic conditions and fluctuating redox, suggesting the presence of lignin-degrading organisms and mechanisms that are different from known fungal decomposers and oxygen-dependent enzyme activities. We explored microbial lignin-degraders by burying bio-traps containing lignin-amended and unamended biosep beads in the soil for 1, 4, 13 and 30 weeks. At each time point, phenol oxidase and peroxidase enzyme activity was found to be elevated in the lignin-amended versus the unamended beads, while cellulolytic enzyme activities were significantly depressed in lignin-amended beads. Quantitative PCR of bacterial communities showed more bacterial colonization in the lignin-amended compared to the unamended beads after one and four weeks, suggesting that the lignin supported increased bacterial abundance. The microbial community was analyzed by small subunit 16S ribosomal RNA genes using microarray (PhyloChip) and by high-throughput amplicon pyrosequencing based on universal primers targeting bacterial, archaeal, and eukaryotic communities. Community trends were significantly affected by time and the presence of lignin on the beads. Lignin-amended beads have higher relative abundances of representatives from the phyla Actinobacteria, Firmicutes, Acidobacteria and Proteobacteria compared to unamended beads. This study suggests that in low and fluctuating redox soils, bacteria could play a role in anaerobic lignin decomposition.	[DeAngelis, Kristen M.; Chavarria, Yaucin; Fortney, Julian L.; Silver, Whendee L.; Hazen, Terry C.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Dept Ecol, Berkeley, CA 94720 USA; [DeAngelis, Kristen M.; Allgaier, Martin; Hugenholtz, Phillip; Simmons, Blake; Hazen, Terry C.] Joint BioEnergy Inst, Microbial Communities Grp, Deconstruct Div, Emeryville, CA USA; [Allgaier, Martin; Hugenholtz, Phillip] DOE Joint Genome Inst, Microbial Ecol Program, Walnut Creek, CA USA; [Simmons, Blake] Sandia Natl Labs, Livermore, CA USA; [Sublette, Kerry] Univ Tulsa, Ctr Appl Biogeosci, Tulsa, OK 74104 USA; [Silver, Whendee L.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); United States Department of Energy (DOE); Sandia National Laboratories; University of Tulsa; University of California System; University of California Berkeley	DeAngelis, KM (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Dept Ecol, Berkeley, CA 94720 USA.	Kristen@post.harvard.edu	Hugenholtz, Philip/AAD-9138-2019; Simmons, Blake/N-6022-2016; Silver, Whendee L./H-1118-2012; Hazen, Terry C/C-1076-2012	Hugenholtz, Philip/0000-0001-5386-7925; Simmons, Blake/0000-0002-1332-1810; Silver, Whendee L./0000-0003-0372-8745; Hazen, Terry C/0000-0002-2536-9993; DeAngelis, Kristen/0000-0002-5585-4551	United States Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; National Science Foundation [DEB 0543558]; Seaborg Fellowship; U.S. Department of Agriculture Forest Service International Institute of Tropical Forestry;  [DEB-008538];  [DEB-0218039]	United States Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Seaborg Fellowship; U.S. Department of Agriculture Forest Service International Institute of Tropical Forestry; ; 	This work was conducted as part of the Joint BioEnergy Institute (http://www.jbei.org) supported by the United States Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U.S. DOE. Additional funding was provided in part by National Science Foundation grant DEB 0543558 to WS, by a Seaborg Fellowship to KMD, by DEB-008538 and DEB-0218039 to Institute for Tropical Ecosystem Studies at the University of Puerto Rico, and by U.S. Department of Agriculture Forest Service International Institute of Tropical Forestry as part of the NSF Long Term Ecological Research (LTER) program in the Luquillo Experimental Forest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2010, MOL BIOSYST, V6, P815, DOI 10.1039/b908966g; Allison SD, 2005, SOIL BIOL BIOCHEM, V37, P937, DOI 10.1016/j.soilbio.2004.09.014; Allison SD, 2004, BIOTROPICA, V36, P285, DOI 10.1646/03180; Aneja MK, 2006, MICROBIAL ECOLOGY; Baldrian P, 2008, FUNGAL ECOL, V1, P4, DOI 10.1016/j.funeco.2008.02.001; Berg B, 1997, ENVIRON REV, V5, P1, DOI DOI 10.1139/ER-5-1-1; Birks SJ, 1997, MICROBIOL-UK, V143, P755, DOI 10.1099/00221287-143-3-755; Blanch HW, 2008, ACS CHEM BIOL, V3, P17, DOI 10.1021/cb700267s; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; Brodie EL, 2006, APPL ENVIRON MICROB, V72, P6288, DOI 10.1128/AEM.00246-06; Bugg TDH, 2011, CURR OPIN BIOTECH, V22, P394, DOI 10.1016/j.copbio.2010.10.009; Chacon N, 2006, BIOGEOCHEMISTRY, V78, P67, DOI 10.1007/s10533-005-2343-3; Charles D, 2009, SCIENCE, V324, P587, DOI 10.1126/science.324_587; Cusack DF, 2009, GLOBAL CHANGE BIOL, V15, P1339, DOI 10.1111/j.1365-2486.2008.01781.x; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; DEANGELIS KM, 2010, ENV MICROBI IN PRESS; DeAngelis KM, 2010, BIOENERG RES, V3, P146, DOI 10.1007/s12155-010-9089-z; Degelmann DM, 2009, FEMS MICROBIOL ECOL, V68, P312, DOI 10.1111/j.1574-6941.2009.00681.x; DeRito CM, 2005, APPL ENVIRON MICROB, V71, P7858, DOI 10.1128/AEM.71.12.7858-7865.2005; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9; DeSantis TZ, 2007, MICROBIAL ECOLOGY; Dien BS, 2006, BIOMASS BIOENERG, V30, P880, DOI 10.1016/j.biombioe.2006.02.004; DUBINSKY EA, 2008, ENV CONTROLS MICROBI; Dubinsky EA, 2010, ECOLOGY, V91, P2604, DOI 10.1890/09-1365.1; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Glissmann K, 2005, FEMS MICROBIOL ECOL, V52, P43, DOI 10.1016/j.femsec.2004.10.004; Heising S, 1998, MICROBIOL-SGM, V144, P2263, DOI 10.1099/00221287-144-8-2263; Hershberger KL, 1996, NATURE, V384, P420, DOI 10.1038/384420a0; Klinke HB, 2004, APPL MICROBIOL BIOT, V66, P10, DOI 10.1007/s00253-004-1642-2; Koga S, 1999, BBA-PROTEIN STRUCT M, V1435, P117, DOI 10.1016/S0167-4838(99)00190-9; Kunin V, 2010, OPEN J; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Liptzin D, 2011, ECOSYSTEMS, V14, P171, DOI 10.1007/s10021-010-9402-x; Liptzin D, 2009, SOIL BIOL BIOCHEM, V41, P1696, DOI 10.1016/j.soilbio.2009.05.013; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Ostertag R, 2001, ECOLOGY, V82, P485, DOI 10.1890/0012-9658(2001)082[0485:EONAPA]2.0.CO;2; PARKIN TB, 1984, SOIL BIOL BIOCHEM, V16, P331, DOI 10.1016/0038-0717(84)90027-0; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; Pett-Ridge J, 2006, BIOGEOCHEMISTRY, V81, P95, DOI 10.1007/s10533-006-9032-8; Pruesse E, 2007, NUCL ACIDS RES, V35; RAMACHANDRA M, 1988, APPL ENVIRON MICROB, V54, P3057, DOI 10.1128/AEM.54.12.3057-3063.1988; Schloss PD, 2006, ENVIRON ENTOMOL, V35, P625, DOI 10.1603/0046-225X-35.3.625; Silver WL, 1999, BIOGEOCHEMISTRY, V44, P301, DOI 10.1007/BF00996995; Singh S, 2009, BIOTECHNOL BIOENG, V104, P68, DOI 10.1002/bit.22386; Steinman HM, 1997, J BACTERIOL, V179, P6831, DOI 10.1128/jb.179.21.6831-6836.1997; Sublette K, 2006, GROUND WATER MONIT R, V26, P70, DOI 10.1111/j.1745-6592.2006.00072.x; Valaskova V, 2009, ISME J, V3, P1218, DOI 10.1038/ismej.2009.64; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Webb CO, 2007, PHYLOCOM SOFTWARE AN; Wei H, 2009, CURR OPIN BIOTECH, V20, P330, DOI 10.1016/j.copbio.2009.05.008; WILSON KH, 1990, J CLIN MICROBIOL, V28, P1942, DOI 10.1128/JCM.28.9.1942-1946.1990	54	125	131	2	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19306	10.1371/journal.pone.0019306	http://dx.doi.org/10.1371/journal.pone.0019306			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559391	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700130
J	Drake, AC; Khoury, M; Leskov, I; Iliopoulou, BP; Fragoso, M; Lodish, H; Chen, JZ				Drake, Adam C.; Khoury, Maroun; Leskov, Ilya; Iliopoulou, Bettina P.; Fragoso, Maria; Lodish, Harvey; Chen, Jianzhu			Human CD34(+) CD133(+) Hematopoietic Stem Cells Cultured with Growth Factors Including Angptl5 Efficiently Engraft Adult NOD-SCID Il2r gamma(-/-) (NSG) Mice	PLOS ONE			English	Article							EX-VIVO EXPANSION; UMBILICAL-CORD BLOOD; PROGENITOR CELLS; TRANSPLANTATION; PROGRESS	Increasing demand for human hematopoietic stem cells (HSCs) in clinical and research applications necessitates expansion of HSCs in vitro. Before these cells can be used they must be carefully evaluated to assess their stem cell activity. Here, we expanded cord blood CD34(+) CD133(+) cells in a defined medium containing angiopoietin like 5 and insulin-like growth factor binding protein 2 and evaluated the cells for stem cell activity in NOD-SCID Il2rg(-/-) (NSG) mice by multi-lineage engraftment, long term reconstitution, limiting dilution and serial reconstitution. The phenotype of expanded cells was characterized by flow cytometry during the course of expansion and following engraftment in mice. We show that the SCID repopulating activity resides in the CD34(+) CD133(+) fraction of expanded cells and that CD34(+) CD133(+) cell number correlates with SCID repopulating activity before and after culture. The expanded cells mediate long-term hematopoiesis and serial reconstitution in NSG mice. Furthermore, they efficiently reconstitute not only neonate but also adult NSG recipients, generating human blood cell populations similar to those reported in mice reconstituted with uncultured human HSCs. These findings suggest an expansion of long term HSCs in our culture and show that expression of CD34 and CD133 serves as a marker for HSC activity in human cord blood cell cultures. The ability to expand human HSCs in vitro should facilitate clinical use of HSCs and large-scale construction of humanized mice from the same donor for research applications.	[Drake, Adam C.; Khoury, Maroun; Leskov, Ilya; Iliopoulou, Bettina P.; Fragoso, Maria; Lodish, Harvey; Chen, Jianzhu] MIT, Dept Biol, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Khoury, Maroun; Chen, Jianzhu] Singapore MIT Alliance Res & Technol SMART, Interdisciplinary Res Grp Infect Dis, Singapore, Singapore; [Lodish, Harvey] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Singapore-MIT Alliance for Research & Technology Centre (SMART); Massachusetts Institute of Technology (MIT); Whitehead Institute	Drake, AC (corresponding author), MIT, Dept Biol, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jchen@mit.edu		Khoury, Maroun/0000-0002-9965-6266	Singapore MIT Alliance for Research and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Singapore MIT Alliance for Research and Technology(Singapore-MIT Alliance for Research & Technology Centre (SMART)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by the Singapore MIT Alliance for Research and Technology Infectious disease research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blom B, 2006, ANNU REV IMMUNOL, V24, P287, DOI 10.1146/annurev.immunol.24.021605.090612; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; CHEN Q, 2009, P NATL ACAD SCI US; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Dieterlen-Lievre F, 2007, CR BIOL, V330, P504, DOI 10.1016/j.crvi.2007.05.003; Giassi LJ, 2008, EXP BIOL MED, V233, P997, DOI 10.3181/0802-RM-70; Gluckman E, 2009, HAEMATOL-HEMATOL J, V94, P451, DOI 10.3324/haematol.2009.005694; Hayakawa J, 2009, STEM CELLS, V27, P175, DOI 10.1634/stemcells.2008-0583; Huynh HD, 2008, STEM CELLS, V26, P1628, DOI 10.1634/stemcells.2008-0064; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Legrand N, 2009, CELL HOST MICROBE, V6, P5, DOI 10.1016/j.chom.2009.06.006; Manz Markus G, 2009, Nat Immunol, V10, P1039, DOI 10.1038/ni1009-1039; Moore KA, 1997, BLOOD, V89, P4337, DOI 10.1182/blood.V89.12.4337; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pecora AL, 2001, CURR OPIN HEMATOL, V8, P142, DOI 10.1097/00062752-200105000-00003; Robinson S, 2005, CYTOTHERAPY, V7, P243, DOI 10.1080/14653240510027172; Sauvageau G, 2010, SCIENCE, V329, P1291, DOI 10.1126/science.1195173; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Weissman IL, 2008, BLOOD, V112, P3543, DOI 10.1182/blood-2008-08-078220; Wodnar-Filipowicz A, 2003, NEWS PHYSIOL SCI, V18, P247, DOI 10.1152/nips.01452.2003; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zhang CC, 2006, NAT MED, V12, P240, DOI 10.1038/nm1342; Zhang CC, 2008, CURR OPIN HEMATOL, V15, P307, DOI 10.1097/MOH.0b013e3283007db5; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510	27	44	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18382	10.1371/journal.pone.0018382	http://dx.doi.org/10.1371/journal.pone.0018382			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559522	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700012
J	Eliasson, B; Svensson, AM; Miftaraj, M; Jonasson, JM; Eeg-Olofsson, K; Sundell, KA; Gudbjornsdottir, S				Eliasson, Bjorn; Svensson, Ann-Marie; Miftaraj, Mervete; Jonasson, Junmei Miao; Eeg-Olofsson, Katarina; Sundell, Karolina Andersson; Gudbjornsdottir, Soffia			Clinical Use and Effectiveness of Lipid Lowering Therapies in Diabetes Mellitus-An Observational Study from the Swedish National Diabetes Register	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ATORVASTATIN; CHOLESTEROL; EFFICACY; METAANALYSIS; SIMVASTATIN; PRAVASTATIN; STATINS	Objectives: To describe the use and evaluate the effectiveness of different lipid lowering therapies in unselected patients with type 1 and type 2 diabetes in clinical practice. Design: Observational population-based study using the personal identification number to link information from the National Diabetes Register, the Prescribed Drug Register and the Patient register in Sweden. All patients in the NDR aged 18-75 years with diabetes more than one year were eligible, but only patients starting any lipid lowering treatment with at least three prescriptions 1 July 2006-30 June 2007 were included (n = 37182). The mean blood lipid levels in 2008 and reductions in LDL cholesterol were examined. Results: Blood lipid levels were similar in patients treated with simvastatin, atorvastatin and rosuvastatin, showing similar lipid lowering effect as currently used. Users of pravastatin, fluvastatin, ezetimib and fibrate more seldom reach treatment goals. Moderate daily doses of the statins were used, with 76% of simvastatin users taking 20 mg or less, 48% of atorvastatin users taking 10 mg, 55% of pravastatin users taking 20 mg, and 76% of rosuvastatin users taking 5 or 10 mg. Conclusions: This observational study shows that the LDL-C levels in patients taking simvastatin, atorvastatin or rosuvastatin are very similar as currently used, as well as their LDL-C lowering abilities. There is potential to intensify lipid lowering treatment to reduce the remaining high residual risk and achieve better fulfilment of treatment goals, since the commonly used doses are only low to moderate.	[Eliasson, Bjorn; Eeg-Olofsson, Katarina; Gudbjornsdottir, Soffia] Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Med, Gothenburg, Sweden; [Jonasson, Junmei Miao] Univ Gothenburg, Inst Clin Sci, Dept Oncol, Gothenburg, Sweden; [Svensson, Ann-Marie; Miftaraj, Mervete; Jonasson, Junmei Miao; Gudbjornsdottir, Soffia] Natl Diabet Register NDR, Gothenburg, Sweden; [Sundell, Karolina Andersson] Nord Sch Publ Hlth, Gothenburg, Sweden	Sahlgrenska University Hospital; University of Gothenburg; University of Gothenburg	Eliasson, B (corresponding author), Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Med, Gothenburg, Sweden.	bjorn.eliasson@gu.se	Sundell, Karolina A Andersson/E-6046-2010; Miao Jonasson, Junmei/B-3242-2014; Eliasson, Bjorn/H-5783-2016	Miao Jonasson, Junmei/0000-0003-0206-8538; Eliasson, Bjorn/0000-0003-2569-4160	Region Vastra Gotaland; Swedish Association of Local Authorities and Regions; Pfizer AB, Sweden	Region Vastra Gotaland; Swedish Association of Local Authorities and Regions; Pfizer AB, Sweden	The Region Vastra Gotaland and the Swedish Association of Local Authorities and Regions fund the NDR. This study was also supported by an unrestricted research grant from Pfizer AB, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, DIABETES CARE S1, V33, pS4, DOI DOI 10.2337/DC10-S004; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Eeg-Olofsson K, 2009, DIABETOLOGIA, V52, P65, DOI 10.1007/s00125-008-1190-x; Eeg-Olofsson K, 2010, DIABETES CARE, V33, P1640, DOI 10.2337/dc10-0398; Eriksson M, 2011, EUR J CARDIOV PREV R, V18, P97, DOI 10.1097/HJR.0b013e32833ba61e; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gudbjornsdottir S, 2009, DIABETIC MED, V26, P53, DOI 10.1111/j.1464-5491.2008.02633.x; Hoelzel W, 2004, CLIN CHEM, V50, P166, DOI 10.1373/clinchem.2003.024802; Jones P, 1998, AM J CARDIOL, V81, P582, DOI 10.1016/S0002-9149(97)00965-X; Jones PH, 2003, AM J CARDIOL, V92, P152, DOI 10.1016/S0002-9149(03)00530-7; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Merlo J, 2000, EUR J EPIDEMIOL, V16, P235, DOI 10.1023/A:1007634722658; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Weng TC, 2010, J CLIN PHARM THER, V35, P139, DOI 10.1111/j.1365-2710.2009.01085.x; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294	17	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18744	10.1371/journal.pone.0018744	http://dx.doi.org/10.1371/journal.pone.0018744			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559521	Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700023
J	Lindgren, J; Uvdal, P; Engdahl, A; Lee, AH; Alwmark, C; Bergquist, KE; Nilsson, E; Ekstrom, P; Rasmussen, M; Douglas, DA; Polcyn, MJ; Jacobs, LL				Lindgren, Johan; Uvdal, Per; Engdahl, Anders; Lee, Andrew H.; Alwmark, Carl; Bergquist, Karl-Erik; Nilsson, Einar; Ekstrom, Peter; Rasmussen, Magnus; Douglas, Desiree A.; Polcyn, Michael J.; Jacobs, Louis L.			Microspectroscopic Evidence of Cretaceous Bone Proteins	PLOS ONE			English	Article							COLLAGEN; PRESERVATION; PURIFICATION; SEQUENCES; HADROSAUR; BACTERIAL	Low concentrations of the structural protein collagen have recently been reported in dinosaur fossils based primarily on mass spectrometric analyses of whole bone extracts. However, direct spectroscopic characterization of isolated fibrous bone tissues, a crucial test of hypotheses of biomolecular preservation over deep time, has not been performed. Here, we demonstrate that endogenous proteinaceous molecules are retained in a humerus from a Late Cretaceous mosasaur (an extinct giant marine lizard). In situ immunofluorescence of demineralized bone extracts shows reactivity to antibodies raised against type I collagen, and amino acid analyses of soluble proteins extracted from the bone exhibit a composition indicative of structural proteins or their breakdown products. These data are corroborated by synchrotron radiation-based infrared microspectroscopic studies demonstrating that amino acid containing matter is located in bone matrix fibrils that express imprints of the characteristic 67 nm D-periodicity typical of collagen. Moreover, the fibrils differ significantly in spectral signature from those of potential modern bacterial contaminants, such as biofilms and collagen-like proteins. Thus, the preservation of primary soft tissues and biomolecules is not limited to large-sized bones buried in fluvial sandstone environments, but also occurs in relatively small-sized skeletal elements deposited in marine sediments.	[Lindgren, Johan; Alwmark, Carl] Lund Univ, Div Geol, Dept Earth & Ecosyst Sci, Lund, Sweden; [Uvdal, Per; Engdahl, Anders] Lund Univ, Max Lab, Lund, Sweden; [Engdahl, Anders] Midwestern Univ, Dept Anat, Glendale, AZ USA; [Bergquist, Karl-Erik; Nilsson, Einar] Lund Univ, Dept Chem, Div Organ Chem, Lund, Sweden; [Ekstrom, Peter; Douglas, Desiree A.] Lund Univ, Dept Biol, Lund, Sweden; [Rasmussen, Magnus] Lund Univ, Dept Clin Sci, Div Infect Med, Lund, Sweden; [Polcyn, Michael J.; Jacobs, Louis L.] So Methodist Univ, Roy M Huffington Dept Earth Sci, Dallas, TX 75275 USA	Lund University; Lund University; Midwestern University; Lund University; Lund University; Lund University; Southern Methodist University	Lindgren, J (corresponding author), Lund Univ, Div Geol, Dept Earth & Ecosyst Sci, Lund, Sweden.	johan.lindgren@geol.lu.se; per.uvdal@chemphys.lu.se	Engdahl, Anders/A-5081-2019	Lee, Andrew/0000-0001-7829-334X; Rasmussen, Magnus/0000-0003-1588-5473; Engdahl, Anders/0000-0001-6562-0639; Jacobs, Louis/0000-0002-7735-3678	Swedish Research Council; Crafoord Foundation; Royal Swedish Academy of Sciences	Swedish Research Council(Swedish Research CouncilEuropean Commission); Crafoord Foundation; Royal Swedish Academy of Sciences	This research was supported by the Swedish Research Council, the Crafoord Foundation and the Royal Swedish Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asara JM, 2007, SCIENCE, V316, P280, DOI 10.1126/science.1137614; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Buckley M, 2008, SCIENCE, V319, DOI 10.1126/science.1147046; Cai SW, 2004, BIOCHEMISTRY-US, V43, P2541, DOI 10.1021/bi030149y; Cai YL, 2006, SCRIPTA MATER, V54, P89, DOI 10.1016/j.scriptamat.2005.09.001; Collins MJ, 2002, ARCHAEOMETRY, V44, P383, DOI 10.1111/1475-4754.t01-1-00071; Derrick M., 1991, BOOK PAPER ANN, V10, P49; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Geigl EM, 2004, ENVIRON CHEM LETT, V2, P45, DOI 10.1007/s10311-004-0059-6; Goffredi SK, 2005, ENVIRON MICROBIOL, V7, P1369, DOI 10.1111/j.1462-2920.2005.00824.x; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Holmberg A, 2009, CLIN MICROBIOL INFEC, V15, P787, DOI 10.1111/j.1469-0691.2009.02747.x; HOSS M, 1993, NUCLEIC ACIDS RES, V21, P3913, DOI 10.1093/nar/21.16.3913; JAKOBSEN RJ, 1983, SCIENCE, V220, P1288, DOI 10.1126/science.6857249; Jamin N, 1998, P NATL ACAD SCI USA, V95, P4837, DOI 10.1073/pnas.95.9.4837; Kaminska A, 1996, POLYM DEGRAD STABIL, V51, P19, DOI 10.1016/0141-3910(95)00159-X; Kaye TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002808; Kennedy CJ, 2003, RESTAURATOR, V24, P61, DOI 10.1515/REST.2003.61; Kolovou P, 2007, NATO SEC SCI B PHYS, P267, DOI 10.1007/978-1-4020-5724-3_24; Lindgren J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011998; Manning PL, 2009, P ROY SOC B-BIOL SCI, V276, P3429, DOI 10.1098/rspb.2009.0812; Paschalis EP, 2001, J BONE MINER RES, V16, P1821, DOI 10.1359/jbmr.2001.16.10.1821; Peterson JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013334; Petibois C, 2001, CLIN CHEM, V47, P730; Rasmussen M, 2003, J BIOL CHEM, V278, P32313, DOI 10.1074/jbc.M304709200; Rohland N, 2007, BIOTECHNIQUES, V42, P343, DOI 10.2144/000112383; Russell D. A., 1967, Bulletin of the Peabody Museum of Natural History, V23, P1; Schweitzer MH, 2009, SCIENCE, V324, P626, DOI 10.1126/science.1165069; Schweitzer MH, 2005, SCIENCE, V307, P1952, DOI 10.1126/science.1108397; Sionkowska A, 2006, INT J PHOTOENERGY, V2006, DOI 10.1155/IJP/2006/29196; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Tuross N, 2002, ARCHAEOMETRY, V44, P427, DOI 10.1111/1475-4754.00075; VANDERREST M, 1991, FASEB J, V5, P2814, DOI 10.1096/fasebj.5.13.1916105; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Zhang FC, 2010, NATURE, V463, P1075, DOI 10.1038/nature08740	35	38	38	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19445	10.1371/journal.pone.0019445	http://dx.doi.org/10.1371/journal.pone.0019445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559386	Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700174
J	Milenkovic, VM; Krejcova, S; Reichhart, N; Wagner, A; Strauss, O				Milenkovic, Vladimir M.; Krejcova, Sarka; Reichhart, Nadine; Wagner, Andrea; Strauss, Olaf			Interaction of Bestrophin-1 and Ca2+ Channel beta-Subunits: Identification of New Binding Domains on the Bestrophin-1 C-Terminus	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; CALCIUM-CHANNELS; BEST-DISEASE; LIGHT PEAK; GENE; ACTIVATION; MUTATIONS; COMPLEX; CELLS; ONSET	Bestrophin-1 modulates currents through voltage-dependent L-type Ca2+ channels by physically interacting with the beta-subunits of Ca2+ channels. The main function of beta-subunits is to regulate the number of pore-forming Ca-V-subunits in the cell membrane and modulate Ca2+ channel currents. To understand the influence of full-length bestrophin-1 on beta-subunit function, we studied binding and localization of bestrophin-1 and Ca2+ channel subunits, together with modulation of Ca(V)1.3 Ca2+ channels currents. In heterologeous expression, bestrophin-1 showed co-immunoprecipitation with either, beta 3-, or beta 4-subunits. We identified a new highly conserved cluster of proline-rich motifs on the bestrophin-1 C-terminus between amino acid position 468 and 486, which enables possible binding to SH3-domains of beta-subunits. A bestrophin-1 that lacks these proline-rich motifs (Delta CT-PxxP bestrophin-1) showed reduced efficiency to co-immunoprecipitate with beta 3 and beta 4-subunits. In the presence of Delta CT-PxxP bestrophin-1, beta 4-subunits and Ca(V)1.3 subunits partly lost membrane localization. Currents from Ca(V)1.3 subunits were modified in the presence of beta 4-subunit and wild-type bestrophin-1: accelerated time-dependent activation and reduced current density. With Delta CTPxxP bestrophin-1, currents showed the same time-dependent activation as with wild-type bestrophin-1, but the current density was further reduced due to decreased number of Ca2+ channels proteins in the cell membrane. In summary, we described new proline-rich motifs on bestrophin-1 C-terminus, which help to maintain the ability of beta-subunits to regulate surface expression of pore-forming Ca-V Ca2+-channel subunits.	[Milenkovic, Vladimir M.; Reichhart, Nadine; Wagner, Andrea; Strauss, Olaf] Univ Med Ctr Regensburg, Hosp Eye, Regensburg, Germany; [Krejcova, Sarka] Univ Klinikum Hamburg Eppendorf, Klin & Poliklin Augenheilkunde, Hamburg, Germany	University of Regensburg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Milenkovic, VM (corresponding author), Univ Med Ctr Regensburg, Hosp Eye, Regensburg, Germany.	strauss@eye-regensburg.de	Strauss, Olaf/AAA-6485-2019	Strauss, Olaf/0000-0002-6272-8596	Deutsche Forschungsgemeinschaft (German Research Council) DFG [STR480/9-2, STRA480/10-1]; Gertrud Kusen Stiftung	Deutsche Forschungsgemeinschaft (German Research Council) DFG(German Research Foundation (DFG)); Gertrud Kusen Stiftung	Deutsche Forschungsgemeinschaft (German Research Council) DFG grants STR480/9-2 and STRA480/10-1 and Gertrud Kusen Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Arden GB, 2006, PROG RETIN EYE RES, V25, P207, DOI 10.1016/j.preteyeres.2005.11.001; Bakall B, 2007, EXP EYE RES, V85, P34, DOI 10.1016/j.exer.2007.02.018; Buraei Z, PHYSL REV, V90, P1461; Burgess R, 2008, AM J HUM GENET, V82, P19, DOI 10.1016/j.ajhg.2007.08.004; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; CROSS HE, 1974, AM J OPHTHALMOL, V77, P46, DOI 10.1016/0002-9394(74)90603-5; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Fan JS, 2001, AM J PHYSIOL-CELL PH, V280, pC565, DOI 10.1152/ajpcell.2001.280.3.C565; FRANGIEH GT, 1982, ARCH OPHTHALMOL-CHIC, V100, P1115; GALLEMORE RP, 1989, J NEUROSCI, V9, P1977; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; Karl MO, 2008, CELL SIGNAL, V20, P1159, DOI 10.1016/j.cellsig.2008.02.005; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Marmorstein AD, 2007, EXP EYE RES, V85, P423, DOI 10.1016/j.exer.2006.03.021; Marmorstein LY, 2006, J GEN PHYSIOL, V127, P577, DOI 10.1085/jgp.200509473; Marquardt A, 1998, HUM MOL GENET, V7, P1517, DOI 10.1093/hmg/7.9.1517; Michna M, 2003, J PHYSIOL-LONDON, V553, P747, DOI 10.1113/jphysiol.2003.053256; Milenkovic VM, 2009, PFLUG ARCH EUR J PHY, V458, P431, DOI 10.1007/s00424-008-0626-y; Mullins RF, 2005, ARCH OPHTHALMOL-CHIC, V123, P1588, DOI 10.1001/archopht.123.11.1588; Mullins RF, 2007, INVEST OPHTH VIS SCI, V48, P3372, DOI 10.1167/iovs.06-0868; OGORMAN S, 1988, ARCH OPHTHALMOL-CHIC, V106, P1261; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Reichhart N, 2010, EXP EYE RES, V91, P630, DOI 10.1016/j.exer.2010.08.001; Renner AB, 2005, OPHTHALMOLOGY, V112, P586, DOI 10.1016/j.ophtha.2004.10.041; Richards MW, 2004, TRENDS PHARMACOL SCI, V25, P626, DOI 10.1016/j.tips.2004.10.008; Rosenthal R, 2005, FASEB J, V19, P178, DOI 10.1096/fj.05-4495fje; Rosenthal R, 2007, MOL VIS, V13, P443; Singh A, 2008, J BIOL CHEM, V283, P20733, DOI 10.1074/jbc.M802254200; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Striessnig J, 2004, BIOCHEM BIOPH RES CO, V322, P1341, DOI 10.1016/j.bbrc.2004.08.039; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Wabbels B, 2006, GRAEF ARCH CLIN EXP, V244, P1453, DOI 10.1007/s00417-006-0286-6; WEINGEIST TA, 1982, ARCH OPHTHALMOL-CHIC, V100, P1108; Wimmers S, 2007, PROG RETIN EYE RES, V26, P263, DOI 10.1016/j.preteyeres.2006.12.002; Yu K, 2008, J NEUROSCI, V28, P5660, DOI 10.1523/JNEUROSCI.0065-08.2008	39	33	33	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19364	10.1371/journal.pone.0019364	http://dx.doi.org/10.1371/journal.pone.0019364			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559412	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700149
J	Moncalero, VL; Costanzo, RV; Perandones, C; Radrizzani, M				Moncalero, Vera L.; Costanzo, Roxana V.; Perandones, Claudia; Radrizzani, Martin			Different Conformations of Phosphatase and Tensin Homolog, Deleted on Chromosome 10 (PTEN) Protein within the Nucleus and Cytoplasm of Neurons	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PTEN; SUBCELLULAR-LOCALIZATION; PRION PROTEIN; EXPRESSION; TISSUE; OLIGOBODIES; MUTATIONS; MOLECULES; GERMLINE; SURVIVAL	PTEN is a critical gene involved in the regulation of many cellular processes. The product of this gene has dual phosphatase activity and is able to dephosphorylate the 59 end of the phosphatidylinositol (3,4,5)-trisphosphate. Within the cellular nucleus, this protein has been associated with regulation of the expression of many genes, although the mechanism of this regulation remains unclear. In this paper, two specific oligonucleotide aptamers were developed and selected, using the SELEX procedure, according to their ability to detect the PTEN protein in different subcellular compartments of neurons. While one aptamer was able to detect PTEN in the nucleus, the other recognized PTEN in the cytoplasm. The recognition pattern of PTEN by both aptamers was confirmed using antibodies in western blots of the proteins purified from mouse cerebellar homogenates and subcellular fractions. Additionally, we demonstrated that the two aptamers recognized different epitopes of the target peptide. The results presented here could not be fully explained by the canonical phosphatase structure of PTEN, suggesting the existence of different conformations of phosphatase in the nucleus and the cytoplasm.	[Moncalero, Vera L.; Radrizzani, Martin] Univ Nacl San Martin, CONICET, Ctr Estudios Salud & Medio Ambiente, Lab Neuro & Citogenet Mol, Buenos Aires, DF, Argentina; [Costanzo, Roxana V.; Perandones, Claudia] Fdn Inst Leloir, Buenos Aires, DF, Argentina; [Perandones, Claudia] Natl Agcy Labs, ANLIS, Buenos Aires, DF, Argentina; [Perandones, Claudia] Hlth Inst Argentina, Buenos Aires, DF, Argentina; [Perandones, Claudia] Univ Buenos Aires, Hosp Clin Jose de San Martin, Parkinsons Dis & Movement Disorders Program, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; University of Buenos Aires	Moncalero, VL (corresponding author), Univ Nacl San Martin, CONICET, Ctr Estudios Salud & Medio Ambiente, Lab Neuro & Citogenet Mol, Buenos Aires, DF, Argentina.	martin.radrizzani@gmail.com			"Consejo Nacional de Investigaciones cientificas y tecnologicas" CONICET [236]	"Consejo Nacional de Investigaciones cientificas y tecnologicas" CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by the "Consejo Nacional de Investigaciones cientificas y tecnologicas" CONICET, PICT 2006 No 236 to M. R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SJ, 2007, CELL, V128, P25, DOI 10.1016/j.cell.2006.12.023; Blanco-Aparicio C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009305; Chung JH, 2005, CANCER RES, V65, P4108, DOI 10.1158/0008-5472.CAN-05-0124; CONTI CJ, 1988, J HISTOCHEM CYTOCHEM, V36, P547, DOI 10.1177/36.5.3282007; Deleris P, 2003, J BIOL CHEM, V278, P38884, DOI 10.1074/jbc.M300816200; Deleris P, 2006, J CELL BIOCHEM, V98, P469, DOI 10.1002/jcb.20695; Denning G, 2007, ONCOGENE, V26, P3930, DOI 10.1038/sj.onc.1210175; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Djordjevic M, 2007, BIOMOL ENG, V24, P179, DOI 10.1016/j.bioeng.2007.03.001; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fischer MB, 2000, NATURE, V408, P479, DOI 10.1038/35044100; Fridberg M, 2007, LEUKEMIA LYMPHOMA, V48, P2221, DOI 10.1080/10428190701636443; Gil A, 2007, CELL DEATH DIFFER, V14, P395, DOI 10.1038/sj.cdd.4402073; Gillespie JW, 2002, AM J PATHOL, V160, P449, DOI 10.1016/S0002-9440(10)64864-X; Gimm O, 2000, AM J PATHOL, V156, P1693, DOI 10.1016/S0002-9440(10)65040-7; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Lachyankar MB, 2000, J NEUROSCI, V20, P1404; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Li AG, 2006, MOL CELL, V23, P575, DOI 10.1016/j.molcel.2006.06.028; Lian ZL, 2005, ONCOGENE, V24, P7394, DOI 10.1038/sj.onc.1209089; Lindsay Y, 2006, J CELL SCI, V119, P5160, DOI 10.1242/jcs.000133; Liu FH, 2005, J CELL BIOCHEM, V96, P221, DOI 10.1002/jcb.20525; Liu JL, 2007, CANCER RES, V67, P11054, DOI 10.1158/0008-5472.CAN-07-1263; Lobo GP, 2008, HUM MOL GENET, V17, P2877, DOI 10.1093/hmg/ddn185; Lobo GP, 2009, HUM MOL GENET, V18, P2851, DOI 10.1093/hmg/ddp220; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Moroncini G, 2006, NEUROBIOL DIS, V23, P717, DOI 10.1016/j.nbd.2006.06.008; Myers MP, 1997, P NATL ACAD SCI USA, V94, P9052, DOI 10.1073/pnas.94.17.9052; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Perandones C, 2004, MOL BRAIN RES, V128, P8, DOI 10.1016/j.molbrainres.2004.05.021; Perren A, 2000, AM J PATHOL, V157, P1097, DOI 10.1016/S0002-9440(10)64624-X; Perren A, 1999, AM J PATHOL, V155, P1253, DOI 10.1016/S0002-9440(10)65227-3; Planchon SM, 2008, J CELL SCI, V121, P249, DOI 10.1242/jcs.022459; Radrizzani M, 1999, MEDICINA-BUENOS AIRE, V59, P753; Radrizzani M, 2000, MEDICINA-BUENOS AIRE, V60, P55; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stokoe D, 2001, CURR BIOL, V11, pR502, DOI 10.1016/S0960-9822(01)00303-7; Tachibana M, 2002, CANCER-AM CANCER SOC, V94, P1955, DOI 10.1002/cncr.0678; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wang JH, 2002, MOL IMMUNOL, V38, P1039, DOI 10.1016/S0161-5890(02)00033-0; Weiss S, 1997, J VIROL, V71, P8790, DOI 10.1128/JVI.71.11.8790-8797.1997; White R, 2001, MOL THER, V4, P567, DOI 10.1006/mthe.2001.0495; Whiteman DC, 2002, INT J CANCER, V99, P63, DOI 10.1002/ijc.10294; Zhou XP, 2000, HUM MOL GENET, V9, P765, DOI 10.1093/hmg/9.5.765; Zhou XP, 2002, AM J PATHOL, V161, P439, DOI 10.1016/S0002-9440(10)64200-9	47	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18857	10.1371/journal.pone.0018857	http://dx.doi.org/10.1371/journal.pone.0018857			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559530	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700028
J	Naoki, H; Nakamuta, S; Kaibuchi, K; Ishii, S				Naoki, Honda; Nakamuta, Shinichi; Kaibuchi, Kozo; Ishii, Shin			Flexible Search for Single-Axon Morphology during Neuronal Spontaneous Polarization	PLOS ONE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; SYMMETRY-BREAKING; POLARITY; TRANSPORT; CRMP-2; MECHANISMS; KINESIN-1; COMPLEX; ESTABLISHMENT; PROTEINS	Polarization, a disruption of symmetry in cellular morphology, occurs spontaneously, even in symmetrical extracellular conditions. This process is regulated by intracellular chemical reactions and the active transport of proteins and it is accompanied by cellular morphological changes. To elucidate the general principles underlying polarization, we focused on developing neurons. Neuronal polarity is stably established; a neuron initially has several neurites of similar length, but only one elongates and is selected to develop into an axon. Polarization is flexibly controlled; when multiple neurites are selected, the selection is eventually reduced to yield a single axon. What is the system by which morphological information is decoded differently based on the presence of a single or multiple axons? How are stability and flexibility achieved? To answer these questions, we constructed a biophysical model with the active transport of proteins that regulate neurite growth. Our mathematical analysis and computer simulation revealed that, as neurites elongate, transported factors accumulate in the growth cone but are degraded during retrograde diffusion to the soma. Such a system effectively works as local activation-global inhibition mechanism, resulting in both stability and flexibility. Our model shows good accordance with a number of experimental observations.	[Naoki, Honda; Ishii, Shin] Kyoto Univ, Grad Sch Informat, Kyoto, Japan; [Nakamuta, Shinichi; Kaibuchi, Kozo] Nagoya Univ, Dept Cell Pharmacol, Aichi, Japan; [Ishii, Shin] RIKEN Computat Sci Res Program, Wako, Saitama, Japan	Kyoto University; Nagoya University; RIKEN	Naoki, H (corresponding author), Kyoto Univ, Grad Sch Informat, Kyoto, Japan.	n-honda@sys.i.kyoto-u.ac.jp	Naoki, Honda/N-5674-2017; Kaibuchi, Kozo/M-4887-2014; Naoki, Honda/AAW-6284-2020	Naoki, Honda/0000-0001-6816-9126; Kaibuchi, Kozo/0000-0003-0714-1992; Naoki, Honda/0000-0001-6816-9126; Ishii, Shin/0000-0001-9385-8230	Japan Society for the Promotion of Science from the MEXT (Ministry of Education, Culture, Sports, Science, and Technology) of Japan [19-11235]; MEXT (Ministry of Education, Culture, Sports, Science, and Technology) of Japan [100081400012]	Japan Society for the Promotion of Science from the MEXT (Ministry of Education, Culture, Sports, Science, and Technology) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT (Ministry of Education, Culture, Sports, Science, and Technology) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Honda Naoki was supported by a research fellowship from the Japan Society for the Promotion of Science from the MEXT (Ministry of Education, Culture, Sports, Science, and Technology) of Japan. Grant number: 19-11235, http://www.jsps.go.jp/j-pd/index.html. Shin Ishii and Honda Naoki were supported by the Next Generation Supercomputing Project (Shin Ishii and Honda Naoki) from the MEXT (Ministry of Education, Culture, Sports, Science, and Technology) of Japan. Grant number: 100081400012, http://www.nsc.riken.jp/index-eng.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura N, 2004, J NEUROBIOL, V58, P34, DOI 10.1002/neu.10269; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Bradke F, 1997, NEURON, V19, P1175, DOI 10.1016/S0896-6273(00)80410-9; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DROZ B, 1963, J COMP NEUROL, V121, P325, DOI 10.1002/cne.901210304; FERREIRA A, 1992, J CELL BIOL, V117, P595, DOI 10.1083/jcb.117.3.595; Fivaz M, 2008, CURR BIOL, V18, P44, DOI 10.1016/j.cub.2007.11.051; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Hirokawa N, 1997, CURR OPIN NEUROBIOL, V7, P605, DOI 10.1016/S0959-4388(97)80079-7; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kawano Y, 2005, MOL CELL BIOL, V25, P9920, DOI 10.1128/MCB.25.22.9920-9935.2005; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; Meinhardt H, 2000, BIOESSAYS, V22, P753, DOI 10.1002/1521-1878(200008)22:8<753::AID-BIES9>3.3.CO;2-Q; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; POPOV S, 1992, J NEUROSCI, V12, P77; Ruthel G, 1998, CELL MOTIL CYTOSKEL, V40, P160, DOI 10.1002/(SICI)1097-0169(1998)40:2<160::AID-CM5>3.0.CO;2-J; Samuels DC, 1996, PHILOS T ROY SOC B, V351, P1147, DOI 10.1098/rstb.1996.0099; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Shinoda T, 2007, J NEUROSCI, V27, P4, DOI 10.1523/JNEUROSCI.3825-06.2007; Taya S, 2007, J NEUROSCI, V27, P15, DOI 10.1523/JNEUROSCI.3826-06.2006; Toriyama M, 2006, J CELL BIOL, V175, P147, DOI 10.1083/jcb.200604160; Toriyama M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.51; Tsuboi D, 2005, J NEUROCHEM, V95, P1629, DOI 10.1111/j.1471-4159.2005.03490.x; TURING AM, 1990, B MATH BIOL, V52, P153, DOI 10.1007/BF02459572; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Yan D, 2006, J CELL BIOL, V174, P415, DOI 10.1083/jcb.200511028; Yoshimura T, 2006, BIOCHEM BIOPH RES CO, V340, P62, DOI 10.1016/j.bbrc.2005.11.147	36	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19034	10.1371/journal.pone.0019034	http://dx.doi.org/10.1371/journal.pone.0019034			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559492	Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700055
J	Quaglio, E; Restelli, E; Garofoli, A; Dossena, S; De Luigi, A; Tagliavacca, L; Imperiale, D; Migheli, A; Salmona, M; Sitia, R; Forloni, G; Chiesa, R				Quaglio, Elena; Restelli, Elena; Garofoli, Anna; Dossena, Sara; De Luigi, Ada; Tagliavacca, Luigina; Imperiale, Daniele; Migheli, Antonio; Salmona, Mario; Sitia, Roberto; Forloni, Gianluigi; Chiesa, Roberto			Expression of Mutant or Cytosolic PrP in Transgenic Mice and Cells Is Not Associated with Endoplasmic Reticulum Stress or Proteasome Dysfunction	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; PATHOLOGICAL PRION PROTEIN; DISEASE-MODEL OCCURS; NERVE GROWTH-FACTOR; TRANSCRIPTION FACTOR; QUALITY-CONTROL; MOUSE MODEL; ER STRESS; UBIQUITIN/PROTEASOME SYSTEM; BIOCHEMICAL-PROPERTIES	The cellular pathways activated by mutant prion protein (PrP) in genetic prion diseases, ultimately leading to neuronal dysfunction and degeneration, are not known. Several mutant PrPs misfold in the early secretory pathway and reside longer in the endoplasmic reticulum (ER) possibly stimulating ER stress-related pathogenic mechanisms. To investigate whether mutant PrP induced maladaptive responses, we checked key elements of the unfolded protein response (UPR) in transgenic mice, primary neurons and transfected cells expressing two different mutant PrPs. Because ER stress favors the formation of untranslocated PrP that might aggregate in the cytosol and impair proteasome function, we also measured the activity of the ubiquitin proteasome system (UPS). Molecular, biochemical and immunohistochemical analyses found no increase in the expression of UPR-regulated genes, such as Grp78/Bip, CHOP/GADD153, or ER stress-dependent splicing of the mRNA encoding the X-box-binding protein 1. No alterations in UPS activity were detected in mutant mouse brains and primary neurons using the Ub(G76V)-GFP reporter and a new fluorogenic peptide for monitoring proteasomal proteolytic activity in vivo. Finally, there was no loss of proteasome function in neurons in which endogenous PrP was forced to accumulate in the cytosol by inhibiting cotranslational translocation. These results indicate that neither ER stress, nor perturbation of proteasome activity plays a major pathogenic role in prion diseases.	[Quaglio, Elena; Restelli, Elena; Garofoli, Anna; Dossena, Sara; Chiesa, Roberto] Dulbecco Telethon Inst, Milan, Italy; [Quaglio, Elena; Restelli, Elena; Garofoli, Anna; Dossena, Sara; Forloni, Gianluigi; Chiesa, Roberto] Mario Negri Inst Pharmacol Res, Dept Neurosci, I-20157 Milan, Italy; [De Luigi, Ada; Salmona, Mario] Mario Negri Inst Pharmacol Res, Dept Biochem & Mol Pharmacol, I-20157 Milan, Italy; [Tagliavacca, Luigina; Sitia, Roberto] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy; [Tagliavacca, Luigina; Sitia, Roberto] Univ Vita Salute San Raffaele, Milan, Italy; [Imperiale, Daniele; Migheli, Antonio] Maria Vittoria Hosp, Neurol Unit, Human Prion Dis Ctr DOMP, Turin, Italy	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Maria Vittoria Hospital	Quaglio, E (corresponding author), Dulbecco Telethon Inst, Milan, Italy.	roberto.chiesa@marionegri.it	Forloni, Gianluigi/AAB-2115-2020; De Luigi, Ada/ABF-7913-2020; Restelli, Elena/J-7449-2018; Chiesa, Roberto/G-1561-2017; salmona, mario/AAA-7116-2020; salmona, mario/ABI-4066-2020; Sitia, Roberto/AAB-5005-2019	Forloni, Gianluigi/0000-0001-5374-3914; De Luigi, Ada/0000-0001-7907-7139; Restelli, Elena/0000-0002-6081-5178; Chiesa, Roberto/0000-0002-3842-3733; salmona, mario/0000-0002-9098-9873; Sitia, Roberto/0000-0001-7086-4152	Fondazione Telethon Italy [TCR05006]; European Community [QLG-CT-2001-2353]; Associazione Italiana Ricerca sul Cancro; Regione Lombardia; Fondazione Cariplo; Fondazione Monzino; Carrefour Foundation	Fondazione Telethon Italy(Fondazione Telethon); European Community(European Commission); Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Regione Lombardia(Regione Lombardia); Fondazione Cariplo(Fondazione Cariplo); Fondazione Monzino; Carrefour Foundation	This work was supported by grants from Fondazione Telethon Italy (TCR05006), the European Community (QLG-CT-2001-2353), Associazione Italiana Ricerca sul Cancro, Regione Lombardia and Fondazione Cariplo. E.Q. was the recipient of fellowships from the Fondazione Monzino and Carrefour Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amici M, 2010, J NEUROSCI RES, V88, P191, DOI 10.1002/jnr.22186; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Apetri AC, 2004, J BIOL CHEM, V279, P18008, DOI 10.1074/jbc.M313581200; Ashok A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000479; BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; Bowman AB, 2005, HUM MOL GENET, V14, P679, DOI 10.1093/hmg/ddi064; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Campana V, 2005, TRENDS CELL BIOL, V15, P102, DOI 10.1016/j.tcb.2004.12.002; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Cenci S, 2006, EMBO J, V25, P1104, DOI 10.1038/sj.emboj.7601009; Cheroni C, 2009, HUM MOL GENET, V18, P82, DOI 10.1093/hmg/ddn319; Chiesa R, 2000, J NEUROCHEM, V75, P72, DOI 10.1046/j.1471-4159.2000.0750072.x; Chiesa R, 2003, J VIROL, V77, P7611, DOI 10.1128/JVI.77.13.7611-7622.2003; Chiesa R, 2000, P NATL ACAD SCI USA, V97, P5574, DOI 10.1073/pnas.97.10.5574; Chiesa R, 2001, NEUROBIOL DIS, V8, P743, DOI 10.1006/nbdi.2001.0433; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; Chiesa R, 2005, P NATL ACAD SCI USA, V102, P238, DOI 10.1073/pnas.0406173102; Chiesa R, 2004, TECHNIQUES PRION RES, P176; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Daude N, 1997, J BIOL CHEM, V272, P11604, DOI 10.1074/jbc.272.17.11604; Dossena S, 2008, NEURON, V60, P598, DOI 10.1016/j.neuron.2008.09.008; Drisaldi B, 2003, J BIOL CHEM, V278, P21732, DOI 10.1074/jbc.M213247200; Ferreiro E, 2006, NEUROBIOL DIS, V23, P669, DOI 10.1016/j.nbd.2006.05.011; Fioriti L, 2005, J BIOL CHEM, V280, P11320, DOI 10.1074/jbc.M412441200; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Harant H, 2006, J BIOL CHEM, V281, P30492, DOI 10.1074/jbc.M607243200; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hetz C, 2005, J NEUROSCI, V25, P2793, DOI 10.1523/JNEUROSCI.4090-04.2005; Hetz C, 2003, EMBO J, V22, P5435, DOI 10.1093/emboj/cdg537; Hetz C, 2008, P NATL ACAD SCI USA, V105, P757, DOI 10.1073/pnas.0711094105; Hetz C, 2007, J BIOL CHEM, V282, P12725, DOI 10.1074/jbc.M611909200; Hetz C, 2009, MOL CELL, V35, P551, DOI 10.1016/j.molcel.2009.08.021; Jornvall H, 2001, J BIOL CHEM, V276, P5140, DOI 10.1074/jbc.M005200200; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; Kang SC, 2004, J PATHOL, V203, P603, DOI 10.1002/path.1555; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Langeveld Jan P M, 2006, BMC Vet Res, V2, P19, DOI 10.1186/1746-6148-2-19; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lehmann S, 1996, J BIOL CHEM, V271, P1633, DOI 10.1074/jbc.271.3.1633; Lindsten K, 2003, NAT BIOTECHNOL, V21, P897, DOI 10.1038/nbt851; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Ma JY, 2001, P NATL ACAD SCI USA, V98, P14955, DOI 10.1073/pnas.011578098; Marijanovic Z, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000426; Massignan T, 2010, MOL CELL PROTEOMICS, V9, P611, DOI 10.1074/mcp.M900271-MCP200; Maynard CJ, 2009, P NATL ACAD SCI USA, V106, P13986, DOI 10.1073/pnas.0906463106; Mead S, 2006, EUR J HUM GENET, V14, P273, DOI 10.1038/sj.ejhg.5201544; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Orsi A, 2006, J BIOL CHEM, V281, P30431, DOI 10.1074/jbc.M605320200; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rane NS, 2008, DEV CELL, V15, P359, DOI 10.1016/j.devcel.2008.06.015; Rask K, 2000, INT J CANCER, V86, P337, DOI 10.1002/(SICI)1097-0215(20000501)86:3<337::AID-IJC6>3.3.CO;2-V; Restelli E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013725; Riek R, 1998, P NATL ACAD SCI USA, V95, P11667, DOI 10.1073/pnas.95.20.11667; Ronzoni R, 2010, TRAFFIC, V11, P947, DOI 10.1111/j.1600-0854.2010.01071.x; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Solomon IH, 2010, CURR ISSUES MOL BIOL, V12, P51; Soto C, 2008, DEV CELL, V15, P339, DOI 10.1016/j.devcel.2008.09.001; Steele AD, 2007, PRION, V1, P243, DOI 10.4161/pri.1.4.5551; Tagliavacca L, 2003, BIOL CHEM, V384, P1273, DOI 10.1515/BC.2003.141; Tang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014207; Torres M, 2011, PLOS ONE, V5; Unterberger U, 2006, J NEUROPATH EXP NEUR, V65, P348, DOI 10.1097/01.jnen.0000218445.30535.6f; Urru SAM, 2010, J MED CHEM, V53, P7452, DOI 10.1021/jm100362x; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Xing XM, 2006, CLIN CHIM ACTA, V364, P308, DOI 10.1016/j.cca.2005.07.016; Yedidia Y, 2001, EMBO J, V20, P5383, DOI 10.1093/emboj/20.19.5383; Yoo BC, 2002, NEUROSCI LETT, V334, P196, DOI 10.1016/S0304-3940(02)01071-6; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Young Katherine, 1999, P139; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec	72	27	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19339	10.1371/journal.pone.0019339	http://dx.doi.org/10.1371/journal.pone.0019339			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559407	Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700141
J	Rehman, AM; Coleman, M; Schwabe, C; Baltazar, G; Matias, A; Gomes, IR; Yellott, L; Aragon, C; Nchama, GN; Mzilahowa, T; Rowland, M; Kleinschmidt, I				Rehman, Andrea M.; Coleman, Mike; Schwabe, Christopher; Baltazar, Giovanna; Matias, Abrahan; Roncon Gomes, Irina; Yellott, Lee; Aragon, Cynthia; Nseng Nchama, Gloria; Mzilahowa, Themba; Rowland, Mark; Kleinschmidt, Immo			How Much Does Malaria Vector Control Quality Matter: The Epidemiological Impact of Holed Nets and Inadequate Indoor Residual Spraying	PLOS ONE			English	Article							EQUATORIAL-GUINEA; BIOKO ISLAND; UNTREATED BEDNETS; INTERVENTIONS; INFECTION; AREA	Background: Insecticide treated nets (ITN) and indoor residual spraying (IRS) are the two pillars of malaria vector control in Africa, but both interventions are beset by quality and coverage concerns. Data from three control programs were used to investigate the impact of: 1) the physical deterioration of ITNs, and 2) inadequate IRS spray coverage, on their respective protective effectiveness. Methods: Malaria indicator surveys were carried out in 2009 and 2010 in Bioko Island, mainland Equatorial Guinea and Malawi to monitor infection with P. falciparum in children, mosquito net use, net condition and spray status of houses. Nets were classified by their condition. The association between infection and quality and coverage of interventions was investigated. Results: There was reduced odds of infection with P. falciparum in children sleeping under ITNs that were intact (Odds ratio (OR): 0.65, 95% CI: 0.55-0.77 and OR: 0.81, 95% CI: 0.56-1.18 in Equatorial Guinea and in Malawi respectively), but the protective effect became less with increasingly worse condition of the net. There was evidence for a linear trend in infection per category increase in deterioration of nets. In Equatorial Guinea IRS offered protection to those in sprayed and unsprayed houses alike when neighbourhood spray coverage was high (>= 80%) compared to those living in areas of low IRS coverage (< 20%), regardless of whether the house they lived in was sprayed or not (adjusted OR=0.54, 95% CI 0.33-0.89). ITNs provided only personal protection, offering no protection to non users. Although similar effects were seen in Malawi, the evidence was much weaker than in Equatorial Guinea. Conclusions: Universal coverage strategies should consider policies for repair and replacement of holed nets and promote the care of nets by their owners. IRS programs should ensure high spray coverage since inadequate coverage gives little or no protection at all.	[Rehman, Andrea M.; Kleinschmidt, Immo] London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, London WC1, England; [Coleman, Mike] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Schwabe, Christopher] Med Care Dev Int, Silver Spring, MD USA; [Baltazar, Giovanna; Matias, Abrahan; Aragon, Cynthia] Med Care Dev Int, Malabo, Equat Guinea; [Roncon Gomes, Irina; Yellott, Lee] Med Care Dev Int, Bata, Equat Guinea; [Nseng Nchama, Gloria] Minist Hlth & Social Welf, Malabo, Equat Guinea; [Mzilahowa, Themba] Malawi Coll Med, Malaria Alert Ctr, Blantyre, Malawi; [Rowland, Mark] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; Liverpool School of Tropical Medicine; University of Liverpool; University of Malawi; University of London; London School of Hygiene & Tropical Medicine	Rehman, AM (corresponding author), London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, London WC1, England.	immo.kleinschmidt@lshtm.ac.uk	Rehman, Andrea/AAP-3172-2020; Rehman, Andrea M/H-1351-2015	Rehman, Andrea/0000-0001-9967-5822; Rehman, Andrea M/0000-0001-9967-5822; Coleman, Michael/0000-0003-4186-3526	government of Equatorial Guinea; Global Fund to Fight Aids, Tuberculosis and Malaria (GFATM); Marathon Foundation; Innovative Vector Control Consortium (Liverpool, United Kingdom); MRC [G0700837] Funding Source: UKRI; Medical Research Council [G0700837] Funding Source: researchfish	government of Equatorial Guinea; Global Fund to Fight Aids, Tuberculosis and Malaria (GFATM); Marathon Foundation; Innovative Vector Control Consortium (Liverpool, United Kingdom); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Bioko Island Malaria Control Project is funded by a consortium led by Marathon Oil Corporation (Houston, TX) under its corporate social responsibility programme and the government of Equatorial Guinea. Other members of the consortium are Noble Energy, Atlantic Methanol Company, SK of Korea, the Sociedad Nacional de Gas of Equatorial Guinea (SONAGAS), and GE Petrol. The EG Malaria Control Initiative on mainland Equatorial Guinea is funded by the Global Fund to Fight Aids, Tuberculosis and Malaria (GFATM) with additional financial support provided by the Marathon Foundation and the government of Equatorial Guinea. The Malaria Decision Support System project in Malawi is funded by the Innovative Vector Control Consortium (Liverpool, United Kingdom). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and have no commercial interest in the findings made in this article.	[Anonymous], 2009, STATA SURVEY DATA RE; [Anonymous], 2004, COCHRANE DB SYST REV; [Anonymous], 2009, STAT REL 11 STAT SOF; [Anonymous], 2006, IND RES SPRAYING US; Binka FN, 1998, AM J TROP MED HYG, V59, P80, DOI 10.4269/ajtmh.1998.59.80; Cano J, 2004, J MED ENTOMOL, V41, P158, DOI 10.1603/0022-2585-41.2.158; Clarke SE, 2001, T ROY SOC TROP MED H, V95, P457, DOI 10.1016/S0035-9203(01)90001-X; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003; Hii JLK, 2001, T ROY SOC TROP MED H, V95, P7, DOI 10.1016/S0035-9203(01)90315-3; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Kleinschmidt I, 2006, AM J TROP MED HYG, V74, P972, DOI 10.4269/ajtmh.2006.74.972; Kleinschmidt I, 2007, AM J TROP MED HYG, V76, P1027, DOI 10.4269/ajtmh.2007.76.1027; Kleinschmidt I, 2009, AM J TROP MED HYG, V81, P519, DOI 10.4269/ajtmh.2009.81.519; Kleinschmidt I, 2009, AM J TROP MED HYG, V80, P882, DOI 10.4269/ajtmh.2009.80.882; Malima RC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-38; Maxwell CA, 1999, T ROY SOC TROP MED H, V93, P4, DOI 10.1016/S0035-9203(99)90158-X; Mwangi TW, 2003, T ROY SOC TROP MED H, V97, P369, DOI 10.1016/S0035-9203(03)90056-3; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Ridl FC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-194; Sharp BL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-52; Sharp BL, 2007, AM J TROP MED HYG, V76, P42, DOI 10.4269/ajtmh.2007.76.42; Spratt M, 2010, AM J EPIDEMIOL, V172, P478, DOI 10.1093/aje/kwq137	24	59	59	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19205	10.1371/journal.pone.0019205	http://dx.doi.org/10.1371/journal.pone.0019205			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559436	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700101
J	Saura, CA; Servian-Morilla, E; Scholl, FG				Saura, Carlos A.; Servian-Morilla, Emilia; Scholl, Francisco G.			Presenilin/gamma-Secretase Regulates Neurexin Processing at Synapses	PLOS ONE			English	Article							SYNAPTIC VESICLE EXOCYTOSIS; AMYLOID PRECURSOR PROTEIN; AUTISM SPECTRUM DISORDER; ALZHEIMERS-DISEASE; ALPHA-NEUREXINS; CELL-ADHESION; LENTIVIRAL VECTORS; ENDOPROTEOLYSIS; MUTATIONS; RELEASE	Neurexins are a large family of neuronal plasma membrane proteins, which function as trans-synaptic receptors during synaptic differentiation. The binding of presynaptic neurexins to postsynaptic partners, such as neuroligins, has been proposed to participate in a signaling pathway that regulates synapse formation/stabilization. The identification of mutations in neurexin genes associated with autism and mental retardation suggests that dysfunction of neurexins may underlie synaptic defects associated with brain disorders. However, the mechanisms that regulate neurexin function at synapses are still unclear. Here, we show that neurexins are proteolytically processed by presenilins (PS), the catalytic components of the gamma-secretase complex that mediates the intramembraneous cleavage of several type I membrane proteins. Inhibition of PS/gamma-secretase by using pharmacological and genetic approaches induces a drastic accumulation of neurexin C-terminal fragments (CTFs) in cultured rat hippocampal neurons and mouse brain. Neurexin-CTFs accumulate mainly at the presynaptic terminals of PS conditional double knockout (PS cDKO) mice lacking both PS genes in glutamatergic neurons of the forebrain. The fact that loss of PS function enhances neurexin accumulation at glutamatergic terminals mediated by neuroligin-1 suggests that PS regulate the processing of neurexins at glutamatergic synapses. Interestingly, presenilin 1 (PS1) is recruited to glutamatergic terminals mediated by neuroligin-1, thus concentrating PS1 at terminals containing beta-neurexins. Furthermore, familial Alzheimer's disease (FAD)-linked PS1 mutations differentially affect beta-neurexin-1 processing. Expression of PS1 M146L and PS1 H163R mutants in PS-/- cells rescues the processing of beta-neurexin-1, whereas PS1 C410Y and PS1 Delta E9 fail to rescue the processing defect. These results suggest that PS regulate the synaptic function and processing of neurexins at glutamatergic synapses, and that impaired neurexin processing by PS may play a role in FAD.	[Saura, Carlos A.] Univ Autonoma Barcelona, Inst Neurociencies, Dept Bioquim & Biol Mol, Ctr Invest Biomed Red Enfermedades Neurodegenerat, E-08193 Barcelona, Spain; [Servian-Morilla, Emilia; Scholl, Francisco G.] Univ Seville, Dept Fisiol Med & Biofis, Inst Biomed Sevilla, Seville, Spain	Autonomous University of Barcelona; CIBERNED; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS)	Saura, CA (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, Dept Bioquim & Biol Mol, Ctr Invest Biomed Red Enfermedades Neurodegenerat, E-08193 Barcelona, Spain.	fgs@us.es	Saura, Carlos A/AFM-9239-2022; IBIS, NEUROGENETICA/P-2947-2015; Saura, Carlos A/D-2727-2011; Gomez Scholl, Francisco/K-7780-2018; SERVIAN MORILLA, EMILIA/S-8354-2017	Saura, Carlos A/0000-0003-3692-5657; Gomez Scholl, Francisco/0000-0003-1762-0700; SERVIAN MORILLA, EMILIA/0000-0002-6467-9740	Junta de Andalucia; Consejeria de Innovacion; Ciencia y Empresa [P07-CVI-02943]; Ministerio de Ciencia e Innovacion of Spain [SAF2010-20925, CIBERNED CB06/05/0042]	Junta de Andalucia(Junta de Andalucia); Consejeria de Innovacion; Ciencia y Empresa; Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grants from the Junta de Andalucia, Consejeria de Innovacion, Ciencia y Empresa to FGS (Proyecto de Excelencia P07-CVI-02943) and Ministerio de Ciencia e Innovacion of Spain to CAS (SAF2010-20925 and CIBERNED CB06/05/0042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Biederer T, 2007, NAT PROTOC, V2, P670, DOI 10.1038/nprot.2007.92; Bot N, 2011, J BIOL CHEM, V286, P2762, DOI 10.1074/jbc.M110.142521; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Fukumori A, 2010, J NEUROSCI, V30, P7853, DOI 10.1523/JNEUROSCI.1443-10.2010; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Gascon S, 2008, J NEUROSCI METH, V168, P104, DOI 10.1016/j.jneumeth.2007.09.023; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Kattenstroth G, 2004, P NATL ACAD SCI USA, V101, P2607, DOI 10.1073/pnas.0308626100; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Koo EH, 2004, NAT MED, V10, pS26, DOI 10.1038/nm1065; Lee H, 2010, J NEUROSCI, V30, P11435, DOI 10.1523/JNEUROSCI.2946-10.2010; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Murayama O, 1999, PROG NEURO-PSYCHOPH, V23, P905, DOI 10.1016/S0278-5846(99)00034-2; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Saura CA, 2000, J BIOL CHEM, V275, P17136, DOI 10.1074/jbc.M909624199; Saura CA, 2005, J NEUROSCI, V25, P6755, DOI 10.1523/JNEUROSCI.1247-05.2005; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Saura CA, 1999, J BIOL CHEM, V274, P13818, DOI 10.1074/jbc.274.20.13818; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Song WH, 1999, P NATL ACAD SCI USA, V96, P6959, DOI 10.1073/pnas.96.12.6959; Steiner H, 1999, BIOCHEMISTRY-US, V38, P14600, DOI 10.1021/bi9914210; Steiner H, 1999, J BIOL CHEM, V274, P7615, DOI 10.1074/jbc.274.12.7615; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Taniguchi H, 2007, J NEUROSCI, V27, P2815, DOI 10.1523/JNEUROSCI.0032-07.2007; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Wines-Samuelson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010195; Winkler E, 2009, BIOCHEMISTRY-US, V48, P1183, DOI 10.1021/bi801204g; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2; Zhang C, 2009, NATURE, V460, P632, DOI 10.1038/nature08177	57	51	52	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19430	10.1371/journal.pone.0019430	http://dx.doi.org/10.1371/journal.pone.0019430			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559374	Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700168
J	Barrio, AM; Ekerljung, M; Jern, P; Benachenhou, F; Sperber, GO; Bongcam-Rudloff, E; Blomberg, J; Andersson, G				Barrio, Alvaro Martinez; Ekerljung, Marie; Jern, Patric; Benachenhou, Farid; Sperber, Goran O.; Bongcam-Rudloff, Erik; Blomberg, Jonas; Andersson, Goran			The First Sequenced Carnivore Genome Shows Complex Host-Endogenous Retrovirus Relationships	PLOS ONE			English	Article							AVIAN TUMOR-VIRUSES; ALIGNMENT; GENES; RECOMBINATION; EVOLUTION; ELEMENTS	Host-retrovirus interactions influence the genomic landscape and have contributed substantially to mammalian genome evolution. To gain further insights, we analyzed a female boxer (Canis familiaris) genome for complexity and integration pattern of canine endogenous retroviruses (CfERV). Intriguingly, the first such in-depth analysis of a carnivore species identified 407 CfERV proviruses that represent only 0.15% of the dog genome. In comparison, the same detection criteria identified about six times more HERV proviruses in the human genome that has been estimated to contain a total of 8% retroviral DNA including solitary LTRs. These observed differences in man and dog are likely due to different mechanisms to purge, restrict and protect their genomes against retroviruses. A novel group of gammaretrovirus-like CfERV with high similarity to HERV-Fc1 was found to have potential for active retrotransposition and possibly lateral transmissions between dog and human as a result of close interactions during at least 10.000 years. The CfERV integration landscape showed a non-uniform intra-and inter-chromosomal distribution. Like in other species, different densities of ERVs were observed. Some chromosomal regions were essentially devoid of CfERVs whereas other regions had large numbers of integrations in agreement with distinct selective pressures at different loci. Most CfERVs were integrated in antisense orientation within 100 kb from annotated protein-coding genes. This integration pattern provides evidence for selection against CfERVs in sense orientation relative to chromosomal genes. In conclusion, this ERV analysis of the first carnivorous species supports the notion that different mammals interact distinctively with endogenous retroviruses and suggests that retroviral lateral transmissions between dog and human may have occurred.	[Barrio, Alvaro Martinez; Jern, Patric] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Ekerljung, Marie; Benachenhou, Farid; Bongcam-Rudloff, Erik; Andersson, Goran] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Biomed Ctr, S-75007 Uppsala, Sweden; [Benachenhou, Farid; Blomberg, Jonas] Uppsala Univ, Dept Med Sci, Virol Sect, Uppsala, Sweden; [Sperber, Goran O.] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Bongcam-Rudloff, Erik] Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden	Uppsala University; Swedish University of Agricultural Sciences; Uppsala University; Uppsala University; Uppsala University	Barrio, AM (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.	Goran.Andersson@hgen.slu.se	Andersson, Goran/AAK-6564-2020; Jern, Patric/AAR-2133-2021	Andersson, Goran/0000-0001-5131-3144; Jern, Patric/0000-0003-3393-5825; Blomberg, Jonas/0000-0001-6492-2491; Bongcam-Rudloff, Erik/0000-0002-1947-8288	European Commission [LHSG-CT-2004-512092]; Wenner-Gren Foundation (Sweden)	European Commission(European CommissionEuropean Commission Joint Research Centre); Wenner-Gren Foundation (Sweden)	This work was supported by the European Commission FP6 Programme (the EMBRACE project, LHSG-CT-2004-512092). PJ was supported by a fellowship from the Wenner-Gren Foundation (Sweden). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Barrio AM, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S18; BARTHOLOMEW C, 1991, MOL CELL BIOL, V11, P1820, DOI 10.1128/MCB.11.4.1820; BEEMON K, 1974, P NATL ACAD SCI USA, V71, P4254, DOI 10.1073/pnas.71.10.4254; Benit L, 2003, VIROLOGY, V312, P159, DOI 10.1016/S0042-6822(03)00163-6; Blikstad V, 2008, CELL MOL LIFE SCI, V65, P3348, DOI 10.1007/s00018-008-8495-2; Blomberg J, 2009, GENE, V448, P115, DOI 10.1016/j.gene.2009.06.007; Chen Wei-Hua, 2009, BMC Res Notes, V2, P155, DOI 10.1186/1756-0500-2-155; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Clough JE, 1996, J MOL EVOL, V42, P52, DOI 10.1007/BF00163211; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; DEININGER PL, 1992, TRENDS GENET, V8, P307, DOI 10.1016/0168-9525(92)90262-3; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jern P, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-50; Jern P, 2004, VIROLOGY, V327, P93, DOI 10.1016/j.virol.2004.06.023; Jern P, 2008, ANNU REV GENET, V42, P709, DOI 10.1146/annurev.genet.42.110807.091501; Karlsson EK, 2008, NAT REV GENET, V9, P713, DOI 10.1038/nrg2382; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Katzourakis A, 2007, J VIROL, V81, P10712, DOI 10.1128/JVI.00410-07; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Liu GE, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-140; Roca AL, 2004, J VIROL, V78, P4370, DOI 10.1128/JVI.78.8.4370-4375.2004; Romano CM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001026; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SHARP PM, 1995, PHILOS T R SOC B, V349, P41, DOI 10.1098/rstb.1995.0089; Smit A, 1996, REPEATMASKER OPEN 30; Sperber GO, 2007, NUCLEIC ACIDS RES, V35, P4964, DOI 10.1093/nar/gkm515; Tarlinton RE, 2006, NATURE, V442, P79, DOI 10.1038/nature04841; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TSICHLIS PN, 1980, J VIROL, V33, P238, DOI 10.1128/JVI.33.1.238-249.1980; van de Lagemaat LN, 2003, TRENDS GENET, V19, P530, DOI 10.1016/j.tig.2003.08.004; van de Lagemaat LN, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r86; Volff JN, 2009, ANN NY ACAD SCI, V1178, P233, DOI 10.1111/j.1749-6632.2009.05005.x; Wilson CA, 2008, CELL MOL LIFE SCI, V65, P3399, DOI 10.1007/s00018-008-8498-z	38	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19832	10.1371/journal.pone.0019832	http://dx.doi.org/10.1371/journal.pone.0019832			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589882	Green Published, Green Submitted, gold			2022-12-27	WOS:000290531100030
J	Osborne, C; Cryan, PM; O'Shea, TJ; Oko, LM; Ndaluka, C; Calisher, CH; Berglund, AD; Klavetter, ML; Bowen, RA; Holmes, KV; Dominguez, SR				Osborne, Christina; Cryan, Paul M.; O'Shea, Thomas J.; Oko, Lauren M.; Ndaluka, Christina; Calisher, Charles H.; Berglund, Andrew D.; Klavetter, Mead L.; Bowen, Richard A.; Holmes, Kathryn V.; Dominguez, Samuel R.			Alphacoronaviruses in New World Bats: Prevalence, Persistence, Phylogeny, and Potential for Interaction with Humans	PLOS ONE			English	Article							SARS-LIKE; CORONAVIRUSES; VIRUSES; TRANSMISSION; COLORADO; RABIES; IDENTIFICATION; RECOMBINATION; INFECTION; RESERVOIR	Bats are reservoirs for many different coronaviruses (CoVs) as well as many other important zoonotic viruses. We sampled feces and/or anal swabs of 1,044 insectivorous bats of 2 families and 17 species from 21 different locations within Colorado from 2007 to 2009. We detected alphacoronavirus RNA in bats of 4 species: big brown bats (Eptesicus fuscus), 10% prevalence; long-legged bats (Myotis volans), 8% prevalence; little brown bats (Myotis lucifugus), 3% prevalence; and western long-eared bats (Myotis evotis), 2% prevalence. Overall, juvenile bats were twice as likely to be positive for CoV RNA as adult bats. At two of the rural sampling sites, CoV RNAs were detected in big brown and long-legged bats during the three sequential summers of this study. CoV RNA was detected in big brown bats in all five of the urban maternity roosts sampled throughout each of the periods tested. Individually tagged big brown bats that were positive for CoV RNA and later sampled again all became CoV RNA negative. Nucleotide sequences in the RdRp gene fell into 3 main clusters, all distinct from those of Old World bats. Similar nucleotide sequences were found in amplicons from gene 1b and the spike gene in both a big-brown and a long-legged bat, indicating that a CoV may be capable of infecting bats of different genera. These data suggest that ongoing evolution of CoVs in bats creates the possibility of a continued threat for emergence into hosts of other species. Alphacoronavirus RNA was detected at a high prevalence in big brown bats in roosts in close proximity to human habitations (10%) and known to have direct contact with people (19%), suggesting that significant potential opportunities exist for cross-species transmission of these viruses. Further CoV surveillance studies in bats throughout the Americas are warranted.	[Osborne, Christina; Berglund, Andrew D.; Dominguez, Samuel R.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Oko, Lauren M.; Holmes, Kathryn V.; Dominguez, Samuel R.] Univ Colorado, Sch Med, Dept Microbiol, Aurora, CO USA; [Cryan, Paul M.; O'Shea, Thomas J.] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO USA; [Klavetter, Mead L.] Pinon Canyon Maneuver Site, Model, CO USA; [Calisher, Charles H.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Ndaluka, Christina; Bowen, Richard A.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; United States Department of the Interior; United States Geological Survey; Colorado State University; Colorado State University	Osborne, C (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA.	samuel.dominguez@ucdenver.edu	O'Shea, Thomas/AAY-5848-2021	Cryan, Paul/0000-0002-2915-8894	NIH [AI-P01-059576, 5K08-AI073525-03, U54-AI065357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI073525, P01AI059576, U54AI065357] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant #AI-P01-059576 (KVH), NIH grant #5K08-AI073525-03 (SRD), and NIH grant #U54-AI065357 (SRD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manscript.	Armstrong D.M., 1994, DISTRIBUTION ECOLOGY; Calisher CH, 2000, EMERG INFECT DIS, V6, P363, DOI 10.3201/eid0604.000406; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Carrington CVF, 2008, EMERG INFECT DIS, V14, P1890, DOI 10.3201/eid1412.080642; Chu DKW, 2006, J GEN VIROL, V87, P2461, DOI 10.1099/vir.0.82203-0; Chua KB, 2007, P NATL ACAD SCI USA, V104, P11424, DOI 10.1073/pnas.0701372104; Chua KB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003803; Chua KB, 1999, LANCET, V354, P1257, DOI 10.1016/S0140-6736(99)04299-3; Dominguez SR, 2007, EMERG INFECT DIS, V13, P1295, DOI 10.3201/eid1309.070491; DONALDSON EF, 2010, J VIROL; Drexler JF, 2010, J VIROL, V84, P11336, DOI 10.1128/JVI.00650-10; FITZGERALD J, 1994, MAMMALS COLORADO; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gloza-Rausch F, 2008, EMERG INFECT DIS, V14, P626, DOI 10.3201/eid1404.071439; Halpin K, 2007, CLIN INFECT DIS, V44, P711, DOI 10.1086/511078; Hoofer SR, 2006, J MAMMAL, V87, P981, DOI 10.1644/05-MAMM-A-425R1.1; Jones KE, 2002, BIOL REV, V77, P223, DOI 10.1017/S1464793101005899; KECK JG, 1988, J VIROL, V62, P1810, DOI 10.1128/JVI.62.5.1810-1813.1988; Kunz T.H., 1982, P1; LAU SK, 2010, J VIROL; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Lau SKP, 2010, J VIROL, V84, P2808, DOI 10.1128/JVI.02219-09; Li LL, 2010, J VIROL, V84, P6955, DOI 10.1128/JVI.00501-10; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Misra V, 2009, J GEN VIROL, V90, P2015, DOI 10.1099/vir.0.010694-0; Mondul A, 2003, J AM VET MED ASSOC, V222, P633, DOI 10.2460/javma.2003.222.633; MONTO AS, 1974, YALE J BIOL MED, V47, P234; Muller MA, 2007, EMERG INFECT DIS, V13, P1367, DOI 10.3201/eid1309.070342; MURRAY K, 1995, EMERG INFECT DIS, V1, P31, DOI 10.3201/eid0101.950107; O'Shea TJ, 2010, J MAMMAL, V91, P418, DOI 10.1644/08-MAMM-A-295.1; OSHEA TJ, URBAN ECOSY IN PRESS; OSHEA TJ, J MAMMALOGY IN PRESS, V92; Pape WJ, 1999, EMERG INFECT DIS, V5, P433, DOI 10.3201/eid0503.990315; Pfefferle S, 2009, EMERG INFECT DIS, V15, P1377, DOI 10.3201/eid1509.090224; Piaggio AJ, 2002, J MAMMAL, V83, P386, DOI 10.1644/1545-1542(2002)083<0386:SOMOCV>2.0.CO;2; Poon LLM, 2005, J VIROL, V79, P2001, DOI 10.1128/JVI.79.4.2001-2009.2005; Pourrut X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-159; SELVEY LA, 1995, MED J AUSTRALIA, V162, P642, DOI 10.5694/j.1326-5377.1995.tb126050.x; Streicker DG, 2010, SCIENCE, V329, P676, DOI 10.1126/science.1188836; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang XC, 2006, J VIROL, V80, P7481, DOI 10.1128/JVI.00697-06; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Tong SX, 2009, EMERG INFECT DIS, V15, P482, DOI 10.3201/eid1503.081013; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; VIJAYKRISHNA D, 2007, J VIROL; Watanabe S, 2010, EMERG INFECT DIS, V16, P1217, DOI 10.3201/eid1608.100208; WONG S, 2006, REV MED VIROL; Woo PCY, 2007, J VIROL, V81, P1574, DOI 10.1128/JVI.02182-06; Woo PCY, 2009, EXP BIOL MED, V234, P1117, DOI 10.3181/0903-MR-94	49	36	40	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19156	10.1371/journal.pone.0019156	http://dx.doi.org/10.1371/journal.pone.0019156			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589915	Green Published, gold, Green Submitted			2022-12-27	WOS:000290531100005
J	Browne, AW; Leddon, JL; Currier, MA; Williams, JP; Frischer, JS; Collins, MH; Ahn, CH; Cripe, TP				Browne, Andrew W.; Leddon, Jennifer L.; Currier, Mark A.; Williams, Jon P.; Frischer, Jason S.; Collins, Margaret H.; Ahn, Chong H.; Cripe, Timothy P.			Cancer Screening by Systemic Administration of a Gene Delivery Vector Encoding Tumor-Selective Secretable Biomarker Expression	PLOS ONE			English	Article							VIRUS; EFFICACY; PROTEIN; NANOPARTICLES; PERMEABILITY; PERSISTENCE; LUCIFERASE; PROMOTER; MARKERS; GROWTH	Cancer biomarkers facilitate screening and early detection but are known for only a few cancer types. We demonstrated the principle of inducing tumors to secrete a serum biomarker using a systemically administered gene delivery vector that targets tumors for selective expression of an engineered cassette. We exploited tumor-selective replication of a conditionally replicative Herpes simplex virus (HSV) combined with a replication-dependent late viral promoter to achieve tumor-selective biomarker expression as an example gene delivery vector. Virus replication, cytotoxicity and biomarker production were low in quiescent normal human foreskin keratinocytes and high in cancer cells in vitro. Following intravenous injection of virus >90% of tumor-bearing mice exhibited higher levels of biomarker than non-tumor-bearing mice and upon necropsy, we detected virus exclusively in tumors. Our strategy of forcing tumors to secrete a serum biomarker could be useful for cancer screening in high-risk patients, and possibly for monitoring response to therapy. In addition, because oncolytic vectors for tumor specific gene delivery are cytotoxic, they may supplement our screening strategy as a "theragnostic'' agent. The cancer screening approach presented in this work introduces a paradigm shift in the utility of gene delivery which we foresee being improved by alternative vectors targeting gene delivery and expression to tumors. Refining this approach will usher a new era for clinical cancer screening that may be implemented in the developed and undeveloped world.	[Browne, Andrew W.; Leddon, Jennifer L.; Currier, Mark A.; Cripe, Timothy P.] Cincinnati Childrens Hosp Med Ctr, Div Oncol, Cincinnati, OH USA; [Williams, Jon P.; Cripe, Timothy P.] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol, Cincinnati, OH USA; [Frischer, Jason S.] Cincinnati Childrens Hosp Med Ctr, Div Surg, Cincinnati, OH USA; [Collins, Margaret H.] Cincinnati Childrens Hosp Med Ctr, Div Pathol, Cincinnati, OH USA; [Browne, Andrew W.; Leddon, Jennifer L.] Univ Cincinnati, Coll Med, Phys Scientist Training Program, Cincinnati, OH USA; [Browne, Andrew W.; Ahn, Chong H.] Univ Cincinnati, Dept Elect & Comp Engn, Cincinnati, OH 45221 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Browne, AW (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Oncol, Cincinnati, OH USA.	timothy.cripe@cchmc.org	Williams, Jon/AAP-2761-2020		CancerFree Kids Pediatric Cancer Research Alliance (AWB); NIH [1R01-CA114001-01A2]; NATIONAL CANCER INSTITUTE [R01CA114001] Funding Source: NIH RePORTER	CancerFree Kids Pediatric Cancer Research Alliance (AWB); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the CancerFree Kids Pediatric Cancer Research Alliance (AWB) and NIH award 1R01-CA114001-01A2 (TPC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghi M, 2008, ONCOGENE, V27, P4249, DOI 10.1038/onc.2008.53; Barton ES, 2003, J CLIN INVEST, V111, P1823, DOI 10.1172/JCI200316303; Bharatan NS, 2002, J PEDIAT HEMATOL ONC, V24, P447, DOI 10.1097/00043426-200208000-00008; BOYCE ST, 1983, J INVEST DERMATOL, V81, pS33, DOI 10.1111/1523-1747.ep12540422; Brannon-Peppas L, 2004, ADV DRUG DELIVER REV, V56, P1649, DOI 10.1016/j.addr.2004.02.014; Currier MA, 2008, MOL THER, V16, P879, DOI 10.1038/mt.2008.49; Do J, 2008, LAB CHIP, V8, P542, DOI 10.1039/b715569g; Fan R, 2008, NAT BIOTECHNOL, V26, P1373, DOI 10.1038/nbt.1507; Fu X, 2003, GENE THER, V10, P1458, DOI 10.1038/sj.gt.3302029; Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994; GUZOWSKI JF, 1994, J VIROL, V68, P7774, DOI 10.1128/JVI.68.12.7774-7789.1994; Harland J, 2003, J NEUROVIROL, V9, P477, DOI 10.1080/13550280390218788; HATAKEYAMA H, 2011, BIOMATERIALS; He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843; Henares TG, 2008, ANAL CHIM ACTA, V611, P17, DOI 10.1016/j.aca.2008.01.064; HENEWEER C, 2011, J NUCL MED; HWANG KJ, 1980, P NATL ACAD SCI-BIOL, V77, P4030, DOI 10.1073/pnas.77.7.4030; Iankov ID, 2009, MOL THER, V17, P1395, DOI 10.1038/mt.2009.92; Kanerva A, 2005, GENE THER, V12, P87, DOI 10.1038/sj.gt.3302387; Kirpotin DB, 2006, CANCER RES, V66, P6732, DOI 10.1158/0008-5472.CAN-05-4199; Ko J, 2007, J CONTROL RELEASE, V123, P109, DOI 10.1016/j.jconrel.2007.07.012; Kocbek P, 2007, J CONTROL RELEASE, V120, P18, DOI 10.1016/j.jconrel.2007.03.012; Lambright ES, 2000, MOL THER, V2, P387, DOI 10.1006/mthe.2000.0133; Li H, 2010, CANCER GENE THER, V17, P550, DOI 10.1038/cgt.2010.10; Maeda H, 2001, ADV ENZYME REGUL, V41, P189, DOI 10.1016/S0065-2571(00)00013-3; Maeda H, 2003, INT IMMUNOPHARMACOL, V3, P319, DOI 10.1016/S1567-5769(02)00271-0; Mahller YY, 2008, CANCER RES, V68, P1170, DOI 10.1158/0008-5472.CAN-07-2734; Mahller YY, 2006, PEDIATR BLOOD CANCER, V46, P745, DOI 10.1002/pbc.20565; Markert JM, 2009, MOL THER, V17, P199, DOI 10.1038/mt.2008.228; Marquardt A, 2011, J GEN VIROL; Martuza RL, 2000, J CLIN INVEST, V105, P841, DOI 10.1172/JCI9744; Palumbo JS, 2003, BLOOD, V102, P2819, DOI 10.1182/blood-2003-03-0881; Peng KW, 2002, NAT MED, V8, P527, DOI 10.1038/nm0502-527; Penheiter AR, 2010, AM J ROENTGENOL, V195, P341, DOI 10.2214/AJR.09.3672; QI X, 2009, CANC SELECT IN PRESS; Rajecki M, 2007, MOL CANCER THER, V6, P742, DOI 10.1158/1535-7163.MCT-06-0403; RODA A, 2011, BIOSENS BIOELECTRON; SHEN Y, 2006, CANCER GENE THER, V7, P7; Shikano T, 2011, CURR CANCER DRUG TAR, V11, P111, DOI 10.2174/156800911793743673; Stoeva SI, 2006, J AM CHEM SOC, V128, P8378, DOI 10.1021/ja0613106; Sugahara KN, 2010, SCIENCE, V328, P1031, DOI 10.1126/science.1183057; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; TANNOUS BA, 2009, NATURE PROTOCOLS, P582; TERADA K, 2006, GENE THER, V19, P19; Wurdinger T, 2008, NAT METHODS, V5, P171, DOI 10.1038/NMETH.1177; Yu W, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh049	46	6	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19530	10.1371/journal.pone.0019530	http://dx.doi.org/10.1371/journal.pone.0019530			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589655	Green Submitted, Green Published, gold			2022-12-27	WOS:000290483600015
J	Xia, W; Sun, CH; Zhang, L; Zhang, X; Wang, JJ; Wang, H; Wu, LJ				Xia, Wei; Sun, Caihong; Zhang, Li; Zhang, Xin; Wang, Jiajia; Wang, Hui; Wu, Lijie			Reproducibility and Relative Validity of a Food Frequency Questionnaire Developed for Female Adolescents in Suihua, North China	PLOS ONE			English	Article							DIETARY ASSESSMENT INSTRUMENTS; HISTORY QUESTIONNAIRE; RELIABILITY; VALIDATION; HEALTH; BEHAVIOR; BOOKLET; HABITS	Background: This study aims to evaluate the reproducibility and validity of a food frequency questionnaire (FFQ) developed for female adolescents in the Suihua area of North China. The FFQ was evaluated against the average of 24-hour dietary recalls (24-HRs). Methodology/Principal Findings: A total of 168 female adolescents aged 12 to 18 completed nine three consecutive 24-HRs (one three consecutive 24-HRs per month) and two FFQs over nine months. The reproducibility of the FFQ was estimated using intraclass correlation coefficients (ICCs), and its relative validity was assessed by comparing it with the 24-HRs. The mean values of the 24-HRs were lower than those of the FFQs, except for protein (in FFQ1) and iron (in FFQ2). The ICCs for all nutrients and food groups in FFQ1 and FFQ2 were moderately correlated (0.4-0.8). However, all the ICCs decreased after adjusting for energy. The weighted kappa statistic showed moderate agreement (0.40-0.6) for all nutrients and food groups, except for niacin and calcium, which showed poor agreement (0.35). The relative validity results indicate that the crude Spearman's correlation coefficients of FFQ1 and the 24-HRs ranged from 0.41 (for Vitamin C) to 0.65 (for fruit). The coefficients of each nutrient and food group in FFQ2 and the 24-HRs were higher than those in FFQ1 and the 24-HRs, indicating good correlation. Although all energy-adjusted Spearman's correlation coefficients were lower than the crude coefficients, de-attenuation to correct for intra-individual variability improved the correlation coefficients. The weighted k coefficients of nutrients and food groups ranged from 0.32 for beans to 0.52 for riboflavin in FFQ1 and the 24-HRs, and 0.32 for Vitamin C to 0.54 for riboflavin in FFQ2 and the 24-HRs. Conclusion: The FFQ developed for female adolescents in the Suihua area is a reliable and valid instrument for ranking individuals within this study.	[Xia, Wei; Sun, Caihong; Wu, Lijie] Harbin Med Univ, Sch Publ Hlth, Dept Children Hlth & Hyg, Harbin, Peoples R China; [Zhang, Li; Zhang, Xin; Wang, Jiajia; Wang, Hui] Harbin Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Xia, W (corresponding author), Harbin Med Univ, Sch Publ Hlth, Dept Children Hlth & Hyg, Harbin, Peoples R China.	lijiewu64@126.com			Research Council of Helongjiang Province of P.R. of China [QC06C059]	Research Council of Helongjiang Province of P.R. of China	This work was supported by a grant from the Research Council of Helongjiang Province of P.R. of China (QC06C059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLOCK G, 1990, J CLIN EPIDEMIOL, V43, P1327, DOI 10.1016/0895-4356(90)90099-B; Bogers RP, 2004, AM J EPIDEMIOL, V159, P900, DOI 10.1093/aje/kwh123; Bolca S, 2009, INT J ENV RES PUB HE, V6, P121, DOI 10.3390/ijerph6010121; Cade J, 2002, PUBLIC HEALTH NUTR, V5, P567, DOI 10.1079/PHN2001318; *CHIN NUTR SOC, 2000, CHIN DRIS; Cruz JAA, 2000, EUR J CLIN NUTR, V54, pS29, DOI 10.1038/sj.ejcn.1600981; Deschamps V, 2009, EUR J CLIN NUTR, V63, P282, DOI 10.1038/sj.ejcn.1602914; Esfahani FH, 2010, J EPIDEMIOL, V20, P150, DOI 10.2188/jea.JE20090083; Goodwin RA, 2001, J AM DIET ASSOC, V101, P926, DOI 10.1016/S0002-8223(01)00229-2; Gulliford MC, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-22; Hakim IA, 2001, CANCER EPIDEM BIOMAR, V10, P667; Horn-Ross PL, 2008, CANCER CAUSE CONTROL, V19, P595, DOI 10.1007/s10552-008-9124-y; Huybrechts I, 2009, INT J ENV RES PUB HE, V6, P382, DOI 10.3390/ijerph6010382; Johnson F, 2002, EUR J CLIN NUTR, V56, P644, DOI 10.1038/sj.ejcn.1601371; Kelemen LE, 2003, J AM DIET ASSOC, V103, P1178, DOI 10.1016/S0002-8223(03)00985-4; Li Li-ming, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P478; Lietz G, 2002, PUBLIC HEALTH NUTR, V5, P783, DOI 10.1079/PHN2002344; Marchioni DML, 2007, CAD SAUDE PUBLICA, V23, P2187, DOI 10.1590/S0102-311X2007000900026; Malekshah AF, 2006, EUR J CLIN NUTR, V60, P971, DOI 10.1038/sj.ejcn.1602407; Mochari H, 2008, J AM DIET ASSOC, V108, P817, DOI 10.1016/j.jada.2008.02.021; Ocke MC, 1997, INT J EPIDEMIOL, V26, pS37, DOI 10.1093/ije/26.suppl_1.S37; PIETINEN P, 1988, AM J EPIDEMIOL, V128, P667, DOI 10.1093/oxfordjournals.aje.a115014; PIETINEN P, 1988, AM J EPIDEMIOL, V128, P655, DOI 10.1093/oxfordjournals.aje.a115013; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; ROSNER B, 1988, AM J EPIDEMIOL, V127, P377, DOI 10.1093/oxfordjournals.aje.a114811; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Shu XO, 2004, EUR J CLIN NUTR, V58, P17, DOI 10.1038/sj.ejcn.1601738; VanLiere MJ, 1997, INT J EPIDEMIOL, V26, pS128, DOI 10.1093/ije/26.suppl_1.S128; Vereecken CA, 2003, PUBLIC HEALTH NUTR, V6, P581, DOI 10.1079/PHN2003466; Wakai K, 2009, J EPIDEMIOL, V19, P1, DOI 10.2188/jea.JE20081007; WANG J, 2009, CHINA SCH HLTH, V30, P535; Willett W., 2012, NUTR EPIDEMIOLOGY; Yang Y.X., 2004, CHINA FOOD COMPOSITI, V1; Yaroch AL, 2000, J AM DIET ASSOC, V100, P1050, DOI 10.1016/S0002-8223(00)00306-0	34	49	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19656	10.1371/journal.pone.0019656	http://dx.doi.org/10.1371/journal.pone.0019656			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589932	Green Published, gold, Green Submitted			2022-12-27	WOS:000290483600019
J	Naik, US; Gangadharan, C; Abbagani, K; Nagalla, B; Dasari, N; Manna, SK				Naik, Usha S.; Gangadharan, Charitha; Abbagani, Kanakalatha; Nagalla, Balakrishna; Dasari, Niranjan; Manna, Sunil K.			A Study of Nuclear Transcription Factor-Kappa B in Childhood Autism	PLOS ONE			English	Article							FACTOR-INDUCED APOPTOSIS; CEREBROSPINAL-FLUID; ACTIVATION; OVEREXPRESSION; CHILDREN; STRESS	Background: Several children with autism show regression in language and social development while maintaining normal motor milestones. A clear period of normal development followed by regression and subsequent improvement with treatment, suggests a multifactorial etiology. The role of inflammation in autism is now a major area of study. Viral and bacterial infections, hypoxia, or medication could affect both foetus and infant. These stressors could upregulate transcription factors like nuclear factor kappa B (NF-kappa B), a master switch for many genes including some implicated in autism like tumor necrosis factor (TNF). On this hypothesis, it was proposed to determine NF-kappa B in children with autism. Methods: Peripheral blood samples of 67 children with autism and 29 control children were evaluated for NF-kappa B using electrophoretic mobility shift assay (EMSA). A phosphor imaging technique was used to quantify values. The fold increase over the control sample was calculated and statistical analysis was carried out using SPSS 15. Results: We have noted significant increase in NF-kappa B DNA binding activity in peripheral blood samples of children with autism. When the fold increase of NF-kappa B in cases (n = 67) was compared with that of controls (n = 29), there was a significant difference (3.14 vs. 1.40, respectively; p < 0.02). Conclusion: This finding has immense value in understanding many of the known biochemical changes reported in autism. As NF-kappa B is a response to stressors of several kinds and a master switch for many genes, autism may then arise at least in part from an NF-kappa B pathway gone awry.	[Naik, Usha S.; Abbagani, Kanakalatha; Dasari, Niranjan] Osmania Med Coll & Hosp, Dept Psychiat, Hyderabad, Andhra Pradesh, India; [Gangadharan, Charitha; Manna, Sunil K.] Ctr DNA Fingerprinting & Diagnost, Immunol Lab, Hyderabad, Andhra Pradesh, India; [Nagalla, Balakrishna] Natl Inst Nutr, Hyderabad 500007, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN)	Naik, US (corresponding author), Osmania Med Coll & Hosp, Dept Psychiat, Hyderabad, Andhra Pradesh, India.	manna@cdfd.org.in	Nagalla, Balakrishna/GRR-4393-2022	Nagalla, Balakrishna/0000-0002-5613-0942	Department of Biotechnology, Ministry of Science and Technology, Government of India	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	The study was funded by a Central Government Grant from the Department of Biotechnology, Ministry of Science and Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Ahn KS, 2005, ANN NY ACAD SCI, V1056, P218, DOI 10.1196/annals.1352.026; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Ashwood P, 2011, BRAIN BEHAV IMMUN, V25, P40, DOI 10.1016/j.bbi.2010.08.003; Bale TL, 2010, BIOL PSYCHIAT, V68, P314, DOI 10.1016/j.biopsych.2010.05.028; BALTIMORE D, 2006, HDB TRANSCRIPTION FA; Chez MG, 2007, PEDIATR NEUROL, V36, P361, DOI 10.1016/j.pediatrneurol.2007.01.012; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Ghosh Sankar, 2007, P1; GILLBERG C, 1983, J AUTISM DEV DISORD, V13, P153, DOI 10.1007/BF01531816; Goines P, 2010, CURR OPIN NEUROL, V23, P111, DOI 10.1097/WCO.0b013e3283373514; Granpeesheh D, 2009, ANN CLIN PSYCHIATRY, V21, P195; Grosjean-Raillard J, 2008, APOPTOSIS, V13, P1148, DOI 10.1007/s10495-008-0243-4; James SJ, 2004, AM J CLIN NUTR, V80, P1611, DOI 10.1093/ajcn/80.6.1611; Jyonouchi H, 2001, J NEUROIMMUNOL, V120, P170, DOI 10.1016/S0165-5728(01)00421-0; Kanner L, 1943, NERV CHILD, V2, P217; Kelley E, 2010, RES AUTISM SPECT DIS, V4, P526, DOI 10.1016/j.rasd.2009.12.001; Licinio J, 2002, MOL PSYCHIATR, V7, P329, DOI 10.1038/sj.mp.4001137; Lord C, 2004, J CHILD PSYCHOL PSYC, V45, P936, DOI 10.1111/j.1469-7610.2004.t01-1-00287.x; Malik M, 2011, IMMUNOBIOLOGY, V216, P80, DOI 10.1016/j.imbio.2010.03.001; Manna SK, 1998, J BIOL CHEM, V273, P13245, DOI 10.1074/jbc.273.21.13245; Manna SK, 1999, ONCOGENE, V18, P4371, DOI 10.1038/sj.onc.1202811; Manna SK, 2010, J BIOL CHEM, V285, P11617, DOI 10.1074/jbc.M109.094961; Pardo A.C., 2005, INT REV PSYCHIATR, V17, P485; PHAL LH, 1999, ONCOGENE, V18, P6853; Sajdel-Sulkowska E.M., 2008, AM J BIOCH BIOTECHNO, V4, P73; Schopler E., 1988, CHILDHOOD AUTISM RAT; Shen C, 2011, J MOL NEUROSCI, V43, P443, DOI 10.1007/s12031-010-9463-5; Shimokawa I., 2004, GERIATRIC GERONTOL I, V4, pS149, DOI [10.1111/j.1447-0594.2004.00183.x, DOI 10.1111/J.1447-0594.2004.00183.X]; Thoh M, 2010, J BIOL CHEM, V285, P5888, DOI 10.1074/jbc.M109.065847; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; VOLKMAR FR, 2009, COMPREHENSIVE TXB PS, V2, P3540; Zimmerman AW, 2005, PEDIATR NEUROL, V33, P195, DOI 10.1016/j.pediatrneurol.2005.03.014	34	53	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19488	10.1371/journal.pone.0019488	http://dx.doi.org/10.1371/journal.pone.0019488			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573053	gold, Green Published, Green Submitted			2022-12-27	WOS:000290386800015
J	Fu, SF; Zhang, JH; Menniti-Ippolito, F; Gao, XM; Galeotti, F; Massari, M; Hu, LM; Zhang, BL; Ferrelli, R; Fauci, A; Firenzuoli, F; Shang, HC; Guerra, R; Raschetti, R				Fu, Shufei; Zhang, Junhua; Menniti-Ippolito, Francesca; Gao, Xiumei; Galeotti, Francesca; Massari, Marco; Hu, Limin; Zhang, Boli; Ferrelli, Rita; Fauci, Alice; Firenzuoli, Fabio; Shang, Hongcai; Guerra, Ranieri; Raschetti, Roberto			Huangqi Injection (a Traditional Chinese Patent Medicine) for Chronic Heart Failure: A Systematic Review	PLOS ONE			English	Article							DIAGNOSIS; UPDATE	Background: Chronic heart failure (CHF) is a global public health problem. Therefore, novel and effective drugs that show few side-effects are needed. Early literature studies indicated that Huangqi injection is one of the most commonly used traditional Chinese patent medicines for CHF in China. As a large number of clinical studies has been carried out and published, it is essential to evaluate the effectiveness and safety of Huangqi injection. Therefore, we carried out this systematic review under the support of the framework of the Joint Sino-Italian Laboratory (JoSIL). Objectives: To evaluate the efficacy and safety of Huangqi injection for CHF according to the available scientific knowledge. Methods: An extensive search including PubMed, EMBASE, CBM, the Cochrane Library and Chinese literature databases was performed up to July 2008. Clinical trials regarding Huangqi injection for the treatment of CHF were searched for, irrespective of languages. The quality of each trial was assessed according to the Cochrane Reviewers' Handbook 5.0, and RevMan 5.0 provided by the Cochrane Collaboration and STATA 9.2 were used for data analysis. Results: After selection of 1,205 articles, 62 RCTs and quasi-RCTs conducted in China and published in Chinese journals were included in the review. The methodological quality of the trials was low. In most trials inclusion and exclusion criteria were not specified. Furthermore, only one study evaluated the outcomes for drug efficacy after an adequate period of time. For these reasons and because of the different baseline characteristics we did not conduct a meta-analysis. Conclusions: Although available studies are not adequate to draw a conclusion on the efficacy and safety of Huangqi injection (a traditional Chinese patent medicine), we hope that our work could provide useful experience on further studies on Huangqi injections. The overall level of TCM clinical research needs to be improved so that the efficacy of TCM can be evaluated by the international community and possibly some TCM can enter into the international market.	[Fu, Shufei; Zhang, Junhua; Gao, Xiumei; Hu, Limin; Shang, Hongcai] Tianjin Univ Tradit Chinese Med, Inst Tradit Chinese Med, Evidence Based Med Ctr, Tianjin, Peoples R China; [Fu, Shufei; Zhang, Junhua; Gao, Xiumei; Hu, Limin; Shang, Hongcai] Tianjin Univ Tradit Chinese Med, Tianjin State Key Lab Modern Chinese Med, Tianjin, Peoples R China; [Menniti-Ippolito, Francesca; Galeotti, Francesca; Massari, Marco; Raschetti, Roberto] Natl Inst Hlth, Natl Ctr Epidemiol Surveillance & Hlth Promot, Rome, Italy; [Zhang, Boli; Ferrelli, Rita; Fauci, Alice; Guerra, Ranieri] Natl Inst Hlth, External Relat Off, Rome, Italy; [Firenzuoli, Fabio] San Giuseppe Hosp, Ctr Nat Med, Empoli, Italy	Tianjin University of Traditional Chinese Medicine; Tianjin University of Traditional Chinese Medicine; Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	Fu, SF (corresponding author), Tianjin Univ Tradit Chinese Med, Inst Tradit Chinese Med, Evidence Based Med Ctr, Tianjin, Peoples R China.	francesca.menniti@iss.it; gaoxiumei@tjutcm.edu.cn	Ferrelli, Rita Maria/A-7072-2015; shang, hongcai/H-1257-2014; Firenzuoli, Fabio/ABG-9563-2021; Fauci, Alice Josephine/F-4394-2015	Ferrelli, Rita Maria/0000-0002-6665-5697; zhang, Junhua/0000-0003-4043-1967; Fauci, Alice Josephine/0000-0002-7699-4633	Science and Technology Ministry [2008DFB30070]; International Science and Technology Supportive Project of China [2009ZX09311-002]; Italian Ministry of Health [6 C I 2]	Science and Technology Ministry; International Science and Technology Supportive Project of China; Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by the International Cooperative Project of Science and Technology Ministry (2008DFB30070); International Science and Technology Supportive Project of China (2009ZX09311-002); Italian Ministry of Health, finalized research ex art. 12 d.lgs 229/99 (6 C I 2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, LANCET, V369, P880; [Anonymous], HEART ASIA, V2, P24; Bai R, 1999, J SHANXI MED COLL CO, V9, P39; Bao X, 1999, PHARM CLIN CHINESE M, V15, P39; Bu Q, 2005, CHINESE J INTEGRATIV, V3, P1006; Cai Q, 2005, SHANXI MED J, V34, P860; Cho WCS, 2007, CANCER LETT, V252, P43, DOI 10.1016/j.canlet.2006.12.001; Chu G, 2000, HUBEI J TRADITIONAL, V22, P29; Denzler KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012561; Durst R, 2011, CARDIOVASC THER, V29, P17, DOI 10.1111/j.1755-5922.2010.00233.x; Ernst E, 2008, J POSTGRAD MED, V54, P214, DOI 10.4103/0022-3859.41806; Fan L, 2004, J PRACTICAL TRADITIO, V20, P501; Fang Z, 2003, CENTRAL PLAINS MED J, V30, P6; Fu SF, 2010, HEART ASIA, V2, P24, DOI 10.1136/ha.2009.001123; Fu T, 2006, CHIN SCI TECHN ACH D; Fu X, 2000, J CHINESE PRACTICAL, V2, P72; Gao J, 2005, ACAD J GUANGDONG COL, V21, P610; Gao Z, 1999, HEBEI MED, V5, P7; Gu D. F., 2003, CHIN J CARDIO, V31, P3, DOI DOI 10.3760/J:ISSN:0253-3758.2003.01.002; Gu X, 2003, HER MED, V22, P556; Guo H., 2006, CENT PLAINS MED J, V33, P85, DOI [10.3760/cma.j.issn.1674-4756.2006.02.070, DOI 10.3760/CMA.J.ISSN.1674-4756.2006.02.070]; Guo H, 2005, PRACTICAL CLIN J INT, V5, P22; Higgins J., 2009, COCHRANE HDB SYSTEMA; Hu J, 2001, CHIN J CLIN PHARM TH, V6, P78; Hu S., 2008, MED INNOVATION RES, V5, P102; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Jiao X, 2006, J SHANXI COLL TRADIT, V29, P19; Jin ZC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010822; Jining Medical College Hospital, 2007, CHIN SCI TECHN ACH D; Kroon PA, 2010, CURR MED CHEM, V17, P2442; Li C, 2002, J MED THEOR PRAC, V15, P1277; Li H, 2006, SICHUAN J PHYSL SCI, V28, P81; Li JianHui, 2007, China Tropical Medicine, V7, P1343; Li MX, 2011, J ETHNOPHARMACOL, V133, P412, DOI 10.1016/j.jep.2010.10.012; Li S, 1997, J ANHUI TCM COLL, V16, P19; Li S, 2003, CHINESE J PRACTICAL, V3, P1665; Li W, 2002, 7 NAT CHIN W MED AC, P35; Liu A, 2005, ZHEJIANG JLTCWM, V15, P32; Liu C, 2004, J LIAONING COLL TCM, V6, P390; Liu Y, 2005, J PRACTICAL TRADITIO, V21, P198; Liu Y, 2005, J XINXIANG MED COLL, V22, P244; Liu Y, 2001, TIANJIN J TRADITIONA, V18, P8; Liu Z, 2006, J CHINESE MODERN MED, V3, P5; Lu Q, 2000, MODERN J INTEGRATED, V9, P61; Lu Z, 2006, PUBLIC MED FORUM MAG, V10, P1; Luo Q, 2004, HEILONGJIANG J TRADI, V3, P8; Luo X, 2003, J EMERG SYNDROMES TR, V12, P35; Lv J, 2008, J PRACTICAL TRADITIO, V24, P164; Ma A, 2007, CHIN J CARDIOL, V35, P1076; Ma L, 2005, HENAN TRADITIONAL CH, V25, P78; Ma Z, 2001, SHANXI J TRADITIONAL, V22, P579; Pang M, 2000, CHINA PHARM, V9, P44; Pittler MH, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005312.pub2; Qin L, 2000, J SHAANXI COLL TRADI, V23, P46; Ramani GV, 2010, MAYO CLIN PROC, V85, P180, DOI 10.4065/mcp.2009.0494; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; *STATACORP, 2003, STAT STAT SOFTW REL; Su X, 2002, J HEZE MED COLL, V14, P21; Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204; Tang JL, 2008, LANCET, V372, P1938, DOI 10.1016/S0140-6736(08)61354-9; The Cochrane Collaboration, 2008, REV MAN REVMAN COMP; The European Agency for the Evaluation of Medicinal Products Human Medicines Evaluation Unit, 1999, NOTE GUIDANCE CLIN I; Tian L, 1997, SHANGHAI MED PHARM J, V11, P16; Tian L, 2005, MODERN J INTEGRATED, V14, P610; Wang H, 2005, J EMERGENCY TRADITIO, V14, P1070; Wang L, 2000, CHONGQING MED J, V29, P71; Wang S, 2002, CHINESE J INTEGRATED, V9, P230; Wang X. N., 2003, HUNAN GUIDING J TCM, V9, P15, DOI [10.3969/j.issn.1672-951X.2003.05.011, DOI 10.3969/J.ISSN.1672-951X.2003.05.011]; Wei Y, 2006, CHINESE J CLIN REHAB, V10, P54; Wongcharoen W, 2009, INT J CARDIOL, V133, P145, DOI 10.1016/j.ijcard.2009.01.073; Wu C, 2001, GUILIN MED, V3, P19; Wu L, 2004, XINJIANG MED J, V34, P107; Wu TX, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-46; Xi Z, 2005, MODERN MED HLTH, V21, P2337; Xu L, 2008, CONTEMP CLIN TRIALS, V29, P727, DOI 10.1016/j.cct.2008.05.003; Yang H, 2005, CHINESE HLTH CARE, V13, P9; Yang J, 2000, MODERN J INTEGRATED, V9, P1131; Yang L, 1996, SHANGHAI MED PHARM J, V2, P17; Yang Y, 2007, WORLD HLTH DIGEST, V4, P31; Yang Z, 1998, TRADITIONAL CHINESE, V9, P80; Yin J, 2002, HEBEI J TCM, V24, P308; Zeng J, 2005, ACADEMIC P NATL EMER, P156; Zhai L, 1995, SHANGHAI MED PHARM J, V11, P11; Zhang D, 2002, MODERN J INTEGRATED, V11, P408; Zhang J, 2005, CHINESE ARCH TRADITI, V23, P2096; Zhang J, 2003, PRACTICAL GERIATRICS, V17, P192; Zhang L, 2000, TIBETAN MED J, V21, P14; Zhao Z, 1998, PRACTICAL J INTEGRAT, V11, P26; Zhenbao Island Pharmaceutical Co. Ltd. in Heilongjiang Province, 2007, CHIN SCI TECHN ACH D; Zhou Z, 2002, HUBEI J TRADITIONAL, V24, P11	90	51	59	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19604	10.1371/journal.pone.0019604	http://dx.doi.org/10.1371/journal.pone.0019604			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573109	Green Submitted, Green Published, gold			2022-12-27	WOS:000290305600034
J	Ivers, LC; Jerome, JG; Cullen, KA; Lambert, W; Celletti, F; Samb, B				Ivers, Louise C.; Jerome, Jean-Gregory; Cullen, Kimberly A.; Lambert, Wesler; Celletti, Francesca; Samb, Badara			Task-Shifting in HIV Care: A Case Study of Nurse-Centered Community-Based Care in Rural Haiti	PLOS ONE			English	Article							HEALTH-WORKERS; ANTIRETROVIRAL THERAPY; HUMAN-RESOURCES; PROGRAM	Introduction: At least 36 countries are suffering from severe shortages of healthcare workers and this crisis of human resources in developing countries is a major obstacle to scale-up of HIV care. We performed a case study to evaluate a health service delivery model where a task-shifting approach to HIV care had been undertaken with tasks shifted from doctors to nurses and community health workers in rural Haiti. Methods: Data were collected using mixed quantitative and qualitative methods at three clinics in rural Haiti. Distribution of tasks for HIV services delivery; types of tasks performed by different cadres of healthcare workers; HIV program outcomes; access to HIV care and acceptability of the model to staff were measured. Results: A shift of tasks occurred from doctors to nurses and to community health workers compared to a traditional doctor-based model of care. Nurses performed most HIV-related tasks except initiation of TB therapy for smear-negative suspects with HIV. Community health workers were involved in over half of HIV-related tasks. HIV services were rapidly scaled-up in the areas served; loss to follow-up of patients living with HIV was less than 5% at 24 months and staff were satisfied with the model of care. Conclusion: Task-shifting using a community-based, nurse-centered model of HIV care in rural Haiti is an effective model for scale-up of HIV services with good clinical and program outcomes. Community health workers can provide essential health services that are otherwise unavailable particularly in rural, poor areas.	[Ivers, Louise C.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Ivers, Louise C.] Harvard Univ, Sch Med, Ctr AIDS Res, Boston, MA USA; [Ivers, Louise C.; Cullen, Kimberly A.] Partners Hlth, Boston, MA USA; [Jerome, Jean-Gregory; Lambert, Wesler] Zanmi Lasante, Cange, Haiti; [Celletti, Francesca; Samb, Badara] WHO, CH-1211 Geneva, Switzerland	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Partners Healthcare System; World Health Organization	Ivers, LC (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	livers@pih.org	Ivers, Louise C/Q-4164-2018	Ivers, Louise C/0000-0003-2314-9230	U.S. Office of Global AIDS; World Health Organization; Joint United Nations Programme on AIDS; Presidents Emergency Fund for AIDS Relief; Direzione Generale Cooperazione allo Sviluppo; Ministry of Foreign Affairs of the Republic of Italy; National Institute of Allergy and Infectious Disease [K23 AI063998]; Harvard Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI063998] Funding Source: NIH RePORTER	U.S. Office of Global AIDS; World Health Organization(World Health Organization); Joint United Nations Programme on AIDS; Presidents Emergency Fund for AIDS Relief; Direzione Generale Cooperazione allo Sviluppo; Ministry of Foreign Affairs of the Republic of Italy; National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Harvard Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The WHO commissioned study on Task Shifting was funded by the U.S. Office of Global AIDS Coordinator, The World Health Organization, Joint United Nations Programme on AIDS, the Presidents Emergency Fund for AIDS Relief, Direzione Generale Cooperazione allo Sviluppo, Ministry of Foreign Affairs of the Republic of Italy. This work was also supported in part by the National Institute of Allergy and Infectious Disease (K23 AI063998 to LCI) and by the Harvard Center for AIDS Research. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JEL, 1994, J NUTR, V124, pS1828, DOI 10.1093/jn/124.suppl_9.1828S; Bang Abhay T, 2005, J Perinatol, V25 Suppl 1, pS92, DOI 10.1038/sj.jp.7211277; Barry MJ, 2001, NEW ENGL J MED, V344, P1373, DOI 10.1056/NEJM200105033441806; Behforouz HL, 2004, CLIN INFECT DIS, V38, pS429, DOI 10.1086/421408; BERMAN PA, 1987, SOC SCI MED, V25, P443, DOI 10.1016/0277-9536(87)90168-7; Bhattacharyya K, 2001, COMMUNITY HLTH WORKE; Bolton-Moore C, 2007, JAMA-J AM MED ASSOC, V298, P1888, DOI 10.1001/jama.298.16.1888; Brownstein JN, 2005, AM J PREV MED, V29, P128, DOI 10.1016/j.amepre.2005.07.024; Bryce J, 2003, LANCET, V362, P159, DOI 10.1016/S0140-6736(03)13870-6; Conille G, 2007, ADDRESSING URGENT HU; Daly J, 2007, J CLIN EPIDEMIOL, V60, P43, DOI 10.1016/j.jclinepi.2006.03.014; Delacollette C, 1996, B WORLD HEALTH ORGAN, V74, P423; Doherty TM, 2005, PUBLIC HEALTH NURS, V22, P360, DOI 10.1111/j.0737-1209.2005.220413.x; Farmer P, 2001, LANCET, V358, P404, DOI 10.1016/S0140-6736(01)05550-7; Fedder DO, 2003, ETHNIC DIS, V13, P22; GILSON L, 1989, Journal of Public Health Policy, V10, P518, DOI 10.2307/3342522; GREENWOOD AM, 1990, J TROP MED HYG, V93, P58; Hongoro C, 2004, LANCET, V364, P1451, DOI 10.1016/S0140-6736(04)17229-2; Ivers LC, 2010, AIDS, V24, pS73, DOI 10.1097/01.aids.0000366085.14064.6f; Jerome G, 2010, AIDS, V24, pS67, DOI 10.1097/01.aids.0000366084.75945.c9; Kironde S, 2002, INT J TUBERC LUNG D, V6, P104; Mavalankar DV, 2005, AM J PUBLIC HEALTH, V95, P200, DOI 10.2105/AJPH.2003.036715; MINISTERE DE LA SANTE PUBLIQUE ET DE LA POPULATION, 2005, PLAN STRAT NAT REF S; Mukherjee J, 2004, LANCET, V363, P1071, DOI 10.1016/S0140-6736(04)15846-7; Mukherjee JS, 2007, AIDS CARE, V19, pS73, DOI 10.1080/09540120601114485; Mukherjee JS, 2008, 17 INT AIDS 3 8 AUG; Mullan F, 2007, LANCET, V370, P2158, DOI 10.1016/S0140-6736(07)60785-5; Pereira C, 1996, BRIT J OBSTET GYNAEC, V103, P508, DOI 10.1111/j.1471-0528.1996.tb09797.x; Richardson G, 1998, HEALTH POLICY, V45, P119, DOI 10.1016/S0168-8510(98)00038-4; Samb B, 2007, NEW ENGL J MED, V357, P2510, DOI 10.1056/NEJMsb071889; Schneider H, 2006, REPROD HEALTH MATTER, V14, P12, DOI 10.1016/S0968-8080(06)27232-X; Severe P, 2005, NEW ENGL J MED, V353, P2325, DOI 10.1056/NEJMoa051908; Shumbusho F, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000163; Strauss A., 1998, BASICS QUALITATIVE R; Tuturu, 2020, COMM CONS HLTH ED; Victora CG, 2004, LANCET, V364, P1541, DOI 10.1016/S0140-6736(04)17279-6; World Health Organization, 2004, SCAL HIV AIDS CAR SE, P1	38	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19276	10.1371/journal.pone.0019276	http://dx.doi.org/10.1371/journal.pone.0019276			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	760DZ	21573152	Green Published, Green Submitted, gold			2022-12-27	WOS:000290305600018
J	Qian, HF; Lu, T; Peng, XF; Han, X; Fu, ZW; Liu, WP				Qian, HaiFeng; Lu, Tao; Peng, XiaoFeng; Han, Xiao; Fu, ZhengWei; Liu, WeiPing			Enantioselective Phytotoxicity of the Herbicide Imazethapyr on the Response of the Antioxidant System and Starch Metabolism in Arabidopsis thaliana	PLOS ONE			English	Article							OXIDATIVE STRESS; HYPERSENSITIVE RESPONSE; PROLINE ACCUMULATION; GENE-EXPRESSION; IMIDAZOLINONE; SULFONYLUREA; PHOSPHATASE; ACCLIMATION; MECHANISMS; SEPARATION	Background: The enantiomers of a chiral compound possess different biological activities, and one of the enantiomers usually shows a higher level of toxicity. Therefore, the exploration of the causative mechanism of enantioselective toxicity is regarded as one of primary goals of biological chemistry. Imazethapyr (IM) is an acetolactate synthase (ALS)-inhibiting chiral herbicide that has been widely used in recent years with racemate. We investigated the enantioselectivity between R- and S-IM to form reactive oxygen species (ROS) and to regulate antioxidant gene transcription and enzyme activity. Results: Dramatic differences between the enantiomers were observed: the enantiomer of R-IM powerfully induced ROS formation, yet drastically reduced antioxidant gene transcription and enzyme activity, which led to an oxidative stress. The mechanism by which IM affects carbohydrate metabolism in chloroplasts has long remained a mystery. Here we report evidence that enantioselectivity also exists in starch metabolism. The enantiomer of R-IM resulted in the accumulation of glucose, maltose and sucrose in the cytoplasm or the chloroplast and disturbed carbohydrates utilization. Conclusion: The study suggests that R-IM more strongly retarded plant growth than S-IM not only by acting on ALS, but also by causing an imbalance in the antioxidant system and the disturbance of carbohydrate metabolism with enantioselective manner.	[Qian, HaiFeng; Lu, Tao; Peng, XiaoFeng; Han, Xiao; Fu, ZhengWei; Liu, WeiPing] Zhejiang Univ Technol, Coll Biol & Environm Engn, Hangzhou, Zhejiang, Peoples R China	Zhejiang University of Technology	Qian, HF (corresponding author), Zhejiang Univ Technol, Coll Biol & Environm Engn, Hangzhou, Zhejiang, Peoples R China.	azwfu2003@yahoo.com.cn; wliu@zjut.edu.cn	Qian, Haifeng/A-7791-2012; Lu, Tao/Y-3535-2018; Fu, Zhengwei/G-3162-2011; Liu, Weiping/E-9208-2010; qian, haifeng/H-4828-2012	Qian, Haifeng/0000-0003-0807-9991; Lu, Tao/0000-0002-2030-3813; Fu, Zhengwei/0000-0003-3351-3075; Liu, Weiping/0000-0002-1173-892X; 	National Basic Research Program of China [2010CB126100]; Natural Science Foundation of China [21077093]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Basic Research Program of China (No. 2010CB126100) and the Natural Science Foundation of China (21077093). These funders provided financial support to the experiments and research related to this report. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, FREE RADICALS BIOL M; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Battaglin WA, 2000, SCI TOTAL ENVIRON, V248, P123, DOI 10.1016/S0048-9697(99)00536-7; Chia T, 2004, PLANT J, V37, P853, DOI 10.1111/j.1365-313X.2003.02012.x; Comparot-Moss S, 2010, PLANT PHYSIOL, V152, P685, DOI 10.1104/pp.109.148981; Dat JF, 1998, PLANT PHYSIOL, V116, P1351, DOI 10.1104/pp.116.4.1351; Doncheva S, 2005, J EXP BOT, V56, P1213, DOI 10.1093/jxb/eri115; Duggleby RG, 2000, J BIOCHEM MOL BIOL, V33, P1; Falconer RL, 1997, J AGR FOOD CHEM, V45, P1946, DOI 10.1021/jf960881m; Forde BG, 2007, J EXP BOT, V58, P2339, DOI 10.1093/jxb/erm121; Foyer CH, 1997, PHYSIOL PLANTARUM, V100, P241, DOI 10.1034/j.1399-3054.1997.1000205.x; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Gaston S, 2002, PHYSIOL PLANTARUM, V114, P524, DOI 10.1034/j.1399-3054.2002.1140404.x; Geoffroy L, 2004, ENVIRON POLLUT, V131, P233, DOI 10.1016/j.envpol.2004.02.021; Halliwell B, 2006, PLANT PHYSIOL, V141, P312, DOI 10.1104/pp.106.077073; Hare PD, 1997, PLANT GROWTH REGUL, V21, P79, DOI 10.1023/A:1005703923347; Hoekstra PF, 2006, CHEMOSPHERE, V64, P174, DOI 10.1016/j.chemosphere.2005.10.043; Inze D, 2000, OXIDATIVE STRESS PLA, P105; Jin YX, 2009, CHEMOSPHERE, V74, P1238, DOI 10.1016/j.chemosphere.2008.11.015; Kang JM, 2003, P NATL ACAD SCI USA, V100, P6872, DOI 10.1073/pnas.1030961100; Karpinski S, 1999, SCIENCE, V284, P654, DOI 10.1126/science.284.5414.654; Kurt-Karakus PB, 2005, ENVIRON SCI TECHNOL, V39, P8671, DOI 10.1021/es051004c; Laplante J, 2009, THEOR APPL GENET, V119, P577, DOI 10.1007/s00122-009-1067-5; Li YZ, 2010, ENVIRON EXP BOT, V69, P158, DOI 10.1016/j.envexpbot.2010.03.009; Lin KD, 2007, CHIRALITY, V19, P171, DOI 10.1002/chir.20359; Liu YD, 2007, PLANT J, V51, P941, DOI 10.1111/j.1365-313X.2007.03191.x; Lu Y, 2005, PLANT PHYSIOL, V138, P2280, DOI 10.1104/pp.105.061903; Mackerness SAH, 1999, PLANT CELL ENVIRON, V22, P1413, DOI 10.1046/j.1365-3040.1999.00499.x; McCourt JA, 2006, P NATL ACAD SCI USA, V103, P569, DOI 10.1073/pnas.0508701103; Milla MAR, 2003, PLANT J, V36, P602, DOI 10.1046/j.1365-313X.2003.01901.x; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Miura E, 2010, J EXP BOT, V61, P2433, DOI 10.1093/jxb/erq075; Miyashita M, 2004, CHEMOSPHERE, V54, P1273, DOI 10.1016/j.chemosphere.2003.10.035; Myouga F, 2008, PLANT CELL, V20, P3148, DOI 10.1105/tpc.108.061341; Nozue K, 2006, PLANT CELL ENVIRON, V29, P396, DOI 10.1111/j.1365-3040.2005.01489.x; Pang SS, 2003, J BIOL CHEM, V278, P7639, DOI 10.1074/jbc.M211648200; Parre E, 2007, PLANT PHYSIOL, V144, P503, DOI 10.1104/pp.106.095281; PRASAD TK, 1994, PLANT CELL, V6, P65, DOI 10.1105/tpc.6.1.65; Qian HF, 2008, AQUAT TOXICOL, V88, P301, DOI 10.1016/j.aquatox.2008.05.009; Qian HF, 2008, ENVIRON TOXICOL CHEM, V27, P182, DOI 10.1897/07-163.1; Qian HF, 2009, CHEMOSPHERE, V76, P885, DOI 10.1016/j.chemosphere.2009.05.009; Qian HF, 2009, ECOTOXICOLOGY, V18, P537, DOI 10.1007/s10646-009-0311-8; Ramel F, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-28; Rao MV, 1999, PLANT J, V17, P603, DOI 10.1046/j.1365-313X.1999.00400.x; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Royuela M, 2000, J PLANT PHYSIOL, V157, P345, DOI 10.1016/S0176-1617(00)80057-7; Rubio MC, 2009, NEW PHYTOL, V181, P851, DOI 10.1111/j.1469-8137.2008.02718.x; Scarponi L, 1996, J AGR FOOD CHEM, V44, P1572, DOI 10.1021/jf950512a; Smith AM, 2006, NAT PROTOC, V1, P1342, DOI 10.1038/nprot.2006.232; Smith AM, 2007, PLANT CELL ENVIRON, V30, P1126, DOI 10.1111/j.1365-3040.2007.01708.x; Sokolov LN, 2006, P NATL ACAD SCI USA, V103, P9732, DOI 10.1073/pnas.0603329103; Stettler M, 2009, MOL PLANT, V2, P1233, DOI 10.1093/mp/ssp093; [孙云 Sun Yun], 2008, [热带作物学报, Chinese Journal of Tropical Crops], V29, P562; TAKAHASHI M, 1988, ARCH BIOCHEM BIOPHYS, V267, P714, DOI 10.1016/0003-9861(88)90080-X; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; To JPC, 2003, PHYSIOL PLANTARUM, V118, P456, DOI 10.1034/j.1399-3054.2003.00127.x; Wang LM, 2009, J ENVIRON SCI HEAL B, V44, P38, DOI 10.1080/03601230802519611; Xu C., 2008, CHEM RES TOXICOL, V47, P4236; Zeeman SC, 2007, FUNCT PLANT BIOL, V34, P465, DOI 10.1071/FP06313; Zeeman SC, 1999, PLANT CELL ENVIRON, V22, P1445, DOI 10.1046/j.1365-3040.1999.00503.x; Zhou QY, 2010, J AGR FOOD CHEM, V58, P4202, DOI 10.1021/jf9038953; Zhou QY, 2009, J AGR FOOD CHEM, V57, P1624, DOI 10.1021/jf803673e; Zhou Y, 2009, CHIRALITY, V21, P421, DOI 10.1002/chir.20607	64	51	55	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19451	10.1371/journal.pone.0019451	http://dx.doi.org/10.1371/journal.pone.0019451			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573119	Green Published, gold, Green Submitted			2022-12-27	WOS:000290305600025
J	Dhar, M; Wiersema, JR; Pourtois, G				Dhar, Monica; Wiersema, Jan Roelf; Pourtois, Gilles			Cascade of Neural Events Leading from Error Commission to Subsequent Awareness Revealed Using EEG Source Imaging	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; MEDIAL FRONTAL-CORTEX; HUMAN ORBITOFRONTAL CORTEX; PREFRONTAL CORTEX; FUNCTIONAL-SIGNIFICANCE; BRAIN POTENTIALS; ANTISACCADE TASK; SOCIAL-BEHAVIOR; RESPONSE ERRORS; CORRECT TRIALS	The goal of the present study was to shed light on the respective contributions of three important action monitoring brain regions (i.e. cingulate cortex, insula, and orbitofrontal cortex) during the conscious detection of response errors. To this end, fourteen healthy adults performed a speeded Go/Nogo task comprising Nogo trials of varying levels of difficulty, designed to elicit aware and unaware errors. Error awareness was indicated by participants with a second key press after the target key press. Meanwhile, electromyogram (EMG) from the response hand was recorded in addition to high-density scalp electroencephalogram (EEG). In the EMG-locked grand averages, aware errors clearly elicited an error-related negativity (ERN) reflecting error detection, and a later error positivity (Pe) reflecting conscious error awareness. However, no Pe was recorded after unaware errors or hits. These results are in line with previous studies suggesting that error awareness is associated with generation of the Pe. Source localisation results confirmed that the posterior cingulate motor area was the main generator of the ERN. However, inverse solution results also point to the involvement of the left posterior insula during the time interval of the Pe, and hence error awareness. Moreover, consecutive to this insular activity, the right orbitofrontal cortex (OFC) was activated in response to aware and unaware errors but not in response to hits, consistent with the implication of this area in the evaluation of the value of an error. These results reveal a precise sequence of activations in these three non-overlapping brain regions following error commission, enabling a progressive differentiation between aware and unaware errors as a function of time elapsed, thanks to the involvement first of interoceptive or proprioceptive processes (left insula), later leading to the detection of a breach in the prepotent response mode (right OFC).	[Dhar, Monica; Wiersema, Jan Roelf; Pourtois, Gilles] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium	Ghent University	Dhar, M (corresponding author), Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium.	monica.dhar@ugent.be		Dhar, Monica/0000-0003-2998-2872; Pourtois, Gilles/0000-0002-5109-2801	European Research Council [200758]; Ghent University [05Z01708]	European Research Council(European Research Council (ERC)European Commission); Ghent University(Ghent University)	This work is supported by grants from the European Research Council (Starting Grant #200758) and Ghent University (BOF Grant #05Z01708). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts K, 2010, COGN AFFECT BEHAV NE, V10, P479, DOI 10.3758/CABN.10.4.479; Barbas H, 2000, BRAIN RES BULL, V52, P319, DOI 10.1016/S0361-9230(99)00245-2; BEALE JM, 1995, COGNITION, V57, P217, DOI 10.1016/0010-0277(95)00669-X; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Beer JS, 2006, J COGNITIVE NEUROSCI, V18, P871, DOI 10.1162/jocn.2006.18.6.871; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Chassagnon S, 2008, J NEUROSURG, V109, P593, DOI 10.3171/JNS/2008/109/10/0593; Coles MGH, 2001, BIOL PSYCHOL, V56, P173, DOI 10.1016/S0301-0511(01)00076-X; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; Danielmeier C, 2011, J NEUROSCI, V31, P1780, DOI 10.1523/JNEUROSCI.4299-10.2011; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Dhar M, 2011, NEUROPSYCHOLOGIA, V49, P1236, DOI 10.1016/j.neuropsychologia.2011.01.006; DUM RP, 1991, J NEUROSCI, V11, P667; Ekman P., 1976, PICTURES FACIAL AFFE; Endrass T, 2007, EUR J NEUROSCI, V26, P1714, DOI 10.1111/j.1460-9568.2007.05785.x; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hajcak G, 2004, BRAIN COGNITION, V56, P189, DOI 10.1016/j.bandc.2003.11.001; Herrmann MJ, 2004, COGNITIVE BRAIN RES, V20, P294, DOI 10.1016/j.cogbrainres.2004.02.013; Hester R, 2009, NEUROPSYCHOPHARMACOL, V34, P2450, DOI 10.1038/npp.2009.67; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Jung J, 2010, HUM BRAIN MAPP, V31, P1217, DOI 10.1002/hbm.20930; Klein TA, 2007, NEUROIMAGE, V34, P1774, DOI 10.1016/j.neuroimage.2006.11.014; Koban L, 2010, SOC NEUROSCI-UK, V5, P360, DOI 10.1080/17470911003651547; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Luu P, 2000, J NEUROSCI, V20, P464, DOI 10.1523/JNEUROSCI.20-01-00464.2000; Maier M, 2008, J COGNITIVE NEUROSCI, V20, P2263, DOI 10.1162/jocn.2008.20159; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; MESULAM MM, 1982, J COMP NEUROL, V212, P1, DOI 10.1002/cne.902120102; Miltner WHR, 2003, BIOL PSYCHOL, V64, P157, DOI 10.1016/S0301-0511(03)00107-8; Modirrousta M, 2008, J NEUROSCI, V28, P14000, DOI 10.1523/JNEUROSCI.4450-08.2008; Nieuwenhuis S, 2004, NEUROSCI BIOBEHAV R, V28, P441, DOI 10.1016/j.neubiorev.2004.05.003; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; Nobre AC, 1999, NAT NEUROSCI, V2, P11, DOI 10.1038/4513; O'Connell RG, 2007, EUR J NEUROSCI, V25, P2571, DOI 10.1111/j.1460-9568.2007.05477.x; Pailing PE, 2004, BRAIN COGNITION, V56, P215, DOI 10.1016/j.bandc.2004.06.005; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pourtois G, 2010, NEUROPSYCHOLOGIA, V48, P1144, DOI 10.1016/j.neuropsychologia.2009.12.020; Redgrave P, 2008, BRAIN RES REV, V58, P322, DOI 10.1016/j.brainresrev.2007.10.007; Ridderinkhof KR, 2009, PSYCHOPHYSIOLOGY, V46, P531, DOI 10.1111/j.1469-8986.2009.00790.x; Rushworth MFS, 2007, TRENDS COGN SCI, V11, P168, DOI 10.1016/j.tics.2007.01.004; Scheffers MK, 2000, J EXP PSYCHOL HUMAN, V26, P141, DOI 10.1037/0096-1523.26.1.141; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sekihara K, 2005, NEUROIMAGE, V25, P1056, DOI 10.1016/j.neuroimage.2004.11.051; Shalgi S, 2009, EUR J NEUROSCI, V29, P1522, DOI 10.1111/j.1460-9568.2009.06690.x; SILVA LR, 1991, SCIENCE, V251, P432, DOI 10.1126/science.1824881; Singer T, 2009, TRENDS COGN SCI, V13, P334, DOI 10.1016/j.tics.2009.05.001; Steinhauser M, 2010, J NEUROSCI, V30, P15643, DOI 10.1523/JNEUROSCI.1899-10.2010; Talairach J., 1988, COPLANAR STEREOTAXIC; Ullsperger M, 2010, BRAIN STRUCT FUNCT, V214, P629, DOI 10.1007/s00429-010-0261-1; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; van Veen V, 2001, NEUROIMAGE, V14, P1302, DOI 10.1006/nimg.2001.0923; Vidal F, 2003, BIOL PSYCHOL, V64, P265, DOI 10.1016/S0301-0511(03)00097-8; Vocat R, 2008, NEUROPSYCHOLOGIA, V46, P2545, DOI 10.1016/j.neuropsychologia.2008.04.006; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI 10.1037/0033-295x.111.4.931	68	48	49	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19578	10.1371/journal.pone.0019578	http://dx.doi.org/10.1371/journal.pone.0019578			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573173	Green Published, gold, Green Submitted			2022-12-27	WOS:000290256400027
J	Wald, NJ; Simmonds, M; Morris, JK				Wald, Nicholas J.; Simmonds, Mark; Morris, Joan K.			Screening for Future Cardiovascular Disease Using Age Alone Compared with Multiple Risk Factors and Age	PLOS ONE			English	Article							BLOOD-PRESSURE; CHOLESTEROL; POPULATION; ACCURACY; SCORE	Background: Risk factors such as blood pressure and serum cholesterol are used, with age, in screening for future cardiovascular disease (CVD) events. The value of using these risk factors with age compared with using age alone is not known. We compared screening for future CVD events using age alone with screening using age and multiple risk factors based on regular Framingham risk assessments. Methods: Ten-year CVD risk was estimated using Framingham risk equations in a hypothetical sample population of 500,000 people aged 0-89 years. Risk estimates were used to identify individuals who did and did not have a CVD event over a ten-year period. For screening using age alone (age screening) and screening using multiple risk factors and age (Framingham screening) we estimated the (i) detection rate (sensitivity); (ii) false-positive rate; (iii) proportion of CVD-free years of life lost in affected individuals with positive results (person-years detection rate); and (iv) cost per CVD-free life year gained from preventive treatment. Results: Age screening using a cut-off of 55 years detected 86% of all first CVD events arising in the population every year and 72% of CVD-free years of life lost for a 24% false-positive rate; for five yearly Framingham screening the false-positive rate was 21% for the same 86% detection rate. The estimated cost per CVD-free year of life gained was 2,000 pound for age screening and 2,200 pound for Framingham screening if a Framingham screen costs 150 pound and the annual cost of preventive treatment is 200 pound. Conclusion: Age screening for future CVD events is simpler than Framingham screening with a similar screening performance and cost-effectiveness. It avoids blood tests and medical examinations. The advantages of age screening in the prevention of heart attack and stroke warrant considering its use in preference to multiple risk factor screening.	[Wald, Nicholas J.; Simmonds, Mark; Morris, Joan K.] Queen Mary Univ London, Barts & London Sch Med & Dent, Wolfson Inst Prevent Med, London, England	University of London; Queen Mary University London	Wald, NJ (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Wolfson Inst Prevent Med, London, England.	n.j.wald@qmul.ac.uk	Wald, Nicholas/AAY-8924-2021; Wald, Nicholas/AAY-2814-2021; Morris, Joan/AAT-9211-2020	Morris, Joan/0000-0002-7164-612X				ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Brindle P, 2006, HEART, V92, P1752, DOI 10.1136/hrt.2006.087932; Brindle P, 2003, BMJ-BRIT MED J, V327, P1267, DOI 10.1136/bmj.327.7426.1267; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; *EUR MED A, 2008, EMEACHMPEWP311890200; Getz L, 2005, BMJ-BRIT MED J, V331, P551, DOI 10.1136/bmj.38555.648623.8F; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Law M, 2003, Health Technol Assess, V7, P1; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; *NAT I CLIN EXC, 2008, NICE CLIN GUID, V67; *OFF NAT STAT, 2007, 2005 MORTALITY STAT; *OFF NAT STAT, 2003, HLTH SURVEY ENGLAND; Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251; Wald NJ, 2005, J MED SCREEN, V12, P197, DOI 10.1258/096914105775220642; WALD NJ, 1994, LANCET, V343, P75, DOI 10.1016/S0140-6736(94)90814-1; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Wald NJ, 1999, BMJ-BRIT MED J, V319, P1562, DOI 10.1136/bmj.319.7224.1562; WALD NJ, 1988, BRIT MED J, V297, P883, DOI 10.1136/bmj.297.6653.883; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988; Yusuf S, 2009, LANCET, V373, P1341, DOI 10.1016/S0140-6736(09)60611-5	26	79	81	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e18742	10.1371/journal.pone.0018742	http://dx.doi.org/10.1371/journal.pone.0018742			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573224	Green Published, gold			2022-12-27	WOS:000290224800006
J	Yoda, K; Murakoshi, M; Tsutsui, K; Kohno, H				Yoda, Ken; Murakoshi, Miku; Tsutsui, Kota; Kohno, Hiroyoshi			Social Interactions of Juvenile Brown Boobies at Sea as Observed with Animal-Borne Video Cameras	PLOS ONE			English	Article							FORAGING ECOLOGY; BEHAVIOR; SEABIRDS; INFORMATION	While social interactions play a crucial role on the development of young individuals, those of highly mobile juvenile birds in inaccessible environments are difficult to observe. In this study, we deployed miniaturised video recorders on juvenile brown boobies Sula leucogaster, which had been hand-fed beginning a few days after hatching, to examine how social interactions between tagged juveniles and other birds affected their flight and foraging behaviour. Juveniles flew longer with congeners, especially with adult birds, than solitarily. In addition, approximately 40% of foraging occurred close to aggregations of congeners and other species. Young seabirds voluntarily followed other birds, which may directly enhance their foraging success and improve foraging and flying skills during their developmental stage, or both.	[Yoda, Ken; Tsutsui, Kota] Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Murakoshi, Miku] Tokai Univ, Grad Sch Marine Sci & Technol, Shizuoka, Japan; [Murakoshi, Miku; Kohno, Hiroyoshi] Tokai Univ, Inst Ocean Res & Dev, Shizuoka, Japan; [Kohno, Hiroyoshi] Tokai Univ, Okinawa Reg Res Ctr, Okinawa, Japan	Nagoya University; Tokai University; Tokai University; Tokai University	Yoda, K (corresponding author), Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	yoda.ken@nagoya-u.jp			ORRC; Iriomote Project; Research Institute for Humanity and Nature; Japan Society for the Promotion of Science [20519002, 18310153]	ORRC; Iriomote Project; Research Institute for Humanity and Nature; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was financially supported by grants from ORRC, the Iriomote Project, Research Institute for Humanity and Nature, and grants from the Japan Society for the Promotion of Science to K.Y. and H.K. (20519002, 18310153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen R. H., 2008, ANAL LINGUISTIC DATA; Ballance L. T., 1999, ACT 22 C INT ORN, P2057; Bates D. M., 2010, LME4 MIXED EFFECTS M; BURGER J, 1983, CONDOR, V85, P467, DOI 10.2307/1367989; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; DUFFY DC, 1983, AUK, V100, P800, DOI 10.1093/auk/100.4.800; Fauchald P, 2009, MAR ECOL PROG SER, V391, P139, DOI 10.3354/meps07818; Galef BG, 2001, ANIM BEHAV, V61, P3, DOI 10.1006/anbe.2000.1557; Gremillet D, 2006, MAR BIOL, V148, P1081, DOI 10.1007/s00227-005-0130-2; KISHIMOTO H, 1989, B I OCEANIC RES DEV, V10, P43; Laland KN, 1997, ANIM BEHAV, V53, P1161, DOI 10.1006/anbe.1996.0318; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Maransky BP, 2001, WILSON BULL, V113, P350, DOI 10.1676/0043-5643(2001)113[0350:FYEARD]2.0.CO;2; Moil RJ, 2007, TRENDS ECOL EVOL, V22, P660, DOI 10.1016/j.tree.2007.09.007; R Core Team, 2018, R LANG ENV STAT COMP; Sato K, 2003, MAR MAMMAL SCI, V19, P384, DOI 10.1111/j.1748-7692.2003.tb01116.x; Surman CA, 2003, J ZOOL, V259, P219, DOI 10.1017/S0952836902003047; Swaney W, 2001, ANIM BEHAV, V62, P591, DOI 10.1006/anbe.2001.1788; Takahashi A, 2004, P ROY SOC B-BIOL SCI, V271, pS281, DOI 10.1098/rsbl.2004.0182; Watanuki Y, 2008, MAR ECOL PROG SER, V356, P283, DOI 10.3354/meps07266; Weimerskirch H, 2009, MAR ECOL PROG SER, V391, P267, DOI 10.3354/meps07981; Yoda K, 2004, P ROY SOC B-BIOL SCI, V271, pS240, DOI 10.1098/rsbl.2003.0157; Yoda K, 2007, DEEP-SEA RES PT II, V54, P321, DOI 10.1016/j.dsr2.2006.11.004	23	29	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19602	10.1371/journal.pone.0019602	http://dx.doi.org/10.1371/journal.pone.0019602			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21573196	Green Submitted, Green Published, gold			2022-12-27	WOS:000290224800037
J	Lindner, HB; Zhang, AG; Eldridge, J; Demcheva, M; Tsichilis, P; Seth, A; Vournakis, J; Muise-Helmericks, RC				Lindner, Haley Buff; Zhang, Aiguo; Eldridge, Juanita; Demcheva, Marina; Tsichilis, Philip; Seth, Arun; Vournakis, John; Muise-Helmericks, Robin C.			Anti-Bacterial Effects of Poly-N-Acetyl-Glucosamine Nanofibers in Cutaneous Wound Healing: Requirement for Akt1	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; HUMAN BETA-DEFENSIN-3; MEDIATED HEMOSTASIS; DEFENSIN-1 PROMOTER; BETA-DEFENSINS; HOST-DEFENSE; IN-VITRO; CELLS; ACTIVATION; MECHANISMS	Background: Treatment of cutaneous wounds with poly-N-acetyl-glucosamine nanofibers (sNAG) results in increased kinetics of wound closure in diabetic animal models, which is due in part to increased expression of several cytokines, growth factors, and innate immune activation. Defensins are also important for wound healing and anti-microbial activities. Therefore, we tested whether sNAG nanofibers induce defensin expression resulting in bacterial clearance. Methodology: The role of sNAG in defensin expression was examined using immunofluoresence microscopy, pharmacological inhibition, and shRNA knockdown in vitro. The ability of sNAG treatment to induce defensin expression and bacterial clearance in WT and AKT1(-/-) mice was carried out using immunofluoresent microscopy and tissue gram staining. Neutralization, using an antibody directed against beta-defensin 3, was utilized to determine if the antimicrobial properties of sNAG are dependent on the induction of defensin expression. Conclusions/Findings: sNAG treatment causes increased expression of both alpha- and beta-type defensins in endothelial cells and beta-type defensins in keratinocytes. Pharmacological inhibition and shRNA knockdown implicates Akt1 in sNAG-dependent defensin expression in vitro, an activity also shown in an in vivo wound healing model. Importantly, sNAG treatment results in increased kinetics of wound closure in wild type animals. sNAG treatment decreases bacterial infection of cutaneous wounds infected with Staphylococcus aureus in wild type control animals but not in similarly treated Akt1 null animals. Furthermore, sNAG treatment of S. aureus infected wounds show an increased expression of beta-defensin 3 which is required for sNAG-dependent bacterial clearance. Our findings suggest that Akt1 is involved in the regulation of defensin expression and the innate immune response important for bacterial clearance. Moreover, these findings support the use of sNAG nanofibers as a novel method for enhancing wound closure while simultaneously decreasing wound infection.	[Lindner, Haley Buff; Eldridge, Juanita; Muise-Helmericks, Robin C.] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Demcheva, Marina; Vournakis, John] Marine Polymer Technol, Danvers, MA USA; [Zhang, Aiguo; Seth, Arun] Univ Toronto, Sunnybrook Res Inst, Toronto, ON, Canada; [Tsichilis, Philip] Tufts Univ, Mol Oncol Res Inst, Medford, MA 02155 USA	Medical University of South Carolina; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Tufts University	Lindner, HB (corresponding author), Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA.	musehelm@musc.edu			Marine Polymer Technologies [R01HL084565-02, 5T32DE017551]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F30DE021612, T32DE017551] Funding Source: NIH RePORTER	Marine Polymer Technologies; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by grants from Marine Polymer Technologies and R01HL084565-02 to RM-H and 5T32DE017551 to HBL (http://syvek.com/). The funders had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Aarbiou J, 2004, AM J RESP CELL MOL, V30, P193, DOI 10.1165/rcmb.2002-0267OC; Carratelli CR, 2009, FEMS IMMUNOL MED MIC, V57, P116, DOI 10.1111/j.1574-695X.2009.00586.x; Fischer TH, 2005, BIOMATERIALS, V26, P5433, DOI 10.1016/j.biomaterials.2005.01.023; Fischer TH, 2007, J BIOMED MATER RES A, V80A, P167, DOI 10.1002/jbm.a.30877; GANZ T, 1987, INFECT IMMUN, V55, P568, DOI 10.1128/IAI.55.3.568-571.1987; GANZ T, 1989, J IMMUNOL, V143, P1358; GANZ T, 1994, CURR OPIN IMMUNOL, V6, P584, DOI 10.1016/0952-7915(94)90145-7; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Ganz T, 2004, CR BIOL, V327, P539, DOI 10.1016/j.crvi.2003.12.007; Garcia JRC, 2001, CELL TISSUE RES, V306, P257, DOI 10.1007/s004410100433; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Hertz CJ, 2003, J IMMUNOL, V171, P6820, DOI 10.4049/jimmunol.171.12.6820; Hirsch Joshua A, 2003, Tech Vasc Interv Radiol, V6, P92, DOI 10.1053/tvir.2003.36446; Huang HW, 2000, BIOCHEMISTRY-US, V39, P8347, DOI 10.1021/bi000946l; Hubert P, 2007, FASEB J, V21, P2765, DOI 10.1096/fj.06-7646com; Imler JL, 2000, CURR OPIN MICROBIOL, V3, P16, DOI 10.1016/S1369-5274(99)00045-4; Lavenburg KR, 2003, FASEB J, V17, P2278, DOI 10.1096/fj.03-0040fje; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Ma YS, 1998, J BIOL CHEM, V273, P8727, DOI 10.1074/jbc.273.15.8727; Mao CC, 2007, J IMMUNOL, V178, P5443, DOI 10.4049/jimmunol.178.9.5443; Mathews M, 1999, INFECT IMMUN, V67, P2740, DOI 10.1128/IAI.67.6.2740-2745.1999; Niyonsaba F, 2004, IMMUNOLOGY, V111, P273, DOI 10.1111/j.0019-2805.2004.01816.x; Niyonsaba F, 2007, J INVEST DERMATOL, V127, P594, DOI 10.1038/sj.jid.5700599; Oren A, 2003, EXP MOL PATHOL, V74, P180, DOI 10.1016/S0014-4800(02)00023-0; Palmer BL, 2004, AM J CARDIOL, V93, P96, DOI 10.1016/j.amjcard.2003.08.077; Pietramaggiori G, 2008, J TRAUMA, V64, P803, DOI 10.1097/01.ta.0000244382.13937.a8; Rieske P, 2001, J BIOL CHEM, V276, P8460, DOI 10.1074/jbc.M007482200; ROHRL J, 2010, J IMMUNOL; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Scherer SS, 2009, ANN SURG, V250, P322, DOI 10.1097/SLA.0b013e3181ae9d45; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Somanath PR, 2008, ANGIOGENESIS, V11, P277, DOI 10.1007/s10456-008-9111-7; Thatte HS, 2004, J TRAUMA, V57, pS13, DOI 10.1097/01.TA.0000136743.12440.89; Threadgill DW, 1997, MAMM GENOME, V8, P390, DOI 10.1007/s003359900453; Vournakis JN, 2008, J VASC RES, V45, P222, DOI 10.1159/000112544; WATT FM, 1983, J INVEST DERMATOL, V81, pS100, DOI 10.1111/1523-1747.ep12540786; Weichhart T, 2008, ANN RHEUM DIS, V67, P70, DOI 10.1136/ard.2008.098459; Williams MJ, 1997, EMBO J, V16, P6120, DOI 10.1093/emboj/16.20.6120; Yaneva M, 2006, J IMMUNOL, V176, P6906, DOI 10.4049/jimmunol.176.11.6906; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525	43	21	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18996	10.1371/journal.pone.0018996	http://dx.doi.org/10.1371/journal.pone.0018996			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559496	Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700049
J	Rittenour, WR; Chen, M; Cahoon, EB; Harris, SD				Rittenour, William R.; Chen, Ming; Cahoon, Edgar B.; Harris, Steven D.			Control of Glucosylceramide Production and Morphogenesis by the Bar1 Ceramide Synthase in Fusarium graminearum	PLOS ONE			English	Article							DETERGENT-RESISTANT MEMBRANES; LIPID RAFTS; PROTEIN-KINASE; CELL-SURFACE; GROWTH; GENE; PATHOGENICITY; BIOSYNTHESIS; INHIBITION; DEFENSINS	The contribution of plasma membrane proteins to the virulence of plant pathogenic fungi is poorly understood. Accordingly, the objective of this study was to characterize the acyl-CoA dependent ceramide synthase Bar1 (previously implicated in plasma membrane organization) in the wheat pathogen Fusarium graminearum. The role of Bar1 in mediating cell membrane organization was confirmed as DBAR1 mutants failed to display a distinct sterol-rich domain at the hyphal tip. The DBAR1 mutants were non-pathogenic when inoculated onto wheat heads, and their in vitro growth also was severely perturbed. DBAR1 mutants were incapable of producing perithecia (sexual fruiting structures) and only produced macroconidia (asexual spores) in the presence of NaCl. Sphingolipid analyses indicated that Bar1 is specifically necessary for the production of glucosylceramides in both F. graminearum and Aspergillus nidulans. Interestingly, glucosylceramides appear to mediate sensitivity to heat stable antifungal factor (HSAF), as, in addition to DBAR1 mutants, a glucosylceramide synthase deficient mutant of Yarrowia lipolytica is also resistant to HSAF.	[Rittenour, William R.; Harris, Steven D.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA; [Chen, Ming; Cahoon, Edgar B.] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA; [Rittenour, William R.; Chen, Ming; Cahoon, Edgar B.; Harris, Steven D.] Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Rittenour, WR (corresponding author), NIOSH, Morgantown, WV USA.	sharri1@unlnotes.unl.edu			Nebraska Research Foundation; United States National Science Foundation [MCB-0843312]	Nebraska Research Foundation; United States National Science Foundation(National Science Foundation (NSF))	This work was supported by the Nebraska Research Foundation (SH) and the United States National Science Foundation (MCB-0843312) (EC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander NJ, 1998, APPL ENVIRON MICROB, V64, P221; Alvarez FJ, 2007, EUKARYOT CELL, V6, P755, DOI 10.1128/EC.00008-07; Ayad-Durieux Y, 2000, J CELL SCI, V113, P4563; Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697; Bagnat M, 2002, P NATL ACAD SCI USA, V99, P14183, DOI 10.1073/pnas.172517799; Barz WP, 1999, MOL BIOL CELL, V10, P1043, DOI 10.1091/mbc.10.4.1043; Bowden RL, 1999, PHYTOPATHOLOGY, V89, P182, DOI 10.1094/PHYTO.1999.89.2.182; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Catlett N.L., 2003, FUNGAL GENET NEWSL, V50, P9, DOI DOI 10.4148/1941-4765.1150; Cerantola V, 2007, BIOCHEM J, V401, P205, DOI 10.1042/BJ20061128; Cheng JJ, 2003, MOL CELL BIOL, V23, P163, DOI 10.1128/MCB.23.1.163-177.2003; Cheng JJ, 2001, MOL CELL BIOL, V21, P6198, DOI 10.1128/MCB.21.18.6198-6209.2001; Cuomo CA, 2007, SCIENCE, V5, P515; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI 10.1111/J.1364-3703.2004.00252.X; HANNUN YA, 1995, TRENDS BIOCHEM SCI, V20, P73, DOI 10.1016/S0968-0004(00)88961-6; Harris SD, 2005, MYCOLOGIA, V97, P880, DOI 10.3852/mycologia.97.4.880; Horio T, 2005, MOL BIOL CELL, V16, P918, DOI 10.1091/mbc.E04-09-0798; Insenser M, 2006, PROTEOMICS, V6, pS74, DOI 10.1002/pmic.200500465; Kapteyn JC, 1996, GLYCOBIOLOGY, V6, P337, DOI 10.1093/glycob/6.3.337; Lauwers E, 2006, TRAFFIC, V7, P1045, DOI 10.1111/j.1600-0854.2006.00445.x; Leipelt M, 2001, J BIOL CHEM, V276, P33621, DOI 10.1074/jbc.M104952200; Li S, 2008, PHYTOPATHOLOGY, V98, P695, DOI 10.1094/PHYTO-98-6-0695; Li SJ, 2007, GENETICS, V176, P243, DOI 10.1534/genetics.106.068239; Li SJ, 2006, MOL BIOL CELL, V17, P1218, DOI 10.1091/mbc.E05-06-0533; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; McMullen M, 1997, PLANT DIS, V81, P1340, DOI 10.1094/PDIS.1997.81.12.1340; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; Proctor RH, 2003, FUNGAL GENET BIOL, V38, P237, DOI 10.1016/S1087-1845(02)00525-X; Ram AFJ, 2006, NAT PROTOC, V1, P2253, DOI 10.1038/nprot.2006.397; Ramamoorthy V, 2007, MOL MICROBIOL, V66, P771, DOI 10.1111/j.1365-2958.2007.05955.x; Ramamoorthy V, 2007, CELL MICROBIOL, V9, P1491, DOI 10.1111/j.1462-5822.2006.00887.x; Ramamoorthy V, 2009, EUKARYOT CELL, V8, P217, DOI 10.1128/EC.00255-08; Rittenour WR, 2010, MOL PLANT PATHOL, V11, P361, DOI [10.1111/J.1364-3703.2010.00609.X, 10.1111/j.1364-3703.2010.00609.x]; Rittershaus PC, 2006, J CLIN INVEST, V116, P1651, DOI 10.1172/JCI27890; Semighini CP, 2008, FEMS MICROBIOL LETT, V279, P259, DOI 10.1111/j.1574-6968.2007.01042.x; Siafakas AR, 2006, EUKARYOT CELL, V5, P488, DOI 10.1128/EC.5.3.488-498.2006; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Takakuwa N, 2008, FEMS YEAST RES, V8, P839, DOI 10.1111/j.1567-1364.2008.00407.x; Thevissen K, 2004, J BIOL CHEM, V279, P3900, DOI 10.1074/jbc.M311165200; Yu FG, 2007, ANTIMICROB AGENTS CH, V51, P64, DOI 10.1128/AAC.00931-06; Zhao XH, 2007, EUKARYOT CELL, V6, P1701, DOI 10.1128/EC.00216-07	41	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19385	10.1371/journal.pone.0019385	http://dx.doi.org/10.1371/journal.pone.0019385			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559419	Green Published, gold			2022-12-27	WOS:000290024700154
J	Verkaar, F; van der Stelt, M; Blankesteijn, WM; van der Doelen, AA; Zaman, GJR				Verkaar, Folkert; van der Stelt, Mario; Blankesteijn, W. Matthijs; van der Doelen, Antoon A.; Zaman, Guido J. R.			Discovery of Novel Small Molecule Activators of beta-Catenin Signaling	PLOS ONE			English	Article							WNT; RECEPTOR; PATHWAY; PROTEINS; TRANSCRIPTION; DISEASE; FAMILY; TARGET	Wnt/beta-catenin signaling plays a major role in embryonic development and adult stem cell maintenance. Reduced activation of the Wnt/beta-catenin pathway underlies neurodegenerative disorders and aberrations in bone formation. Screening of a small molecule compound library with a beta-galactosidase fragment complementation assay measuring beta-catenin nuclear entry revealed bona fide activators of beta-catenin signaling. The compounds stabilized cytoplasmic beta-catenin and activated beta-catenin-dependent reporter gene activity. Although the mechanism through which the compounds activate beta-catenin signaling has yet to be determined, several key regulators of Wnt/beta-catenin signaling, including glycogen synthase kinase 3 and Frizzled receptors, were excluded as the molecular target. The compounds displayed remarkable selectivity, as they only induced beta-catenin signaling in a human osteosarcoma U2OS cell line and not in a variety of other cell lines examined. Our data indicate that differences in cellular Wnt/beta-catenin signaling machinery can be exploited to identify cell type-specific activators of Wnt/beta-catenin signaling.	[Verkaar, Folkert; van der Doelen, Antoon A.; Zaman, Guido J. R.] Merck Res Labs, Dept Mol Pharmacol, Oss, Netherlands; [Blankesteijn, W. Matthijs] Maastricht Univ, Dept Pharmacol & Toxicol, Maastricht, Netherlands; [van der Stelt, Mario] Merck Res Labs, Dept Med Chem, Oss, Netherlands	Merck & Company; Maastricht University; Merck & Company	Verkaar, F (corresponding author), Merck Res Labs, Dept Mol Pharmacol, Oss, Netherlands.	guido.zaman@spcorp.com			Dutch government BSIK [03033]	Dutch government BSIK(Ministry of Economic Affairs, Netherlands)	The work was supported by the Dutch government BSIK grant 03033 (to FV and WMB) (http://www.senternovem.nl/bsik) and carried out at Merck Research Laboratories in Oss, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Hoeppner LH, 2009, EXPERT OPIN THER TAR, V13, P485, DOI [10.1517/14728220902841961, 10.1517/14728220902841961 ]; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Major MB, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.2000037; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Terstappen GC, 2006, IDRUGS, V9, P35; VANDERSTELT M, 2010, Patent No. 2010063666; Verkaar F, 2010, FASEB J, V24, P1205, DOI 10.1096/fj.09-141671; Verkaar F, 2009, CELL SIGNAL, V21, P22, DOI 10.1016/j.cellsig.2008.09.008; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611	22	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19185	10.1371/journal.pone.0019185	http://dx.doi.org/10.1371/journal.pone.0019185			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559429	gold, Green Published, Green Submitted			2022-12-27	WOS:000290024700095
J	Groen, G; Sokolov, AN; Jonas, C; Roebling, R; Spitzer, M				Groen, Georg; Sokolov, Alexander N.; Jonas, Christina; Roebling, Robert; Spitzer, Manfred			Increased Resting-State Perfusion after Repeated Encoding Is Related to Later Retrieval of Declarative Associative Memories	PLOS ONE			English	Article							LONG-TERM-MEMORY; COMPLEMENTARY LEARNING-SYSTEMS; CA1 REGION; TEMPORAL CORTEX; HIPPOCAMPAL; REACTIVATION; PERSISTENCE; DOPAMINE; POTENTIATION; MAINTENANCE	Electrophysiological studies in animals have shown coordinated reactivation of neuronal ensembles during a restricted time period of behavioral inactivity that immediately followed active encoding. In the present study we directly investigated offline processing of associative memory formation in the human brain. Subjects' regional cerebral blood flow (rCBF) as a surrogate marker of neural activity during rest was measured by MR-based perfusion imaging in a sample of 14 healthy male subjects prior to (Pre2) and after (Post) extensive learning of 24 face-name associations within a selective reminding task (SR). Results demonstrated significant Post-Pre2 rCBF increases in hippocampal and temporal lobe regions, while in a control comparison of two perfusion scans with no learning task in-between (Pre2-Pre1) no differences in rCBF emerged. Post perfusion scanning was followed by a surprise cued associative recall task from which two types of correctly retrieved names were obtained: older names already correctly retrieved at least once during one of the SR blocks, and recent names acquired during the last SR block immediately prior to the Post scan. In the anterior hippocampus individual perfusion increases were correlated with both correct retrievals of older and recent names. By contrast, older but not recently learned names showed a significant correlation with perfusion increases in the left lateral temporal cortex known to be associated with long-term memory. Recent, but not older names were correlated with dopaminergic midbrain structures reported to contribute to the persistence of memory traces for novel information. Although the direct investigation of off-line memory processing did not permit concomitant experimental control, neither intentional rehearsal, nor substantial variations in subjects' states of alertness appear to contribute to present results. We suggest that the observed rCBF increases might reflect processes that possibly contribute to the long-term persistence of memory traces.	[Groen, Georg; Sokolov, Alexander N.; Jonas, Christina; Roebling, Robert; Spitzer, Manfred] Univ Ulm, Dept Psychiat, Sect Neuropsychol & Funct Imaging, Ulm, Germany; [Sokolov, Alexander N.] Univ Tubingen, Ctr Ophthalmol, Low Vis Clin, Tubingen, Germany; [Sokolov, Alexander N.] Univ Tubingen, Res Lab, Tubingen, Germany	Ulm University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen	Groen, G (corresponding author), Univ Ulm, Dept Psychiat, Sect Neuropsychol & Funct Imaging, Ulm, Germany.	georg.groen@uni-ulm.de		Gron, Georg/0000-0002-0282-3575	Europaischer Sozialfonds (ESF)	Europaischer Sozialfonds (ESF)(European Commission)	This work was supported by a grant from Europaischer Sozialfonds (ESF) to AS and CJ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Adolph O, 2010, NEUROIMAGE, V49, P720, DOI 10.1016/j.neuroimage.2009.08.034; Albert NB, 2009, CURR BIOL, V19, P1023, DOI 10.1016/j.cub.2009.04.028; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bethus I, 2010, J NEUROSCI, V30, P1610, DOI 10.1523/JNEUROSCI.2721-09.2010; BORTZ J, 1995, STAT SOZIALWISSENSCH; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; Daselaar SM, 2010, NEUROBIOL LEARN MEM, V93, P422, DOI 10.1016/j.nlm.2009.12.009; DEsposito M, 1997, NEUROPSYCHOLOGIA, V35, P725, DOI 10.1016/S0028-3932(96)00121-2; Detre JA, 2002, CLIN NEUROPHYSIOL, V113, P621, DOI 10.1016/S1388-2457(02)00038-X; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; FREY U, 1991, NEUROSCI LETT, V129, P111, DOI 10.1016/0304-3940(91)90732-9; FREY U, 1990, BRAIN RES, V522, P69, DOI 10.1016/0006-8993(90)91578-5; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; Garrard P, 2000, J NEUROL, V247, P409, DOI 10.1007/s004150070169; Gasbarri A, 1997, PROG NEURO-PSYCHOPH, V21, P1, DOI 10.1016/S0278-5846(96)00157-1; Graham KS, 1999, CURR OPIN NEUROBIOL, V9, P245, DOI 10.1016/S0959-4388(99)80035-X; Hasselmo ME, 1999, CURR OPIN NEUROBIOL, V9, P184, DOI 10.1016/S0959-4388(99)80025-7; Hoffman KL, 2002, SCIENCE, V297, P2070, DOI 10.1126/science.1073538; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; Jackson JC, 2006, J NEUROSCI, V26, P12415, DOI 10.1523/JNEUROSCI.4118-06.2006; Kahana MJ, 1996, MEM COGNITION, V24, P103, DOI 10.3758/BF03197276; Karlsson MP, 2009, NAT NEUROSCI, V12, P913, DOI 10.1038/nn.2344; Kirwan CB, 2004, HIPPOCAMPUS, V14, P919, DOI 10.1002/hipo.20014; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Lisman JE, 2001, HIPPOCAMPUS, V11, P551; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MARR D, 1970, PROC R SOC SER B-BIO, V176, P161, DOI 10.1098/rspb.1970.0040; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McGuire PK, 1996, PSYCHOL MED, V26, P29, DOI 10.1017/S0033291700033699; Miyashita Y, 1998, NEUROBIOL LEARN MEM, V70, P197, DOI 10.1006/nlme.1998.3848; Murray GK, 2008, MOL PSYCHIATR, V13, P267, DOI 10.1038/sj.mp.4002058; Nakamura K, 1996, BEHAV BRAIN RES, V77, P53, DOI 10.1016/0166-4328(95)00227-8; O'Carroll CM, 2006, LEARN MEMORY, V13, P760, DOI 10.1101/lm.321006; O'Reilly RC, 2002, TRENDS COGN SCI, V6, P505, DOI 10.1016/S1364-6613(02)02005-3; Peigneux P, 2003, NEUROIMAGE, V20, P125, DOI 10.1016/S1053-8119(03)00278-7; Peigneux P, 2006, PLOS BIOL, V4, P647, DOI 10.1371/journal.pbio.0040100; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Petrides M, 2005, NATURE, V435, P1235, DOI 10.1038/nature03628; Rossato JI, 2009, SCIENCE, V325, P1017, DOI 10.1126/science.1172545; Saumier Daniel, 2002, Curr Neurol Neurosci Rep, V2, P516, DOI 10.1007/s11910-002-0039-9; Schott BH, 2004, LEARN MEMORY, V11, P383, DOI 10.1101/lm.75004; Shohamy D, 2008, NEURON, V60, P378, DOI 10.1016/j.neuron.2008.09.023; Silvani A, 2008, AM J PHYSIOL-REG I, V294, pR1686, DOI 10.1152/ajpregu.00756.2007; Small SA, 2001, NAT NEUROSCI, V4, P442, DOI 10.1038/86115; Sperling R, 2003, NEUROIMAGE, V20, P1400, DOI 10.1016/S1053-8119(03)00391-4; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Sutherland GR, 2000, CURR OPIN NEUROBIOL, V10, P180, DOI 10.1016/S0959-4388(00)00079-9; Takashima A, 2009, J NEUROSCI, V29, P10087, DOI 10.1523/JNEUROSCI.0799-09.2009; Tambini A, 2010, NEURON, V65, P280, DOI 10.1016/j.neuron.2010.01.001; Tempini MLG, 1998, BRAIN, V121, P2103, DOI 10.1093/brain/121.11.2103; Wang JJ, 2005, RADIOLOGY, V235, P218, DOI 10.1148/radiol.2351031663; Wang JJ, 2003, NEUROIMAGE, V19, P1449, DOI 10.1016/S1053-8119(03)00255-6; Wang JJ, 2003, MAGN RESON MED, V49, P796, DOI 10.1002/mrm.10437; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Yamashita K, 2009, J NEUROSCI, V29, P10335, DOI 10.1523/JNEUROSCI.1328-09.2009; Zeineh MM, 2003, SCIENCE, V299, P577, DOI 10.1126/science.1077775	60	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19985	10.1371/journal.pone.0019985	http://dx.doi.org/10.1371/journal.pone.0019985			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	763CL	21589884	Green Published, Green Submitted, gold			2022-12-27	WOS:000290531100037
J	Zhao, N; Pang, B; Shyu, CR; Korkin, D				Zhao, Nan; Pang, Bin; Shyu, Chi-Ren; Korkin, Dmitry			Structural Similarity and Classification of Protein Interaction Interfaces	PLOS ONE			English	Article							INTERACTION PREDICTION; SEQUENCE; MIMICRY; CONSERVATION; VALIDATION; DATABASE; GROWTH; CAPRI; PRISM	Interactions between proteins play a key role in many cellular processes. Studying protein-protein interactions that share similar interaction interfaces may shed light on their evolution and could be helpful in elucidating the mechanisms behind stability and dynamics of the protein complexes. When two complexes share structurally similar subunits, the similarity of the interaction interfaces can be found through a structural superposition of the subunits. However, an accurate detection of similarity between the protein complexes containing subunits of unrelated structure remains an open problem. Here, we present an alignment-free machine learning approach to measure interface similarity. The approach relies on the feature-based representation of protein interfaces and does not depend on the superposition of the interacting subunit pairs. Specifically, we develop an SVM classifier of similar and dissimilar interfaces and derive a feature-based interface similarity measure. Next, the similarity measure is applied to a set of 2,80662,806 binary complex pairs to build a hierarchical classification of protein-protein interactions. Finally, we explore case studies of similar interfaces from each level of the hierarchy, considering cases when the subunits forming interactions are either homologous or structurally unrelated. The analysis has suggested that the positions of charged residues in the homologous interfaces are not necessarily conserved and may exhibit more complex conservation patterns.	[Zhao, Nan; Pang, Bin; Shyu, Chi-Ren; Korkin, Dmitry] Univ Missouri, Inst Informat, Columbia, MO 65211 USA; [Zhao, Nan; Pang, Bin; Shyu, Chi-Ren; Korkin, Dmitry] Univ Missouri, Dept Comp Sci, Columbia, MO USA; [Korkin, Dmitry] Univ Missouri, Bond Life Sci Ctr, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Zhao, N (corresponding author), Univ Missouri, Inst Informat, Columbia, MO 65211 USA.	korkin@korkinlab.org	Zhao, Nan/K-4015-2015	Zhao, Nan/0000-0002-7897-2374	National Science Foundation [DBI-0845196]; Direct For Biological Sciences [0845196] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors acknowledge funding from the National Science Foundation (DBI-0845196 to DK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi I, 1999, PARASITOL RES, V85, P844, DOI 10.1007/s004360050643; Alberts B., 1998, ESSENTIAL CELL BIOL; Aloy P, 2003, J MOL BIOL, V332, P989, DOI 10.1016/j.jmb.2003.07.006; Aloy P, 2003, BIOINFORMATICS, V19, P161, DOI 10.1093/bioinformatics/19.1.161; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Aytuna AS, 2005, BIOINFORMATICS, V21, P2850, DOI 10.1093/bioinformatics/bti443; Beckett D, 2004, BIOCHEMISTRY-US, V43, P7983, DOI 10.1021/bi049890b; Belyaeva OV, 2005, BIOCHEMISTRY-US, V44, P7035, DOI 10.1021/bi050226k; Berman HM, 2008, ACTA CRYSTALLOGR A, V64, P88, DOI 10.1107/S0108767307035623; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Chandonia JM, 2004, NUCLEIC ACIDS RES, V32, pD189, DOI 10.1093/nar/gkh034; CIACCIA P, 1997, M TREE EFFICIENT ACC; Comaniciu D, 2000, PROC CVPR IEEE, P142, DOI 10.1109/CVPR.2000.854761; Davis FP, 2005, BIOINFORMATICS, V21, P1901, DOI 10.1093/bioinformatics/bti277; Elde NC, 2009, NAT REV MICROBIOL, V7, P787, DOI 10.1038/nrmicro2222; FAUCHERE JL, 1983, EUR J MED CHEM, V18, P369; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Guharoy M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-286; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291; HUBBARD S, 1994, PROTRUDER FORTRAN PR; Hubbard S.J., 1992, NACCESS COMPUTER PRO; Huo S, 2002, J COMPUT CHEM, V23, P15, DOI 10.1002/jcc.1153; Janin J, 2003, PROTEINS, V52, P2, DOI 10.1002/prot.10381; Joachims T, 1999, ADVANCES IN KERNEL METHODS, P169; Jones S, 1997, J MOL BIOL, V272, P121, DOI 10.1006/jmbi.1997.1234; Keskin O, 2005, J MOL BIOL, V345, P1281, DOI 10.1016/j.jmb.2004.10.077; Keskin O, 2008, METHODS MOL BIOL, V484, P505, DOI 10.1007/978-1-59745-398-1_30; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; Lensink MF, 2007, PROTEINS, V69, P704, DOI 10.1002/prot.21804; Levy ED, 2006, PLOS COMPUT BIOL, V2, P1395, DOI 10.1371/journal.pcbi.0020155; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Ogmen U, 2005, NUCLEIC ACIDS RES, V33, pW331, DOI 10.1093/nar/gki585; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Prehna G, 2006, CELL, V126, P869, DOI 10.1016/j.cell.2006.06.056; Prieto C, 2010, PROTEINS, V78, P109, DOI 10.1002/prot.22569; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Shamim MTA, 2007, BIOINFORMATICS, V23, P3320, DOI 10.1093/bioinformatics/btm527; Shatsky M, 2004, PROTEINS, V56, P143, DOI 10.1002/prot.10628; Sheinerman FB, 2000, CURR OPIN STRUC BIOL, V10, P153, DOI 10.1016/S0959-440X(00)00065-8; Shulman-Peleg A, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-43; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Teyra J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-9; Theodoridis S, 2006, PATTERN RECOGNITION, 3RD EDITION, P1; Tsai CJ, 1996, J MOL BIOL, V260, P604, DOI 10.1006/jmbi.1996.0424; Winter C, 2006, NUCLEIC ACIDS RES, V34, pD310, DOI 10.1093/nar/gkj099	48	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19554	10.1371/journal.pone.0019554	http://dx.doi.org/10.1371/journal.pone.0019554			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589874	Green Published, gold, Green Submitted			2022-12-27	WOS:000290531100018
J	Citterio, L; Simonini, M; Zagato, L; Salvi, E; Carpini, SD; Lanzani, C; Messaggio, E; Casamassima, N; Frau, F; D'Avila, F; Cusi, D; Barlassina, C; Manunta, P				Citterio, Lorena; Simonini, Marco; Zagato, Laura; Salvi, Erika; Carpini, Simona Delli; Lanzani, Chiara; Messaggio, Elisabetta; Casamassima, Nunzia; Frau, Francesca; D'Avila, Francesca; Cusi, Daniele; Barlassina, Cristina; Manunta, Paolo			Genes Involved in Vasoconstriction and Vasodilation System Affect Salt-Sensitive Hypertension	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DEPENDENT NA+/CA2+ EXCHANGERS; BLOOD-PRESSURE; ALPHA-ADDUCIN; DIETARY SALT; COMMON DISEASES; SODIUM; SUSCEPTIBILITY; CA2+; POLYMORPHISMS	The importance of excess salt intake in the pathogenesis of hypertension is widely recognized. Blood pressure is controlled primarily by salt and water balance because of the infinite gain property of the kidney to rapidly eliminate excess fluid and salt. Up to fifty percent of patients with essential hypertension are salt-sensitive, as manifested by a rise in blood pressure with salt loading. We conducted a two-stage genetic analysis in hypertensive patients very accurately phenotyped for their salt-sensitivity. All newly discovered never treated before, essential hypertensives underwent an acute salt load to monitor the simultaneous changes in blood pressure and renal sodium excretion. The first stage consisted in an association analysis of genotyping data derived from genome-wide array on 329 subjects. Principal Component Analysis demonstrated that this population was homogenous. Among the strongest results, we detected a cluster of SNPs located in the first introns of PRKG1 gene (rs7897633, p = 2.34E-05) associated with variation in diastolic blood pressure after acute salt load. We further focused on two genetic loci, SLC24A3 and SLC8A1 (plasma membrane sodium/calcium exchange proteins, NCKX3 and NCX1, respectively) with a functional relationship with the previous gene and associated to variations in systolic blood pressure (the imputed rs3790261, p = 4.55E-06; and rs434082, p = 4.7E-03). In stage 2, we characterized 159 more patients for the SNPs in PRKG1, SLC24A3 and SLC8A1. Combined analysis showed an epistatic interaction of SNPs in SLC24A3 and SLC8A1 on the pressure-natriuresis (p interaction = 1.55E-04, p model = 3.35E-05), supporting their pathophysiological link in cellular calcium homeostasis. In conclusions, these findings point to a clear association between body sodium-blood pressure relations and molecules modulating the contractile state of vascular cells through an increase in cytoplasmic calcium concentration.	[Citterio, Lorena; Simonini, Marco; Zagato, Laura; Carpini, Simona Delli; Lanzani, Chiara; Messaggio, Elisabetta; Casamassima, Nunzia; Manunta, Paolo] Univ Vita Salute San Raffaele Hosp, Div Nephrol & Dialysis, San Raffaele Sci Inst, Milan, Italy; [Salvi, Erika; Frau, Francesca; D'Avila, Francesca; Cusi, Daniele; Barlassina, Cristina] Univ Milan, Dept Med Surg & Dent, AO San Paolo, Milan, Italy; [Cusi, Daniele; Barlassina, Cristina] Univ Milan, Grad Sch Nephrol, Milan, Italy; [Cusi, Daniele; Barlassina, Cristina] Fdn Filarete, Genom & Bioinformat Unit, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan; University of Milan	Citterio, L (corresponding author), Univ Vita Salute San Raffaele Hosp, Div Nephrol & Dialysis, San Raffaele Sci Inst, Milan, Italy.	citterio.lorena@hsr.it	Manunta, Paolo/ABH-5476-2020; Simonini, Marco/T-8570-2018; Salvi, Erika/C-1033-2015; Salvi, Erika/AAA-1415-2019; Lanzani, Chiara Livia/AAN-2284-2020; Zagato, Laura/AAC-7739-2022; Citterio, Lorena/AAC-1589-2019	Manunta, Paolo/0000-0003-3976-9696; Simonini, Marco/0000-0003-0664-4600; Salvi, Erika/0000-0002-2724-2291; Salvi, Erika/0000-0002-2724-2291; Lanzani, Chiara Livia/0000-0002-5332-4012; Citterio, Lorena/0000-0001-6455-2291; Zagato, Laura/0000-0002-0441-2120; Barlassina, Cristina/0000-0001-7407-2697	European Union [LSMH-CT-2006-037093, HEALTH-F4-2007-201550]; Italian Ministry of Health [RF-FSR-2008-1141719]; Italian Ministry of University and Scientific Research [2008W5AZEC_001]	European Union(European Commission); Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR))	This study was supported in part by European Union grant LSMH-CT-2006-037093 InGenious HyperCare (www.hypercare.eu), HEALTH-F4-2007-201550 HYPERGENES (www.hypergenes.eu), Italian Ministry of Health RF-FSR-2008-1141719 (www.salute.gov.it) (PM), and Italian Ministry of University and Scientific Research 2008W5AZEC_001 (www.miur.it) (PM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Barlassina C, 2000, KIDNEY INT, V57, P1083, DOI 10.1046/j.1523-1755.2000.00935.x; Bianchi G, 2005, AM J PHYSIOL-REG I, V289, pR1536, DOI 10.1152/ajpregu.00441.2005; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blaustein MP, 2009, HYPERTENSION, V53, P291, DOI 10.1161/HYPERTENSIONAHA.108.119974; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Bourgeois CF, 2004, PROG NUCLEIC ACID RE, V78, P37, DOI 10.1016/S0079-6603(04)78002-2; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campese VM, 1994, HYPERTENSION, V23, P531, DOI 10.1161/01.HYP.23.4.531; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; CITTERIO L, 2010, BIOCH BIOPHYS ACTA; Cowley AW, 1997, AM J CLIN NUTR, V65, P587; Cusi D, 1997, LANCET, V349, P1353, DOI 10.1016/S0140-6736(97)01029-5; de la Sierra A, 2002, J HUM HYPERTENS, V16, P255, DOI 10.1038/sj.jhh.1001375; Di Rienzo A, 2005, TRENDS GENET, V21, P596, DOI 10.1016/j.tig.2005.08.007; Dong H, 2006, AM J PHYSIOL-HEART C, V291, pH1226, DOI 10.1152/ajpheart.00196.2006; Feil R, 2002, CIRC RES, V90, P1080, DOI 10.1161/01.RES.0000019586.95768.40; Feil Robert, 2009, Commun Integr Biol, V2, P298; GUYTON AC, 1964, CIRC RES, V15, P187; Haddy FJ, 2006, LIFE SCI, V79, P1585, DOI 10.1016/j.lfs.2006.05.017; Hill MA, 2009, TRENDS PHARMACOL SCI, V30, P363, DOI 10.1016/j.tips.2009.04.008; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Iwamoto T, 2004, NAT MED, V10, P1193, DOI 10.1038/nm1118; Karaki H, 1997, PHARMACOL REV, V49, P157; Lee GS, 2009, AM J PHYSIOL-RENAL, V297, pF371, DOI 10.1152/ajprenal.90615.2008; LEVY D, 2009, NAT GENET; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Manunta P, 1998, KIDNEY INT, V53, P1471, DOI 10.1046/j.1523-1755.1998.00931.x; Manunta P, 2001, HYPERTENSION, V38, P198, DOI 10.1161/01.HYP.38.2.198; Manunta P, 2008, HYPERTENSION, V52, P366, DOI 10.1161/HYPERTENSIONAHA.108.113977; McCarthy MI, 2008, HUM MOL GENET, V17, pR156, DOI 10.1093/hmg/ddn289; Meneton P, 2005, PHYSIOL REV, V85, P679, DOI 10.1152/physrev.00056.2003; Michael SK, 2008, P NATL ACAD SCI USA, V105, P6702, DOI 10.1073/pnas.0802128105; Navis G, 2010, NEPHROL DIAL TRANSPL, V25, P1382, DOI 10.1093/ndt/gfq091; Newton-Cheh C., 2009, NAT GENET, V41, P666, DOI [10.1038/ng.361, DOI 10.1038/NG.361]; Org E, 2009, HUM MOL GENET, V18, P2288, DOI 10.1093/hmg/ddp135; Pahl R, 2010, BIOINFORMATICS, V26, P2093, DOI 10.1093/bioinformatics/btq399; Pfeifer A, 1998, EMBO J, V17, P3045, DOI 10.1093/emboj/17.11.3045; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sanders PW, 2009, HYPERTENSION, V53, P442, DOI 10.1161/HYPERTENSIONAHA.108.120303; Sober S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006034; Tamura N, 1996, HYPERTENSION, V27, P552, DOI 10.1161/01.HYP.27.3.552; Visser F, 2007, J BIOL CHEM, V282, P4453, DOI 10.1074/jbc.M610582200; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Wang Y, 2009, P NATL ACAD SCI USA, V106, P226, DOI 10.1073/pnas.0808358106; Weber S, 2007, CIRC RES, V101, P1096, DOI 10.1161/CIRCRESAHA.107.154351; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551; Zhao Q, 2008, PHARMACOGENET GENOM, V18, P459, DOI 10.1097/FPC.0b013e3282f97fb2	51	44	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19620	10.1371/journal.pone.0019620	http://dx.doi.org/10.1371/journal.pone.0019620			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573014	Green Submitted, gold, Green Published			2022-12-27	WOS:000290386800026
J	Cuisinier, R; Olivier, I; Vaugoyeau, M; Nougier, V; Assaiante, C				Cuisinier, Remy; Olivier, Isabelle; Vaugoyeau, Marianne; Nougier, Vincent; Assaiante, Christine			Reweighting of Sensory Inputs to Control Quiet Standing in Children from 7 to 11 and in Adults	PLOS ONE			English	Article							POSTURAL CONTROL; BALANCE CONTROL; TENDON VIBRATION; MATURATION; SYSTEMS; TASK; AGE	How sensory organization for postural control matures in children is not clear at this time. The present study examined, in children aged 7 to 11 and in adults, the postural control modifications in quiet standing when somatosensory inputs from the ankle were disturbed. Since the reweighting of sensory inputs is not mature before 10, we hypothesized that postural stability was more affected in children than in adults when somatosensory inputs were altered and that this postural instability decreased as age increased during childhood. 37 children aged 7 to 11 years and 9 adults participated in the experiments. The postural task was a semi-tandem position with the right foot in front of the left one. Postural performance was measured by means of a force platform. Two experimental conditions were presented to the participants to maintain quiet standing: With or without altered somatosensory inputs (i.e., with or without ankles vibration). Results showed that postural stability -and thus how the reweighting process of the visual/somatosensory inputs matured-increased non-monotonically between 7 years of age and adult age: There was a linear improvement of postural stability from 7 to 10, followed by a more steady behaviour between 10 and 11 and then postural stability increased to reach the adults' level of performance.	[Cuisinier, Remy; Olivier, Isabelle; Nougier, Vincent] UJF Grenoble 1 CNRS TIMC IMAG, UMR 5525, Grenoble, France; [Vaugoyeau, Marianne; Assaiante, Christine] Univ Aix Marseille 1, CNRS, UMR Grp Dev & Pathol Act 61 49, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Cuisinier, R (corresponding author), UJF Grenoble 1 CNRS TIMC IMAG, UMR 5525, Grenoble, France.	isabelle.olivier@ujf-grenoble.fr	Nougier, Vincent M/B-4993-2013; Nougier, Vincent/AAG-5794-2021; Olivier, Isabelle/M-6054-2014	Nougier, Vincent M/0000-0002-9917-0004; 				ASSAIANTE C, 1995, HUM MOVEMENT SCI, V14, P13, DOI 10.1016/0167-9457(94)00048-J; Assaiante Christine, 2005, Neural Plasticity, V12, P109, DOI 10.1155/NP.2005.109; Bair WN, 2007, EXP BRAIN RES, V183, P435, DOI 10.1007/s00221-007-1057-2; Barela JA, 2003, EXP BRAIN RES, V150, P434, DOI 10.1007/s00221-003-1441-5; Duarte M, 2002, EXP BRAIN RES, V146, P60, DOI 10.1007/s00221-002-1154-1; Ferber-Viart C, 2007, INT J PEDIATR OTORHI, V71, P1041, DOI 10.1016/j.ijporl.2007.03.012; FIGURA F, 1991, J SPORT MED PHYS FIT, V31, P235; FITZPATRICK R, 1994, J PHYSIOL-LONDON, V478, P173, DOI 10.1113/jphysiol.1994.sp020240; FORSSBERG H, 1982, J NEUROSCI, V2, P545; Hatzitaki V, 2002, J MOTOR BEHAV, V34, P161, DOI 10.1080/00222890209601938; JOUEN F, 1985, BEHAV BRAIN RES, V15, P241, DOI 10.1016/0166-4328(85)90178-0; MAKI BE, 1990, J AM GERIATR SOC, V38, P1, DOI 10.1111/j.1532-5415.1990.tb01588.x; Olivier I, 2007, NEUROREPORT, V18, P817, DOI 10.1097/WNR.0b013e3280e129e1; Palluel E, 2008, CLIN NEUROPHYSIOL, V119, P2546, DOI 10.1016/j.clinph.2008.08.001; Peterka R J, 1990, J Vestib Res, V1, P73; Peterson ML, 2006, GAIT POSTURE, V23, P455, DOI 10.1016/j.gaitpost.2005.05.003; Riach C.L., 1994, GAIT POSTURE, V2, P167, DOI [10.1016/0966-6362(94)90004-3, DOI 10.1016/0966-6362(94)90004-3]; Rival C, 2005, NEUROSCI LETT, V376, P133, DOI 10.1016/j.neulet.2004.11.042; ROLL JP, 1982, EXP BRAIN RES, V47, P177; ROLL JP, 1989, EXP BRAIN RES, V76, P213; Roncesvalles MN, 2005, J MOTOR BEHAV, V37, P404, DOI 10.3200/JMBR.37.5.404-416; Schmitz C, 2002, NEUROSCI LETT, V330, P215, DOI 10.1016/S0304-3940(02)00590-6; SHUMWAYCOOK A, 1985, J MOTOR BEHAV, V17, P131; Sparto PJ, 2006, EXP BRAIN RES, V168, P505, DOI 10.1007/s00221-005-0109-8; Steindl R, 2006, DEV MED CHILD NEUROL, V48, P477, DOI 10.1017/S0012162206001022; Sundermier L, 2001, EXP BRAIN RES, V136, P340, DOI 10.1007/s002210000579; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd	27	42	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19697	10.1371/journal.pone.0019697	http://dx.doi.org/10.1371/journal.pone.0019697			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	761GX	21573028	Green Submitted, gold, Green Published			2022-12-27	WOS:000290386800032
J	Kondo, N; Takahashi, A; Mori, E; Noda, T; Zdzienicka, MZ; Thompson, LH; Helleday, T; Suzuki, M; Kinashi, Y; Masunaga, S; Ono, K; Hasegawa, M; Ohnishi, T				Kondo, Natsuko; Takahashi, Akihisa; Mori, Eiichiro; Noda, Taichi; Zdzienicka, Malgorzata Z.; Thompson, Larry H.; Helleday, Thomas; Suzuki, Minoru; Kinashi, Yuko; Masunaga, Shinichiro; Ono, Koji; Hasegawa, Masatoshi; Ohnishi, Takeo			FANCD1/BRCA2 Plays Predominant Role in the Repair of DNA Damage Induced by ACNU or TMZ	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; FANCONI-ANEMIA; HOMOLOGOUS RECOMBINATION; MALIGNANT GLIOMA; MOLECULAR TARGET; MAMMALIAN-CELLS; LIGASE IV; PROTEIN; BRCA2; TEMOZOLOMIDE	Nimustine (ACNU) and temozolomide (TMZ) are DNA alkylating agents which are commonly used in chemotherapy for glioblastomas. ACNU is a DNA cross-linking agent and TMZ is a methylating agent. The therapeutic efficacy of these agents is limited by the development of resistance. In this work, the role of the Fanconi anemia (FA) repair pathway for DNA damage induced by ACNU or TMZ was examined. Cultured mouse embryonic fibroblasts were used: FANCA(-/-), FANCC(-/-), FANCA(-/-)C(-/-), FANCD2(-/-) cells and their parental cells, and Chinese hamster ovary and lung fibroblast cells were used: FANCD1/BRCA2mt, FANCG(-/-) and their parental cells. Cell survival was examined after a 3 h ACNU or TMZ treatment by using colony formation assays. All FA repair pathways were involved in ACNU-induced DNA damage. However, FANCG and FANCD1/BRCA2 played notably important roles in the repair of TMZ-induced DNA damage. The most effective molecular target correlating with cellular sensitivity to both ACNU and TMZ was FANCD1/BRCA2. In addition, it was found that FANCD1/BRCA2 small interference RNA efficiently enhanced cellular sensitivity toward ACNU and TMZ in human glioblastoma A172 cells. These findings suggest that the down-regulation of FANCD1/BRCA2 might be an effective strategy to increase cellular chemo-sensitization towards ACNU and TMZ.	[Kondo, Natsuko; Suzuki, Minoru; Kinashi, Yuko; Masunaga, Shinichiro; Ono, Koji] Kyoto Univ, Inst Res Reactor, Particle Radiat Oncol Res Ctr, Osaka 59004, Japan; [Takahashi, Akihisa] Gunma Univ, Adv Sci Res Leaders Dev Unit, Gunma, Japan; [Mori, Eiichiro; Hasegawa, Masatoshi; Ohnishi, Takeo] Nara Med Univ, Dept Radiat Oncol, Sch Med, Nara, Japan; [Noda, Taichi] Nara Med Univ, Dept Dermatol, Sch Med, Nara, Japan; [Zdzienicka, Malgorzata Z.] UMK Coll Med, Dept Mol Cell Genet, Bydgoszcz, Poland; [Thompson, Larry H.] Lawrence Livermore Natl Lab, BBR Program, Livermore, CA USA; [Helleday, Thomas] Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden	Kyoto University; Gunma University; Nara Medical University; Nara Medical University; Nicolaus Copernicus University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Stockholm University	Kondo, N (corresponding author), Kyoto Univ, Inst Res Reactor, Particle Radiat Oncol Res Ctr, Osaka 59004, Japan.	tohnishi@naramed-u.ac.jp	Mori, Eiichiro/AAY-6830-2020; Helleday, Thomas/D-5224-2013	Mori, Eiichiro/0000-0003-0945-196X; Helleday, Thomas/0000-0002-7384-092X	Ministry of Education, Culture, Sports, Science and Technology of Japan; Central Research Institute of the Electric Power Industry in Japan; Japan Space Forum; MRC [G0700730] Funding Source: UKRI; Medical Research Council [G0700730] Funding Source: researchfish	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Central Research Institute of the Electric Power Industry in Japan; Japan Space Forum; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. This work was also funded in part by a grant from the Central Research Institute of the Electric Power Industry in Japan, and by a grant for Exploratory Research for Space Utilization from the Japan Space Forum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen PR, 2004, GENE DEV, V18, P1958, DOI 10.1101/gad.1196104; Bruun D, 2003, DNA REPAIR, V2, P1007, DOI 10.1016/S1568-7864(03)00112-5; Chen CC, 2007, J MOL MED, V85, P497, DOI 10.1007/s00109-006-0153-2; Ciccia A, 2007, MOL CELL, V25, P331, DOI 10.1016/j.molcel.2007.01.003; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Giese A, 2004, J NEURO-ONCOL, V66, P351, DOI 10.1023/B:NEON.0000014539.90077.db; Groth P, 2010, J MOL BIOL, V402, P70, DOI 10.1016/j.jmb.2010.07.010; Gupta R, 2005, J BIOL CHEM, V280, P25450, DOI 10.1074/jbc.M501995200; Helleday T, 1998, CARCINOGENESIS, V19, P973, DOI 10.1093/carcin/19.6.973; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Kondo N, 2010, CANCER SCI, V101, P1881, DOI 10.1111/j.1349-7006.2010.01591.x; Kondo N, 2009, BIOCHEM BIOPH RES CO, V387, P656, DOI 10.1016/j.bbrc.2009.07.045; Kraakman-van der Zwet M, 2002, MOL CELL BIOL, V22, P669, DOI 10.1128/MCB.22.2.669-679.2002; Ling C, 2007, EMBO J, V26, P2104, DOI 10.1038/sj.emboj.7601666; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; Meetei AR, 2005, NAT GENET, V37, P958, DOI 10.1038/ng1626; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Roos WP, 2009, DNA REPAIR, V8, P72, DOI 10.1016/j.dnarep.2008.09.003; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Stachelek GC, 2010, CANCER RES, V70, P409, DOI 10.1158/0008-5472.CAN-09-1353; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Takahashi A, 2004, CANCER RES, V64, P8839, DOI 10.1158/0008-5472.CAN-04-1876; TAKAKURA K, 1986, J NEUROSURG, V64, P53, DOI 10.3171/jns.1986.64.1.0053; Tebbs RS, 2005, DNA REPAIR, V4, P11, DOI 10.1016/j.dnarep.2004.06.013; Thompson LH, 2009, MUTAT RES-FUND MOL M, V668, P54, DOI 10.1016/j.mrfmmm.2009.02.003; Trivedi RN, 2005, CANCER RES, V65, P6394, DOI 10.1158/0008-5472.CAN-05-0715; WALKER MD, 1980, NEW ENGL J MED, V303, P1323, DOI 10.1056/NEJM198012043032303; Wiegant WW, 2006, MUTAT RES-FUND MOL M, V600, P79, DOI 10.1016/j.mrfmmm.2006.03.001; Wilson JB, 2008, ONCOGENE, V27, P3641, DOI 10.1038/sj.onc.1211034; Wolff JEA, 2008, J NEURO-ONCOL, V88, P57, DOI 10.1007/s11060-008-9533-5; Yamamoto K, 2005, MOL CELL BIOL, V25, P34, DOI 10.1128/MCB.25.1.34-43.2005; Yamamoto K, 2003, MOL CELL BIOL, V23, P5421, DOI 10.1128/MCB.23.15.5421-5430.2003; Yang YG, 2005, CARCINOGENESIS, V26, P1731, DOI 10.1093/carcin/bgi134	37	31	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19659	10.1371/journal.pone.0019659	http://dx.doi.org/10.1371/journal.pone.0019659			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573016	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000290386800030
J	Derda, R; Tang, SKY; Laromaine, A; Mosadegh, B; Hong, E; Mwangi, M; Mammoto, A; Ingber, DE; Whitesides, GM				Derda, Ratmir; Tang, Sindy K. Y.; Laromaine, Anna; Mosadegh, Bobak; Hong, Estrella; Mwangi, Martin; Mammoto, Akiko; Ingber, Donald E.; Whitesides, George M.			Multizone Paper Platform for 3D Cell Cultures	PLOS ONE			English	Article							SPOT-SYNTHESIS; IN-VITRO; MICROFLUIDIC PLATFORM; STROMAL FIBROBLASTS; SPHEROID MODEL; TISSUE; CANCER; CELLULOSE; BIOLOGY; MORPHOGENESIS	In vitro 3D culture is an important model for tissues in vivo. Cells in different locations of 3D tissues are physiologically different, because they are exposed to different concentrations of oxygen, nutrients, and signaling molecules, and to other environmental factors (temperature, mechanical stress, etc). The majority of high-throughput assays based on 3D cultures, however, can only detect the average behavior of cells in the whole 3D construct. Isolation of cells from specific regions of 3D cultures is possible, but relies on low-throughput techniques such as tissue sectioning and micromanipulation. Based on a procedure reported previously ("cells-in-gels-in-paper'' or CiGiP), this paper describes a simple method for culture of arrays of thin planar sections of tissues, either alone or stacked to create more complex 3D tissue structures. This procedure starts with sheets of paper patterned with hydrophobic regions that form 96 hydrophilic zones. Serial spotting of cells suspended in extracellular matrix (ECM) gel onto the patterned paper creates an array of 200 micron-thick slabs of ECM gel (supported mechanically by cellulose fibers) containing cells. Stacking the sheets with zones aligned on top of one another assembles 96 3D multilayer constructs. De-stacking the layers of the 3D culture, by peeling apart the sheets of paper, "sections'' all 96 cultures at once. It is, thus, simple to isolate 200-micron-thick cell-containing slabs from each 3D culture in the 96-zone array. Because the 3D cultures are assembled from multiple layers, the number of cells plated initially in each layer determines the spatial distribution of cells in the stacked 3D cultures. This capability made it possible to compare the growth of 3D tumor models of different spatial composition, and to examine the migration of cells in these structures.	[Derda, Ratmir; Tang, Sindy K. Y.; Laromaine, Anna; Hong, Estrella; Mwangi, Martin; Whitesides, George M.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Derda, Ratmir; Tang, Sindy K. Y.; Laromaine, Anna; Mosadegh, Bobak; Ingber, Donald E.; Whitesides, George M.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Cambridge, MA 02138 USA; [Mammoto, Akiko; Ingber, Donald E.] Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA; [Mammoto, Akiko; Ingber, Donald E.] Harvard Univ, Sch Med, Boston, MA USA; [Ingber, Donald E.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University	Derda, R (corresponding author), Univ Alberta, Dept Chem, Edmonton, AB, Canada.	ratmir.derda@ualberta.ca; gwhitesides@gmwgroup.harvard.edu	Laromaine, Anna/M-5294-2019; Ingber, Donald E/AAC-5894-2019; Laromaine, Anna/D-1964-2009; Thuo, Martin/C-2281-2009	Laromaine, Anna/0000-0002-4764-0780; Laromaine, Anna/0000-0002-4764-0780; Thuo, Martin/0000-0003-3448-8027	Vertex Inc.; Wyss Institute of Biologically Inspired Engineering; Fulbright-Generalitat de Catalunya; American Heart Association; National Institutes of Health [ES 016665]; Department of Defense; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016665] Funding Source: NIH RePORTER	Vertex Inc.(Vertex Pharmaceuticals); Wyss Institute of Biologically Inspired Engineering; Fulbright-Generalitat de Catalunya(Generalitat de Catalunya); American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by funds from Vertex Inc., the Wyss Institute of Biologically Inspired Engineering, Fulbright-Generalitat de Catalunya (to A.L.), the American Heart Association (to A.M.), and by National Institutes of Health Grant ES 016665 (to G. M. W.), and a Department of Defense Breast Cancer Innovator Award (to D.E.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a; Abraham VC, 2004, TRENDS BIOTECHNOL, V22, P15, DOI 10.1016/j.tibtech.2003.10.012; ACKER H, 1987, BRIT J CANCER, V56, P325, DOI 10.1038/bjc.1987.197; Angeli F, 2009, TUMOR BIOL, V30, P109, DOI 10.1159/000218708; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Blackwell HE, 2006, CURR OPIN CHEM BIOL, V10, P203, DOI 10.1016/j.cbpa.2006.04.026; Bowman MD, 2004, ORG LETT, V6, P2019, DOI 10.1021/ol049313f; Bruzewicz DA, 2008, ANAL CHEM, V80, P3387, DOI 10.1021/ac702605a; Carrilho E, 2009, ANAL CHEM, V81, P7091, DOI 10.1021/ac901071p; Chung S, 2009, LAB CHIP, V9, P269, DOI 10.1039/b807585a; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d; Dang TT, 2009, BIOMATERIALS, V30, P6896, DOI 10.1016/j.biomaterials.2009.09.012; De Wever O, 2003, J PATHOL, V200, P429, DOI 10.1002/path.1398; Derda R, 2009, P NATL ACAD SCI USA, V106, P18457, DOI 10.1073/pnas.0910666106; Doheny JG, 1999, BIOCHEM J, V339, P429, DOI 10.1042/0264-6021:3390429; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; Du YA, 2008, P NATL ACAD SCI USA, V105, P9522, DOI 10.1073/pnas.0801866105; DURAND RE, 1982, J HISTOCHEM CYTOCHEM, V30, P117, DOI 10.1177/30.2.6174559; Echeverria V, J BIOMOL SCREEN, V15, P1144; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; FRANKO AJ, 1979, RADIAT RES, V79, P439, DOI 10.2307/3575173; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Gelain F, 2007, MACROMOL BIOSCI, V7, P544, DOI 10.1002/mabi.200700033; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Hilpert K, 2007, NAT PROTOC, V2, P1333, DOI 10.1038/nprot.2007.160; Horning JL, 2008, MOL PHARMACEUT, V5, P849, DOI 10.1021/mp800047v; Huang CP, 2009, LAB CHIP, V9, P1740, DOI 10.1039/b818401a; Huang S, 1999, NAT CELL BIOL, V1, pE131, DOI 10.1038/13043; Hui EE, 2007, P NATL ACAD SCI USA, V104, P5722, DOI 10.1073/pnas.0608660104; Ifkovits JL, 2007, TISSUE ENG, V13, P2369, DOI 10.1089/ten.2007.0093; Justice BA, 2009, DRUG DISCOV TODAY, V14, P102, DOI 10.1016/j.drudis.2008.11.006; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kim S, 2010, INTEGR BIOL-UK, V2, P584, DOI 10.1039/c0ib00055h; Kunz-Schughart LA, 2004, J BIOMOL SCREEN, V9, P273, DOI 10.1177/1087057104265040; Lang P, 2006, NAT REV DRUG DISCOV, V5, P343, DOI 10.1038/nrd2008; Lee MH, 2008, J CELL SCI, V121, P1141, DOI 10.1242/jcs.016634; Legant WR, 2010, NAT METHODS, V7, P969, DOI 10.1038/NMETH.1531; Legant WR, 2009, P NATL ACAD SCI USA, V106, P10097, DOI 10.1073/pnas.0900174106; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765; Martinez AW, 2007, ANGEW CHEM INT EDIT, V46, P1318, DOI 10.1002/anie.200603817; McGuigan AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002258; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Mosadegh B, 2007, LANGMUIR, V23, P10910, DOI 10.1021/la7026835; MuellerKlieser W, 1997, AM J PHYSIOL-CELL PH, V273, pC1109, DOI 10.1152/ajpcell.1997.273.4.C1109; Nelson CM, 2008, NAT PROTOC, V3, P674, DOI 10.1038/nprot.2008.35; Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936; Orner BP, 2004, J AM CHEM SOC, V126, P10808, DOI 10.1021/ja0474291; Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612; Radisic M, 2006, BIOTECHNOL BIOENG, V93, P332, DOI 10.1002/bit.20722; Schmeichel KL, 2003, J CELL SCI, V116, P2377, DOI 10.1242/jcs.00503; Shastri VP, 2000, P NATL ACAD SCI USA, V97, P1970, DOI 10.1073/pnas.97.5.1970; Steff AM, 2001, CYTOMETRY, V45, P237, DOI 10.1002/1097-0320(20011201)45:4<237::AID-CYTO10024>3.0.CO;2-J; SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290; Thurber GM, 2008, ADV DRUG DELIVER REV, V60, P1421, DOI 10.1016/j.addr.2008.04.012; Torisawa YS, 2010, INTEGR BIOL-UK, V2, P680, DOI 10.1039/c0ib00041h; Torisawa YS, 2009, INTEGR BIOL-UK, V1, P649, DOI 10.1039/b915965g; Walenta S, 2002, BIOMOL ENG, V18, P249, DOI 10.1016/S1389-0344(01)00107-1; WATANABE K, 1993, CYTOTECHNOLOGY, V13, P107, DOI 10.1007/BF00749937; Weibel DB, 2006, CURR OPIN CHEM BIOL, V10, P584, DOI 10.1016/j.cbpa.2006.10.016; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Widhe M, 2010, BIOMATERIALS, V31, P9575, DOI 10.1016/j.biomaterials.2010.08.061; Wodarz A, 2007, NAT CELL BIOL, V9, P1016, DOI 10.1038/ncb433; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874; Zhang XH, 2009, ADV DRUG DELIVER REV, V61, P988, DOI 10.1016/j.addr.2009.07.005	70	169	171	2	129	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e18940	10.1371/journal.pone.0018940	http://dx.doi.org/10.1371/journal.pone.0018940			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573103	Green Submitted, gold, Green Published			2022-12-27	WOS:000290305600010
J	Kenah, E; Chao, DL; Matrajt, L; Halloran, ME; Longini, IM				Kenah, Eben; Chao, Dennis L.; Matrajt, Laura; Halloran, M. Elizabeth; Longini, Ira M., Jr.			The Global Transmission and Control of Influenza	PLOS ONE			English	Article							A H1N1 VIRUS; SEASONAL INFLUENZA; EPIDEMIC MODELS; UNITED-STATES; SPREAD; VACCINATION; NETWORKS; MOBILITY; A(H1N1)	New strains of influenza spread around the globe via the movement of infected individuals. The global dynamics of influenza are complicated by different patterns of influenza seasonality in different regions of the world. We have released an open-source stochastic mathematical model of the spread of influenza across 321 major, strategically located cities of the world. Influenza is transmitted between cities via infected airline passengers. Seasonality is simulated by increasing the transmissibility in each city at the times of the year when influenza has been observed to be most prevalent. The spatiotemporal spread of pandemic influenza can be understood through clusters of global transmission and links between them, which we identify using the epidemic percolation network (EPN) of the model. We use the model to explain the observed global pattern of spread for pandemic influenza A(H1N1) 2009-2010 (pandemic H1N1 2009) and to examine possible global patterns of spread for future pandemics depending on the origin of pandemic spread, time of year of emergence, and basic reproductive number (R-0). We also use the model to investigate the effectiveness of a plausible global distribution of vaccine for various pandemic scenarios. For pandemic H1N1 2009, we show that the biggest impact of vaccination was in the temperate northern hemisphere. For pandemics starting in the temperate northern hemisphere in May or April, vaccination would have little effect in the temperate southern hemisphere and a small effect in the tropics. With the increasing interconnectedness of the world's population, we must take a global view of infectious disease transmission. Our open-source, computationally simple model can help public health officials plan for the next pandemic as well as deal with interpandemic influenza.	[Kenah, Eben; Chao, Dennis L.; Halloran, M. Elizabeth; Longini, Ira M., Jr.] Fred Hutchinson Canc Res Ctr, Ctr Stat & Quantitat Infect Dis, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Kenah, Eben; Halloran, M. Elizabeth; Longini, Ira M., Jr.] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA; [Matrajt, Laura] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kenah, E (corresponding author), Fred Hutchinson Canc Res Ctr, Ctr Stat & Quantitat Infect Dis, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.	dchao@fhcrc.org	Matrajt, Laura/AAV-5216-2020	Chao, Dennis/0000-0002-8253-6321	National Institute of General Medical Sciences MIDAS [U01-GM070749]; National Institute of Allergy and Infectious Diseases [R01-AI32042]; GlaxoSmithKline; National Institute of General Medical Sciences [F32-GM085945]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070749, F32GM085945] Funding Source: NIH RePORTER	National Institute of General Medical Sciences MIDAS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); GlaxoSmithKline(GlaxoSmithKline); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by the National Institute of General Medical Sciences MIDAS grant U01-GM070749, the National Institute of Allergy and Infectious Diseases grant R01-AI32042, and by a grant from GlaxoSmithKline. EK was also supported by National Institute of General Medical Sciences grant F32-GM085945. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45; Basta NE, 2008, AM J EPIDEMIOL, V168, P1343, DOI 10.1093/aje/kwn259; Bedford T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000918; Bonabeau E, 1998, P ROY SOC B-BIOL SCI, V265, P2421, DOI 10.1098/rspb.1998.0593; Central Intelligence Agency, 2009, WORLD FACTB 2009; Chao DL, 2010, J INFECT DIS, V202, P877, DOI 10.1086/655810; Edler D., 2010, MAP GENERATOR SOFTWA, DOI http://www.mapequation.org; Flahault A, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-129; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Hill AN, 2003, MATH BIOSCI, V181, P85, DOI 10.1016/S0025-5564(02)00129-3; HOPESIMPSON RE, 1981, J HYG-CAMBRIDGE, V86, P35, DOI 10.1017/S0022172400068728; Institute for Health Metrics and Evaluation, GROSS DOM PROD GDP D; Jones E., 2001, SCIPY OPEN SOURCE SC; Kenah E, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036113; Kenah E, 2007, J THEOR BIOL, V249, P706, DOI 10.1016/j.jtbi.2007.09.011; Khan K, 2009, NEW ENGL J MED, V361, P212, DOI 10.1056/NEJMc0904559; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; McBryde ES, 2009, EUROSURVEILLANCE, V14, P45; MURPHY BR, 1980, INFECT IMMUN, V29, P348; Nelson MI, 2007, PLOS PATHOG, V3, P1220, DOI 10.1371/journal.ppat.0030131; Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125; Park AW, 2007, LANCET INFECT DIS, V7, P543, DOI 10.1016/S1473-3099(07)70186-X; Patel R, 2005, J THEOR BIOL, V234, P201, DOI 10.1016/j.jtbi.2004.11.032; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; RVACHEV LA, 1985, MATH BIOSCI, V75, P3, DOI 10.1016/0025-5564(85)90064-1; Schanzer DL, 2010, INFLUENZA OTHER RESP, V4, P295, DOI 10.1111/j.1750-2659.2010.00154.x; Shaman J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000316; Shek Lynette Pei-Chi, 2003, Paediatr Respir Rev, V4, P105, DOI 10.1016/S1526-0542(03)00024-1; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Viboud C, 2004, EMERG INFECT DIS, V10, P32, DOI 10.3201/eid1001.020705; Weycker D, 2005, VACCINE, V23, P1284, DOI 10.1016/j.vaccine.2004.08.044; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	36	52	52	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19515	10.1371/journal.pone.0019515	http://dx.doi.org/10.1371/journal.pone.0019515			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573121	Green Published, gold, Green Submitted			2022-12-27	WOS:000290305600028
J	Latzka, J; Gaier, S; Hofstetter, G; Balazs, N; Smole, U; Ferrone, S; Scheiner, O; Breiteneder, H; Pehamberger, H; Wagner, S				Latzka, Julia; Gaier, Sonja; Hofstetter, Gerlinde; Balazs, Nina; Smole, Ursula; Ferrone, Soldano; Scheiner, Otto; Breiteneder, Heimo; Pehamberger, Hubert; Wagner, Stefan			Specificity of Mimotope-Induced Anti-High Molecular Weight-Melanoma Associated Antigen (HMW-MAA) Antibodies Does Not Ensure Biological Activity	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; TUMOR-GROWTH; IN-VITRO; CANCER-IMMUNOTHERAPY; PEPTIDE MIMOTOPES; IMMUNE-RESPONSE; CELL-SURFACE; VACCINATION; EPITOPE; MICE	Vaccines based on peptide mimics (mimotopes) of conformational tumor antigen epitopes have been investigated for a variety of human tumors including breast cancer, tumors expressing the carcinoembryonic antigen, B cell lymphoma, neuroblastoma, and melanoma. In our previous work, we designed a vaccine based on a mimotope of the high molecular weight-melanoma associated antigen (HMW-MAA) that elicited HMW-MAA-specific antibodies (Abs) with anti-tumor activity in vitro and in vivo. In this study, we aimed to identify mimotopes of additional distinct HMW-MAA epitopes, since they could be used to construct a polymimotope melanoma vaccine. For this purpose, random peptide phage libraries were screened with the anti-HMW-MAA monoclonal antibodies (mAbs) VT80.12 and VF1-TP43 yielding one peptide ligand for each mAb. Both peptides inhibited the binding of the corresponding mAb to the HMW-MAA. Furthermore, when coupled to the carrier protein keyhole limpet hemocyanin (KLH), both HMW-MAA mimotopes elicited peptide-specific Abs in rabbits or BALB/c mice, but only the mimotope isolated with the mAb VT80.12 elicited HMW-MAA-specific Abs and only in mice. However, the latter Abs had no detectable effect on HMW-MAA expressing human melanoma cells in vitro. These results describe limitations related to the phage display technique and emphasize the need to characterize the functional properties of the mAb utilized to isolate mimotopes of the corresponding epitopes.	[Latzka, Julia; Gaier, Sonja; Hofstetter, Gerlinde; Balazs, Nina; Smole, Ursula; Scheiner, Otto; Breiteneder, Heimo; Wagner, Stefan] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria; [Ferrone, Soldano] Univ Pittsburgh, Inst Canc, Dept Surg Immunol & Pathol, Pittsburgh, PA USA; [Pehamberger, Hubert] Med Univ Vienna, Dept Dermatol, Div Gen Dermatol, Vienna, Austria	Medical University of Vienna; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Medical University of Vienna	Latzka, J (corresponding author), Med Univ Vienna, Dept Pathophysiol & Allergy Res, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria.	stefan.wagner@meduniwien.ac.at		Smole, Ursula/0000-0001-5124-2024	Austrian Academy of Sciences at the Department of Pathophysiology and Allergy Research (Medical University of Vienna, Vienna, Austria)	Austrian Academy of Sciences at the Department of Pathophysiology and Allergy Research (Medical University of Vienna, Vienna, Austria)	SG was a recipient of a DOC-fFORTE-fellowship of the Austrian Academy of Sciences at the Department of Pathophysiology and Allergy Research (Medical University of Vienna, Vienna, Austria). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bramswig KH, 2007, CLIN CANCER RES, V13, P6501, DOI 10.1158/1078-0432.CCR-07-0692; Brunner R, 2010, IMMUNOL LETT, V128, P29, DOI 10.1016/j.imlet.2009.10.005; Campoli M, 2010, ADV CANCER RES, V109, P73, DOI 10.1016/B978-0-12-380890-5.00003-X; Campoli MR, 2004, CRIT REV IMMUNOL, V24, P267, DOI 10.1615/CritRevImmunol.v24.i4.40; Chang CC, 2004, ANN NY ACAD SCI, V1028, P340, DOI 10.1196/annals.1322.040; CHEE DO, 1976, CANCER RES, V36, P1503; Engelhard VH, 2002, IMMUNOL REV, V188, P136, DOI 10.1034/j.1600-065X.2002.18812.x; FELICI F, 1991, J MOL BIOL, V222, P301, DOI 10.1016/0022-2836(91)90213-P; GIACOMINI P, 1984, CANCER RES, V44, P1281; Hafner C, 2005, MELANOMA RES, V15, P111, DOI 10.1097/00008390-200504000-00005; Hafner C, 2005, INT J CANCER, V114, P426, DOI 10.1002/ijc.20769; Hartmann C, 2010, ONCOGENE, V29, P4517, DOI 10.1038/onc.2010.195; Holmes K, 2001, Curr Protoc Immunol, VChapter 5, DOI 10.1002/0471142735.im0503s44; Jasinska J, 2003, INT J CANCER, V107, P976, DOI 10.1002/ijc.11485; Jiang BH, 2005, J BIOL CHEM, V280, P4656, DOI 10.1074/jbc.M411047200; Li M, 2006, CELL IMMUNOL, V239, P136, DOI 10.1016/j.cellimm.2006.05.005; Maciag PC, 2008, CANCER RES, V68, P8066, DOI 10.1158/0008-5472.CAN-08-0287; MATSUI M, 1987, J IMMUNOL, V139, P2088; MITTELMAN A, 1992, P NATL ACAD SCI USA, V89, P466, DOI 10.1073/pnas.89.2.466; MITTELMAN A, 1994, CANCER RES, V54, P415; Perosa F, 2005, ANN NY ACAD SCI, V1051, P672, DOI 10.1196/annals.1361.112; Perosa F, 2007, J IMMUNOL, V179, P7967, DOI 10.4049/jimmunol.179.11.7967; Perosa F, 2009, J IMMUNOL, V182, P416, DOI 10.4049/jimmunol.182.1.416; Ray S, 2009, CLIN DERMATOL, V27, P603, DOI 10.1016/j.clindermatol.2008.09.019; Riemer AB, 2005, JNCI-J NATL CANCER I, V97, P1663, DOI 10.1093/jnci/dji373; Riemer AB, 2005, CANCER IMMUNOL IMMUN, V54, P677, DOI 10.1007/s00262-004-0632-7; Riemer AB, 2004, J IMMUNOL, V173, P394, DOI 10.4049/jimmunol.173.1.394; Spiridon CI, 2002, CLIN CANCER RES, V8, P1720; vanElsas A, 1997, J IMMUNOTHER, V20, P343, DOI 10.1097/00002371-199709000-00003; Wagner S, 2005, J IMMUNOL, V174, P976, DOI 10.4049/jimmunol.174.2.976; Wagner S, 2007, BREAST CANCER RES TR, V106, P29, DOI 10.1007/s10549-006-9469-4; Wagner S, 2008, CLIN CANCER RES, V14, P8178, DOI 10.1158/1078-0432.CCR-08-0371; Wang X, 2010, CURR MOL MED, V10, P419, DOI 10.2174/156652410791316977; WILSON BS, 1981, INT J CANCER, V28, P293, DOI 10.1002/ijc.2910280307; Yang XD, 2009, REV MED VIROL, V19, P77, DOI 10.1002/rmv.602; Zhao L, 2008, EXPERT REV VACCINES, V7, P1547, DOI 10.1586/14760584.7.10.1547	36	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19383	10.1371/journal.pone.0019383	http://dx.doi.org/10.1371/journal.pone.0019383			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573118	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000290305600024
J	Tan, NX; Messina, JP; Yang, LG; Yang, B; Emch, M; Chen, XS; Cohen, MS; Tucker, JD				Tan, Nicholas X.; Messina, Jane P.; Yang, Li-Gang; Yang, Bin; Emch, Michael; Chen, Xiang-Sheng; Cohen, Myron S.; Tucker, Joseph D.			A Spatial Analysis of County-level Variation in Syphilis and Gonorrhea in Guangdong Province, China	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; FEMALE SEX WORKERS; TO-URBAN MIGRANTS; MALE RURAL MIGRANTS; HIV-INFECTION; RISK-FACTORS; EASTERN CHINA; HEPATITIS-B; DRUG-USERS; MEN	Background: Sexually transmitted infections (STI) have made a resurgence in many rapidly developing regions of southern China, but there is little understanding of the social changes that contribute to this spatial distribution of STI. This study examines county-level socio-demographic characteristics associated with syphilis and gonorrhea in Guangdong Province. Methods/Principal Findings: This study uses linear regression and spatial lag regression to determine county-level (n = 97) socio-demographic characteristics associated with a greater burden of syphilis, gonorrhea, and a combined syphilis/gonorrhea index. Data were obtained from the 2005 China Population Census and published public health data. A range of socio-demographic variables including gross domestic product, the Gender Empowerment Measure, standard of living, education level, migrant population and employment are examined. Reported syphilis and gonorrhea cases are disproportionately clustered in the Pearl River Delta, the central region of Guangdong Province. A higher fraction of employed men among the adult population, higher fraction of divorced men among the adult population, and higher standard of living (based on water availability and people per room) are significantly associated with higher STI cases across all three models. Gross domestic product and gender inequality measures are not significant predictors of reported STI in these models. Conclusions/Significance: Although many ecological studies of STIs have found poverty to be associated with higher reported STI, this analysis found a greater number of reported syphilis cases in counties with a higher standard of living. Spatially targeted syphilis screening measures in regions with a higher standard of living may facilitate successful control efforts. This analysis also reinforces the importance of changing male sexual behaviors as part of a comprehensive response to syphilis control in China.	[Tan, Nicholas X.; Tucker, Joseph D.] Harvard Univ, Cambridge, MA 02138 USA; [Messina, Jane P.; Emch, Michael] Univ N Carolina, Dept Geog, Chapel Hill, NC USA; [Yang, Li-Gang; Yang, Bin; Tucker, Joseph D.] Guangdong Prov STI Control Ctr, Guangzhou, Guangdong, Peoples R China; [Chen, Xiang-Sheng] Natl Ctr STD Control, Nanjing, Peoples R China; [Cohen, Myron S.; Tucker, Joseph D.] Univ N Carolina, Sch Med, Div Infect Dis, Chapel Hill, NC USA	Harvard University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Tan, NX (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.	yanglg3@yahoo.com; jtucker4@partners.org		Tucker, Joseph/0000-0003-2804-1181	National Institutes of Health (NIH) [US NIH 1K01TW008200-01A1]; University of North Carolina (UNC) [NIH FIC D43 TW01039]; UNC Social Science Research on HIV/AIDS in China [NIH NICHD R24 HD056670-01]; Harvard Institute for Global Health; American Society of Tropical Medicine and Hygiene; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R24HD056670] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [K01TW008200, D43TW001039] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina (UNC); UNC Social Science Research on HIV/AIDS in China; Harvard Institute for Global Health; American Society of Tropical Medicine and Hygiene; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The authors acknowledge a National Institutes of Health (NIH) Fogarty K01 Award (US NIH 1K01TW008200-01A1; JT), the University of North Carolina (UNC) Fogarty AIDS International Research and Training Program (NIH FIC D43 TW01039), the UNC Social Science Research on HIV/AIDS in China (NIH NICHD R24 HD056670-01), the Harvard Institute for Global Health, and Burroughs Wellcome Fund/American Society of Tropical Medicine and Hygiene Wellcome Postdoctoral Fellowship in Tropical Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZDARDET C, 1985, SEX TRANSM DIS, V12, P166, DOI 10.1097/00007435-198507000-00016; Buchacz K, 2004, AIDS, V18, P2075, DOI 10.1097/00002030-200410210-00012; Chen ZQ, 2007, LANCET, V369, P132, DOI 10.1016/S0140-6736(07)60074-9; Choi KH, 2004, AIDS EDUC PREV, V16, P19, DOI 10.1521/aeap.16.1.19.27721; DUBOISARBER F, 1993, SOC SCI MED, V37, P1539, DOI 10.1016/0277-9536(93)90188-A; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Fan CC, 1999, INT MIGR REV, V33, P954, DOI 10.2307/2547359; Gillespie S, 2007, AIDS, V21, pS1, DOI 10.1097/01.aids.0000300530.67107.45; He N, 2006, AIDS EDUC PREV, V18, P176, DOI 10.1521/aeap.2006.18.2.176; He N, 2005, SEX TRANSM DIS, V32, P286, DOI 10.1097/01.olq.0000152219.58592.9b; He N, 2007, BIOSCI TRENDS, V1, P72; Hesketh T, 2006, SEX TRANSM INFECT, V82, P11, DOI 10.1136/sti.2004.014043; Holtgrave DR, 2003, SEX TRANSM INFECT, V79, P62, DOI 10.1136/sti.79.1.62; Hong FC, 2010, SEX TRANSM DIS, V37, P26, DOI 10.1097/OLQ.0b013e3181b3915b; Hong Y, 2006, AIDS BEHAV, V10, P421, DOI 10.1007/s10461-005-9039-5; Jewkes R, 2010, SCIENCE, V329, P145, DOI 10.1126/science.1193794; Jia YJ, 2008, HARM REDUCT J, V5, DOI 10.1186/1477-7517-5-29; Jiang J, 2006, SEX TRANSM DIS, V33, P118, DOI 10.1097/01.olq.0000199763.14766.2b; Johnson K, 2006, JAIDS-J ACQ IMM DEF, V42, P627, DOI 10.1097/01.qai.0000225870.87456.ae; Kalichman SC, 2006, SOC SCI MED, V62, P1641, DOI 10.1016/j.socscimed.2005.08.021; Kilmarx PH, 1997, AM J PUBLIC HEALTH, V87, P1937, DOI 10.2105/AJPH.87.12.1937; Law DCG, 2004, SEX TRANSM INFECT, V80, P294, DOI 10.1136/sti.2003.006700; Li DL, 2010, AIDS PATIENT CARE ST, V24, P595, DOI 10.1089/apc.2010.0083; Li SH, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-195; LIDDON N, 2010, J WOMENS HLTH LARCHM; LIU DLLL, 2005, HOMOSEXUALITY RES CH, V47, P274; Liu HJ, 2006, SEX TRANSM DIS, V33, P111, DOI 10.1097/01.olq.0000199762.28231.ee; Liu HJ, 2005, AIDS PATIENT CARE ST, V19, P49, DOI 10.1089/apc.2005.19.49; Lu F, 2009, SE ASIAN J TROP MED, V40, P263; Mbonu NC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-334; *NAT BUR STAT CHIN, 1 NAT POP SAMPL SURV; Parish WL, 2003, JAMA-J AM MED ASSOC, V289, P1265, DOI 10.1001/jama.289.10.1265; Piot P, 2007, PLOS MED, V4, P1571, DOI 10.1371/journal.pmed.0040314; Reynolds SJ, 2006, SEX TRANSM INFECT, V82, P121, DOI 10.1136/sti.2005.015040; Ruan YH, 2004, SEX TRANSM DIS, V31, P623; Ruan YH, 2006, SEX TRANSM DIS, V33, P719, DOI 10.1097/01.olq.0000218881.01437.99; Ruan YH, 2009, JAIDS-J ACQ IMM DEF, V52, P604, DOI 10.1097/QAI.0b013e3181b31f5c; Schleihauf E, 2009, SEX TRANSM INFECT, V85, P45, DOI 10.1136/sti.2008.030197; Shahmanesh M, 2000, SEX TRANSM INFECT, V76, P268, DOI 10.1136/sti.76.4.268; THOMAS JC, 1995, AM J PUBLIC HEALTH, V85, P1119, DOI 10.2105/AJPH.85.8_Pt_1.1119; Tladi L S, 2006, SAHARA J, V3, P369; Tucker JD, 2005, AIDS, V19, P539, DOI 10.1097/01.aids.0000163929.84154.87; TUCKER JD, 2010, GENDER POLICY HIV CH; Tucker JD, 2010, B WORLD HEALTH ORGAN, V88, P452, DOI 10.2471/BLT.09.070326; Tucker JD, 2010, NEW ENGL J MED, V362, P1658, DOI 10.1056/NEJMp0911149; Turmen T, 2003, INT J GYNECOL OBSTET, V82, P411, DOI 10.1016/S0020-7292(03)00202-9; *UNDP, HUM DEV REP HDR UN D; Uretsky E, 2008, CULT HEALTH SEX, V10, P801, DOI 10.1080/13691050802380966; Wang B, 2007, SEX TRANSM DIS, V34, P1, DOI 10.1097/01.olq.0000222668.95038.03; Wang Man, 2009, Zhonghua Yu Fang Yi Xue Za Zhi, V43, P1004; Xia GM, 2005, AIDS EDUC PREV, V17, P143, DOI 10.1521/aeap.17.3.143.62904; Xu JJ, 2010, SEX TRANSM DIS, V37, P432, DOI 10.1097/OLQ.0b013e3181d13eed; YANG H, 2010, SEX TRANSM DIS; YANG LG, 2010, ANN STD SURVEILLANCE; YANG LG, BMC PUBLIC IN PRESS; Yang LG, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-793; Yang X, 2007, AIDS CARE, V19, P282, DOI 10.1080/09540120600909414; Yang XS, 2006, STUD FAMILY PLANN, V37, P241, DOI 10.1111/j.1728-4465.2006.00103.x; Yi HS, 2010, PSYCHOL HEALTH MED, V15, P172, DOI 10.1080/13548501003623914; Yin Lu, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P293; Yu XJ, 2007, LANDSCAPE URBAN PLAN, V79, P96, DOI 10.1016/j.landurbplan.2006.03.008; [张北川 Zhang Beichuan], 2002, [中华皮肤科杂志, Chinese Journa of Dermatology], V35, P214	62	16	16	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19648	10.1371/journal.pone.0019648	http://dx.doi.org/10.1371/journal.pone.0019648			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	760DZ	21573127	Green Published, gold, Green Submitted			2022-12-27	WOS:000290305600038
J	Teixido, L; Carrasco, B; Alonso, JC; Barbe, J; Campoy, S				Teixido, Laura; Carrasco, Begona; Alonso, Juan C.; Barbe, Jordi; Campoy, Susana			Fur Activates the Expression of Salmonella enterica Pathogenicity Island 1 by Directly Interacting with the hilD Operator In Vivo and In Vitro	PLOS ONE			English	Article							III SECRETION SYSTEM; TYPHIMURIUM INVASION GENES; ESCHERICHIA-COLI; SEROVAR TYPHIMURIUM; NEISSERIA-MENINGITIDIS; TRANSCRIPTIONAL REPRESSION; COORDINATE REGULATION; OXIDATIVE STRESS; IRON-METABOLISM; VIRULENCE GENES	Previous studies have established that the expression of Salmonella enterica pathogenicity island 1 (SPI1), which is essential for epithelial invasion, is mainly regulated by the HilD protein. The ferric uptake regulator, Fur, in turn modulates the expression of the S. enterica hilD gene, albeit through an unknown mechanism. Here we report that S. enterica Fur, in its metal-bound form, specifically binds to an AT-rich region (BoxA), located upstream of the hilD promoter (P-hilD), at position -191 to -163 relative to the hilD transcription start site. Furthermore, in a P-hilD variant with mutations in BoxA, P-hilD*, Fur-Mn2+ binding is impaired. In vivo experiments using S. enterica strains carrying wild-type P-hilD or the mutant variant P-hilD* showed that Fur activates hilD expression, while in vitro experiments revealed that the Fur-Mn2+ protein is sufficient to increase hilD transcription. Together, these results present the first evidence that Fur-Mn2+, by binding to the upstream BoxA sequence, directly stimulates the expression of hilD in S. enterica.	[Teixido, Laura; Barbe, Jordi; Campoy, Susana] Univ Autonoma Barcelona, Dept Genet & Microbiol, Fac Biociencies, Bellaterra, Spain; [Carrasco, Begona] Univ Oviedo, Area Microbiol, Fac Med, Oviedo, Spain; [Alonso, Juan C.] CSIC, Ctr Nacl Biotecnol, Madrid, Spain	Autonomous University of Barcelona; University of Oviedo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Teixido, L (corresponding author), Univ Autonoma Barcelona, Dept Genet & Microbiol, Fac Biociencies, Bellaterra, Spain.	Susana.Campoy@uab.cat	Barbe, Jordi/G-5212-2015; campoy, susana/E-4346-2010; Alonso, Juan Carlos/D-2595-2009; Campoy, Susana/C-7335-2008	Barbe, Jordi/0000-0003-4408-013X; campoy, susana/0000-0003-1369-0197; Alonso, Juan Carlos/0000-0002-5178-7179; Campoy, Susana/0000-0003-1369-0197; Carrasco, Begona/0000-0002-5671-1296	Ministerio de Ciencia e Innovacion (MICIIN) [BFU2008-01078, BFU2009-07167]; Generalitat de Catalunya [2009SGR1106]	Ministerio de Ciencia e Innovacion (MICIIN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported by the Ministerio de Ciencia e Innovacion (MICIIN) [grants BFU2008-01078 to J.B. and BFU2009-07167 to J.C.A.]; and the Generalitat de Catalunya [2009SGR1106 to J.B.]. B. C. was the recipient of a Juan de la Cierva fellowship from the MICIIN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADHYA S, 1993, GENE, V132, P1, DOI 10.1016/0378-1119(93)90507-Y; Alamuri P, 2006, J BACTERIOL, V188, P5325, DOI 10.1128/JB.00104-06; Altier C, 2005, J MICROBIOL, V43, P85; Baichoo N, 2002, J BACTERIOL, V184, P5826, DOI 10.1128/JB.184.21.5826-5832.2002; Bajaj V, 1996, MOL MICROBIOL, V22, P703, DOI 10.1046/j.1365-2958.1996.d01-1718.x; Baxter MA, 2003, INFECT IMMUN, V71, P1295, DOI 10.1128/IAI.71.3.1295-1305.2003; Bjarnason J, 2003, J BACTERIOL, V185, P4973, DOI 10.1128/JB.185.16.4973-4982.2003; Bsat N, 1999, J BACTERIOL, V181, P4299, DOI 10.1128/JB.181.14.4299-4307.1999; Campoy S, 2003, MOL MICROBIOL, V49, P769, DOI 10.1046/j.1365-2958.2003.03592.x; Campoy S, 2002, MICROBIOL-SGM, V148, P1039, DOI 10.1099/00221287-148-4-1039; Carpenter BM, 2009, INFECT IMMUN, V77, P2590, DOI 10.1128/IAI.00116-09; Carrasco B, 2008, DNA REPAIR, V7, P990, DOI 10.1016/j.dnarep.2008.03.019; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; COLLIS CM, 1989, NUCLEIC ACIDS RES, V17, P9447, DOI 10.1093/nar/17.22.9447; Conrad ME, 2002, BLOOD CELL MOL DIS, V29, P336, DOI 10.1006/bcmd.2002.0564; Darwin KH, 1999, J BACTERIOL, V181, P4949; Darwin KH, 2001, EMBO J, V20, P1850, DOI 10.1093/emboj/20.8.1850; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis R., 1980, ADV BACTERIAL GENETI; de la Hoz AB, 2000, P NATL ACAD SCI USA, V97, P728, DOI 10.1073/pnas.97.2.728; Delany I, 2004, MOL MICROBIOL, V52, P1081, DOI 10.1111/j.1365-2958.2004.04030.x; DELORENZO V, 1987, J BACTERIOL, V169, P2624, DOI 10.1128/jb.169.6.2624-2630.1987; DELORENZO V, 1988, J MOL BIOL, V203, P875, DOI 10.1016/0022-2836(88)90113-1; Eichelberg K, 1999, INFECT IMMUN, V67, P4099, DOI 10.1128/IAI.67.8.4099-4105.1999; Ekhnovich IN, 2007, J BACTERIOL, V189, P6882, DOI 10.1128/JB.00905-07; Ellermeier CD, 2005, MOL MICROBIOL, V57, P691, DOI 10.1111/j.1365-2958.2005.04737.x; Ellermeier CD, 2003, J BACTERIOL, V185, P5096, DOI 10.1128/JB.185.17.5096-5108.2003; Ellermeier JR, 2008, J BACTERIOL, V190, P476, DOI 10.1128/JB.00926-07; Ellermeier JR, 2007, CURR OPIN MICROBIOL, V10, P24, DOI 10.1016/j.mib.2006.12.002; Escolar L, 2000, J BIOL CHEM, V275, P24709, DOI 10.1074/jbc.M002839200; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Gao H, 2008, J BACTERIOL, V190, P3063, DOI 10.1128/JB.01910-07; GARCIADELPORTILLO F, 1993, INFECT IMMUN, V61, P4489, DOI 10.1128/IAI.61.10.4489-4492.1993; Garrido ME, 2003, MICROBIOL-SGM, V149, P2273, DOI 10.1099/mic.0.26370-0; Grifantini R, 2004, MOL MICROBIOL, V54, P962, DOI 10.1111/j.1365-2958.2004.04315.x; GRIGGS DW, 1989, J BACTERIOL, V171, P1048, DOI 10.1128/jb.171.2.1048-1054.1989; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Janakiraman A, 2000, MOL MICROBIOL, V35, P1146, DOI 10.1046/j.1365-2958.2000.01783.x; Jones BD, 2005, J MICROBIOL, V43, P110; Lavrrar JL, 2003, J BACTERIOL, V185, P2194, DOI 10.1128/JB.185.7.2194-2202.2003; Lee HJ, 2007, J BACTERIOL, V189, P2629, DOI 10.1128/JB.01791-06; Lee JW, 2007, BIOMETALS, V20, P485, DOI 10.1007/s10534-006-9070-7; LITWIN CM, 1992, J BACTERIOL, V174, P1897, DOI 10.1128/jb.174.6.1897-1903.1992; Lostroh CP, 2001, MICROBES INFECT, V3, P1281; Lostroh CP, 2000, MOL MICROBIOL, V37, P300, DOI 10.1046/j.1365-2958.2000.01991.x; Lucas RL, 2001, J BACTERIOL, V183, P2733, DOI 10.1128/JB.183.9.2733-2745.2001; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; Mastroeni P, 2009, NAT REV MICROBIOL, V7, P73, DOI 10.1038/nrmicro2034; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; Mazon G, 2004, MOL GENET GENOMICS, V271, P40, DOI 10.1007/s00438-003-0952-x; Munch R, 2005, BIOINFORMATICS, V21, P4187, DOI 10.1093/bioinformatics/bti635; Nandal A, 2010, MOL MICROBIOL, V75, P637, DOI 10.1111/j.1365-2958.2009.06977.x; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Olekhnovich IN, 2002, J BACTERIOL, V184, P4148, DOI 10.1128/JB.184.15.4148-4160.2002; Outten FW, 2004, MOL MICROBIOL, V52, P861, DOI 10.1111/j.1365-2958.2004.04025.x; PANG T, 1995, TRENDS MICROBIOL, V3, P253, DOI 10.1016/S0966-842X(00)88937-4; PARK SJ, 1995, J BACTERIOL, V177, P6255, DOI 10.1128/jb.177.21.6255-6262.1995; PEGUES DA, 1995, MOL MICROBIOL, V17, P169, DOI 10.1111/j.1365-2958.1995.mmi_17010169.x; PRINCE RW, 1993, J BACTERIOL, V175, P2589, DOI 10.1128/JB.175.9.2589-2598.1993; Prouty AM, 2000, INFECT IMMUN, V68, P6763, DOI 10.1128/IAI.68.12.6763-6769.2000; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Rojo F, 2001, CURR OPIN MICROBIOL, V4, P145, DOI 10.1016/S1369-5274(00)00180-6; Saini S, 2010, PLOS PATHOG, V6, DOI [10.1371/annotation/df7e26bc-4c62-43b4-865f-a39274d98ab3, 10.1371/journal.ppat.1001025]; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Schechter LM, 2003, INFECT IMMUN, V71, P5432, DOI 10.1128/IAI.71.9.5432-5435.2003; Schechter LM, 2001, MOL MICROBIOL, V40, P1289, DOI 10.1046/j.1365-2958.2001.02462.x; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; STOJILJKOVIC I, 1994, J MOL BIOL, V236, P531, DOI 10.1006/jmbi.1994.1163; TARDAT B, 1993, MOL MICROBIOL, V9, P53, DOI 10.1111/j.1365-2958.1993.tb01668.x; Teixido L, 2010, INT MICROBIOL, V13, P33, DOI 10.2436/20.1501.01.109; Teplitski M, 2003, J BACTERIOL, V185, P7257, DOI 10.1128/JB.185.24.7257-7265.2003; THOMAS CE, 1994, MOL MICROBIOL, V11, P725, DOI 10.1111/j.1365-2958.1994.tb00350.x; TOUATI D, 1988, J BACTERIOL, V170, P2511, DOI 10.1128/jb.170.6.2511-2520.1988; TRAVERS AA, 1989, ANNU REV BIOCHEM, V58, P427, DOI 10.1146/annurev.biochem.58.1.427; Troxell B, 2011, J BACTERIOL, V193, P497, DOI 10.1128/JB.00942-10; TSOLIS RM, 1995, J BACTERIOL, V177, P4628, DOI 10.1128/jb.177.16.4628-4637.1995; Vassinova N, 2000, MICROBIOL-SGM, V146, P3171, DOI 10.1099/00221287-146-12-3171; Vivero A, 2008, J BACTERIOL, V190, P1152, DOI 10.1128/JB.01206-07; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; WEINBERG ED, 1978, MICROBIOL REV, V42, P45, DOI 10.1128/MMBR.42.1.45-66.1978; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0	84	57	63	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19711	10.1371/journal.pone.0019711	http://dx.doi.org/10.1371/journal.pone.0019711			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573071	Green Published, Green Submitted, gold			2022-12-27	WOS:000290305600042
J	Li, H; Hughes, AL; Bano, N; McArdle, S; Livingston, S; Deubner, H; McMahon, BJ; Townshend-Bulson, L; McMahan, R; Rosen, HR; Gretch, DR				Li, Hui; Hughes, Austin L.; Bano, Nazneen; McArdle, Susan; Livingston, Stephen; Deubner, Heike; McMahon, Brian J.; Townshend-Bulson, Lisa; McMahan, Rachel; Rosen, Hugo R.; Gretch, David R.			Genetic Diversity of Near Genome-Wide Hepatitis C Virus Sequences during Chronic Infection: Evidence for Protein Structural Conservation Over Time	PLOS ONE			English	Article							ORDERED RNA STRUCTURE; ALASKA NATIVES; NONSYNONYMOUS SUBSTITUTION; MOLECULAR EVOLUTION; IN-VIVO; INTERFERON; MUTATIONS; RIBAVIRIN; DYNAMICS; IMMUNITY	Infection with hepatitis C virus (HCV) is one of the leading causes of chronic hepatitis, liver cirrhosis and end-stage liver disease worldwide. The genetics of HCV infection in humans and the disease course of chronic hepatitis C are both remarkably variable. Although the response to interferon treatment is largely dependent on HCV genotypes, whether or not a relationship exists between HCV genome variability and clinical course of hepatitis C disease still remains unknown. To more thoroughly understand HCV genome evolution over time in association with disease course, near genome-wide HCV genomes present in 9 chronically infected participants over 83 total study years were sequenced. Overall, within HCV genomes, the number of synonymous substitutions per synonymous site (d(S)) significantly exceeded the number of non-synonymous substitutions per site (d(N)). Although both d(S) and d(N) significantly increased with duration of chronic infection, there was a highly significant decrease in d(N)/d(S) ratio in HCV genomes over time. These results indicate that purifying selection acted to conserve viral protein structure despite persistence of high level of nucleotide mutagenesis inherent to HCV replication. Based on liver biopsy fibrosis scores, HCV genomes from participants with advanced fibrosis had significantly greater d(S) values and lower d(N)/d(S) ratios compared to participants with mild liver disease. Over time, viral genomes from participants with mild disease had significantly greater annual changes in d(N), along with higher d(N)/d(S) ratios, compared to participants with advanced fibrosis. Yearly amino acid variations in the HCV p7, NS2, NS3 and NS5B genes were all significantly lower in participants with severe versus mild disease, suggesting possible pathogenic importance of protein structural conservation for these viral gene products.	[Li, Hui; Bano, Nazneen; McArdle, Susan; Gretch, David R.] Univ Washington, Med Ctr, Dept Lab Med, Seattle, WA 98195 USA; [Hughes, Austin L.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Livingston, Stephen; McMahon, Brian J.; Townshend-Bulson, Lisa] Alaska Native Tribal Hlth Consortium, Liver Dis & Hepatitis Program, Anchorage, AK USA; [Deubner, Heike] Univ Washington, Med Ctr, Dept Pathol, Seattle, WA 98195 USA; [McMahan, Rachel; Rosen, Hugo R.] Univ Colorado, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Aurora, CO USA; [Gretch, David R.] Univ Washington, Med Ctr, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Alaska Native Tribal Health Consortium; University of Washington; University of Washington Seattle; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Washington; University of Washington Seattle	Li, H (corresponding author), Univ Washington, Med Ctr, Dept Lab Med, Seattle, WA 98195 USA.	gretch@u.washington.edu			NIH [AI 48214, AI 7044-28]; Alaska Science and Technology Foundation [99-4-113]; Alaska Native Tribal Health Consortium; National Centers for Infectious Diseases, Centers for Disease Control and Prevention; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007044, U19AI048214] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alaska Science and Technology Foundation; Alaska Native Tribal Health Consortium; National Centers for Infectious Diseases, Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by NIH grants AI 48214, AI 7044-28, and Alaska Science and Technology Foundation Grant Agreement Number 99-4-113 to the University of Washington, the Liver Disease and Hepatitis Program of the Alaska Native Tribal Health Consortium, and the Arctic Investigations Program of the National Centers for Infectious Diseases, Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowen DG, 2005, J EXP MED, V201, P1709, DOI 10.1084/jem.20050808; Bruce MG, 2008, J VIRAL HEPATITIS, V15, P179, DOI 10.1111/j.1365-2893.2007.00928.x; Bruce MG, 2006, LIVER INT, V26, P643, DOI 10.1111/j.1478-3231.2006.01281.x; DAVIDSON F, 1995, J GEN VIROL, V76, P1197, DOI 10.1099/0022-1317-76-5-1197; Davis M, 2008, J VIROL, V82, P11824, DOI 10.1128/JVI.01078-08; Domingo E, 2006, CURR TOP MICROBIOL, V299, P51; El-Shamy A, 2008, HEPATOLOGY, V48, P38, DOI 10.1002/hep.22339; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; FAZOLLAH MR, 1994, INTRO INFORM THEORY; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Golden-Mason L, 2008, J IMMUNOL, V180, P3637, DOI 10.4049/jimmunol.180.6.3637; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Horner SM, 2009, J INTERF CYTOK RES, V29, P489, DOI 10.1089/jir.2009.0063; Hughes AL, 2008, ANN NY ACAD SCI, V1133, P162, DOI 10.1196/annals.1438.001; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Joyce MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000291; Kimura M., 1983, NEUTRAL THEORY MOL E; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; KORBER BTM, 1994, J VIROL, V68, P7467, DOI 10.1128/JVI.68.11.7467-7481.1994; Kuiken Carla, 2009, V510, P33, DOI 10.1007/978-1-59745-394-3_4; Li H, 2008, J VIROL, V82, P7524, DOI 10.1128/JVI.02220-07; Li H, 2008, VIROLOGY, V375, P580, DOI 10.1016/j.virol.2008.02.012; Li H, 2010, VIROLOGY, V402, P248, DOI 10.1016/j.virol.2010.03.040; LI WH, 1978, GENETICS, V90, P349; LI WH, 1993, J MOL EVOL, V36, P96, DOI 10.1007/BF02407308; MCMAHAN RH, 2010, J CLIN INVEST; McMahon BJ, 2004, HEPATOLOGY, V39, P325, DOI 10.1002/hep.20046; McMahon BJ, 2010, GASTROENTEROLOGY, V138, P922, DOI 10.1053/j.gastro.2009.10.056; McMullan LK, 2007, P NATL ACAD SCI USA, V104, P2879, DOI 10.1073/pnas.0611267104; Mishima K, 2010, VIROLOGY, V405, P361, DOI 10.1016/j.virol.2010.06.020; Missale G, 1996, J CLIN INVEST, V98, P706, DOI 10.1172/JCI118842; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nei M., 2000, MOL EVOLUTION PHYLOG; OHTA T, 1976, THEOR POPUL BIOL, V10, P254, DOI 10.1016/0040-5809(76)90019-8; Pavio N, 2005, ONCOGENE, V24, P6119, DOI 10.1038/sj.onc.1208749; Rehermann B, 1996, BAILLIERE CLIN GASTR, V10, P483, DOI 10.1016/S0950-3528(96)90054-8; Scheuer Peter J, 2002, Clin Liver Dis, V6, P335, DOI 10.1016/S1089-3261(02)00009-0; SEEFF LB, 1997, HEPATOLOGY S1, V26, P21; Shoukry NH, 2004, ANNU REV MICROBIOL, V58, P391, DOI 10.1146/annurev.micro.58.030603.123836; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Simmonds P, 2004, RNA, V10, P1337, DOI 10.1261/rna.7640104; Sullivan DG, 2007, J INFECT DIS, V196, P239, DOI 10.1086/518895; Suzuki T, 2007, J GASTROENTEROL, V42, P411, DOI 10.1007/s00535-007-2030-3; Thimme R, 2006, ANTIVIR RES, V69, P129, DOI 10.1016/j.antiviral.2005.12.001; WHO, 1999, WKLY EPIDEMIOL REC, V74, P425; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; Wohnsland A, 2007, CLIN MICROBIOL REV, V20, P23, DOI 10.1128/CMR.00010-06; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Young KC, 2003, HEPATOLOGY, V38, P869, DOI 10.1053/jhep.2003.50445	49	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19562	10.1371/journal.pone.0019562	http://dx.doi.org/10.1371/journal.pone.0019562			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573177	Green Submitted, gold, Green Published			2022-12-27	WOS:000290256400024
J	Watson, VG; Motsinger-Reif, A; Hardison, NE; Peters, EJ; Havener, TM; Everitt, L; Auman, JT; Comins, DL; McLeod, HL				Watson, Venita Gresham; Motsinger-Reif, Alison; Hardison, Nicholas E.; Peters, Eric J.; Havener, Tammy M.; Everitt, Lorraine; Auman, James Todd; Comins, Daniel L.; McLeod, Howard L.			Identification and Replication of Loci Involved in Camptothecin-Induced Cytotoxicity Using CEPH Pedigrees	PLOS ONE			English	Article							TOPOISOMERASE-I INHIBITORS; GENE-EXPRESSION PROFILES; CANCER-CELL LINES; HUMAN GENOME; DNA-DAMAGE; DISCOVERY; CISPLATIN; APOPTOSIS; SCREEN; SENSITIVITY	To date, the Centre d'Etude Polymorphism Humain (CEPH) cell line model has only been used as a pharmacogenomic tool to evaluate which genes are responsible for the disparity in response to a single drug. The purpose of this study was demonstrate the model's ability to establish a specific pattern of quantitative trait loci (QTL) related to a shared mechanism for multiple structurally related drugs, the camptothecins, which are Topoisomerase 1 inhibitors. A simultaneous screen of six camptothecin analogues for in vitro sensitivity in the CEPH cell lines resulted in cytotoxicity profiles and orders of potency which were in agreement with the literature. For all camptothecins studied, heritability estimates for cytotoxic response averaged 23.1 +/- 2.6%. Nonparametric linkage analysis was used to identify a relationship between genetic markers and response to the camptothecins. Ten QTLs on chromosomes 1, 3, 5, 6, 11, 12, 16 and 20 were identified as shared by all six camptothecin analogues. In a separate validation experiment, nine of the ten QTLs were replicated at the significant and suggestive levels using three additional camptothecin analogues. To further refine this list of QTLs, another validation study was undertaken and seven of the nine QTLs were independently replicated for all nine camptothecin analogues. This is the first study using the CEPH cell lines that demonstrates that a specific pattern of QTLs could be established for a class of drugs which share a mechanism of action. Moreover, it is the first study to report replication of linkage results for drug-induced cytotoxicity using this model. The QTLs, which have been identified as shared by all camptothecins and replicated across multiple datasets, are of considerable interest; they harbor genes related to the shared mechanism of action for the camptothecins, which are responsible for variation in response.	[Watson, Venita Gresham; Peters, Eric J.; Havener, Tammy M.; Everitt, Lorraine; Auman, James Todd; McLeod, Howard L.] Univ N Carolina, Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Inst Pharmacogen & Individualized Therapy, Chapel Hill, NC 27599 USA; [Motsinger-Reif, Alison; Hardison, Nicholas E.] N Carolina State Univ, Dept Stat, Bioinformat Res Ctr, Raleigh, NC 27695 USA; [Comins, Daniel L.] N Carolina State Univ, Dept Chem, Raleigh, NC 27695 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Watson, VG (corresponding author), Univ N Carolina, Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Inst Pharmacogen & Individualized Therapy, Chapel Hill, NC 27599 USA.	hmcleod@unc.edu	Motsinger-Reif, Alison/I-4167-2018; McLeod, Howard/ABD-8364-2021; Auman, James/AAY-7748-2020	Motsinger-Reif, Alison/0000-0003-1346-2493; McLeod, Howard/0000-0002-9004-9232; Havener, Tammy/0000-0002-4613-0498; Auman, James/0000-0002-9328-8829	Pharmacogenetics Research Network [U01 GM63340]; National Research Service Award [F31 CA1199385]; National Institute of Environmental Health Sciences [2 T32 ES007329]; Greensboro Golfers Against Cancer; NATIONAL CANCER INSTITUTE [F31CA119938, R01CA161608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM063340] Funding Source: NIH RePORTER	Pharmacogenetics Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Greensboro Golfers Against Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Pharmacogenetics Research Network (grant number U01 GM63340), a National Research Service Award Fellowship to VGW (grant number F31 CA1199385), and a National Institute of Environmental Health Sciences training grant to NEH (grant number 2 T32 ES007329). This work was also supported by the Greensboro Golfers Against Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Baetz K, 2004, P NATL ACAD SCI USA, V101, P4525, DOI 10.1073/pnas.0307122101; Bartz SR, 2006, MOL CELL BIOL, V26, P9377, DOI 10.1128/MCB.01229-06; Beretta GL, 2008, EXPERT OPIN THER TAR, V12, P1243, DOI [10.1517/14728222.12.10.1243, 10.1517/14728222.12.10.1243 ]; BERETTA GL, 2006, CURR MED CHEM ANTICA, P3291; Blower P. E., 2002, Pharmacogenomics Journal, V2, P259, DOI 10.1038/sj.tpj.6500116; Borrell B, 2010, NATURE, V463, P858, DOI 10.1038/463858a; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Choy E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000287; COHEN D, 1993, NATURE, V366, P698, DOI 10.1038/366698a0; Daoud SS, 2003, CANCER RES, V63, P2782; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dolan ME, 2004, CANCER RES, V64, P4353, DOI 10.1158/0008-5472.CAN-04-0340; Duan SW, 2007, CANCER RES, V67, P5425, DOI 10.1158/0008-5472.CAN-06-4431; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gresham V, 2009, ADV DRUG DELIVER REV, V61, P369, DOI 10.1016/j.addr.2008.12.002; Guo YY, 2006, NAT BIOTECHNOL, V24, P531, DOI 10.1038/nbt1195; Hayward RL, 2003, CLIN CANCER RES, V9, P2856; Hill R, 2000, TRENDS PHARMACOL SCI, V21, P244, DOI 10.1016/S0165-6147(00)01502-9; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang RY, 2005, CANCER RES, V65, P5890, DOI 10.1158/0008-5472.CAN-04-4093; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Nakatsu N, 2005, MOL CANCER THER, V4, P399; Pardanani A, 2008, BLOOD, V111, P2785, DOI 10.1182/blood-2007-06-095703; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Peters EJ, 2009, PHARMACOGENET GENOM, V19, P399, DOI 10.1097/FPC.0b013e328329fdec; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; RDC Team, 2005, R LANG ENV STAT COMP; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Smirnov DA, 2009, NATURE, V459, P587, DOI 10.1038/nature07940; Takeba Y, 2007, J PHARMACOL SCI, V104, P232, DOI 10.1254/jphs.FP0070442; TANIZAWA A, 1994, J NATL CANCER I, V86, P836, DOI 10.1093/jnci/86.11.836; Ulukan H, 2002, DRUGS, V62, P2039, DOI 10.2165/00003495-200262140-00004; Watters JW, 2004, P NATL ACAD SCI USA, V101, P11809, DOI 10.1073/pnas.0404580101; Welsh M, 2009, PHARMACOL REV, V61, P413, DOI 10.1124/pr.109.001461; Zembutsu H, 2002, CANCER RES, V62, P518; Zhou Y, 2002, CANCER RES, V62, P1688	41	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e17561	10.1371/journal.pone.0017561	http://dx.doi.org/10.1371/journal.pone.0017561			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573211	Green Submitted, Green Published, gold			2022-12-27	WOS:000290256400001
J	Richmond, P; Buesing, L; Giugliano, M; Vasilaki, E				Richmond, Paul; Buesing, Lars; Giugliano, Michele; Vasilaki, Eleni			Democratic Population Decisions Result in Robust Policy-Gradient Learning: A Parametric Study with GPU Simulations	PLOS ONE			English	Article							SPIKING NEURAL-NETWORKS; LAYERED NETWORKS; REINFORCEMENT; MODEL; NAVIGATION; INTEGRATE; REWARD; PLASTICITY; CODES	High performance computing on the Graphics Processing Unit (GPU) is an emerging field driven by the promise of high computational power at a low cost. However, GPU programming is a non-trivial task and moreover architectural limitations raise the question of whether investing effort in this direction may be worthwhile. In this work, we use GPU programming to simulate a two-layer network of Integrate-and-Fire neurons with varying degrees of recurrent connectivity and investigate its ability to learn a simplified navigation task using a policy-gradient learning rule stemming from Reinforcement Learning. The purpose of this paper is twofold. First, we want to support the use of GPUs in the field of Computational Neuroscience. Second, using GPU computing power, we investigate the conditions under which the said architecture and learning rule demonstrate best performance. Our work indicates that networks featuring strong Mexican-Hat-shaped recurrent connections in the top layer, where decision making is governed by the formation of a stable activity bump in the neural population (a "non-democratic" mechanism), achieve mediocre learning results at best. In absence of recurrent connections, where all neurons "vote" independently ("democratic") for a decision via population vector readout, the task is generally learned better and more robustly. Our study would have been extremely difficult on a desktop computer without the use of GPU programming. We present the routines developed for this purpose and show that a speed improvement of 5x up to 42x is provided versus optimised Python code. The higher speed is achieved when we exploit the parallelism of the GPU in the search of learning parameters. This suggests that efficient GPU programming can significantly reduce the time needed for simulating networks of spiking neurons, particularly when multiple parameter configurations are investigated.	[Richmond, Paul; Vasilaki, Eleni] Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England; [Buesing, Lars] UCL, Gatsby Computat Neurosci Unit, London, England; [Giugliano, Michele] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium	University of Sheffield; University of London; University College London; University of Antwerp	Richmond, P (corresponding author), Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England.	E.Vasilaki@sheffield.ac.uk	Giugliano, Michele/A-5666-2012	Giugliano, Michele/0000-0003-2626-594X; Vasilaki, Eleni/0000-0003-3705-7070; Richmond, Paul/0000-0002-4657-5518	Royal Society [2009/R4]; Flanders Research Foundation [G.0836.09, G.0244.08]	Royal Society(Royal Society of London); Flanders Research Foundation(FWO)	This work has been supported by the Royal Society International Joint Projects grant 2009/R4 (royalsociety.org) for EV and MG. MG acknowledges support from the Flanders Research Foundation grants G.0836.09 and G.0244.08 (www.fwo.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; AMARI SI, 1977, BIOL CYBERN, V27, P77, DOI 10.1007/BF00337259; AMARI SI, 1975, BIOL CYBERN, V17, P211, DOI 10.1007/BF00339367; ANANTHANARAYANA.R, 2009, SC 09; Arleo A, 2000, BIOL CYBERN, V83, P287, DOI 10.1007/s004220000171; Baras D, 2007, NEURAL COMPUT, V19, P2245, DOI 10.1162/neco.2007.19.8.2245; BARTO AG, 1983, IEEE T SYST MAN CYB, V13, P834, DOI 10.1109/TSMC.1983.6313077; BARTO AG, 1985, HUM NEUROBIOL, V4, P229; Baxter J, 2001, J ARTIF INTELL RES, V15, P351, DOI 10.1613/jair.807; BEIERHOLM U, 2010, PLOS COMPUTATIONAL B, P6; Bell N., 2008, NVR2008004 NVID CORP; BERNHARD F, 2006, INT C COMP SCI ICCS, P236; Bhuiyan M. A., 2010, 2010 IEEE INT S PARA, P1, DOI [10.1109/IPDPSW.2010.5470899, DOI 10.1109/IPDPSW.2010.5470899]; BILL J, 2010, FRONTIERS COMPUTATIO, V4, P12; BRUEDERLE D, 2010, P 2010 IEEE INT S CI, P2784; BRUEDERLE D, 2009, FRONTIERS NEUROINFOR, V3; Buck I, 2004, ACM T GRAPHIC, V23, P777, DOI 10.1145/1015706.1015800; COULTRIP R, 1992, NEURAL NETWORKS, V5, P47, DOI 10.1016/S0893-6080(05)80006-1; CYRILLE R, 2010, FRONT NEUROINFORM, V4, P12; DAVISON A, 2010, COMMON LANGUAGE NEUR; Davison A., 2007, BMC NEUROSCI, V8, pP2; Davison AP, 2009, FRONT NEUROSCI-SWITZ, V3, P374, DOI 10.3389/neuro.01.036.2009; Davison Andrew P, 2008, Front Neuroinform, V2, P11, DOI 10.3389/neuro.11.011.2008; DAYAN P, 2008, ROLE VALUE SYSTEMS D, P51; Dayan P, 2009, NEURAL NETWORKS, V22, P213, DOI 10.1016/j.neunet.2009.03.004; Dayan P, 2008, COGN AFFECT BEHAV NE, V8, P429, DOI 10.3758/CABN.8.4.429; DICASTRO D, 2009, NIPS, V22, P385; EPPLER J, 2008, FRONTIERS NEUROINFOR, V2; Farries MA, 2007, J NEUROPHYSIOL, V98, P3648, DOI 10.1152/jn.00364.2007; Fiete IR, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.048104; Florian RV, 2007, NEURAL COMPUT, V19, P1468, DOI 10.1162/neco.2007.19.6.1468; Foster DJ, 2000, HIPPOCAMPUS, V10, P1, DOI 10.1002/(SICI)1098-1063(2000)10:1<1::AID-HIPO1>3.0.CO;2-1; Friedrich J, 2010, NEURAL COMPUT, V22, P1698, DOI 10.1162/neco.2010.05-09-1010; Furber S, 2008, STUD COMPUT INTELL, V115, P763, DOI 10.1098/rsif.2006.0177; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Gerstner W, 2002, SPIKING NEURON MODEL; Goodman Dan, 2008, Front Neuroinform, V2, P5, DOI 10.3389/neuro.11.005.2008; Goodman DFM, 2010, NEUROINFORMATICS, V8, P183, DOI 10.1007/s12021-010-9082-x; Goodman DFM, 2009, FRONT NEUROSCI-SWITZ, V3, P192, DOI 10.3389/neuro.01.026.2009; Gummaraju J, 2005, INT SYMP MICROARCH, P343; Hamaguchi K, 2005, NEURAL COMPUT, V17, P2034, DOI 10.1162/0899766054322937; Hines ML, 2004, J COMPUT NEUROSCI, V17, P7, DOI 10.1023/B:JCNS.0000023869.22017.2e; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Jensen O, 2000, J NEUROPHYSIOL, V83, P2602, DOI 10.1152/jn.2000.83.5.2602; Kempter R, 1999, PHYS REV E, V59, P4498, DOI 10.1103/PhysRevE.59.4498; Legenstein R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000894; Legenstein R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000180; Ly D. L., 2008, NEURAL NETWORKS GPUS; Markram H, 2006, NAT REV NEUROSCI, V7, P153, DOI 10.1038/nrn1848; Martinez-Zarzuela M, 2007, LECT NOTES COMPUT SC, V4507, P463; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nageswaran JM, 2009, NEURAL NETWORKS, V22, P791, DOI 10.1016/j.neunet.2009.06.028; NVIDIA Corporation, 2008, NVIDIA CUDA PROGR GU; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Pfister JP, 2006, NEURAL COMPUT, V18, P1318, DOI 10.1162/neco.2006.18.6.1318; Piekniewski F, 2010, LECT NOTES ARTIF INT, V6114, P64, DOI 10.1007/978-3-642-13232-2_9; Potjans W, 2009, NEURAL COMPUT, V21, P301, DOI 10.1162/neco.2008.08-07-593; RENAUD S, 2007, CIRCUITS SYSTEMS 200, P3355; RICHMOND P, 2008, P EUROSIS ESM 2008; Richmond P, 2010, BRIEF BIOINFORM, V11, P334, DOI 10.1093/bib/bbp073; Sanders J., 2010, CUDA EXAMPLE INTRO G; Sengupta S, 2007, GRAPHICS HARDWARE 2007: ACM SIGGRAPH / EUROGRAPHICS SYMPOSIUM PROCEEDINGS, P97; Seung HS, 2003, NEURON, V40, P1063, DOI 10.1016/S0896-6273(03)00761-X; Sheynikhovich D, 2005, LECT NOTES ARTIF INT, V3575, P245; Spiridon M, 2001, NETWORK-COMP NEURAL, V12, P409, DOI 10.1088/0954-898X/12/4/301; STEIN RB, 1965, BIOPHYS J, V5, P173, DOI 10.1016/S0006-3495(65)86709-1; Strosslin T, 2005, NEURAL NETWORKS, V18, P1125, DOI 10.1016/j.neunet.2005.08.012; Suri RE, 2001, NEURAL COMPUT, V13, P841, DOI 10.1162/089976601300014376; Sutton R.S., 1990, LEARNING COMPUTATION, P497; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; Talmi D, 2009, J NEUROSCI, V29, P14617, DOI 10.1523/JNEUROSCI.2026-09.2009; van Meel JA, 2008, MOL SIMULAT, V34, P259, DOI 10.1080/08927020701744295; van Rossum MCW, 2004, NEUROCOMPUTING, V58, P265, DOI 10.1016/j.neucom.2004.01.054; van Rossum MCW, 2002, J NEUROSCI, V22, P1956, DOI 10.1523/JNEUROSCI.22-05-01956.2002; Van Rossum MCW, 2001, J COMPUT NEUROSCI, V10, P303, DOI 10.1023/A:1011268215708; Vasilaki E, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000586; Vasilaki E, 2009, BIOL CYBERN, V100, P147, DOI 10.1007/s00422-008-0288-z; WANG X, 2006, MICROCIRCUIT MODEL P, P92; Watkins C. J. C. H., 1989, LEARNING DELAYED REW; WILLIAMS RJ, 1992, MACH LEARN, V8, P229, DOI 10.1007/BF00992696; Xie XH, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.041909	83	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e18539	10.1371/journal.pone.0018539	http://dx.doi.org/10.1371/journal.pone.0018539			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21572529	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000290224800002
J	D'Avanzo, N; Hyrc, K; Enkvetchakul, D; Covey, DF; Nichols, CG				D'Avanzo, Nazzareno; Hyrc, Krzysztof; Enkvetchakul, Decha; Covey, Douglas F.; Nichols, Colin G.			Enantioselective Protein-Sterol Interactions Mediate Regulation of Both Prokaryotic and Eukaryotic Inward Rectifier K+ Channels by Cholesterol	PLOS ONE			English	Article							BILAYER-MEMBRANES; ANION CURRENT; IN-VITRO; SENSITIVITY; MODULATION; HYPERCHOLESTEROLEMIA; ELASTICITY; EXPRESSION; KIR2.1; ASSAY	Cholesterol is the major sterol component of all mammalian cell plasma membranes and plays a critical role in cell function and growth. Previous studies have shown that cholesterol inhibits inward rectifier K+ (Kir) channels, but have not distinguished whether this is due directly to protein-sterol interactions or indirectly to changes in the physical properties of the lipid bilayer. Using purified bacterial and eukaryotic Kir channels reconstituted into liposomes of controlled lipid composition, we demonstrate by Rb-86(+) influx assays that bacterial Kir channels (KirBac1.1 and KirBac3.1) and human Kir2.1 are all inhibited by cholesterol, most likely by locking the channels into prolonged closed states, whereas the enantiomer, ent-cholesterol, does not inhibit these channels. These data indicate that cholesterol regulates Kir channels through direct protein-sterol interactions likely taking advantage of an evolutionarily conserved binding pocket.	[D'Avanzo, Nazzareno; Hyrc, Krzysztof; Nichols, Colin G.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [D'Avanzo, Nazzareno; Hyrc, Krzysztof; Nichols, Colin G.] Washington Univ, Sch Med, Ctr Invest Membrane Excitabil Dis, St Louis, MO USA; [Enkvetchakul, Decha] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA; [Covey, Douglas F.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Saint Louis University; Washington University (WUSTL)	D'Avanzo, N (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	cnichols@wustl.edu	Nichols, Colin/D-6336-2012	Hyrc, Krzysztof/0000-0002-8830-6324	National Institutes of Health [HL54171, DK069424, GM47969]; Neuroscience Blueprint [P30NS057105]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Neuroscience Blueprint; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grant HL54171 (CGN), DK069424 (DE), GM47969 (DFC) and Neuroscience Blueprint Core Grant P30NS057105 to Washington University in St. Louis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alakoskela JM, 2008, LANGMUIR, V24, P830, DOI 10.1021/la702909q; Ambudkar Indu S, 2004, Sci STKE, V2004, ppe32, DOI 10.1126/stke.2432004pe32; BOLOTINA V, 1989, PFLUG ARCH EUR J PHY, V415, P262, DOI 10.1007/BF00370875; Bowles DK, 2004, J APPL PHYSIOL, V96, P2240, DOI 10.1152/japplphysiol.01229.2003; Bukiya AN, 2011, J GEN PHYSIOL, V137, P93, DOI 10.1085/jgp.201010519; CADENHEAD DA, 1979, CHEM PHYS LIPIDS, V25, P329, DOI 10.1016/0009-3084(79)90115-4; Cheng WWL, 2011, BIOPHYS J, V100, P620, DOI 10.1016/j.bpj.2010.12.3724; Cheng WWL, 2009, J GEN PHYSIOL, V133, P295, DOI 10.1085/jgp.200810125; Covey DF, 2009, STEROIDS, V74, P577, DOI 10.1016/j.steroids.2008.11.019; D'Avanzo N, 2010, J BIOL CHEM, V285, P37129, DOI 10.1074/jbc.C110.186692; D'Avanzo N, 2010, CHANNELS, V4, P139, DOI 10.4161/chan.4.3.12129; D'Avanzo N, 2010, PROTEIN EXPRES PURIF, V71, P115, DOI 10.1016/j.pep.2010.01.010; DEMEL RA, 1976, BIOCHIM BIOPHYS ACTA, V457, P109, DOI 10.1016/0304-4157(76)90008-3; Enkvetchakul D, 2005, J BIOL CHEM, V280, P35785, DOI 10.1074/jbc.C500355200; Enkvetchakul D, 2004, J BIOL CHEM, V279, P47076, DOI 10.1074/jbc.C400417200; Epand RM, 2005, BIOCHEM J, V390, P541, DOI 10.1042/BJ20050649; Epshtein Y, 2009, P NATL ACAD SCI USA, V106, P8055, DOI 10.1073/pnas.0809847106; EVANS E, 1987, J PHYS CHEM-US, V91, P4219, DOI 10.1021/j100300a003; Gidwani A, 2001, BIOCHEMISTRY-US, V40, P12422, DOI 10.1021/bi010496c; Heaps CL, 2005, AM J PHYSIOL-HEART C, V288, pH568, DOI 10.1152/ajpheart.00157.2004; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Jiang X, 2002, J ORG CHEM, V67, P4893, DOI 10.1021/jo025535k; Kahya N, 2006, MOL MEMBR BIOL, V23, P29, DOI 10.1080/09687860500489099; Kellner-Weibel G, 1999, ATHEROSCLEROSIS, V146, P309, DOI 10.1016/S0021-9150(99)00155-0; LEDERER WJ, 1989, J PHYSIOL-LONDON, V419, P193, DOI 10.1113/jphysiol.1989.sp017869; Levitan I, 2000, J GEN PHYSIOL, V115, P405, DOI 10.1085/jgp.115.4.405; Liu J, 2005, BIOCHEM J, V391, P389, DOI 10.1042/BJ20050428; Lockwich TP, 2000, J BIOL CHEM, V275, P11934, DOI 10.1074/jbc.275.16.11934; Lundbaek JA, 1996, BIOCHEMISTRY-US, V35, P3825, DOI 10.1021/bi952250b; Lundbaek JA, 2004, J GEN PHYSIOL, V123, P599, DOI 10.1085/jgp.200308996; Mannock DA, 2003, BIOPHYS J, V84, P1038, DOI 10.1016/S0006-3495(03)74920-0; Martens JR, 2000, J BIOL CHEM, V275, P7443, DOI 10.1074/jbc.275.11.7443; MURARI R, 1986, BIOCHEMISTRY-US, V25, P1062, DOI 10.1021/bi00353a017; NEEDHAM D, 1990, BIOPHYS J, V58, P997, DOI 10.1016/S0006-3495(90)82444-9; Nimigean CM, 2006, NAT PROTOC, V1, P1207, DOI 10.1038/nprot.2006.166; Romanenko VG, 2004, BIOPHYS J, V87, P3850, DOI 10.1529/biophysj.104.043273; Romanenko VG, 2004, J GEN PHYSIOL, V123, P77, DOI 10.1085/jgp.200308882; Romanenko VG, 2002, BIOPHYS J, V83, P3211, DOI 10.1016/S0006-3495(02)75323-X; Rosenhouse-Dantsker A, 2010, CHANNELS, V4, P63, DOI 10.4161/chan.4.1.10366; Salton MR, 1997, BIOMEMBRANE, V1, P1; Singh DK, 2009, J BIOL CHEM, V284, P30727, DOI 10.1074/jbc.M109.011221; Tikku S, 2007, AM J PHYSIOL-CELL PH, V293, pC440, DOI 10.1152/ajpcell.00492.2006; Toselli M, 2005, BIOPHYS J, V89, P2443, DOI 10.1529/biophysj.105.065623; Wang J, 2006, J BIOL CHEM, V281, P27894, DOI 10.1074/jbc.M605603200; Westover EJ, 2003, STEROIDS, V68, P159, DOI 10.1016/S0039-128X(02)00174-5; WU CC, 1995, J MOL CELL CARDIOL, V27, P1263, DOI 10.1016/S0022-2828(05)82388-0; YEAGLE PL, 1991, BIOCHIMIE, V73, P1303, DOI 10.1016/0300-9084(91)90093-G; YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P267, DOI 10.1016/0304-4157(85)90011-5; Yeagle PL, 1985, CHOLESTEROL MEMBRANE, P1	49	48	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19393	10.1371/journal.pone.0019393	http://dx.doi.org/10.1371/journal.pone.0019393			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559361	Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700156
J	Gosline, SJC; Nascimento, M; McCall, LI; Zilberstein, D; Thomas, DY; Matlashewski, G; Hallett, M				Gosline, Sara J. C.; Nascimento, Mirna; McCall, Laura-Isobel; Zilberstein, Dan; Thomas, David Y.; Matlashewski, Greg; Hallett, Michael			Intracellular Eukaryotic Parasites Have a Distinct Unfolded Protein Response	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; LEISHMANIA-DONOVANI; TRANSCRIPTION FACTOR; TRANSLATIONAL CONTROL; KINASE GCN2; GENE; IDENTIFICATION; EXPRESSION; A2; DIFFERENTIATION	Insult to the endoplasmic reticulum (ER) activates the Unfolded Protein Response (UPR), a set of signaling pathways that protect the cell from the potential damage caused by improperly folded proteins. Accumulation of misfolded proteins in the ER lumen initiates a series of signal transduction events via activation of three transmembrane ER proteins: Ire1, Atf6 and PERK. Activation of these proteins results in the transcriptional up-regulation of the components of the folding, trafficking and degradation machinery in the ER. PERK further reduces the load on the ER via the phosphorylation of eIF2 alpha, attenuating general protein translation. It is believed that the UPR evolved as a transcriptional response that up-regulates protein folding machinery in the ER and later gained the ability to decrease ER load by attenuating general protein translation in metazoa. However, our in silico analyses of protozoan parasites revealed an absence of proteins involved in the transcriptionally mediated UPR and the presence of both PERK and its target eIF2 alpha. Consistent with these observations, stimulation of the UPR in Leishmania donovani identified an absence of up-regulation of the ER chaperone BiP, the canonical ER chaperone modulated by the UPR in higher eukaryotes, while exhibiting increased phosphorylation of eIF2 alpha which has been shown to attenuate protein translation. We further observed that L. donovani is more sensitive to UPR inducing agents than host macrophages, suggesting that the less evolved stress response could provide a new avenue for therapeutic treatment of parasitic infections.	[Gosline, Sara J. C.; Hallett, Michael] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada; [Gosline, Sara J. C.; Hallett, Michael] McGill Univ, McGill Sch Comp Sci, Montreal, PQ, Canada; [Gosline, Sara J. C.; Hallett, Michael] McGill Univ, Rosalind & Morris Goodman Canc Ctr, Montreal, PQ, Canada; [Nascimento, Mirna; McCall, Laura-Isobel; Matlashewski, Greg] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Zilberstein, Dan] Technion Israel Inst Technol, Fac Biol, Haifa, Israel; [Thomas, David Y.; Hallett, Michael] McGill Univ, Dept Biochem, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; Technion Israel Institute of Technology; McGill University	Gosline, SJC (corresponding author), McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada.	greg.matlashewski@mcgill.ca; hallett@mcb.mcgill.ca	; Thomas, David/M-7661-2017	Gosline, Sara/0000-0002-6534-4774; Thomas, David/0000-0002-8854-762X; Hallett, Michael/0000-0001-6738-6786	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Israel Ministry of Health Chief Scientist Foundation [33928]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Israel Ministry of Health Chief Scientist Foundation	This research was supported by the Canadian Institutes of Health Research (DYT, GM, MN), the Natural Sciences and Engineering Research Council of Canada (Discovery Grant, MH; PGS D, SJCG), and by grant number 33928 from the Israel Ministry of Health Chief Scientist Foundation (DZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barak E, 2005, MOL BIOCHEM PARASIT, V141, P99, DOI 10.1016/j.molbiopara.2005.02.004; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Boelens J, 2007, IN VIVO, V21, P215; CHAREST H, 1994, MOL CELL BIOL, V14, P2975, DOI 10.1128/MCB.14.5.2975; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Elofsson A, 2007, ANNU REV BIOCHEM, V76, P125, DOI 10.1146/annurev.biochem.76.052705.163539; Fels DR, 2006, CANCER BIOL THER, V5, P723, DOI 10.4161/cbt.5.7.2967; FUNK VA, 1994, MOL BIOCHEM PARASIT, V63, P23, DOI 10.1016/0166-6851(94)90005-1; Goldshmidt H, PLOS PATHOG, V6; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Iwata Y, 2005, P NATL ACAD SCI USA, V102, P5280, DOI 10.1073/pnas.0408941102; Koong AC, 2006, CANCER BIOL THER, V5, P756, DOI 10.4161/cbt.5.7.2973; Koumandou VL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-298; Lahav T, 2010, FASEB J; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Martinez IM, 2003, PLANT CELL, V15, P561, DOI 10.1105/tpc.007609; McCall LI, 2010, MOL MICROBIOL, V77, P518, DOI 10.1111/j.1365-2958.2010.07229.x; Moraes MCS, 2007, EUKARYOT CELL, V6, P1979, DOI 10.1128/EC.00249-07; Mori K, 2009, J BIOCH; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Narasimhan J, 2008, J BIOL CHEM, V283, P16591, DOI 10.1074/jbc.M800681200; Nascimento M, 2003, MOL MICROBIOL, V50, P1517, DOI 10.1046/j.1365-2958.2003.03811.x; Padyana AK, 2005, J BIOL CHEM, V280, P29289, DOI 10.1074/jbc.M504096200; Reiner DS, 2001, CELL MICROBIOL, V3, P459, DOI 10.1046/j.1462-5822.2001.00129.x; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Roy G, 2000, MOL BIOCHEM PARASIT, V110, P195, DOI 10.1016/S0166-6851(00)00270-X; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Silverman JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r35; Trusina A, 2008, P NATL ACAD SCI USA, V105, P20280, DOI 10.1073/pnas.0803476105; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang WW, 1996, MOL BIOCHEM PARASIT, V78, P79, DOI 10.1016/S0166-6851(96)02612-6; Zhang WW, 2003, J BIOL CHEM, V278, P35508, DOI 10.1074/jbc.M305030200	42	41	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19118	10.1371/journal.pone.0019118	http://dx.doi.org/10.1371/journal.pone.0019118			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559456	Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700068
J	Klarenbeek, JB; Goedhart, J; Hink, MA; Gadella, TWJ; Jalink, K				Klarenbeek, Jeffrey B.; Goedhart, Joachim; Hink, Mark A.; Gadella, Theodorus W. J.; Jalink, Kees			A mTurquoise-Based cAMP Sensor for Both FLIM and Ratiometric Read-Out Has Improved Dynamic Range	PLOS ONE			English	Article							FLUORESCENT INDICATORS; EPAC ACTIVATION; CYAN; PROTEINS	FRET-based sensors for cyclic Adenosine Mono Phosphate (cAMP) have revolutionized the way in which this important intracellular messenger is studied. The currently prevailing sensors consist of the cAMP-binding protein Epac1, sandwiched between suitable donor-and acceptor fluorescent proteins (FPs). Through a conformational change in Epac1, alterations in cellular cAMP levels lead to a change in FRET that is most commonly detected by either Fluorescence Lifetime Imaging (FLIM) or by Sensitized Emission (SE), e.g., by simple ratio-imaging. We recently reported a range of different Epac-based cAMP sensors with high dynamic range and signal-to-noise ratio. We showed that constructs with cyan FP as donor are optimal for readout by SE, whereas other constructs with green FP donors appeared much more suited for FLIM detection. In this study, we present a new cAMP sensor, termed (T)Epac(VV), which employs mTurquoise as donor. Spectrally very similar to CFP, mTurquoise has about doubled quantum efficiency and unlike CFP, its fluorescence decay is strictly single-exponential. We show that (T)Epac(VV) appears optimal for detection both by FLIM and SE, that it has outstanding FRET span and signal-to-noise ratio, and improved photostability. Hence, (T)Epac(VV) should become the cAMP sensor of choice for new experiments, both for FLIM and ratiometric detection.	[Klarenbeek, Jeffrey B.; Jalink, Kees] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands; [Goedhart, Joachim; Hink, Mark A.; Gadella, Theodorus W. J.] Univ Amsterdam, Sect Mol Cytol, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Klarenbeek, Jeffrey B.; Goedhart, Joachim; Hink, Mark A.; Gadella, Theodorus W. J.; Jalink, Kees] van Leeuwenhoek Ctr Adv Microscopy, Amsterdam, Netherlands	Netherlands Cancer Institute; University of Amsterdam	Klarenbeek, JB (corresponding author), Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands.	k.jalink@nki.nl		Gadella, Theodorus/0000-0002-7639-219X; Jalink, Kees/0000-0001-7019-3440; Goedhart, Joachim/0000-0002-0630-3825	Nederlandse organisatie voor Wetenschappelijk Onderzoek; Nefkens Foundation	Nederlandse organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission); Nefkens Foundation	This study was supported by equipment grants from the Nederlandse organisatie voor Wetenschappelijk Onderzoek and the Nefkens Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 2005, MOL PHARMACOL, V67, P1493, DOI 10.1124/mol.104.008342; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Goedhart J, 2010, NAT METHODS, V7, P137, DOI [10.1038/nmeth.1415, 10.1038/NMETH.1415]; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Shcherbo D, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-24; van der Krogt GNM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001916; van Munster EB, 2005, ADV BIOCHEM ENG BIOT, V95, P143; Villoing A, 2008, BIOCHEMISTRY-US, V47, P12483, DOI 10.1021/bi801400d	13	135	138	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19170	10.1371/journal.pone.0019170	http://dx.doi.org/10.1371/journal.pone.0019170			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559477	gold, Green Published, Green Submitted			2022-12-27	WOS:000290024700088
J	Lin, K; Taylor, JR; Wu, TD; Gutierrez, J; Elliott, JM; Vernes, JM; Koeppen, H; Phillips, HS; de Sauvage, FJ; Meng, YG				Lin, Kui; Taylor, James R., Jr.; Wu, Thomas D.; Gutierrez, Johnny; Elliott, J. Michael; Vernes, Jean-Michel; Koeppen, Hartmut; Phillips, Heidi S.; de Sauvage, Frederic J.; Meng, Y. Gloria			TMEFF2 Is a PDGF-AA Binding Protein with Methylation-Associated Gene Silencing in Multiple Cancer Types Including Glioma	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; PROSTATE-CANCER; TRANSMEMBRANE PROTEIN; ABERRANT METHYLATION; RECEPTOR EXPRESSION; DISEASE PROGRESSION; CDNA CLONING; FACTOR-ALPHA; B CHAINS; CELLS	Background: TMEFF2 is a protein containing a single EGF-like domain and two follistatin-like modules. The biological function of TMEFF2 remains unclear with conflicting reports suggesting both a positive and a negative association between TMEFF2 expression and human cancers. Methodology/Principal Findings: Here we report that the extracellular domain of TMEFF2 interacts with PDGF-AA. This interaction requires the amino terminal region of the extracellular domain containing the follistatin modules and cannot be mediated by the EGF-like domain alone. Furthermore, the extracellular domain of TMEFF2 interferes with PDGF-AA-stimulated fibroblast proliferation in a dose-dependent manner. TMEFF2 expression is downregulated in human brain cancers and is negatively correlated with PDGF-AA expression. Suppressed expression of TMEFF2 is associated with its hypermethylation in several human tumor types, including glioblastoma and cancers of ovarian, rectal, colon and lung origins. Analysis of glioma subtypes indicates that TMEFF2 hypermethylation and decreased expression are associated with a subset of non-Proneural gliomas that do not display CpG island methylator phentoype. Conclusions/Significance: These data provide the first evidence that TMEFF2 can function to regulate PDGF signaling and that it is hypermethylated and downregulated in glioma and several other cancers, thereby suggesting an important role for this protein in the etiology of human cancers.	[Lin, Kui; Taylor, James R., Jr.; Wu, Thomas D.; Gutierrez, Johnny; Elliott, J. Michael; Vernes, Jean-Michel; Koeppen, Hartmut; Phillips, Heidi S.; de Sauvage, Frederic J.; Meng, Y. Gloria] Genentech Inc, San Francisco, CA 94080 USA	Roche Holding; Genentech	Lin, K (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	klin@gene.com	de Sauvage, Frederic/ABE-8400-2020	de Sauvage, Frederic/0000-0002-5275-2584	Genentech	Genentech(Roche HoldingGenentech)	This study was funded by Genentech. The funder had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Afar DEH, 2004, MOL CANCER THER, V3, P921; Belshaw NJ, 2004, CANCER EPIDEM BIOMAR, V13, P1495; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI [10.2217/epi.09.14, 10.2217/EPI.09.14]; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; CALZOLARI F, BRAIN PATHOL, V20, P527; Carey KD, 2006, CANCER RES, V66, P8163, DOI 10.1158/0008-5472.CAN-06-0453; Chang CB, 2003, DEV BIOL, V255, P1, DOI 10.1016/S0012-1606(02)00075-1; CLAESSONWELSH L, 1989, P NATL ACAD SCI USA, V86, P4917, DOI 10.1073/pnas.86.13.4917; CLAESSONWELSH L, 1988, MOL CELL BIOL, V8, P3476, DOI 10.1128/MCB.8.8.3476; Fudge K, 1996, PROSTATE, V29, P282; FUDGE K, 1994, MODERN PATHOL, V7, P549; Geddert H, 2004, INT J CANCER, V110, P208, DOI 10.1002/ijc.20058; Gery S, 2002, ONCOGENE, V21, P4739, DOI 10.1038/sj.onc.1205142; Glynne-Jones E, 2001, INT J CANCER, V94, P178, DOI 10.1002/ijc.1450; Harms PW, 2003, GENE DEV, V17, P2624, DOI 10.1101/gad.1127703; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; HERMANSON M, 1992, CANCER RES, V52, P3213; Hermanson M, 1996, CANCER RES, V56, P164; Hoch RV, 2003, DEVELOPMENT, V130, P4769, DOI 10.1242/dev.00721; Horie M, 2000, GENOMICS, V67, P146, DOI 10.1006/geno.2000.6228; HUSE JT, 2011, GLIA IN PRESS; Katano M, 1998, ANN SURG, V227, P365, DOI 10.1097/00000658-199803000-00008; Keyt BA, 1996, J BIOL CHEM, V271, P5638, DOI 10.1074/jbc.271.10.5638; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Liang GN, 2000, CANCER RES, V60, P4907; Lin H, 2003, LIFE SCI, V73, P1617, DOI 10.1016/S0024-3205(03)00514-9; Mohler JL, 2002, PROSTATE, V51, P247, DOI 10.1002/pros.10086; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Patel K, 1998, INT J BIOCHEM CELL B, V30, P1087, DOI 10.1016/S1357-2725(98)00064-8; PATTHY L, 1993, TRENDS NEUROSCI, V16, P76, DOI 10.1016/0166-2236(93)90021-D; Phillips DJ, 1998, FRONT NEUROENDOCRIN, V19, P287, DOI 10.1006/frne.1998.0169; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Polakis P, 2005, CURR OPIN PHARMACOL, V5, P382, DOI 10.1016/j.coph.2005.04.008; Quayle SN, 2006, GENOMICS, V87, P633, DOI 10.1016/j.ygeno.2005.12.004; RAINES EW, 1992, P NATL ACAD SCI USA, V89, P1281, DOI 10.1073/pnas.89.4.1281; ROSS R, 1990, PHILOS T ROY SOC B, V327, P155, DOI 10.1098/rstb.1990.0051; ROSS R, 1974, P NATL ACAD SCI USA, V71, P1207, DOI 10.1073/pnas.71.4.1207; Sato F, 2002, CANCER RES, V62, P6820; SEIFERT RA, 1993, J BIOL CHEM, V268, P4473; SEIFERT RA, 1989, J BIOL CHEM, V264, P8771; Shibata DM, 2002, CANCER RES, V62, P5637; Soroceanu L, 2007, P NATL ACAD SCI USA, V104, P3466, DOI 10.1073/pnas.0611271104; Suzuki M, 2005, BRIT J CANCER, V93, P1029, DOI 10.1038/sj.bjc.6602837; Suzuki M, 2005, ONCOGENE, V24, P1302, DOI 10.1038/sj.onc.1208263; Takahashi T, 2004, CLIN CANCER RES, V10, P6126, DOI 10.1158/1078-0432.CCR-04-0579; Uchida T, 1999, BIOCHEM BIOPH RES CO, V266, P593, DOI 10.1006/bbrc.1999.1873; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Westermark B, 1989, Prog Growth Factor Res, V1, P253, DOI 10.1016/0955-2235(89)90014-8; Wynter CVA, 2004, GUT, V53, P573, DOI 10.1136/gut.2003.030841; Young J, 2001, P NATL ACAD SCI USA, V98, P265, DOI 10.1073/pnas.011415298	52	58	60	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18608	10.1371/journal.pone.0018608	http://dx.doi.org/10.1371/journal.pone.0018608			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559523	Green Published, gold, Green Submitted			2022-12-27	WOS:000290024700016
J	Spassov, DS; Ahuja, D; Wong, CH; Moasser, MM				Spassov, Danislav S.; Ahuja, Deepika; Wong, Ching Hang; Moasser, Mark M.			The Structural Features of Trask That Mediate Its Anti-Adhesive Functions	PLOS ONE			English	Article							DOMAIN-CONTAINING PROTEIN-1; TYROSINE PHOSPHORYLATION; SUBSTRATE TRASK; CANCER-CELLS; SRC; ADHESION; EXPRESSION; ADENOCARCINOMA; EPITHELIA; INTEGRINS	Trask/CDCP1 is a transmembrane protein with a large extracellular and small intracellular domains. The intracellular domain (ICD) undergoes tyrosine phosphorylation by Src kinases during anchorage loss and, when phosphorylated, Trask functions to inhibit cell adhesion. The extracellular domain (ECD) undergoes proteolytic cleavage by serine proteases, although the functional significance of this remains unknown. There is conflicting evidence regarding whether it functions to signal the phosphorylation of the ICD. To better define the structural determinants that mediate the anti-adhesive functions of Trask, we generated a series of deletion mutants of Trask and expressed them in tet-inducible cell models to define the structural elements involved in cell adhesion signaling. We find that the ECD is dispensable for the phosphorylation of the ICD or for the inhibition of cell adhesion. The anti-adhesive functions of Trask are entirely embodied within its ICD and are specifically due to tyrosine phosphorylation of the ICD as this function is completely lost in a phosphorylation-defective tyrosine-phenylalanine mutant. Both full length and cleaved ECDs are fully capable of phosphorylation and undergo phosphorylation during anchorage loss and cleavage is not an upstream signal for ICD phosphorylation. These data establish that the anti-adhesive functions of Trask are mediated entirely through its tyrosine phosphorylation. It remains to be defined what role, if any, the Trask ECD plays in its adhesion functions.	[Spassov, Danislav S.; Ahuja, Deepika; Wong, Ching Hang; Moasser, Mark M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Spassov, Danislav S.; Ahuja, Deepika; Wong, Ching Hang; Moasser, Mark M.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Spassov, DS (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	mark.moasser@ucsf.edu	Spassov, Danislav S/GQA-4368-2022	Spassov, Danislav S/0000-0002-6680-877X	National Institutes of Health [CA113952]; Susan G. Komen; California Breast Cancer Research Program; NATIONAL CANCER INSTITUTE [R01CA113952] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen(Susan G. Komen Breast Cancer Foundation); California Breast Cancer Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the National Institutes of Health CA113952 (MMM). DS was funded by a Susan G. Komen for the Cure Postdoctoral Fellowship. CHW was funded by a California Breast Cancer Research Program Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatt AS, 2005, ONCOGENE, V24, P5333, DOI 10.1038/sj.onc.1208582; Brown TA, 2004, J BIOL CHEM, V279, P14772, DOI 10.1074/jbc.M309678200; HE Y, 2010, J BIOL CHEM; Hooper JD, 2003, ONCOGENE, V22, P1783, DOI 10.1038/sj.onc.1206220; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Ikeda JI, 2006, J PATHOL, V210, P75, DOI 10.1002/path.2026; Ikeda JI, 2009, CANCER SCI, V100, P429, DOI 10.1111/j.1349-7006.2008.01066.x; Mamat S, 2010, ONCOL REP, V23, P1221, DOI 10.3892/or_00000753; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Miyazawa Y, 2010, CANCER RES, V70, P5136, DOI 10.1158/0008-5472.CAN-10-0220; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Scherl-Mostageer M, 2001, ONCOGENE, V20, P4402, DOI 10.1038/sj.onc.1204566; Shattil SJ, 2005, TRENDS CELL BIOL, V15, P399, DOI 10.1016/j.tcb.2005.06.005; Siva AC, 2008, CANCER RES, V68, P3759, DOI 10.1158/0008-5472.CAN-07-1657; Spassov DS, 2009, AM J PATHOL, V174, P1756, DOI 10.2353/ajpath.2009.080890; Uekita T, 2008, AM J PATHOL, V172, P1729, DOI 10.2353/ajpath.2008.070981; Vuori K, 1998, J MEMBRANE BIOL, V165, P191, DOI 10.1007/s002329900433; Wong CH, 2009, CLIN CANCER RES, V15, P2311, DOI 10.1158/1078-0432.CCR-08-2533	18	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19154	10.1371/journal.pone.0019154	http://dx.doi.org/10.1371/journal.pone.0019154			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559459	gold, Green Published, Green Submitted			2022-12-27	WOS:000290024700081
J	Everest, SJ; Ramsay, AM; Chaplin, MJ; Everitt, S; Stack, MJ; Neale, MH; Jeffrey, M; Moore, SJ; Bellworthy, SJ; Terry, LA				Everest, Sally J.; Ramsay, Andrew M.; Chaplin, Melanie J.; Everitt, Sharon; Stack, Michael J.; Neale, Michael H.; Jeffrey, Martin; Moore, S. Jo; Bellworthy, Susan J.; Terry, Linda A.			Detection and Localisation of PrPSc in the Liver of Sheep Infected with Scrapie and Bovine Spongiform Encephalopathy	PLOS ONE			English	Article							RESISTANT PRION PROTEIN; TISSUE DISTRIBUTION; BLOOD-TRANSFUSION; NATURAL SCRAPIE; BRITISH SHEEP; BSE; FLOCK; TRANSMISSION; ACCUMULATION; DISEASES	Prions are largely contained within the nervous and lymphoid tissue of transmissible spongiform encephalopathy (TSE) infected animals. However, following advances in diagnostic sensitivity, PrPSc, a marker for prion disease, can now be located in a wide range of viscera and body fluids including muscle, saliva, blood, urine and milk, raising concerns that exposure to these materials could contribute to the spread of disease in humans and animals. Previously we demonstrated low levels of infectivity in the liver of sheep experimentally challenged with bovine spongiform encephalopathy. In this study we show that PrPSc accumulated in the liver of 89% of sheep naturally infected with scrapie and 100% of sheep challenged with BSE, at both clinical and preclinical stages of the disease. PrPSc was demonstrated in the absence of obvious inflammatory foci and was restricted to isolated resident cells, most likely Kupffer cells.	[Everest, Sally J.; Ramsay, Andrew M.; Chaplin, Melanie J.; Everitt, Sharon; Stack, Michael J.; Neale, Michael H.; Moore, S. Jo; Bellworthy, Susan J.; Terry, Linda A.] Vet Labs Agcy, Dept Pathol & Host Susceptibil, New Haw, Surrey, England; [Jeffrey, Martin] Vet Labs Agcy VLA Lasswade, Dept Pathol & Host Susceptibil, Penicuik, Midlothian, Scotland		Everest, SJ (corresponding author), Vet Labs Agcy, Dept Pathol & Host Susceptibil, New Haw, Surrey, England.	m.neale@vla.defra.gsi.gov.uk	Ramsay, Andrew/E-2148-2015; Jeffrey, Martin/D-2251-2009	Moore, S Jo/0000-0001-5276-1723	Food Standards Agency UK [MO3060]	Food Standards Agency UK	This work was supported by funding from the Food Standards Agency UK, project MO3060. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoletti O, 2000, J GEN VIROL, V81, P3115, DOI 10.1099/0022-1317-81-12-3115; Baylis M, 2002, TRENDS MICROBIOL, V10, P563, DOI 10.1016/S0966-842X(02)02477-0; Bellworthy SJ, 2005, VET REC, V156, P197, DOI 10.1136/vr.156.7.197; Di Bari MA, 2008, J GEN VIROL, V89, P2975, DOI 10.1099/vir.0.2008/005520-0; Ferguson NM, 2002, NATURE, V415, P420, DOI 10.1038/nature709; Foster JD, 2001, J GEN VIROL, V82, P2319, DOI 10.1099/0022-1317-82-10-2319; Heikenwalder M, 2005, SCIENCE, V307, P1107, DOI 10.1126/science.1106460; Houston F, 2008, BLOOD, V112, P4739, DOI 10.1182/blood-2008-04-152520; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; Kao RR, 2002, SCIENCE, V295, P332, DOI 10.1126/science.1067475; Ligios C, 2005, NAT MED, V11, P1137, DOI 10.1038/nm1105-1137; Ligios C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000859; Madec JY, 2000, MICROB PATHOGENESIS, V28, P353, DOI 10.1006/mpat.2000.0357; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Ryder SJ, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-9; Stack M, 2006, J GEN VIROL, V87, P2099, DOI 10.1099/vir.0.81254-0; Stack MJ, 2002, ACTA NEUROPATHOL, V104, P279, DOI 10.1007/s00401-002-0556-2; van Keulen LJM, 2008, ARCH VIROL, V153, P445, DOI 10.1007/s00705-007-0007-4; van Keulen LJM, 1999, J COMP PATHOL, V121, P55, DOI 10.1053/jcpa.1998.0300; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; WILESMITH JW, 1991, VET REC, V128, P199, DOI 10.1136/vr.128.9.199	21	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19737	10.1371/journal.pone.0019737	http://dx.doi.org/10.1371/journal.pone.0019737			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589864	Green Published, Green Submitted, gold			2022-12-27	WOS:000290531100024
J	Roescher, N; Vosters, JL; Yin, HE; Illei, GG; Tak, PP; Chiorini, JA				Roescher, Nienke; Vosters, Jelle L.; Yin, Hongen; Illei, Gabor G.; Tak, Paul P.; Chiorini, John A.			Effect of Soluble ICAM-1 on a Sjogren's Syndrome-like Phenotype in NOD Mice Is Disease Stage Dependent	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; SALIVARY-GLANDS; GENE-TRANSFER; CELLS; EXPRESSION; ACTIVATION; PATHWAYS; SELECTIN	Introduction: Intercellular adhesion molecule-1 (ICAM-1) is involved in migration and co-stimulation of T and B cells. Membrane bound ICAM-1 is over expressed in the salivary glands (SG) of Sjogren's syndrome (SS) patients and has therefore been proposed as a potential therapeutic target. To test the utility of ICAM-1 as a therapeutic target, we used local gene therapy in Non Obese Diabetic (NOD) mice to express soluble (s) ICAM-1 to compete with membrane bound ICAM-1 for binding with its receptor. Therapy was given prior to and just after the influx of immune cells into the SG. Methods: A recombinant serotype 2 adeno associated virus (rAAV2) encoding ICAM-1/Fc was constructed and its efficacy tested in the female NOD mice after retrograde instillation in SG at eight (early treatment) and ten (late treatment) weeks of age. SG inflammation was evaluated by focus score and immunohistochemical quantification of infiltrating cell types. Serum and SG tissue were analyzed for immunoglobulins (Ig). Results: Early treatment with ICAM-1/Fc resulted in decreased average number of inflammatory foci without changes in T and B cell composition. In contrast, late treated mice did not show any change in focus scores, but immunohistochemical staining showed an increase in the overall number of CD4+ and CD8+ T cells. Moreover, early treated mice showed decreased IgM within the SGs, whereas late treated mice had increased IgM levels, and on average higher IgG and IgA. Conclusions: Blocking the ICAM-1/LFA-1 interaction with sICAM-1/Fc may result in worsening of a SS like phenotype when infiltrates have already formed within the SG. As a treatment for human SS, caution should be taken targeting the ICAM-1 axis since most patients are diagnosed when inflammation is clearly present within the SG.	[Roescher, Nienke; Vosters, Jelle L.; Tak, Paul P.] Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands; [Roescher, Nienke; Vosters, Jelle L.; Yin, Hongen; Illei, Gabor G.; Chiorini, John A.] Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD USA	University of Amsterdam; Academic Medical Center Amsterdam; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Roescher, N (corresponding author), Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	jchiorini@dir.nidcr.nih.gov			Dutch Arthritis Association [NR 07-1-406]; NIH, NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000704, ZIADE000695] Funding Source: NIH RePORTER	Dutch Arthritis Association; NIH, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work is supported by a Dutch Arthritis Association grant [NR 07-1-406] to JLV and an NIH, NIDCR intramural research grant to JAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ME, 2003, PEPTIDES, V24, P487, DOI 10.1016/S0196-9781(03)00083-4; Aziz K E, 1992, J Clin Lab Immunol, V37, P39; Bertry-Coussot L, 2002, J IMMUNOL, V168, P3641, DOI 10.4049/jimmunol.168.7.3641; Cha S, 2002, ARTHRITIS RHEUM-US, V46, P1390, DOI 10.1002/art.10258; Chen WS, 2009, J RHEUMATOL, V36, P989, DOI 10.3899/jrheum.080733; Deeths MJ, 1999, EUR J IMMUNOL, V29, P45, DOI 10.1002/(SICI)1521-4141(199901)29:01<45::AID-IMMU45>3.0.CO;2-I; DOERCK S, PLOS ONE, V5; FAVEEUW C, 1994, J IMMUNOL, V152, P5969; Gottenberg JE, 2006, P NATL ACAD SCI USA, V103, P2770, DOI 10.1073/pnas.0510837103; Haringman JJ, 2005, ARTHRITIS RES THER, V7, pR862, DOI 10.1186/ar1757; Kaludov N, 2001, J VIROL, V75, P6884, DOI 10.1128/JVI.75.15.6884-6893.2001; Kapsogeorgou EK, 2001, CLIN EXP IMMUNOL, V124, P126, DOI 10.1046/j.1365-2249.2001.01500.x; Kok MR, 2003, HUM GENE THER, V14, P1605, DOI 10.1089/104303403322542257; Kok MR, 2003, ANN RHEUM DIS, V62, P1038, DOI 10.1136/ard.62.11.1038; Martin S, 1998, DIABETOLOGIA, V41, P1298, DOI 10.1007/s001250051068; Mikulowska-Mennis A, 2001, AM J PATHOL, V159, P671, DOI 10.1016/S0002-9440(10)61738-5; MOUTSOPOULOS HM, 1994, CLIN IMMUNOL IMMUNOP, V72, P162, DOI 10.1006/clin.1994.1123; NIKOLOV NP, 2009, ARTHRITIS RHEUM, V60, P499; POUDRIER J, 1994, J EXP MED, V179, P1417, DOI 10.1084/jem.179.5.1417; Thanou-Stavraki A, 2008, SEMIN ARTHRITIS RHEU, V37, P273, DOI 10.1016/j.semarthrit.2007.06.002; Tsunawaki S, 2002, J RHEUMATOL, V29, P1884; Turkcapar N, 2005, J RHEUMATOL, V32, P1063; Voutetakis A, 2004, P NATL ACAD SCI USA, V101, P3053, DOI 10.1073/pnas.0400136101; WU AJ, 1994, J CELL PHYSIOL, V161, P217, DOI 10.1002/jcp.1041610205; Yamano S, 2002, HUM GENE THER, V13, P287, DOI 10.1089/10430340252769806	25	14	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19962	10.1371/journal.pone.0019962	http://dx.doi.org/10.1371/journal.pone.0019962			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589878	Green Published, Green Submitted, gold			2022-12-27	WOS:000290531100035
J	Li, YP; Li, XL; Shi, L; Yang, M; Yang, Y; Tao, WY; Shi, L; Xiong, YX; Zhang, Y; Yao, YF				Li, Yiping; Li, Xianli; Shi, Li; Yang, Man; Yang, Ying; Tao, Wenyu; Shi, Lei; Xiong, Yuxin; Zhang, Ying; Yao, Yufeng			Association of Adiponectin SNP+45 and SNP+276 with Type 2 Diabetes in Han Chinese Populations: A Meta-Analysis of 26 Case-Control Studies	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; IMPAIRED GLUCOSE-TOLERANCE; GENE-ENCODING ADIPONECTIN; ADIPOSE-SPECIFIC PROTEIN; INSULIN-RESISTANCE; APM1 GENE; SUSCEPTIBILITY GENES; PROXIMAL PROMOTER; OBESITY; RISK	Recently, many studies have reported that the SNP+45(T>G) and SNP+276(G>T) polymorphisms in the adiponectin gene are associated with type 2 diabetes (T2DM) in the Chinese Han population. However, the previous studies yielded many conflicting results. Thus, a meta-analysis of the association of the adiponectin gene with T2DM in the Chinese Han population is required. In the current study, we first determined the distribution of the adiponectin SNP+276 polymorphism in T2DM and nondiabetes (NDM) control groups. Our results suggested that the genotype and allele frequencies for SNP+276 did not differ significantly between the T2DM and NDM groups. Then, a meta-analysis of 23 case-control studies of SNP+45, with a total of 4161 T2DM patients and 3709 controls, and 11 case-control studies of SNP+276, with 2533 T2DM patients and 2212 controls, was performed. All subjects were Han Chinese. The fixed-effects model and random-effects model were applied for dichotomous outcomes to combine the results of the included studies. The results revealed a trend towards an increased risk of T2DM for the SNP+45G allele as compared with the SNP+45T allele (OR = 1.34; 95% CI, 1.11-1.62; P<0.01) in the Chinese Han population. However, there was no association between SNP+276 and T2DM (OR = 0.90; 95% CI, 0.73-1.10; P = 0.31). The results of our association study showed there was no association between the adiponectin SNP+276 polymorphism and T2DM in the Yunnan Han population. The meta-analysis results suggested that the SNP+45G allele might be a susceptibility allele for T2DM in the Chinese Han population. However, we did not observe an association between SNP+276 and T2DM.	[Li, Yiping; Li, Xianli; Yang, Man; Yang, Ying; Tao, Wenyu; Xiong, Yuxin; Zhang, Ying] Second Peoples Hosp Yunnan Prov, Dept Endocrinol & Metab, Kunming, Yunnan, Peoples R China; [Shi, Li; Shi, Lei; Yao, Yufeng] Chinese Acad Med Sci, Inst Med Biol, Kunming, Yunnan, Peoples R China; [Shi, Li; Shi, Lei; Yao, Yufeng] Peking Union Med Coll, Kunming, Yunnan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Li, YP (corresponding author), Second Peoples Hosp Yunnan Prov, Dept Endocrinol & Metab, Kunming, Yunnan, Peoples R China.	zy5311780@126.com; leoyyf@gmail.com		Xiong, Yuxin/0000-0003-0120-6126	Education Department Fund of Yunnan Province [09C0296]	Education Department Fund of Yunnan Province	This work was supported by grants 09C0296 from Education Department Fund of Yunnan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi F, 2004, DIABETES, V53, P585, DOI 10.2337/diabetes.53.3.585; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Behre CJ, 2007, METABOLISM, V56, P1022, DOI 10.1016/j.metabol.2007.03.010; Chen W., 2007, J ZHENGZHOU U MED SC, V42, P1145; [初明峰 CHU Mingfeng], 2006, [中华内分泌代谢杂志, Chinese Journal of Endocrinology and Metabolism], V22, P24; [董艳 Dong Yan], 2004, [上海第二医科大学学报, Acta Universitatis Medicinalis Secondae Shanghai], V24, P1001; [杜鹏飞 Du Fengfei], 2004, [中华糖尿病杂志, Chinese Journal of Diabetes], V12, P393; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fumeron F, 2004, DIABETES, V53, P1150, DOI 10.2337/diabetes.53.4.1150; Gibson F, 2004, DIABETES, V53, P2977, DOI 10.2337/diabetes.53.11.2977; Gu HF, 2004, DIABETES, V53, pS31, DOI 10.2337/diabetes.53.2007.S31; GU MF, 2007, J JIANGSU U MED ED, V17, P498; Hao J. M., 2009, HAINAN MED J, V20, P1; Hara K, 2002, DIABETES, V51, P536, DOI 10.2337/diabetes.51.2.536; [何岚 HE Lan], 2006, [第四军医大学学报, Journal of the Fourth Military Medical University], V27, P1493; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; JIN LZ, 2003, J TIANJIN MED U, V9, P211; [康庄 KANG Zhuang], 2008, [中国糖尿病杂志, = Chinese Journal of Diabetes], V16, P718; Kern PA, 2003, DIABETES, V52, P1779, DOI 10.2337/diabetes.52.7.1779; Kissebah AH, 2000, P NATL ACAD SCI USA, V97, P14478, DOI 10.1073/pnas.97.26.14478; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Li SB, 2008, CLIN ENDOCRINOL, V68, P885, DOI 10.1111/j.1365-2265.2007.03114.x; [李奕平 Li Yiping], 2011, [中国糖尿病杂志, Chinese Journal of Diabetes], V19, P101; Mori Y, 2002, DIABETES, V51, P1247, DOI 10.2337/diabetes.51.4.1247; Nakaoka H, 2009, J HUM GENET, V54, P615, DOI 10.1038/jhg.2009.95; Populaire C, 2003, DIABETOLOGIA, V46, P443, DOI 10.1007/s00125-003-1050-7; Ru Ying, 2005, Zhonghua Yixue Yichuanxue Zazhi, V22, P698; [史晓红 Shi XH], 2007, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V11, P6815; [史晓红 Shi Xiaohong], 2007, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V11, P4941; Stumvoll M, 2002, DIABETES, V51, P37, DOI 10.2337/diabetes.51.1.37; Sun H, 2008, BRIT J CLIN PHARMACO, V65, P917, DOI 10.1111/j.1365-2125.2008.03145.x; Sun Y. Z., 2007, SHANXI MED J, V36, P661; Takahashi M, 2000, INT J OBESITY, V24, P861, DOI 10.1038/sj.ijo.0801244; Tschritter O, 2003, DIABETES, V52, P239, DOI 10.2337/diabetes.52.2.239; Tso AWK, 2006, DIABETOLOGIA, V49, P1806, DOI 10.1007/s00125-006-0324-2; Vasseur F, 2005, DIABETOLOGIA, V48, P892, DOI 10.1007/s00125-005-1729-z; Vasseur F, 2002, HUM MOL GENET, V11, P2607, DOI 10.1093/hmg/11.21.2607; Vionnet N, 2000, AM J HUM GENET, V67, P1470, DOI 10.1086/316887; [王长江 Wang Changjiang], 2005, [中华糖尿病杂志, Chinese Journal of Diabetes], V13, P324; [王吉影 WANG Jiying], 2007, [第二军医大学学报, Academic Journal of Second Military Medical University], V28, P143; Wang K, 2009, J TIANJIN MED U, V15, P190, DOI [10.3969/j.issn.1006-8147.2009.02.009, DOI 10.3969/J.ISSN.1006-8147.2009.02.009]; [王淑芳 WANG Shufang], 2007, [中华内分泌代谢杂志, Chinese Journal of Endocrinology and Metabolism], V23, P51; Wang Y.X., 2010, SHANDONG MED J, V50, P1; Wang YB, 2009, J GENET GENOMICS, V36, P417, DOI 10.1016/S1673-8527(08)60131-9; Wang Yan, 2008, Progress in Modern Biomedicine, V8, P84; [魏颖丽 WEI Yingli], 2007, [中国糖尿病杂志, Chinese Journal of Diabetes], V15, P583; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Xia Z, 2004, CHIN J ENDOCRINOL ME, V20, P236; Xin YP, 2009, CHINESE J PRACTICAL, V12, P29; [叶红 YE Hong], 2009, [药学服务与研究, Pharmaceutical Care and Research], V9, P158; Zacharova J, 2005, DIABETES, V54, P893, DOI 10.2337/diabetes.54.3.893; ZHAI B, 2006, CHIN J CLIN REHABIL, V10, P28; Zhang HX, 2007, SHANDONG MED J, V47, P1	55	28	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19686	10.1371/journal.pone.0019686	http://dx.doi.org/10.1371/journal.pone.0019686			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589658	Green Published, gold, Green Submitted			2022-12-27	WOS:000290483600021
J	Gay, C; Dibben, O; Anderson, JA; Stacey, A; Mayo, AJ; Norris, PJ; Kuruc, JD; Salazar-Gonzalez, JF; Li, H; Keele, BF; Hicks, C; Margolis, D; Ferrari, G; Haynes, B; Swanstrom, R; Shaw, GM; Hahn, BH; Eron, JJ; Borrow, P; Cohen, MS				Gay, Cynthia; Dibben, Oliver; Anderson, Jeffrey A.; Stacey, Andrea; Mayo, Ashley J.; Norris, Philip J.; Kuruc, JoAnn D.; Salazar-Gonzalez, Jesus F.; Li, Hui; Keele, Brandon F.; Hicks, Charles; Margolis, David; Ferrari, Guido; Haynes, Barton; Swanstrom, Ronald; Shaw, George M.; Hahn, Beatrice H.; Eron, Joseph J.; Borrow, Persephone; Cohen, Myron S.			Cross-Sectional Detection of Acute HIV Infection: Timing of Transmission, Inflammation and Antiretroviral Therapy	PLOS ONE			English	Article							PLASMA CYTOKINE LEVELS; CD4(+) T-CELLS; SEXUAL TRANSMISSION; VIRUS; VIREMIA; AMPLIFICATION; RESPONSES; MULTIPLE; REPLICATION; EFFICIENT	Background: Acute HIV infection (AHI) is a critical phase of infection when irreparable damage to the immune system occurs and subjects are very infectious. We studied subjects with AHI prospectively to develop better treatment and public health interventions. Methods: Cross-sectional screening was employed to detect HIV RNA positive, antibody negative subjects. Date of HIV acquisition was estimated from clinical history and correlated with sequence diversity assessed by single genome amplification (SGA). Twenty-two cytokines/chemokines were measured from enrollment through week 24. Results: Thirty-seven AHI subjects were studied. In 7 participants with limited exposure windows, the median exposure to HIV occurred 14 days before symptom onset. Lack of viral sequence diversification confirmed the short duration of infection. Transmission dates estimated by SGA/sequencing using molecular clock models correlated with transmission dates estimated by symptom onset in individuals infected with single HIV variants (mean of 28 versus 33 days). Only 10 of 22 cytokines/chemokines were significantly elevated among AHI participants at enrollment compared to uninfected controls, and only 4 participants remained seronegative at enrollment. Discussion: The results emphasize the difficulty in recruiting subjects early in AHI. Viral sequence diversity proved accurate in estimating time of infection. Regardless of aggressive screening, peak viremia and inflammation occurred before enrollment and potential intervention. Given the personal and public health importance, improved AHI detection is urgently needed.	[Gay, Cynthia; Anderson, Jeffrey A.; Mayo, Ashley J.; Kuruc, JoAnn D.; Margolis, David; Swanstrom, Ronald; Eron, Joseph J.; Cohen, Myron S.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27515 USA; [Dibben, Oliver; Stacey, Andrea; Borrow, Persephone] Univ Oxford, Nuffield Dept Clin Med, Weatherall Inst Mol Med, Oxford, England; [Norris, Philip J.] Blood Syst Res Inst, San Francisco, CA USA; [Norris, Philip J.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Salazar-Gonzalez, Jesus F.; Li, Hui; Keele, Brandon F.; Shaw, George M.; Hahn, Beatrice H.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Hicks, Charles; Ferrari, Guido; Haynes, Barton] Duke Univ, Durham, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Oxford; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; University of Alabama System; University of Alabama Birmingham; Duke University	Gay, C (corresponding author), Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27515 USA.	cynthia_gay@med.unc.edu	Margolis, David M./Y-2468-2019; Ferrari, Guido/A-6088-2015; Ferrari, Guido/Z-2137-2019; Gay, Cynthia/AAG-2927-2019	Margolis, David M./0000-0001-5714-0002; Ferrari, Guido/0000-0001-7747-3349; Salazar-Gonzalez, Jesus F./0000-0003-4626-6448; Gay, Cynthia/0000-0002-3620-3059; Borrow, Persephone/0000-0002-3877-9780; Hahn, Beatrice/0000-0002-9400-9887	Division of AIDS, U.S. National Institute of Allergy and Infectious Diseases, U.S. National Institutes of Health [AI67854]; Division of Research Resources [RR025747]; UNC Center for AIDS Research (CFAR) National Institutes of Health [AI50410]; Bristol Myers Squibb; Gilead Sciences; GSK; Merck; Tibotec; Gilead; Myriad Pharmaceuticals; Pfizer; Abbott; Roche; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067854, U01AI067854, P30AI050410] Funding Source: NIH RePORTER	Division of AIDS, U.S. National Institute of Allergy and Infectious Diseases, U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division of Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); UNC Center for AIDS Research (CFAR) National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bristol Myers Squibb(Bristol-Myers Squibb); Gilead Sciences(Gilead Sciences); GSK(GlaxoSmithKline); Merck(Merck & Company); Tibotec; Gilead(Gilead Sciences); Myriad Pharmaceuticals; Pfizer(Pfizer); Abbott(Abbott Laboratories); Roche(Roche Holding); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Division of AIDS, U.S. National Institute of Allergy and Infectious Diseases, U.S. National Institutes of Health (grant AI67854), from a UNC Clinical and Translational Science Award (CTSA) of the Division of Research Resources (grant RR025747), and AI50410 UNC Center for AIDS Research (CFAR) National Institutes of Health. P.B. is a Jenner Institute Investigator. Bristol Myers Squibb and Gilead Sciences, Inc, provided antiretroviral medications for a treatment study in which participants of this study could co-enroll. These companies and all other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; C.G. has received research support from Bristol Myers Squibb and Gilead Sciences for studies which participants in this study could co-enroll on, but not for the CHAVI 001 study. C.H. has received grant support and/or consulting/honoraria from BMS, GSK, Merck, Tibotec, Gilead, Myriad Pharmaceuticals, Pfizer, none of which is related to this study. D.M. has received research support from Bristol Myers Squibb, Gilead Sciences, Merck, Abbott, and Roche, but none for this study, and is a honoraria for professional services to Bristol Myers Squibb, Merck, Chimerix, and Tibotec Therapeutics. J.E. receives research support from Merck and GlaxoSmithKline which is not related to this study and is a consultant to Bristol Myers Squibb, Merck, and Tibotec Therapeutics. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The remaining authors have no competing interests to declare.	Abecasis AB, 2009, J VIROL, V83, P12917, DOI 10.1128/JVI.01022-09; Abel K, 2005, J VIROL, V79, P12164, DOI 10.1128/JVI.79.19.12164-12172.2005; Anderson JA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001053; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Bowman MC, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000970; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; de Oliveira T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009311; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; EDMONSON PF, 1992, NUCLEIC ACIDS RES, V20, P4933, DOI 10.1093/nar/20.18.4933; FIDLER S, 2010, COMPARISON HIV VIRAL; Fidler S, 2008, CURR OPIN INFECT DIS, V21, P4, DOI 10.1097/QCO.0b013e3282f428bf; GAY C, 2008, EFFICACY NNRTI BASED; GIANELLA S, 2010, IMPACT EARLY ART PRO; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Haissman JM, 2009, JAIDS-J ACQ IMM DEF, V52, P493, DOI 10.1097/QAI.0b013e3181b627dc; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; KUMAR S, 1994, COMPUT APPL BIOSCI, V10, P189; Lee HY, 2009, J THEOR BIOL, V261, P341, DOI 10.1016/j.jtbi.2009.07.038; Lee HH, 2010, J INFECT DIS, V201, pS65, DOI 10.1086/650385; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Lindback S, 2000, AIDS, V14, P2333, DOI 10.1097/00002030-200010200-00014; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Mehandru S, 2006, PLOS MED, V3, P2335, DOI 10.1371/journal.pmed.0030484; MELLORS JW, 1995, ANN INTERN MED, V122, P573, DOI 10.7326/0003-4819-122-8-199504150-00003; Miller WC, 2010, CURR OPIN HIV AIDS, V5, P277, DOI 10.1097/COH.0b013e32833a0d3a; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; Pilcher CD, 2005, NEW ENGL J MED, V352, P1873, DOI 10.1056/NEJMoa042291; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Regidor DL, 2011, AIDS, V25, P303, DOI 10.1097/QAD.0b013e32834273ad; RIEDER P, 2010, STRONG EFFECT EARLY; Roberts L, 2010, AIDS, V24, P819, DOI 10.1097/QAD.0b013e3283367836; Sachdeva RK, 2010, J INTERF CYTOK RES, V30, P299, DOI 10.1089/jir.2009.0056; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; SIMMONDS P, 1990, J VIROL, V64, P5840, DOI 10.1128/JVI.64.12.5840-5850.1990; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411	44	54	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19617	10.1371/journal.pone.0019617	http://dx.doi.org/10.1371/journal.pone.0019617			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21573003	Green Published, gold			2022-12-27	WOS:000290440200014
J	Wang, H; Siddharthan, V; Hall, JO; Morrey, JD				Wang, Hong; Siddharthan, Venkatraman; Hall, Jeffery O.; Morrey, John D.			Autonomic Nervous Dysfunction in Hamsters Infected with West Nile Virus	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; POSTPRANDIAL INTESTINAL MOTILITY; ACUTE FLACCID PARALYSIS; MONOCLONAL-ANTIBODY; ATRIOVENTRICULAR NODE; GOLDEN-HAMSTER; UNITED-STATES; ENCEPHALITIS; CONDUCTION; MYOCARDITIS	Clinical studies and case reports clearly document that West Nile virus (WNV) can cause respiratory and gastrointestinal (GI) complications. Other functions controlled by the autonomic nervous system may also be directly affected by WNV, such as bladder and cardiac functions. To investigate how WNV can cause autonomic dysfunctions, we focused on the cardiac and GI dysfunctions of rodents infected with WNV. Infected hamsters had distension of the stomach and intestines at day 9 after viral challenge. GI motility was detected by a dye retention assay; phenol red dye was retained more in the stomachs of infected hamsters as compared to sham-infected hamsters. The amplitudes of electromygraphs (EMGs) of intestinal muscles were significantly reduced. Myenteric neurons that innervate the intestines, in addition to neurons in the brain stem, were identified to be infected with WNV. These data suggest that infected neurons controlling autonomic function were the cause of GI dysfunction in WNV-infected hamsters. Using radiotelemetry to record electrocardiograms and to measure heart rate variability (HRV), a well-accepted readout for autonomic function, we determined that HRV and autonomic function were suppressed in WNV-infected hamsters. Cardiac histopathology was observed at day 9 only in the right atrium, which was coincident with WNV staining. A subset of WNV infected cells was identified among cells with hyperplarization-activated cyclic nucleotide-gated potassium channel 4 (HCN4) as a marker for cells in the sinoatrial (SA) and atrioventricular (AV) nodes. The unique contribution of this study is the discovery that WNV infection of hamsters can lead to autonomic dysfunction as determined by reduced HRV and reduced EMG amplitudes of the GI tract. These data may model autonomic dysfunction of the human West Nile neurological disease.	[Wang, Hong; Siddharthan, Venkatraman; Hall, Jeffery O.; Morrey, John D.] Utah State Univ, Dept Anim Dairy & Vet Sci, Inst Antiviral Res, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	Wang, H (corresponding author), Utah State Univ, Dept Anim Dairy & Vet Sci, Inst Antiviral Res, Logan, UT 84322 USA.	john.morrey@usu.edu			Rocky Mountain Regional Centers of Excellence, NIAID, NIH [U54 AI-065357-04]; Virology Branch, NIAID, NIH [N01-AI-30063]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI030063, U54AI065357] Funding Source: NIH RePORTER	Rocky Mountain Regional Centers of Excellence, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Virology Branch, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by U54 AI-065357-04 Rocky Mountain Regional Centers of Excellence, NIAID, NIH, and N01-AI-30063 Virology Branch, NIAID, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abroug F, 2006, INTENS CARE MED, V32, P1636, DOI 10.1007/s00134-006-0298-z; Betensley AD, 2004, THORAX, V59, P268, DOI 10.1136/thorax.2003.009092; Bilchick KC, 2006, J CARDIOVASC ELECTR, V17, P691, DOI 10.1111/j.1540-8167.2006.00501.x; Bode AV, 2006, CLIN INFECT DIS, V42, P1234, DOI 10.1086/503038; Buttow NC, 2004, BIOCELL, V28, P135; Camm AJ, 1996, EUR HEART J, V17, P354; DEBRITO T, 1992, PATHOL RES PRACT, V188, P177, DOI 10.1016/S0344-0338(11)81176-3; Doron SI, 2003, CLIN INFECT DIS, V37, pE74, DOI 10.1086/377177; FIORAMONTI J, 1994, AM J PHYSIOL-GASTR L, V267, pG960, DOI 10.1152/ajpgi.1994.267.6.G960; Franssen H, 2006, ACTA NEUROL BELG, V106, P73; Gibbs SEJ, 2005, J WILDLIFE DIS, V41, P354, DOI 10.7589/0090-3558-41.2.354; HARRISON AK, 1982, EXP MOL PATHOL, V37, P292, DOI 10.1016/0014-4800(82)90043-0; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; HUIKURI HV, 1993, CIRCULATION, V87, P1220, DOI 10.1161/01.CIR.87.4.1220; Hunsperger EA, 2006, J NEUROVIROL, V12, P129, DOI 10.1080/13550280600758341; Jeha LE, 2003, NEUROLOGY, V61, P55, DOI 10.1212/01.WNL.0000073617.08185.0A; Kabatas S, 2008, NEUROSCIENCE, V154, P1627, DOI 10.1016/j.neuroscience.2008.04.071; Khouzam RN, 2009, SOUTH MED J, V102, P527, DOI 10.1097/SMJ.0b013e31819e9bf7; Kushawaha Anurag, 2009, Cases J, V2, P7147, DOI 10.1186/1757-1626-2-7147; Lanciotti RS, 2001, J CLIN MICROBIOL, V39, P4506, DOI 10.1128/JCM.39.12.4506-4513.2001; Lanciotti RS, 2002, VIROLOGY, V298, P96, DOI 10.1006/viro.2002.1449; Leis A Arturo, 2005, Curr Treat Options Neurol, V7, P15, DOI 10.1007/s11940-005-0002-6; Lichtensteiger CA, 2003, EMERG INFECT DIS, V9, P1303; Lindsey Nicole P., 2010, Morbidity and Mortality Weekly Report, V59, P1; MAYER RF, 1966, PSYCHOSOM MED, V28, P475, DOI 10.1097/00006842-196607000-00026; McMahon HT, 1996, P NATL ACAD SCI USA, V93, P4760, DOI 10.1073/pnas.93.10.4760; Mongue-Din H, 2009, AM J PHYSIOL-REG I, V296, pR610, DOI 10.1152/ajpregu.90376.2008; Morrey JD, 2004, ANTIVIR RES, V63, P41, DOI 10.1016/j.antiviral.2004.02.005; Morrey JD, 2008, J NEUROVIROL, V14, P152, DOI 10.1080/13550280801958930; Morrey JD, 2007, ANTIMICROB AGENTS CH, V51, P2396, DOI 10.1128/AAC.00147-07; Morrey JD, 2006, J INFECT DIS, V194, P1300, DOI 10.1086/508293; Morrey JD, 2010, J NEUROVIROL, V16, P318, DOI 10.3109/13550284.2010.501847; Niskanen JP, 2004, COMPUT METH PROG BIO, V76, P73, DOI 10.1016/j.cmpb.2004.03.004; OBEYESEKERE I, 1973, AM HEART J, V85, P186, DOI 10.1016/0002-8703(73)90459-6; Omalu BI, 2003, BRAIN PATHOL, V13, P465, DOI 10.1111/j.1750-3639.2003.tb00477.x; Ori Z, 1992, Cardiol Clin, V10, P499; Park SK, 2010, ENVIRON HEALTH PERSP, V118, P1406, DOI 10.1289/ehp.0901778; Pergam SA, 2006, AM J TROP MED HYG, V75, P1232, DOI 10.4269/ajtmh.2006.75.1232; Petrecca K, 1997, J PHYSIOL-LONDON, V501, P263, DOI 10.1111/j.1469-7793.1997.263bn.x; RODRIGUEZMEMBRILLA A, 1995, J PHARMACOL EXP THER, V275, P486; Saad M, 2005, J INFECTION, V51, P120, DOI 10.1016/j.jinf.2004.10.005; Samuel MA, 2007, P NATL ACAD SCI USA, V104, P17140, DOI 10.1073/pnas.0705837104; Sarnelli G, 2009, DIGEST LIVER DIS, V41, P185, DOI 10.1016/j.dld.2008.06.004; SCHMELZER JD, 1989, P NATL ACAD SCI USA, V86, P1639, DOI 10.1073/pnas.86.5.1639; Sejvar JJ, 2006, EMERG INFECT DIS, V12, P514, DOI 10.3201/eid1203.050643; Sejvar JJ, 2005, EMERG INFECT DIS, V11, P1021, DOI 10.3201/eid1107.040991; Sgoifo A, 1996, PHYSIOL BEHAV, V60, P1397, DOI 10.1016/S0031-9384(96)00228-4; Shpall AI, 2003, UROLOGY, V61, DOI 10.1016/S0090-4295(03)00119-5; Siddharthan V, 2009, J VIROL, V83, P4251, DOI 10.1128/JVI.00017-09; Stein PK, 2005, J CARDIOVASC ELECTR, V16, P13, DOI 10.1046/j.1540-8167.2005.04358.x; Tesh RB, 2005, J INFECT DIS, V192, P287, DOI 10.1086/431153; THOMAS PK, 1981, J NEUROL NEUROSUR PS, V44, P233, DOI 10.1136/jnnp.44.3.233; Tonry JH, 2005, AM J TROP MED HYG, V72, P320, DOI 10.4269/ajtmh.2005.72.320; Tsuji H, 1996, CIRCULATION, V94, P2850, DOI 10.1161/01.CIR.94.11.2850; Vernino S, 2003, J NEUROPHYSIOL, V90, P2053, DOI 10.1152/jn.00408.2003; Viswanathan S, 2007, J MOL CELL CARDIOL, V42, P946, DOI 10.1016/j.yjmcc.2007.02.008; Wang H, 2009, J NEUROVIROL, V15, P293, DOI 10.1080/13550280902973978; Weiss D, 2001, EMERG INFECT DIS, V7, P654, DOI 10.3201/eid0704.010409; Xiao SY, 2001, EMERG INFECT DIS, V7, P714; Yoo S, 2006, CIRCULATION, V114, P1360, DOI 10.1161/CIRCULATIONAHA.106.613182; ZAPANTA L, 2005, THESIS MIT	61	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19575	10.1371/journal.pone.0019575	http://dx.doi.org/10.1371/journal.pone.0019575			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573009	Green Published, gold			2022-12-27	WOS:000290386800020
J	Mutapi, F; Imai, N; Nausch, N; Bourke, CD; Rujeni, N; Mitchell, KM; Midzi, N; Woolhouse, MEJ; Maizels, RM; Mduluza, T				Mutapi, Francisca; Imai, Natsuko; Nausch, Norman; Bourke, Claire D.; Rujeni, Nadine; Mitchell, Kate M.; Midzi, Nicholas; Woolhouse, Mark E. J.; Maizels, Rick M.; Mduluza, Takafira			Schistosome Infection Intensity Is Inversely Related to Auto-Reactive Antibody Levels	PLOS ONE			English	Article							AUTOIMMUNE-DISEASES; HAEMATOBIUM; MANSONI; MALARIA; INTERLEUKIN-10; HELMINTHS; RESPONSES; ZIMBABWE; HYGIENE; ATOPY	In animal experimental models, parasitic helminth infections can protect the host from auto-immune diseases. We conducted a population-scale human study investigating the relationship between helminth parasitism and auto-reactive antibodies and the subsequent effect of anti-helminthic treatment on this relationship. Levels of antinuclear antibodies (ANA) and plasma IL-10 were measured by enzyme linked immunosorbent assay in 613 Zimbabweans (aged 2-86 years) naturally exposed to the blood fluke Schistosoma haematobium. ANA levels were related to schistosome infection intensity and systemic IL-10 levels. All participants were offered treatment with the anti-helminthic drug praziquantel and 102 treated schoolchildren (5-16 years) were followed up 6 months post-antihelminthic treatment. ANA levels were inversely associated with current infection intensity but were independent of host age, sex and HIV status. Furthermore, after allowing for the confounding effects of schistosome infection intensity, ANA levels were inversely associated with systemic levels of IL-10. ANA levels increased significantly 6 months after anti-helminthic treatment. Our study shows that ANA levels are attenuated in helminth-infected humans and that anti-helminthic treatment of helminth-infected people can significantly increase ANA levels. The implications of these findings are relevant for understanding both the aetiology of immune disorders mediated by auto-reactive antibodies and in predicting the long-term consequences of large-scale schistosomiasis control programs.	[Mutapi, Francisca; Imai, Natsuko; Nausch, Norman; Bourke, Claire D.; Rujeni, Nadine; Mitchell, Kate M.; Woolhouse, Mark E. J.; Maizels, Rick M.] Univ Edinburgh, Ashworth Labs, Sch Biol Sci, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland; [Midzi, Nicholas] Natl Inst Hlth Res, Harare, Zimbabwe; [Mduluza, Takafira] Univ Zimbabwe, Dept Biochem, Harare, Zimbabwe	University of Edinburgh; University of Zimbabwe	Mutapi, F (corresponding author), Univ Edinburgh, Ashworth Labs, Sch Biol Sci, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland.	f.mutapi@ed.ac.uk	Imai, Natsuko/J-5817-2017; Nausch, Norman/M-4526-2019; Mitchell, Kate/ABE-5796-2020; Nausch, Norman/L-9276-2013	Imai, Natsuko/0000-0002-4218-9716; Nausch, Norman/0000-0002-9704-2148; Nausch, Norman/0000-0002-9704-2148; Mutapi, Francisca/0000-0002-2537-3466; Bourke, Claire/0000-0002-7244-0895	Cunningham Trust; Carnegie Trust for the Universities of Scotland, Tenovus Scotland; Wellcome Trust [WT082028MA]	Cunningham Trust; Carnegie Trust for the Universities of Scotland, Tenovus Scotland; Wellcome Trust(Wellcome TrustEuropean Commission)	The investigation received financial support from the Cunningham Trust, the Carnegie Trust for the Universities of Scotland, Tenovus Scotland and the Wellcome Trust (Grant no WT082028MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADU D, 1982, CLIN EXP IMMUNOL, V49, P310; Araujo MI, 2006, CHEM IMMUNOL ALLERGY, V90, P29, DOI 10.1159/000088879; Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Bach JF, 2005, J AUTOIMMUN, V25, P74, DOI 10.1016/j.jaut.2005.09.024; Blank M, 2007, CLIN REV ALLERG IMMU, V32, P111; Braat H, 2006, CLIN GASTROENTEROL H, V4, P754, DOI 10.1016/j.cgh.2006.03.028; Cooke A, 1999, PARASITE IMMUNOL, V21, P169, DOI 10.1046/j.1365-3024.1999.00213.x; Cooper GS, 2003, AUTOIMMUN REV, V2, P119, DOI 10.1016/S1568-9972(03)00006-5; Cooper PJ, 2003, J ALLERGY CLIN IMMUN, V111, P995, DOI 10.1067/mai.2003.1348; Daniel-Ribeiro CT, 2000, ACTA TROP, V76, P205, DOI 10.1016/S0001-706X(00)00099-1; Endara P, 2010, CLIN EXP ALLERGY, V40, P1669, DOI 10.1111/j.1365-2222.2010.03559.x; Fesel C, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-5; Fleming JO, 2006, NEUROLOGY, V67, P2085, DOI 10.1212/01.wnl.0000247663.40297.2d; Graham AL, 2010, SCIENCE, V330, P662, DOI 10.1126/science.1194878; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Joseph S, 2004, J INFECT DIS, V190, P835, DOI 10.1086/422604; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; La Flamme AC, 2003, INFECT IMMUN, V71, P4996, DOI 10.1128/IAI.71.9.4996-5004.2003; Liu ZG, 2010, J MOL MED, V88, P27, DOI 10.1007/s00109-009-0546-0; Lleo A, AUTOIMMUN REV, V9, pA259; Lynch NR, 1999, THORAX, V54, P659, DOI 10.1136/thx.54.8.659; Mabaso MLH, 2005, TROP MED INT HEALTH, V10, P909, DOI 10.1111/j.1365-3156.2005.01462.x; Mabaso Musawenkoi L H, 2006, Int J Health Geogr, V5, P20; Maizels RM, 2009, J EXP MED, V206, P2059, DOI 10.1084/jem.20091903; Maizels RM, 2005, CURR OPIN IMMUNOL, V17, P656, DOI 10.1016/j.coi.2005.09.001; Midzi N, 2010, ACTA TROP, V115, P103, DOI 10.1016/j.actatropica.2010.02.010; Milner TM, 2010, PARASITE IMMUNOL; Mingomataj EC, 2006, ALLERGY, V61, P400, DOI 10.1111/j.1398-9995.2006.00983.x; MOTT KE, 1983, B SOC PATHOL EXOT, V76, P101; Mutapi F, 2005, J INFECT DIS, V192, P1108, DOI 10.1086/432553; Mutapi F, 1997, PARASITE IMMUNOL, V19, P255, DOI 10.1046/j.1365-3024.1997.d01-206.x; Mutapi F, 2002, LANCET INFECT DIS, V2, P219, DOI 10.1016/S1473-3099(02)00240-2; Nagayama Y, 2004, J IMMUNOL, V173, P2167, DOI 10.4049/jimmunol.173.3.2167; Ndhlovu P, 1996, PARASITE IMMUNOL, V18, P181, DOI 10.1046/j.1365-3024.1996.d01-78.x; Ndhlovu P, 1996, 1992 NATL SCHISTOSOM; Osada Y, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/743758; Pichler WJ, 2003, CURR OPIN ALLERGY CL, V3, P249, DOI 10.1097/01.all.0000083955.99396.25; Scofield RH, 2004, LANCET, V363, P1544, DOI 10.1016/S0140-6736(04)16154-0; Smith P, 2007, J IMMUNOL, V178, P4557, DOI 10.4049/jimmunol.178.7.4557; Smits HH, 2007, J ALLERGY CLIN IMMUN, V120, P932, DOI 10.1016/j.jaci.2007.06.009; Stanley Midzi VT, 2004, ZIMBABWE ROLL BACK M; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; TAYLOR P, 1986, T ROY SOC TROP MED H, V80, P12, DOI 10.1016/0035-9203(86)90185-9; van den Biggelaar AHJ, 2004, J INFECT DIS, V189, P892, DOI 10.1086/381767; van den Biggelaar AHJ, 2000, LANCET, V356, P1723, DOI 10.1016/S0140-6736(00)03206-2; Woolhouse MEJ, 1998, PARASITOL TODAY, V14, P428, DOI 10.1016/S0169-4758(98)01318-0; World Health Organization, 2002, PREV CONTR SCHIST SO; Youinou P, 2010, J AUTOIMMUN, V34, pJ163, DOI 10.1016/j.jaut.2009.12.005	48	32	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19149	10.1371/journal.pone.0019149	http://dx.doi.org/10.1371/journal.pone.0019149			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573157	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000290305600013
J	Loukin, S; Su, ZW; Kung, C				Loukin, Stephen; Su, Zhenwei; Kung, Ching			Increased Basal Activity Is a Key Determinant in the Severity of Human Skeletal Dysplasia Caused by TRPV4 Mutations	PLOS ONE			English	Article							NONSELECTIVE CATION CHANNEL; CALMODULIN-BINDING SITE; OF-FUNCTION MUTATIONS; METATROPIC DYSPLASIA; RECEPTOR; ACTIVATION; GENE; BRACHYOLMIA; MECHANISMS; DISEASE	TRPV4 is a mechanically activated Ca2+-passing channel implicated in the sensing of forces, including those acting on bones. To date, 33 mutations are known to affect human bone development to different extents. The spectrum of these skeletal dysplasias (SD) ranges from dominantly inherited mild brachylomia (BO) to neonatal lethal forms of metatropic dysplasia (MD). Complexities of the results from fluorescence and electrophysiological studies have led to questions on whether channel activity is a good predictor of disease severity. Here we report on a systematic examination of 14 TRPV4 mutant alleles covering the entire SD spectrum. Expressed in Xenopus oocyte and without any stimulation, the wild-type channel had a similar to 1% open probability (Po) while those of most of the lethal MD channels approached 100%. All mutant channels had higher basal open probabilities, which limited their further increase by agonist or hypotonicity. The magnitude of this limitation revealed a clear correlation between the degree of over-activity (the molecular phenotype) and the severity of the disease over the entire spectrum (the biological phenotype). Thus, while other factors are at play, our results are consistent with the increased TRPV4 basal activity being a critical determinant of the severity of skeletal dysplasia. We discuss how the channel over-activity may lead to the "gain-of-function'' phenotype and speculate that the function of wild-type TRPV4 may be secondary in normal bone development but crucial in an acute process such as fracture repair in the adult.	[Loukin, Stephen; Su, Zhenwei; Kung, Ching] Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA; [Kung, Ching] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Loukin, S (corresponding author), Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA.	shloukin@wisc.edu	Su, Zhenwei/C-3185-2018	Su, Zhenwei/0000-0002-5591-418X	National Institutes of Health (NIH) [GM054867, NS067360, GM047856]; Vilas Trust of the University of Wisconsin, Madison; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS067360] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vilas Trust of the University of Wisconsin, Madison; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grant GM054867 (to S.L. and Y.S.), NS067360 and GM047856 (to C.K.) and by the Vilas Trust of the University of Wisconsin, Madison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer-Grumbach M, 2010, NAT GENET, V42, P160, DOI 10.1038/ng.508; Becker D, 2009, EUR J CELL BIOL, V88, P141, DOI 10.1016/j.ejcb.2008.10.002; Camacho N, 2010, AM J MED GENET A, V152A, P1169, DOI 10.1002/ajmg.a.33392; Cameron TL, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-20; Cao DS, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-5; Clark AL, 2010, ARTHRITIS RHEUM-US, V62, P2973, DOI 10.1002/art.27624; Dai J, 2010, J MED GENET, V47, P704, DOI 10.1136/jmg.2009.075358; Dai J, 2010, J HUM GENET, V55, P400, DOI 10.1038/jhg.2010.37; Deng HX, 2010, NAT GENET, V42, P165, DOI 10.1038/ng.509; Fan HC, 2009, J BIOL CHEM, V284, P27884, DOI 10.1074/jbc.M109.028803; Fernandes J, 2008, J CELL BIOL, V181, P143, DOI 10.1083/jcb.200712058; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Garcia-Elias A, 2008, J BIOL CHEM, V283, P31284, DOI 10.1074/jbc.C800184200; Genevieve D, 2008, AM J MED GENET A, V146A, P992, DOI 10.1002/ajmg.a.32191; Grimm C, 2007, P NATL ACAD SCI USA, V104, P19583, DOI 10.1073/pnas.0709846104; HRUSKA KA, 1995, NEW ENGL J MED, V333, P166, DOI 10.1056/NEJM199507203330307; Kannu P, 2007, AM J MED GENET A, V143A, P2512, DOI 10.1002/ajmg.a.31941; Klausen TK, 2009, J MED CHEM, V52, P2933, DOI 10.1021/jm9001007; KOZLOWSKI K, 1988, Australasian Radiology, V32, P325, DOI 10.1111/j.1440-1673.1988.tb02748.x; Krakow D, 2009, AM J HUM GENET, V84, P307, DOI 10.1016/j.ajhg.2009.01.021; Landoure G, 2010, NAT GENET, V42, P170, DOI 10.1038/ng.512; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liedtke W, 2008, ANN NY ACAD SCI, V1144, P42, DOI 10.1196/annals.1418.012; Lorenzo IM, 2008, P NATL ACAD SCI USA, V105, P12611, DOI 10.1073/pnas.0803970105; Loukin S, 2010, J BIOL CHEM, V285, P27176, DOI 10.1074/jbc.M110.143370; Loukin S, 2010, J BIOL CHEM, V285, P19884, DOI 10.1074/jbc.M110.113936; Masuyama R, 2008, CELL METAB, V8, P257, DOI 10.1016/j.cmet.2008.08.002; Mizoguchi F, 2008, J CELL PHYSIOL, V216, P47, DOI 10.1002/jcp.21374; Muramatsu S, 2007, J BIOL CHEM, V282, P32158, DOI 10.1074/jbc.M706158200; Myers BR, 2008, NEURON, V58, P362, DOI 10.1016/j.neuron.2008.04.012; Nishimura G, 2010, AM J MED GENET A, V152A, P1443, DOI 10.1002/ajmg.a.33414; Nural Mehmet Selim, 2006, Diagn Interv Radiol, V12, P70; Rock MJ, 2008, NAT GENET, V40, P999, DOI 10.1038/ng.166; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; SHOHAT M, 1989, AM J MED GENET, V33, P209, DOI 10.1002/ajmg.1320330214; Smith PL, 2006, J BIOL CHEM, V281, P29897, DOI 10.1074/jbc.M605394200; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Strotmann R, 2003, J BIOL CHEM, V278, P26541, DOI 10.1074/jbc.M302590200; Strotmann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010580; Su ZW, 2007, P NATL ACAD SCI USA, V104, P19607, DOI 10.1073/pnas.0708584104; Thodeti CK, 2009, CIRC RES, V104, P1123, DOI 10.1161/CIRCRESAHA.108.192930; Thorneloe KS, 2008, J PHARMACOL EXP THER, V326, P432, DOI 10.1124/jpet.108.139295; Tian W, 2009, P NATL ACAD SCI USA, V106, P14034, DOI 10.1073/pnas.0904084106; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2003, CELL CALCIUM, V33, P489, DOI 10.1016/S0143-4160(03)00064-2; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Wegierski T, 2009, J BIOL CHEM, V284, P2923, DOI 10.1074/jbc.M805357200; Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104; Yoon J, 2000, J NEUROSCI, V20, P649, DOI 10.1523/JNEUROSCI.20-02-00649.2000; Zhu GH, 2009, HUM MOL GENET, V18, P2053, DOI 10.1093/hmg/ddp111	52	42	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19533	10.1371/journal.pone.0019533	http://dx.doi.org/10.1371/journal.pone.0019533			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573172	Green Submitted, gold, Green Published			2022-12-27	WOS:000290256400020
J	Cohen-Kupiec, R; Pasmanik-Chor, M; Oron-Karni, V; Weil, M				Cohen-Kupiec, Rachel; Pasmanik-Chor, Metsada; Oron-Karni, Varda; Weil, Miguel			Effects of IKAP/hELP1 Deficiency on Gene Expression in Differentiating Neuroblastoma Cells: Implications for Familial Dysautonomia	PLOS ONE			English	Article							AXON GUIDANCE; NEURAL CREST; MOUSE IKBKAP; ELONGATOR; CLONING; GROWTH; IDENTIFICATION; CYTOSKELETAL; ORGANIZATION; MUTATIONS	Familial dysautonomia (FD) is a developmental neuropathy of the sensory and autonomous nervous systems. The IKBKAP gene, encoding the IKAP/hELP1 subunit of the RNA polymerase II Elongator complex is mutated in FD patients, leading to a tissue-specific mis-splicing of the gene and to the absence of the protein in neuronal tissues. To elucidate the function of IKAP/hELP1 in the development of neuronal cells, we have downregulated IKBKAP expression in SHSY5Y cells, a neuroblastoma cell line of a neural crest origin. We have previously shown that these cells exhibit abnormal cell adhesion when allowed to differentiate under defined culture conditions on laminin substratum. Here, we report results of a microarray expression analysis of IKAP/hELP1 downregulated cells that were grown on laminin under differentiation or non-differentiation growth conditions. It is shown that under non-differentiation growth conditions, IKAP/hELP1 downregulation affects genes important for early developmental stages of the nervous system, including cell signaling, cell adhesion and neural crest migration. IKAP/hELP1 downregulation during differentiation affects the expression of genes that play a role in late neuronal development, in axonal projection and synapse formation and function. We also show that IKAP/hELP1 deficiency affects the expression of genes involved in calcium metabolism before and after differentiation of the neuroblastoma cells. Hence, our data support IKAP/hELP1 importance in the development and function of neuronal cells and contribute to the understanding of the FD phenotype.	[Cohen-Kupiec, Rachel; Weil, Miguel] Tel Aviv Univ, Dept Cell Res & Immunol, Ramat Aviv, Israel; [Pasmanik-Chor, Metsada; Oron-Karni, Varda] Tel Aviv Univ, Bioinformat Unit, Ramat Aviv, Israel	Tel Aviv University; Tel Aviv University	Cohen-Kupiec, R (corresponding author), Tel Aviv Univ, Dept Cell Res & Immunol, Ramat Aviv, Israel.	miguelw@tauex.tau.ac.il			FD Foundation Inc.; FD Israel Foundation; Israel Science Foundation [1491/09]	FD Foundation Inc.; FD Israel Foundation; Israel Science Foundation(Israel Science Foundation)	This study was supported by a grant from the FD research consortium (FD Hope http://www.fdhope.org/, FD Foundation Inc. http://www.familialdysautonomia.org/, FD Israel Foundation http://www.fd-israel.org.il/) and a grant from the Israel Science Foundation www.isf.org.il/english/(grant No. 1491/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta S, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-12; Anderson SL, 2001, AM J HUM GENET, V68, P753, DOI 10.1086/318808; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Arighi E, 2005, CYTOKINE GROWTH F R, V16, P441, DOI 10.1016/j.cytogfr.2005.05.010; Axelrod FB, 2004, MUSCLE NERVE, V29, P352, DOI 10.1002/mus.10499; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cheishvili D, 2011, HUM MOL GENET; Cheishvili D, 2007, HUM MOL GENET, V16, P2097, DOI 10.1093/hmg/ddm157; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chen YT, 2009, MOL CELL BIOL, V29, P736, DOI 10.1128/MCB.01313-08; Cisternas FA, 2003, GENOMICS, V81, P279, DOI 10.1016/S0888-7543(02)00040-X; Close P, 2006, MOL CELL, V22, P521, DOI 10.1016/j.molcel.2006.04.017; Cohen-Kupiec R, CELL ADH MIGR, V4; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Cuajungco MP, 2001, DNA CELL BIOL, V20, P579, DOI 10.1089/104454901317094990; Davies A, 2007, TRENDS PHARMACOL SCI, V28, P220, DOI 10.1016/j.tips.2007.03.005; DAWSON TM, 1992, ANN NEUROL, V32, P297, DOI 10.1002/ana.410320302; Dent EW, 2003, NEUROSCIENTIST, V9, P343, DOI 10.1177/1073858403252683; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; FISCHERCOLBRIE R, 1995, PROG NEUROBIOL, V46, P49, DOI 10.1016/0301-0082(94)00060-U; Gebbink MFBG, 1997, J CELL BIOL, V137, P1603, DOI 10.1083/jcb.137.7.1603; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Gow AJ, 2001, J CELL PHYSIOL, V187, P277, DOI 10.1002/jcp.1085; Hawkes NA, 2002, J BIOL CHEM, V277, P3047, DOI 10.1074/jbc.M110445200; Hintsch G, 2002, MOL CELL NEUROSCI, V21, P393, DOI 10.1006/mcne.2002.1181; Huang X, 2004, DEV BIOL, V275, P1, DOI 10.1016/j.ydbio.2004.07.033; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johansen LD, 2008, J CELL SCI, V121, P854, DOI 10.1242/jcs.013722; Kantor DB, 2004, NEURON, V44, P961, DOI 10.1016/j.neuron.2004.12.002; Keren H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015884; Konecna A, 2006, MOL BIOL CELL, V17, P3651, DOI 10.1091/mbc.E06-02-0112; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lipardi C, FLY AUSTIN, V4, P30; Lorenzon NM, 2008, CHANNELS, V2, P163, DOI 10.4161/chan.2.3.5950; Lykissas MG, 2007, CURR NEUROVASC RES, V4, P143, DOI 10.2174/156720207780637216; Maayan C, 2002, OSTEOPOROSIS INT, V13, P429, DOI 10.1007/s001980200050; Manie S, 2001, TRENDS GENET, V17, P580, DOI 10.1016/S0168-9525(01)02420-9; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Naumanen T, 2008, CELL ADHES MIGR, V2, P236, DOI 10.4161/cam.2.4.6630; Nguyen L, 2010, TRENDS MOL MED, V16, P1, DOI 10.1016/j.molmed.2009.11.002; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Pachnis V, 1998, AM J PHYSIOL-GASTR L, V275, pG183, DOI 10.1152/ajpgi.1998.275.2.G183; Rico B, 2004, NAT NEUROSCI, V7, P1059, DOI 10.1038/nn1317; SCHULTZ D, 1993, P NATL ACAD SCI USA, V90, P6228, DOI 10.1073/pnas.90.13.6228; Sefton M, 1998, DEVELOPMENT, V125, P3111; Shibata T, 1997, J BIOL CHEM, V272, P5236, DOI 10.1074/jbc.272.8.5236; Shilo BZ, 2005, DEVELOPMENT, V132, P4017, DOI 10.1242/dev.02006; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; Solinger JA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000820; Svejstrup JQ, 2007, CURR OPIN CELL BIOL, V19, P331, DOI 10.1016/j.ceb.2007.04.005; Taneyhill LA, 2008, CELL ADHES MIGR, V2, P223, DOI 10.4161/cam.2.4.6835; Woo J, 2009, MOL CELL NEUROSCI, V42, P1, DOI 10.1016/j.mcn.2009.05.008; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yarden Y, 2007, CELL, V131, DOI 10.1016/j.cell.2007.11.013; Young HM, 2004, AUTON NEUROSCI-BASIC, V112, P1, DOI 10.1016/j.autneu.2004.02.008; Zaczek A, 2005, HISTOL HISTOPATHOL, V20, P1005, DOI 10.14670/HH-20.1005; Zhang Y, 2003, J BIOL CHEM, V278, P573, DOI 10.1074/jbc.M203094200; Zimmermann DR, 2008, HISTOCHEM CELL BIOL, V130, P635, DOI 10.1007/s00418-008-0485-9	61	22	23	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19147	10.1371/journal.pone.0019147	http://dx.doi.org/10.1371/journal.pone.0019147			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559466	gold, Green Published, Green Submitted			2022-12-27	WOS:000290024700076
J	Narzisi, G; Mishra, B				Narzisi, Giuseppe; Mishra, Bud			Comparing De Novo Genome Assembly: The Long and Short of It	PLOS ONE			English	Article							SHORT DNA-SEQUENCES; ALGORITHM; VIRULENCE; MILLIONS; READS	Recent advances in DNA sequencing technology and their focal role in Genome Wide Association Studies (GWAS) have rekindled a growing interest in the whole-genome sequence assembly (WGSA) problem, thereby, inundating the field with a plethora of new formalizations, algorithms, heuristics and implementations. And yet, scant attention has been paid to comparative assessments of these assemblers' quality and accuracy. No commonly accepted and standardized method for comparison exists yet. Even worse, widely used metrics to compare the assembled sequences emphasize only size, poorly capturing the contig quality and accuracy. This paper addresses these concerns: it highlights common anomalies in assembly accuracy through a rigorous study of several assemblers, compared under both standard metrics (N50, coverage, contig sizes, etc.) as well as a more comprehensive metric (Feature-Response Curves, FRC) that is introduced here; FRC transparently captures the trade-offs between contigs' quality against their sizes. For this purpose, most of the publicly available major sequence assemblers - both for low-coverage long (Sanger) and high-coverage short (Illumina) reads technologies - are compared. These assemblers are applied to microbial (Escherichia coli, Brucella, Wolbachia, Staphylococcus, Helicobacter) and partial human genome sequences (Chr. Y), using sequence reads of various read-lengths, coverages, accuracies, and with and without mate-pairs. It is hoped that, based on these evaluations, computational biologists will identify innovative sequence assembly paradigms, bioinformaticists will determine promising approaches for developing "next-generation'' assemblers, and biotechnologists will formulate more meaningful design desiderata for sequencing technology platforms. A new software tool for computing the FRC metric has been developed and is available through the AMOS open-source consortium.	[Narzisi, Giuseppe; Mishra, Bud] NYU, Courant Inst Math Sci, New York, NY 10003 USA; [Mishra, Bud] NYU, Sch Med, New York, NY USA	New York University; New York University	Narzisi, G (corresponding author), NYU, Courant Inst Math Sci, New York, NY 10003 USA.	narzisi@nyu.edu			Abraxis BioScience; NSF CDI	Abraxis BioScience; NSF CDI(National Science Foundation (NSF))	The research reported here was supported by grants from Abraxis BioScience and NSF CDI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Anantharaman TS, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P385; Anantharaman TS, 1997, J COMPUT BIOL, V4, P91, DOI 10.1089/cmb.1997.4.91; Anantharaman TS., 1997, GENOMICS VIA OPTICAL, P18; Antoniotti M, 2001, GENOMICS VIA OPTICAL; Ariyaratne PN, 2011, BIOINFORMATICS, V27, P167, DOI 10.1093/bioinformatics/btq626; Aston C, 1999, TRENDS BIOTECHNOL, V17, P297, DOI 10.1016/S0167-7799(99)01326-8; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Boisvert S, 2010, J COMPUT BIOL, V17, P1519, DOI 10.1089/cmb.2009.0238; Bryant DW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-69; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; Dohm JC, 2007, GENOME RES, V17, P1697, DOI 10.1101/gr.6435207; Eppinger M, 2006, PLOS GENET, V2, P1097, DOI 10.1371/journal.pgen.0020120; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Green P, 1996, PHRAP DOCUMENTATION; Hall SS, 2010, REVOLUTION POSTPONED, P60; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Hossain MS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S16; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huang XQ, 2003, GENOME RES, V13, P2164, DOI 10.1101/gr.1390403; Hung RW, 2006, DISCRETE APPL MATH, V154, P76, DOI 10.1016/j.dam.2005.07.002; Jeck WR, 2007, BIOINFORMATICS, V23, P2942, DOI 10.1093/bioinformatics/btm451; Kidd JM, 2010, NAT METHODS, V7, P365, DOI 10.1038/NMETH.1451; Kim S., 2007, GENOME SEQUENCING TE; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Medvedev P, 2007, LECT N BIOINFORMAT, V4645, P289, DOI 10.1007/978-3-540-74126-8_27; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Mishra B, 2005, OPTICAL MAPPING ENCY; Mullikin JC, 2003, GENOME RES, V13, P81, DOI 10.1101/gr.731003; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Narzisi G, 2011, BIOINFORMATICS, V27, P153, DOI 10.1093/bioinformatics/btq646; Paulsen IT, 2002, P NATL ACAD SCI USA, V99, P13148, DOI 10.1073/pnas.192319099; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Phillippy AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r55; Salzberg SL, 2005, BIOINFORMATICS, V21, P4320, DOI 10.1093/bioinformatics/bti769; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schmidt B, 2009, BIOINFORMATICS, V25, P2279, DOI 10.1093/bioinformatics/btp374; Schwartz DC, 2010, J COMPUT SCI TECH-CH, V25, P3, DOI 10.1007/s11390-010-9300-x; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Sutton G. G., 1995, GENOME SCI TECHNOL, V1, P9, DOI [10.1089/gst.1995.1.9, DOI 10.1089/GST.1995.1.9]; TARHIO J, 1988, THEOR COMPUT SCI, V57, P131, DOI 10.1016/0304-3975(88)90167-3; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zerbino DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008407	52	70	70	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19175	10.1371/journal.pone.0019175	http://dx.doi.org/10.1371/journal.pone.0019175			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559467	gold, Green Submitted, Green Published			2022-12-27	WOS:000290024700091
J	Van Houtan, KS; Halley, JM				Van Houtan, Kyle S.; Halley, John M.			Long-Term Climate Forcing in Loggerhead Sea Turtle Nesting	PLOS ONE			English	Article							SURFACE-TEMPERATURE; OSCILLATION; PATTERNS	The long-term variability of marine turtle populations remains poorly understood, limiting science and management. Here we use basin-scale climate indices and regional surface temperatures to estimate loggerhead sea turtle (Caretta caretta) nesting at a variety of spatial and temporal scales. Borrowing from fisheries research, our models investigate how oceanographic processes influence juvenile recruitment and regulate population dynamics. This novel approach finds local populations in the North Pacific and Northwest Atlantic are regionally synchronized and strongly correlated to ocean conditions-such that climate models alone explain up to 88% of the observed changes over the past several decades. In addition to its performance, climate-based modeling also provides mechanistic forecasts of historical and future population changes. Hindcasts in both regions indicate climatic conditions may have been a factor in recent declines, but future forecasts are mixed. Available climatic data suggests the Pacific population will be significantly reduced by 2040, but indicates the Atlantic population may increase substantially. These results do not exonerate anthropogenic impacts, but highlight the significance of bottom-up oceanographic processes to marine organisms. Future studies should consider environmental baselines in assessments of marine turtle population variability and persistence.	[Van Houtan, Kyle S.] Pacific Isl Fisheries Sci Ctr, NOAA Fisheries Serv, Marine Turtle Assessment Program, Honolulu, HI USA; [Van Houtan, Kyle S.] Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC USA; [Halley, John M.] Univ Ioannina, Dept Biol Applicat & Technol, GR-45110 Ioannina, Greece	National Oceanic Atmospheric Admin (NOAA) - USA; Duke University; University of Ioannina	Van Houtan, KS (corresponding author), Pacific Isl Fisheries Sci Ctr, NOAA Fisheries Serv, Marine Turtle Assessment Program, Honolulu, HI USA.	kyle.vanhoutan@gmail.com	Halley, John M/AAP-3004-2020; Van Houtan, Kyle Schuyler/A-4695-2008; Van Houtan, Kyle S/GRY-0874-2022	Van Houtan, Kyle/0000-0001-5725-1773				BEAMISH RJ, 1993, CAN J FISH AQUAT SCI, V50, P1002, DOI 10.1139/f93-116; Bolten AB, 1998, ECOL APPL, V8, P1; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; CARR AF, 1952, SCIENCE, V309, P1236; Chaloupka M, 2008, J EXP MAR BIOL ECOL, V356, P136, DOI 10.1016/j.jembe.2007.12.009; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Clark J. S, 2007, MODELS ECOLOGICAL DA; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Dawe EG, 2007, FISH OCEANOGR, V16, P303, DOI 10.1111/j.1365-2419.2007.00431.x; Drinkwater K.F., 2003, GEOPHYS MONOGR SER, V134, P211; Edwards M, 2010, TRENDS ECOL EVOL, V25, P602, DOI 10.1016/j.tree.2010.07.007; Enfield DB, 2001, GEOPHYS RES LETT, V28, P2077, DOI 10.1029/2000GL012745; Estes JA, 1998, SCIENCE, V282, P473, DOI 10.1126/science.282.5388.473; Halley J, 2002, OIKOS, V99, P518, DOI 10.1034/j.1600-0706.2002.11962.x; Halley JM, 2009, PHYSICA A, V388, P2492, DOI 10.1016/j.physa.2009.02.027; Hatase H, 2004, MAR BIOL, V144, P807, DOI 10.1007/s00227-003-1232-3; Hjort J, 1914, RAPPORTS PROCES VERB, V20, P3; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Hurvich CM, 1998, J ROY STAT SOC B, V60, P271, DOI 10.1111/1467-9868.00125; Intergovernmental Panel on Climate Change, 2022, CLIMATE CHANGE 2022; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; KAMEZAKI N, 2002, CURRENT STATUS JAPAN; Knight JR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026242; Knight JR, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024233; Lasker R., 1981, P79; Lewison RL, 2009, ECOL APPL, V19, P920, DOI 10.1890/08-0623.1; Mansfield KL, 2009, MAR BIOL, V156, P2555, DOI 10.1007/s00227-009-1279-x; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; Matsuzawa Y, 2010, NESTING BEACH MANAGE; Natl Res Council, 2010, ASSESSMENT OF SEA-TURTLE STATUS AND TRENDS: INTEGRATING DEMOGRAPHY AND ABUNDANCE, P1; Nyberg J, 2007, NATURE, V447, P698, DOI 10.1038/nature05895; Ottersen G, 2001, OECOLOGIA, V128, P1, DOI 10.1007/s004420100655; Pearson A, 2009, NEW SCI, V201, P33; PHILANDER SGH, 1990, EL NINO LA NINA S OS; PIMM SL, 1982, FOOD WEBS; Polovina J, 2006, DEEP-SEA RES PT II, V53, P326, DOI 10.1016/j.dsr2.2006.01.006; POLOVINA JJ, 2011, ICES J MAR SCI, DOI DOI 10.1093/ICESJMS/FSQ1198; Rivalan P, 2005, OECOLOGIA, V145, P564, DOI 10.1007/s00442-005-0159-4; Rivalan P, 2005, J WILDLIFE MANAGE, V69, P540, DOI 10.2193/0022-541X(2005)069[0540:MLEOTL]2.0.CO;2; Saba VS, 2007, J APPL ECOL, V44, P395, DOI 10.1111/j.1365-2664.2007.01276.x; SASSO CR, ANN SURVIVA IN PRESS; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Snover, 2002, GROWTH ONTOGENY SEA; Solow AR, 2002, ECOL LETT, V5, P742, DOI 10.1046/j.1461-0248.2002.00374.x; STEARNS SC, 1986, EVOLUTION, V40, P893, DOI 10.1111/j.1558-5646.1986.tb00560.x; STEELE JH, 1985, NATURE, V313, P355, DOI 10.1038/313355a0; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; TAKESHITA H, 2005, P 2 W PAC SEA TURTL, P27; THOMPSON N, 2009, NMFSSEFSC575 NOAA TU; Tomillo PS, 2008, CONSERV BIOL, V22, P1216, DOI 10.1111/j.1523-1739.2008.00987.x; Van Houtan KS, 2007, CURR BIOL, V17, pR590, DOI 10.1016/j.cub.2007.06.021; Van Houtan KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012900; Van Houtan KS, 2009, CONSERV LETT, V2, P254, DOI 10.1111/j.1755-263X.2009.00081.x; Wallace BP, 2006, MAR ECOL PROG SER, V318, P263, DOI 10.3354/meps318263; Wallace BP, 2010, CONSERV LETT, V3, P131, DOI 10.1111/j.1755-263X.2010.00105.x; Witherington B, 2009, ECOL APPL, V19, P30, DOI 10.1890/08-0434.1	56	54	56	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e19043	10.1371/journal.pone.0019043	http://dx.doi.org/10.1371/journal.pone.0019043			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21589639	Green Published, gold, Green Submitted			2022-12-27	WOS:000290019400023
J	Kim, HY; Tsai, S; Lo, SC; Wear, DJ; Izadjoo, MJ				Kim, Hyung-Yong; Tsai, Shien; Lo, Shyh-Ching; Wear, Douglas J.; Izadjoo, Mina J.			Production and Characterization of Chimeric Monoclonal Antibodies against Burkholderia pseudomallei and B. mallei Using the DHFR Expression System	PLOS ONE			English	Article							IMMUNOGLOBULIN VARIABLE DOMAINS; CAPSULAR POLYSACCHARIDE; CHO-CELLS; MELIOIDOSIS; PROTEIN; LIPOPOLYSACCHARIDE; PATHOGENICITY; LIPOPROTEIN; VACCINES; VECTORS	Burkholderia pseudomallei (BP) and B. mallei (BM) are closely related gram-negative, facultative anaerobic bacteria which cause life-threatening melioidosis in human and glanders in horse, respectively. Our laboratory has previously generated and characterized more than 100 mouse monoclonal antibodies (MAbs) against BP and BM, according to in vitro and in vivo assay. In this study, 3 MAbs (BP7 10B11, BP7 2C6, and BP1 7F7) were selected to develop into chimeric mouse-human monoclonal antibodies (cMAbs) against BP and/or BM. For the stable production of cMAbs, we constructed 4 major different vector systems with a dihydrofolate reductase (DHFR) amplification marker, and optimized transfection/selection conditions in mammalian host cells with the single-gene and/or double-gene expression system. These 3 cMAbs were stably produced by the DHFR double mutant Chinese hamster ovarian (CHO)-DG44 cells. By ELISA and Western blot analysis using whole bacterial antigens treated by heat (65 degrees C/90 min), sodium periodate, and proteinase K, the cMAb BP7 10B11 (cMAb CK1) reacted with glycoproteins (34, 38, 48 kDa in BP; 28, 38, 48 kDa in BM). The cMAb BP7 2C6 (cMAb CK2) recognized surface-capsule antigens with molecular sizes of 38 to 52 kDa, and 200 kDa in BM. The cMAb CK2 was weakly reactive to 14 similar to 28, 200 kDa antigens in BP. The cMAb BP1 7F7 (cMAb CK3) reacted with lipopolysaccharides (38 similar to 52 kDa in BP; 38 similar to 60 kDa in B. thailandensis). Western blot results with the outer surface antigens of the 3 Burkholderia species were consistent with results with the whole Burkholderia cell antigens, suggesting that these immunodominant antigens reacting with the 3 cMAbs were primarily present on the outer surface of the Burkholderia species. These 3 cMAbs would be useful for analyzing the role of the major outer surface antigens in Burkholderia infection.	[Kim, Hyung-Yong; Tsai, Shien; Wear, Douglas J.; Izadjoo, Mina J.] Armed Forces Inst Pathol, Dept Environm & Infect Dis Sci, Washington, DC 20306 USA; [Kim, Hyung-Yong; Tsai, Shien; Wear, Douglas J.; Izadjoo, Mina J.] Amer Registry Pathol, Washington, DC USA; [Lo, Shyh-Ching] US Food & Drug Adm FDA, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Bethesda, MD USA; [Lo, Shyh-Ching] US Food & Drug Adm FDA, Div Human Tissues, Ctr Biol Evaluat & Res, Bethesda, MD USA	United States Department of Defense; US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Kim, HY (corresponding author), Armed Forces Inst Pathol, Dept Environm & Infect Dis Sci, Washington, DC 20306 USA.	izadjoo@afip.osd.mil	Kim, Hyojoong/AAT-8734-2021; Lee, Seunghwan/E-4992-2011	Kim, Hyojoong/0000-0002-1706-2991	Defense Threat Reduction Agency-Joint Science and Technology Office [2.1_05_AF_B, 2.1_07_AF_B]	Defense Threat Reduction Agency-Joint Science and Technology Office(United States Department of DefenseDefense Threat Reduction Agency)	This research was supported by grants 2.1_05_AF_B & 2.1_07_AF_B from the Defense Threat Reduction Agency-Joint Science and Technology Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bianchi AA, 2003, BIOTECHNOL BIOENG, V84, P439, DOI 10.1002/bit.10790; Bondi SK, 2008, EXPERT REV VACCINES, V7, P1357, DOI 10.1586/14760584.7.9.1357; Brekke OH, 2003, NAT REV DRUG DISCOV, V2, P52, DOI 10.1038/nrd984; Casadevall A, 2002, EMERG INFECT DIS, V8, P833, DOI 10.3201/eid0808.010516; Chan SW, 2004, J BIOCHEM MOL BIOL, V37, P556; CHAOWAGUL W, 1989, J INFECT DIS, V159, P890, DOI 10.1093/infdis/159.5.890; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Chinnasamy D, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-14; Chusainow J, 2009, BIOTECHNOL BIOENG, V102, P1182, DOI 10.1002/bit.22158; CRAVITZ L, 1950, J INFECT DIS, V86, P46, DOI 10.1093/infdis/86.1.46; Dinnis DM, 2005, BIOTECHNOL BIOENG, V91, P180, DOI 10.1002/bit.20499; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Felgner PL, 2009, P NATL ACAD SCI USA, V106, P13499, DOI 10.1073/pnas.0812080106; Feng SH, 2006, HYBRIDOMA, V25, P193, DOI 10.1089/hyb.2006.25.193; Hara Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006496; HOWE C, 1971, J INFECT DIS, V124, P598, DOI 10.1093/infdis/124.6.598; HOWE C, 1947, ANN INTERN MED, V26, P93, DOI 10.7326/0003-4819-26-1-93; Jones SM, 2002, J MED MICROBIOL, V51, P1055, DOI 10.1099/0022-1317-51-12-1055; Kim HY, 1998, J CLIN MICROBIOL, V36, P3278, DOI 10.1128/JCM.36.11.3278-3284.1998; Kim HY, 2002, INFECT IMMUN, V70, P4132, DOI 10.1128/IAI.70.8.4132-4141.2002; Kim SJ, 1998, BIOTECHNOL BIOENG, V58, P73, DOI 10.1002/(SICI)1097-0290(19980405)58:1<73::AID-BIT8>3.0.CO;2-R; Leelarasamee A, 2004, CURR OPIN INFECT DIS, V17, P131, DOI 10.1097/00001432-200404000-00011; LEELARASAMEE A, 1989, REV INFECT DIS, V11, P413; Lucas BK, 1996, NUCLEIC ACIDS RES, V24, P1774, DOI 10.1093/nar/24.9.1774; Nelson M, 2004, J MED MICROBIOL, V53, P1177, DOI 10.1099/jmm.0.45766-0; ORLANDI R, 1989, P NATL ACAD SCI USA, V86, P3833, DOI 10.1073/pnas.86.10.3833; Plesa M, 2004, J MED MICROBIOL, V53, P389, DOI 10.1099/jmm.0.05504-0; Reckseidler SL, 2001, INFECT IMMUN, V69, P34, DOI 10.1128/IAI.69.1.34-44.2001; REFF ME, 1994, BLOOD, V83, P435; Rogul M, 1970, J BACTERIOL, V101, P827, DOI 10.1128/JB.101.3.827-835.1970; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; Trevino SR, 2006, INFECT IMMUN, V74, P1958, DOI 10.1128/IAI.74.3.1958-1961.2006; Vaughan TJ, 1998, NAT BIOTECHNOL, V16, P535, DOI 10.1038/nbt0698-535; Vernel-Pauillac F, 2006, INFECT IMMUN, V74, P4172, DOI 10.1128/IAI.00447-06; WALLS MA, 1993, NUCLEIC ACIDS RES, V21, P2921, DOI 10.1093/nar/21.12.2921; Werner RG, 1998, ARZNEIMITTEL-FORSCH, V48, P870; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; WOODWARD MP, 1985, J IMMUNOL METHODS, V78, P143, DOI 10.1016/0022-1759(85)90337-0; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Zhang HW, 1998, INFECT IMMUN, V66, P5196, DOI 10.1128/IAI.66.11.5196-5201.1998; Zhang SM, 2011, CLIN VACCINE IMMUNOL, V18, P825, DOI 10.1128/CVI.00533-10; Zou NX, 2008, HYBRIDOMA, V27, P231, DOI 10.1089/hyb.2008.0012	44	77	82	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19867	10.1371/journal.pone.0019867	http://dx.doi.org/10.1371/journal.pone.0019867			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573027	Green Published, gold, Green Submitted			2022-12-27	WOS:000290386800039
J	da Silva, JM; dos Santos, A; Cunha, MR; Costa, FO; Creer, S; Carvalho, GR				da Silva, Joana Matzen; dos Santos, Antonina; Cunha, Marina R.; Costa, Filipe O.; Creer, Simon; Carvalho, Gary R.			Multigene Molecular Systematics Confirm Species Status of Morphologically Convergent Pagurus Hermit Crabs	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; MITOCHONDRIAL 16S; DNA-SEQUENCES; DECAPODA; CRUSTACEA; PHYLOGENY; ANOMURA; POPULATIONS; BRACHYURA; EVOLUTION	Introduction: In spite of contemporary morphological taxonomy appraisals, apparent high morphological similarity raises uncertainty about the species status of certain Pagurus hermit crabs. This is exemplified between two European species, Pagurus excavatus (Herbst, 1791) and Pagurus alatus (Fabricius 1775), whose species status is still difficult to resolve using morphological criteria alone. Methodology/Principal Findings: To address such ambiguities, we used combinations of Maximum Likelihood (ML) and Bayesian Inference (BI) methods to delineate species boundaries of P. alatus and P. excavatus and formulate an intermediate Pagurus phylogenetic hypothesis, based upon single and concatenated mitochondrial (cytochrome oxidase I [COI]) and nuclear (16S and 28s ribosomal RNA) gene partitions. The molecular data supported the species status of P. excavatus and P. alatus and also clearly resolved two divergent clades within hermit crabs from the Northeast Atlantic Ocean and the Mediterranean Sea. Conclusions/Significance: Despite the abundance and prominent ecological role of hermit crabs, Pagurus, in North East Atlantic Ocean and Mediterranean Sea ecosystems, many important aspects of their taxonomy, biology, systematics and evolution remain poorly explored. The topologies presented here should be regarded as hypotheses that can be incorporated into the robust and integrated understanding of the systematic relationships within and between species of the genus Pagurus inhabiting the Northeast Atlantic Ocean and the Mediterranean Sea.	[da Silva, Joana Matzen; Creer, Simon; Carvalho, Gary R.] Bangor Univ, Mol Ecol & Fisheries Genet Lab, Sch Biol Sci, Environm Ctr Wales, Bangor, Gwynedd, Wales; [da Silva, Joana Matzen; Cunha, Marina R.] Univ Aveiro, Dept Biol, Ctr Estudos Ambiente & Mar, P-3800 Aveiro, Portugal; [dos Santos, Antonina] L IPIMAR, Inst Nacl Recursos Biol, Lisbon, Portugal; [Costa, Filipe O.] Univ Minho, Dept Biol, Ctr Biol Mol Ambiental CBMA, Braga, Portugal	Bangor University; Universidade de Aveiro; Portuguese Institute of Sea & Fisheries Research (IPIMAR); Universidade do Minho	da Silva, JM (corresponding author), Bangor Univ, Mol Ecol & Fisheries Genet Lab, Sch Biol Sci, Environm Ctr Wales, Bangor, Gwynedd, Wales.	joanamatzen@yahoo.com; g.r.carvalho@bangor.ac.uk	Costa, Ana/HDL-9297-2022; Costa, Filipe/GSD-2439-2022; Cunha, Marina R/B-7644-2008; Costa, Ana Cristina M R/L-8023-2013; Dos Santos, Antonina/B-9055-2011; Costa, Ana Cristina de Matos Ricardo/H-3775-2019; Costa, Filipe/B-5890-2009; Costa, Filipe/M-9623-2019	Costa, Filipe/0000-0001-5398-3942; Cunha, Marina R/0000-0001-8833-6980; Costa, Ana Cristina M R/0000-0002-0258-3460; Dos Santos, Antonina/0000-0002-2238-9315; Costa, Ana Cristina de Matos Ricardo/0000-0002-0258-3460; Costa, Filipe/0000-0001-5398-3942; 	Fundacao para a Ciencia e Tecnologia (Portugal) [SFRH/BD/25568/2006]; European Centre for Arctic Environmental Research [ARCFAC-026129-2008-21]; LusoMarBol FCT [PTDC/MAR/69892/2006]	Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); European Centre for Arctic Environmental Research; LusoMarBol FCT	The Fundacao para a Ciencia e Tecnologia (Portugal) provided a doctoral fellowship (SFRH/BD/25568/2006) to Joana Matzen da Silva. This research was partially supported by the European Centre for Arctic Environmental Research ARCFAC-026129-2008-21 and LusoMarBol FCT research grant PTDC/MAR/69892/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Appel M, 2009, ANIM BEHAV, V78, P1373, DOI 10.1016/j.anbehav.2009.09.008; Avise JC, 1997, P NATL ACAD SCI USA, V94, P7748, DOI 10.1073/pnas.94.15.7748; Brian JV, 2006, J EXP MAR BIOL ECOL, V329, P47, DOI 10.1016/j.jembe.2005.08.002; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; Cruickshank Robert H., 2002, Systematic and Applied Acarology, V7, P3; Cuesta JA, 1998, J NAT HIST, V32, P1499, DOI 10.1080/00222939800771031; CUNNINGHAM CW, 1992, NATURE, V355, P539, DOI 10.1038/355539a0; da Silva JM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028233, 10.1371/journal.pone.0019449]; DACOZ CD, 2001, ARQUIPELAGO A, V18, P61; DACOZ CD, 1999, INVENTAIRE DISTRIBUT; De Grave S, 2009, RAFFLES B ZOOL, P1; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ellis JR, 2000, ESTUAR COAST SHELF S, V51, P299, DOI 10.1006/ecss.2000.0677; ELWOOD RW, 1985, ANIM BEHAV, V33, P620, DOI 10.1016/S0003-3472(85)80086-5; ELWOOD RW, 1981, ANIM BEHAV, V29, P1239, DOI 10.1016/S0003-3472(81)80075-9; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Groeneveld JC, 2007, MOL PHYLOGENET EVOL, V45, P102, DOI 10.1016/j.ympev.2007.06.002; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Harrison JS, 2004, MOL PHYLOGENET EVOL, V30, P743, DOI 10.1016/S1055-7903(03)00250-1; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hiller A, 2006, MOL PHYLOGENET EVOL, V40, P547, DOI 10.1016/j.ympev.2006.03.030; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; INGLE RW, 1985, J NAT HIST, V19, P745, DOI 10.1080/00222938500770461; JACKSON NW, 1989, ANIM BEHAV, V37, P529, DOI 10.1016/0003-3472(89)90032-8; JACKSON NW, 1989, ANIM BEHAV, V38, P951, DOI 10.1016/S0003-3472(89)80136-8; JAGT JWM, 2003, REV MEXICANA CIENCIA, V23, P364; KELLOGG CW, 1976, J EXP MAR BIOL ECOL, V22, P101, DOI 10.1016/0022-0981(76)90112-X; Kumar S, 1996, GENETICS, V143, P537; LANCASTER I, 1988, Field Studies, V7, P189; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; Malay MCD, 2010, EVOLUTION, V64, P634, DOI 10.1111/j.1558-5646.2009.00848.x; Mantelatto FLM, 2006, ZOOSYSTEMA, V28, P495; Mantelatto FL, 2009, ZOOTAXA, P20, DOI 10.11646/zootaxa.2133.1.2; Mathews LM, 2009, MOL PHYLOGENET EVOL, V50, P268, DOI 10.1016/j.ympev.2008.10.026; Mathews LM, 2002, MOL ECOL, V11, P1427, DOI 10.1046/j.1365-294X.2002.01539.x; MCLAUGHLIN PA, 1988, J CRUSTACEAN BIOL, V8, P262, DOI 10.2307/1548319; McLaughlin PA, 1997, CONTRIB ZOOL, V67, P79, DOI 10.1163/18759866-06702001; McLaughlin PA, 2007, J CRUSTACEAN BIOL, V27, P97, DOI 10.1651/S-2675.1; McLaughlin PA, 2010, RAFFLES B ZOOL, P5; McLaughlin Patsy A., 2003, Memoirs of Museum Victoria, V60, P111; NEIL SJ, 1985, J EXP MAR BIOL ECOL, V94, P99, DOI 10.1016/0022-0981(85)90052-8; Palumbi Stephen R., 1991, Molecular Marine Biology and Biotechnology, V1, P27; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; Radulovici AE, 2009, MOL ECOL RESOUR, V9, P181, DOI 10.1111/j.1755-0998.2009.02643.x; Rivera M Jorge, 2006, Rev. biol. mar. oceanogr., V41, P239; Scelzo MA, 2010, ZOOL STUD, V49, P421; Schubart CD, 2000, CRUSTACEAN ISS, V12, P817; SCHUBART CD, 2005, NAUPLIUS, V12, P99; Schubart Christoph D., 2009, Crustacean Issues, V18, P47; Schwentner M, 2009, MOL PHYLOGENET EVOL, V53, P716, DOI 10.1016/j.ympev.2009.07.021; Shih HT, 2007, ZOOL SCI, V24, P57, DOI 10.2108/zsj.24.57; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Spivak ED, 2003, J CRUSTACEAN BIOL, V23, P212, DOI 10.1651/0278-0372(2003)023[0212:SSIQAM]2.0.CO;2; STAMATAKIS A, 2008, RAXML; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TAYLOR PR, 1982, J EXP MAR BIOL ECOL, V57, P229, DOI 10.1016/0022-0981(82)90194-0; TAYLOR PR, 1981, J EXP MAR BIOL ECOL, V52, P205, DOI 10.1016/0022-0981(81)90037-X; von Rintelen K, 2007, MOL PHYLOGENET EVOL, V45, P1033, DOI 10.1016/j.ympev.2007.07.002; Whiting MF, 2002, ZOOL SCR, V31, P93, DOI 10.1046/j.0300-3256.2001.00095.x; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Yang ZH, 2000, GENETICS, V155, P431; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yang ZH, 1999, J MOL EVOL, V48, P274, DOI 10.1007/PL00006470; Young AM, 2002, MAR BIOL, V140, P1059, DOI 10.1007/s00227-002-0780-2; [Заславская Н.И. Zaslavskaya N.I.], 2009, [Зоология беспозвоночных, Invertebrate Zoology, Zoologiya bespozvonochnykh], V6, P147	71	147	151	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28233	10.1371/journal.pone.0028233	http://dx.doi.org/10.1371/journal.pone.0028233			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	21589909	Green Published, gold, Green Submitted			2022-12-27	WOS:000298365700024
J	Dalmasso, G; Hang, TTN; Yan, YT; Laroui, H; Charania, MA; Ayyadurai, S; Sitaraman, SV; Merlin, D				Dalmasso, Guillaume; Hang Thi Thu Nguyen; Yan, Yutao; Laroui, Hamed; Charania, Moiz A.; Ayyadurai, Saravanan; Sitaraman, Shanthi V.; Merlin, Didier			Microbiota Modulate Host Gene Expression via MicroRNAs	PLOS ONE			English	Article								Microbiota are known to modulate host gene expression, yet the underlying molecular mechanisms remain elusive. MicroRNAs (miRNAs) are importantly implicated in many cellular functions by post-transcriptionally regulating gene expression via binding to the 3'-untranslated regions (3'-UTRs) of the target mRNAs. However, a role for miRNAs in microbiota-host interactions remains unknown. Here we investigated if miRNAs are involved in microbiota-mediated regulation of host gene expression. Germ-free mice were colonized with the microbiota from pathogen-free mice. Comparative profiling of miRNA expression using miRNA arrays revealed one and eight miRNAs that were differently expressed in the ileum and the colon, respectively, of colonized mice relative to germ-free mice. A computational approach was then employed to predict genes that were potentially targeted by the dysregulated miRNAs during colonization. Overlapping the miRNA potential targets with the microbiota-induced dysregulated genes detected by a DNA microarray performed in parallel revealed several host genes that were regulated by miRNAs in response to colonization. Among them, Abcc3 was identified as a highly potential miRNA target during colonization. Using the murine macrophage RAW 264.7 cell line, we demonstrated that mmu-miR-665, which was dysregulated during colonization, down-regulated Abcc3 expression by directly targeting the Abcc3 3'-UTR. In conclusion, our study demonstrates that microbiota modulate host microRNA expression, which could in turn regulate host gene expression.	[Dalmasso, Guillaume; Hang Thi Thu Nguyen; Yan, Yutao; Laroui, Hamed; Charania, Moiz A.; Ayyadurai, Saravanan; Sitaraman, Shanthi V.; Merlin, Didier] Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA; [Merlin, Didier] Vet Affairs Med Ctr, Decatur, GA 30033 USA	Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Dalmasso, G (corresponding author), Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA.	gdalmas@emory.edu	Dalmasso, Guillaume/N-2443-2018; Nguyen, Hang/N-2441-2018	Dalmasso, Guillaume/0000-0002-3433-870X; Nguyen, Hang/0000-0001-7431-5126	National Institutes of Health of Diabetes and Digestive and Kidney Diseases [R24-DK-064399, RO1-DK-071594, RO1-DK-55850]; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055850, R01DK071594, R24DK064399] Funding Source: NIH RePORTER	National Institutes of Health of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health of Diabetes and Digestive and Kidney Diseases [R24-DK-064399 center grant, RO1-DK-071594 to D.M., RO1-DK-55850 to S.V.S.]; and a research fellowship award from the Crohn's and Colitis Foundation of America [to G.D.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BUSSEY KJ, 2003, GENOME BIOL, V4, pNIL81; Chen J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn387; Dalmasso G, 2010, DIFFERENTIATION, V80, P147, DOI 10.1016/j.diff.2010.06.005; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; WHITT DD, 1980, INFECT IMMUN, V29, P144, DOI 10.1128/IAI.29.1.144-151.1980; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	17	168	182	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19293	10.1371/journal.pone.0019293	http://dx.doi.org/10.1371/journal.pone.0019293			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21886824	Green Published, Green Submitted, gold			2022-12-27	WOS:000290024700127
J	Kim, H; Lee, S; Jang, Y				Kim, Hyojoong; Lee, Seunghwan; Jang, Yikweon			Macroevolutionary Patterns in the Aphidini Aphids (Hemiptera: Aphididae): Diversification, Host Association, and Biogeographic Origins	PLOS ONE			English	Article							MISSING DATA; MITOCHONDRIAL-DNA; INCOMPLETE TAXA; PHYLOGENETIC-RELATIONSHIPS; HISTORICAL BIOGEOGRAPHY; MOLECULAR PHYLOGENIES; NUCLEAR EF1-ALPHA; FLOWERING PLANTS; DIVERGENCE TIME; RAPID RADIATION	Background: Due to its biogeographic origins and rapid diversification, understanding the tribe Aphidini is key to understanding aphid evolution. Major questions about aphid evolution include origins of host alternation as well as age and patterns of diversification in relation to host plants. To address these questions, we reconstructed the phylogeny of the Aphidini which contains Aphis, the most diverse genus in the family. We used a combined dataset of one nuclear and four mitochondrial DNA regions. A molecular dating approach, calibrated with fossil records, was used to estimate divergence times of these taxa. Principal Findings: Most generic divergences in Aphidini occurred in the Middle Tertiary, and species-level divergences occurred between the Middle and Late Tertiary. The ancestral state of host use for Aphidini was equivocal with respect to three states: monoecy on trees, heteroecy, and monoecy on grasses. The ancestral state of Rhopalosiphina likely included both heteroecy and monoecy, whereas that of Aphidina was most likely monoecy. The divergence times of aphid lineages at the generic or subgeneric levels are close to those of their primary hosts. The species-level divergences in aphids are consistent with the diversification of the secondary hosts, as a few examples suggest. The biogeographic origin of Aphidini as a whole was equivocal, but the major lineages within Aphidina likely separated into Nearctic, Western Palearctic, and Eastern Palearctic regions. Conclusions: Most generic divergences in Aphidini occurred in the Middle Tertiary when primary hosts, mainly in the Rosaceae, were diverging, whereas species-level divergences were contemporaneous with diversification of the secondary hosts such as Poaceae in the Middle to Late Tertiary. Our results suggest that evolution of host alternation within Aphidini may have occurred during the Middle Tertiary (Oligocene) when the secondary hosts emerged.	[Kim, Hyojoong; Jang, Yikweon] Ewha Womans Univ, Div EcoSci, Seoul, South Korea; [Kim, Hyojoong; Jang, Yikweon] Ewha Womans Univ, Res Inst EcoSci, Seoul, South Korea; [Lee, Seunghwan] Seoul Natl Univ, Dept Agr Biotechnol, Res Inst Agr & Life Sci, Seoul, South Korea	Ewha Womans University; Ewha Womans University; Seoul National University (SNU)	Kim, H (corresponding author), Ewha Womans Univ, Div EcoSci, Seoul, South Korea.	seung@snu.ac.kr; jangy@ewha.ac.kr	Kim, Hyojoong/AAT-8734-2021; Lee, Seunghwan/E-4992-2011	Kim, Hyojoong/0000-0002-1706-2991	Ewha Womans University	Ewha Womans University	The paper was supported by RP-Grant 2010 of Ewha Womans University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], APHIDS WORLDS HERBAC; Blackman R. L., 2000, Aphids on the world's crops: an identification and information guide.; Blackman R.L., 2021, APHIDS WORLDS PLANTS; Bouchenak-Khelladi Y, 2008, MOL PHYLOGENET EVOL, V47, P488, DOI 10.1016/j.ympev.2008.01.035; Bremer B, 2009, INT J PLANT SCI, V170, P766, DOI 10.1086/599077; Bremer K, 2004, SYST BIOL, V53, P496, DOI 10.1080/10635150490445913; Carletto J, 2009, SYST ENTOMOL, V34, P307, DOI 10.1111/j.1365-3113.2008.00458.x; CASTRESANA J, 2002, GBLOCLKS SELECTION C; Clark MA, 1999, MOL BIOL EVOL, V16, P1586, DOI 10.1093/oxfordjournals.molbev.a026071; Coeur d'Acier A, 2007, MOL PHYLOGENET EVOL, V42, P598, DOI 10.1016/j.ympev.2006.10.006; Dixon AFG, 1987, APHIDS THEIR BIOL NA, P197; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dunn KA, 2003, MOL PHYLOGENET EVOL, V27, P259, DOI 10.1016/S1055-7903(02)00442-6; Farrell BD, 1998, BIOL J LINN SOC, V63, P553, DOI 10.1006/bijl.1997.0207; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; FAVRET C, 2011, APHID SPECIES FILE V; Felsenstein J, 1984, DNAML PHYLIP 2 6; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foottit RG, 2008, MOL ECOL RESOUR, V8, P1189, DOI 10.1111/j.1755-0998.2008.02297.x; Ford VS, 2007, SYST BOT, V32, P348, DOI 10.1600/036364407781179725; Fulton TL, 2006, MOL PHYLOGENET EVOL, V41, P165, DOI 10.1016/j.ympev.2006.05.025; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; Gradstein FM, 2004, LETHAIA, V37, P175, DOI 10.1080/00241160410006483; Harry M, 1998, MOL PHYLOGENET EVOL, V9, P542, DOI 10.1006/mpev.1998.0508; Havill NP, 2007, MOL PHYLOGENET EVOL, V44, P357, DOI 10.1016/j.ympev.2006.11.008; Havill NP, 2007, ANNU REV ENTOMOL, V52, P325, DOI 10.1146/annurev.ento.52.110405.091303; Heie O.E., 1987, World Crop Pests, V2A, P367; Heie OE, 1992, APHIDOIDEA HEMIPTE 1; Heie OE, 1994, APHIDOIDEA HEMIPTE 2; HEIE OE, 1986, APHIDOIDEA HEMIPTERA, V3; Heie Ole E., 1994, P409; HOLMAN J, 1987, ACTA ENTOMOL BOHEMOS, V84, P353; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; JERMIIN LS, 1994, J MOL EVOL, V38, P282, DOI 10.1007/BF00176090; Jian SG, 2008, SYST BIOL, V57, P38, DOI 10.1080/10635150801888871; Kim H, 2008, SYST ENTOMOL, V33, P711, DOI 10.1111/J.1365-3113.2008.00440.x; Kim H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011608; Kim H, 2010, ANN ENTOMOL SOC AM, V103, P532, DOI 10.1603/AN09166; Kim KJ, 2005, MOL BIOL EVOL, V22, P1783, DOI 10.1093/molbev/msi174; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; KUNDU R, 1995, J ANIM ECOL, V64, P245, DOI 10.2307/5759; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Lee S, 2006, EC INSECTS KOREA S35; Lee S, 2002, ILLUSTRATED CATALO 1; Lopez-Vaamonde C, 2006, J EVOLUTION BIOL, V19, P1314, DOI 10.1111/j.1420-9101.2005.01070.x; Lopez-Vaamonde C, 2001, MOL PHYLOGENET EVOL, V21, P55, DOI 10.1006/mpev.2001.0993; Lopez-Vaamonde C, 2009, MOL PHYLOGENET EVOL, V52, P715, DOI 10.1016/j.ympev.2009.05.028; Mackenzie A, 1996, EVOLUTION, V50, P155, DOI 10.1111/j.1558-5646.1996.tb04482.x; MACKENZIE A, 1990, AM NAT, V136, P132, DOI 10.1086/285086; Maddison D.R., 2007, MESQUITE 2 MODULAR S; Martinez-Torres D, 2001, MOL PHYLOGENET EVOL, V20, P437, DOI 10.1006/mpev.2001.0983; MITTER C, 1991, TRENDS ECOL EVOL, V6, P290, DOI 10.1016/0169-5347(91)90007-K; MORAN NA, 1988, AM NAT, V132, P681, DOI 10.1086/284882; MORAN NA, 1993, P ROY SOC B-BIOL SCI, V253, P167, DOI 10.1098/rspb.1993.0098; MORAN NA, 1989, SCIENCE, V245, P173, DOI 10.1126/science.245.4914.173; MORAN NA, 1992, ANNU REV ENTOMOL, V37, P321, DOI 10.1146/annurev.en.37.010192.001541; MORAN NA, 1990, AM NAT, V136, P135, DOI 10.1086/285087; Normark BB, 1996, EVOLUTION, V50, P734, DOI 10.1111/j.1558-5646.1996.tb03883.x; Nylander JAA, 2004, MRMODELTEST 2 0; Ortiz-Rivas B, 2010, MOL PHYLOGENET EVOL, V55, P305, DOI 10.1016/j.ympev.2009.12.005; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Pagel M, 2007, BAYESTRAITS IN PRESS; Palumbi Stephen R., 1996, P205; Parham JF, 2008, AM NAT, V171, P132, DOI 10.1086/524198; Percy DM, 2004, SYST BIOL, V53, P120, DOI 10.1080/10635150490264996; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Powell G, 2006, ANNU REV ENTOMOL, V51, P309, DOI 10.1146/annurev.ento.51.110104.151107; Qiao Gexia, 2008, Zootaxa, V1746, P1; Rambaut A, 2010, FIGTREE V131; Rambaut A., 2007, TRACER V1 5; Remaudiere G., 1997, CATALOGUE APHIDIDAE; Richardson JE, 2004, PHILOS T R SOC B, V359, P1495, DOI 10.1098/rstb.2004.1537; Rutschmann F., 2005, BAYESIAN MOL DATING; Rutschmann F, 2007, SYST BIOL, V56, P591, DOI 10.1080/10635150701491156; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Simon C, 1991, MOL TECHNIQUES TAXON; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stefanovic S, 2009, SYST BOT, V34, P115, DOI 10.1600/036364409787602221; STERN DL, 1994, P ROY SOC B-BIOL SCI, V256, P203, DOI 10.1098/rspb.1994.0071; Stroyan H. L. G., 1984, Handbooks for the Identification of British Insects, Royal Entomological Society, UK, V2; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Taylor TN, 2009, PALEOBOTANY: THE BIOLOGY AND EVOLUTION OF FOSSIL PLANTS, 2ND EDITION, P1; Teulon DAJ, 1998, CURRENT STATUS NZ IN, P1; Thao ML, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-25; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Turcinaviciene J, 2006, EUR J ENTOMOL, V103, P597, DOI 10.14411/eje.2006.080; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vicentini A, 2008, GLOBAL CHANGE BIOL, V14, P2963, DOI 10.1111/j.1365-2486.2008.01688.x; von Dohlen CD, 2006, MOL PHYLOGENET EVOL, V38, P316, DOI 10.1016/j.ympev.2005.04.035; Von Dohlen CD, 2003, ANN ENTOMOL SOC AM, V96, P107, DOI 10.1603/0013-8746(2003)096[0107:PAHBON]2.0.CO;2; von Dohlen CD, 2002, MOL PHYLOGENET EVOL, V23, P257, DOI 10.1016/S1055-7903(02)00025-8; Von Dohlen CD, 2000, BIOL J LINN SOC, V71, P689, DOI 10.1006/bijl.2000.0470; Wang HC, 2009, P NATL ACAD SCI USA, V106, P3853, DOI 10.1073/pnas.0813376106; Weiblen GD, 2001, SYST BIOL, V50, P243; Wiens JJ, 2006, J BIOMED INFORM, V39, P34, DOI 10.1016/j.jbi.2005.04.001; Wiens JJ, 2005, SYST BIOL, V54, P731, DOI 10.1080/10635150500234583; Wiens JJ, 2003, SYST BIOL, V52, P528, DOI 10.1080/10635150390218330; Wiens JJ, 2003, J VERTEBR PALEONTOL, V23, P297, DOI 10.1671/0272-4634(2003)023[0297:ITICAP]2.0.CO;2; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Wojciechowski W., 1992, STUDIES SYSTEMATIC S; Yamamoto S, 2007, MOL PHYLOGENET EVOL, V44, P711, DOI 10.1016/j.ympev.2006.12.027; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZX, 2010, ENTOMOL SCI, V13, P351, DOI 10.1111/j.1479-8298.2010.00391.x; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	112	77	82	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24749	10.1371/journal.pone.0024749	http://dx.doi.org/10.1371/journal.pone.0024749			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21573027	gold, Green Published, Green Submitted			2022-12-27	WOS:000295041700055
J	Shieh, JC; Schaar, BT; Srinivasan, K; Brodsky, FM; McConnell, SK				Shieh, Jennifer C.; Schaar, Bruce T.; Srinivasan, Karpagam; Brodsky, Frances M.; McConnell, Susan K.			Endocytosis Regulates Cell Soma Translocation and the Distribution of Adhesion Proteins in Migrating Neurons	PLOS ONE			English	Article							ALPHA-3-BETA-1 INTEGRIN; MEDIATED ENDOCYTOSIS; RADIAL MIGRATION; FOCAL ADHESIONS; MYOSIN-II; DYNAMIN; MEMBRANE; GROWTH; BETA-1-INTEGRINS; CONTRACTION	Newborn neurons migrate from their birthplace to their final location to form a properly functioning nervous system. During these movements, young neurons must attach and subsequently detach from their substrate to facilitate migration, but little is known about the mechanisms cells use to release their attachments. We show that the machinery for clathrin-mediated endocytosis is positioned to regulate the distribution of adhesion proteins in a subcellular region just proximal to the neuronal cell body. Inhibiting clathrin or dynamin function impedes the movement of migrating neurons both in vitro and in vivo. Inhibiting dynamin function in vitro shifts the distribution of adhesion proteins to the rear of the cell. These results suggest that endocytosis may play a critical role in regulating substrate detachment to enable cell body translocation in migrating neurons.	[Shieh, Jennifer C.; Srinivasan, Karpagam; McConnell, Susan K.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Shieh, Jennifer C.] Stanford Univ, Program Neurosci, Stanford, CA 94305 USA; [Schaar, Bruce T.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Brodsky, Frances M.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Brodsky, Frances M.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Brodsky, Frances M.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Stanford University; Stanford University; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Shieh, JC (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	suemcc@stanford.edu		Brodsky, Frances/0000-0002-1334-9258	National Institutes of Health (NIH) [MH51864, GM038093]; National Defense Science and Engineering Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051864, R37MH051864] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Defense Science and Engineering Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funded by National Institutes of Health (NIH) MH51864 (SKM) and NIH GM038093 (FMB). JCS was supported by a National Defense Science and Engineering Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beadle C, 2008, MOL BIOL CELL, V19, P3357, DOI 10.1091/mbc.E08-03-0319; Bellion A, 2005, J NEUROSCI, V25, P5691, DOI 10.1523/JNEUROSCI.1030-05.2005; Belvindrah R, 2007, J NEUROSCI, V27, P13854, DOI 10.1523/JNEUROSCI.4494-07.2007; Belvindrah R, 2007, J NEUROSCI, V27, P2704, DOI 10.1523/JNEUROSCI.2991-06.2007; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bonanomi D, 2008, J CELL SCI, V121, P3757, DOI 10.1242/jcs.033803; Bretscher MS, 2008, J CELL SCI, V121, P2625, DOI 10.1242/jcs.031120; BRETSCHER MS, 1976, NATURE, V260, P21, DOI 10.1038/260021a0; Bretscher MS, 1996, CELL, V85, P465, DOI 10.1016/S0092-8674(00)81246-5; Bretscher MS, 1996, CELL, V87, P601, DOI 10.1016/S0092-8674(00)81380-X; BRODSKY FM, 1983, J MOL BIOL, V167, P197, DOI 10.1016/S0022-2836(83)80041-2; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Chao WT, 2009, FEBS LETT, V583, P1337, DOI 10.1016/j.febslet.2009.03.037; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; DAVIES PJA, 1984, DIABETES CARE, V7, P35; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Doetsch F, 1997, J NEUROSCI, V17, P5046; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; EDMONDSON JC, 1988, J CELL BIOL, V106, P505, DOI 10.1083/jcb.106.2.505; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; Fatemi SH, 2009, SCHIZOPHRENIA BULL, V35, P528, DOI 10.1093/schbul/sbn187; Fletcher SJ, 2010, TRENDS CELL BIOL, V20, P71, DOI 10.1016/j.tcb.2009.11.006; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Friedl P, 2000, CELL MOL LIFE SCI, V57, P41, DOI 10.1007/s000180050498; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; GASSER UE, 1990, P NATL ACAD SCI USA, V87, P4543, DOI 10.1073/pnas.87.12.4543; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; GREGORY WA, 1988, J NEUROSCI, V8, P1728; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hawthorne AL, 2010, J NEUROSCI, V30, P420, DOI 10.1523/JNEUROSCI.2333-09.2010; He M, 2010, J NEUROSCI, V30, P10885, DOI 10.1523/JNEUROSCI.0240-10.2010; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hines JH, 2010, NAT NEUROSCI, V13, P829, DOI 10.1038/nn.2554; Homayouni R, 1999, J NEUROSCI, V19, P7507, DOI 10.1523/JNEUROSCI.19-17-07507.1999; Ji L, 2008, NAT CELL BIOL, V10, P1393, DOI 10.1038/ncb1797; Jovic M, 2007, J CELL SCI, V120, P802, DOI 10.1242/jcs.03383; Kamiguchi H, 2003, MOL NEUROBIOL, V28, P219, DOI 10.1385/MN:28:3:219; Kamiguchi H, 1998, J NEUROSCI, V18, P5311, DOI 10.1523/JNEUROSCI.18-14-05311.1998; Kaverina I, 2002, INT J BIOCHEM CELL B, V34, P746, DOI 10.1016/S1357-2725(01)00171-6; Kawauchi T, 2010, NEURON, V67, P588, DOI 10.1016/j.neuron.2010.07.007; Kirfel G, 2004, EUR J CELL BIOL, V83, P717, DOI 10.1078/0171-9335-00421; Kruchten AE, 2006, J CELL SCI, V119, P1683, DOI 10.1242/jcs.02963; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Le Roy C, 2005, DEV CELL, V9, P167, DOI 10.1016/j.devcel.2005.07.007; Levecque C, 2009, AM J PHYSIOL-CELL PH, V297, pC160, DOI 10.1152/ajpcell.00630.2008; Liu SH, 1998, J CELL BIOL, V140, P1023, DOI 10.1083/jcb.140.5.1023; Marin O, 2006, TRENDS NEUROSCI, V29, P655, DOI 10.1016/j.tins.2006.10.001; Martini FJ, 2010, J NEUROSCI, V30, P8660, DOI 10.1523/JNEUROSCI.1962-10.2010; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McManus MF, 2005, J CHILD NEUROL, V20, P280, DOI 10.1177/08830738050200040301; Moskowitz HS, 2003, MOL BIOL CELL, V14, P4437, DOI 10.1091/mbc.e03-04-0230; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; NANDI PK, 1981, BIOCHEMISTRY-US, V20, P6706, DOI 10.1021/bi00526a028; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; OROURKE NA, 1995, DEVELOPMENT, V121, P2165; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Palecek SP, 1996, J CELL SCI, V109, P941; Panicker AK, 2006, EXP CELL RES, V312, P299, DOI 10.1016/j.yexcr.2005.10.031; Paracchini S, 2006, HUM MOL GENET, V15, P1659, DOI 10.1093/hmg/ddl089; Pellinen T, 2006, J CELL SCI, V119, P3723, DOI 10.1242/jcs.03216; PHONPHOK Y, 1991, FEBS LETT, V281, P188, DOI 10.1016/0014-5793(91)80390-O; Pierini LM, 2000, BLOOD, V95, P2471; Quan A, 2007, MOL PHARMACOL, V72, P1425, DOI 10.1124/mol.107.034207; Rid R, 2005, CELL MOTIL CYTOSKEL, V61, P161, DOI 10.1002/cm.20076; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sanada K, 2004, NEURON, V42, P197, DOI 10.1016/S0896-6273(04)00222-3; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Schmid RS, 2004, DEVELOPMENT, V131, P6023, DOI 10.1242/dev.01532; Schneider IC, 2009, MOL BIOL CELL, V20, P3155, DOI 10.1091/mbc.E09-03-0219; Shan YL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000116; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shastry BS, 2007, J HUM GENET, V52, P104, DOI 10.1007/s10038-006-0088-z; Smilenov LB, 1999, SCIENCE, V286, P1172, DOI 10.1126/science.286.5442.1172; Solecki DJ, 2009, NEURON, V63, P63, DOI 10.1016/j.neuron.2009.05.028; Strachan LR, 2004, J CELL BIOL, V167, P545, DOI 10.1083/jcb.200405024; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Teckchandani A, 2009, J CELL BIOL, V186, P98, DOI 10.1083/jcb.200812160; Thelen K, 2002, J NEUROSCI, V22, P4918, DOI 10.1523/JNEUROSCI.22-12-04918.2002; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Vallee RB, 2009, TRENDS CELL BIOL, V19, P347, DOI 10.1016/j.tcb.2009.03.009; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Vicente-Manzanares M, 2005, J CELL SCI, V118, DOI 10.1242/jcs.02662; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Ward Michael E., 2004, V294, P137; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Wilson PM, 2010, J NEUROSCI, V30, P8529, DOI 10.1523/JNEUROSCI.0032-10.2010; Yuasa S, 1996, INT J DEV NEUROSCI, V14, P429, DOI 10.1016/S0736-5748(96)00021-4; Zhou PC, 2007, NEURON, V55, P53, DOI 10.1016/j.neuron.2007.05.030	105	58	61	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e17802	10.1371/journal.pone.0017802	http://dx.doi.org/10.1371/journal.pone.0017802			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21573063	Green Published, Green Submitted, gold			2022-12-27	WOS:000288809100009
J	da Silva, JM; Creer, S; dos Santos, A; Costa, AC; Cunha, MR; Costa, FO; Carvalho, GR				da Silva, Joana Matzen; Creer, Simon; dos Santos, Antonina; Costa, Ana C.; Cunha, Marina R.; Costa, Filipe O.; Carvalho, Gary R.			Systematic and Evolutionary Insights Derived from mtDNA COI Barcode Diversity in the Decapoda (Crustacea: Malacostraca)	PLOS ONE			English	Article							FRESH-WATER CRAYFISH; GENUS MACROBRACHIUM BATE; DNA BARCODES; MITOCHONDRIAL PSEUDOGENES; DEMERSAL FISH; BODY-SIZE; BIOLOGICAL IDENTIFICATIONS; MOLECULAR SYSTEMATICS; SPECIES COMPLEX; MUTATIONAL BIAS	Background: Decapods are the most recognizable of all crustaceans and comprise a dominant group of benthic invertebrates of the continental shelf and slope, including many species of economic importance. Of the 17635 morphologically described Decapoda species, only 5.4% are represented by COI barcode region sequences. It therefore remains a challenge to compile regional databases that identify and analyse the extent and patterns of decapod diversity throughout the world. Methodology/Principal Findings: We contributed 101 decapod species from the North East Atlantic, the Gulf of Cadiz and the Mediterranean Sea, of which 81 species represent novel COI records. Within the newly-generated dataset, 3.6% of the species barcodes conflicted with the assigned morphological taxonomic identification, highlighting both the apparent taxonomic ambiguity among certain groups, and the need for an accelerated and independent taxonomic approach. Using the combined COI barcode projects from the Barcode of Life Database, we provide the most comprehensive COI data set so far examined for the Order (1572 sequences of 528 species, 213 genera, and 67 families). Patterns within families show a general predicted molecular hierarchy, but the scale of divergence at each taxonomic level appears to vary extensively between families. The range values of mean K2P distance observed were: within species 0.285% to 1.375%, within genus 6.376% to 20.924% and within family 11.392% to 25.617%. Nucleotide composition varied greatly across decapods, ranging from 30.8 % to 49.4 % GC content. Conclusions/Significance: Decapod biological diversity was quantified by identifying putative cryptic species allowing a rapid assessment of taxon diversity in groups that have until now received limited morphological and systematic examination. We highlight taxonomic groups or species with unusual nucleotide composition or evolutionary rates. Such data are relevant to strategies for conservation of existing decapod biodiversity, as well as elucidating the mechanisms and constraints shaping the patterns observed.	[da Silva, Joana Matzen; Creer, Simon; Carvalho, Gary R.] Bangor Univ, Mol Ecol & Fisheries Genet Lab, Sch Biol Sci, Environm Ctr Wales, Bangor, Gwynedd, Wales; [da Silva, Joana Matzen; Cunha, Marina R.] Univ Aveiro, Ctr Estudos Ambiente & Mar, Dept Biol, P-3800 Aveiro, Portugal; [dos Santos, Antonina] Inst Nacl Recursos Biol L IPIMAR, Lisbon, Portugal; [Costa, Ana C.] Univ Acores, Dept Biol, Sao Miguel, Portugal; [Costa, Filipe O.] Univ Minho, CBMA, Dept Biol, Braga, Portugal	Bangor University; Universidade de Aveiro; Universidade dos Acores; Universidade do Minho	da Silva, JM (corresponding author), Bangor Univ, Mol Ecol & Fisheries Genet Lab, Sch Biol Sci, Environm Ctr Wales, Bangor, Gwynedd, Wales.	joanamatzen@yahoo.com	Costa, Ana/HDL-9297-2022; Costa, Filipe/GSD-2439-2022; Cunha, Marina R/B-7644-2008; Costa, Ana Cristina M R/L-8023-2013; Dos Santos, Antonina/B-9055-2011; Costa, Ana Cristina de Matos Ricardo/H-3775-2019; Costa, Filipe/B-5890-2009; Costa, Filipe/M-9623-2019	Costa, Filipe/0000-0001-5398-3942; Cunha, Marina R/0000-0001-8833-6980; Costa, Ana Cristina M R/0000-0002-0258-3460; Dos Santos, Antonina/0000-0002-2238-9315; Costa, Ana Cristina de Matos Ricardo/0000-0002-0258-3460; Costa, Filipe/0000-0001-5398-3942; 	The Fundacao para a Ciencia e Tecnologia (Portugal) [SFRH/BD/25568/2006]; HERMES; European Commission [GOCE-CT-2005-511234]; LusoMarBol FCT [PTDC/MAR/69892/2006]	The Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); HERMES(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); LusoMarBol FCT	The Fundacao para a Ciencia e Tecnologia (Portugal) provided a doctoral fellowship (SFRH/BD/25568/2006) to Joana Matzen da Silva. This research was partially supported by the HERMES project, EC contract GOCE-CT-2005-511234, funded by the European Commission's Sixth Framework Programme under the priority Sustainable Development, Global Change and Ecosystems and LusoMarBol FCT research grant PTDC/MAR/69892/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekhnovich AV, 2001, RUSS J ECOL+, V32, P420, DOI 10.1023/A:1012586218096; Apte S, 2007, MOL ECOL, V16, P1897, DOI 10.1111/j.1365-294X.2007.03224.x; Arif I. A., 2009, Animal Biodiversity and Conservation, V32, P9; Bachtrog D, 2006, EVOLUTION, V60, P292, DOI 10.1111/j.0014-3820.2006.tb01107.x; Baer CF, 2007, NAT REV GENET, V8, P619, DOI 10.1038/nrg2158; Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; Banerjee T, 2005, BIOSYSTEMS, V81, P11, DOI 10.1016/j.biosystems.2005.01.002; Baratti M, 2005, J EXP MAR BIOL ECOL, V315, P225, DOI 10.1016/j.jembe.2004.09.020; Barber PH, 2006, EVOLUTION, V60, P1825; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bernardi G, 1995, ANNU REV GENET, V29, P445, DOI 10.1146/annurev.ge.29.120195.002305; Bierne N, 2003, P ROY SOC B-BIOL SCI, V270, P1399, DOI 10.1098/rspb.2003.2404; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Blaxter M, 2003, NATURE, V421, P122, DOI 10.1038/421122a; Boero Ferdinando, 2010, Diversity, V2, P115; Bracken Heather D., 2009, Crustacean Issues, V18, P281; Brokeland W, 2008, ZOOL J LINN SOC-LOND, V152, P655, DOI 10.1111/j.1096-3642.2008.00362.x; Bucciarelli G, 2002, GENE, V295, P153, DOI 10.1016/S0378-1119(02)00733-3; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Calado R, 2006, SCI MAR, V70, P389, DOI 10.3989/scimar.2006.70n3389; Cartes JE, 2002, SCI MAR, V66, P209, DOI 10.3989/scimar.2002.66s2209; CARTES JE, 2007, DEEP-SEA RES, V1, P263; Casiraghi M, 2010, BRIEF BIOINFORM, V11, P440, DOI 10.1093/bib/bbq003; Chan TY, 2004, MEMOIR MUS NATL HIST, V191, P293; CHAN TY, 1991, P BIOL SOC WASH, V104, P545; CHAN TY, NEW DEEP SEA SHRIMP, P119; Chandor A, 2007, CR CHIM, V10, P756, DOI 10.1016/j.crci.2007.02.019; Chang CH, 2009, PEDOBIOLOGIA, V52, P171, DOI 10.1016/j.pedobi.2008.08.002; CHILDRESS JJ, 1990, DEEP-SEA RES, V37, P929, DOI 10.1016/0198-0149(90)90104-4; CHILDRESS JJ, 1995, TRENDS ECOL EVOL, V10, P30, DOI 10.1016/S0169-5347(00)88957-0; CINZIA V, 2006, ANTARCTIC SCI, V19, P271; Clare EL, 2008, J MOL EVOL, V66, P362, DOI 10.1007/s00239-008-9088-2; Company JB, 1998, DEEP-SEA RES PT I, V45, P1861, DOI 10.1016/S0967-0637(98)00034-X; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; Costa FO., 2007, GENOMICS SOC POLICY, V3, P29; Cuesta JA, 2000, HYDROBIOLOGIA, V436, P119, DOI 10.1023/A:1026576614590; Cuesta JA, 1998, J NAT HIST, V32, P1499, DOI 10.1080/00222939800771031; CUNNINGHAM CW, 1992, NATURE, V355, P539, DOI 10.1038/355539a0; DACOZ CD, 1999, INVENTAIRE DISTRIBUT; De Grave S, 2008, HYDROBIOLOGIA, V595, P287, DOI 10.1007/s10750-007-9024-2; de Grave Sammy, 2006, Aquatic Invasions, V1, P204; De Grave S, 2009, RAFFLES B ZOOL, P1; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Dimmock A, 2004, AQUACULT INT, V12, P435, DOI 10.1023/B:AQUI.0000042140.48340.c8; Drake JW, 2006, GENETICS, V173, P1; Drake JW, 1998, GENETICS, V148, P1667; Ebach MC, 2005, NATURE, V434, P697, DOI 10.1038/434697b; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FORTUNATO C, 1998, 4 INT CRUST C AMST; Foster PG, 1997, J MOL EVOL, V44, P282, DOI 10.1007/PL00006145; Fourment M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-1; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; FRIEDBERG EC, 1995, TRENDS BIOCHEM SCI, V20, P381, DOI 10.1016/S0968-0004(00)89082-9; Garcia Raso J.E., 1989, Miscellania Zoologica (Barcelona), V11, P113; Garcia-Castrillo Gerardo, 1995, ICES Marine Science Symposia, V199, P151; Gerstein M, 2006, SCI AM, V295, P48, DOI 10.1038/scientificamerican0806-48; Gillooly JF, 2007, ECOLOGY, V88, P1890, DOI 10.1890/06-1935.1; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gillooly JF, 2005, P NATL ACAD SCI USA, V102, P140, DOI 10.1073/pnas.0407735101; Gomez A, 2007, P ROY SOC B-BIOL SCI, V274, P199, DOI 10.1098/rspb.2006.3718; GONZALEZGORILLO JI, 2001, INVERTEBRATE REPROD, V39, P165; Gouws G, 2006, MAR FRESHWATER RES, V57, P837, DOI 10.1071/MF05248; Grabowski Michal, 2006, Aquatic Invasions, V1, P116; Gregory TR, 2005, NATURE, V434, P1067, DOI 10.1038/4341067b; Guerao G, 1997, J CRUSTACEAN BIOL, V17, P459, DOI 10.2307/1549440; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hajibabaei M, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-24; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hall S, 2009, J BIOGEOGR, V36, P2125, DOI 10.1111/j.1365-2699.2009.02153.x; Harris DJ, 2003, TRENDS ECOL EVOL, V18, P317, DOI 10.1016/S0169-5347(03)00150-2; Harrison JS, 2004, MOL PHYLOGENET EVOL, V30, P743, DOI 10.1016/S1055-7903(03)00250-1; Hassanin A, 2006, MOL PHYLOGENET EVOL, V38, P100, DOI 10.1016/j.ympev.2005.09.012; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hebert PDN, 2002, EVOLUTION, V56, P909; Herring PJ, 1998, DEEP-SEA RES PT I, V45, P2105, DOI 10.1016/S0967-0637(98)00050-8; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Holthuis L. B., 1950, Siboga Expeditie Leiden, V39a9, P1; Hultgren KM, 2008, MOL PHYLOGENET EVOL, V48, P986, DOI 10.1016/j.ympev.2008.05.004; IVANOVA NV, 2007, MOL ECOL NOTES, P1; Jones GP, 2007, OCEANOGRAPHY, V20, P100, DOI 10.5670/oceanog.2007.33; JONG G, 2004, NEW PHYTOL, V166, P101; KIRKPATRICK K, 1985, J EXP MAR BIOL ECOL, V93, P61, DOI 10.1016/0022-0981(85)90148-0; Komai T, 1999, J NAT HIST, V33, P1265, DOI 10.1080/002229399299914; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; LEVESQUE R, 2008, SPSS PROGRAMMING DAT; Liu MY, 2007, ZOOL STUD, V46, P272; MACPHERSON E, 1991, MAR ECOL PROG SER, V71, P103, DOI 10.3354/meps071103; Maki H, 2002, ANNU REV GENET, V36, P279, DOI 10.1146/annurev.genet.36.042602.094806; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; MALLET J, 2007, TRENDS ECOL EVOL, V18, P57; Marin IN, 2005, ZOOL STUD, V44, P234; MARKLE DF, 1988, CAN J ZOOL, V66, P1952, DOI 10.1139/z88-286; MARTIN AP, 1993, P NATL ACAD SCI USA, V90, P4087, DOI 10.1073/pnas.90.9.4087; MARTIN AP, 1992, NATURE, V357, P153, DOI 10.1038/357153a0; Martin J.W., 2001, UPDATED CLASSIFICATI, VVolume 39, P1; Martin JW, 2009, DECAPOD CRUSTACEAN P; Mashiko K, 2000, J CRUSTACEAN BIOL, V20, P118, DOI 10.1651/0278-0372(2000)020[0118:DOPWDS]2.0.CO;2; Mathews LM, 2007, MAR BIOL, V152, P645, DOI 10.1007/s00227-007-0718-9; Mathews LM, 2009, MOL PHYLOGENET EVOL, V50, P268, DOI 10.1016/j.ympev.2008.10.026; Matz MV, 2005, PHILOS T R SOC B, V360, P1969, DOI 10.1098/rstb.2005.1728; MATZ MV, 2005, SCIENCE; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miller SE, 2007, P NATL ACAD SCI USA, V104, P4775, DOI 10.1073/pnas.0700466104; Min XJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000325; Minelli A, 2003, TRENDS ECOL EVOL, V18, P75, DOI 10.1016/S0169-5347(02)00051-4; Mooers AO, 2000, TRENDS ECOL EVOL, V15, P365, DOI 10.1016/S0169-5347(00)01934-0; Munasinghe DHN, 2003, J CRUSTACEAN BIOL, V23, P402, DOI 10.1651/0278-0372(2003)023[0402:UOMDSF]2.0.CO;2; Murphy NP, 2005, ZOOL SCR, V34, P187, DOI 10.1111/j.1463-6409.2005.00185.x; Nguyen TTT, 2002, ANIM GENET, V33, P304, DOI 10.1046/j.1365-2052.2002.00867.x; NOEL PY, 1992, CLE PRELIMINAIRE IDE, P1; OHTA T, 1992, ANNU REV ECOL SYST, V23, P263, DOI 10.1146/annurev.es.23.110192.001403; Olaso I., 1995, ICES Marine Science Symposia, V199, P209; OLIVER I, 1993, CONSERV BIOL, V7, P562, DOI 10.1046/j.1523-1739.1993.07030562.x; Ostrow D, 2007, GENETICS, V176, P1653, DOI 10.1534/genetics.107.074666; PAGE RDM, 1998, BIOL LETTERS, V1, P139; Palumbi SR, 2003, ECOL APPL, V13, pS146; Payne RW, 2009, WILEY INTERDISCIP RE, V1, P255, DOI 10.1002/wics.32; Perez-Barros P, 2008, BIOL J LINN SOC, V94, P421, DOI 10.1111/j.1095-8312.2008.00987.x; Pfeiler E, 2005, MAR BIOL, V146, P559, DOI 10.1007/s00227-004-1463-y; Polunin NVC, 2001, MAR ECOL PROG SER, V220, P13; Porter ML, 2005, MOL PHYLOGENET EVOL, V37, P355, DOI 10.1016/j.ympev.2005.06.021; Puillandre N, 2009, MOL ECOL RESOUR, V9, P1311, DOI 10.1111/j.1755-0998.2009.02576.x; Radulovici Adriana E., 2010, Diversity, V2, P450; Radulovici AE, 2009, MOL ECOL RESOUR, V9, P181, DOI 10.1111/j.1755-0998.2009.02643.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Reuschel S, 2010, MOL PHYLOGENET EVOL, V55, P765, DOI 10.1016/j.ympev.2010.03.021; Rock J, 2008, ANTARCT SCI, V20, P253, DOI 10.1017/S0954102008001120; Roe AD, 2007, MOL PHYLOGENET EVOL, V44, P325, DOI 10.1016/j.ympev.2006.12.005; Romiguier J, 2010, GENOME RES, V20, P1001, DOI 10.1101/gr.104372.109; SALMAN DS, 2006, AQUAT INVASIONS, V1, P109; Sanchez JA, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-122; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Schindel DE, 2005, NATURE, V435, P17, DOI 10.1038/435017b; SCHUBART CD, 1996, PHYLOGENY N ATLANTIC, P83; Schubart Christoph D., 2009, Crustacean Issues, V18, P47; Seibel BA, 1997, BIOL BULL, V192, P262, DOI 10.2307/1542720; Seibel BA, 2000, DEEP-SEA RES PT I, V47, P1247, DOI 10.1016/S0967-0637(99)00103-X; Semon M, 2005, HUM MOL GENET, V14, P421, DOI 10.1093/hmg/ddi038; Shih HT, 2007, ZOOL SCI, V24, P57, DOI 10.2108/zsj.24.57; Sicot FX, 2000, J MOL BIOL, V302, P811, DOI 10.1006/jmbi.2000.4505; Silliman BR, 2003, J CRUSTACEAN BIOL, V23, P876, DOI 10.1651/C-2410; Smith MA, 2008, MOL ECOL RESOUR, V8, P235, DOI 10.1111/j.1471-8286.2007.01964.x; Somero GN, 2003, COMP BIOCHEM PHYS B, V136, P577, DOI 10.1016/S1096-4959(03)00215-X; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Stevens Bradley G., 2000, Journal of Northwest Atlantic Fishery Science, V27, P77, DOI 10.2960/J.v27.a7; Summerbell RC, 2005, PHILOS T R SOC B, V360, P1897, DOI 10.1098/rstb.2005.1721; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TAYLOR AC, 1987, MAR BIOL, P521; TAYLOR WR, 1986, J THEOR BIOL, V119, P205, DOI 10.1016/S0022-5193(86)80075-3; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsang LM, 2008, MOL PHYLOGENET EVOL, V48, P359, DOI 10.1016/j.ympev.2008.04.009; TSANG LM, 2009, MOL PHYLOGENET EVOL, P1; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Williams ST, 2001, MOL BIOL EVOL, V18, P1484, DOI 10.1093/oxfordjournals.molbev.a003934; WILLIAMSON D I, 1972, Crustaceana (Leiden), V23, P282, DOI 10.1163/156854072X00174; Wilson EO, 2003, TRENDS ECOL EVOL, V18, P77, DOI 10.1016/S0169-5347(02)00040-X; Wilson EO, 2003, ISSUES SCI TECHNOL, V19, P45; Wilson EO, 2003, PALEOBIOLOGY, V29, P14, DOI 10.1666/0094-8373(2003)029<0014:OGBE>2.0.CO;2; WONG JTY, 1990, AQUACULTURE, V88, P151, DOI 10.1016/0044-8486(90)90290-4; Zaklan SD, 2002, LOW WAKE FI, V19, P751; Zaksek V, 2009, MOL ECOL, V18, P931, DOI 10.1111/j.1365-294X.2008.04061.x; ZANG AB, 2010, MOL PHYLOGENET EVOL, P1035; ZARIQUIEY-ALVAREZ R, 1968, Investigacion Pesquera (Barcelona), V32, P1	174	147	151	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19449	10.1371/journal.pone.0019449	http://dx.doi.org/10.1371/journal.pone.0019449			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589909	Green Published, Green Submitted, gold			2022-12-27	WOS:000290531100010
J	Zhou, JX; Brusch, L; Huang, S				Zhou, Joseph Xu; Brusch, Lutz; Huang, Sui			Predicting Pancreas Cell Fate Decisions and Reprogramming with a Hierarchical Multi-Attractor Model	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; ROBUST DEVELOPMENT; NETWORK MODELS; STEM-CELLS; DIFFERENTIATION; EXPRESSION; ALPHA; DIVERSIFICATION; PRECURSORS; PLASTICITY	Cell fate reprogramming, such as the generation of insulin-producing beta cells from other pancreas cells, can be achieved by external modulation of key transcription factors. However, the known gene regulatory interactions that form a complex network with multiple feedback loops make it increasingly difficult to design the cell reprogramming scheme because the linear regulatory pathways as schemes of causal influences upon cell lineages are inadequate for predicting the effect of transcriptional perturbation. However, sufficient information on regulatory networks is usually not available for detailed formal models. Here we demonstrate that by using the qualitatively described regulatory interactions as the basis for a coarse-grained dynamical ODE (ordinary differential equation) based model, it is possible to recapitulate the observed attractors of the exocrine and beta, delta, alpha endocrine cells and to predict which gene perturbation can result in desired lineage reprogramming. Our model indicates that the constraints imposed by the incompletely elucidated regulatory network architecture suffice to build a predictive model for making informed decisions in choosing the set of transcription factors that need to be modulated for fate reprogramming.	[Zhou, Joseph Xu; Brusch, Lutz] Tech Univ Dresden, Ctr Informat Serv & High Performance Comp, Dresden, Germany; [Zhou, Joseph Xu; Huang, Sui] Univ Calgary, Inst Biocomplex & Informat, Calgary, AB, Canada; [Zhou, Joseph Xu] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA	Technische Universitat Dresden; University of Calgary; University of California System; University of California Santa Barbara	Zhou, JX (corresponding author), Tech Univ Dresden, Ctr Informat Serv & High Performance Comp, Dresden, Germany.	joseph.x.zhou@gmail.com	Yu, Hanry/C-1031-2013	Yu, Hanry/0000-0002-0339-3685; Mahara, Sylvia/0000-0001-7261-1423	German Ministry for Education and Research [0315259]; National Science Foundation [PHY05-51164]	German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); National Science Foundation(National Science Foundation (NSF))	This research was partially supported by the German Ministry for Education and Research through grant no. 0315259. It was also supported in part by the National Science Foundation under Grant No. PHY05-51164. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abematsu Masahiko, 2006, Curr Stem Cell Res Ther, V1, P267, DOI 10.2174/157488806776956887; Aldana M, 2003, PERSPECTIVES AND PROBLEMS IN NONLINEAR SCIENCE, P23; Aldana M, 2007, J THEOR BIOL, V245, P433, DOI 10.1016/j.jtbi.2006.10.027; Bokes P, 2009, MATH MED BIOL, V26, P117, DOI 10.1093/imammb/dqn026; Bonifer C, 2008, SEMIN IMMUNOL, V20, P257, DOI 10.1016/j.smim.2008.05.001; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Chickarmane V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003478; Chickarmane V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000268; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Foster DV, 2009, J THEOR BIOL, V260, P589, DOI 10.1016/j.jtbi.2009.07.005; Fukuda A, 2008, DIABETES, V57, P2421, DOI 10.2337/db07-1558; Furusawa C, 2003, J THEOR BIOL, V224, P413, DOI 10.1016/S0022-5193(03)00189-9; Gittes GK, 2009, DEV BIOL, V326, P4, DOI 10.1016/j.ydbio.2008.10.024; Graf T, 2002, BLOOD, V99, P3089, DOI 10.1182/blood.V99.9.3089; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Guney MA, 2009, BIRTH DEFECTS RES C, V87, P232, DOI 10.1002/bdrc.20156; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; Higham DJ, 2001, SIAM REV, V43, P525, DOI 10.1137/S0036144500378302; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Huang S, 2001, PHARMACOGENOMICS, V2, P203, DOI 10.1517/14622416.2.3.203; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Jacquemin P, 2000, MOL CELL BIOL, V20, P4445, DOI 10.1128/MCB.20.12.4445-4454.2000; Jensen J, 2004, DEV DYNAM, V229, P176, DOI 10.1002/dvdy.10460; Jensen J, 2000, DIABETES, V49, P163, DOI 10.2337/diabetes.49.2.163; Joshi CV, 2002, CURR OPIN CELL BIOL, V14, P749, DOI 10.1016/S0955-0674(02)00392-7; Kaneko K, 1999, J THEOR BIOL, V199, P243, DOI 10.1006/jtbi.1999.0952; Kubicek S, 2004, CELL, V119, P903, DOI 10.1016/j.cell.2004.12.006; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; MacArthur BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003086; Mehta S, 2005, J HEPATO-BILIARY-PAN, V12, P208, DOI 10.1007/s00534-005-0981-4; Miyatsuka T, 2008, EXPERT OPIN THER TAR, V12, P1431, DOI [10.1517/14728222.12.11.1431, 10.1517/14728222.12.11.1431 ]; Murtaugh LC, 2007, DEVELOPMENT, V134, P427, DOI 10.1242/dev.02770; Nakajima A, 2008, J THEOR BIOL, V253, P779, DOI 10.1016/j.jtbi.2008.04.007; Offield MF, 1996, DEVELOPMENT, V122, P983; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Ptashne M, 2007, CURR BIOL, V17, pR233, DOI 10.1016/j.cub.2007.02.030; Ralston A, 2005, CLIN GENET, V68, P106, DOI 10.1111/j.1399-0004.2005.00478.x; SAVAGEAU MA, 1995, J THEOR BIOL, V176, P115, DOI 10.1006/jtbi.1995.0181; Serra R, 2004, J THEOR BIOL, V227, P149, DOI 10.1016/j.jtbi.2003.10.018; Servitja JM, 2004, DIABETOLOGIA, V47, P597, DOI 10.1007/s00125-004-1368-9; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; TINBERGEN N., 1952, QUART REV BIOL, V27, P1; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Wang J, 2010, BIOPHYS J, V99, P29, DOI 10.1016/j.bpj.2010.03.058; White P, 2008, DIABETES, V57, P654, DOI 10.2337/db07-1362; Yamanaka S, 2008, CELL PROLIFERAT, V41, P51, DOI 10.1111/j.1365-2184.2008.00493.x; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; ZHOU Q, 2008, NATURE	57	110	115	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e14752	10.1371/journal.pone.0014752	http://dx.doi.org/10.1371/journal.pone.0014752			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21589872	gold, Green Published, Green Submitted			2022-12-27	WOS:000288512400002
